PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Marshall-Pescini, S; Passalacqua, C; Valsecchi, P; Prato-Previde, E				Marshall-Pescini, S.; Passalacqua, C.; Valsecchi, P.; Prato-Previde, E.			Comment on "Differential Sensitivity to Human Communication in Dogs, Wolves, and Human Infants"	SCIENCE			English	Editorial Material							DOMESTIC DOGS	Topal et al. (Reports, 4 September 2009, p. 1269) showed that dogs, like infants but unlike wolves, make perseverative search errors that can be explained by the use of ostensive cues from the experimenter. We suggest that a simpler learning process, local enhancement, can account for errors made by dogs.	[Marshall-Pescini, S.; Passalacqua, C.; Prato-Previde, E.] Univ Milan, Dept Biomed Sci & Technol, I-20134 Milan, Italy; [Valsecchi, P.] Univ Parma, Dept Evolutionary & Funct Biol, I-43100 Parma, Italy	University of Milan; University of Parma	Marshall-Pescini, S (corresponding author), Univ Milan, Dept Biomed Sci & Technol, I-20134 Milan, Italy.	sarah.marshall@unimi.it	Fiset, Sylvain/J-5550-2019	Fiset, Sylvain/0000-0002-9173-8304; Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701				Brauer J, 2006, J COMP PSYCHOL, V120, P38, DOI 10.1037/0735-7036.120.1.38; Call J, 2003, J COMP PSYCHOL, V117, P257, DOI 10.1037/0735-7036.117.3.257; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Kaminski J, 2004, SCIENCE, V304, P1682, DOI 10.1126/science.1097859; Miklosi A, 2006, ANIM COGN, V9, P81, DOI 10.1007/s10071-005-0008-1; Miller HC, 2009, BEHAV PROCESS, V80, P109, DOI 10.1016/j.beproc.2008.09.011; Range F, 2007, CURR BIOL, V17, P868, DOI 10.1016/j.cub.2007.04.026; ROBERTS D., 1941, BULL ANIMAL BEHAVIOR [LONDON], V1, P11; Topal J, 2008, SCIENCE, V321, P1831, DOI 10.1126/science.1161437; Topal J, 2006, ANIM COGN, V9, P355, DOI 10.1007/s10071-006-0051-6; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Zentall TR, 2006, ANIM COGN, V9, P335, DOI 10.1007/s10071-006-0039-2	12	14	14	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988								10.1126/science.1187748	http://dx.doi.org/10.1126/science.1187748			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616252				2022-12-28	WOS:000279635200016
J	Fiset, S				Fiset, Sylvain			Comment on "Differential Sensitivity to Human Communication in Dogs, Wolves, and Human Infants"	SCIENCE			English	Editorial Material							CANIS-FAMILIARIS; OBJECT PERMANENCE; SEARCH BEHAVIOR	Topal et al. (Reports, 4 September 2009, p. 1269) reported that dogs' sensitivity to reading and using human signals contributes to the emergence of a spatial perseveration error (the A-not-B error) for locating objects. Here, I argue that the authors' conclusion was biased by two confounding factors: the use of an atypical A-not-B search task and an inadequate nonsocial condition as a control.	Univ Moncton, Secteur Sci Humaines, Edmundston, NB E3V 2S8, Canada	University of Moncton	Fiset, S (corresponding author), Univ Moncton, Secteur Sci Humaines, Campus Edmundston, Edmundston, NB E3V 2S8, Canada.	sylvain.fiset@umce.ca	Fiset, Sylvain/J-5550-2019	Fiset, Sylvain/0000-0002-9173-8304; Valsecchi, Paola/0000-0002-0491-9845; Marshall-Pescini, Sarah/0000-0002-5944-4701				Collier-Baker E, 2004, J COMP PSYCHOL, V118, P421, DOI 10.1037/0735-7036.118.4.421; Coppinger R., 2001, DOGS STARTLING NEW U; Fiset S, 2007, ANIM COGN, V10, P211, DOI 10.1007/s10071-006-0060-5; FRANK H, 1987, MAN WOLF ADV ISSUES, P143; GAGNON S, 1994, J COMP PSYCHOL, V108, P220, DOI 10.1037/0735-7036.108.3.220; GAGNON S, 1992, J COMP PSYCHOL, V106, P58, DOI 10.1037/0735-7036.106.1.58; GAGNON S, 1993, ANIM LEARN BEHAV, V21, P246, DOI 10.3758/BF03197989; Piaget J., 1937, CONSTRUCTION REEL CH; Range F, 2009, ANIM COGN, V12, P181, DOI 10.1007/s10071-008-0181-0; Topal J, 2009, SCIENCE, V325, P1269, DOI 10.1126/science.1176960; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028	11	14	14	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988								10.1126/science.1184045	http://dx.doi.org/10.1126/science.1184045			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616252				2022-12-28	WOS:000279635200015
J	Tsai, MC; Manor, O; Wan, Y; Mosammaparast, N; Wang, JK; Lan, F; Shi, Y; Segal, E; Chang, HY				Tsai, Miao-Chih; Manor, Ohad; Wan, Yue; Mosammaparast, Nima; Wang, Jordon K.; Lan, Fei; Shi, Yang; Segal, Eran; Chang, Howard Y.			Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes	SCIENCE			English	Article							CHROMATIN-STRUCTURE; GENE-EXPRESSION; X-CHROMOSOME; DEMETHYLATION; PROTEIN; CELLS; STATE; LSD1	Long intergenic noncoding RNAs (lincRNAs) regulate chromatin states and epigenetic inheritance. Here, we show that the lincRNA HOTAIR serves as a scaffold for at least two distinct histone modification complexes. A 5' domain of HOTAIR binds polycomb repressive complex 2 (PRC2), whereas a 3' domain of HOTAIR binds the LSD1/CoREST/REST complex. The ability to tether two distinct complexes enables RNA-mediated assembly of PRC2 and LSD1 and coordinates targeting of PRC2 and LSD1 to chromatin for coupled histone H3 lysine 27 methylation and lysine 4 demethylation. Our results suggest that lincRNAs may serve as scaffolds by providing binding surfaces to assemble select histone modification enzymes, thereby specifying the pattern of histone modifications on target genes.	[Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Tsai, Miao-Chih; Wan, Yue; Wang, Jordon K.; Chang, Howard Y.] Stanford Univ, Sch Med, Program Epithelial Biol, Stanford, CA 94305 USA; [Manor, Ohad; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, IL-76100 Rehovot, Israel; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Cambridge, MA 02138 USA; [Mosammaparast, Nima; Lan, Fei; Shi, Yang] Childrens Hosp Boston, Dept Med, Div New Born Med, Cambridge, MA 02138 USA; [Lan, Fei] Constellat Pharmaceut, Cambridge, MA 02142 USA	Howard Hughes Medical Institute; Stanford University; Stanford University; Weizmann Institute of Science; Harvard University; Harvard University; Boston Children's Hospital	Chang, HY (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	howchang@stanford.edu	jia, xu/A-8386-2016; Segal, Eran/AAF-4855-2019	Tsai, Miao-Chih/0000-0003-4471-4825; Wang, Jordon/0000-0003-1108-2534; Segal, Eran/0000-0002-6859-1164	California Institute for Regenerative Medicine [RN1-00529-1]; NIH [R01-HG004361, R01-CA118487]; Susan G. Komen Foundation; Azrieli Foundation; NSF; Agency for Science, Technology, and Research; NATIONAL CANCER INSTITUTE [R01CA118487, R01CA118750, R01CA119176] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Azrieli Foundation; NSF(National Science Foundation (NSF)); Agency for Science, Technology, and Research(Agency for Science Technology & Research (A*STAR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Microarray data are deposited in Gene Expression Omnibus (www.ncbi.nlm.nih.gov/geo/) under accession number GSE22345. We thank members of the D. Herschlag lab for assistance with RNA footprinting and X. Tan, P. Khavari, and J. Wysocka for critical reading of the manuscript. This work was supported by the California Institute for Regenerative Medicine (RN1-00529-1 to H.Y.C.), NIH (R01-HG004361 to H.Y.C. and E. S and R01-CA118487 to Y.S), the Susan G. Komen Foundation (M.-C. T.), the Azrieli Foundation (O.M.), NSF (J. K. W.), and the Agency for Science, Technology, and Research (Y.W.). E. S. is the incumbent of the Soretta and Henry Shapiro career development chair. Y.S. is co-founder and on the scientific advisory board of Constellation Pharmaceuticals. H.Y.C. is an Early Career Scientist of the Howard Hughes Medical Institute.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Di Stefano L, 2007, CURR BIOL, V17, P808, DOI 10.1016/j.cub.2007.03.068; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Lee MG, 2005, NATURE, V437, P432, DOI 10.1038/nature04021; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Lunyak VV, 2002, SCIENCE, V298, P1747, DOI 10.1126/science.1076469; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Nagano T, 2008, SCIENCE, V322, P1717, DOI 10.1126/science.1163802; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Rando OJ, 2009, ANNU REV BIOCHEM, V78, P245, DOI 10.1146/annurev.biochem.78.071107.134639; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	24	2425	2618	25	498	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 6	2010	329	5992					689	693		10.1126/science.1192002	http://dx.doi.org/10.1126/science.1192002			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616235	Green Submitted, Green Accepted			2022-12-28	WOS:000280602700041
J	Rosenbaum, S; Gruber, J				Rosenbaum, Sara; Gruber, Jonathan			Buying Health Care, the Individual Mandate, and the Constitution.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rosenbaum, Sara] George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA; [Gruber, Jonathan] MIT, Cambridge, MA 02139 USA	George Washington University; Massachusetts Institute of Technology (MIT)	Rosenbaum, S (corresponding author), George Washington Univ, Med Ctr, Dept Hlth Policy, Sch Publ Hlth & Hlth Serv, Washington, DC 20037 USA.							Balkin JM, 2010, NEW ENGL J MED, V362, P482, DOI 10.1056/NEJMp1000087	1	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					401	403		10.1056/NEJMp1005897	http://dx.doi.org/10.1056/NEJMp1005897			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	632GS	20573918				2022-12-28	WOS:000280411300001
J	Audeh, MW; Carmichael, J; Penson, RT; Friedlander, M; Powell, B; Bell-McGuinn, KM; Scott, C; Weitzel, JN; Oaknin, A; Loman, N; Lu, K; Schmutzler, RK; Matulonis, U; Wickens, M; Tutt, A				Audeh, M. William; Carmichael, James; Penson, Richard T.; Friedlander, Michael; Powell, Bethan; Bell-McGuinn, Katherine M.; Scott, Clare; Weitzel, Jeffrey N.; Oaknin, Ana; Loman, Niklas; Lu, Karen; Schmutzler, Rita K.; Matulonis, Ursula; Wickens, Mark; Tutt, Andrew			Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial	LANCET			English	Article							HOMOLOGY-DIRECTED REPAIR; MUTANT-CELLS; DNA-REPAIR; TUMORS; THERAPY; SENSITIVITY; DELETION; AZD2281; BREAKS; DEFECT	Background Olaparib is a novel, orally active poly(ADP-ribose) polymerase (PARP) inhibitor that induces synthetic lethality in homozygous BRCA-deficient cells. We aimed to assess the efficacy and safety of olaparib for treatment of advanced ovarian cancer in patients with BRCA1 or BRCA2 mutations. Methods In this international, multicentre, phase 2 study, we enrolled two sequential cohorts of women (aged >= 18 years) with confirmed genetic BRCA1 or BRCA2 mutations, and recurrent, measurable disease. The study was undertaken in 12 centres in Australia, Germany, Spain, Sweden, and the USA. The first cohort (n=33) was given continuous oral olaparib at the maximum tolerated dose of 400 mg twice daily, and the second cohort (n=24) was given continuous oral olaparib at 100 mg twice daily. The primary efficacy endpoint was objective response rate (ORR). This study is registered with ClinicalTrials.gov, number NCT00494442. Findings Patients had been given a median of three (range 1-16) previous chemotherapy regimens. ORR was 11 (33%) of 33 patients (95% CI 20-51) in the cohort assigned to olaparib 400 mg twice daily, and three (13%) of 24 (4-31) in the cohort assigned to 100 mg twice daily. In patients given olaparib 400 mg twice daily, the most frequent causally related adverse events were nausea (grade 1 or 2,14 [42%]; grade 3 or 4, two [6%]), fatigue (grade 1 or 2, ten [30%]; grade 3 or 4, one [3%]), and anaemia (grade 1 or two, five [15%1; grade 3 or 4, one [3%]). The most frequent causally related adverse events in the cohort given 100 mg twice daily were nausea (grade 1 or 2, seven [29%]; grade 3 or 4, two [8%]) and fatigue (grade 1 or 2, nine [38%]; none grade 3 or 4). Interpretation Findings from this phase 2 study provide positive proof of concept of the efficacy and tolerability of genetically targeted treatment with olaparib in BRCA-mutated advanced ovarian cancer.	[Audeh, M. William] Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USA; [Carmichael, James; Wickens, Mark] AstraZeneca, Macclesfield, Cheshire, England; [Penson, Richard T.; Matulonis, Ursula] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Penson, Richard T.; Matulonis, Ursula] Dana Farber Canc Inst, Boston, MA 02115 USA; [Friedlander, Michael] Prince Wales Canc Ctr, Sydney, NSW, Australia; [Powell, Bethan] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Bell-McGuinn, Katherine M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Scott, Clare] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Scott, Clare] Royal Melbourne Hosp, Melbourne, Vic, Australia; [Weitzel, Jeffrey N.] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Oaknin, Ana] Hosp Gen Valle Hebron, Barcelona, Spain; [Loman, Niklas] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Lu, Karen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Schmutzler, Rita K.] Univ Cologne, Ctr Familial Breast, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Integrated Oncol, Cologne, Germany; [Tutt, Andrew] Kings Coll London, Breakthrough Breast Canc Res Unit, Sch Med, London WC2R 2LS, England	Cedars Sinai Medical Center; AstraZeneca; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California San Francisco; Memorial Sloan Kettering Cancer Center; Walter & Eliza Hall Institute; Royal Melbourne Hospital; City of Hope; Hospital Universitari Vall d'Hebron; Lund University; Skane University Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Cologne; University of Cologne; University of Cologne; University of London; King's College London	Audeh, MW (corresponding author), Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USA.	william.audeh@cshs.org	friedlander, michael l/G-3490-2013	friedlander, michael l/0000-0002-6488-0604; OAKNIN, ANA/0000-0002-3592-7194; Tutt, Andrew/0000-0001-8715-2901	AstraZeneca	AstraZeneca(AstraZeneca)	MWA has received honoraria for consultancy from AstraZeneca and Myriad Genetic Laboratories, and funding support for travel to investigators' meetings from AstraZeneca and to advisory board meetings from Myriad Genetic Laboratories. RTP has received honoraria and funding support for travel to investigators' meetings from AstraZeneca, and RTP's institution has received grants from AstraZeneca. ME has received honoraria as a clinical advisory board member and funding support for travel to investigators' meetings from AstraZeneca. BP's institution has received funding support for patient care, and BP has received funding support for travel to an investigators' meeting from AstraZeneca. KMB's institution has received study grants, and KMB has received funding support for travel to investigators' meetings from AstraZeneca. CS has received funding support for travel to investigators' meetings from AstraZeneca. N1:s institution has received funding support for the conduct of the study and travel to investigators' meetings from AstraZeneca, and NL has received honoraria for lectures to patient groups that were organised and funded by AstraZeneca. RKS's institution has received fees to cover study expenses, and RKS has received funding support for travel to investigators' meetings from AstraZeneca. UM's institution has received fees to cover study expenses, and UM has received funding support for travel to investigators' meetings from AstraZeneca. MW and JC are employees of AstraZeneca, and JC has AstraZeneca stock options. AT has received a payment from the UK Institute of Cancer Research's rewards to inventors programme for work on use of PARP inhibitors to target cancers associated with BRCA1 and BRCA2 mutations, and has received funding support for travel to investigators' meetings and an honorarium for an academic lecture from AstraZeneca. AO, KL, and JNW declare that they have no conflicts of interest.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Ashworth A, 2008, J CLIN ONCOL, V26, P3785, DOI 10.1200/JCO.2008.16.0812; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Evers B, 2008, CLIN CANCER RES, V14, P3916, DOI 10.1158/1078-0432.CCR-07-4953; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hay T, 2005, CANCER RES, V65, P10145, DOI 10.1158/0008-5472.CAN-05-1186; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kwon JS, 2010, J CLIN ONCOL, V28, P675, DOI 10.1200/JCO.2008.21.4684; Martin SA, 2010, J PATHOL, V220, P281, DOI 10.1002/path.2631; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2002, ONCOGENE, V21, P8994, DOI 10.1038/sj.onc.1206177; Newcombe RG, 2000, STAT CONFIDENCE, P39; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Yang XH, 1999, BREAST CANCER RES TR, V54, P1, DOI 10.1023/A:1006189906896	28	1048	1084	0	118	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 24	2010	376	9737					245	251		10.1016/S0140-6736(10)60893-8	http://dx.doi.org/10.1016/S0140-6736(10)60893-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20609468				2022-12-28	WOS:000280457200033
J	Prochnik, SE; Umen, J; Nedelcu, AM; Hallmann, A; Miller, SM; Nishii, I; Ferris, P; Kuo, A; Mitros, T; Fritz-Laylin, LK; Hellsten, U; Chapman, J; Simakov, O; Rensing, SA; Terry, A; Pangilinan, J; Kapitonov, V; Jurka, J; Salamov, A; Shapiro, H; Schmutz, J; Grimwood, J; Lindquist, E; Lucas, S; Grigoriev, IV; Schmitt, R; Kirk, D; Rokhsar, DS				Prochnik, Simon E.; Umen, James; Nedelcu, Aurora M.; Hallmann, Armin; Miller, Stephen M.; Nishii, Ichiro; Ferris, Patrick; Kuo, Alan; Mitros, Therese; Fritz-Laylin, Lillian K.; Hellsten, Uffe; Chapman, Jarrod; Simakov, Oleg; Rensing, Stefan A.; Terry, Astrid; Pangilinan, Jasmyn; Kapitonov, Vladimir; Jurka, Jerzy; Salamov, Asaf; Shapiro, Harris; Schmutz, Jeremy; Grimwood, Jane; Lindquist, Erika; Lucas, Susan; Grigoriev, Igor V.; Schmitt, Ruediger; Kirk, David; Rokhsar, Daniel S.			Genomic Analysis of Organismal Complexity in the Multicellular Green Alga Volvox carteri	SCIENCE			English	Article							CYTOPLASMIC BRIDGE SYSTEM; CHLAMYDOMONAS-REINHARDTII; EXTRACELLULAR-MATRIX; EVOLUTION; DIVISION; MORPHOGENESIS; EUKARYOTES; REVEALS; PROTEIN; ORIGIN	The multicellular green alga Volvox carteri and its morphologically diverse close relatives (the volvocine algae) are well suited for the investigation of the evolution of multicellularity and development. We sequenced the 138-mega-base pair genome of V. carteri and compared its similar to 14,500 predicted proteins to those of its unicellular relative Chlamydomonas reinhardtii. Despite fundamental differences in organismal complexity and life history, the two species have similar protein-coding potentials and few species-specific protein-coding gene predictions. Volvox is enriched in volvocine-algal-specific proteins, including those associated with an expanded and highly compartmentalized extracellular matrix. Our analysis shows that increases in organismal complexity can be associated with modifications of lineage-specific proteins rather than large-scale invention of protein-coding capacity.	[Umen, James; Ferris, Patrick] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Prochnik, Simon E.; Kuo, Alan; Hellsten, Uffe; Chapman, Jarrod; Terry, Astrid; Pangilinan, Jasmyn; Salamov, Asaf; Shapiro, Harris; Lindquist, Erika; Lucas, Susan; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Nedelcu, Aurora M.] Univ New Brunswick, Dept Biol, Fredericton, NB E3B 5A3, Canada; [Hallmann, Armin] Univ Bielefeld, Dept Cellular & Dev Biol Plants, D-33615 Bielefeld, Germany; [Miller, Stephen M.] Univ Maryland Baltimore Cty, Dept Biol Sci, Baltimore, MD 21250 USA; [Nishii, Ichiro] Nara Womens Univ, Nara 6308506, Japan; [Mitros, Therese; Fritz-Laylin, Lillian K.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Simakov, Oleg] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Rensing, Stefan A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Kapitonov, Vladimir; Jurka, Jerzy] Genet Informat Res Inst, Mountain View, CA 94043 USA; [Schmutz, Jeremy; Grimwood, Jane] HudsonAlpha Inst Biotechnol, Huntsville, AL 35806 USA; [Schmitt, Ruediger] Univ Regensburg, Dept Genet, D-93040 Regensburg, Germany; [Kirk, David] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Salk Institute; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of New Brunswick; University of Bielefeld; University System of Maryland; University of Maryland Baltimore County; Nara Womens University; University of California System; University of California Berkeley; European Molecular Biology Laboratory (EMBL); University of Freiburg; HudsonAlpha Institute for Biotechnology; University of Regensburg; Washington University (WUSTL)	Umen, J (corresponding author), Salk Inst Biol Studies, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	umen@salk.edu; dsrokhsar@gmail.com	Terry, Astrid Y/A-2538-2011; Grimwood, Jane/ABD-5737-2021; Schmutz, Jeremy/N-3173-2013; Hallmann, Armin/G-5823-2011; Umen, James G/K-9120-2013; Simakov, Oleg/G-4572-2015; Simakov, Oleg/AAV-2494-2020; Miller, Allison/F-2293-2019	Terry, Astrid Y/0000-0002-5234-1224; Schmutz, Jeremy/0000-0001-8062-9172; Hallmann, Armin/0000-0001-5977-6143; Umen, James G/0000-0003-4094-9045; Simakov, Oleg/0000-0002-3585-4511; Simakov, Oleg/0000-0002-3585-4511; Fritz-Laylin, Lillian/0000-0002-9237-9403; Rokhsar, Daniel/0000-0002-8704-2224; Miller, Allison/0000-0002-2722-9361; Grigoriev, Igor/0000-0002-3136-8903	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; NIH [R01 GM078376, 5 P41 LM006252]; Coypu Foundation; Natural Sciences and Engineering Research Council-Canada; NSF [IBN-0444896, IBN-0744719]; Japan Society for the Promotion of Science [20247032, 22570203]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078376] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [P41LM006252] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coypu Foundation; Natural Sciences and Engineering Research Council-Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The work conducted by the Joint Genome Institute of the U.S. Department of Energy is supported by the Office of Science of the U.S. Department of Energy under contract number DE-AC02-05CH11231 and by NIH grant R01 GM078376 and a Coypu Foundation grant to J.U.; a grant from the Natural Sciences and Engineering Research Council-Canada to A.M.N.; NSF grants IBN-0444896 and IBN-0744719 to S.M.M.; Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research numbers 20247032 and 22570203 to I.N.; and NIH grant 5 P41 LM006252 to J.J. We thank M. Cipriano for Pfam annotations; E. Hom, E. Harris, and M. Stanke for Augustus u9 gene models; and R. Howson for artwork. Sequence data from this study are deposited at the DNA Databank of Japan/European Molecular Biology Laboratory/GenBank under the project accession no. ACJH00000000.	Baldauf SL, 2003, SCIENCE, V300, P1703, DOI 10.1126/science.1085544; Buss LW, 2006, EVOLUTION INDIVIDUAL; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cheng Q, 2003, DEV GENES EVOL, V213, P328, DOI 10.1007/s00427-003-0332-x; De Veylder L, 2007, NAT REV MOL CELL BIO, V8, P655, DOI 10.1038/nrm2227; Fang SC, 2006, PLOS GENET, V2, P1565, DOI 10.1371/journal.pgen.0020167; Ferris P, 2010, SCIENCE, V328, P351, DOI 10.1126/science.1186222; Ferris PJ, 2005, PLANT CELL, V17, P597, DOI 10.1105/tpc.104.028035; GREEN KJ, 1981, J CELL BIOL, V91, P743, DOI 10.1083/jcb.91.3.743; GREEN KJ, 1981, J CELL BIOL, V91, P756, DOI 10.1083/jcb.91.3.756; Hallmann A, 2006, PLANT J, V45, P292, DOI 10.1111/j.1365-313X.2005.02627.x; Hallmann A, 2003, INT REV CYTOL, V227, P131, DOI 10.1016/S0074-7696(03)01009-X; Herron MD, 2009, P NATL ACAD SCI USA, V106, P3254, DOI 10.1073/pnas.0811205106; King N, 2003, SCIENCE, V301, P361, DOI 10.1126/science.1083853; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Kirk DL, 2005, BIOESSAYS, V27, P299, DOI 10.1002/bies.20197; Kirk DL., 1998, VOLVOX MOL GENETIC O; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Miller SM, 1999, DEVELOPMENT, V126, P649; Molnar A, 2007, NATURE, V447, P1126, DOI 10.1038/nature05903; Nishii I, 2003, CELL, V113, P743, DOI 10.1016/S0092-8674(03)00431-8; Peterson KJ, 2009, BIOESSAYS, V31, P736, DOI 10.1002/bies.200900033; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reisz RR, 2004, TRENDS GENET, V20, P237, DOI 10.1016/j.tig.2004.03.007; Zhao T, 2007, GENE DEV, V21, P1190, DOI 10.1101/gad.1543507	26	420	443	4	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					223	226		10.1126/science.1188800	http://dx.doi.org/10.1126/science.1188800			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616280	Green Accepted, Green Submitted			2022-12-28	WOS:000279635200051
J	Richards, D				Richards, Dana			Martin Gardner (1914-2010)	SCIENCE			English	Biographical-Item									George Mason Univ, Dept Comp Sci, Fairfax, VA 22030 USA	George Mason University	Richards, D (corresponding author), George Mason Univ, Dept Comp Sci, 4400 Univ Dr, Fairfax, VA 22030 USA.	richards@cs.gmu.edu							0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					157	157		10.1126/science.1194002	http://dx.doi.org/10.1126/science.1194002			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616260				2022-12-28	WOS:000279635200027
J	Maunakea, AK; Nagarajan, RP; Bilenky, M; Ballinger, TJ; D'Souza, C; Fouse, SD; Johnson, BE; Hong, CB; Nielsen, C; Zhao, YJ; Turecki, G; Delaney, A; Varhol, R; Thiessen, N; Shchors, K; Heine, VM; Rowitch, DH; Xing, XY; Fiore, C; Schillebeeckx, M; Jones, SJM; Haussler, D; Marra, MA; Hirst, M; Wang, T; Costello, JF				Maunakea, Alika K.; Nagarajan, Raman P.; Bilenky, Mikhail; Ballinger, Tracy J.; D'Souza, Cletus; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Nielsen, Cydney; Zhao, Yongjun; Turecki, Gustavo; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Shchors, Ksenya; Heine, Vivi M.; Rowitch, David H.; Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Jones, Steven J. M.; Haussler, David; Marra, Marco A.; Hirst, Martin; Wang, Ting; Costello, Joseph F.			Conserved role of intragenic DNA methylation in regulating alternative promoters	NATURE			English	Article							WIDE; ARCHITECTURE; METHYLOME	Although it is known that the methylation of DNA in 5' promoters suppresses gene expression, the role of DNA methylation in gene bodies is unclear(1-5). In mammals, tissue-and cell type-specific methylation is present in a small percentage of 5' CpG island (CGI) promoters, whereas a far greater proportion occurs across gene bodies, coinciding with highly conserved sequences(5-10). Tissue-specific intragenic methylation might reduce(3), or, paradoxically, enhance transcription elongation efficiency(1,2,4,5). Capped analysis of gene expression (CAGE) experiments also indicate that transcription commonly initiates within and between genes(11-15). To investigate the role of intragenic methylation, we generated a map of DNA methylation from the human brain encompassing 24.7 million of the 28 million CpG sites. From the dense, high-resolution coverage of CpG islands, the majority of methylated CpG islands were shown to be in intragenic and intergenic regions, whereas less than 3% of CpG islands in 59 promoters were methylated. The CpG islands in all three locations overlapped with RNA markers of transcription initiation, and unmethylated CpG islands also overlapped significantly with trimethylation of H3K4, a histone modification enriched at promoters 16. The general and CpG-island-specific patterns of methylation are conserved in mouse tissues. An in-depth investigation of the human SHANK3 locus(17,18) and its mouse homologue demonstrated that this tissue-specific DNA methylation regulates intragenic promoter activity in vitro and in vivo. These methylation-regulated, alternative transcripts are expressed in a tissue-and cell type-specific manner, and are expressed differentially within a single cell type from distinct brain regions. These results support a major role for intragenic methylation in regulating cell context-specific alternative promoters in gene bodies.	[Ballinger, Tracy J.; Haussler, David; Wang, Ting] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Maunakea, Alika K.; Nagarajan, Raman P.; Fouse, Shaun D.; Johnson, Brett E.; Hong, Chibo; Costello, Joseph F.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, Dept Neurosurg, Brain Tumor Res Ctr, San Francisco, CA 94158 USA; [Bilenky, Mikhail; D'Souza, Cletus; Nielsen, Cydney; Zhao, Yongjun; Delaney, Allen; Varhol, Richard; Thiessen, Nina; Jones, Steven J. M.; Marra, Marco A.; Hirst, Martin] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 1L3, Canada; [Turecki, Gustavo] Douglas Hosp, Res Ctr, McGill Grp Suicide Studies, Verdun, PQ H4H 1R3, Canada; [Shchors, Ksenya] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94158 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, San Francisco, CA 94143 USA; [Heine, Vivi M.; Rowitch, David H.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Xing, Xiaoyun; Fiore, Chris; Schillebeeckx, Maximiliaan; Wang, Ting] Washington Univ, Ctr Genome Sci & Syst Biol, Dept Genet, St Louis, MO 63108 USA; [Haussler, David] Univ Calif Santa Cruz, Howard Hughes Med Inst, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; British Columbia Cancer Agency; McGill University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Washington University (WUSTL); Howard Hughes Medical Institute; University of California System; University of California Santa Cruz	Wang, T (corresponding author), Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA.	twang@wustl.edu; jcostello@cc.ucsf.edu	Jones, Steven J/C-3621-2009; Heine, Vivi M/F-1741-2011; Turecki, Gustavo/K-5100-2015; Hirst, Martin/B-7684-2016; Marra, Marco A/B-5987-2008	Jones, Steven J/0000-0003-3394-2208; Heine, Vivi M/0000-0003-4416-3875; Marra, Marco A/0000-0001-7146-7175; Turecki, Gustavo/0000-0003-4075-2736; Rowitch, David/0000-0002-0079-0060	NIH [NRSA-F31, NRSA-F32]; National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017154] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Brain Tumor Society; Goldhirsh Foundation; British Columbia Cancer Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank S. Vandenberg for technical assistance and The Pleiades Promoter Project and their funders Genome Canada, Genome British Columbia, GlaxoSmithKline R&D Ltd, BC Mental Health and Addiction Services, Child & Family Research Institute, UBC Institute of Mental Health, and the UBC Office of the Vice President Research. This work was supported in part by an NIH NRSA-F31 fellowship to A. K. M. and an NIH NRSA-F32 fellowship to R.P.N., a grant from the National Brain Tumor Society and Goldhirsh Foundation to J.F.C., and by the British Columbia Cancer Foundation. T.W. was a Helen Hay Whitney Fellow and M.A.M. is a Terry Fox Young Investigator and a Michael Smith Senior Research Scholar.	Appanah R, 2007, PLOS GENET, V3, P241, DOI 10.1371/journal.pgen.0030027; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Baylin S, 2002, CANCER CELL, V1, P299, DOI 10.1016/S1535-6108(02)00061-2; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003; Ching TT, 2005, NAT GENET, V37, P645, DOI 10.1038/ng1563; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Flanagan James M, 2007, Genome Biol, V8, P307, DOI 10.1186/gb-2007-8-6-307; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kapranov P, 2005, GENOME RES, V15, P987, DOI 10.1101/gr.3455305; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kimura K, 2006, GENOME RES, V16, P55, DOI 10.1101/gr.4039406; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; LORINCZ MC, 2004, NATURE STRUCT MOL BI; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Song F, 2005, P NATL ACAD SCI USA, V102, P3336, DOI 10.1073/pnas.0408436102; Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wilson HL, 2003, J MED GENET, V40, P575, DOI 10.1136/jmg.40.8.575; Zhang XY, 2006, CELL, V126, P1189, DOI 10.1016/j.cell.2006.08.003	30	1184	1210	1	142	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					253	U131		10.1038/nature09165	http://dx.doi.org/10.1038/nature09165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613842	Green Submitted, Green Accepted			2022-12-28	WOS:000279580800040
J	Crowder, DW; Northfield, TD; Strand, MR; Snyder, WE				Crowder, David W.; Northfield, Tobin D.; Strand, Michael R.; Snyder, William E.			Organic agriculture promotes evenness and natural pest control	NATURE			English	Article							PREDATOR DIVERSITY; CURRENT KNOWLEDGE; BIODIVERSITY; METAANALYSIS; COMMUNITIES; SERVICES; ECOLOGY; CONSEQUENCES; EXPLOITATION; LANDSCAPES	Human activity can degrade ecosystem function by reducing species number (richness)(1-4) and by skewing the relative abundance of species (evenness)(5-7). Conservation efforts often focus on restoring or maintaining species number(8,9), reflecting the well-known impacts of richness on many ecological processes(1-4). In contrast, the ecological effects of disrupted evenness have received far less attention(7), and developing strategies for restoring evenness remains a conceptual challenge(7). In farmlands, agricultural pest-management practices often lead to altered food web structure and communities dominated by a few common species, which together contribute to pest outbreaks(6,7,10,11). Here we show that organic farming methods mitigate this ecological damage by promoting evenness among natural enemies. In field enclosures, very even communities of predator and pathogen biological control agents, typical of organic farms, exerted the strongest pest control and yielded the largest plants. In contrast, pest densities were high and plant biomass was low when enemy evenness was disrupted, as is typical under conventional management. Our results were independent of the numerically dominant predator or pathogen species, and so resulted from evenness itself. Moreover, evenness effects among natural enemy groups were independent and complementary. Our results strengthen the argument that rejuvenation of ecosystem function requires restoration of species evenness, rather than just richness. Organic farming potentially offers a means of returning functional evenness to ecosystems.	[Crowder, David W.; Northfield, Tobin D.; Snyder, William E.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Strand, Michael R.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA	Washington State University; University System of Georgia; University of Georgia	Crowder, DW (corresponding author), Washington State Univ, Dept Entomol, Pullman, WA 99164 USA.	dcrowder@wsu.edu	Northfield, Tobin/I-2323-2013	Northfield, Tobin/0000-0002-0563-485X; Crowder, David/0000-0002-3720-1581; Snyder, William/0000-0002-2747-3102	National Research Initiative of the USDA National Institute of Food and Agriculture	National Research Initiative of the USDA National Institute of Food and Agriculture	J. Owen and M. Thomas provided comments on the manuscript. G. Chang, R. Ramirez and A. Snyder provided survey data from potato fields. This project was supported by the National Research Initiative of the USDA National Institute of Food and Agriculture.	Bengtsson J, 2005, J APPL ECOL, V42, P261, DOI 10.1111/j.1365-2664.2005.01005.x; Bianchi FJJA, 2006, P ROY SOC B-BIOL SCI, V273, P1715, DOI 10.1098/rspb.2006.3530; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casula P, 2006, ECOL LETT, V9, P995, DOI 10.1111/j.1461-0248.2006.00945.x; Chapin FS, 1997, SCIENCE, V277, P500, DOI 10.1126/science.277.5325.500; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Donnelly A, 2001, NEW PHYTOL, V149, P265, DOI 10.1046/j.1469-8137.2001.00015.x; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Finke DL, 2004, NATURE, V429, P407, DOI 10.1038/nature02554; Gitay H, 1996, J ECOL, V84, P121, DOI 10.2307/2261706; Hedges LV, 1999, ECOLOGY, V80, P1150, DOI 10.1890/0012-9658(1999)080[1150:TMAORR]2.0.CO;2; Hillebrand H, 2008, ECOLOGY, V89, P1510, DOI 10.1890/07-1053.1; Hole DG, 2005, BIOL CONSERV, V122, P113, DOI 10.1016/j.biocon.2004.07.018; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Koss AM, 2005, ENVIRON ENTOMOL, V34, P87, DOI 10.1603/0046-225X-34.1.87; Kutner M., 2005, APPL LINEAR STAT MOD; Landis DA, 2008, P NATL ACAD SCI USA, V105, P20552, DOI 10.1073/pnas.0804951106; Letourneau DK, 2008, FRONT ECOL ENVIRON, V6, P430, DOI 10.1890/070081; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Macfadyen S, 2009, ECOL LETT, V12, P229, DOI 10.1111/j.1461-0248.2008.01279.x; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Ramirez RA, 2009, ECOLOGY, V90, P2832, DOI 10.1890/08-1941.1; Ramirez RA, 2009, BIOL CONTROL, V48, P147, DOI 10.1016/j.biocontrol.2008.10.010; Benayas JMR, 2009, SCIENCE, V325, P1121, DOI 10.1126/science.1172460; Schmitz OJ, 2007, ECOLOGY, V88, P2415, DOI 10.1890/06-0937.1; Silvertown J, 1999, NATURE, V400, P61, DOI 10.1038/21877; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Tylianakis JM, 2007, NATURE, V445, P202, DOI 10.1038/nature05429; Whittingham MJ, 2006, J ANIM ECOL, V75, P1182, DOI 10.1111/j.1365-2656.2006.01141.x; Wilsey BJ, 2002, ECOL LETT, V5, P676, DOI 10.1046/j.1461-0248.2002.00372.x; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463	33	352	376	15	513	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					109	U123		10.1038/nature09183	http://dx.doi.org/10.1038/nature09183			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596021				2022-12-28	WOS:000279343800044
J	Randhawa, I; Nussbaum, E				Randhawa, Inderpal; Nussbaum, Eliezer			Not All That Wheezes Is Bronchial Asthma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Randhawa, Inderpal; Nussbaum, Eliezer] Miller Childrens Hosp, Long Beach, CA USA		Randhawa, I (corresponding author), Miller Childrens Hosp, Long Beach, CA USA.	docrandhawa@verizon.net							0	2	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					E1	E1		10.1056/NEJMicm0906105	http://dx.doi.org/10.1056/NEJMicm0906105			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592296	Green Published			2022-12-28	WOS:000279343000011
J	Sonnenburg, ED; Zheng, HJ; Joglekar, P; Higginbottom, SK; Firbank, SJ; Bolam, DN; Sonnenburg, JL				Sonnenburg, Erica D.; Zheng, Hongjun; Joglekar, Payal; Higginbottom, Steven K.; Firbank, Susan J.; Bolam, David N.; Sonnenburg, Justin L.			Specificity of Polysaccharide Use in Intestinal Bacteroides Species Determines Diet-Induced Microbiota Alterations	CELL			English	Article							OUTER-MEMBRANE PROTEINS; HUMAN GUT MICROBIOTA; SYMBIOTIC BACTERIA; IN-VIVO; STARCH; INULIN; OLIGOFRUCTOSE; CATABOLISM; PREDICTION; MODEL	The intestinal microbiota impacts many facets of human health and is associated with human diseases. Diet impacts microbiota composition, yet mechanisms that link dietary changes to microbiota alterations remain ill-defined. Here we elucidate the basis of Bacteroides proliferation in response to fructans, a class of fructose-based dietary polysaccharides. Structural and genetic analysis disclosed a fructose-binding, hybrid two-component signaling sensor that controls the fructan utilization locus in Bacteroides thetaiotaomicron. Gene content of this locus differs among Bacteroides species and dictates the specificity and breadth of utilizable fructans. BT1760, an extracellular beta 2-6 endo-fructanase, distinguishes B. thetaiotaomicron genetically and functionally, and enables the use of the beta 2-6-linked fructan levan. The genetic and functional differences between Bacteroides species are predictive of in vivo competitiveness in the presence of dietary fructans. Gene sequences that distinguish species' metabolic capacity serve as potential biomarkers in microbiomic datasets to enable rational manipulation of the microbiota via diet.	[Zheng, Hongjun; Firbank, Susan J.; Bolam, David N.] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Sonnenburg, Erica D.; Joglekar, Payal; Higginbottom, Steven K.; Sonnenburg, Justin L.] Stanford Univ, Dept Microbiol & Immunol, Sch Med, Stanford, CA 94305 USA	Newcastle University - UK; Stanford University	Bolam, DN (corresponding author), Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	d.n.bolam@ncl.ac.uk; jsonnenburg@stanford.edu		higginbottom, steven/0000-0002-4609-6840; Bolam, David/0000-0003-0314-3122	National Institutes of Health [DP2-OD006515]; NIDDK [K01-DK077053]; Stanford Digestive Disease Center [PO3-DK56339]; BBSRC [BB/F014163/1]; Biotechnology and Biological Sciences Research Council [BB/F014163/1] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK077053, P30DK056339, R01DK085025] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006515] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Stanford Digestive Disease Center; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Karla Kirkegaard and Stanley Falkow for valuable comments and Sara Fisher for editing the manuscript. Inulin and FOS for mouse experiments were a kind gift from Beneo-Orafti. Levan was a kind gift from Montana Polysaccharides. We thank Jeffrey Gordon and members of the Gordon Lab for valuable advice; Carl Morland for excellent technical assistance; and Eric Martens and Andrew Goodman for development of genetic tools used in this paper. Some Bacteroides genomic data were produced by The Genome Center at Washington University School of Medicine in St. Louis (genome.wustl.edu). This work was funded in part by grants from National Institutes of Health through the NIH Director's New Innovator Award Program (DP2-OD006515) the NIDDK (K01-DK077053), the Stanford Digestive Disease Center (PO3-DK56339) and the BBSRC (BB/F014163/1).	[Anonymous], 1994, J RAPID METHOD AUTOM, DOI DOI 10.1111/J.1745-4581.1994.TB00308.X; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bolam DN, 2004, J BIOL CHEM, V279, P22953, DOI 10.1074/jbc.M313317200; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Dethlefsen L, 2008, PLOS BIOL, V6, P2383, DOI 10.1371/journal.pbio.0060280; Duncan SH, 2008, INT J OBESITY, V32, P1720, DOI 10.1038/ijo.2008.155; Duncan SH, 2003, APPL ENVIRON MICROB, V69, P1136, DOI 10.1128/AEM.69.2.1136-1142.2003; Dwyer MA, 2004, CURR OPIN STRUC BIOL, V14, P495, DOI 10.1016/j.sbi.2004.07.004; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Falke JJ, 2009, STRUCTURE, V17, P1149, DOI 10.1016/j.str.2009.08.005; Flint HJ, 2008, NAT REV MICROBIOL, V6, P121, DOI 10.1038/nrmicro1817; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Jernberg C, 2007, ISME J, V1, P56, DOI 10.1038/ismej.2007.3; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kolida S, 2007, EUR J CLIN NUTR, V61, P1189, DOI 10.1038/sj.ejcn.1602636; Koropatkin N, 2009, BIOCHEMISTRY-US, V48, P1532, DOI 10.1021/bi801942a; Koropatkin NM, 2008, STRUCTURE, V16, P1105, DOI 10.1016/j.str.2008.03.017; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; LEY R, 2006, NATURE, V444, P1023; Louis P, 2007, J APPL MICROBIOL, V102, P1197, DOI 10.1111/j.1365-2672.2007.03322.x; Lozupone CA, 2008, P NATL ACAD SCI USA, V105, P15076, DOI 10.1073/pnas.0807339105; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Menne E, 2000, J NUTR, V130, P1197, DOI 10.1093/jn/130.5.1197; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; ROBERFROID M, 1993, NUTR REV, V51, P137, DOI 10.1111/j.1753-4887.1993.tb03090.x; Rossi M, 2005, APPL ENVIRON MICROB, V71, P6150, DOI 10.1128/AEM.71.10.6150-6158.2005; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Shipman JA, 2000, J BACTERIOL, V182, P5365, DOI 10.1128/JB.182.19.5365-5372.2000; Sonnenburg ED, 2006, P NATL ACAD SCI USA, V103, P8834, DOI 10.1073/pnas.0603249103; Sonnenburg JL, 2005, SCIENCE, V307, P1955, DOI 10.1126/science.1109051; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van der Meulen R, 2006, APPL ENVIRON MICROB, V72, P1006, DOI 10.1128/AEM.72.2.1006-1012.2006; Westover BP, 2005, BIOINFORMATICS, V21, P880, DOI 10.1093/bioinformatics/bti123; Xu J, 2003, SCIENCE, V299, P2074, DOI 10.1126/science.1080029; Xu J, 2007, PLOS BIOL, V5, P1574, DOI 10.1371/journal.pbio.0050156	43	483	502	8	170	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1241	U256		10.1016/j.cell.2010.05.005	http://dx.doi.org/10.1016/j.cell.2010.05.005			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603004	Bronze, Green Accepted			2022-12-28	WOS:000279148100020
J	van der Hart, HW				van der Hart, H. W.			When Does Photoemission Begin?	SCIENCE			English	Editorial Material							MOLECULES; DYNAMICS		Queens Univ Belfast, Sch Math & Phys, Ctr Theoret Atom Mol & Opt Phys, Belfast BT7 1NN, Antrim, North Ireland	Queens University Belfast	van der Hart, HW (corresponding author), Queens Univ Belfast, Sch Math & Phys, Ctr Theoret Atom Mol & Opt Phys, Belfast BT7 1NN, Antrim, North Ireland.	h.vanderhart@qub.ac.uk						Baker S, 2006, SCIENCE, V312, P424, DOI 10.1126/science.1123904; Bryan WA, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.053402; Ergler T, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.103004; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lysaght MA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.193001; Mauritsson J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073003; Morishita T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083003; Parker JS, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.133001; Schultze M, 2010, SCIENCE, V328, P1658, DOI 10.1126/science.1189401; Smirnova O, 2009, NATURE, V460, P972, DOI 10.1038/nature08253; WEISSBLUTH M, 1978, ATOMS MOL; ZEWAIL AH, 1993, J PHYS CHEM-US, V97, P12427, DOI 10.1021/j100150a001	12	5	5	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1645	1646		10.1126/science.1191842	http://dx.doi.org/10.1126/science.1191842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576879				2022-12-28	WOS:000279107400029
J	Clayton, J				Clayton, Julie			Chagas disease: pushing through the pipeline	NATURE			English	Editorial Material							TRYPANOSOMA-CRUZI; ERGOSTEROL BIOSYNTHESIS; POSACONAZOLE; AMIODARONE; INFECTION											Benaim G, 2006, J MED CHEM, V49, P892, DOI 10.1021/jm050691f; *CLINICALTRIALS GO, 2005, BENEFIT TRIAL EV US; Doyle PS, 2007, ANTIMICROB AGENTS CH, V51, P3932, DOI 10.1128/AAC.00436-07; *GEORG I INT HLTH, 2007, G FINDER GLOB FUND I; *INT FED PHARM MAN, 2009, HLTH PARTN DEV WORLD; Marin-Neto JA, 2008, AM HEART J, V156, P37, DOI 10.1016/j.ahj.2008.04.001; Munoz J, 2009, CLIN INFECT DIS, V48, P1736, DOI 10.1086/599223; Paniz-Mondolfi AE, 2009, CHEMOTHERAPY, V55, P228, DOI 10.1159/000219436; Pinazo MJ, 2010, AM J TROP MED HYG, V82, P583, DOI 10.4269/ajtmh.2010.09-0620; Romanha AJ, 2010, MEM I OSWALDO CRUZ, V105, P233, DOI 10.1590/S0074-02762010000200022; Silva DT, 2006, INT J ANTIMICROB AG, V27, P530, DOI 10.1016/j.ijantimicag.2005.12.012; Urbina JA, 2009, MEM I OSWALDO CRUZ, V104, P311, DOI 10.1590/S0074-02762009000900041; Yun O, 2009, PLOS NEGLECT TROP D, V3, P1	13	111	112	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S12	S15		10.1038/nature09224	http://dx.doi.org/10.1038/nature09224			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571548	Bronze			2022-12-28	WOS:000279056900028
J	Yusuf, HR; Atrash, HK				Yusuf, Hussain R.; Atrash, Hani K.			Parents' death and survival of their children	LANCET			English	Editorial Material							MATERNAL MORTALITY		[Yusuf, Hussain R.; Atrash, Hani K.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Yusuf, HR (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.							Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; *DEP REPR HLTH RES, 1999, WHO RED MAT MORT JOI; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Katz J, 2003, B WORLD HEALTH ORGAN, V81, P717; Obaid TA, 2009, INT J GYNECOL OBSTET, V106, P102, DOI 10.1016/j.ijgo.2009.03.017; Paxton A, 2005, INT J GYNECOL OBSTET, V88, P181, DOI 10.1016/j.ijgo.2004.11.026; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; ROSENFIELD A, 1985, LANCET, V2, P83; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Starrs AM, 2006, LANCET, V368, P1130, DOI 10.1016/S0140-6736(06)69385-9; Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021; 1995, INT C POP DEV ICPD 9	12	3	4	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1944	1946		10.1016/S0140-6736(10)60899-9	http://dx.doi.org/10.1016/S0140-6736(10)60899-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569825				2022-12-28	WOS:000278689600006
J	Chassin, MR; Loeb, JM; Schmaltz, SP; Wachter, RM				Chassin, Mark R.; Loeb, Jerod M.; Schmaltz, Stephen P.; Wachter, Robert M.			Accountability Measures - Using Measurement to Promote Quality Improvement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COMMUNITY-ACQUIRED PNEUMONIA		[Chassin, Mark R.; Loeb, Jerod M.; Schmaltz, Stephen P.] Joint Commiss, Oak Brook Terrace, IL USA; [Wachter, Robert M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	University of California System; University of California San Francisco	Chassin, MR (corresponding author), Joint Commiss, Oak Brook Terrace, IL USA.							*CTR MED MED SERV, MED MOD UPD; *CTR MED MED SERV, HOSP QUAL IN HOSP QU; *GOV ACC OFF, 2006, HOSP QUAL DAT CMS NE; Houck PM, 2004, ARCH INTERN MED, V164, P637, DOI 10.1001/archinte.164.6.637; Jha AK, 2009, NEW ENGL J MED, V361, P2637, DOI 10.1056/NEJMsa0904859; *JOINT COMM, 2009 ORYX PERF MEAS; *JOINT COMM, LIST SYST SUPP COR M; *JOINT COMM, PERF MEAS IN; *JOINT COMM CTR ME, 2009, SPEC MAN NAT HOSP QU; Kanwar M, 2007, CHEST, V131, P1865, DOI 10.1378/chest.07-0164; Lee KY, 2000, HLTH SERVICES OUTCOM, V1, P63; National Quality Forum, NQF END STAND; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; The Joint Commission, IMPR AM HOSP JOINT C; Wachter RM, 2008, ANN INTERN MED, V149, P29, DOI 10.7326/0003-4819-149-1-200807010-00007; Williams SC, 2005, NEW ENGL J MED, V353, P255, DOI 10.1056/NEJMsa043778	16	337	340	2	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					683	688		10.1056/NEJMsb1002320	http://dx.doi.org/10.1056/NEJMsb1002320			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636TN	20573915				2022-12-28	WOS:000280764600015
J	Gregg, C; Zhang, JW; Butler, JE; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Butler, James E.; Haig, David; Dulac, Catherine			Sex-Specific Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							X-CHROMOSOME INACTIVATION; DOSAGE COMPENSATION; INTERLEUKIN-18; EVOLUTION; GENES	Genomic imprinting results in preferential gene expression from paternally versus maternally inherited chromosomes. We used a genome-wide approach to uncover sex-specific parent-of-origin allelic effects in the adult mouse brain. Our study identified preferential selection of the maternally inherited X chromosome in glutamatergic neurons of the female cortex. Moreover, analysis of the cortex and hypothalamus identified 347 autosomal genes with sex-specific imprinting features. In the hypothalamus, sex-specific imprinted genes were mostly found in females, which suggests parental influence over the hypothalamic function of daughters. We show that interleukin-18, a gene linked to diseases with sex-specific prevalence, is subject to complex, regional, and sex-specific parental effects in the brain. Parent-of-origin effects thus provide new avenues for investigation of sexual dimorphism in brain function and disease.	[Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Butler, James E.; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University	Dulac, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; [Anonymous], 2008, SEX DIFFERENCES BRAI; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; Baysal BE, 2004, AM J MED GENET C, V129C, P85, DOI 10.1002/ajmg.c.30018; Chadwick LH, 2005, MAMM GENOME, V16, P691, DOI 10.1007/s00335-005-0059-2; Davies W, 2005, NAT GENET, V37, P625, DOI 10.1038/ng1577; FALCONER DS, 1982, GENET RES, V39, P237, DOI 10.1017/S0016672300020930; FOWLIS DJ, 1991, GENET RES, V58, P63, DOI 10.1017/S001667230002961X; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Hager R, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-303; Haig D, 2006, CYTOGENET GENOME RES, V113, P68, DOI 10.1159/000090816; Haig D, 2006, EVOLUTION, V60, P440; HALL JG, 1990, AM J HUM GENET, V46, P857; Heard E, 1997, ANNU REV GENET, V31, P571, DOI 10.1146/annurev.genet.31.1.571; Herrera BM, 2008, NEUROLOGY, V71, P799, DOI 10.1212/01.wnl.0000312377.50395.00; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; McCarthy MM, 2009, J NEUROSCI, V29, P12815, DOI 10.1523/JNEUROSCI.3331-09.2009; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Raefski AS, 2005, NAT GENET, V37, P620, DOI 10.1038/ng1567; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Skuse DH, 1997, NATURE, V387, P705, DOI 10.1038/42706; TAN SS, 1993, NAT GENET, V3, P170, DOI 10.1038/ng0293-170; Wang JB, 2001, NAT GENET, V28, P371, DOI 10.1038/ng574; Zechner U, 2001, TRENDS GENET, V17, P697, DOI 10.1016/S0168-9525(01)02446-5; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	27	246	251	2	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					682	685		10.1126/science.1190831	http://dx.doi.org/10.1126/science.1190831			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616234	Green Accepted			2022-12-28	WOS:000280602700039
J	Qi, HH; Sarkissian, M; Hu, GQ; Wang, ZB; Bhattacharjee, A; Gordon, DB; Gonzales, M; Lan, F; Ongusaha, PP; Huarte, M; Yaghi, NK; Lim, H; Garcia, BA; Brizuela, L; Zhao, KJ; Roberts, TM; Shi, Y				Qi, Hank H.; Sarkissian, Madathia; Hu, Gang-Qing; Wang, Zhibin; Bhattacharjee, Arindam; Gordon, D. Benjamin; Gonzales, Michelle; Lan, Fei; Ongusaha, Pat P.; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Garcia, Benjamin A.; Brizuela, Leonardo; Zhao, Keji; Roberts, Thomas M.; Shi, Yang			Histone H4K20/H3K9 demethylase PHF8 regulates zebrafish brain and craniofacial development	NATURE			English	Article							STRUCTURAL INSIGHTS; MENTAL-RETARDATION; GENES; TRANSCRIPTION; METHYLATION; FAMILY; IDENTIFICATION; LYSINE-20; GENOME; MUTATIONS	X-linked mental retardation (XLMR) is a complex human disease that causes intellectual disability(1). Causal mutations have been found in approximately 90 X-linked genes(2); however, molecular and biological functions of many of these genetically defined XLMR genes remain unknown. PHF8 (PHD (plant homeo domain) finger protein 8) is a JmjC domain-containing protein and its mutations have been found in patients with XLMR and craniofacial deformities. Here we provide multiple lines of evidence establishing PHF8 as the first mono-methyl histone H4 lysine 20 (H4K20me1) demethylase, with additional activities towards histone H3K9me1 and me2. PHF8 is located around the transcription start sites (TSS) of similar to 7,000 RefSeq genes and in gene bodies and intergenic regions (non-TSS). PHF8 depletion resulted in upregulation of H4K20me1 and H3K9me1 at the TSS and H3K9me2 in the non-TSS sites, respectively, demonstrating differential substrate specificities at different target locations. PHF8 positively regulates gene expression, which is dependent on its H3K4me3-binding PHD and catalytic domains. Importantly, patient mutations significantly compromised PHF8 catalytic function. PHF8 regulates cell survival in the zebrafish brain and jaw development, thus providing a potentially relevant biological context for understanding the clinical symptoms associated with PHF8 patients. Lastly, genetic and molecular evidence supports a model whereby PHF8 regulates zebrafish neuronal cell survival and jaw development in part by directly regulating the expression of the homeodomain transcription factor MSX1/MSXB, which functions downstream of multiple signalling and developmental pathways(3). Our findings indicate that an imbalance of histone methylation dynamics has a critical role in XLMR.	[Qi, Hank H.; Lan, Fei; Huarte, Maite; Yaghi, Nasser K.; Lim, Huijun; Shi, Yang] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Qi, Hank H.; Lim, Huijun; Shi, Yang] Childrens Hosp, Dept Med, Div Newborn Med, Boston, MA 02115 USA; [Sarkissian, Madathia; Roberts, Thomas M.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Hu, Gang-Qing; Wang, Zhibin; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Bhattacharjee, Arindam; Gordon, D. Benjamin; Brizuela, Leonardo] Agilent Technol, Santa Clara, CA 95051 USA; [Gonzales, Michelle; Garcia, Benjamin A.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Ongusaha, Pat P.] Brigham & Womens Hosp, Vasc Med Res Unit, Cambridge, MA 02139 USA; [Ongusaha, Pat P.] Harvard Univ, Sch Med, Cambridge, MA 02139 USA	Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Agilent Technologies; Princeton University; Harvard University; Brigham & Women's Hospital; Harvard University	Shi, Y (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	Thomas_Roberts@dfci.harvard.edu; yshi@hms.harvard.edu	Huarte, Maite/J-6903-2014; HU, GANGQING/K-5849-2012; Hu, Gangqing/ABA-3507-2020; Yaghi, Nasser/AAL-7001-2021	Huarte, Maite/0000-0003-3753-6493; HU, GANGQING/0000-0001-5453-6888; Qi, Hank/0000-0002-3401-4940; Yaghi, Nasser/0000-0003-0810-8502	Ruth L. Kirschstein-National Service [T32 NS007473, T32 CA09031-32]; Harvard SHURP; Agency for Science, Technology and Research (A*STAR); National Science Foundation [CBET-0941143]; NIH [GM 071004, NCI118487, CA50661]; Ellison Foundation; NATIONAL CANCER INSTITUTE [P01CA050661, T32CA009031] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006031, ZIAHL006030, ZIAHL005801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071004] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007473] Funding Source: NIH RePORTER	Ruth L. Kirschstein-National Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard SHURP; Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Foundation(Lawrence Ellison Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shi laboratory members for helpful discussions and N. Mosammaparast and S. Chen for providing the nucleosomes. We thank G. Rosenfeld for sharing unpublished PHF8 results, and G. Rosenfeld, A. Schier and P. Hinds for discussions. H.H.Q. is a recipient of Ruth L. Kirschstein-National Service Research Award (T32 NS007473 and T32 CA09031-32). N.K.Y. was supported by Harvard SHURP (Summer Honors Undergraduate Research Program). H.L. is a recipient of the Agency for Science, Technology and Research (A*STAR) National Science Scholarship. This work was supported by grants from the National Science Foundation (CBET-0941143) to B.A.G.; NIH (GM 071004 and NCI118487) to Y. S.; a Senior Scholar Grant from the Ellison Foundation, and an NIH PO1 grant (CA50661) to T.M.R.	Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cau E, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-36; Chiurazzi P, 2008, EUR J HUM GENET, V16, P422, DOI 10.1038/sj.ejhg.5201994; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; DARZYNKIEWICZ Z, 1999, CURR PROTOC CELL BIO, V1; Di Fonzo A, 2009, NEUROLOGY, V72, P240, DOI 10.1212/01.wnl.0000338144.10967.2b; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Koivisto AM, 2007, CLIN GENET, V72, P145, DOI 10.1111/j.1399-0004.2007.00836.x; Li Y, 2009, J BIOL CHEM, V284, P34283, DOI 10.1074/jbc.M109.034462; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Lupo G, 2006, NAT REV NEUROSCI, V7, P103, DOI 10.1038/nrn1843; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Phillips BT, 2006, DEV BIOL, V294, P376, DOI 10.1016/j.ydbio.2006.03.001; Plazas-Mayorca MD, 2009, J PROTEOME RES, V8, P5367, DOI 10.1021/pr900777e; Postlethwait JH, 2006, GENOME DYN, V2, P183, DOI 10.1159/000095104; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Ramos C, 2005, TRENDS GENET, V21, P624, DOI 10.1016/j.tig.2005.09.001; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Ropers HH, 2006, CURR OPIN GENET DEV, V16, P260, DOI 10.1016/j.gde.2006.04.017; Tetel MJ, 2009, J NEUROENDOCRINOL, V21, P229, DOI 10.1111/j.1365-2826.2009.01827.x; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Yu L, 2010, CELL RES, V20, P166, DOI 10.1038/cr.2010.8; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340	39	212	222	0	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					503	U11		10.1038/nature09261	http://dx.doi.org/10.1038/nature09261			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622853	Green Accepted			2022-12-28	WOS:000280141200039
J	Chan, FKL; Lanas, A; Scheiman, J; Berger, MF; Nguyen, H; Goldstein, JL				Chan, Francis K. L.; Lanas, Angel; Scheiman, James; Berger, Manuela F.; Nguyen, Ha; Goldstein, Jay L.			Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial	LANCET			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; EVIDENCE-BASED RECOMMENDATIONS; PLUS OMEPRAZOLE; GASTROINTESTINAL TOXICITY; OARSI RECOMMENDATIONS; KNEE OSTEOARTHRITIS; MUCOSAL INJURY; RISK; MANAGEMENT; NAPROXEN	Background Cyclo-oxygenase (COX)-2-selective non-steroidal anti-inflammatory drugs (NSAIDs) and non-selective NSAIDs plus a proton-pump inhibitor (PPI) have similar upper gastrointestinal outcomes, but risk of clinical outcomes across the entire gastrointestinal tract might be lower with selective drugs than with non-selective drugs. We aimed to compare risk of gastrointestinal events associated with celecoxib versus diclofenac slow release plus omeprazole. Methods We undertook a 6-month, double-blind, randomised trial in patients with osteoarthritis or rheumatoid arthritis at increased gastrointestinal risk at 196 centres in 32 countries or territories. Patients tested negative for Helicobacter pylori and were aged 60 years and older or 18 years and older with previous gastroduodenal ulceration. We used a computer-generated randomisation schedule to assign patients in a 1:1 ratio to receive celecoxib 200 mg twice a day or diclofenac slow release 75 mg twice a day plus omeprazole 20 mg once a day. Patients and investigators were masked to treatment allocation. The primary endpoint was a composite of clinically significant upper or lower gastrointestinal events adjudicated by an independent committee. Analysis was by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00141102. Findings 4484 patients were randomly allocated to treatment (2238 celecoxib; 2246 diclofenac plus omeprazole) and were included in intention-to-treat analyses. 20 (0.9%) patients receiving celecoxib and 81 (3.8%) receiving diclofenac plus omeprazole met criteria for the primary endpoint (hazard ratio 4.3, 95% CI 2.6-7.0; p<0.0001). 114 (6%) patients taking celecoxib versus 167 (8%) taking diclofenac plus omeprazole withdrew early because of gastrointestinal adverse events (p=0.0006). Interpretation Risk of clinical outcomes throughout the gastrointestinal tract was lower in patients treated with a COX-2-selective NSAID than in those receiving a non-selective NSAID plus a PPI. These findings should encourage review of approaches to reduce risk of NSAID treatment.	[Chan, Francis K. L.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, Shatin, Hong Kong, Peoples R China; [Lanas, Angel] Univ Zaragoza, I CS, CIBERehd, Zaragoza, Spain; [Scheiman, James] Univ Michigan, Ann Arbor, MI 48109 USA; [Berger, Manuela F.; Nguyen, Ha] Pfizer Inc, New York, NY USA; [Goldstein, Jay L.] Univ Illinois, Chicago, IL USA	Chinese University of Hong Kong; Prince of Wales Hospital; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Zaragoza; University of Michigan System; University of Michigan; Pfizer; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Chan, FKL (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Med & Therapeut, 30-32 Ngan Shing St, Shatin, Hong Kong, Peoples R China.	fklchan@cuhk.edu.hk	Chan, Francis K. L./F-4851-2010	Chan, Francis K. L./0000-0001-7388-2436	Pfizer Inc.; AstraZeneca; Takeda; TAP; Novartis; Pozen; Logical Therapeutics; Given	Pfizer Inc.(Pfizer); AstraZeneca(AstraZeneca); Takeda(Takeda Pharmaceutical Company Ltd); TAP; Novartis(Novartis); Pozen; Logical Therapeutics; Given	Funding Pfizer Inc.; FKLC, JLG, AL, and JS are all consultants to Pfizer. FKLC is the International Associate Editor of the American Journal of Gastroenterology and has also served as a consultant for Eisai, Takeda, and Otsuka. He has received grants from Pfizer and has been paid lecture fees (including service on speakers' bureaus) by Pfizer, AstraZeneca, and Takeda. JLG reports having served as a consultant to AstraZeneca, TAP, Takeda, Novartis, Pozen, Logical Therapeutics, Proctor and Gamble, PLX, Wyeth, Astellas. Amgen, Given, GlaxoSmithKline, and Merck, and has received grant support and honoraria from Pfizer, AstraZeneca, TAP, Takeda, Novartis. Pozen, Logical Therapeutics, Amgen, and Given. He has also been paid lecture fees (including service on speakers' bureaus) by AstraZeneca, TAP, Takeda, Novartis, Pozen, Logical Therapeutics, and Given. AL reports having received grants and lecture fees from Pfizer and AstraZeneca. and having been involved in the steering committee of studies conducted by Pfizer (CONDOR) and AstraZeneca (Energib and Cades Studies). IS reports serving as a consultant to AstraZeneca, Takeda, Pozen, Bayer. Novartis, and Nicox and has received a grant from AstraZeneca. He has also been paid lecture fees (including service on speakers' bureaus) by AstraZeneca and Takeda. MFB and HN are boils currently employees of Pfizer Inc and own Pfizer stock.; The study was sponsored by Pfizer Inc. We thank all the study site investigators (listed in webappendix), and the members of the data safety monitoring, executive, cardiovascular adjudication, and steering committees, and George Sands for critical review and comments, Mark Li for statistical advice, and Simon Lowry, Liviu Niculescu, Gail Cawkwell, and Mitchell Gandelman for their invaluable support. Editing and formatting of the report was provided by L Prevost of PAREXEL, funded by Pfizer Inc.	ALLISON MC, 1992, NEW ENGL J MED, V327, P749, DOI 10.1056/NEJM199209103271101; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; BJARNASON I, 1983, GASTROENTEROLOGY, V85, P318; Bjarnason I, 2009, J GASTROENTEROL, V44, P23, DOI 10.1007/s00535-008-2266-6; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2002, NEW ENGL J MED, V347, P2104, DOI 10.1056/NEJMoa021907; Chan FKL, 2008, AM J GASTROENTEROL, V103, P2908, DOI 10.1111/j.1572-0241.2008.02200.x; Chan FKL, 2010, J RHEUMATOL, V37, P167, DOI 10.3899/jrheum.090168; Chaves PHM, 2005, J GERONTOL A-BIOL, V60, P729, DOI 10.1093/gerona/60.6.729; Goldstein JL, 2007, ALIMENT PHARM THER, V25, P1211, DOI 10.1111/j.1365-2036.2007.03312.x; Goldstein JL, 2005, CLIN GASTROENTEROL H, V3, P133, DOI 10.1016/S1542-3565(04)00619-6; Graham DY, 2005, CLIN GASTROENTEROL H, V3, P55, DOI 10.1016/S1542-3565(04)00603-2; KOCH GG, 1984, AM J MED, V77, P43; Lai KC, 2005, AM J MED, V118, P1271, DOI 10.1016/j.amjmed.2005.04.031; Lanas A, 2000, NEW ENGL J MED, V343, P834, DOI 10.1056/NEJM200009213431202; Lanas A, 2003, CURR PHARM DESIGN, V9, P2253, DOI 10.2174/1381612033453992; Penninx BWJH, 2006, J GERONTOL A-BIOL, V61, P474, DOI 10.1093/gerona/61.5.474; Peters MJL, 2010, ANN RHEUM DIS, V69, P325, DOI 10.1136/ard.2009.113696; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Scheiman JM, 2007, LANCET, V369, P1580, DOI 10.1016/S0140-6736(07)60722-3; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Singh G, 2006, AM J MED, V119, P255, DOI 10.1016/j.amjmed.2005.09.054; Spiegel BM, 2006, AM J MED, V119, pe27; Zakai NA, 2005, ARCH INTERN MED, V165, P2214, DOI 10.1001/archinte.165.19.2214; Zhang MJ, 2001, LIFETIME DATA ANAL, V7, P243, DOI 10.1023/A:1011636407958; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang W, 2007, ANN RHEUM DIS, V66, P377, DOI 10.1136/ard.2006.062091; Zhang W, 2010, OSTEOARTHR CARTILAGE, V18, P476, DOI 10.1016/j.joca.2010.01.013	30	217	251	1	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					173	179		10.1016/S0140-6736(10)60673-3	http://dx.doi.org/10.1016/S0140-6736(10)60673-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20638563				2022-12-28	WOS:000280313100024
J	Kraus, S; Hofmann, KH; Menten, KM; Schertl, D; Weigelt, G; Wyrowski, F; Meilland, A; Perraut, K; Petrov, R; Robbe-Dubois, S; Schilke, P; Testi, L				Kraus, Stefan; Hofmann, Karl-Heinz; Menten, Karl M.; Schertl, Dieter; Weigelt, Gerd; Wyrowski, Friedrich; Meilland, Anthony; Perraut, Karine; Petrov, Romain; Robbe-Dubois, Sylvie; Schilke, Peter; Testi, Leonardo			A hot compact dust disk around a massive young stellar object	NATURE			English	Article							SPECTRAL ENERGY-DISTRIBUTIONS; T-TAURI STARS; SOUTHERN-HEMISPHERE; RADIATIVE-TRANSFER; ACCRETION; CANDIDATES; EMISSION; OUTFLOWS; GLIMPSE; SYSTEMS	Circumstellar disks are an essential ingredient of the formation(1) of low-mass stars. It is unclear, however, whether the accretion-disk paradigm can also account for the formation of stars more massive than about 10 solar masses(2), in which strong radiation pressure might halt mass infall(3,4). Massive stars may form by stellar merging(5), although more recent theoretical investigations suggest that the radiative-pressure limit may be overcome by considering more complex, non-spherical infall geometries(6,7). Clear observational evidence, such as the detection of compact dusty disks(8) around massive young stellar objects, is needed to identify unambiguously the formation mode of the most massive stars. Here we report near-infrared interferometric observations that spatially resolve the astronomical-unit-scale distribution of hot material around a high-mass (similar to 20 solar masses) young stellar object. The image shows an elongated structure with a size of similar to 13 x 19 astronomical units, consistent with a disk seen at an inclination angle of similar to 45 degrees. Using geometric and detailed physical models, we found a radial temperature gradient in the disk, with a dust-free region less than 9.5 astronomical units from the star, qualitatively and quantitatively similar to the disks observed in low-mass star formation. Perpendicular to the disk plane we observed a molecular outflow and two bow shocks, indicating that a bipolar outflow emanates from the inner regions of the system.	[Kraus, Stefan] Univ Michigan, Dept Astron, Ann Arbor, MI 48103 USA; [Hofmann, Karl-Heinz; Menten, Karl M.; Schertl, Dieter; Weigelt, Gerd; Wyrowski, Friedrich; Meilland, Anthony] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Meilland, Anthony; Petrov, Romain; Robbe-Dubois, Sylvie] Univ Nice Sophia Antipolis, CNRS, Observ Cote Azur, Lab Hippolyte Fizeau,UMR 6525, F-06108 Nice 2, France; [Perraut, Karine] Univ Grenoble 1, CNRS, UMR 5571, Lab Astrophys Grenoble, F-38041 Grenoble 9, France; [Schilke, Peter] Univ Cologne, Inst Phys 1, D-50937 Cologne, Germany; [Testi, Leonardo] INAF Osservatorio Astrofis Arcetri, I-50125 Florence, Italy	University of Michigan System; University of Michigan; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Observatoire de la Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); University of Cologne; Istituto Nazionale Astrofisica (INAF)	Kraus, S (corresponding author), Univ Michigan, Dept Astron, 500 Church St, Ann Arbor, MI 48103 USA.	stefankr@umich.edu	Testi, Leonardo/L-7038-2013	Petrov, Romain/0000-0003-4759-6051; Kraus, Stefan/0000-0001-6017-8773	NASA	NASA(National Aeronautics & Space Administration (NASA))	This work was done in part under contract with the California Institute of Technology (Caltech), funded by NASA through the Sagan Fellowship Program (S.K. is a Sagan Fellow). We thank the ESO Paranal staff for support and their efforts in improving the VLTI. This paper is based on observations made with ESO telescopes at the La Silla Paranal Observatory and archival data obtained with the Spitzer Space Telescope, operated by the Jet Propulsion Laboratory, Caltech, under a contract with NASA. We also used data acquired with APEX, a collaboration between the Max-Planck-Institut fur Radioastronomie, ESO, and the Onsala Space Observatory.	Beltran MT, 2006, ASTRON ASTROPHYS, V447, P221, DOI 10.1051/0004-6361:20053999; Benjamin RA, 2003, PUBL ASTRON SOC PAC, V115, P953, DOI 10.1086/376696; Bernasconi PA, 1996, ASTRON ASTROPHYS, V307, P829; BLANDFORD RD, 1982, MON NOT R ASTRON SOC, V199, P883, DOI 10.1093/mnras/199.4.883; BODENHEIMER P, 1995, ANNU REV ASTRON ASTR, V33, P199; Bonnell IA, 1998, MON NOT R ASTRON SOC, V298, P93, DOI 10.1046/j.1365-8711.1998.01590.x; Bonnell IA, 2005, MON NOT R ASTRON SOC, V362, P915, DOI 10.1111/j.1365-2966.2005.09360.x; CABRIT S, 1990, ASTROPHYS J, V354, P687, DOI 10.1086/168725; Cesaroni R., 2007, PROTOSTARS PLANETS, VV, P197; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Eisner JA, 2007, ASTROPHYS J, V657, P347, DOI 10.1086/510833; Fontani F, 2005, ASTRON ASTROPHYS, V432, P921, DOI 10.1051/0004-6361:20041810; Grave JMC, 2009, ASTRON ASTROPHYS, V498, P147, DOI 10.1051/0004-6361/200810902; HOFMANN KH, 1993, ASTRON ASTROPHYS, V278, P328; Hollenbach D. J., 2000, Protostars and planets 4, P401; KAHN FD, 1974, ASTRON ASTROPHYS, V37, P149; Kraus S, 2009, ASTRON ASTROPHYS, V497, P195, DOI 10.1051/0004-6361/200810368; Kraus S, 2008, ASTROPHYS J, V676, P490, DOI 10.1086/527427; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; McKee CF, 2002, NATURE, V416, P59, DOI 10.1038/416059a; Mckee CF, 2007, ANNU REV ASTRON ASTR, V45, P565, DOI 10.1146/annurev.astro.45.051806.110602; Monnier JD, 2005, ASTROPHYS J, V624, P832, DOI 10.1086/429266; Petrov RG, 2007, ASTRON ASTROPHYS, V464, P1, DOI 10.1051/0004-6361:20066496; Robitaille TP, 2007, ASTROPHYS J SUPPL S, V169, P328, DOI 10.1086/512039; Robitaille TP, 2006, ASTROPHYS J SUPPL S, V167, P256, DOI 10.1086/508424; Smith HA, 2006, ASTROPHYS J, V645, P1264, DOI 10.1086/504370; Tobin JJ, 2007, ASTROPHYS J, V659, P1404, DOI 10.1086/512720; Whitney BA, 2003, ASTROPHYS J, V591, P1049, DOI 10.1086/375415; WOLFIRE MG, 1987, ASTROPHYS J, V319, P850, DOI 10.1086/165503; Zinnecker H, 2007, ANNU REV ASTRON ASTR, V45, P481, DOI 10.1146/annurev.astro.44.051905.092549	30	118	118	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					339	342		10.1038/nature09174	http://dx.doi.org/10.1038/nature09174			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631793	Green Submitted			2022-12-28	WOS:000279867100042
J	Toynbee, P				Toynbee, Polly			White Paper GPs have reasons not to be so cheerful over commissioning plans	BRITISH MEDICAL JOURNAL			English	Editorial Material												polly.toynbee@guardian.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 15	2010	341								c3839	10.1136/bmj.c3839	http://dx.doi.org/10.1136/bmj.c3839			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XD	20634341				2022-12-28	WOS:000280156800009
J	Hurley, R				Hurley, Richard			HIV/AIDS How Ukraine is tackling Europe's worst HIV epidemic	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England			rhurley@bmj.com						[Anonymous], 2008, EP FACT SHEET HIV AI; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; *MIN HLTH WHO UKR, 2009, INT HIV AIDS ALL UKR; Ministry of Health of Ukraine, 2010, UKR NAT REP MON PROG; *UNAIDS, 2008, E EUR CENTR AS FACTS	5	5	5	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3538	10.1136/bmj.c3538	http://dx.doi.org/10.1136/bmj.c3538			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627980				2022-12-28	WOS:000280156600007
J	Lombard, C; Deeks, A; Jolley, D; Ball, K; Teede, H				Lombard, Catherine; Deeks, Amanda; Jolley, Damien; Ball, Kylie; Teede, Helena			A low intensity, community based lifestyle programme to prevent weight gain in women with young children: cluster randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INTRACLASS CORRELATION-COEFFICIENTS; CARDIOVASCULAR-DISEASE; SELF-MANAGEMENT; PRIMARY-CARE; RISK-FACTOR; INTERVENTIONS; EDUCATION; OBESITY; MINNESOTA; EFFICACY	Objective To develop and evaluate the effectiveness of a community behavioural intervention to prevent weight gain and improve health related behaviours in women with young children. Design Cluster randomised controlled trial. Setting A community setting in urban Australia. Participants 250 adult women with a mean age of 40. 39 years (SD 4.77, range 25-51) and a mean body mass index of 27.82 kg/m(2) (SD 5.42, range 18-47) were recruited as clusters through 12 primary (elementary) schools. Intervention Schools were randomly assigned to the intervention or the control. Mothers whose schools fell in the intervention group (n=127) attended four interactive group sessions that involved simple health messages, behaviour change strategies, and group discussion, and received monthly support using mobile telephone text messages for 12 months. The control group (n=123) attended one non-interactive information session based on population dietary and physical activity guidelines. Main outcome measures The main outcome measures were weight change and difference in weight change between the intervention group and the control group at 12 months. Secondary outcomes were changes in serum concentrations of fasting lipids and glucose, and changes in dietary behaviours, physical activity, and self management behaviours. Results All analyses were adjusted for baseline values and the possible clustering effect. Women in the control group gained weight over the 12 month study period (0.83 kg, 95% confidence interval (CI) 0.12 to 1.54), whereas those in the intervention group lost weight (-0.20 kg, -0.90 to 0.49). The difference in weight change between the intervention group and the control group at 12 months was -1.13 kg (-2.03 to -0.24 kg; P<0.05) on the basis of observed values and -1.11 kg (-2.17 to -0.04) after multiple imputation to account for possible bias created by missing values. Secondary analyses after multiple imputation showed a difference in the intervention group compared with the control group for total cholesterol concentration (-0.35 mmol/l, -0.70 to -0.001), self management behaviours (diet score 0.18, 0.13 to 0.33; physical activity score 0.24, 0.05 to 0.43), and confidence to control weight (0.40, 0.11 to 0.69). Regular self weighing was associated with weight loss in the intervention group only (-1.98 kg, -3.75 to -0.23). Conclusions Weight gain in women with young children could be prevented using a low intensity self management intervention delivered in a community setting. Self management of health behaviours improved with the intervention. The response rate of 12%, although comparable with that in other community studies, might limit the ability to generalise to other populations.	[Lombard, Catherine; Deeks, Amanda; Teede, Helena] Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Grp, Melbourne, Vic 3004, Australia; [Ball, Kylie] Deakin Univ, Sch Exercise & Nutr Sci, Melbourne, Vic, Australia; [Teede, Helena] Southern Hlth, Diabet Res Unit, Melbourne, Vic, Australia	Monash University; Deakin University	Teede, H (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Jean Hailes Res Grp, Melbourne, Vic 3004, Australia.	helena.teede@med.monash.edu.au	Ball, Kylie/B-5866-2015	Ball, Kylie/0000-0003-2893-8415; Lombard, Catherine/0000-0001-9091-8090; Teede, Helena/0000-0001-7609-577X	National Health and Medical Research Council [ID 545888, ID 479513]; VicHealth, Victoria, Australia; Monash University, Melbourne, Australia; William Buckland Foundation, Melbourne, Australia	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); VicHealth, Victoria, Australia; Monash University, Melbourne, Australia(Monash University); William Buckland Foundation, Melbourne, Australia	HT is supported by a National Health and Medical Research Council Research Fellowship (ID 545888), KB is funded by a National Health and Medical Research Council Senior Research Fellowship (ID 479513), and CL was awarded a PhD scholarship by VicHealth, Victoria, Australia and a postgraduate writing award by Monash University, Melbourne, Australia. Research costs were funded by a project grant from the William Buckland Foundation, Melbourne, Australia. The researchers were independent of the funder. The organisation responsible for funding had no role in the design or conduct of the study, or in collection, analysis, and interpretation of data or preparation, review, or approval of this manuscript. The authors had full access to all data and had final responsibility for the decision to submit for publication.	[Anonymous], 2006, SOC IND AR SEIFA; *AUSTR GOV, 2003, FOOD HLTH DIET GUID; Australian Government, 2005, NAT PHYS ACT GUID AD; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Barr E, 2005, AUSTR DIABETES OBESI; Berry JD, 2009, CIRCULATION, V119, P382, DOI 10.1161/CIRCULATIONAHA.108.800235; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; Davies MJ, 2008, BMJ-BRIT MED J, V336, P491, DOI 10.1136/bmj.39474.922025.BE; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Elmer PJ, 2006, ANN INTERN MED, V144, P485, DOI 10.7326/0003-4819-144-7-200604040-00007; Food Standards Australia New Zealand, 2006, NUTR DAT TABL US AUS; Gorin AA, 2008, INT J OBESITY, V32, P1678, DOI 10.1038/ijo.2008.150; Hallal PC, 2004, MED SCI SPORT EXER, V36, P556, DOI 10.1249/01.MSS.0000117161.66394.07; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hodge A, 2000, AUST NZ J PUBL HEAL, V24, P576, DOI 10.1111/j.1467-842X.2000.tb00520.x; IPAQ, 2005, INT PHYS ACT QUEST; Jeffery RW, 1999, AM J PUBLIC HEALTH, V89, P747, DOI 10.2105/AJPH.89.5.747; JEFFERY RW, 1993, ANN INTERN MED, V119, P719, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00018; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Lombard C, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-2, 10.1186/1471-2458-9-213]; Lombard CB, 2009, PUBLIC HEALTH NUTR, V12, P2236, DOI 10.1017/S1368980009990577; LUEPKER RV, 1994, AM J PUBLIC HEALTH, V84, P1383, DOI 10.2105/AJPH.84.9.1383; MCLEAN N, 2003, OBES REV, V27, P987; Parker DR, 2005, CONTEMP CLIN TRIALS, V26, P260, DOI 10.1016/j.cct.2005.01.002; Resnick HE, 2000, J EPIDEMIOL COMMUN H, V54, P596, DOI 10.1136/jech.54.8.596; Saelens BE, 2000, BEHAV THER, V31, P365, DOI 10.1016/S0005-7894(00)80020-9; SALLIS JF, 1988, HLTH ED RES, V3, P238; Shaw K, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003818.pub2; Sherwood NE, 2006, INT J OBESITY, V30, P1565, DOI 10.1038/sj.ijo.0803295; Simkin-Silverman LR, 2003, ANN BEHAV MED, V26, P212, DOI 10.1207/S15324796ABM2603_06; Smeeth L, 2002, CONTROL CLIN TRIALS, V23, P409, DOI 10.1016/S0197-2456(02)00208-8; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Trost SG, 2003, AM J PREV MED, V25, P277, DOI 10.1016/S0749-3797(03)00217-4; VANDAM RM, 2008, BMJ-BRIT MED J, V337, P742; VanWormer JJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-54; VanWormer JJ, 2009, AM J PREV MED, V36, P70, DOI 10.1016/j.amepre.2008.09.022; Wadden TA, 2005, NEW ENGL J MED, V353, P2111, DOI 10.1056/NEJMoa050156; Wadden TA, 2007, GASTROENTEROLOGY, V132, P2226, DOI 10.1053/j.gastro.2007.03.051; WHO, 2000, OB PREV MAN GLOB EP; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wing RR, 2008, J CONSULT CLIN PSYCH, V76, P1015, DOI 10.1037/a0014159; 2005, AUSTR WOMEN THEIR WE	44	71	71	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3215	10.1136/bmj.c3215	http://dx.doi.org/10.1136/bmj.c3215			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XB	20627974	Green Published, hybrid			2022-12-28	WOS:000280156600003
J	Azria, D; Bourgier, C				Azria, David; Bourgier, Celine			Partial breast irradiation: new standard for selected patients	LANCET			English	Editorial Material							RADIATION; LUMPECTOMY; TAMOXIFEN; THERAPY; WOMEN		[Azria, David] CRLC Val Aurelle, Dept Radiat Oncol, F-34298 Montpellier 05, France; [Azria, David] CRLC Val Aurelle, INSERM, U896, F-34298 Montpellier 05, France; [Bourgier, Celine] Inst Gustave Roussy, Dept Radiat Oncol, Villejuif, France	UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM); UNICANCER; Gustave Roussy	Azria, D (corresponding author), CRLC Val Aurelle, Dept Radiat Oncol, F-34298 Montpellier 05, France.	David.Azria@valdorel.fnclcc.fr	Bourgier, Celine/Y-8679-2019					Abe O, 2005, LANCET, V366, P2087; Azria D, 2010, LANCET ONCOL, V11, P258, DOI 10.1016/S1470-2045(10)70013-9; Bartelink H, 2007, J CLIN ONCOL, V25, P3259, DOI 10.1200/JCO.2007.11.4991; BOURGIER C, 2009, INT J RADIAT ONCOL, V75, P82; Bourgier C, 2010, RADIOTHER ONCOL, V96, P199, DOI 10.1016/j.radonc.2010.02.028; Bourgier C, 2010, INT J RADIAT ONCOL, V76, P956, DOI 10.1016/j.ijrobp.2009.10.026; Dubois JB, 1997, FRONT RADIAT THER ON, V31, P131; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; Lemanski C, 2010, INT J RADIAT ONCOL, V76, P698, DOI 10.1016/j.ijrobp.2009.02.039; Smith BD, 2009, INT J RADIAT ONCOL, V74, P987, DOI 10.1016/j.ijrobp.2009.02.031; VAIDYA JS, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60837-9; 2010, RAD THERAPY TREATING	13	24	24	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					71	72		10.1016/S0140-6736(10)60898-7	http://dx.doi.org/10.1016/S0140-6736(10)60898-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20570344				2022-12-28	WOS:000279943200004
J	Hentze, MW; Muckenthaler, MU; Galy, B; Camaschella, C				Hentze, Matthias W.; Muckenthaler, Martina U.; Galy, Bruno; Camaschella, Clara			Two to Tango: Regulation of Mammalian Iron Metabolism	CELL			English	Review							HEREDITARY HEMOCHROMATOSIS PROTEIN; HEPCIDIN EXPRESSION; MOLECULAR-BASIS; MICROCYTIC ANEMIA; CHANNELS PROVIDE; MOUSE MODEL; CELL; TRANSFERRIN; RECEPTOR; HOMEOSTASIS		[Hentze, Matthias W.; Galy, Bruno] European Mol Biol Lab, D-69117 Heidelberg, Germany; [Hentze, Matthias W.; Muckenthaler, Martina U.] European Mol Biol Lab, Mol Med Partnership Unit, D-69120 Heidelberg, Germany; [Hentze, Matthias W.; Muckenthaler, Martina U.] Heidelberg Univ, D-69120 Heidelberg, Germany; [Muckenthaler, Martina U.] Dept Pediat Oncol Hematol & Immunol, D-69120 Heidelberg, Germany; [Camaschella, Clara] Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy; [Camaschella, Clara] Univ Vita Salute San Raffaele, I-20132 Milan, Italy	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Ruprecht Karls University Heidelberg; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Vita-Salute San Raffaele University	Hentze, MW (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.	hentze@embl.de	Camaschella, Clara/A-3289-2015; Girelli, Domenico/B-1183-2008; Hentze, Matthias W/V-3980-2017	Girelli, Domenico/0000-0001-9684-1899; Hentze, Matthias W/0000-0002-4023-7876; Galy, Bruno/0000-0002-0501-6357; Muckenthaler, Martina/0000-0002-3778-510X	European Commission; BMBF; Deutsche Forschungsgemeinschaft; Telethon Rome [GGP08089]	European Commission(European CommissionEuropean Commission Joint Research Centre); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Telethon Rome(Fondazione Telethon)	We are grateful to Petra Riedinger for graphic design. Work in the laboratory of M. W. H. was supported by grants from the European Commission (EuroIron) and the BMBF (HepatoSys). M.U.M. acknowledges support from the Deutsche Forschungsgemeinschaft, BMBF (HepatoSys, Erare), and European Commission (EuroIron), and C.C. from Telethon Rome, grant GGP08089, and the European Commission (EuroIron).	Andrews NC, 2009, NAT GENET, V41, P1161, DOI 10.1038/ng1109-1161; Andriopoulos B, 2009, NAT GENET, V41, P482, DOI 10.1038/ng.335; AROSIO P, 2010, BIOCHIM BIOPHYS ACTA, DOI DOI 10.1016/J.BBA-GEN.2010.02.005; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Beutler E, 2002, LANCET, V359, P211, DOI 10.1016/S0140-6736(02)07447-0; Butt J, 1996, P NATL ACAD SCI USA, V93, P4345, DOI 10.1073/pnas.93.9.4345; Camaschella C, 2005, BLOOD, V106, P3710, DOI 10.1182/blood-2005-05-1857; Casanovas G, 2009, J MOL MED, V87, P471, DOI 10.1007/s00109-009-0447-2; Chen TT, 2005, J EXP MED, V202, P955, DOI 10.1084/jem.20042433; Chen W, 2009, P NATL ACAD SCI USA, V106, P16263, DOI 10.1073/pnas.0904519106; Cooperman SS, 2005, BLOOD, V106, P1084, DOI 10.1182/blood-2004-12-4703; Corradini E, 2009, GASTROENTEROLOGY, V137, P1489, DOI 10.1053/j.gastro.2009.06.057; DAUTRYVARSAT A, 1983, P NATL ACAD SCI-BIOL, V80, P2258, DOI 10.1073/pnas.80.8.2258; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; De Domenico I, 2009, P NATL ACAD SCI USA, V106, P3800, DOI 10.1073/pnas.0900453106; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Donovan A, 2000, NATURE, V403, P776, DOI 10.1038/35001596; Donovan A, 2005, CELL METAB, V1, P191, DOI 10.1016/j.cmet.2005.01.003; Du X, 2008, SCIENCE, V320, P1088, DOI 10.1126/science.1157121; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Fernandes A, 2009, BLOOD, V114, P437, DOI 10.1182/blood-2008-03-146134; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ferris CD, 1999, NAT CELL BIOL, V1, P152, DOI 10.1038/11072; Finberg KE, 2010, BLOOD, V115, P3817, DOI 10.1182/blood-2009-05-224808; Fleming RE, 2007, GASTROENTEROLOGY, V132, P447, DOI 10.1053/j.gastro.2006.11.049; Gaasch JA, 2007, NEUROCHEM RES, V32, P1686, DOI 10.1007/s11064-007-9313-1; Galy B, 2005, BLOOD, V106, P2580, DOI 10.1182/blood-2005-04-1365; GALY B, 2010, CELL METAB IN PRESS; Galy B, 2008, CELL METAB, V7, P79, DOI 10.1016/j.cmet.2007.10.006; Ganz T, 2008, BLOOD, V112, P4292, DOI 10.1182/blood-2008-02-139915; Gao JW, 2010, BLOOD, V115, P3374, DOI 10.1182/blood-2009-09-245209; Gao JW, 2009, CELL METAB, V9, P217, DOI 10.1016/j.cmet.2009.01.010; Goforth JB, 2010, RNA, V16, P154, DOI 10.1261/rna.1857210; Goswami T, 2006, J BIOL CHEM, V281, P28494, DOI 10.1074/jbc.C600197200; Grimsrud CD, 1999, J BONE MINER RES, V14, P475, DOI 10.1359/jbmr.1999.14.4.475; Gunshin H, 2005, J CLIN INVEST, V115, P1258, DOI [10.1172/JCI200524356, 10.1172/JCI24356]; Gunshin H, 1997, NATURE, V388, P482, DOI 10.1038/41343; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Huang H, 2009, BLOOD, V113, P3593, DOI 10.1182/blood-2008-08-173641; Huang MLH, 2009, P NATL ACAD SCI USA, V106, P16381, DOI 10.1073/pnas.0906784106; Iolascon A, 2009, HAEMATOL-HEMATOL J, V94, P395, DOI 10.3324/haematol.13619; Jordan JB, 2009, J BIOL CHEM, V284, P24155, DOI 10.1074/jbc.M109.017764; Kautz L, 2009, BLOOD, V114, P2515, DOI 10.1182/blood-2009-02-206771; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Lee DH, 2010, BLOOD, V115, P3136, DOI 10.1182/blood-2009-11-251199; Leimberg JM, 2008, TRANSL RES, V151, P88, DOI 10.1016/j.trsl.2007.12.002; Li JY, 2009, DEV CELL, V16, P35, DOI 10.1016/j.devcel.2008.12.002; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Ludwiczek S, 2007, NAT MED, V13, P448, DOI 10.1038/nm1542; Mastrogiannaki M, 2009, J CLIN INVEST, V119, P1159, DOI 10.1172/JCI38499; Mckie AT, 2008, BIOCHEM SOC T, V36, P1239, DOI 10.1042/BST0361239; McKie AT, 2000, MOL CELL, V5, P299, DOI 10.1016/S1097-2765(00)80425-6; Meynard D, 2009, NAT GENET, V41, P478, DOI 10.1038/ng.320; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Mleczko-Sanecka K, 2010, BLOOD, V115, P2657, DOI 10.1182/blood-2009-09-238105; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nicolas G, 2003, NAT GENET, V34, P97, DOI 10.1038/ng1150; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Ohgami RS, 2005, NAT GENET, V37, P1264, DOI 10.1038/ng1658; Oudit GY, 2003, NAT MED, V9, P1187, DOI 10.1038/nm920; Pak M, 2006, BLOOD, V108, P3730, DOI 10.1182/blood-2006-06-028787; Pantopoulos K, 1998, P NATL ACAD SCI USA, V95, P10559, DOI 10.1073/pnas.95.18.10559; Peslova G, 2009, BLOOD, V113, P6225, DOI 10.1182/blood-2009-01-201590; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Pipemo A, 2007, BLOOD, V110, P4096, DOI 10.1182/blood-2007-06-096503; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Recalcati S, 2010, ANTIOXID REDOX SIGN, V13, P1593, DOI 10.1089/ars.2009.2983; Robach P, 2009, BLOOD, V113, P6707, DOI 10.1182/blood-2008-09-178095; Salahudeen AA, 2009, SCIENCE, V326, P722, DOI 10.1126/science.1176326; Sanchez M, 2007, NAT STRUCT MOL BIOL, V14, P420, DOI 10.1038/nsmb1222; Sasu BJ, 2010, BLOOD, V115, P3616, DOI 10.1182/blood-2009-09-245977; Schmidt PJ, 2008, CELL METAB, V7, P205, DOI 10.1016/j.cmet.2007.11.016; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Sheftel AD, 2009, ANN MED, V41, P82, DOI 10.1080/07853890802322229; Shi HF, 2008, SCIENCE, V320, P1207, DOI 10.1126/science.1157643; Silvestri L, 2008, BLOOD, V111, P924, DOI 10.1182/blood-2007-07-100677; Silvestri L, 2008, CELL METAB, V8, P502, DOI 10.1016/j.cmet.2008.09.012; Smith SR, 2006, BLOOD CELL MOL DIS, V36, P283, DOI 10.1016/j.bcmd.2005.12.006; Soe-Lin S, 2009, P NATL ACAD SCI USA, V106, P5960, DOI 10.1073/pnas.0900808106; Tanno T, 2007, NAT MED, V13, P1096, DOI 10.1038/nm1629; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Truksa J, 2007, BLOOD, V110, P3436, DOI 10.1182/blood-2007-05-091108; Truksa J, 2009, BRIT J HAEMATOL, V147, P571, DOI 10.1111/j.1365-2141.2009.07873.x; Vashisht AA, 2009, SCIENCE, V326, P718, DOI 10.1126/science.1176333; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang RH, 2005, CELL METAB, V2, P399, DOI 10.1016/j.cmet.2005.10.010; Weinstein DA, 2002, BLOOD, V100, P3776, DOI 10.1182/blood-2002-04-1260; Weizer-Stern O, 2007, BRIT J HAEMATOL, V138, P253, DOI 10.1111/j.1365-2141.2007.06638.x; Ye H, 2010, J CLIN INVEST, V120, P1749, DOI 10.1172/JCI40372; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang DL, 2009, CELL METAB, V9, P461, DOI 10.1016/j.cmet.2009.03.006	99	1316	1388	18	279	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					24	38		10.1016/j.cell.2010.06.028	http://dx.doi.org/10.1016/j.cell.2010.06.028			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603012	Bronze			2022-12-28	WOS:000279637300010
J	Goldacre, MJ; Laxton, L; Lambert, TW				Goldacre, Michael J.; Laxton, L.; Lambert, T. W.			Medical graduates' early career choices of specialty and their eventual specialty destinations: UK prospective cohort studies	BRITISH MEDICAL JOURNAL			English	Article							UNITED-KINGDOM; DOCTORS; REASONS; WOMEN	Objective To report on doctors' early choices of specialty at selected intervals after qualification, and eventual career destinations. Design Questionnaire surveys. Setting United Kingdom. Participants Total of 15 759 doctors who qualified in 1974, 1977, 1983, 1993, and 1996, and their career destinations 10 years after graduation. Results 15 759 doctors were surveyed one and three years after graduation and 12 108 five years after graduation. Career preferences at years 1, 3, and 5, and destinations at 10 years, were known for, respectively, 64% (n=10 154), 62% (n=9702), and 61% (n=7429) of the survey population. In the 1993 and 1996 cohorts, career destinations matched with year 1 choices for 54% (1890/3508) of doctors in year 1, 70% (2494/3579) in year 3, and 83% (2916/3524) in year 5. Corresponding results for the earlier cohorts (1974-83) were similar: 53% (3310/6264), 74% (4233/5752), and 82% (2976/3646). The match rates varied by specialty; for example, the rates were consistently high for surgery. Career destinations matched with year 1 choices for 74% (722/982) of doctors who specified a definite (rather than probable or uncertain) specialty choice in their first postgraduate year. About half of those who chose a hospital specialty but did not eventually work in it were working in general practice by year 10. Conclusions Ten years after qualification about a quarter of doctors were working in a specialty that was different from the one chosen in their third year after graduation. This stayed reasonably constant across graduation cohorts despite the changes in training programmes over time. Subject to the availability of training posts, postgraduate training should permit those who have made early, definite choices to progress quickly into their chosen specialty, while recognising the need for flexibility for those who choose later.	[Goldacre, Michael J.; Laxton, L.; Lambert, T. W.] Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, UK Med Careers Res Grp, Oxford OX3 7LF, England	University of Oxford	Goldacre, MJ (corresponding author), Univ Oxford, Dept Publ Hlth, Unit Hlth Care Epidemiol, UK Med Careers Res Grp, Oxford OX3 7LF, England.	michael.goldacre@dphpc.ox.ac.uk		Lambert, Trevor/0000-0001-9688-3036	Department of Health; National Institute for Health Research	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))	The UK Medical Careers Research Group is funded by the Department of Health's policy research programme. The Unit of HealthCare Epidemiology is funded by the National Institute for Health Research. The study sponsors had no role in the design, conduct, analysis, or reporting of the study. The views and opinions expressed in this paper do not necessarily reflect those of the sponsors.	Agresti A., 1990, CATEGORICAL DATA ANA, pXV; Calman KC, 1999, MED EDUC, V33, P28; DONALDSON L, 2002, UNFINISHED BUSINESS; Lambert TW, 2006, PSYCHOL MED, V36, P679, DOI 10.1017/S0033291705007038; Lambert TW, 1996, BRIT MED J, V313, P19, DOI 10.1136/bmj.313.7048.19; Lambert TW, 2003, MED EDUC, V37, P312, DOI 10.1046/j.1365-2923.2003.01473.x; McManus IC, 2000, J EPIDEMIOL COMMUN H, V54, P10, DOI 10.1136/jech.54.1.10; *NAT RES MATCH PRO, RES DAT 2009 MAIN RE; SOETHOUT MBM, 2004, FACTORS ASS NATURE T; Taylor KS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1735; Tooke J., 2007, ASPIRING EXCELLENCE; *WORK GROUP SPEC M, 1993, HOSP DOCT TRAIN FUT	12	72	72	0	10	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2010	341								c3199	10.1136/bmj.c3199	http://dx.doi.org/10.1136/bmj.c3199			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DK	20605892	Green Published, hybrid			2022-12-28	WOS:000279874200003
J	Lauer, MS				Lauer, Michael S.			Risk for Venous Thromboembolism in Patients With Superficial Venous Thrombosis	ANNALS OF INTERNAL MEDICINE			English	Letter									NHLBI, Bethesda, MD 20824 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Lauer, MS (corresponding author), NHLBI, Bethesda, MD 20824 USA.		Lauer, Michael S/L-9656-2013	Lauer, Michael S/0000-0002-9217-8177				Decousus H, 2010, ANN INTERN MED, V152, P218, DOI 10.7326/0003-4819-152-4-201002160-00006	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					62	62		10.7326/0003-4819-153-1-201007060-00023	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00023			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20621914				2022-12-28	WOS:000279487700020
J	Hillman, BJ; Goldsmith, JC				Hillman, Bruce J.; Goldsmith, Jeff C.			The Uncritical Use of High-Tech Medical Imaging	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hillman, Bruce J.] Univ Virginia, Dept Radiol, Charlottesville, VA 22903 USA; [Hillman, Bruce J.; Goldsmith, Jeff C.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Goldsmith, Jeff C.] Hlth Futures, Charlottesville, VA USA	University of Virginia; University of Virginia	Hillman, BJ (corresponding author), Univ Virginia, Dept Radiol, Charlottesville, VA 22903 USA.							[Anonymous], 2008, GAO08452; Baker LC, 2008, HEALTH AFFAIR, V27, P1467, DOI 10.1377/hlthaff.27.6.1467; *MASS MED SOC, 2008, 108 MASS MED SOC; *MED PAYM ADV COMM, 2009, IMP PHYS SELF REF US, P81	4	108	112	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					4	6		10.1056/NEJMp1003173	http://dx.doi.org/10.1056/NEJMp1003173			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618HR	20573920				2022-12-28	WOS:000279343000002
J	Grow, EJ; Wysocka, J				Grow, Edward J.; Wysocka, Joanna			Flipping MLL1's Switch One Proline at a Time	CELL			English	Editorial Material									[Grow, Edward J.; Wysocka, Joanna] Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Grow, Edward J.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu						CHANG PY, 2010, J MOL BIOL; Chen J, 2008, CANCER RES, V68, P6199, DOI 10.1158/0008-5472.CAN-07-6514; Hom RA, 2010, J MOL BIOL, V400, P145, DOI 10.1016/j.jmb.2010.04.067; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Slany RK, 2009, HAEMATOL-HEMATOL J, V94, P984, DOI 10.3324/haematol.2008.002436; Wang Y, 2008, FEBS LETT, V582, P835, DOI 10.1016/j.febslet.2008.01.055; Xia ZB, 2003, P NATL ACAD SCI USA, V100, P8342, DOI 10.1073/pnas.1436338100	8	10	10	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1108	1110		10.1016/j.cell.2010.06.013	http://dx.doi.org/10.1016/j.cell.2010.06.013			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602992	Bronze			2022-12-28	WOS:000279148100006
J	Prie, D; Friedlander, G				Prie, Dominique; Friedlander, Gerard			Mechanisms of Disease: Genetic Disorders of Renal Phosphate Transport.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GROWTH-FACTOR 23; FAMILIAL ISOLATED HYPOPARATHYROIDISM; MINERAL ION HOMEOSTASIS; HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; TUMORAL CALCINOSIS; SERUM PHOSPHORUS; INTACT FIBROBLAST-GROWTH-FACTOR-23; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; HYPOPHOSPHATEMIC RICKETS		[Prie, Dominique; Friedlander, Gerard] Paris Descartes Univ, INSERM, U845, Growth & Signaling Res Ctr, F-75015 Paris, France; [Prie, Dominique; Friedlander, Gerard] Paris Descartes Univ, INSERM, U845, Dept Physiol, F-75015 Paris, France; [Prie, Dominique] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, Paris, France; [Friedlander, Gerard] Georges Pompidou European Hosp, Assistance Publ Hop Paris, Serv Physiol Explorat Fonct, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite	Friedlander, G (corresponding author), Paris Descartes Univ, INSERM, U845, Growth & Signaling Res Ctr, 156 Rue Vaugirard, F-75015 Paris, France.	gerard.friedlander@inserm.fr		Friedlander, Gerard/0000-0002-6854-4261	INSERM, Paris Descartes University, Association Laboratoire de Recherches Physiologiques; Agence Nationale pour la Recherche [ANR-07-PHYSIO-017-01]	INSERM, Paris Descartes University, Association Laboratoire de Recherches Physiologiques(Institut National de la Sante et de la Recherche Medicale (Inserm)); Agence Nationale pour la Recherche(French National Research Agency (ANR))	Supported by grants from INSERM, Paris Descartes University, Association Laboratoire de Recherches Physiologiques and by a grant (ANR-07-PHYSIO-017-01) from the Agence Nationale pour la Recherche.	Amling M, 1999, ENDOCRINOLOGY, V140, P4982, DOI 10.1210/en.140.11.4982; Antoniucci DM, 2006, J CLIN ENDOCR METAB, V91, P3144, DOI 10.1210/jc.2006-0021; Araya K, 2005, J CLIN ENDOCR METAB, V90, P5523, DOI 10.1210/jc.2005-0301; Bai XY, 2003, J BIOL CHEM, V278, P9843, DOI 10.1074/jbc.M210490200; Baumber L, 2005, J MED GENET, V42, P443, DOI 10.1136/jmg.2004.026898; BAYLINK D, 1971, J CLIN INVEST, V50, P2519, DOI 10.1172/JCI106752; Beck GR, 2003, J CELL BIOCHEM, V90, P234, DOI 10.1002/jcb.10622; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Benet-Pages A, 2005, HUM MOL GENET, V14, P385, DOI 10.1093/hmg/ddi034; Brown WW, 2009, J CLIN ENDOCR METAB, V94, P17, DOI 10.1210/jc.2008-0220; Burnett SAM, 2006, J BONE MINER RES, V21, P1187, DOI 10.1359/JBMR.060507; Busch AE, 1996, P NATL ACAD SCI USA, V93, P5347, DOI 10.1073/pnas.93.11.5347; Bushinsky DA, 2000, KIDNEY INT, V57, P550; Canaff L, 2009, HUM MUTAT, V30, P85, DOI 10.1002/humu.20827; Chau H, 2003, J BONE MINER RES, V18, P644, DOI 10.1359/jbmr.2003.18.4.644; Connolly GM, 2009, TRANSPLANTATION, V87, P1040, DOI 10.1097/TP.0b013e31819cd122; Dhingra R, 2007, ARCH INTERN MED, V167, P879, DOI 10.1001/archinte.167.9.879; Ding CL, 2001, J CLIN INVEST, V108, P1215, DOI 10.1172/JCI13180; Duchatelet S, 2005, HUM MOL GENET, V14, P1, DOI 10.1093/hmg/ddi001; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Farrow EG, 2009, J AM SOC NEPHROL, V20, P955, DOI 10.1681/ASN.2008070783; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Ferrari SL, 2005, J CLIN ENDOCR METAB, V90, P1519, DOI 10.1210/jc.2004-1039; Foley RN, 2009, J AM SOC NEPHROL, V20, P397, DOI 10.1681/ASN.2008020141; FRANCIS F, 1995, NAT GENET, V11, P130, DOI 10.1038/ng1095-130; Garringer HJ, 2006, J CLIN ENDOCR METAB, V91, P4037, DOI 10.1210/jc.2006-0305; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gisler SM, 2001, J BIOL CHEM, V276, P9206, DOI 10.1074/jbc.M008745200; GLORIEUX FH, 1980, NEW ENGL J MED, V303, P1023, DOI 10.1056/NEJM198010303031802; Gupta A, 2004, J CLIN ENDOCR METAB, V89, P4489, DOI 10.1210/jc.2004-0724; Hayashibara T, 2007, J BONE MINER RES, V22, P1743, DOI 10.1359/JBMR.070709; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; HOCHBERG Z, 1992, J PEDIATR-US, V121, P803, DOI 10.1016/S0022-3476(05)81919-5; Ichikawa S, 2005, J CLIN ENDOCR METAB, V90, P2420, DOI 10.1210/jc.2004-2302; Ichikawa S, 2007, J CLIN ENDOCR METAB, V92, P1943, DOI 10.1210/jc.2006-1825; Ichikawa S, 2009, ENDOCRINOLOGY, V150, P2543, DOI 10.1210/en.2008-0877; Jobert AS, 1998, J CLIN INVEST, V102, P34, DOI 10.1172/JCI2918; Karaplis AC, 1998, ENDOCRINOLOGY, V139, P5255, DOI 10.1210/en.139.12.5255; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Katai K, 1999, BIOCHEM J, V343, P705, DOI 10.1042/0264-6021:3430705; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kolek OI, 2005, AM J PHYSIOL-GASTR L, V289, pG1036, DOI 10.1152/ajpgi.00243.2005; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Lapointe JY, 2006, KIDNEY INT, V69, P2261, DOI 10.1038/sj.ki.5000437; Larsson T, 2005, ENDOCRINOLOGY, V146, P3883, DOI 10.1210/en.2005-0431; Larsson T, 2005, J CLIN ENDOCR METAB, V90, P2424, DOI 10.1210/jc.2004-2238; Larsson T, 2004, ENDOCRINOLOGY, V145, P3087, DOI 10.1210/en.2003-1768; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Liu SG, 2003, J BIOL CHEM, V278, P37419, DOI 10.1074/jbc.M304544200; Liu SG, 2006, J AM SOC NEPHROL, V17, P1305, DOI 10.1681/ASN.2005111185; Lorenz-Depiereux B, 2006, NAT GENET, V38, P1248, DOI 10.1038/ng1868; Magne D, 2003, J BONE MINER RES, V18, P1430, DOI 10.1359/jbmr.2003.18.8.1430; Mahon MJ, 2003, MOL ENDOCRINOL, V17, P2355, DOI 10.1210/me.2003-0043; Mahon MJ, 2002, NATURE, V417, P858, DOI 10.1038/nature00816; Mahon MJ, 2004, J BIOL CHEM, V279, P23550, DOI 10.1074/jbc.M313229200; Mannstadt M, 2008, J CLIN ENDOCR METAB, V93, P3568, DOI 10.1210/jc.2007-2167; Mansfield K, 1999, J CELL PHYSIOL, V179, P276, DOI 10.1002/(SICI)1097-4652(199906)179:3<276::AID-JCP5>3.0.CO;2-#; Mansfield K, 2001, BONE, V28, P1, DOI 10.1016/S8756-3282(00)00409-9; Mirams M, 2004, BONE, V35, P1192, DOI 10.1016/j.bone.2004.06.014; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Murer H, 2000, PHYSIOL REV, V80, P1373, DOI 10.1152/physrev.2000.80.4.1373; Nakatani T, 2009, FASEB J, V23, P433, DOI 10.1096/fj.08-114397; Perwad F, 2005, ENDOCRINOLOGY, V146, P5358, DOI 10.1210/en.2005-0777; PORTALE AA, 1989, J CLIN INVEST, V83, P1494, DOI 10.1172/JCI114043; Pri? D., 2009, IBMS BONEKEY, V6, P357, DOI [10.1138/20090400, DOI 10.1138/20090400]; Prie D, 2002, NEW ENGL J MED, V347, P983, DOI 10.1056/NEJMoa020028; Prie D, 2001, KIDNEY INT, V60, P272, DOI 10.1046/j.1523-1755.2001.00796.x; Prie D, 2009, KIDNEY INT, V75, P882, DOI 10.1038/ki.2008.643; Riminucci M, 2003, J CLIN INVEST, V112, P683, DOI 10.1172/JC120031899; Sabbagh Y, 2005, P NATL ACAD SCI USA, V102, P9637, DOI 10.1073/pnas.0502249102; Sabbagh Y, 2009, J AM SOC NEPHROL, V20, P2348, DOI 10.1681/ASN.2009050559; Saito H, 2003, J BIOL CHEM, V278, P2206, DOI 10.1074/jbc.M207872200; Saito H, 2005, J BIOL CHEM, V280, P2543, DOI 10.1074/jbc.M408903200; Schipani E, 1999, J CLIN ENDOCR METAB, V84, P3052, DOI 10.1210/jc.84.9.3052; Schipani E, 1997, MOL ENDOCRINOL, V11, P851, DOI 10.1210/me.11.7.851; SCHIPANI E, 1995, SCIENCE, V268, P98, DOI 10.1126/science.7701349; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2004, BIOCHEM BIOPH RES CO, V314, P409, DOI 10.1016/j.bbrc.2003.12.102; Shimada T, 2001, P NATL ACAD SCI USA, V98, P6500, DOI 10.1073/pnas.101545198; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Stubbs JR, 2007, J AM SOC NEPHROL, V18, P2116, DOI 10.1681/ASN.2006121385; Tenenhouse HS, 2004, AM J PHYSIOL-RENAL, V286, pF675, DOI 10.1152/ajprenal.00362.2003; Thomee C, 2005, J CLIN ENDOCR METAB, V90, P2487, DOI 10.1210/jc.2004-2450; Tiosano D, 2009, J BONE MINER METAB, V27, P392, DOI 10.1007/s00774-009-0079-1; Tonelli, 2007, CIRCULATION, V116, pE556, DOI 10.1161/CIRCULATIONAHA.107.187927; Tonelli M, 2005, CIRCULATION, V112, P2627, DOI 10.1161/CIRCULATIONAHA.105.553198; Tonelli M, 2009, CIRCULATION, V120, P1784, DOI 10.1161/CIRCULATIONAHA.109.851873; Topaz O, 2004, NAT GENET, V36, P579, DOI 10.1038/ng1358; Tsujikawa H, 2003, MOL ENDOCRINOL, V17, P2393, DOI 10.1210/me.2003-0048; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Villa-Bellosta R, 2010, PFLUG ARCH EUR J PHY, V459, P499, DOI 10.1007/s00424-009-0746-z; WALTON RJ, 1975, LANCET, V2, P309, DOI 10.1016/S0140-6736(75)92736-1; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Xu H, 2002, AM J PHYSIOL-CELL PH, V282, pC487, DOI 10.1152/ajpcell.00412.2001; Xu H, 1999, GENOMICS, V62, P281, DOI 10.1006/geno.1999.6009; Yamazaki Y, 2002, J CLIN ENDOCR METAB, V87, P4957, DOI 10.1210/jc.2002-021105; Yamazaki Y, 2008, J BONE MINER RES, V23, P1509, DOI 10.1359/JBMR.080417; Yeung SJ, 2000, J CLIN ENDOCR METAB, V85, P549, DOI 10.1210/jc.85.2.549; Yu XJ, 2005, BONE, V36, P971, DOI 10.1016/j.bone.2005.03.002; Zhang MYH, 2002, ENDOCRINOLOGY, V143, P587, DOI 10.1210/en.143.2.587; Zhang P, 1998, J CLIN ENDOCR METAB, V83, P3365, DOI 10.1210/jc.83.9.3373; Zkao NX, 2000, ENDOCRINOLOGY, V141, P2159	106	56	57	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2399	2409		10.1056/NEJMra0904186	http://dx.doi.org/10.1056/NEJMra0904186			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573928				2022-12-28	WOS:000279043800009
J	Elliott, P; Toledano, MB; Bennett, J; Beale, L; de Hoogh, K; Best, N; Briggs, DJ				Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.			Mobile phone base stations and early childhood cancers: case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CENTRAL-NERVOUS-SYSTEM; TELEVISION TRANSMITTERS; GREAT-BRITAIN; ELECTROMAGNETIC-FIELDS; EXPOSURE METRICS; RADIO; LEUKEMIA; HEALTH; BRAIN; EPIDEMIOLOGY	Objective To investigate the risk of early childhood cancers associated with the mother's exposure to radiofrequency from and proximity to macrocell mobile phone base stations (masts) during pregnancy. Design Case-control study. Setting Cancer registry and national birth register data in Great Britain. Participants 1397 cases of cancer in children aged 0-4 from national cancer registry 1999-2001 and 5588 birth controls from national birth register, individually matched by sex and date of birth (four controls per case). Main outcome measures Incidence of cancers of the brain and central nervous system, leukaemia, and non-Hodgkin's lymphomas, and all cancers combined, adjusted for small area measures of education level, socioeconomic deprivation, population density, and population mixing. Results Mean distance of registered address at birth from a macrocell base station, based on a national database of 76890 base station antennas in 1996-2001, was similar for cases and controls (1107 (SD 1131) m v 1073 (SD 1130) m, P=0.31), as was total power output of base stations within 700 m of the address (2.89 (SD 5.9) kW v 3.00 (SD 6.0) kW, P=0.54) and modelled power density (-30.3 (SD 21.7) dBm v-29.7 (SD 21.5) dBm, P=0.41). For modelled power density at the address at birth, compared with the lowest exposure category the adjusted odds ratios were 1.01 (95% confidence interval 0.87 to 1.18) in the intermediate and 1.02 (0.88 to 1.20) in the highest exposure category for all cancers (P=0.79 for trend), 0.97 (0.69 to 1.37) and 0.76 (0.51 to 1.12), respectively, for brain and central nervous system cancers (P=0.33 for trend), and 1.16 (0.90 to 1.48) and 1.03 (0.79 to 1.34) for leukaemia and non-Hodgkin's lymphoma (P=0.51 for trend). Conclusions There is no association between risk of early childhood cancers and estimates of the mother's exposure to mobile phone base stations during pregnancy.	[Elliott, Paul; Toledano, Mireille B.; Bennett, J.; Beale, L.; de Hoogh, K.; Best, N.; Briggs, D. J.] Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, London W2 1PG, England	Imperial College London	Elliott, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Small Area Hlth Stat Unit, MRC HPA Ctr Environm & Hlth, Dept Epidemiol & Biostat,Sch Publ Hlth, St Marys Campus, London W2 1PG, England.	p.elliott@imperial.ac.uk		Elliott, Paul/0000-0002-7511-5684; Bennett, James Elston/0000-0002-9616-6878	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056, G0801056B] Funding Source: researchfish	UK Mobile Telecommunications Health Research (MTHR); UK Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: The study was funded through the UK Mobile Telecommunications Health Research (MTHR) Programme (www.mthr.org.uk), an independent body set up to provide funding for research into the possible health effects of mobile telecommunications. The MTHR is jointly funded by the UK Department of Health and the mobile telecommunications industry. Members of the independent MTHR programme management committee approved the study design and commented on a draft manuscript. Data collection and analysis, interpretation of data, and the decision to submit the paper for publication were the sole responsibility of the authors.	Adair RK, 2003, RADIAT RES, V159, P128, DOI 10.1667/0033-7587(2003)159[0128:EOTTPP]2.0.CO;2; Ahlbom A, 1998, HEALTH PHYS, V74, P494; Belson M, 2007, ENVIRON HEALTH PERSP, V115, P138, DOI 10.1289/ehp.9023; Berg-Beckhoff G, 2009, OCCUP ENVIRON MED, V66, P124, DOI 10.1136/oem.2008.039834; Blettner M, 2009, OCCUP ENVIRON MED, V66, P118, DOI 10.1136/oem.2007.037721; Canfield MA, 2006, J EXPO SCI ENV EPID, V16, P538, DOI 10.1038/sj.jes.7500501; CARSTAIRS V, 1989, BRIT MED J, V299, P886, DOI 10.1136/bmj.299.6704.886; Cooper D, 2001, AM J EPIDEMIOL, V153, P202, DOI 10.1093/aje/153.2.202; Dolk H, 1997, AM J EPIDEMIOL, V145, P10, DOI 10.1093/oxfordjournals.aje.a009026; Dolk H, 1997, AM J EPIDEMIOL, V145, P1, DOI 10.1093/oxfordjournals.aje.a009025; Eaton N, 1997, BRIT J CANCER, V75, P1080, DOI 10.1038/bjc.1997.184; Eger H, 2004, UMWELT MED GESELLSCH, V17, P325; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Ha M, 2008, AM J EPIDEMIOL, V167, P884, DOI 10.1093/aje/kwn013; Ha M, 2007, AM J EPIDEMIOL, V166, P270, DOI 10.1093/aje/kwm083; Hocking B, 1996, MED J AUSTRALIA, V165, P601, DOI 10.5694/j.1326-5377.1996.tb138661.x; Kheifets L, 2005, PEDIATRICS, V116, pE303, DOI 10.1542/peds.2004-2541; Khurana VG, 2009, SURG NEUROL, V72, P205, DOI 10.1016/j.surneu.2009.01.019; Krewski D, 2007, J TOXICOL ENV HEAL B, V10, P287, DOI 10.1080/15287390600974973; Kundi Michael, 2009, Pathophysiology, V16, P123, DOI 10.1016/j.pathophys.2009.01.008; Kundi M, 2009, ENVIRON HEALTH PERSP, V117, P316, DOI 10.1289/ehp.11902; MANN SM, 2000, R321 NRPB; Maskarinec Gertraud, 1994, Journal of Environmental Pathology Toxicology and Oncology, V13, P33; McKenzie DR, 1998, AUST NZ J PUBL HEAL, V22, P360, DOI 10.1111/j.1467-842X.1998.tb01392.x; Merzenich H, 2008, AM J EPIDEMIOL, V168, P1169, DOI 10.1093/aje/kwn230; Michelozzi P, 2002, AM J EPIDEMIOL, V155, P1096, DOI 10.1093/aje/155.12.1096; *NAT COUNC RAD PRO, 2003, BIOL EFF MOD RAD FIE; Nelson PD, 2006, NEUROLOGY, V66, P284, DOI 10.1212/01.wnl.0000194218.79519.ea; Neubauer G, 2007, BIOELECTROMAGNETICS, V28, P224, DOI 10.1002/bem.20298; OBERFELD G, 2008, UMWELTEPIDEMIOLOGISC; *ORDN SURV, 2010, ADDR POINT; Otitoloju AA, 2010, B ENVIRON CONTAM TOX, V84, P51, DOI 10.1007/s00128-009-9894-2; Park SK, 2004, INT ARCH OCC ENV HEA, V77, P387, DOI 10.1007/s00420-004-0512-7; *R FDN STAT COMP, 2010, R PROJ STAT CMP; Regel SJ, 2006, ENVIRON HEALTH PERSP, V114, P1270, DOI 10.1289/ehp.8934; Rodrigues L, 1991, STUDIES MED POPULATI, P47; Schmiedel S, 2009, BIOELECTROMAGNETICS, V30, P81, DOI 10.1002/bem.20460; Schuz J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004389; Schuz J, 2000, J EXPO ANAL ENV EPID, V10, P600, DOI 10.1038/sj.jea.7500115; Schuz J, 2009, BIOELECTROMAGNETICS, V30, P511, DOI 10.1002/bem.20510; Siegrist M, 2005, RISK ANAL, V25, P1253, DOI 10.1111/j.1539-6924.2005.00672.x; Stewart W., 2000, REPORT INDEPENDENT E, P1; Wolf R, 2004, INT J CANC PREVENTIO, V1, P1; [No title captured]	44	30	31	0	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3077	10.1136/bmj.c3077	http://dx.doi.org/10.1136/bmj.c3077			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570865	hybrid, Green Published			2022-12-28	WOS:000279346300005
J	Horton, R				Horton, Richard			Offline: The Chatham House Rule, over-ruled	LANCET			English	Editorial Material												richard.horton@lancet.com							0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2132	2132		10.1016/S0140-6736(10)60970-1	http://dx.doi.org/10.1016/S0140-6736(10)60970-1			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20609940				2022-12-28	WOS:000279255100010
J	Funk, LM; Weiser, TG; Berry, WR; Lipsitz, SR; Merry, AF; Enright, AC; Wilson, IH; Dziekan, G; Gawande, AA				Funk, Luke M.; Weiser, Thomas G.; Berry, William R.; Lipsitz, Stuart R.; Merry, Alan F.; Enright, Angela C.; Wilson, Iain H.; Dziekan, Gerald; Gawande, Atul A.			Global operating theatre distribution and pulse oximetry supply: an estimation from reported data	LANCET			English	Article							DEVELOPING-COUNTRIES; SIERRA-LEONE; ANESTHESIA; WORKFORCE; DISEASES; SURGERY; HEALTH	Background Surgery is an essential part of health care, but resources to ensure the availability of surgical services are often inadequate. We estimated the global distribution of operating theatres and quantified the availability of pulse oximetry, which is an essential monitoring device during surgery and a potential measure of operating theatre resources. Methods We calculated ratios of the number of operating theatres to hospital beds in seven geographical regions worldwide on the basis of profiles from 769 hospitals in 92 countries that participated in WHO's safe surgery saves lives initiative. We used hospital bed figures from 190 WHO member states to estimate the number of operating theatres per 100 000 people in 21 subregions throughout the world. To estimate availability of pulse oximetry, we sent surveys to anaesthesia providers in 72 countries selected to ensure a geographically and demographically diverse sample. A predictive regression model was used to estimate the pulse oximetry need for countries that did not provide data. Findings The estimated number of operating theatres ranged from 1.0 (95% Cl 0.9-1.2) per 100 000 people in west sub-Saharan Africa to 25.1 (20.9-30.1) per 100 000 in eastern Europe. High-income subregions all averaged more than 14 per 100 000 people, whereas all low-income subregions, representing 2.2 billion people, had fewer than two theatres per 100 000. Pulse oximetry data from 54 countries suggested that around 77 700 (63 195-95 533) theatres worldwide (19.2% [15.2-23.9]) were not equipped with pulse oximeters. Interpretation Improvements in public-health strategies and monitoring are needed to reduce disparities for more than 2 billion people without adequate access to surgical care.	[Funk, Luke M.; Weiser, Thomas G.; Berry, William R.; Gawande, Atul A.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Funk, Luke M.; Weiser, Thomas G.; Berry, William R.; Lipsitz, Stuart R.; Gawande, Atul A.] Brigham & Womens Hosp, Ctr Surg & Publ Hlth, Boston, MA 02115 USA; [Merry, Alan F.] Univ Auckland, Dept Anaesthesiol, Auckland 1, New Zealand; [Merry, Alan F.] Auckland City Hosp, Dept Anaesthesia, Auckland, New Zealand; [Enright, Angela C.] Univ British Columbia, Royal Jubilee Hosp, Victoria, BC, Canada; [Wilson, Iain H.] Royal Devon & Exeter NHS Fdn Trust, Exeter, Devon, England; [Dziekan, Gerald] WHO, Patient Safety Programme, CH-1211 Geneva, Switzerland	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; University of Auckland; Auckland City Hospital; University of British Columbia; University of Exeter; World Health Organization	Funk, LM (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.	lfunk@partners.org	Weiser, Thomas G/AAC-4609-2022	Weiser, Thomas G/0000-0002-3118-3888; Merry, Alan/0000-0001-7100-009X; Gawande, Atul/0000-0002-1824-9176; Funk, Luke/0000-0003-4475-304X	WHO	WHO(World Health Organization)	WHO provides grant support to the Harvard School of Public Health to conduct the Safe Surgery Saves Lives project, which this project is related to and several authors participate in (LMF, WRB, SRL, AAG). AM has been a Temporary Consultant for WHO and has Chaired the Safety and Quality Committee for the World Federation of Societies of Anaesthesiologists. AFM was the founder of Safer Sleep LLC, and is director and a shareholder of the company. TGW, ACE, IHW, and GD declare no conflicts of interest.	Ahmed M, 1999, TROP MED INT HEALTH, V4, P846, DOI 10.1046/j.1365-3156.1999.00490.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; [Anonymous], 2008, WORLD HLTH STAT 2008; [Anonymous], [No title captured]; [Anonymous], WHO TOOL SIT AN ASS; [Anonymous], GLOB BURD DIS INJ RI; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; International Taskforce on Anaesthesia Safety, 1993, EUR J ANAESTH     S7, V10, P12, DOI DOI 10.1109/79.248551; Jochberger S, 2008, ANESTH ANALG, V106, P942, DOI 10.1213/ane.0b013e318166ecb8; Kingham TP, 2009, WORLD J SURG, V33, P1194, DOI 10.1007/s00268-009-0014-6; Kingham TP, 2009, ARCH SURG-CHICAGO, V144, P122, DOI 10.1001/archsurg.2008.540; MacGowan W A, 1987, Bull Am Coll Surg, V72, P5; McCoullagh P., 1989, GEN LINEAR MODELS, V2nd ed.; Neilson JP, 2003, BRIT MED BULL, V67, P191, DOI 10.1093/bmb/ldg018; Nordberg Erik, 2002, Afr J Health Sci, V9, P17; Nugent R, 2008, ANN NY ACAD SCI, V1136, P70, DOI 10.1196/annals.1425.027; Ozgediz D, 2008, WORLD J SURG, V32, P1208, DOI 10.1007/s00268-008-9473-4; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Thoms GMM, 2007, ANAESTHESIA, V62, P75, DOI 10.1111/j.1365-2044.2007.05305.x; United Nations Statistics Division, SOC IND; Walker IA, 2009, ANAESTHESIA, V64, P1051, DOI 10.1111/j.1365-2044.2009.06067.x; Wall LL, 2006, LANCET, V368, P1201, DOI 10.1016/S0140-6736(06)69476-2; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Alliance for Patient Safety, 2008, WHO GUID SAF SURG; *WORLD BANK, 2007, DAT STAT COUNTR CLAS; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, WHO STAT INF SYST WH; World Health Organization, GLOB PULS OX PROJ	30	240	242	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2010	376	9746					1055	1061		10.1016/S0140-6736(10)60392-3	http://dx.doi.org/10.1016/S0140-6736(10)60392-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	657KM	20598365				2022-12-28	WOS:000282411600032
J	Myles, PS; Haller, G				Myles, Paul S.; Haller, Guy			Global distribution of access to surgical services	LANCET			English	Editorial Material							DEVELOPING-COUNTRIES		[Myles, Paul S.] Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia; [Myles, Paul S.] Monash Univ, Melbourne, Vic 3004, Australia; [Haller, Guy] Univ Geneva, Univ Hosp Geneva, Dept Anaesthesia Pharmacol & Intens Care, Div Clin Epidemiol, Geneva, Switzerland	Florey Institute of Neuroscience & Mental Health; Monash University; University of Geneva	Myles, PS (corresponding author), Alfred Hosp, Dept Anaesthesia & Perioperat Med, Melbourne, Vic 3004, Australia.	p.myles@alfred.org.au	Myles, Paul/AAU-9524-2020	Myles, Paul/0000-0002-3324-5456; haller, guy/0000-0001-7367-7029				Chirdan LB, 2010, J PEDIATR SURG, V45, P610, DOI 10.1016/j.jpedsurg.2009.11.007; Debas HT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1245; Dubowitz G, 2010, WORLD J SURG, V34, P438, DOI 10.1007/s00268-009-0229-6; Funk LM, 2010, LANCET, V376, P1055, DOI 10.1016/S0140-6736(10)60392-3; Gnaegi A, 1997, CRIT CARE MED, V25, P213, DOI 10.1097/00003246-199702000-00003; Hodges SC, 2007, ANAESTHESIA, V62, P4, DOI 10.1111/j.1365-2044.2006.04907.x; Kuehn BM, 2007, JAMA-J AM MED ASSOC, V298, P1853, DOI 10.1001/jama.298.16.1853; Kushner AL, 2010, ARCH SURG-CHICAGO, V145, P154, DOI 10.1001/archsurg.2009.263; Luboga S, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000200; Sheldon George F, 2008, Adv Surg, V42, P63, DOI 10.1016/j.yasu.2008.04.006; Thoms GMM, 2007, ANAESTHESIA, V62, P75, DOI 10.1111/j.1365-2044.2007.05305.x; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; World Health Organization, 2008, INT RECR HLTH PERS D	13	13	13	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP-OCT	2010	376	9746					1027	1028		10.1016/S0140-6736(10)60520-X	http://dx.doi.org/10.1016/S0140-6736(10)60520-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	657KM	20598364				2022-12-28	WOS:000282411600004
J	Busskamp, V; Duebel, J; Balya, D; Fradot, M; Viney, TJ; Siegert, S; Groner, AC; Cabuy, E; Forster, V; Seeliger, M; Biel, M; Humphries, P; Paques, M; Mohand-Said, S; Trono, D; Deisseroth, K; Sahel, JA; Picaud, S; Roska, B				Busskamp, Volker; Duebel, Jens; Balya, David; Fradot, Mathias; Viney, Tim James; Siegert, Sandra; Groner, Anna C.; Cabuy, Erik; Forster, Valerie; Seeliger, Mathias; Biel, Martin; Humphries, Peter; Paques, Michel; Mohand-Said, Saddek; Trono, Didier; Deisseroth, Karl; Sahel, Jose A.; Picaud, Serge; Roska, Botond			Genetic Reactivation of Cone Photoreceptors Restores Visual Responses in Retinitis Pigmentosa	SCIENCE			English	Article							HALORHODOPSIN; CELLS; MODEL; SELECTIVITY; EXPRESSION; SEROTYPES; DIRECTION	Retinitis pigmentosa refers to a diverse group of hereditary diseases that lead to incurable blindness, affecting two million people worldwide. As a common pathology, rod photoreceptors die early, whereas light-insensitive, morphologically altered cone photoreceptors persist longer. It is unknown if these cones are accessible for therapeutic intervention. Here, we show that expression of archaebacterial halorhodopsin in light-insensitive cones can substitute for the native phototransduction cascade and restore light sensitivity in mouse models of retinitis pigmentosa. Resensitized photoreceptors activate all retinal cone pathways, drive sophisticated retinal circuit functions (including directional selectivity), activate cortical circuits, and mediate visually guided behaviors. Using human ex vivo retinas, we show that halorhodopsin can reactivate light-insensitive human photoreceptors. Finally, we identified blind patients with persisting, light-insensitive cones for potential halorhodopsin-based therapy.	[Busskamp, Volker; Duebel, Jens; Balya, David; Viney, Tim James; Siegert, Sandra; Cabuy, Erik; Roska, Botond] Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland; [Busskamp, Volker; Groner, Anna C.; Trono, Didier] Natl Ctr Competence Res Frontiers, Genet Program, CH-1211 Geneva, Switzerland; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] INSERM, UMR S968, Inst Vis, Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Fradot, Mathias; Forster, Valerie; Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.; Picaud, Serge] CNRS, UMR 7210, F-75012 Paris, France; [Groner, Anna C.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland; [Seeliger, Mathias] Univ Tubingen, Dept Ophthalmol 2, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Biel, Martin] Univ Munich, Ctr Integrated Prot Sci Munich, Munich, Germany; [Biel, Martin] Univ Munich, Dept Pharm, Munich, Germany; [Humphries, Peter] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Paques, Michel; Mohand-Said, Saddek; Sahel, Jose A.] Ctr Hosp Natl Ophtalmol Quinze Vingts, INSERM, Ctr Invest Clin 503, Paris, France; [Paques, Michel; Sahel, Jose A.; Picaud, Serge] Fdn Ophtalmol Adolphe de Rothschild, Paris, France; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Friedrich Miescher Institute for Biomedical Research; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; University of Munich; Trinity College Dublin; CHNO des Quinze-Vingts; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Stanford University; Stanford University	Roska, B (corresponding author), Friedrich Miescher Inst Biomed Res, Neural Circuit Labs, Basel, Switzerland.	botond.roska@fmi.ch	Busskamp, Volker/E-6339-2015; Roska, Botond/AAD-7268-2021; Biel, Martin/G-1175-2014; Siegert, Sandra/GWC-4507-2022; Picaud, Serge/H-4012-2014; Sahel, Jose-Alain/F-3172-2017	Busskamp, Volker/0000-0001-7517-8944; Biel, Martin/0000-0002-9974-3052; Siegert, Sandra/0000-0001-8635-0877; Picaud, Serge/0000-0002-0548-5145; Sahel, Jose-Alain/0000-0002-4831-1153; Paques, Michel/0000-0002-9102-9196; Duebel, Jens/0000-0002-9906-5597; Viney, Tim/0000-0001-6444-1188	Friedrich Miescher Institute; U.S. Office of Naval Research; Marie Curie Excellence grant; European Union (EU) [HEALTH-F2-223156]; Agence nationale de la recherche; Foundation Fighting Blindness (U.S); Swiss National Science Foundation; Marie Curie Postdoctoral Fellowship; National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland	Friedrich Miescher Institute; U.S. Office of Naval Research(Office of Naval Research); Marie Curie Excellence grant(European Commission); European Union (EU)(CGIAREuropean Commission); Agence nationale de la recherche(French National Research Agency (ANR)); Foundation Fighting Blindness (U.S); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Marie Curie Postdoctoral Fellowship(European Commission); National Centers of Competence in Research Frontiers in Genetics; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	We thank B. G. Scherf, S. Djaffer, and H. Kohler for technical assistance and P. Lagali, K. Farrow, A. Matus, and S. Oakeley for their comments on the manuscript. pAAV2.1-Rho-EGFP was provided by A. Auricchio, and J. Nathans provided the pRed2.1lacZ. Post-mortem human retinas were provided by T. Wesseling and E. Pels at the Cornea Bank in Amsterdam (Netherlands). This study was supported by Friedrich Miescher Institute funds; a U.S. Office of Naval Research Naval International Cooperative Opportunities in Science and Technology Program grant; a Marie Curie Excellence grant and a European Union (EU) HEALTH-F2-223156 grant to B. R.; a grant from the EU (RETICIRC) to B. R. and S. P.; grants from the Agence nationale de la recherche (MEDINAS, RETINE) to S. P.; a Center Grant from Foundation Fighting Blindness (U.S.) to S.M.-S. and J. A. S.; grants from the Swiss National Science Foundation and the EU to D. T.; a grant from the EU (TREATRUSH) to J. A. S., S. P., and B. R.; a Marie Curie Postdoctoral Fellowship to D. B.; and a National Centers of Competence in Research Frontiers in Genetics fellowship to V. B. and A. C. G. The Ocular Genetics Unit at Trinity College Dublin is supported by Science Foundation Ireland. The data discussed in this publication have been deposited in NCBI's Gene Expression Omnibus (GEO) and are accessible through GEO Series accession no. GSE22338 (www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE22338).	Abdejalil J, 2005, VISION RES, V45, P1439, DOI 10.1016/j.visres.2004.12.015; Allocca M, 2007, J VIROL, V81, P11372, DOI 10.1128/JVI.01327-07; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; Banin E, 1999, NEURON, V23, P549, DOI 10.1016/S0896-6273(00)80807-7; BARLOW HB, 1963, SCIENCE, V139, P412, DOI 10.1126/science.139.3553.412; BARLOW HB, 1953, J PHYSIOL-LONDON, V119, P69, DOI 10.1113/jphysiol.1953.sp004829; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Claes E, 2004, INVEST OPHTH VIS SCI, V45, P2039, DOI 10.1167/iovs.03-0741; Cronin T, 2007, CURR GENE THER, V7, P121, DOI 10.2174/156652307780363143; Degenaar P, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/3/035007; Demb JB, 2007, NEURON, V55, P179, DOI 10.1016/j.neuron.2007.07.001; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; FARBER DB, 1994, PROG RETIN EYE RES, V13, P31, DOI 10.1016/1350-9462(94)90004-3; Gao GP, 2002, P NATL ACAD SCI USA, V99, P11854, DOI 10.1073/pnas.182412299; Gollisch T, 2010, NEURON, V65, P150, DOI 10.1016/j.neuron.2009.12.009; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; KUFFLER SW, 1953, J NEUROPHYSIOL, V16, P37, DOI 10.1152/jn.1953.16.1.37; Lebherz C, 2008, J GENE MED, V10, P375, DOI 10.1002/jgm.1126; Leveillard T, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000866; LI ZY, 1995, J NEUROSCI, V15, P5429; Lin B, 2009, EXP EYE RES, V88, P589, DOI 10.1016/j.exer.2008.11.022; Marc RE, 2003, PROG RETIN EYE RES, V22, P607, DOI 10.1016/S1350-9462(03)00039-9; Milam AH, 1998, PROG RETIN EYE RES, V17, P175; Nikonov SS, 2006, J GEN PHYSIOL, V127, P359, DOI 10.1085/jgp.200609490; Punzo C, 2009, NAT NEUROSCI, V12, P44, DOI 10.1038/nn.2234; SCHOBERT B, 1982, J BIOL CHEM, V257, P306; Seki A, 2007, BIOPHYS J, V92, P2559, DOI 10.1529/biophysj.106.093153; Shintani K, 2009, OPTOMETRY, V80, P384, DOI 10.1016/j.optm.2008.01.026; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yang Y, 2009, MOL THER, V17, P787, DOI 10.1038/mt.2009.28; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zhu XM, 2002, FEBS LETT, V524, P116, DOI 10.1016/S0014-5793(02)03014-4; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	33	436	475	2	112	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					413	417		10.1126/science.1190897	http://dx.doi.org/10.1126/science.1190897			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20576849	Green Submitted			2022-12-28	WOS:000280196500030
J	Schmid, MC; Mrowka, SW; Turchi, J; Saunders, RC; Wilke, M; Peters, AJ; Ye, FQ; Leopold, DA				Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Ye, Frank Q.; Leopold, David A.			Blindsight depends on the lateral geniculate nucleus	NATURE			English	Article							VISUAL RESPONSE PROPERTIES; SUPERIOR COLLICULUS; AREA MT; STRIATE CORTEX; MACAQUE MONKEY; GANGLION-CELLS; AFFERENT BASIS; PROJECTION; NEURONS; ACTIVATION	Injury to the primary visual cortex (V1) leads to the loss of visual experience. Nonetheless, careful testing shows that certain visually guided behaviours can persist even in the absence of visual awareness(1-4). The neural circuits supporting this phenomenon, which is often termed blindsight, remain uncertain(4). Here we demonstrate that the thalamic lateral geniculate nucleus (LGN) has a causal role in V1-independent processing of visual information. By comparing functional magnetic resonance imaging (fMRI) and behavioural measures with and without temporary LGN inactivation, we assessed the contribution of the LGN to visual functions of macaque monkeys (Macaca mulatta) with chronic V1 lesions. Before LGN inactivation, high-contrast stimuli presented to the lesion-affected visual field (scotoma) produced significant V1-independent fMRI activation in the extrastriate cortical areas V2, V3, V4, V5/middle temporal (MT), fundus of the superior temporal sulcus (FST) and lateral intraparietal area (LIP) and the animals correctly located the stimuli in a detection task. However, following reversible inactivation of the LGN in the V1-lesioned hemisphere, fMRI responses and behavioural detection were abolished. These results demonstrate that direct LGN projections to the extrastriate cortex have a critical functional contribution to blindsight. They suggest a viable pathway to mediate fast detection during normal vision.	[Schmid, Michael C.; Mrowka, Sylwia W.; Turchi, Janita; Saunders, Richard C.; Wilke, Melanie; Peters, Andrew J.; Leopold, David A.] NIMH, Neuropsychol Lab, Bethesda, MD 20892 USA; [Ye, Frank Q.; Leopold, David A.] NEI, Neurophysiol Imaging Facil, NIMH, NINDS, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); NIH National Institute of Mental Health (NIMH); NIH National Institute of Neurological Disorders & Stroke (NINDS)	Schmid, MC (corresponding author), NIMH, Neuropsychol Lab, 49 Convent Dr, Bethesda, MD 20892 USA.	schmidmicha@gmail.com	Schmid, Michael Christoph/AAH-4835-2020; Schmid, Michael C./G-1867-2010	Schmid, Michael Christoph/0000-0003-1424-130X; Schmid, Michael C./0000-0003-1424-130X; Peters, Andrew/0000-0001-9351-1456; Leopold, David/0000-0002-1345-6360	NIMH; NINDS; NEI; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002838, ZICMH002899, ZIAMH002896] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank A. Maier and D. McMahon for comments on the manuscript; S. Smirnakis, R. Berman, R. Wurtz, B. Richmond, S. Guderian and M. Fukushima for discussions; C. Zhu and H. Merkle for magnetic resonance coil construction; K. Smith, N. Phipps, J. Yu, G. Dold, D. Ide and T. Talbot for technical assistance; D. Sheinberg for developing visual stimulation software; and members of the Brian Wandell laboratory for developing and sharing mrVista software. This work was supported by the Intramural Research Programme of the NIMH, the NINDS, and the NEI.	Baseler HA, 1999, J NEUROSCI, V19, P2619; BENDER DB, 1983, BRAIN RES, V279, P258, DOI 10.1016/0006-8993(83)90188-9; Berman RA, 2010, J NEUROSCI, V30, P6342, DOI 10.1523/JNEUROSCI.6176-09.2010; Brewer AA, 2002, J NEUROSCI, V22, P10416; Bridge H, 2008, BRAIN, V131, P1433, DOI 10.1093/brain/awn063; BULLIER J, 1983, EXP BRAIN RES, V53, P168; CAMPION J, 1983, BEHAV BRAIN SCI, V6, P423, DOI 10.1017/S0140525X00016861; Collins CE, 2003, J NEUROSCI, V23, P2251; Cope DW, 2005, J NEUROSCI, V25, P11553, DOI 10.1523/JNEUROSCI.3362-05.2005; COWEY A, 1989, EXP BRAIN RES, V75, P631, DOI 10.1007/bf00249914; COWEY A, 1989, NEUROSCIENCE, V29, P65, DOI 10.1016/0306-4522(89)90333-3; COWEY A, 1995, NATURE, V373, P247, DOI 10.1038/373247a0; Cowey A, 1997, NEUROPSYCHOLOGIA, V35, P929, DOI 10.1016/S0028-3932(97)00021-3; Cowey A, 2010, EXP BRAIN RES, V200, P3, DOI 10.1007/s00221-009-1914-2; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; DIAMOND IT, 1969, SCIENCE, V164, P251, DOI 10.1126/science.164.3877.251; Goebel R, 2001, VISION RES, V41, P1459, DOI 10.1016/S0042-6989(01)00069-4; HARTING JK, 1991, J COMP NEUROL, V304, P275, DOI 10.1002/cne.903040210; KEATING EG, 1980, BRAIN RES, V187, P271, DOI 10.1016/0006-8993(80)90203-6; Lyon DC, 2010, NEURON, V65, P270, DOI 10.1016/j.neuron.2010.01.003; MAUNSELL JHR, 1990, J NEUROSCI, V10, P3323; McAnany JJ, 2007, VISION RES, V47, P2327, DOI 10.1016/j.visres.2007.05.013; MOHLER CW, 1977, J NEUROPHYSIOL, V40, P74, DOI 10.1152/jn.1977.40.1.74; RODMAN HR, 1989, J NEUROSCI, V9, P2033; RODMAN HR, 1990, J NEUROSCI, V10, P1154; SCHILLER PH, 1990, NATURE, V343, P68, DOI 10.1038/343068a0; Schmid MC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005527; Sincich LC, 2004, NAT NEUROSCI, V7, P1123, DOI 10.1038/nn1318; Stepniewska I, 1999, EUR J NEUROSCI, V11, P469, DOI 10.1046/j.1460-9568.1999.00461.x; WEISKRANTZ L, 1974, BRAIN, V97, P709, DOI 10.1093/brain/97.1.709	30	224	227	2	83	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					373	377		10.1038/nature09179	http://dx.doi.org/10.1038/nature09179			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574422	Green Accepted			2022-12-28	WOS:000279867100050
J	Trivedi, B				Trivedi, Bijal			The primate connection	NATURE			English	Editorial Material																			0	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S5	S5		10.1038/nature09236	http://dx.doi.org/10.1038/nature09236			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631704	Bronze			2022-12-28	WOS:000279867100025
J	Willyard, C				Willyard, Cassandra			Tiny steps towards an HIV vaccine	NATURE			English	Editorial Material							MONKEYS; INFECTION; RESPONSES											Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	5	3	3	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S8	S8		10.1038/nature09238	http://dx.doi.org/10.1038/nature09238			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631706				2022-12-28	WOS:000279867100027
J	Runeson, B; Tidemalm, D; Dahlin, M; Lichtenstein, P; Langstrom, N				Runeson, Bo; Tidemalm, Dag; Dahlin, Marie; Lichtenstein, Paul; Langstrom, Niklas			Method of attempted suicide as predictor of subsequent successful suicide: national long term cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELIBERATE SELF-HARM; 5-YEAR FOLLOW-UP; RISK-FACTORS; MORTALITY; REPETITION; DISORDER; BEHAVIOR; PEOPLE; EUROPE; INTENT	Objective To study the association between method of attempted suicide and risk of subsequent successful suicide. Design Cohort study with follow-up for 21-31 years. Setting Swedish national register linkage study. Participants 48 649 individuals admitted to hospital in 1973-82 after attempted suicide. Main outcome measure Completed suicide, 1973-2003. Multiple Cox regression modelling was conducted for each method at the index (first) attempt, with poisoning as the reference category. Relative risks were expressed as hazard ratios with 95% confidence intervals. Results 5740 individuals (12%) committed suicide during follow-up. The risk of successful suicide varied substantially according to the method used at the index attempt. Individuals who had attempted suicide by hanging, strangulation, or suffocation had the worst prognosis. In this group, 258 (54%) men and 125 (57%) women later successfully committed suicide (hazard ratio 6.2, 95% confidence interval 5.5 to 6.9, after adjustment for age, sex, education, immigrant status, and co-occurring psychiatric morbidity), and 333 (87%) did so with a year after the index attempt. For other methods (gassing, jumping from a height, using a firearm or explosive, or drowning), risks were significantly lower than for hanging but still raised at 1.8 to 4.0. Cutting, other methods, and late effect of suicide attempt or other self inflicted harm conferred risks at levels similar to that for the reference category of poisoning (used by 84%). Most of those who successfully committed suicide used the same method as they did at the index attempt-for example, >90% for hanging in men and women. Conclusion The method used at an unsuccessful suicide attempt predicts later completed suicide, after adjustment for sociodemographic confounding and psychiatric disorder. Intensified aftercare is warranted after suicide attempts involving hanging, drowning, firearms or explosives, jumping from a height, or gassing.	[Runeson, Bo; Tidemalm, Dag; Dahlin, Marie] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, SE-11281 Stockholm, Sweden; [Lichtenstein, Paul; Langstrom, Niklas] Karolinska Inst, Dept Med Epidemiol & Biostat, SE-17177 Stockholm, Sweden; [Langstrom, Niklas] Karolinska Inst, Ctr Violence Prevent, SE-10435 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Runeson, B (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, SE-11281 Stockholm, Sweden.	bo.runeson@ki.se	Langstrom, Niklas/C-5615-2009; Dahlin, Marie/A-5489-2013	Langstrom, Niklas/0000-0002-2686-6799; lichtenstein, paul/0000-0003-3037-5287; Runeson, Bo/0000-0003-4122-4636	Stockholm County Council; Karolinska Institutet; Swedish Research Council-Medicine	Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Swedish Research Council-Medicine(Swedish Research Council)	This study was funded by Stockholm County Council and Karolinska Institutet. NL is funded by the Swedish Research Council-Medicine.	Beck A.T., 1974, DEV SUICIDAL INTENT; Bradvik L, 2003, SUICIDE LIFE-THREAT, V33, P381, DOI 10.1521/suli.33.4.381.25234; Conner KR, 2005, PSYCHOL MED, V35, P1197, DOI 10.1017/S003329170500454X; Coryell W, 2005, J CLIN PSYCHIAT, V66, P412, DOI 10.4088/JCP.v66n0401; DeMoore GM, 1996, BRIT J PSYCHIAT, V169, P489, DOI 10.1192/bjp.169.4.489; Harriss L, 2005, BRIT J PSYCHIAT, V186, P60, DOI 10.1192/bjp.186.1.60; Haukka J, 2008, AM J EPIDEMIOL, V167, P1155, DOI 10.1093/aje/kwn017; Hawton K, 1998, BRIT MED J, V317, P441; Hawton K, 2003, BRIT J PSYCHIAT, V182, P537, DOI 10.1192/bjp.182.6.537; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Holley HL, 1998, SOC PSYCH PSYCH EPID, V33, P543, DOI 10.1007/s001270050092; Jenkins GR, 2002, BRIT MED J, V325, P1155, DOI 10.1136/bmj.325.7373.1155; Kamper-Jorgensen F, 2005, SCAND J PUBLIC HEALT, V33, P46, DOI 10.1080/14034950510033282; Madge N, 2008, J CHILD PSYCHOL PSYC, V49, P667, DOI 10.1111/j.1469-7610.2008.01879.x; Mann JJ, 2005, JAMA-J AM MED ASSOC, V294, P2064, DOI 10.1001/jama.294.16.2064; National Board of Health and Welfare, 2009, CAUS DEATH REG; Neeleman J, 1997, PSYCHOL MED, V27, P467, DOI 10.1017/S0033291796004631; NIELSEN B, 1990, ACTA PSYCHIAT SCAND, V81, P250, DOI 10.1111/j.1600-0447.1990.tb06490.x; Nimeus A, 1997, J AFFECT DISORDERS, V42, P137, DOI 10.1016/S0165-0327(96)01404-8; NIMEUS A., 2002, ARCH SUICIDE RES, V6, P211, DOI DOI 10.1080/13811110214142; NORDENTOFT M, 1993, BRIT MED J, V306, P1637, DOI 10.1136/bmj.306.6893.1637; NORDSTROM P, 1995, ACTA PSYCHIAT SCAND, V91, P336, DOI 10.1111/j.1600-0447.1995.tb09791.x; Ostamo A, 2001, SOC PSYCH PSYCH EPID, V36, P29, DOI 10.1007/s001270050287; Owens D, 2002, BRIT J PSYCHIAT, V181, P193, DOI 10.1192/bjp.181.3.193; PIERCE DW, 1981, BRIT J PSYCHIAT, V139, P391, DOI 10.1192/bjp.139.5.391; Skogman K, 2004, SOC PSYCH PSYCH EPID, V39, P113, DOI 10.1007/s00127-004-0709-9; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; SUOKAS J, 1991, ACTA PSYCHIAT SCAND, V84, P545, DOI 10.1111/j.1600-0447.1991.tb03191.x; Suokas J, 2001, ACTA PSYCHIAT SCAND, V104, P117, DOI 10.1034/j.1600-0447.2001.00243.x; Suominen K, 2004, AM J PSYCHIAT, V161, P562, DOI 10.1176/appi.ajp.161.3.562; Suominen K, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-11; Tidemalm D, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2205; TRASKMAN L, 1981, ARCH GEN PSYCHIAT, V38, P631; Tuisku V, 2009, J ADOLESCENCE, V32, P1125, DOI 10.1016/j.adolescence.2009.03.001	34	234	240	2	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3222	10.1136/bmj.c3222	http://dx.doi.org/10.1136/bmj.c3222			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XB	20627975	hybrid, Green Published			2022-12-28	WOS:000280156600004
J	Loewer, A; Batchelor, E; Gaglia, G; Lahav, G				Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit			Basal Dynamics of p53 Reveal Transcriptionally Attenuated Pulses in Cycling Cells	CELL			English	Article							P53-MDM2 FEEDBACK LOOP; DNA-DAMAGE; HISTONE H2AX; ACETYLATION; ATM; PHOSPHATASE; PATHWAY; KINASE; WIP1; PHOSPHORYLATION	The tumor suppressor p53 is activated by stress and leads to cellular outcomes such as apoptosis and cell-cycle arrest. Its activation must be highly sensitive to ensure that cells react appropriately to damage. However, proliferating cells often encounter transient damage during normal growth, where cell-cycle arrest or apoptosis may be unfavorable. How does the p53 pathway achieve the right balance between high sensitivity and tolerance to intrinsic damage? Using quantitative time-lapse microscopy of individual human cells, we found that proliferating cells show spontaneous pulses of p53, which are triggered by an excitable mechanism during cell-cycle phases associated with intrinsic DNA damage. However, in the absence of sustained damage, posttranslational modifications keep p53 inactive, preventing it from inducing p21 expression and cell-cycle arrest. Our approach of quantifying basal dynamics in individual cells can now be used to study how other pathways in human cells achieve sensitivity in noisy environments.	[Loewer, Alexander; Batchelor, Eric; Gaglia, Giorgio; Lahav, Galit] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Lahav, G (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	galit@hms.harvard.edu	Loewer, Alexander/AAL-6943-2021	Loewer, Alexander/0000-0002-8819-3040; Batchelor, Eric/0000-0003-3870-5615	National Institutes of Health [GM083303]; German Research Foundation; Charles A. King Trust; American Cancer Society; P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011382] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Charles A. King Trust; American Cancer Society(American Cancer Society); P. and E. Taft Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Hornung and M. Oren for the p21 reporter construct; T. Mitchison for the Lamin A/C antibody and for comments; K. Janes and J. Brugge for MCF10A; B. Vogelstein for HCT p53<SUP>-/-</SUP>; S. Elledge for RPE-hTERT and R. Agami for MCF7+p53shRNA cell lines; O. Gozani and E. Appella for antibodies; Martin Tenniswood for help with obtaining JW1521; J. Alzate and M. DiBona for technical assistance; J. Waters (Nikon Imaging Center at Harvard Medical School) for advice on live-cell imaging; and J. Paulsson, U. Alon, Y. Pilpel, M. Springer, B. Ward, M. Jain, and S. Loewer for comments and discussions. This research was supported by National Institutes of Health grant GM083303. A.L. was supported by fellowships from the German Research Foundation and the Charles A. King Trust. E.B. was supported by the American Cancer Society, P. and E. Taft Postdoctoral Fellowship.	Adams CJ, 2008, EMBO REP, V9, P1222, DOI 10.1038/embor.2008.186; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bakkenist CJ, 2004, CELL, V118, P9, DOI 10.1016/j.cell.2004.06.023; Bar-Or RL, 2000, P NATL ACAD SCI USA, V97, P11250, DOI 10.1073/pnas.210171597; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Batchelor E, 2008, MOL CELL, V30, P277, DOI 10.1016/j.molcel.2008.03.016; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Brummelkamp TR, 2002, CANCER CELL, V2, P243, DOI 10.1016/S1535-6108(02)00122-8; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Dart DA, 2004, J BIOL CHEM, V279, P16433, DOI 10.1074/jbc.M314212200; Demonacos C, 2004, NAT CELL BIOL, V6, P968, DOI 10.1038/ncb1170; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fiscella M, 1997, P NATL ACAD SCI USA, V94, P6048, DOI 10.1073/pnas.94.12.6048; Geva-Zatorsky N, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100068; Godar S, 2008, CELL, V134, P62, DOI 10.1016/j.cell.2008.06.006; Harris SL, 2005, ONCOGENE, V24, P2899, DOI 10.1038/sj.onc.1208615; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Huang J, 2006, NATURE, V444, P629, DOI 10.1038/nature05287; Huang LC, 1996, P NATL ACAD SCI USA, V93, P4827, DOI 10.1073/pnas.93.10.4827; Ichijima Y, 2005, BIOCHEM BIOPH RES CO, V336, P807, DOI 10.1016/j.bbrc.2005.08.164; Ivanov GS, 2007, MOL CELL BIOL, V27, P6756, DOI 10.1128/MCB.00460-07; Kaku S, 2001, NUCLEIC ACIDS RES, V29, P1989, DOI 10.1093/nar/29.9.1989; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Li AG, 2007, MOL CELL, V28, P408, DOI 10.1016/j.molcel.2007.09.006; Lu XB, 2007, CANCER CELL, V12, P342, DOI 10.1016/j.ccr.2007.08.033; Mangan S, 2003, J MOL BIOL, V334, P197, DOI 10.1016/j.jmb.2003.09.049; Michael D, 2003, SEMIN CANCER BIOL, V13, P49, DOI 10.1016/S1044-579X(02)00099-8; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Roy S, 2005, CELL DEATH DIFFER, V12, P482, DOI 10.1038/sj.cdd.4401581; Roy S, 2007, J BIOL CHEM, V282, P4765, DOI 10.1074/jbc.M609588200; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; SHILOH Y, 1983, CARCINOGENESIS, V4, P1317, DOI 10.1093/carcin/4.10.1317; Shreeram S, 2006, MOL CELL, V23, P757, DOI 10.1016/j.molcel.2006.07.010; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Tanaka T, 2006, CELL CYCLE, V5, P1940, DOI 10.4161/cc.5.17.3191; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toettcher JE, 2009, P NATL ACAD SCI USA, V106, P785, DOI 10.1073/pnas.0806196106; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vassilev LT, 2006, CELL CYCLE, V5, P2555, DOI 10.4161/cc.5.22.3463; Vassilev LT, 2006, P NATL ACAD SCI USA, V103, P10660, DOI 10.1073/pnas.0600447103; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126	51	180	186	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					89	100		10.1016/j.cell.2010.05.031	http://dx.doi.org/10.1016/j.cell.2010.05.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20598361	Green Accepted, Bronze			2022-12-28	WOS:000279637300015
J	Cuello, LG; Jogini, V; Cortes, DM; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Perozo, Eduardo			Structural mechanism of C-type inactivation in K+ channels	NATURE			English	Article							SHAKER POTASSIUM CHANNELS; SELECTIVITY FILTER; SLOW INACTIVATION; ION CONDUCTION; TETRAETHYLAMMONIUM BLOCKADE; CRYSTAL-STRUCTURE; OPEN STATE; KCSA; PORE; MUTATIONS	Interconversion between conductive and non-conductive forms of the K+ channel selectivity filter underlies a variety of gating events, from flicker transitions (at the microsecond timescale) to C-type inactivation (millisecond to second timescale). Here we report the crystal structure of the Streptomyces lividans K+ channel KcsA in its open-inactivated conformation and investigate the mechanism of C-type inactivation gating at the selectivity filter from channels 'trapped' in a series of partially open conformations. Five conformer classes were identified with openings ranging from 12 angstrom in closed KcsA (C alpha-C alpha distances at Thr 112) to 32 angstrom when fully open. They revealed a remarkable correlation between the degree of gate opening and the conformation and ion occupancy of the selectivity filter. We show that a gradual filter backbone reorientation leads first to a loss of the S2 ion binding site and a subsequent loss of the S3 binding site, presumably abrogating ion conduction. These structures indicate a molecular basis for C-type inactivation in K+ channels.	[Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	eperozo@uchicago.edu			NIH [R01-GM57846]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057846] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, B. Roux, H. Mchaourab and R. Nakamoto for discussions and comments on the manuscript. K. Locher for comments on the manuscripts. R. Mackinnon provided the Fab-expressing hybridoma cells. We also thank S. Chakrapani, J. Cordero-Morales, J. Santos, S. Uysal, O. Dalmas and the members of the Perozo laboratory for discussions and comments on the manuscript. We are thankful to K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory. This work was supported in part by NIH grant R01-GM57846 and by a gift from the Palmer family.	Ader C, 2009, J AM CHEM SOC, V131, P170, DOI 10.1021/ja806306e; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Alam A, 2009, NAT STRUCT MOL BIOL, V16, P30, DOI 10.1038/nsmb.1531; Aqvist J, 2000, NATURE, V404, P881, DOI 10.1038/35009114; Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; BEZANILLA F, 1972, J GEN PHYSIOL, V60, P588, DOI 10.1085/jgp.60.5.588; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2010, FEBS LETT, V584, P1133, DOI 10.1016/j.febslet.2010.02.015; Cuello LG, 2010, FEBS LETT, V584, P1126, DOI 10.1016/j.febslet.2010.02.003; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; Domene C, 2008, J AM CHEM SOC, V130, P9474, DOI 10.1021/ja801792g; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Kiss L, 1998, BIOPHYS J, V74, P1840, DOI 10.1016/S0006-3495(98)77894-4; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2006, PROG BIOPHYS MOL BIO, V92, P185, DOI 10.1016/j.pbiomolbio.2005.10.001; Levy DI, 1996, BIOPHYS J, V70, P798, DOI 10.1016/S0006-3495(96)79619-4; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Loots E, 1998, J GEN PHYSIOL, V112, P377, DOI 10.1085/jgp.112.4.377; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; Molina A, 1997, J PHYSIOL-LONDON, V499, P361, DOI 10.1113/jphysiol.1997.sp021933; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Ogielska EM, 1999, J GEN PHYSIOL, V113, P347, DOI 10.1085/jgp.113.2.347; Olcese R, 1997, J GEN PHYSIOL, V110, P579, DOI 10.1085/jgp.110.5.579; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1998, NAT STRUCT BIOL, V5, P459, DOI 10.1038/nsb0698-459; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Piskorowski RA, 2006, J GEN PHYSIOL, V127, P557, DOI 10.1085/jgp.200509482; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Schlief T, 1996, PFLUG ARCH EUR J PHY, V431, P483, DOI 10.1007/BF02191894; Starkus JG, 1997, J GEN PHYSIOL, V110, P539, DOI 10.1085/jgp.110.5.539; Takeuchi K, 2007, J BIOL CHEM, V282, P15179, DOI 10.1074/jbc.M608264200; Thompson AN, 2008, P NATL ACAD SCI USA, V105, P6900, DOI 10.1073/pnas.0800873105; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; YELLEN G, 1994, BIOPHYS J, V66, P1068, DOI 10.1016/S0006-3495(94)80888-4; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	353	357	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					203	U73		10.1038/nature09153	http://dx.doi.org/10.1038/nature09153			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613835	Green Accepted			2022-12-28	WOS:000279580800029
J	London, M; Roth, A; Beeren, L; Hausser, M; Latham, PE				London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael; Latham, Peter E.			Sensitivity to perturbations in vivo implies high noise and suggests rate coding in cortex	NATURE			English	Article							PYRAMIDAL NEURONS; VISUAL-CORTEX; NETWORKS; PRECISION; MODEL; COMPUTATION; DENDRITES; NEOCORTEX; PATTERNS; SYSTEMS	It is well known that neural activity exhibits variability, in the sense that identical sensory stimuli produce different responses(1-3), but it has been difficult to determine what this variability means. Is it noise, or does it carry important information-about, for example, the internal state of the organism? Here we address this issue from the bottom up, by asking whether small perturbations to activity in cortical networks are amplified. Based on in vivo whole-cell patch-clamp recordings in rat barrel cortex, we find that a perturbation consisting of a single extra spike in one neuron produces approximately 28 additional spikes in its postsynaptic targets. We also show, using simultaneous intra-and extracellular recordings, that a single spike in a neuron produces a detectable increase in firing rate in the local network. Theoretical analysis indicates that this amplification leads to intrinsic, stimulus-independent variations in membrane potential of the order of +/- 2.2-4.5 mV-variations that are pure noise, and so carry no information at all. Therefore, for the brain to perform reliable computations, it must either use a rate code, or generate very large, fast depolarizing events, such as those proposed by the theory of synfire chains(4,5). However, in our in vivo recordings, we found that such events were very rare. Our findings are thus consistent with the idea that cortex is likely to use primarily a rate code.	[Latham, Peter E.] UCL, Gatsby Computat Neurosci Unit, London WC1N 3AR, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [London, Michael; Roth, Arnd; Beeren, Lisa; Haeusser, Michael] UCL, Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; University of London; University College London	Latham, PE (corresponding author), UCL, Gatsby Computat Neurosci Unit, Queen Sq, London WC1N 3AR, England.	pel@gatsby.ucl.ac.uk	Hausser, Michael/AAW-6827-2020; London, Michael/B-4175-2010	Hausser, Michael/0000-0002-2673-8957; London, Michael/0000-0001-5137-1707; Roth, Arnd/0000-0003-0325-4287	Gatsby Charitable Foundation; US National Institute of Mental Health [R01 MH62447]; Wellcome Trust; Engineering and Physical Sciences Research Council; Medical Research Council; MRC [G0500244] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/C010841/1] Funding Source: researchfish; Medical Research Council [G0500244] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH062447] Funding Source: NIH RePORTER	Gatsby Charitable Foundation; US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Trust(Wellcome Trust); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank P. Dayan for discussions, I. van Welie and P. Dayan for comments on the manuscript, and H. Cuntz for comments on the spike detection algorithm. P. E. L. was supported by the Gatsby Charitable Foundation and US National Institute of Mental Health grant R01 MH62447. M. L., A. R., L. B. and M. H. were supported by the Wellcome Trust, the Gatsby Charitable Foundation, the Engineering and Physical Sciences Research Council and the Medical Research Council.	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; Arabzadeh E, 2006, J NEUROSCI, V26, P9216, DOI 10.1523/JNEUROSCI.1491-06.2006; Ariav G, 2003, J NEUROSCI, V23, P7750; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Banerjee A, 2008, NEURAL COMPUT, V20, P974, DOI 10.1162/neco.2008.05-06-206; Barbour B, 2007, TRENDS NEUROSCI, V30, P622, DOI 10.1016/j.tins.2007.09.005; Binzegger T, 2004, J NEUROSCI, V24, P8441, DOI 10.1523/JNEUROSCI.1400-04.2004; Braitenberg V, 1991, ANATOMY CORTEX; Crochet S, 2006, NAT NEUROSCI, V9, P608, DOI 10.1038/nn1690; de Kock CPJ, 2009, P NATL ACAD SCI USA, V106, P16446, DOI 10.1073/pnas.0904143106; Ferezou I, 2006, NEURON, V50, P617, DOI 10.1016/j.neuron.2006.03.043; Hausser M, 2003, CURR OPIN NEUROBIOL, V13, P372, DOI 10.1016/S0959-4388(03)00075-8; Hausser M, 1997, J NEUROSCI, V17, P7606; Hecht S, 1942, J GEN PHYSIOL, V25, P819, DOI 10.1085/jgp.25.6.819; Herrmann A, 2001, J COMPUT NEUROSCI, V11, P135, DOI 10.1023/A:1012841516004; Hines ML, 1997, NEURAL COMPUT, V9, P1179, DOI 10.1162/neco.1997.9.6.1179; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; Izhikevich EM, 2006, NEURAL COMPUT, V18, P245, DOI 10.1162/089976606775093882; Larkum ME, 1999, NATURE, V398, P338, DOI 10.1038/18686; Latham PE, 2000, J NEUROPHYSIOL, V83, P808, DOI 10.1152/jn.2000.83.2.808; London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703; Mainen ZF, 1995, NEURON, V15, P1427, DOI 10.1016/0896-6273(95)90020-9; Margrie TW, 2002, PFLUG ARCH EUR J PHY, V444, P491, DOI 10.1007/s00424-002-0831-z; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Murayama M, 2009, NATURE, V457, P1137, DOI 10.1038/nature07663; Richardson MJE, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.021919; RICHMOND BJ, 1987, J NEUROPHYSIOL, V57, P132, DOI 10.1152/jn.1987.57.1.132; SMALE S, 1967, B AM MATH SOC, V73, P747, DOI 10.1090/S0002-9904-1967-11798-1; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; TOLHURST DJ, 1983, VISION RES, V23, P775, DOI 10.1016/0042-6989(83)90200-6; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Victor JD, 1996, J NEUROPHYSIOL, V76, P1310, DOI 10.1152/jn.1996.76.2.1310	35	270	272	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					123	U142		10.1038/nature09086	http://dx.doi.org/10.1038/nature09086			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596024	Green Accepted			2022-12-28	WOS:000279343800047
J	Patenaude, G				Patenaude, Genevieve			Climate class for business schools	NATURE			English	Editorial Material									Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland	University of Edinburgh	Patenaude, G (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland.	genevieve.patenaude@ed.ac.uk	Patenaude, Genevieve/F-3115-2010	Patenaude, Genevieve/0000-0001-7552-7470				*ASP I, GREY PINSTR 2009 201, P23114; Boykoff MT, 2004, GLOBAL ENVIRON CHANG, V14, P125, DOI 10.1016/j.gloenvcha.2003.10.001; *EC COM, WHICH MBA 2009 FULL, P23114; Felicelli M., 2008, 2008 ROUTE TOP; Goodall AH, 2008, J MANAGE INQUIRY, V17, P408, DOI 10.1177/1056492607311930; *PRICEWATERHOUSECO, 2009, GLOB 500 REP, P23114; Roger E.M, 2003, DIFFUSION INNOVATION, V5th; *UNFCCC, GREENH GAS INV DAT 2, P23114	8	11	11	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					30	30		10.1038/466030a	http://dx.doi.org/10.1038/466030a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618HW	20595996				2022-12-28	WOS:000279343800020
J	Seligman, HK; Schillinger, D				Seligman, Hilary K.; Schillinger, Dean			Hunger and Socioeconomic Disparities in Chronic Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							FOOD INSECURITY		[Seligman, Hilary K.; Schillinger, Dean] Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Seligman, Hilary K.; Schillinger, Dean] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94110 USA; [Schillinger, Dean] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Schillinger, Dean] Calif Dept Publ Hlth, Calif Diabet Program, Sacramento, CA USA	University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; California Department of Public Health	Seligman, HK (corresponding author), Univ Calif San Francisco, Ctr Vulnerable Populat, San Francisco, CA 94143 USA.							Drewnowski A, 2004, AM J CLIN NUTR, V79, P6; Nelson K, 2001, J GEN INTERN MED, V16, P404, DOI 10.1046/j.1525-1497.2001.016006404.x; Nord M, 2009, HOUSEHOLD FOOD SECUR; Seligman HK, 2007, J GEN INTERN MED, V22, P1018, DOI 10.1007/s11606-007-0192-6; Seligman HK, 2010, J NUTR, V140, P304, DOI 10.3945/jn.109.112573	5	269	277	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					6	9		10.1056/NEJMp1000072	http://dx.doi.org/10.1056/NEJMp1000072			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618HR	20592297				2022-12-28	WOS:000279343000003
J	Huh, D; Matthews, BD; Mammoto, A; Montoya-Zavala, M; Hsin, HY; Ingber, DE				Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.			Reconstituting Organ-Level Lung Functions on a Chip	SCIENCE			English	Article							HUMAN ENDOTHELIAL-CELLS; IN-VITRO MODEL; SILICA NANOPARTICLES; CULTURE; BARRIER; MECHANISMS; SYSTEMS; TISSUE; TOXICITY; CHANNELS	Here, we describe a biomimetic microsystem that reconstitutes the critical functional alveolar-capillary interface of the human lung. This bioinspired microdevice reproduces complex integrated organ-level responses to bacteria and inflammatory cytokines introduced into the alveolar space. In nanotoxicology studies, this lung mimic revealed that cyclic mechanical strain accentuates toxic and inflammatory responses of the lung to silica nanoparticles. Mechanical strain also enhances epithelial and endothelial uptake of nanoparticulates and stimulates their transport into the underlying microvascular channel. Similar effects of physiological breathing on nanoparticle absorption are observed in whole mouse lung. Mechanically active "organ-on-a-chip" microdevices that reconstitute tissue-tissue interfaces critical to organ function may therefore expand the capabilities of cell culture models and provide low-cost alternatives to animal and clinical studies for drug screening and toxicology applications.	[Huh, Dongeun; Montoya-Zavala, Martin; Ingber, Donald E.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Pathol, Vasc Biol Program, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Huh, Dongeun; Matthews, Benjamin D.; Mammoto, Akiko; Montoya-Zavala, Martin; Hsin, Hong Yuan; Ingber, Donald E.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Matthews, Benjamin D.] Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Ingber, Donald E.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University	Ingber, DE (corresponding author), Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA.	don.ingber@wyss.harvard.edu	Huh, Dong Eun/J-5715-2012; Huh, Dongeun/I-4152-2013; Ingber, Donald E/AAC-5894-2019		NIH [R01-ES016665]; American Heart Association [0835618D]; Department of Defense [W81XWH-05-1-0115]; Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES016665] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Wyss Institute for Biologically Inspired Engineering at Harvard University; Wyss Technology Development Fellowship; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank C. K. Thodeti for his help with ROS assays; G. M. Whitesides and P. Cherukuri for providing carbon nanotubes, gold nanoparticles, and helpful comments; N. Korin for helpful discussions; R. Ruch for providing alveolar epithelial cells; R. Mannix for his imaging assistance; and M. Butte for help with neutrophil isolation. This work was supported by grants from NIH (R01-ES016665), the American Heart Association (0835618D), the Department of Defense (W81XWH-05-1-0115), and the Wyss Institute for Biologically Inspired Engineering at Harvard University; D. H. is a recipient of a Wyss Technology Development Fellowship, and D. E. I. is a recipient of a Department of Defense Breast Cancer Innovator Award. A patent on the device described is pending.	Baudoin R, 2007, BIOTECHNOL PROGR, V23, P1245, DOI 10.1021/bp0603513; Bilek AM, 2003, J APPL PHYSIOL, V94, P770, DOI 10.1152/japplphysiol.00764.2002; Birukov KG, 2003, AM J PHYSIOL-LUNG C, V285, pL785, DOI 10.1152/ajplung.00336.2002; Carraro A, 2008, BIOMED MICRODEVICES, V10, P795, DOI 10.1007/s10544-008-9194-3; Colvin VL, 2003, NAT BIOTECHNOL, V21, P1166, DOI 10.1038/nbt875; Davila JC, 1998, ANNU REV PHARMACOL, V38, P63, DOI 10.1146/annurev.pharmtox.38.1.63; El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063; Frerking I, 2001, INTENS CARE MED, V27, P1699, DOI 10.1007/s00134-001-1121-5; Harris SG, 2003, BIOTECHNOL BIOPROC E, V8, P246, DOI 10.1007/BF02942273; Hermanns MI, 2009, CELL TISSUE RES, V336, P91, DOI 10.1007/s00441-008-0750-1; Huh D, 2007, P NATL ACAD SCI USA, V104, P18886, DOI 10.1073/pnas.0610868104; IBA T, 1991, MICROVASC RES, V42, P245, DOI 10.1016/0026-2862(91)90059-K; Ingber DE, 2006, FASEB J, V20, P811, DOI 10.1096/fj.05-5424rev; Jang K, 2008, ANAL BIOANAL CHEM, V390, P825, DOI 10.1007/s00216-007-1752-7; Jang KJ, 2010, LAB CHIP, V10, P36, DOI 10.1039/b907515a; Khademhosseini A, 2006, P NATL ACAD SCI USA, V103, P2480, DOI 10.1073/pnas.0507681102; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kim KJ, 2003, AM J PHYSIOL-LUNG C, V284, pL247, DOI 10.1152/ajplung.00235.2002; Lam MT, 2009, BIOMATERIALS, V30, P1150, DOI 10.1016/j.biomaterials.2008.11.014; Lee PJ, 2007, BIOTECHNOL BIOENG, V97, P1340, DOI 10.1002/bit.21360; Lin WS, 2006, TOXICOL APPL PHARM, V217, P252, DOI 10.1016/j.taap.2006.10.004; Mahler GJ, 2009, BIOTECHNOL BIOENG, V104, P193, DOI 10.1002/bit.22366; Merget R, 2002, ARCH TOXICOL, V75, P625, DOI 10.1007/S002040100266; Meyvantsson I, 2008, ANNU REV ANAL CHEM, V1, P423, DOI 10.1146/annurev.anchem.1.031207.113042; Mills NL, 2009, NAT CLIN PRACT CARD, V6, P36, DOI 10.1038/ncpcardio1399; Napierska D, 2009, SMALL, V5, P846, DOI 10.1002/smll.200800461; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Oberdorster G, 2005, ENVIRON HEALTH PERSP, V113, P823, DOI 10.1289/ehp.7339; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Park JW, 2006, NAT PROTOC, V1, P2128, DOI 10.1038/nprot.2006.316; Powers MJ, 2002, BIOTECHNOL BIOENG, V78, P257, DOI 10.1002/bit.10143; Shin M, 2004, BIOMED MICRODEVICES, V6, P269, DOI 10.1023/B:BMMD.0000048559.29932.27; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; Sin A, 2004, BIOTECHNOL PROGR, V20, P338, DOI 10.1021/bp034077d; Song JW, 2005, ANAL CHEM, V77, P3993, DOI 10.1021/ac050131o; Takayama S, 2001, ADV MATER, V13, P570, DOI 10.1002/1521-4095(200104)13:8<570::AID-ADMA570>3.0.CO;2-B; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Wagner JG, 2000, PHARMACOL REV, V52, P349; Whitesides GM, 2001, ANNU REV BIOMED ENG, V3, P335, DOI 10.1146/annurev.bioeng.3.1.335; WONG D, 1992, J NEUROIMMUNOL, V39, P11, DOI 10.1016/0165-5728(92)90170-P; Zhang C, 2009, LAB CHIP, V9, P3185, DOI 10.1039/b915147h	41	2281	2388	93	1698	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1662	1668		10.1126/science.1188302	http://dx.doi.org/10.1126/science.1188302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576885	Green Accepted			2022-12-28	WOS:000279107400035
J	Giudice, LC				Giudice, Linda C.			Endometriosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PELVIC PAIN; ADD-BACK; DIAGNOSIS; DYSMENORRHEA; WOMEN; LAPAROSCOPY; ADOLESCENTS; MANAGEMENT; PILL		Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Giudice, LC (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 505 Parnassus Ave,M1491, San Francisco, CA 94143 USA.	giudice@obgyn.ucsf.edu			Bayer Schering Pharma; Neurocrine Biosciences; Endo Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD055764] Funding Source: NIH RePORTER	Bayer Schering Pharma(Bayer AG); Neurocrine Biosciences; Endo Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Dr. Giudice reports receiving consulting fees from Bayer Schering Pharma, Neurocrine Biosciences, Endo Pharmaceuticals, and Schering-Plough, holding stock in Merck and Pfizer, and serving on advisory committees for the Endometriosis Association and Baylor College of Medicine. No other potential conflict of interest relevant to this article was reported.	Abou-Setta AM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005072; ACOG Committee on Practice Bulletins--Gynecology, 2004, Obstet Gynecol, V103, P589; Al Kadri H, 2009, COCHRANE DB SYST REV, V1; Al-Inany HG, 2000, HUM REPROD, V15, P2447, DOI 10.1093/humrep/15.11.2447-a; ALLEN C, 2005, COCHRANE DB SYST REV, V4; *AM SOC REPR MED P, 2008, FERTIL STERIL S, V90, P260; *AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS156; [Anonymous], 2005, OBSTET GYNECOL, V105, P921; BARBIERI RL, 1992, AM J OBSTET GYNECOL, V166, P740, DOI 10.1016/0002-9378(92)91706-G; Barnhart K, 2002, FERTIL STERIL, V77, P1148, DOI 10.1016/S0015-0282(02)03112-6; Berkley KJ, 2005, SCIENCE, V308, P1587, DOI 10.1126/science.1111445; Brosens I, 2004, BEST PRACT RES CL OB, V18, P285, DOI 10.1016/j.bpobgyn.2004.03.002; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Canis M, 1997, FERTIL STERIL, V67, P817; D'Hooghe T, 2006, HUM REPROD, V21, P2743, DOI 10.1093/humrep/del123; Diamanti-Kandarakis E, 2009, ENDOCR REV, V30, P293, DOI 10.1210/er.2009-0002; DiVasta AD, 2007, J PEDIATR ADOL GYNEC, V20, P293, DOI 10.1016/j.jpag.2007.04.008; Eskenazi B, 1997, OBSTET GYN CLIN N AM, V24, P235, DOI 10.1016/S0889-8545(05)70302-8; Evans S, 2007, PAIN, V132, pS22, DOI 10.1016/j.pain.2007.07.006; Giudice L. C., 2010, ENDOCRINOLOGY, P2356; GOLDSTEIN DP, 1980, J REPROD MED, V24, P251; Guzick DS, 1999, NEW ENGL J MED, V340, P177, DOI 10.1056/NEJM199901213400302; Hadfield R, 1996, HUM REPROD, V11, P878; Harada T, 2008, FERTIL STERIL, V90, P1583, DOI 10.1016/j.fertnstert.2007.08.051; Hart RJ, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004992.pub3; Hornstein MD, 1998, OBSTET GYNECOL, V91, P16, DOI 10.1016/S0029-7844(97)00620-0; Hughes E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000155.pub2; Jacobson TZ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001300.pub2; Jacobson TZ, 2002, COCHRANE DB SYST REV, V4, pCD001398, DOI DOI 10.1002/14651858.CD001398; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Missmer SA, 2004, FERTIL STERIL, V82, P1501, DOI 10.1016/j.fertnstert.2004.04.065; Missmer SA, 2004, AM J EPIDEMIOL, V160, P784, DOI 10.1093/aje/kwh275; MISSMER SA, 2010, HUM REPROD      0323; Mol BWJ, 1998, FERTIL STERIL, V70, P1101, DOI 10.1016/S0015-0282(98)00355-0; Montgomery GW, 2008, HUM REPROD UPDATE, V14, P447, DOI 10.1093/humupd/dmn016; Patwardhan S, 2008, BJOG-INT J OBSTET GY, V115, P818, DOI 10.1111/j.1471-0528.2008.01740.x; PRENTICE A, 2000, COCHRANE DB SYST REV, V2; Proctor ML, 2005, COCHRANE DB SYST REV, V4; RIPPS BA, 1991, J REPROD MED, V36, P470; SAGSVEEN M, 2003, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD001297; Sallam HN, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004635.pub2; SANFILIPPO JS, 1986, AM J OBSTET GYNECOL, V154, P39, DOI 10.1016/0002-9378(86)90389-3; Simoens S, 2007, HUM REPROD UPDATE, V13, P395, DOI 10.1093/humupd/dmm010; Struthers RS, 2009, J CLIN ENDOCR METAB, V94, P545, DOI 10.1210/jc.2008-1695; Sutton CJG, 1997, FERTIL STERIL, V68, P1070, DOI 10.1016/S0015-0282(97)00403-2; Tokushige N, 2006, HUM REPROD, V21, P3001, DOI 10.1093/humrep/del260; Vercellini P, 2003, FERTIL STERIL, V80, P560, DOI 10.1016/S0015-0282(03)00794-5; Vercellini P, 1997, FERTIL STERIL, V68, P393, DOI 10.1016/S0015-0282(97)00193-3; Vincent K, 2010, FERTIL STERIL, V93, P62, DOI 10.1016/j.fertnstert.2008.09.056; Wayne PM, 2008, J PEDIATR ADOL GYNEC, V21, P247, DOI 10.1016/j.jpag.2007.07.008; YAP C, 2004, COCHRANE DB SYST REV, V3	51	1175	1225	10	210	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2389	2398		10.1056/NEJMcp1000274	http://dx.doi.org/10.1056/NEJMcp1000274			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573927	Green Accepted			2022-12-28	WOS:000279043800008
J	Petherick, A				Petherick, Anna			Campaigning for Chagas disease	NATURE			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S21	S22		10.1038/nature09227	http://dx.doi.org/10.1038/nature09227			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571551	Bronze			2022-12-28	WOS:000279056900031
J	Mayr, FB; Yende, S; Linde-Zwirble, WT; Peck-Palmer, OM; Barnato, AE; Weissfeld, LA; Angus, DC				Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Weissfeld, Lisa A.; Angus, Derek C.			Infection Rate and Acute Organ Dysfunction Risk as Explanations for Racial Differences in Severe Sepsis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; EPIDEMIOLOGY; DISEASES; OUTCOMES; ADULTS; CARE	Context Severe sepsis, defined as infection complicated by acute organ dysfunction, occurs more frequently and leads to more deaths in black than in white individuals. The optimal approach to minimize these disparities is unclear. Objective To determine the extent to which higher severe sepsis rates in black than in white patients are due to higher infection rates or to a higher risk of acute organ dysfunction. Design, Setting, and Participants Analysis of infection-related hospitalizations from the 2005 hospital discharge data of 7 US states and infection-related emergency department visits from the 2003-2007 National Hospital Ambulatory Care Survey. Main Outcome Measure Age-and sex-standardized severe sepsis and infection hospitalization rates and the risk of acute organ dysfunction. Results Of 8 661 227 non-childbirth-related discharges, 2 261 857 were associated with an infection, and of these, 381 787 (16.8%) had severe sepsis. Black patients had a 67% higher age-and sex-standardized severe sepsis rate than did white patients (9.4; 95% confidence interval [CI], 9.3-9.5 vs 5.6; 95% CI, 5.6-5.6 per 1000 population; P<.001) and 80% higher standardized mortality (1.8, 95% CI, 1.8-1.9 vs 1.0, 95% CI, 1.0-1.1 per 1000 population; P<.001). The higher severe sepsis rate was explained by both a higher infection rate in black patients (47.3; 95% CI, 47.1-47.4 vs 34.0; 95% CI, 33.9-34.0 per 1000 population; incidence rate ratio, 1.39; P<.001) and a higher risk of developing acute organ dysfunction (age-and sex-adjusted odds ratio [OR], 1.29; 95% CI, 1.27-1.30; P<.001). Differences in infection presented broadly across different sites and etiology of infection and for community-and hospital-acquired infections and occurred despite a lower likelihood of being admitted for infection from the emergency department (adjusted OR, 0.70; 95% CI, 0.64-0.76; P<.001). The higher risk of organ dysfunction persisted but was attenuated after adjusting for age, sex, comorbid conditions, poverty, and hospital effect (OR, 1.14; 95% CI, 1.13-1.16; P<.001). Racial disparities in infection and severe sepsis incidence and mortality rates were largest among younger adults (eg, the proportion of invasive pneumococcal disease occurring in adults <65 years was 73.9% among black patients vs 44.5% among white patients, P<.001). Conclusion Racial differences in severe sepsis are explained by both a higher infection rate and a higher risk of acute organ dysfunction in black than in white individuals. JAMA. 2010; 303(24): 2495-2503	[Yende, Sachin] Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, Pittsburgh, PA 15261 USA; [Mayr, Florian B.; Yende, Sachin; Linde-Zwirble, Walter T.; Peck-Palmer, Octavia M.; Barnato, Amber E.; Angus, Derek C.] Univ Pittsburgh, Clin Res Invest & Syst Modeling Acute Illness Lab, Pittsburgh, PA 15261 USA; [Peck-Palmer, Octavia M.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Barnato, Amber E.] Univ Pittsburgh, Ctr Res Hlth Care, Pittsburgh, PA 15261 USA; [Weissfeld, Lisa A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Linde-Zwirble, Walter T.] ZD Associates, Perkasie, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Yende, S (corresponding author), Univ Pittsburgh, Dept Crit Care Med, CRISMA Lab, 642A Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	yendes@upmc.edu	Angus, Derek C/E-9671-2012		National Institutes of Health [T32 HL007820-10, K23GM083215]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007820] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K23GM083215] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Mayr was supported by grant T32 HL007820-10, and Dr Yende was supported by grant K23GM083215 both from the National Institutes of Health.	Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V283, P1723, DOI 10.1001/jama.283.13.1723; [Anonymous], NATL HOSP AMBULATORY; BAMATO AE, 2008, AM J RESP CRIT CARE, V177, P279; BRANCATI FL, 1992, JAMA-J AM MED ASSOC, V268, P3079, DOI 10.1001/jama.268.21.3079; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; CARRIERE KC, 1994, AM J EPIDEMIOL, V140, P472, DOI 10.1093/oxfordjournals.aje.a117269; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dowd JB, 2009, SOC SCI MED, V68, P699, DOI 10.1016/j.socscimed.2008.12.010; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Ferwerda B, 2009, P NATL ACAD SCI USA, V106, P10272, DOI 10.1073/pnas.0811273106; Jackson LA, 2008, CLIN INFECT DIS, V47, P1328, DOI 10.1086/592691; JOLLIS JG, 1993, ANN INTERN MED, V119, P844, DOI 10.7326/0003-4819-119-8-199310150-00011; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Laterre PF, 2005, CRIT CARE MED, V33, P952, DOI 10.1097/01.CCM.0000162381.24074.D7; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Liu JH, 2003, ARCH SURG-CHICAGO, V138, P1106, DOI 10.1001/archsurg.138.10.1106; Localio AR, 2001, ANN INTERN MED, V135, P112, DOI 10.7326/0003-4819-135-2-200107170-00012; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Morse DL, 2009, ANN INTERN MED, V150, P40, DOI 10.7326/0003-4819-150-1-200901060-00008; Mrus JM, 2005, CRIT CARE, V9, pR623, DOI 10.1186/cc3811; OBRIEN TR, 1989, JAMA-J AM MED ASSOC, V262, P1485, DOI 10.1001/jama.262.11.1485; READE MC, 2009, SEPSIS NONINFECTIOUS; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979; Yang HL, 2008, SINGAP MED J, V49, P441; Zajacova A, 2009, J GERONTOL A-BIOL, V64, P272, DOI 10.1093/gerona/gln012	27	164	176	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2495	2503		10.1001/jama.2010.851	http://dx.doi.org/10.1001/jama.2010.851			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571016	Green Accepted, Bronze			2022-12-28	WOS:000279010900027
J	Abdool Karim, Q; AbouZahr, C; Dehne, K; Mangiaterra, V; Moodley, J; Rollins, N; Say, L; Schaffer, N; Rosen, JE; de Zoysa, I				Abdool Karim, Quarraisha; AbouZahr, Carla; Dehne, Karl; Mangiaterra, Viviana; Moodley, Jack; Rollins, Nigel; Say, Lale; Schaffer, Nathan; Rosen, James E.; de Zoysa, Isabelle			HIV and maternal mortality: turning the tide	LANCET			English	Editorial Material							SOUTH-AFRICA; MORBIDITY; MALAWI; WOMEN		[AbouZahr, Carla; Mangiaterra, Viviana; Rollins, Nigel; Say, Lale; Schaffer, Nathan; de Zoysa, Isabelle] WHO, CH-1211 Geneva 27, Switzerland; [Abdool Karim, Quarraisha] Ctr AIDS Programme Res S Africa, Durban, Kwazulu Natal, South Africa; [Dehne, Karl] UNAIDS, Geneva, Switzerland; [Moodley, Jack] Univ KwaZulu Natal, Durban, Kwazulu Natal, South Africa; [Rosen, James E.] Univ KwaZulu Natal, Washington, DC USA	World Health Organization; UNAIDS; University of Kwazulu Natal	de Zoysa, I (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.		Abdool Karim, Quarraisha/GVS-1160-2022; , lalesay/AAG-1912-2021	Abdool Karim, Quarraisha/0000-0002-0985-477X; MANGIATERRA, VIVIANA/0000-0002-8815-0841				Bicego G, 2002, AIDS, V16, P1078, DOI 10.1097/00002030-200205030-00019; Black V, 2009, OBSTET GYNECOL, V114, P292, DOI 10.1097/AOG.0b013e3181af33e6; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Horton R, 2009, LANCET, V374, P1400, DOI 10.1016/S0140-6736(09)61669-X; Khan M, 2001, AIDS, V15, P1857, DOI 10.1097/00002030-200109280-00016; Le Coeur S, 2005, AIDS, V19, P69, DOI 10.1097/00002030-200501030-00008; Louis J, 2007, OBSTET GYNECOL, V110, P385, DOI 10.1097/01.AOG.0000275263.81272.fc; Mbizvo M T, 2005, Cent Afr J Med, V51, P91; McIntyre J, 2003, BRIT MED BULL, V67, P127, DOI 10.1093/bmb/ldg012; National Committee for Confidential Enquiry into Maternal Deaths, 2008, 4 NAT COMM CONF ENQ; Price JE, 2009, AIDS CARE, V21, P608, DOI 10.1080/09540120802310957; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; Sewankambo NK, 2000, AIDS, V14, P2391, DOI 10.1097/00002030-200010200-00021; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1; 2010, LANCET, V375, P865	16	42	44	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1948	1949		10.1016/S0140-6736(10)60747-7	http://dx.doi.org/10.1016/S0140-6736(10)60747-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569827	Green Submitted			2022-12-28	WOS:000278689600008
J	Caplan, AL; Moreno, JD				Caplan, Arthur L.; Moreno, Jonathan D.			The Havasu 'Baaja tribe and informed consent	LANCET			English	Editorial Material									[Caplan, Arthur L.; Moreno, Jonathan D.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Caplan, AL (corresponding author), Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA.	caplan@mail.med.upenn.edu						Caplan Arthur, 2009, TRAFFICKING ORGANS T; Elger BS, 2006, EMBO REP, V7, P661, DOI 10.1038/sj.embor.7400740; Eriksson S, 2005, EUR J HUM GENET, V13, P1071, DOI 10.1038/sj.ejhg.5201458; Harmon A, 2010, NY TIMES        0422, P17; MARKOW T, 1993, AM J HUM GENET, V53, P943; MARKOW TA, 1993, ANN HUM BIOL, V20, P389, DOI 10.1080/03014469300002792; Skloot R., 2011, IMMORTAL LIFE HENRIE; Solbakk JH, 2009, ETHICS OF RESEARCH BIOBANKING, P1, DOI 10.1007/978-0-387-93872-1; Wadman M, 2009, NATURE, V462, P837, DOI 10.1038/462837a	9	3	3	0	5	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					621	622		10.1016/S0140-6736(10)60818-5	http://dx.doi.org/10.1016/S0140-6736(10)60818-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	20630579				2022-12-28	WOS:000287776600009
J	Gregg, C; Zhang, JW; Weissbourd, B; Luo, SJ; Schroth, GP; Haig, D; Dulac, C				Gregg, Christopher; Zhang, Jiangwen; Weissbourd, Brandon; Luo, Shujun; Schroth, Gary P.; Haig, David; Dulac, Catherine			High-Resolution Analysis of Parent-of-Origin Allelic Expression in the Mouse Brain	SCIENCE			English	Article							IMPRINTED GENE; H19; IGF2; POLYADENYLATION; IDENTIFICATION; MECHANISMS; MUTATION; CELLS	Genomic imprinting results in preferential expression of the paternal or maternal allele of certain genes. We have performed a genome-wide characterization of imprinting in the mouse embryonic and adult brain. This approach uncovered parent-of-origin allelic effects of more than 1300 loci. We identified parental bias in the expression of individual genes and of specific transcript isoforms, with differences between brain regions. Many imprinted genes are expressed in neural systems associated with feeding and motivated behaviors, and parental biases preferentially target genetic pathways governing metabolism and cell adhesion. We observed a preferential maternal contribution to gene expression in the developing brain and a major paternal contribution in the adult brain. Thus, parental expression bias emerges as a major mode of epigenetic regulation in the brain.	[Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Gregg, Christopher; Weissbourd, Brandon; Dulac, Catherine] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Haig, David] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Luo, Shujun; Schroth, Gary P.] Illumina Inc, Hayward, CA 94545 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Illumina	Gregg, C (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	cgregg@mcb.harvard.edu; dulac@fas.harvard.edu	Zhang, Jiangwen/A-7654-2013	Zhang, Jiangwen/0000-0002-2911-8446; Dulac, Catherine/0000-0001-5024-5418	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research	Klarman Foundation for Eating Disorders; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Human Frontiers long-term fellowship; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric)	We thank L. Luo, T. Maniatis, R. Losick, S. Hippenmeyer, and members of the Maniatis and Dulac labs for critical comments on the manuscript. We thank R. Hellmiss for help with figures and R. Jaenisch for X<SUP>egfp</SUP> mice. This work was supported by the Klarman Foundation for Eating Disorders and the Howard Hughes Medical Institute (HHMI). C. G. is supported by a Human Frontiers long-term fellowship and Alberta Heritage Foundation for Medical Research Incentive Award. C. D. is an HHMI investigator. All data can be found in GEO: GSE22131.	ALLEN ND, 1995, P NATL ACAD SCI USA, V92, P10782, DOI 10.1073/pnas.92.23.10782; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Babak T, 2008, CURR BIOL, V18, P1735, DOI 10.1016/j.cub.2008.09.044; Barel O, 2008, AM J HUM GENET, V83, P193, DOI 10.1016/j.ajhg.2008.07.010; Bartolomei MS, 1997, ANNU REV GENET, V31, P493, DOI 10.1146/annurev.genet.31.1.493; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; BARTOLOMEI MS, 1993, GENE DEV, V7, P1663, DOI 10.1101/gad.7.9.1663; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bhalla K, 2008, AM J HUM GENET, V83, P703, DOI 10.1016/j.ajhg.2008.10.020; Caqueret A, 2005, HORM RES, V64, P222, DOI 10.1159/000088977; Cassidy SB, 2009, EUR J HUM GENET, V17, P3, DOI 10.1038/ejhg.2008.165; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Delaval K, 2006, BIOESSAYS, V28, P453, DOI 10.1002/bies.20407; Gao Q, 2007, ANNU REV NEUROSCI, V30, P367, DOI 10.1146/annurev.neuro.30.051606.094324; Gregg C, 2010, SCIENCE, V329, P682, DOI 10.1126/science.1190831; Haig D, 2004, ANNU REV GENET, V38, P553, DOI 10.1146/annurev.genet.37.110801.142741; HALL JG, 1990, AM J HUM GENET, V46, P857; Hemberger M, 1998, DEV GENES EVOL, V208, P393, DOI 10.1007/s004270050195; Hernandez A, 2002, ENDOCRINOLOGY, V143, P4483, DOI 10.1210/en.2002-220800; HU JF, 1995, MOL ENDOCRINOL, V9, P628, DOI 10.1210/me.9.5.628; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Keverne EB, 2007, ADV GENET, V59, P217, DOI 10.1016/S0065-2660(07)59008-5; Keverne EB, 1996, DEV BRAIN RES, V92, P91, DOI 10.1016/0165-3806(95)00209-X; Keverne EB, 2001, HORM BEHAV, V40, P146, DOI 10.1006/hbeh.2001.1685; Koc EC, 2001, J BIOL CHEM, V276, P43958, DOI 10.1074/jbc.M106510200; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; MCEWEN KR, 2009, GENOMIC IMPRINTING M, P235; Mochida GH, 2009, AM J HUM GENET, V85, P897, DOI 10.1016/j.ajhg.2009.10.027; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Smit MA, 2005, MAMM GENOME, V16, P801, DOI 10.1007/s00335-004-2415-z; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Van Buggenhout G, 2009, EUR J HUM GENET, V17, P1367, DOI 10.1038/ejhg.2009.67; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang YD, 2004, MOL CELL BIOL, V24, P270, DOI 10.1128/MCB.24.1.270-279.2004; Webber AL, 1998, NATURE, V391, P711, DOI 10.1038/35655; Wilkinson LS, 2007, NAT REV NEUROSCI, V8, P832, DOI 10.1038/nrn2235; Wood AJ, 2008, GENE DEV, V22, P1141, DOI 10.1101/gad.473408; Wood AJ, 2007, NUCLEIC ACIDS RES, V35, P7031, DOI 10.1093/nar/gkm742; Yamasaki Y, 2005, HUM MOL GENET, V14, P2511, DOI 10.1093/hmg/ddi255	46	394	401	1	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 6	2010	329	5992					643	648		10.1126/science.1190830	http://dx.doi.org/10.1126/science.1190830			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634RV	20616232	Green Accepted			2022-12-28	WOS:000280602700029
J	Cantor, JD				Cantor, Julie D.			Bracing for the Impact of Expanded Second Amendment Rights	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Cantor, Julie D.] Goldman Ismail Tomaselli Brennan & Baum, Santa Monica, CA USA; [Cantor, Julie D.] Univ Calif Los Angeles, Sch Law, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Cantor, JD (corresponding author), Goldman Ismail Tomaselli Brennan & Baum, Santa Monica, CA USA.								0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					506	508		10.1056/NEJMp1006890	http://dx.doi.org/10.1056/NEJMp1006890			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634BB	20592292				2022-12-28	WOS:000280552700003
J	DeWeerdt, S				DeWeerdt, Sarah			Dancing with an escape artist	NATURE			English	Editorial Material							HIV-1											Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Levesque MC, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000107	3	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S6	S7		10.1038/nature09237	http://dx.doi.org/10.1038/nature09237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631705	Bronze			2022-12-28	WOS:000279867100026
J	DesRoches, CM; Rao, SR; Fromson, JA; Birnbaum, RJ; Iezzoni, L; Vogeli, C; Campbell, EG				DesRoches, Catherine M.; Rao, Sowmya R.; Fromson, John A.; Birnbaum, Robert J.; Iezzoni, Lisa; Vogeli, Christine; Campbell, Eric G.			Physicians' Perceptions, Preparedness for Reporting, and Experiences Related to Impaired and Incompetent Colleagues	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NATIONAL-SURVEY; PROFESSIONALISM	Context Peer monitoring and reporting are the primary mechanisms for identifying physicians who are impaired or otherwise incompetent to practice, but data suggest that the rate of such reporting is lower than it should be. Objective To understand physicians' beliefs, preparedness, and actual experiences related to colleagues who are impaired or incompetent to practice medicine. Design, Setting, and Participants Nationally representative survey of 2938 eligible physicians practicing in the United States in 2009 in anesthesiology, cardiology, family practice, general surgery, internal medicine, pediatrics, and psychiatry. Overall, 1891 physicians (64.4%) responded. Main Outcome Measures Beliefs about and preparedness for reporting and experiences with colleagues who practice medicine while impaired or who are incompetent in their medical practice. Results Sixty-four percent (n=1120) of surveyed physicians agreed with the professional commitment to report physicians who are significantly impaired or otherwise incompetent to practice. Nonetheless, only 69% (n=1208) of physicians reported being prepared to effectively deal with impaired colleagues in their medical practice, and 64% (n=1126) reported being so prepared to deal with incompetent colleagues. Seventeen percent (n=309) of physicians had direct personal knowledge of a physician colleague who was incompetent to practice medicine in their hospital, group, or practice. Of those with this knowledge, 67% (n=204) reported this colleague to the relevant authority. Underrepresented minorities and graduates of non-US medical schools were less likely than their counterparts to report, and physicians working in hospitals or medical schools were most likely to report. The most frequently cited reason for taking no action was the belief that someone else was taking care of the problem (19% [n=58]), followed by the belief that nothing would happen as a result of the report (15% [n=46]) and fear of retribution (12% [n=36]). Conclusion Overall, physicians support the professional commitment to report all instances of impaired or incompetent colleagues in their medical practice to a relevant authority; however, when faced with these situations, many do not report. JAMA. 2010; 304(2): 187-193 www.jama.com	[DesRoches, Catherine M.; Rao, Sowmya R.; Iezzoni, Lisa; Vogeli, Christine; Campbell, Eric G.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; [Rao, Sowmya R.] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA; [Fromson, John A.; Birnbaum, Robert J.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	DesRoches, CM (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,Ste 900, Boston, MA 02114 USA.	cdesroches@partners.org	DesRoches, Catherine/ABC-9869-2020	DesRoches, Catherine/0000-0001-5373-855X	Institute on Medicine	Institute on Medicine	This study, which is the second in the series, was supported by a grant from the Institute on Medicine as a Profession.	*AMA, COD MED ETH; BARNARD A, 2002, BOSTON GLOBE    0520, pA1; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; FROMSON J, 2004, PATIENT SAFETY HDB, P423; *HJ KAIS FAM FDN, 2008, NUMB PAID MED MALP C; Kohn KT, 2000, ERR IS HUMAN BUILDIN; Korn EL., 1999, ANAL HLTH SURVEYS; Kurlander JE, 2004, AM J BIOETHICS, V4, P33, DOI 10.1162/152651604323097736; Leape LL, 2006, ANN INTERN MED, V144, P107, DOI 10.7326/0003-4819-144-2-200601170-00008; Neff KE, 2000, ENHANCING PHYS PERFO, P45; Papadakis MA, 2004, ACAD MED, V79, P244, DOI 10.1097/00001888-200403000-00011; Samkoff J S, 1990, Pa Med, V93, P40; Sharpe V.A., 1998, MED HARM HIST CONCEP; Sox HC, 2002, ANN INTERN MED, V136, P243, DOI 10.7326/0003-4819-136-3-200202050-00012; SWIDEY N, 2004, BOSTON GLOBE    0104; Wynia MK, 2008, PERSPECT BIOL MED, V51, P565, DOI 10.1353/pbm.0.0051	17	120	121	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					187	193		10.1001/jama.2010.921	http://dx.doi.org/10.1001/jama.2010.921			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628132	Bronze			2022-12-28	WOS:000279811000025
J	Cuello, LG; Jogini, V; Cortes, DM; Pan, AC; Gagnon, DG; Dalmas, O; Cordero-Morales, JF; Chakrapani, S; Roux, B; Perozo, E				Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo			Structural basis for the coupling between activation and inactivation gates in K+ channels	NATURE			English	Article							MOLECULAR ARCHITECTURE; EXTERNAL K+; POTASSIUM; ION; DYNAMICS; KCSA; PORE; MECHANISMS; MUTATIONS; STATE	The coupled interplay between activation and inactivation gating is a functional hallmark of K+ channels(1,2). This coupling has been experimentally demonstrated through ion interaction effects(3,4) and cysteine accessibility(1), and is associated with a well defined boundary of energetically coupled residues(2). The structure of the K+ channel KcsA in its fully open conformation, in addition to four other partial channel openings, richly illustrates the structural basis of activation-inactivation gating(5). Here, we identify the mechanistic principles by which movements on the inner bundle gate trigger conformational changes at the selectivity filter, leading to the non-conductive C-type inactivated state. Analysis of a series of KcsA open structures suggests that, as a consequence of the hinge-bending and rotation of the TM2 helix, the aromatic ring of Phe 103 tilts towards residues Thr 74 and Thr 75 in the pore-helix and towards Ile 100 in the neighbouring subunit. This allows the network of hydrogen bonds among residues Trp 67, Glu 71 and Asp 80 to destabilize the selectivity filter(6,7), allowing entry to its non-conductive conformation. Mutations at position 103 have a size-dependent effect on gating kinetics: small side-chain substitutions F103A and F103C severely impair inactivation kinetics, whereas larger side chains such as F103W have more subtle effects. This suggests that the allosteric coupling between the inner helical bundle and the selectivity filter might rely on straightforward mechanical deformation propagated through a network of steric contacts. Average interactions calculated from molecular dynamics simulations show favourable open-state interaction-energies between Phe 103 and the surrounding residues. We probed similar interactions in the Shaker K+ channel where inactivation was impaired in the mutant I470A. We propose that side-chain rearrangements at position 103 mechanically couple activation and inactivation in KcsA and a variety of other K+ channels.	[Cuello, Luis G.; Jogini, Vishwanath; Cortes, D. Marien; Pan, Albert C.; Gagnon, Dominique G.; Dalmas, Olivier; Cordero-Morales, Julio F.; Chakrapani, Sudha; Roux, Benoit; Perozo, Eduardo] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Roux, Benoit; Perozo, Eduardo] Univ Chicago, Inst Biophys Dynam, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Perozo, E (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 929 E 57th St, Chicago, IL 60637 USA.	eperozo@uchcicago.edu	Pan, Albert/G-1475-2013	chakrapani, sudha/0000-0003-0722-2338; Cordero Morales, Julio/0000-0002-6505-5403; Pan, Albert/0000-0001-5050-5603	NIH [R01-GM57846]; Palmer family [R01-GM62342]; NRSA; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057846, R01GM062342] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Palmer family; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank F. Bezanilla, H Mchaourab and R. Nakamoto for discussions and comments on the manuscript. We also thank K. Locher for comments on the manuscript. R. Mackinnon provided the Fab-expressing hybridoma cells. We thank the members of the Perozo laboratory for comments on the manuscript. We thank K. R. Rajashankar, R. Sanishvili and the staff at the NE-CAT 24ID and GM-CA 23ID beamlines at the Advanced Photon Source, Argonne National Laboratory for assistance during data collection. This work was supported in part by NIH grant R01-GM57846 and a gift from the Palmer family to E.P., by grant R01-GM62342 to B.R. and by an NRSA postdoctoral fellowship to A.C.P.	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; Armstrong Clay M, 2003, Sci STKE, V2003, pre10, DOI 10.1126/stke.2003.188.re10; Baukrowitz T, 1996, SCIENCE, V271, P653, DOI 10.1126/science.271.5249.653; Ben-Abu Y, 2009, NAT STRUCT MOL BIOL, V16, P71, DOI 10.1038/nsmb.1525; Berneche S, 2000, BIOPHYS J, V78, P2900, DOI 10.1016/S0006-3495(00)76831-7; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakrapani S, 2007, J GEN PHYSIOL, V130, P465, DOI 10.1085/jgp.200709843; Chapman M, 2006, PFLUG ARCH EUR J PHY, V451, P776, DOI 10.1007/s00424-005-1515-2; Chen J, 2002, P NATL ACAD SCI USA, V99, P12461, DOI 10.1073/pnas.192367299; CHOI KL, 1991, P NATL ACAD SCI USA, V88, P5092, DOI 10.1073/pnas.88.12.5092; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cortes DM, 2001, J GEN PHYSIOL, V117, P165, DOI 10.1085/jgp.117.2.165; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; Cuello LG, 2004, SCIENCE, V306, P491, DOI 10.1126/science.1101373; Cuello LG, 1998, BIOCHEMISTRY-US, V37, P3229, DOI 10.1021/bi972997x; DELCOUR AH, 1989, BIOPHYS J, V56, P631, DOI 10.1016/S0006-3495(89)82710-9; DEMO SD, 1992, BIOPHYS J, V61, P639, DOI 10.1016/S0006-3495(92)81869-6; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jogini V, 2007, BIOPHYS J, V93, P3070, DOI 10.1529/biophysj.107.112540; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kiss L, 1999, BIOPHYS J, V76, P253, DOI 10.1016/S0006-3495(99)77194-8; Klement G, 2008, BIOPHYS J, V94, P3014, DOI 10.1529/biophysj.107.119842; Liu Y, 1996, NEURON, V16, P859, DOI 10.1016/S0896-6273(00)80106-3; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Liu YS, 2001, NAT STRUCT BIOL, V8, P883, DOI 10.1038/nsb1001-883; LOPEZBARNEO J, 1993, RECEPTOR CHANNEL, V1, P61; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Olcese R, 2001, J GEN PHYSIOL, V117, P149, DOI 10.1085/jgp.117.2.149; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Panyi G, 2006, J GEN PHYSIOL, V128, P547, DOI 10.1085/jgp.200609644; Perozo E, 1999, SCIENCE, V285, P73, DOI 10.1126/science.285.5424.73; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Proks P, 2001, J GEN PHYSIOL, V118, P341, DOI 10.1085/jgp.118.4.341; Rotem D, 2010, J GEN PHYSIOL, V135, P29, DOI 10.1085/jgp.200910305; Sadovsky E, 2007, P NATL ACAD SCI USA, V104, P19813, DOI 10.1073/pnas.0708120104; Schulte U, 2001, J PHYSIOL-LONDON, V534, P49, DOI 10.1111/j.1469-7793.2001.t01-1-00049.x; SWENSON RP, 1981, NATURE, V291, P427, DOI 10.1038/291427a0; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	44	223	224	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					272	U154		10.1038/nature09136	http://dx.doi.org/10.1038/nature09136			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613845	Green Accepted			2022-12-28	WOS:000279580800044
J	Borthwick, E; Ferguson, A				Borthwick, Emma; Ferguson, Andrew			Perioperative acute kidney injury: risk factors, recognition, management, and outcomes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GELATINASE-ASSOCIATED LIPOCALIN; ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; PREDICT; MORTALITY		[Ferguson, Andrew] Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland; [Borthwick, Emma] Belfast City Hosp, Belfast BT12 7BA, Antrim, North Ireland	Belfast City Hospital	Ferguson, A (corresponding author), Craigavon Area Hosp, Portadown BT63 5QQ, North Ireland.	fergua@yahoo.ca	Ferguson, Andrew J/B-8878-2012	Ferguson, Andrew J/0000-0002-4081-1567	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	Northern Ireland Kidney Research Fund; Northern Ireland Research and Development Office	All authors have completed the Unified Competing Interest form at http://www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) EB and AF have had no support from any company for the submitted work; (2) AF has no relationships with any company that might have an interest in the submitted work in the previous 3 years. EB received travel and accommodation expenses for conference attendance in 2009 from Biosite (Inverness Medical), who manufacture a point of care testing device for NGAL. EB's salary was funded by the Northern Ireland Kidney Research Fund from August 2008 to August 2009. EB received a bursary for part time MPhil fees from the Northern Ireland Research and Development Office; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) EB and AF have no non-financial interests that may be relevant to the submitted work.	Abelha FJ, 2009, NEFROLOGIA, V29, P404, DOI 10.3265/Nefrologia.2009.29.5.5456.en.full; Abelha FJ, 2009, CRIT CARE, V13, DOI 10.1186/cc7894; Awad AS, 2007, AM J PHYSIOL-RENAL, V293, pF28, DOI 10.1152/ajprenal.00159.2007; Bellomo R, 2004, CRIT CARE, V8, pR204, DOI 10.1186/cc2872; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brienza N, 2009, CRIT CARE MED, V37, P2079, DOI 10.1097/CCM.0b013e3181a00a43; Briguori C, 2004, EUR HEART J, V25, P206, DOI 10.1016/j.ehj.2003.11.016; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; De Santo LS, 2010, J HEART VALVE DIS, V19, P139; Dent CL, 2007, CRIT CARE, V11, DOI 10.1186/cc6192; Englberger L, 2011, J THORAC CARDIOV SUR, V141, P552, DOI 10.1016/j.jtcvs.2010.02.045; Friedrich JO, 2005, ANN INTERN MED, V142, P510, DOI 10.7326/0003-4819-142-7-200504050-00010; Haase M, 2009, ANN THORAC SURG, V88, P124, DOI 10.1016/j.athoracsur.2009.04.023; Haase-Fielitz A, 2009, CRIT CARE MED, V37, P553, DOI 10.1097/CCM.0b013e318195846e; Kagan A, 2010, CLIN CARDIOL, V33, P62, DOI 10.1002/clc.20687; Kheterpal S, 2007, ANESTHESIOLOGY, V107, P892, DOI 10.1097/01.anes.0000290588.29668.38; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kolhe Nitin V, 2008, Crit Care, V12 Suppl 1, pS2, DOI 10.1186/cc7003; Landoni G, 2008, J CARDIOTHOR VASC AN, V22, P27, DOI 10.1053/j.jvca.2007.07.015; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Levy MM, 2005, CRIT CARE MED, V33, P2194, DOI 10.1097/01.CCM.0000182798.39709.84; Macedo E, 2008, RENAL FAILURE, V30, P287, DOI 10.1080/08860220701857522; McCullough PA, 2005, CRIT CARE CLIN, V21, P261, DOI 10.1016/j.ccc.2004.12.003; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nickolas TL, 2008, ANN INTERN MED, V148, P810, DOI 10.7326/0003-4819-148-11-200806030-00003; Stewart J, 2009, ADDING INSULT INJURY; Sward K, 2004, CRIT CARE MED, V32, P1310; Uchino S, 2010, NEPHROL DIAL TRANSPL, V25, P1833, DOI 10.1093/ndt/gfp624; Zappitelli M, 2007, CRIT CARE, V11, DOI 10.1186/cc6089	29	84	88	1	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 5	2010	341								c3365	10.1136/bmj.c3365	http://dx.doi.org/10.1136/bmj.c3365			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603317				2022-12-28	WOS:000279874000002
J	Blomberg, J; Lagergren, P; Martin, L; Mattsson, F; Lagergren, J				Blomberg, John; Lagergren, Pernilla; Martin, Lena; Mattsson, Fredrik; Lagergren, Jesper			Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERISTOMAL INFECTION; RISK; COMPLICATIONS; TRIMETHOPRIM; METAANALYSIS; CANCER	Objective To evaluate a new and simpler strategy of antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG). Design Single centre, two arm, randomised, controlled, double blind clinical trial. Setting Endoscopy unit in Karolinska University Hospital, Stockholm, Sweden, between 3 June 2005 and 31 October 2009. Participants 234 patients with an indication for PEG who gave informed consent to participate. Intervention A single 20 ml dose of the oral solution of sulfamethoxazole and trimethoprim (also known as co-trimoxazole or Bactrim; F Hoffmann-La Roche Ltd, Basel, Switzerland) deposited in the PEG catheter immediately after insertion. The control group received standard prophylaxis consisting of a single intravenous dose of 1.5 g cefuroxime (Zinacef; GlaxoSmithKline, London) administered before insertion of the PEG tube. Main outcome measure Primary outcome was the occurrence of clinically evident wound infection within 14 days after insertion of the PEG catheter. Secondary outcomes were positive bacterial culture and blood tests (highly sensitive C reactive protein and white blood cell count). All randomised patients were included in an intention to treat analysis. Results Of the 234 patients included in this study, 116 were randomly assigned to co-trimoxazole and 118 to cefuroxime. At follow-up 7-14 days after insertion of the PEG catheter, wound infection was found in 10 (8.6%) patients in the co-trimoxazole group and 14 (11.9%) in the cefuroxime group, which corresponds to a percentage point difference of -3.3% (95% confidence interval -10.9% to 4.5%). The per protocol analysis, which comprised 100 patients in each group, gave similar results-10% and 13% infection in the co-trimoxazole and cefuroxime groups, respectively (percentage point difference -3.0%, 95% CI -11.8% to 5.8%). Both these analyses indicate non-inferiority of co-trimoxazole compared with cefuroxime because the upper bounds of the confidence intervals are lower than the pre-determined non-inferiority margin of 15%. Analyses of the secondary outcomes supported this finding. Conclusion 20 ml of co-trimoxazole solution deposited in a newly inserted PEG catheter is at least as effective as cefuroxime prophylaxis given intravenously before PEG at preventing wound infections in patients undergoing PEG.	[Blomberg, John; Lagergren, Pernilla; Martin, Lena; Mattsson, Fredrik; Lagergren, Jesper] Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden; [Blomberg, John] Karolinska Univ Hosp, Dept Surg, Gastroctr, SE-14186 Stockholm, Sweden; [Lagergren, Jesper] Kings Coll London, London WC2R 2LS, England	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of London; King's College London	Blomberg, J (corresponding author), Karolinska Inst, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden.	john.blomberg@karolinska.se		Lagergren, Jesper/0000-0002-5143-5448; Lagergren, Pernilla/0000-0002-4634-0233	Swedish Cancer Society; Swedish Research Council	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was funded by the Swedish Cancer Society and Swedish Research Council.	Ahmad I, 2003, ALIMENT PHARM THER, V18, P209, DOI 10.1046/j.1365-2036.2003.01684.x; Allison MC, 2009, GUT, V58, P869, DOI 10.1136/gut.2007.136580; BURKE JF, 1961, SURGERY, V50, P161; Carignan A, 2008, CLIN INFECT DIS, V46, P1838, DOI 10.1086/588291; GAUDERER MWL, 1980, J PEDIATR SURG, V15, P872, DOI 10.1016/S0022-3468(80)80296-X; Gencosmanoglu R, 2003, HEPATO-GASTROENTEROL, V50, P886; Geroulanos S, 2001, J CHEMOTHERAPY, V13, P23, DOI 10.1179/joc.2001.13.Supplement-2.23; Grant DG, 2009, CLIN OTOLARYNGOL, V34, P103, DOI 10.1111/j.1749-4486.2009.01889.x; GRANT JP, 1993, ANN SURG, V217, P168, DOI 10.1097/00000658-199302000-00011; Hiki N, 2008, J AM COLL SURGEONS, V207, P737, DOI 10.1016/j.jamcollsurg.2008.06.335; Jafri NS, 2007, ALIMENT PHARM THER, V25, P647, DOI 10.1111/j.1365-2036.2007.03247.x; Kulling D, 2000, GASTROINTEST ENDOSC, V51, P152, DOI 10.1016/S0016-5107(00)70410-X; Lee JH, 2002, DIGEST LIVER DIS, V34, P857, DOI 10.1016/S1590-8658(02)80256-0; Lee LH, 2001, CORNEA, V20, P179, DOI 10.1097/00003226-200103000-00014; Lipp A, 2006, COCHRANE DB SYST REV, V4; Lipp A, 2009, J CLIN NURS, V18, P938, DOI 10.1111/j.1365-2702.2008.02585.x; Luman W., 2001, SMJ Singapore Medical Journal, V42, P460; Maclean AA, 2004, AM SURGEON, V70, P827; Mahadeva S, 2009, INT J CLIN PRACT, V63, P760, DOI 10.1111/j.1742-1241.2008.01881.x; McClave SA, 2003, GASTROINTEST ENDOSC, V58, P739, DOI 10.1016/S0016-5107(03)02147-3; MITCHELL NJ, 1980, J ANTIMICROB CHEMOTH, V6, P393, DOI 10.1093/jac/6.3.393; Mukhtar S, 2006, J HOSP INFECT, V64, P93, DOI 10.1016/j.jhin.2006.05.006; Napolitano LM, 2008, SURG INFECT, V9, pS17, DOI 10.1089/sur.2008.063.supp; Norman K, 2008, CLIN NUTR, V27, P5, DOI 10.1016/j.clnu.2007.10.007; PETRI JWA, 2006, GOODMAN GILMANS PHAR; Potack Jonathan Z, 2008, Medscape J Med, V10, P142; Saadeddin A, 2005, ALIMENT PHARM THER, V22, P565, DOI 10.1111/j.1365-2036.2005.02578.x; Sharma VK, 2000, AM J GASTROENTEROL, V95, P3133; Sheehan J J, 2003, Ir Med J, V96, P265; SINGLAS E, 1982, EUR J CLIN PHARMACOL, V21, P409, DOI 10.1007/BF00542328	30	31	33	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 2	2010	341								c3115	10.1136/bmj.c3115	http://dx.doi.org/10.1136/bmj.c3115			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NX	20601414	Green Published, hybrid			2022-12-28	WOS:000279586700004
J	Di Santo, JP				Di Santo, James P.			A Guardian of T Cell Fate	SCIENCE			English	Editorial Material							DELTA-LIKE 4; MICE; NOTCH1; IL-7		[Di Santo, James P.] Inst Pasteur, Innate Immun Unit, F-75724 Paris, France; [Di Santo, James P.] INSERM, U668, F-75724 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm)	Di Santo, JP (corresponding author), Inst Pasteur, Innate Immun Unit, F-75724 Paris, France.	james.di-santo@pasteur.fr	Di Santo, James P/M-4298-2014	Di Santo, James P/0000-0002-7146-1862	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060723] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR060723] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alves NL, 2009, P NATL ACAD SCI USA, V106, P1512, DOI 10.1073/pnas.0809559106; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Ikawa T, 2010, SCIENCE, V329, P93, DOI 10.1126/science.1188995; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Li L, 2010, SCIENCE, V329, P89, DOI 10.1126/science.1188989; Li P, 2010, SCIENCE, V329, P85, DOI 10.1126/science.1188063; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rothenberg EV, 2007, NAT IMMUNOL, V8, P441, DOI 10.1038/ni1461; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927	13	12	13	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					44	45		10.1126/science.1191664	http://dx.doi.org/10.1126/science.1191664			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595605				2022-12-28	WOS:000279402700024
J	Chudler, EH				Chudler, Eric H.			Resources for Anyone Interested in the Brain	SCIENCE			English	Editorial Material									Univ Washington, Dept Bioengn, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chudler, EH (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	chudler@u.washington.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [R25RR012312] Funding Source: NIH RePORTER; NCRR NIH HHS [R25RR12312] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		American Association for the Advancement of Science (AAAS), 1993, BENCHM SCI LIT; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; CHUDLER EH, 2002, NEUR ABSTR; CHUDLER EH, 2007, NEUR ABSTR; *DANA, DANA ALL BRAIN IN; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Moore RW, 1997, J RES SCI TEACH, V34, P327, DOI 10.1002/(SICI)1098-2736(199704)34:4<327::AID-TEA3>3.3.CO;2-V; *NIH, 1997, R25RR12312 NIH NAT C; Society for Neuroscience, 2008, BRAIN FACTS PRIM BRA	9	2	2	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1648	1649		10.1126/science.1186935	http://dx.doi.org/10.1126/science.1186935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576881				2022-12-28	WOS:000279107400031
J	Narod, SA				Narod, Steven A.			Genes, the environment, and breast cancer	LANCET			English	Editorial Material							MUTATION CARRIERS; RISK; THERAPY; BRCA1		Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada	University of Toronto; University Toronto Affiliates; Womens College Hospital	Narod, SA (corresponding author), Womens Coll Res Inst, Toronto, ON M5G 1N8, Canada.	steven.narod@wchospital.ca	Narod, Steven A/AAA-6112-2022					Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Cullinane CA, 2005, INT J CANCER, V117, P988, DOI 10.1002/ijc.21273; Eisen A, 2008, J NATL CANCER I, V100, P1361, DOI 10.1093/jnci/djn313; Jernstrom H, 2004, JNCI-J NATL CANCER I, V96, P1094, DOI 10.1093/jnci/djh211; Ravdin PM, 2007, NEW ENGL J MED, V356, P1670, DOI 10.1056/NEJMsr070105; Travis RC, 2010, LANCET, V375, P2143, DOI 10.1016/S0140-6736(10)60636-8; Wacholder S, 2010, NEW ENGL J MED, V362, P986, DOI 10.1056/NEJMoa0907727	7	6	6	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2123	2124		10.1016/S0140-6736(10)60876-8	http://dx.doi.org/10.1016/S0140-6736(10)60876-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BF	20617549				2022-12-28	WOS:000279255100004
J	Bhutta, ZA; Chopra, M; Axelson, H; Berman, P; Boerma, T; Bryce, J; Bustreo, F; Cavagnero, E; Cometto, G; Daelmans, B; de Francisco, A; Fogstad, H; Gupta, N; Laski, L; Lawn, J; Maliqi, B; Mason, E; Pitt, C; Requejo, J; Starrs, A; Victora, CG; Wardlaw, T				Bhutta, Zulfiqar A.; Chopra, Mickey; Axelson, Henrik; Berman, Peter; Boerma, Ties; Bryce, Jennifer; Bustreo, Flavia; Cavagnero, Eleonora; Cometto, Giorgio; Daelmans, Bernadette; de Francisco, Andres; Fogstad, Helga; Gupta, Neeru; Laski, Laura; Lawn, Joy; Maliqi, Blerta; Mason, Elizabeth; Pitt, Catherine; Requejo, Jennifer; Starrs, Ann; Victora, Cesar G.; Wardlaw, Tessa			Countdown to 2015 decade report (2000-10): taking stock of maternal, newborn, and child survival	LANCET			English	Review							DEVELOPING-COUNTRIES; HEALTH; MORTALITY	The Countdown to 2015 for Maternal, Newborn, and Child Survival monitors coverage of priority interventions to achieve the Millennium Development Goals (MDGs) for child mortality and maternal health. We reviewed progress between 1990 and 2010 in coverage of 26 key interventions in 68 Countdown priority countries accounting for more than 90% of maternal and child deaths worldwide. 19 countries studied were on track to meet MDG 4, in 47 we noted acceleration in the yearly rate of reduction in mortality of children younger than 5 years, and in 12 countries progress had decelerated since 2000. Progress towards reduction of neonatal deaths has been slow, and maternal mortality remains high in most Countdown countries, with little evidence of progress. Wide and persistent disparities exist in the coverage of interventions between and within countries, but some regions have successfully reduced longstanding inequities. Coverage of interventions delivered directly in the community on scheduled occasions was higher than for interventions relying on functional health systems. Although overseas development assistance for maternal, newborn, and child health has increased, funding for this sector accounted for only 31% of all development assistance for health in 2007. We provide evidence from several countries showing that rapid progress is possible and that focused and targeted interventions can reduce inequities related to socioeconomic status and sex. However, much more can and should be done to address maternal and newborn health and improve coverage of interventions related to family planning, care around childbirth, and case management of childhood illnesses.	[Bhutta, Zulfiqar A.] Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan; [Chopra, Mickey; Wardlaw, Tessa] UNICEF, New York, NY USA; [Axelson, Henrik; Bustreo, Flavia; de Francisco, Andres] Partnership Maternal Newborn & Child Hlth, Geneva, Switzerland; [Berman, Peter] World Bank, Washington, DC 20433 USA; [Boerma, Ties; Cavagnero, Eleonora; Daelmans, Bernadette; Gupta, Neeru; Maliqi, Blerta; Mason, Elizabeth] WHO, CH-1211 Geneva, Switzerland; [Bryce, Jennifer; Requejo, Jennifer] Johns Hopkins Univ, Baltimore, MD USA; [Cometto, Giorgio] Global Hlth Workforce Alliance, Geneva, Switzerland; [Fogstad, Helga] Norwegian Agcy Dev, Oslo, Norway; [Laski, Laura] UN Populat Fund, New York, NY USA; [Lawn, Joy] Save Children, Saving Newborn Lives, Washington, DC USA; [Pitt, Catherine] London Sch Hyg & Trop Med, London WC1, England; [Starrs, Ann] Family Care Int, New York, NY USA; [Victora, Cesar G.] Univ Pelotas, Pelotas, Brazil	Aga Khan University; UNICEF; The World Bank; World Health Organization; Johns Hopkins University; United Nations Population Fund; Save the Children; University of London; London School of Hygiene & Tropical Medicine	Bhutta, ZA (corresponding author), Aga Khan Univ, Div Women & Child Hlth, Karachi 74800, Pakistan.		Pitt, Catherine K/K-3001-2012; Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013; Lawn, Joy/ABE-6382-2020	Pitt, Catherine K/0000-0003-4967-8966; Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Lawn, Joy/0000-0002-4573-1443; Gupta, Neeru/0000-0002-3806-4435	Bill & Melinda Gates Foundation, UK Department for International Development, Government of Norway	Bill & Melinda Gates Foundation, UK Department for International Development, Government of Norway(Bill & Melinda Gates Foundation)	This report was funded by the Bill & Melinda Gates Foundation, UK Department for International Development, Government of Norway. Partnership for Maternal, Newborn and Child Health, Save the Children USA and UK, UNICEF, United Nations Population Fund, and WHO We thank Holly Newby and Archana Dwivedi from UNICEF for their work in helping to construct the Countdown databases, Julia David from the Johns Hopkins University for her help with the initial review and analysis, Stan Bernstein and Edilberto Loaiza from the UN Population Fund for their inputs on the family planning indicators and analyses, Aluisio Barros for his work on the equity analyses. and Nancy Terreri for her review of the data We also thank all members of the five Countdown working groups that have contributed to the conceptualisation of the Countdown 2010 report and products and all individuals that have contributed to data collection. tabulation, and analysis Details about Countdown membership are provided on the Countdown website The authors alone are responsible for the views expressed m this publication and they do not necessarily represent the decisions or the stated policy of WHO	*AID HARM AL, 2005, PAR DECL AID EFF; [Anonymous], 2010, WORLD HLTH STAT 2010; Bhutta Z.A., 2010, GLOB HLTH WORKFORCE, V1, P61; Bhutta ZA, 2010, LANCET, V375, P1058, DOI 10.1016/S0140-6736(10)60352-2; Bishai D, 2002, HEALTH POLICY PLANN, V17, P412, DOI 10.1093/heapol/17.4.412; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Boerma T, 2009, MONITORING EVALUATIO; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; *COMM SOC DET HLTH, 2008, CLOS GAP ON GEN HLTH; *COUNTD COR GROUP, 2005, TRACK PROGR CHILD SU; DeSavigny D, 2009, SYSTEMS THINKING FOR HEALTH SYSTEMS STRENGTHENING, P1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *INT HLTH PARTN RE, 2008, MON PERF EV PROGR SC; Lewin S, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004015.pub3; Lu CL, 2010, LANCET, V375, P1375, DOI 10.1016/S0140-6736(10)60233-4; MONTEIRO CA, 2010, B WORLD HEALTH ORGAN, V88, P241; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rudan I, 2010, LANCET, V375, P1083, DOI 10.1016/S0140-6736(10)60060-8; Rutstein SO, 2005, INT J GYNECOL OBSTET, V89, pS7, DOI 10.1016/j.ijgo.2004.11.012; UNICEF, 2007, PROTECTING THE WORLD'S CHILDREN: IMPACT OF THE CONVENTION ON THE RIGHTS OF THE CHILD IN DIVERSE LEGAL SYSTEMS, P1; UNICEF, 2009, STAT WORLDS CHILDR; United Nations, 2009, MILL DEV GOALS REP 2; Victora CG, 2010, PEDIATRICS, V125, pE473, DOI 10.1542/peds.2009-1519; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; You D, 2010, LANCET, V375, P100, DOI 10.1016/S0140-6736(09)61601-9; COUNTDOWN 2015 MATER	28	472	474	0	46	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2010	375	9730					2032	2044		10.1016/S0140-6736(10)60678-2	http://dx.doi.org/10.1016/S0140-6736(10)60678-2			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609WT	20569843				2022-12-28	WOS:000278689600030
J	Kahn, R; Gale, EAM				Kahn, Richard; Gale, Edwin A. M.			Gridlocked guidelines for diabetes	LANCET			English	Editorial Material									[Kahn, Richard] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Gale, Edwin A. M.] Univ Bristol, Fac Med, Bristol BS8 1TH, Avon, England	University of North Carolina; University of North Carolina Chapel Hill; University of Bristol	Kahn, R (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA.	rak6200@gmail.com						*AACE DIAB MELL CL, 2007, ENDOCR PRACT S1, V13, P1; [Anonymous], 1989, DIABETES CARE, V12, P365; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; Ferket BS, 2010, ARCH INTERN MED, V170, P27, DOI 10.1001/archinternmed.2009.434; International Diabetes Federation, 2005, GLOB GUID TYP 2 DIAB; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Sniderman AD, 2009, JAMA-J AM MED ASSOC, V301, P429, DOI 10.1001/jama.2009.15; Stone MA, 2010, DIABETES RES CLIN PR, V87, P252, DOI 10.1016/j.diabres.2009.10.020	10	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2203	2204		10.1016/S0140-6736(10)60714-3	http://dx.doi.org/10.1016/S0140-6736(10)60714-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609960				2022-12-28	WOS:000279652900009
J	Rawlins, M				Rawlins, Michael			Huntington's disease out of the closet?	LANCET			English	Editorial Material									Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine	Rawlins, M (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	michael.rawlins@nice.org.uk						Harper PS, 2002, HUNTINGTONS DIS; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Paulsen JS, 2006, ARCH NEUROL-CHICAGO, V63, P883, DOI 10.1001/archneur.63.6.883; Wexler A, 2010, LANCET, V376, P18, DOI 10.1016/S0140-6736(10)60957-9	4	44	45	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 23	2010	376	9750					1372	1373		10.1016/S0140-6736(10)60974-9	http://dx.doi.org/10.1016/S0140-6736(10)60974-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	672ZO	20594589				2022-12-28	WOS:000283627500009
J	Mahecha, MD; Reichstein, M; Carvalhais, N; Lasslop, G; Lange, H; Seneviratne, SI; Vargas, R; Ammann, C; Arain, MA; Cescatti, A; Janssens, IA; Migliavacca, M; Montagnani, L; Richardson, AD				Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta; Lange, Holger; Seneviratne, Sonia I.; Vargas, Rodrigo; Ammann, Christof; Arain, M. Altaf; Cescatti, Alessandro; Janssens, Ivan A.; Migliavacca, Mirco; Montagnani, Leonardo; Richardson, Andrew D.			Global Convergence in the Temperature Sensitivity of Respiration at Ecosystem Level	SCIENCE			English	Article							ORGANIC-MATTER DECOMPOSITION; SOIL RESPIRATION; CARBON; CLIMATE; DEPENDENCE; MODEL; EXCHANGE; ASSIMILATION; INTEGRATION; SEPARATION	The respiratory release of carbon dioxide (CO2) from the land surface is a major flux in the global carbon cycle, antipodal to photosynthetic CO2 uptake. Understanding the sensitivity of respiratory processes to temperature is central for quantifying the climate-carbon cycle feedback. We approximated the sensitivity of terrestrial ecosystem respiration to air temperature (Q(10)) across 60 FLUXNET sites with the use of a methodology that circumvents confounding effects. Contrary to previous findings, our results suggest that Q(10) is independent of mean annual temperature, does not differ among biomes, and is confined to values around 1.4 +/- 0.1. The strong relation between photosynthesis and respiration, by contrast, is highly variable among sites. The results may partly explain a less pronounced climate-carbon cycle feedback than suggested by current carbon cycle climate models.	[Mahecha, Miguel D.; Reichstein, Markus; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, D-07745 Jena, Germany; [Mahecha, Miguel D.; Seneviratne, Sonia I.] Swiss Fed Inst Technol, Inst Atmospher & Climate Sci, CH-8092 Zurich, Switzerland; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, P-2829516 Caparica, Portugal; [Lange, Holger] Norsk Inst Skog Landskap, N-1431 As, Norway; [Vargas, Rodrigo] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Ammann, Christof] Agroscope ART, Fed Res Stn, CH-8046 Zurich, Switzerland; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON L8S 4L8, Canada; [Cescatti, Alessandro] European Commiss, Joint Res Ctr, Inst Environm & Sustainabil, I-21027 Ispra, Italy; [Janssens, Ivan A.] Univ Antwerp, Dept Biol, B-2610 Antwerp, Belgium; [Migliavacca, Mirco] Univ Milano Bicocca, DISAT, Remote Sensing Environm Dynam Lab, I-20126 Milan, Italy; [Montagnani, Leonardo] Prov Autonoma Bolzano, Serv Forestali Agenzia Ambiente, I-39100 Bolzano, Italy; [Montagnani, Leonardo] Free Univ Bozen Bolzano, Fac Sci & Technol, I-39100 Bolzano, Italy; [Richardson, Andrew D.] Harvard Univ Herbaria, Harvard Univ Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA	Max Planck Society; Swiss Federal Institutes of Technology Domain; ETH Zurich; Universidade Nova de Lisboa; University of California System; University of California Berkeley; Swiss Federal Research Station Agroscope; McMaster University; European Commission Joint Research Centre; EC JRC ISPRA Site; University of Antwerp; University of Milano-Bicocca; Free University of Bozen-Bolzano; Harvard University	Mahecha, MD (corresponding author), Max Planck Inst Biogeochem, D-07745 Jena, Germany.	mmahecha@bgc-jena.mpg.de	Migliavacca, mirco/C-1260-2011; Richardson, Andrew/F-5691-2011; Seneviratne, Sonia I./G-8761-2011; Reichstein, Markus/A-7494-2011; Montagnani, Leonardo/F-1837-2016; Migliavacca, Mirco/J-9986-2019; Janssens, Ivan A/P-1331-2014; Lange, Holger/A-2458-2012; Vargas, Rodrigo/C-4720-2008; Arain, M. Altaf/ABA-9750-2020; Mahecha, Miguel D/F-2443-2010; Cescatti, Alessandro/ABE-6319-2020	Richardson, Andrew/0000-0002-0148-6714; Seneviratne, Sonia I./0000-0001-9528-2917; Reichstein, Markus/0000-0001-5736-1112; Montagnani, Leonardo/0000-0003-2957-9071; Migliavacca, Mirco/0000-0003-3546-8407; Janssens, Ivan A/0000-0002-5705-1787; Lange, Holger/0000-0001-7099-8740; Vargas, Rodrigo/0000-0001-6829-5333; Arain, M. Altaf/0000-0002-1433-5173; Mahecha, Miguel D/0000-0003-3031-613X; Ammann, Christof/0000-0002-0783-5444; Carvalhais, Nuno/0000-0003-0465-1436; Lasslop, Gitta/0000-0001-9939-1459	CarboEuropeIP; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF; University of Tuscia; U.S. Department of Energy; U.S. Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917]; European Research Council; European Commission [FP7-ENV2008-1-226701]; Max Planck Society	CarboEuropeIP(European Commission); FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS); Max Planck Institute for Biogeochemistry; NSF(National Science Foundation (NSF)); University of Tuscia; U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); European Research Council(European Research Council (ERC)European Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); Max Planck Society(Max Planck SocietyFoundation CELLEX)	This work is the outcome of the La Thuile FLUXNET workshop 2007, which would not have been possible without the support provided by CarboEuropeIP, FAO-GTOS-TCO, the Integrated Land Ecosystem-Atmosphere Processes Study (iLEAPS, a core project of IGBP), Max Planck Institute for Biogeochemistry, NSF, University of Tuscia, and U.S. Department of Energy. Moreover, we acknowledge databasing and technical support from the Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. The following networks provided flux data: AmeriFlux, AsiaFlux, CarboEuropeIP, ChinaFlux, FluxnetCanada, Canadian Carbon Program, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. AmeriFlux is supported by U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program grant DE-FG02-04ER63917. This work was also supported by the European Research Council via the ERC-Staring Grant QUASOM, the European Commission project CARBO-Extreme (FP7-ENV2008-1-226701), and a grant by the Max Planck Society establishing the MPRG Biogeochemical Model-Data Integration. We appreciate the collaboration of the FLUXNET synthesis team as documented at (23), and we thank M. Bahn, D. Baldocchi, H.-R. Kunsch, D. Papale, P. Rayner, M. Rodeghiero, and S. Zaehle for very valuable comments. M.D.M., M.R., N.C., and G.L. conceived the study and developed the methodology with substantial input from H.L.M.D.M. performed the analysis and co-wrote the paper with M.R. All other authors gave substantial scientific input during the analysis and/or writing phase.	Agren GI, 2007, SOIL BIOL BIOCHEM, V39, P1794, DOI 10.1016/j.soilbio.2007.02.007; Amthor JS, 2000, ANN BOT-LONDON, V86, P1, DOI 10.1006/anbo.2000.1175; Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Fang CM, 2005, NATURE, V433, P57, DOI 10.1038/nature03138; Frank DC, 2010, NATURE, V463, P527, DOI 10.1038/nature08769; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gu LH, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003164; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Heinemeyer A, 2006, NEW PHYTOL, V171, P159, DOI 10.1111/j.1469-8137.2006.01730.x; Jones CD, 2003, TELLUS B, V55, P642, DOI 10.1034/j.1600-0889.2003.01440.x; Katterer T, 1998, BIOL FERT SOILS, V27, P258, DOI 10.1007/s003740050430; Kirschbaum MUF, 2010, GLOBAL CHANGE BIOL, V16, P2117, DOI 10.1111/j.1365-2486.2009.02093.x; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; KNORR W, 1995, TELLUS B, V47, P471, DOI 10.1034/j.1600-0889.47.issue4.7.x; Knorr W, 2005, NATURE, V433, P298, DOI 10.1038/nature03226; Krinner G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2003GB002199; KUZYAKOV Z, 2010, GLOBAL CHANGE BIOL, DOI DOI 10.1111/J.1365-2486.2010.02179.X; Lasslop G, 2010, GLOBAL CHANGE BIOL, V16, P187, DOI 10.1111/j.1365-2486.2009.02041.x; Lenton TM, 2003, GLOBAL CHANGE BIOL, V9, P1333, DOI 10.1046/j.1365-2486.2003.00674.x; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo YQ, 2001, NATURE, V413, P622, DOI 10.1038/35098065; Migliavacca M, 2011, GLOBAL CHANGE BIOL, V17, P390, DOI 10.1111/j.1365-2486.2010.02243.x; Moyano FE, 2008, AGR FOREST METEOROL, V148, P135, DOI 10.1016/j.agrformet.2007.09.006; Peng SS, 2009, SOIL BIOL BIOCHEM, V41, P1008, DOI 10.1016/j.soilbio.2008.10.023; Randerson JT, 2009, GLOBAL CHANGE BIOL, V15, P2462, DOI 10.1111/j.1365-2486.2009.01912.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1754, DOI 10.1111/j.1365-2486.2005.001010.x; Reichstein M, 2005, GLOBAL CHANGE BIOL, V11, P1424, DOI 10.1111/j.1365-2486.2005.001002.x; Reichstein M, 2008, J PLANT NUTR SOIL SC, V171, P344, DOI 10.1002/jpln.200700075; Sampson DA, 2007, GLOBAL CHANGE BIOL, V13, P2008, DOI 10.1111/j.1365-2486.2007.01414.x; Thornton PE, 2002, AGR FOREST METEOROL, V113, P185, DOI 10.1016/S0168-1923(02)00108-9	34	351	367	21	375	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					838	840		10.1126/science.1189587	http://dx.doi.org/10.1126/science.1189587			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603495				2022-12-28	WOS:000280809900050
J	Lyne, A; Hobbs, G; Kramer, M; Stairs, I; Stappers, B				Lyne, Andrew; Hobbs, George; Kramer, Michael; Stairs, Ingrid; Stappers, Ben			Switched Magnetospheric Regulation of Pulsar Spin-Down	SCIENCE			English	Article							FREE PRECESSION; TIMING PACKAGE; GLITCHES; TEMPO2; MODEL	Pulsars are famed for their rotational clocklike stability and their highly repeatable pulse shapes. However, it has long been known that there are unexplained deviations (often termed timing noise) from the rate at which we predict these clocks should run. We show that timing behavior often results from two different spin-down rates. Pulsars switch abruptly between these states, often quasi-periodically, leading to the observed spin-down patterns. We show that for six pulsars the timing noise is correlated with changes in the pulse shape. Many pulsar phenomena, including mode changing, nulling, intermittency, pulse-shape variability, and timing noise, are therefore linked and are caused by changes in the pulsar's magnetosphere. We consider the possibility that high-precision monitoring of pulse profiles could lead to the formation of highly stable pulsar clocks.	[Lyne, Andrew; Kramer, Michael; Stappers, Ben] Univ Manchester, Sch Phys & Astron, Ctr Astrophys, Jodrell Bank, Manchester M13 9PL, Lancs, England; [Hobbs, George] CSIRO, Australia Telescope Natl Facil, Epping, NSW 1710, Australia; [Kramer, Michael] MPI Radioastron, D-53121 Bonn, Germany; [Stairs, Ingrid] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada	University of Manchester; Jodrell Bank Centre for Astrophysics; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Max Planck Society; University of British Columbia	Lyne, A (corresponding author), Univ Manchester, Sch Phys & Astron, Ctr Astrophys, Jodrell Bank, Manchester M13 9PL, Lancs, England.	andrew.lyne@manchester.ac.uk	Hobbs, George/AAS-5025-2020	Kramer, Michael/0000-0002-4175-2271	UK Science and Technology Facilities Council; Australian Research Council [DP0878388]; Max-Planck Society; Natural Sciences and Engineering Research Council; Science and Technology Facilities Council [ST/G002487/1] Funding Source: researchfish; STFC [ST/G002487/1] Funding Source: UKRI	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Australian Research Council(Australian Research Council); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	Pulsar research at the Jodrell Bank Centre for Astrophysics is supported by a Rolling Grant from the UK Science and Technology Facilities Council. G. H. is the recipient of an Australian Research Council QEII Fellowship (no. DP0878388). M. K. is supported by a salary from the Max-Planck Society. Pulsar research at the University of British Columbia is supported by a Natural Sciences and Engineering Research Council Discovery Grant.	ANDERSON PW, 1975, NATURE, V256, P25, DOI 10.1038/256025a0; BACKER DC, 1970, NATURE, V228, P1297, DOI 10.1038/2281297a0; BOYNTON PE, 1972, ASTROPHYS J, V175, P217, DOI 10.1086/151550; CHENG KS, 1987, ASTROPHYS J, V321, P799, DOI 10.1086/165672; Cordes JM, 2008, ASTROPHYS J, V682, P1152, DOI 10.1086/589425; CORDES JM, 1985, ASTROPHYS J SUPPL S, V59, P343, DOI 10.1086/191076; DETWEILER S, 1979, ASTROPHYS J, V234, P1100, DOI 10.1086/157593; Edwards RT, 2006, MON NOT R ASTRON SOC, V372, P1549, DOI 10.1111/j.1365-2966.2006.10870.x; Foster G, 1996, ASTRON J, V112, P1709, DOI 10.1086/118137; FOWLER LA, 1981, ASTRON ASTROPHYS, V93, P54; Hobbs G, 2007, AIP CONF PROC, V968, P173; Hobbs G, 2010, MON NOT R ASTRON SOC, V402, P1027, DOI 10.1111/j.1365-2966.2009.15938.x; Hobbs GB, 2006, MON NOT R ASTRON SOC, V369, P655, DOI 10.1111/j.1365-2966.2006.10302.x; Janssen GH, 2006, ASTRON ASTROPHYS, V457, P611, DOI 10.1051/0004-6361:20065267; Jenet FA, 2005, ASTROPHYS J, V625, pL123, DOI 10.1086/431220; KASPI VM, 1994, ASTROPHYS J, V428, P713, DOI 10.1086/174280; Kramer M, 2006, SCIENCE, V314, P97, DOI 10.1126/science.1132305; Kramer M, 2006, SCIENCE, V312, P549, DOI 10.1126/science.1124060; Lorimer D. R., 2012, HDB PULSAR ASTRONOMY; Lyne A., 2005, PULSAR ASTRONOMY, V3rd ed.; LYNE AG, 1971, MON NOT R ASTRON SOC, V153, pP27, DOI 10.1093/mnras/153.1.27P; MORRIS D, 1981, MON NOT R ASTRON SOC, V194, pP7, DOI 10.1093/mnras/194.1.7P; MORRIS D, 1980, ASTRON ASTROPHYS, V84, P260; Petit G, 1996, ASTRON ASTROPHYS, V308, P290; Qiao GJ, 2003, ASTRON ASTROPHYS, V407, pL25, DOI 10.1051/0004-6361:20031055; Sazhin M. V., 1979, Soviet Astronomy, V22, P36; SCARGLE JD, 1982, APJ, V263, P835, DOI DOI 10.1086/160554; Scherer K, 1997, SCIENCE, V278, P1919, DOI 10.1126/science.278.5345.1919; Shabanova TV, 2007, ASTROPHYS SPACE SCI, V308, P591, DOI 10.1007/s10509-007-9302-5; SHAHAM J, 1977, ASTROPHYS J, V214, P251, DOI 10.1086/155249; Stairs IH, 2000, NATURE, V406, P484, DOI 10.1038/35020010; Wang N, 2007, MON NOT R ASTRON SOC, V377, P1383, DOI 10.1111/j.1365-2966.2007.11703.x; Zou WZ, 2004, MON NOT R ASTRON SOC, V354, P811, DOI 10.1111/j.1365-2966.2004.08241.x	33	317	321	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 23	2010	329	5990					408	412		10.1126/science.1186683	http://dx.doi.org/10.1126/science.1186683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20576852	Green Submitted			2022-12-28	WOS:000280196500029
J	McManus, R; Mant, J; Bray, EP; Holder, R; Jones, MI; Greenfield, S; Kaambwa, B; Banting, M; Bryan, S; Little, P; Williams, B; Hobbs, FDR				McManus, Richard; Mant, Jonathan; Bray, Emma P.; Holder, Roger; Jones, Miren I.; Greenfield, Sheila; Kaambwa, Billingsley; Banting, Miriam; Bryan, Stirling; Little, Paul; Williams, Bryan; Hobbs, F. D. Richard			Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial	LANCET			English	Article							BLOOD-PRESSURE; HOME; INTERVENTIONS; VALIDATION; PROTOCOL; SOCIETY; GLUCOSE; OFFICE; DRUGS; CARE	Background Control of blood pressure is a key component of cardiovascular disease prevention, but is difficult to achieve and until recently has been the sole preserve of health professionals. This study assessed whether self-management by people with poorly controlled hypertension resulted in better blood pressure control compared with usual care. Methods This randomised controlled trial was undertaken in 24 general practices in the UK. Patients aged 35-85 years were eligible for enrolment if they had blood pressure more than 140/90 mm Hg despite antihypertensive treatment and were willing to self-manage their hypertension. Participants were randomly assigned in a 1:1 ratio to self-management, consisting of self-monitoring of blood pressure and self-titration of antihypertensive drugs, combined with telemonitoring of home blood pressure measurements or to usual care. Randomisation was done by use of a central web-based system and was stratified by general practice with minimisation for sex, baseline systolic blood pressure, and presence or absence of diabetes or chronic kidney disease. Neither participants nor investigators were masked to group assignment. The primary endpoint was change in mean systolic blood pressure between baseline and each follow-up point (6 months and 12 months). All randomised patients who attended follow-up visits at 6 months and 12 months and had complete data for the primary outcome were included in the analysis, without imputation for missing data. This study is registered as an International Standard Randomised Controlled Trial, number ISRCTN17585681. Findings 527 participants were randomly assigned to self-management (n=263) or control (n=264), of whom 480 (91%; self-management, n=234; control, n=246) were included in the primary analysis. Mean systolic blood pressure decreased by 12.9 mm Hg (95% CI 10.4-15-5) from baseline to 6 months in the self-management group and by 9.2 mm Hg (6.7-11.8) in the control group (difference between groups 3.7 mm Hg, 0.8-6.6; p=0.013). From baseline to 12 months, systolic blood pressure decreased by 17.6 mm Hg (14.9-20.3) in the self-management group and by 12.2 mm Hg (9.5-14.9) in the control group (difference between groups 5.4 mm Hg, 2-4-8-5; p=0.0004). Frequency of most side-effects did not differ between groups, apart from leg swelling (self-management, 74 patients [32%]; control, 55 patients [22%]; p=0.022). Interpretation Self-management of hypertension in combination with telemonitoring of blood pressure measurements represents an important new addition to control of hypertension in primary care.	[McManus, Richard; Kaambwa, Billingsley] Univ Birmingham, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; NIHR, Natl Sch Primary Care Res, Birmingham, W Midlands, England; [Mant, Jonathan] Univ Cambridge, Inst Publ Hlth, Gen Practice & Primary Care Res Unit, Cambridge, England; [Bryan, Stirling] Univ British Columbia, Ctr Clin Epidemiol & Evaluat, Vancouver Coastal Hlth Res Inst, Vancouver, BC V5Z 1M9, Canada; [Bryan, Stirling] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Little, Paul] Univ Southampton, Sch Med, Southampton, Hants, England; [Little, Paul] NIHR, Natl Sch Primary Care Res, Southampton, Hants, England; [Williams, Bryan] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Williams, Bryan] Glenfield Gen Hosp, Leicester NIHR Cardiovasc Biomed Res Unit, Leicester LE3 9QP, Leics, England	University of Birmingham; University of Birmingham; University of Cambridge; University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of Southampton; University of Southampton; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	McManus, R (corresponding author), Univ Birmingham, Hlth Econ Unit, Primary Care Clin Sci Bldg, Birmingham B15 2TT, W Midlands, England.	r.j.mcmanus@bham.ac.uk		Little, Paul/0000-0003-3664-1873; Williams, Bryan/0000-0002-8094-1841; Bray, Emma/0000-0001-9882-3539; KAAMBWA, BILLINGSLEY/0000-0002-2128-3404; hobbs, richard/0000-0001-7976-7172; Mant, Jonathan/0000-0002-9531-0268	Department of Health Policy; National Coordinating Centre for Research Capacity Development; Midlands Research Practices Consortium (MidReC); National Institute for Health Reserch (NIHR); Primary Care Clinical Research and Trials Unit (PCCRTU); NIHR National School for Primary Care Research; National Institute for Health Research [NF-SI-0509-10222, CDF/01/017, RP-PG-0606-1153] Funding Source: researchfish	Department of Health Policy; National Coordinating Centre for Research Capacity Development; Midlands Research Practices Consortium (MidReC); National Institute for Health Reserch (NIHR)(National Institute for Health Research (NIHR)); Primary Care Clinical Research and Trials Unit (PCCRTU); NIHR National School for Primary Care Research; National Institute for Health Research(National Institute for Health Research (NIHR))	Department of Health Policy Research Programme, National Coordinating Centre for Research Capacity Development, and Midlands Research Practices Consortium.; RIM is funded by an National Institute for Health Reserch (NIHR) Career Development Fellowship. He received a consultancy fee from Tplus Medical (2006) to advise on telemonitoring services. FDRH has received limited research support in terms of blood pressure devices from Microlife and BpTRU. All other authors declare that they have no conflicts of interest.; This study received joint funding from the Department of Health Policy Research Programme, National Coordinating Centre for Research Capacity Development, and Midlands Research Practices Consortium (MidReC). Service support costs were obtained from the Department of Health in collaboration with MidReC. Support was received from the Primary Care Clinical Research and Trials Unit (PCCRTU) and the Midlands Research Practices Consortium (MidReC). The Departments of Primary Care in Birmingham and Southampton also receive funding from NIHR National School for Primary Care Research. This research would not have been possible without the help of the participating patients and practice staff. We thank the particular input of trial secretaries Amanda Davies and Sheila Bailey.	Barber JA, 2000, STAT MED, V19, P3219, DOI 10.1002/1097-0258(20001215)19:23<3219::AID-SIM623>3.0.CO;2-P; Bennett H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-456; Bosworth HB, 2007, AM HEART J, V153, P918, DOI 10.1016/j.ahj.2007.03.004; Bosworth HB, 2009, ANN INTERN MED, V151, P687, DOI 10.7326/0003-4819-151-10-200911170-00148; Bray EP, 2010, ANN MED, V42, P371, DOI 10.3109/07853890.2010.489567; *BRIT MED ASS, NHS EMPL QUAL OUTC F; Burke TA, 2006, J HYPERTENS, V24, P1193, DOI 10.1097/01.hjh.0000226211.95936.f5; Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120; Coleman A, 2006, BLOOD PRESS MONIT, V11, P27, DOI 10.1097/01.mbp.0000189788.05736.5f; CRAIG R, 2006, HLTH SURVEY ENGLAND; Dickinson HO, 2006, J HYPERTENS, V24, P215, DOI 10.1097/01.hjh.0000199800.72563.26; Fitzmaurice DA, 2005, BRIT MED J, V331, P1057, DOI 10.1136/bmj.38618.580903.AE; Green BB, 2008, JAMA-J AM MED ASSOC, V299, P2857, DOI 10.1001/jama.299.24.2857; KATZMAN R, 1983, AM J PSYCHIAT, V140, P734; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Levi Marcel, 2008, Expert Rev Cardiovasc Ther, V6, P979, DOI 10.1586/14779072.6.7.979; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mattu GS, 2004, BLOOD PRESS MONIT, V9, P47, DOI 10.1097/00126097-200402000-00009; McAndrew L, 2007, DIABETES EDUCATOR, V33, P991, DOI 10.1177/0145721707309807; McManus RJ, 2008, FAM PRACT, V25, P56, DOI 10.1093/fampra/cmm065; McManus RJ, 2009, BMC CARDIOVASC DISOR, V9, DOI 10.1186/1471-2261-9-6; McManus RJ, 2005, BMJ-BRIT MED J, V331, P493, DOI 10.1136/bmj.38558.393669.E0; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; NHS Information Centre, QUAL OUTC FRAM 2008; *NICE, 2006, CG34 HYP PERS HIGH B; NICE, NICE GUID CG66 TYP 2; Office for National Statistics, NEIGHB STAT; Ogedegbe Gbenga, 2006, J Clin Hypertens (Greenwich), V8, P174, DOI 10.1111/j.1524-6175.2006.04872.x; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Polisena J, 2010, J TELEMED TELECARE, V16, P68, DOI 10.1258/jtt.2009.090406; Powell H, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004107; Staessen JA, 2004, JAMA-J AM MED ASSOC, V291, P955, DOI 10.1001/jama.291.8.955; Staessen JA, 1997, LANCET, V350, P757, DOI 10.1016/S0140-6736(97)05381-6; Staessen JA, 2008, BLOOD PRESS MONIT, V13, P352, DOI 10.1097/MBP.0b013e3283108f93; Williams B, 2004, J HUM HYPERTENS, V18, P139, DOI 10.1038/sj.jhh.1001683; Zarnke KB, 1997, AM J HYPERTENS, V10, P58, DOI 10.1016/S0895-7061(96)00305-6	36	383	398	0	60	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					163	172		10.1016/S0140-6736(10)60964-6	http://dx.doi.org/10.1016/S0140-6736(10)60964-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20619448				2022-12-28	WOS:000280313100023
J	Buschmann, S; Warkentin, E; Xie, H; Langer, JD; Ermler, U; Michel, H				Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut			The Structure of cbb(3) Cytochrome Oxidase Provides Insights into Proton Pumping	SCIENCE			English	Article							C-OXIDASE; ACTIVE-SITE; ENERGY TRANSDUCTION; RESPIRATORY-CHAIN; INPUT CHANNEL; OXYGEN; RESOLUTION; REDUCTASES; IDENTIFICATION; MECHANISM	The heme-copper oxidases (HCOs) accomplish the key event of aerobic respiration; they couple O-2 reduction and transmembrane proton pumping. To gain new insights into the still enigmatic process, we structurally characterized a C-family HCO-essential for the pathogenicity of many bacteria-that differs from the two other HCO families, A and B, that have been structurally analyzed. The x-ray structure of the C-family cbb(3) oxidase from Pseudomonas stutzeri at 3.2 angstrom resolution shows an electron supply system different from families A and B. Like family-B HCOs, C HCOs have only one pathway, which conducts protons via an alternative tyrosine-histidine cross-link. Structural differences around hemes b and b(3) suggest a different redox-driven proton-pumping mechanism and provide clues to explain the higher activity of family-C HCOs at low oxygen concentrations.	[Buschmann, Sabine; Warkentin, Eberhard; Xie, Hao; Langer, Julian D.; Ermler, Ulrich; Michel, Hartmut] Max Planck Inst Biophys, D-60438 Frankfurt, Germany	Max Planck Society	Michel, H (corresponding author), Max Planck Inst Biophys, Max von Laue Str 3, D-60438 Frankfurt, Germany.	hartmut.michel@mpibp-frankfurt.mpg.de		Xie, Hao/0000-0002-2422-2527; Langer, Julian David/0000-0002-5190-577X	Max Planck Society; Deutsche Forschungsgemeinschaft [SFB 472]; Cluster of Excellence Macromolecular Complexes Frankfurt	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence Macromolecular Complexes Frankfurt	This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft (SFB 472), and the Cluster of Excellence Macromolecular Complexes Frankfurt. We thank the staffs of the Swiss Light Source and the European Synchrotron Radiation Facility for assistance. Coordinates and structure factors of cbb<INF>3</INF> oxidase of P. stutzeri have been deposited under the pdb accession code 3MK7, the nucleotide sequences under gene bank accession number HM130676.	Abramson J, 2000, NAT STRUCT BIOL, V7, P910; Arslan E, 2000, FEBS LETT, V470, P7, DOI 10.1016/S0014-5793(00)01277-1; Chang HY, 2009, P NATL ACAD SCI USA, V106, P16169, DOI 10.1073/pnas.0905264106; Ducluzeau AL, 2008, MOL BIOL EVOL, V25, P1158, DOI 10.1093/molbev/msn062; Forte E, 2001, EUR J BIOCHEM, V268, P6486, DOI 10.1046/j.0014-2956.2001.02597.x; Hemp J, 2007, BIOCHEMISTRY-US, V46, P9963, DOI 10.1021/bi700659y; Hemp J, 2006, BIOCHEMISTRY-US, V45, P15405, DOI 10.1021/bi062026u; Hosler JP, 2006, ANNU REV BIOCHEM, V75, P165, DOI 10.1146/annurev.biochem.75.062003.101730; Huang YF, 2008, P NATL ACAD SCI USA, V105, P20257, DOI 10.1073/pnas.0805429106; IWATA S, 1995, NATURE, V376, P660, DOI 10.1038/376660a0; Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003; Moser CC, 2006, PHILOS T R SOC B, V361, P1295, DOI 10.1098/rstb.2006.1868; Ostermeier C, 1997, P NATL ACAD SCI USA, V94, P10547, DOI 10.1073/pnas.94.20.10547; Ozturk M, 2007, MOL BIOL REP, V34, P165, DOI 10.1007/s11033-006-9031-9; Pereira MM, 2008, BBA-BIOENERGETICS, V1777, P929, DOI 10.1016/j.bbabio.2008.05.441; Peters A, 2008, J BACTERIOL, V190, P5576, DOI 10.1128/JB.00534-08; Pitcher RS, 2004, BBA-BIOENERGETICS, V1655, P388, DOI 10.1016/j.bbabio.2003.09.017; Pitcher RS, 2002, J BIOL CHEM, V277, P31474, DOI 10.1074/jbc.M204103200; Preisig O, 1996, J BACTERIOL, V178, P1532, DOI 10.1128/JB.178.6.1532-1538.1996; Qin L, 2006, P NATL ACAD SCI USA, V103, P16117, DOI 10.1073/pnas.0606149103; Rauhamaki V, 2006, P NATL ACAD SCI USA, V103, P16135, DOI 10.1073/pnas.0606254103; Rauhamaki V, 2009, J BIOL CHEM, V284, P11301, DOI 10.1074/jbc.M808839200; Reimann J, 2007, BBA-BIOENERGETICS, V1767, P362, DOI 10.1016/j.bbabio.2007.03.006; Richter OMH, 2009, BBA-BIOENERGETICS, V1787, P626, DOI 10.1016/j.bbabio.2009.02.020; Sharma V, 2008, BIOCHEMISTRY-US, V47, P4221, DOI 10.1021/bi702088r; Sharma V, 2006, BIOCHEMISTRY-US, V45, P5754, DOI 10.1021/bi060169a; Soulimane T, 2000, EMBO J, V19, P1766, DOI 10.1093/emboj/19.8.1766; Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8; Tsukihara T, 1996, SCIENCE, V272, P1136, DOI 10.1126/science.272.5265.1136; Urbani A, 2001, FEBS LETT, V508, P29, DOI 10.1016/S0014-5793(01)03006-X; Verkhovsky MI, 1996, NATURE, V380, P268, DOI 10.1038/380268a0; Weingarten RA, 2008, APPL ENVIRON MICROB, V74, P1367, DOI 10.1128/AEM.02261-07; Wikstrom M, 2007, BBA-BIOENERGETICS, V1767, P1200, DOI 10.1016/j.bbabio.2007.06.008; Zumft WG, 2005, J INORG BIOCHEM, V99, P194, DOI 10.1016/j.jinorgbio.2004.09.024	34	193	198	2	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					327	330		10.1126/science.1187303	http://dx.doi.org/10.1126/science.1187303			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576851				2022-12-28	WOS:000279925900043
J	Wu, YK; Yang, Y; Ye, S; Jiang, YX				Wu, Yunkun; Yang, Yi; Ye, Sheng; Jiang, Youxing			Structure of the gating ring from the human large-conductance Ca2+-gated K+ channel	NATURE			English	Article							DEPENDENT ACTIVATION; VOLTAGE SENSOR; LIPID-MEMBRANE; BKCA CHANNEL; ION-BINDING; RCK DOMAIN; CA2+; SENSITIVITY; MECHANISM; MG2+	Large-conductance Ca2+-gated K+ (BK) channels are essential for many biological processes such as smooth muscle contraction and neurotransmitter release(1-4). This group of channels can be activated synergistically by both voltage and intracellular Ca2+, with the large carboxy-terminal intracellular portion being responsible for Ca2+ sensing(5-13). Here we present the crystal structure of the entire cytoplasmic region of the human BK channel in a Ca2+-free state. The structure reveals four intracellular subunits, each comprising two tandem RCK domains, assembled into a gating ring similar to that seen in the MthK channel 14 and probably representing its physiological assembly. Three Ca2+ binding sites including the Ca2+ bowl are mapped onto the structure based on mutagenesis data. The Ca2+ bowl, located within the second RCK domain, forms an EF-hand-like motif and is strategically positioned close to the assembly interface between two subunits. The other two Ca2+ (or Mg2+) binding sites, Asp 367 and Glu 374/Glu 399, are located on the first RCK domain. The Asp 367 site has high Ca2+ sensitivity and is positioned in the groove between the amino-and carboxyterminal subdomains of RCK1, whereas the low-affinity Mg2+-binding Glu 374/Glu 399 site is positioned on the upper plateau of the gating ring and close to the membrane. Our structure also contains the linker connecting the transmembrane and intracellular domains, allowing us to dock a voltage-gated K+ channel pore of known structure onto the gating ring with reasonable accuracy and generate a structural model for the full BK channel.	[Wu, Yunkun; Yang, Yi; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Wu, Yunkun; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Ye, Sheng] Zhejiang Univ, Inst Life Sci, Hangzhou 310058, Zhejiang, Peoples R China	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Zhejiang University	Jiang, YX (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	youxing.jiang@utsouthwestern.edu			Howard Hughes Medical Institute; NIH/NIGMS [RO1 GM071621]; Welch Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071621] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Alam and M. Derebe for manuscript preparation; A. Pico for discussion in the early stages of this study; and X. Zhang for help in structure determination. Use of the Advanced Photon Source (APS) was supported by the US Department of Energy, Office of Energy Research. We thank the beamline (23ID and 19ID) staff for assistance in data collection. This work was supported by Howard Hughes Medical Institute and by grants from the NIH/NIGMS (RO1 GM071621) and Welch Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bao L, 2004, J GEN PHYSIOL, V123, P475, DOI 10.1085/jgp.200409052; Bao L, 2002, J GEN PHYSIOL, V120, P173, DOI 10.1085/jgp.20028627; Cronin CN, 2007, PROTEIN SCI, V16, P2023, DOI 10.1110/ps.072931407; Cui J, 2009, CELL MOL LIFE SCI, V66, P852, DOI 10.1007/s00018-008-8609-x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Hou SW, 2008, NAT STRUCT MOL BIOL, V15, P403, DOI 10.1038/nsmb.1398; Hou SW, 2009, PHYSIOLOGY, V24, P26, DOI 10.1152/physiol.00032.2008; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Kaczorowski GJ, 1996, J BIOENERG BIOMEMBR, V28, P255, DOI 10.1007/BF02110699; Kim HJ, 2006, J BIOL CHEM, V281, P38573, DOI 10.1074/jbc.M604769200; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Lingle CJ, 2002, J GEN PHYSIOL, V120, P261, DOI 10.1085/jgp.20028689; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Magleby RL, 2003, J GEN PHYSIOL, V121, P81, DOI 10.1085/jgp.20028721; Niu XW, 2004, NEURON, V42, P745, DOI 10.1016/j.neuron.2004.05.001; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schreiber M, 1997, BIOPHYS J, V73, P1355, DOI 10.1016/S0006-3495(97)78168-2; Shi JY, 2002, NATURE, V418, P876, DOI 10.1038/nature00941; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang LG, 2009, NATURE, V461, P292, DOI 10.1038/nature08291; WEI A, 1994, NEURON, V13, P671, DOI 10.1016/0896-6273(94)90034-5; Xia XM, 2004, J NEUROSCI, V24, P5585, DOI 10.1523/JNEUROSCI.1296-04.2004; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Yusifov T, 2008, P NATL ACAD SCI USA, V105, P376, DOI 10.1073/pnas.0705261105; Zeng XH, 2005, J GEN PHYSIOL, V125, P273, DOI 10.1085/jgp.200409239; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797; Zhang X, 2001, J GEN PHYSIOL, V118, P607, DOI 10.1085/jgp.118.5.607	39	152	156	2	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					393	U148		10.1038/nature09252	http://dx.doi.org/10.1038/nature09252			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20574420	Green Accepted			2022-12-28	WOS:000279867100054
J	Brenner, DJ; Hricak, H				Brenner, David J.; Hricak, Hedvig			Radiation Exposure From Medical Imaging Time to Regulate?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMPUTED-TOMOGRAPHY; CANCER		[Brenner, David J.] Columbia Univ, Med Ctr, Ctr Radiol Res, New York, NY 10024 USA; [Hricak, Hedvig] Mem Sloan Kettering Canc Ctr, Dept Radiol, New York, NY 10021 USA	Columbia University; Memorial Sloan Kettering Cancer Center	Brenner, DJ (corresponding author), Columbia Univ, Med Ctr, Ctr Radiol Res, 630 W 168th St, New York, NY 10024 USA.	djb3@columbia.edu		Hricak, Hedvig/0000-0003-2240-9694				Amis E Stephen Jr, 2007, J Am Coll Radiol, V4, P272, DOI 10.1016/j.jacr.2007.03.002; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Brenner DJ, 2003, P NATL ACAD SCI USA, V100, P13761, DOI 10.1073/pnas.2235592100; Destouet Judy M, 2005, J Am Coll Radiol, V2, P585; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Lehnert BE, 2010, J AM COLL RADIOL, V7, P192, DOI 10.1016/j.jacr.2009.11.010; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Sistrom CL, 2009, RADIOLOGY, V251, P147, DOI 10.1148/radiol.2511081174; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; U.S. Food and Drug Administration website, WHIT PAP IN RED UNN	10	150	158	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					208	209		10.1001/jama.2010.973	http://dx.doi.org/10.1001/jama.2010.973			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628137				2022-12-28	WOS:000279811000030
J	O'Hare, AM; Rodriguez, RA; Hailpern, SM; Larson, EB; Tamura, MK				O'Hare, Ann M.; Rodriguez, Rudolph A.; Hailpern, Susan M.; Larson, Eric B.; Tamura, Manjula Kurella			Regional Variation in Health Care Intensity and Treatment Practices for End-stage Renal Disease in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OF-LIFE CARE; DECISION-MAKING; NATIONAL-SURVEY; UNITED-STATES; DIALYSIS; POPULATION	Context An increasing number of older adults are being treated for end-stage renal disease (ESRD) with long-term dialysis. Objectives To determine how ESRD treatment practices for older adults vary across regions with differing end-of-life intensity of care. Design, Setting, and Participants Retrospective observational study using a national ESRD registry to identify a cohort of 41 420 adults (of white or black race), aged 65 years or older, who started long-term dialysis or received a kidney transplant between June 1, 2005, and May 31, 2006. Regional end-of-life intensity of care was defined using an index from the Dartmouth Atlas of Healthcare. Main Outcome Measures Incidence of treated ESRD (dialysis or transplant), preparedness for ESRD (under the care of a nephrologist, having a fistula [vs graft or catheter] at time of hemodialysis initiation), and end-of-life care practices. Results Among whites, the incidence of ESRD was progressively higher in regions with greater intensity of care and this trend was most pronounced at older ages. Among blacks, a similar relationship was present only at advanced ages (men aged >= 80 years and women aged >= 85 years). Patients living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to be under the care of a nephrologist before the onset of ESRD (62.3% [95% confidence interval {CI}, 61.3%-63.3%] vs 71.1% [95% CI, 69.9%-72.2%], respectively) and less likely to have a fistula (vs graft or catheter) at the time of hemodialysis initiation (11.2% [95% CI, 10.6%-11.8%] vs 16.9% [95% CI, 15.9%-17.8%]). Among patients who died within 2 years of ESRD onset (n=21 190), those living in regions in the highest compared with lowest quintile of end-of-life intensity of care were less likely to have discontinued dialysis before death (22.2% [95% CI, 21.1%-23.4%] vs 44.3% [95% CI, 42.5%-46.1%], respectively), less likely to have received hospice care (20.7% [95% CI, 19.5%-21.9%] vs 33.5% [95% CI, 31.7%-35.4%]), and more likely to have died in the hospital (67.8% [95% CI, 66.5%-69.1%] vs 50.3% [95% CI, 48.5%-52.1%]). These differences persisted in adjusted analyses. Conclusion There are pronounced regional differences in treatment practices for ESRD in older adults that are not explained by differences in patient characteristics. JAMA. 2010; 304(2): 180-186 www.jama.com	[O'Hare, Ann M.; Rodriguez, Rudolph A.] VA Puget Sound Healthcare Syst, Dept Med, Seattle, WA 98108 USA; [O'Hare, Ann M.] VA Puget Sound Healthcare Syst, HSR&D Ctr Excellence, Seattle, WA 98108 USA; [O'Hare, Ann M.; Rodriguez, Rudolph A.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Tamura, Manjula Kurella] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Tamura, Manjula Kurella] VA Palo Alto Healthcare Syst, Dept Med, Palo Alto, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle; Group Health Cooperative; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	O'Hare, AM (corresponding author), VA Puget Sound Healthcare Syst, Dept Med, 111J Nephrol,1660 S Columbian Way, Seattle, WA 98108 USA.	Ann.OHare@va.gov	Tamura, Manjula Kurella/C-8284-2014	Tamura, Manjula Kurella/0000-0001-5227-2479	Beeson Career Development Award [K23AG28980, K23AG028952]; National Institutes of Health; Satellite Research; Amgen; American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco; NATIONAL INSTITUTE ON AGING [K23AG028952, K23AG028980] Funding Source: NIH RePORTER	Beeson Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Satellite Research; Amgen(Amgen); American Society of Nephrology; Association of Subspecialty Professors; University of California, San Francisco(University of California System); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr O'Hare reported receiving royalties from UpToDate, an honorarium from the Japanese Society for Foot Care, and a Career Development Award from the Department of Veterans Affairs' Health Services Research and Development Service and serving as the principal investigator on an interagency agreement between the Centers for Disease Control and Prevention and the VA Puget Sound Healthcare System. Dr Hailpern reported being employed by LipoScience (Raleigh, North Carolina) during the time frame that she was working on this study but her work on the project was completed during her free time and was not part of her work for the company. Dr Larson reported receiving research support from the National Institutes of Health, royalties from UpToDate, Springer, and Elsevier, and speaker honoraria from universities and other nonprofit organizations. Dr Kurella Tamura reported receiving research funding from Satellite Research, Amgen, a Junior Development Award in Geriatric Nephrology from the American Society of Nephrology and Association of Subspecialty Professors, and an intramural grant from the University of California, San Francisco. The financial disclosures listed herein for Drs O'Hare and Kurella Tamura are for the last 5 years.; Dr O'Hare is supported by Beeson Career Development Award K23AG28980. Dr Kurella Tamura is supported by Beeson Career Development Award K23AG028952.	Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Davison SN, 2006, CLIN J AM SOC NEPHRO, V1, P1256, DOI 10.2215/CJN.02040606; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Galla JH, 2000, J AM SOC NEPHROL, V11, P1340, DOI 10.1681/ASN.V1171340; Holley JL, 2003, AM J KIDNEY DIS, V42, P813, DOI 10.1016/S0272-6386(03)00868-0; Kurella M, 2007, ANN INTERN MED, V146, P177, DOI 10.7326/0003-4819-146-3-200702060-00006; Mau LW, 2010, AM J KIDNEY DIS, V55, P549, DOI 10.1053/j.ajkd.2009.11.014; Murray AM, 2006, CLIN J AM SOC NEPHRO, V1, P1248, DOI 10.2215/CJN.00970306; Murtagh FEM, 2007, NEPHROL DIAL TRANSPL, V22, P1955, DOI 10.1093/ndt/gfm153; Prendergast TJ, 1998, AM J RESP CRIT CARE, V158, P1163, DOI 10.1164/ajrccm.158.4.9801108; Sekkarie MA, 1998, AM J KIDNEY DIS, V31, P464, DOI 10.1053/ajkd.1998.v31.pm9506683; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813; Teno JM, 2010, JAMA-J AM MED ASSOC, V303, P544, DOI 10.1001/jama.2010.79	13	96	96	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					180	186		10.1001/jama.2010.924	http://dx.doi.org/10.1001/jama.2010.924			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628131	Green Accepted			2022-12-28	WOS:000279811000024
J	Cheung, N; Mitchell, P; Wong, TY				Cheung, Ning; Mitchell, Paul; Wong, Tien Yin			Diabetic retinopathy	LANCET			English	Article							RETINAL VASCULAR CALIBER; ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB INJECTION; MACULAR EDEMA; RISK-FACTORS; MICROVASCULAR OUTCOMES; 10-YEAR PROGRESSION; KINASE INHIBITOR; CATARACT-SURGERY; RANDOMIZED-TRIAL	Diabetic retinopathy is a common and specific microvascular complication of diabetes, and remains the leading cause of preventable blindness in working-aged people. It is identified in a third of people with diabetes and associated with increased risk of life-threatening systemic vascular complications, including stroke, coronary heart disease, and heart failure. Optimum control of blood glucose, blood pressure, and possibly blood lipids remains the foundation for reduction of risk of retinopathy development and progression. Timely laser therapy is effective for preservation of sight in proliferative retinopathy and macular oedema, but its ability to reverse visual loss is poor. Vitrectomy surgery might occasionally be needed for advanced retinopathy. New therapies, such as intraocular injection of steroids and antivascular endothelial growth-factor agents, are less destructive to the retina than are older therapies, and could be useful in patients who respond poorly to conventional therapy. The outlook for future treatment modalities, such as inhibition of other angiogenic factors, regenerative therapy, and topical therapy, is promising.	[Cheung, Ning; Wong, Tien Yin] Natl Univ Singapore, Singapore Eye Res Inst, Singapore 168751, Singapore; [Cheung, Ning; Wong, Tien Yin] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Mitchell, Paul] Univ Sydney, Westmead Millennium Inst, Ctr Vis Res, Sydney, NSW 2006, Australia	National University of Singapore; Singapore National Eye Center; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; University of Sydney; Westmead Institute for Medical Research	Wong, TY (corresponding author), Natl Univ Singapore, Singapore Eye Res Inst, 11 3rd Hosp Ave, Singapore 168751, Singapore.	ophwty@nus.edu.sg	Wong, Tien Yin/AAC-9724-2020	Wong, Tien Yin/0000-0002-8448-1264	Novartis; Pfizer; Allergan; Solvay; National Health and Medical Research Council, Australia [NHMRC 529923, 590212, 632521]; Juvenile Diabetes Research Foundation, Australia; National Medical Research Council [NMRC/STaR/0003/2008]	Novartis(Novartis); Pfizer(Pfizer); Allergan(AbbVieAllergan); Solvay(Solvay SA); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Research Foundation, Australia(Juvenile Diabetes Research Foundation); National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	PM and TYW are on advisory boards for Novartis, Pfizer, and Allergan and have received travel, honoraria, and research support from Novartis, Pfizer, Allergan, and Solvay, but have no stocks, equity, contract of employment, or named position on company board. NC declares that he has no conflicts of interest.; TYW and NC were supported by grants from the National Health and Medical Research Council (NHMRC 529923; 590212; 632521), Australia; the Juvenile Diabetes Research Foundation, Australia; and the National Medical Research Council (NMRC/STaR/0003/2008).	Abhary S, 2009, DIABETES, V58, P2137, DOI 10.2337/db09-0059; Abraham P, 2006, OPHTHALMOLOGY, V113, P2221, DOI 10.1016/j.ophtha.2006.07.032; Aiello LP, 2008, NEW ENGL J MED, V359, P967, DOI 10.1056/NEJMcibr0804551; Aiello LP, 2007, ARCH OPHTHALMOL-CHIC, V125, P318; Aiello LP, 2005, NEW ENGL J MED, V353, P839, DOI 10.1056/NEJMe058142; AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Ambrosius WT, 2010, ARCH OPHTHALMOL-CHIC, V128, P312, DOI 10.1001/archophthalmol.2009.310; [Anonymous], 1995, Arch Ophthalmol, V113, P1144; [Anonymous], 1988, OPHTHALMOLOGY, V95, P1307; [Anonymous], 1991, LANCET, V338, P1425; [Anonymous], 1981, OPHTHALMOLOGY, V88, P583; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Becerra SP, 2002, NEW ENGL J MED, V347, P1968, DOI 10.1056/NEJMcibr022629; Beck RW, 2009, ARCH OPHTHALMOL-CHIC, V127, P245, DOI 10.1001/archophthalmol.2008.610; Bolton WK, 2004, AM J NEPHROL, V24, P32, DOI 10.1159/000075627; Boyer DS, 2009, OPHTHALMOLOGY, V116, P1731, DOI 10.1016/j.ophtha.2009.05.024; Carrasco E, 2007, DIABETES CARE, V30, P2902, DOI 10.2337/dc07-0332; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Chaturvedi N, 1998, LANCET, V351, P28, DOI 10.1016/S0140-6736(97)06209-0; Chaturvedi N, 2008, LANCET, V372, P1394, DOI 10.1016/S0140-6736(08)61412-9; Cheema RA, 2009, J CATARACT REFR SURG, V35, P18, DOI 10.1016/j.jcrs.2008.09.019; Chen J, 2009, INVEST OPHTH VIS SCI, V50, P1329, DOI 10.1167/iovs.08-2521; Cheung N, 2009, DIABETES CARE, V32, P106, DOI 10.2337/dc08-1233; Cheung N, 2008, DIABETES CARE, V31, P1842, DOI 10.2337/dc08-0189; Cheung N, 2008, J AM COLL CARDIOL, V51, P1573, DOI 10.1016/j.jacc.2007.11.076; Cheung N, 2008, PROG RETIN EYE RES, V27, P161, DOI 10.1016/j.preteyeres.2007.12.001; Cheung N, 2008, LANCET, V371, P721, DOI 10.1016/S0140-6736(08)60333-5; Cheung N, 2007, OPHTHALMOLOGY, V114, P2098, DOI 10.1016/j.ophtha.2007.07.010; Cheung N, 2007, DIABETES CARE, V30, P1742, DOI 10.2337/dc07-0264; Cheung N, 2007, SURV OPHTHALMOL, V52, P180, DOI 10.1016/j.survophthal.2006.12.003; Cheung N, 2007, STROKE, V38, P398, DOI 10.1161/01.STR.0000254547.91276.50; Ciulla TA, 2003, DIABETES CARE, V26, P2653, DOI 10.2337/diacare.26.9.2653; Congdon NG, 2003, JAMA-J AM MED ASSOC, V290, P2057, DOI 10.1001/jama.290.15.2057; Conway BN, 2009, ARCH OPHTHALMOL-CHIC, V127, P1494, DOI 10.1001/archophthalmol.2009.274; Curtis TM, 2009, EYE, V23, P1496, DOI 10.1038/eye.2009.108; Davis MD, 2009, INVEST OPHTH VIS SCI, V50, P1, DOI 10.1167/iovs.08-2473; *DIAB RET CLIN RES, 2010, OPHTHALMOLOGY, V117, P1067; Diabet Contr Complicat Trial Res Grp, 1998, ARCH OPHTHALMOL-CHIC, V116, P874; Diabet Control Complications Trial Res Grp, 1997, DIABETES, V46, P1829; Diabetes Control and Complications, 2000, DIABETES CARE, V23, P1084; Donaghue KC, 2003, DIABETES CARE, V26, P1224, DOI 10.2337/diacare.26.4.1224; Doukas J, 2008, J CELL PHYSIOL, V216, P29, DOI 10.1002/jcp.21426; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Early Treatment Diabetic Retinopathy Study Res Grp, 1991, OPHTHALMOLOGY, V98, P766; Einarsdottir AB, 2009, LANCET, V373, P1316, DOI 10.1016/S0140-6736(09)60750-9; Farley TF, 2008, ANN FAM MED, V6, P428, DOI 10.1370/afm.857; Fong DS, 2004, DIABETES CARE, V27, P2540, DOI 10.2337/diacare.27.10.2540; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Gallego PH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a918; Gao BB, 2007, NAT MED, V13, P181, DOI 10.1038/nm1534; Garcia-Ramirez M, 2008, DIABETES CARE, V31, P1189, DOI 10.2337/dc07-2075; Gardiner TA, 2007, MICROCIRCULATION, V14, P25, DOI 10.1080/10739680601072123; Gardner TW, 2007, NAT MED, V13, P131, DOI 10.1038/nm0207-131; Genuth S, 2005, DIABETES, V54, P3103, DOI 10.2337/diabetes.54.11.3103; Genuth Saul, 2006, Endocr Pract, V12 Suppl 1, P34; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gillies MC, 2007, NEW ENGL J MED, V356, P748; GINSBURG LH, 1993, FOCAL POINTS AAO, V11, P1; Grover D, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005656.pub2; Haller JA, 2010, OPHTHALMOLOGY, V117, P1087, DOI 10.1016/j.ophtha.2009.10.040; Hoerger TJ, 2008, DIABETES CARE, V31, P81, DOI 10.2337/dc07-1572; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Hong T, 2009, OPHTHALMOLOGY, V116, P1510, DOI 10.1016/j.ophtha.2009.03.003; *INT DIAB FED, DIAB ATL 2007; Ip MS, 2008, OPHTHALMOLOGY, V115, P1447, DOI 10.1016/j.ophtha.2008.06.015; Islam FMA, 2009, EYE, V23, P1719, DOI 10.1038/eye.2008.362; Jeganathan VSE, 2008, DIABETES CARE, V31, P1905, DOI 10.2337/dc08-0342; Katsura Y, 2005, DIABETES CARE, V28, P2252, DOI 10.2337/diacare.28.9.2252; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kim SJ, 2007, OPHTHALMOLOGY, V114, P881, DOI 10.1016/j.ophtha.2006.08.053; Klein BEK, 2009, ARCH OPHTHALMOL-CHIC, V127, P1175, DOI 10.1001/archophthalmol.2009.172; KLEIN BEK, 1990, DIABETES CARE, V13, P1034, DOI 10.2337/diacare.13.10.1034; KLEIN BEK, 1990, DIABETES CARE, V13, P34, DOI 10.2337/diacare.13.1.34; KLEIN R, 1995, OPHTHALMOLOGY, V102, P7; Klein R, 2006, ARCH OPHTHALMOL-CHIC, V124, P87, DOI 10.1001/archopht.124.1.87; Klein R, 2004, ARCH OPHTHALMOL-CHIC, V122, P76, DOI 10.1001/archopht.122.1.76; Klein R, 2008, OPHTHALMOLOGY, V115, P1859, DOI 10.1016/j.ophtha.2008.08.023; Klein R, 2006, OPHTHALMOLOGY, V113, P1488, DOI 10.1016/j.ophtha.2006.03.028; Klein R, 2008, CONTEMP DIABETES, P67, DOI 10.1007/978-1-59745-563-3_3; Klein R, 2009, OPHTHALMOLOGY, V116, P1937, DOI 10.1016/j.ophtha.2009.03.012; Klein R, 2006, CONTEMP DIAB, P473; Klein R, 2009, OPHTHALMOLOGY, V116, P497, DOI 10.1016/j.ophtha.2008.10.016; Liew Gerald, 2009, Int Ophthalmol Clin, V49, P35, DOI 10.1097/IIO.0b013e31819fd5d7; Liew G, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b441; Lonn E, 2002, DIABETES CARE, V25, P1919, DOI 10.2337/diacare.25.11.1919; Lyons TJ, 2004, INVEST OPHTH VIS SCI, V45, P910, DOI 10.1167/iovs.02-0648; Machalinska A, 2009, CURR EYE RES, V34, P748, DOI 10.1080/02713680903050592; Maia OO, 2009, AM J OPHTHALMOL, V147, P291, DOI 10.1016/j.ajo.2008.08.024; Mandecka A, 2007, DIABETES CARE, V30, P3048, DOI 10.2337/dc07-0927; Mauer M, 2009, NEW ENGL J MED, V361, P40, DOI 10.1056/NEJMoa0808400; McLeod D, 2005, BRIT J OPHTHALMOL, V89, P229, DOI 10.1136/bjo.2004.058347; Mitchell P, 2008, LANCET, V372, P1361, DOI 10.1016/S0140-6736(08)61413-0; Mohamed Q, 2007, JAMA-J AM MED ASSOC, V298, P902, DOI 10.1001/jama.298.8.902; Mohamed Q, 2008, EXPERT OPIN EMERG DR, V13, P675, DOI [10.1517/14728210802584035, 10.1517/14728210802584035 ]; Nathan DM, 2008, ARCH OPHTHALMOL-CHIC, V126, P1707, DOI 10.1001/archopht.126.12.1707; NGUYEN T, 2009, INVEST OPHTH VIS SCI, V34, P1082; Nguyen TT, 2009, DIABETES CARE, V32, P2075, DOI 10.2337/dc09-0075; Nguyen TT, 2009, DIABETES CARE, V32, P1704, DOI 10.2337/dc09-0102; Nguyen TT, 2008, DIABETES CARE, V31, P544, DOI 10.2337/dc07-1528; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Olsen BS, 2004, J DIABETES COMPLICAT, V18, P160, DOI 10.1016/S1056-8727(03)00073-4; Patel A, 2007, LANCET, V370, P829, DOI 10.1016/S0140-6736(07)61303-8; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Raman R, 2009, OPHTHALMOLOGY, V116, P311, DOI 10.1016/j.ophtha.2008.09.010; Raymond NT, 2009, DIABETES CARE, V32, P410, DOI 10.2337/dc08-1422; Rema M, 2005, INVEST OPHTH VIS SCI, V46, P2328, DOI 10.1167/iovs.05-0019; Rogers SL, 2008, DIABETES CARE, V31, P761, DOI 10.2337/dc07-1622; Roy MS, 2004, ARCH OPHTHALMOL-CHIC, V122, P546, DOI 10.1001/archopht.122.4.546; Ryan EH, 2006, RETINA-J RET VIT DIS, V26, P562, DOI 10.1097/00006982-200605000-00011; Saaddine JB, 2006, ANN INTERN MED, V144, P465, DOI 10.7326/0003-4819-144-7-200604040-00005; Saaddine JB, 2008, ARCH OPHTHALMOL-CHIC, V126, P1740, DOI 10.1001/archopht.126.12.1740; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schwartz SG, 2009, DRUG TODAY, V45, P269, DOI [10.1358/dot.2009.045.004.1354195, 10.1358/dot.2009.45.4.1354195]; Shannon H, 2000, NEW ENGL J MED, V342, P381; Shen LQ, 2008, ARCH OPHTHALMOL-CHIC, V126, P793, DOI 10.1001/archopht.126.6.793; Sjolie AK, 2008, LANCET, V372, P1385, DOI 10.1016/S0140-6736(08)61411-7; Sloan FA, 2008, ARCH OPHTHALMOL-CHIC, V126, P1548, DOI 10.1001/archopht.126.11.1548; Stefansson E, 2009, GRAEF ARCH CLIN EXP, V247, P147, DOI 10.1007/s00417-008-0980-7; Stolk RP, 2008, DIABETES CARE, V31, P708, DOI 10.2337/dc07-1657; Suzuma I, 2001, DIABETES, V50, P444, DOI 10.2337/diabetes.50.2.444; Takamura Y, 2009, OPHTHALMOLOGY, V116, P1151, DOI 10.1016/j.ophtha.2009.01.014; The Diabetic Retinopathy Vitrectomy Study Research Group, 1985, ARCH OPHTHALMOL-CHIC, V103, P1644; Tikellis G, 2007, DIABETOLOGIA, V50, P2263, DOI 10.1007/s00125-007-0822-x; Varma R, 2008, OPHTHALMOLOGY, V115, P1857, DOI 10.1016/j.ophtha.2008.09.023; Vasilaki A, 2009, PHARMACOL THERAPEUT, V122, P324, DOI 10.1016/j.pharmthera.2009.03.010; Wang FH, 2009, OPHTHALMOLOGY, V116, P461, DOI 10.1016/j.ophtha.2008.10.003; Wang SQ, 2008, SURV OPHTHALMOL, V53, P512, DOI 10.1016/j.survophthal.2008.06.003; Watanabe D, 2005, NEW ENGL J MED, V353, P782, DOI 10.1056/NEJMoa041773; White NH, 2010, DIABETES, V59, P1244, DOI 10.2337/db09-1216; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Williams GA, 2004, OPHTHALMOLOGY, V111, P1055, DOI 10.1016/j.ophtha.2004.02.004; Wirostko B, 2008, PROG RETIN EYE RES, V27, P608, DOI 10.1016/j.preteyeres.2008.09.002; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; Wong TY, 2008, LANCET, V371, P736, DOI 10.1016/S0140-6736(08)60343-8; Wong TY, 2007, LANCET, V370, P204, DOI 10.1016/S0140-6736(07)61104-0; Wong TY, 2006, INVEST OPHTH VIS SCI, V47, P2341, DOI 10.1167/iovs.05-1539; Wong TY, 2006, BRIT J OPHTHALMOL, V90, P506, DOI 10.1136/bjo.2005.083733; Wong TY, 2006, AM J OPHTHALMOL, V141, P446, DOI 10.1016/j.ajo.2005.08.063; Xie XW, 2008, GRAEF ARCH CLIN EXP, V246, P1519, DOI 10.1007/s00417-008-0884-6; Xu HP, 2009, PROG RETIN EYE RES, V28, P348, DOI 10.1016/j.preteyeres.2009.06.001; Yang JK, 2010, DIABETES CARE, V33, P1018, DOI 10.2337/dc09-1784; Yilmaz T, 2009, OPHTHALMOLOGY, V116, P902, DOI 10.1016/j.ophtha.2009.02.002; Younis N, 2003, LANCET, V361, P195, DOI 10.1016/S0140-6736(03)12267-2; Zhang JF, 2008, INVEST OPHTH VIS SCI, V49, P732, DOI 10.1167/iovs.07-0721; 2000, DIABETES CARE S1, V23, P73	147	1757	1826	17	271	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					124	136		10.1016/S0140-6736(09)62124-3	http://dx.doi.org/10.1016/S0140-6736(09)62124-3			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20580421				2022-12-28	WOS:000279943200028
J	Chapman, GB; Li, M; Colby, H; Yoon, H				Chapman, Gretchen B.; Li, Meng; Colby, Helen; Yoon, Haewon			Opting In vs Opting Out of Influenza Vaccination	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							DEFAULT OPTIONS		[Chapman, Gretchen B.; Li, Meng; Colby, Helen; Yoon, Haewon] Rutgers State Univ, Sch Arts & Sci, Dept Psychol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick	Chapman, GB (corresponding author), Rutgers State Univ, Sch Arts & Sci, Dept Psychol, Piscataway, NJ 08854 USA.	gbc@rci.rutgers.edu		Yoon, Haewon/0000-0002-6211-7680; Chapman, Gretchen/0000-0002-1146-480X				Choi JJ, 2003, AM ECON REV, V93, P180, DOI 10.1257/000282803321947010; Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Johnson EJ, 2003, SCIENCE, V302, P1338, DOI 10.1126/science.1091721; Kressel LM, 2007, J GEN INTERN MED, V22, P1007, DOI 10.1007/s11606-007-0204-6; Thaler RH., 2021, NUDGE FINAL EDITION	5	133	135	0	16	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					43	44		10.1001/jama.2010.892	http://dx.doi.org/10.1001/jama.2010.892			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606147	Bronze			2022-12-28	WOS:000279519600019
J	Kimber, J; Copeland, L; Hickman, M; Macleod, J; McKenzie, J; De Angelis, D; Robertson, JR				Kimber, Jo; Copeland, Lorraine; Hickman, Matthew; Macleod, John; McKenzie, James; De Angelis, Daniela; Robertson, James Roy			Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment	BMJ-BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP; MAINTENANCE TREATMENT; CHANGING PATTERNS; AMSTERDAM COHORT; METHADONE; MORTALITY; RELAPSE; PREVENTION; DEPENDENCE; EPIDEMIC	Objectives To examine survival and long term cessation of injecting in a cohort of drug users and to assess the influence of opiate substitution treatment on these outcomes. Design Prospective open cohort study. Setting A single primary care facility in Edinburgh. Participants 794 patients with a history of injecting drug use presenting between 1980 and 2007; 655 (82%) were followed up by interview or linkage to primary care records and mortality register, or both, and contributed 10 390 person years at risk; 557 (85%) had received opiate substitution treatment. Main outcome measures Duration of injecting: years from first injection to long term cessation, defined as last injection before period of five years of non-injecting; mortality before cessation; overall survival. Results In the entire cohort 277 participants achieved long term cessation of injecting, and 228 died. Half of the survivors had poor health related quality of life. Median duration from first injection to death was 24 years for participants with HIV and 41 years for those without HIV. For each additional year of opiate substitution treatment the hazard of death before long term cessation fell 13% (95% confidence interval 17% to 9%) after adjustment for HIV, sex, calendar period, age at first injection, and history of prison and overdose. Conversely exposure to opiate substitution treatment was inversely related to the chances of achieving long term cessation. Conclusions Opiate substitution treatment in injecting drug users in primary care reduces this risk of mortality, with survival benefits increasing with cumulative exposure to treatment. Treatment does not reduce the overall duration of injecting.	[Kimber, Jo; Hickman, Matthew] Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England; [Kimber, Jo; Macleod, John] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2052, Australia; [Copeland, Lorraine; McKenzie, James; Robertson, James Roy] Muirhouse Med Grp, Edinburgh EH4 4P, Midlothian, Scotland; [De Angelis, Daniela] Univ Cambridge, Inst Publ Hlth, MRC, Biostat Unit, Cambridge CB2 1TN, England; [De Angelis, Daniela] Ctr Infect, Hlth Protect Agcy, London, England; [Robertson, James Roy] Univ Edinburgh, Div Community Hlth Sci, Edinburgh EH8 9AG, Midlothian, Scotland	University of Bristol; University of New South Wales Sydney; Kirby Institute; MRC Biostatistics Unit; University of Cambridge; Health Protection Agency; University of Edinburgh	Hickman, M (corresponding author), Univ Bristol, Dept Social Med, Bristol BS8 2PS, Avon, England.	matthew.hickman@bristol.ac.uk	Hickman, Matthew/Y-2400-2019	Hickman, Matthew/0000-0001-9864-459X; Kimber, Jo/0000-0002-8608-7906; De Angelis, Daniela/0000-0001-6619-6112; Macleod, John/0000-0001-8202-1144	Chief Scientist Office for Scotland [CZH/4/318]; National Institute of Health Research; Australian National Health and Medical Research (NHMRC); Australian Government Department of Health and Ageing; Health Protection Agency; Medical Research Council [U.1052.00.007]; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G9815508, MC_U105260556] Funding Source: researchfish; Chief Scientist Office [CZH/4/440] Funding Source: researchfish; ESRC [ES/G007543/1] Funding Source: UKRI; MRC [MC_U105260556] Funding Source: UKRI	Chief Scientist Office for Scotland; National Institute of Health Research(National Institute for Health Research (NIHR)); Australian National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); Health Protection Agency; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Chief Scientist Office; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The present follow-up study of the Edinburgh Addiction Cohort was supported by the Chief Scientist Office for Scotland (CZH/4/318). At the time they undertook this work JM and MH were supported by career scientist fellowship awards from the National Institute of Health Research. JK is supported by an Australian National Health and Medical Research (NHMRC) postdoctoral training fellowship. The National Centre in HIV Epidemiology and Clinical Research is core-funded by the Australian Government Department of Health and Ageing. LC and JMcK were funded by the chief scientist office grant (CZH/4/318), with the latter being seconded to the study by the community drug problem service, (CDPS), Lothian. DDA is funded by Health Protection Agency and the Medical Research Council (grant No U.1052.00.007).	*ADV COUNC MISS DR, 1982, TREATM REH; Allison PD., 1982, SOCIOL METHODOL, V13, P61, DOI 10.2307/270718; Bargagli AM, 2006, EUR J PUBLIC HEALTH, V16, P198, DOI 10.1093/eurpub/cki168; Berrington A, 2000, J ROY STAT SOC A STA, V163, P127, DOI 10.1111/1467-985X.00162; Blane DB, 1996, SOC SCI MED, V42, P751, DOI 10.1016/0277-9536(95)00340-1; Collet D., 2003, MODELLING SURVIVAL D; Copeland L, 2004, ARCH INTERN MED, V164, P1214, DOI 10.1001/archinte.164.11.1214; Darke S, 2005, J SUBST ABUSE TREAT, V28, P255, DOI 10.1016/j.jsat.2005.01.006; Davoli M, 2007, ADDICTION, V102, P1954, DOI 10.1111/j.1360-0443.2007.02025.x; Degenhardt L, 2006, SEX TRANSM INFECT, V82, pIII56, DOI 10.1136/sti.2005.019273; Department of Health (England) and the devolved administrations, 2007, DRUG MIS DEP UK GUID; Fugelstad A, 2007, ADDICTION, V102, P406, DOI 10.1111/j.1360-0443.2006.01714.x; Gossop M, 2003, ADDICTION, V98, P291, DOI 10.1046/j.1360-0443.2003.00296.x; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Gowing LR, 2006, J GEN INTERN MED, V21, P193, DOI 10.1111/j.1525-1497.2005.00287.x; HARTSOCK P, 1991, LONGITUDINAL STUDIES; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Hser YI, 2001, ARCH GEN PSYCHIAT, V58, P503, DOI 10.1001/archpsyc.58.5.503; Hubbard RL, 2003, J SUBST ABUSE TREAT, V25, P125, DOI 10.1016/S0740-5472(03)00130-2; Kind P, 1999, 172 CTR HLTH EC; Langendam MW, 2000, ADDICTION, V95, P591, DOI 10.1046/j.1360-0443.2000.95459110.x; Macleod J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-101; McCowan C, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2225; McKeganey N, 2006, ADDICT RES THEORY, V14, P557, DOI 10.1080/16066350601002369; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; OPPENHEIMER E, 1994, ADDICTION, V89, P1299, DOI 10.1111/j.1360-0443.1994.tb03309.x; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rathod NH, 2005, BRIT J PSYCHIAT, V187, P421, DOI 10.1192/bjp.187.5.421; Robertson JR, 2006, ADDICTION, V101, P1752, DOI 10.1111/j.1360-0443.2006.01603.x; ROBERTSON JR, 1986, BRIT MED J, V292, P527, DOI 10.1136/bmj.292.6519.527; Shah NG, 2006, DRUG ALCOHOL DEPEN, V83, P147, DOI 10.1016/j.drugalcdep.2005.11.007; SKIDMORE CA, 1990, BRIT MED J, V300, P219, DOI 10.1136/bmj.300.6719.219; Sweeting MJ, 2009, STAT METHODS MED RES, V18, P381, DOI 10.1177/0962280208094704; Termorshuizen F, 2005, AM J EPIDEMIOL, V161, P271, DOI 10.1093/aje/kwi035; Termorshuizen F, 2005, DRUG ALCOHOL DEPEN, V79, P231, DOI 10.1016/j.drugalcdep.2005.01.013; VAILLANT GE, 1988, BRIT J ADDICT, V83, P1147; Ward J., 1997, METHADONE MAINTENANC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	40	140	140	0	21	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 1	2010	341								c3172	10.1136/bmj.c3172	http://dx.doi.org/10.1136/bmj.c3172			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621NW	20595255	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000279586600002
J	Jackson, LP; Kelly, BT; McCoy, AJ; Gaffry, T; James, LC; Collins, BM; Honing, S; Evans, PR; Owen, DJ				Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Gaffry, Thomas; James, Leo C.; Collins, Brett M.; Hoening, Stefan; Evans, Philip R.; Owen, David J.			A Large-Scale Conformational Change Couples Membrane Recruitment to Cargo Binding in the AP2 Clathrin Adaptor Complex	CELL			English	Article							COATED VESICLES; STRUCTURAL EXPLANATION; SORTING SIGNALS; MEDIATED ENDOCYTOSIS; MOLECULAR-GRAPHICS; PHASE INFORMATION; APPENDAGE DOMAIN; ALPHA-ADAPTIN; PROTEINS; RECOGNITION	The AP2 adaptor complex (alpha, beta 2, sigma 2, and mu 2 sub-units) crosslinks the endocytic clathrin scaffold to PtdIns4,5P(2)-containing membranes and transmembrane protein cargo. In the "locked" cytosolic form, AP2's binding sites for the two endocytic motifs, Yxx Phi on the C-terminal domain of mu 2 (C-mu 2) and [ED]xxxL[LI] on sigma 2, are blocked by parts of beta 2. Using protein crystallography, we show that AP2 undergoes a large conformational change in which C-mu 2 relocates to an orthogonal face of the complex, simultaneously unblocking both cargo-binding sites; the previously unstructured mu 2 linker becomes helical and binds back onto the complex. This structural rearrangement results in AP2's four PtdIns4,5P(2)- and two endocytic motif-binding sites becoming coplanar, facilitating their simultaneous interaction with PtdIns4,5P(2)/cargo-containing membranes. Using a range of biophysical techniques, we show that the endocytic cargo binding of AP2 is driven by its interaction with PtdIns4,5P(2)-containing membranes.	[James, Leo C.; Evans, Philip R.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Jackson, Lauren P.; Kelly, Bernard T.; McCoy, Airlie J.; Owen, David J.] Univ Cambridge, Dept Clin Biochem, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Gaffry, Thomas; Hoening, Stefan] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia	MRC Laboratory Molecular Biology; University of Cambridge; University of Cologne; University of Cologne; University of Queensland	Evans, PR (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	pre@mrc-lmb.cam.ac.uk; djo30@cam.ac.uk	Collins, Brett/J-1563-2014	Collins, Brett/0000-0002-6070-3774; Jackson, Lauren/0000-0002-3705-6126	Wellcome Trust; German Science Foundation [SFB 635, TP3, SFB 670 TP7]; Center for Molecular Medicine Cologne [TP C3]; National Health and Medical Research Council (NHMRC), Australia; MRC [MC_U105181010, MC_U105178845] Funding Source: UKRI; Medical Research Council [MC_U105181010, MC_U105178845] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); German Science Foundation(German Research Foundation (DFG)); Center for Molecular Medicine Cologne; National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank the staff of ID29 at the ESRF, especially Elspeth Gordon, and beamline staff at Diamond Lightsource, especially Katherine McAuley and Dave Hall. We also thank Maria Jose Sanchez Barrena for assistance in data collection, Meredith Roberts-Thompson for assistance with fluorescence anisotropy measurements, and Margaret Robinson for access to the transmembrane protein database. We thank Lesley McKeane for creating part of Figure 3. D.J.O., L.P.J., and B. T. K. are supported by a Wellcome Trust Senior Fellowship to D.J.O.; T. G. and S. H. are supported by the German Science Foundation (SFB 635, TP3, SFB 670 TP7) and the Center for Molecular Medicine Cologne (TP C3); and B. M. C. is supported by a Career Development Award from the National Health and Medical Research Council (NHMRC), Australia.	Abrahams JP, 1997, ACTA CRYSTALLOGR D, V53, P371, DOI 10.1107/S0907444996015272; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Austin C, 2000, J BIOL CHEM, V275, P21862, DOI 10.1074/jbc.M908875199; Baust T, 2006, P NATL ACAD SCI USA, V103, P3159, DOI 10.1073/pnas.0511062103; Boehm M, 2001, EMBO J, V20, P6265, DOI 10.1093/emboj/20.22.6265; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chaudhuri R, 2009, J VIROL, V83, P2518, DOI 10.1128/JVI.02227-08; CHEN HJ, 1993, J BIOL CHEM, V268, P22338; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; Gaidarov I, 1996, J BIOL CHEM, V271, P20922, DOI 10.1074/jbc.271.34.20922; Grosse-Kunstleve RW, 2003, ACTA CRYSTALLOGR D, V59, P1966, DOI 10.1107/S0907444903018043; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; HELLER H, 1993, J PHYS CHEM-US, V97, P8343, DOI 10.1021/j100133a034; HEUSER JE, 1988, J CELL BIOL, V107, P877, DOI 10.1083/jcb.107.3.877; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; KEEN JH, 1981, J BIOL CHEM, V256, P2538; Kelly BT, 2008, NATURE, V456, P976, DOI 10.1038/nature07422; Kim SH, 2009, J BIOL CHEM, V284, P32803, DOI 10.1074/jbc.M109.039149; KRISSINEL E, 2005, DETECTION PROTEIN AS; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee I, 2008, J CELL BIOL, V180, P467, DOI 10.1083/jcb.200709037; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li YH, 2001, J BIOL CHEM, V276, P18000, DOI 10.1074/jbc.M101589200; Loerke D, 2009, PLOS BIOL, V7, P628, DOI 10.1371/journal.pbio.1000057; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Paleotti O, 2005, J BIOL CHEM, V280, P21661, DOI 10.1074/jbc.m503099200; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; PEARSE BMF, 1984, EMBO J, V3, P1951, DOI 10.1002/j.1460-2075.1984.tb02075.x; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Rohde G, 2002, J CELL BIOL, V158, P209, DOI 10.1083/jcb.200203103; Rohrer J, 1996, J CELL BIOL, V132, P565, DOI 10.1083/jcb.132.4.565; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P195, DOI 10.1107/S0907444901019291; Semerdjieva S, 2008, J CELL BIOL, V183, P499, DOI 10.1083/jcb.200806016; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Traub LM, 2009, NAT REV MOL CELL BIO, V10, P583, DOI 10.1038/nrm2751; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VOORHEES P, 1995, EMBO J, V14, P4961, DOI 10.1002/j.1460-2075.1995.tb00179.x	55	232	239	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1220	U213		10.1016/j.cell.2010.05.006	http://dx.doi.org/10.1016/j.cell.2010.05.006			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603002	Green Published, hybrid			2022-12-28	WOS:000279148100018
J	Odeh, JH; Clarfield, AM; Waterston, T				Odeh, Jumana H.; Clarfield, A. Mark; Waterston, Tony			Dialogue What can cooperation between Israeli and Palestinian doctors achieve?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Odeh, Jumana H.] Palestinian Happy Child Ctr, Ramallah, Palestine; [Clarfield, A. Mark] Ben Gurion Univ Negev, Med Sch Int Hlth, IL-84105 Beer Sheva, Israel	Ben Gurion University	Odeh, JH (corresponding author), Palestinian Happy Child Ctr, Ramallah, Palestine.	jhodeh@gmail.com; markclar@bgu.ac.il; A.J.R.Waterston@newcastle.ac.uk							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2010	340								c3081	10.1136/bmj.c3081	http://dx.doi.org/10.1136/bmj.c3081			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IR	20581030				2022-12-28	WOS:000279346600001
J	Schultze, M; Fiess, M; Karpowicz, N; Gagnon, J; Korbman, M; Hofstetter, M; Neppl, S; Cavalieri, AL; Komninos, Y; Mercouris, T; Nicolaides, CA; Pazourek, R; Nagele, S; Feist, J; Burgdorfer, J; Azzeer, AM; Ernstorfer, R; Kienberger, R; Kleineberg, U; Goulielmakis, E; Krausz, F; Yakovlev, VS				Schultze, M.; Fiess, M.; Karpowicz, N.; Gagnon, J.; Korbman, M.; Hofstetter, M.; Neppl, S.; Cavalieri, A. L.; Komninos, Y.; Mercouris, Th.; Nicolaides, C. A.; Pazourek, R.; Nagele, S.; Feist, J.; Burgdoerfer, J.; Azzeer, A. M.; Ernstorfer, R.; Kienberger, R.; Kleineberg, U.; Goulielmakis, E.; Krausz, F.; Yakovlev, V. S.			Delay in Photoemission	SCIENCE			English	Article							STREAKING MEASUREMENTS; ATTOSECOND PULSES; TIME-DELAY; ELECTRON; DYNAMICS; OPTICS; SCALE	Photoemission from atoms is assumed to occur instantly in response to incident radiation and provides the basis for setting the zero of time in clocking atomic-scale electron motion. We used attosecond metrology to reveal a delay of 21 +/- 5 attoseconds in the emission of electrons liberated from the 2p orbitals of neon atoms with respect to those released from the 2s orbital by the same 100-electron volt light pulse. Small differences in the timing of photoemission from different quantum states provide a probe for modeling many-electron dynamics. Theoretical models refined with the help of attosecond timing metrology may provide insight into electron correlations and allow the setting of the zero of time in atomic-scale chronoscopy with a precision of a few attoseconds.	[Schultze, M.; Gagnon, J.; Hofstetter, M.; Krausz, F.; Yakovlev, V. S.] Univ Munich, Dept Phys, D-85748 Garching, Germany; [Schultze, M.; Fiess, M.; Karpowicz, N.; Gagnon, J.; Korbman, M.; Cavalieri, A. L.; Kienberger, R.; Kleineberg, U.; Goulielmakis, E.; Krausz, F.; Yakovlev, V. S.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Neppl, S.; Ernstorfer, R.; Kienberger, R.] Tech Univ Munich, Dept Phys, D-85748 Garching, Germany; [Komninos, Y.; Mercouris, Th.; Nicolaides, C. A.] Natl Hellen Res Fdn, Inst Theoret & Phys Chem, GR-11635 Athens, Greece; [Pazourek, R.; Nagele, S.; Feist, J.; Burgdoerfer, J.] Vienna Univ Technol, Inst Theoret Phys, A-1040 Vienna, Austria; [Feist, J.] Harvard Smithsonian Ctr Astrophys, Inst Theoret Atom Mol & Opt Phys ITAMP, Cambridge, MA 02138 USA; [Azzeer, A. M.] King Saud Univ, Dept Phys & Astron, Riyadh 11451, Saudi Arabia	University of Munich; Max Planck Society; Technical University of Munich; National Hellenic Research Foundation; Technische Universitat Wien; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; King Saud University	Schultze, M (corresponding author), Univ Munich, Dept Phys, Coulombwall 1, D-85748 Garching, Germany.	Martin.Schultze@mpq.mpg.de; Vladislav.Yakovlev@physik.uni-muenchen.de	Goulielmakis, Eleftherios/F-1693-2011; Goulielmakis, Eleftherios/AAZ-1052-2020; Yakovlev, Vladislav S/C-4091-2015; Azzeer, Abdallah M/A-4542-2011; Feist, Johannes/J-7394-2012; Nagele, Stefan/E-6938-2011; Ernstorfer, Ralph/D-1590-2009; Hädrich, Steffen/B-4331-2008	Goulielmakis, Eleftherios/0000-0003-3386-0245; Yakovlev, Vladislav S/0000-0002-0648-9375; Azzeer, Abdallah M/0000-0001-8334-9256; Feist, Johannes/0000-0002-7972-0646; Nagele, Stefan/0000-0003-1213-0294; Ernstorfer, Ralph/0000-0001-6665-3520; Gagnon, Justin/0000-0001-9133-9541; Schultze, Martin/0000-0003-0438-9255; Neppl, Stefan/0000-0003-0536-1932; Kienberger, Reinhard/0000-0001-8781-3685	Max Planck Society; Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics; King Saud University-Max-Planck-Institut fur Quantenoptik collaboration; NSF [TG-PHY090031]; Austrian Science Fund (FWF) [FWF-SFB016]; Marie-Curie Reintegration grant [MERG-CT-2007-208643]; Alexander von Humboldt Foundation; ERC	Max Planck Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics(German Research Foundation (DFG)); King Saud University-Max-Planck-Institut fur Quantenoptik collaboration; NSF(National Science Foundation (NSF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Marie-Curie Reintegration grant(European Commission); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); ERC(European Research Council (ERC)European Commission)	Supported by the Max Planck Society and the Deutsche Forschungsgemeinschaft Cluster of Excellence: Munich Centre for Advanced Photonics (www.munich-photonics.de) and the King Saud University-Max-Planck-Institut fur Quantenoptik collaboration. Supported in part by NSF through TeraGrid resources provided by the National Institute for Computational Sciences and Texas Advanced Computing Center under grant TG-PHY090031. R.P., S.N., and J.B. acknowledge support from the Austrian Science Fund (FWF) under grant FWF-SFB016. J.F. acknowledges support by NSF through a grant to ITAMP. E. G. acknowledges a Marie-Curie Reintegration grant (MERG-CT-2007-208643). R. K. acknowledges support from the Sofia Kovalevskaja award of the Alexander von Humboldt Foundation and an ERC starting grant. We thank A. Maquet and R. Taieb for fruitful discussions.	Baggesen JC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.209903; Baggesen JC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.043602; Baltuska A, 2003, NATURE, V421, P611, DOI 10.1038/nature01414; BECKER U, 1997, VUV SOFT XRAY PHOTOI, pCH5; Borisov A, 2004, CHEM PHYS LETT, V387, P95, DOI 10.1016/j.cplett.2004.01.114; Cavalieri AL, 2007, NATURE, V449, P1029, DOI 10.1038/nature06229; Cavalieri AL, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/242; de Carvalho CAA, 2002, PHYS REP, V364, P83, DOI 10.1016/S0370-1573(01)00092-8; Einstein A, 1905, ANN PHYS-BERLIN, V17, P132; Gagnon J, 2008, APPL PHYS B-LASERS O, V92, P25, DOI 10.1007/s00340-008-3063-x; Gagnon J, 2009, OPT EXPRESS, V17, P17678, DOI 10.1364/OE.17.017678; Goulielmakis E, 2008, SCIENCE, V320, P1614, DOI 10.1126/science.1157846; Hallwachs W, 1888, ANN PHY CHEMIE, V269, P301, DOI [10.1002/andp.18882690206, DOI 10.1002/ANDP.18882690206]; Hentschel M, 2001, NATURE, V414, P509, DOI 10.1038/35107000; Hertz H. R., 1887, ANN PHYS-NEW YORK, V267, P983, DOI [10.1002/andp.18872670827, DOI 10.1002/ANDP.18872670827]; Ivanov MY, 2007, J MOD OPTIC, V54, P899, DOI 10.1080/09500340701210581; Kazansky AK, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.177401; Kienberger R, 2004, NATURE, V427, P817, DOI 10.1038/nature02277; Lemell C, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.062901; Mairesse Y, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011401; Manson ST, 2006, RADIAT PHYS CHEM, V75, P2119, DOI 10.1016/j.radphyschem.2005.03.001; Mauritsson J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.073003; Mercouris T, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033417; Nicolaides CA, 2002, J PHYS B-AT MOL OPT, V35, pL271, DOI 10.1088/0953-4075/35/12/105; Nisoli M, 2009, PROG QUANT ELECTRON, V33, P17, DOI 10.1016/j.pquantelec.2008.10.004; Parker JS, 2003, J PHYS B-AT MOL OPT, V36, pL393, DOI 10.1088/0953-4075/36/21/L04; Rudenko A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.073003; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Schultze M, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/7/243; SMITH FT, 1960, PHYS REV, V118, P349, DOI 10.1103/PhysRev.118.349; STARACE AF, 1982, HDB PHYS, V31; WIGNER EP, 1955, PHYS REV, V98, P145, DOI 10.1103/PhysRev.98.145	32	740	744	13	189	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1658	1662		10.1126/science.1189401	http://dx.doi.org/10.1126/science.1189401			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576884				2022-12-28	WOS:000279107400034
J	Johnson, KS; Riser, SC; Karl, DM				Johnson, Kenneth S.; Riser, Stephen C.; Karl, David M.			Nitrate supply from deep to near-surface waters of the North Pacific subtropical gyre	NATURE			English	Article							NITROGEN-FIXATION; OXYGEN; FLUX; STOICHIOMETRY; CHLOROPHYLL; PHOSPHORUS; CYCLE; ZONE	Concentrations of dissolved inorganic carbon (DIC) decrease in the surface mixed layers during spring and summer in most of the oligotrophic ocean. Mass balance calculations require that the missing DIC is converted into particulate carbon by photosynthesis(1-3). This DIC uptake represents one of the largest components of net community production in the world ocean(2,4). However, mixed-layer waters in these regions of the ocean typically contain negligible concentrations of plant nutrients such as nitrate and phosphate(3,5). Combined nutrient supply mechanisms including nitrogen fixation, diffusive transport and vertical entrainment are believed to be insufficient to supply the required nutrients for photosynthesis(6,7). The basin-scale potential for episodic nutrient transport by eddy events is unresolved(8,9). As a result, it is not understood how biologically mediated DIC uptake can be supported in the absence of nutrients. Here we report on high-resolution measurements of nitrate (NO3-) and oxygen (O-2) concentration made over 21 months using a profiling float deployed near the Hawaii Ocean Time-series station in the North Pacific subtropical gyre. Our measurements demonstrate that as O-2 was produced and DIC was consumed over two annual cycles, a corresponding seasonal deficit in dissolved NO3- appeared in water at depths from 100 to 250 m. The deep-water deficit in NO3- was in near-stoichiometric balance with the fixed nitrogen exported to depth. Thus, when the water column from the surface to 250 m is considered as a whole, there is near equivalence between nutrient supply and demand. Short-lived transport events (<10 days) that connect deep stocks of nitrate to nutrient-poor surface waters were clearly present in 12 of the 127 vertical profiles.	[Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Riser, Stephen C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Karl, David M.] Univ Hawaii, Ctr Microbial Oceanog Res & Educ, Sch Ocean & Earth Sci & Technol, Honolulu, HI 96822 USA	Monterey Bay Aquarium Research Institute; University of Washington; University of Washington Seattle; University of Hawaii System	Johnson, KS (corresponding author), Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA.	johnson@mbari.org	Johnson, Kenneth S/F-9742-2011; Karl, David/AFP-3837-2022	Johnson, Kenneth S/0000-0001-5513-5584; Karl, David/0000-0002-6660-6721	David and Lucile Packard Foundation; National Science Foundation; National Oceanic and Atmospheric Administration; US Office of Naval Research; Gordon and Betty Moore Foundation; Center for Microbial Oceanography: Research and Education; Directorate For Geosciences [0824990] Funding Source: National Science Foundation	David and Lucile Packard Foundation(The David & Lucile Packard Foundation); National Science Foundation(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); US Office of Naval Research(Office of Naval Research); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Center for Microbial Oceanography: Research and Education; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was made possible by the engineering efforts of L. Coletti, H. Jannasch and D. Swift to integrate ISUS with the APEX float. C. Sakamoto performed ISUS sensor calibration. This work was supported by the David and Lucile Packard Foundation, the National Science Foundation, the National Oceanic and Atmospheric Administration and the US Office of Naval Research through the National Oceanographic Partnership Program. Funding was also provided by the Gordon and Betty Moore Foundation and the Center for Microbial Oceanography: Research and Education.	Abell J, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002285; ANDERSON LA, 1995, DEEP-SEA RES PT I, V42, P1675, DOI 10.1016/0967-0637(95)00072-E; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Emerson S, 1997, NATURE, V389, P951, DOI 10.1038/40111; EMERSON S, 1995, J MAR RES, V53, P499, DOI 10.1357/0022240953213179; Emerson S, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003095; Hannides CCS, 2009, DEEP-SEA RES PT I, V56, P73, DOI 10.1016/j.dsr.2008.08.003; Jenkins WJ, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2003GB002085; Johnson KS, 2002, DEEP-SEA RES PT I, V49, P1291, DOI 10.1016/S0967-0637(02)00020-1; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Karl DM, 2008, MAR ECOL PROG SER, V364, P257, DOI 10.3354/meps07547; Karl DM, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P705, DOI 10.1016/B978-0-12-372522-6.00016-5; Karl DM, 2003, GLO CH IGBP, P239; Karl DM, 2001, DEEP-SEA RES PT II, V48, P1529, DOI 10.1016/S0967-0645(00)00152-1; Keeling CD, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002227; Kortzinger A, 2005, J ATMOS OCEAN TECH, V22, P302, DOI 10.1175/JTECH1701.1; Lamborg CH, 2008, DEEP-SEA RES PT II, V55, P1540, DOI 10.1016/j.dsr2.2008.04.011; LEDWELL JR, 1993, NATURE, V364, P701, DOI 10.1038/364701a0; Lee K, 2001, LIMNOL OCEANOGR, V46, P1287, DOI 10.4319/lo.2001.46.6.1287; Letelier RM, 2004, LIMNOL OCEANOGR, V49, P508, DOI 10.4319/lo.2004.49.2.0508; Martin AP, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2003JC001841; McGillicuddy DJ, 2007, SCIENCE, V316, P1021, DOI 10.1126/science.1136256; McGillicuddy DJ, 1998, NATURE, V394, P263, DOI 10.1038/28367; MICHAELS AF, 1994, NATURE, V372, P537, DOI 10.1038/372537a0; Riser SC, 2008, NATURE, V451, P323, DOI 10.1038/nature06441; Sakamoto CM, 2009, LIMNOL OCEANOGR-METH, V7, P132, DOI 10.4319/lom.2009.7.132; Tengberg A, 2006, LIMNOL OCEANOGR-METH, V4, P7, DOI 10.4319/lom.2006.4.7; Villareal TA, 1999, NATURE, V397, P423, DOI 10.1038/17103; Williams RG, 2003, GLO CH IGBP, P19	30	168	172	2	99	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1062	1065		10.1038/nature09170	http://dx.doi.org/10.1038/nature09170			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577212				2022-12-28	WOS:000279056900049
J	Hutcheon, JA; Chiolero, A; Hanley, JA				Hutcheon, Jennifer A.; Chiolero, Arnaud; Hanley, James A.			Random measurement error and regression dilution bias	BMJ-BRITISH MEDICAL JOURNAL			English	Article							BLOOD-PRESSURE; ASSOCIATION; IMPACT; PROOF		[Hutcheon, Jennifer A.] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Chiolero, Arnaud; Hanley, James A.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ H3A 1A2, Canada; [Chiolero, Arnaud] Univ Hosp Ctr, Inst Social & Prevent Med IUMSP, Lausanne, Switzerland; [Chiolero, Arnaud] Univ Lausanne, Lausanne, Switzerland	University of British Columbia; McGill University; University of Lausanne	Hutcheon, JA (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada.	james.hanley@mcgill.ca	Chiolero, Arnaud/A-4322-2010	Chiolero, Arnaud/0000-0002-5544-8510; Hutcheon, Jennifer/0000-0002-6618-6018				Andersen PK, 2003, BIOSTATISTICS, V4, P633, DOI 10.1093/biostatistics/4.4.633; Bland JM, 1996, BRIT MED J, V313, P744; Brown W, 1910, BRIT J PSYCHOL, V3, P296, DOI 10.1111/j.2044-8295.1910.tb00207.x; Carroll R., 1995, MEASUREMENT ERROR NO; DAY NE, 1997, BMJ-BRIT MED J, V315, P484; Den Hond E, 2003, BLOOD PRESS MONIT, V8, P173, DOI 10.1097/01.mbp.0000090400.29806.37; Diego MA, 2006, PSYCHOSOM MED, V68, P747, DOI 10.1097/01.psy.0000238212.21598.7b; Dudley NJ, 2005, ULTRASOUND OBST GYN, V25, P80, DOI 10.1002/uog.1751; Dyer AR, 1996, BRIT MED J, V312, P1661, DOI 10.1136/bmj.312.7047.1661; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Fitzmaurice G, 2002, NUTRITION, V18, P112, DOI 10.1016/S0899-9007(01)00624-4; Frost C, 2005, INT J EPIDEMIOL, V34, P1359, DOI 10.1093/ije/dyi148; Knuiman MW, 1998, ANN EPIDEMIOL, V8, P56, DOI 10.1016/S1047-2797(97)00107-5; Lash, 2008, MODERN EPIDEMIOLOGY, P345; Last JM., 2001, DICT EPIDEMIOLOGY, V4th; LIU K, 1988, AM J EPIDEMIOL, V127, P864, DOI 10.1093/oxfordjournals.aje.a114870; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Perkins DO, 2000, BIOL PSYCHIAT, V47, P762, DOI 10.1016/S0006-3223(00)00837-4; Pickering TG, 2006, NEW ENGL J MED, V354, P2368, DOI 10.1056/NEJMra060433; ROSE G, 1965, LANCET, V1, P673; ROSNER B, 1992, AM J EPIDEMIOL, V136, P1400, DOI 10.1093/oxfordjournals.aje.a116453; Smith GD, 1996, BMJ-BRIT MED J, V312, P1659, DOI 10.1136/bmj.312.7047.1659; SMITH GD, 1997, BMJ-BRIT MED J, V315, P484; Spearman C, 1910, BRIT J PSYCHOL, V3, P271, DOI 10.1111/j.2044-8295.1910.tb00206.x; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stergiou GS, 2010, J HYPERTENS, V28, P226, DOI 10.1097/HJH.0b013e3283346e0b; Whitlock G, 2001, EUR J EPIDEMIOL, V17, P907, DOI 10.1023/A:1016228410194	28	419	421	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2010	340								c2289	10.1136/bmj.c2289	http://dx.doi.org/10.1136/bmj.c2289			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IP	20573762				2022-12-28	WOS:000279346400002
J	Torjesen, I				Torjesen, Ingrid			Primary Care Recession medicine	BRITISH MEDICAL JOURNAL			English	Editorial Material							WELFARE BENEFITS ADVICE; HEALTH; IMPACT					ingrid_torjesen@hotmail.com						Abbott S, 2000, PUBLIC HEALTH, V114, P324, DOI 10.1016/S0033-3506(00)00356-5; Abbott S, 2006, HEALTH SOC CARE COMM, V14, P1, DOI 10.1111/j.1365-2524.2005.00582.x; ASTHMA UK, 2009, RECESSION FORCING PE; BEALE N, 1988, BRIT MED J, V296, P1508, DOI 10.1136/bmj.296.6635.1508; Gallo WT, 2006, OCCUP ENVIRON MED, V63, P683, DOI 10.1136/oem.2006.026823; *MIND, WORK TURN ANT REC TA; *NHS HLTH DEV AG, 2005, WORKL HLTH WHAT DO W; NHS Information Centre, 2009, PRESCR COST AN; Waddell G., 2006, IS WORK GOOD YOUR HL	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2010	340								c3114	10.1136/bmj.c3114	http://dx.doi.org/10.1136/bmj.c3114			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IN	20566598				2022-12-28	WOS:000279346200005
J	Travis, RC; Reeves, GK; Green, J; Bull, D; Tipper, SJ; Baker, K; Beral, V; Peto, R; Bell, J; Zelenika, D; Lathrop, M				Travis, Ruth C.; Reeves, Gillian K.; Green, Jane; Bull, Diana; Tipper, Sarah J.; Baker, Krys; Beral, Valerie; Peto, Richard; Bell, John; Zelenika, Diana; Lathrop, Mark		Million Women Study Collaborators	Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study	LANCET			English	Article							GENOME-WIDE ASSOCIATION; CONFER SUSCEPTIBILITY; COMMON VARIANTS; FGFR2; RISK; ALLELES; MAP3K1	Background Information is scarce about the combined effects on breast cancer incidence of low-penetrance genetic susceptibility polymorphisms and environmental factors (reproductive, behavioural, and anthropometric risk factors for breast cancer). To test for evidence of gene environment interactions, we compared genotypic relative risks for breast cancer across the other risk factors in a large UK prospective study. Methods We tested gene environment interactions in 7610 women who developed breast cancer and 10196 controls without the disease, studying the effects of 12 polymorphisms (FGFR2-rs2981582, TNRC9-rs3803662, 2q35-rs13387042, MAP3K1-rs889312, 8q24-rs13281615, 2p-rs4666451, 5p12-rs981782, CASP8-rs1045485, LSP1-rs3817198, 5q-rs30099, TGFB1-rs1982073, and ATM-rs1800054) in relation to prospectively collected information about ten established environmental risk factors (age at menarche, parity, age at first birth, breastfeeding, menopausal status, age at menopause, use of hormone replacement therapy, body-mass index, height, and alcohol consumption). Findings After allowance for multiple testing none of the 120 comparisons yielded significant evidence of a gene environment interaction. By contrast with previous suggestions, there was little evidence that the genotypic relative risks were affected by use of hormone replacement therapy, either overall or for oestrogen-receptor-positive disease. Only one of the 12 polymorphisms was correlated with any of the ten other risk factors: carriers of the high-risk C allele of MAP3K1-rs889312 were significantly shorter than non-carriers (mean height 162.4 cm [95% CI 162-1-162.7] vs 163.1 cm [162.9-163.2]; p=0.01 after allowance for multiple testing). Interpretation Risks of breast cancer associated with low-penetrance susceptibility polymorphisms do not vary significantly with these ten established environmental risk factors.	[Travis, Ruth C.; Reeves, Gillian K.; Green, Jane; Bull, Diana; Tipper, Sarah J.; Baker, Krys; Beral, Valerie] Univ Oxford, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Peto, Richard] Univ Oxford, Clin Trial Serv Unit, Epidemiol Studies Unit, Oxford OX3 7LF, England; [Bell, John] Univ Oxford, Div Med Sci, Oxford OX3 7LF, England	University of Oxford; University of Oxford; University of Oxford	Travis, RC (corresponding author), Univ Oxford, Canc Epidemiol Unit, Richard Doll Bldg,Roosevelt Dr, Oxford OX3 7LF, England.	ruth.travis@ceu.ox.ac.uk		Balkwill, Angela/0000-0002-6327-6245	Cancer Research UK; UK Medical Research Council; Medical Research Council [MC_U137686850, G0700474] Funding Source: researchfish; MRC [MC_U137686850, G0700474] Funding Source: UKRI	Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding Cancer Research UK and the UK Medical Research Council.	Ahmed S, 2009, NAT GENET, V41, P585, DOI 10.1038/ng.354; Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Banks E, 2001, J Epidemiol Biostat, V6, P357; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Beral V, 2001, LANCET, V358, P1389, DOI 10.1016/S0140-6736(01)06524-2; Cox A, 2007, NAT GENET, V39, P352, DOI 10.1038/ng1981; Craig EA, 2008, DEV DYNAM, V237, P3102, DOI 10.1002/dvdy.21750; Dorgan JF, 2002, JNCI-J NATL CANCER I, V94, P606; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Huijts PEA, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1793; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Kawase T, 2009, INT J CANCER, V125, P1946, DOI 10.1002/ijc.24505; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Liang J, 2008, CARCINOGENESIS, V29, P2341, DOI 10.1093/carcin/bgn235; Prentice RL, 2009, CANCER EPIDEM BIOMAR, V18, P3079, DOI 10.1158/1055-9965.EPI-09-0611; Rebbeck TR, 2009, CARCINOGENESIS, V30, P269, DOI 10.1093/carcin/bgn247; Reeves GK, 2009, BRIT J CANCER, V100, P538, DOI 10.1038/sj.bjc.6604853; Reeves GK, 2007, BRIT MED J, V335, P1134, DOI 10.1136/bmj.39367.495995.AE; Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131; Stacey SN, 2007, NAT GENET, V39, P865, DOI 10.1038/ng2064; TAMIMI RM, 2010, CANCER CAUSE CONTROL, DOI DOI 10.1007/S10552-009-9446-7; The Million Women Study Collaborative Group, 1999, BREAST CANCER RES, V1, P73, DOI DOI 10.1186/BCR16; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318	24	99	102	0	31	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2143	2151		10.1016/S0140-6736(10)60636-8	http://dx.doi.org/10.1016/S0140-6736(10)60636-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BF	20605201	Green Submitted, Green Published			2022-12-28	WOS:000279255100024
J	Paul, VK				Paul, Vinod K.			India: conditional cash transfers for in-facility deliveries	LANCET			English	Editorial Material									All India Inst Med Sci, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Paul, VK (corresponding author), All India Inst Med Sci, New Delhi 110029, India.							AIYER S, 2010, INDIA TOADY     0531, P44; Bhutta ZA, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-S1-S7; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; *IIPS, 2008, DISTR LEV HOUS SURV; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; *MIN HLTH FAM WELF, 2009, 3 COMM REV MISS REP; Mohapatra B., 2008, Health and Population - Perspectives and Issues, V31, P120; Shobha Malini, 2008, Health and Population - Perspectives and Issues, V31, P126; *UNFPA CORT, 2007, ASS ASHA JAN SUR YOJ	10	24	24	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1943	1944		10.1016/S0140-6736(10)60901-4	http://dx.doi.org/10.1016/S0140-6736(10)60901-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569824				2022-12-28	WOS:000278689600005
J	Samuel, VT; Petersen, KF; Shulman, GI				Samuel, Varman T.; Petersen, Kitt Falk; Shulman, Gerald I.			Lipid-induced insulin resistance: unravelling the mechanism	LANCET			English	Article							PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM STRESS; FATTY LIVER-DISEASE; PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; IMPAIRED GLUCOSE-TOLERANCE; MUSCLE GLYCOGEN-SYNTHESIS; SKELETAL-MUSCLE; HEPATIC STEATOSIS; DIABETES-MELLITUS; ADIPOSE-TISSUE	Insulin resistance has long been associated with obesity. More than 40 years ago, Randle and colleagues postulated that lipids impaired insulin-stimulated glucose use by muscles through inhibition of glycolysis at key points. However, work over the past two decades has shown that lipid-induced insulin resistance in skeletal muscle stems from defects in insulin-stimulated glucose transport activity. The steatotic liver is also resistant to insulin in terms of inhibition of hepatic glucose production and stimulation of glycogen synthesis. In muscle and liver, the intracellular accumulation of lipids-namely, diacylglycerol-triggers activation of novel protein kinases C with subsequent impairments in insulin signalling. This unifying hypothesis accounts for the mechanism of insulin resistance in obesity, type 2 diabetes, lipodystrophy, and ageing; and the insulin-sensitising effects of thiazolidinediones.	[Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA; [Samuel, Varman T.; Petersen, Kitt Falk; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06536 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06536 USA; [Samuel, Varman T.] Vet Affairs Med Ctr, West Haven, CT USA	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06536 USA.	gerald.shulman@yale.edu	Shulman, Gerald I./P-7176-2019	Shulman, Gerald I./0000-0003-1529-5668	Veterans Administration; US Public Health Service [R01 AG-23686, R01 DK-49230, P01 DK-068229, R01 DK-40936, P30 DK-45735, U24 DK-59635, UL1 RR-024139, K23 RR17404, UL1 RR024139]; American Diabetes Association; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024139, K23RR017404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, P01DK068229, P30DK045735, R01DK049230, R01DK040936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023686, R56AG023686] Funding Source: NIH RePORTER	Veterans Administration(US Department of Veterans Affairs); US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); American Diabetes Association(American Diabetes Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were supported by grants from the Veterans Administration Merit Review Award, the US Public Health Service: R01 AG-23686, R01 DK-49230, P01 DK-068229, R01 DK-40936, P30 DK-45735, U24 DK-59635, UL1 RR-024139, K23 RR17404, and UL1 RR024139; and Distinguished Clinical Scientist Awards from the American Diabetes Association (KFP and GIS).	Abbatecola AM, 2004, J AM GERIATR SOC, V52, P399, DOI 10.1111/j.1532-5415.2004.52112.x; Abdelmalek MF, 2007, MED CLIN N AM, V91, P1125, DOI 10.1016/j.mcna.2007.06.001; Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; ANDERSON CM, 1991, J BIOL CHEM, V266, P21760; Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Bajaj M, 2004, J CLIN ENDOCR METAB, V89, P200, DOI 10.1210/jc.2003-031315; Befroy DE, 2007, DIABETES, V56, P1376, DOI 10.2337/db06-0783; BODEN G, 1994, J CLIN INVEST, V93, P2438, DOI 10.1172/JCI117252; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Boden G, 2008, DIABETES, V57, P2438, DOI 10.2337/db08-0604; Boumezbeur F, 2010, J CEREBR BLOOD F MET, V30, P211, DOI 10.1038/jcbfm.2009.197; Brechtel K, 2001, MAGNET RESON MED, V45, P179, DOI 10.1002/1522-2594(200102)45:2<179::AID-MRM1023>3.0.CO;2-D; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Chibalin AV, 2008, CELL, V132, P375, DOI 10.1016/j.cell.2007.12.035; Choi CS, 2007, P NATL ACAD SCI USA, V104, P16480, DOI 10.1073/pnas.0706794104; Choi CS, 2007, J CLIN INVEST, V117, P1995, DOI 10.1172/JCI13579; Ciaraldi TP, 1995, J CLIN INVEST, V96, P2820, DOI 10.1172/JCI118352; Cline GW, 1999, NEW ENGL J MED, V341, P240, DOI 10.1056/NEJM199907223410404; Corbould A, 2005, AM J PHYSIOL-ENDOC M, V288, pE1047, DOI 10.1152/ajpendo.00361.2004; Cree MG, 2004, J CLIN ENDOCR METAB, V89, P3864, DOI 10.1210/jc.2003-031986; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Dresner A, 1999, J CLIN INVEST, V103, P253, DOI 10.1172/JCI5001; Dries DR, 2007, J BIOL CHEM, V282, P826, DOI 10.1074/jbc.C600268200; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Felber JP, 2002, INT J OBESITY, V26, pS39, DOI 10.1038/sj.ijo.0802126; FOLLI F, 1993, J CLIN INVEST, V92, P1787, DOI 10.1172/JCI116768; Garg A, 2004, NEW ENGL J MED, V350, P1220, DOI 10.1056/NEJMra025261; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gastaldelli A, 2004, J CLIN ENDOCR METAB, V89, P3914, DOI 10.1210/jc.2003-031941; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Goudriaan JR, 2003, J LIPID RES, V44, P2270, DOI 10.1194/jlr.M300143-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Hajri T, 2002, J CLIN INVEST, V109, P1381, DOI [10.1172/JCI200214596, 10.1172/JCI0214596]; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Harris MI, 1998, DIABETES CARE, V21, P518, DOI 10.2337/diacare.21.4.518; He SQ, 2010, J BIOL CHEM, V285, P6706, DOI 10.1074/jbc.M109.064501; HENRY RR, 1985, J CLIN ENDOCR METAB, V61, P917, DOI 10.1210/jcem-61-5-917; HENRY RR, 1986, DIABETES, V35, P990, DOI 10.2337/diabetes.35.9.990; Hoehn KL, 2010, CELL METAB, V11, P70, DOI 10.1016/j.cmet.2009.11.008; Hotamisligil GS, 2005, DIABETES, V54, pS73, DOI 10.2337/diabetes.54.suppl_2.S73; Hundal RS, 2002, J CLIN INVEST, V109, P1321, DOI 10.1172/JCI200214955; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Itani SI, 2001, METABOLISM, V50, P553, DOI 10.1053/meta.2001.22512; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Kantartzis K, 2009, DIABETES, V58, P2616, DOI 10.2337/db09-0279; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kim JK, 2000, J CLIN INVEST, V105, P1791, DOI 10.1172/JCI8305; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Kim JK, 2001, J CLIN INVEST, V108, P153, DOI 10.1172/JCI10294; Kim JK, 2001, J CLIN INVEST, V108, P437, DOI 10.1172/JCI11559; Kotronen A, 2008, DIABETOLOGIA, V51, P130, DOI 10.1007/s00125-007-0867-x; Kotronen A, 2009, DIABETOLOGIA, V52, P1056, DOI 10.1007/s00125-009-1285-z; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Krssak M, 2000, J CLIN ENDOCR METAB, V85, P748, DOI 10.1210/jc.85.2.748; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LEWIS RE, 1990, BIOCHEMISTRY-US, V29, P1807, DOI 10.1021/bi00459a020; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Liska D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000569; Liu L, 2007, J CLIN INVEST, V117, P1679, DOI 10.1172/JCI30565; MAGNUSSON I, 1992, J CLIN INVEST, V90, P1323, DOI 10.1172/JCI115997; Marchesini G, 2008, J CLIN ENDOCR METAB, V93, pS74, DOI 10.1210/jc.2008-1399; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Mayerson AB, 2002, DIABETES, V51, P797, DOI 10.2337/diabetes.51.3.797; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Miyazaki Y, 2002, AM J PHYSIOL-ENDOC M, V283, pE1135, DOI 10.1152/ajpendo.0327.2001; Miyazaki Y, 2002, J CLIN ENDOCR METAB, V87, P2784, DOI 10.1210/jc.87.6.2784; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Morino K, 2005, J CLIN INVEST, V115, P3587, DOI 10.1172/JCI25151; Morino K, 2008, DIABETES, V57, P2644, DOI 10.2337/db06-0454; Nakagawa Y, 2007, GERONTOLOGY, V53, P218, DOI 10.1159/000100869; Neschen S, 2006, DIABETES, V55, P924, DOI 10.2337/diabetes.55.04.06.db05-0985; Neschen S, 2002, AM J PHYSIOL-ENDOC M, V282, pE395, DOI 10.1152/ajpendo.00414.2001; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Perseghin G, 1997, DIABETES, V46, P1001, DOI 10.2337/diabetes.46.6.1001; Perseghin G, 1999, DIABETES, V48, P1600, DOI 10.2337/diabetes.48.8.1600; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen KF, 2005, DIABETES, V54, P603, DOI 10.2337/diabetes.54.3.603; PETERSEN KF, 2004, NEW ENGL J MED, V350, P664, DOI [10.1056/NEJMoa031314, DOI 10.1056/NEJMOA031314]; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Petersen KF, 2006, P NATL ACAD SCI USA, V103, P18273, DOI 10.1073/pnas.0608537103; Petersen KF, 2010, NEW ENGL J MED, V362, P1082, DOI 10.1056/NEJMoa0907295; PILLAY TS, 1990, BIOCHEM SOC T, V18, P494, DOI 10.1042/bst0180494; Prentice AM, 2008, INT J OBESITY, V32, P1607, DOI 10.1038/ijo.2008.147; Previs SF, 2000, J BIOL CHEM, V275, P38990, DOI 10.1074/jbc.M006490200; RANDLE PJ, 1963, LANCET, V1, P785; REBRIN K, 1995, DIABETES, V44, P1038, DOI 10.2337/diabetes.44.9.1038; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Rodriguez A, 2005, METABOLISM, V54, P542, DOI 10.1016/j.metabol.2004.11.010; Romeo S, 2008, NAT GENET, V40, P1461, DOI 10.1038/ng.257; ROTHMAN DL, 1992, J CLIN INVEST, V89, P1069, DOI 10.1172/JCI115686; ROTHMAN DL, 1995, P NATL ACAD SCI USA, V92, P983, DOI 10.1073/pnas.92.4.983; SAAD MJA, 1993, J CLIN INVEST, V92, P2065, DOI 10.1172/JCI116803; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2006, J CLIN INVEST, V116, P817, DOI 10.1172/JCI27300; Schenk S, 2007, J CLIN INVEST, V117, P1690, DOI 10.1172/JCI30566; SchmitzPeiffer C, 1997, DIABETES, V46, P169, DOI 10.2337/diabetes.46.2.169; Shepherd PR, 1999, NEW ENGL J MED, V341, P248, DOI 10.1056/NEJM199907223410406; Sherry B, 2004, ARCH PEDIAT ADOL MED, V158, P1116, DOI 10.1001/archpedi.158.12.1116; Shimomura I, 1999, NATURE, V401, P73, DOI 10.1038/43448; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; SHULMAN GI, 2000, J CLIN INVEST, V106, P171, DOI DOI 10.1172/JCI10583; Stahelin RV, 2005, J BIOL CHEM, V280, P19784, DOI 10.1074/jbc.M411285200; Stefan N, 2002, DIABETES, V51, P1884, DOI 10.2337/diabetes.51.6.1884; Stefan N, 2008, ARCH INTERN MED, V168, P1609, DOI 10.1001/archinte.168.15.1609; Stefan N, 2010, DIABETES CARE, V33, P405, DOI [10.2337/dc10-0002, 10.2337/dc09-0544]; STORLIEN LH, 1991, DIABETES, V40, P280, DOI 10.2337/diabetes.40.2.280; TAKAYAMA S, 1988, J BIOL CHEM, V263, P3440; TAYLOR R, 1992, MAGNET RESON MED, V27, P13, DOI 10.1002/mrm.1910270103; Tiikkainen M, 2004, DIABETES, V53, P2169, DOI 10.2337/diabetes.53.8.2169; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Varela GM, 2008, AM J PHYSIOL-GASTR L, V295, pG621, DOI 10.1152/ajpgi.90204.2008; Wang H, 2009, DIABETES, V58, P116, DOI 10.2337/db07-1839; Watson RT, 2007, CELL SIGNAL, V19, P2209, DOI 10.1016/j.cellsig.2007.06.003; Weiss R, 2003, J CLIN ENDOCR METAB, V88, P2014, DOI 10.1210/jc.2002-021711; WHO, 2003, WHO TECH REP SER, V916, P1; WILSON PWF, 1986, AM J MED, V80, P3, DOI 10.1016/0002-9343(86)90532-2; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	138	765	799	2	186	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2267	2277		10.1016/S0140-6736(10)60408-4	http://dx.doi.org/10.1016/S0140-6736(10)60408-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609972	Green Accepted			2022-12-28	WOS:000279652900023
J	Baranowski, T; Adams, L; Baranowski, J; Canada, A; Cullen, KW; Dobbins, MH; Jago, R; Oceguera, A; Rodriguez, AX; Speich, C; Tatum, LT; Thompson, D; White, MA; Williams, CG; Goldberg, L; Cusimano, D; DeBar, L; Elliot, D; Grund, HM; Kuehl, K; McCormick, S; Moe, E; Roullet, JB; Stadler, D; Foster, GD; Brown, J; Creighton, B; Faith, M; Ford, EG; Glick, H; Kumanyika, S; Nachmani, J; Rosen, J; Rosen, L; Sherman, S; Solomon, S; Virus, A; Volpe, SL; Willi, S; Cooper, D; Bassin, S; Bruecker, S; Ford, D; Galassetti, P; Greenfield, S; Hartstein, J; Krause, M; Opgrand, N; Rodriguez, Y; Schneider, M; Harrell, JS; Anderson, A; Blackshear, T; Buse, J; Bridgman, J; Gerstel, A; Giles, C; Hall, W; Jessup, A; Kennel, P; Matthews, R; McMurray, RG; Rubin, D; Siega-Riz, AM; Smith, M; Steckler, A; Stringer, A; Zeveloff, A; Marcus, MD; Carter, M; Clayton, S; Gillis, B; Hindes, K; Jakicic, J; Meehan, R; Noll, R; Songer, T; Vanucci, J; Venditti, EM; Trevino, R; Garcia, A; Hale, D; Hernandez, AE; Hernandez, I; Mobley, C; Murray, T; Surapiboonchai, K; Yin, Z; Kaufman, F; Resnicow, K; Goran, M; Engelgau, M; Wang, LY; Zhang, P; Hirst, K; Drews, KL; Edelstein, S; El Ghormli, L; Firrell, LS; Huang, M; Feit, PK; Mazzuto, SL; Pham, T; Wheeler, A; Linder, B; Hunter, C; Staten, M; Marcovina, SM; Nader, P; Chin, M; Dagogo-Jack, S; Dolan, L; Espeland, M; Pate, R; Schatz, D				Baranowski, T.; Adams, L.; Baranowski, J.; Canada, A.; Cullen, K. W.; Dobbins, M. H.; Jago, R.; Oceguera, A.; Rodriguez, A. X.; Speich, C.; Tatum, L. T.; Thompson, D.; White, M. A.; Williams, C. G.; Goldberg, L.; Cusimano, D.; DeBar, L.; Elliot, D.; Grund, H. M.; Kuehl, K.; McCormick, S.; Moe, E.; Roullet, J. B.; Stadler, D.; Foster, G. D.; Brown, J.; Creighton, B.; Faith, M.; Ford, E. G.; Glick, H.; Kumanyika, S.; Nachmani, J.; Rosen, J.; Rosen, L.; Sherman, S.; Solomon, S.; Virus, A.; Volpe, S. L.; Willi, S.; Cooper, D.; Bassin, S.; Bruecker, S.; Ford, D.; Galassetti, P.; Greenfield, S.; Hartstein, J.; Krause, M.; Opgrand, N.; Rodriguez, Y.; Schneider, M.; Harrell, J. S.; Anderson, A.; Blackshear, T.; Buse, J.; Bridgman, J.; Gerstel, A.; Giles, C.; Hall, W.; Jessup, A.; Kennel, P.; Matthews, R.; McMurray, R. G.; Rubin, D.; Siega-Riz, A. M.; Smith, M.; Steckler, A.; Stringer, A.; Zeveloff, A.; Marcus, M. D.; Carter, M.; Clayton, S.; Gillis, B.; Hindes, K.; Jakicic, J.; Meehan, R.; Noll, R.; Songer, T.; Vanucci, J.; Venditti, E. M.; Trevino, R.; Garcia, A.; Hale, D.; Hernandez, A. E.; Hernandez, I.; Mobley, C.; Murray, T.; Surapiboonchai, K.; Yin, Z.; Kaufman, F.; Resnicow, K.; Goran, M.; Engelgau, M.; Wang, L. Y.; Zhang, P.; Hirst, K.; Drews, K. L.; Edelstein, S.; El Ghormli, L.; Firrell, L. S.; Huang, M.; Feit, P. K.; Mazzuto, S. L.; Pham, T.; Wheeler, A.; Linder, B.; Hunter, C.; Staten, M.; Marcovina, S. M.; Nader, P.; Chin, M.; Dagogo-Jack, S.; Dolan, L.; Espeland, M.; Pate, R.; Schatz, D.		HEALTHY Study Grp	A School-Based Intervention for Diabetes Risk Reduction.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INSULIN-RESISTANCE; GLUCOSE-LEVELS; OBESITY; PREVENTION; RATIONALE; HEALTHY; DESIGN; ADOLESCENTS; PREVALENCE; STRATEGIES	Background: We examined the effects of a multicomponent, school-based program addressing risk factors for diabetes among children whose race or ethnic group and socioeconomic status placed them at high risk for obesity and type 2 diabetes. Methods: Using a cluster design, we randomly assigned 42 schools to either a multicomponent school-based intervention (21 schools) or assessment only (control, 21 schools). A total of 4603 students participated (mean [+/-SD] age, 11.3+/-0.6 years; 54.2% Hispanic and 18.0% black; 52.7% girls). At the beginning of 6th grade and the end of 8th grade, students underwent measurements of body-mass index (BMI), waist circumference, and fasting glucose and insulin levels. Results: There was a decrease in the primary outcome -- the combined prevalence of overweight and obesity -- in both the intervention and control schools, with no significant difference between the school groups. The intervention schools had greater reductions in the secondary outcomes of BMI z score, percentage of students with waist circumference at or above the 90th percentile, fasting insulin levels (P=0.04 for all comparisons), and prevalence of obesity (P=0.05). Similar findings were observed among students who were at or above the 85th percentile for BMI at baseline. Less than 3% of the students who were screened had an adverse event; the proportions were nearly equivalent in the intervention and control schools. Conclusions: Our comprehensive school-based program did not result in greater decreases in the combined prevalence of overweight and obesity than those that occurred in control schools. However, the intervention did result in significantly greater reductions in various indexes of adiposity. These changes may reduce the risk of childhood-onset type 2 diabetes. (Funded by the National Institutes of Health and the American Diabetes Association; ClinicalTrials.gov number, NCT00458029.) N Engl J Med 2010;363:443-53.	[Foster, G. D.] Temple Univ, Ctr Obes Res & Educ, Philadelphia, PA 19140 USA; [Baranowski, T.; Adams, L.; Baranowski, J.; Canada, A.; Cullen, K. W.; Dobbins, M. H.; Jago, R.; Oceguera, A.; Rodriguez, A. X.; Speich, C.; Tatum, L. T.; Thompson, D.; White, M. A.; Williams, C. G.] Baylor Coll Med, Houston, TX 77030 USA; [Goldberg, L.; Cusimano, D.; DeBar, L.; Elliot, D.; Grund, H. M.; Kuehl, K.; McCormick, S.; Moe, E.; Roullet, J. B.; Stadler, D.] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Cooper, D.; Bassin, S.; Bruecker, S.; Ford, D.; Galassetti, P.; Greenfield, S.; Hartstein, J.; Krause, M.; Opgrand, N.; Rodriguez, Y.; Schneider, M.] Univ Calif Irvine, Irvine, CA 92717 USA; [Harrell, J. S.; Anderson, A.; Blackshear, T.; Buse, J.; Bridgman, J.; Gerstel, A.; Giles, C.; Hall, W.; Jessup, A.; Kennel, P.; Matthews, R.; McMurray, R. G.; Rubin, D.; Siega-Riz, A. M.; Smith, M.; Steckler, A.; Stringer, A.; Zeveloff, A.] Univ N Carolina, Chapel Hill, NC USA; [Marcus, M. D.; Carter, M.; Clayton, S.; Gillis, B.; Hindes, K.; Jakicic, J.; Meehan, R.; Noll, R.; Songer, T.; Vanucci, J.; Venditti, E. M.] Univ Pittsburgh, Pittsburgh, PA 15260 USA; [Trevino, R.; Garcia, A.; Hale, D.; Hernandez, A. E.; Hernandez, I.; Mobley, C.; Murray, T.; Surapiboonchai, K.; Yin, Z.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Kaufman, F.] Childrens Hosp Los Angeles, Los Angeles, CA USA; [Resnicow, K.] Univ Michigan, Ann Arbor, MI 48109 USA; [Goran, M.] Univ So Calif, Los Angeles, CA 90089 USA; [Engelgau, M.; Wang, L. Y.; Zhang, P.] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Hirst, K.; Drews, K. L.; Edelstein, S.; El Ghormli, L.; Firrell, L. S.; Huang, M.; Feit, P. K.; Mazzuto, S. L.; Pham, T.; Wheeler, A.] George Washington Univ, Washington, DC 20052 USA; [Marcovina, S. M.] Univ Washington, NW Lipid Metab Lab, Seattle, WA 98195 USA; [Marcovina, S. M.] Univ Washington, Diabet Res Lab, Seattle, WA 98195 USA; [Nader, P.] Univ Calif San Diego, San Diego, CA 92103 USA; [Chin, M.] Univ Chicago, Chicago, IL 60637 USA; [Dagogo-Jack, S.] Univ Tennessee Hlth Sci Ctr, Knoxville, TN 37996 USA; [Dolan, L.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Espeland, M.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Pate, R.] Univ S Carolina, Columbia, SC 29208 USA; [Schatz, D.] Univ Florida, Gainesville, FL 32611 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine; Oregon Health & Science University; University of California System; University of California Irvine; University of North Carolina; University of North Carolina Chapel Hill; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Texas System; University of Texas Health San Antonio; Children's Hospital Los Angeles; University of Michigan System; University of Michigan; University of Southern California; Centers for Disease Control & Prevention - USA; George Washington University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; University of Chicago; University of Tennessee Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; Wake Forest University; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; State University System of Florida; University of Florida	Foster, GD (corresponding author), Temple Univ, Ctr Obes Res & Educ, 3223 N Broad St,Suite 175, Philadelphia, PA 19140 USA.	gfoster@temple.edu	Hernandez, Arthur/K-9322-2019; Bujan, Miren Karmele/F-5542-2014; RUBIN, DANIELA/AAC-4206-2022; Cooper, Dan/AAA-6699-2022; Jago, Russell/ABD-6271-2021; Blackshear, Tara/AAL-9942-2020; Thompson, Debbe/GOV-5741-2022; Buse, John Bernard/J-9742-2019	Jago, Russell/0000-0002-3394-0176; Blackshear, Tara/0000-0002-4908-0609; Thompson, Debbe/0000-0002-5491-8816; Buse, John Bernard/0000-0002-9723-3876; Baranowski, Tom/0000-0002-0653-2222; Willi, Steven/0000-0002-4910-2425; Schneider, Margaret/0000-0002-8314-0732; Songer, Thomas/0000-0002-5253-2514	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health [U01-DK61230, U01-DK61249, U01-DK61231, U01-DK61223]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061230, U01DK061249, U01DK061223, U01DK061231] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by grants (U01-DK61230, U01-DK61249, U01-DK61231, and U01-DK61223) from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health to the Studies to Treat or Prevent Pediatric Type 2 Diabetes (STOPP-T2D) collaborative group, with additional support from the American Diabetes Association.	Baranowski T, 2006, DIABETES CARE, V29, P212; Baranowski T, 2002, AM J HEALTH BEHAV, V26, P486, DOI 10.5993/AJHB.26.6.9; Caballero B, 2003, AM J CLIN NUTR, V78, P1030, DOI 10.1093/ajcn/78.5.1030; Debar LL, 2009, INT J OBESITY, V33, pS52, DOI 10.1038/ijo.2009.117; Diggle P., 2002, ANAL LONGITUDINAL DA, DOI DOI 10.2307/2983303; Drews KL, 2009, INT J OBESITY, V33, pS21, DOI 10.1038/ijo.2009.113; Duncan GE, 2006, ARCH PEDIAT ADOL MED, V160, P523, DOI 10.1001/archpedi.160.5.523; Foster GD, 2008, PEDIATRICS, V121, pE794, DOI 10.1542/peds.2007-1365; Gillis B, 2009, INT J OBESITY, V33, pS29, DOI 10.1038/ijo.2009.114; Gortmaker SL, 1999, ARCH PEDIAT ADOL MED, V153, P409, DOI 10.1001/archpedi.153.4.409; Hannon TS, 2006, PEDIATR RES, V60, P759, DOI 10.1203/01.pdr.0000246097.73031.27; HEALTHY Study Grp, 2009, INT J OBESITY, V33, pS4, DOI 10.1038/ijo.2009.112; Institute of Medicine, 2005, PREV CHILDH OB HLTH; James J, 2004, BMJ-BRIT MED J, V328, P1237, DOI 10.1136/bmj.38077.458438.EE; James J, 2004, BRIT MED J, V328, P1236; Katz DL, 2008, INT J OBESITY, V32, P1780, DOI 10.1038/ijo.2008.158; Kaufman FR, 2009, DIABETES CARE, V32, P953, DOI 10.2337/dc08-1774; KIMM SY, 2002, PEDIATRICS, V110, P54; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Lee S, 2006, J PEDIATR-US, V148, P188, DOI 10.1016/j.jpeds.2005.10.001; Luepker RV, 1996, JAMA-J AM MED ASSOC, V275, P768, DOI 10.1001/jama.275.10.768; McMurray RG, 2009, INT J OBESITY, V33, pS37, DOI 10.1038/ijo.2009.115; Molenberghs G., 2005, MODELS DISCRETE LONG; Murray DM, 1998, DESIGN ANAL GROUP RA; Ogden CL, 2010, JAMA-J AM MED ASSOC, V303, P242, DOI 10.1001/jama.2009.2012; Rosenbaum M, 2007, J CLIN ENDOCR METAB, V92, P504, DOI 10.1210/jc.2006-1516; Schneider M, 2009, INT J OBESITY, V33, pS60, DOI 10.1038/ijo.2009.118; Thompson JW, 2009, PEDIATRICS, V124, pS73, DOI 10.1542/peds.2008-3586J; Trevino, 2005, ARCH PEDIAT ADOL MED, V159, P341; Trevino RP, 2004, ARCH PEDIAT ADOL MED, V158, P911, DOI 10.1001/archpedi.158.9.911; Venditti EM, 2009, INT J OBESITY, V33, pS44, DOI 10.1038/ijo.2009.116; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Weiss R, 2004, NEW ENGL J MED, V350, P2362, DOI 10.1056/NEJMoa031049; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; WHITLOCK EP, 2008, AHRO PUBLICATION	35	241	244	1	42	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 29	2010	363	5					443	453		10.1056/NEJMoa1001933	http://dx.doi.org/10.1056/NEJMoa1001933			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632GS	20581420	Green Accepted, Green Submitted			2022-12-28	WOS:000280411300008
J	Horton, R				Horton, Richard			Science will never be the same again	LANCET			English	Editorial Material							CLIMATE-CHANGE; HEALTH		The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; Haines A, 2007, LANCET, V370, P1264, DOI 10.1016/S0140-6736(07)61257-4; Haines A, 2009, LANCET, V374, P2104, DOI 10.1016/S0140-6736(09)61759-1; PEARCE R, 2010, CLIMATE FILES; [No title captured]	5	5	6	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 17	2010	376	9736					143	144		10.1016/S0140-6736(10)61091-4	http://dx.doi.org/10.1016/S0140-6736(10)61091-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638553				2022-12-28	WOS:000280313100004
J	Viner, RM; Roche, E; Maguire, SA; Nicholls, DE				Viner, Russell M.; Roche, Edna; Maguire, Sabine A.; Nicholls, Dasha E.			Childhood protection and obesity: framework for practice	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SEXUAL-ABUSE; BIRTH COHORT; ADULTHOOD; NEGLECT; CARE; MALTREATMENT; OUTCOMES; CHILDREN; ISSUE; RISK		[Viner, Russell M.] UCL Inst Child Hlth, London WC1N 3EH, England; [Roche, Edna] Univ Dublin Trinity Coll, Dublin 2, Ireland; [Maguire, Sabine A.] Cardiff Univ, Sch Med, Cardiff, Wales; [Nicholls, Dasha E.] Great Ormond St Hosp Sick Children, London, England	University of London; University College London; Trinity College Dublin; Cardiff University; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	Viner, RM (corresponding author), UCL Inst Child Hlth, London WC1N 3EH, England.	rviner@ich.ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247				Alexander SM, 2009, MED J AUSTRALIA, V190, P136, DOI 10.5694/j.1326-5377.2009.tb02313.x; Bentley T, 2009, OBESITY, V17, P1900, DOI 10.1038/oby.2009.160; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Cole A, 2007, BRIT MED J, V334, P1343, DOI 10.1136/bmj.39259.668565.DB; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Edwards C, 2006, EUR J CLIN NUTR, V60, P587, DOI 10.1038/sj.ejcn.1602353; FISHER BA, 2006, DEPAUL L REV, V55, P711; Fitzpatrick M, 2008, BRIT J GEN PRACT, V58, P742, DOI 10.3399/bjgp08X342589; FREEMAN S, 2009, DAILY MAIL      1207; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Greenfield EA, 2009, SOC SCI MED, V68, P791, DOI 10.1016/j.socscimed.2008.12.004; Grilo CM, 2006, OBES SURG, V16, P454, DOI 10.1381/096089206776327288; Hadfield SC, 2008, CHILD CARE HLTH DEV, V34, P710, DOI 10.1111/j.1365-2214.2008.00874.x; HENDERSON M, 2009, TIMES           1207; JEFFREYS B, 2007, BBC NEWS        0614; Kamath CC, 2008, J CLIN ENDOCR METAB, V93, P4606, DOI 10.1210/jc.2006-2411; LISSAU I, 1994, LANCET, V343, P324, DOI 10.1016/S0140-6736(94)91163-0; Lobstein T, 2007, TACKLING OBESITIES F; Mamun AA, 2007, OBESITY, V15, P2103, DOI 10.1038/oby.2007.250; Pinhas-Hamiel O, 2009, ACTA PAEDIATR, V98, P144, DOI 10.1111/j.1651-2227.2008.01044.x; ROBERTS B, 2008, MIRROR          1008; SHERMAN J, 2008, TIMES           0816; Varness T, 2009, PEDIATRICS, V123, P399, DOI 10.1542/peds.2008-0712; Viner R, 2005, ARCH DIS CHILD, V90, P385, DOI 10.1136/adc.2004.062224; Viner RM, 2005, BRIT MED J, V330, P1354, DOI 10.1136/bmj.38453.422049.E0; Whitaker RC, 2007, CHILD ABUSE NEGLECT, V31, P1187, DOI 10.1016/j.chiabu.2007.04.008	27	21	21	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2010	341								c3074	10.1136/bmj.c3074	http://dx.doi.org/10.1136/bmj.c3074			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XD	20634344	Green Accepted			2022-12-28	WOS:000280156800001
J	Kroenke, K; Theobald, D; Wu, JW; Norton, K; Morrison, G; Carpenter, J; Tu, WZ				Kroenke, Kurt; Theobald, Dale; Wu, Jingwei; Norton, Kelli; Morrison, Gwendolyn; Carpenter, Janet; Tu, Wanzhu			Effect of Telecare Management on Pain and Depression in Patients With Cancer A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRIMARY-CARE PATIENTS; COGNITIVE-BEHAVIORAL INTERVENTION; LONGER-TERM OUTCOMES; FORM HEALTH SURVEY; STAR-ASTERISK-D; COLLABORATIVE CARE; MENTAL-HEALTH; MUSCULOSKELETAL PAIN; SYMPTOM MANAGEMENT; ANXIETY DISORDERS	Context Pain and depression are 2 of the most prevalent and treatable cancer-related symptoms, yet they frequently go unrecognized, undertreated, or both. Objective To determine whether centralized telephone-based care management coupled with automated symptom monitoring can improve depression and pain in patients with cancer. Design, Setting, and Patients Randomized controlled trial conducted in 16 community-based urban and rural oncology practices involved in the Indiana Cancer Pain and Depression (INCPAD) trial. Recruitment occurred from March 2006 through August 2008 and follow-up concluded in August 2009. The participating patients had depression (Patient Health Questionnaire-9 score >= 10), cancer-related pain (Brief Pain Inventory [BPI] worst pain score >= 6), or both. Intervention The 202 patients randomly assigned to receive the intervention and 203 to receive usual care were stratified by symptom type. Patients in the intervention group received centralized telecare management by a nurse-physician specialist team coupled with automated home-based symptom monitoring by interactive voice recording or Internet. Main Outcome Measures Blinded assessment at baseline and at months 1, 3, 6, and 12 for depression (20-item Hopkins Symptom Checklist [HSCL-20]) and pain (BPI) severity. Results Of the 405 participants enrolled in the study, 131 had depression only, 96 had pain only, and 178 had both depression and pain. Of the 274 patients with pain, 137 patients in the intervention group had greater improvements in BPI pain severity over the 12 months of the trial whether measured as a continuous severity score or as a categorical pain responder (>= 30% decrease in BPI) than the 137 patients in the usual-care group (P<.001 for both). Similarly, of the 309 patients with depression, the 154 patients in the intervention group had greater improvements in HSCL-20 depression severity over the 12 months of the trial whether measured as a continuous severity score or as a categorical depression responder (>= 50% decrease in HSCL) than the 155 patients in the usual care group (P<.001 for both). The standardized effect size for between-group differences at 3 and 12 months was 0.67 (95% confidence interval [CI], 0.33-1.02) and 0.39 (95% CI, 0.01-0.77) for pain, and 0.42 (95% CI, 0.16-0.69) and 0.41 (95% CI, 0.08-0.72) for depression. Conclusion Centralized telecare management coupled with automated symptom monitoring resulted in improved pain and depression outcomes in cancer patients receiving care in geographically dispersed urban and rural oncology practices.	[Kroenke, Kurt; Norton, Kelli; Morrison, Gwendolyn; Tu, Wanzhu] Regenstrief Inst Inc, Indianapolis, IN 46202 USA; [Theobald, Dale] Community Canc Care, Indianapolis, IN USA; [Theobald, Dale] Community Hlth Network, Indianapolis, IN USA; [Kroenke, Kurt] Richard Roudebush VA Med Ctr, Ctr Implementing Evidence Based Practice, Indianapolis, IN USA; [Kroenke, Kurt; Wu, Jingwei; Tu, Wanzhu] Indiana Univ, Dept Med, Indianapolis, IN USA; [Carpenter, Janet] Indiana Univ, Sch Nursing, Indianapolis, IN 46204 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Kroenke, K (corresponding author), Regenstrief Inst Inc, 6th Floor,1050 Wishard Blvd, Indianapolis, IN 46202 USA.	kkroenke@regenstrief.org	Wu, Jing/GZK-5063-2022	Kroenke, Kurt/0000-0002-0114-4669	Eli Lilly; Pfizer; National Cancer Institute [R01 CA-115369]; NATIONAL CANCER INSTITUTE [R01CA115369] Funding Source: NIH RePORTER	Eli Lilly(Eli Lilly); Pfizer(Pfizer); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr Kroenke reported receiving research funding from Eli Lilly and Pfizer, and honoraria as a speaker, consultant, or advisory board member from Eli Lilly, Pfizer, and Forest Laboratories. No other authors reported disclosures.; This study was supported by grant R01 CA-115369 from the National Cancer Institute (Dr Kroenke).	*AM MED ASS, 2004, PAIN MAN 4; [Anonymous], 1991, EFFECT CANC QUALITY; Bookbinder M, 1996, J PAIN SYMPTOM MANAG, V12, P334, DOI 10.1016/S0885-3924(96)00204-7; Bottomley A, 1998, Eur J Cancer Care (Engl), V7, P181; Callahan CM, 2002, MED CARE, V40, P771, DOI 10.1097/00005650-200209000-00007; Caraceni A, 1999, PAIN, V82, P263, DOI 10.1016/S0304-3959(99)00073-1; CARR D, 2002, AHRQ PUBLICATION; Cintron A, 2006, J PALLIAT MED, V9, P1454, DOI 10.1089/jpm.2006.9.1454; CLEELAND CS, 1994, NEW ENGL J MED, V330, P592, DOI 10.1056/NEJM199403033300902; Cleeland CS, 1998, JAMA-J AM MED ASSOC, V279, P1914, DOI 10.1001/jama.279.23.1914; Cleeland CS, 1989, ADV PAIN RES THER, P391, DOI DOI 10.1093/BRAIN/113.5.1589; Coleman K, 2009, ANNU REV PUBL HEALTH, V30, P385, DOI 10.1146/annurev.publhealth.031308.100249; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Dobscha SK, 2009, JAMA-J AM MED ASSOC, V301, P1242, DOI 10.1001/jama.2009.377; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Ell K, 2008, J CLIN ONCOL, V26, P4488, DOI 10.1200/JCO.2008.16.6371; Fallowfield L, 2001, BRIT J CANCER, V84, P1011, DOI 10.1054/bjoc.2001.1724; Fann JR, 2009, J GEN INTERN MED, V24, P417, DOI 10.1007/s11606-009-0999-4; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Given C, 2004, J CLIN ONCOL, V22, P507, DOI 10.1200/JCO.2004.01.241; Given CW, 2001, J PAIN SYMPTOM MANAG, V21, P456, DOI 10.1016/S0885-3924(01)00284-6; GIVEN CW, 1994, CANCER, V74, P2128, DOI 10.1002/1097-0142(19941001)74:7+<2128::AID-CNCR2820741721>3.0.CO;2-J; Katon W, 1999, ARCH GEN PSYCHIAT, V56, P1109, DOI 10.1001/archpsyc.56.12.1109; KAZIS LE, 1989, MED CARE, V27, pS178, DOI 10.1097/00005650-198903001-00015; Keller MB, 2003, JAMA-J AM MED ASSOC, V289, P3152, DOI 10.1001/jama.289.23.3152; KELLER MB, 1996, WHO TECHNICAL REPORT, V804; Kroenke K, 2001, JAMA-J AM MED ASSOC, V286, P2947, DOI 10.1001/jama.286.23.2947; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2007, GEN HOSP PSYCHIAT, V29, P506, DOI 10.1016/j.genhosppsych.2007.08.005; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2009, GEN HOSP PSYCHIAT, V31, P240, DOI 10.1016/j.genhosppsych.2009.01.007; Kroenke K, 2009, JAMA-J AM MED ASSOC, V301, P2099, DOI 10.1001/jama.2009.723; Kurtz ME, 2001, CANCER PRACT, V9, P11, DOI 10.1046/j.1523-5394.2001.91004.x; Kurtz ME, 2002, SUPPORT CARE CANCER, V10, P494, DOI 10.1007/s00520-001-0338-8; Kurtz ME, 1999, WOMEN HEALTH, V29, P1, DOI 10.1300/J013v29n03_01; Lesser IM, 2007, MED CARE, V45, P1043, DOI 10.1097/MLR.0b013e3181271462; Mallinckrodt CH, 2001, DRUG INF J, V35, P1215, DOI 10.1177/009286150103500418; MCHORNEY CA, 1993, MED CARE, V31, P247, DOI 10.1097/00005650-199303000-00006; Passik SD, 1998, J CLIN ONCOL, V16, P1594, DOI 10.1200/JCO.1998.16.4.1594; Portenoy RK, 1999, LANCET, V353, P1695, DOI 10.1016/S0140-6736(99)01310-0; Rollman BL, 2009, JAMA-J AM MED ASSOC, V302, P2095, DOI 10.1001/jama.2009.1670; Rost K, 2001, J GEN INTERN MED, V16, P143, DOI 10.1111/j.1525-1497.2001.00537.x; Rush AJ, 2006, AM J PSYCHIAT, V163, P1905, DOI 10.1176/appi.ajp.163.11.1905; Sharpe M, 2004, BRIT J CANCER, V90, P314, DOI 10.1038/sj.bjc.6601578; Sheehan DV, 1996, INT CLIN PSYCHOPHARM, V11, P89, DOI 10.1097/00004850-199606003-00015; Sherwood P, 2005, ONCOL NURS FORUM, V32, P1190, DOI 10.1188/05.ONF.1190-1198; Sikorskii A, 2007, J PAIN SYMPTOM MANAG, V34, P253, DOI 10.1016/j.jpainsymman.2006.11.018; Simon GE, 2004, JAMA-J AM MED ASSOC, V292, P935, DOI 10.1001/jama.292.8.935; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Stommel M, 2002, CANCER-AM CANCER SOC, V94, P2719, DOI 10.1002/cncr.10533; Strong V, 2008, LANCET, V372, P40, DOI 10.1016/S0140-6736(08)60991-5; Unutzer J, 2001, MED CARE, V39, P785, DOI 10.1097/00005650-200108000-00005; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; WAGNER EH, 1993, J AM GERIATR SOC, V41, P241, DOI 10.1111/j.1532-5415.1993.tb06700.x; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; Williams JW, 2007, GEN HOSP PSYCHIAT, V29, P91, DOI 10.1016/j.genhosppsych.2006.12.003; Williams LS, 2007, STROKE, V38, P998, DOI 10.1161/01.STR.0000257319.14023.61; Williams LS, 2004, NEUROLOGY, V63, P674, DOI 10.1212/01.WNL.0000134669.05005.95; 2004, CANC PAIN VERSION 1	60	218	222	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					163	171		10.1001/jama.2010.944	http://dx.doi.org/10.1001/jama.2010.944			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624IN	20628129	Green Accepted			2022-12-28	WOS:000279811000022
J	MacKay, C; Declais, AC; Lundin, C; Agostinho, A; Deans, AJ; MacArtney, TJ; Hofmann, K; Gartner, A; West, SC; Helleday, T; Lilley, DMJ; Rouse, J				MacKay, Craig; Declais, Anne-Cecile; Lundin, Cecilia; Agostinho, Ana; Deans, Andrew J.; MacArtney, Thomas J.; Hofmann, Kay; Gartner, Anton; West, Stephen C.; Helleday, Thomas; Lilley, David M. J.; Rouse, John			Identification of KIAA1018/FAN1, a DNA Repair Nuclease Recruited to DNA Damage by Monoubiquitinated FANCD2	CELL			English	Article							HOLLIDAY JUNCTION RESOLVASE; FANCONI-ANEMIA; CROSS-LINKS; REPLICATION; PROTEIN; ACTIVATION; KINETICS; DOMAINS; FAAP24; BRCA1	DNA interstrand crosslinks (ICLs) are highly toxic because they block the progression of replisomes. The Fanconi Anemia (FA) proteins, encoded by genes that are mutated in FA, are important for repair of ICLs. The FA core complex catalyzes the monoubiquitination of FANCD2, and this event is essential for several steps of ICL repair. However, how monoubiquitination of FANCD2 promotes ICL repair at the molecular level is unknown. Here, we describe a highly conserved protein, KIAA1018/MTMR15/FAN1, that interacts with, and is recruited to sites of DNA damage by, the monoubiquitinated form of FANCD2. FAN1 exhibits endonuclease activity toward 50 flaps and has 5' exonuclease activity, and these activities are mediated by an ancient VRR_nuc domain. Depletion of FAN1 from human cells causes hypersensitivity to ICLs, defects in ICL repair, and genome instability. These data at least partly explain how ubiquitination of FANCD2 promotes DNA repair.	[MacKay, Craig; MacArtney, Thomas J.; Rouse, John] Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland; [MacKay, Craig; Lilley, David M. J.] Univ Dundee, Coll Life Sci, CRUK Nucle Acids Struct Res Grp, Dundee DD1 5EH, Scotland; [Agostinho, Ana; Gartner, Anton] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee DD1 5EH, Scotland; [Lundin, Cecilia; Helleday, Thomas] Univ Oxford, Gray Inst Radiat Oncol & Biol, Oxford OX3 7DQ, England; [Hofmann, Kay] Miltenyi Biotec GmbH, D-51429 Bergisch Gladbach, Germany; [Deans, Andrew J.; West, Stephen C.] Canc Res UK, London Res Inst, Clare Hall Labs, S Mimms EN6 3LD, Herts, England; [Helleday, Thomas] Stockholm Univ, Dept Genet Microbiol & Toxicol, S-10691 Stockholm, Sweden	University of Dundee; University of Dundee; University of Dundee; University of Oxford; Miltenyi Biotec; Cancer Research UK; Stockholm University	Rouse, J (corresponding author), Univ Dundee, Coll Life Sci, MRC, Prot Phosphorylat Unit, Dundee DD1 5EH, Scotland.	j.rouse@dundee.ac.uk	Deans, Andrew/U-3515-2019; Deans, Andrew J/E-5817-2011; Helleday, Thomas/D-5224-2013; Hofmann, Kay/D-6714-2011	Deans, Andrew/0000-0002-5271-4422; Deans, Andrew J/0000-0002-5271-4422; Hofmann, Kay/0000-0002-2289-9083; Declais, Anne-Cecile/0000-0002-1904-6469; Gartner, Anton/0000-0003-4639-9902; Helleday, Thomas/0000-0002-7384-092X; Agostinho, Ana/0000-0001-6270-7384; West, Stephen/0000-0001-8848-9418	UK Medical Research Council; Cancer Research UK; Fanconi Anemia Research Fund; Biotechnology and Biological Sciences Research Council [BB/E001777/1] Funding Source: researchfish; Cancer Research UK [11582] Funding Source: researchfish; Medical Research Council [MC_U127070192, G0700730] Funding Source: researchfish; BBSRC [BB/E001777/1] Funding Source: UKRI; MRC [MC_U127070192, G0700730] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Fanconi Anemia Research Fund; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to Katja Kratz and Joe Jiricny for experimental advice, for helping us with the purification of FAN1, and for communicating results prior to publication. We thank K.J. Patel, Johan de Winter, and Maureen Hoatlin for kind gifts of antibodies. pDEST40-V5-FANCD2 wild-type and pDEST40-V5-FANCD2 K561R plasmids were kind gifts from Niall Howlett and Thomas Glover. We thank Alan d'Andrea for the kind gifts of FANCD2<SUP>-/-</SUP> fibroblasts (PD20 cells) corrected with vector, FANCD2 wild-type, or FANCD2 K561R. We are grateful to James Hastie, Hilary MacLauchlan, and the Antibody Production Team at Division of Signal Transduction Therapy, University of Dundee, to Bob Gourlay, Sanjay Kothiya, and Nick Morrice for help with mass spectrometry, and to the DNA Sequencing Service at the College of Life Sciences (CLS), University of Dundee. We are grateful to the microscopy facility, CLS, University of Dundee for assistance with microscopy. We thank Jim Haber and the J.R. lab for critical reading of the manuscript. This work was funded by the UK Medical Research Council (C.M., T.J.H., and J.R.), Cancer Research UK (A.C.D, A.G., and D.M.J.L.), and the Fanconi Anemia Research Fund (A.J.D. and S.C.W.).	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bhagwat N, 2009, MOL CELL BIOL, V29, P6427, DOI 10.1128/MCB.00086-09; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; BRENNER S, 1974, GENETICS, V77, P71; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2007, MOL CELL, V25, P331, DOI 10.1016/j.molcel.2007.01.003; Collis SJ, 2008, MOL CELL, V32, P313, DOI 10.1016/j.molcel.2008.10.014; Deans AJ, 2009, MOL CELL, V36, P943, DOI 10.1016/j.molcel.2009.12.006; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Hanada K, 2007, NAT STRUCT MOL BIOL, V14, P1096, DOI 10.1038/nsmb1313; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Iyer LM, 2006, CELL CYCLE, V5, P775, DOI 10.4161/cc.5.7.2629; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Leskovac A, 2010, TOHOKU J EXP MED, V221, P69, DOI 10.1620/tjem.221.69; Ling C, 2007, EMBO J, V26, P2104, DOI 10.1038/sj.emboj.7601666; Mccabe KM, 2009, J CELL PHYSIOL, V220, P569, DOI 10.1002/jcp.21811; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Munoz IM, 2009, MOL CELL, V35, P116, DOI 10.1016/j.molcel.2009.06.020; Nakanishi K, 2005, P NATL ACAD SCI USA, V102, P1110, DOI 10.1073/pnas.0407796102; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Swann PF, 1996, SCIENCE, V273, P1109, DOI 10.1126/science.273.5278.1109; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159	32	230	238	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					65	76		10.1016/j.cell.2010.06.021	http://dx.doi.org/10.1016/j.cell.2010.06.021			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603015	Bronze, Green Accepted			2022-12-28	WOS:000279637300013
J	Jordan, KD; Johnson, MA				Jordan, Kenneth D.; Johnson, Mark A.			Downsizing the Hydrated Electron's Lair	SCIENCE			English	Editorial Material							WATER; SPECTRUM; CLUSTER		[Jordan, Kenneth D.] Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA; [Johnson, Mark A.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yale University	Jordan, KD (corresponding author), Univ Pittsburgh, Dept Chem, Pittsburgh, PA 15260 USA.	jordan@pitt.edu; mark.johnson@yale.edu						Choi TH, 2009, CHEM PHYS LETT, V475, P293, DOI 10.1016/j.cplett.2009.05.059; Hammer NI, 2004, SCIENCE, V306, P675, DOI 10.1126/science.1102792; KEVAN L, 1981, ACCOUNTS CHEM RES, V14, P138, DOI 10.1021/ar00065a002; Ma L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3245859; MARSELEK O, UNPUB; PLATZMAN RL, 1953, US NATL ACAD SCI PUB, V305, P34; Roscioli JR, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2827475; SCHNITKER J, 1988, PHYS REV LETT, V60, P456, DOI 10.1103/PhysRevLett.60.456; Turi L, 2005, SCIENCE, V310, DOI 10.1126/science.1119314; Verlet JRR, 2005, SCIENCE, V310, P1769, DOI 10.1126/science.1119113; Yokoyama K, 1998, J PHYS CHEM A, V102, P6957, DOI 10.1021/jp981809p	13	27	28	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					42	43		10.1126/science.1191707	http://dx.doi.org/10.1126/science.1191707			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595604				2022-12-28	WOS:000279402700023
J	Hotchkiss, RS; Opal, S				Hotchkiss, Richard S.; Opal, Steven			Immunotherapy for Sepsis - A New Approach against an Ancient Foe	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA; [Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63130 USA; [Opal, Steven] Mem Hosp Rhode Isl, Div Infect Dis, Providence, RI USA; [Opal, Steven] Brown Univ, Alpert Med Sch, Providence, RI 02912 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Brown University	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63130 USA.				NIGMS NIH HHS [R01 GM044118] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044118] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Huang X, 2009, P NATL ACAD SCI USA, V106, P6303, DOI 10.1073/pnas.0809422106; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Opal SM, 2009, JAMA-J AM MED ASSOC, V302, P2367, DOI 10.1001/jama.2009.1774; Said EA, 2010, NAT MED, V16, P452, DOI 10.1038/nm.2106	5	268	303	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					87	89		10.1056/NEJMcibr1004371	http://dx.doi.org/10.1056/NEJMcibr1004371			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592301	Green Published, Green Accepted			2022-12-28	WOS:000279343000016
J	Maeda, K; Benetti, S; Stritzinger, M; Ropke, FK; Folatelli, G; Sollerman, J; Taubenberger, S; Nomoto, K; Leloudas, G; Hamuy, M; Tanaka, M; Mazzali, PA; Elias-Rosa, N				Maeda, K.; Benetti, S.; Stritzinger, M.; Roepke, F. K.; Folatelli, G.; Sollerman, J.; Taubenberger, S.; Nomoto, K.; Leloudas, G.; Hamuy, M.; Tanaka, M.; Mazzali, P. A.; Elias-Rosa, N.			An asymmetric explosion as the origin of spectral evolution diversity in type Ia supernovae	NATURE			English	Article							DETONATION MODEL; NUCLEOSYNTHESIS; IGNITION; DECLINE; 1991BG	Type Ia supernovae form an observationally uniform class of stellar explosions, in that more luminous objects have smaller decline-rates(1). This one-parameter behaviour allows type Ia supernovae to be calibrated as cosmological 'standard candles', and led to the discovery of an accelerating Universe(2,3). Recent investigations, however, have revealed that the true nature of type Ia supernovae is more complicated. Theoretically, it has been suggested(4-8) that the initial thermonuclear sparks are ignited at an offset from the centre of the white-dwarf progenitor, possibly as a result of convection before the explosion(4). Observationally, the diversity seen in the spectral evolution of type Ia supernovae beyond the luminosity-decline-rate relation is an unresolved issue(9,10). Here we report that the spectral diversity is a consequence of random directions from which an asymmetric explosion is viewed. Our findings suggest that the spectral evolution diversity is no longer a concern when using type Ia supernovae as cosmological standard candles. Furthermore, this indicates that ignition at an offset from the centre is a generic feature of type Ia supernovae.	[Maeda, K.; Nomoto, K.; Tanaka, M.] Univ Tokyo, IPMU, Chiba 2778583, Japan; [Benetti, S.] INAF Osservatorio Astron Padova, I-35122 Padua, Italy; [Stritzinger, M.] Las Campanas Observ, Carnegie Inst Sci, La Serena, Chile; [Stritzinger, M.; Sollerman, J.; Leloudas, G.] Univ Copenhagen, Niels Bohr Inst, Dark Cosmol Ctr, DK-2100 Copenhagen O, Denmark; [Roepke, F. K.; Taubenberger, S.; Mazzali, P. A.] Max Planck Inst Astrophys, D-85741 Garching, Germany; [Folatelli, G.; Hamuy, M.] Univ Chile, Dept Astron, Santiago, Chile; [Sollerman, J.] Stockholm Univ, Dept Astron, Oskar Klein Ctr, S-10691 Stockholm, Sweden; [Mazzali, P. A.] Scuola Normale Super Pisa, I-56127 Pisa, Italy; [Elias-Rosa, N.] CALTECH, Spitzer Sci Ctr, Pasadena, CA 91125 USA	University of Tokyo; Istituto Nazionale Astrofisica (INAF); Carnegie Institution for Science; University of Copenhagen; Niels Bohr Institute; Max Planck Society; Universidad de Chile; Oskar Klein Centre; Stockholm University; Scuola Normale Superiore di Pisa; California Institute of Technology	Maeda, K (corresponding author), Univ Tokyo, IPMU, 5-1-5 Kashiwanoha, Chiba 2778583, Japan.	keiichi.maeda@ipmu.jp	Elias-Rosa, Nancy/D-3759-2014; Tanaka, Masaomi/A-4354-2011; Hamuy, Mario/G-7541-2016; Folatelli, Gaston/A-4484-2011; Leloudas, Giorgos/E-4470-2015	Elias-Rosa, Nancy/0000-0002-1381-9125; Benetti, Stefano/0000-0002-3256-0016; Ropke, Friedrich/0000-0002-4460-0097; Mazzali, Paolo/0000-0001-6876-8284; Folatelli, Gaston/0000-0001-5247-1486; Leloudas, Giorgos/0000-0002-8597-0756; Maeda, Keiichi/0000-0003-2611-7269; stritzinger, maximilian/0000-0002-5571-1833; Sollerman, Jesper/0000-0003-1546-6615	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan; JSPS; ASI; National Science Foundation; German Research Foundation; Cluster of Excellence 'Origin and Structure of the Universe'; Iniciativa Cientifica Milenio; CONICYT; Knut and Alice Wallenberg Foundation; Transregional Collaborative Research Centre; Danish National Research Foundation	World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ASI(Agenzia Spaziale Italiana (ASI)); National Science Foundation(National Science Foundation (NSF)); German Research Foundation(German Research Foundation (DFG)); Cluster of Excellence 'Origin and Structure of the Universe'; Iniciativa Cientifica Milenio; CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Transregional Collaborative Research Centre; Danish National Research Foundation(Danmarks Grundforskningsfond)	We thank W. Hillebrandt for discussions. This study is partly based on observations obtained at the Gemini Observatory, Chile (GS-2009B-Q-8, GS-2008B-Q-32/40/46), the Magellan Telescopes, Chile, and by ESO Telescopes at the La Silla or Paranal Observatories under programme 080.A-0516. This research made use of the SUSPECT archive, at the Department of Physics and Astronomy, University of Oklahoma. This work was supported by World Premier International Research Center Initiative (WPI Initiative), MEXT, Japan. K. M. was supported by a JSPS Grant-in-Aid for young scientists; S. B. acknowledges partial support from ASI contracts 'COFIS'; M. S. was supported by the National Science Foundation; F. K. R. was supported through the Emmy Noether Program of the German Research Foundation and by the Cluster of Excellence 'Origin and Structure of the Universe'; G. F. and M. H. acknowledge support from Iniciativa Cientifica Milenio and CONICYT programmes FONDECYT/FONDAP/BASAL; J.S. is a Royal Swedish Academy of Sciences Research Fellow supported by the Knut and Alice Wallenberg Foundation; and S. T. acknowledges support from the Transregional Collaborative Research Centre under the programme 'The dark Universe'. The Dark Cosmology Centre is funded by the Danish National Research Foundation.	Altavilla G, 2007, ASTRON ASTROPHYS, V475, P585, DOI 10.1051/0004-6361:20077487; Benetti S, 2004, MON NOT R ASTRON SOC, V348, P261, DOI 10.1111/j.1365-2966.2004.07357.x; Benetti S, 2005, ASTROPHYS J, V623, P1011, DOI 10.1086/428608; BRANCH D, 1993, ASTRON J, V106, P2383, DOI 10.1086/116810; BRANCH D, 1988, ASTROPHYS J, V330, pL117, DOI 10.1086/185217; Cappellaro E, 2001, ASTROPHYS J, V549, pL215, DOI 10.1086/319178; FILIPPENKO AV, 1992, ASTRON J, V104, P1543, DOI 10.1086/116339; FINK M, 2010, ASTRON ASTROPH UNPUB; Hoflich P, 1996, ASTROPHYS J, V472, pL81, DOI 10.1086/310363; Iwamoto K, 1999, ASTROPHYS J SUPPL S, V125, P439, DOI 10.1086/313278; Jha S, 1999, ASTROPHYS J SUPPL S, V125, P73, DOI 10.1086/313275; Jordan GC, 2008, ASTROPHYS J, V681, P1448, DOI 10.1086/588269; Kasen D, 2009, NATURE, V460, P869, DOI 10.1038/nature08256; KHOKHLOV AM, 1991, ASTRON ASTROPHYS, V245, P114; Kuhlen M, 2006, ASTROPHYS J, V640, P407, DOI 10.1086/500105; Maeda K, 2010, ASTROPHYS J, V712, P624, DOI 10.1088/0004-637X/712/1/624; Maeda K, 2010, ASTROPHYS J, V708, P1703, DOI 10.1088/0004-637X/708/2/1703; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; MORRELL N, 2007, CENT BUR ELECT TELEG, V1131; Neill JD, 2009, ASTROPHYS J, V707, P1449, DOI 10.1088/0004-637X/707/2/1449; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Perlmutter S, 1999, ASTROPHYS J, V517, P565, DOI 10.1086/307221; Riess AG, 1998, ASTRON J, V116, P1009, DOI 10.1086/300499; Ropke FK, 2007, ASTROPHYS J, V660, P1344, DOI 10.1086/512769; Stehle M, 2005, MON NOT R ASTRON SOC, V360, P1231, DOI 10.1111/j.1365-2966.2005.09116.x; Turatto M, 1996, MON NOT R ASTRON SOC, V283, P1; Wang LF, 2007, SCIENCE, V315, P212, DOI 10.1126/science.1121656; Wang X, 2009, ASTROPHYS J LETT, V699, pL139, DOI 10.1088/0004-637X/699/2/L139; WOOSLEY SE, 1986, ANNU REV ASTRON ASTR, V24, P205, DOI 10.1146/annurev.aa.24.090186.001225	30	190	190	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					82	85		10.1038/nature09122	http://dx.doi.org/10.1038/nature09122			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596015	Green Submitted			2022-12-28	WOS:000279343800038
J	Biertumpfel, C; Zhao, Y; Kondo, Y; Ramon-Maiques, S; Gregory, M; Lee, JY; Masutani, C; Lehmann, AR; Hanaoka, F; Yang, W				Biertuempfel, Christian; Zhao, Ye; Kondo, Yuji; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Masutani, Chikahide; Lehmann, Alan R.; Hanaoka, Fumio; Yang, Wei			Structure and mechanism of human DNA polymerase eta	NATURE			English	Article							SYN THYMINE DIMER; TRANSLESION SYNTHESIS; CRYSTAL-STRUCTURE; MOLECULAR ANALYSIS; BYPASS; LESION; RECOGNITION; REPLICATION; MUTATIONS; CISPLATIN	The variant form of the human syndrome xeroderma pigmentosum (XPV) is caused by a deficiency in DNA polymerase eta (Pol eta), a DNA polymerase that enables replication through ultraviolet-induced pyrimidine dimers. Here we report high-resolution crystal structures of human Pol eta at four consecutive steps during DNA synthesis through cis-syn cyclobutane thymine dimers. Pol eta acts like a 'molecular splint' to stabilize damaged DNA in a normal B-form conformation. An enlarged active site accommodates the thymine dimer with excellent stereochemistry for two-metal ion catalysis. Two residues conserved among Pol eta orthologues form specific hydrogen bonds with the lesion and the incoming nucleotide to assist translesion synthesis. On the basis of the structures, eight Pol eta missense mutations causing XPV can be rationalized as undermining the molecular splint or perturbing the active-site alignment. The structures also provide an insight into the role of Pol eta in replicating through D loop and DNA fragile sites.	[Biertuempfel, Christian; Zhao, Ye; Ramon-Maiques, Santiago; Gregory, Mark; Lee, Jae Young; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Zhao, Ye] Zhejiang Univ, Inst Nucl Agr Sci, Hangzhou 310029, Zhejiang, Peoples R China; [Kondo, Yuji; Masutani, Chikahide; Hanaoka, Fumio] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Lehmann, Alan R.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Hanaoka, Fumio] Gakushuin Univ, Fac Sci, Toshima Ku, Tokyo 1718588, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Zhejiang University; Osaka University; University of Sussex; Gakushuin University	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, 9000 Rockville Pike,Bldg 5,Room B103, Bethesda, MD 20892 USA.	fumio.hanaoka@gakushuin.ac.jp; wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020; Zhao, Ye/I-2936-2014; Masutani, Chikahide/I-6160-2014; Ramon-Maiques, Santiago/R-2533-2019	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195; Zhao, Ye/0000-0002-5455-2586; Biertumpfel, Christian/0000-0002-7528-6547; Ramon-Maiques, Santiago/0000-0001-9674-8088; Masutani, Chikahide/0000-0002-8600-8227	NIDDK, NIH; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Chinese Ministry of Education; NIH-Zhejiang University; Human Frontiers Science Program; MRC [G0501450] Funding Source: UKRI; Medical Research Council [G0501450, G0801130B] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036146, ZIADK036119] Funding Source: NIH RePORTER	NIDDK, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Chinese Ministry of Education(Ministry of Education, China); NIH-Zhejiang University; Human Frontiers Science Program(Human Frontier Science Program); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Leahy, M. Gellert and R. Craigie for critical reading of the manuscript. The research was funded by the intramural research program of NIDDK, NIH, and grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. Y.Z. is the recipient of a Chinese Ministry of Education scholarship and joint PhD student in NIH-Zhejiang University Graduate Partnership Program. S.R.-M. received a fellowship from the Human Frontiers Science Program.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bassett E, 2003, BIOCHEMISTRY-US, V42, P14197, DOI 10.1021/bi035359p; Bauer J, 2007, P NATL ACAD SCI USA, V104, P14905, DOI 10.1073/pnas.0700717104; Brash DE, 1997, TRENDS GENET, V13, P410, DOI 10.1016/S0168-9525(97)01246-8; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Broyde S, 2008, TRENDS BIOCHEM SCI, V33, P209, DOI 10.1016/j.tibs.2008.02.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Bugreev DV, 2007, NAT STRUCT MOL BIOL, V14, P746, DOI 10.1038/nsmb1268; Chaney SG, 2005, CRIT REV ONCOL HEMAT, V53, P3, DOI 10.1016/j.critrevonc.2004.08.008; Creighton S, 1995, METHOD ENZYMOL, V262, P232; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Lucca J, 2009, EUR J CANCER, V45, P3228, DOI 10.1016/j.ejca.2009.04.034; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Glick E, 2001, EMBO J, V20, P7303, DOI 10.1093/emboj/20.24.7303; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; Hishida T, 2009, NATURE, V457, P612, DOI 10.1038/nature07580; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; Jia L, 2008, NUCLEIC ACIDS RES, V36, P6571, DOI 10.1093/nar/gkn719; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kawamoto T, 2005, MOL CELL, V20, P793, DOI 10.1016/j.molcel.2005.10.016; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Kusumoto R, 2004, GENES CELLS, V9, P1139, DOI 10.1111/j.1365-2443.2004.00797.x; Kusumoto R, 2002, BIOCHEMISTRY-US, V41, P6090, DOI 10.1021/bi025549k; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li Y, 2004, NAT STRUCT MOL BIOL, V11, P784, DOI 10.1038/nsmb792; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; Ling H, 2003, NATURE, V424, P1083, DOI 10.1038/nature01919; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 2000, EMBO J, V19, P3100, DOI 10.1093/emboj/19.12.3100; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; McCulloch SD, 2004, NATURE, V428, P97, DOI 10.1038/nature02352; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Mees A, 2004, SCIENCE, V306, P1789, DOI 10.1126/science.1101598; Min JH, 2007, NATURE, V449, P570, DOI 10.1038/nature06155; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park H, 2002, P NATL ACAD SCI USA, V99, P15965, DOI 10.1073/pnas.242422699; Rey L, 2009, MOL CELL BIOL, V29, P3344, DOI 10.1128/MCB.00115-09; Saribasak H, 2009, PHILOS T R SOC B, V364, P605, DOI 10.1098/rstb.2008.0188; Scrima A, 2008, CELL, V135, P1213, DOI 10.1016/j.cell.2008.10.045; Sugasawa K, 2008, ADV EXP MED BIOL, V637, P47; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; VASSYLYEV DG, 1995, CELL, V83, P773, DOI 10.1016/0092-8674(95)90190-6; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wang F, 2009, CELL, V139, P1279, DOI 10.1016/j.cell.2009.11.043; Wang LH, 2009, J MOL BIOL, V389, P787, DOI 10.1016/j.jmb.2009.04.029; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Yao JQ, 2001, ENVIRON MOL MUTAGEN, V38, P19, DOI 10.1002/em.1046	58	248	249	2	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1044	U102		10.1038/nature09196	http://dx.doi.org/10.1038/nature09196			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577208	Green Accepted			2022-12-28	WOS:000279056900045
J	Money, NP				Money, Nicholas P.			Cecil Terence Ingold (1905-2010) OBITUARY	NATURE			English	Biographical-Item									Miami Univ, Dept Bot, Oxford, OH 45056 USA	University System of Ohio; Miami University	Money, NP (corresponding author), Miami Univ, Dept Bot, Oxford, OH 45056 USA.	moneynp@muohio.edu							0	3	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1025	1025		10.1038/4651025a	http://dx.doi.org/10.1038/4651025a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577204	Bronze			2022-12-28	WOS:000279056900039
J	Unwin, N; Whiting, D; Roglic, G				Unwin, Nigel; Whiting, David; Roglic, Gojka			Social determinants of diabetes and challenges of prevention	LANCET			English	Editorial Material							HEALTH; CHINA		[Unwin, Nigel] Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England; [Whiting, David] Int Diabet Federat, Brussels, Belgium; [Roglic, Gojka] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland	Newcastle University - UK; World Health Organization	Unwin, N (corresponding author), Newcastle Univ, Inst Hlth & Soc, WHO Collaborating Ctr Res & Training Diabet, Newcastle Upon Tyne NE2 4AX, Tyne & Wear, England.	n.c.unwin@ncl.ac.uk		Unwin, Nigel/0000-0002-1368-1648; Roglic, Gojka/0000-0003-0872-0689; Whiting, David/0000-0001-9827-2896				Goldstein J, 2005, PREV MED, V41, P800, DOI 10.1016/j.ypmed.2005.06.001; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; *INT DIAB FED, 2010, DIAB ATL; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Normile D, 2010, SCIENCE, V328, P422, DOI 10.1126/science.328.5977.422; Shobhana R, 2000, DIABETES RES CLIN PR, V48, P37, DOI 10.1016/S0168-8227(99)00130-8; Simmons RK, 2010, DIABETES RES CLIN PR, V87, P143, DOI 10.1016/j.diabres.2009.10.003; Stevenson CR, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-234; Stuckler D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000241; Whiting D, 2010, EQUITY, SOCIAL DETERMINANTS AND PUBLIC HEALTH PROGRAMMES, P77; World Health Organization, 2004, GLOB STRAT DIET PHYS; Yang WY, 2010, NEW ENGL J MED, V362, P1090, DOI 10.1056/NEJMoa0908292	12	18	19	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2204	2205		10.1016/S0140-6736(10)60840-9	http://dx.doi.org/10.1016/S0140-6736(10)60840-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609961				2022-12-28	WOS:000279652900010
J	Wintemute, GJ; Braga, AA; Kennedy, DM				Wintemute, Garen J.; Braga, Anthony A.; Kennedy, David M.			Private-Party Gun Sales, Regulation, and Public Safety	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Wintemute, Garen J.] Univ Calif Davis, Sch Med, Violence Prevent Res Program, Sacramento, CA 95817 USA; [Wintemute, Garen J.] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Braga, Anthony A.] Rutgers State Univ, Sch Criminal Justice, Newark, NJ 07102 USA; [Braga, Anthony A.] Harvard Univ, John F Kennedy Sch Govt, Program Criminal Justice, Cambridge, MA 02138 USA; [Kennedy, David M.] CUNY John Jay Coll Criminal Justice, Ctr Crime Prevent & Control, New York, NY 10019 USA	University of California System; University of California Davis; University of California System; University of California Davis; Rutgers State University Newark; Rutgers State University New Brunswick; Harvard University; City University of New York (CUNY) System; John Jay College of Criminal Justice (CUNY)	Wintemute, GJ (corresponding author), Univ Calif Davis, Sch Med, Violence Prevent Res Program, Sacramento, CA 95817 USA.							Braga AA, 2000, GEORGETOWN PUBLIC PO, V6, P7; Hepburn L, 2007, INJURY PREV, V13, P15, DOI 10.1136/ip.2006.013607; Ludwig J, 2000, JAMA-J AM MED ASSOC, V284, P585, DOI 10.1001/jama.284.5.585; Webster DW, 2009, J URBAN HEALTH, V86, P525, DOI 10.1007/s11524-009-9351-x; Wintemute G.J., 2009, INSIDE GUN SHOWS WHA	5	24	24	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 5	2010	363	6					508	511		10.1056/NEJMp1006326	http://dx.doi.org/10.1056/NEJMp1006326			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	634BB	20592291				2022-12-28	WOS:000280552700004
J	Sibai, BM				Sibai, Baha M.			Vitamin C and E to prevent pre-eclampsia in diabetic women	LANCET			English	Editorial Material							PREGNANT-WOMEN; RISK; TRIAL		Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH 45278 USA	University System of Ohio; University of Cincinnati	Sibai, BM (corresponding author), Univ Cincinnati, Dept Obstet & Gynecol, Cincinnati, OH 45278 USA.	baha.sibai@uc.edu						Beazley D, 2005, AM J OBSTET GYNECOL, V192, P520, DOI 10.1016/j.ajog.2004.09.005; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; McCance DR, 2010, LANCET, V376, P259, DOI 10.1016/S0140-6736(10)60630-7; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Sibai BM, 2000, AM J OBSTET GYNECOL, V183, P1520, DOI 10.1067/mob.2000.107621; SIBAI BM, 2000, AM J OBSTET GYNECOL, V182, P674; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Temple RC, 2006, BJOG-INT J OBSTET GY, V113, P1329, DOI 10.1111/j.1471-0528.2006.01071.x; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; Xu HR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.050	12	1	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					214	216		10.1016/S0140-6736(10)61007-0	http://dx.doi.org/10.1016/S0140-6736(10)61007-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20580424				2022-12-28	WOS:000280457200008
J	Clark, RH; McTaggart, JS; Webster, R; Mannikko, R; Iberl, M; Sim, XL; Rorsman, P; Glitsch, M; Beeson, D; Ashcroft, FM				Clark, Rebecca H.; McTaggart, James S.; Webster, Richard; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Rorsman, Patrik; Glitsch, Maike; Beeson, David; Ashcroft, Frances M.			Muscle Dysfunction Caused by a K-ATP Channel Mutation in Neonatal Diabetes Is Neuronal in Origin	SCIENCE			English	Article							SULFONYLUREA RECEPTOR; KIR6.2; INSULIN; KCNJ11; THERAPY; SUBUNIT; MYOCARDIUM; PATIENT; GENE	Gain-of-function mutations in Kir6.2 (KCNJ11), the pore-forming subunit of the adenosine triphosphate (ATP)-sensitive potassium (K-ATP) channel, cause neonatal diabetes. Many patients also suffer from hypotonia (weak and flaccid muscles) and balance problems. The diabetes arises from suppressed insulin secretion by overactive K-ATP channels in pancreatic beta-cells, but the source of the motor phenotype is unknown. By using mice carrying a human Kir6.2 mutation (Val(59)-> Met(59)) targeted to either muscle or nerve, we show that analogous motor impairments originate in the central nervous system rather than in muscle or peripheral nerves. We also identify locomotor hyperactivity as a feature of K-ATP channel overactivity. These findings suggest that drugs targeted against neuronal, rather than muscle, K-ATP channels are needed to treat the motor deficits and that such drugs require high blood-brain barrier permeability.	[Clark, Rebecca H.; McTaggart, James S.; Mannikko, Roope; Iberl, Michaela; Sim, Xiu Li; Glitsch, Maike; Ashcroft, Frances M.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England; [Webster, Richard; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Rorsman, Patrik] Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England	University of Oxford; University of Oxford; University of Oxford	Ashcroft, FM (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Parks Rd, Oxford OX1 3PT, England.	frances.ashcroft@dpag.ox.ac.uk	Mannikko, Roope/Q-3567-2016; Rorsman, Patrik/A-4331-2016	Mannikko, Roope/0000-0002-8727-9184; Rorsman, Patrik/0000-0001-7578-0767; Glitsch, Maike/0000-0003-0723-3117; Webster, Richard/0000-0001-7893-1348	Wellcome Trust; Medical Research Council; Royal Society; European Union [LHSB-CT-2004-005137, HEALTH-F4-2007-201924]; Muscular Dystrophy Campaign; Myasthenia Gravis Association; MRC [G0701521] Funding Source: UKRI; Medical Research Council [G0701521] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London); European Union(European Commission); Muscular Dystrophy Campaign(Muscular Dystrophy AssociationEuropean Commission); Myasthenia Gravis Association; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank C. Girard for generating the ROSA mouse and help with early experiments; J. Bruning for the Mck-Cre mice; R. Deacon for help with the mouse behavioral tests and for the use of the OXION mouse behavior facility; and the Wellcome Trust, the Medical Research Council, the Royal Society, the European Union (LHSB-CT-2004-005137 and HEALTH-F4-2007-201924), the Muscular Dystrophy Campaign, and Myasthenia Gravis Association for support. R. H. C. holds an OXION Wellcome Trust prize studentship and J. S. M. holds a Medical Research Council studentship. F. M. A. is a Royal Society University Research Professor.	Ashcroft FM, 2007, AM J PHYSIOL-ENDOC M, V293, pE880, DOI 10.1152/ajpendo.00348.2007; Ghosh S, 2001, J AM COLL CARDIOL, V37, P711, DOI 10.1016/S0735-1097(00)01161-X; Girard CA, 2009, J CLIN INVEST, V119, P80, DOI 10.1172/JCI35772; Gribble FM, 2003, DIABETOLOGIA, V46, P875, DOI 10.1007/s00125-003-1143-3; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; Karschin C, 1997, FEBS LETT, V401, P59, DOI 10.1016/S0014-5793(96)01438-X; Koster JC, 2008, J CLIN ENDOCR METAB, V93, P1054, DOI 10.1210/jc.2007-1826; Mlynarski WC, 2007, NAT CLIN PRACT NEURO, V3, P640, DOI 10.1038/ncpneuro0640; MOURRE C, 1990, BRAIN RES, V519, P29, DOI 10.1016/0006-8993(90)90057-I; Nichols CG, 1996, SCIENCE, V272, P1785, DOI 10.1126/science.272.5269.1785; Nichols CG, 2006, NATURE, V440, P470, DOI 10.1038/nature04711; Pearson ER, 2006, NEW ENGL J MED, V355, P467, DOI 10.1056/NEJMoa061759; Quast U, 2004, DIABETES, V53, pS156, DOI 10.2337/diabetes.53.suppl_3.S156; Simpson SH, 2006, CAN MED ASSOC J, V174, P169, DOI 10.1503/cmaj.050748; Slingerland AS, 2008, DIABETIC MED, V25, P277, DOI 10.1111/j.1464-5491.2007.02373.x; Slingerland AS, 2006, DIABETOLOGIA, V49, P2559, DOI 10.1007/s00125-006-0407-0; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4	19	70	72	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					458	461		10.1126/science.1186146	http://dx.doi.org/10.1126/science.1186146			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595581	Green Accepted			2022-12-28	WOS:000280196500042
J	Agnelli, G; Becattini, C				Agnelli, Giancarlo; Becattini, Cecilia			Current Concepts: Acute Pulmonary Embolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							RIGHT-VENTRICULAR DYSFUNCTION; MOLECULAR-WEIGHT HEPARIN; COMPUTED-TOMOGRAPHY; PROGNOSTIC VALUE; VENOUS THROMBOEMBOLISM; NATRIURETIC PEPTIDE; RISK STRATIFICATION; 1ST EPISODE; D-DIMER; CT		[Agnelli, Giancarlo; Becattini, Cecilia] Univ Perugia, Internal & Cardiovasc Med & Stroke Unit, I-06132 Perugia, Italy	University of Perugia	Agnelli, G (corresponding author), Univ Perugia, Internal & Cardiovasc Med & Stroke Unit, I-06132 Perugia, Italy.	agnellig@unipg.it	Platzek, Ivan/AAZ-8124-2020; Beyer-Westendorf, Jan/K-7569-2019	Platzek, Ivan/0000-0002-5933-8108; Beyer-Westendorf, Jan/0000-0002-6983-9993; BECATTINI, Cecilia/0000-0002-8343-4888	Sanofi-Aventis; Bayer; Astellas	Sanofi-Aventis(Sanofi-Aventis); Bayer(Bayer AG); Astellas(Astellas Pharmaceuticals)	Dr. Agnelli reports receiving consulting fees from Sanofi-Aventis, Bayer, and Astellas. No other potential conflict of interest relevant to this article was reported.	Agnelli G, 2003, ANN INTERN MED, V139, P19, DOI 10.7326/0003-4819-139-1-200307010-00008; Anderson DR, 2007, JAMA-J AM MED ASSOC, V298, P2743, DOI 10.1001/jama.298.23.2743; Araoz PA, 2007, RADIOLOGY, V242, P889, DOI 10.1148/radiol.2423051441; Aujesky D, 2006, ARCH INTERN MED, V166, P169, DOI 10.1001/archinte.166.2.169; Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Binder L, 2005, CIRCULATION, V112, P1573, DOI 10.1161/CIRCULATIONAHA.105.552216; Bourjeily G, 2010, LANCET, V375, P500, DOI 10.1016/S0140-6736(09)60996-X; Bruinstroop E, 2009, EUR J INTERN MED, V20, P441, DOI 10.1016/j.ejim.2008.12.004; Buller HR, 2003, NEW ENGL J MED, V349, P1695; BULLER HR, 2009, 51 AM SOC HEM ANN M; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Fremont B, 2008, CHEST, V133, P358, DOI 10.1378/chest.07-1231; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grifoni S, 2000, CIRCULATION, V101, P2817, DOI 10.1161/01.CIR.101.24.2817; Gupta RT, 2009, AM J ROENTGENOL, V193, P425, DOI 10.2214/AJR.08.2186; Jimenez D, 2008, EUR RESPIR J, V31, P847, DOI 10.1183/09031936.00113307; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; Klok FA, 2008, AM J RESP CRIT CARE, V178, P425, DOI 10.1164/rccm.200803-459OC; Konstantinides S, 2002, NEW ENGL J MED, V347, P1143, DOI 10.1056/NEJMoa021274; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2005, ARCH INTERN MED, V165, P1777, DOI 10.1001/archinte.165.15.1777; Kuo WT, 2009, J VASC INTERV RADIOL, V20, P1431, DOI 10.1016/j.jvir.2009.08.002; Laporte S, 2008, CIRCULATION, V117, P1711, DOI 10.1161/CIRCULATIONAHA.107.726232; Le Gal G, 2006, ANN INTERN MED, V144, P165, DOI 10.7326/0003-4819-144-3-200602070-00004; Le Gal G, 2006, THROMB HAEMOSTASIS, V95, P963, DOI 10.1160/TH06-03-0158; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; Marik PE, 2008, NEW ENGL J MED, V359, P2025, DOI 10.1056/NEJMra0707993; Palla A, 2004, NEW ENGL J MED, V350, P423; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Perrier A, 2005, NEW ENGL J MED, V352, P1760, DOI 10.1056/NEJMoa042905; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Raschke RA, 1996, ARCH INTERN MED, V156, P1645, DOI 10.1001/archinte.156.15.1645; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Righini M, 2008, LANCET, V371, P1343, DOI 10.1016/S0140-6736(08)60594-2; Sanchez O, 2008, EUR HEART J, V29, P1569, DOI 10.1093/eurheartj/ehn208; Sanchez O, 2010, AM J RESP CRIT CARE, V181, P168, DOI 10.1164/rccm.200906-0970OC; Schulman S, 2009, NEW ENGL J MED, V361, P2342, DOI 10.1056/NEJMoa0906598; SMITH SB, 2010, CHEST           0115; Sostman HD, 2008, RADIOLOGY, V246, P941, DOI 10.1148/radiol.2463070270; Squizzato A, 2009, EUR RESPIR J, V33, P1148, DOI 10.1183/09031936.00133608; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Stein PD, 2010, ANN INTERN MED, V152, P434, DOI 10.7326/0003-4819-152-7-201004060-00008; STEIN PD, 1995, CHEST, V108, P978, DOI 10.1378/chest.108.4.978; Subramaniam RM, 2009, J MED IMAG RADIAT ON, V53, P361, DOI 10.1111/j.1754-9485.2009.02092.x; Torbicki A, 2008, EUR HEART J, V29, P2276, DOI 10.1093/eurheartj/ehn310; van Belle A, 2006, JAMA-J AM MED ASSOC, V295, P172; van der Meer RW, 2005, RADIOLOGY, V235, P798, DOI 10.1148/radiol.2353040593; Wan S, 2004, CIRCULATION, V110, P744, DOI 10.1161/01.CIR.0000137826.09715.9C; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002	51	285	315	2	36	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					266	274		10.1056/NEJMra0907731	http://dx.doi.org/10.1056/NEJMra0907731			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20592294				2022-12-28	WOS:000279864200009
J	Paal, P; Braun, P; Brugger, H; Strappazzon, G; Falk, M				Paal, Peter; Braun, Patrick; Brugger, Hermann; Strappazzon, Giacomo; Falk, Markus			Medicine and the Media How the media and animal rights activists put avalanche burial study on ice	BRITISH MEDICAL JOURNAL			English	Editorial Material							SURVIVAL; HYPOTHERMIA		[Paal, Peter; Braun, Patrick] Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria; [Brugger, Hermann; Strappazzon, Giacomo] EURAC Inst Mt Emergency Med, Bolzano, Italy; [Falk, Markus] Inova Q, Brunico, Italy	Medical University of Innsbruck; European Academy of Bozen-Bolzano	Paal, P (corresponding author), Innsbruck Med Univ, Dept Anesthesiol & Crit Care Med, Innsbruck, Austria.	peter.paal@uki.at	Paal, Peter/E-2110-2011	Brugger, Hermann/0000-0003-2752-6929; Paal, Peter/0000-0002-2939-4782; Falk, Markus/0000-0002-5297-0776				Boyd J, 2009, CAN MED ASSOC J, V180, P507, DOI 10.1503/cmaj.081327; Brugger H, 2003, RESUSCITATION, V58, P81, DOI 10.1016/S0300-9572(03)00113-8; Brugger H, 2001, RESUSCITATION, V51, P7, DOI 10.1016/S0300-9572(01)00383-5; Brugger H, 2010, NATURE, V463, P877, DOI 10.1038/463877a; FALK M, 1994, NATURE, V368, P21, DOI 10.1038/368021a0; GRAY R, LORD DRAYSON WINNING; Gunga HC, 2009, RESP PHYSIOL NEUROBI, V169, pS63, DOI 10.1016/j.resp.2009.04.005; Han YS, 2010, AM J PHYSIOL-HEART C, V298, pH890, DOI 10.1152/ajpheart.00805.2009; Oberhammer R, 2008, RESUSCITATION, V76, P474, DOI 10.1016/j.resuscitation.2007.09.004; *PROT, PROT STAND UP SCI	10	7	7	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3778	10.1136/bmj.c3778	http://dx.doi.org/10.1136/bmj.c3778			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630957				2022-12-28	WOS:000280156700013
J	Lee, C; Goldberg, J				Lee, Changwook; Goldberg, Jonathan			Structure of Coatomer Cage Proteins and the Relationship among COPI, COPII, and Clathrin Vesicle Coats	CELL			English	Article							ADP-RIBOSYLATION FACTOR; MOLECULAR ARCHITECTURE; ENDOPLASMIC-RETICULUM; ALPHA-COP; IN-VITRO; COMPLEX; CARGO; MEMBRANE; SUBUNITS; EXCHANGE	COPI-coated vesicles form at the Golgi apparatus from two cytosolic components, ARF G protein and coatomer, a heptameric complex that can polymerize into a cage to deform the membrane into a bud. Although coatomer shares a common evolutionary origin with COPII and clathrin vesicle coat proteins, the architectural relationship among the three cages is unclear. Strikingly, the alpha beta'-COP core of coatomer crystallizes as a triskelion in which three copies of a beta'-COP beta-propeller domain converge through their axial ends. We infer that the trimer constitutes the vertex of the COPI cage. Our model proposes that the COPI cage is intermediate in design between COPII and clathrin: COPI shares with clathrin an arrangement of three curved alpha-solenoid legs radiating from a common center, and COPI shares with COPII highly similar vertex interactions involving the axial ends of beta-propeller domains.	[Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Lee, Changwook; Goldberg, Jonathan] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA	Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Goldberg, J (corresponding author), Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, 1275 York Ave, New York, NY 10065 USA.	jonathan@ximpact4.ski.mskcc.org	Lee, Changwook/D-6010-2011		Howard Hughes Medical Institute	Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank staff at beamline X25 of the NSLS and beamline 24ID of the APS for use of and assistance with synchrotron facilities. We thank Felix Wieland and Marianna Breitman for providing full-length cDNA and baculoviruses for expression of COPI subunits. This work was supported by a grant from the Howard Hughes Medical Institute.	Antonny B, 1997, BIOCHEMISTRY-US, V36, P4675, DOI 10.1021/bi962252b; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Brohawn SG, 2009, NAT STRUCT MOL BIOL, V16, P1173, DOI 10.1038/nsmb.1713; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chardin P, 1996, NATURE, V384, P481, DOI 10.1038/384481a0; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380; DUDEN R, 1994, J BIOL CHEM, V269, P24486; Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985; Eugster A, 2004, MOL BIOL CELL, V15, P1011, DOI 10.1091/mbc.E03-10-0724; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Heldwein EE, 2004, P NATL ACAD SCI USA, V101, P14108, DOI 10.1073/pnas.0406102101; Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398; Lowe M, 1995, J BIOL CHEM, V270, P31364, DOI 10.1074/jbc.270.52.31364; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Nickel W, 1998, J CELL SCI, V111, P3081; ORCI L, 1993, NATURE, V364, P732, DOI 10.1038/364732a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen DJ, 2004, ANNU REV CELL DEV BI, V20, P153, DOI 10.1146/annurev.cellbio.20.010403.104543; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521; SERAFINI T, 1991, CELL, V67, P239, DOI 10.1016/0092-8674(91)90176-Y; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; Zhao LY, 1997, P NATL ACAD SCI USA, V94, P4418, DOI 10.1073/pnas.94.9.4418; ZLOTNICK A, 1994, J MOL BIOL, V241, P59, DOI 10.1006/jmbi.1994.1473	41	137	141	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					123	132		10.1016/j.cell.2010.05.030	http://dx.doi.org/10.1016/j.cell.2010.05.030			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20579721	Green Accepted, Bronze			2022-12-28	WOS:000279637300018
J	Thabut, G; Christie, JD; Kremers, WK; Fournier, M; Halpern, SD				Thabut, Gabriel; Christie, Jason D.; Kremers, Walter K.; Fournier, Michel; Halpern, Scott D.			Survival Differences Following Lung Transplantation Among US Transplant Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HOSPITAL VOLUME; MORTALITY; OUTCOMES; REGISTRY; BENEFIT; IMPACT	Context Although case loads vary substantially among US lung transplant centers, the impact of center effects on patient outcomes following lung transplantation is unknown. Objective To assess variability in long-term survival following lung transplantation among US lung transplant centers. Design, Setting, and Patients Analysis of data from the United Network for Organ Sharing registry for 15 642 adult patients undergoing lung transplantation between 1987 and 2009 in 61 US transplantation centers still active in 2008. Main Outcome Measures Mixed-effect Cox models were fitted to assess survival following lung transplantation at individual centers. Results In 2008, 19 centers (31.1%) performed between 1 and 10 lung transplantations; 18 centers (29.5%), from 11 to 25 transplantations; 20 centers (32.8%), from 26 to 50 transplantations; and 4 centers (6.6%), more than 50 transplantations. One-month, 1-year, 3-year, and 5-year survival rates among all 61 centers were 93.4% (95% confidence interval [CI], 93.0% to 93.8%), 79.7% (95% CI, 79.1% to 80.4%), 63.0% (95% CI, 62.2% to 63.8%), and 49.5% (95% CI, 48.6% to 50.5%), respectively. Characteristics of donors, recipients, and surgical techniques varied substantially among centers. After adjustment for these factors, marked variability remained among centers, with hazard ratios for death ranging from 0.70 (95% CI, 0.59 to 0.82) to 1.71 (95% CI, 1.36 to 2.14) for low-vs high-risk centers, for 5-year survival rates of 30.0% to 61.1%. Higher lung transplantation volumes were associated with improved long-term survival and accounted for 15% of among-center variability; however, variability in center performance remained significant after controlling for procedural volume (P<.001). Conclusions Center-specific variation in survival following lung transplantation was only partly associated with procedural volume. However, other statistically significant sources of variability remain to be identified. JAMA. 2010; 304(1): 53-60 www.jama.com	[Thabut, Gabriel; Fournier, Michel] Hop Bichat Claude Bernard, AP HP, Ser Pneumol & Transplantat Pulm B, F-75018 Paris, France; [Thabut, Gabriel; Kremers, Walter K.] Mayo Clin, Coll Med, Dept Hlth Sci Res, Rochester, MN USA; [Kremers, Walter K.] Mayo Clin, Coll Med, Div Biostat & Informat, Rochester, MN USA; [Christie, Jason D.; Halpern, Scott D.] Univ Penn, Dept Med, Div Pulm Allergy & Crit Care, Philadelphia, PA 19104 USA; [Christie, Jason D.; Halpern, Scott D.] Univ Penn, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Ctr Bioeth, Philadelphia, PA 19104 USA; [Halpern, Scott D.] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Thabut, Gabriel] INSERM, U738, Paris, France; [Thabut, Gabriel; Fournier, Michel] Univ Paris Diderot, Fac Med, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Mayo Clinic; Mayo Clinic; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Thabut, G (corresponding author), Hop Bichat Claude Bernard, AP HP, Ser Pneumol & Transplantat Pulm B, 46 Rue Henri Huchard, F-75018 Paris, France.	gabriel.thabut@bch.aphp.fr		Christie, Jason/0000-0003-0519-218X	Assistance Publique-Hopitaux de Paris; College des Enseignants de Pneumologie (CEP); AstraZeneca; Agency for Healthcare Research and Quality [1K08 HS018406-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K08HS018406] Funding Source: NIH RePORTER	Assistance Publique-Hopitaux de Paris; College des Enseignants de Pneumologie (CEP); AstraZeneca(AstraZeneca); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr Thabut received support for his work from Assistance Publique-Hopitaux de Paris and College des Enseignants de Pneumologie (CEP) and AstraZeneca during his fellowship. Dr Halpern was supported by grant 1K08 HS018406-01 from the Agency for Healthcare Research and Quality.	Aigner C, 2007, EUR J CARDIO-THORAC, V31, P468, DOI 10.1016/j.ejcts.2006.11.049; Arcasoy SM, 1999, NEW ENGL J MED, V340, P1081, DOI 10.1056/NEJM199904083401406; Bach PB, 2001, NEW ENGL J MED, V345, P181, DOI 10.1056/NEJM200107193450306; Christie JD, 2009, J HEART LUNG TRANSPL, V28, P1031, DOI 10.1016/j.healun.2009.08.004; Edwards EB, 1999, NEW ENGL J MED, V341, P2049, DOI 10.1056/NEJM199912303412703; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grambsch PM, 1995, BIOMETRICS, V51, P1469, DOI 10.2307/2533277; GREENLAND S, 1989, AM J EPIDEMIOL, V130, P1066, DOI 10.1093/oxfordjournals.aje.a115409; Gutierrez C, 2007, AM J TRANSPLANT, V7, P1271, DOI 10.1111/j.1600-6143.2006.01681.x; HOSMER D, 1999, APPL SURVIVAL ANAL R, V1; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Karvanen J, 2009, STAT MED, V28, P1957, DOI 10.1002/sim.3591; Panageas KS, 2007, STAT MED, V26, P2017, DOI 10.1002/sim.2657; Panageas KS, 2003, ANN INTERN MED, V139, P658, DOI 10.7326/0003-4819-139-8-200310210-00009; Phibbs CS, 2007, NEW ENGL J MED, V356, P2165, DOI 10.1056/NEJMsa065029; Stavem K, 2006, J HEART LUNG TRANSPL, V25, P75, DOI 10.1016/j.healun.2005.06.025; Thabut G, 2008, AM J RESP CRIT CARE, V177, P1156, DOI 10.1164/rccm.200708-1283OC; Thabut G, 2008, LANCET, V371, P744, DOI 10.1016/S0140-6736(08)60344-X; Thabut G, 2009, ANN INTERN MED, V151, P767, DOI 10.7326/0003-4819-151-11-200912010-00004; Therneau TM, 2000, MODELING SURVIVAL DA; Titman A, 2009, AM J TRANSPLANT, V9, P1640, DOI 10.1111/j.1600-6143.2009.02613.x; *US DEP HHS, DON TRANSPL COMM PRA; Weiss ES, 2009, ANN THORAC SURG, V88, P1062, DOI 10.1016/j.athoracsur.2009.06.005	23	104	107	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					53	60		10.1001/jama.2010.885	http://dx.doi.org/10.1001/jama.2010.885			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606149	Bronze			2022-12-28	WOS:000279519600021
J	Clark, S; Horton, R				Clark, Stephanie; Horton, Richard			Putting research into context-revisited	LANCET			English	Editorial Material							TRIALS		[Clark, Stephanie; Horton, Richard] The Lancet, London NW1 7BY, England		Clark, S (corresponding author), The Lancet, London NW1 7BY, England.							Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Clarke M, 2010, LANCET, V376, P20, DOI 10.1016/S0140-6736(10)61045-8; Ellis P, 2009, LANCET, V373, P1681, DOI 10.1016/S0140-6736(09)60740-6; Young C, 2005, LANCET, V366, P107, DOI 10.1016/S0140-6736(05)66846-8	4	33	33	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 3	2010	376	9734					10	11		10.1016/S0140-6736(10)61001-X	http://dx.doi.org/10.1016/S0140-6736(10)61001-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20609979				2022-12-28	WOS:000279841600009
J	D'Angiolella, V; Donato, V; Vijayakumar, S; Saraf, A; Florens, L; Washburn, MP; Dynlacht, B; Pagano, M				D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Saraf, Anita; Florens, Laurence; Washburn, Michael P.; Dynlacht, Brian; Pagano, Michele			SCFCyclin F controls centrosome homeostasis and mitotic fidelity through CP110 degradation	NATURE			English	Article							PROTEOMIC ANALYSIS; UBIQUITIN LIGASE; CYCLIN-F; IDENTIFICATION; BIOGENESIS; MECHANISMS; SUBSTRATE	Generally, F-box proteins are the substrate recognition subunits of SCF (Skp1-Cul1-F-box protein) ubiquitin ligase complexes, which mediate the timely proteolysis of important eukaryotic regulatory proteins(1,2). Mammalian genomes encode roughly 70 F-box proteins, but only a handful have established functions(3,4). The F-box protein family obtained its name from Cyclin F (also called Fbxo1), in which the F-box motif (the similar to 40-amino-acid domain required for binding to Skp1) was first described(5). Cyclin F, which is encoded by an essential gene, also contains a cyclin box domain, but in contrast to most cyclins, it does not bind or activate any cyclin-dependent kinases (CDKs)(5-7). However, like other cyclins, Cyclin F oscillates during the cell cycle, with protein levels peaking in G2. Despite its essential nature and status as the founding member of the F-box protein family, Cyclin F remains an orphan protein, whose functions are unknown. Starting from an unbiased screen, we identified CP110, a protein that is essential for centrosome duplication, as an interactor and substrate of Cyclin F. Using a mode of substrate binding distinct from other F-box protein-substrate pairs, CP110 and Cyclin F physically associate on the centrioles during the G2 phase of the cell cycle, and CP110 is ubiquitylated by the SCFCyclin F ubiquitin ligase complex, leading to its degradation. siRNA-mediated depletion of Cyclin F in G2 induces centrosomal and mitotic abnormalities, such as multipolar spindles and asymmetric, bipolar spindles with lagging chromosomes. These phenotypes were reverted by co-silencing CP110 and were recapitulated by expressing a stable mutant of CP110 that cannot bind Cyclin F. Finally, expression of a stable CP110 mutant in cultured cells also promotes the formation of micronuclei, a hallmark of chromosome instability. We propose that SCFCyclin F-mediated degradation of CP110 is required for the fidelity of mitosis and genome integrity.	[D'Angiolella, Vincenzo; Donato, Valerio; Vijayakumar, Sangeetha; Dynlacht, Brian; Pagano, Michele] NYU, Sch Med, Inst Canc, Dept Pathol, New York, NY 10016 USA; [Saraf, Anita; Florens, Laurence; Washburn, Michael P.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Pathol & Lab Med, Kansas City, KS 66160 USA; [Pagano, Michele] Howard Hughes Med Inst, Chevy Chase, MD USA	New York University; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Howard Hughes Medical Institute	Pagano, M (corresponding author), NYU, Sch Med, Inst Canc, Dept Pathol, 522 1st Ave,SRB 1107, New York, NY 10016 USA.	michele.pagano@nyumc.org		Florens, Laurence/0000-0002-9310-6650; pagano, michele/0000-0003-3210-2442; Washburn, Michael/0000-0001-7568-2585	American Italian Cancer Foundation; March of Dimes [1-FY08-372]; National Institutes of Health [R01-GM057587, R37-CA076584, R21-AG032560]; Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE [R37CA076584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG032560] Funding Source: NIH RePORTER	American Italian Cancer Foundation; March of Dimes(March of Dimes); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stowers Institute for Medical Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Elledge for Cyclin F<SUP>Flox/-</SUP> and Cyclin F<SUP>-/-</SUP> MEFs, J.R. Skaar for reading the manuscript and F. M. Forrester for technical help. M. P. is grateful to T. M. Thor for continuous support. This work was funded by fellowships from the American Italian Cancer Foundation to V.D'A. and V. D., a grant from the March of Dimes (1-FY08-372) to B. D. and grants from the National Institutes of Health (R01-GM057587, R37-CA076584 and R21-AG032560) to M. P. A. S., L. F. and M. P. W. are supported by the Stowers Institute for Medical Research. V.D'A. is a Leukemia & Lymphoma Society Fellow. M. P. is an Investigator with the Howard Hughes Medical Institute.	Bai C, 1996, CELL, V86, P263, DOI 10.1016/S0092-8674(00)80098-7; BAI C, 1994, EMBO J, V13, P6087, DOI 10.1002/j.1460-2075.1994.tb06955.x; BALCZON R, 1995, J CELL BIOL, V130, P105, DOI 10.1083/jcb.130.1.105; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 2001, J CELL BIOL, V153, P1381, DOI 10.1083/jcb.153.7.1381; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Fung TK, 2002, J BIOL CHEM, V277, P35140, DOI 10.1074/jbc.M205503200; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Guardavaccaro D, 2008, NATURE, V452, P365, DOI 10.1038/nature06641; Jin JP, 2004, GENE DEV, V18, P2573, DOI 10.1101/gad.1255304; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; McDonald WH, 2002, INT J MASS SPECTROM, V219, P245, DOI 10.1016/S1387-3806(02)00563-8; Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245; PAGANO M, 1992, EMBO J, V11, P961, DOI 10.1002/j.1460-2075.1992.tb05135.x; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Skaar JR, 2009, CELL, V137, P1358, DOI 10.1016/j.cell.2009.05.040; Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tetzlaff MT, 2004, MOL CELL BIOL, V24, P2487, DOI 10.1128/MCB.24.6.2487-2498.2004; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	34	174	180	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					138	U161		10.1038/nature09140	http://dx.doi.org/10.1038/nature09140			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596027	Green Accepted			2022-12-28	WOS:000279343800050
J	Hansson, GK; Bjorkholm, M				Hansson, Goran K.; Bjorkholm, Magnus			Tackling Two Diseases with HDL	SCIENCE			English	Editorial Material							CELLS		[Hansson, Goran K.] Karolinska Inst, Ctr Mol Med, SE-17176 Stockholm, Sweden; Karolinska Inst, Dept Med, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Hansson, GK (corresponding author), Karolinska Inst, Ctr Mol Med, SE-17176 Stockholm, Sweden.	goran.hansson@ki.se	Hansson, Goran K/B-7423-2012	Hansson, Goran/0000-0003-4148-5190				FELDMAN DL, 1991, ARTERIOSCLER THROMB, V11, P985, DOI 10.1161/01.ATV.11.4.985; Giebel B, 2004, BLOOD, V104, P2332, DOI 10.1182/blood-2004-02-0511; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Peeters SDPWM, 2006, EXP HEMATOL, V34, P622, DOI 10.1016/j.exphem.2006.01.020; Tall AR, 2008, J INTERN MED, V263, P256, DOI 10.1111/j.1365-2796.2007.01898.x; VITOLS S, 1985, LANCET, V2, P1150; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731	7	12	12	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1641	1642		10.1126/science.1191663	http://dx.doi.org/10.1126/science.1191663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576876				2022-12-28	WOS:000279107400026
J	Smith, J; Van Dyken, JD; Zee, PC				Smith, Jeff; Van Dyken, J. David; Zee, Peter C.			A Generalization of Hamilton's Rule for the Evolution of Microbial Cooperation	SCIENCE			English	Article							SOCIAL EVOLUTION; KIN SELECTION; BACTERIAL-POPULATIONS; CONFLICT; MICROORGANISMS; COMPETITION; AMEBA; MODEL	Hamilton's rule states that cooperation will evolve if the fitness cost to actors is less than the benefit to recipients multiplied by their genetic relatedness. This rule makes many simplifying assumptions, however, and does not accurately describe social evolution in organisms such as microbes where selection is both strong and nonadditive. We derived a generalization of Hamilton's rule and measured its parameters in Myxococcus xanthus bacteria. Nonadditivity made cooperative sporulation remarkably resistant to exploitation by cheater strains. Selection was driven by higher-order moments of population structure, not relatedness. These results provide an empirically testable cooperation principle applicable to both microbes and multicellular organisms and show how nonlinear interactions among cells insulate bacteria against cheaters.	[Smith, Jeff; Van Dyken, J. David; Zee, Peter C.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington	Smith, J (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA.	smith74@indiana.edu	smith, jeff/A-7486-2011	smith, jeff/0000-0001-8445-586X	NIH [GM07690, R01GM084238]; Genetics, Cellular and Molecular Sciences Training Grant [T32GM007757]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079690, R01GM084238, T32GM007757] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Genetics, Cellular and Molecular Sciences Training Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Velicer for funding and laboratory support through NIH grant GM07690 and S. Alizon, W. Castle, D. Queller, and W. Ratcliff for discussion and comments on the manuscript. J.D.V.D. was supported by NIH grant R01GM084238 to M.J. Wade. P.C.Z. was supported by the Genetics, Cellular and Molecular Sciences Training Grant (T32GM007757). All authors conceived the project, discussed the results, and commented on the paper. j.s. and D. V. D. designed the theoretical approach. j.s. did the math, designed and performed the experiments, and wrote the paper. j.s. and P.C.Z. analyzed the data.	Brown SP, 2009, PHILOS T R SOC B, V364, P3157, DOI 10.1098/rstb.2009.0055; Crozier R.H., 1996, EVOLUTION SOCIAL INS; Diggle SP, 2007, NATURE, V450, P411, DOI 10.1038/nature06279; Gardner A, 2007, AM NAT, V169, P207, DOI 10.1086/510602; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Godfrey-Smith P, 2009, AM NAT, V174, P906, DOI 10.1086/646605; Grafen A., 1985, Oxford Surveys in Evolutionary Biology, V2, P28; Griffin AS, 2002, TRENDS ECOL EVOL, V17, P15, DOI 10.1016/S0169-5347(01)02355-2; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI [10.1016/0022-5193(64)90038-4, 10.1016/0022-5193(64)90039-6]; Keller L, 1999, LEVELS SELECTION EVO; Kummerli R, 2010, J EVOLUTION BIOL, V23, P699, DOI 10.1111/j.1420-9101.2010.01936.x; Leimar O, 2006, J EVOLUTION BIOL, V19, P1403, DOI 10.1111/j.1420-9101.2006.01156.x; LEIMAR O, 2006, J EVOLUTION BIOL, V19, P1426; MacLean RC, 2006, NATURE, V441, P498, DOI 10.1038/nature04624; QUELLER DC, 1992, EVOLUTION, V46, P376, DOI 10.1111/j.1558-5646.1992.tb02045.x; Rainey PB, 2003, NATURE, V425, P72, DOI 10.1038/nature01906; Ross-Gillespie A, 2007, AM NAT, V170, P331, DOI 10.1086/519860; Smith J, 2001, P ROY SOC B-BIOL SCI, V268, P61, DOI 10.1098/rspb.2000.1330; Strassmann JE, 2000, NATURE, V408, P965, DOI 10.1038/35050087; Szathmary E, 1995, MAJOR TRANSITIONS EV; Taylor PD, 1996, J THEOR BIOL, V180, P27, DOI 10.1006/jtbi.1996.0075; Turner PE, 1999, NATURE, V398, P441, DOI 10.1038/18913; Velicer GJ, 2000, NATURE, V404, P598, DOI 10.1038/35007066; Velicer GJ, 2009, ANNU REV MICROBIOL, V63, P599, DOI 10.1146/annurev.micro.091208.073158; Wenseleers T, 2006, J EVOLUTION BIOL, V19, P1419, DOI 10.1111/j.1420-9101.2006.01144.x; WENSELEERS T, 2006, J EVOLUTION BIOL, V19, P1426; West SA, 2007, ANNU REV ECOL EVOL S, V38, P53, DOI 10.1146/annurev.ecolsys.38.091206.095740; West SA, 2006, NAT REV MICROBIOL, V4, P597, DOI 10.1038/nrmicro1461; Whitlock MC, 2002, GENETICS, V160, P1191; Wright S, 1931, GENETICS, V16, P0097	30	56	58	3	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1700	1703		10.1126/science.1189675	http://dx.doi.org/10.1126/science.1189675			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576891	Green Accepted			2022-12-28	WOS:000279107400045
J	Christensen, K; Hassan, MHA; Gelhaus, SL; Scholz, B; Cao, C				Christensen, Kathleen; Hassan, Mohamed H. A.; Gelhaus, Stacy L.; Scholz, Beate; Cao, Cong			Inequities exposed in salary survey	NATURE			English	Editorial Material													Cao, Cong/U-1847-2019; Gelhaus, Stacy/AAF-2570-2019						0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1006	1007		10.1038/4651006a	http://dx.doi.org/10.1038/4651006a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KI	20577190				2022-12-28	WOS:000279056900018
J	Jenkins, HE; Aylward, RB; Gasasira, A; Donnelly, CA; Mwanza, M; Corander, J; Garnier, S; Chauvin, C; Abanida, E; Pate, MA; Adu, F; Baba, M; Grassly, NC				Jenkins, Helen E.; Aylward, R. Bruce; Gasasira, Alex; Donnelly, Christl A.; Mwanza, Michael; Corander, Jukka; Garnier, Sandra; Chauvin, Claire; Abanida, Emmanuel; Pate, Muhammad Ali; Adu, Festus; Baba, Marycelin; Grassly, Nicholas C.			Implications of a Circulating Vaccine-Derived Poliovirus in Nigeria.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ERADICATION; POLIOMYELITIS; INFECTION	Background: The largest recorded outbreak of a circulating vaccine-derived poliovirus (cVDPV), detected in Nigeria, provides a unique opportunity to analyze the pathogenicity of the virus, the clinical severity of the disease, and the effectiveness of control measures for cVDPVs as compared with wild-type poliovirus (WPV). Methods: We identified cases of acute flaccid paralysis associated with fecal excretion of type 2 cVDPV, type 1 WPV, or type 3 WPV reported in Nigeria through routine surveillance from January 1, 2005, through June 30, 2009. The clinical characteristics of these cases, the clinical attack rates for each virus, and the effectiveness of oral polio vaccines in preventing paralysis from each virus were compared. Results: No significant differences were found in the clinical severity of paralysis among the 278 cases of type 2 cVDPV, the 2323 cases of type 1 WPV, and the 1059 cases of type 3 WPV. The estimated average annual clinical attack rates of type 1 WPV, type 2 cVDPV, and type 3 WPV per 100,000 susceptible children under 5 years of age were 6.8 (95% confidence interval [CI], 5.9 to 7.7), 2.7 (95% CI, 1.9 to 3.6), and 4.0 (95% CI, 3.4 to 4.7), respectively. The estimated effectiveness of trivalent oral polio vaccine against paralysis from type 2 cVDPV was 38% (15 to 54%) per dose, which was substantially higher than that against paralysis from type 1 WPV (13%; 95% CI, 8 to 18%), or type 3 WPV (20%; 95% CI, 12 to 26%). The more frequent use of serotype 1 and serotype 3 monovalent oral polio vaccines has resulted in improvements in vaccine-induced population immunity against these serotypes and in declines in immunity to type 2 cVDPV. Conclusions: The attack rate and severity of disease associated with the recent cVDPV identified in Nigeria are similar to those associated with WPV. International planning for the management of the risk of WPV, both before and after eradication, must include scenarios in which equally virulent and pathogenic cVDPVs could emerge. N Engl J Med 2010;362:2360-9.	[Jenkins, Helen E.; Donnelly, Christl A.; Grassly, Nicholas C.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Aylward, R. Bruce; Garnier, Sandra; Chauvin, Claire] WHO, Global Polio Eradicat Initiat, Geneva, NY USA; [Gasasira, Alex; Mwanza, Michael] WHO Nigeria, Abuja, Nigeria; [Abanida, Emmanuel; Pate, Muhammad Ali] Natl Primary Hlth Care Dev Agcy, Garki, Abuja, Nigeria; [Adu, Festus] Univ Ibadan, Coll Med, Dept Virol, WHO Polio Lab, Ibadan, Nigeria; [Baba, Marycelin] Univ Maiduguri, Coll Med Sci, Dept Med Lab Sci, Maiduguri, Nigeria; [Corander, Jukka] Univ Helsinki, Dept Math & Stat, Helsinki, Finland	Imperial College London; World Health Organization; University of Ibadan; University of Helsinki	Jenkins, HE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Infect Dis Epidemiol, MRC,Ctr Outbreak Anal & Modelling, London W2 1PG, England.	jenkins.helen@gmail.com	Grassly, Nicholas C/C-6381-2008	Grassly, Nicholas C/0000-0001-6067-4507; Jenkins, Helen/0000-0003-4749-1591; Baba, Marycelin/0000-0002-1004-1717; Donnelly, Christl/0000-0002-0195-2463	Royal Society; Medical Research Council; Medical Research Council [G0600719B] Funding Source: researchfish	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by a University Research Fellowship from the Royal Society (to Dr. Grassly) and funding from the Medical Research Council (to Ms. Jenkins).	*ADV COMM POL ER, 2009, ENG OV POL TRAD LEAD; *ADV COMM POL ER, 2009, WKLY EPIDEMIOL REC, V84, P289; Agol VI, 2006, BIOLOGICALS, V34, P103, DOI 10.1016/j.biologicals.2006.02.007; Arita I, 2006, SCIENCE, V312, P852, DOI 10.1126/science.1124959; Caceres VM, 2001, CLIN INFECT DIS, V33, P531, DOI 10.1086/321905; Chumakov K, 2007, NAT REV MICROBIOL, V5, P952, DOI 10.1038/nrmicro1769; El-Sayed N, 2008, NEW ENGL J MED, V359, P1655, DOI 10.1056/NEJMoa0800390; Estivariz CF, 2008, J INFECT DIS, V197, P347, DOI 10.1086/525049; GELFAND HM, 1957, AM J HYG, V65, P367, DOI 10.1093/oxfordjournals.aje.a119876; Grassly NC, 2007, LANCET, V369, P1356, DOI 10.1016/S0140-6736(07)60531-5; Grassly NC, 2006, SCIENCE, V314, P1150, DOI 10.1126/science.1130388; Jenkins HE, 2008, NEW ENGL J MED, V359, P1666, DOI 10.1056/NEJMoa0803259; Kew OM, 2005, ANNU REV MICROBIOL, V59, P587, DOI 10.1146/annurev.micro.58.030603.123625; Marx A, 2000, EPIDEMIOL REV, V22, P298, DOI 10.1093/oxfordjournals.epirev.a018041; Minor Philip D., 1997, P555; *NAT POP COMM FED, 2007, LEG NOT PUBL 2006 CE; *NPC ORC MACR, 2004, NIG DEM HLTH SURV 20; PATRIARCA PA, 1991, REV INFECT DIS, V13, P926; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x; Wringe A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003433; Yang CF, 2003, J VIROL, V77, P8366, DOI 10.1128/JVI.77.15.8366-8377.2003; 2007, WKLY EPIDEMIOL REC, V82, P337; 2009, WKLY EPIDEMIOL REC, V84, P390; 2009, WKLY EPIDEMIOL REC, V84, P133; 2001, MMWR MORB MORTAL WKL, V50, P222; 2010, WKLY EPIDEMIOL REC, V85, P1; 1997, WKLY EPIDEMIOL REC, V74, P121	27	102	109	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2360	2369		10.1056/NEJMoa0910074	http://dx.doi.org/10.1056/NEJMoa0910074			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573924				2022-12-28	WOS:000279043800005
J	Ronsmans, C; Chowdhury, ME; Dasgupta, SK; Ahmed, A; Koblinsky, M				Ronsmans, Carine; Chowdhury, Mahbub E.; Dasgupta, Sushil K.; Ahmed, Anisuddin; Koblinsky, Marge			Effect of parent's death on child survival in rural Bangladesh: a cohort study	LANCET			English	Article							CAUSE-SPECIFIC MORTALITY; MATERNAL MORTALITY; POOLED ANALYSIS; INFANT; MOTHERS; AFRICA; HIV; MATLAB	Background The effect of a parent's death on the survival of the children has been assessed in only a few studies. We therefore investigated the effect of the death of the mother or father on the survival of the child up to age 10 years in rural Bangladesh. Methods We used data from population surveillance during 1982-2005 in Matlab, Bangladesh. We used Kaplan-Meier and Poisson regression analyses to compute the cumulative probabilities of survival and rates of age-specific death up to age 10 years, according to the survival status of the mother or father during that period. Findings There were 144 861 livebirths, and 14 868 children died by 10 years of age. The cumulative probability of survival to age 10 years was 24% in children whose mothers died (n=1385) before their tenth birthday, compared with 89% in those whose mothers remained alive (n=143 473). The greatest effect was noted in children aged 2-5 months whose mothers had died (rate ratio 25.05, 95% CI 18.57-33.81). The effect of the father's death (n=2691) on cumulative probability of survival of the child up to 10 years of age was negligible. Age-specific death rates did not differ in children whose fathers died compared with children whose fathers were alive. Interpretation The devastating effects of the mother's death on the survival of the child were most probably due to the abrupt cessation of breastfeeding, but the persistence of the effects up to 10 years of age suggest that the absence of maternal care might be a crucial factor.	[Ronsmans, Carine] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, London WC1E 7HT, England; [Chowdhury, Mahbub E.; Dasgupta, Sushil K.; Ahmed, Anisuddin; Koblinsky, Marge] Int Ctr Diarrhoeal Dis Res, Dhaka 1000, Bangladesh; [Chowdhury, Mahbub E.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Koblinsky, Marge] John Snow, Arlington, VA USA	University of London; London School of Hygiene & Tropical Medicine; International Centre for Diarrhoeal Disease Research (ICDDR); Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Ronsmans, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, Infect Dis Epidemiol Unit, Keppel St, London WC1E 7HT, England.				US Agency for International Development (USAID) [GHS-A00-0300019-00]; UK Department for International Development (DFID) [AG 3318, D-00024, GR 00458]; National Institutes of Health Fogarty International Center [TW007587-04]; FOGARTY INTERNATIONAL CENTER [D43TW007587] Funding Source: NIH RePORTER	US Agency for International Development (USAID)(United States Agency for International Development (USAID)); UK Department for International Development (DFID); National Institutes of Health Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by the US Agency for International Development (USAID, grant number GHS-A00-0300019-00), UK Department for International Development (DFID, grant number AG 3318), and a DFID grant through the Research Program Consortium (grant number D-00024) The salaries of MEC and CR were supported by DFID through the Research Program Consortium (GR 00458) MEC was partly supported by a training grant from the National Institutes of Health Fogarty International Center (TW007587-04) SKD. AA, and MK were partly supported by the USAID grant International Centre for Diarrhoeal Disease Research, Bangladesh acknowledges with gratitude the commitment of USAID and DFID to the centre's research efforts We thank Tom Marshall for help with the statistical analysis	Adjuik M, 2006, B WORLD HEALTH ORGAN, V84, P181, DOI 10.2471/BLT.05.026492; Anderson FWJ, 2007, MATERN CHILD HLTH J, V11, P395, DOI 10.1007/s10995-006-0173-0; Andersson T, 1996, ACTA PAEDIATR, V85, P981, DOI 10.1111/j.1651-2227.1996.tb14198.x; *BANGL BUR STAT PL, 2008, LIT ASS SURV 2008; Baqui AH, 2001, ACTA PAEDIATR, V90, P682, DOI 10.1080/080352501750258775; Bhuiya A, 1997, POP STUD-J DEMOG, V51, P57, DOI 10.1080/0032472031000149726; Blum LS, 2009, SOC SCI MED, V68, P1720, DOI 10.1016/j.socscimed.2009.01.020; BRITTAIN AW, 1992, HUM BIOL, V64, P223; CHEN LC, 1974, STUD FAMILY PLANN, V5, P334, DOI 10.2307/1965185; Chowdhury ME, 2007, LANCET, V370, P1320, DOI 10.1016/S0140-6736(07)61573-6; El Arifeen S, 2008, J HEALTH POPUL NUTR, V26, P273; FAUVEAU V, 1989, INT J EPIDEMIOL, V18, P139, DOI 10.1093/ije/18.1.139; FAUVEAU V, 1991, INT J EPIDEMIOL, V20, P729, DOI 10.1093/ije/20.3.729; Fauveau Vincent, 1994, MATLAB WOMEN CHILDRE, P65; Giashuddin MS, 2004, INDIAN J MED RES, V119, P267; *ICDDR B, 1985, 63 ICDDR B; icddr b., 2007, HLTH DEM SURV SYST M; Jayaraman A, 2009, INT PERSPECT SEX R H, V35, P29, DOI 10.1363/ifpp.35.029.09; Katz J, 2003, B WORLD HEALTH ORGAN, V81, P717; KOENIG MA, 1988, STUD FAMILY PLANN, V19, P69, DOI 10.2307/1966492; *MIN HLTH FAM WELF, 2008, SER SURV REP DHAK; National Institute of population Research and training (NIPORT), 2009, BANGL DEM HLTH SURV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Pavard S, 2005, J BIOSOC SCI, V37, P209, DOI 10.1017/S0021932004006571; Reed H, 1999, CONSEQUENCES REPROD; Richter L., 2006, BABA MEN FATHERHOOD; Saha KK, 2008, AM J CLIN NUTR, V87, P1852, DOI 10.1093/ajcn/87.6.1852; Sear R, 2002, DEMOGRAPHY, V39, P43, DOI 10.1353/dem.2002.0010; Taha TET, 1996, AIDS, V10, P111, DOI 10.1097/00002030-199601000-00021; Tamis-LeMonda C.S., 2002, HDB FATHER INVOLVEME; Victora CG, 2000, LANCET, V355, P451, DOI 10.1016/S0140-6736(00)82011-5; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	32	83	85	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					2024	2031		10.1016/S0140-6736(10)60704-0	http://dx.doi.org/10.1016/S0140-6736(10)60704-0			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569842				2022-12-28	WOS:000278689600029
J	Bergenstal, RM; Tamborlane, WV; Ahmann, A; Buse, JB; Dailey, G; Davis, SN; Joyce, C; Peoples, T; Perkins, BA; Welsh, JB; Willi, SM; Wood, MA				Bergenstal, Richard M.; Tamborlane, William V.; Ahmann, Andrew; Buse, John B.; Dailey, George; Davis, Stephen N.; Joyce, Carol; Peoples, Tim; Perkins, Bruce A.; Welsh, John B.; Willi, Steven M.; Wood, Michael A.		STAR 3 Study Grp	Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INJECTIONS	BACKGROUND Recently developed technologies for the treatment of type 1 diabetes mellitus include a variety of pumps and pumps with glucose sensors. METHODS In this 1-year, multicenter, randomized, controlled trial, we compared the efficacy of sensor-augmented pump therapy (pump therapy) with that of a regimen of multiple daily insulin injections (injection therapy) in 485 patients (329 adults and 156 children) with inadequately controlled type 1 diabetes. Patients received recombinant insulin analogues and were supervised by expert clinical teams. The primary end point was the change from the baseline glycated hemoglobin level. RESULTS At 1 year, the baseline mean glycated hemoglobin level (8.3% in the two study groups) had decreased to 7.5% in the pump-therapy group, as compared with 8.1% in the injection-therapy group (P<0.001). The proportion of patients who reached the glycated hemoglobin target (<7%) was greater in the pump-therapy group than in the injection-therapy group. The rate of severe hypoglycemia in the pump-therapy group (13.31 cases per 100 person-years) did not differ significantly from that in the injection-therapy group (13.48 per 100 person-years, P=0.58). There was no significant weight gain in either group. CONCLUSIONS In both adults and children with inadequately controlled type 1 diabetes, sensor-augmented pump therapy resulted in significant improvement in glycated hemoglobin levels, as compared with injection therapy. A significantly greater proportion of both adults and children in the pump-therapy group than in the injection-therapy group reached the target glycated hemoglobin level. (ClinicalTrials.gov number, NCT00417989.)	[Bergenstal, Richard M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA; [Tamborlane, William V.] Yale Univ, New Haven, CT USA; [Ahmann, Andrew] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Buse, John B.] Univ N Carolina, Sch Med, Chapel Hill, NC USA; [Dailey, George] Scripps Inst, La Jolla, CA USA; [Peoples, Tim; Welsh, John B.] Medtronic, Northridge, CA USA; [Davis, Stephen N.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Joyce, Carol] Mem Univ Newfoundland, Hlth Sci Ctr, St John, NF, Canada; [Perkins, Bruce A.] Toronto Gen Hosp, Toronto, ON, Canada; [Willi, Steven M.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Wood, Michael A.] Helen DeVos Childrens Hosp, Grand Rapids, MI USA	International Diabetes Center; Yale University; Oregon Health & Science University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Scripps Research Institute; Medtronic; University System of Maryland; University of Maryland Baltimore; Memorial University Newfoundland; University of Manitoba; Children's Hospital Research Institute of Manitoba; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Bergenstal, RM (corresponding author), Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA.	richard.bergenstal@parknicollet.com	Buse, John Bernard/J-9742-2019; Perkins, Bruce A/L-3726-2017	Buse, John Bernard/0000-0002-9723-3876; Battelino, Tadej/0000-0002-0273-4732; Willi, Steven/0000-0002-4910-2425; Orszag, Andrej/0000-0002-0027-1607	Abbott Diabetes Care; Amylin; Bayer; Calibra; Eli Lilly; Intarcia; MannKind; Medtronic; Novo Nordisk; Pfizer; ResMed; Roche; Sanofi-Aventis; Takeda; Biodel; Hygieia; Intuity; LifeScan; UnitedHealth Group; Valeritas; GlaxoSmithKline; Becton Dickinson; Hoffmann-La Roche; GlycoMark; Wyeth; Daiichi Sankyo; Bristol-Myers Squibb; Bayhill Therapeutics; LipoScience; MicroIslet; Exsulin; Abbott; GI Dynamics; Tolerex; Osiris; Novartis; Halozyme; Interkrin; Merck; Dexcom; Johnson Johnson; Fujisawa; Boehringer Ingelheim; Medtronic MiniMed; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637] Funding Source: NIH RePORTER	Abbott Diabetes Care(Abbott Laboratories); Amylin; Bayer(Bayer AG); Calibra; Eli Lilly(Eli Lilly); Intarcia; MannKind; Medtronic(Medtronic); Novo Nordisk(Novo Nordisk); Pfizer(Pfizer); ResMed; Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Takeda(Takeda Pharmaceutical Company Ltd); Biodel; Hygieia; Intuity; LifeScan; UnitedHealth Group; Valeritas; GlaxoSmithKline(GlaxoSmithKline); Becton Dickinson; Hoffmann-La Roche(Hoffmann-La Roche); GlycoMark; Wyeth(Wyeth); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bristol-Myers Squibb(Bristol-Myers Squibb); Bayhill Therapeutics; LipoScience; MicroIslet; Exsulin; Abbott(Abbott Laboratories); GI Dynamics; Tolerex; Osiris; Novartis(Novartis); Halozyme; Interkrin; Merck(Merck & Company); Dexcom; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Fujisawa; Boehringer Ingelheim(Boehringer Ingelheim); Medtronic MiniMed; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Bergenstal reports that the International Diabetes Center has received consulting fees from Abbott Diabetes Care, Amylin, Bayer, Calibra, Eli Lilly, Intarcia, MannKind, Medtronic, Novo Nordisk, Pfizer, ResMed, Roche, Sanofi-Aventis, and Takeda for his services; grant support from Abbott Diabetes Care, Biodel, Eli Lilly, Hygieia, Intuity, LifeScan, Medtronic, Novo Nordisk, Pfizer, ResMed, Roche, Sanofi-Aventis, Takeda, UnitedHealth Group, and Valeritas; honoraria from Abbott Diabetes Care, Amylin, Bayer, Calibra, Eli Lilly, Intarcia, MannKind, Medtronic, Novo Nordisk, Pfizer, ResMed, Roche, Sanofi-Aventis, and Takeda; royalties on his behalf for the Betty Crocker Diabetes Cookbook; and travel and accommodation reimbursements from Abbott Diabetes Care, Amylin, Bayer, Biodel, Calibra, Eli Lilly, Hygieia, Intarcia, Intuity, LifeScan, MannKind, Medtronic, Novo Nordisk, Pfizer, ResMed, Roche, Sanofi-Aventis, Takeda, UnitedHealth Group, and Valeritas; and having an equity interest in Merck. Dr. Tamborlane reports receiving consulting fees from Medtronic Diabetes as a member of the Diabetes Advisory Board. Dr. Ahmann reports that Oregon Health and Science University has received consulting fees from Biodel, Novo Nordisk, and GlaxoSmithKline for his services; grant support from Amylin, Medtronic, and Novo Nordisk; and honoraria from Amylin, Lilly, Animas, NDEI, and Medical Education Resources. Dr. Buse reports that for his services the University of North Carolina School of Medicine has received consulting fees from Novo Nordisk, Amylin, Becton Dickinson, Eli Lilly, Hoffmann-La Roche, GlycoMark, Wyeth, Daiichi Sankyo, Bristol-Myers Squibb, Bayhill Therapeutics, LipoScience, MannKind, Valeritas, MicroIslet, GlaxoSmithKline, Abbott, Exsulin, and GI Dynamics; funding from Novo Nordisk for expert testimony; grant support from Amylin, Novo Nordisk, Medtronic, Lilly, Novartis, Tolerex, Osiris, Halozyme, Pfizer, Hoffmann-La Roche, Interkrin, Merck, Sanofi-Aventis, Dexcom, Johnson & Johnson, Bristol-Myers Squibb, Fujisawa, and Novartis; and travel and accommodation reimbursement from Novo Nordisk, Amylin, Medtronic, Novartis, Tolerex, Becton Dickinson, Eli Lilly, Hoffmann-La Roche, Fujisawa, GlycoMark, Wyeth, Daiichi Sankyo, Bristol-Myers Squibb, Bayhill Therapeutics, Osiris, Interkrin, Merck, Sanofi-Aventis, Dexcom, Johnson & Johnson, Halozyme, Pfizer, LipoScience, MannKind, Valeritas, MicroIslet, GlaxoSmithKline, Abbott, Exsulin, and GI Dynamics; he also reports having an equity interest in Insulet. Dr. Joyce reports receiving consulting fees from Eli Lilly, Sanofi-Aventis, and AstraZeneca, travel reimbursement from AstraZeneca, and grant support (paid to the Memorial University of Newfoundland) from Eli Lilly, Sanofi-Aventis, AstraZeneca, and Boehringer Ingelheim. Mr. Peoples and Dr. Welsh report being employees of and having an equity interest in Medtronic and receiving compensation for manuscript preparation. Dr. Willi reports that the Children's Hospital of Philadelphia has received grant support from Sanofi-Aventis for his services. Dr. Wood reports receiving consulting fees from Medtronic MiniMed. No other potential conflict of interest relevant to this article was reported. Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Beck RW, 2009, DIABETES CARE, V32, P1947, DOI 10.2337/dc09-0889; Davis SN, 2010, DIABETES TECHNOL THE, V12, P249, DOI 10.1089/dia.2009.0145; DCCT Res Grp, 1994, J PEDIATR-US, V125, P177, DOI 10.1016/S0022-3476(94)70190-3; Hermanides J, 2009, DIABETOLOGIA, V52, pS43; Hirsch IB, 2005, NEW ENGL J MED, V352, P174, DOI 10.1056/NEJMra040832; Hirsch IB, 2008, DIABETES TECHNOL THE, V10, P377, DOI 10.1089/dia.2008.0068; Misso ML, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005103.pub2; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Pickup JC, 2008, DIABETIC MED, V25, P765, DOI 10.1111/j.1464-5491.2008.02486.x; Raccah D, 2009, DIABETES CARE, V32, P2245, DOI 10.2337/dc09-0750; Tamborlane WV, 2008, NEW ENGL J MED, V359, P1464, DOI 10.1056/NEJMoa0805017	13	562	588	5	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					311	320		10.1056/NEJMoa1002853	http://dx.doi.org/10.1056/NEJMoa1002853			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628RU	20587585	Green Published			2022-12-28	WOS:000280139300004
J	Fischer, N; Konevega, AL; Wintermeyer, W; Rodnina, MV; Stark, H				Fischer, Niels; Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.; Stark, Holger			Ribosome dynamics and tRNA movement by time-resolved electron cryomicroscopy	NATURE			English	Article							ELONGATION-FACTOR-G; ESCHERICHIA-COLI RIBOSOMES; MESSENGER-RNA; L1 STALK; INTERMEDIATE STATES; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; SINGLE RIBOSOMES; GTP HYDROLYSIS; HYBRID STATES	The translocation step of protein synthesis entails large-scale rearrangements of the ribosome-transfer RNA (tRNA) complex. Here we have followed tRNA movement through the ribosome during translocation by time-resolved single-particle electron cryomicroscopy (cryo-EM). Unbiased computational sorting of cryo-EM images yielded 50 distinct three-dimensional reconstructions, showing the tRNAs in classical, hybrid and various novel intermediate states that provide trajectories and kinetic information about tRNA movement through the ribosome. The structures indicate how tRNA movement is coupled with global and local conformational changes of the ribosome, in particular of the head and body of the small ribosomal subunit, and show that dynamic interactions between tRNAs and ribosomal residues confine the path of the tRNAs through the ribosome. The temperature dependence of ribosome dynamics reveals a surprisingly flat energy landscape of conformational variations at physiological temperature. The ribosome functions as a Brownian machine that couples spontaneous conformational changes driven by thermal energy to directed movement.	[Fischer, Niels; Stark, Holger] Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, D-37077 Gottingen, Germany; [Konevega, Andrey L.; Wintermeyer, Wolfgang; Rodnina, Marina V.] Max Planck Inst Biophys Chem, Dept Phys Biochem, D-37077 Gottingen, Germany; [Konevega, Andrey L.] Petersburg Nucl Phys Inst, Gatchina 188300, Russia	Max Planck Society; Max Planck Society; National Research Centre - Kurchatov Institute; Petersburg Nuclear Physics Institute	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Elect Cryomicroscopy Grp 3D, Fassberg 11, D-37077 Gottingen, Germany.	hstark1@gwdg.de	Fischer, Niels/ABA-5342-2021; Rodnina, Marina V./AAD-4667-2019; Konevega, Andrey L./B-7887-2008	Fischer, Niels/0000-0002-4609-4052; Rodnina, Marina V./0000-0003-0105-3879; Konevega, Andrey L./0000-0003-0125-7150; Holger, Stark/0000-0002-6161-1118; Wintermeyer, Wolfgang/0000-0001-5119-8481	Federal Ministry of Education and Research (BMBF), Germany; European Union; state of Lower-Saxony; Volkswagen Foundation, Hannover, Germany; Boehringer-Ingelheim fellowship; Deutsche Forschungsgemeinschaft	Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); state of Lower-Saxony(European Commission); Volkswagen Foundation, Hannover, Germany(Volkswagen); Boehringer-Ingelheim fellowship(Boehringer Ingelheim); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank C. Blau for technical help in preparing Fig. 4. Research in the laboratory of H.S. was supported by grants from the Federal Ministry of Education and Research (BMBF), Germany, the Sixth Framework Programme of the European Union via the Integrated Project 3DRepertoire, by the state of Lower-Saxony and the Volkswagen Foundation, Hannover, Germany. N.F. was supported by a Boehringer-Ingelheim fellowship. M.V.R. and W.W. were supported by grants from the Deutsche Forschungsgemeinschaft.	Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Astumian RD, 1997, SCIENCE, V276, P917, DOI 10.1126/science.276.5314.917; BELLARE JR, 1988, J ELECTRON MICR TECH, V10, P87, DOI 10.1002/jemt.1060100111; BHAT TN, 1984, J APPL CRYSTALLOGR, V17, P244, DOI 10.1107/S0021889884011456; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; CORDOVA NJ, 1992, P NATL ACAD SCI USA, V89, P339, DOI 10.1073/pnas.89.1.339; Cornish PV, 2008, MOL CELL, V30, P578, DOI 10.1016/j.molcel.2008.05.004; Cornish PV, 2009, P NATL ACAD SCI USA, V106, P2571, DOI 10.1073/pnas.0813180106; DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297; Ermolenko DN, 2007, J MOL BIOL, V370, P530, DOI 10.1016/j.jmb.2007.04.042; Fei J, 2008, MOL CELL, V30, P348, DOI 10.1016/j.molcel.2008.03.012; Fei JY, 2009, P NATL ACAD SCI USA, V106, P15702, DOI 10.1073/pnas.0908077106; Frank J, 2000, NATURE, V406, P318, DOI 10.1038/35018597; Fredrick K, 2003, SCIENCE, V300, P1159, DOI 10.1126/science.1084571; GAVRILOVA LP, 1976, J MOL BIOL, V101, P537, DOI 10.1016/0022-2836(76)90243-6; Jenner L, 2007, EMBO REP, V8, P846, DOI 10.1038/sj.embor.7401044; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; Kim HD, 2007, BIOPHYS J, V93, P3575, DOI 10.1529/biophysj.107.109884; Konevega AL, 2007, NAT STRUCT MOL BIOL, V14, P318, DOI 10.1038/nsmb1221; Korostelev A, 2006, CELL, V126, P1065, DOI 10.1016/j.cell.2006.08.032; Lancaster LE, 2008, MOL MICROBIOL, V69, P390, DOI 10.1111/j.1365-2958.2008.06283.x; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Marshall RA, 2008, P NATL ACAD SCI USA, V105, P15364, DOI 10.1073/pnas.0805299105; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Munro JB, 2007, MOL CELL, V25, P505, DOI 10.1016/j.molcel.2007.01.022; Munro JB, 2010, P NATL ACAD SCI USA, V107, P709, DOI 10.1073/pnas.0908597107; Pan DL, 2007, MOL CELL, V25, P519, DOI 10.1016/j.molcel.2007.01.014; PAULSEN H, 1986, BIOCHEMISTRY-US, V25, P2749, DOI 10.1021/bi00358a002; ROBERTSON JM, 1986, J MOL BIOL, V192, P351, DOI 10.1016/0022-2836(86)90370-0; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Sander B, 2005, J STRUCT BIOL, V151, P92, DOI [10.1016/j.jsb.2005.04.004, 10.1016/j.jsb,2005.04.004]; Sander B, 2003, J STRUCT BIOL, V143, P219, DOI 10.1016/j.jsb.2003.08.001; Sander B, 2003, J STRUCT BIOL, V142, P392, DOI 10.1016/S1047-8477(03)00072-8; Savelsbergh A, 2005, EMBO J, V24, P4316, DOI 10.1038/sj.emboj.7600884; Savelsbergh A, 2003, MOL CELL, V11, P1517, DOI 10.1016/S1097-2765(03)00230-2; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Shoji S, 2006, MOL CELL, V24, P931, DOI 10.1016/j.molcel.2006.11.025; Taylor DJ, 2007, EMBO J, V26, P2421, DOI 10.1038/sj.emboj.7601677; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Villa E, 2009, P NATL ACAD SCI USA, V106, P1063, DOI 10.1073/pnas.0811370106; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	44	295	297	0	74	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					329	333		10.1038/nature09206	http://dx.doi.org/10.1038/nature09206			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631791				2022-12-28	WOS:000279867100040
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling The case of the sugar sweetened beverage tax	BRITISH MEDICAL JOURNAL			English	Editorial Material												dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	11	11	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 14	2010	341								c3719	10.1136/bmj.c3719	http://dx.doi.org/10.1136/bmj.c3719			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XC	20630952				2022-12-28	WOS:000280156700006
J	Kidd, LR; Hanumantharaya, DH				Kidd, Lawrence R.; Hanumantharaya, D. H.			Case report Sprouting a warfarin interaction	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							ANTICOAGULATION		[Kidd, Lawrence R.] Singleton Hosp, Swansea SA2 8QA, W Glam, Wales; [Hanumantharaya, D. H.] Morriston Hosp, Swansea, W Glam, Wales	Singleton Hospital; Morriston Hospital	Kidd, LR (corresponding author), Singleton Hosp, Swansea SA2 8QA, W Glam, Wales.	kiddlr@cardiff.ac.uk						Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Baglin TP, 2006, BRIT J HAEMATOL, V132, P277, DOI 10.1111/j.1365-2141.2005.05856.x; Booth Sarah L., 1993, Journal of Food Composition and Analysis, V6, P109, DOI 10.1006/jfca.1993.1014; CHOW WH, 1990, POSTGRAD MED J, V66, P855, DOI 10.1136/pgmj.66.780.855; CONLY JM, 1994, AM J GASTROENTEROL, V89, P915; HARRIS JE, 1995, J AM DIET ASSOC, V95, P580, DOI 10.1016/S0002-8223(95)00158-1; KEMPIN SJ, 1983, NEW ENGL J MED, V308, P1229; Makris M, 2010, J THROMB THROMBOLYS, V29, P171, DOI 10.1007/s11239-009-0412-5; NELSESTUEN GL, 1976, J BIOL CHEM, V251, P5648; OKAJIMA K, 1990, THROMB HAEMOSTASIS, V63, P48; WALKER FB, 1984, ARCH INTERN MED, V144, P2089, DOI 10.1001/archinte.144.10.2089; Watson HG, 2001, BRIT J HAEMATOL, V115, P145, DOI 10.1046/j.1365-2141.2001.03070.x; WELLS PS, 1994, ANN INTERN MED, V121, P676, DOI 10.7326/0003-4819-121-9-199411010-00009	13	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2010	341								c2621	10.1136/bmj.c2621	http://dx.doi.org/10.1136/bmj.c2621			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XC	20630973				2022-12-28	WOS:000280156700001
J	Wang, KL				Wang, Kelin			Finding Fault in Fault Zones	SCIENCE			English	Editorial Material							EARTHQUAKES; RECORD		[Wang, Kelin] Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada; [Wang, Kelin] Univ Victoria, Sch Earth & Ocean Sci, Victoria, BC V8W 3P6, Canada	Natural Resources Canada; Lands & Minerals Sector - Natural Resources Canada; Geological Survey of Canada; University of Victoria	Wang, KL (corresponding author), Geol Survey Canada, Pacific Geosci Ctr, Sidney, BC V8L 4B2, Canada.	kwang@nrcan.gc.ca						Bilek SL, 2003, GEOLOGY, V31, P455, DOI 10.1130/0091-7613(2003)031<0455:COSROE>2.0.CO;2; Dean SM, 2010, SCIENCE, V329, P207, DOI 10.1126/science.1189373; Dixon T., 2007, SEISMOGENIC ZONE SUB; Hacker BR, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001127; Kimura H, 2010, SCIENCE, V329, P210, DOI 10.1126/science.1187115; Kodaira S, 2000, SCIENCE, V289, P104, DOI 10.1126/science.289.5476.104; MELTZNER A, 2009, AGU FALL M S; Meneghini F, 2010, GEOL SOC AM BULL, V122, P1280, DOI 10.1130/B30049.1; RUFF LJ, 1989, PURE APPL GEOPHYS, V129, P263, DOI 10.1007/BF00874629; Sibson RH, 2003, B SEISMOL SOC AM, V93, P1169, DOI 10.1785/0120020061; Templeton EL, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005529; Tilmann FJ, 2010, GEOPHYS J INT, V181, P1261, DOI 10.1111/j.1365-246X.2010.04597.x; Vannucchi P, 2008, NATURE, V451, P699, DOI 10.1038/nature06486; von Huene R, 2009, FRONT EARTH SCI SER, P137; Wang KL, 2010, GEOLOGY, V38, P431, DOI 10.1130/G30597.1; Wang KL, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2003GL018644; Wesnousky SG, 2006, NATURE, V444, P358, DOI 10.1038/nature05275; Wibberley CAJ, 2008, GEOL SOC SPEC PUBL, V299, P5, DOI 10.1144/SP299.2	18	14	17	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					152	153		10.1126/science.1192223	http://dx.doi.org/10.1126/science.1192223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616257				2022-12-28	WOS:000279635200024
J	Goodall, J; Pintea, L				Goodall, Jane; Pintea, Lilian			Securing a future for chimpanzees	NATURE			English	Editorial Material									[Goodall, Jane; Pintea, Lilian] Jane Goodall Inst, Arlington, VA 22203 USA		Goodall, J (corresponding author), Jane Goodall Inst, 4245 N Fairfax Dr,Suite 600, Arlington, VA 22203 USA.	lpintea@janegoodall.org							0	2	2	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					180	181		10.1038/466180a	http://dx.doi.org/10.1038/466180a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613821				2022-12-28	WOS:000279580800016
J	Sinclair, AJ; Burdon, MA; Nightingale, PG; Ball, AK; Good, P; Matthews, TD; Jacks, A; Lawden, M; Clarke, CE; Stewart, PM; Walker, EA; Tomlinson, JW; Rauz, S				Sinclair, Alexandra J.; Burdon, Michael A.; Nightingale, Peter G.; Ball, Alexandra K.; Good, Peter; Matthews, Timothy D.; Jacks, Andrew; Lawden, Mark; Clarke, Carl E.; Stewart, Paul M.; Walker, Elizabeth A.; Tomlinson, Jeremy W.; Rauz, Saaeha			Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							WEIGHT-LOSS; HEADACHE IMPACT; FOLLOW-UP; ACETAZOLAMIDE; TOPIRAMATE; CEREBRI	Objective To observe intracranial pressure in women with idiopathic intracranial hypertension who follow a low energy diet. Design Prospective cohort study. Setting Outpatient department and the clinical research facility based at two separate hospitals within the United Kingdom. Participants 25 women with body mass index (BMI) > 25, with active (papilloedema and intracranial pressure > 25 cm H2O), chronic (over three months) idiopathic intracranial hypertension. Women who had undergone surgery to treat idiopathic intracranial hypertension were excluded. Intervention Stage 1: no new intervention; stage 2: nutritionally complete low energy (calorie) diet (1777 kJ/day (425 kcal/day)); stage 3: follow-up period after the diet. Each stage lasted three months. Main outcome measure The primary outcome was reduction in intracranial pressure after the diet. Secondary measures included score on headache impact test-6, papilloedema (as measured by ultrasonography of the elevation of the optic disc and diameter of the nerve sheath, together with thickness of the peripapillary retina measured by optical coherence tomography), mean deviation of Humphrey visual field, LogMAR visual acuity, and symptoms. Outcome measures were assessed at baseline and three, six, and nine months. Lumbar puncture, to quantify intracranial pressure, was measured at baseline and three and six months. Results All variables remained stable over stage 1. During stage 2, there were significant reductions in weight (mean 15.7 (SD 8.0) kg, P<0.001), intracranial pressure (mean 8.0 (SD 4.2) cm H2O, P<0.001), score on headache impact test (7.6 (SD 10.1), P=0.004), and papilloedema (optic disc elevation (mean 0.15 (SD 0.23) mm, P=0.002), diameter of the nerve sheath (mean 0.7 (SD 0.8) mm, P=0.004), and thickness of the peripapillary retina (mean 25.7 (SD 36.1) mu, P=0.001)). Mean deviation of the Humphrey visual field remained stable, and in only five patients, the LogMAR visual acuity improved by one line. Fewer women reported symptoms including tinnitus, diplopia, and obscurations (10 v 4, P=0.004; 7 v 0, P=0.008; and 4 v 0, P=0.025, respectively). Re-evaluation at three months after the diet showed no significant change in weight (0.21 (SD 6.8) kg), and all outcome measures were maintained. Conclusion Women with idiopathic intracranial hypertension who followed a low energy diet for three months had significantly reduced intracranial pressure compared with pressure measured in the three months before the diet, as well as improved symptoms and reduced papilloedema. These reductions persisted for three months after they stopped the diet.	[Sinclair, Alexandra J.; Rauz, Saaeha] Univ Birmingham, Acad Unit Ophthalmol, Sch Immun & Infect, Coll Med & Dent Sci,MRC, Birmingham B15 2TT, W Midlands, England; [Sinclair, Alexandra J.] Univ Birmingham, Ctr Endocrinol Diabet & Metab, Sch Clin & Expt Med, Coll Med & Dent Sci,MRC, Birmingham B15 2TT, W Midlands, England; [Nightingale, Peter G.] Univ Birmingham, Wellcome Trust Clin Res Facil, Coll Med & Dent Sci, Birmingham B15 2TT, W Midlands, England; [Good, Peter; Matthews, Timothy D.; Jacks, Andrew] Univ Hosp Birmingham NHS Fdn Trust, Birmingham Neuroophthalmol Unit, Birmingham B15 2TH, W Midlands, England; [Lawden, Mark] Leicester Gen Hosp, Dept Neurol, Leicester LE5 4PW, Leics, England	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University Hospitals of Leicester NHS Trust; Leicester General Hospital	Rauz, S (corresponding author), Univ Birmingham, Acad Unit Ophthalmol, Sch Immun & Infect, Coll Med & Dent Sci,MRC, Birmingham B15 2TT, W Midlands, England.	s.rauz@bham.ac.uk	Rauz, Saaeha/ABF-2202-2021	Clarke, Carl/0000-0003-2478-3436; Rauz, Saaeha/0000-0003-4627-3496; Sinclair, Alexandra/0000-0003-2777-5132; Tomlinson, Jeremy/0000-0002-3170-8533	British Medical Association; Sandwell and West Birmingham Hospitals NHS Trust; West Midlands Neuroscience Teaching and Research Fund; Birmingham Eye Foundation (Registered (UK) [257549]; MRC [G0601430] Funding Source: UKRI; Medical Research Council [G0601430] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	British Medical Association; Sandwell and West Birmingham Hospitals NHS Trust; West Midlands Neuroscience Teaching and Research Fund; Birmingham Eye Foundation (Registered (UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Vera Down (Neurological Diseases) 2005 and Clark and McMaster (Blinding Diseases) 2005 Awards funded by the British Medical Association, a research and development award 2005 from Sandwell and West Birmingham Hospitals NHS Trust, and by the West Midlands Neuroscience Teaching and Research Fund. AJS is a Brain Trust entry/exit scholar, Ipsen Research Fellow and MRC clinical training fellow (G0601430). The Academic Unit of Ophthalmology is supported by the Birmingham Eye Foundation (Registered (UK) Charity 257549). JWT is a MRC senior clinical fellow.	Bynke G, 2004, NEUROLOGY, V63, P1314, DOI 10.1212/01.WNL.0000140699.43019.48; Celebisoy N, 2007, ACTA NEUROL SCAND, V116, P322, DOI 10.1111/j.1600-0404.2007.00905.x; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; CORBETT JJ, 1982, ARCH NEUROL-CHICAGO, V39, P461, DOI 10.1001/archneur.1982.00510200003001; Castro DPE, 2008, ARQ BRAS OFTALMOL, V71, P523, DOI 10.1590/S0004-27492008000400011; Evers S, 2004, SCHMERZ, V18, P351; *FDA, 2009, ORL MARK ALL XEN EAR; Flum DR, 2009, NEW ENGL J MED, V361, P445, DOI 10.1056/NEJMoa0901836; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; FRISEN L, 1982, J NEUROL NEUROSUR PS, V45, P13, DOI 10.1136/jnnp.45.1.13; Glueck CJ, 2005, J LAB CLIN MED, V145, P72, DOI 10.1016/j.lab.2004.09.011; Johnson LN, 1998, OPHTHALMOLOGY, V105, P2313, DOI 10.1016/S0161-6420(98)91234-9; Kosinski M, 2003, QUAL LIFE RES, V12, P963, DOI 10.1023/A:1026119331193; Kupersmith MJ, 1998, NEUROLOGY, V50, P1094, DOI 10.1212/WNL.50.4.1094; Li ZP, 2005, ANN INTERN MED, V142, P532, DOI 10.7326/0003-4819-142-7-200504050-00012; LUECK C, 2005, COCHRANE DB SYST REV, V3; NEWBORG B, 1974, ARCH INTERN MED, V133, P802, DOI 10.1001/archinte.133.5.802; Rebolleda G, 2009, INVEST OPHTH VIS SCI, V50, P5197, DOI 10.1167/iovs.08-2528; Rosenfeld WE, 1997, CLIN THER, V19, P1294, DOI 10.1016/S0149-2918(97)80006-9; Sacks FM, 2009, NEW ENGL J MED, V360, P859, DOI 10.1056/NEJMoa0804748; Shin HE, 2008, J CLIN NEUROL, V4, P158, DOI 10.3988/jcn.2008.4.4.158; Sinclair AJ, 2008, J NEUROIMMUNOL, V201, P212, DOI 10.1016/j.jneuroim.2008.06.029; SUGERMAN HJ, 1995, NEUROLOGY, V45, P1655, DOI 10.1212/WNL.45.9.1655; Tamburrelli C, 2000, INVEST OPHTH VIS SCI, V41, P2960; Tomlinson JW, 2004, J CLIN ENDOCR METAB, V89, P2711, DOI 10.1210/jc.2003-031376; Whiteley W, 2006, NEUROLOGY, V67, P1690, DOI 10.1212/01.wnl.0000242704.60275.e9; Who,, 2010, BMI CLASSIFICATION; Williams G, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c824; Wong R, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-15	29	171	173	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 7	2010	341								c2701	10.1136/bmj.c2701	http://dx.doi.org/10.1136/bmj.c2701			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DL	20610512	hybrid, Green Published			2022-12-28	WOS:000279874300001
J	Ikawa, T; Hirose, S; Masuda, K; Kakugawa, K; Satoh, R; Shibano-Satoh, A; Kominami, R; Katsura, Y; Kawamoto, H				Ikawa, Tomokatsu; Hirose, Satoshi; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Kominami, Ryo; Katsura, Yoshimoto; Kawamoto, Hiroshi			An Essential Developmental Checkpoint for Production of the T Cell Lineage	SCIENCE			English	Article							PROGENITORS; COMMITMENT; GENE; EXPRESSION; THYMUS; BCL11B; MICE; PAX5	In early T cell development, progenitors retaining the potential to generate myeloid and natural killer lineages are eventually determined to a specific T cell lineage. The molecular mechanisms that drive this determination step remain unclarified. We show that, when murine hematopoietic progenitors were cultured on immobilized Notch ligand DLL4 protein in the presence of a cocktail of cytokines including interleukin-7, progenitors developing toward T cells were arrested and the arrested cells entered a self-renewal cycle, maintaining non-T lineage potentials. Reduced concentrations of interleukin-7 promoted T cell lineage determination. A similar arrest and self-renewal of progenitors were observed in thymocytes of mice deficient in the transcription factor Bcl11b. Our study thus identifies the earliest checkpoint during T cell development and shows that it is Bcl11b-dependent.	[Ikawa, Tomokatsu; Masuda, Kyoko; Kakugawa, Kiyokazu; Satoh, Rumi; Shibano-Satoh, Asako; Katsura, Yoshimoto; Kawamoto, Hiroshi] RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Hirose, Satoshi; Kominami, Ryo] Niigata Univ, Grad Sch Med & Dent Sci, Dept Mol Genet, Niigata 9518510, Japan; [Katsura, Yoshimoto] Nihon Univ, Sch Med, Adv Med Res Ctr, Div Cell Regenerat & Transplantat, Tokyo 1738610, Japan	RIKEN; Niigata University; Nihon University	Kawamoto, H (corresponding author), RIKEN, Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan.	kawamoto@rcai.riken.jp	Hirose, Satoshi/CAF-1500-2022	Hirose, Satoshi/0000-0001-7825-501X; Kakugawa, Kiyokazu/0000-0002-2560-5562	Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors are grateful to C. Murre, T. Kadesch, Y. Agata, and S. Yamasaki for providing us with reagents and protocols, and to P. Burrows for critical reading of the manuscript. This work was partially supported by Grant-in-Aid for Young Scientists (A) from the Ministry of Education, Science, Sports, and Culture, Japan.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Fehling HJ, 1997, CURR OPIN IMMUNOL, V9, P263, DOI 10.1016/S0952-7915(97)80146-X; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Ikawa T, 2004, IMMUNITY, V20, P349, DOI 10.1016/S1074-7613(04)00049-4; Katsura Y, 2002, NAT REV IMMUNOL, V2, P127, DOI 10.1038/nri721; Katsura Y, 2001, Int Rev Immunol, V20, P1, DOI 10.3109/08830180109056720; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Lu M, 2002, J IMMUNOL, V169, P3519, DOI 10.4049/jimmunol.169.7.3519; Masuda K, 2007, J IMMUNOL, V179, P3699, DOI 10.4049/jimmunol.179.6.3699; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Takahama Y, 2006, NAT REV IMMUNOL, V6, P127, DOI 10.1038/nri1781; Wada H, 2008, NATURE, V452, P768, DOI 10.1038/nature06839; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wakabayashi Y, 2003, BIOCHEM BIOPH RES CO, V301, P598, DOI 10.1016/S0006-291X(02)03069-3; Yu Q, 2004, J EXP MED, V200, P797, DOI 10.1084/jem.20032183	21	228	230	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					93	96		10.1126/science.1188995	http://dx.doi.org/10.1126/science.1188995			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595615				2022-12-28	WOS:000279402700040
J	Li, L; Leid, M; Rothenberg, EV				Li, Long; Leid, Mark; Rothenberg, Ellen V.			An Early T Cell Lineage Commitment Checkpoint Dependent on the Transcription Factor Bcl11b	SCIENCE			English	Article							ALPHA-BETA; DENDRITIC CELLS; EXPRESSION; DIFFERENTIATION; SURVIVAL; PATHWAY; GENE; DECISION; GATA-3; NOTCH1	The identities of the regulators that mediate commitment of hematopoietic precursors to the T lymphocyte lineage have been unknown. The last stage of T lineage commitment in vivo involves mechanisms to suppress natural killer cell potential, to suppress myeloid and dendritic cell potential, and to silence the stem cell or progenitor cell regulatory functions that initially provide T cell receptor-independent self-renewal capability. The zinc finger transcription factor Bcl11b is T cell-specific in expression among hematopoietic cell types and is first expressed in precursors immediately before T lineage commitment. We found that Bcl11b is necessary for T lineage commitment in mice and is specifically required both to repress natural killer cell-associated genes and to down-regulate a battery of stem cell or progenitor cell genes at the pivotal stage of commitment.	[Li, Long; Rothenberg, Ellen V.] CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA; [Leid, Mark] Oregon State Univ, Dept Pharmaceut Sci, Corvallis, OR 97331 USA	California Institute of Technology; Oregon State University	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X; Li, Long/0000-0002-4727-9307	California Institute; NIH [R33 HL089123, RC2 CA148278, R01 GM60852]; Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER [F06TW002367] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [RC2CA148278] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL089123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060852] Funding Source: NIH RePORTER	California Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Caltech-City of Hope Biomedical Initiative; Louis Garfinkle Memorial Laboratory; Al Sherman Foundation; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Liu, H. Kawamoto, P. Li, T. Ikawa, D. Scripture-Adams, and members of the Rothenberg lab for sharing unpublished results and helpful discussion; D. Metzger and J.-M. Bornert for help with generation of the floxed Bcl11b mice; H.-Y. Kueh for guidance in data analysis; T. Taghon and F. Costantini for vectors and mice; D. Perez and R. Diamond for flow cytometry support; and R. Butler and S. Washburn for animal care and breeding supervision. Supported by a California Institute for Regenerative Medicine fellowship (L. L.), NIH grants R33 HL089123 and RC2 CA148278 (E. V. R.), NIH grant R01 GM60852 (M. L.), the Caltech-City of Hope Biomedical Initiative, the Louis Garfinkle Memorial Laboratory Fund, the Al Sherman Foundation, and the A. B. Ruddock Professorship.	Albu DI, 2007, J EXP MED, V204, P3003, DOI 10.1084/jem.20070863; Bain G, 1999, J EXP MED, V189, P289, DOI 10.1084/jem.189.2.289; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Ciofani M, 2006, IMMUNOL RES, V34, P117, DOI 10.1385/IR:34:2:117; David-Fung ES, 2009, DEV BIOL, V325, P444, DOI 10.1016/j.ydbio.2008.10.021; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787; Georgescu C, 2008, P NATL ACAD SCI USA, V105, P20100, DOI 10.1073/pnas.0806501105; Golonzhka O, 2009, J INVEST DERMATOL, V129, P1459, DOI 10.1038/jid.2008.392; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Inoue J, 2006, J IMMUNOL, V176, P5871, DOI 10.4049/jimmunol.176.10.5871; Kamimura K, 2007, BIOCHEM BIOPH RES CO, V355, P538, DOI 10.1016/j.bbrc.2007.02.003; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Martin CH, 2003, NAT IMMUNOL, V4, P866, DOI 10.1038/ni965; O'Neil J, 2004, CANCER CELL, V5, P587, DOI 10.1016/j.ccr.2004.05.023; Przybylski GK, 2005, LEUKEMIA, V19, P201, DOI 10.1038/sj.leu.2403619; Rosenbauer F, 2006, NAT GENET, V38, P27, DOI 10.1038/ng1679; Rothenberg EV, 2008, NAT REV IMMUNOL, V8, P9, DOI 10.1038/nri2232; Rothenberg EV, 2007, IMMUNITY, V26, P690, DOI 10.1016/j.immuni.2007.06.005; Shigematsu H, 2004, IMMUNITY, V21, P43, DOI 10.1016/j.immuni.2004.06.011; Takatori H, 2009, J EXP MED, V206, P35, DOI 10.1084/jem.20072713; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; Vosshenrich CAJ, 2007, J EXP MED, V204, P2569, DOI 10.1084/jem.20071451; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Welner RS, 2007, BLOOD, V109, P4825, DOI 10.1182/blood-2006-08-043810; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yui MA, 2010, J IMMUNOL, V185, P284, DOI 10.4049/jimmunol.1000679; Zhong Y, 2007, ONCOGENE, V26, P6937, DOI 10.1038/sj.onc.1210494	32	264	268	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					89	93		10.1126/science.1188989	http://dx.doi.org/10.1126/science.1188989			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595614	Green Accepted			2022-12-28	WOS:000279402700039
J	O'Reilly, J; Jones, MM; Parnham, J; Lovibond, K; Rudolf, M				O'Reilly, John; Jones, Melvyn M.; Parnham, Jill; Lovibond, Kate; Rudolf, Michael		Guideline Dev Grp	Guidelines Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AIR-FLOW OBSTRUCTION; DIAGNOSIS; COPD		[O'Reilly, John] Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England; [Jones, Melvyn M.] UCL, Sch Med, Dept Primary Care & Populat Hlth, London N19 5LW, England; [Jones, Melvyn M.] Warden Lodge Surg, Cheshunt EN8 8NW, England; [Parnham, Jill; Lovibond, Kate] Royal Coll Phys London, Natl Clin Guideline Ctr, London NW1 4LE, England; [Rudolf, Michael] Ealing Hosp NHS Trust, Ealing UB1 3HW, England	Aintree University Hospitals NHS Foundation Trust; University of London; University College London; UCL Medical School	O'Reilly, J (corresponding author), Aintree Univ Hosp NHS Fdn Trust, Liverpool L9 7AL, Merseyside, England.	john.oreilly@aintree.nhs.uk	Jones, Melvyn/C-2300-2008	Jones, Melvyn/0000-0002-8766-7443; O'Reilly, John/0000-0001-6708-2459; GRUFFYDD-JONES, KEVIN/0000-0002-4651-5961				[Anonymous], 2008, GLOB STRAT DIAGN MAN; British Lung Foundation, 2007, INV LIV CHRON OBSTR; Celli BR, 2003, EUR RESPIR J, V22, P268, DOI 10.1183/09031936.03.00075102; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; Cerveri I, 2008, THORAX, V63, P1040, DOI 10.1136/thx.2008.095554; Department of Health, 2010, CONS STRAT SERV COPD; FLETCHER CM, 1959, BMJ-BRIT MED J, V2, P257, DOI 10.1136/bmj.2.5147.257; Hardie JA, 2002, EUR RESPIR J, V20, P1117, DOI 10.1183/09031936.02.00023202; *HC, 2006, CLEAN AIR NAT STUD C; Hnizdo Eva, 2006, COPD, V3, P95, DOI 10.1080/15412550600651552; *NAT I HLTH CLIN E, 2008, PUBL HLTH GUID NAT I, V10; *NAT I HLTH CLIN E, 2007, 123 NAT I HLTH CLIN; *NAT I HLTH CLIN E, 2010, CLIN GUID NAT I HLTH, V101; Perez-Padilla Rogelio, 2007, COPD, V4, P113, DOI 10.1080/15412550701341012; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Shirtcliffe P, 2007, EUR RESPIR J, V30, P232, DOI 10.1183/09031936.00157906; Swanney MP, 2008, THORAX, V63, P1046, DOI 10.1136/thx.2008.098483; 2008, THORAX S7, V63; 2004, THORAX S1, V59	20	55	56	1	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 25	2010	340								c3134	10.1136/bmj.c3134	http://dx.doi.org/10.1136/bmj.c3134			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IR	20581031				2022-12-28	WOS:000279346600002
J	Armitage, JM; Bowman, L; Clarke, RJ; Wallendszus, K; Bulbulia, R; Rahimi, K; Haynes, R; Parish, S; Sleight, P; Peto, R; Collins, R				Armitage, Jane M.; Bowman, Louise; Clarke, Robert J.; Wallendszus, Karl; Bulbulia, Richard; Rahimi, Kazem; Haynes, Richard; Parish, Sarah; Sleight, Peter; Peto, Richard; Collins, Rory		SEARCH Collaborative Grp	Effects of Homocysteine-Lowering With Folic Acid Plus Vitamin B-12 vs Placebo on Mortality and Major Morbidity in Myocardial Infarction Survivors A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REQUIRING PROLONGED OBSERVATION; CARDIOVASCULAR EVENTS; RISK-FACTOR; PLASMA HOMOCYSTEINE; STROKE PREVENTION; VASCULAR-DISEASE; HIP FRACTURE; B-VITAMINS; SUPPLEMENTATION; FORTIFICATION	Context Blood homocysteine levels are positively associated with cardiovascular disease, but it is uncertain whether the association is causal. Objective To assess the effects of reducing homocysteine levels with folic acid and vitamin B-12 on vascular and nonvascular outcomes. Design, Setting, and Patients Double-blind randomized controlled trial of 12 064 survivors of myocardial infarction in secondary care hospitals in the United Kingdom between 1998 and 2008. Interventions 2 mg folic acid plus 1 mg vitamin B12 daily vs matching placebo. Main Outcome Measures First major vascular event, defined as major coronary event (coronary death, myocardial infarction, or coronary revascularization), fatal or nonfatal stroke, or noncoronary revascularization. Results Allocation to the study vitamins reduced homocysteine by a mean of 3.8 mu mol/L (28%). During 6.7 years of follow-up, major vascular events occurred in 1537 of 6033 participants (25.5%) allocated folic acid plus vitamin B12 vs 1493 of 6031 participants (24.8%) allocated placebo (risk ratio [RR], 1.04; 95% confidence interval [CI], 0.97-1.12; P=.28). There were no apparent effects on major coronary events (vitamins, 1229 [20.4%], vs placebo, 1185 [19.6%]; RR, 1.05; 95% CI, 0.97-1.13), stroke (vitamins, 269 [4.5%], vs placebo, 265 [4.4%]; RR, 1.02; 95% CI, 0.86-1.21), or noncoronary revascularizations (vitamins, 178 [3.0%], vs placebo, 152 [2.5%]; RR, 1.18; 95% CI, 0.95-1.46). Nor were there significant differences in the numbers of deaths attributed to vascular causes (vitamins, 578 [9.6%], vs placebo, 559 [9.3%]) or nonvascular causes (vitamins, 405 [6.7%], vs placebo, 392 [6.5%]) or in the incidence of any cancer (vitamins, 678 [11.2%], vs placebo, 639 [10.6%]). Conclusion Substantial long-term reductions in blood homocysteine levels with folic acid and vitamin B12 supplementation did not have beneficial effects on vascular outcomes but were also not associated with adverse effects on cancer incidence.	[Armitage, Jane M.; Bowman, Louise; Clarke, Robert J.; Wallendszus, Karl; Bulbulia, Richard; Rahimi, Kazem; Haynes, Richard; Parish, Sarah; Peto, Richard; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7LF, England; [Sleight, Peter] Univ Oxford, Dept Cardiovasc Med, Oxford OX3 7LF, England	University of Oxford; University of Oxford	Armitage, JM (corresponding author), Univ Oxford, Clin Trial Serv Unit, Richard Doll Bldg,Old Rd Campus,Roosevelt Dr, Oxford OX3 7LF, England.	search@ctsu.ox.ac.uk	Rahimi, Kazem/Q-1279-2015; Rahimi, Kazem/AAA-4250-2022; Collins, Rory/ABA-8487-2020; Lindley, Richard/B-8148-2013	Rahimi, Kazem/0000-0002-4807-4610; Lindley, Richard/0000-0002-0104-5679; Haynes, Richard/0000-0002-1179-0023; Dunachie, Susanna/0000-0001-5665-6293; Townend, Jonathan/0000-0002-5881-5806; Wallendszus, Karl/0000-0003-0971-3026; Emberson, Jonathan/0000-0001-7792-9422; Offer, Alison/0000-0002-3367-3207	Merck; UK Medical Research Council; British Heart Foundation; MRC [MC_U137686861] Funding Source: UKRI; Medical Research Council [MC_U137686861] Funding Source: researchfish	Merck(Merck & Company); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by Merck (manufacturers of simvastatin and suppliers of the vitamins). The CTSU also receives core support from the UK Medical Research Council and the British Heart Foundation.	Albert CM, 2008, JAMA-J AM MED ASSOC, V299, P2027, DOI 10.1001/jama.299.17.2027; [Anonymous], 2007, AM HEART J, V154, P815, DOI 10.1016/j.ahj.2007.06.034; [Anonymous], 1991, Lancet, V338, P131, DOI 10.1016/0140-6736(91)90133-A; BAKER F, 2002, CIRCULATION S2, V106, P2; Bazzano LA, 2006, JAMA-J AM MED ASSOC, V296, P2720, DOI 10.1001/jama.296.22.2720; Bazzano LA, 2009, AM J MED SCI, V338, P48, DOI 10.1097/MAJ.0b013e3181aaefd6; Bonaa KH, 2006, NEW ENGL J MED, V354, P1578, DOI 10.1056/NEJMoa055227; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; Brady CB, 2009, AM J KIDNEY DIS, V54, P440, DOI 10.1053/j.ajkd.2009.05.013; Brattstrom L, 1998, BMJ-BRIT MED J, V316, P894, DOI 10.1136/bmj.316.7135.894; Clarke R, 1998, ARCH NEUROL-CHICAGO, V55, P1449, DOI 10.1001/archneur.55.11.1449; Clarke R, 2005, AM J CLIN NUTR, V82, P806, DOI 10.1093/ajcn/82.4.806; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; CLARKE R, 1991, NEW ENGL J MED, V324, P1149, DOI 10.1056/NEJM199104253241701; Clarke R, 2008, BRIT J NUTR, V100, P1054, DOI 10.1017/S0007114508958001; Cole BF, 2007, JAMA-J AM MED ASSOC, V297, P2351, DOI 10.1001/jama.297.21.2351; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; de Jager CA, 2003, INT J GERIATR PSYCH, V18, P318, DOI 10.1002/gps.830; Durga J, 2007, ANN INTERN MED, V146, P1, DOI 10.7326/0003-4819-146-1-200701020-00003; Ebbing M, 2008, JAMA-J AM MED ASSOC, V300, P795, DOI 10.1001/jama.300.7.795; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Figueiredo JC, 2009, JNCI-J NATL CANCER I, V101, P432, DOI 10.1093/jnci/djp019; Gates GA, 2005, LANCET, V366, P1111, DOI 10.1016/S0140-6736(05)67423-5; Hin H, 2006, AGE AGEING, V35, P416, DOI 10.1093/ageing/afl033; Jamison RL, 2007, JAMA-J AM MED ASSOC, V298, P1163, DOI 10.1001/jama.298.10.1163; LANG JM, 1991, STAT MED, V10, P1585, DOI 10.1002/sim.4780101010; Levey Andrew S., 2000, Journal of the American Society of Nephrology, V11, p155A; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Logan RFA, 2008, GASTROENTEROLOGY, V134, P29, DOI 10.1053/j.gastro.2007.10.014; Lonn E, 2006, NEW ENGL J MED, V354, P1567, DOI 10.1056/NEJMoa060900; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; McLean RR, 2008, J CLIN ENDOCR METAB, V93, P2206, DOI 10.1210/jc.2007-2710; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; PEDERSEN TR, 1994, LANCET, V344, P1383; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; PETO R, 1995, J CLIN EPIDEMIOL, V48, P23, DOI 10.1016/0895-4356(94)00150-O; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; ROSEN W G, 1980, Journal of Clinical Neuropsychology, V2, P135, DOI 10.1080/01688638008403788; Sacks FM, 1996, NEW ENGL J MED, V335, P1001, DOI 10.1056/NEJM199610033351401; Saposnik G, 2009, STROKE, V40, P1365, DOI 10.1161/STROKEAHA.108.529503; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; Smith AD, 2008, AM J CLIN NUTR, V87, P517; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Wang XB, 2007, LANCET, V369, P1876, DOI 10.1016/S0140-6736(07)60854-X; Wu K, 2009, AM J CLIN NUTR, V90, P1623, DOI 10.3945/ajcn.2009.28319; [No title captured]	48	231	241	2	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2486	2494		10.1001/jama.2010.840	http://dx.doi.org/10.1001/jama.2010.840			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571015	Bronze			2022-12-28	WOS:000279010900026
J	Biggs, ML; Mukamal, KJ; Luchsinger, JA; Ix, JH; Carnethon, MR; Newman, AB; de Boer, IH; Strotmeyer, ES; Mozaffarian, D; Siscovick, DS				Biggs, Mary L.; Mukamal, Kenneth J.; Luchsinger, Jose A.; Ix, Joachim H.; Carnethon, Mercedes R.; Newman, Anne B.; de Boer, Ian H.; Strotmeyer, Elsa S.; Mozaffarian, Dariush; Siscovick, David S.			Association Between Adiposity in Midlife and Older Age and Risk of Diabetes in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; FAT DISTRIBUTION; WAIST CIRCUMFERENCE; TISSUE DISTRIBUTION; LIFE-STYLE; WEIGHT CHANGE; VISCERAL FAT; MELLITUS; HEALTH; WOMEN	Context Adiposity is a well-recognized risk factor for type 2 diabetes among young and middle-aged adults, but the relationship between body composition and type 2 diabetes is not well described among older adults. Objective To examine the relationship between adiposity, changes in adiposity, and risk of incident type 2 diabetes in adults 65 years of age and older. Design, Setting, and Participants Prospective cohort study (1989-2007) of 4193 men and women 65 years of age and older in the Cardiovascular Health Study. Measures of adiposity were derived from anthropometry and bioelectrical impedance data at baseline and anthropometry repeated 3 years later. Main Outcome Measure Incident diabetes was ascertained based on use of antidiabetic medication or a fasting glucose level of 126 mg/dL or greater. Results Over median follow-up of 12.4 years (range, 0.9-17.8 years), 339 cases of incident diabetes were ascertained (7.1/1000 person-years). The adjusted hazard ratio (HR) (95% confidence interval [CI]) of type 2 diabetes for participants in the highest quintile of baseline measures compared with those in the lowest was 4.3 (95% CI, 2.9-6.5) for body mass index (BMI [calculated as weight in kilograms divided by height in meters squared]), 3.0 (95% CI, 2.0-4.3) for BMI at 50 years of age, 4.2 (95% CI, 2.8-6.4) for weight, 4.0 (95% CI, 2.6-6.0) for fat mass, 4.2 (95% CI, 2.8-6.2) for waist circumference, 2.4 (95% CI, 1.6-3.5) for waist-hip ratio, and 3.8 (95% CI, 2.6-5.5) for waist-height ratio. However, when stratified by age, participants 75 years of age and older had HRs approximately half as large as those 65 to 74 years of age. Compared with weight-stable participants (+/- 2 kg), those who gained the most weight from 50 years of age to baseline (>= 9 kg), and from baseline to the third follow-up visit (>= 6 kg), had HRs for type 2 diabetes of 2.8 (95% CI, 1.9-4.3) and 2.0 (95% CI, 1.1-3.7), respectively. Participants with a greater than 10-cm increase in waist size from baseline to the third follow-up visit had an HR of type 2 diabetes of 1.7 (95% CI, 1.1-2.8) compared with those who gained or lost 2 cm or less. Conclusion Among older adults, overall and central adiposity, and weight gain during middle age and after the age of 65 years are associated with risk of diabetes. JAMA. 2010; 303(24): 2504-2512	[Biggs, Mary L.] Univ Washington, Sch Publ Hlth & Community Med, Dept Biostat, Seattle, WA 98195 USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA; [Mukamal, Kenneth J.] Harvard Univ, Sch Med, Boston, MA USA; [Luchsinger, Jose A.] Columbia Univ, Taub Inst Res Alzheimers Dis & Aging Brain, Med Ctr, New York, NY USA; [Luchsinger, Jose A.] Columbia Univ, Dept Med, Med Ctr, New York, NY USA; [Ix, Joachim H.] Univ Calif San Diego, Dept Med, Div Nephrol, San Diego, CA 92103 USA; [Ix, Joachim H.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Carnethon, Mercedes R.] Northwestern Univ, Dept Prevent Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Strotmeyer, Elsa S.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA; [de Boer, Ian H.] Univ Washington, Dept Med, Div Nephrol, Seattle, WA 98195 USA; [Newman, Anne B.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA; [Mozaffarian, Dariush] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Cardiovasc Med, Boston, MA 02115 USA; [Siscovick, David S.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Siscovick, David S.] Univ Washington, Dept Epidemiolf, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Columbia University; Columbia University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Biggs, ML (corresponding author), Bldg 29,Ste 310,6200 NE 74th St, Seattle, WA 98115 USA.	mlbiggs@u.washington.edu	Mozaffarian, Dariush/B-2276-2008; de Boer, Ian/GYJ-3282-2022; Newman, Anne B./C-6408-2013; Mukamal, Kenneth/GVR-7978-2022	Newman, Anne B./0000-0002-0106-1150; Carnethon, Mercedes/0000-0001-7035-0848; Strotmeyer, Elsa/0000-0002-4093-6036; Luchsinger, Jose/0000-0002-5886-3648	National Heart, Lung, and Blood Institute [N01-HC-85079, N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, U01 HL080295, R01 HL-075366, R01 HL-094555]; National Institute on Aging [R01 AG-023629, R01 AG-15928, R01 AG-20098, AG-027058]; University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center [P30-AG-024827]; National Institute of Neurological Disorders and Stroke; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC085081, N01HC085083, N01HC075150, N01HC085080, N01HC035129, N01HC085084, N01HC085085, N01HC085086, N01HC085082, N01HC015103, N01HC055222, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094555, R01HL075366, U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG020098, R01AG015928, R01AG023629, R01AG027058, P30AG024827] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); University of Pittsburgh Claude; University of Pittsburgh Claude. D. Pepper Older Americans Independence Center; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The research reported in this article was supported by contract numbers N01-HC-85079 through N01-HC-85086, N01-HC-35129, N01-HC-15103, N01-HC-55222, N01-HC-75150, N01-HC-45133, and grant numbers U01 HL080295, R01 HL-075366, and R01 HL-094555 from the National Heart, Lung, and Blood Institute; R01 AG-023629, R01 AG-15928, R01 AG-20098, and AG-027058 from the National Institute on Aging; the University of Pittsburgh Claude. D. Pepper Older Americans Independence Center P30-AG-024827, with additional contribution from the National Institute of Neurological Disorders and Stroke.	Baik I, 2000, AM J EPIDEMIOL, V152, P264, DOI 10.1093/aje/152.3.264; Carey VJ, 1997, AM J EPIDEMIOL, V145, P614, DOI 10.1093/oxfordjournals.aje.a009158; CASSANO PA, 1992, AM J EPIDEMIOL, V136, P1474, DOI 10.1093/oxfordjournals.aje.a116468; *CDCP, 2008, DIAB DAT TRENDS; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Deurenberg P, 1990, Basic Life Sci, V55, P391; Diehr P, 1998, AM J PUBLIC HEALTH, V88, P623, DOI 10.2105/AJPH.88.4.623; Flegal KM, 2005, JAMA-J AM MED ASSOC, V293, P1861, DOI 10.1001/jama.293.15.1861; Folsom AR, 2000, ARCH INTERN MED, V160, P2117, DOI 10.1001/archinte.160.14.2117; Ford ES, 1997, AM J EPIDEMIOL, V146, P214, DOI 10.1093/oxfordjournals.aje.a009256; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Goodpaster BH, 2003, DIABETES CARE, V26, P372, DOI 10.2337/diacare.26.2.372; Hamman RF, 2006, DIABETES CARE, V29, P2102, DOI 10.2337/dc06-0560; Harris TB, 2002, AM J EPIDEMIOL, V156, P122, DOI 10.1093/aje/kwf024; Harris TB, 2000, ANN NY ACAD SCI, V904, P462; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Kanaya AM, 2004, DIABETES CARE, V27, P1375, DOI 10.2337/diacare.27.6.1375; Koh-Banerjee P, 2004, AM J EPIDEMIOL, V159, P1150, DOI 10.1093/aje/kwh167; Kuk JL, 2005, AM J CLIN NUTR, V81, P1330; LUNDGREN H, 1989, INT J OBESITY, V13, P413; Mozaffarian D, 2009, ARCH INTERN MED, V169, P798, DOI 10.1001/archinternmed.2009.21; *NAT CHOL ED PROGR, 2002, NIH PUBL; Newman AB, 2005, AM J CLIN NUTR, V82, P872, DOI 10.1093/ajcn/82.4.872; Poehlman ET, 2000, J CLIN ENDOCR METAB, V85, P2463, DOI 10.1210/jc.85.7.2463; PSATY BM, 1992, J CLIN EPIDEMIOL, V45, P683, DOI 10.1016/0895-4356(92)90143-B; RIMM EB, 1995, AM J EPIDEMIOL, V141, P1117, DOI 10.1093/oxfordjournals.aje.a117385; Schulze MB, 2006, DIABETES CARE, V29, P1921, DOI 10.2337/dc06-0895; Snijder MB, 2002, INT J OBESITY, V26, P984, DOI 10.1038/sj.ijo.0801968; Snijder MB, 2005, DIABETOLOGIA, V48, P301, DOI 10.1007/s00125-004-1637-7; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Storti KL, 2006, OBESITY, V14, P244, DOI 10.1038/oby.2006.31; TAYLOR HL, 1978, J CHRON DIS, V31, P741, DOI 10.1016/0021-9681(78)90058-9; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Wang ZM, 2007, EUR J CARDIOV PREV R, V14, P172, DOI 10.1097/01.hjr.0000220580.34763.fb; Wedick NM, 2001, AM J EPIDEMIOL, V153, P1199, DOI 10.1093/aje/153.12.1199; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; World Health Organization, 1995, WHO TECH REP SER, V854, P1	41	107	108	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2504	2512		10.1001/jama.2010.843	http://dx.doi.org/10.1001/jama.2010.843			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571017	Green Accepted, Bronze			2022-12-28	WOS:000279010900028
J	Cooper, BA; Branley, P; Bulfone, L; Collins, JF; Craig, JC; Fraenkel, MB; Harris, A; Johnson, DW; Kesselhut, J; Li, JJ; Luxton, G; Pilmore, A; Tiller, DJ; Harris, DC; Pollock, CA				Cooper, Bruce A.; Branley, Pauline; Bulfone, Liliana; Collins, John F.; Craig, Jonathan C.; Fraenkel, Margaret B.; Harris, Anthony; Johnson, David W.; Kesselhut, Joan; Li, Jing Jing; Luxton, Grant; Pilmore, Andrew; Tiller, David J.; Harris, David C.; Pollock, Carol A.		IDEAL Study	A Randomized, Controlled Trial of Early versus Late Initiation of Dialysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESIDUAL RENAL-FUNCTION; START; COMORBIDITY; PREDICTION; CREATININE	BACKGROUND In clinical practice, there is considerable variation in the timing of the initiation of maintenance dialysis for patients with stage V chronic kidney disease, with a worldwide trend toward early initiation. In this study, conducted at 32 centers in Australia and New Zealand, we examined whether the timing of the initiation of maintenance dialysis influenced survival among patients with chronic kidney disease. METHODS We randomly assigned patients 18 years of age or older with progressive chronic kidney disease and an estimated glomerular filtration rate (GFR) between 10.0 and 15.0 ml per minute per 1.73 m(2) of body-surface area (calculated with the use of the Cockcroft-Gault equation) to planned initiation of dialysis when the estimated GFR was 10.0 to 14.0 ml per minute (early start) or when the estimated GFR was 5.0 to 7.0 ml per minute (late start). The primary outcome was death from any cause. RESULTS Between July 2000 and November 2008, a total of 828 adults (mean age, 60.4 years; 542 men and 286 women; 355 with diabetes) underwent randomization, with a median time to the initiation of dialysis of 1.80 months (95% confidence interval [CI], 1.60 to 2.23) in the early-start group and 7.40 months (95% CI, 6.23 to 8.27) in the late-start group. A total of 75.9% of the patients in the late-start group initiated dialysis when the estimated GFR was above the target of 7.0 ml per minute, owing to the development of symptoms. During a median follow-up period of 3.59 years, 152 of 404 patients in the early-start group (37.6%) and 155 of 424 in the late-start group (36.6%) died (hazard ratio with early initiation, 1.04; 95% CI, 0.83 to 1.30; P = 0.75). There was no significant difference between the groups in the frequency of adverse events (cardiovascular events, infections, or complications of dialysis). CONCLUSIONS In this study, planned early initiation of dialysis in patients with stage V chronic kidney disease was not associated with an improvement in survival or clinical outcomes. (Funded by the National Health and Medical Research Council of Australia and others; Australian New Zealand Clinical Trials Registry number, 12609000266268.)	[Cooper, Bruce A.; Kesselhut, Joan; Pollock, Carol A.] Royal N Shore Hosp, Sydney Med Sch, Dept Renal Med, Sydney, NSW, Australia; [Craig, Jonathan C.] Childrens Hosp Westmead, Sydney Sch Publ Hlth, Dept Nephrol, Sydney, NSW, Australia; [Tiller, David J.] Sydney Med Sch, Sch Rural Hlth, Sydney, NSW, Australia; [Harris, David C.] Univ Sydney, Westmead Millennium Inst, Ctr Transplantat & Renal Res, Sydney, NSW 2006, Australia; [Luxton, Grant] Univ New S Wales, Prince Wales Hosp, Dept Nephrol, Sydney, NSW, Australia; [Branley, Pauline] Monash Med Ctr, Melbourne, Vic, Australia; [Branley, Pauline] Eastern Hlth Renal Units, Melbourne, Vic, Australia; [Bulfone, Liliana] Deakin Univ, Sch Hlth & Social Dev, Burwood, Australia; [Fraenkel, Margaret B.] Austin Hosp, Dept Renal Med, Heidelberg, Vic 3084, Australia; [Harris, Anthony; Li, Jing Jing] Monash Univ, Ctr Hlth Econ, Clayton, Vic, Australia; [Johnson, David W.] Univ Queensland, Princess Alexandra Hosp, Ctr Kidney Dis Res, Brisbane, Qld, Australia; [Collins, John F.; Pilmore, Andrew] Auckland City Hosp, Dept Renal Med, Auckland, New Zealand	Royal North Shore Hospital; University of Sydney; University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of New South Wales Sydney; Monash University; Deakin University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Monash University; University of Queensland; Auckland City Hospital	Cooper, BA (corresponding author), Royal N Shore Hosp, Dept Renal Med, St Leonards, NSW 2065, Australia.	bcooper@med.usyd.edu.au	Hug, Balthasar L./G-1568-2010; Gray, Nicholas Andrew/D-8340-2011; Healy, Helen/G-2686-2010; Gray, Nicholas/O-4300-2019; Fassett, Robert G/F-1752-2010; Craig, Jonathan/E-2813-2013; Harris, David/W-4786-2019; Mantha, Murty/W-2825-2019; Johnson, David/F-2897-2011	Gray, Nicholas Andrew/0000-0001-9112-0304; Healy, Helen/0000-0003-4342-5300; Gray, Nicholas/0000-0001-9112-0304; Fassett, Robert G/0000-0002-5318-6940; Craig, Jonathan/0000-0002-2548-4035; Johnson, David/0000-0001-5491-3460; Bulfone, Liliana/0000-0001-6406-5231; Harris, Anthony/0000-0003-1641-3320	National Health and Medical Research Council of Australia [211146, 465095]; Australian Health Ministers Advisory Council [PDR 2001/10]; Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology; National Heart Foundation (Australia); National Heart Foundation (New Zealand); Baxter Healthcare; Health Funding Authority New Zealand; International Society for Peritoneal Dialysis; Amgen Australia; Janssen-Cilag; Amgen; Roche; AstraZeneca; Fresenius Medical Care; Shire	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Health Ministers Advisory Council; Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology; National Heart Foundation (Australia)(National Heart Foundation of Australia); National Heart Foundation (New Zealand); Baxter Healthcare; Health Funding Authority New Zealand; International Society for Peritoneal Dialysis; Amgen Australia(Amgen); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Amgen(Amgen); Roche(Roche Holding); AstraZeneca(AstraZeneca); Fresenius Medical Care; Shire	Supported by grants from the National Health and Medical Research Council of Australia (211146 and 465095), the Australian Health Ministers Advisory Council (PDR 2001/10), the Royal Australasian College of Physicians/Australian and New Zealand Society of Nephrology (Don and Lorraine Jacquot Fellowship), the National Heart Foundation (Australia), and the National Heart Foundation (New Zealand), and by unrestricted grants from Baxter Healthcare, Health Funding Authority New Zealand (Te Mana Putea Hauora O Aotearoa), the International Society for Peritoneal Dialysis, Amgen Australia, and Janssen-Cilag.; Dr. Johnson reports receiving consulting fees from Baxter Healthcare, Amgen, Roche, and AstraZeneca, grant support from Baxter Healthcare, lecture fees from Baxter Healthcare, Fresenius Medical Care, Amgen, Shire, Roche, and Janssen-Cilag, payment for development of educational presentations from Shire and Janssen-Cilag, and travel support from Amgen, Baxter Healthcare, and Roche; Dr. D. C. Harris, receiving consulting fees and travel support from Amgen Australia; and Dr. Pollock, receiving consulting fees from Amgen, lecture fees from Amgen and Baxter Healthcare, payment for development of educational presentations from Amgen and Baxter Healthcare, and travel support from Amgen. The University of Queensland Princess Alexandra Hospital has received grant support from Baxter Healthcare for services provided by Dr. Johnson. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2001, Am J Kidney Dis, V37, pS65; [Anonymous], 1997, Am J Kidney Dis, V30, pS67; [Anonymous], 2006, AM J KIDNEY DIS, DOI [10.1053/j.ajkd.2006.03.051, DOI 10.1053/J.AJKD.2006.03.051.MEDLINE]; ANSELL D, 2009, CLIN PRACT S1, V111, pC113; *AUSTR NZ DIAL TRA, 2009, REG REP 2008; Beddhu S, 2003, J AM SOC NEPHROL, V14, P2305, DOI 10.1097/01.ASN.0000080184.67406.11; BONOMINI V, 1986, NEPHRON, V44, P267, DOI 10.1159/000184004; BONOMINI V, 1978, KIDNEY INT, pS112; Churchill DN, 1999, J AM SOC NEPHROL, V10, pS289; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Cooper BA, 2004, PERITON DIALYSIS INT, V24, P176; Du Bois D, 1916, ARCH INTERN MED, V17, P863, DOI 10.1001/archinte.1916.00080130010002; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; Grassmann A, 2005, NEPHROL DIAL TRANSPL, V20, P2587, DOI 10.1093/ndt/gfi159; Grassmann A, 2006, ARTIF ORGANS, V30, P895, DOI 10.1111/j.1525-1594.2006.00321.x; HAKIM RM, 1995, J AM SOC NEPHROL, V6, P1319; Hawthorne G, 1999, QUAL LIFE RES, V8, P209, DOI 10.1023/A:1008815005736; Kazmi WH, 2005, AM J KIDNEY DIS, V46, P887, DOI 10.1053/j.ajkd.2005.08.005; Kelly J, 2005, NEPHROLOGY, V10, pS46, DOI 10.1111/j.1440-1797.2005.00486_1.x; Kim Seoung Gu, 2009, Korean Journal of Internal Medicine, V24, P55, DOI 10.3904/kjim.2009.24.1.55; Lassalle M, 2010, KIDNEY INT, V77, P700, DOI 10.1038/ki.2010.14; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liu H, 2008, RENAL FAILURE, V30, P685, DOI 10.1080/08860220802212619; Paniagua R, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1351307; Pollack MH, 2005, CNS SPECTRUMS, V10, P4, DOI 10.1017/S1092852900026481; Pollock C, 2005, NEPHROLOGY, V10, pS177, DOI 10.1111/j.1440-1797.2005.00506.x; Rosansky SJ, 2009, KIDNEY INT, V76, P257, DOI 10.1038/ki.2009.161; Stel VS, 2009, NEPHROL DIAL TRANSPL, V24, P3175, DOI 10.1093/ndt/gfp264; TATTERSALL J, 1995, AM J NEPHROL, V15, P283, DOI 10.1159/000168850; Traynor JP, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000025294.40179.E8; 2006, AM J KIDNEY DIS S1, V48, pS98	31	567	596	1	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 12	2010	363	7					609	619		10.1056/NEJMoa1000552	http://dx.doi.org/10.1056/NEJMoa1000552			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636TN	20581422	Bronze			2022-12-28	WOS:000280764600004
J	Mangan, SA; Schnitzer, SA; Herre, EA; Mack, KML; Valencia, MC; Sanchez, EI; Bever, JD				Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Mack, Keenan M. L.; Valencia, Mariana C.; Sanchez, Evelyn I.; Bever, James D.			Negative plant-soil feedback predicts tree-species relative abundance in a tropical forest	NATURE			English	Article							LOCAL NEIGHBORHOOD; DENSITY-DEPENDENCE; SEEDLING MORTALITY; MAINTAIN DIVERSITY; SPATIAL-PATTERNS; PATHOGENS; COMMUNITY; GROWTH; RECRUITMENT; COEXISTENCE	The accumulation of species-specific enemies around adults is hypothesized to maintain plant diversity by limiting the recruitment of conspecific seedlings relative to heterospecific seedlings(1-6). Although previous studies in forested ecosystems have documented patterns consistent with the process of negative feedback(7-16), these studies are unable to address which classes of enemies (for example, pathogens, invertebrates, mammals) exhibit species-specific effects strong enough to generate negative feedback(17), and whether negative feedback at the level of the individual tree is sufficient to influence community-wide forest composition. Here we use fully reciprocal shade-house and field experiments to test whether the performance of conspecific tree seedlings (relative to heterospecific seedlings) is reduced when grown in the presence of enemies associated with adult trees. Both experiments provide strong evidence for negative plant-soil feedback mediated by soil biota. In contrast, above-ground enemies (mammals, foliar herbivores and foliar pathogens) contributed little to negative feedback observed in the field. In both experiments, we found that tree species that showed stronger negative feedback were less common as adults in the forest community, indicating that susceptibility to soil biota may determine species relative abundance in these tropical forests. Finally, our simulation models confirm that the strength of local negative feedback that we measured is sufficient to produce the observed community-wide patterns in tree-species relative abundance. Our findings indicate that plant-soil feedback is an important mechanism that can maintain species diversity and explain patterns of tree-species relative abundance in tropical forests.	[Mangan, Scott A.; Schnitzer, Stefan A.] Univ Wisconsin, Dept Biol Sci, Milwaukee, WI 53201 USA; [Mangan, Scott A.; Schnitzer, Stefan A.; Herre, Edward A.; Sanchez, Evelyn I.] Smithsonian Trop Res Inst, MRC 0580 06, Dpo, AA 34002 USA; [Mack, Keenan M. L.; Bever, James D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Valencia, Mariana C.] Univ Illinois, Dept Biol Sci, Chicago, IL 60607 USA	University of Wisconsin System; University of Wisconsin Milwaukee; Smithsonian Institution; Smithsonian Tropical Research Institute; Indiana University System; Indiana University Bloomington; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Mangan, SA (corresponding author), Univ Wisconsin, Dept Biol Sci, POB 413, Milwaukee, WI 53201 USA.	smangan37@gmail.com		Schnitzer, Stefan/0000-0002-2715-9455	Smithsonian Tropical Research Institute (STRI); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation; STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092660] Funding Source: NIH RePORTER	Smithsonian Tropical Research Institute (STRI)(Smithsonian InstitutionSmithsonian Tropical Research Institute); University of Wisconsin-Milwaukee (UWM) Research Growth Initiative; UWM Research Foundation; National Science Foundation(National Science Foundation (NSF)); STRI Soil Initiative; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Adler, M. Kaspari, E. Leigh, T. Lambert, I. Rubinoff, E. Tanner, M. Tobin, B. Turner, S. Van Bael and N. Wurzburger for providing discussions and comments on the manuscript. R. Kolodziej, K. Meyer, K. McElligott and T. Shirshac provided greenhouse and field assistance. Logistical support was provided by the Smithsonian Tropical Research Institute. The Center of Tropical Forest Science provided BCI tree abundance data published online at https://ctfs.arnarb.harvard.edu/webatlas/datasets/bci/abundance. This study was supported by a Smithsonian Tropical Research Institute (STRI) postdoctoral fellowship to S. A. M., a University of Wisconsin-Milwaukee (UWM) Research Growth Initiative grant to S. A. S., a fellowship from the UWM Research Foundation, and a grant from the National Science Foundation to J.D.B. We thank I. Rubinoff for his support of the STRI Soil Initiative.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Bell T, 2006, ECOL LETT, V9, P569, DOI 10.1111/j.1461-0248.2006.00905.x; Bever JD, 1997, J ECOL, V85, P561, DOI 10.2307/2960528; Bever JD, 2003, NEW PHYTOL, V157, P465, DOI 10.1046/j.1469-8137.2003.00714.x; Bever JD, 2002, P ROY SOC B-BIOL SCI, V269, P2595, DOI 10.1098/rspb.2002.2162; BEVER JD, 1994, ECOLOGY, V75, P1965, DOI 10.2307/1941601; Carson WP., 2008, TROPICAL FOREST COMM, P210; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; COMITA LS, SCIENCE IN PRESS, DOI DOI 10.1126/SCIENCE.1190772; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hood LA, 2004, J ECOL, V92, P816, DOI 10.1111/j.0022-0477.2004.00917.x; HUBBELI SP, 2001, UNIFIED NEUTRAL THEO; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Kardol P, 2007, ECOL MONOGR, V77, P147, DOI 10.1890/06-0502; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kulmatiski A, 2008, ECOL LETT, V11, P980, DOI 10.1111/j.1461-0248.2008.01209.x; McCarthy-Neumann S, 2010, J ECOL, V98, P396, DOI 10.1111/j.1365-2745.2009.01619.x; Mills KE, 1998, ECOLOGY, V79, P1595, DOI 10.1890/0012-9658(1998)079[1595:MODWPC]2.0.CO;2; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Petermann JS, 2008, ECOLOGY, V89, P2399, DOI 10.1890/07-2056.1; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Roesch LF, 2007, ISME J, V1, P283, DOI 10.1038/ismej.2007.53; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	30	704	726	20	664	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					752	U10		10.1038/nature09273	http://dx.doi.org/10.1038/nature09273			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20581819	Green Submitted			2022-12-28	WOS:000280562500038
J	Tutt, A; Robson, M; Garber, JE; Domchek, SM; Audeh, MW; Weitzel, JN; Friedlander, M; Arun, B; Loman, N; Schmutzler, RK; Wardley, A; Mitchell, G; Earl, H; Wickens, M; Carmichael, J				Tutt, Andrew; Robson, Mark; Garber, Judy E.; Domchek, Susan M.; Audeh, M. William; Weitzel, Jeffrey N.; Friedlander, Michael; Arun, Banu; Loman, Niklas; Schmutzler, Rita K.; Wardley, Andrew; Mitchell, Gillian; Earl, Helena; Wickens, Mark; Carmichael, James			Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial	LANCET			English	Article							HOMOLOGY-DIRECTED REPAIR; WILD-TYPE ALLELE; MUTANT-CELLS; PHASE-II; TUMORS; GENE; ANTHRACYCLINE; RESISTANCE; TAXANE; DEFECT	Background Olaparib, a novel, orally active poly(ADP-ribose) polymerase (PARP) inhibitor, induced synthetic lethality in BRCA-deficient cells. A maximum tolerated dose and initial signal of efficacy in BRCA-deficient ovarian cancers have been reported. We therefore assessed the efficacy, safety, and tolerability of olaparib alone in women with BRCA1 or BRCA2 mutations and advanced breast cancer. Methods Women (aged years) with confirmed BRCA1 or BRCA2 mutations and recurrent, advanced breast cancer were assigned to two sequential cohorts in a phase 2 study undertaken in 16 centres in Australia, Germany, Spain, Sweden, the UK, and the USA. The first cohort (n=27) was given continuous oral olaparib at the maximum tolerated dose (400 mg twice daily), and the second (n=27) was given a lower dose (100 mg twice daily). The primary efficacy endpoint was objective response rate (ORR). This study is registered with ClinicalTrials.gov, number NCT00494234. Findings Patients had been given a median of three previous chemotherapy regimens (range 1-5 in cohort 1, and 2-4 in cohort 2). ORR was 11 (41%) of 27 patients (95% CI 25-59) in the cohort assigned to 400 mg twice daily, and six (22%) of 27 (11-41) in the cohort assigned to 100 mg twice daily. Toxicities were mainly at low grades. The most frequent causally related adverse events in the cohort given 400 mg twice daily were fatigue (grade 1 or 2, 11 [41%]; grade 3 or 4, four [15%]), nausea (grade 1 or 2, 11 [41%]; grade 3 or 4, four [15%]), vomiting (grade 1 or 2, three [11%]; grade 3 or 4, three [11%]), and anaemia (grade 1 or 2, one [4%]; grade 3 or 4, three [11%]). The most frequent causally related adverse events in the cohort given 100 mg twice daily were nausea (grade 1 or 2, 11 [41%]; none grade 3 or 4) and fatigue (grade 1 or 2, seven [26%]; grade 3 or 4, one [4%]). Interpretation The results of this study provide positive proof of concept for PARP inhibition in BRCA-deficient breast cancers and shows a favourable therapeutic index for a novel targeted treatment strategy in patients with tumours that have genetic loss of function of BRCA1-associated or BRCA2-associated DNA repair. Toxicity in women with BRCA1 and BRCA2 mutations was similar to that reported previously in those without such mutations.	[Tutt, Andrew] Kings Coll London, Sch Med, Breakthrough Breast Canc Res Unit, London SE1 9RT, England; [Robson, Mark] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Garber, Judy E.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Domchek, Susan M.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Audeh, M. William] Cedars Sinai Med Ctr, Samuel Oschin Canc Inst, Los Angeles, CA 90048 USA; [Weitzel, Jeffrey N.] City Hope Comprehens Canc Ctr, Duarte, CA USA; [Friedlander, Michael] Prince Wales Canc Ctr, Sydney, NSW, Australia; [Arun, Banu] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Loman, Niklas] Lund Univ, Skane Univ Hosp, Dept Oncol, Lund, Sweden; [Schmutzler, Rita K.] Univ Cologne, Ctr Familial Breast & Ovarian Canc, Cologne, Germany; [Schmutzler, Rita K.] Univ Cologne, Ctr Integrated Oncol, Cologne, Germany; [Wardley, Andrew] Christie Hosp NHS Fdn Trust, Manchester, Lancs, England; [Mitchell, Gillian] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Earl, Helena] Univ Cambridge, Dept Oncol, Cambridge, England; [Earl, Helena] Cambridge Biomed Res Ctr, Natl Inst Hlth Res, Cambridge, England; [Wickens, Mark; Carmichael, James] AstraZeneca, Macclesfield, Cheshire, England	University of London; King's College London; Memorial Sloan Kettering Cancer Center; Harvard University; Dana-Farber Cancer Institute; University of Pennsylvania; Pennsylvania Medicine; Cedars Sinai Medical Center; City of Hope; University of Texas System; UTMD Anderson Cancer Center; Lund University; Skane University Hospital; University of Cologne; University of Cologne; Christie NHS Foundation Trust; Christie Hospital; Peter Maccallum Cancer Center; University of Cambridge; University of Cambridge; AstraZeneca	Tutt, A (corresponding author), Kings Coll London, Sch Med, Breakthrough Breast Canc Res Unit, 3rd Floor,Bermondsey Wing,Guys Hosp Campus, London SE1 9RT, England.	andrew.tutt@icr.ac.uk	Wardley, Andrew/N-8135-2015; Wardley, Andrew Michael/GLU-5636-2022; friedlander, michael l/G-3490-2013	Wardley, Andrew/0000-0002-9639-0888; Wardley, Andrew Michael/0000-0002-9639-0888; friedlander, michael l/0000-0002-6488-0604; Robson, Mark/0000-0002-3109-1692; Tutt, Andrew/0000-0001-8715-2901; Earl, Helena/0000-0003-1549-8094	AstraZeneca	AstraZeneca(AstraZeneca)	AT has received a payment from the Institute of Cancer Research Rewards to inventors programme for work on use of PARP inhibitors to target BRCA1-associated and BRCA2-associated cancers; and support for travel to investigators' meetings and an honorarium, funded by AstraZeneca, for an academic lecture. MR has received research grants, support for travel to investigators' meetings and funding for patient payment to undertake study from AstraZeneca, and has received honoraria as a clinical advisory board member for Pfizer. JEG has received funding support for the trial and is a co-investigator for clinical trials for a PARP inhibitor. SMD has received funding support for the trial and for travel to investigators' meetings. MWA has received honoraria for consultancy from AstraZeneca and Myriad Genetics. MF has received honoraria as a clinical advisory board member and support for travel to meetings from AstraZeneca. BA has received a grant from AstraZeneca for a research study. NL has received funding support for the conduct of the trial. RKS has received funding support for the conduct of the trial and for travel to investigators' meetings. AW has received speaking honoraria (including speakers' bureau) and research funding from AstraZeneca. GM has received support for travel to investigators' meetings and funding for patient payment to undertake study from AstraZeneca. MW and JC are employees of AstraZeneca, and JC holds AstraZeneca stock options. JNW and HE declare that they have no conflicts of interest.	Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; BYRSKI T, 2009, J CLIN ONCOL, V27, P1099; COLDITZ GA, 1993, CANCER-AM CANCER SOC, V71, P1480, DOI 10.1002/cncr.2820710413; COLLINS N, 1995, ONCOGENE, V10, P1673; CORNELIS RS, 1995, GENE CHROMOSOME CANC, V13, P203, DOI 10.1002/gcc.2870130310; DEGARDIN M, 1994, ANN ONCOL, V5, P423, DOI 10.1093/oxfordjournals.annonc.a058873; Domchek SM, 2006, ONCOGENE, V25, P5825, DOI 10.1038/sj.onc.1209881; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Edwards SL, 2008, NATURE, V451, P1111, DOI 10.1038/nature06548; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2010, J CLIN ONCOL, V28, P2512, DOI 10.1200/JCO.2009.26.9589; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fumoleau P, 2004, EUR J CANCER, V40, P536, DOI 10.1016/j.ejca.2003.11.007; Gronwald J, 2009, J CLIN ONCOL, V27; JONKERS J, 2001, NAT GENET, V5, P5; Kaelin WG, 2005, NAT REV CANCER, V5, P689, DOI 10.1038/nrc1691; Kriege M, 2009, J CLIN ONCOL, V27, P3764, DOI 10.1200/JCO.2008.19.9067; Lakhani SR, 2002, J CLIN ONCOL, V20, P2310, DOI 10.1200/JCO.2002.09.023; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Merajver SD, 1995, CLIN CANCER RES, V1, P539; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Newcombe R. G., 2000, STAT CONFIDENCE, V2, P45; Osin P P, 1999, Breast Cancer Res, V1, P36, DOI 10.1186/bcr11; Perez EA, 2007, J CLIN ONCOL, V25, P3407, DOI 10.1200/JCO.2006.09.3849; Sakai W, 2008, NATURE, V451, P1116, DOI 10.1038/nature06633; Sakai W, 2009, CANCER RES, V69, P6381, DOI 10.1158/0008-5472.CAN-09-1178; Swisher EM, 2008, CANCER RES, V68, P2581, DOI 10.1158/0008-5472.CAN-08-0088; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tirkkonen M, 1999, GENE CHROMOSOME CANC, V24, P56, DOI 10.1002/(SICI)1098-2264(199901)24:1<56::AID-GCC8>3.0.CO;2-X; Tirkkonen M, 1997, CANCER RES, V57, P1222; Tutt A, 1999, CURR BIOL, V9, P1107, DOI 10.1016/S0960-9822(99)80479-5; Tutt A, 2002, TRENDS MOL MED, V8, P571, DOI 10.1016/S1471-4914(02)02434-6; Tutt A, 2001, EMBO J, V20, P4704, DOI 10.1093/emboj/20.17.4704; Tutt ANJ, 2005, COLD SH Q B, V70, P139, DOI 10.1101/sqb.2005.70.012; Tutt ANJ, 2002, EMBO REP, V3, P255, DOI 10.1093/embo-reports/kvf037; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0	41	1350	1400	1	234	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					235	244		10.1016/S0140-6736(10)60892-6	http://dx.doi.org/10.1016/S0140-6736(10)60892-6			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20609467				2022-12-28	WOS:000280457200032
J	Bernal, W; Auzinger, G; Dhawan, A; Wendon, J				Bernal, William; Auzinger, Georg; Dhawan, Anil; Wendon, Julia			Acute liver failure	LANCET			English	Article							FULMINANT HEPATIC-FAILURE; INFLAMMATORY RESPONSE SYNDROME; ACUTE VIRAL-HEPATITIS; ORNITHINE-L-ASPARTATE; VIRUS HEV INFECTION; UNITED-STATES; ARTERIAL AMMONIA; A VIRUS; PROGNOSTIC-FACTORS; SOUTHWEST ENGLAND	Acute liver failure is a rare disorder with high mortality and resource cost. In the developing world, viral causes predominate, with hepatitis E infection recognised as a common cause in many countries. In the USA and much of western Europe, the incidence of virally induced disease has declined substantially in the past few years, with most cases now arising from drug-induced liver injury, often from paracetamol. However, a large proportion of cases are of unknown origin. Acute liver failure can be associated with rapidly progressive multiorgan failure and devastating complications; however, outcomes have been improved by use of emergency liver transplantation. An evidence base for practice is emerging for supportive care, and a better understanding of the pathophysiology of the disorder, especially in relation to hepatic encephalopathy, will probably soon lead to further improvements in survival rates.	[Bernal, William; Auzinger, Georg; Wendon, Julia] Kings Coll Hosp London, Inst Liver Studies, Liver Intens Therapy Unit, London SE5 9RS, England; [Dhawan, Anil] Kings Coll Hosp London, Inst Liver Studies, Paediat Liver Serv, London SE5 9RS, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Bernal, W (corresponding author), Kings Coll Hosp London, Inst Liver Studies, Liver Intens Therapy Unit, Denmark Hill, London SE5 9RS, England.	william.bernal@kcl.ac.uk	Hug, Balthasar L./G-1568-2010; Solebo, Colette N/B-6615-2008; Auzinger, Georg/E-8426-2015; Dhawan, Anil/B-6730-2009	Solebo, Colette N/0000-0001-9764-2541; Auzinger, Georg/0000-0003-3231-1332; Dhawan, Anil/0000-0002-4942-0845				Acharya S K, 2002, J Gastroenterol Hepatol, V17 Suppl 3, pS268, DOI 10.1046/j.1440-1746.17.s3.12.x; Acharya SK, 2002, NATL MED J INDIA, V15, P267; Acharya SK, 2007, J HEPATOL, V46, P387, DOI 10.1016/j.jhep.2006.09.016; Acharya SK, 2009, GASTROENTEROLOGY, V136, P2159, DOI 10.1053/j.gastro.2009.02.050; Albrecht J, 2006, HEPATOLOGY, V44, P788, DOI 10.1002/hep.21357; Ananthakrishnan AN, 2008, LIVER TRANSPLANT, V14, P1347, DOI 10.1002/lt.21519; Andrade RJ, 2005, GASTROENTEROLOGY, V129, P512, DOI 10.1053/j.gastro.2005.05.006; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; Bailey B, 2003, CRIT CARE MED, V31, P299, DOI 10.1097/00003246-200301000-00048; Berna W, 2007, J HEPATOL, V47, P664, DOI 10.1016/j.jhep.2007.05.011; Bernal W, 2003, SEMIN LIVER DIS, V23, P227; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2008, SEMIN LIVER DIS, V28, P188, DOI 10.1055/s-2008-1073118; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernal W, 2009, CLIN GASTROENTEROL H, V7, P249, DOI 10.1016/j.cgh.2008.09.009; Bernal W, 2009, J HEPATOL, V50, P306, DOI 10.1016/j.jhep.2008.09.012; BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; BERNUAU J, 1986, SEMIN LIVER DIS, V6, P97, DOI 10.1055/s-2008-1040593; Bernuau J, 2008, HEPATOLOGY, V48, P1380, DOI 10.1002/hep.22619; Bertani H, 2002, INT J ARTIF ORGANS, V25, P903, DOI 10.1177/039139880202501002; Bhaduri BR, 1996, SEMIN LIVER DIS, V16, P349, DOI 10.1055/s-2007-1007248; Bhatia V, 2006, GUT, V55, P98, DOI 10.1136/gut.2004.061754; Bhatia V, 2004, J HEPATOL, V41, P89, DOI 10.1016/j.jhep.2004.03.017; Bhatia V, 2008, HEPATOLOGY, V48, P1577, DOI 10.1002/hep.22493; Bianco E, 2003, DIGEST LIVER DIS, V35, P404, DOI 10.1016/S1590-8658(03)00157-9; Bjerring PN, 2009, METAB BRAIN DIS, V24, P5, DOI 10.1007/s11011-008-9116-3; Bjornsson E, 2007, ALIMENT PHARM THERAP, V25, P1411, DOI 10.1111/j.1365-2036.2007.03330.x; Bjornsson E, 2006, DIGEST LIVER DIS, V38, P33, DOI 10.1016/j.dld.2005.06.004; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bower WA, 2007, AM J GASTROENTEROL, V102, P2459, DOI 10.1111/j.1572-0241.2007.01388.x; Brandsaeter B, 2002, LIVER TRANSPLANT, V8, P1055, DOI 10.1053/jlts.2002.35556; Burroughs AK, 2006, LANCET, V367, P225, DOI 10.1016/S0140-6736(06)68033-1; Campsen J, 2008, LIVER TRANSPLANT, V14, P1273, DOI 10.1002/lt.21500; Chadha Mandeep S, 2003, Indian J Gastroenterol, V22, P11; Chatauret N, 2006, J HEPATOL, V44, P1083, DOI 10.1016/j.jhep.2005.11.048; Clemmesen JO, 2000, GASTROENTEROLOGY, V118, P1131, DOI 10.1016/S0016-5085(00)70366-0; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Cote GA, 2009, AM J GASTROENTEROL, V104, P592, DOI 10.1038/ajg.2008.84; Czaja AJ, 2007, LIVER TRANSPLANT, V13, P953, DOI 10.1002/lt.21088; Dagan R, 2005, JAMA-J AM MED ASSOC, V294, P202, DOI 10.1001/jama.294.2.202; Dalton HR, 2008, EUR J CLIN MICROBIOL, V27, P579, DOI 10.1007/s10096-008-0480-z; Dalton HR, 2008, LANCET INFECT DIS, V8, P698, DOI 10.1016/S1473-3099(08)70255-X; Dalton HR, 2008, EUR J GASTROEN HEPAT, V20, P784, DOI 10.1097/MEG.0b013e3282f5195a; Daly AK, 2007, GASTROENTEROLOGY, V132, P272, DOI 10.1053/j.gastro.2006.11.023; Daly AK, 2009, NAT GENET, V41, P816, DOI 10.1038/ng.379; Damink SWMO, 2002, HEPATOLOGY, V36, P1163, DOI 10.1053/jhep.2002.36497; Daniels Danni, 2009, Morbidity and Mortality Weekly Report, V58, P1; Dart RC, 2007, PHARMACOTHERAPY, V27, P1219, DOI 10.1592/phco.27.9.1219; Davern TJ, 2006, GASTROENTEROLOGY, V130, P687, DOI 10.1053/j.gastro.2006.01.033; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Escorsell A, 2007, LIVER TRANSPLANT, V13, P1389, DOI 10.1002/lt.21119; Fabris P, 2000, J HEPATOL, V32, P661, DOI 10.1016/S0168-8278(00)80229-9; Felipo V, 2002, PROG NEUROBIOL, V67, P259, DOI 10.1016/S0301-0082(02)00019-9; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Gimenez-Barcons M, 1999, J HEPATOL, V30, P1028, DOI 10.1016/S0168-8278(99)80256-6; Gorman DR, 2007, PUBLIC HEALTH, V121, P45, DOI 10.1016/j.puhe.2006.08.014; Gow P, 2005, J GASTROEN HEPATOL, V20, P555, DOI 10.1111/j.1440-1746.2005.03605.x; Gow PJ, 2004, J GASTROEN HEPATOL, V19, P154, DOI 10.1111/j.1440-1746.2004.03273.x; Greene SL, 2006, POSTGRAD MED J, V82, P520, DOI 10.1136/pgmj.2005.042036; Hadem J, 2008, CLIN GASTROENTEROL H, V6, P339, DOI 10.1016/j.cgh.2007.12.039; Halasz R, 1999, GUT, V44, P274, DOI 10.1136/gut.44.2.274; HARRISON PM, 1991, NEW ENGL J MED, V324, P1852, DOI 10.1056/NEJM199106273242604; Harry R, 2002, HEPATOLOGY, V36, P395, DOI 10.1053/jhep.2002.34514; Hashikura Y, 2009, TRANSPLANTATION, V88, P110, DOI 10.1097/TP.0b013e3181aaccb0; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Heard K, 2007, ALIMENT PHARM THERAP, V26, P283, DOI 10.1111/j.1365-2036.2007.03368.x; Huang YS, 2007, J HEPATOL, V47, P128, DOI 10.1016/j.jhep.2007.02.009; Huang YS, 2002, HEPATOLOGY, V35, P883, DOI 10.1053/jhep.2002.32102; Ichai P, 2005, LIVER TRANSPLANT, V11, P1550, DOI 10.1002/lt.20545; Ichai P, 2008, LIVER TRANSPLANT, V14, pS67, DOI 10.1002/lt.21612; Ichai P, 2007, LIVER TRANSPLANT, V13, P996, DOI 10.1002/lt.21036; Ikegami T, 2008, J AM COLL SURGEONS, V206, P412, DOI 10.1016/j.jamcollsurg.2007.08.018; Jalan R, 2007, MED HYPOTHESES, V69, P1064, DOI 10.1016/j.mehy.2006.12.061; Jalan R, 2004, GASTROENTEROLOGY, V127, P1338, DOI 10.1053/j.gastro.2004.08.005; Jalan R, 2006, LANCET, V368, P2195, DOI 10.1016/S0140-6736(06)69874-7; Jalan R, 2009, GASTROENTEROLOGY, V136, P2048, DOI 10.1053/j.gastro.2009.04.016; James LP, 2006, PEDIATRICS, V118, pE676, DOI 10.1542/peds.2006-0069; Jiang Q, 2009, J GASTROEN HEPATOL, V24, P9, DOI 10.1111/j.1440-1746.2008.05582.x; Joshi D, 2010, LANCET, V375, P594, DOI 10.1016/S0140-6736(09)61495-1; Kamar Nassim, 2008, N Engl J Med, V358, P811, DOI 10.1056/NEJMoa0706992; Katoonizadeh A, 2007, LIVER INT, V27, P329, DOI 10.1111/j.1478-3231.2006.01429.x; Katz LH, 2008, J VIRAL HEPATITIS, V15, P89, DOI 10.1111/j.1365-2893.2007.00902.x; Kessler WR, 2004, CLIN GASTROENTEROL H, V2, P625, DOI 10.1016/S1542-3565(04)00246-0; Khuroo MS, 2009, J VIRAL HEPATITIS, V16, P519, DOI 10.1111/j.1365-2893.2009.01101.x; Khuroo MS, 2003, J VIRAL HEPATITIS, V10, P224, DOI 10.1046/j.1365-2893.2003.00415.x; Kumar M, 2007, HEPATOLOGY, V45, P97, DOI 10.1002/hep.21486; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee WM, 2009, GASTROENTEROLOGY, V137, P856, DOI 10.1053/j.gastro.2009.06.006; Leithead JA, 2009, GUT, V58, P443, DOI 10.1136/gut.2008.154120; Liu CL, 2003, LIVER TRANSPLANT, V9, P1185, DOI 10.1053/jlts.2003.50235; Liu JP, 2004, COCHRANE DB SYST REV, V2004, DOI 10.1002/14651858.CD003628.pub2; Lucena MI, 2008, HEPATOLOGY, V48, P588, DOI 10.1002/hep.22370; Mansuy JM, 2009, J CLIN VIROL, V44, P74, DOI 10.1016/j.jcv.2008.09.010; Mindikoglu AL, 2006, CLIN GASTROENTEROL H, V4, P1076, DOI 10.1016/j.cgh.2006.05.027; Mindikoglu AL, 2009, LIVER TRANSPLANT, V15, P719, DOI 10.1002/lt.21692; Miyake Y, 2008, INTERNAL MED, V47, P1293, DOI 10.2169/internalmedicine.47.1061; Mochida S, 2008, HEPATOL RES, V38, P970, DOI 10.1111/j.1872-034X.2008.00368.x; Molina RA, 2004, AM J TRANSPLANT, V4, P1656, DOI 10.1111/j.1600-6143.2004.00559.x; Mudawi HMY, 2007, DIGEST DIS SCI, V52, P3266, DOI 10.1007/s10620-006-9730-z; Murphy N, 2004, HEPATOLOGY, V39, P464, DOI 10.1002/hep.20056; Navarro VJ, 2006, NEW ENGL J MED, V354, P731, DOI 10.1056/NEJMra052270; Neuberger J, 2008, GUT, V57, P252, DOI 10.1136/gut.2007.131730; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; Ostapowicz G, 2002, ANN INTERN MED, V137, P947, DOI 10.7326/0003-4819-137-12-200212170-00007; Parekh NK, 2007, HEPATOLOGY, V45, P1489, DOI 10.1002/hep.21640; Patra S, 2007, ANN INTERN MED, V147, P28, DOI 10.7326/0003-4819-147-1-200707030-00005; Petrowsky H, 2009, SEMIN LIVER DIS, V29, P121, DOI 10.1055/s-0029-1192060; Potts M, 2003, BRIT MED J, V327, P1287, DOI 10.1136/bmj.327.7426.1287-c; Prescott LF, 1996, PARACETAMOL ACETAMIN; Quaglia A, 2008, LIVER TRANSPLANT, V14, P1437, DOI 10.1002/lt.21568; Rantala Merja, 2008, Euro Surveill, V13; Rezende G, 2003, HEPATOLOGY, V38, P613, DOI 10.1053/jhep.2003.50366; Rolando N, 2000, HEPATOLOGY, V32, P734, DOI 10.1053/jhep.2000.17687; Romero-Gomez M, 2009, METAB BRAIN DIS, V24, P147, DOI 10.1007/s11011-008-9124-3; Sagnelli E, 2006, J VIRAL HEPATITIS, V13, P67, DOI 10.1111/j.1365-2893.2005.00659.x; Samandari T, 2004, VACCINE, V22, P4342, DOI 10.1016/j.vaccine.2004.04.014; Sarwar Shahid, 2006, J Coll Physicians Surg Pak, V16, P112; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2005, HEPATOLOGY, V41, P26, DOI 10.1002/hep.20511; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Simpson KJ, 2009, LIVER TRANSPLANT, V15, P600, DOI 10.1002/lt.21681; Spital A, 2005, AM J TRANSPLANT, V5, P2619, DOI 10.1111/j.1600-6143.2005.01083.x; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Stravitz RT, 2009, CRIT CARE MED, V37, pS258, DOI 10.1097/CCM.0b013e3181aa5fb8; Surman OS, 2002, NEW ENGL J MED, V346, P1038, DOI 10.1056/NEJM200204043461402; Takikawa H, 2009, HEPATOL RES, V39, P427, DOI 10.1111/j.1872-034X.2008.00486.x; Tassopoulos NC, 2008, J GASTROEN HEPATOL, V23, P1208, DOI 10.1111/j.1440-1746.2008.05454.x; Taylor RM, 2006, HEPATOLOGY, V44, P1589, DOI 10.1002/hep.21439; Temple AR, 2007, CLIN TOXICOL, V45, P36, DOI 10.1080/15563650601120792; Tillmann HL, 2006, J VIRAL HEPATITIS, V13, P256, DOI 10.1111/j.1365-2893.2005.00695.x; Trey C, 1970, Prog Liver Dis, V3, P282; Tung J, 2000, J PEDIATR GASTR NUTR, V31, P557, DOI 10.1097/00005176-200011000-00019; Umemura T, 2003, J INFECT DIS, V188, P1545, DOI 10.1086/379216; van Hoek B, 1999, J HEPATOL, V30, P699; Vaquero J, 2005, J HEPATOL, V43, P1067, DOI 10.1016/j.jhep.2005.05.039; Vaquero J, 2003, GASTROENTEROLOGY, V125, P755, DOI 10.1016/S0016-5085(03)01051-5; Vento S, 1998, NEW ENGL J MED, V338, P286, DOI 10.1056/NEJM199801293380503; Wai CT, 2007, LIVER INT, V27, P465, DOI 10.1111/j.1478-3231.2007.01461.x; Wai CT, 2005, J VIRAL HEPATITIS, V12, P192, DOI 10.1111/j.1365-2893.2005.00581.x; Walsh TS, 2000, CRIT CARE MED, V28, P649, DOI 10.1097/00003246-200003000-00008; Wasley A, 2006, EPIDEMIOL REV, V28, P101, DOI 10.1093/epirev/mxj012; Watkins PB, 2006, JAMA-J AM MED ASSOC, V296, P87, DOI 10.1001/jama.296.1.87; Wei G, 2007, J INTERN MED, V262, P393, DOI 10.1111/j.1365-2796.2007.01818.x; Wei G, 2008, SCAND J GASTROENTERO, V43, P984, DOI 10.1080/00365520801965399; WENDON JA, 1994, HEPATOLOGY, V19, P1407, DOI 10.1016/0270-9139(94)90235-6; Wigg AJ, 2005, LIVER TRANSPLANT, V11, P27, DOI 10.1002/lt.20289; Willner IR, 1998, ANN INTERN MED, V128, P111, DOI 10.7326/0003-4819-128-2-199801150-00006; Wright G, 2007, METAB BRAIN DIS, V22, P375, DOI 10.1007/s11011-007-9071-4; Yaghi Cesar, 2006, Gastroenterol Clin Biol, V30, P763, DOI 10.1016/S0399-8320(06)73311-5; Yeo W, 2004, BRIT J CANCER, V90, P1306, DOI 10.1038/sj.bjc.6601699; Zanetti AR, 2008, VACCINE, V26, P6266, DOI 10.1016/j.vaccine.2008.09.056; HYPOTHERMIA PREVENT	153	644	697	3	114	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					190	201		10.1016/S0140-6736(10)60274-7	http://dx.doi.org/10.1016/S0140-6736(10)60274-7			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20638564				2022-12-28	WOS:000280313100027
J	Alic, J; Sarewitz, D; Weiss, C; Bonvillian, W				Alic, John; Sarewitz, Daniel; Weiss, Charles; Bonvillian, William			A new strategy for energy innovation	NATURE			English	Editorial Material									[Sarewitz, Daniel] Arizona State Univ, Consortium Sci Policy & Outcomes, Tempe, AZ 85287 USA; [Weiss, Charles] Georgetown Univ, Sch Foreign Serv, Washington, DC 20057 USA; [Bonvillian, William] MIT, Washington Off, Washington, DC 20002 USA	Arizona State University; Arizona State University-Tempe; Georgetown University; Massachusetts Institute of Technology (MIT)		john_alic@earthlink.net						Alic JA, 2007, TRILLIONS FOR MILITARY TECHNOLOGY: HOW THE PENTAGON INNOVATES AND WHY IT COSTS SO MUCH, P1, DOI 10.1057/9780230606876; [Anonymous], 2009, INN POL CLIM CHANG; BIRKLER JL, 1982, DEV PRODUCTION COST; BONVILLIAN WB, 2009, INNOVATIONS, P289; Vane HR, 2009, J ECON PERSPECT, V23, P109, DOI 10.1257/jep.23.3.109; Weiss C., 2009, STRUCT EN TECHN REV; YOUNOSSI O, 2002, MILITARY JET ENGINE, P66	7	20	20	2	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					316	317		10.1038/466316a	http://dx.doi.org/10.1038/466316a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625BP	20631780				2022-12-28	WOS:000279867100018
J	Arroll, B; Doughty, R; Andersen, V				Arroll, Bruce; Doughty, Robert; Andersen, Victoria			Investigation and management of congestive heart failure	BMJ-BRITISH MEDICAL JOURNAL			English	Review							CLINICAL-OUTCOMES; MORTALITY; SURVIVAL; TRIAL		[Arroll, Bruce; Doughty, Robert] Univ Auckland, Dept Med, Auckland 1142, New Zealand	University of Auckland	Arroll, B (corresponding author), Univ Auckland, Dept Med, Private Bag 92019, Auckland 1142, New Zealand.	b.arroll@auckland.ac.nz						[Anonymous], 2009, J AM COLL CARDIOL, V53, P1343; *BMJ BEST PRACT, CHRON CONG HEART FAI; Brophy JM, 2004, AM J MED, V116, P300, DOI 10.1016/j.amjmed.2003.09.035; Calvert MJ, 2009, FAM PRACT, V26, P145, DOI 10.1093/fampra/cmn105; Chen YT, 1999, AM J MED, V106, P605, DOI 10.1016/S0002-9343(99)00126-6; Doughty RN, 2002, EUR HEART J, V23, P139, DOI 10.1053/euhj.2001.2712; Emberson JR, 2007, J AM COLL CARDIOL, V49, P311; Ezekowitz JA, 2009, EUR HEART J, V30, P469, DOI 10.1093/eurheartj/ehn543; Gott M, 2008, SOC SCI MED, V67, P1113, DOI 10.1016/j.socscimed.2008.05.024; *HEART FAIL ASS ES, 2008, EUR J HEART FAIL, V10, P933; *HEART FAIL SOC AM, STAG HEART FAIL NYHA; HO KKL, 1993, CIRCULATION, V88, P107, DOI 10.1161/01.CIR.88.1.107; HOOD WB, 2004, COCHRANE DB SYST REV, V2; *I PRESERVE INV, 2008, NEW ENGL J MED, V359, P2456; Koelling TM, 2004, J HEART LUNG TRANSPL, V23, P1414, DOI 10.1016/j.healun.2003.10.002; Konstam MA, 2009, LANCET, V374, P1840, DOI 10.1016/S0140-6736(09)61913-9; LAFUENTELAFUENT.C, 2010, BRIT MED J, V339, pB5216; Mant J., 2009, HLTH TECHNOL ASSESS, V13; Massie BM, 2001, ARCH INTERN MED, V161, P165, DOI 10.1001/archinte.161.2.165; MCKEE PA, 1971, NEW ENGL J MED, V285, P1441, DOI 10.1056/NEJM197112232852601; MCKELVIE R, 2010, CLIN EVID; Meyer P, 2008, AM J CARDIOL, V102, P1681, DOI 10.1016/j.amjcard.2008.05.068; *NAT I HLTH CLIN E, 2003, CHRON HEART FAIL; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Salpeter S, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003566.pub2; Scottish Intercollegiate Guidelines Network, 2007, MAN CHRON HEART FAIL; Sloan J., 2009, BITTER PILL MED SYST; Wald DS, 2002, QJM-INT J MED, V95, P55, DOI 10.1093/qjmed/95.1.55; Yusuf S, 2003, LANCET, V362, P777, DOI 10.1016/S0140-6736(03)14285-7	30	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2010	341								c3657	10.1136/bmj.c3657	http://dx.doi.org/10.1136/bmj.c3657			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XC	20630951				2022-12-28	WOS:000280156700003
J	Smith, A				Smith, Andrew			Monitoring of neuromuscular blockade in general anaesthesia	LANCET			English	Editorial Material							MANAGEMENT		[Smith, Andrew] Royal Lancaster Infirm, Dept Anaesthesia, Lancaster LA1 4RP, England; [Smith, Andrew] Royal Lancaster Infirm, Patient Safety Res Unit, Lancaster LA1 4RP, England		Smith, A (corresponding author), Royal Lancaster Infirm, Dept Anaesthesia, Lancaster LA1 4RP, England.	andrew.f.smith@mbht.nhs.uk	Smith, Andrew F/C-5384-2012					Abrishami A, 2009, COCHRANE DB SYST REV, V4; Arbous MS, 2005, ANESTHESIOLOGY, V102, P257, DOI 10.1097/00000542-200502000-00005; Association of Anaesthestists of Great Britain and Ireland, 2007, REC STAND MON AN REC; Claudius C, 2008, ANESTHESIOLOGY, V108, P1117, DOI 10.1097/ALN.0b013e318173f62f; Debaene B, 2003, ANESTHESIOLOGY, V98, P1042, DOI 10.1097/00000542-200305000-00004; ERIKSSON LI, 1992, ACTA ANAESTH SCAND, V36, P710, DOI 10.1111/j.1399-6576.1992.tb03550.x; Grayling M, 2007, ANAESTHESIA, V62, P806, DOI 10.1111/j.1365-2044.2007.05101.x; Hovhannisyan K, 2009, COCHRANE DB SYST REV, V4; Murphy GS, 2008, ANESTHESIOLOGY, V109, P389, DOI 10.1097/ALN.0b013e318182af3b; Naguib M, 2010, ANESTH ANALG, V111, P110, DOI 10.1213/ANE.0b013e3181c07428; Smith AF, 2003, ANAESTHESIA, V58, P1070, DOI 10.1046/j.1365-2044.2003.03404.x; Srivastava A, 2009, BRIT J ANAESTH, V103, P115, DOI 10.1093/bja/aep093; Sundman E, 2000, ANESTHESIOLOGY, V92, P977, DOI 10.1097/00000542-200004000-00014	13	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					77	79		10.1016/S0140-6736(10)60542-9	http://dx.doi.org/10.1016/S0140-6736(10)60542-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20621223				2022-12-28	WOS:000279943200008
J	Loxterkamp, DA				Loxterkamp, David A.			Old Men and the Sea	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												dr.loxterkamp@myfairpoint.net							0	1	1	4	15	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					18	19		10.1001/jama.2010.902	http://dx.doi.org/10.1001/jama.2010.902			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606138				2022-12-28	WOS:000279519600001
J	Ayesh, A; Yahya, A; Abu Qara', AA; Dababat, A; Abu Hadeed, A; Shoaibi, A; Abu Mahmoud, D; Issa, F; Qaisi, F; Hasan, F; Saadeh, H; Alami, H; el Hadi, H; Abu Hamda, H; Al Kawazba, L; Ya'qoub, M; Hannoon, M; Ibrahim, M; Bsiso, M; Jarar, M; Daraghmeh, M; Fahmawi, N; Saeed, NH; Harhash, N; Darwish, N; Omar, O; Shu'ibi, R; Hazineh, RE; Abu Safat, R; Shraim, R; Shamasna, S; Odeh, SB; Shamasneh, S; Ali, SA; Mitwali, S				Ayesh, Abeer; Yahya, Ala'; Abu Qara', Areem Ahamd; Dababat, Ayman; Abu Hadeed, Abed; Shoaibi, Azza; Abu Mahmoud, Dawlat; Issa, Fadi; Qaisi, Faten; Hasan, Faten; Saadeh, Hanan; Alami, Hatem; el Hadi, Haya; Abu Hamda, Heba; Al Kawazba, Lamia; Ya'qoub, Maha; Hannoon, Majdi; Ibrahim, Mamdouh; Bsiso, Maysoun; Jarar, Mohammad; Daraghmeh, Mustafa; Fahmawi, Na'ela; Saeed, Nehaya Hassan; Harhash, Nehaya; Darwish, Niveen; Omar, Osama; Shu'ibi, Rana; Hazineh, Rasha e; Abu Safat, Reema; Shraim, Rimah; Shamasna, Sameer; Odeh, Sawsan Bani; Shamasneh, Siham; Ali, Suzan Al Haj; Mitwali, Suzan			Making the future ours in the occupied Palestinian territory	LANCET			English	Editorial Material									[Ayesh, Abeer; Yahya, Ala'; Abu Qara', Areem Ahamd; Dababat, Ayman; Abu Hadeed, Abed; Shoaibi, Azza; Abu Mahmoud, Dawlat; Issa, Fadi; Qaisi, Faten; Hasan, Faten; Saadeh, Hanan; Alami, Hatem; el Hadi, Haya; Abu Hamda, Heba; Al Kawazba, Lamia; Ya'qoub, Maha; Hannoon, Majdi; Ibrahim, Mamdouh; Bsiso, Maysoun; Jarar, Mohammad; Daraghmeh, Mustafa; Fahmawi, Na'ela; Saeed, Nehaya Hassan; Harhash, Nehaya; Darwish, Niveen; Omar, Osama; Shu'ibi, Rana; Hazineh, Rasha e; Abu Safat, Reema; Shraim, Rimah; Shamasna, Sameer; Odeh, Sawsan Bani; Shamasneh, Siham; Ali, Suzan Al Haj; Mitwali, Suzan] Birzeit Univ, West Bank, Birzeit, Israel	Birzeit University	Shoaibi, A (corresponding author), Birzeit Univ, West Bank, Birzeit, Israel.	ashoaibi@birzeit.edu		Issa, Fadi/0000-0002-8279-7732				[Anonymous], 2009, LANCET; GOLBERG ML, 2010, UN DISPATCH GLOBAL N; RAVID B, 2010, NETANYAHU I REGRET G; The United Nations, 2008, QUEST PAL UN	4	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					8	10		10.1016/S0140-6736(10)60968-3	http://dx.doi.org/10.1016/S0140-6736(10)60968-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20609978				2022-12-28	WOS:000279841600008
J	Bromm, V				Bromm, Volker			To Cool or Not to Cool	SCIENCE			English	Editorial Material							CHEMICAL ENRICHMENT; 1ST		Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bromm, V (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	vbromm@astro.as.utexas.edu						Barkana R, 2001, PHYS REP, V349, P126, DOI 10.1016/s0370-1573(01)00019-9; BARKAT Z, 1967, PHYS REV LETT, V18, P379, DOI 10.1103/PhysRevLett.18.379; Bromm V, 2009, NATURE, V459, P49, DOI 10.1038/nature07990; Fan XH, 2006, ANNU REV ASTRON ASTR, V44, P415, DOI 10.1146/annurev.astro.44.051905.092514; Frebel A, 2009, MON NOT R ASTRON SOC, V392, pL50, DOI 10.1111/j.1745-3933.2008.00587.x; Gal-Yam A, 2009, NATURE, V462, P624, DOI 10.1038/nature08579; Greif TH, 2010, ASTROPHYS J, V716, P510, DOI 10.1088/0004-637X/716/1/510; Heger A, 2002, ASTROPHYS J, V567, P532, DOI 10.1086/338487; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; Johnson JL, 2006, MON NOT R ASTRON SOC, V366, P247, DOI 10.1111/j.1365-2966.2005.09846.x; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Kreckel H, 2010, SCIENCE, V329, P69, DOI 10.1126/science.1187191; Wise JH, 2008, ASTROPHYS J, V685, P40, DOI 10.1086/590417	13	2	2	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					45	46		10.1126/science.1192014	http://dx.doi.org/10.1126/science.1192014			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595606				2022-12-28	WOS:000279402700025
J	Masand, M				Masand, Mahesh			Personal View Accidental strangulation with a Venetian blind cord-a near miss	BRITISH MEDICAL JOURNAL			English	Editorial Material									Dr Grays Hosp, Elgin, Moray, England		Masand, M (corresponding author), Dr Grays Hosp, Elgin, Moray, England.	mmasand@nhs.net						[Anonymous], DAILY MAIL; *BBC, TODDL DIES BEDR ACC; *BBC, CHILD DIED WAV GRAND; *BBC, SAF CALL CHILD STRAN; LANGMIAID A, HERALD SUN; NIXON JW, 1995, ARCH DIS CHILD, V72, P6, DOI 10.1136/adc.72.1.6; RUCHSCHWALBE R, 1997, JAMA-J AM MED ASSOC, V277, P1696; 2009, IRISH TIMES     0428	8	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2010	340								c3458	10.1136/bmj.c3458	http://dx.doi.org/10.1136/bmj.c3458			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NS	20587554				2022-12-28	WOS:000279586200002
J	Carter, J; Poulet, F; Bibring, JP; Murchie, S				Carter, J.; Poulet, F.; Bibring, J. -P.; Murchie, S.			Detection of Hydrated Silicates in Crustal Outcrops in the Northern Plains of Mars	SCIENCE			English	Article							SPECTRAL EVIDENCE; PHYLLOSILICATES; DIVERSITY; EVOLUTION; LOWLANDS; HISTORY; WATER	The composition of the ancient martian crust is a key ingredient in deciphering the environment and evolution of early Mars. We present an analysis of the composition of large craters in the martian northern plains based on data from spaceborne imaging spectrometers. Nine of the craters have excavated assemblages of phyllosilicates from ancient, Noachian crust buried beneath the plains' cover. The phyllosilicates are indistinguishable from those exposed in widespread locations in the southern highlands, demonstrating that liquid water once altered both hemispheres of Mars.	[Carter, J.; Poulet, F.; Bibring, J. -P.] Univ Paris 11, CNRS, IAS, F-91405 Orsay, France; [Murchie, S.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Carter, J (corresponding author), Univ Paris 11, CNRS, IAS, F-91405 Orsay, France.	John.carter@ias.u-psud.fr	Murchie, Scott L/E-8030-2015	Murchie, Scott L/0000-0002-1616-8751				Abramov O, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2005JE002453; BAKER VR, 1991, NATURE, V352, P589, DOI 10.1038/352589a0; Bandfield JL, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001510; Baratoux D, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002890; Bibring J.-P., 2004, EUR SPACE AGENCY SPE, V1240, P37; Bibring JP, 2005, SCIENCE, V307, P1576, DOI 10.1126/science.1108806; Bibring JP, 2006, SCIENCE, V312, P400, DOI 10.1126/science.1122659; Bishop JL, 2008, CLAY MINER, V43, P35, DOI 10.1180/claymin.2008.043.1.03; CARTER J, 2009, P LUNAR PLANET SCI C, V40; Christensen PR, 2005, NATURE, V436, P504, DOI 10.1038/nature03639; Clark R.N., 2007, USGS DIGITAL DATA SE, V231; Dickson JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL037472; Ehlmann BL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003339; Frey M., 1999, LOW GRADE METAMORPHI; GONDET B, 2007, 7 INT C MARS LUN PLA; Head JW, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2000JE001445; Kreslavsky MA, 2006, METEORIT PLANET SCI, V41, P1633, DOI 10.1111/j.1945-5100.2006.tb00441.x; Kreslavsky MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015392; Kreslavsky MA, 2002, J GEOPHYS RES-PLANET, V107, DOI 10.1029/2001JE001831; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003344; Murchie SL, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003342; Mustard JF, 2005, SCIENCE, V307, P1594, DOI 10.1126/science.1109098; Mustard JF, 2008, NATURE, V454, P305, DOI 10.1038/nature07097; Pelkey SM, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002831; Picardi G, 2005, SCIENCE, V310, P1925, DOI 10.1126/science.1122165; Poulet F, 2005, NATURE, V438, P623, DOI 10.1038/nature04274; Rathbun JA, 2002, ICARUS, V157, P362, DOI 10.1006/icar.2002.6838; Rogers D, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001913; Ruff SW, 2004, ICARUS, V168, P131, DOI 10.1016/j.icarus.2003.11.003; SALVATORE MR, 2009, P LUNAR PLANET SCI C, V40; Schwenzer SP, 2009, GEOLOGY, V37, P1091, DOI 10.1130/G30340A.1; Stockstill-Cahill KR, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003036; Tanaka KL, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE001908; Wyatt MB, 2002, NATURE, V417, P263, DOI 10.1038/417263a; Zuber MT, 2000, SCIENCE, V287, P1788, DOI 10.1126/science.287.5459.1788	35	115	116	2	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1682	1686		10.1126/science.1189013	http://dx.doi.org/10.1126/science.1189013			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576889				2022-12-28	WOS:000279107400040
J	Kasanetz, F; Deroche-Gamonet, V; Berson, N; Balado, E; Lafourcade, M; Manzoni, O; Piazza, PV				Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo			Transition to Addiction Is Associated with a Persistent Impairment in Synaptic Plasticity	SCIENCE			English	Article							LONG-TERM DEPRESSION; DRUG-SEEKING; COCAINE ADDICTION; NEURAL MECHANISMS; NUCLEUS-ACCUMBENS; BEHAVIOR; LTD; VTA	Chronic exposure to drugs of abuse induces countless modifications in brain physiology. However, the neurobiological adaptations specifically associated with the transition to addiction are unknown. Cocaine self-administration rapidly suppresses long-term depression (LTD), an important form of synaptic plasticity in the nucleus accumbens. Using a rat model of addiction, we found that animals that progressively develop the behavioral hallmarks of addiction have permanently impaired LTD, whereas LTD is progressively recovered in nonaddicted rats maintaining a controlled drug intake. By making drug seeking consistently resistant to modulation by environmental contingencies and consequently more and more inflexible, a persistently impaired LTD could mediate the transition to addiction.	[Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] INSERM, U862, NeuroCtr Magendie, F-33077 Bordeaux, France; [Kasanetz, Fernando; Deroche-Gamonet, Veronique; Berson, Nadege; Balado, Eric; Lafourcade, Mathieu; Manzoni, Olivier; Piazza, Pier Vincenzo] Univ Bordeaux, F-33077 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Manzoni, O (corresponding author), INSERM, U862, NeuroCtr Magendie, 147 Rue Leo Saignat, F-33077 Bordeaux, France.	olivier.manzoni@inserm.fr; pier-vincenzo.piazza@inserm.fr	Lafourcade, Mathieu/GQZ-7267-2022; Deroche-Gamonet, Véronique/E-5728-2010; Manzoni, Olivier/M-7899-2016	Manzoni, Olivier/0000-0002-5579-6208; Lafourcade, Mathieu/0000-0001-6117-1194; Kasanetz, Fernando/0000-0003-4585-2314; Deroche-Gamonet, Veronique/0000-0002-9704-6624	ANR [2005]; EU-STREPPheCOMP; MILDT/INCa/Inserm [2008]	ANR(French National Research Agency (ANR)); EU-STREPPheCOMP; MILDT/INCa/Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)Institut National du Cancer (INCA) France)	Supported by ANR (2005), EU-STREPPheCOMP (FP6), MILDT/INCa/Inserm (2008) grants to P. V. P., O.M., and V. D.-G. The authors report no conflict of interest.	Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Chen BT, 2008, NEURON, V59, P288, DOI 10.1016/j.neuron.2008.05.024; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Everitt BJ, 2008, PHILOS T R SOC B, V363, P3125, DOI 10.1098/rstb.2008.0089; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kalivas PW, 2009, NAT REV NEUROSCI, V10, P561, DOI 10.1038/nrn2515; Kalivas PW, 2005, NAT NEUROSCI, V8, P1440, DOI 10.1038/nn1105-1440; Kalivas PW, 2005, NEURON, V45, P647, DOI 10.1016/j.neuron.2005.02.005; Kauer JA, 2007, NAT REV NEUROSCI, V8, P844, DOI 10.1038/nrn2234; Koob GF, 2005, NAT NEUROSCI, V8, P1442, DOI 10.1038/nn1105-1442; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Martin M, 2006, NAT NEUROSCI, V9, P868, DOI 10.1038/nn1713; Maze I, 2010, SCIENCE, V327, P213, DOI 10.1126/science.1179438; Moussawi K, 2009, NAT NEUROSCI, V12, P182, DOI 10.1038/nn.2250; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; OBrien CP, 1997, SCIENCE, V278, P66, DOI 10.1126/science.278.5335.66; Panlilio LV, 2007, ADDICTION, V102, P1863, DOI 10.1111/j.1360-0443.2007.02011.x; Robbe D, 2002, J NEUROSCI, V22, P4346, DOI 10.1523/JNEUROSCI.22-11-04346.2002; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Shaham Y, 2005, NAT NEUROSCI, V8, P1437, DOI 10.1038/nn1105-1437; Stuber GD, 2008, SCIENCE, V321, P1690, DOI 10.1126/science.1160873; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; WARNER LA, 1995, ARCH GEN PSYCHIAT, V52, P219; Wolf ME, 2004, NEUROPHARMACOLOGY, V47, P61, DOI 10.1016/j.neuropharm.2004.07.006; Yin HH, 2009, NAT NEUROSCI, V12, P333, DOI 10.1038/nn.2261	30	270	274	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1709	1712		10.1126/science.1187801	http://dx.doi.org/10.1126/science.1187801			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576893				2022-12-28	WOS:000279107400048
J	Clayton, J				Clayton, Julie			Chagas disease 101	NATURE			English	Editorial Material							TRYPANOSOMA-CRUZI DNA; LESIONS											de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Jannin J, 2006, OPSHDMCD42506 PAN AM, P1; JONES EM, 1993, AM J TROP MED HYG, V48, P348, DOI 10.4269/ajtmh.1993.48.348; Schijman AG, 2004, AM J TROP MED HYG, V70, P210, DOI 10.4269/ajtmh.2004.70.210; *WORLD EXP COMM, 2002, WHO TECH REP SER, V905, pR1	5	104	106	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S4	S5		10.1038/nature09220	http://dx.doi.org/10.1038/nature09220			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571553	Bronze			2022-12-28	WOS:000279056900024
J	Greenland, PT; Lynch, SA; van der Meer, AFG; Murdin, BN; Pidgeon, CR; Redlich, B; Vinh, NQ; Aeppli, G				Greenland, P. T.; Lynch, S. A.; van der Meer, A. F. G.; Murdin, B. N.; Pidgeon, C. R.; Redlich, B.; Vinh, N. Q.; Aeppli, G.			Coherent control of Rydberg states in silicon	NATURE			English	Article							DONORS; EXCITATION; BLOCKADE	Laser cooling and electromagnetic traps have led to a revolution in atomic physics, yielding dramatic discoveries ranging from Bose-Einstein condensation to the quantum control of single atoms(1). Of particular interest, because they can be used in the quantum control of one atom by another, are excited Rydberg states(2-4), where wavefunctions are expanded from their ground-state extents of less than 0.1 nm to several nanometres and even beyond; this allows atoms far enough apart to be non-interacting in their ground states to strongly interact in their excited states. For eventual application of such states(5), a solid-state implementation is very desirable. Here we demonstrate the coherent control of impurity wavefunctions in the most ubiquitous donor in a semiconductor, namely phosphorus-doped silicon. In our experiments, we use a free-electron laser to stimulate and observe photon echoes(6,7), the orbital analogue of the Hahn spin echo(8), and Rabi oscillations familiar from magnetic resonance spectroscopy. As well as extending atomic physicists' explorations(1-3,9) of quantum phenomena to the solid state, our work adds coherent terahertz radiation, as a particularly precise regulator of orbitals in solids, to the list of controls, such as pressure and chemical composition, already familiar to materials scientists(10).	[Greenland, P. T.; Lynch, S. A.; Aeppli, G.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England; [Greenland, P. T.; Lynch, S. A.; Aeppli, G.] UCL, Dept Phys & Astron, London WC1H 0AH, England; [van der Meer, A. F. G.; Redlich, B.; Vinh, N. Q.] FOM Inst Plasma Phys Rijnhuizen, NL-3430 BE Nieuwegein, Netherlands; [Murdin, B. N.] Univ Surrey, Adv Technol Inst, Guildford GU2 7XH, Surrey, England; [Pidgeon, C. R.] Heriot Watt Univ, Dept Phys, Edinburgh EH14 4AS, Midlothian, Scotland	University of London; University College London; University of London; University College London; University of Surrey; Heriot Watt University	Greenland, PT (corresponding author), UCL, London Ctr Nanotechnol, London WC1H 0AH, England.	ptg@globalnet.co.uk	Lynch, Stephen A/A-1850-2010; Redlich, Britta/F-9689-2015	Lynch, Stephen A/0000-0001-9818-2284; Pidgeon, Carl/0000-0001-8554-3669; Nguyen, Vinh/0000-0002-3071-1722; Murdin, Ben/0000-0001-9219-652X	Netherlands Organisation for Scientific Research; Engineering and Physical Sciences Research Council [EP/H026622/1, EP/E061265/1]; EPSRC [EP/E061265/1, EP/H026622/1] Funding Source: UKRI	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We are grateful for conversations with A. J. Fisher, A. M. Stoneham, C. Kay and G. Morley; to R. Hulet for pointing out ref. 8; and for experimental assistance from K. Litvinenko and G. Morley. We acknowledge financial support from the Netherlands Organisation for Scientific Research and the Engineering and Physical Sciences Research Council (COMPASSS, grant reference EP/H026622/1, and Advanced Research Fellowship EP/E061265/1).	ABELLA ID, 1966, PHYS REV, V141, P391, DOI 10.1103/PhysRev.141.391; AGARWAL GS, 1978, PHYS REV A, V18, P1490, DOI 10.1103/PhysRevA.18.1490; ALLEN L, 1987, OPTICAL RESONANCE 2, P195; BROWN RA, 1967, PHYS REV, V153, P890, DOI 10.1103/PhysRev.153.890; Gaetan A, 2009, NAT PHYS, V5, P115, DOI 10.1038/NPHYS1183; Haffner H, 2008, PHYS REP, V469, P155, DOI 10.1016/j.physrep.2008.09.003; HAHN EL, 1950, PHYS REV, V80, P580, DOI 10.1103/PhysRev.80.580; JAGANNATH C, 1981, PHYS REV B, V23, P2082, DOI 10.1103/PhysRevB.23.2082; Karaiskaj D, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.186402; KOHN W, 1955, PHYS REV, V98, P915, DOI 10.1103/PhysRev.98.915; Kroner M, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2837193; Larsen DM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.165204; OEPTS D, 1995, INFRARED PHYS TECHN, V36, P297, DOI 10.1016/1350-4495(94)00074-U; Petta JR, 2005, SCIENCE, V309, P2180, DOI 10.1126/science.1116955; Raitzsch U, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.013002; Ruess FJ, 2004, NANO LETT, V4, P1969, DOI 10.1021/nl048808v; SCHWARZSCHILD B, 2009, PHYS TODAY, V62, P15; Shoemaker R. L., 1978, LASER COHERENCE SPEC, P197; Stoneham AM, 2003, J PHYS-CONDENS MAT, V15, pL447, DOI 10.1088/0953-8984/15/27/102; Tokura Y, 2000, SCIENCE, V288, P462, DOI 10.1126/science.288.5465.462; Tsyplenkov VV, 2008, SEMICONDUCTORS+, V42, P1016, DOI 10.1134/S1063782608090030; Urban E, 2009, NAT PHYS, V5, P110, DOI 10.1038/NPHYS1178; Vinh NQ, 2008, P NATL ACAD SCI USA, V105, P10649, DOI 10.1073/pnas.0802721105; Zrenner A, 2002, NATURE, V418, P612, DOI 10.1038/nature00912	24	103	106	1	92	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1057	U116		10.1038/nature09112	http://dx.doi.org/10.1038/nature09112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577211	Green Submitted			2022-12-28	WOS:000279056900048
J	Heidenreich, KD				Heidenreich, Katherine D.			Benign Paroxysmal Positional Vertigo.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Michigan Hlth Syst, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Heidenreich, KD (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI USA.	kheidenr@med.umich.edu							0	1	1	5	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					e70	e70		10.1056/NEJMicm0907386	http://dx.doi.org/10.1056/NEJMicm0907386			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20573921				2022-12-28	WOS:000279043800011
J	Connors, EE; Gostin, LO				Connors, Elenora E.; Gostin, Lawrence O.			Health Care Reform-A Historic Moment in US Social Policy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Connors, Elenora E.; Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA	Georgetown University	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				ABELSON R, 2010, NY TIMES        0113; De-Navas-Walt C, 2008, US CENSUS BUREAU CUR; ELMENDORF DW, 2010, COST ESTIMATE AMENDM; Gostin LO, 2010, JAMA-J AM MED ASSOC, V303, P1188, DOI 10.1001/jama/2010.375; Henry J., FOC HLTH REF SUMM NE; *HJ KAIS FAM FDN, 2009, FOC HLTH REF NAT HLT; JOST TS, 2009, LEGAL SOLUTIONS HLTH; PEAR R, 2010, NY TIMES        0423; SHOEN C, 2008, HLTH AFF MILLWOOD, V27, P298	9	33	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2521	2522		10.1001/jama.2010.856	http://dx.doi.org/10.1001/jama.2010.856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571019	Green Published			2022-12-28	WOS:000279010900031
J	Booth, A; Clarke, M; Ghersi, D; Moher, D; Petticrew, M; Stewart, L				Booth, Alison; Clarke, Mike; Ghersi, Davina; Moher, David; Petticrew, Mark; Stewart, Lesley			An international registry of systematic-review protocols	LANCET			English	Editorial Material									[Booth, Alison; Stewart, Lesley] Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England; [Clarke, Mike] UK Cochrane Ctr, Oxford, England; [Ghersi, Davina] WHO, Int Clin Trials Registry Platform, CH-1211 Geneva, Switzerland; [Moher, David] Ottawa Hosp, Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Petticrew, Mark] London Sch Hyg & Trop Med, Publ & Environm Hlth Res Unit, London WC1, England	University of York - UK; Cochrane Centre; World Health Organization; University of Ottawa; Ottawa Hospital Research Institute; University of London; London School of Hygiene & Tropical Medicine	Booth, A (corresponding author), Univ York, Ctr Reviews & Disseminat, York YO10 5DD, N Yorkshire, England.	ab42@york.ac.uk	Moher, David/I-3408-2019; Petticrew, Mark/AAY-6274-2021; Booth, Alison/I-8044-2015	Moher, David/0000-0003-2434-4206; Booth, Alison/0000-0001-7138-6295; Stewart, Lesley/0000-0003-0287-4724	National Institute for Health Research [NF-SI-0507-10259] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Brown M, 2007, PLOS MED, V4, P1421, DOI 10.1371/journal.pmed.0040288; Centre for Reviews and Dissemination, CRD DAT; Centre for Reviews and Dissemination, CRD INT REG ONG SYST; De Angelis C, 2004, CAN MED ASSOC J, V171, P606, DOI 10.1503/cmaj.1041281; Kirkham JJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009810; Kirkham JJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c365; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1016/j.ijsu.2010.02.007, 10.1136/bmj.b2535]; Moher D, 2007, PLOS MED, V4, P447, DOI 10.1371/journal.pmed.0040078; National Public Health Service for Wales, 2010, ALL WAL SYST REV REG; Silagy CA, 2002, JAMA-J AM MED ASSOC, V287, P2831, DOI 10.1001/jama.287.21.2831; Straus S, 2010, CAN MED ASSOC J, V182, P13, DOI 10.1503/cmaj.081849	12	269	273	2	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 8	2011	377	9760					108	109		10.1016/S0140-6736(10)60903-8	http://dx.doi.org/10.1016/S0140-6736(10)60903-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	707NH	20630580				2022-12-28	WOS:000286292800009
J	Migueles, SA; Connors, M				Migueles, Stephen A.; Connors, Mark			Long-term Nonprogressive Disease Among Untreated HIV-Infected Individuals Clinical Implications of Understanding Immune Control of HIV	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CD8(+) T-CELLS; VIRAL REPLICATION CAPACITY; LOW-LEVEL VIREMIA; HLA-C ALLELES; ANTIRETROVIRAL THERAPY; ELITE SUPPRESSORS; TYPE-1 INFECTION; HIV-1-INFECTED PATIENTS; LYMPHOCYTE ACTIVATION	As of 2008, more than 33 million adults and children have been estimated to be living with human immunodeficiency virus (HIV). Among them are rare patients (<0.5%) who have remained clinically well without antiretroviral therapy after almost 20 years of infection. They maintain stable CD4 cell counts and suppressed HIV replication to levels comparable with those measured in patients receiving combination antiretroviral therapy. No known epidemiologic or behavioral factors are predictive of untreated, nonprogressive HIV infection; however, host genetics and immune response factors, most specifically HLA antigen class I-restricted HIV-specific CD8 T cells, appear to be primarily responsible for this remarkable phenotype in a majority of these individuals. These patients offer hope that durable control of HIV infection is possible and can provide important insight to inform the development of the next generation of HIV/AIDS vaccines and immune-based therapies. This article reviews clinical features of these unique patients and discusses them in the context of nonprogressors enrolled in other cohorts. Potential mechanisms underlying nonprogressive HIV infection and scientific discoveries, facilitated by the participation of these patients in clinical trials, of relevance to the design of an efficacious HIV/AIDS vaccine are also highlighted. JAMA. 2010; 304(2): 194-201 www.jama.com	[Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Connors, M (corresponding author), NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bldg 10,Room 11B-07, Bethesda, MD 20892 USA.	mconnors@nih.gov			National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000855] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Aberg JA, 2009, CLIN INFECT DIS, V49, P651, DOI 10.1086/605292; Andrade A, 2008, CLIN INFECT DIS, V46, pE78, DOI 10.1086/529387; [Anonymous], [No title captured]; Arrode G, 2005, EUR J IMMUNOL, V35, P159, DOI 10.1002/eji.200425744; Bailey JR, 2008, J VIROL, V82, P7395, DOI 10.1128/JVI.00800-08; Betts MR, 2006, BLOOD, V107, P4781, DOI 10.1182/blood-2005-12-4818; Blankson JN, 2007, J VIROL, V81, P2508, DOI 10.1128/JVI.02165-06; Blankson JN, 2010, ANTIVIR RES, V85, P295, DOI 10.1016/j.antiviral.2009.08.007; Brockman MA, 2007, J VIROL, V81, P12608, DOI 10.1128/JVI.01369-07; Cao K, 2001, HUM IMMUNOL, V62, P1009, DOI 10.1016/S0198-8859(01)00298-1; Catano G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003636; Chessman D, 2008, IMMUNITY, V28, P822, DOI 10.1016/j.immuni.2008.04.020; DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Dean M, 1996, SCIENCE, V273, P1856, DOI 10.1126/science.273.5283.1856; Dinoso JB, 2008, CLIN INFECT DIS, V47, P102, DOI 10.1086/588791; Draenert R, 2004, J VIROL, V78, P630, DOI 10.1128/JVI.78.2.630-641.2004; Emu B, 2005, J VIROL, V79, P14169, DOI 10.1128/JVI.79.22.14169-14178.2005; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Flores-Villanueva PO, 2001, P NATL ACAD SCI USA, V98, P5140, DOI 10.1073/pnas.071548198; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Friedrich TC, 2007, J VIROL, V81, P3465, DOI 10.1128/JVI.02392-06; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Grinspoon S, 2009, CIRCULATION, V119, P770, DOI 10.1161/CIRCULATIONAHA.108.835710; Grossman Z, 2002, NAT MED, V8, P319, DOI 10.1038/nm0402-319; Han YF, 2008, AIDS, V22, P541, DOI 10.1097/QAD.0b013e3282f470e4; Hatano H, 2009, J VIROL, V83, P329, DOI 10.1128/JVI.01763-08; Hetherington S, 2002, LANCET, V359, P1121, DOI 10.1016/S0140-6736(02)08158-8; Ho JE, 2009, HEART, V95, P1193, DOI 10.1136/hrt.2008.161463; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Horton H, 2006, J IMMUNOL, V177, P7406, DOI 10.4049/jimmunol.177.10.7406; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Jagannathan P, 2009, J VIROL, V83, P2728, DOI 10.1128/JVI.02128-08; Jenisch S, 1998, AM J HUM GENET, V63, P191, DOI 10.1086/301899; Kaslow RA, 1996, NAT MED, V2, P405, DOI 10.1038/nm0496-405; Khan MA, 2002, ANN INTERN MED, V136, P896, DOI 10.7326/0003-4819-136-12-200206180-00011; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; KLEIN MR, 1995, TRENDS MICROBIOL, V3, P386, DOI 10.1016/S0966-842X(00)88984-2; Kloosterboer N, 2005, VIROLOGY, V339, P70, DOI 10.1016/j.virol.2005.06.001; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lauer GM, 2002, J VIROL, V76, P2817, DOI 10.1128/JVI.76.6.2817-2826.2002; Lefrere JJ, 1999, J INFECT DIS, V180, P526, DOI 10.1086/314906; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lopez M, 2008, AIDS RES HUM RETROV, V24, P1185, DOI 10.1089/aid.2008.0006; MARINCOLA F, 1997, HLA 1997, P348; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Migueles SA, 2003, J VIROL, V77, P6889, DOI 10.1128/JVI.77.12.6889-6898.2003; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Migueles Stephen A, 2004, Curr HIV/AIDS Rep, V1, P12, DOI 10.1007/s11904-004-0002-2; Migueles SA, 2009, J VIROL, V83, P11876, DOI 10.1128/JVI.01153-09; Migueles SA, 2008, IMMUNITY, V29, P1009, DOI 10.1016/j.immuni.2008.10.010; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Navis M, 2007, J IMMUNOL, V179, P3133, DOI 10.4049/jimmunol.179.5.3133; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pereyra F, 2009, J INFECT DIS, V200, P984, DOI 10.1086/605446; Saez-Cirion A, 2007, P NATL ACAD SCI USA, V104, P6776, DOI 10.1073/pnas.0611244104; Saez-Cirion A, 2009, J IMMUNOL, V182, P7828, DOI 10.4049/jimmunol.0803928; Sedaghat AR, 2009, CLIN INFECT DIS, V49, P1763, DOI 10.1086/648081; Sulkowski MS, 2008, J HEPATOL, V48, P353, DOI 10.1016/j.jhep.2007.11.009; Thomas DL, 2008, ANNU REV MED, V59, P473, DOI 10.1146/annurev.med.59.081906.081110; Trambas CM, 2003, NAT IMMUNOL, V4, P399, DOI 10.1038/ni0503-399; UNAIDS, 2008, REP GLOB AIDS EP; Westrop SJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005474; Zimmerli SC, 2005, P NATL ACAD SCI USA, V102, P7239, DOI 10.1073/pnas.0502393102	67	96	97	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					194	201		10.1001/jama.2010.925	http://dx.doi.org/10.1001/jama.2010.925			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628133				2022-12-28	WOS:000279811000026
J	Cao, L; Liu, XL; Lin, EJD; Wang, CS; Choi, EY; Riban, V; Lin, B; During, MJ				Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; Lin, Benjamin; During, Matthew J.			Environmental and Genetic Activation of a Brain-Adipocyte BDNF/Leptin Axis Causes Cancer Remission and Inhibition	CELL			English	Article							NEUROTROPHIC FACTOR; STRESS; LEPTIN; EXERCISE; OBESITY; BDNF; HYPOTHALAMUS; ADAPTATION; PLASTICITY; ENRICHMENT	Cancer is influenced by its microenvironment, yet broader, environmental effects also play a role but remain poorly defined. We report here that mice living in an enriched housing environment show reduced tumor growth and increased remission. We found this effect in melanoma and colon cancer models, and that it was not caused by physical activity alone. Serum from animals held in an enriched environment (EE) inhibited cancer proliferation in vitro and was markedly lower in leptin. Hypothalamic brain-derived neurotrophic factor (BDNF) was selectively upregulated by EE, and its genetic overexpression reduced tumor burden, whereas BDNF knockdown blocked the effect of EE. Mechanistically, we show that hypothalamic BDNF downregulated leptin production in adipocytes via sympathoneural beta-adrenergic signaling. These results suggest that genetic or environmental activation of this BDNF/leptin axis may have therapeutic significance for cancer.	[Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Dept Neurosci & Neurol Surg, Columbus, OH 43210 USA; [Cao, Lei; Liu, Xianglan; Lin, En-Ju D.; Wang, Chuansong; Choi, Eugene Y.; Riban, Veronique; During, Matthew J.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Cao, Lei; Lin, Benjamin; During, Matthew J.] Cornell Univ, Weill Med Coll, Dept Neurol Surg, New York, NY 10021 USA; [During, Matthew J.] Univ Auckland, Ctr Brain Res, Dept Mol Med & Pathol, Fac Med & Hlth Sci, Auckland 1023, New Zealand	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Cornell University; University of Auckland	Cao, L (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	cao.76@osu.edu; during.1@osu.edu	During, Matthew/AAC-1388-2020; During, Matthew/E-3003-2011; Cao, Lei/E-2841-2011; Cao, Lei/H-3185-2019	During, Matthew/0000-0002-3797-5026; Cao, Lei/0000-0003-0322-4985	National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044576] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. F. Lee of Weill Medical College of Cornell University for providing the BDNF<SUP>+/-</SUP> mice and Professors C. Croce, J. Groden, and M. Caligiuri for helpful comments and discussion on the manuscript. We appreciate the technical assistance of Michael Cahill and Adam Martin. This work was supported in part by the National Institutes of Health.	AARONSON SA, 1991, SCIENCE, V254, P1146, DOI 10.1126/science.1659742; Barb D, 2007, AM J CLIN NUTR, V86, p858S, DOI 10.1093/ajcn/86.3.858S; Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419; Bartness TJ, 2007, PHYSIOL BEHAV, V91, P343, DOI 10.1016/j.physbeh.2007.04.002; Benaroya-Milshtein N, 2004, EUR J NEUROSCI, V20, P1341, DOI 10.1111/j.1460-9568.2004.03587.x; Brandon EL, 2009, CANCER BIOL THER, V8, P1871, DOI 10.4161/cbt.8.19.9650; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cao L, 2009, NAT MED, V15, P447, DOI 10.1038/nm.1933; Cirillo D, 2008, J CELL BIOCHEM, V105, P956, DOI 10.1002/jcb.21911; Darnell RB, 2006, SEMIN ONCOL, V33, P270, DOI 10.1053/j.seminoncol.2006.03.008; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhillo WS, 2007, THYROID, V17, P433, DOI 10.1089/thy.2007.0018; DRANOFF G, 1993, P NATL ACAD SCI USA, V90, P3539, DOI 10.1073/pnas.90.8.3539; Evans BA, 1999, FEBS LETT, V444, P149, DOI 10.1016/S0014-5793(99)00049-6; Fountzilas G, 2008, ANN ONCOL, V19, P853, DOI [10.1093/annonc/mdm539, 10.1093/annonc/mdm464]; Fujisawa T, 2008, GUT, V57, P1531, DOI 10.1136/gut.2008.159293; Garofalo C, 2006, J CELL PHYSIOL, V207, P12, DOI 10.1002/jcp.20472; Hahn S, 2006, EUR J ENDOCRINOL, V154, P287, DOI 10.1530/eje.1.02078; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HUGHES P, 1993, NEUROSCIENCE, V57, P319, DOI 10.1016/0306-4522(93)90065-N; Jenkins PJ, 2004, EUR J ENDOCRINOL, V151, pS17, DOI 10.1530/eje.0.151S017; Jonsdottir IH, 2000, INT J SPORTS MED, V21, pS20; Larsson F, 2002, PHARMACOL BIOCHEM BE, V73, P193, DOI 10.1016/S0091-3057(02)00782-7; Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726; Lu YP, 2006, P NATL ACAD SCI USA, V103, P16301, DOI 10.1073/pnas.0607789103; Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239; McDougall SJ, 2005, AUTON NEUROSCI-BASIC, V123, P1, DOI 10.1016/j.autneu.2005.09.005; McEwen BS, 2007, PHYSIOL REV, V87, P873, DOI 10.1152/physrev.00041.2006; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Mehl KA, 2005, J APPL PHYSIOL, V98, P2219, DOI 10.1152/japplphysiol.00975.2004; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MILSUM JH, 1985, BEHAV SCI, V30, P179, DOI 10.1002/bs.3830300402; Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028; Nagatomi R, 2006, EXERC IMMUNOL REV, V12, P54; NEDIVI E, 1993, NATURE, V363, P718, DOI 10.1038/363718a0; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; PELLEYMOUNTER MA, 1995, EXP NEUROL, V131, P229, DOI 10.1016/0014-4886(95)90045-4; Rage F, 2002, NEUROSCIENCE, V112, P309, DOI 10.1016/S0306-4522(02)00072-6; Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748; Selye H., 1974, STRESS DISTRESS; Sterling P., 1988, HDB LIFE STRESS COGN, P629, DOI DOI 10.1016/0005-7967(90)90076-U; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki K, 2005, EUR J APPL PHYSIOL, V94, P514, DOI 10.1007/s00421-005-1378-4; Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Wauters M, 2000, EUR J ENDOCRINOL, V143, P293, DOI 10.1530/eje.0.1430293; Wisse BE, 2003, NAT NEUROSCI, V6, P655, DOI 10.1038/nn0703-655; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073; Young D, 1999, NAT MED, V5, P448, DOI 10.1038/7449	49	232	240	2	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					52	64		10.1016/j.cell.2010.05.029	http://dx.doi.org/10.1016/j.cell.2010.05.029			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603014	Green Accepted, Bronze			2022-12-28	WOS:000279637300012
J	Jaenike, J; Unckless, R; Cockburn, SN; Boelio, LM; Perlman, SJ				Jaenike, John; Unckless, Robert; Cockburn, Sarah N.; Boelio, Lisa M.; Perlman, Steve J.			Adaptation via Symbiosis: Recent Spread of a Drosophila Defensive Symbiont	SCIENCE			English	Article							MYCOPHAGOUS DROSOPHILA; IMMUNE-SYSTEM; EVOLUTION; WOLBACHIA; NEMATODE; HOST; ASSOCIATIONS; ENDOSYMBIONT; SPIROPLASMA; PROTECTION	Recent studies have shown that some plants and animals harbor microbial symbionts that protect them against natural enemies. Here we demonstrate that a maternally transmitted bacterium, Spiroplasma, protects Drosophila neotestacea against the sterilizing effects of a parasitic nematode, both in the laboratory and the field. This nematode parasitizes D. neotestacea at high frequencies in natural populations, and, until recently, almost all infections resulted in complete sterility. Several lines of evidence suggest that Spiroplasma is spreading in North American populations of D. neotestacea and that a major adaptive change to a symbiont-based mode of defense is under way. These findings demonstrate the profound and potentially rapid effects of defensive symbionts, which are increasingly recognized as major players in the ecology of species interactions.	[Jaenike, John; Unckless, Robert; Boelio, Lisa M.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Cockburn, Sarah N.; Perlman, Steve J.] Univ Victoria, Dept Biol, Victoria, BC V8W 3N5, Canada	University of Rochester; University of Victoria	Jaenike, J (corresponding author), Univ Rochester, Dept Biol, Rochester, NY 14627 USA.	john.jaenike@rochester.edu			NSF [DEB-0542094, DEB-0918872]; Natural Sciences and Engineering Research Council of Canada; Direct For Biological Sciences [0918872] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by NSF grants DEB-0542094 and DEB-0918872 to J.J. and a Natural Sciences and Engineering Research Council of Canada Discovery Grant to S.J.P. S.J.P. is a Scholar in the Canadian Institute for Advanced Research. We thank C. Cornish, P. Gibas, and K. Dyer for collecting some of the North American D. neotestacea used in this study; A. Marshall and L. Harris for technical assistance; N. Polet for the cloning work; D. Grimaldi for providing museum specimens of D. neotestacea; and J. Coyne, R. Minckley, K. Oliver, and D. Presgraves for comments on the manuscript. Sequences have been deposited in GenBank under accession numbers GU552299 to GU552304, HM126644 to HM126667, and HM133591 to HM133593.	Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Arnold AE, 2003, P NATL ACAD SCI USA, V100, P15649, DOI 10.1073/pnas.2533483100; Bird DM, 2009, ANNU REV PHYTOPATHOL, V47, P333, DOI 10.1146/annurev-phyto-080508-081839; Dobson A, 2008, P NATL ACAD SCI USA, V105, P11482, DOI 10.1073/pnas.0803232105; Dyer KA, 2005, EVOLUTION, V59, P1518; Dyer KA, 2004, GENETICS, V168, P1443, DOI 10.1534/genetics.104.027854; Flainik MF, 2004, TRENDS IMMUNOL, V25, P640, DOI 10.1016/j.it.2004.10.001; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; Haselkorn TS, 2009, MOL ECOL, V18, P1294, DOI 10.1111/j.1365-294X.2009.04085.x; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hughes AL, 1997, MOL BIOL EVOL, V14, P1, DOI 10.1093/oxfordjournals.molbev.a025694; Hurst GDD, 2000, EMERG INFECT DIS, V6, P329, DOI 10.3201/eid0604.000402; Jaenike J, 1996, EVOLUTION, V50, P2241, DOI [10.1111/j.1558-5646.1996.tb03613.x, 10.2307/2410694]; Jaenike J, 2002, ECOLOGY, V83, P917, DOI 10.2307/3071901; Jaenike J, 2002, AM NAT, V160, pS23, DOI 10.1086/342137; Jaenike J, 2010, MOL ECOL, V19, P414, DOI 10.1111/j.1365-294X.2009.04448.x; Johnstone RA, 1996, BIOL J LINN SOC, V58, P453, DOI 10.1111/j.1095-8312.1996.tb01446.x; Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531; Litman GW, 2005, NAT REV IMMUNOL, V5, P866, DOI 10.1038/nri1712; Mateos M, 2006, GENETICS, V174, P363, DOI 10.1534/genetics.106.058818; MONTAGUE JR, 1985, ECOLOGY, V66, P624, DOI 10.2307/1940412; NICKLE W.R., 1974, INSECT DISEASES, VII, P327; Obbard DJ, 2009, PHILOS T R SOC B, V364, P99, DOI 10.1098/rstb.2008.0168; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Oliver KM, 2003, P NATL ACAD SCI USA, V100, P1803, DOI 10.1073/pnas.0335320100; Parkinson J, 2004, NAT GENET, V36, P1259, DOI 10.1038/ng1472; Perlman SJ, 2003, EVOLUTION, V57, P1543, DOI 10.1111/j.0014-3820.2003.tb00362.x; Perlman SJ, 2003, MOL ECOL, V12, P237, DOI 10.1046/j.1365-294X.2003.01721.x; Poinar GO., 1983, NATURAL HIST NEMATOD; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Regassa LB, 2006, FRONT BIOSCI-LANDMRK, V11, P2983, DOI 10.2741/2027; Rosenstiel P, 2009, J INNATE IMMUN, V1, P291, DOI 10.1159/000211193; Sackton TB, 2007, NAT GENET, V39, P1461, DOI 10.1038/ng.2007.60; Scarborough CL, 2005, SCIENCE, V310, P1781, DOI 10.1126/science.1120180; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; WILLIAMSON DL, 1965, J INVERTEBR PATHOL, V7, P493, DOI 10.1016/0022-2011(65)90126-6	36	358	370	1	185	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					212	215		10.1126/science.1188235	http://dx.doi.org/10.1126/science.1188235			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616278				2022-12-28	WOS:000279635200048
J	Sifers, RN				Sifers, Richard N.			Clearing Conformational Disease	SCIENCE			English	Editorial Material							ENDOPLASMIC-RETICULUM; QUALITY-CONTROL; ALPHA(1)-ANTITRYPSIN; ACCUMULATION; TRANSPORT; LIVER		Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA	Baylor College of Medicine	Sifers, RN (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA.	rsifers@bcm.edu	Sifers, Richard Norman/AGQ-7262-2022					Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; CARLSON JA, 1989, J CLIN INVEST, V83, P1183, DOI 10.1172/JCI113999; Choudhury P, 1997, NEWS PHYSIOL SCI, V12, P162; Hidvegi T, 2010, SCIENCE, V329, P229, DOI 10.1126/science.1190354; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; Perlmutter D. H., 1989, AM J PHYSIOL, V257, pL147; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; QU D, 1966, J BIOL CHEM, V271, P2791; Teckman JH, 2000, AM J PHYSIOL-GASTR L, V279, pG961, DOI 10.1152/ajpgi.2000.279.5.G961; YU MH, 1995, NAT STRUCT BIOL, V2, P363, DOI 10.1038/nsb0595-363	12	11	13	1	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					154	155		10.1126/science.1192681	http://dx.doi.org/10.1126/science.1192681			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616258				2022-12-28	WOS:000279635200025
J	Haga, S; Hattori, T; Sato, T; Sato, K; Matsuda, S; Kobayakawa, R; Sakano, H; Yoshihara, Y; Kikusui, T; Touhara, K				Haga, Sachiko; Hattori, Tatsuya; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Kobayakawa, Reiko; Sakano, Hitoshi; Yoshihara, Yoshihiro; Kikusui, Takefumi; Touhara, Kazushige			The male mouse pheromone ESP1 enhances female sexual receptive behaviour through a specific vomeronasal receptor	NATURE			English	Article							GENES; ORGANIZATION; EXPRESSION; NUCLEUS; NEURONS; CONVERGENCE; PROJECTIONS; PATHWAYS; FAMILIES; PEPTIDE	Various social behaviours in mice are regulated by chemical signals called pheromones that act through the vomeronasal system(1-3). Exocrine gland-secreting peptide 1 (ESP1) is a 7-kDa peptide that is released intomale tear fluids and stimulates vomeronasal sensory neurons in female mice(4). Here, we describe the molecular and neural mechanisms that are involved in the decoding of ESP1 signals in the vomeronasal system, which leads to behavioural output in female mice. ESP1 is recognized by a specific vomeronasal receptor, V2Rp5, and the ligand-receptor interaction results in sex-specific signal transmission to the amygdaloid and hypothalamic nuclei via the accessory olfactory bulb. Consequently, ESP1 enhances female sexual receptive behaviour upon male mounting (lordosis), allowing successful copulation. In V2Rp5-deficient mice, ESP1 induces neither neural activation nor sexual behaviour. These findings show that ESP1 is a crucial male pheromone that regulates female reproductive behaviour through a specific receptor in the mouse vomeronasal system.	[Haga, Sachiko; Sato, Toru; Sato, Koji; Matsuda, Soichiro; Touhara, Kazushige] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan; [Hattori, Tatsuya; Kikusui, Takefumi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Kobayakawa, Reiko] Osaka Biosci Inst, Dept Funct Neurosci, Suita, Osaka 5650874, Japan; [Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Tokyo 1130032, Japan; [Yoshihara, Yoshihiro] RIKEN, Brain Sci Inst, Lab Neurobiol Synapse, Wako, Saitama 3510198, Japan	University of Tokyo; Azabu University; University of Tokyo; RIKEN	Touhara, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo 1138657, Japan.	ktouhara@mail.ecc.u-tokyo.ac.jp	Yoshihara, Yoshihiro/N-6481-2015	Yoshihara, Yoshihiro/0000-0002-0319-7166; xing zhi, zuo teng/0000-0001-6198-6406; Kobayakawa, Reiko/0000-0001-6613-5969	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank R. Axel, C. R. Yu, M. Cappechi, M. Sugita and T. Shiroishi for mice and plasmids; RIKEN BSI Research Resource Center, Y. Zhang, J. He, C. R. Yu, H. Kimoto, N. Matsumoto, M. Ohmoto, K. Abe, S. Mitsui, T. Kaneko-Goto, and T. Abe for experimental help and advice; and Y. Sakuma, Y. Mori, M. Ichikawa and H. Terasawa for valuable comments and discussions. This work was supported by grants from the Program for Promotion of Basic Research Activities for Innovative Biosciences, Japan Society for the Promotion of Science, and Ministry of Education, Culture, Sports, Science and Technology, Japan.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Blaustein J. D., 2002, HORMONES BRAIN BEHAV, P139; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; Bunting M, 1999, GENE DEV, V13, P1524, DOI 10.1101/gad.13.12.1524; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Del Punta K, 2002, NEURON, V35, P1057, DOI 10.1016/S0896-6273(02)00904-2; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Haga S, 2007, PURE APPL CHEM, V79, P775, DOI 10.1351/pac200779040775; Halem HA, 1999, J NEUROBIOL, V39, P249, DOI 10.1002/(SICI)1097-4695(199905)39:2<249::AID-NEU9>3.3.CO;2-I; He J, 2008, SCIENCE, V320, P535, DOI 10.1126/science.1154476; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Ishii T, 2008, J NEUROSCI, V28, P2332, DOI 10.1523/JNEUROSCI.4807-07.2008; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kudwa AE, 2005, P NATL ACAD SCI USA, V102, P4608, DOI 10.1073/pnas.0500752102; Lalioti MD, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.3.e14; Leypold BG, 2002, P NATL ACAD SCI USA, V99, P6376, DOI 10.1073/pnas.082127599; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Meredith M, 1998, ANN NY ACAD SCI, V855, P349, DOI 10.1111/j.1749-6632.1998.tb10593.x; Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; Pierman S, 2008, EUR J NEUROSCI, V27, P423, DOI 10.1111/j.1460-9568.2007.06016.x; Semmelhack JL, 2009, NATURE, V459, P218, DOI 10.1038/nature07983; SIMERLY RB, 1986, J COMP NEUROL, V246, P312, DOI 10.1002/cne.902460304; SKENE JHP, 1989, J CELL BIOL, V108, P613, DOI 10.1083/jcb.108.2.613; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Touhara K, 2007, ADV GENET, V59, P147, DOI 10.1016/S0065-2660(07)59006-1; Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209; von Campenhausen H, 2000, EUR J NEUROSCI, V12, P33, DOI 10.1046/j.1460-9568.2000.00879.x; Wu MV, 2009, CELL, V139, P61, DOI 10.1016/j.cell.2009.07.036; Yoon HY, 2005, CELL, V123, P669, DOI 10.1016/j.cell.2005.08.039; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	35	261	267	0	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					118	U136		10.1038/nature09142	http://dx.doi.org/10.1038/nature09142			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596023				2022-12-28	WOS:000279343800046
J	Redelmeier, DA; McAlister, FA; Kandel, CE; Lu, H; Daneman, N				Redelmeier, Donald A.; McAlister, Finlay A.; Kandel, Christopher E.; Lu, Hong; Daneman, Nick			Postoperative pneumonia in elderly patients receiving acid suppressants: a retrospective cohort analysis	BRITISH MEDICAL JOURNAL			English	Article								Study question Do gastric acid suppressants increase the risk of postoperative pneumonia after elective surgery? Summary answer No, after adjustment for patient and surgical characteristics, acid suppressants are not associated with an increased risk of postoperative pneumonia among elderly patients admitted for elective surgery. What is known and what this paper adds Postoperative pneumonia is a common and serious complication after major surgery, and use of gastric acid suppressants may increase patients' risk of pneumonia. This study found that patients who received gastric acid suppressants were at increased risk of postoperative pneumonia but were also predisposed to independent risk factors for postoperative pneumonia. Adjustment for these risk factors revealed no direct association between gastric acid suppressants and a patient's risk of postoperative pneumonia. Participants and setting Consecutive patients aged >65 years admitted for an elective operation to Canadian acute care hospitals between 1 April 1992 and 31 March 2008. Design, size, duration This population-wide, retrospective cohort analysis covered 16 years and included 593?265 patients. Main results About 21% of patients (n=121?850) were receiving an acid suppressant (most commonly omeprazole or ranitidine) and 79% (n=471?415) were not receiving an acid suppressant. The two groups were similar in mean age, fitness for surgery, and duration of surgery, but other risk factors for postoperative pneumonia were imbalanced against the acid suppressant group (including a history of chronic obstructive pulmonary disease, heart failure, Parkinson's disease, and prior pneumonia; nasogastric tubes; and prescriptions of antipsychotics). Overall, 6389 patients developed postoperative pneumonia, with a rate significantly higher for those taking acid suppressants (13 per 1000) than controls (10 per 1000), equivalent to a 30% increase in frequency (odds ratio 1.30 (95% confidence interval 1.23 to 1.38), P<0.001). However, after adjustment for duration of surgery, site of surgery, and other confounders, no increase in risk was observed (odds ratio 1.02 (0.96 to 1.09), P=0.48). The general safety of acid suppressants extended to those patients prescribed proton pump inhibitors (the most potent acid suppressants), experiencing long term treatment, receiving high doses, and undergoing high risk procedures. As expected, other factors were significant predictors of postoperative pneumonia (see table).	[Redelmeier, Donald A.; Daneman, Nick] Sunnybrook Hlth Sci Ctr, Clin Epidemiol Program, Toronto, ON M4N 3M5, Canada; [Redelmeier, Donald A.; Kandel, Christopher E.; Daneman, Nick] Univ Toronto, Dept Med, Toronto, ON, Canada; [Redelmeier, Donald A.; Lu, Hong; Daneman, Nick] Inst Clin Evaluat Sci Ontario, Toronto, ON, Canada; [Redelmeier, Donald A.] Sunnybrook Hlth Sci Ctr, Patient Safety Serv, Toronto, ON M4N 3M5, Canada; [McAlister, Finlay A.] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Alberta	Redelmeier, DA (corresponding author), Sunnybrook Hlth Sci Ctr, Clin Epidemiol Program, G-151,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	dar@ices.on.ca	McAlister, Finlay/C-4151-2013	McAlister, Finlay/0000-0001-7435-3341	Canadian Forces Health Services; Physicians Services Incorporated Foundation of Ontario; Alberta Heritage Foundation for Medical Research; University of Toronto	Canadian Forces Health Services; Physicians Services Incorporated Foundation of Ontario; Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); University of Toronto(University of Toronto)	This project was supported by the Canada Research Chair in Medical Decision Sciences, Canadian Forces Health Services, the Physicians Services Incorporated Foundation of Ontario, the Alberta Heritage Foundation for Medical Research, and the University of Toronto Comprehensive Research Experience for Medical Students programme. These organisations had no role in the design and conduct of the study, collection and management of the data, or preparation of the manuscript. The authors report no competing interests.		0	11	11	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2010	340								c2608	10.1136/bmj.c2608	http://dx.doi.org/10.1136/bmj.c2608			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IN	20566596	hybrid			2022-12-28	WOS:000279346200003
J	Richards, C; Cullins, V				Richards, Cecile; Cullins, Vanessa			A tale of two pills: when culture trumps technology	LANCET			English	Editorial Material									[Richards, Cecile; Cullins, Vanessa] Planned Parenthood Federat Amer, New York, NY 10001 USA		Richards, C (corresponding author), Planned Parenthood Federat Amer, 434 W 33rd St, New York, NY 10001 USA.							*NAT CTR HLTH STAT, 1967, VIT STAT US 1965 A, V2; Singh S, 2009, ADDING IT COSTS BENE; Sonfield A, 2004, PERSPECT SEX REPRO H, V36, P72, DOI 10.1363/3607204; *US BUR CENS, 2010, EARN DEGR CONF LEV S; *US BUR CENS, 2009, STAT ABSTR US 2010 N; 2000, POP REP, V28, P1	6	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1950	1951		10.1016/S0140-6736(10)60843-4	http://dx.doi.org/10.1016/S0140-6736(10)60843-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569828				2022-12-28	WOS:000278689600009
J	Wu, XL; Yang, ZY; Li, YX; Hogerkorp, CM; Schief, WR; Seaman, MS; Zhou, TQ; Schmidt, SD; Wu, L; Xu, L; Longo, NS; McKee, K; O'Dell, S; Louder, MK; Wycuff, DL; Feng, Y; Nason, M; Doria-Rose, N; Connors, M; Kwong, PD; Roederer, M; Wyatt, RT; Nabel, GJ; Mascola, JR				Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Schief, William R.; Seaman, Michael S.; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Nason, Martha; Doria-Rose, Nicole; Connors, Mark; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.			Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1	SCIENCE			English	Article							TYPE-1 INFECTION; HIGH-AFFINITY; VIRUS; GP120; BREADTH; GLYCOPROTEIN; INDIVIDUALS; PANEL; IMMUNOGENICITY; SPECIFICITIES	Cross-reactive neutralizing antibodies (NAbs) are found in the sera of many HIV-1-infected individuals, but the virologic basis of their neutralization remains poorly understood. We used knowledge of HIV-1 envelope structure to develop antigenically resurfaced glycoproteins specific for the structurally conserved site of initial CD4 receptor binding. These probes were used to identify sera with NAbs to the CD4-binding site (CD4bs) and to isolate individual B cells from such an HIV-1-infected donor. By expressing immunoglobulin genes from individual cells, we identified three monoclonal antibodies, including a pair of somatic variants that neutralized over 90% of circulating HIV-1 isolates. Exceptionally broad HIV-1 neutralization can be achieved with individual antibodies targeted to the functionally conserved CD4bs of glycoprotein 120, an important insight for future HIV-1 vaccine design.	[Wu, Xueling; Yang, Zhi-Yong; Li, Yuxing; Hogerkorp, Carl-Magnus; Zhou, Tongqing; Schmidt, Stephen D.; Wu, Lan; Xu, Ling; Longo, Nancy S.; McKee, Krisha; O'Dell, Sijy; Louder, Mark K.; Wycuff, Diane L.; Feng, Yu; Kwong, Peter D.; Roederer, Mario; Wyatt, Richard T.; Nabel, Gary J.; Mascola, John R.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Nason, Martha] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Doria-Rose, Nicole; Connors, Mark] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Schief, William R.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Seaman, Michael S.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Nabel, GJ (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	gnabel@nih.gov; jmascola@nih.gov	Schief, William/ABF-3645-2020; Roederer, Mario/G-1887-2011; Schmidt, Stephen/B-5398-2012; Mascola, John/AAI-7193-2021; Zhou, Tongqing/A-6880-2010; Feng, Yu/A-3396-2012; Schmidt, Stephen/AAC-6967-2019	Schief, William/0000-0002-1120-0150; Zhou, Tongqing/0000-0002-3935-4637; 	Vaccine Research Center; Division of Clinical Research; Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH; Bill and Melinda Gates Foundation; International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001090, ZIAAI005002, ZIAAI005095, ZIAAI005010, ZIAAI005089, ZIAAI005067, ZIAAI005022] Funding Source: NIH RePORTER	Vaccine Research Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Division of Clinical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); International AIDS Vaccine Initiative; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, the Division of Clinical Research and the Laboratory of Immunoregulation of National Institute of Allergy and Infectious Diseases, NIH. M.S.S. was supported in part by the Bill and Melinda Gates Foundation's Collaboration for AIDS Vaccine Discovery, Comprehensive Antibody-Vaccine Immune Monitoring Consortium, grant number 38619. W.R.S. was supported by the Bill and Melinda Gates Foundation Collaboration for AIDS Vaccine Discovery through a grant to Seattle Biomedical Research Institute and by the International AIDS Vaccine Initiative. Nucleotide sequences of VRC01, VRC02, and VRC03 variable regions are available under GenBank accession numbers GU980702 to GU980707. Patent applications have been filed by the NIH on mAbs VRC01, VRC02, and VRC03 (listed investigators are X.W., Z.Y.Y., Y.L., C.M.H, W.R.S., T.Z., M.C., P.D.K., M.R., R.T.W., G.J.N., and J.R.M.) and on the RSC3 probe (listed investigators are Z.Y.Y., W.R.S., T.Z., P.D.K. and G.J.N.). We thank M. Nussenzweig and J. Scheid (Laboratory of Molecular Immunology, Howard Hughes Medical Institute, Rockefeller University, New York, NY) for sharing expertise and reagents for IgG cloning and expression; B. Haynes (Duke University Medical Center, Durham, NC) for sharing reagents and PCR methods; S. Perfetto, R. Nguyen, and D. Ambrozak for assistance with cell sorting; E. Lybarger for neutralization assays; J. Stuckey and B. Hartman for assistance with figures; A. Tislerics for manuscript preparation; D. Follman for statistical advice; C. Carrico for discussions on resurfacing; Y.-E.A. Ban and L. Kong for glycan modeling; P. Chattopadhyay and J. Yu for fluorescent antibody production and qualification; C. Williamson (University of Capetown, Capetown, South Africa), M. Thomson (Instituto de Salud Carlos III, Madrid, Spain), J. Overbaugh (Fred Hutchinson Cancer Research Center, Seattle, WA), and S. Tovanabutra and E. Sanders-Buell (Henry M. Jackson Foundation and the U. S. Military HIV Research Program, Rockville, MD) for contributing HIV-1 Env plasmids for pseudovirus production.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Chen B, 2005, NATURE, V433, P834, DOI 10.1038/nature03327; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Decker JM, 2005, J EXP MED, V201, P1407, DOI 10.1084/jem.20042510; Decks SG, 2006, J VIROL, V80, P6155, DOI 10.1128/JVI.00093-06; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Forsman A, 2008, J VIROL, V82, P12069, DOI 10.1128/JVI.01379-08; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Korber B, 2009, CURR OPIN HIV AIDS, V4, P408, DOI 10.1097/COH.0b013e32832f129e; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Montefiori DC, 2007, CURR OPIN HIV AIDS, V2, P169, DOI 10.1097/COH.0b013e3280ef691e; Moore JP, 1996, J VIROL, V70, P1863, DOI 10.1128/JVI.70.3.1863-1872.1996; Pantophlet R, 2006, ANNU REV IMMUNOL, V24, P739, DOI 10.1146/annurev.immunol.24.021605.090557; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Seaman MS, 2010, J VIROL, V84, P1439, DOI 10.1128/JVI.02108-09; Shen XY, 2009, J VIROL, V83, P3617, DOI 10.1128/JVI.02631-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Smith DM, 2006, VIROLOGY, V355, P1, DOI 10.1016/j.virol.2006.08.009; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Yuste E, 2006, J VIROL, V80, P3030, DOI 10.1128/JVI.80.6.3030-3041.2006; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580; Zolla-Pazner S, 2004, NAT REV IMMUNOL, V4, P199, DOI 10.1038/nri1307	33	1278	1397	2	186	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					856	861		10.1126/science.1187659	http://dx.doi.org/10.1126/science.1187659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616233	Green Accepted			2022-12-28	WOS:000280809900055
J	Ismail-Beigi, F; Craven, T; Banerji, MA; Basile, J; Calles, J; Cohen, RM; Cuddihy, R; Cushman, WC; Genuth, S; Grimm, RH; Hamilton, BP; Hoogwerf, B; Karl, D; Katz, L; Krikorian, A; O'Connor, P; Pop-Busui, R; Schubart, U; Simmons, D; Taylor, H; Thomas, A; Weiss, D; Hramiak, I				Ismail-Beigi, Faramarz; Craven, Timothy; Banerji, Mary Ann; Basile, Jan; Calles, Jorge; Cohen, Robert M.; Cuddihy, Robert; Cushman, William C.; Genuth, Saul; Grimm, Richard H., Jr.; Hamilton, Bruce P.; Hoogwerf, Byron; Karl, Diane; Katz, Lois; Krikorian, Armand; O'Connor, Patrick; Pop-Busui, Rodica; Schubart, Ulrich; Simmons, Debra; Taylor, Harris; Thomas, Abraham; Weiss, Daniel; Hramiak, Irene		ACCORD Trial Grp	Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial	LANCET			English	Article							URINARY ALBUMIN EXCRETION; RISK-FACTORS; COMPLICATIONS; PROGRESSION; MELLITUS; RETINOPATHY	Background Hyperglycaemia is associated with increased risk of cardiovascular complications in people with type 2 diabetes. We investigated whether reduction of blood glucose concentration decreases the rate of microvascular complications in people with type 2 diabetes. Methods ACCORD was a parallel-group, randomised trial done in 77 clinical sites in North America. People with diabetes, high HbA(1c). concentrations (>7.5%), and cardiovascular disease (or >= 2 cardiovascular risk factors) were randomly assigned by central randomisation to intensive (target haemoglobin A(1c) [HbA(1c)] of <6.0%) or standard (7.0-7.9%) glycaemic therapy. In this analysis, the prespecified composite outcomes were: dialysis or renal transplantation, high serum creatinine (>291.7 mu mol/L), or retinal photocoagulation or vitrectomy (first composite outcome); or peripheral neuropathy plus the first composite outcome (second composite outcome). 13 prespecified secondary measures of kidney, eye, and peripheral nerve function were also assessed. Investigators and participants were aware of treatment group assignment. Analysis was done for all patients who were assessed for microvascular outcomes, on the basis of treatment assignment, irrespective of treatments received or compliance to therapies. ACCORD is registered with ClinicalTrials.gov, number NCT00000620. Findings 10 251 patients were randomly assigned, 5128 to the intensive glycaemia control group and 5123 to standard group. Intensive therapy was stopped before study end because of higher mortality in that group, and patients were transitioned to standard therapy. At transition, the first composite outcome was recorded in 443 of 5107 patients in the intensive group versus 444 of 5108 in the standard group (HR 1.00, 95% CI 0.88-1.14; p=1.00), and the second composite outcome was noted in 1591 of 5107 versus 1659 of 5108 (0.96, 0.89-1.02; p=0.19). Results were similar at study end (first composite outcome 556 of 5119 vs 586 of 5115 [HR 0.95,95% CI 0.85-1.07, p=0.44]; and second 1956 of 5119 vs 2046 of 5115, respectively [0.95, 0.89-1.01, p=0.12]). Intensive therapy did not reduce the risk of advanced measures of microvascular outcomes, but delayed the onset of albuminuria and some measures of eye complications and neuropathy. Seven secondary measures at study end favoured intensive therapy (p<0.05). Interpretation Microvascular benefits of intensive therapy should be weighed against the increase in total and cardiovascular disease-related mortality, increased weight gain, and high risk for severe hypoglycaemia.	[Ismail-Beigi, Faramarz] Case Western Reserve Univ, Dept Med, Div Clin & Mol Endocrinol, Cleveland, OH 44106 USA; [Craven, Timothy] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Banerji, Mary Ann] Suny Downstate Med Ctr, New York, NY USA; [Basile, Jan] Med Univ S Carolina, Ralph H Johnson VA Med Ctr, Charleston, SC 29425 USA; [Calles, Jorge] Wake Forest Univ, Baptist Med Ctr, Winston Salem, NC 27109 USA; [Cohen, Robert M.] Univ Cincinnati, Cincinnati, OH USA; [Cohen, Robert M.] Cincinnati Vet Affairs Med Ctr, Cincinnati, OH USA; [Cuddihy, Robert] Int Diabet Ctr Pk Nicollet, Minneapolis, MN USA; [Cuddihy, Robert] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Cushman, William C.] Memphis Vet Affairs Med Ctr, Memphis, TN USA; [Grimm, Richard H., Jr.] Berman Ctr Outcomes & Clin Res, Minneapolis, MN USA; [Hamilton, Bruce P.] VA Med Ctr, Baltimore, MD USA; [Hamilton, Bruce P.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Hoogwerf, Byron] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Karl, Diane] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Katz, Lois] NYU, Sch Med, VA New York Harbor Healthcare Syst, New York, NY 10003 USA; [O'Connor, Patrick] HealthPartners Res Fdn, Minneapolis, MN USA; [Pop-Busui, Rodica] Univ Michigan, Med Ctr, Ann Arbor, MI USA; [Schubart, Ulrich] Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10467 USA; [Simmons, Debra] Univ Arkansas Med Sci, Little Rock, AR 72205 USA; Henry Ford Hosp, Detroit, MI 48202 USA; [Weiss, Daniel] Your Diabet Endocrine Nutr Grp, Mentor, OH USA; [Hramiak, Irene] St Josephs Hlth Care, London, ON, Canada	Case Western Reserve University; Wake Forest University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Cincinnati VA Medical Center; International Diabetes Center; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University System of Maryland; University of Maryland Baltimore; Eli Lilly; Oregon Health & Science University; New York University; HealthPartners Institute for Education & Research; University of Michigan System; University of Michigan; Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine; University of Arkansas System; University of Arkansas Medical Sciences; Henry Ford Health System; Henry Ford Hospital; Western University (University of Western Ontario)	Ismail-Beigi, F (corresponding author), Case Western Reserve Univ, Dept Med, Div Clin & Mol Endocrinol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	faramarz.ismail-beigi@case.edu	Karl, David/AFP-3837-2022; Gerstein, Hertzel/ABB-8781-2020; Force, Rex W/K-4094-2012; Bryan, R. Nick/P-1661-2014; O'Connor, Patrick/HII-2987-2022; Buse, John Bernard/J-9742-2019; Hramiak, Irene/G-3305-2011; Friedewald, William T/C-8034-2011; Krikorian, Armand/AAH-1571-2020	Gerstein, Hertzel/0000-0001-8072-2836; Buse, John Bernard/0000-0002-9723-3876; Pop-Busui, Rodica/0000-0002-2042-1350; Yusuf, Salim/0000-0003-4776-5601; O'Connor, Patrick/0000-0002-2324-6228; Arrey, Frida/0000-0003-4543-4219; Katz, Lois/0000-0002-6937-8170; Kaiser, Peter/0000-0001-5126-045X; Thomas, Abraham/0000-0002-3941-1195	National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, IAA-Y1-HC-1010]; National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health, National Institute on Aging; National Institutes of Health, National Eye Institute; Centers for Disease Control and Prevention; General Clinical Research Centers; Novartis; Boehringer Ingelheim; Roche; Sanofi-Aventis; BMS; Takeda; Eli Lilly; Merck; US National Institutes of Health; Roche Diabetes; Novo Nordisk; Cequr; Bayer; Eli Lily; Abbott; Amylin; Dalichi-Sankyo; Edwards Lifesciences; Dexcom; Johnson and Johnson/Lifescan; Mannkind; Medtronic; Quotient Diagnostics; ResMed; King Pharmaceuticals; Lawson Research Institute; Bristol-Myers Squibb; Hofmann-La Roche; Merck Frosst; Pfizer; Eisai; Inekrin; Oresigen; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095178, N01HC095184, N01HC095180, N01HC095183, N01HC095179, N01HC095181, N01HC095182] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL095181, R01HL073030, R43HL095181] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); BMS(Bristol-Myers Squibb); Takeda(Takeda Pharmaceutical Company Ltd); Eli Lilly(Eli Lilly); Merck(Merck & Company); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Roche Diabetes; Novo Nordisk(Novo Nordisk); Cequr; Bayer(Bayer AG); Eli Lily; Abbott(Abbott Laboratories); Amylin; Dalichi-Sankyo; Edwards Lifesciences; Dexcom; Johnson and Johnson/Lifescan(Johnson & JohnsonJohnson & Johnson USA); Mannkind; Medtronic(Medtronic); Quotient Diagnostics; ResMed; King Pharmaceuticals; Lawson Research Institute; Bristol-Myers Squibb(Bristol-Myers Squibb); Hofmann-La Roche; Merck Frosst; Pfizer(Pfizer); Eisai(Eisai Co Ltd); Inekrin; Oresigen; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The ACCORD Trial was supported by grants (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute; by other components of the National Institutes of Health, including the National Institute of Diabetes and Digestive and Kidney Diseases, the National Institute on Aging, and the National Eye Institute; by the Centers for Disease Control and Prevention; and by General Clinical Research Centers. The following companies provided study medications, equipment, or supplies: Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals LP, Bayer HealthCare LLC, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, Sanofi-Aventis US, and Takeda Pharmaceuticals.; MAB has received consulting fees from Novartis, Boehringer Ingelheim, Roche, and Sanofi-Aventis; board membership fees from Novartis and BMS; grants from Roche, Boehringer Ingleheim, Takeda, Novartis, and Eli Lilly; honoraria from Merck and Sanofi-Aventis; and travel expenses from the US National Institutes of Health, Merck, Sanofi-Aventis, Roche and Boehringer Ingelheim. JC has received grants from Merck and honoraria and travel expenses from Sanofi-Aventis and Merck. RMC has received grants from the US National Institutes of Health and holds stock in Abbott Laboratories. RC has received grant and travel support from the US National Institutes of Health; board membership fees from Roche Diabetes; consultancy fees from Novo Nordisk, Cequr, Bayer, Eli Lily, Abbott; grant support from Amylin, Abbott, Bayer, Dalichi-Sankyo, Edwards Lifesciences, Elil Lily, Dexcom, Johnson and Johnson/Lifescan, Mannkind, Medtronic, Merck, NovoNordisk, Quotient Diagnostics, ResMed, Roche, Sanofi-Aventis, and Takeda; honoraria from Novo Nordisk and Roche; and payment for development of educational presentations from Eli Lilly, Johnson and Johnson/Lifescan, Merck, Novartis, Sanofi-Aventis. WCC has received consulting fees from Novartis, Sanofi-Aventis, Takeda, Bristol-Myers Squibb, King Pharmaceuticals, and Daiichi-Sankyo, and grant funding from Novartis and GlaxoSmithKline and NHLBI. RHG has received Data and Safety Monitoring Boards funding for Pfizer. BH has received travel support from NHLBI. BH has received full-time employment salary with stock benefits from Eli Lilly. IH has received consulting fees from GlaxoSmithKline; grants from Lawson Research Institute, Bristol-Myers Squibb, Eli Lilly, Hofmann-La Roche, Merck Frosst, Novo Nordisk, Pfizer, Sanofi-Aventis, and Abbott; honoraria from Boehringer Ingelheim, Eli Lilly, Bristol Myers Squibb, Merck Frosst, GlaxoSmithKline, Medtronic, Novo Nordisk, and Sanofi-Aventis; payment for development of educational programs from Bristol-Myers Squibb, AstraZeneca, and Merck Frosst; and travel support from Merck Frosst and Sanofi-Aventis. Fl-B has received travel support from NHLBI. DK has received grants from Amylin and Sanofi-Aventis, and honoraria from Amylin, Sanofi-Aventis, and Novo Nordisk, and travel support from NHLBI. LK has received grants from Novartis and Abbott; honoraria from Novartis; and travel support from Narrows Research Foundation. PO'C has received grant and travel support from NHLBI. RP-B has received consulting fees from Pfizer; grants from Amylin; and honoraria from GlaxoSmithKline and Pfizer. US has received grant and travel support from NHLBI. AT has received consulting fees from Novo Nordisk and Takeda; grants from Eli Lily, Amylin, Roche, and Abbot; and travel support from Novo Nordisk, Takeda, and NHLBI. DW reports grants from Amylin, Boehringer Ingelheim, Bristol-Myers Squibb, Eisai, Eli Lily, Inekrin, Mannkind, Novo Nordisk, Oresigen, Sanofi-Aventis, Takeda; honoraria from Amylin, AstraZeneca, Bristol-Myers Squibb, Daiichi-Sankyo, Eli Lily, GlaxoSmithKline, Merk, Novo Nordisk, Sanofi-Aventis, and Takeda; and payment for development of educational materials from Daiichi Sankyo. All other authors declare that they have no conflicts of interest.	Adler AI, 1997, DIABETES CARE, V20, P1162, DOI 10.2337/diacare.20.7.1162; BALLARD DJ, 1988, DIABETES, V37, P405, DOI 10.2337/diabetes.37.4.405; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; CHEW EY, N ENGL J ME IN PRESS; CULL C, 1993, DIABETOLOGIA, V36, P1021; Derhaschnig U, 2002, NEPHROL DIAL TRANSPL, V17, P81, DOI 10.1093/ndt/17.1.81; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Dyer AR, 2004, AM J EPIDEMIOL, V160, P1122, DOI 10.1093/aje/kwh326; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2007, AM J CARDIOL, V99, p34I, DOI 10.1016/j.amjcard.2007.03.004; Giorgino F, 2004, DIABETOLOGIA, V47, P1020, DOI 10.1007/s00125-004-1413-8; KLEIN R, 1984, ARCH OPHTHALMOL-CHIC, V102, P527, DOI 10.1001/archopht.1984.01040030405011; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; LAW CG, 1992, STAT MED, V11, P1569, DOI 10.1002/sim.4780111204; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Levine M, 2001, PHARMACOTHERAPY, V21, P405, DOI 10.1592/phco.21.5.405.34503; Meguro S, 2009, INTERNAL MED, V48, P657, DOI 10.2169/internalmedicine.48.1865; Moritz T, 2009, NEW ENGL J MED, V361, P1024, DOI 10.1056/NEJMc096250; Newman D J, 2005, Health Technol Assess, V9, piii; Newman DJ, 2005, HEALTH TECHNOL ASSES, V9, P1; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Perkins BA, 2003, NEW ENGL J MED, V348, P2285, DOI 10.1056/NEJMoa021835; PHILLIPOU G, 1994, DIABETES CARE, V17, P425, DOI 10.2337/diacare.17.5.425; RITHNAJARIAN SJ, 1992, DIABETES CARE, V15, P1386, DOI 10.2337/diacare.15.10.1386; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Savage S, 1996, DIABETES CARE, V19, P1243, DOI 10.2337/diacare.19.11.1243; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Stratton IM, 2001, DIABETOLOGIA, V44, P156, DOI 10.1007/s001250051594; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003	32	916	960	3	67	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					419	430		10.1016/S0140-6736(10)60576-4	http://dx.doi.org/10.1016/S0140-6736(10)60576-4			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20594588	Green Accepted			2022-12-28	WOS:000281012900027
J	Bellott, DW; Skaletsky, H; Pyntikova, T; Mardis, ER; Graves, T; Kremitzki, C; Brown, LG; Rozen, S; Warren, WC; Wilson, RK; Page, DC				Bellott, Daniel W.; Skaletsky, Helen; Pyntikova, Tatyana; Mardis, Elaine R.; Graves, Tina; Kremitzki, Colin; Brown, Laura G.; Rozen, Steve; Warren, Wesley C.; Wilson, Richard K.; Page, David C.			Convergent evolution of chicken Z and human X chromosomes by expansion and gene acquisition	NATURE			English	Article							SEX-CHROMOSOMES; RAPID EVOLUTION; GENOME; REGION; SEQUENCE; PLATYPUS; SYNTENY; STRATA; BIRD; MAP	In birds, as in mammals, one pair of chromosomes differs between the sexes. In birds, males are ZZ and females ZW. In mammals, males are XY and females XX. Like the mammalian XY pair, the avian ZW pair is believed to have evolved from autosomes, with most change occurring in the chromosomes found in only one sex-the W and Y chromosomes(1-5). By contrast, the sex chromosomes found in both sexes-the Z and X chromosomes-are assumed to have diverged little from their autosomal progenitors(2). Here we report findings that challenge this assumption for both the chicken Z chromosome and the human X chromosome. The chicken Z chromosome, which we sequenced essentially to completion, is less gene-dense than chicken autosomes but contains a massive tandem array containing hundreds of duplicated genes expressed in testes. A comprehensive comparison of the chicken Z chromosome with the finished sequence of the human X chromosome demonstrates that each evolved independently from different portions of the ancestral genome. Despite this independence, the chicken Z and human X chromosomes share features that distinguish them from autosomes: the acquisition and amplification of testis-expressed genes, and a low gene density resulting from an expansion of intergenic regions. These features were not present on the autosomes from which the Z and X chromosomes originated but were instead acquired during the evolution of Z and X as sex chromosomes. We conclude that the avian Z and mammalian X chromosomes followed convergent evolutionary trajectories, despite their evolving with opposite (female versus male) systems of heterogamety. More broadly, in birds and mammals, sex chromosome evolution involved not only gene loss in sex-specific chromosomes, but also marked expansion and gene acquisition in sex chromosomes common to males and females.	[Bellott, Daniel W.; Skaletsky, Helen; Pyntikova, Tatyana; Brown, Laura G.; Rozen, Steve; Page, David C.] MIT, Howard Hughes Med Inst, Whitehead Inst, Cambridge, MA 02142 USA; [Bellott, Daniel W.; Skaletsky, Helen; Pyntikova, Tatyana; Brown, Laura G.; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Mardis, Elaine R.; Graves, Tina; Kremitzki, Colin; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL)	Page, DC (corresponding author), MIT, Howard Hughes Med Inst, Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Mardis, Elaine/W-2202-2019; Wilson, Richard K./AAF-4139-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; Rozen, Steven G./0000-0002-4288-0056; Kremitzki, Colin/0000-0001-9175-3136	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank E. Rapoport for technical assistance, S. Repping and S. van Daalen for experimental advice, and E. Anderson, T. Endo, M. Gill, A. Hochwagen, C. Hongay, Y. Hu, J. Hughes, J. Marszalek, J. Mueller and Y. Soh for comments on the manuscript. We thank the Broad Institute Genome Sequencing Platform and Genome Sequencing and Analysis Program, F. Di Palma and K. Lindblad-Toh for making the unpublished data for Gasterosteus aculeatus available. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Boardman PE, 2002, CURR BIOL, V12, P1965, DOI 10.1016/S0960-9822(02)01296-4; Ezaz T, 2006, CURR BIOL, V16, pR736, DOI 10.1016/j.cub.2006.08.021; Filatov DA, 2005, GENETICS, V170, P975, DOI 10.1534/genetics.104.037069; Flicek P, 2003, GENOME RES, V13, P46, DOI 10.1101/gr.830003; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grutzner F, 2004, NATURE, V432, P913, DOI 10.1038/nature03021; Handley LL, 2004, GENETICS, V167, P367, DOI 10.1534/genetics.167.1.367; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hori T, 1996, CHROMOSOME RES, V4, P411, DOI 10.1007/BF02265048; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Korf I, 2001, BIOINFORMATICS, V17, pS140, DOI DOI 10.1093/BI0INF0RMATICS/17.SUPPL_; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Morisson M, 2002, GENET SEL EVOL, V34, P521, DOI [10.1051/gse:2002021, 10.1186/1297-9686-34-4-521]; Muller HJ, 1914, J EXP ZOOL, V17, P325, DOI 10.1002/jez.1400170303; Nanda I, 2002, CYTOGENET GENOME RES, V99, P178, DOI 10.1159/000071591; Nanda I, 1999, NAT GENET, V21, P258, DOI 10.1038/6769; Nicolas M, 2005, PLOS BIOL, V3, P47, DOI 10.1371/journal.pbio.0030004; Ohno S., 1967, SEX CHROMOSOMES SEX; Rens W, 2004, P NATL ACAD SCI USA, V101, P16257, DOI 10.1073/pnas.0405702101; RICE WR, 1984, EVOLUTION, V38, P735, DOI 10.1111/j.1558-5646.1984.tb00346.x; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Scanlan Matthew J, 2004, Cancer Immun, V4, P1; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SMIT AFA, 2007, REPEATMASKER OPEN 3; Smith JJ, 2007, GENETICS, V177, P607, DOI 10.1534/genetics.107.072033; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Wallis JW, 2004, NATURE, V432, P761, DOI 10.1038/nature03030; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; WICHMAN HA, 1992, GENETICA, V86, P287, DOI 10.1007/BF00133727; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	39	146	151	1	56	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					612	U3		10.1038/nature09172	http://dx.doi.org/10.1038/nature09172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20622855	Green Submitted, Green Accepted			2022-12-28	WOS:000280412100051
J	Reulen, RC; Winter, DL; Frobisher, C; Lancashire, ER; Stiller, CA; Jenney, ME; Skinner, R; Stevens, MC; Hawkins, MM				Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Stiller, Charles A.; Jenney, Meriel E.; Skinner, Roderick; Stevens, Michael C.; Hawkins, Michael M.		British Childhood Canc Survivor	Long-term Cause-Specific Mortality Among Survivors of Childhood Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							2ND MALIGNANT NEOPLASMS; 5-YEAR SURVIVORS; LATE DEATHS; ADOLESCENCE; OUTCOMES; COHORT	Context Survivors of childhood cancer are at increased risk of premature mortality compared with the general population, but little is known about the long-term risks of specific causes of death, particularly beyond 25 years from diagnosis at ages when background mortality in the general population starts to increase substantially. Objective To investigate long-term cause-specific mortality among 5-year survivors of childhood cancer in a large-scale population-based cohort. Design, Setting, and Patients British Childhood Cancer Survivor Study, a population-based cohort of 17 981 5-year survivors of childhood cancer diagnosed with cancer before age 15 years between 1940 and 1991 in Britain and followed up until the end of 2006. Main Outcome Measures Cause-specific standardized mortality ratios (SMRs) and absolute excess risks (AERs). Results Overall, 3049 deaths were observed, which was 11 times the number expected (SMR, 10.7; 95% confidence interval [CI], 10.3-11.1). The SMR declined with follow-up but was still 3-fold higher than expected (95% CI, 2.5-3.9) 45 years from diagnosis. The AER for deaths from recurrence declined from 97 extra deaths (95% CI, 92-101) per 10 000 person-years at 5 to 14 years from diagnosis, to 8 extra deaths (95% CI, 3-22) beyond 45 years from diagnosis. In contrast, during the same periods of follow-up, the AER for deaths from second primary cancers and circulatory causes increased from 8 extra deaths (95% CI, 7-10) and 2 extra deaths (95% CI, 2-3) to 58 extra deaths (95% CI, 38-90) and 29 extra deaths (95% CI, 16-56), respectively. Beyond 45 years from diagnosis, recurrence accounted for 7% of the excess number of deaths observed while second primary cancers and circulatory deaths together accounted for 77%. Conclusion Among a cohort of British survivors of childhood cancer, excess mortality from second primary cancers and circulatory diseases continued to occur beyond 25 years from diagnosis. JAMA. 2010; 304(2): 172-179 www.jama.com	[Reulen, Raoul C.; Winter, David L.; Frobisher, Clare; Lancashire, Emma R.; Hawkins, Michael M.] Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England; [Stiller, Charles A.] Univ Oxford, Childhood Canc Res Grp, Oxford, England; [Jenney, Meriel E.] Childrens Hosp Wales, Cardiff, Wales; [Skinner, Roderick] Newcastle Upon Tyne Hosp NHS Fdn Trust, Royal Victoria Infirm, Dept Paediat & Adolescent Oncol, Newcastle Upon Tyne, Tyne & Wear, England; [Stevens, Michael C.] Univ Bristol, Inst Child Life & Hlth, Bristol, Avon, England	University of Birmingham; University of Oxford; Newcastle University - UK; Newcastle Upon Tyne Hospitals NHS Foundation Trust; University of Bristol	Reulen, RC (corresponding author), Univ Birmingham, Ctr Childhood Canc Survivor Studies, Sch Hlth & Populat Sci, Publ Hlth Bldg, Birmingham B15 2TT, W Midlands, England.	r.c.reulen@bham.ac.uk	Frobisher, Clare/AAC-5728-2020; Reulen, Raoul/AAO-1033-2020; Pritchard-Jones, Kathy/F-4286-2014	Frobisher, Clare/0000-0003-1099-163X; Reulen, Raoul/0000-0002-7328-0467; Pritchard-Jones, Kathy/0000-0002-2384-9475; Stevens, Michael/0000-0001-6466-551X; Stiller, Charles/0000-0002-3006-7869	Cancer Research UK; Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	Cancer Research UK(Cancer Research UK); Kay Kendall Leukaemia Fund; Department of Health; Scottish Ministers	This work was supported by Cancer Research UK and the Kay Kendall Leukaemia Fund. Dr Reulen was supported by a Cancer Research UK Graduate Training Fellowship. The Childhood Cancer Research Group receives funding from the Department of Health and the Scottish Ministers.; Cancer Research UK, the Kay Kendall Leukaemia Fund, the Department of Health, and the Scottish Ministers had no role in the design and conduct of the study; in the collection, management, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Bowers DC, 2006, J CLIN ONCOL, V24, P5277, DOI 10.1200/JCO.2006.07.2884; Breslow NE., 1987, STAT METHODS CANC RE, P81; Cardous-Ubbink MC, 2004, PEDIATR BLOOD CANCER, V42, P563, DOI 10.1002/pbc.20028; Coviello V, 2004, STATA J, V4, P103, DOI 10.1177/1536867X0400400201; Dama E, 2006, HAEMATOLOGICA, V91, P1084; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; HAWKINS MM, 1990, ARCH DIS CHILD, V65, P1356, DOI 10.1136/adc.65.12.1356; Jenkinson HC, 2004, BRIT J CANCER, V91, P1905, DOI 10.1038/sj.bjc.6602226; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Lipshultz SE, 2008, HEART, V94, P525, DOI 10.1136/hrt.2007.136093; MacArthur AC, 2007, PEDIATR BLOOD CANCER, V48, P460, DOI 10.1002/pbc.20922; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mertens AC, 2007, PEDIATR BLOOD CANCER, V48, P723, DOI 10.1002/pbc.21114; Moller TR, 2001, J CLIN ONCOL, V19, P3173; Morris B, 2009, NEUROLOGY, V73, P1906, DOI 10.1212/WNL.0b013e3181c17ea8; MULROONEY DA, 2009, BMJ-BRIT MED J, V339, DOI DOI 10.1136/BMJ.B4606; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; *OFF NAT STAT, 2006, MORT STAT; Olsen JH, 2009, JNCI-J NATL CANCER I, V101, P806, DOI 10.1093/jnci/djp104; ROBERTSON CM, 1994, BRIT MED J, V309, P162, DOI 10.1136/bmj.309.6948.162; Taylor A, 2004, PEDIATR BLOOD CANCER, V42, P161, DOI 10.1002/pbc.10482; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; Yeh JM, 2010, ANN INTERN MED, V152, P409, DOI 10.7326/0003-4819-152-7-201004060-00005; Yu CL, 2009, JNCI-J NATL CANCER I, V101, P581, DOI 10.1093/jnci/djp046	26	295	297	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					172	179		10.1001/jama.2010.923	http://dx.doi.org/10.1001/jama.2010.923			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628130	Bronze			2022-12-28	WOS:000279811000023
J	Chakraborty, K; Chatila, M; Sinha, J; Shi, QY; Poschner, BC; Sikor, M; Jiang, GX; Lamb, DC; Hartl, FU; Hayer-Hartl, M				Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Sikor, Martin; Jiang, Guoxin; Lamb, Don C.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			Chaperonin-Catalyzed Rescue of Kinetically Trapped States in Protein Folding	CELL			English	Article							IN-VIVO; ENTROPIC BARRIERS; MALTOSE-BINDING; DISULFIDE BONDS; GROEL; CONFINEMENT; MECHANISM; TMAO	GroEL and GroES form a chaperonin nano-cage for single protein molecules to fold in isolation. The folding properties that render a protein chaperonin dependent are not yet understood. Here, we address this question using a double mutant of the maltose-binding protein DM-MBP as a substrate. Upon spontaneous refolding, DM-MBP populates a kinetically trapped intermediate that is collapsed but structurally disordered. Introducing two long-range disulfide bonds into DM-MBP reduces the entropic folding barrier of this intermediate and strongly accelerates native state formation. Strikingly, steric confinement of the protein in the chaperonin cage mimics the kinetic effect of constraining disulfides on folding, in a manner mediated by negative charge clusters in the cage wall. These findings suggest that chaperonin dependence correlates with the tendency of proteins to populate entropically stabilized folding intermediates. The capacity to rescue proteins from such folding traps may explain the uniquely essential role of chaperonin cages within the cellular chaperone network.	[Chakraborty, Kausik; Chatila, Manal; Sinha, Jyoti; Shi, Qiaoyun; Poschner, Bernhard C.; Jiang, Guoxin; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Dept Chem, Ctr Nanosci, D-81377 Munich, Germany; [Sikor, Martin; Lamb, Don C.] Univ Munich, Munich Ctr Integrated Prot Sci CiPSM, D-81377 Munich, Germany; [Lamb, Don C.] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	Max Planck Society; University of Munich; University of Munich; University of Illinois System; University of Illinois Urbana-Champaign	Hartl, FU (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Lamb, Don C/G-9501-2014; Chakraborty, Kausik/AAL-5748-2021; Sinha, Jyoti/AAW-6161-2020; Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Lamb, Don C/0000-0002-0232-1903; Sinha, Jyoti/0000-0001-9202-1789; Hayer-Hartl, Manajit/0000-0001-8213-6742; chakraborty, kausik/0000-0001-6000-8379	Deutsche Forschungsgemeinschaft [SFB 596, SFB 749]; Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ludwig-Maximi-lians-University Munich; Nanosystems Initiative Munich (NIM); Ernst-Jung Foundation; Korber Foundation	We thank J.R. Engen for sharing with us the blueprints of his home-built micro-flow HPLC system and A.R. Lange for technical assistance. We gratefully acknowledge financial support from Deutsche Forschungsgemeinschaft (SFB 596 to F.U.H. and M.H.-H., and SFB 749 to D.C.L.), the Ludwig-Maximi-lians-University Munich (LMUInnovativ BioImaging Network), Nanosystems Initiative Munich (NIM), the Ernst-Jung Foundation, and the Korber Foundation.	Apetri AC, 2008, P NATL ACAD SCI USA, V105, P17351, DOI 10.1073/pnas.0809794105; Bartlett AI, 2009, NAT STRUCT MOL BIOL, V16, P582, DOI 10.1038/nsmb.1592; Baumketner A, 2003, J MOL BIOL, V332, P701, DOI 10.1016/S0022-2836(03)00929-X; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; CAMACHO CJ, 1995, PROTEINS, V22, P27, DOI 10.1002/prot.340220105; CHUN SY, 1993, J BIOL CHEM, V268, P20855; CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111; England JL, 2008, BIOPHYS J, V95, P3391, DOI [10.1529/biophysj.108.131037, 10.1529/biophysj.l08.131037]; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hayer-Hartl M, 2006, BIOCHEMISTRY-US, V45, P13356, DOI 10.1021/bi061597j; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Horwich AL, 2009, FEBS LETT, V583, P2654, DOI 10.1016/j.febslet.2009.06.049; Houry WA, 1999, NATURE, V402, P147, DOI 10.1038/45977; Jewett AI, 2010, CELL MOL LIFE SCI, V67, P255, DOI 10.1007/s00018-009-0164-6; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Lucent D, 2007, P NATL ACAD SCI USA, V104, P10430, DOI 10.1073/pnas.0608256104; Mainathambika BS, 2008, ANNU REV CELL DEV BI, V24, P211, DOI 10.1146/annurev.cellbio.24.110707.175333; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Qu YX, 2003, BIOCHEMISTRY-US, V42, P5837, DOI 10.1021/bi0206457; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shtilerman M, 1999, SCIENCE, V284, P822, DOI 10.1126/science.284.5415.822; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Thirumalai D, 2001, ANNU REV BIOPH BIOM, V30, P245, DOI 10.1146/annurev.biophys.30.1.245; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Vendruscolo M, 2003, P NATL ACAD SCI USA, V100, P14817, DOI 10.1073/pnas.2036516100; Wallin S, 2006, J PHYS-CONDENS MAT, V18, pS307, DOI 10.1088/0953-8984/18/14/S14; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zou Q, 2002, J AM CHEM SOC, V124, P1192, DOI 10.1021/ja004206b	39	105	108	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					112	122		10.1016/j.cell.2010.05.027	http://dx.doi.org/10.1016/j.cell.2010.05.027			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603018	Bronze			2022-12-28	WOS:000279637300017
J	Sharpe, HJ; Stevens, TJ; Munro, S				Sharpe, Hayley J.; Stevens, Tim J.; Munro, Sean			A Comprehensive Comparison of Transmembrane Domains Reveals Organelle-Specific Properties	CELL			English	Article							LIPID-PROTEIN INTERACTIONS; MEMBRANE-PROTEINS; ENDOPLASMIC-RETICULUM; BILAYER THICKNESS; PLASMA-MEMBRANE; GOLGI-APPARATUS; HYDROPHOBICITY SCALE; LOCALIZATION; VESICLES; HELICES	The various membranes of eukaryotic cells differ in composition, but it is at present unclear if this results in differences in physical properties. The sequences of transmembrane domains (TMDs) of integral membrane proteins should reflect the physical properties of the bilayers in which they reside. We used large datasets from both fungi and vertebrates to perform a comprehensive comparison of the TMDs of proteins from different organelles. We find that TMDs are not generic but have organelle-specific properties with a dichotomy in TMD length between the early and late parts of the secretory pathway. In addition, TMDs from post-ER organelles show striking asymmetries in amino acid compositions across the bilayer that is linked to residue size and varies between organelles. The pervasive presence of organelle-specific features among the TMDs of a particular organelle has implications for TMD prediction, regulation of protein activity by location, and sorting of proteins and lipids in the secretory pathway.	[Sharpe, Hayley J.; Munro, Sean] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Stevens, Tim J.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	MRC Laboratory Molecular Biology; University of Cambridge	Munro, S (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	sean@mrc-lmb.cam.ac.uk	sharpe, Hayley/U-2214-2019	sharpe, Hayley/0000-0002-4723-298X; Munro, Sean/0000-0001-6160-5773; Stevens, Tim/0000-0001-6475-2074	Medical Research Council (UK); MRC [MC_U105178783] Funding Source: UKRI; Medical Research Council [MC_U105178783] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We would like to thank Arne Elofsson (Stockholm University) for help with Zpred2 and Madan Babu, Chantal Christis, Matthew Freeman, Alison Gillingham, Tobias Kloeper, Katja Roper, and Isabel Torres for comments on the manuscript. Funding was from the Medical Research Council (UK).	Almen MS, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-50; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; Bacia K, 2004, J BIOL CHEM, V279, P37951, DOI 10.1074/jbc.M407020200; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; BRASITUS TA, 1980, BIOCHEMISTRY-US, V19, P2763, DOI 10.1021/bi00553a035; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Chou KC, 2007, J PROTEOME RES, V6, P1728, DOI 10.1021/pr060635i; Dukhovny A, 2009, J CELL SCI, V122, P1759, DOI 10.1242/jcs.039339; ENGELMAN DM, 1986, ANNU REV BIOPHYS BIO, V15, P321, DOI 10.1146/annurev.bb.15.060186.001541; Frick M, 2007, CURR BIOL, V17, P462, DOI 10.1016/j.cub.2007.01.069; Hessa T, 2005, NATURE, V433, P377, DOI 10.1038/nature03216; Holthuis JCM, 2001, PHYSIOL REV, V81, P1689, DOI 10.1152/physrev.2001.81.4.1689; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Levine TP, 2000, MOL BIOL CELL, V11, P2267, DOI 10.1091/mbc.11.7.2267; LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2; Lundin C, 2008, P NATL ACAD SCI USA, V105, P15702, DOI 10.1073/pnas.0804842105; Mathai JC, 2008, J GEN PHYSIOL, V131, P69, DOI 10.1085/jgp.200709848; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mitragotri S, 1999, BIOPHYS J, V77, P1268, DOI 10.1016/S0006-3495(99)76978-X; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Papaloukas C, 2008, PROTEIN SCI, V17, P271, DOI 10.1110/ps.073036108; Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044; PAULSON JC, 1989, J BIOL CHEM, V264, P17615; Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147; Pontius J, 1996, J MOL BIOL, V264, P121, DOI 10.1006/jmbi.1996.0628; Ronchi P, 2008, J CELL BIOL, V181, P105, DOI 10.1083/jcb.200710093; Russ WP, 2000, J MOL BIOL, V296, P911, DOI 10.1006/jmbi.1999.3489; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; Shatkay H, 2007, BIOINFORMATICS, V23, P1410, DOI 10.1093/bioinformatics/btm115; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SIMONS K, 1988, BIOCHEMISTRY-US, V27, P6197, DOI 10.1021/bi00417a001; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stevens TJ, 2000, PROTEINS, V39, P417, DOI 10.1002/(SICI)1097-0134(20000601)39:4<417::AID-PROT140>3.0.CO;2-Y; Tafesse FG, 2006, J BIOL CHEM, V281, P29421, DOI 10.1074/jbc.R600021200; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; VAN MEER G, 1989, ANNU REV CELL BIOL, V5, P247, DOI 10.1146/annurev.cellbio.5.1.247; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vanIjzendoorn SCD, 1997, J CELL BIOL, V137, P347, DOI 10.1083/jcb.137.2.347; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842	51	371	374	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					158	169		10.1016/j.cell.2010.05.037	http://dx.doi.org/10.1016/j.cell.2010.05.037			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603021	Green Published, hybrid			2022-12-28	WOS:000279637300021
J	Larsen, RE; Glover, WJ; Schwartz, BJ				Larsen, Ross E.; Glover, William J.; Schwartz, Benjamin J.			Does the Hydrated Electron Occupy a Cavity?	SCIENCE			English	Article							OPTICAL-ABSORPTION SPECTRUM; AQUEOUS SOLVATED ELECTRON; PUMP-PROBE SPECTROSCOPY; RAMAN-SPECTRA; DYNAMICS; WATER; MODEL; SIMULATION; CLUSTERS	Since the discovery of the hydrated electron more than 40 years ago, a general consensus has emerged that the hydrated electron occupies a quasispherical cavity in liquid water. We simulated the electronic structure and dynamics of the hydrated electron using a rigorously derived pseudopotential to treat the electron-water interaction, which incorporates attractive oxygen and repulsive hydrogen features that have not been included in previous pseudopotentials. What emerged was a hydrated electron that did not reside in a cavity but instead occupied a similar to 1-nanometer-diameter region of enhanced water density. Both the calculated ground-state absorption spectrum and the excited-state spectral dynamics after simulated photoexcitation of this noncavity hydrated electron showed excellent agreement with experiment. The relaxation pathway involves a rapid internal conversion followed by slow ground-state cooling, the opposite of the mechanism implicated by simulations in which the hydrated electron occupies a cavity.	[Larsen, Ross E.; Glover, William J.; Schwartz, Benjamin J.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Larsen, RE (corresponding author), Natl Renewable Energy Lab, Golden, CO 80401 USA.	Ross.Larsen@nrel.gov; schwartz@chem.ucla.edu	Larsen, Ross E/E-4225-2010; Glover, William/A-6968-2010	Larsen, Ross E/0000-0002-2928-9835; Glover, William/0000-0002-2908-5680; Schwartz, Benjamin/0000-0003-3257-9152	NSF [CHE-0908548]	NSF(National Science Foundation (NSF))	This research was funded by NSF under grant CHE-0908548. We thank M. C. Larsen and A. E. Bragg for helpful discussions, C. N. Mejia for performing the preliminary Hartree-Fock calculations that we used to generate the new electron-water pseudopotential, and K. D. Jordan for a critical reading of the manuscript.	Baltuska A, 1999, J PHYS CHEM A, V103, P10065, DOI 10.1021/jp992482a; Boero M, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.226403; Bragg AE, 2004, SCIENCE, V306, P669, DOI 10.1126/science.1103527; Cavanagh MC, 2004, CHEM PHYS LETT, V396, P359, DOI 10.1016/j.cplett.2004.07.109; Jacobson LD, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3089425; JOU FY, 1979, J PHYS CHEM-US, V83, P2383, DOI 10.1021/j100481a016; Kee TW, 2001, J PHYS CHEM A, V105, P8434, DOI 10.1021/jp004516g; KEVAN L, 1981, ACCOUNTS CHEM RES, V14, P138, DOI 10.1021/ar00065a002; KIMURA Y, 1994, J PHYS CHEM-US, V98, P3450, DOI 10.1021/j100064a029; Larsen RE, 2006, J PHYS CHEM B, V110, P20055, DOI 10.1021/jp0629745; Larsen RE, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3175801; Pshenichnikov MS, 2004, CHEM PHYS LETT, V389, P171, DOI 10.1016/j.cplett.2004.03.107; ROSENTHAL SJ, 1994, CHEM PHYS LETT, V229, P443, DOI 10.1016/0009-2614(94)01090-0; SCHNITKER J, 1988, PHYS REV LETT, V60, P456, DOI 10.1103/PhysRevLett.60.456; SCHNITKER J, 1987, J CHEM PHYS, V86, P3462, DOI 10.1063/1.452002; Schnitker J, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3175802; SCHWARTZ BJ, 1994, PHYS REV LETT, V72, P3282, DOI 10.1103/PhysRevLett.72.3282; SCHWARTZ BJ, 1994, J CHEM PHYS, V101, P6902, DOI 10.1063/1.468319; SCHWARTZ BJ, 1994, J CHEM PHYS, V101, P6917, DOI 10.1063/1.468320; Smallwood CJ, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2218834; Sobolewski AL, 2002, PHYS CHEM CHEM PHYS, V4, P4, DOI 10.1039/b107373g; Sommerfeld T, 2008, J PHYS CHEM A, V112, P11021, DOI 10.1021/jp806077h; Tauber MJ, 2003, J AM CHEM SOC, V125, P1394, DOI 10.1021/ja021134a; Tauber MJ, 2001, J PHYS CHEM A, V105, P10952, DOI 10.1021/jp012184p; Turi L, 2002, J CHEM PHYS, V117, P6186, DOI 10.1063/1.1503308; Turi L, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3173276; Walrafen GE, 1973, J SOLUTION CHEM, V2, P159, DOI 10.1007/BF00651971; Yokoyama K, 1998, J PHYS CHEM A, V102, P6957, DOI 10.1021/jp981809p	29	184	187	3	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					65	69		10.1126/science.1189588	http://dx.doi.org/10.1126/science.1189588			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595609	Green Submitted			2022-12-28	WOS:000279402700032
J	Lambert, O; Bianucci, G; Post, K; de Muizon, C; Salas-Gismondi, R; Urbina, M; Reumer, J				Lambert, Olivier; Bianucci, Giovanni; Post, Klaas; de Muizon, Christian; Salas-Gismondi, Rodolfo; Urbina, Mario; Reumer, Jelle			The giant bite of a new raptorial sperm whale from the Miocene epoch of Peru	NATURE			English	Article							MARINE MAMMALS; CETACEA	The modern giant sperm whale Physeter macrocephalus, one of the largest known predators, preys upon cephalopods at great depths(1,2). Lacking a functional upper dentition, it relies on suction for catching its prey(3); in contrast, several smaller Miocene sperm whales (Physeteroidea) have been interpreted as raptorial (versus suction) feeders(4,5), analogous to the modern killer whale Orcinus orca. Whereas very large physeteroid teeth have been discovered in various Miocene localities, associated diagnostic cranial remains have not been found so far(6-8). Here we report the discovery of a new giant sperm whale from the Middle Miocene of Peru (approximately 12-13 million years ago), Leviathan melvillei, described on the basis of a skull with teeth and mandible. With a 3-m-long head, very large upper and lower teeth (maximum diameter and length of 12 cm and greater than 36 cm, respectively), robust jaws and a temporal fossa considerably larger than in Physeter, this stem physeteroid represents one of the largest raptorial predators and, to our knowledge, the biggest tetrapod bite ever found. The appearance of gigantic raptorial sperm whales in the fossil record coincides with a phase of diversification and size-range increase of the baleen-bearing mysticetes in the Miocene. We propose that Leviathan fed mostly on high-energy content medium-size baleen whales. As a top predator, together with the contemporaneous giant shark Carcharocles megalodon, it probably had a profound impact on the structuring of Miocene marine communities. The development of a vast supracranial basin in Leviathan, extending on the rostrum as in Physeter, might indicate the presence of an enlarged spermaceti organ in the former that is not associated with deep diving or obligatory suction feeding.	[Lambert, Olivier] Inst Royal Sci Nat Belgique, Dept Paleontol, B-1000 Brussels, Belgium; [Bianucci, Giovanni] Univ Pisa, Dipartimento Sci Terra, I-56126 Pisa, Italy; [Post, Klaas; Reumer, Jelle] Nat Hist Museum Rotterdam, NL-3001 KL Rotterdam, Netherlands; [de Muizon, Christian] Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France; [Salas-Gismondi, Rodolfo; Urbina, Mario] Univ Nacl Mayor San Marcos, Museo Hist Nat, Lima 14, Peru; [Reumer, Jelle] Univ Utrecht, Dept Geosci, NL-3508 TA Utrecht, Netherlands	University of Pisa; Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Mayor de San Marcos; Utrecht University	Lambert, O (corresponding author), Museum Natl Hist Nat, Dept Hist Terre, F-75005 Paris, France.	olambert@mnhn.fr; bianucci@dst.unipi.it	De Muizon, Christian/Q-7986-2019; Lambert, Olivier/AEN-2469-2022; De Muizon, Christian/P-4335-2017	De Muizon, Christian/0000-0002-1247-8867; Lambert, Olivier/0000-0003-0740-5791; De Muizon, Christian/0000-0002-1247-8867; Salas-Gismondi, Rodolfo/0000-0001-9990-8841	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office	Board of the Natuurhistorisch Museum Rotterdam Foundation; Belgian Federal Science Policy Office(Belgian Federal Science Policy Office)	We thank W. Aguirre, A. Altamirano, E. Diaz, A. Martinez and N. Valencia for assistance during fieldwork and preparation of the specimen; C. Letenneur for the reconstruction of Leviathan; P. Loubry for the photo of the tooth of Orcinus; D. J. Bohaska, G. Lenglet, J. G. Mead, C. Potter, H. van der Es, R. van Zelst and A. Varola for access to collections; M. D. Uhen for his compilation of cetacean data in The Paleobiology Database, and the Board of the Natuurhistorisch Museum Rotterdam Foundation for financial support of our research on fossil cetaceans in Peru. The work of O.L. at IRSNB was funded by the Belgian Federal Science Policy Office.	Abel O., 1905, MEMOIRES MUSEE ROYAL, V3, P1; Bianucci G, 2006, ZOOL J LINN SOC-LOND, V148, P103, DOI 10.1111/j.1096-3642.2006.00228.x; Brand LR, 2004, GEOLOGY, V32, P165, DOI 10.1130/G20079.1; Caldwell D.K., 1989, P235; Carrier DR, 2002, J EXP BIOL, V205, P1755; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; DALHEIM ME, 1999, HDB MARINE MAMMALS, V6, P281; Fordyce RE., 2001, SECONDARY ADAPTATION, P169; HIROTA K, 1996, ISL ARC, V3, P453; Hohn AA, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P11; Hone DWE, 2005, TRENDS ECOL EVOL, V20, P4, DOI 10.1016/j.tree.2004.10.012; JEFFERSON TA, 1991, MAMMAL REV, V21, P151, DOI 10.1111/j.1365-2907.1991.tb00291.x; KATO S, 1984, BIOPHYS J, V46, P35, DOI 10.1016/S0006-3495(84)83996-X; Kellogg AR, 1925, CONTRIBUTIONS PALAEO, V348, P1; Lambert O, 2008, CR PALEVOL, V7, P361, DOI 10.1016/j.crpv.2008.06.002; Leidy J., 1877, J ACAD NATURAL SCI P, V8, P209; Lindberg DR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P67; Marx FG, 2009, P ROY SOC B-BIOL SCI, V276, P887, DOI 10.1098/rspb.2008.1473; Purdy RW, 1996, GREAT WHITE SHARKS, P67, DOI 10.1016/B978-012415031-7/50009-4; Reeves RR, 2006, WHALES, WHALING, AND OCEAN ECOSYSTEMS, P174; RICE DW, 1989, HDB MARINE MAMMALS, V56, P177; Springer AM, 2003, P NATL ACAD SCI USA, V100, P12223, DOI 10.1073/pnas.1635156100; TAYLOR MA, 1992, PHILOS T ROY SOC B, V335, P247, DOI 10.1098/rstb.1992.0022; Uhen MD, 2007, PALAEONTOL ELECTRON, V10; Watwood SL, 2006, J ANIM ECOL, V75, P814, DOI 10.1111/j.1365-2656.2006.01101.x; Werth Alexander, 2000, P487, DOI 10.1016/B978-012632590-4/50017-4; Werth Alexander J., 2004, Aquatic Mammals, V30, P405, DOI 10.1578/AM.30.3.2004.405; Whitehead H., 2003, SPERM WHALES SOCIAL; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	30	138	144	1	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					105	108		10.1038/nature09067	http://dx.doi.org/10.1038/nature09067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596020				2022-12-28	WOS:000279343800043
J	Sigman, DM; Hain, MP; Haug, GH				Sigman, Daniel M.; Hain, Mathis P.; Haug, Gerald H.			The polar ocean and glacial cycles in atmospheric CO2 concentration	NATURE			English	Review							ANTARCTIC SEA-ICE; SOUTHERN-OCEAN; CARBON-CYCLE; RADIOCARBON AGES; CLIMATE; TEMPERATURE; IRON; STRATIFICATION; PACIFIC; PRODUCTIVITY	Global climate and the atmospheric partial pressure of carbon dioxide (p(CO2atm)) are correlated over recent glacial cycles, with lower p(CO2atm) during ice ages, but the causes of the p(CO2atm) changes are unknown. The modern Southern Ocean releases deeply sequestered CO2 to the atmosphere. Growing evidence suggests that the Southern Ocean CO2 'leak' was stemmed during ice ages, increasing ocean CO2 storage. Such a change would also have made the global ocean more alkaline, driving additional ocean CO2 uptake. This explanation for lower ice-age p(CO2atm), if correct, has much to teach us about the controls on current ocean processes.	[Sigman, Daniel M.; Hain, Mathis P.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Hain, Mathis P.; Haug, Gerald H.] Univ Potsdam, Inst Geosci, DFG Leibniz Ctr Earth Surface Proc & Climate Stud, D-14476 Potsdam, Germany; [Haug, Gerald H.] ETH, Dept Earth Sci, Inst Geol, CH-8092 Zurich, Switzerland	Princeton University; University of Potsdam; Swiss Federal Institutes of Technology Domain; ETH Zurich	Sigman, DM (corresponding author), Princeton Univ, Dept Geosci, Guyot Hall, Princeton, NJ 08544 USA.	sigman@princeton.edu	Sigman, Daniel M/A-2649-2008; Hain, Mathis P/I-5252-2012	Sigman, Daniel M/0000-0002-7923-1973; Hain, Mathis P/0000-0002-8478-1857	US NSF; German DFG; Humboldt Foundation; MacArthur Foundation; Siebel Energy Grand Challenge at Princeton	US NSF(National Science Foundation (NSF)); German DFG(German Research Foundation (DFG)); Humboldt Foundation(Alexander von Humboldt Foundation); MacArthur Foundation; Siebel Energy Grand Challenge at Princeton	We thank J. F. Adkins, R. F. Anderson, and J. Lynch-Stieglitz for discussions. Support was provided by the US NSF, the German DFG, the Humboldt and MacArthur Foundations, the Siebel Energy Grand Challenge at Princeton, and O. Happel.	Abelmann A, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001199; Adkins JF, 2002, SCIENCE, V298, P1769, DOI 10.1126/science.1076252; Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Archer D, 2000, REV GEOPHYS, V38, P159, DOI 10.1029/1999RG000066; Archer DE, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000760; Augustin L, 2004, NATURE, V429, P623, DOI 10.1038/nature02599; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Bouttes N, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001707; BOYLE EA, 1988, NATURE, V331, P55, DOI 10.1038/331055a0; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; Brunelle BG, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001205; Brzezinski MA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL014349; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Cutler KB, 2003, EARTH PLANET SC LETT, V206, P253, DOI 10.1016/S0012-821X(02)01107-X; de Boer AM, 2008, J PHYS OCEANOGR, V38, P435, DOI 10.1175/2007JPO3731.1; de Boer AM, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001242; Deutsch C, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002189; Francois R, 1997, NATURE, V389, P929, DOI 10.1038/40073; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Galbraith ED, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001518; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Gildor H, 2001, GEOPHYS RES LETT, V28, P2421, DOI 10.1029/2000GL012571; Grootes PM, 1997, J GEOPHYS RES-OCEANS, V102, P26455, DOI 10.1029/97JC00880; Haug GH, 2009, NAT GEOSCI, V2, P91, DOI 10.1038/ngeo423; Hemming SR, 2004, REV GEOPHYS, V42, DOI 10.1029/2003RG000128; Hodell D.A., 2002, P OCEAN DRILL PROGRA, V177, P1; Hodell DA, 2003, GEOCHEM GEOPHY GEOSY, V4, DOI 10.1029/2002GC000367; Hodell DA, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001211; Huang RX, 1999, J PHYS OCEANOGR, V29, P727, DOI 10.1175/1520-0485(1999)029<0727:MAEOTO>2.0.CO;2; Hughen K, 2004, SCIENCE, V303, P202, DOI 10.1126/science.1090300; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Ito T, 2005, J MAR RES, V63, P813, DOI 10.1357/0022240054663231; Jaccard SL, 2009, EARTH PLANET SC LETT, V277, P156, DOI 10.1016/j.epsl.2008.10.017; Jaccard SL, 2005, SCIENCE, V308, P1003, DOI 10.1126/science.1108696; Jouzel J, 2007, SCIENCE, V317, P793, DOI 10.1126/science.1141038; Keeling RF, 2001, NATURE, V412, P605, DOI 10.1038/35088129; Keigwin LD, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2004PA001029; Keir RS, 1988, PALEOCEANOGRAPHY, V3, P413, DOI 10.1029/PA003i004p00413; KNOX F, 1984, J GEOPHYS RES-ATMOS, V89, P4629, DOI 10.1029/JD089iD03p04629; Kohfeld KE, 2005, SCIENCE, V308, P74, DOI 10.1126/science.11053 75; Kuhlbrodt T, 2007, REV GEOPHYS, V45, DOI 10.1029/2004RG000166; KUMAR N, 1995, NATURE, V378, P675, DOI 10.1038/378675a0; Lamy F, 2007, EARTH PLANET SC LETT, V259, P400, DOI 10.1016/j.epsl.2007.04.040; Lefevre N, 1999, GLOBAL BIOGEOCHEM CY, V13, P727, DOI 10.1029/1999GB900034; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Liu ZY, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021929; Loubere P, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000986; Luthi D, 2008, NATURE, V453, P379, DOI 10.1038/nature06949; Lynch-Stieglitz J, 2007, SCIENCE, V316, P66, DOI 10.1126/science.1137127; Mahowald N, 1999, J GEOPHYS RES-ATMOS, V104, P15895, DOI 10.1029/1999JD900084; MANABE S, 1993, NATURE, V364, P215, DOI 10.1038/364215a0; Maqueda MAM, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013240; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Martin JH, 1990, GLOBAL BIOGEOCHEM CY, V4, P5, DOI 10.1029/GB004i001p00005; Martin JH, 1990, PALEOCEANOGRAPHY, V5, P1, DOI 10.1029/PA005i001p00001; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Matson JS, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-16; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MITCHELL BG, 1991, LIMNOL OCEANOGR, V36, P1662, DOI 10.4319/lo.1991.36.8.1662; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; MORTLOCK RA, 1991, NATURE, V351, P220, DOI 10.1038/351220a0; Munk W, 1998, DEEP-SEA RES PT I, V45, P1977, DOI 10.1016/S0967-0637(98)00070-3; Orsi AH, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC000976; Paillard D, 2004, EARTH PLANET SC LETT, V227, P263, DOI 10.1016/j.epsl.2004.08.023; Peacock S, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002448; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Ren H, 2009, SCIENCE, V323, P244, DOI 10.1126/science.1165787; Robinson RS, 2008, QUATERNARY SCI REV, V27, P1076, DOI 10.1016/j.quascirev.2008.02.005; Robinson RS, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001114; SARMIENTO JL, 1984, NATURE, V308, P621, DOI 10.1038/308621a0; Schmittner A, 2003, EARTH PLANET SC LETT, V213, P53, DOI 10.1016/S0012-821X(03)00291-7; Schmittner A., 2007, GEOPHYS MONOGR SER, V173, P209, DOI DOI 10.1029/173GM20; Siegenthaler U, 2005, SCIENCE, V310, P1313, DOI 10.1126/science.1120130; SIEGENTHALER U, 1984, NATURE, V308, P624, DOI 10.1038/308624a0; Sigman D.M., 2007, OCEAN CIRCULATION ME, V173, P335, DOI [10.1029/173GM21, DOI 10.1029/173GM21]; Sigman D. M., 2003, TREATISE GEOCHEMISTR, V6, P491, DOI DOI 10.1016/B978-0-08-095975-7.00618-5; Sigman DM, 1998, GLOBAL BIOGEOCHEM CY, V12, P409, DOI 10.1029/98GB01184; Sigman DM, 2004, NATURE, V428, P59, DOI 10.1038/nature02357; Sigman DM, 2000, NATURE, V407, P859, DOI 10.1038/35038000; Sikes EL, 2000, NATURE, V405, P555, DOI 10.1038/35014581; SOWERS T, 1995, SCIENCE, V269, P210, DOI 10.1126/science.269.5221.210; Spero HJ, 2002, SCIENCE, V296, P522, DOI 10.1126/science.1069401; Stephens BB, 2000, NATURE, V404, P171, DOI 10.1038/35004556; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Timmermann A, 2009, J CLIMATE, V22, P1626, DOI 10.1175/2008JCLI2161.1; Toggweiler JR, 2009, SCIENCE, V323, P1434, DOI 10.1126/science.1169823; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; Toggweiler JR, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001154; Toggweiler JR, 1999, PALEOCEANOGRAPHY, V14, P571, DOI 10.1029/1999PA900033; Toggweiler JR, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001841; Venz KA, 1999, PALEOCEANOGRAPHY, V14, P42, DOI 10.1029/1998PA900013; Watson AJ, 2006, TELLUS B, V58, P73, DOI 10.1111/j.1600-0889.2005.00167.x; Watson AJ, 2000, NATURE, V407, P730, DOI 10.1038/35037561; Wolff EW, 2006, NATURE, V440, P491, DOI 10.1038/nature04614	99	508	527	14	300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					47	55		10.1038/nature09149	http://dx.doi.org/10.1038/nature09149			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596012				2022-12-28	WOS:000279343800033
J	Binder, A; Ellis, S				Binder, Allan; Ellis, Spencer			Rational Testing Investigating symmetrical polyarthritis of recent origin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RHEUMATOID-ARTHRITIS; DISEASE; RECOMMENDATIONS; PROTEIN				Binder, A (corresponding author), Lister Hosp, Stevenage SG1 4AB, Herts, England.	allan.binder@nhs.net						ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Mjaavatten MD, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2820; Mjaavatten MD, 2009, J RHEUMATOL, V36, P1401, DOI 10.3899/jrheum.081217; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HTLH, V79; Ostergaard M, 2008, BEST PRACT RES CL RH, V22, P1019, DOI 10.1016/j.berh.2008.09.014; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Smolen JS, 2010, ANN RHEUM DIS, V69, P964, DOI 10.1136/ard.2009.126532; Smolen JS, 2010, ANN RHEUM DIS, V69, P631, DOI 10.1136/ard.2009.123919; Soderlin MK, 2002, ANN RHEUM DIS, V61, P911, DOI 10.1136/ard.61.10.911; Sokka T, 2009, J RHEUMATOL, V36, P1387, DOI 10.3899/jrheum.080770; SYMMONS DPM, 1994, BRIT J RHEUMATOL, V33, P735; Syversen SW, 2008, ANN RHEUM DIS, V67, P212, DOI 10.1136/ard.2006.068247; van Dongen H, 2007, ARTHRITIS RHEUM-US, V56, P1424, DOI 10.1002/art.22525; Visser H, 2002, ARTHRITIS RHEUM, V46, P357, DOI 10.1002/art.10117	14	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 30	2010	340								c3110	10.1136/bmj.c3110	http://dx.doi.org/10.1136/bmj.c3110			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591966				2022-12-28	WOS:000279586300014
J	Lupski, JR				Lupski, James R.			Retrotransposition and Structural Variation in the Human Genome	CELL			English	Editorial Material									[Lupski, James R.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Lupski, JR (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	jlupski@bcm.edu						Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; EDWARDS MC, 1992, GENOMICS, V14, P590, DOI 10.1016/S0888-7543(05)80156-9; Ewing AD, 2010, GENOME RES, V20, P1262, DOI 10.1101/gr.106419.110; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; VERSALOVIC J, 1991, NUCLEIC ACIDS RES, V19, P6823, DOI 10.1093/nar/19.24.6823; Zhang F, 2009, TRENDS GENET, V25, P298, DOI 10.1016/j.tig.2009.05.005	7	33	33	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1110	1112		10.1016/j.cell.2010.06.014	http://dx.doi.org/10.1016/j.cell.2010.06.014			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602993	Bronze			2022-12-28	WOS:000279148100007
J	Hedges, MP; Longdell, JJ; Li, YM; Sellars, MJ				Hedges, Morgan P.; Longdell, Jevon J.; Li, Yongmin; Sellars, Matthew J.			Efficient quantum memory for light	NATURE			English	Article							FIELDS	Storing and retrieving a quantum state of light on demand, without corrupting the information it carries, is an important challenge in the field of quantum information processing. Classical measurement and reconstruction strategies for storing light must necessarily destroy quantum information as a consequence of the Heisenberg uncertainty principle. There has been significant effort directed towards the development of devices so-called quantum memories-capable of avoiding this penalty. So far, successful demonstrations(1-6) of non-classical storage and on-demand recall have used atomic vapours and have been limited to low efficiencies, of less than 17 per cent, using weak quantum states with an average photon number of around one. Here we report a low-noise, highly efficient (up to 69 per cent) quantum memory for light that uses a solid-state medium. The device allows the storage and recall of light more faithfully than is possible using a classical memory, for weak coherent states at the single-photon level through to bright states of up to 500 photons. For input coherent states containing on average 30 photons or fewer, the performance exceeded the no-cloning limit. This guaranteed that more information about the inputs was retrieved from the memory than was left behind or destroyed, a feature that will provide security in communications applications.	[Hedges, Morgan P.; Sellars, Matthew J.] Australian Natl Univ, Res Sch Phys & Engn, Laser Phys Ctr, Canberra, ACT 0200, Australia; [Longdell, Jevon J.] Univ Otago, Dept Phys, Jack Dodd Ctr, Dunedin 9016, New Zealand; [Li, Yongmin] Shanxi Univ, State Key Lab Quantum Opt & Quantum Opt Devices, Inst Optoelect, Taiyuan 030006, Peoples R China	Australian National University; University of Otago; Shanxi University; State Key Laboratory of Quantum Optics & Quantum Optics Devices	Hedges, MP (corresponding author), Australian Natl Univ, Res Sch Phys & Engn, Laser Phys Ctr, GPO Box 4, Canberra, ACT 0200, Australia.	mph111@physics.anu.edu.au	Sellars, Matthew/J-3130-2014	Sellars, Matthew/0000-0002-0502-0444	Australian Research Council; New Zealand Foundation for Research Science and Technology	Australian Research Council(Australian Research Council); New Zealand Foundation for Research Science and Technology(New Zealand Foundation for Research, Science and Technology)	The authors gratefully acknowledge S. Beavan, R. Ahlefeldt and J. Bartholomew for proofreading the manuscript. M.J.S. was supported by the Australian Research Council. J.J.L. was supported by a New Economy Research Fund grant from the New Zealand Foundation for Research Science and Technology	Afzelius M, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052329; Ahlefeldt RL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.205106; Alexander A L, 2007, THESIS AUSTR NATL U; Alexander AL, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043602; Appel J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093602; Bottger T, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.115104; Chaneliere T, 2005, NATURE, V438, P833, DOI 10.1038/nature04315; Choi KS, 2008, NATURE, V452, P67, DOI 10.1038/nature06670; de Riedmatten H, 2008, NATURE, V456, P773, DOI 10.1038/nature07607; Eisaman MD, 2005, NATURE, V438, P837, DOI 10.1038/nature04327; Grosshans F, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.010301; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Hetet G, 2008, OPT LETT, V33, P2323, DOI 10.1364/OL.33.002323; Hetet G, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.023601; Honda K, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.093601; Hosseini M, 2009, NATURE, V461, P241, DOI 10.1038/nature08325; Julsgaard B, 2004, NATURE, V432, P482, DOI 10.1038/nature03064; Kraus B, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.020302; Lauritzen B, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.080502; Lobino M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.203601; LONGDELL J, 2008, PHYS REV A, V78, P1; Longdell JJ, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195101; Longdell JJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.063601; Novikova I, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.021802; Nunn J, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.011401; Sangouard N., 2009, QUANTUM REPEATERS BA; Sun Y, 2002, J LUMIN, V98, P281, DOI 10.1016/S0022-2313(02)00281-8; Tittel W, 2010, LASER PHOTONICS REV, V4, P244, DOI 10.1002/lpor.200810056; Varnava M, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.120501; WALLS D, 1994, QUANTUM OPT, P20	31	420	425	6	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1052	1056		10.1038/nature09081	http://dx.doi.org/10.1038/nature09081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577210				2022-12-28	WOS:000279056900047
J	Horton, R				Horton, Richard			The continuing invisibility of women and children	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							Bhutta ZA, 2010, LANCET, V375, P2032, DOI 10.1016/S0140-6736(10)60678-2; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Commission on the Social Determinants of Health, 2008, CLOS GAP GEN HLTH EQ; EinarsduEttir Jonina., 2004, TIRED WEEPING MOTHER; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Lim SS, 2010, LANCET, V375, P2009, DOI 10.1016/S0140-6736(10)60744-1; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Ronsmans C, 2010, LANCET, V375, P2024, DOI 10.1016/S0140-6736(10)60704-0; Shiffman J, 2010, LANCET, V375, P2045, DOI 10.1016/S0140-6736(10)60710-6; Smillie I., 2009, FREEDOM WANT REMARKA; Tripathy P, 2010, LANCET, V375, P1182, DOI 10.1016/S0140-6736(09)62042-0; WINTOUR P, 2007, GUARDIAN LONDON 1211, pP14	13	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1941	1943		10.1016/S0140-6736(10)60902-6	http://dx.doi.org/10.1016/S0140-6736(10)60902-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569823				2022-12-28	WOS:000278689600004
J	Mbanya, JCN; Motala, AA; Sobngwi, E; Assah, FK; Enoru, ST				Mbanya, Jean Claude N.; Motala, Ayesha A.; Sobngwi, Eugene; Assah, Felix K.; Enoru, Sostanie T.			Diabetes in sub-Saharan Africa	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; NEAR-NORMOGLYCEMIC REMISSION; ACTIVITY ENERGY-EXPENDITURE; BLACK-AND-WHITE; RISK-FACTORS; PHYSICAL-ACTIVITY; HIGH PREVALENCE; WEST AFRICANS; SOUTH-AFRICA; CARIBBEAN MIGRANTS	In Sub-Saharan Africa, prevalence and burden of type 2 diabetes are rising quickly. Rapid uncontrolled urbanisation and major changes in lifestyle could be driving this epidemic. The increase presents a substantial public health and socioeconomic burden in the face of scarce resources. Some types of diabetes arise at younger ages in African than in European populations. Ketosis-prone atypical diabetes is mostly recorded in people of African origin, but its epidemiology is not understood fully because data for pathogenesis and subtypes of diabetes in sub-Saharan African communities are scarce. The rate of undiagnosed diabetes is high in most countries of sub-Saharan Africa, and individuals who are unaware they have the disorder are at very high risk of chronic complications. Therefore, the rate of diabetes-related morbidity and mortality in this region could grow substantially. A multisectoral approach to diabetes control and care is vital for expansion of socioculturally appropriate diabetes programmes in sub-Saharan African countries.	[Mbanya, Jean Claude N.; Sobngwi, Eugene] Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon; [Motala, Ayesha A.] Univ KwaZulu Natal, Nelson R Mandela Sch Med, Dept Endocrinol & Diabet, Durban, South Africa; [Sobngwi, Eugene] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Assah, Felix K.] Addenbrookes Hosp, MRC, Epidemiol Unit, Inst Metab Sci, Cambridge, England; [Enoru, Sostanie T.] Hop Cent, Natl Obes Ctr, Yaounde, Cameroon	University of Yaounde I; University of Kwazulu Natal; Newcastle University - UK; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Mbanya, JCN (corresponding author), Univ Yaounde I, Fac Med & Biomed Sci, Dept Internal Med & Specialties, Yaounde, Cameroon.	jcmbanya@yahoo.co.uk	Mbanya, Jean Claude N/T-5147-2018	Mbanya, Jean Claude N/0000-0001-9651-8653; Motala, Ayesha/0000-0003-0517-1784				AFOKE AO, 1992, DIABETES CARE, V15, P1310, DOI 10.2337/diacare.15.10.1310; Agyemang C, 2009, PUBLIC HEALTH NUTR, V12, P909, DOI 10.1017/S1368980008003510; AHREN B, 1984, DIABETOLOGIA, V26, P333, DOI 10.1007/BF00266032; ALBERTI KGM, 1997, DIABETES AFRICA; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Amoah AGB, 2003, PUBLIC HEALTH NUTR, V6, P751, DOI 10.1079/PHN2003506; Amoah AGB, 2002, DIABETES RES CLIN PR, V56, P197, DOI 10.1016/S0168-8227(01)00374-6; Amos A F, 1997, Diabet Med, V14 Suppl 5, pS1; Aspray TJ, 2000, T ROY SOC TROP MED H, V94, P637, DOI 10.1016/S0035-9203(00)90216-5; Assah FK, 2009, DIABETES CARE, V32, P367, DOI 10.2337/dc08-1538; ASSAH FK, 2009, THESIS U CAMBRIDGE C; Awah PK, 2008, HEALTH EDUC RES, V23, P612, DOI 10.1093/her/cym037; Balasubramanyam A, 2008, ENDOCR REV, V29, P292, DOI 10.1210/er.2007-0026; Balde NM, 2007, DIABETES METAB, V33, P114, DOI 10.1016/j.diabet.2006.10.001; Banerji MA, 1996, DIABETES, V45, P337, DOI 10.2337/diabetes.45.3.337; Beran D, 2006, LANCET, V368, P1689, DOI 10.1016/S0140-6736(06)69704-3; Bourne LT, 2002, PUBLIC HEALTH NUTR, V5, P157, DOI 10.1079/PHN2001288; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Chen Guanjie, 2007, Diabetes Res Clin Pract, V78, pe1, DOI 10.1016/j.diabres.2007.04.010; Chen YX, 2005, ANN EPIDEMIOL, V15, P153, DOI 10.1016/j.annepidem.2004.05.014; Chiou CC, 2006, J AM ACAD DERMATOL, V54, pS14, DOI 10.1016/j.jaad.2005.03.057; Choukem SP, 2008, DIABETES CARE, V31, P2332, DOI 10.2337/dc08-0914; Christensen DL, 2009, DIABETES RES CLIN PR, V84, P303, DOI 10.1016/j.diabres.2009.03.007; CHRISTENSEN DL, 2008, THESIS U COPENHAGEN; COLE AH, 1987, BRIT J NUTR, V58, P357, DOI 10.1079/BJN19870105; Cooper RS, 1997, DIABETES CARE, V20, P343, DOI 10.2337/diacare.20.3.343; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; DOWSE GK, 1991, DIABETES CARE, V14, P968, DOI 10.2337/diacare.14.11.968; Ducorps M, 1996, DIABETES CARE, V19, P761, DOI 10.2337/diacare.19.7.761; Dugas LR, 2009, EUR J CLIN NUTR, V63, P667, DOI 10.1038/ejcn.2008.8; ELAMIN A, 1992, DIABETES CARE, V15, P1556, DOI 10.2337/diacare.15.11.1556; ELAMIN A, 1989, DIABETES CARE, V12, P430, DOI 10.2337/diacare.12.6.430; Elbagir MN, 1998, DIABETIC MED, V15, P164, DOI 10.1002/(SICI)1096-9136(199802)15:2<164::AID-DIA536>3.0.CO;2-A; Elbagir MN, 1996, DIABETES CARE, V19, P1126, DOI 10.2337/diacare.19.10.1126; Elrayah H, 2005, DIABETES RES CLIN PR, V70, P159, DOI 10.1016/j.diabres.2005.03.034; ERASMUS RT, 1989, T ROY SOC TROP MED H, V83, P417, DOI 10.1016/0035-9203(89)90524-5; Expert Committee, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; FISCH A, 1987, DIABETOLOGIA, V30, P859; Gavin JR, 1997, DIABETES CARE, V20, P1183; Gill GV, 2008, DIABETIC MED, V25, P606, DOI 10.1111/j.1464-5491.2008.02421.x; Gill G, 2009, DIABETOLOGIA, V52, P8, DOI 10.1007/s00125-008-1167-9; HARRIS M, 1979, DIABETES, V28, P1039; Heini AF, 1996, EUR J CLIN NUTR, V50, P284; Helgason A, 2007, NAT GENET, V39, P218, DOI 10.1038/ng1960; HUSSASHMORE R, 1989, EUR J CLIN NUTR, V43, P737; *IDF, 2006, DIAB ATL; IDF, 2009, DIAB ATL; JOFFE BI, 1992, LANCET, V340, P460, DOI 10.1016/0140-6736(92)91777-6; Justin-Temu M, 2009, East Afr Med J, V86, P110; KALK WJ, 1993, POSTGRAD MED J, V69, P552, DOI 10.1136/pgmj.69.813.552; Kengne AP, 2009, PRIM CARE DIABETES, V3, P181, DOI 10.1016/j.pcd.2009.08.005; Kengne AP, 2005, CIRCULATION, V112, P3592, DOI 10.1161/CIRCULATIONAHA.105.544312; Kiawi E, 2006, ETHNIC DIS, V16, P503; KING H, 1993, DIABETES CARE, V16, P157, DOI 10.2337/diacare.16.1.157; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kirigia JM, 2009, BMC INT HEALTH HUM R, V9, DOI 10.1186/1472-698X-9-6; Kolbe-Alexander TL, 2006, J AGING PHYS ACTIV, V14, P98, DOI 10.1123/japa.14.1.98; LESTER FT, 1984, DIABETES CARE, V7, P6, DOI 10.2337/diacare.7.1.6; Levitt NS, 2008, HEART, V94, P1376, DOI 10.1136/hrt.2008.147306; LEVITT NS, 1993, DIABETES CARE, V16, P601, DOI 10.2337/diacare.16.4.601; Levitt NS, 2006, DIABETIC MED, V23, P103, DOI 10.1111/j.1464-5491.2006.01768.x; Levitt NS, 1999, DIABETIC MED, V16, P946, DOI 10.1046/j.1464-5491.1999.00185.x; Levitt NS, 2000, DIABETIC MED, V17, P381, DOI 10.1046/j.1464-5491.2000.00264.x; Luke A, 2009, AM J CLIN NUTR, V89, P169, DOI 10.3945/ajcn.2008.26630; LUTALE J, 2007, J AUTOIMMUNE DIS, V27, P4; Mauvais-Jarvis F, 2004, DIABETES, V53, P645, DOI 10.2337/diabetes.53.3.645; Mayosi BM, 2009, LANCET, V374, P934, DOI 10.1016/S0140-6736(09)61087-4; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P191, DOI 10.1097/00043798-200306000-00006; Mbanya JC, 2003, J CARDIOVASC RISK, V10, P97, DOI [10.1097/00043798-200304000-00004, 10.1097/01.hjr.0000060842.48106.78]; Mbanya JC, 2001, EUR J IMMUNOGENET, V28, P459, DOI 10.1046/j.0960-7420.2001.00247.x; Mbanya JCN, 1997, DIABETOLOGIA, V40, P824, DOI 10.1007/s001250050755; Mbanya JCN, 1999, DIABETES CARE, V22, P434, DOI 10.2337/diacare.22.3.434; Mbanya JCN, 2000, DIABETES CARE, V23, P1761, DOI 10.2337/diacare.23.12.1761; McFarlane SI, 2001, DIABETIC MED, V18, P10, DOI 10.1046/j.1464-5491.2001.00395.x; MCLARTY DG, 1990, DIABETIC MED, V7, P670, DOI 10.1111/j.1464-5491.1990.tb01470.x; MCLARTY DG, 1989, LANCET, V1, P871; MCLARTY DG, 1990, DIABETES RES CLIN PR, V9, P219, DOI 10.1016/0168-8227(90)90048-X; Mennen LI, 2001, PUBLIC HEALTH NUTR, V4, P765, DOI 10.1079/PHN2000117; MOLLENTZE WF, 1995, S AFR MED J, V85, P90; Motala AA, 2008, EPIDEMIOLOGY DIABETE, P133; Motala AA, 2008, DIABETES CARE, V31, P1783, DOI 10.2337/dc08-0212; Neilson HK, 2008, AM J CLIN NUTR, V87, P279, DOI 10.1093/ajcn/87.2.279; Ntandou G, 2009, NUTR RES, V29, P180, DOI 10.1016/j.nutres.2009.02.001; OHWOVORIOLE AE, 1988, DIABETES RES CLIN PR, V4, P153, DOI 10.1016/S0168-8227(88)80010-X; Olatunbosun ST, 1998, J NATL MED ASSOC, V90, P293; Oli JM, 2009, METAB SYNDR RELAT D, V7, P595, DOI 10.1089/met.2009.0002; OLI JM, 1980, LANCET, V1, P1090; OMAR MAK, 1993, S AFR MED J, V83, P641; OMAR MAK, 1986, HORM METAB RES, V18, P126, DOI 10.1055/s-2007-1012247; OMAR MAK, 1984, TROP GEOGR MED, V36, P133; OMAR MAK, 1994, DIABETES CARE, V17, P70, DOI 10.2337/diacare.17.1.70; OMRAN AR, 1971, MILBANK MEML FUND Q, V49, P509, DOI 10.2307/3349375; Osei K, 2003, J CARDIOVASC RISK, V10, P85, DOI 10.1097/00043798-200304000-00003; Osei-Hyiaman D, 2001, DIABETES, V50, P2169, DOI 10.2337/diabetes.50.9.2169; Panz VR, 2000, DIABETIC MED, V17, P524, DOI 10.1046/j.1464-5491.2000.00324.x; Pirie FJ, 2005, TISSUE ANTIGENS, V66, P125, DOI 10.1111/j.1399-0039.2005.00454.x; Popkin BM, 2004, INT J OBESITY, V28, pS2, DOI [10.1038/sj.ijo.0802804, 10.1038/sj.ijo.0802557]; RAMAIYA KL, 1991, DIABETIC MED, V8, P738, DOI 10.1111/j.1464-5491.1991.tb01693.x; Renzaho AMN, 2004, HEALTH PLACE, V10, P105, DOI 10.1016/S1353-8292(03)00051-0; Rotimi CN, 2004, DIABETES, V53, P838, DOI 10.2337/diabetes.53.3.838; Schuster DP, 1998, AM J MED SCI, V316, P361, DOI 10.1097/00000441-199812000-00002; SINGH J, 1989, BRIT J NUTR, V62, P315, DOI 10.1079/BJN19890033; Sobngwi E, 2004, INT J EPIDEMIOL, V33, P769, DOI 10.1093/ije/dyh044; Sobngwi E, 2005, J CLIN ENDOCR METAB, V90, P4446, DOI 10.1210/jc.2004-2545; Sobngwi E, 2009, DIABETES METAB, V35, P404, DOI 10.1016/j.diabet.2009.04.006; Sobngwi E, 2002, DIABETES METAB, V28, P5; Sobngwi E, 2008, JAMA-J AM MED ASSOC, V299, P2770, DOI 10.1001/jama.299.23.2770; Sobngwi E, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-31; Sumner AE, 1999, DIABETES CARE, V22, P71, DOI 10.2337/diacare.22.1.71; SWAI ABM, 1990, DIABETES RES CLIN PR, V8, P227, DOI 10.1016/0168-8227(90)90121-9; SWAI ABM, 1990, BMJ-BRIT MED J, V300, P1103, DOI 10.1136/bmj.300.6732.1103; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; TEUSCHER T, 1987, LANCET, V1, P765; Tong Y, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-15; Umpierrez GE, 2006, ANN INTERN MED, V144, P350, DOI 10.7326/0003-4819-144-5-200603070-00011; *UN OHRLLS, LEAST DEV COUNTR COU; *UN POP FUND, STAT WORLD POP 2007; United Nations. Department of Economic and Social Affairs, 2008, WORLD URB PROSP 2007, DOI 10.1007/BF03343625; Unwin N, 2006, J HUM HYPERTENS, V20, P704, DOI 10.1038/sj.jhh.1002056; Vorster HH, 2005, PUBLIC HEALTH NUTR, V8, P480, DOI 10.1079/PHN2005784; Wareham NJ, 1998, INT J OBESITY, V22, pS30; Whiting DR, 2003, J CARDIOVASC RISK, V10, P103, DOI 10.1097/00043798-200304000-00005; *WHO, 2004, STEPW APPR CHRON DIS; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; World Bank, KEY DEV DAT STAT; World Health Organization, STEPS COUNTR REP; World Health Organization, 1985, WHO TECHN REP SER, V727; World Health Organization, 1980, WHO TECHN REP SER, V646; Young F, 2009, GLOBALIZATION HEALTH, V5, DOI 10.1186/1744-8603-5-9; Ziraba AK, 2009, BMC HEALTH SERV RES, V9, DOI [10.1186/1471-2458-9-465, 10.1186/1472-6963-9-46]	130	417	429	0	35	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2254	2266		10.1016/S0140-6736(10)60550-8	http://dx.doi.org/10.1016/S0140-6736(10)60550-8			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609971				2022-12-28	WOS:000279652900022
J	Neumann, P; Beck, J; Steiner, M; Rempp, F; Fedder, H; Hemmer, PR; Wrachtrup, J; Jelezko, F				Neumann, Philipp; Beck, Johannes; Steiner, Matthias; Rempp, Florian; Fedder, Helmut; Hemmer, Philip R.; Wrachtrup, Joerg; Jelezko, Fedor			Single-Shot Readout of a Single Nuclear Spin	SCIENCE			English	Article							ELECTRONIC SPIN; DIAMOND; DYNAMICS; QUBITS	Projective measurement of single electron and nuclear spins has evolved from a gedanken experiment to a problem relevant for applications in atomic-scale technologies like quantum computing. Although several approaches allow for detection of a spin of single atoms and molecules, multiple repetitions of the experiment that are usually required for achieving a detectable signal obscure the intrinsic quantum nature of the spin's behavior. We demonstrated single-shot, projective measurement of a single nuclear spin in diamond using a quantum nondemolition measurement scheme, which allows real-time observation of an individual nuclear spin's state in a room-temperature solid. Such an ideal measurement is crucial for realization of, for example, quantum error correction protocols in a quantum register.	[Neumann, Philipp; Beck, Johannes; Steiner, Matthias; Rempp, Florian; Fedder, Helmut; Wrachtrup, Joerg; Jelezko, Fedor] Univ Stuttgart, Inst Phys 3, D-70550 Stuttgart, Germany; [Neumann, Philipp; Beck, Johannes; Steiner, Matthias; Rempp, Florian; Fedder, Helmut; Wrachtrup, Joerg; Jelezko, Fedor] Univ Stuttgart, Res Ctr SCoPE, D-70550 Stuttgart, Germany; [Hemmer, Philip R.] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX 77843 USA	University of Stuttgart; University of Stuttgart; Texas A&M University System; Texas A&M University College Station	Wrachtrup, J (corresponding author), Univ Stuttgart, Inst Phys 3, Pfaffenwaldring 57, D-70550 Stuttgart, Germany.	wrachtrup@physik.uni-stuttgart.de; f.jelezko@physik.uni-stuttgart.de	Steiner, Matthias/J-2683-2014	Steiner, Matthias/0000-0002-9298-0581; Beck, Johannes/0000-0002-6692-6688; Neumann, Philipp/0000-0003-2146-0412	European Union; Deutsche Forschungsgemeinschaft [SFB/TR21, FOR1482]; Bundesministerium fur Bildung und Forschung; Landesstiftung BW	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Landesstiftung BW	We thank F. Dolde for fabrication of microwave structures; N. Zarrabi for assistance with data analysis; J. Mayer and P. Bertet for helpful information on QND measurements in superconducting qubits; and M. D. Lukin, J. Twamley, F. Y. Khalili, and J. O'Brien for comments and discussions. We thank G. Denninger for the loan of a X-band microwave synthesizer. This work was supported by the European Union, Deutsche Forschungsgemeinschaft (SFB/TR21 and FOR1482), Bundesministerium fur Bildung und Forschung, and Landesstiftung BW.	Babinec TM, 2010, NAT NANOTECHNOL, V5, P195, DOI [10.1038/NNANO.2010.6, 10.1038/nnano.2010.6]; Balasubramanian G, 2008, NATURE, V455, P648, DOI 10.1038/nature07278; Batalov A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.077401; Braginsky VB, 1996, REV MOD PHYS, V68, P1, DOI 10.1103/RevModPhys.68.1; CAVES CM, 1980, REV MOD PHYS, V52, P341, DOI 10.1103/RevModPhys.52.341; Childress L, 2006, SCIENCE, V314, P281, DOI 10.1126/science.1131871; Fuchs GD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117601; Gershenfeld NA, 1997, SCIENCE, V275, P350, DOI 10.1126/science.275.5298.350; Gorshkov AV, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.110503; Dutt MVG, 2007, SCIENCE, V316, P1312, DOI 10.1126/science.1139831; IMOTO N, 1985, PHYS REV A, V32, P2287, DOI 10.1103/PhysRevA.32.2287; Jacques V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057403; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Jiang L, 2009, SCIENCE, V326, P267, DOI 10.1126/science.1176496; Jiang L, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.062323; Knill E, 2005, NATURE, V434, P39, DOI 10.1038/nature03350; Ladd TD, 2010, NATURE, V464, P45, DOI 10.1038/nature08812; Maze JR, 2008, NATURE, V455, P644, DOI 10.1038/nature07279; Neumann P, 2008, SCIENCE, V320, P1326, DOI 10.1126/science.1157233; Ralph TC, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.012113; Reichenbach I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.123001; Steiner M, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.035205; Warren WS, 1997, SCIENCE, V277, P1688, DOI 10.1126/science.277.5332.1688	25	433	444	3	125	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 30	2010	329	5991					542	544		10.1126/science.1189075	http://dx.doi.org/10.1126/science.1189075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20595582				2022-12-28	WOS:000280483500029
J	Ohiorhenuan, IE; Mechler, F; Purpura, KP; Schmid, AM; Hu, Q; Victor, JD				Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.			Sparse coding and high-order correlations in fine-scale cortical networks	NATURE			English	Article							PRIMARY VISUAL-CORTEX; NEURONS; CONNECTIVITY; INFORMATION; POPULATION; RESPONSES; RETINA	Connectivity in the cortex is organized at multiple scales(1-5), suggesting that scale-dependent correlated activity is particularly important for understanding the behaviour of sensory cortices and their function in stimulus encoding. We analysed the scale-dependent structure of cortical interactions by using maximum entropy models(6-9) to characterize multiple-tetrode recordings from primary visual cortex of anaesthetized macaque monkeys (Macaca mulatta). We compared the properties of firing patterns among local clusters of neurons (<300 mm apart) with those of neurons separated by larger distances (600-2,500 mu m). Here we report that local firing patterns are distinctive: whereas multi-neuronal firing patterns at larger distances can be predicted by pairwise interactions, patterns within local clusters often show evidence of high-order correlations. Surprisingly, these local correlations are flexible and rapidly reorganized by visual input. Although they modestly reduce the amount of information that a cluster conveys, they also modify the format of this information, creating sparser codes by increasing the periods of total quiescence, and concentrating information into briefer periods of common activity. These results imply a hierarchical organization of neuronal correlations: simple pairwise correlations link neurons over scales of tens to hundreds of minicolumns, but on the scale of a few minicolumns, ensembles of neurons form complex subnetworks whose moment-to-moment effective connectivity is dynamically reorganized by the stimulus.	[Ohiorhenuan, Ifije E.; Mechler, Ferenc; Purpura, Keith P.; Schmid, Anita M.; Hu, Qin; Victor, Jonathan D.] Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA	Cornell University	Ohiorhenuan, IE (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, New York, NY 10065 USA.	ifo2001@med.cornell.edu	Victor, Jonathan D./D-2931-2009	Victor, Jonathan D./0000-0002-9293-0111	National Institutes of Health [EY19454, GM07739, EY09314]; NATIONAL EYE INSTITUTE [F31EY019454, R01EY009314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Nirenberg for comments on a draft of the manuscript. This work was supported by National Institutes of Health grants EY19454 and GM07739 (to I.E.O.) and EY09314 (to J.D.V.).	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Buzsaki G, 2004, NAT NEUROSCI, V7, P446, DOI 10.1038/nn1233; Cover TM, 1991, ELEMENTS INFORM THEO; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; Fee MS, 1996, J NEUROSCI METH, V69, P175, DOI 10.1016/S0165-0270(96)00050-7; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Henze DA, 2000, J NEUROPHYSIOL, V84, P390, DOI 10.1152/jn.2000.84.1.390; HUBEL DH, 1974, J COMP NEUROL, V158, P267, DOI 10.1002/cne.901580304; Kennel MB, 2005, NEURAL COMPUT, V17, P1531, DOI 10.1162/0899766053723050; Meister M, 1996, P NATL ACAD SCI USA, V93, P609, DOI 10.1073/pnas.93.2.609; Mountcastle VB, 1997, BRAIN, V120, P701, DOI 10.1093/brain/120.4.701; MOUNTCASTLE VB, 1957, J NEUROPHYSIOL, V20, P408, DOI 10.1152/jn.1957.20.4.408; Nirenberg S, 2001, NATURE, V411, P698, DOI 10.1038/35079612; Puchalla JL, 2005, NEURON, V46, P493, DOI 10.1016/j.neuron.2005.03.026; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Reid RC, 1997, VISUAL NEUROSCI, V14, P1015, DOI 10.1017/S0952523800011743; Samonds JM, 2006, J NEUROPHYSIOL, V95, P2602, DOI 10.1152/jn.01070.2005; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; STEVENS CF, 1995, NEURON, V14, P795, DOI 10.1016/0896-6273(95)90223-6; Tang A, 2008, J NEUROSCI, V28, P505, DOI 10.1523/JNEUROSCI.3359-07.2008; Thomson MGA, 2001, NETWORK-COMP NEURAL, V12, P271, DOI 10.1088/0954-898X/12/3/303; Victor JD, 2006, J NEUROPHYSIOL, V95, P379, DOI 10.1152/jn.00498.2005; Yoshimura Y, 2005, NATURE, V433, P868, DOI 10.1038/nature03252; Yoshimura Y, 2005, NAT NEUROSCI, V8, P1552, DOI 10.1038/nn1565; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	30	220	221	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					617	U4		10.1038/nature09178	http://dx.doi.org/10.1038/nature09178			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20601940	Green Accepted			2022-12-28	WOS:000280412100052
J	Hughes, V				Hughes, Virginia			The outlook for a cure	NATURE			English	Editorial Material							COMBINATION THERAPY; HIV-1 INFECTION											Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Richman DD, 2009, SCIENCE, V323, P1304, DOI 10.1126/science.1165706; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939	5	5	5	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S11	S13		10.1038/nature09240	http://dx.doi.org/10.1038/nature09240			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631696				2022-12-28	WOS:000279867100029
J	Maxmen, A				Maxmen, Amy			Grassroots initiatives	NATURE			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S20	S20		10.1038/nature09244	http://dx.doi.org/10.1038/nature09244			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631701	Bronze			2022-12-28	WOS:000279867100033
J	Marusic, I; Mathis, R; Hutchins, N				Marusic, I.; Mathis, R.; Hutchins, N.			Predictive Model for Wall-Bounded Turbulent Flow	SCIENCE			English	Article							LARGE-EDDY SIMULATION; LAYER; FEATURES; REGION; PIPE	The behavior of turbulent fluid motion, particularly in the thin chaotic fluid layers immediately adjacent to solid boundaries, can be difficult to understand or predict. These layers account for up to 50% of the aerodynamic drag on modern airliners and occupy the first 100 meters or so of the atmosphere, thus governing wider meteorological phenomena. The physics of these layers is such that the most important processes occur very close to the solid boundary-the region where accurate measurements and simulations are most challenging. We propose a mathematical model to predict the near-wall turbulence given only large-scale information from the outer boundary layer region. This predictive capability may enable new strategies for the control of turbulence and may provide a basis for improved engineering and weather prediction simulations.	[Marusic, I.; Mathis, R.; Hutchins, N.] Univ Melbourne, Dept Mech Engn, Melbourne, Vic 3010, Australia	University of Melbourne	Marusic, I (corresponding author), Univ Melbourne, Dept Mech Engn, Melbourne, Vic 3010, Australia.	imarusic@unimelb.edu.au	Marusic, Ivan/N-8456-2019; Marusic, Ivan/M-1903-2015	Marusic, Ivan/0000-0003-2700-8435; Marusic, Ivan/0000-0003-2700-8435; HUTCHINS, NICHOLAS/0000-0003-1599-002X; Mathis, Romain/0000-0001-7066-9023	Australian Research Council [FF0668703, DP0984577, DP1092585]	Australian Research Council(Australian Research Council)	Supported by Australian Research Council grants FF0668703, DP0984577, and DP1092585.	Adrian RJ, 2007, PHYS FLUIDS, V19, DOI 10.1063/1.2717527; *AUSTR RES COUNC, FF0668703 AUSTR RES; BROWN GL, 1977, PHYS FLUIDS, V20, pS243, DOI 10.1063/1.861737; Chung D, 2009, J FLUID MECH, V631, P281, DOI 10.1017/S0022112009006867; DeGraaff DB, 2000, J FLUID MECH, V422, P319, DOI 10.1017/S0022112000001713; Hof B, 2010, SCIENCE, V327, P1491, DOI 10.1126/science.1186091; Hoyas S, 2006, PHYS FLUIDS, V18, DOI 10.1063/1.2162185; Hutchins N, 2007, J FLUID MECH, V579, P1, DOI 10.1017/S0022112006003946; Hutchins N, 2009, J FLUID MECH, V635, P103, DOI 10.1017/S0022112009007721; Hutchins N, 2007, PHILOS T R SOC A, V365, P647, DOI 10.1098/rsta.2006.1942; Kim KC, 1999, PHYS FLUIDS, V11, P417, DOI 10.1063/1.869889; Kunkel GJ, 2006, J FLUID MECH, V548, P375, DOI 10.1017/S0022112005007780; Marusic I, 2003, PHYS FLUIDS, V15, P2461, DOI 10.1063/1.1589014; Marusic I, 2001, J FLUID MECH, V446, P309, DOI 10.1017/S0022112001005924; Marusic I, 2008, FLOW TURBUL COMBUST, V81, P115, DOI 10.1007/s10494-007-9116-0; Marusic I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.114504; Mathis R, 2009, J FLUID MECH, V628, P311, DOI 10.1017/S0022112009006946; Meneveau C, 2000, ANNU REV FLUID MECH, V32, P1, DOI 10.1146/annurev.fluid.32.1.1; Metzger MM, 2001, PHYS FLUIDS, V13, P692, DOI 10.1063/1.1344894; Moin P, 1998, ANNU REV FLUID MECH, V30, P539, DOI 10.1146/annurev.fluid.30.1.539; Monty JP, 2007, J FLUID MECH, V589, P147, DOI [10.1017/S0022II200700777X, 10.1017/S002211200700777X]; Nickels TB, 2007, PHILOS T R SOC A, V365, P807, DOI 10.1098/rsta.2006.1950; Nickels TB, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.074501; Piomelli U, 2002, ANNU REV FLUID MECH, V34, P349, DOI 10.1146/annurev.fluid.34.082901.144919; Piomelli U, 1999, PROG AEROSP SCI, V35, P335, DOI 10.1016/S0376-0421(98)00014-1; Pope S. B, 2001, TURBULENT FLOWS; Townsend A.A, 1976, STRUCTURE TURBULENT, P64; Zagarola MV, 1998, J FLUID MECH, V373, P33, DOI 10.1017/S0022112098002419	28	301	312	2	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					193	196		10.1126/science.1188765	http://dx.doi.org/10.1126/science.1188765			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616273				2022-12-28	WOS:000279635200042
J	Eisenberg, MS; Psaty, BM				Eisenberg, Mickey S.; Psaty, Bruce M.			Cardiopulmonary Resuscitation Celebration and Challenges	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITAL CARDIAC-ARREST; DEFIBRILLATION; EXPERIENCE		[Eisenberg, Mickey S.; Psaty, Bruce M.] Univ Washington, Dept Med, Seattle, WA USA; [Psaty, Bruce M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Psaty, Bruce M.] Univ Washington, Dept Hlth Serv, Seattle, WA 98195 USA; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative	Psaty, BM (corresponding author), Cardiovasc Hlth Res Unit, 1730 Minor Ave,Ste 1360, Seattle, WA 98101 USA.	psaty@u.washington.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295, R01HL078888, R01HL080295, R01HL085251, R01HL087652] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL085251, HL078888, HL080295, HL087652] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; CULLEY LL, 1991, ANN EMERG MED, V20, P362, DOI 10.1016/S0196-0644(05)81655-5; KOUWENHOVEN WB, 1960, JAMA-J AM MED ASSOC, V173, P1064, DOI 10.1001/jama.1960.03020280004002; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Rea TD, 2010, RESUSCITATION, V81, P163, DOI 10.1016/j.resuscitation.2009.10.025; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Steen S, 2003, RESUSCITATION, V58, P249, DOI 10.1016/S0300-9572(03)00265-X; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; White RD, 2005, RESUSCITATION, V65, P279, DOI 10.1016/j.resuscitation.2004.10.018	10	9	9	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					87	88		10.1001/jama.2010.898	http://dx.doi.org/10.1001/jama.2010.898			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606154				2022-12-28	WOS:000279519600026
J	Mulherin, TC				Mulherin, Timothy C.			Personal View Don't forget the family	BRITISH MEDICAL JOURNAL			English	Editorial Material									Deakin Univ, Melbourne, Vic, Australia	Deakin University	Mulherin, TC (corresponding author), Deakin Univ, Melbourne, Vic, Australia.	tmulherin1@hotmail.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3486	10.1136/bmj.c3486	http://dx.doi.org/10.1136/bmj.c3486			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610495				2022-12-28	WOS:000279874300007
J	Cho, MK; Relman, DA				Cho, Mildred K.; Relman, David A.			Synthetic "Life," Ethics, National Security, and Public Discourse	SCIENCE			English	Editorial Material							GENOME		[Cho, Mildred K.; Relman, David A.] Stanford Univ, Stanford, CA 94305 USA; [Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Cho, MK (corresponding author), Stanford Univ, Stanford, CA 94305 USA.	micho@stanford.edu		Relman, David A./0000-0001-8331-1354	NCRR NIH HHS [U54 RR024374-01A1] Funding Source: Medline; NHGRI NIH HHS [P50 HG003389] Funding Source: Medline; NIH HHS [DP1-OD000964] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG003389] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000964] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Amsellem Z, 2002, NAT BIOTECHNOL, V20, P1035, DOI 10.1038/nbt743; Balmer A., 2008, SYNTHETIC BIOL SOCIA; Boldt J, 2008, NAT BIOTECHNOL, V26, P387, DOI 10.1038/nbt0408-387; Carr PA, 2009, NAT BIOTECHNOL, V27, P1151, DOI 10.1038/nbt.1590; Casadevall A, 2010, NAT REV MICROBIOL, V8, P149, DOI 10.1038/nrmicro2299; Cho MK, 1999, SCIENCE, V286, P2087, DOI 10.1126/science.286.5447.2087; Editorial, 2010, NATURE, V464, P649; Gaisser Sibylle, 2009, Syst Synth Biol, V3, P109, DOI 10.1007/s11693-009-9027-6; Garfinkel M.S., 2007, SYNTHETIC GENOMICS O; Gibson DG, 2010, SCIENCE, V329, P52, DOI 10.1126/science.1190719; Lucas K. V., 2006, UNDERSTANDING ACTION; National Research Council, 2006, GLOB BIOS FUT LIF SC; National Science Advisory Board for Biosecurity (NSABB), 2008, STRAT PLAN OUTR ED D; National Science Advisory Board for Biosecurity (NSABB), 2006, ADDR BIOS CONC REL S; Obama B, 2010, COMMUNICATION   0520; PARENS E, 2009, SYNTHETIC BIOL PROJE, P3; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Relman DA, 2010, NAT IMMUNOL, V11, P275, DOI 10.1038/ni0410-275; RODEMEYER M, 2009, SYNTHETIC BIOL PROJE, P33; Schmidt Markus, 2009, Syst Synth Biol, V3, P3, DOI 10.1007/s11693-009-9034-7; US Department of Health and Human Services (DHHS), 2009, FED REGISTER, V74, P62319; Wade N, 2010, NY TIMES, pA1	22	16	17	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					38	39		10.1126/science.1193749	http://dx.doi.org/10.1126/science.1193749			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	619BL	20595601				2022-12-28	WOS:000279402700020
J	Langley, JA; Megonigal, JP				Langley, J. Adam; Megonigal, J. Patrick			Ecosystem response to elevated CO2 levels limited by nitrogen-induced plant species shift	NATURE			English	Article							SOIL NUTRIENT; CLIMATE; COMPETITION; LIMITATION; FEEDBACKS; DIVERSITY	Terrestrial ecosystems gain carbon through photosynthesis and lose it mostly in the form of carbon dioxide (CO2). The extent to which the biosphere can act as a buffer against rising atmospheric CO2 concentration in global climate change projections remains uncertain at the present stage(1-4). Biogeochemical theory predicts that soil nitrogen (N) scarcity may limit natural ecosystem response to elevated CO2 concentration, diminishing the CO2-fertilization effect on terrestrial plant productivity in unmanaged ecosystems(3-7). Recent models have incorporated such carbon-nitrogen interactions and suggest that anthropogenic N sources could help sustain the future CO2-fertilization effect(8,9). However, conclusive demonstration that added N enhances plant productivity in response to CO2-fertilization in natural ecosystems remains elusive. Here we manipulated atmospheric CO2 concentration and soil N availability in a herbaceous brackish wetland where plant community composition is dominated by a C-3 sedge and C-4 grasses, and is capable of responding rapidly to environmental change(10). We found that N addition enhanced the CO2-stimulation of plant productivity in the first year of a multi-year experiment, indicating N-limitation of the CO2 response. But we also found that N addition strongly promotes the encroachment of C-4 plant species that respond less strongly to elevated CO2 concentrations. Overall, we found that the observed shift in the plant community composition ultimately suppresses the CO2-stimulation of plant productivity by the third and fourth years. Although extensive research has shown that global change factors such as elevated CO2 concentrations and N pollution affect plant species differently(11-13), and that they may drive plant community changes(14-17), we demonstrate that plant community shifts can act as a feedback effect that alters the whole ecosystem response to elevated CO2 concentrations. Moreover, we suggest that trade-offs between the abilities of plant taxa to respond positively to different perturbations may constrain natural ecosystem response to global change.	[Langley, J. Adam; Megonigal, J. Patrick] Smithsonian Environm Res Ctr, Edgewater, MD 21037 USA; [Langley, J. Adam] Villanova Univ, Dept Biol, Villanova, PA 19084 USA	Smithsonian Institution; Smithsonian Environmental Research Center; Villanova University	Langley, JA (corresponding author), Smithsonian Environm Res Ctr, POB 28, Edgewater, MD 21037 USA.	langleya@si.edu		Megonigal, Patrick/0000-0002-2018-7883	USGS [06ERAG0011]; US Department of Energy [DE-FG02-97ER62458]; US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University; Smithsonian Institution; Direct For Biological Sciences [0950080] Funding Source: National Science Foundation	USGS(United States Geological Survey); US Department of Energy(United States Department of Energy (DOE)); US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University(United States Department of Energy (DOE)); Smithsonian Institution(Smithsonian Institution); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We acknowledge the support of D. Cahoon, our primary US Geological Survey collaborator, who co-developed the experimental design of this study. We thank J. Duls, J. Keller, M. Sigrist, G. Peresta, B. Drake, E. Sage, A. Martin, D. McKinley, N. Mudd and K. White for the construction and maintenance of the field site at the Smithsonian Climate Change Facility. We appreciate comments from S. Chapman, A. Classen, J. Hines, B. Hungate, T. Mozdzer, A. Sutton-Grier and D. Whigham. The field study was supported by the USGS Global Change Research Program (cooperative agreement 06ERAG0011), the US Department of Energy (grant DE-FG02-97ER62458), the US Department of Energy's Office of Science (BER) through the Coastal Center of the National Institute of Climate Change Research at Tulane University, and the Smithsonian Institution.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Chapman SK, 2006, NEW PHYTOL, V169, P27, DOI 10.1111/j.1469-8137.2005.01571.x; Craine JM, 2003, ECOL LETT, V6, P623, DOI 10.1046/j.1461-0248.2003.00467.x; Craine JM., 2009, RESOURCE STRATEGIES; de Graaff MA, 2006, GLOBAL CHANGE BIOL, V12, P2077, DOI 10.1111/j.1365-2486.2006.01240.x; Denman KL, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P499; Dukes JS, 2005, PLOS BIOL, V3, P1829, DOI 10.1371/journal.pbio.0030319; Erickson JE, 2007, GLOBAL CHANGE BIOL, V13, P202, DOI 10.1111/j.1365-2486.2006.01285.x; Hooper DU, 1997, SCIENCE, V277, P1302, DOI 10.1126/science.277.5330.1302; Hungate BA, 2003, SCIENCE, V302, P1512, DOI 10.1126/science.1091390; Jablonski LM, 2002, NEW PHYTOL, V156, P9, DOI 10.1046/j.1469-8137.2002.00494.x; Keller JK, 2009, BIOGEOCHEMISTRY, V96, P101, DOI 10.1007/s10533-009-9347-3; Langley JA, 2009, P NATL ACAD SCI USA, V106, P6182, DOI 10.1073/pnas.0807695106; Levine JM, 1998, J ECOL, V86, P285, DOI 10.1046/j.1365-2745.1998.00253.x; Luo Y, 2004, BIOSCIENCE, V54, P731, DOI 10.1641/0006-3568(2004)054[0731:PNLOER]2.0.CO;2; Luo YQ, 2007, ANNU REV ECOL EVOL S, V38, P683, DOI 10.1146/annurev.ecolsys.38.091206.095808; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Pennings SC, 2005, OIKOS, V110, P547, DOI 10.1111/j.0030-1299.2005.13792.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NEW PHYTOL, V150, P435, DOI 10.1046/j.1469-8137.2001.00114.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Reich PB, 2009, SCIENCE, V326, P1399, DOI 10.1126/science.1178820; REYNOLDS HL, 1993, AM NAT, V141, P51, DOI 10.1086/285460; Schneider MK, 2004, GLOBAL CHANGE BIOL, V10, P1377, DOI 10.1111/j.1365-2486.2004.00803.x; Smith MD, 2009, ECOLOGY, V90, P3279, DOI 10.1890/08-1815.1; Sokolov AP, 2008, J CLIMATE, V21, P3776, DOI 10.1175/2008JCLI2038.1; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; TILMAN D, 1988; Xia JY, 2008, NEW PHYTOL, V179, P428, DOI 10.1111/j.1469-8137.2008.02488.x; Zavaleta ES, 2003, ECOL MONOGR, V73, P585, DOI 10.1890/02-4053	30	174	183	4	274	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					96	99		10.1038/nature09176	http://dx.doi.org/10.1038/nature09176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596018				2022-12-28	WOS:000279343800041
J	Zhang, JT; Tang, Y; Lee, K; Ouyang, M				Zhang, Jiatao; Tang, Yun; Lee, Kwan; Ouyang, Min			Tailoring light-matter-spin interactions in colloidal hetero-nanostructures	NATURE			English	Article							QUANTUM-DOT; ELECTRON-SPIN; DYNAMICS; MANIPULATION; PLASMONICS; ENERGY	The interplay between light and matter is the basis of many fundamental processes and various applications(1). Harnessing light-matter interactions in principle allows operation of solid state devices under new physical principles: for example, the a. c. optical Stark effect (OSE) has enabled coherent quantum control schemes of spins in semiconductors, with the potential for realizing quantum devices based on spin qubits(2-5). However, as the dimension of semiconductors is reduced, light-matter coupling is typically weakened, thus limiting applications at the nanoscale. Recent experiments have demonstrated significant enhancement of nanoscale light-matter interactions, albeit with the need for a high-finesse cavity(6,7), ultimately preventing device down-scaling and integration. Here we report that a sizable OSE can be achieved at substantial energy detuning in a cavity-free colloidal metal-semiconductor core-shell hetero-nanostructure, in which the metal surface plasmon is tuned to resonate spectrally with a semiconductor exciton transition. We further demonstrate that this resonantly enhanced OSE exhibits polarization dependence and provides a viable mechanism for coherent ultrafast spin manipulation within colloidal nanostructures. The plasmon-exciton resonant nature further enables tailoring of both OSE and spin manipulation by tuning plasmon resonance intensity and frequency. These results open a pathway for tailoring light-matter-spin interactions through plasmon-exciton resonant coupling in a judiciously engineered nanostructure, and offer a basis for future applications in quantum information processing at the nanoscale. More generally, integrated nanostructures with resonantly enhanced light-matter interactions should serve as a test bed for other emerging fields, including nano-biophotonics and nano-energy(8,9).	[Zhang, Jiatao; Tang, Yun; Lee, Kwan; Ouyang, Min] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Zhang, Jiatao; Tang, Yun; Lee, Kwan; Ouyang, Min] Univ Maryland, Ctr Nanophys & Adv Mat, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ouyang, M (corresponding author), Univ Maryland, Dept Phys, College Pk, MD 20742 USA.	mouyang@umd.edu	TANG, Yun/C-7602-2016	TANG, Yun/0000-0002-2999-9626; LEE, KWAN/0000-0002-8269-6579	ONR [N000140710787]; NSF [DMR-0547194]; Beckman YIP grant [0609259093]	ONR(Office of Naval Research); NSF(National Science Foundation (NSF)); Beckman YIP grant	We acknowledge funding from an ONR YIP award (N000140710787), an NSF CAREER award (DMR-0547194), and a Beckman YIP grant (0609259093). We also thank P. Kolb and A. O. Govorov for discussions.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Awschalom DD, 2002, NANOSCI TECHNOL, P147; Battaglia D, 2003, ANGEW CHEM INT EDIT, V42, P5035, DOI 10.1002/anie.200352120; Beaulac R, 2009, SCIENCE, V325, P973, DOI 10.1126/science.1174419; Berezovsky J, 2008, SCIENCE, V320, P349, DOI 10.1126/science.1154798; Berezovsky J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.081309; Berezovsky J, 2006, NAT PHYS, V2, P831, DOI 10.1038/nphys458; DUBOWSKI JJ, 2006, PHOTON BASED NANOSCI; DURACH M, 2008, P SPIE, V7032; Gupta JA, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.125307; Gupta JA, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.085303; Gupta JA, 2001, SCIENCE, V292, P2458, DOI 10.1126/science.1061169; Janben N., 2008, NANO LETT, V8, P1991; JOFFRE M, 1989, PHYS REV LETT, V62, P74, DOI 10.1103/PhysRevLett.62.74; Khitrova G, 2006, NAT PHYS, V2, P81, DOI 10.1038/nphys227; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; Ouyang M, 2003, SCIENCE, V301, P1074, DOI 10.1126/science.1086963; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530; Pryor CE, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2206679; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Tsuda S, 1996, APPL PHYS LETT, V68, P1093, DOI 10.1063/1.115723; Unold T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.157401; Vasa P, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.116801; Weiner J., 2003, LIGHT MATTER INTERAC, V1; Yang Y, 2003, CHEM PHYS LETT, V370, P1, DOI 10.1016/S0009-2614(02)01863-8; Zhang JT, 2010, SCIENCE, V327, P1634, DOI 10.1126/science.1184769; Zhang W, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.146804	29	207	212	2	332	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					91	95		10.1038/nature09150	http://dx.doi.org/10.1038/nature09150			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596017				2022-12-28	WOS:000279343800040
J	Okiyoneda, T; Barriere, H; Bagdany, M; Rabeh, WM; Du, K; Hohfeld, J; Young, JC; Lukacs, GL				Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Hoehfeld, Joerg; Young, Jason C.; Lukacs, Gergely L.			Peripheral Protein Quality Control Removes Unfolded CFTR from the Plasma Membrane	SCIENCE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; E3 UBIQUITIN LIGASE; RETICULUM-ASSOCIATED DEGRADATION; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; SECRETORY PATHWAY; CHIP; HSC70; CELLS; CFTR-DELTA-F508	Therapeutic efforts to restore biosynthetic processing of the cystic fibrosis transmembrane conductance regulator lacking the F508 residue (Delta F508CFTR) are hampered by ubiquitin-dependent lysosomal degradation of nonnative, rescued Delta F508CFTR from the plasma membrane. Here, functional small interfering RNA screens revealed the contribution of chaperones, cochaperones, and ubiquitin-conjugating and -ligating enzymes to the elimination of unfolded CFTR from the cell surface, as part of a peripheral protein quality-control system. Ubiquitination of nonnative CFTR was required for efficient internalization and lysosomal degradation. This peripheral protein quality-control mechanism probably participates in the preservation of cellular homeostasis by degrading damaged plasma membrane proteins that have escaped from the endoplasmic reticulum quality control or are generated by environmental stresses in situ.	[Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Lukacs, Gergely L.] McGill Univ, Dept Physiol, Montreal, PQ H3G 1Y6, Canada; [Okiyoneda, Tsukasa; Barriere, Herve; Bagdany, Miklos; Rabeh, Wael M.; Du, Kai; Young, Jason C.; Lukacs, Gergely L.] McGill Univ, GRASP, Montreal, PQ H3G 1Y6, Canada; [Hoehfeld, Joerg] Univ Bonn, Inst Cell Biol, D-53121 Bonn, Germany; [Young, Jason C.] McGill Univ, Dept Chem, Montreal, PQ H3G 1Y6, Canada	McGill University; McGill University; University of Bonn; McGill University	Lukacs, GL (corresponding author), McGill Univ, Dept Physiol, 3655 Drummond St, Montreal, PQ H3G 1Y6, Canada.	gergely.lukacs@mcgill.ca	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581; Okiyoneda, Tsukasa/0000-0002-5175-2224; Lukacs, Gergely/0000-0003-0900-0675	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft; Canadian Institute of Health Resources; NIH; Cystic Fibrosis Foundation Therapeutics; Canadian Foundation for Innovation	Canadian Cystic Fibrosis Foundation; Groupe de Recherche Axe sur la Structure des Proteines (GRASP); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Canadian Institute of Health Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation Therapeutics(Italian Cystic Fibrosis Research Foundation); Canadian Foundation for Innovation(Canada Foundation for Innovation)	We thank J. Tavares and C. M. Mulvihill for CHIP purification and generating CFTR-His10 cells, respectively; H. Stenmark for Hrs antibody; and H. Lewis, C. Lima, and K. Iwai for NBD1-3S, SUMO, Ulp1, and UbcH5 plasmids, respectively. Lamp1, Lamp2, and CD63 antibodies were developed by J. August and J. Hildreth (University of Iowa). T.O. and W.M.R. were supported by a Canadian Cystic Fibrosis Foundation and a Groupe de Recherche Axe sur la Structure des Proteines (GRASP) postdoctoral fellowship, respectively. This work was supported by grants to J. H. from Deutsche Forschungsgemeinschaft, J.C.Y. and G.L.L. from the Canadian Institute of Health Resources, NIH, Cystic Fibrosis Foundation Therapeutics, the Canadian Cystic Fibrosis Foundation, and the Canadian Foundation for Innovation. J.C.Y. and G.L.L. are holders of Canada Research Chairs.	Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Arndt V, 2007, CELL MOL LIFE SCI, V64, P2525, DOI 10.1007/s00018-007-7188-6; Arvan P, 2002, TRAFFIC, V3, P771, DOI 10.1034/j.1600-0854.2002.31102.x; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; Dupre S, 2004, BBA-MOL CELL RES, V1695, P89, DOI 10.1016/j.bbamcr.2004.09.024; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Harada K, 2006, J BIOL CHEM, V281, P12841, DOI 10.1074/jbc.M512975200; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Hebert DN, 2007, PHYSIOL REV, V87, P1377, DOI 10.1152/physrev.00050.2006; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Loo MA, 1998, EMBO J, V17, P6879, DOI 10.1093/emboj/17.23.6879; Meacham GC, 1999, EMBO J, V18, P1492, DOI 10.1093/emboj/18.6.1492; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Minami Y, 1996, J BIOL CHEM, V271, P19617, DOI 10.1074/jbc.271.32.19617; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Okiyoneda T, 2004, MOL BIOL CELL, V15, P563, DOI 10.1091/mbc.E03-06-0379; Pedemonte N, 2005, J CLIN INVEST, V115, P2564, DOI 10.1172/JCI24898; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Sato BK, 2009, MOL CELL, V34, P212, DOI 10.1016/j.molcel.2009.03.010; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang XD, 2006, CELL, V127, P803, DOI 10.1016/j.cell.2006.09.043; Xu WP, 2002, P NATL ACAD SCI USA, V99, P12847, DOI 10.1073/pnas.202365899; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065; Zhang MH, 2005, MOL CELL, V20, P525, DOI 10.1016/j.molcel.2005.09.023	38	322	323	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					805	810		10.1126/science.1191542	http://dx.doi.org/10.1126/science.1191542			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20595578	Green Accepted			2022-12-28	WOS:000280809900042
J	Song, H; Hu, JX; Chen, W; Elliott, G; Andre, P; Gao, B; Yang, YZ				Song, Hai; Hu, Jianxin; Chen, Wen; Elliott, Gene; Andre, Philipp; Gao, Bo; Yang, Yingzi			Planar cell polarity breaks bilateral symmetry by controlling ciliary positioning	NATURE			English	Article							LEFT-RIGHT ASYMMETRY; NODAL EXPRESSION; GENE-EXPRESSION; SITUS-INVERSUS; LEFTWARD FLOW; PATHWAYS; MOUSE; ESTABLISHMENT; POLARIZATION; REGULATOR	Defining the three body axes is a central event of vertebrate morphogenesis. Establishment of left-right (L-R) asymmetry in development follows the determination of dorsal-ventral and anterior-posterior (A-P) body axes 1,2, although the molecular mechanism underlying precise L-R symmetry breaking in reference to the other two axes is still poorly understood. Here, by removing both Vangl1 and Vangl2, the two mouse homologues of a Drosophila core planar cell polarity (PCP) gene Van Gogh (Vang), we reveal a previously unrecognized function of PCP in the initial breaking of lateral symmetry. The leftward nodal flow across the posterior notochord (PNC) has been identified as the earliest event in the de novo formation of L-R asymmetry(3,4). We show that PCP is essential in interpreting the A-P patterning information and linking it to L-R asymmetry. In the absence of Vangl1 and Vangl2, cilia are positioned randomly around the centre of the PNC cells and nodal flow is turbulent, which results in disrupted L-R asymmetry. PCP in mouse, unlike what has been implicated in other vertebrate species, is not required for ciliogenesis, cilium motility, Sonic hedgehog (Shh) signalling or apical docking of basal bodies in ciliated tracheal epithelial cells. Our data suggest that PCP acts earlier than the unidirectional nodal flow during bilateral symmetry breaking in vertebrates and provide insight into the functional mechanism of PCP in organizing the vertebrate tissues in development.	[Song, Hai; Hu, Jianxin; Chen, Wen; Andre, Philipp; Gao, Bo; Yang, Yingzi] NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Yang, YZ (corresponding author), NHGRI, Dev Genet Sect, Genet Dis Res Branch, Bethesda, MD 20892 USA.	yingzi@mail.nih.gov		Gao, Bo/0000-0002-8684-5199	National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000187, ZIAHG200342, ZICHG200349] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank members of the Yang laboratory for stimulating discussion; M. Kuehn, A. Kumar and J. Regard for critical reading of the manuscript; J. Fekecs and D. Leja for preparing the graphics; D. Wu for teaching us to dissect the mouse cochlea; and M. Kelley for the anti-Vangl2 antibodies. This study is supported by the intramural research programme of National Human Genome Research Institute.	Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Borovina A, 2010, NAT CELL BIOL, V12, P407, DOI 10.1038/ncb2042; BROWN NA, 1990, DEVELOPMENT, V109, P1; Collignon J, 1996, NATURE, V381, P155, DOI 10.1038/381155a0; Gros J, 2009, SCIENCE, V324, P941, DOI 10.1126/science.1172478; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Hamada H, 2002, NAT REV GENET, V3, P103, DOI 10.1038/nrg732; Hashimoto M, 2010, NAT CELL BIOL, V12, P170, DOI 10.1038/ncb2020; Hayashi S, 2003, GENESIS, V37, P51, DOI 10.1002/gene.10225; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kishimoto N, 2008, DEV CELL, V14, P954, DOI 10.1016/j.devcel.2008.03.010; Lawrence PA, 2007, NAT REV GENET, V8, P555, DOI 10.1038/nrg2125; Lee JD, 2008, DEV DYNAM, V237, P3464, DOI 10.1002/dvdy.21598; Lowe LA, 1996, NATURE, V381, P158, DOI 10.1038/381158a0; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; McGrath J, 2003, CELL, V114, P61, DOI 10.1016/S0092-8674(03)00511-7; Meno C, 1998, CELL, V94, P287, DOI 10.1016/S0092-8674(00)81472-5; Nakamura T, 2006, DEV CELL, V11, P495, DOI 10.1016/j.devcel.2006.08.002; Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268; Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5; Okada Y, 2005, CELL, V121, P633, DOI 10.1016/j.cell.2005.04.008; Park TJ, 2006, NAT GENET, V38, P303, DOI 10.1038/ng1753; POOLE CA, 1985, CELL MOTIL CYTOSKEL, V5, P175, DOI 10.1002/cm.970050302; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Sharma N, 2008, CURR TOP DEV BIOL, V85, P371, DOI 10.1016/S0070-2153(08)00813-2; Simons M, 2005, NAT GENET, V37, P537, DOI 10.1038/ng1552; Tabin CJ, 2006, CELL, V127, P27, DOI 10.1016/j.cell.2006.09.018; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wilhelmi H, 1921, ARCH ENTWICKLUNG ORG, V48, P517, DOI 10.1007/BF02554577; Yoshioka H, 1998, CELL, V94, P299, DOI 10.1016/S0092-8674(00)81473-7	32	211	213	0	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					378	U130		10.1038/nature09129	http://dx.doi.org/10.1038/nature09129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20562861	Green Accepted			2022-12-28	WOS:000279867100051
J	Torsvik, TH; Burke, K; Steinberger, B; Webb, SJ; Ashwal, LD				Torsvik, Trond H.; Burke, Kevin; Steinberger, Bernhard; Webb, Susan J.; Ashwal, Lewis D.			Diamonds sampled by plumes from the core-mantle boundary	NATURE			English	Article							TRUE POLAR WANDER; VELOCITY PROVINCES; KIMBERLITES; MARGINS; ORIGIN	Diamonds are formed under high pressure more than 150 kilometres deep in the Earth's mantle and are brought to the surface mainly by volcanic rocks called kimberlites. Several thousand kimberlites have been mapped on various scales(1-4), but it is the distribution of kimberlites in the very old cratons (stable areas of the continental lithosphere that are more than 2.5 billion years old and 300 kilometres thick or more(5)) that have generated the most interest, because kimberlites from those areas are the major carriers of economically viable diamond resources. Kimberlites, which are themselves derived from depths of more than 150 kilometres, provide invaluable information on the composition of the deep subcontinental mantle lithosphere, and on melting and metasomatic processes at or near the interface with the underlying flowing mantle. Here we use plate reconstructions and tomographic images to show that the edges of the largest heterogeneities in the deepest mantle, stable for at least 200 million years and possibly for 540 million years, seem to have controlled the eruption of most Phanerozoic kimberlites. We infer that future exploration for kimberlites and their included diamonds should therefore be concentrated in continents with old cratons that once overlay these plume-generation zones at the core-mantle boundary.	[Torsvik, Trond H.; Steinberger, Bernhard] Univ Oslo, N-0316 Oslo, Norway; [Torsvik, Trond H.; Steinberger, Bernhard] Geol Survey Norway, Ctr Geodynam, N-7491 Trondheim, Norway; [Torsvik, Trond H.; Burke, Kevin; Webb, Susan J.; Ashwal, Lewis D.] Univ Witwatersrand, Sch Geosci, ZA-2050 Johannesburg, South Africa; [Burke, Kevin] Univ Houston, Dept Geosci, Houston, TX 77204 USA; [Steinberger, Bernhard] German Res Ctr Geosci, Helmholtz Ctr Potsdam, D-14473 Potsdam, Germany	University of Oslo; Geological Survey of Norway; University of Witwatersrand; University of Houston System; University of Houston; Helmholtz Association; Helmholtz-Center Potsdam GFZ German Research Center for Geosciences	Torsvik, TH (corresponding author), Univ Oslo, N-0316 Oslo, Norway.	trond.torsvik@ngu.no	Steinberger, Bernhard/ABB-9204-2021; Steinberger, Bernhard/AAG-7148-2019	Steinberger, Bernhard/0000-0002-3643-3049; Webb, Susan/0000-0002-8532-4164	Statoil; Norwegian Research Council	Statoil; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank R. Tronnes, S. Haggerty, M. Gurnis and C. Gaina for comments and discussions, and S. King and D. Evans for reviews. We acknowledge Statoil and the Norwegian Research Council for financial support.	Becker TW, 2002, GEOCHEM GEOPHY GEOSY, V3, DOI 10.1029/2001GC000168; Boschi L, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001733; Bryan SE, 2008, EARTH-SCI REV, V86, P175, DOI 10.1016/j.earscirev.2007.08.008; Burke K, 2008, EARTH PLANET SC LETT, V265, P49, DOI 10.1016/j.epsl.2007.09.042; Castle JC, 2000, J GEOPHYS RES-SOL EA, V105, P21543, DOI 10.1029/2000JB900193; Courtillot V, 1999, EARTH PLANET SC LETT, V166, P177, DOI 10.1016/S0012-821X(98)00282-9; Davaille A, 2005, EARTH PLANET SC LETT, V239, P233, DOI 10.1016/j.epsl.2005.07.024; Davies RA, 2004, LITHOS, V77, P99, DOI 10.1016/j.lithos.2004.04.008; ENGLAND P, 1984, EARTH PLANET SC LETT, V67, P109, DOI 10.1016/0012-821X(84)90043-8; Foulger GR, 2007, GEOL SOC AM SPEC PAP, V430, P1; Garnero EJ, 2007, GEOL SOC AM SPEC PAP, V430, P79, DOI 10.1130/2007.2430(05); Haggerty SE, 1999, SCIENCE, V285, P851, DOI 10.1126/science.285.5429.851; Hayman PC, 2005, CONTRIB MINERAL PETR, V149, P430, DOI 10.1007/s00410-005-0657-8; Heaman LM, 2003, LITHOS, V71, P153, DOI 10.1016/j.lithos.2003.07.005; Heaman LM, 2000, EARTH PLANET SC LETT, V178, P253, DOI 10.1016/S0012-821X(00)00079-0; JAQUES AL, 1998, AGSO J AUST GEOL GEO, V17, P153; Jelsma HA, 2004, S AFR J GEOL, V107, P301, DOI 10.2113/107.1-2.301; Jelsma H, 2009, LITHOS, V112, P155, DOI 10.1016/j.lithos.2009.06.030; Johnston ST, 2008, ANNU REV EARTH PL SC, V36, P495, DOI 10.1146/annurev.earth.36.031207.124331; Jordan T. H., 1979, MANTLE SAMPLE INCLUS, P1, DOI DOI 10.1029/SP016P0001; Kinny P.D., 1997, RUSSIAN GEOLOGY GEOP, V38, P97; Kjarsgaard B.A., 2007, SPECIAL PUBLICATION, V5, P245; Kuo BY, 2000, J GEOPHYS RES-SOL EA, V105, P28139, DOI 10.1029/2000JB900334; Le Roex AP, 2003, J PETROL, V44, P2261, DOI 10.1093/petrology/egg077; Li ZX, 2009, PHYS EARTH PLANET IN, V176, P143, DOI 10.1016/j.pepi.2009.05.004; Mitchell R. H., 1986, KIMBERLITES MINERALO; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; RINGWOOD AE, 1992, EARTH PLANET SC LETT, V113, P521, DOI 10.1016/0012-821X(92)90129-J; Sleep NH, 2006, EARTH-SCI REV, V77, P231, DOI 10.1016/j.earscirev.2006.03.007; Stachel T, 2009, LITHOS, V112, P625, DOI 10.1016/j.lithos.2009.04.017; Steinberger B, 2004, NATURE, V430, P167, DOI 10.1038/nature02660; Steinberger B, 2008, NATURE, V452, P620, DOI 10.1038/nature06824; TAN E, 2009, EOS, V90; Thorne MS, 2004, PHYS EARTH PLANET IN, V146, P47, DOI 10.1016/j.pepi.2003.09.026; Torsvik TH, 2008, REV GEOPHYS, V46, DOI 10.1029/2007RG000227; Torsvik TH, 2008, EARTH PLANET SC LETT, V267, P444, DOI 10.1016/j.epsl.2007.12.004; Torsvik TH, 2008, EARTH PLANET SC LETT, V276, P273, DOI 10.1016/j.epsl.2008.09.026; Torsvik TH, 2006, GEOPHYS J INT, V167, P1447, DOI 10.1111/j.1365-246X.2006.03158.x; van der Meer DG, 2010, NAT GEOSCI, V3, P36, DOI 10.1038/NGEO708; WYLLIE PJ, 1980, J GEOPHYS RES, V85, P6902, DOI 10.1029/JB085iB12p06902; Yakubchuk A, 2009, ORE GEOL REV, V35, P155, DOI 10.1016/j.oregeorev.2008.10.002; Zhong SJ, 2007, EARTH PLANET SC LETT, V261, P551, DOI 10.1016/j.epsl.2007.07.049	42	337	357	4	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					352	U100		10.1038/nature09216	http://dx.doi.org/10.1038/nature09216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631796	Green Submitted			2022-12-28	WOS:000279867100045
J	Vaidya, JS; Joseph, DJ; Tobias, JS; Bulsara, M; Wenz, F; Saunders, C; Alvarado, M; Flyger, HL; Massarut, S; Eiermann, W; Keshtgar, M; Dewar, J; Kraus-Tiefenbacher, U; Sutterlin, M; Esserman, L; Holtveg, HMR; Roncadin, M; Pigorsch, S; Metaxas, M; Falzon, M; Matthews, A; Corica, T; Williams, NR; Baum, M				Vaidya, Jayant S.; Joseph, David J.; Tobias, Jeffrey S.; Bulsara, Max; Wenz, Frederik; Saunders, Christobel; Alvarado, Michael; Flyger, Henrik L.; Massarut, Samuele; Eiermann, Wolfgang; Keshtgar, Mohammed; Dewar, John; Kraus-Tiefenbacher, Uta; Suetterlin, Marc; Esserman, Laura; Holtveg, Helle M. R.; Roncadin, Mario; Pigorsch, Steffi; Metaxas, Marinos; Falzon, Mary; Matthews, April; Corica, Tammy; Williams, Norman R.; Baum, Michael			Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial	LANCET			English	Article							ENERGY X-RAYS; RADIATION-THERAPY; CONSERVATIVE SURGERY; AXILLARY DISSECTION; TUMOR RECURRENCE; CLINICAL-TRIAL; IRRADIATION; LUMPECTOMY; SURVIVAL; WOMEN	Background After breast-conserving surgery, 90% of local recurrences occur within the index quadrant despite the presence of multicentric cancers elsewhere in the breast. Thus, restriction of radiation therapy to the tumour bed during surgery might be adequate for selected patients. We compared targeted intraoperative radiotherapy with the conventional policy of whole breast external beam radiotherapy. Methods Having safely piloted the new technique of single-dose targeted intraoperative radiotherapy with Intrabeam, we launched the TARGIT-A trial on March 24, 2000. In this prospective, randomised, non-inferiority trial, women aged 45 years or older with invasive ductal breast carcinoma undergoing breast-conserving surgery were enrolled from 28 centres in nine countries. Patients were randomly assigned in a 1:1 ratio to receive targeted intraoperative radiotherapy or whole breast external beam radiotherapy, with blocks stratified by centre and by timing of delivery of targeted intraoperative radiotherapy. Neither patients nor investigators or their teams were masked to treatment assignment. Postoperative discovery of predefined factors (eg, lobular carcinoma) could trigger addition of external beam radiotherapy to targeted intraoperative radiotherapy (in an expected 15% of patients). The primary outcome was local recurrence in the conserved breast. The predefined non-inferiority margin was an absolute difference of 2.5% in the primary endpoint. All randomised patients were included in the intention-to-treat analysis. This trial is registered with ClinicalTrials.gov, number NCT00983684. Findings 1113 patients were randomly allocated to targeted intraoperative radiotherapy and 1119 were allocated to external beam radiotherapy. Of 996 patients who received the allocated treatment in the targeted intraoperative radiotherapy group, 854 (86%) received targeted intraoperative radiotherapy only and 142 (14%) received targeted intraoperative radiotherapy plus external beam radiotherapy. 1025 (92%) patients in the external beam radiotherapy group received the allocated treatment. At 4 years, there were six local recurrences in the intraoperative radiotherapy group and five in the external beam radiotherapy group. The Kaplan-Meier estimate of local recurrence in the conserved breast at 4 years was 1.20% (95% CI 0.53-2.71) in the targeted intraoperative radiotherapy and 0.95% (0.39-2.31) in the external beam radiotherapy group (difference between groups 0.25%, -1.04 to 1.54; p=0.41). The frequency of any complications and major toxicity was similar in the two groups (for major toxicity, targeted intraoperative radiotherapy, 37 [3.3%] of 1113 vs external beam radiotherapy, 44 [3.9%] of 1119; p=0.44). Radiotherapy toxicity (Radiation Therapy Oncology Group grade 3) was lower in the targeted intraoperative radiotherapy group (six patients [0.5%]) than in the external beam radiotherapy group (23 patients [2.1%]; p=0.002). Interpretation For selected patients with early breast cancer, a single dose of radiotherapy delivered at the time of surgery by use of targeted intraoperative radiotherapy should be considered as an alternative to external beam radiotherapy delivered over several weeks.	[Vaidya, Jayant S.] UCL, Div Surg & Intervent Sci, Dept Surg Res, London N19 5LW, England; [Williams, Norman R.; Baum, Michael] UCL, Div Surg & Intervent Sci, Clin Trials Grp, London N19 5LW, England; [Joseph, David J.; Corica, Tammy] Sir Charles Gairdner Hosp, Dept Radiat Oncol, Perth, WA, Australia; [Saunders, Christobel] Sir Charles Gairdner Hosp, Dept Surg, Perth, WA, Australia; [Falzon, Mary] Univ Coll London Hosp, Dept Pathol, London, England; [Metaxas, Marinos] Univ Coll London Hosp, Dept Radiat Phys, London, England; [Tobias, Jeffrey S.] Univ Coll London Hosp, Dept Clin Oncol, London, England; [Bulsara, Max] Univ Notre Dame, Dept Biostat, Fremantle, WA, Australia; [Wenz, Frederik; Kraus-Tiefenbacher, Uta] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Radiat Oncol, Heidelberg, Germany; [Suetterlin, Marc] Heidelberg Univ, Univ Med Ctr Mannheim, Dept Gynecol & Obstet, Heidelberg, Germany; [Saunders, Christobel] Univ Western Australia, Sch Surg, Perth, WA 6009, Australia; [Alvarado, Michael; Esserman, Laura] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA; [Flyger, Henrik L.; Holtveg, Helle M. R.] Univ Copenhagen, Dept Breast Surg, Copenhagen, Denmark; [Massarut, Samuele] Ctr Riferimento Oncol, Dept Surg, I-33081 Aviano, Italy; [Roncadin, Mario] Ctr Riferimento Oncol, Dept Radiat Oncol, I-33081 Aviano, Italy; [Eiermann, Wolfgang] Red Cross Hosp, Dept Gynecol & Obstet, Munich, Germany; [Pigorsch, Steffi] Tech Univ Munich, Dept Radiat Oncol, Munich, Germany; [Dewar, John] Ninewells Hosp, Dept Radiat Oncol, Dundee DD1 9SY, Scotland; [Keshtgar, Mohammed] Royal Free Hosp, London NW3 2QG, England; [Matthews, April] Natl Inst Canc Res, Psychosocial Oncol Clin Studies Grp, London, England	University of London; University College London; University of London; University College London; University of Western Australia; University of Western Australia; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of Notre Dame Australia; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; University of Western Australia; University of California System; University of California San Francisco; University of Copenhagen; IRCCS Aviano (CRO); IRCCS Aviano (CRO); Technical University of Munich; University of Dundee; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School	Vaidya, JS (corresponding author), UCL, Div Surg & Intervent Sci, Dept Surg Res, 2nd Floor Clerkenwell Bldg,Highgate Hill, London N19 5LW, England.	jayant.vaidya@ucl.ac.uk	Flyger, Henrik/AAM-6494-2021; WILLIAMS, Norman/C-2002-2008; Massarut, Samuele/J-2995-2018; Vaidya, Jayant S/A-7218-2008; Corica, Tammy/J-4670-2013; Vaidya, Jayant S/F-7717-2010; Saunders, Christobel M/H-5779-2014	WILLIAMS, Norman/0000-0001-6496-312X; Massarut, Samuele/0000-0003-4717-0544; Vaidya, Jayant S/0000-0003-1760-1278; Corica, Tammy/0000-0002-1197-0120; Vaidya, Jayant S/0000-0003-1760-1278; Saunders, Christobel M/0000-0003-2281-9829	University College London Hospitals (UCLH); UCL Comprehensive Biomedical Research Centre; UCLH Charities; National Institute for Health Research Health Technology Assessment programme; Ninewells Cancer Campaign; National Health and Medical Research Council; German Federal Ministry of Education and Research (BMBF) [FKZ 01ZP0508]; National Institute for Health Research [07/60/49] Funding Source: researchfish	University College London Hospitals (UCLH); UCL Comprehensive Biomedical Research Centre; UCLH Charities; National Institute for Health Research Health Technology Assessment programme(National Institute for Health Research (NIHR)); Ninewells Cancer Campaign; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); National Institute for Health Research(National Institute for Health Research (NIHR))	Funding University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre, UCLH Charities, National Institute for Health Research Health Technology Assessment programme, Ninewells Cancer Campaign, National Health and Medical Research Council, and German Federal Ministry of Education and Research (BMBF).; The trial was initiated by an academic insight and collaboration with the industry was solely for the development of the device. The manufacturers of the Intrabeam device (Carl Zeiss) did not have any part in concept, design, or management of the trial, or in data analysis, data interpretation, or writing of the report. The study was sponsored by University College London Hospitals (UCLH)/UCL Comprehensive Biomedical Research Centre. Funding was provided by UCLH Charities, National Institute for Health Research (NIHR) Health Technology Assessment programme, Ninewells Cancer Campaign, National Health and Medical Research Council, and German Federal Ministry of Education and Research (BM B F) FKZ 01ZP0508. The infrastructure of the trial operations office in London, UK, was supported by core funding from Cancer Research Campaign (now Cancer Research UK) when the trial was initiated. We thank Michael D O'Shea (Tessella, Abingdon, UK) for database development, Mo Thaha for help in data collection, and Hrisheekesh J Vaidya for help with figure 1A, as well as several contributors who have now left the individual centres. Travel and accommodation for meetings of the international steering committee and data monitoring committee were provided by Carl Zeiss. Funding for the TARGIT Trials Operations Office was provided by the NIHR Health Technology Assessment programme. Individual centres were self-financed. We thank all the patients who kindly participated in the trial.	Abe O, 2005, LANCET, V366, P2087; ABE O, 1995, NEW ENGL J MED, V333, P1444; Alvarado M, 2010, EJC SUPPL, V8, P126, DOI 10.1016/S1359-6349(10)70260-3; Armitage P., 2001, STAT METHODS MED RES; Astor MB, 2000, INT J RADIAT ONCOL, V47, P809, DOI 10.1016/S0360-3016(00)00472-7; Athas WF, 2000, J NATL CANCER I, V92, P269, DOI 10.1093/jnci/92.3.269; Baum M, 1997, LANCET, V349, P208, DOI 10.1016/S0140-6736(05)60950-6; Belletti B, 2008, CLIN CANCER RES, V14, P1325, DOI 10.1158/1078-0432.CCR-07-4453; Bentzen SM, 2008, LANCET ONCOL, V9, P331, DOI [10.1016/S1470-2045(08)70077-9, 10.1016/S1470-2045(08)60348-7]; Bouchardy C, 2010, ANN ONCOL, V21, P459, DOI 10.1093/annonc/mdp341; BOYAGES J, 1990, RADIOTHER ONCOL, V19, P29, DOI 10.1016/0167-8140(90)90163-Q; Brenner DJ, 1999, PHYS MED BIOL, V44, P323, DOI 10.1088/0031-9155/44/2/002; CLARK RM, 1982, INT J RADIAT ONCOL, V8, P967, DOI 10.1016/0360-3016(82)90163-8; CLARK RM, 1992, JNCI-J NATL CANCER I, V84, P683, DOI 10.1093/jnci/84.9.683; Enderling H, 2007, J THEOR BIOL, V246, P245, DOI 10.1016/j.jtbi.2006.12.010; Fisher B, 2002, J CLIN ONCOL, V20, P4141, DOI 10.1200/JCO.2002.11.101; FISHER B, 1995, NEW ENGL J MED, V333, P1456, DOI 10.1056/NEJM199511303332203; FISHER ER, 1992, SEMIN SURG ONCOL, V8, P161; Fyles AW, 2004, NEW ENGL J MED, V351, P963, DOI 10.1056/NEJMoa040595; Halsted W S, 1894, Ann Surg, V20, P497, DOI 10.1097/00000658-189407000-00075; Herskind C, 2005, RADIAT RES, V163, P208, DOI 10.1667/RR3292; Herskind C, 2008, INT J RADIAT ONCOL, V72, P1575, DOI 10.1016/j.ijrobp.2008.08.009; Hughes KS, 2004, NEW ENGL J MED, V351, P971, DOI 10.1056/NEJMoa040587; JOSEPH D, 2006, EUR J SURG ONCOL S1, V32, pS79; Katz SJ, 2005, J CLIN ONCOL, V23, P5526, DOI 10.1200/JCO.2005.06.217; Kraus-Tiefenbacher U, 2006, ONKOLOGIE, V29, P77, DOI 10.1159/000091160; Kraus-Tiefenbacher U, 2006, INT J RADIAT ONCOL, V66, P377, DOI 10.1016/j.ijrobp.2006.05.042; KURTZ JM, 1989, CANCER, V63, P1630, DOI 10.1002/1097-0142(19890415)63:8<1630::AID-CNCR2820630833>3.0.CO;2-U; Mikeljevic JS, 2004, BRIT J CANCER, V90, P1343, DOI 10.1038/sj.bjc.6601693; Moher David, 2010, BMJ, V340, pc869, DOI [10.1016/j.jclinepi.2010.03.004, 10.1136/bmj.c869]; Orecchia R, 2003, BREAST, V12, P483, DOI 10.1016/S0960-9776(03)00156-5; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Polgar C, 2007, INT J RADIAT ONCOL, V69, P694, DOI 10.1016/j.ijrobp.2007.04.022; Punglia RS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c845; Retsky MW, 2008, APMIS, V116, P730, DOI 10.1111/j.1600-0463.2008.00990.x; SCHNITT SJ, 1984, CANCER, V53, P1049, DOI 10.1002/1097-0142(19840301)53:5<1049::AID-CNCR2820530506>3.0.CO;2-O; Thewes B, 2005, LANCET ONCOL, V6, P581, DOI 10.1016/S1470-2045(05)70254-0; Vaidya JS, 2010, EJC SUPPL, V8, P131, DOI 10.1016/S1359-6349(10)70275-5; Vaidya JS, 2007, NAT CLIN PRACT ONCOL, V4, P384, DOI 10.1038/ncponc0850; Vaidya JS, 2006, INT J RADIAT ONCOL, V66, P1335, DOI 10.1016/j.ijrobp.2006.07.1378; Vaidya JS, 2009, INT J RADIAT ONCOL, V74, P976, DOI 10.1016/j.ijrobp.2009.02.041; Vaidya JS, 2005, SEMIN RADIAT ONCOL, V15, P84, DOI 10.1016/j.semradonc.2004.10.007; Vaidya JS, 2004, LANCET ONCOL, V5, P165, DOI 10.1016/S1470-2045(04)01412-3; Vaidya JS, 2002, EUR J SURG ONCOL, V28, P447, DOI 10.1053/ejso.2002.1275; Vaidya JS, 2001, ANN ONCOL, V12, P1075, DOI 10.1023/A:1011609401132; Vaidya JS, 1996, BRIT J CANCER, V74, P820, DOI 10.1038/bjc.1996.442; VAIDYA JS, 2009, CANCER RES, V69, P1; Vaidya JS, 2008, INT J RADIAT ONCOL, V72, P1575; VAIDYA JS, 2002, THESIS U LONDON; VAIDYA JS, 1995, HONG KONG INT CANC C; VERONESI U, 1990, ANN SURG, V211, P250; VERONESI U, 1993, NEW ENGL J MED, V328, P1587, DOI 10.1056/NEJM199306033282202	52	522	540	1	76	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					91	102		10.1016/S0140-6736(10)60837-9	http://dx.doi.org/10.1016/S0140-6736(10)60837-9			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20570343	Bronze			2022-12-28	WOS:000279943200031
J	Guenther, MG; Young, RA				Guenther, Matthew G.; Young, Richard A.			Repressive Transcription	SCIENCE			English	Editorial Material							GENE-EXPRESSION; NONCODING RNAS; CHROMATIN; POLYCOMB; PROTEINS; CELLS		[Guenther, Matthew G.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Guenther, MG (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647	NHGRI NIH HHS [R01 HG002668, R01 HG002668-07] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buratowski S, 2008, SCIENCE, V322, P1804, DOI 10.1126/science.1168805; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Grewal SIS, 2007, NATURE, V447, P399, DOI 10.1038/nature05914; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; TSAI MC, 2010, SCIENCE         0708, DOI DOI 10.1126/SCIENCE.1192002; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	17	39	40	1	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					150	151		10.1126/science.1193995	http://dx.doi.org/10.1126/science.1193995			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616255	Green Accepted, Green Submitted			2022-12-28	WOS:000279635200022
J	Weyand, S; Iwata, S				Weyand, Simone; Iwata, So			Old Gate Gets a New Look	SCIENCE			English	Editorial Material							HUMAN BK CHANNEL; K+ CHANNEL; POTASSIUM CHANNEL; RESOLUTION		[Weyand, Simone; Iwata, So] Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England; [Weyand, Simone; Iwata, So] Membrane Prot Lab, Diamond Light Source, Didcot OX11 0DE, Oxon, England; [Iwata, So] Kyoto Univ, Grad Sch Med, Dept Cell Biol, Sakyo Ku, Kyoto 6068501, Japan	Imperial College London; Diamond Light Source; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Kyoto University	Weyand, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Membrane Prot Crystallog Grp, Div Mol Biosci, London SW7 2AZ, England.	s.iwata@imperial.ac.uk						Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2001, NEURON, V29, P593, DOI 10.1016/S0896-6273(01)00236-7; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Yuan P, 2010, SCIENCE, V329, P182, DOI 10.1126/science.1190414; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	6	2	2	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					151	152		10.1126/science.1192680	http://dx.doi.org/10.1126/science.1192680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616256				2022-12-28	WOS:000279635200023
J	Mulitza, S; Heslop, D; Pittauerova, D; Fischer, HW; Meyer, I; Stuut, JB; Zabel, M; Mollenhauer, G; Collins, JA; Kuhnert, H; Schulz, M				Mulitza, Stefan; Heslop, David; Pittauerova, Daniela; Fischer, Helmut W.; Meyer, Inka; Stuut, Jan-Berend; Zabel, Matthias; Mollenhauer, Gesine; Collins, James A.; Kuhnert, Henning; Schulz, Michael			Increase in African dust flux at the onset of commercial agriculture in the Sahel region	NATURE			English	Article							DESERTIFICATION; DESERT; REINTERPRETATION; VEGETATION; TRANSPORT; ATLANTIC; RAINFALL; DROUGHT; EROSION; LOAD	The Sahara Desert is the largest source of mineral dust in the world(1). Emissions of African dust increased sharply in the early 1970s (ref. 2), a change that has been attributed mainly to drought in the Sahara/Sahel region(2) caused by changes in the global distribution of sea surface temperature(3,4). The human contribution to land degradation and dust mobilization in this region remains poorly understood(5-11), owing to the paucity of data that would allow the identification of long-term trends in desertification(12). Direct measurements of airborne African dust concentrations only became available in the mid-1960s from a station on Barbados(2) and subsequently from satellite imagery since the late 1970s: they do not cover the onset of commercial agriculture in the Sahel region similar to 170 years ago(11,13,14). Here we construct a 3,200-year record of dust deposition off northwest Africa by investigating the chemistry and grain-size distribution of terrigenous sediments deposited at a marine site located directly under the West African dust plume. With the help of our dust record and a proxy record for West African precipitation(15) we find that, on the century scale, dust deposition is related to precipitation in tropical West Africa until the seventeenth century. At the beginning of the nineteenth century, a sharp increase in dust deposition parallels the advent of commercial agriculture in the Sahel region. Our findings suggest that human-induced dust emissions from the Sahel region have contributed to the atmospheric dust load for about 200 years.	[Mulitza, Stefan; Heslop, David; Meyer, Inka; Stuut, Jan-Berend; Zabel, Matthias; Mollenhauer, Gesine; Collins, James A.; Kuhnert, Henning; Schulz, Michael] Univ Bremen, Ctr Marine Environm Sci, MARUM, D-28359 Bremen, Germany; [Pittauerova, Daniela; Fischer, Helmut W.] Univ Bremen, Inst Environm Phys, D-28359 Bremen, Germany; [Stuut, Jan-Berend] Royal Netherlands Inst Sea Res, NL-1790 AB Den Burg, Texel, Netherlands; [Mollenhauer, Gesine] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany	University of Bremen; University of Bremen; Utrecht University; Royal Netherlands Institute for Sea Research (NIOZ); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Mulitza, S (corresponding author), Univ Bremen, Ctr Marine Environm Sci, MARUM, Leobener Str, D-28359 Bremen, Germany.	smulitza@uni-bremen.de	Schulz, Michael/P-7276-2016; Mollenhauer, Gesine/AAD-8167-2019; Heslop, David/G-6412-2011; Zabel, Matthias/E-5044-2011; Stuut, Jan-Berend/K-2073-2013; Heslop, David/AGE-1592-2022; Fischer, Helmut W./K-6207-2012; Pittauer, Daniela/G-8854-2014; Meyer, Inka/C-7117-2016; Mulitza, Stefan/G-5357-2011; Mollenhauer, Gesine/B-5190-2015	Schulz, Michael/0000-0001-6500-2697; Mollenhauer, Gesine/0000-0001-5138-564X; Heslop, David/0000-0001-8245-0555; Zabel, Matthias/0000-0003-4681-1821; Stuut, Jan-Berend/0000-0002-5348-2512; Heslop, David/0000-0001-8245-0555; Fischer, Helmut W./0000-0002-0593-5564; Pittauer, Daniela/0000-0002-3643-333X; Meyer, Inka/0000-0001-6219-2237; Mulitza, Stefan/0000-0002-3842-1447; Mollenhauer, Gesine/0000-0001-5138-564X; Kuhnert, Henning/0000-0001-5242-4495	DFG Research Center/Cluster of Excellence	DFG Research Center/Cluster of Excellence(German Research Foundation (DFG))	Radiocarbon datings were performed at the Leibniz-Laboratory for Radiometric Dating and Stable Isotope Research in Kiel and at the Poznan Radiocarbon Laboratory. This work was funded through the DFG Research Center/Cluster of Excellence "The Ocean in the Earth System''. We thank M. Prange for plotting the TOMS data in Fig. 1 and U. Rohl, K. Enneking, V. Lukies and M. Klann for technical support.	Austin G, 2009, INT REV SOC HIST, V54, P1, DOI 10.1017/S0020859009000017; Brooks N, 2005, J NORTH AFR STUD, V10, P253, DOI 10.1080/13629380500336680; Engelstaedter S, 2006, EARTH-SCI REV, V79, P73, DOI 10.1016/j.earscirev.2006.06.004; FOLLAND CK, 1986, NATURE, V320, P602, DOI 10.1038/320602a0; Gac J. Y, 1986, SCI GEOL B, V39, P99; Giannini A, 2003, SCIENCE, V302, P1027, DOI 10.1126/science.1089357; Hein L, 2006, GLOBAL CHANGE BIOL, V12, P751, DOI 10.1111/j.1365-2486.2006.01135.x; Isupova MV, 2008, WATER RESOUR+, V35, P30, DOI 10.1134/S0097807808010041; KATTAN Z, 1987, J HYDROL, V92, P59, DOI 10.1016/0022-1694(87)90089-8; KOOPMANN B, 1981, METEOR FORSCHUNGSE C, V0035; Mahowald NM, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2002JD002097; Mbow C, 2008, GLOBAL PLANET CHANGE, V64, P210, DOI 10.1016/j.gloplacha.2008.09.008; Moreno T, 2006, CHEMOSPHERE, V65, P261, DOI 10.1016/j.chemosphere.2006.02.052; Nicholson SE, 1998, B AM METEOROL SOC, V79, P815, DOI 10.1175/1520-0477(1998)079<0815:DDASVA>2.0.CO;2; Orange D, 1990, GEODYNAMIQUE, V5, P51; Prince SD, 2007, GLOBAL CHANGE BIOL, V13, P1308, DOI 10.1111/j.1365-2486.2007.01356.x; Prospero JM, 2003, SCIENCE, V302, P1024, DOI 10.1126/science.1089915; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; PROSPERO JM, 1981, PURE APPL GEOPHYS, V119, P677, DOI 10.1007/BF00878167; Shanahan TM, 2009, SCIENCE, V324, P377, DOI 10.1126/science.1166352; Solmon F, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035900; Sterk G, 2003, LAND DEGRAD DEV, V14, P95, DOI 10.1002/ldr.526; Stuut JB, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005161; TEGEN I, 1995, J GEOPHYS RES-ATMOS, V100, P18707, DOI 10.1029/95JD02051; TUCKER CJ, 1991, SCIENCE, V253, P299, DOI 10.1126/science.253.5017.299; WEBB JLA, 1995, DESERT FRONTIER ECOL, P1600; Yoshioka M, 2007, J CLIMATE, V20, P1445, DOI 10.1175/JCLI4056.1	27	178	180	3	120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					226	228		10.1038/nature09213	http://dx.doi.org/10.1038/nature09213			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613839				2022-12-28	WOS:000279580800034
J	Kreckel, H; Bruhns, H; Cizek, M; Glover, SCO; Miller, KA; Urbain, X; Savin, DW				Kreckel, H.; Bruhns, H.; Cizek, M.; Glover, S. C. O.; Miller, K. A.; Urbain, X.; Savin, D. W.			Experimental Results for H-2 Formation from H- and H and Implications for First Star Formation	SCIENCE			English	Article							MERGED-BEAMS EXPERIMENTS; ASSOCIATIVE DETACHMENT; CROSS-SECTIONS; DISSOCIATIVE ATTACHMENT; RATE-CONSTANT; ATOMS; GAS; DESTRUCTION; IONIZATION; COLLISION	During the epoch of first star formation, molecular hydrogen (H-2) generated via associative detachment (AD) of H- and H is believed to have been the main coolant of primordial gas for temperatures below 10(4) kelvin. The uncertainty in the cross section for this reaction has limited our understanding of protogalaxy formation during this epoch and of the characteristic masses and cooling times for the first stars. We report precise energy-resolved measurements of the AD reaction, made with the use of a specially constructed merged-beams apparatus. Our results agreed well with the most recent theoretically calculated cross section, which we then used in cosmological simulations to demonstrate how the reduced AD uncertainty improves constraints of the predicted masses for Population III stars.	[Kreckel, H.; Bruhns, H.; Miller, K. A.; Savin, D. W.] Columbia Univ, Columbia Astrophys Lab, New York, NY 10027 USA; [Cizek, M.] Charles Univ Prague, Fac Math & Phys, Inst Theoret Phys, CR-18000 Prague 8, Czech Republic; [Glover, S. C. O.] Univ Heidelberg, Zentrum Astron, Inst Theoret Astrophys, D-69120 Heidelberg, Germany; [Urbain, X.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	Columbia University; Charles University Prague; Ruprecht Karls University Heidelberg; Universite Catholique Louvain	Kreckel, H (corresponding author), Columbia Univ, Columbia Astrophys Lab, 538 W 120th St, New York, NY 10027 USA.	hkreckel@illinois.edu	Cizek, Martin/A-8069-2008; Savin, Daniel Wolf/B-9576-2012; Kreckel, Holger/F-4969-2010	Cizek, Martin/0000-0003-1134-2404; Savin, Daniel Wolf/0000-0002-1111-6610; Kreckel, Holger/0000-0003-0511-0738; Bruhns, Hjalmar/0000-0002-8363-5989	Deutscher Akademischer Austauschdienst; Grantova Agentura Ceske Republiky [202/07/0833]; "Vyzkumny zamer" [MSM 0021620860]; German Bundesministerium fur Bildung und Forschung [05A09VHA]; Deutsche Forschungsgemeinschaft [KL 1358/4]; Heidelberg University; German Excellence Initiative; Landesstiftung Baden-Wurttemberg [P-LS-SPII/18]; NSF [CHE-0520660, AST-0606960, AST-0807436]; Division Of Astronomical Sciences [0807436] Funding Source: National Science Foundation	Deutscher Akademischer Austauschdienst(Deutscher Akademischer Austausch Dienst (DAAD)); Grantova Agentura Ceske Republiky(Grant Agency of the Czech Republic); "Vyzkumny zamer"; German Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Heidelberg University; German Excellence Initiative; Landesstiftung Baden-Wurttemberg; NSF(National Science Foundation (NSF)); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	Supported by the Deutscher Akademischer Austauschdienst (H.B.); Grantova Agentura Ceske Republiky grant 202/07/0833 and "Vyzkumny zamer" grant MSM 0021620860 (M.C.); German Bundesministerium fur Bildung und Forschung (via STAR FORMAT grant 05A09VHA), Deutsche Forschungsgemeinschaft grant KL 1358/4, and Heidelberg University, sponsored by the German Excellence Initiative and the Landesstiftung Baden-Wurttemberg (International Collaboration II grant P-LS-SPII/18) (S.C.O.G.); and NSF grants CHE-0520660, AST-0606960, and AST-0807436. X.U. is a Senior Research Associate of the Fonds de la Recherche Scientifique-FNRS, Belgium.	Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; BARNETT CF, 1990, ORNL6086 CONTR FUS A, V1; BOULIOU A, 1983, CR ACAD SCI II, V296, P1377; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2009, NATURE, V459, P49, DOI 10.1038/nature07990; BROWNING R, 1970, J PHYS PT B ATOM M P, V3, P667, DOI 10.1088/0022-3700/3/5/009; Bruhns H, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3280227; Cizek M, 1998, J PHYS B-AT MOL OPT, V31, P2571, DOI 10.1088/0953-4075/31/11/018; CRANDALL DH, 1975, REV SCI INSTRUM, V46, P562, DOI 10.1063/1.1134258; FEHSENFELD FC, 1973, J CHEM PHYS, V58, P5841, DOI 10.1063/1.1679215; Glover SCO, 2008, MON NOT R ASTRON SOC, V388, P1627, DOI 10.1111/j.1365-2966.2008.13224.x; Glover SC, 2006, ASTROPHYS J, V640, P553, DOI 10.1086/500166; HAVENER CC, 1989, PHYS REV A, V39, P1725, DOI 10.1103/PhysRevA.39.1725; KVALE TJ, 1995, PHYS REV A, V51, P1351, DOI 10.1103/PhysRevA.51.1351; LAUNAY JM, 1991, ASTRON ASTROPHYS, V252, P842; Martinez O, 2009, ASTROPHYS J LETT, V705, pL172, DOI 10.1088/0004-637X/705/2/L172; Navarro JF, 1997, ASTROPHYS J, V490, P493, DOI 10.1086/304888; Phaneuf RA, 1999, REP PROG PHYS, V62, P1143, DOI 10.1088/0034-4885/62/7/202; SAKIMOTO K, 1989, CHEM PHYS LETT, V164, P294, DOI 10.1016/0009-2614(89)85032-8; SASLAW WC, 1967, NATURE, V216, P976, DOI 10.1038/216976a0; SCHMELTEKOPF AL, 1967, ASTROPHYS J, V148, pL155, DOI 10.1086/180035; Seely DG, 2008, NUCL INSTRUM METH A, V585, P69, DOI 10.1016/j.nima.2007.10.041; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Tegmark M, 1997, ASTROPHYS J, V474, P1, DOI 10.1086/303434; WILLIAMS ID, 1984, J PHYS B-AT MOL OPT, V17, P811, DOI 10.1088/0022-3700/17/5/020; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259	26	97	97	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					69	71		10.1126/science.1187191	http://dx.doi.org/10.1126/science.1187191			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595610				2022-12-28	WOS:000279402700033
J	Beck, CR; Collier, P; Macfarlane, C; Malig, M; Kidd, JM; Eichler, EE; Badge, RM; Moran, JV				Beck, Christine R.; Collier, Pamela; Macfarlane, Catriona; Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.; Badge, Richard M.; Moran, John V.			LINE-1 Retrotransposition Activity in Human Genomes	CELL			English	Article							HIGH-FREQUENCY RETROTRANSPOSITION; MULTIPLE SEQUENCE ALIGNMENT; HUMAN L1 RETROTRANSPOSITION; CULTURED HUMAN-CELLS; STRUCTURAL VARIATION; TRANSCRIPTION INITIATION; MAMMALIAN-CELLS; ELEMENTS; ENDONUCLEASE; DIVERSITY	Highly active (i.e., "hot") long interspersed element-1 (LINE-1 or L1) sequences comprise the bulk of retrotransposition activity in the human genome; however, the abundance of hot L1s in the human population remains largely unexplored. Here, we used a fosmid-based, paired-end DNA sequencing strategy to identify 68 full-length L1s that are differentially present among individuals but are absent from the human genome reference sequence. The majority of these L1s were highly active in a cultured cell retrotransposition assay. Genotyping 26 elements revealed that two L1s are only found in Africa and that two more are absent from the H952 subset of the Human Genome Diversity Panel. Therefore, these results suggest that hot L1s are more abundant in the human population than previously appreciated, and that ongoing L1 retrotransposition continues to be a major source of interindividual genetic variation.	[Beck, Christine R.; Moran, John V.] Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Dept Internal Med, Sch Med, Ann Arbor, MI 48109 USA; [Moran, John V.] Univ Michigan, Howard Hughes Med Inst, Sch Med, Ann Arbor, MI 48109 USA; [Collier, Pamela; Macfarlane, Catriona; Badge, Richard M.] Univ Leicester, Dept Genet, Leicester LE1 7RH, Leics, England; [Malig, Maika; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Leicester; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Beck, CR (corresponding author), Univ Michigan, Dept Human Genet, Sch Med, Ann Arbor, MI 48109 USA.	cregina@umich.edu; moranj@umich.edu		Kidd, Jeffrey/0000-0002-9631-1465; macfarlane, catriona/0000-0002-4733-5356; Badge, Richard/0000-0003-3201-336X	NIH [T32GM7544, T32000040, GM066695, GM060518]; National Science Foundation; Wellcome Trust [075163/Z/04/Z]; University of Michigan Cancer Center [5P30CA46592];  [HG004120]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG004120, T32HG000040] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007544, R01GM066695, R01GM060518, R01GM082970] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Wellcome Trust(Wellcome TrustEuropean Commission); University of Michigan Cancer Center(University of Michigan System); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Professor Sir Alec Jeffreys FRS for access to CEPH and Zimbabwean DNA samples and Professor Mark Jobling for access to HGDP DNA samples. We thank Dr. Elizabeth Marchani for advice on maximum likelihood age estimates and Dr. Jose Luis Garcia-Perez for plasmid JJ105/L1.3. We thank Dr. Garcia-Perez and members of the Moran lab for helpful comments. C. R. B. was supported in part by NIH training grants T32GM7544 and T32000040. J.M.K. was supported by a National Science Foundation Graduate Research Fellowship. Work in the laboratory of E. E. E. was supported by grant HG004120. P. C. and C. M. were supported by a Wellcome Trust Project Grant (075163/Z/04/Z) to R. M. B. and Professor Sir Alec Jeffreys FRS. J.V.M. is supported by NIH grants GM066695 and GM060518. The University of Michigan Cancer Center Support Grant (5P30CA46592) helped defray sequencing costs incurred in this study. J.V.M. and E. E. E. are Investigators of the Howard Hughes Medical Institute. E. E. E. is a member of the SAB for Pacific Biosciences.	Alisch RS, 2006, GENE DEV, V20, P210, DOI 10.1101/gad.1380406; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Athanikar JN, 2004, NUCLEIC ACIDS RES, V32, P3846, DOI 10.1093/nar/gkh698; Babushok DV, 2007, HUM MUTAT, V28, P527, DOI 10.1002/humu.20486; Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; Bennett EA, 2008, GENOME RES, V18, P1875, DOI 10.1101/gr.081737.108; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Boeke JD, 2003, GENOME RES, V13, P1975, DOI 10.1101/gr.1392003; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Boissinot SP, 2001, MOL BIOL EVOL, V18, P2186, DOI 10.1093/oxfordjournals.molbev.a003765; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Brouha B, 2002, AM J HUM GENET, V71, P327, DOI 10.1086/341722; Cann HM, 2002, SCIENCE, V296, P261; Carroll ML, 2001, J MOL BIOL, V311, P17, DOI 10.1006/jmbi.2001.4847; Cordaux R, 2004, TRENDS GENET, V20, P464, DOI 10.1016/j.tig.2004.07.012; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cost GJ, 1998, BIOCHEMISTRY-US, V37, P18081, DOI 10.1021/bi981858s; DEININGER PL, 1992, TRENDS GENET, V8, P307, DOI 10.1016/0168-9525(92)90262-3; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; DOMBROSKI BA, 1993, P NATL ACAD SCI USA, V90, P6513, DOI 10.1073/pnas.90.14.6513; Donahue William F, 2007, Curr Protoc Hum Genet, VChapter 5, DOI 10.1002/0471142905.hg0520s54; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng QH, 1996, CELL, V87, P905, DOI 10.1016/S0092-8674(00)81997-2; FREEMAN JD, 1994, BIOTECHNIQUES, V17, P46; Frikke-Schmidt R, 2010, ATHEROSCLEROSIS, V208, P305, DOI 10.1016/j.atherosclerosis.2009.06.005; Garcia-Perez JL, 2007, GENOME RES, V17, P602, DOI 10.1101/gr.5870107; Gilbert N, 2005, MOL CELL BIOL, V25, P7780, DOI 10.1128/MCB.25.17.7780-7795.2005; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Goodier JL, 2000, HUM MOL GENET, V9, P653, DOI 10.1093/hmg/9.4.653; GRIMALDI G, 1983, NUCLEIC ACIDS RES, V11, P321, DOI 10.1093/nar/11.2.321; Han KD, 2005, GENOME RES, V15, P655, DOI 10.1101/gr.3492605; HOLMES SE, 1994, NAT GENET, V7, P143, DOI 10.1038/ng0694-143; Huang CRL, 2010, CELL, V141, P1171, DOI 10.1016/j.cell.2010.05.026; Huson DH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-460; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lavie L, 2004, GENOME RES, V14, P2253, DOI 10.1101/gr.2745804; Lutz SM, 2003, AM J HUM GENET, V73, P1431, DOI 10.1086/379744; Marchani EE, 2009, GENOMICS, V94, P78, DOI 10.1016/j.ygeno.2009.04.002; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Moran JV, 1999, SCIENCE, V283, P1530, DOI 10.1126/science.283.5407.1530; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Morrish TA, 2007, NATURE, V446, P208, DOI 10.1038/nature05560; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; Penzkofer T, 2005, NUCLEIC ACIDS RES, V33, pD498, DOI 10.1093/nar/gki044; Pickeral OK, 2000, GENOME RES, V10, P411, DOI 10.1101/gr.10.4.411; Rosenberg NA, 2006, ANN HUM GENET, V70, P841, DOI 10.1111/j.1469-1809.2006.00285.x; Sambrook J., 2002, MOL CLONING LAB MANU; Sassaman DM, 1997, NAT GENET, V16, P37, DOI 10.1038/ng0597-37; Seleme MDC, 2006, P NATL ACAD SCI USA, V103, P6611, DOI 10.1073/pnas.0601324103; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; SMIT AFA, 1995, J MOL BIOL, V246, P401, DOI 10.1006/jmbi.1994.0095; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Tarraga J, 2007, NUCLEIC ACIDS RES, V35, pW38, DOI 10.1093/nar/gkm224; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei W, 2000, ANAL BIOCHEM, V284, P435, DOI 10.1006/abio.2000.4675; Weichenrieder O, 2004, STRUCTURE, V12, P975, DOI 10.1016/j.str.2004.04.011; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	77	383	389	2	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1159	U110		10.1016/j.cell.2010.05.021	http://dx.doi.org/10.1016/j.cell.2010.05.021			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602998	Bronze, Green Accepted			2022-12-28	WOS:000279148100013
J	Bock, M; Schmitt, J; Moller, L; Spahni, R; Blunier, T; Fischer, H				Bock, Michael; Schmitt, Jochen; Moeller, Lars; Spahni, Renato; Blunier, Thomas; Fischer, Hubertus			Hydrogen Isotopes Preclude Marine Hydrate CH4 Emissions at the Onset of Dansgaard-Oeschger Events	SCIENCE			English	Article							ATMOSPHERIC CH4; CLIMATE VARIABILITY; RAPID CHANGES; METHANE; GREENLAND; RECORD; ANTARCTICA; PERIODS; CYCLE	The causes of past changes in the global methane cycle and especially the role of marine methane hydrate (clathrate) destabilization events are a matter of debate. Here we present evidence from the North Greenland Ice Core Project ice core based on the hydrogen isotopic composition of methane [delta D(CH4)] that clathrates did not cause atmospheric methane concentration to rise at the onset of Dansgaard-Oeschger (DO) events 7 and 8. Box modeling supports boreal wetland emissions as the most likely explanation for the interstadial increase. Moreover, our data show that delta D(CH4) dropped 500 years before the onset of DO 8, with CH4 concentration rising only slightly. This can be explained by an early climate response of boreal wetlands, which carry the strongly depleted isotopic signature of high-latitude precipitation at that time.	[Bock, Michael; Schmitt, Jochen; Spahni, Renato; Fischer, Hubertus] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Bock, Michael; Schmitt, Jochen; Spahni, Renato; Fischer, Hubertus] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Bock, Michael; Schmitt, Jochen; Moeller, Lars; Fischer, Hubertus] Alfred Wegener Inst Polar & Marine Res, D-27568 Bremerhaven, Germany; [Blunier, Thomas] Univ Copenhagen, Ctr Ice & Climate, Niels Bohr Inst, DK-2100 Copenhagen O, Denmark	University of Bern; University of Bern; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Copenhagen; Niels Bohr Institute	Bock, M (corresponding author), Univ Bern, Inst Phys, Sidlerstr 5, CH-3012 Bern, Switzerland.	bock@climate.unibe.ch	Schmitt, Jochen/B-7893-2009; Blunier, Thomas/M-4609-2014; Fischer, Hubertus/A-1211-2014	Schmitt, Jochen/0000-0003-4695-3029; Blunier, Thomas/0000-0002-6065-7747; Fischer, Hubertus/0000-0002-2787-4221; Moller, Lars/0000-0002-8880-5019	German Secretary of Education and Research; Deutsche Forschungsgemeinschaft (DFG); Schweizerischer Nationalfonds (SNF); European Research Council; Denmark (SNF); Belgium (FNRS-CFB); France (IFRTP); France (INSU/CNRS); Germany (AWI); Iceland (RannIs); Japan (MEXT); Sweden (SPRS); Switzerland (SNF); United States (NSF)	German Secretary of Education and Research; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Schweizerischer Nationalfonds (SNF)(Swiss National Science Foundation (SNSF)); European Research Council(European Research Council (ERC)European Commission); Denmark (SNF); Belgium (FNRS-CFB)(Fonds de la Recherche Scientifique - FNRS); France (IFRTP); France (INSU/CNRS)(Centre National de la Recherche Scientifique (CNRS)); Germany (AWI); Iceland (RannIs); Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sweden (SPRS); Switzerland (SNF); United States (NSF)	We thank I. Levin for providing a reference air tank along with calibrated isotope values. We thank T. Sowers and two anonymous reviewers for carefully reviewing the manuscript. Financial support for this study was provided in part by the German Secretary of Education and Research program GEOTECHNOLOGIEN, by Deutsche Forschungsgemeinschaft (DFG project MEPHISTO), Schweizerischer Nationalfonds (SNF project primeMETHANE), and the European Research Council advanced grant MATRICs. This work is a contribution to the North-GRIP ice core project, which is directed and organized by the Department of Geophysics at the Niels Bohr Institute for Astronomy, Physics and Geophysics, University of Copenhagen. It is supported by funding agencies in Denmark (SNF), Belgium (FNRS-CFB), France (IFRTP and INSU/CNRS), Germany (AWI), Iceland (RannIs), Japan (MEXT), Sweden (SPRS), Switzerland (SNF), and the United States (NSF).	Andersen KK, 2004, NATURE, V431, P147, DOI 10.1038/nature02805; Barbante C, 2006, NATURE, V444, P195, DOI 10.1038/nature05301; Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; Bock M, 2010, RAPID COMMUN MASS SP, V24, P621, DOI 10.1002/rcm.4429; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Burns SJ, 2003, SCIENCE, V301, P1365, DOI 10.1126/science.1086227; CHAPPELLAZ J, 1993, NATURE, V366, P443, DOI 10.1038/366443a0; Dallenbach A, 2000, GEOPHYS RES LETT, V27, P1005, DOI 10.1029/1999GL010873; de Abreu L, 2003, MAR GEOL, V196, P1, DOI 10.1016/S0025-3227(03)00046-X; de Garidel-Thoron T, 2004, P NATL ACAD SCI USA, V101, P9187, DOI 10.1073/pnas.0402909101; Etiope G, 2004, ENVIRON GEOL, V46, P997, DOI 10.1007/s00254-004-1085-1; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Huber C, 2006, EARTH PLANET SC LETT, V243, P504, DOI 10.1016/j.epsl.2006.01.002; Jouzel J, 2000, QUATERNARY SCI REV, V19, P363, DOI 10.1016/S0277-3791(99)00069-4; KENNETT JP, 2003, AGU SPECIAL PUBLICAT, V54; Keppler F, 2006, NATURE, V439, P187, DOI 10.1038/nature04420; Lelieveld J, 1998, TELLUS B, V50, P128, DOI 10.1034/j.1600-0889.1998.t01-1-00002.x; LEVIN I, 1994, NATO ASI SERIES I, V17, P1; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Nisbet EG, 2009, SCIENCE, V324, P477, DOI 10.1126/science.1172001; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Quay P, 1999, GLOBAL BIOGEOCHEM CY, V13, P445, DOI 10.1029/1998GB900006; Schrag DP, 2002, QUATERNARY SCI REV, V21, P331, DOI 10.1016/S0277-3791(01)00110-X; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Sowers T, 2006, SCIENCE, V311, P838, DOI 10.1126/science.1121235; Tierney JE, 2008, SCIENCE, V322, P252, DOI 10.1126/science.1160485; Walter KM, 2007, SCIENCE, V318, P633, DOI 10.1126/science.1142924; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; WHITICAR MJ, 1993, ATMOSPHERIC METHANE, P138	29	47	49	2	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1686	1689		10.1126/science.1187651	http://dx.doi.org/10.1126/science.1187651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576890	Green Published			2022-12-28	WOS:000279107400041
J	King, A				King, Anthony			A Wellcome Change?	CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1105	1107		10.1016/j.cell.2010.06.012	http://dx.doi.org/10.1016/j.cell.2010.06.012			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602991	Bronze			2022-12-28	WOS:000279148100005
J	Einfeld, SL; Brown, R				Einfeld, Stewart L.; Brown, Rebecca			Down Syndrome-New Prospects for an Ancient Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							DOWN-SYNDROME; CHROMOSOME-21; RESCUE		[Einfeld, Stewart L.] Univ Sydney, Fac Hlth Sci, Camperdown, NSW 2050, Australia; [Einfeld, Stewart L.; Brown, Rebecca] Univ Sydney, Brain & Mind Res Inst, Camperdown, NSW 2050, Australia	University of Sydney; University of Sydney	Einfeld, SL (corresponding author), Univ Sydney, Fac Hlth Sci, BMRI Level 3,94 Mallett St, Camperdown, NSW 2050, Australia.	stewart.einfeld@sydney.edu.au						Baek KH, 2009, NATURE, V459, P1126, DOI 10.1038/nature08062; Costa ACS, 2008, NEUROPSYCHOPHARMACOL, V33, P1624, DOI 10.1038/sj.npp.1301535; Delabar Jean-Maurice, 1993, European Journal of Human Genetics, V1, P114; Down J. T., 1866, LONDON HOSP REPORTS, V3, P259; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; LEJEUNE J, 1959, CR HEBD ACAD SCI, V248, P1721; Rachidi M, 2008, EUR J PAEDIATR NEURO, V12, P168, DOI 10.1016/j.ejpn.2007.08.010; Richard F, 1998, CHROMOSOME RES, V6, P263, DOI 10.1023/A:1009262622325; Shin M, 2009, PEDIATRICS, V124, P1565, DOI 10.1542/peds.2009-0745; WISNIEWSKI KE, 1985, ANN NEUROL, V17, P278, DOI 10.1002/ana.410170310	10	5	5	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2525	2526		10.1001/jama.2010.842	http://dx.doi.org/10.1001/jama.2010.842			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571021				2022-12-28	WOS:000279010900033
J	Engemise, S; Gordon, C; Konje, JC				Engemise, Samuel; Gordon, Cerys; Konje, Justin C.			Easily Missed Endometriosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSIS; WOMEN; ACCURACY		[Engemise, Samuel; Konje, Justin C.] Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England; [Engemise, Samuel; Konje, Justin C.] Univ Leicester, Leicester LE2 7LX, Leics, England; [Gordon, Cerys] S Wigston Hlth Ctr, Wigston LE18 4SE, England	University Hospitals of Leicester NHS Trust; University of Leicester; University of Leicester	Konje, JC (corresponding author), Univ Hosp Leicester NHS Trust, Dept Canc Studies & Mol Med, Reprod Sci Sect, Leicester LE2 7LX, Leics, England.	jck4@le.ac.uk						Ballard KD, 2008, BJOG-INT J OBSTET GY, V115, P1382, DOI 10.1111/j.1471-0528.2008.01878.x; Barnard A., 2001, PAIN OBSTET GYNAECOL, P145; CARTER JE, 1994, J AM ASSOC GYN LAP, V2, P43, DOI 10.1016/S1074-3804(05)80830-8; Cramer DW, 2002, ANN NY ACAD SCI, V955, P11, DOI 10.1111/j.1749-6632.2002.tb02761.x; *EUR NETW END, INTR; Kennedy S, 2005, HUM REPROD, V20, P2698, DOI 10.1093/humrep/dei135; Laufer M R, 1997, J Pediatr Adolesc Gynecol, V10, P199; Lockhat FB, 2005, HUM REPROD, V20, P789, DOI 10.1093/humrep/deh650; Louden Sally F., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P307, DOI 10.3109/01443619509030929; MEURSSZOJDA MM, 2009, COLORECTAL DIS  1013; Moore J, 2002, ULTRASOUND OBST GYN, V20, P630, DOI 10.1046/j.1469-0705.2002.00862.x; *NHS EV, WOM HLTH ANN EV UPD; Rosa-e-Silva JC, 2008, CLIMACTERIC, V11, P525, DOI 10.1080/13697130802490256; *ROYAL COLL OBST G, 2007, INV MAN END; Winkel CA, 2003, OBSTET GYNECOL, V102, P397, DOI 10.1016/S0029-7844(03)00474-5; Wykes CB, 2004, BJOG-INT J OBSTET GY, V111, P1204, DOI 10.1111/j.1471-0528.2004.00433.x	16	14	15	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2010	340								c2168	10.1136/bmj.c2168	http://dx.doi.org/10.1136/bmj.c2168			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IP	20573761				2022-12-28	WOS:000279346400001
J	Horton, R				Horton, Richard			Offline: The shadow of Empire	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1952	1952		10.1016/S0140-6736(10)60904-X	http://dx.doi.org/10.1016/S0140-6736(10)60904-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609WT	20569829				2022-12-28	WOS:000278689600010
J	Sarwar, N; Gao, P; Seshasai, SRK; Gobin, R; Kaptoge, S; Di Angelantonio, E; Ingelsson, E; Lawlor, DA; Selvin, E; Stampfer, M; Stehouwer, CDA; Lewington, S; Pennells, L; Thompson, A; Sattar, N; White, IR; Ray, KK; Danesh, J; Tipping, RW; Ford, CE; Pressel, SL; Folsom, AR; Chambless, LE; Wagenknecht, LE; Panagiotakos, DB; Pitsavos, C; Chrysohoou, C; Stefanadis, C; Knuiman, M; Whincup, PH; Wannamethee, SG; Morris, RW; Kiechl, S; Willeit, J; Oberhollenzer, F; Mayr, A; Wald, N; Ebrahim, S; Yarnell, JW; Gallacher, J; Casiglia, E; Tikhonoff, V; Nietert, PJ; Sutherland, SE; Bachman, DL; Keil, JE; de Boer, IH; Kizer, JR; Mukamal, KJ; Tybjaerg-Hansen, A; Nordestgaard, BG; Benn, M; Frikke-Schmidt, R; Giampaoli, S; Palmieri, L; Panico, S; Vanuzzo, D; Pilotto, L; de la Camara, AG; Rubio, MA; Simons, L; McCallum, J; Friedlander, Y; Fowkes, FGR; Lee, AJ; Taylor, J; Guralnik, JM; Phillips, CL; Wallace, R; Guralnik, JM; Phillips, CL; Blazer, DG; Guralnik, JM; Phillips, CL; Phillips, CL; Guralnik, JM; Khaw, KT; Brenner, H; Raum, E; Muller, H; Rothenbacher, D; Jansson, JH; Wennberg, P; Nissinen, A; Donfrancesco, C; Giampaoli, S; Salomaa, V; Harald, K; Jousilahti, P; Vartiainen, E; Woodward, M; D'Agostino, RB; Vasan, RS; Fox, CS; Pencina, MJ; Bladbjerg, E; Jorgensen, T; Moller, L; Jespersen, J; Dankner, R; Chetrit, A; Lubin, F; Wilhelmsen, L; Eriksson, H; Svardsudd, K; Welin, L; Rosengren, A; Wilhelmsen, L; Lappas, G; Eriksson, H; Bjorkelund, C; Lissner, L; Bengtsson, C; Cremer, P; Nagel, D; Strandberg, TE; Salomaa, V; Tilvis, RS; Miettinen, TA; Tilvis, RS; Strandberg, TE; Kiyohara, Y; Arima, H; Doi, Y; Ninomiya, T; Rodriguez, B; Dekker, JM; Nijpels, G; Stehouwer, CDA; Rimm, E; Pai, JK; Sato, S; Iso, H; Kitamura, A; Noda, H; Goldbourt, U; Nyyssonen, K; Tuomainen, TP; Salonen, JT; Deeg, D; Poppelaars, JL; Meade, TW; Cooper, JA; Hedblad, B; Berglund, G; Engstrom, G; Verschuren, WMM; Blokstra, A; Cushman, M; Folsom, AR; Psaty, BM; Shea, S; Doring, A; Koenig, W; Meisinger, C; Mraz, W; Verschuren, WMM; Blokstra, A; Bueno-De-Mesquita, HB; Wilhelmsen, L; Rosengren, A; Lappas, G; Fletcher, A; Kuller, LH; Grandits, G; Selmer, R; Tverdal, A; Nystad, W; Gillum, R; Mussolino, M; Rimm, E; Hankinson, S; Manson, JE; Pai, JK; Salomaa, V; Harald, K; Jousilahti, P; Vartiainen, E; Cooper, JA; Bauer, KA; Davidson, KW; Kirkland, S; Shaffer, J; Korin, MR; Kitamura, A; Sato, S; Iso, H; Holme, I; Selmer, R; Tverdal, A; Nystad, W; Ducimetiere, P; Jouven, X; Bakker, SJL; Gansevoort, RT; Hillege, HL; Crespo, CJ; Palmieri, MRG; Amouyel, P; Arveiler, D; Evans, A; Ferrieres, J; Schulte, H; Assmann, G; Westendorp, RG; Buckley, BM; Packard, CJ; Sattar, N; Cantin, B; Lamarche, B; Despres, JP; Dagenais, GR; Barrett-Connor, E; Wingard, DL; Bettencourt, R; Gudnason, V; Aspelund, T; Sigurdsson, G; Thorsson, B; Trevisan, M; Witteman, J; Kardys, I; Breteler, M; Hofman, A; Tunstall-Pedoe, H; Tavendale, R; Lowe, GDO; Woodward, M; Howard, BV; Zhang, Y; Best, L; Umans, J; Ben-Shlomo, Y; Davey-Smith, G; Onat, A; Hergenc, G; Can, G; Njolstad, I; Mathiesen, EB; Lochen, ML; Wilsgaard, T; Zethelius, B; Riserus, U; Berne, C; Ingelsson, E; Gaziano, JM; Stampfer, M; Ridker, P; Gaziano, JM; Ridker, P; Ulmer, H; Diem, G; Concin, H; Tosetto, A; Rodeghiero, F; Manson, JE; Tinker, L; Liu, S; Howard, BV; Marmot, IM; Clarke, R; Collins, R; Fletcher, A; Brunner, E; Shipley, M; Ridker, P; Buring, J; Shepherd, J; Cobbe, SM; Ford, I; Robertson, M; Ibanez, AM; Feskens, EJM; Kromhout, D; Walker, M; Watson, S; Alexander, M; Di Angelantonio, E; Erqou, S; Gao, P; Gobin, R; Haycock, P; Kaptoge, S; Seshasai, SRK; Lewington, S; Pennells, L; Perry, PL; Ray, KK; Sarwar, N; Thompson, A; Thompson, SG; Walker, M; Watson, S; White, IR; Wood, AM; Wormser, D; Danesh, J				Sarwar, N.; Gao, P.; Seshasai, S. R. Kondapally; Gobin, R.; Kaptoge, S.; Di Angelantonio, E.; Ingelsson, E.; Lawlor, D. A.; Selvin, E.; Stampfer, M.; Stehouwer, C. D. A.; Lewington, S.; Pennells, L.; Thompson, A.; Sattar, N.; White, I. R.; Ray, K. K.; Danesh, J.; Tipping, R. W.; Ford, C. E.; Pressel, S. L.; Folsom, A. R.; Chambless, L. E.; Wagenknecht, L. E.; Panagiotakos, D. B.; Pitsavos, C.; Chrysohoou, C.; Stefanadis, C.; Knuiman, M.; Whincup, P. H.; Wannamethee, S. G.; Morris, R. W.; Kiechl, S.; Willeit, J.; Oberhollenzer, F.; Mayr, A.; Wald, N.; Ebrahim, S.; Yarnell, J. W.; Gallacher, J.; Casiglia, E.; Tikhonoff, V.; Nietert, P. J.; Sutherland, S. E.; Bachman, D. L.; Keil, J. E.; de Boer, I. H.; Kizer, J. R.; Mukamal, K. J.; Tybjaerg-Hansen, A.; Nordestgaard, B. G.; Benn, M.; Frikke-Schmidt, R.; Giampaoli, S.; Palmieri, L.; Panico, S.; Vanuzzo, D.; Pilotto, L.; de la Camara, A. Gomez; Rubio, M. A.; Simons, L.; McCallum, J.; Friedlander, Y.; Fowkes, F. G. R.; Lee, A. J.; Taylor, J.; Guralnik, J. M.; Phillips, C. L.; Wallace, R.; Guralnik, J. M.; Phillips, C. L.; Blazer, D. G.; Guralnik, J. M.; Phillips, C. L.; Phillips, C. L.; Guralnik, J. M.; Khaw, K. T.; Brenner, H.; Raum, E.; Mueller, H.; Rothenbacher, D.; Jansson, J. H.; Wennberg, P.; Nissinen, A.; Donfrancesco, C.; Giampaoli, S.; Salomaa, V.; Harald, K.; Jousilahti, P.; Vartiainen, E.; Woodward, M.; D'Agostino, R. B.; Vasan, R. S.; Fox, C. S.; Pencina, M. J.; Bladbjerg, E.; Jorgensen, T.; Moller, L.; Jespersen, J.; Dankner, R.; Chetrit, A.; Lubin, F.; Wilhelmsen, L.; Eriksson, H.; Svardsudd, K.; Welin, L.; Rosengren, A.; Wilhelmsen, L.; Lappas, G.; Eriksson, H.; Bjorkelund, C.; Lissner, L.; Bengtsson, C.; Cremer, P.; Nagel, D.; Strandberg, T. E.; Salomaa, V.; Tilvis, R. S.; Miettinen, T. A.; Tilvis, R. S.; Strandberg, T. E.; Kiyohara, Y.; Arima, H.; Doi, Y.; Ninomiya, T.; Rodriguez, B.; Dekker, J. M.; Nijpels, G.; Stehouwer, C. D. A.; Rimm, E.; Pai, J. K.; Sato, S.; Iso, H.; Kitamura, A.; Noda, H.; Goldbourt, U.; Nyyssonen, K.; Tuomainen, T. P.; Salonen, J. T.; Deeg, D.; Poppelaars, J. L.; Meade, T. W.; Cooper, J. A.; Hedblad, B.; Berglund, G.; Engstrom, G.; Verschuren, W. M. M.; Blokstra, A.; Cushman, M.; Folsom, A. R.; Psaty, B. M.; Shea, S.; Doring, A.; Koenig, W.; Meisinger, C.; Mraz, W.; Verschuren, W. M. M.; Blokstra, A.; Bueno-de-Mesquita, H. Bas; Wilhelmsen, L.; Rosengren, A.; Lappas, G.; Fletcher, A.; Kuller, L. H.; Grandits, G.; Selmer, R.; Tverdal, A.; Nystad, W.; Gillum, R.; Mussolino, M.; Rimm, E.; Hankinson, S.; Manson, J. E.; Pai, J. K.; Salomaa, V.; Harald, K.; Jousilahti, P.; Vartiainen, E.; Cooper, J. A.; Bauer, K. A.; Davidson, K. W.; Kirkland, S.; Shaffer, J.; Korin, M. R.; Kitamura, A.; Sato, S.; Iso, H.; Holme, I.; Selmer, R.; Tverdal, A.; Nystad, W.; Ducimetiere, P.; Jouven, X.; Bakker, S. J. L.; Gansevoort, R. T.; Hillege, H. L.; Crespo, C. J.; Palmieri, M. R. Garcia; Amouyel, P.; Arveiler, D.; Evans, A.; Ferrieres, J.; Schulte, H.; Assmann, G.; Westendorp, R. G.; Buckley, B. M.; Packard, C. J.; Sattar, N.; Cantin, B.; Lamarche, B.; Despres, J. P.; Dagenais, G. R.; Barrett-Connor, E.; Wingard, D. L.; Bettencourt, R.; Gudnason, V.; Aspelund, T.; Sigurdsson, G.; Thorsson, B.; Trevisan, M.; Witteman, J.; Kardys, I.; Breteler, M.; Hofman, A.; Tunstall-Pedoe, H.; Tavendale, R.; Lowe, G. D. O.; Woodward, M.; Howard, B. V.; Zhang, Y.; Best, L.; Umans, J.; Ben-Shlomo, Y.; Davey-Smith, G.; Onat, A.; Hergenc, G.; Can, G.; Njolstad, I.; Mathiesen, E. B.; Lochen, M. L.; Wilsgaard, T.; Zethelius, B.; Riserus, U.; Berne, C.; Ingelsson, E.; Gaziano, J. M.; Stampfer, M.; Ridker, P.; Gaziano, J. M.; Ridker, P.; Ulmer, H.; Diem, G.; Concin, H.; Tosetto, A.; Rodeghiero, F.; Manson, J. E.; Tinker, L.; Liu, S.; Howard, B. V.; Marmot, I. M.; Clarke, R.; Collins, R.; Fletcher, A.; Brunner, E.; Shipley, M.; Ridker, P.; Buring, J.; Shepherd, J.; Cobbe, S. M.; Ford, I.; Robertson, M.; Ibanez, A. Marin; Feskens, E. J. M.; Kromhout, D.; Walker, M.; Watson, S.; Alexander, M.; Di Angelantonio, E.; Erqou, S.; Gao, P.; Gobin, R.; Haycock, P.; Kaptoge, S.; Seshasai, S. R. Kondapally; Lewington, S.; Pennells, L.; Perry, P. L.; Ray, K. K.; Sarwar, N.; Thompson, A.; Thompson, S. G.; Walker, M.; Watson, S.; White, I. R.; Wood, A. M.; Wormser, D.; Danesh, J.		Emerging Risk Factors Collabor	Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies	LANCET			English	Article							CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PATHOPHYSIOLOGY; ATHEROSCLEROSIS; MORTALITY; THERAPY	Background Uncertainties persist about the magnitude of associations of diabetes mellitus and fasting glucose concentration with risk of coronary heart disease and major stroke subtypes. We aimed to quantify these associations for a wide range of circumstances. Methods We undertook a meta-analysis of individual records of diabetes, fasting blood glucose concentration, and other risk factors in people without initial vascular disease from studies in the Emerging Risk Factors Collaboration. We combined within-study regressions that were adjusted for age, sex, smoking, systolic blood pressure, and body-mass index to calculate hazard ratios (HRs) for vascular disease. Findings Analyses included data for 698 782 people (52765 non-fatal or fatal vascular outcomes; 8.49 million person-years at risk) from 102 prospective studies. Adjusted HRs with diabetes were: 2.00 (95% CI 1.83-2.19) for coronary heart disease; 2.27 (1.95-2.65) for ischaemic stroke; 1.56 (1.19-2.05) for haemorrhagic stroke; 1.84 (1.59-2.13) for unclassified stroke; and 1.73 (1.51-1.98) for the aggregate of other vascular deaths. HRs did not change appreciably after further adjustment for lipid, inflammatory, or renal markers. HRs for coronary heart disease were higher in women than in men, at 40-59 years than at 70 years and older, and with fatal than with non-fatal disease. At an adult population-wide prevalence of 10%, diabetes was estimated to account for 11% (10-12%) of vascular deaths. Fasting blood glucose concentration was non-linearly related to vascular risk, with no significant associations between 3.90 mmol/L and 5.59 mmol/L. Compared with fasting blood glucose concentrations of 3.90-5.59 mmol/L, HRs for coronary heart disease were: 1.07 (0.97-1.18) for lower than 3.90 mmol/L; 1.11 (1.04-1.18) for 5.60-6-09 mmol/L; and 1.17 (1.08-1.26) for 6.10-6.99 mmol/L. In people without a history of diabetes, information about fasting blood glucose concentration or impaired fasting glucose status did not significantly improve metrics of vascular disease prediction when added to information about several conventional risk factors. Interpretation Diabetes confers about a two-fold excess risk for a wide range of vascular diseases, independently from other conventional risk factors. In people without diabetes, fasting blood glucose concentration is modestly and nonlinearly associated with risk of vascular disease.	[Sarwar, N.] Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England; [Ingelsson, E.] Karolinska Inst, S-10401 Stockholm, Sweden; [Lawlor, D. A.] Univ Bristol, Bristol BS8 1TH, Avon, England; [Selvin, E.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Stampfer, M.] Harvard Univ, Sch Publ Hlth, Cambridge, MA 02138 USA; [Stehouwer, C. D. A.] Maastricht Univ, Med Ctr, Maastricht, Netherlands; [Lewington, S.] Univ Oxford, Oxford OX1 2JD, England; [Sattar, N.] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [White, I. R.] MRC, Biostat Unit, London W1N 4AL, England	University of Cambridge; Karolinska Institutet; University of Bristol; Johns Hopkins University; Harvard University; Harvard T.H. Chan School of Public Health; Maastricht University; University of Oxford; University of Glasgow; MRC Biostatistics Unit	Sarwar, N (corresponding author), Univ Cambridge, Emerging Risk Factors Collaborat Coordinating Ctr, Dept Publ Hlth & Primary Care, Strangeways Res Lab, Cambridge CB1 8RN, England.		Ford, Ian/ABE-6145-2020; DiAngelantonio, Emanuele/ABE-6852-2020; Jørgensen, Torben/Z-1335-2018; vhmpp, aks/F-9756-2012; Breteler, Monique M.B./J-5058-2014; Gudnason, Vilmundur/AAE-7126-2019; Woodward, Mark/L-6817-2017; Tikhonoff, Valerie/AAC-3728-2019; de Boer, Ian/GYJ-3282-2022; Lamarche, Benoit/ABA-4785-2021; Bakker, Stephan J. L./J-4023-2015; Gudnason, Vilmundur/K-6885-2015; Davidson, Karina/AAG-2388-2019; Dankner, Rachel/Q-5245-2019; Benn, Marianne/O-4164-2019; Ray, Kausik/Z-2055-2019; Panagiotakos, Demosthenes/M-9167-2019; Lennon, Lucy/ABB-9433-2020; Panagiotakos, Demosthenes/K-8294-2019; Feskens, Edith/ABI-1446-2020; Can, Günay/AAB-1669-2020; Gao, Pei/R-4794-2018; Wald, Nicholas/AAY-2814-2021; Gao, Pei/AAF-3065-2019; Ulmer, Hanno/S-6615-2019; Wood, Angela/GZA-5762-2022; Ben-Shlomo, Yoav/ABD-2004-2021; Davidson, Karina/GWC-0996-2022; Panagiotakos, Demosthenes/C-9776-2013; Ramachandran, Vasan/Y-2527-2019; Mukamal, Kenneth/GVR-7978-2022; Njolstad, Inger/X-3784-2019; Stehouwer, Coen/AAB-3435-2021; Davey Smith, George/A-7407-2013; Aspelund, Thor/K-7022-2019; PALMIERI, LUIGI/O-1845-2017; Rubio, Miguel Angel/GRJ-0134-2022; Stefanadis, Christodoulos/ABH-2232-2020; Wald, Nicholas/AAY-8924-2021; Brunner, Eric/H-2114-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Tosetto, Alberto/AAB-9320-2022; Meisinger, Christine/B-5358-2014; Tosetto, Alberto/AAM-3200-2020; Ferrieres, Jean/S-7993-2016; Marmot, Michael/Y-3920-2019; donfrancesco, chiara/K-1460-2016	Breteler, Monique M.B./0000-0002-0626-9305; Gudnason, Vilmundur/0000-0001-5696-0084; Tikhonoff, Valerie/0000-0001-7846-0101; Lamarche, Benoit/0000-0002-4443-5378; Bakker, Stephan J. L./0000-0003-3356-6791; Gudnason, Vilmundur/0000-0001-5696-0084; Davidson, Karina/0000-0002-9162-477X; Dankner, Rachel/0000-0001-6454-6000; Benn, Marianne/0000-0002-1701-595X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Lennon, Lucy/0000-0002-1738-1351; Feskens, Edith/0000-0001-5819-2488; Gao, Pei/0000-0001-8649-1290; Gao, Pei/0000-0001-8649-1290; Ulmer, Hanno/0000-0001-5911-1002; Wood, Angela/0000-0002-7937-304X; Ben-Shlomo, Yoav/0000-0001-6648-3007; Davidson, Karina/0000-0002-9162-477X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Ramachandran, Vasan/0000-0001-7357-5970; Davey Smith, George/0000-0002-1407-8314; Aspelund, Thor/0000-0002-7998-5433; PALMIERI, LUIGI/0000-0002-4298-2642; Rubio, Miguel Angel/0000-0002-0495-6240; Stefanadis, Christodoulos/0000-0001-5974-6454; Brunner, Eric/0000-0002-0595-4474; Tosetto, Alberto/0000-0002-0119-5204; Ferrieres, Jean/0000-0001-6144-1297; Lewington, Sarah/0000-0002-4496-4771; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Marmot, Michael/0000-0002-2431-6419; Bladbjerg, Else Marie/0000-0003-0912-2437; Stehouwer, Coen/0000-0001-8752-3223; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Whincup, Peter/0000-0002-5589-4107; Morris, Richard/0000-0001-7240-4563; Nietert, Paul/0000-0002-3933-4986; Haycock, Philip/0000-0001-5001-3350; Rothenbacher, Dietrich/0000-0002-3563-2791; Pennells, Lisa Anne/0000-0002-8594-3061; White, Ian/0000-0002-6718-7661; Di Angelantonio, Emanuele/0000-0001-8776-6719; Gomez de la Camara, Agustin/0000-0001-6827-6319; Jespersen, Jorgen/0000-0002-3059-2356; Kirkland, Susan/0000-0002-8182-2369; Cushman, Mary/0000-0002-7871-6143; Tverdal, Aage/0000-0002-2909-5678; Lawlor, Debbie A/0000-0002-6793-2262; donfrancesco, chiara/0000-0002-8040-5571; s, hema/0000-0002-3440-9475; Woodward, Mark/0000-0001-9800-5296; Korin, Maya/0000-0002-8010-7769; Jorgensen, Torben/0000-0001-9453-2830; Lochen, Maja-Lisa/0000-0002-8532-6573; Engstrom, Gunnar/0000-0002-8618-9152; Koenig, Wolfgang/0000-0002-2064-9603; Nordestgaard, Borge/0000-0002-1954-7220; Amouyel, Philippe/0000-0001-9088-234X	British Heart Foundation [RG/08/014]; UK Medical Research Council; Pfizer; BUPA Foundation; Denka; diaDexus; European Union; Evelyn Trust; Fogarty International Centre; GlaxoSmithKline; Merck Sharp; Dohme; National Heart, Lung and Blood Institute; National Institute of Neurological Disorders and Stroke; Novartis; Roche; Wellcome Trust; UK Biobank; Dorothy Hodgkin Postgraduate Award; Gates Cambridge Trust; Overseas Research Studentship Award; Addendrookes Charitable Trust; ERFC; British Heart Foundation [RG/08/013/25942, RG/07/008/23674, RG/08/014/24067] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G19/35, G0100222, G0401527, G0600705, MC_U137686857, G0701619, MC_U105260792, G0902037, MC_U105260558, G8802774] Funding Source: researchfish; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G0600705, G0701619, MC_U105260792, MC_U105260558, MC_U137686857, G0902037] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R03AG021162] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); BUPA Foundation; Denka; diaDexus; European Union(European Commission); Evelyn Trust; Fogarty International Centre(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); GlaxoSmithKline(GlaxoSmithKline); Merck Sharp; Dohme; National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Novartis(Novartis); Roche(Roche Holding); Wellcome Trust(Wellcome TrustEuropean Commission); UK Biobank; Dorothy Hodgkin Postgraduate Award; Gates Cambridge Trust; Overseas Research Studentship Award; Addendrookes Charitable Trust; ERFC; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding British Heart Foundation, UK Medical Research Council, and Pfizer.r JD has received research funding from the British Heart Foundation, BUPA Foundation, Denka, diaDexus, European Union, Evelyn Trust, Fogarty International Centre, GlaxoSmithKline, Medical Research Council, Merck Sharp and Dohme, National Heart, Lung and Blood Institute, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, Wellcome Trust, and UK Biobank, and has served on advisory boards for Merck and Novartis, for which he has received compensation. AT has received honoraria and reimbursement of costs for speaking at scientific meetings from GlaxoSmitliKline. All other members of the writing committee declare that they have no conflicts of interest.r The ERFC Coordinating Centre was supported by the British Heart Foundation (RG/08/014), UK Medical Research Council, and a specific grant from Pfizer. RG is supported by a Dorothy Hodgkin Postgraduate Award. SRKS is supported by the Gates Cambridge Trust Scholarship, Overseas Research Studentship Award Scheme, and the Addendrookes Charitable Trust Clinical Research Fellowship. Various sources have supported recruitment, follow-up, and laboratory measurements in the cohorts contributing to the ERFC. Investigators of several of these studies have contributed to a list (http://www.phpc.cam.ac.uk/ceu/erfc) naming relevant funding sources.	Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Avendano M, 2006, LANCET, V368, P1631, DOI 10.1016/S0140-6736(06)69675-X; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Danaei G, 2006, LANCET, V368, P1651, DOI 10.1016/S0140-6736(06)69700-6; Danesh J, 2009, STAT MED, V28, P389, DOI 10.1002/sim.3378; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; EASTON DF, 1991, STAT MED, V10, P1025, DOI 10.1002/sim.4780100703; *EM RISK FACT COLL, 2010, INT J EPIDEMIOL, DOI DOI 10.1093/IJE/DYQ063; GAN D, 2007, DIABETES ATLAS; Gao Weiguo, 2004, Clin Lab, V50, P609; Graubard BI, 2007, STAT MED, V26, P2639, DOI 10.1002/sim.2734; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Janghorbani M, 2007, DIABETES CARE, V30, P1730, DOI 10.2337/dc06-2363; Kanaya AM, 2002, ARCH INTERN MED, V162, P1737, DOI 10.1001/archinte.162.15.1737; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lopez AD, 2006, GLOBAL BURDEN OF DISEASE AND RISK FACTORS, P1; Natali A, 2000, DIABETOLOGIA, V43, P632, DOI 10.1007/s001250051352; Ryden L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]; SARWAR N, 2007, EUR HEART J, V249, P1; Sarwar N, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000278; Schramm TK, 2008, CIRCULATION, V117, P1945, DOI 10.1161/CIRCULATIONAHA.107.720847; Spencer EA, 2008, EUR J EPIDEMIOL, V23, P793, DOI 10.1007/s10654-008-9298-3; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Woodward M, 2003, DIABETES CARE, V26, P360	30	2820	2913	20	308	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2215	2222		10.1016/s0140-6736(10)60484-9	http://dx.doi.org/10.1016/s0140-6736(10)60484-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609967	Green Published, Green Accepted			2022-12-28	WOS:000279652900018
J	Petersen, TH; Calle, EA; Zhao, LP; Lee, EJ; Gui, LQ; Raredon, MB; Gavrilov, K; Yi, T; Zhuang, ZW; Breuer, C; Herzog, E; Niklason, LE				Petersen, Thomas H.; Calle, Elizabeth A.; Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Raredon, MichaSam B.; Gavrilov, Kseniya; Yi, Tai; Zhuang, Zhen W.; Breuer, Christopher; Herzog, Erica; Niklason, Laura E.			Tissue-Engineered Lungs for in Vivo Implantation	SCIENCE			English	Article							EMBRYONIC STEM-CELLS; II CELLS; VITRO; TRANSPLANTATION; MATRIX; ACID	Because adult lung tissue has limited regeneration capacity, lung transplantation is the primary therapy for severely damaged lungs. To explore whether lung tissue can be regenerated in vitro, we treated lungs from adult rats using a procedure that removes cellular components but leaves behind a scaffold of extracellular matrix that retains the hierarchical branching structures of airways and vasculature. We then used a bioreactor to culture pulmonary epithelium and vascular endothelium on the acellular lung matrix. The seeded epithelium displayed remarkable hierarchical organization within the matrix, and the seeded endothelial cells efficiently repopulated the vascular compartment. In vitro, the mechanical characteristics of the engineered lungs were similar to those of native lung tissue, and when implanted into rats in vivo for short time intervals (45 to 120 minutes) the engineered lungs participated in gas exchange. Although representing only an initial step toward the ultimate goal of generating fully functional lungs in vitro, these results suggest that repopulation of lung matrix is a viable strategy for lung regeneration.	[Petersen, Thomas H.; Calle, Elizabeth A.; Raredon, MichaSam B.; Niklason, Laura E.] Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA; [Petersen, Thomas H.] Duke Univ, Dept Biomed Engn, Durham, NC 27708 USA; [Zhao, Liping; Lee, Eun Jung; Gui, Liqiong; Niklason, Laura E.] Yale Univ, Dept Anesthesia, New Haven, CT 06520 USA; [Gavrilov, Kseniya] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Yi, Tai; Breuer, Christopher] Yale Univ, Dept Surg, New Haven, CT 06520 USA; [Zhuang, Zhen W.; Herzog, Erica] Yale Univ, Dept Internal Med, New Haven, CT 06520 USA	Yale University; Duke University; Yale University; Yale University; Yale University; Yale University	Niklason, LE (corresponding author), Yale Univ, Dept Biomed Engn, New Haven, CT 06520 USA.	laura.niklason@yale.edu	aksel, hacer/H-1572-2015	Raredon, Micha Sam/0000-0003-1441-6122; Breuer, Christopher/0000-0003-0987-3898; Petersen, Thomas/0000-0002-4667-7493	Yale University Department of Anesthesia; NIH [HL 098220, T32 GM007171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER	Yale University Department of Anesthesia; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Colehour for help with bioreactor development and Western blotting, R. Homer for histologic assessment, and B. Stripp for the CCSP antibody. This work was funded by Yale University Department of Anesthesia and by NIH grant HL 098220 (to L.E.N.). T.H.P. is supported by NIH T32 GM007171. L.E.N. holds stock in Humacyte, a regenerative medicine company. The authors (L.E.N., T.H.P., and E.A.C.) and Yale University have filed a patent application related to tissue engineering of lungs.	*AM LUNG ASS, LUND DIS DAT 2008; Andrade CF, 2007, AM J PHYSIOL-LUNG C, V292, pL510, DOI 10.1152/ajplung.00175.2006; Baptista PM, 2009, IEEE ENG MED BIO, P6526, DOI 10.1109/IEMBS.2009.5333145; Bittar EE, 2002, PULMONARY BIOL HLTH; Cortiella J, 2006, TISSUE ENG, V12, P1213, DOI 10.1089/ten.2006.12.1213; DEFOUW DO, 1983, AM REV RESPIR DIS, V127, pS9; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; Gray TE, 1996, AM J RESP CELL MOL, V14, P104, DOI 10.1165/ajrcmb.14.1.8534481; Inanlou MR, 2005, HISTOL HISTOPATHOL, V20, P1261, DOI 10.14670/HH-20.1261; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Lin YM, 2006, J BIOMATER APPL, V21, P109, DOI 10.1177/0885328206057952; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; MASSARO D, 1985, J CLIN INVEST, V76, P1297, DOI 10.1172/JCI112103; Mondrinos MJ, 2006, TISSUE ENG, V12, P717, DOI 10.1089/ten.2006.12.717; Orens Jonathan B, 2009, Proc Am Thorac Soc, V6, P13, DOI 10.1513/pats.200807-072GO; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Rippon Helen J, 2008, Proc Am Thorac Soc, V5, P717, DOI 10.1513/pats.200801-008AW; Roszell B, 2009, TISSUE ENG PT A, V15, P3351, DOI 10.1089/ten.TEA.2008.0664; Sporty JL, 2008, EXPERT OPIN DRUG MET, V4, P333, DOI [10.1517/17425255.4.4.333, 10.1517/17425255.4.4.333 ]; STAUB NC, 1998, PHYSIOLOGY, pCH32; SUGIHARA H, 1993, AM J PATHOL, V142, P783; Wang DC, 2010, MOL THER, V18, P625, DOI 10.1038/mt.2009.317; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	23	836	884	2	330	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 30	2010	329	5991					538	541		10.1126/science.1189345	http://dx.doi.org/10.1126/science.1189345			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	633EX	20576850	Green Accepted			2022-12-28	WOS:000280483500028
J	Furukawa, H; Ko, N; Go, YB; Aratani, N; Choi, SB; Choi, E; Yazaydin, AO; Snurr, RQ; O'Keeffe, M; Kim, J; Yaghi, OM				Furukawa, Hiroyasu; Ko, Nakeun; Go, Yong Bok; Aratani, Naoki; Choi, Sang Beom; Choi, Eunwoo; Yazaydin, A. Oezguer; Snurr, Randall Q.; O'Keeffe, Michael; Kim, Jaheon; Yaghi, Omar M.			Ultrahigh Porosity in Metal-Organic Frameworks	SCIENCE			English	Article							HYDROGEN STORAGE; SURFACE-AREAS; COORDINATION POLYMERS; ADSORPTION; DESIGN; ROUTE; SITES	Crystalline solids with extended non-interpenetrating three-dimensional crystal structures were synthesized that support well-defined pores with internal diameters of up to 48 angstroms. The Zn(4)O(CO(2))(6) unit was joined with either one or two kinds of organic link, 4,4',4 ''-[benzene-1,3,5-triyl-tris (ethyne-2,1-diyl)]tribenzoate (BTE), 4,4',44 ''-[benzene-1,3,5-triyl-tris(benzene-4,1-diyl)]tribenzoate (BBC), 4,4',44 ''-benzene-1,3,5-triyl-tribenzoate (BTB)/2,6-naphthalenedicarboxylate (NDC), and BTE/biphenyl-4,4'-dicarboxylate (BPDC), to give four metal-organic frameworks (MOFs), MOF-180, -200, -205, and -210, respectively. Members of this series of MOFs show exceptional porosities and gas (hydrogen, methane, and carbon dioxide) uptake capacities. For example, MOF-210 has Brunauer-Emmett-Teller and Langmuir surface areas of 6240 and 10,400 square meters per gram, respectively, and a total carbon dioxide storage capacity of 2870 milligrams per gram. The volume-specific internal surface area of MOF-210 (2060 square meters per cubic centimeter) is equivalent to the outer surface of nanoparticles (3-nanometer cubes) and near the ultimate adsorption limit for solid materials.	[Ko, Nakeun; Choi, Sang Beom; Kim, Jaheon] Soongsil Univ, Dept Chem, Seoul 156743, South Korea; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Calif NanoSyst Inst, Ctr Reticular Chem, Los Angeles, CA 90095 USA; [Furukawa, Hiroyasu; Go, Yong Bok; Aratani, Naoki; Choi, Eunwoo; O'Keeffe, Michael; Yaghi, Omar M.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Yazaydin, A. Oezguer; Snurr, Randall Q.] Northwestern Univ, Dept Chem & Biol Engn, Evanston, IL 60208 USA; [Yaghi, Omar M.] Univ Calif Los Angeles, Inst Genom & Prote, Dept Energy, Los Angeles, CA 90095 USA	Soongsil University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Northwestern University; University of California System; University of California Los Angeles	Kim, J (corresponding author), Soongsil Univ, Dept Chem, Seoul 156743, South Korea.	jaheon@ssu.ac.kr; yaghi@chem.ucla.edu	Yaghi, Omar M/C-6749-2013; Snurr, Randall Q/E-4900-2011; Snurr, Randall Q/B-6699-2009; Aratani, Naoki/D-1626-2011; Yazaydin, A. Ozgur/F-4075-2019; Furukawa, Hiroyasu/C-5910-2008	Snurr, Randall Q/0000-0003-2925-9246; Aratani, Naoki/0000-0002-3181-6526; Yazaydin, A. Ozgur/0000-0001-8562-723X; Furukawa, Hiroyasu/0000-0002-6082-1738; Yaghi, Omar/0000-0002-5611-3325	BASF SE; DOE Office of Basic Energy Sciences [DE-FG02-08ER15935]; DOE [FG36-05GO15001]; Ministry of Education, Science and Technology of Korea; Defense Threat Reduction Agency [HDTRA1-08-C-005]	BASF SE(BASF); DOE Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE)); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency)	This work is partially supported by BASF SE. The synthesis, characterization of MOF-200, and nitrogen, methane, and carbon dioxide adsorption measurements of the MOFs are supported by the DOE Office of Basic Energy Sciences (DE-FG02-08ER15935 to O.M.Y.), and hydrogen adsorption measurements are supported by the DOE (DE-FG36-05GO15001 to O.M.Y.). We thank the Hydrogen Energy R&D Center, one of the 21st Century Frontier R&D Programs (the Ministry of Education, Science and Technology of Korea to J.K.), and the Defense Threat Reduction Agency (HDTRA1-08-C-005 to R. Q. S.). We thank N. W. Ockwig (Sandia National Laboratories) for his initial work, S. Khan (UCLA) for his help in single-crystal x-ray structure collection and analysis of MOF-200, Y. K. Park and E. Jo (Soongsil University) for their synthesis work of organic links, Accelrys Korea for MS Modeling support, and Pohang Accelerator Laboratory, Korea (2009-2063-12, 2009-2063-18). Crystallographic data for the structures reported in this paper have been deposited with the Cambridge Crystallographic Data Centre under reference numbers CCDC 775690 to 775693. These data can be obtained free of charge via www.ccdc.cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK).	Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; Chae HK, 2003, ANGEW CHEM INT EDIT, V42, P3907, DOI 10.1002/anie.200351546; Chen BL, 2001, SCIENCE, V291, P1021, DOI 10.1126/science.1056598; Dinca M, 2008, ANGEW CHEM INT EDIT, V47, P6766, DOI 10.1002/anie.200801163; Doonan CJ, 2009, J AM CHEM SOC, V131, P9492, DOI 10.1021/ja903251e; El-Kaderi HM, 2007, SCIENCE, V316, P268, DOI 10.1126/science.1139915; Ferey G, 2005, SCIENCE, V309, P2040, DOI 10.1126/science.1116275; Furukawa H, 2007, J MATER CHEM, V17, P3197, DOI 10.1039/b703608f; Kaye SS, 2007, J AM CHEM SOC, V129, P14176, DOI 10.1021/ja076877g; Kitagawa S, 2004, ANGEW CHEM INT EDIT, V43, P2334, DOI 10.1002/anie.200300610; Klein N, 2009, ANGEW CHEM INT EDIT, V48, P9954, DOI 10.1002/anie.200904599; Koh K, 2009, J AM CHEM SOC, V131, P4184, DOI 10.1021/ja809985t; Lee J, 2009, CHEM SOC REV, V38, P1450, DOI 10.1039/b807080f; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Lin X, 2007, CRYSTENGCOMM, V9, P438, DOI 10.1039/b706207a; Llewellyn PL, 2008, LANGMUIR, V24, P7245, DOI 10.1021/la800227x; Ma SQ, 2008, J AM CHEM SOC, V130, P1012, DOI 10.1021/ja0771639; Mueller U, 2006, J MATER CHEM, V16, P626, DOI 10.1039/b511962f; Nelson AP, 2009, J AM CHEM SOC, V131, P458, DOI 10.1021/ja808853q; O'Keeffe M, 2008, ACCOUNTS CHEM RES, V41, P1782, DOI 10.1021/ar800124u; Rowsell JLC, 2005, SCIENCE, V309, P1350, DOI 10.1126/science.1113247; Schnobrich JK, 2010, LANGMUIR, V26, P5808, DOI 10.1021/la9037292; Walton KS, 2007, J AM CHEM SOC, V129, P8552, DOI 10.1021/ja071174k; Wong-Foy AG, 2006, J AM CHEM SOC, V128, P3494, DOI 10.1021/ja058213h; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yan Y, 2009, CHEM COMMUN, P1025, DOI 10.1039/b900013e; Zhao XB, 2004, SCIENCE, V306, P1012, DOI 10.1126/science.1101982	27	2870	2983	91	3747	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					424	428		10.1126/science.1192160	http://dx.doi.org/10.1126/science.1192160			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595583				2022-12-28	WOS:000280196500033
J	Wang, LA; Liu, YH				Wang, Lian; Liu, Yong-Hong			Balo's concentric sclerosis	LANCET			English	Editorial Material									[Wang, Lian] Kunming Gen Hosp Chengdu Mil Reg, Kunming 650032, Peoples R China; [Liu, Yong-Hong] Fourth Mil Med Univ, Xijing Hosp, Dept Neurol, Xian 710032, Peoples R China	Kunming General Hospital; Air Force Military Medical University	Wang, LA (corresponding author), Kunming Gen Hosp Chengdu Mil Reg, Kunming 650032, Peoples R China.	lianwangping@163.com							0	7	7	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 17	2010	376	9736					189	189		10.1016/S0140-6736(09)61876-6	http://dx.doi.org/10.1016/S0140-6736(09)61876-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20630582	Bronze			2022-12-28	WOS:000280313100026
J	Seo, J; Roushan, P; Beidenkopf, H; Hor, YS; Cava, RJ; Yazdani, A				Seo, Jungpil; Roushan, Pedram; Beidenkopf, Haim; Hor, Y. S.; Cava, R. J.; Yazdani, Ali			Transmission of topological surface states through surface barriers	NATURE			English	Article							HGTE QUANTUM-WELLS; INSULATOR; CONFINEMENT; CORRALS; BI2TE3; WAVES; PHASE	Topological surface states are a class of novel electronic states that are of potential interest in quantum computing or spintronic applications(1-7). Unlike conventional two-dimensional electron states, these surface states are expected to be immune to localization and to overcome barriers caused by material imperfection(8-14). Previous experiments have demonstrated that topological surface states do not backscatter between equal and opposite momentum states, owing to their chiral spin texture(15-18). However, so far there is no evidence that these states in fact transmit through naturally occurring surface defects. Here we use a scanning tunnelling microscope to measure the transmission and reflection probabilities of topological surface states of antimony through naturally occurring crystalline steps separating atomic terraces. In contrast to nontopological surface states of common metals (copper, silver and gold)(19-23), which are either reflected or absorbed by atomic steps, we show that topological surface states of antimony penetrate such barriers with high probability. This demonstration of the extended nature of antimony's topological surface states suggests that such states may be useful for high current transmission even in the presence of atomic-scale irregularities-an electronic feature sought to efficiently interconnect nanoscale devices.	[Seo, Jungpil; Roushan, Pedram; Beidenkopf, Haim; Yazdani, Ali] Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA; [Seo, Jungpil; Roushan, Pedram; Beidenkopf, Haim; Yazdani, Ali] Princeton Univ, Dept Phys, Princeton, NJ 08544 USA; [Hor, Y. S.; Cava, R. J.] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA	Princeton University; Princeton University; Princeton University	Yazdani, A (corresponding author), Princeton Univ, Joseph Henry Labs, Princeton, NJ 08544 USA.	yazdani@princeton.edu	San Hor, Yew/S-1429-2017	San Hor, Yew/0000-0002-1417-4357; beidenkopf, haim/0000-0003-0139-1835; Seo, Jungpil/0000-0002-0442-288X; Yazdani, Ali/0000-0003-4996-8904	NSF-MRSEC through the Princeton Center for Complex Materials; ARO; DOE; NSF-DMR; W. M. Keck Foundation; NSF	NSF-MRSEC through the Princeton Center for Complex Materials(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); ARO; DOE(United States Department of Energy (DOE)); NSF-DMR(National Science Foundation (NSF)); W. M. Keck Foundation(W.M. Keck Foundation); NSF(National Science Foundation (NSF))	We gratefully acknowledge discussions with B. A. Bernevig, B. Boyanov, M. Z. Hasan and N. P. Ong. This work was supported by grants from the NSF-MRSEC programme through the Princeton Center for Complex Materials, the ARO, the DOE, the NSF-DMR and the W. M. Keck Foundation. P. R. acknowledges support by a NSF graduate fellowship.	Alpichshev Z, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.016401; AVOURIS P, 1994, SCIENCE, V264, P942, DOI 10.1126/science.264.5161.942; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BISWAS RR, 2010, SCATTERING SURFACE S; Burgi L, 1999, PHYS REV LETT, V82, P4516, DOI 10.1103/PhysRevLett.82.4516; Burgi L, 1998, PHYS REV LETT, V81, P5370, DOI 10.1103/PhysRevLett.81.5370; Chen YL, 2009, SCIENCE, V325, P178, DOI 10.1126/science.1173034; CROMMIE MF, 1993, NATURE, V363, P524, DOI 10.1038/363524a0; Fiete GA, 2003, REV MOD PHYS, V75, P933, DOI 10.1103/RevModPhys.75.933; Fu L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106803; Gomes K. K, 2009, QUANTUM IMAGING TOPO; Guo HM, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.041102; HELLER EJ, 1994, NATURE, V369, P464, DOI 10.1038/369464a0; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Hsieh D, 2009, SCIENCE, V323, P919, DOI 10.1126/science.1167733; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Li JT, 1998, PHYS REV LETT, V80, P3332, DOI 10.1103/PhysRevLett.80.3332; LI YY, 2009, GROWTH DYNAMICS THIC; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Mugarza A, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.245419; Pivetta M, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.193402; Roushan P, 2009, NATURE, V460, P1106, DOI 10.1038/nature08308; Roy R, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.195321; Zhang HJ, 2009, NAT PHYS, V5, P438, DOI 10.1038/NPHYS1270; Zhang T, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.266803; Zhou XT, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245317	27	161	163	4	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					343	346		10.1038/nature09189	http://dx.doi.org/10.1038/nature09189			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631794	Green Submitted			2022-12-28	WOS:000279867100043
J	Lianov, L; Johnson, M				Lianov, Liana; Johnson, Mark			Physician Competencies for Prescribing Lifestyle Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBESITY		[Lianov, Liana] Univ Calif Davis, Berkeley HeartLab, Fair Oaks, CA 95628 USA; [Lianov, Liana] Univ Calif Davis, Dept Publ Hlth Sci, Fair Oaks, CA 95628 USA; [Johnson, Mark] Jefferson Cty Publ Hlth, Golden, CO USA; [Lianov, Liana; Johnson, Mark] Amer Coll Prevent Med, Washington, DC USA		Lianov, L (corresponding author), Univ Calif Davis, Berkeley HeartLab, POB 1461, Fair Oaks, CA 95628 USA.	llianov@bhlinc.com						Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Calfas KJ, 1996, PREV MED, V25, P225, DOI 10.1006/pmed.1996.0050; Eilat-Adar S, 2008, J NUTR, V138, P1699, DOI 10.1093/jn/138.9.1699; Foster GD, 2003, OBES RES, V11, P1168, DOI 10.1038/oby.2003.161; Huang J, 2004, ACAD MED, V79, P156, DOI 10.1097/00001888-200402000-00012; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; *NAT HEART LUNG BL, 2003, 7 NAT HEART LUNG BLO; Partnership for Prevention, 2007, PREV CAR NAT PROF US PREV CAR NAT PROF US; Stafford RS, 2000, ARCH FAM MED, V9, P631, DOI 10.1001/archfami.9.7.631	9	136	139	1	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					202	203		10.1001/jama.2010.903	http://dx.doi.org/10.1001/jama.2010.903			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628134				2022-12-28	WOS:000279811000027
J	Tong, P; Yeoh, CJ; Yong, EL				Tong, Pearl; Yeoh, C. J.; Yong, E. L.			Abdominal mass and a forgotten haemorrhagic fever	LANCET			English	Editorial Material									[Tong, Pearl; Yeoh, C. J.; Yong, E. L.] Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Singapore Hosp, Singapore 119074, Singapore	National University of Singapore	Yong, EL (corresponding author), Natl Univ Singapore, Dept Obstet & Gynecol, Yong Loo Lin Sch Med, Natl Univ Singapore Hosp, Lower Kent Ridge Rd, Singapore 119074, Singapore.	obgyel@nus.edu.sg		Yong, Eu-Leong/0000-0001-6511-770X				Fitzgerald JEF, 2009, INT J SURG, V7, P150, DOI 10.1016/j.ijsu.2009.01.007; Ganeshwaran Y., 2001, Ceylon Medical Journal, V46, P105; James RF, 2005, LANCET, V365, P1824, DOI 10.1016/S0140-6736(05)66587-7; Teixeira MG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4338	4	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					140	140		10.1016/S0140-6736(10)60671-X	http://dx.doi.org/10.1016/S0140-6736(10)60671-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20621235				2022-12-28	WOS:000279943200030
J	Wozny, M				Wozny, Michael			The biological passport and doping in athletics	LANCET			English	Editorial Material									Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA	Loma Linda University	Wozny, M (corresponding author), Loma Linda Univ, Sch Med, Loma Linda, CA 92350 USA.	mwozny@llu.edu						MCGRATH M, 2010, BBC NEWS CHANNE 0701; NIILER E, 2010, DISCOVERY NEWS  0507; *WORLD AN AG, 2009, QUEST ANSW ATHL BIOL; 2010, BRIT ATHLETES GET BI	4	10	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					79	79		10.1016/S0140-6736(10)61058-6	http://dx.doi.org/10.1016/S0140-6736(10)61058-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20621224				2022-12-28	WOS:000279943200009
J	Kratz, K; Schopf, B; Kaden, S; Sendoel, A; Eberhard, R; Lademann, C; Cannavo, E; Sartori, AA; Hengartner, MO; Jiricny, J				Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Sendoel, Ataman; Eberhard, Ralf; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Hengartner, Michael O.; Jiricny, Josef			Deficiency of FANCD2-Associated Nuclease KIAA1018/FAN1 Sensitizes Cells to Interstrand Crosslinking Agents	CELL			English	Article							STRUCTURE-SPECIFIC ENDONUCLEASE; FANCONI-ANEMIA PATHWAY; DNA; PROTEINS; REPAIR; IDENTIFICATION; REPLICATION; RECOMBINATION; BREAKS; ALPHA	Cytotoxicity of cisplatin and mitomycin C (MMC) is ascribed largely to their ability to generate interstrand crosslinks (ICLs) in DNA, which block the progression of replication forks. The processing of ICLs requires the Fanconi anemia (FA) pathway, excision repair, and translesion DNA synthesis (TLS). It also requires homologous recombination (HR), which repairs double-strand breaks (DSBs) generated by cleavage of the blocked replication forks. Here we describe KIAA1018, an evolutionarily conserved protein that has an N-terminal ubiquitin-binding zinc finger (UBZ) and a C-terminal nuclease domain. KIAA1018 is a 5' -> 3' exonuclease and a structure-specific endonuclease that preferentially incises 50 flaps. Like cells from FA patients, human cells depleted of KIAA1018 are sensitized to ICL-inducing agents and display chromosomal instability. The link of KIAA1018 to the FA pathway is further strengthened by its recruitment to DNA damage through interaction of its UBZ domain with monoubiquitylated FANCD2. We therefore propose to name KIAA1018 FANCD2-associated nuclease, FAN1.	[Kratz, Katja; Schoepf, Barbara; Kaden, Svenja; Lademann, Claudio; Cannavo, Elda; Sartori, Alessandro A.; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Sendoel, Ataman; Eberhard, Ralf; Hengartner, Michael O.] Univ Zurich, Inst Mol Life Sci, CH-8057 Zurich, Switzerland; [Jiricny, Josef] ETH, Dept Biol, CH-8057 Zurich, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Jiricny, J (corresponding author), Univ Zurich, Inst Mol Canc Res, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	jiricny@imcr.uzh.ch	Hengartner, Michael O/E-6235-2011; Sartori, Alessandro/AAK-7840-2021	Sartori, Alessandro/0000-0003-2770-0333; Sendoel, Ataman/0000-0002-0381-9965; Hengartner, Michael/0000-0002-7584-596X; Port, Barbara/0000-0002-8941-954X	Swiss National Science Foundation [3100A0-118158, 3100A0-128675]; Bonizzi-Theler; Ernst Hadorn	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Bonizzi-Theler; Ernst Hadorn	We express our gratitude to John Rouse for the KIAA1018 antibody and for sharing unpublished information, to Milica Enoiu for discussions and for critical reading of the manuscript, Stephanie Felscher for help with evaluation of chromosomal instability, Myriam Marti for help with western blot analyses, Ian Hickson for MUS81/EME1, Ulrich Hubscher for FEN1, Pavel Janscak and Rajakrishnan Kanagaraj for the oligonucleotides, Jordi Surralles for the FANCD2-deficient and WT- or K561R- complemented PD20 cells, Petr Cejka for the Sf9 expression system, and Stefano Ferrari for MG132. We also acknowledge collaborations with Johan de Winter and Hans Joenje and with the group of Shunichi Takeda. The C01G5.8(tm423) deletion allele was kindly provided by Dr. Shohei Mitani (Japanese National Bioresource Project). This work was supported by Swiss National Science Foundation grants nr. 3100A0-118158 (J.J.) and 3100A0-128675 (M.H.). The generous support of the Bonizzi-Theler (J.J.) and Ernst Hadorn (M.H.) Foundations is also gratefully acknowledged.	Akkari YMN, 2000, MOL CELL BIOL, V20, P8283, DOI 10.1128/MCB.20.21.8283-8289.2000; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Cannavo E, 2007, J BIOL CHEM, V282, P2976, DOI 10.1074/jbc.M609989200; Ciccia A, 2008, ANNU REV BIOCHEM, V77, P259, DOI 10.1146/annurev.biochem.77.070306.102408; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; De Silva IU, 2000, MOL CELL BIOL, V20, P7980, DOI 10.1128/MCB.20.21.7980-7990.2000; Ermolova NV, 2003, PROTEIN EXPRES PURIF, V29, P123, DOI 10.1016/S1046-5928(03)00014-7; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gari K, 2008, MOL CELL, V29, P141, DOI 10.1016/j.molcel.2007.11.032; Hanada K, 2006, EMBO J, V25, P4921, DOI 10.1038/sj.emboj.7601344; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Hofmann K, 2009, DNA REPAIR, V8, P544, DOI 10.1016/j.dnarep.2009.01.003; Kadyrov FA, 2007, J BIOL CHEM, V282, P37181, DOI 10.1074/jbc.M707617200; Kaliraman V, 2001, GENE DEV, V15, P2730, DOI 10.1101/gad.932201; Kinch LN, 2005, NUCLEIC ACIDS RES, V33, P3598, DOI 10.1093/nar/gki676; Kosinski J, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-172; Meetei AR, 2003, MOL CELL BIOL, V23, P3417, DOI 10.1128/MCB.23.10.3417-3426.2003; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedernhofer LJ, 2004, MOL CELL BIOL, V24, P5776, DOI 10.1128/MCB.24.13.5776-5787.2004; Peng M, 2007, EMBO J, V26, P3238, DOI 10.1038/sj.emboj.7601754; Pichierri P, 2004, EMBO J, V23, P1178, DOI 10.1038/sj.emboj.7600113; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Rothfuss A, 2004, MOL CELL BIOL, V24, P123, DOI 10.1128/MCB.24.1.123-134.2004; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Zhang NX, 2002, MOL CELL BIOL, V22, P2388, DOI 10.1128/MCB.22.7.2388-2397.2002	29	204	213	3	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					77	88		10.1016/j.cell.2010.06.022	http://dx.doi.org/10.1016/j.cell.2010.06.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603016	Bronze			2022-12-28	WOS:000279637300014
J	Yi, JJ; Barnes, AP; Hand, R; Polleux, F; Ehlers, MD				Yi, Jason J.; Barnes, Anthony P.; Hand, Randal; Polleux, Franck; Ehlers, Michael D.			TGF-beta Signaling Specifies Axons during Brain Development	CELL			English	Article							GROWTH-FACTOR-BETA; POLARITY PROTEIN PAR6; TRANSFORMING GROWTH-FACTOR-BETA-1; TARGETED DISRUPTION; NEUROTROPHIC FACTOR; NERVOUS-SYSTEM; CELL-POLARITY; RECEPTOR; NEURONS; EXPRESSION	In the mammalian brain, the specification of a single axon and multiple dendrites occurs early in the differentiation of most neuron types. Numerous intracellular signaling events for axon specification have been described in detail. However, the identity of the extracellular factor(s) that initiate neuronal polarity in vivo is unknown. Here, we report that transforming growth factor beta (TGF-beta) initiates signaling pathways both in vivo and in vitro to fate naive neurites into axons. Neocortical neurons lacking the type II TGF-beta receptor (T beta R2) fail to initiate axons during development. Exogenous TGF-beta is sufficient to direct the rapid growth and differentiation of an axon, and genetic enhancement of receptor activity promotes the formation of multiple axons. Finally, we show that the bulk of these TGF-beta-dependent events are mediated by site-specific phosphorylation of Par6. These results define an extrinsic cue for neuronal polarity in vivo that patterns neural circuits in the developing brain.	[Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Yi, Jason J.; Ehlers, Michael D.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Ehlers, Michael D.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Barnes, Anthony P.; Hand, Randal; Polleux, Franck] Univ N Carolina, Dept Pharmacol, Ctr Neurosci, Chapel Hill, NC 27599 USA	Duke University; Duke University; Duke University; Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill	Ehlers, MD (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	ehlers@neuro.duke.edu	, UNC Neuroscience Microscopy Core/AAE-8305-2022; Polleux, Franck/H-9948-2014	Barnes, Anthony/0000-0002-4598-9591; Polleux, Franck/0000-0003-4313-0481	NIMH; NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [K01MH080259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047574] Funding Source: NIH RePORTER	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Irina Lebedeva and Marguerita Klein for excellent technical assistance and Ben Arenkiel, Ian Davison, Juliet Hernandez, Matt Kennedy, and Fan Wang for helpful discussion and critical review of the manuscript. We thank Irwin Liu and Xiao-Fan Wang for the Tgfbr1 shRNA constructs. This work was supported by grants from the NIMH and NINDS to M.D.E. and a Ruth K. Broad Biomedical Foundation fellowship to J.J.Y. M.D.E. is an Investigator of the Howard Hughes Medical Institute.	Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Charron F, 2005, DEVELOPMENT, V132, P2251, DOI 10.1242/dev.01830; Chen ZL, 2009, DEV BIOL, V327, P158, DOI 10.1016/j.ydbio.2008.12.006; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Gripp KW, 2000, NAT GENET, V25, P205, DOI 10.1038/76074; Hand R, 2005, NEURON, V48, P45, DOI 10.1016/j.neuron.2005.08.032; Hatanaka Y, 2002, J COMP NEUROL, V454, P1, DOI 10.1002/cne.10421; HEINE UI, 1987, J CELL BIOL, V105, P2861, DOI 10.1083/jcb.105.6.2861; Hung TJ, 1999, DEVELOPMENT, V126, P127; Ikegami R, 2004, DEV CELL, V6, P383, DOI 10.1016/S1534-5807(04)00057-7; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8; Kappeler L, 2008, PLOS BIOL, V6, P2144, DOI 10.1371/journal.pbio.0060254; Kawano H, 1999, J COMP NEUROL, V408, P147, DOI 10.1002/(SICI)1096-9861(19990531)408:2<147::AID-CNE1>3.0.CO;2-L; KLEIN R, 1993, CELL, V75, P113, DOI 10.1016/0092-8674(93)90683-H; Kriegstein AR, 2004, TRENDS NEUROSCI, V27, P392, DOI 10.1016/j.tins.2004.05.001; Li M, 2008, J BIOL CHEM, V283, P36257, DOI 10.1074/jbc.M806786200; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Mecha M, 2008, DEV DYNAM, V237, P1709, DOI 10.1002/dvdy.21558; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ng J, 2008, DEVELOPMENT, V135, P4025, DOI 10.1242/dev.028209; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; Polleux F, 1997, J COMP NEUROL, V385, P95; POLLEUX F, 2002, SCI STKE, pPL9; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; SAAD B, 1991, J CELL BIOL, V115, P473, DOI 10.1083/jcb.115.2.473; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Scherner O, 2007, J BIOL CHEM, V282, P13934, DOI 10.1074/jbc.M611062200; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shelly M, 2010, SCIENCE, V327, P547, DOI 10.1126/science.1179735; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sometani A, 2001, J NEUROSCI RES, V66, P369, DOI 10.1002/jnr.1229; SONG Y, 2002, TECHNOL CANCER RES T, V1, P1; Sosa L, 2006, NAT NEUROSCI, V9, P993, DOI 10.1038/nn1742; SPORN MB, 1980, NEW ENGL J MED, V303, P878, DOI 10.1056/NEJM198010093031511; Tomoda T, 1996, DEV BIOL, V179, P79, DOI 10.1006/dbio.1996.0242; Vicario-Abejon C, 2004, NEUROREPORT, V15, P2769; WALTER J, 1987, DEVELOPMENT, V101, P685; WRANA JL, 1992, CELL, V71, P1003, DOI 10.1016/0092-8674(92)90395-S; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	51	199	201	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					144	157		10.1016/j.cell.2010.06.010	http://dx.doi.org/10.1016/j.cell.2010.06.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603020	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000279637300020
J	Benazeraf, B; Francois, P; Baker, RE; Denans, N; Little, CD; Pourquie, O				Benazeraf, Bertrand; Francois, Paul; Baker, Ruth E.; Denans, Nicolas; Little, Charles D.; Pourquie, Olivier			A random cell motility gradient downstream of FGF controls elongation of an amniote embryo	NATURE			English	Article							CHICK-EMBRYO; MOVEMENT; SOMITOGENESIS; GASTRULATION; BOUNDARY; DYNAMICS; MATRIX	Vertebrate embryos are characterized by an elongated anteroposterior (AP) body axis, which forms by progressive cell deposition from a posterior growth zone in the embryo. Here, we used tissue ablation in the chicken embryo to demonstrate that the caudal presomitic mesoderm (PSM) has a key role in axis elongation. Using time-lapse microscopy, we analysed the movements of fluorescently labelled cells in the PSM during embryo elongation, which revealed a clear posterior-to-anterior gradient of cell motility and directionality in the PSM. We tracked the movement of the PSM extracellular matrix in parallel with the labelled cells and subtracted the extracellular matrix movement from the global motion of cells. After subtraction, cell motility remained graded but lacked directionality, indicating that the posterior cell movements associated with axis elongation in the PSM are not intrinsic but reflect tissue deformation. The gradient of cell motion along the PSM parallels the fibroblast growth factor (FGF)/mitogenactivated protein kinase (MAPK) gradient(1), which has been implicated in the control of cell motility in this tissue(2). Both FGF signalling gain-and loss-of-function experiments lead to disruption of the motility gradient and a slowing down of axis elongation. Furthermore, embryos treated with cell movement inhibitors (blebbistatin or RhoK inhibitor), but not cell cycle inhibitors, show a slower axis elongation rate. We propose that the gradient of random cell motility downstream of FGF signalling in the PSM controls posterior elongation in the amniote embryo. Our data indicate that tissue elongation is an emergent property that arises from the collective regulation of graded, random cell motion rather than by the regulation of directionality of individual cellular movements.	[Benazeraf, Bertrand; Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Benazeraf, Bertrand; Denans, Nicolas; Pourquie, Olivier] Univ Strasbourg, CNRS, INSERM, IGBMC,UMR 7104,U964, F-67400 Illkirch Graffenstaden, France; [Francois, Paul] Rockefeller Univ, Ctr Studies Phys & Biol, New York, NY 10065 USA; [Baker, Ruth E.] Univ Oxford, Math Inst, Ctr Math Biol, Oxford OX1 3LB, England; [Little, Charles D.; Pourquie, Olivier] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Howard Hughes Medical Institute; Stowers Institute for Medical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Rockefeller University; University of Oxford; University of Kansas; University of Kansas Medical Center	Pourquie, O (corresponding author), Howard Hughes Med Inst, Kansas City, MO 64110 USA.	pourquie@igbmc.fr	Francois, Paul/G-5673-2010; Pourquié, Olivier/CAJ-5443-2022; Benazeraf, Bertrand/X-9968-2019	Francois, Paul/0000-0002-2223-839X; Pourquié, Olivier/0000-0001-5189-1227; Baker, Ruth/0000-0002-6304-9333; denans, nicolas/0000-0002-1875-0841	Howard Hughes Medical Institute; Stowers Institute for Medical Research; NIH [R02 HD043158]; Chaire d'excellence; NSF [DMR-0129848]; Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship; Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043158] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076692] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stowers Institute for Medical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chaire d'excellence(French National Research Agency (ANR)); NSF(National Science Foundation (NSF)); Lavoisier Fellowship; RCUK Fellowship in Mathematical Biology; Microsoft European Postdoctoral Research Fellowship(Microsoft); Mathers Charitable Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank R. Li, D. Roellig and members of the Pourquie laboratory for critical reading of the manuscript. The authors acknowledge E. Siggia for support, B. Rongish, M. Filla, C. Cui, A. Peterson, K. Perko, R. Alexander, R. Fender, J. D. Fauny, T. Cheuvront, and members of the IGBMC imaging center for assistance with imaging-related techniques. We thank L. Kennedy and T. Iimura for help with the experiments, and the members of the Cytometry Facility at the Stowers Institute for Medical Research for assistance. We thank S. Leblanc, H. Li, N. Wicker and P. Moncuquet for help with statistical analysis. The authors thank S. Esteban for artwork and J. Chatfield for editorial assistance. This research was supported by the Howard Hughes Medical Institute, the Stowers Institute for Medical Research, NIH grant R02 HD043158 and a Chaire d'excellence to O.P.; P.F. is supported by NSF grant DMR-0129848 (attributed to E. Siggia) and Lavoisier Fellowship. R. E. B. is supported by an RCUK Fellowship in Mathematical Biology and a Microsoft European Postdoctoral Research Fellowship. C. D. L. is supported by the Mathers Charitable Foundation.	AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Araki I, 1999, DEVELOPMENT, V126, P5127; BEDDINGTON RSP, 1994, DEVELOPMENT, V120, P613; BELLAIRS R, 1963, J EMBRYOL EXP MORPH, V11, P697; Berg, 2018, RANDOM WALKS BIOL; Cai AQ, 2006, B MATH BIOL, V68, P25, DOI 10.1007/s11538-005-9028-x; Chapman SC, 2001, DEV DYNAM, V220, P284, DOI 10.1002/1097-0177(20010301)220:3<284::AID-DVDY1102>3.0.CO;2-5; Charrier JB, 1999, DEVELOPMENT, V126, P4771; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Czirok A, 2002, J MICROSC-OXFORD, V206, P209, DOI 10.1046/j.1365-2818.2002.01032.x; Czirok A, 2006, CURR TOP DEV BIOL, V73, P237, DOI 10.1016/S0070-2153(05)73008-8; Delfini MC, 2005, P NATL ACAD SCI USA, V102, P11343, DOI 10.1073/pnas.0502933102; Dubrulle J, 2004, NATURE, V427, P419, DOI 10.1038/nature02216; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HAMBURGER V, 1992, DEV DYNAM, V195, P273, DOI 10.1002/dvdy.1001950405; Keller R, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015007; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Lawson A, 2001, ANAT RECORD, V262, P238, DOI 10.1002/1097-0185(20010301)262:3<238::AID-AR1041>3.0.CO;2-8; MARTIN P, 1992, NATURE, V360, P179, DOI 10.1038/360179a0; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Rupp PA, 2003, BIOTECHNIQUES, V34, P274, DOI 10.2144/03342st01; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; SPRATT NT, 1955, J EXP ZOOL, V128, P121, DOI 10.1002/jez.1401280106; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Waddington CH, 1932, PHILOS T R SOC LON B, V221, P179, DOI 10.1098/rstb.1932.0003; Watanabe T, 2007, DEV BIOL, V305, P625, DOI 10.1016/j.ydbio.2007.01.042; Yang XS, 2002, DEV CELL, V3, P425, DOI 10.1016/S1534-5807(02)00256-3; Zamir EA, 2006, P NATL ACAD SCI USA, V103, P19806, DOI 10.1073/pnas.0606100103; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247	30	197	199	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					248	252		10.1038/nature09151	http://dx.doi.org/10.1038/nature09151			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613841	Green Accepted			2022-12-28	WOS:000279580800039
J	Hollander, JA; Im, HI; Amelio, AL; Kocerha, J; Bali, P; Lu, Q; Willoughby, D; Wahlestedt, C; Conkright, MD; Kenny, PJ				Hollander, Jonathan A.; Im, Heh-In; Amelio, Antonio L.; Kocerha, Jannet; Bali, Purva; Lu, Qun; Willoughby, David; Wahlestedt, Claes; Conkright, Michael D.; Kenny, Paul J.			Striatal microRNA controls cocaine intake through CREB signalling	NATURE			English	Article							ADDICTION-LIKE BEHAVIOR; GENE-EXPRESSION; DORSAL STRIATUM; DRUG-ADDICTION; RAF INHIBITOR; ACTIVATION; SEEKING; BRAIN; NEUROPLASTICITY; PLASTICITY	Cocaine addiction is characterized by a gradual loss of control over drug use, but the molecular mechanisms regulating vulnerability to this process remain unclear. Here we report that microRNA-212 (miR-212) is upregulated in the dorsal striatum of rats with a history of extended access to cocaine. Striatal miR-212 decreases responsiveness to the motivational properties of cocaine by markedly amplifying the stimulatory effects of the drug on cAMP response element binding protein (CREB) signalling. This action occurs through miR-212-enhanced Raf1 activity, resulting in adenylyl cyclase sensitization and increased expression of the essential CREB co-activator TORC (transducer of regulated CREB; also known as CRTC). Our findings indicate that striatal miR-212 signalling has a key role in determining vulnerability to cocaine addiction, reveal new molecular regulators that control the complex actions of cocaine in brain reward circuitries and provide an entirely new direction for the development of anti-addiction therapeutics based on the modulation of noncoding RNAs.	[Hollander, Jonathan A.; Im, Heh-In; Bali, Purva; Lu, Qun; Kenny, Paul J.] Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Amelio, Antonio L.; Conkright, Michael D.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Neurosci, Jupiter, FL 33458 USA; [Kocerha, Jannet; Wahlestedt, Claes] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 33458 USA; [Willoughby, David] Ocean Ridge Biosci, Palm Beach Gardens, FL 33410 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute	Kenny, PJ (corresponding author), Scripps Res Inst, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu		Amelio, Antonio L./0000-0002-6295-2694	National Institute on Drug Abuse (NIDA); NATIONAL CANCER INSTITUTE [F32CA134121] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA025983, F32DA024932] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by a grant from the National Institute on Drug Abuse (NIDA) to P.J.K. and C.W., and NIDA post-doctoral awards to J.A.H. and H.-I.I. We thank M. Fallahi-Sichani for help with miRNA expression analysis and T. Balla for the Raf1 expression constructs. We also thank C. Fowler and P. Griffin for comments on the manuscript, and NIDA for supplying the cocaine used in these studies. This is manuscript 19873 from Scripps Florida.	Ahmed SH, 1998, SCIENCE, V282, P298, DOI 10.1126/science.282.5387.298; Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Amelio AL, 2007, P NATL ACAD SCI USA, V104, P20314, DOI 10.1073/pnas.0707999105; Anthony JC, 1994, EXP CLIN PSYCHOPHARM, V2, P244, DOI 10.1037/1064-1297.2.3.244; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Beazely MA, 2005, MOL PHARMACOL, V67, P250, DOI 10.1124/mol.104.001370; Belin D, 2008, NEURON, V57, P432, DOI 10.1016/j.neuron.2007.12.019; Belin D, 2009, BIOL PSYCHIAT, V65, P863, DOI 10.1016/j.biopsych.2008.05.031; Bondeva T, 2002, MOL BIOL CELL, V13, P2323, DOI 10.1091/mbc.E02-01-0019; Brems H, 2007, NAT GENET, V39, P1120, DOI 10.1038/ng2113; Caine S. B., 1993, BEHAV NEUROSCIENCE P, V2, P117; Carlezon WA, 1998, SCIENCE, V282, P2272, DOI 10.1126/science.282.5397.2272; Chandrasekar V, 2009, MOL CELL NEUROSCI, V42, P350, DOI 10.1016/j.mcn.2009.08.009; Chin PC, 2004, J NEUROCHEM, V90, P595, DOI 10.1111/j.1471-4159.2004.02530.x; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Ding QM, 2004, MOL PHARMACOL, V66, P921, DOI 10.1124/mol.66.4.921; DiNieri JA, 2009, J NEUROSCI, V29, P1855, DOI 10.1523/JNEUROSCI.5104-08.2009; DUMAN RS, 1988, J PHARMACOL EXP THER, V246, P1033; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Hatzivassiliou G, 2010, NATURE, V464, P431, DOI 10.1038/nature08833; Ito R, 2002, J NEUROSCI, V22, P6247; Kalivas PW, 2008, NEUROPSYCHOPHARMACOL, V33, P166, DOI 10.1038/sj.npp.1301564; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; McClung CA, 2008, NEUROPSYCHOPHARMACOL, V33, P3, DOI 10.1038/sj.npp.1301544; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Paterson NE, 2003, NEUROREPORT, V14, P2229, DOI 10.1097/00001756-200312020-00019; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Perkins DO, 2005, MOL PSYCHIATR, V10, P69, DOI 10.1038/sj.mp.4001577; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Piazza PV, 2000, J NEUROSCI, V20, P4226; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Rogaev EI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P1404, DOI 10.1007/s10541-005-0276-z; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Thomas MJ, 2008, BRIT J PHARMACOL, V154, P327, DOI 10.1038/bjp.2008.77; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Vanderschuren LJMJ, 2005, J NEUROSCI, V25, P8665, DOI 10.1523/JNEUROSCI.0925-05.2005; Vanderschuren LJMJ, 2004, SCIENCE, V305, P1017, DOI 10.1126/science.1098975; Varga EV, 2002, EUR J PHARMACOL, V451, P101, DOI 10.1016/S0014-2999(02)02220-3; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	59	294	327	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					197	U66		10.1038/nature09202	http://dx.doi.org/10.1038/nature09202			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613834	Green Accepted			2022-12-28	WOS:000279580800028
J	Bassett, IV; Sax, PE				Bassett, Ingrid V.; Sax, Paul E.			Untreated HIV: harmful even at high CD4 cell counts	LANCET			English	Editorial Material							GENERAL-POPULATION; INFECTED ADULTS; MORTALITY; AIDS; MORBIDITY; RISK		[Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Bassett, Ingrid V.] Massachusetts Gen Hosp, Div Gen Med, Boston, MA 02114 USA; [Sax, Paul E.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Infect Dis, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bassett, IV (corresponding author), Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA.		Bassett, Ingrid V./ABI-7674-2020	Bassett, Ingrid V./0000-0001-6920-6080	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI068458] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090326] Funding Source: NIH RePORTER; NIAID NIH HHS [K23 AI068458] Funding Source: Medline; NIMH NIH HHS [R01 MH090326] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		[Anonymous], [No title captured]; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; Gnavi R, 2004, INT J EPIDEMIOL, V33, P864, DOI 10.1093/ije/dyh089; *INSIGHT, STRAT TIM ANT THER S, P24501; Katzmarzyk P T, 2003, Obes Rev, V4, P257, DOI 10.1046/j.1467-789X.2003.00120.x; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Moh R, 2007, AIDS, V21, P2483, DOI 10.1097/QAD.0b013e3282f09876; Neuhaus J, 2010, AIDS, V24, P697, DOI 10.1097/QAD.0b013e3283365356; *STUD GROUP DEATH, 2010, LANCET, P24501, DOI DOI 10.1016/S0140-6736(10)60932-4; van Sighem A, 2010, AIDS, V24, P1527, DOI 10.1097/QAD.0b013e32833a3946; Zwahlen M, 2009, INT J EPIDEMIOL, V38, P1624, DOI 10.1093/ije/dyp306	15	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					306	308		10.1016/S0140-6736(10)61033-1	http://dx.doi.org/10.1016/S0140-6736(10)61033-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	636FW	20638117	Green Accepted			2022-12-28	WOS:000280717900005
J	Mohammed, AJ; AlAwaidy, S; Bawikar, S; Kurup, PJ; Elamir, E; Shaban, MMA; Sharif, SM; van der Avoort, HGAM; Pallansch, MA; Malankar, P; Burton, A; Sreevatsava, M; Sutter, RW				Mohammed, Ali Jafer; AlAwaidy, Salah; Bawikar, Shyam; Kurup, Padmamohan J.; Elamir, Emadaldin; Shaban, Mahmoud M. A.; Sharif, Sharif M.; van der Avoort, Harrie G. A. M.; Pallansch, Mark A.; Malankar, Pradeep; Burton, Anthony; Sreevatsava, Meghana; Sutter, Roland W.			Fractional Doses of Inactivated Poliovirus Vaccine in Oman.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTIBODY-RESPONSES; IMMUNE-RESPONSE; INFANTS; NEEDLE; POLIOMYELITIS; INJECTION; TRIAL	Background: We conducted a clinical trial of fractional doses of inactivated poliovirus vaccine administered to infants in Oman, in order to evaluate strategies for making the vaccine affordable for use in developing countries. Methods: We compared fractional doses of inactivated poliovirus vaccine (0.1 ml, representing one fifth of a full dose) given intradermally with the use of a needle-free jet injector device, with full doses of vaccine given intramuscularly, with respect to immunogenicity and reactogenicity. Infants were randomly assigned at birth to receive either a fractional dose or a full dose of inactivated poliovirus vaccine at 2, 4, and 6 months. We also administered a challenge dose of monovalent type 1 oral poliovirus vaccine at 7 months and collected stool samples before and 7 days after administration of the challenge dose. Results: A total of 400 infants were randomized, of whom 373 (93.2%) fulfilled the study requirements. No significant baseline differences between the groups were detected. Thirty days after completion of the three-dose schedule, the rates of seroconversion to types 1, 2, and 3 poliovirus were 97.3%, 95.7%, and 97.9%, respectively, in the fractional-dose group, as compared with 100% seroconversion to all serotypes in the full-dose group (P=0.01 for the comparison with respect to type 2 poliovirus; results with respect to types 1 and 3 poliovirus were not significant). The median titers were significantly lower in the fractional-dose group than in the full-dose group (P<0.001 for all three poliovirus serotypes). At 7 months, 74.8% of the infants in the fractional-dose group and 63.1% of those in full-dose group excreted type 1 poliovirus (P=0.03). Between birth and 7 months, 42 hospitalizations were reported, all related to infectious causes, anemia, or falls, with no significant difference between vaccination groups. Conclusions: These data show that fractional doses of inactivated poliovirus vaccine administered intradermally at 2, 4, and 6 months, as compared with full doses of inactivated poliovirus vaccine given intramuscularly on the same schedule, induce similar levels of seroconversion but significantly lower titers. (Current Controlled Trials number, ISRCTN17418767.) N Engl J Med 2010;362:2351-9.	[van der Avoort, Harrie G. A. M.] Natl Inst Publ Hlth & Environm, NL-3720 BA Bilthoven, Netherlands; [Pallansch, Mark A.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Malankar, Pradeep; Burton, Anthony; Sreevatsava, Meghana; Sutter, Roland W.] WHO, Geneva, NY USA	Netherlands National Institute for Public Health & the Environment; Centers for Disease Control & Prevention - USA; World Health Organization	Sutter, RW (corresponding author), 20 Ave Appia, CH-1211 Geneva 27, Switzerland.	sutterr@who.int	Awaidy, Salah Al/AAF-5884-2020	Awaidy, Salah Al/0000-0001-5112-3893; KURUP, PADMAMOHAN/0000-0003-0746-7546	Ministry of Health, Oman; Program for Appropriate Technology in Health (PATH), Seattle; World Health Organization, Geneva	Ministry of Health, Oman; Program for Appropriate Technology in Health (PATH), Seattle; World Health Organization, Geneva(World Health Organization)	Supported by the Ministry of Health, Oman, the Program for Appropriate Technology in Health (PATH), Seattle, and the World Health Organization, Geneva.	[Anonymous], 2010, Wkly Epidemiol Rec, V85, P178; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P425; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P25; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P165; [Anonymous], 2001, MMWR-MORBID MORTAL W, V50, P249; Belshe RB, 2004, NEW ENGL J MED, V351, P2286, DOI 10.1056/NEJMoa043555; BIEDENBENDER RD, 2002, AM GER SOC ANN SCI M; BOTTIGER M, 1987, SCAND J INFECT DIS, V19, P595, DOI 10.3109/00365548709117192; Brave A, 2005, MOL THER, V12, P1197, DOI 10.1016/j.ymthe.2005.06.473; BRYAN JP, 1992, CLIN INFECT DIS, V14, P697, DOI 10.1093/clinids/14.3.697; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P222; Conover William Jay, 1998, PRACTICAL NONPARAMET, V350; Dove AW, 1997, SCIENCE, V277, P779, DOI 10.1126/science.277.5327.779; Efron B., 1994, MONOGRAPHS STAT APPL; Epstein JE, 2002, HUM GENE THER, V13, P1551, DOI 10.1089/10430340260201644; Greenwood BM, 1997, J INFECT DIS, V175, pS215; HINGSON R A, 1957, GP, V15, P94; Kenney RT, 2004, NEW ENGL J MED, V351, P2295, DOI 10.1056/NEJMoa043540; Kreeftenberg H, 2006, BIOLOGICALS, V34, P155, DOI 10.1016/j.biologicals.2006.02.011; LIPSON MJ, 1958, AM J PUBLIC HEALTH N, V48, P599, DOI 10.2105/AJPH.48.5.599; Nirmal S, 1998, VACCINE, V16, P928, DOI 10.1016/S0264-410X(97)00293-4; Orenstein W, 2002, CLIN INFECT DIS, V34, P72, DOI 10.1086/338262; Organization W.H., 1988, GLOB ER POL YEAR 200; PLOTKIN S, 2008, VACCINES, V25, P605; *POL ER IN, GLOB ACT PL IN PRESS; *POL ER IN, 2005, CESS ROUT OR POL VAC; Prymula R, 2009, LANCET, V374, P1339, DOI 10.1016/S0140-6736(09)61208-3; *R DEV COR TEAM, 2006, R LANG ENV COMP; Reinis M, 2004, CURR OPIN MOL THER, V6, P436; Resik S, 2010, J INFECT DIS, V201, P1344, DOI 10.1086/651611; SALK JE, 1953, PEDIATRICS, V12, P471; SALK JE, 1953, JAMA-J AM MED ASSOC, V151, P1081, DOI 10.1001/jama.1953.13.1081; SAMUEL BU, 1992, VACCINE, V10, P135, DOI 10.1016/0264-410X(92)90039-M; SAMUEL BU, 1991, LANCET, V338, P343, DOI 10.1016/0140-6736(91)90480-D; *SAS I, 1989, SAS STAT US GUID VER; Simizu B, 2006, BIOLOGICALS, V34, P151, DOI 10.1016/j.biologicals.2006.02.010; SIMOES EAF, 1985, AM J DIS CHILD, V139, P977, DOI 10.1001/archpedi.1985.02140120023021; Sutter RW, 2000, NEW ENGL J MED, V343, P767, DOI 10.1056/NEJM200009143431103; SUTTER RW, 1995, ANN NY ACAD SCI, V754, P289, DOI 10.1111/j.1749-6632.1995.tb44462.x; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x; Timmerman JM, 2002, CANCER RES, V62, P5845; WAHL M, 1987, SCAND J INFECT DIS, V19, P617, DOI 10.3109/00365548709117195; Wang RB, 2001, P NATL ACAD SCI USA, V98, P10817, DOI 10.1073/pnas.181123498; Weniger BG, 2008, VACCINES-BASEL, Vfifth, P1357, DOI [10.1016/B978-1-4160-3611-1.50065-9, DOI 10.1016/B978-1-4160-3611-1.50065-9, 10.1016/b978-1-4160-3611-1.50065-9]; *WHO, 1997, WHOEPILHIS9701; World Health Organization, 2004, WHOIVB0410; World Health Organization, 1991, WHOEPIRD913REV1; 2004, WKLY EPIDEMIOL REC, V79, P401	48	115	118	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2351	2359		10.1056/NEJMoa0909383	http://dx.doi.org/10.1056/NEJMoa0909383			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573923				2022-12-28	WOS:000279043800004
J	Starrs, A; Sankore, R				Starrs, Ann; Sankore, Rotimi			Momentum, mandates, and money: achieving health MDGs	LANCET			English	Editorial Material									[Starrs, Ann] Family Care Int, New York, NY 10012 USA; [Sankore, Rotimi] Africa Publ Hlth Alliance & 15 Campaign, Lagos, Nigeria		Starrs, A (corresponding author), Family Care Int, New York, NY 10012 USA.							[Anonymous], [No title captured]; *ASADI, 2009, SCI ACT SAV LIV AFR; Cometto G, 2009, LANCET, V373, P1500, DOI 10.1016/S0140-6736(09)60835-7; *CONS MAT, NEWB CHILD HLTH; *HIGH LEV TASKF IN, MOR MON HLTH MOR HLT; *INT HLTH PARTN, 2009, HLTH WOM HLTH CHILDR; SANKORE R, 2010, HLTH FIN PAP AU JUL; WHO, 2008, MAX POS SYN HLTH SYS; 2010, SEN STRAT M APR 14 1; 2010, EXPLORING OPTIONS OP	10	4	4	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					1946	1948		10.1016/S0140-6736(10)60841-0	http://dx.doi.org/10.1016/S0140-6736(10)60841-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569826				2022-12-28	WOS:000278689600007
J	Ogedegbe, G				Ogedegbe, Gbenga			Self-titration for treatment of uncomplicated hypertension	LANCET			English	Editorial Material									NYU, Sch Med, Dept Med, Ctr Healthful Behav Change,Div Gen Internal Med, New York, NY 10010 USA	New York University	Ogedegbe, G (corresponding author), NYU, Sch Med, Dept Med, Ctr Healthful Behav Change,Div Gen Internal Med, New York, NY 10010 USA.	olugbenga.ogedegbe@nyumc.org			NHLBI NIH HHS [R01HL078566, R01 HL087301, R01 HL078566] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078566, R01HL087301] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bennett H, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-456; Bobrie G, 2007, AM J HYPERTENS, V20, P1314, DOI 10.1016/j.amjhyper.2007.08.011; Bosworth HB, 2007, AM HEART J, V153, P918, DOI 10.1016/j.ahj.2007.03.004; Clar C, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14120; Hyman DJ, 2001, NEW ENGL J MED, V345, P479, DOI 10.1056/NEJMoa010273; Levi Marcel, 2008, Expert Rev Cardiovasc Ther, V6, P979, DOI 10.1586/14779072.6.7.979; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Pare G, 2007, J AM MED INFORM ASSN, V14, P269, DOI 10.1197/jamia.M2270; Pickering TG, 2008, HYPERTENSION, V52, P10, DOI 10.1161/HYPERTENSIONAHA.107.189010; Powell H, 2002, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004107; Zarnke KB, 1997, AM J HYPERTENS, V10, P58, DOI 10.1016/S0895-7061(96)00305-6	11	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					144	146		10.1016/S0140-6736(10)61050-1	http://dx.doi.org/10.1016/S0140-6736(10)61050-1			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20619449	Green Accepted			2022-12-28	WOS:000280313100005
J	Fuller, RA; McDonald-Madden, E; Wilson, KA; Carwardine, J; Grantham, HS; Watson, JEM; Klein, CJ; Green, DC; Possingham, HP				Fuller, Richard A.; McDonald-Madden, Eve; Wilson, Kerrie A.; Carwardine, Josie; Grantham, Hedley S.; Watson, James E. M.; Klein, Carissa J.; Green, David C.; Possingham, Hugh P.			Replacing underperforming protected areas achieves better conservation outcomes	NATURE			English	Article							PROPERTY-RIGHTS; GLOBAL-NETWORK; GAP ANALYSIS; THAILAND; RESERVE; PRIORITIES; DIVERSITY; WORLD; COSTS; SAVE	Protected areas vary enormously in their contribution to conserving biodiversity, and the inefficiency of protected area systems is widely acknowledged(1-3). However, conservation plans focus overwhelmingly on adding new sites to current protected area estates(4). Here we show that the conservation performance of a protected area system can be radically improved, without extra expenditure, by replacing a small number of protected areas with new ones that achieve more for conservation. Replacing the least cost-effective 1% of Australia's 6,990 strictly protected areas could increase the number of vegetation types that have 15% or more of their original extent protected from 18 to 54, of a maximum possible of 58. Moreover, it increases markedly the area that can be protected, with no increase in overall spending. This new paradigm for protected area system expansion could yield huge improvements to global conservation at a time when competition for land is increasingly intense.	[Fuller, Richard A.; McDonald-Madden, Eve; Wilson, Kerrie A.; Carwardine, Josie; Grantham, Hedley S.; Watson, James E. M.; Klein, Carissa J.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, St Lucia, Qld 4072, Australia; [Fuller, Richard A.; McDonald-Madden, Eve; Carwardine, Josie] CSIRO Climate Adaptat Flagship, St Lucia, Qld 4072, Australia; [Fuller, Richard A.; McDonald-Madden, Eve; Carwardine, Josie] CSIRO Sustainable Ecosyst, St Lucia, Qld 4072, Australia; [Green, David C.] Univ Queensland, Informat Technol Serv, St Lucia, Qld 4072, Australia	University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Queensland	Fuller, RA (corresponding author), Univ Queensland, Ctr Ecol, St Lucia, Qld 4072, Australia.	r.a.fuller@dunelm.org.uk	Carwardine, Josie/A-5801-2011; McDonald-Madden, Eve/A-5186-2012; POSSINGHAM, HUGH/R-8310-2019; Watson, James Edward Maxwell/D-8779-2013; Klein, Carissa J/F-1632-2011; Wilson, Kerrie A/C-8058-2009; Possingham, Hugh/B-1337-2008; Wilson, Kerrie/W-4181-2019; Fuller, Richard/B-7971-2008	McDonald-Madden, Eve/0000-0001-7755-2338; POSSINGHAM, HUGH/0000-0001-7755-996X; Watson, James Edward Maxwell/0000-0003-4942-1984; Klein, Carissa J/0000-0002-6299-6451; Wilson, Kerrie A/0000-0002-0092-935X; Possingham, Hugh/0000-0001-7755-996X; Wilson, Kerrie/0000-0002-0092-935X; Fuller, Richard/0000-0001-9468-9678	Centre for Applied Environmental Decision Analysis, an Australian Commonwealth Environment Research Facility	Centre for Applied Environmental Decision Analysis, an Australian Commonwealth Environment Research Facility	We thank J. Stein for providing subcatchment data, and L. Barr, C. Fuller, B. Kendall, T. Martin and H. Wilson for discussion. This work was funded by the Centre for Applied Environmental Decision Analysis, an Australian Commonwealth Environment Research Facility.	Ando A, 1998, SCIENCE, V279, P2126, DOI 10.1126/science.279.5359.2126; Carwardine J, 2008, P NATL ACAD SCI USA, V105, P11446, DOI 10.1073/pnas.0707157105; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Child K, 2009, J EAST AFR STUD, V3, P240, DOI 10.1080/17531050902972659; Dearden P, 1998, ENVIRON CONSERV, V25, P195, DOI 10.1017/S0376892998000241; *DEP ENV WAT HER A, AUSTR STRAT NAT RES; *DEP ENV WAT HER A, COLL AUSTR PROT AR D; ERNERTON L, 2006, SUSTAINABLE FINANCIN; HARDIN G, 1968, SCIENCE, V162, P1248; Jaffre T, 1998, BIODIVERS CONSERV, V7, P109, DOI 10.1023/A:1008815930865; Meir E, 2004, ECOL LETT, V7, P615, DOI 10.1111/j.1461-0248.2004.00624.x; Mora C, 2006, SCIENCE, V312, P1750, DOI 10.1126/science.1125295; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; NORTONGRIFFITHS M, 1995, ECOL ECON, V12, P125, DOI 10.1016/0921-8009(94)00041-S; Roberts CM, 2001, SCIENCE, V294, P1920, DOI 10.1126/science.294.5548.1920; Rodrigues ASL, 2004, BIOSCIENCE, V54, P1092, DOI 10.1641/0006-3568(2004)054[1092:GGAPRF]2.0.CO;2; Rodrigues ASL, 2004, NATURE, V428, P640, DOI 10.1038/nature02422; SCOTT JM, 1993, WILDLIFE MONOGR, P1; STEIN J, 2005, LINKING RIVERS LANDS, P448; Strange N, 2006, BIOL CONSERV, V131, P33, DOI 10.1016/j.biocon.2006.02.002; SUSSMAN RW, 1994, HUM ECOL, V22, P333, DOI 10.1007/BF02168856; Underwood EC, 2009, CONSERV BIOL, V23, P43, DOI 10.1111/j.1523-1739.2008.01072.x; Vandergeest P, 1996, ENVIRON CONSERV, V23, P259, DOI 10.1017/S037689290003887X; Vandergeest P, 1999, ENVIRON CONSERV, V26, P7, DOI 10.1017/S037689299900003X; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; VEIT PG, 2008, PROTECTED AREAS PROP; Wiersma YF, 2009, BIOL CONSERV, V142, P1639, DOI 10.1016/j.biocon.2009.02.034	27	172	184	4	202	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					365	367		10.1038/nature09180	http://dx.doi.org/10.1038/nature09180			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20592729				2022-12-28	WOS:000279867100048
J	Reyes, A; Haynes, M; Hanson, N; Angly, FE; Heath, AC; Rohwer, F; Gordon, JI				Reyes, Alejandro; Haynes, Matthew; Hanson, Nicole; Angly, Florent E.; Heath, Andrew C.; Rohwer, Forest; Gordon, Jeffrey I.			Viruses in the faecal microbiota of monozygotic twins and their mothers	NATURE			English	Article							GENOMIC ANALYSIS; VIRAL COMMUNITY; DIVERSITY; PROTEIN; GENE; IDENTIFICATION; SOFTWARE; PROPHAGE; TOOL	Viral diversity and life cycles are poorly understood in the human gut and other body habitats. Phages and their encoded functions may provide informative signatures of a human microbiota and of microbial community responses to various disturbances, and may indicate whether community health or dysfunction is manifest after apparent recovery from a disease or therapeutic intervention. Here we report sequencing of the viromes (metagenomes) of virus-like particles isolated from faecal samples collected from healthy adult female monozygotic twins and their mothers at three time points over a one-year period. We compared these data sets with data sets of sequenced bacterial 16S ribosomal RNA genes and total-faecal-community DNA. Co-twins and their mothers share a significantly greater degree of similarity in their faecal bacterial communities than do unrelated individuals. In contrast, viromes are unique to individuals regardless of their degree of genetic relatedness. Despite remarkable interpersonal variations in viromes and their encoded functions, intrapersonal diversity is very low, with >95% of virotypes retained over the period surveyed, and with viromes dominated by a few temperate phages that exhibit remarkable genetic stability. These results indicate that a predatory viral-microbial dynamic, manifest in a number of other characterized environmental ecosystems, is notably absent in the very distal intestine.	[Reyes, Alejandro; Gordon, Jeffrey I.] Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA; [Haynes, Matthew; Hanson, Nicole; Angly, Florent E.; Rohwer, Forest] San Diego State Univ, Dept Biol, San Diego, CA 92182 USA; [Angly, Florent E.] Univ Queensland, Adv Water Management Ctr, Brisbane, Qld 4072, Australia; [Heath, Andrew C.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63108 USA	Washington University (WUSTL); California State University System; San Diego State University; University of Queensland; Washington University (WUSTL)	Gordon, JI (corresponding author), Washington Univ, Sch Med, Ctr Genome Sci & Syst Biol, St Louis, MO 63108 USA.	jgordon@wustl.edu	Reyes, Alejandro/AAD-8445-2022; Angly, Florent E/A-7717-2011; Rohwer, Forest/AAC-5315-2019	Reyes, Alejandro/0000-0003-2907-3265; Angly, Florent E/0000-0002-8999-0738; Rohwer, Forest/0000-0003-1548-5429	NIH [DK78669]; Crohn's and Colitis Foundation of America; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; International Fulbright Science and Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK078669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K05AA017688] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America; Dr. Miriam and Sheldon G. Adelson Medical Research Foundation; International Fulbright Science and Technology Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank S. Wagoner and J. Manchester for technical assistance, J. Faith for help developing Phage_omics and, together with F. Rey, for microbial RNA-Seq data sets, P. Turnbaugh for assistance with faecal metagenomic studies, and B. Rodriguez-Mueller and D. Willner for valuable discussions. This work was supported in part by grants from the NIH (American Recovery and Reinvestment Act supplemental funding of DK78669), the Crohn's and Colitis Foundation of America and the Dr. Miriam and Sheldon G. Adelson Medical Research Foundation. A. R. is the recipient of an International Fulbright Science and Technology Program award.	Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly F, 2009, ENVIRON MICROBIOL, V11, P2863, DOI 10.1111/j.1462-2920.2009.02021.x; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; Angly FE, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000593; Becker A, 1995, MOL GEN GENET, V249, P487, DOI 10.1007/BF00290574; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Breitbart M, 2008, RES MICROBIOL, V159, P367, DOI 10.1016/j.resmic.2008.04.006; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faith JJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-344; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Garriga X, 1996, BIOCHEM BIOPH RES CO, V229, P189, DOI 10.1006/bbrc.1996.1778; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Gon S, 2006, ANTIOXID REDOX SIGN, V8, P735, DOI 10.1089/ars.2006.8.735; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Heath AC, 2002, TWIN RES, V5, P107, DOI 10.1375/twin.5.2.107; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Oliver KM, 2009, SCIENCE, V325, P992, DOI 10.1126/science.1174463; Padovani D, 2001, BIOCHEMISTRY-US, V40, P6713, DOI 10.1021/bi002936q; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; R Core Team, 2020, R LANG ENV STAT COMP; Rey FE, 2010, J BIOL CHEM, V285, P22082, DOI 10.1074/jbc.M110.117713; Rodriguez-Brito B, 2010, ISME J, V4, P739, DOI 10.1038/ismej.2010.1; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2001, BIOTECHNIQUES, V31, P108, DOI 10.2144/01311rr02; Schuch R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006532; Sharon I, 2009, NATURE, V461, P258, DOI 10.1038/nature08284; TABOR CW, 1976, ANNU REV BIOCHEM, V45, P285, DOI 10.1146/annurev.bi.45.070176.001441; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Turnbaugh PJ, 2010, P NATL ACAD SCI USA, V107, P7503, DOI 10.1073/pnas.1002355107; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	50	764	798	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					334	U81		10.1038/nature09199	http://dx.doi.org/10.1038/nature09199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631792	Green Accepted			2022-12-28	WOS:000279867100041
J	Rhodes, T; Sarang, A; Vickerman, P; Hickman, M				Rhodes, Tim; Sarang, Anya; Vickerman, Peter; Hickman, Matthew			Policy resistance to harm reduction for drug users and potential effect of change	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RUSSIAN-FEDERATION; TOGLIATTI CITY; INJECT DRUGS; HIV; PEOPLE; RISK; CARE		[Rhodes, Tim; Vickerman, Peter] London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England; [Sarang, Anya] Andrey Rylkov Fdn Hlth & Social Justice, Moscow, Russia; [Vickerman, Peter; Hickman, Matthew] Univ Bristol, Bristol BS8 1TH, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of Bristol	Rhodes, T (corresponding author), London Sch Hyg & Trop Med, Ctr Res Drugs & Hlth Behav, London WC1E 8HT, England.	tim.rhodes@lshtm.ac.uk	Sarang, Anya/K-3359-2015; Hickman, Matthew/Y-2400-2019; Rhodes, Tim/DNJ-9679-2022	Sarang, Anya/0000-0003-0361-1264; Hickman, Matthew/0000-0001-9864-459X; Rhodes, Tim/0000-0003-2400-9838; Vickerman, Peter/0000-0002-8291-5890	ESRC [ES/G007543/1] Funding Source: UKRI; MRC [G0701627] Funding Source: UKRI; Economic and Social Research Council [ES/G007543/1] Funding Source: researchfish; Medical Research Council [G0701627] Funding Source: Medline; Department of Health Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		[Anonymous], 2007, PREV HIV INF INJ DRU; BABAYAN EA, 1985, TXB ALCOHOLISM DRUG; Bobrik A, 2005, J PUBLIC HEALTH POL, V26, P30, DOI 10.1057/palgrave.jphp.3200002; DEGENHARDT L, 2010, LANCET IN PRESS; Elovich R, 2008, HARM REDUCT J, V5, DOI 10.1186/1477-7517-5-23; Gowing L, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004145.pub3; Human Rights Watch, 2007, REH REQ RUSS HUM RIG; Jarlais DCD, 2007, AIDS, V21, pS109, DOI 10.1097/01.aids.0000304705.79541.34; LATYPOV A, 2010, INT J DRUG POLI 0223; Lert F, 2007, INT J DRUG POLICY, V18, P255, DOI 10.1016/j.drugpo.2007.05.002; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Mendelevich Vladimir, 2006, HIV AIDS Policy Law Rev, V11, P82; PLAVINSKY SL, 2009, SEXUALLY TRANSMITTED; PLAVINSKY SL, 2008, GLOBUS PROJECT NEWSL, V7; Rhodes T, 2004, JAIDS-J ACQ IMM DEF, V35, P293, DOI 10.1097/00126334-200403010-00011; Rhodes T, 2003, SOC SCI MED, V57, P39, DOI 10.1016/S0277-9536(02)00521-X; Roux P, 2008, ADDICTION, V103, P1828, DOI 10.1111/j.1360-0443.2008.02323.x; *SEC COUNC RUSS FE, 2009, STEN M IMPR STAT POL; STRATHDEE SA, 2010, LANCET IN PRESS; *UNAIDS, 2009, AIDS EP UPD; Van den Berg C, 2007, ADDICTION, V102, P1454, DOI 10.1111/j.1360-0443.2007.01912.x; VICKERMAN P, 2006, J ACQ IMMUN DEF SYND, V42, P255; Wood E, 2009, LANCET, V373, P989, DOI 10.1016/S0140-6736(09)60455-4	24	36	36	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3439	10.1136/bmj.c3439	http://dx.doi.org/10.1136/bmj.c3439			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628XB	20627977	Green Accepted			2022-12-28	WOS:000280156600006
J	Dwyer, ND; Winckler, B				Dwyer, Noelle D.; Winckler, Bettina			TGF-beta Receptors PAR-ticipate in Axon Formation	CELL			English	Editorial Material							NEURONAL POLARIZATION; CORTICAL-NEURONS; SAD KINASES		[Dwyer, Noelle D.] Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA; [Winckler, Bettina] Univ Virginia, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia	Dwyer, ND (corresponding author), Univ Virginia, Dept Cell Biol, Charlottesville, VA 22908 USA.	ndwyer@virginia.edu; bwinckler@virginia.edu		Dwyer, Noelle/0000-0002-1995-7203				Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; Kwiatkowski AV, 2007, NEURON, V56, P441, DOI 10.1016/j.neuron.2007.09.008; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; POLLEUX F, 2010, COLD SPRING HARBOR P, V2; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012	9	2	2	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					21	23		10.1016/j.cell.2010.06.024	http://dx.doi.org/10.1016/j.cell.2010.06.024			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603011	Bronze			2022-12-28	WOS:000279637300009
J	Jernelov, A				Jernelov, Arne			How to defend against future oil spills	NATURE			English	Editorial Material									Inst Futures Studies, SE-10131 Stockholm, Sweden		Jernelov, A (corresponding author), Inst Futures Studies, Box 591, SE-10131 Stockholm, Sweden.	arne.jernelov@chello.at						JERNELOV A, 1981, NATURE, V10, P299	1	143	150	3	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					182	183		10.1038/466182a	http://dx.doi.org/10.1038/466182a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613822				2022-12-28	WOS:000279580800017
J	Wilkens, P; Scheel, IB; Grundnes, O; Hellum, C; Storheim, K				Wilkens, Philip; Scheel, Inger B.; Grundnes, Oliver; Hellum, Christian; Storheim, Kjersti			Effect of Glucosamine on Pain-Related Disability in Patients With Chronic Low Back Pain and Degenerative Lumbar Osteoarthritis A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; KNEE OSTEOARTHRITIS; SULFATE; CHONDROITIN; QUESTIONNAIRE; SYMPTOMS; DISEASE; DISK	Context Chronic low back pain (LBP) with degenerative lumbar osteoarthritis (OA) is widespread in the adult population. Although glucosamine is increasingly used by patients with chronic LBP, little is known about its effect in this setting. Objective To investigate the effect of glucosamine in patients with chronic LBP and degenerative lumbar OA. Design, Setting, and Participants A double-blind, randomized, placebo-controlled trial conducted at Oslo University Hospital Outpatient Clinic, Oslo, Norway, with 250 patients older than 25 years of age with chronic LBP (>6 months) and degenerative lumbar OA. Interventions Daily intake of 1500 mg of oral glucosamine (n=125) or placebo (n=125) for 6 months, with assessment of effect after the 6-month intervention period and at 1 year (6 months postintervention). Main Outcome Measures The primary outcome was pain-related disability measured with the Roland Morris Disability Questionnaire (RMDQ). Secondary outcomes were numerical scores from pain-rating scales of patients at rest and during activity, and the quality-of-life EuroQol-5 Dimensions (EQ-5D) instrument. Data collection occurred during the intervention period at baseline, 6 weeks, 3 and 6 months, and again 6 months following the intervention at 1 year. Group differences were analyzed using linear mixed models analysis. Results At baseline, mean RMDQ scores were 9.2 (95% confidence interval [CI], 8.4-10.0) for glucosamine and 9.7 (95% CI, 8.9-10.5) for the placebo group (P=.37). At 6 months, the mean RMDQ score was the same for the glucosamine and placebo groups (5.0; 95% CI, 4.2-5.8). At 1 year, the mean RMDQ scores were 4.8 (95% CI, 3.9-5.6) for glucosamine and 5.5 (95% CI, 4.7-6.4) for the placebo group. No statistically significant difference in change between groups was found when assessed after the 6-month intervention period and at 1 year: RMDQ(P=.72), LBP at rest (P=.91), LBP during activity (P=.97), and quality-of-life EQ-5D (P=.20). Mild adverse events were reported in 40 patients in the glucosamine group and 46 in the placebo group (P=.48). Conclusions Among patients with chronic LBP and degenerative lumbar OA, 6-month treatment with oral glucosamine compared with placebo did not result in reduced pain-related disability after the 6-month intervention and after 1-year follow-up.	[Wilkens, Philip] Oslo Univ Hosp, Dept Orthopaed, FOU, OS,BD, N-0460 Oslo, Norway; [Wilkens, Philip; Grundnes, Oliver; Hellum, Christian; Storheim, Kjersti] Univ Oslo, Oslo, Norway; [Scheel, Inger B.] SINTEF Hlth Res, Oslo, Norway; [Wilkens, Philip; Storheim, Kjersti] Norwegian Res Ctr Act Rehabil NAR, Oslo, Norway	University of Oslo; University of Oslo; SINTEF	Wilkens, P (corresponding author), Oslo Univ Hosp, Dept Orthopaed, FOU, OS,BD, Bygg 73,Kirkeveien 166, N-0460 Oslo, Norway.	philip.wilkens@medisin.uio.no			Norwegian Foundation for Health and Rehabilitation through the Norwegian Low Back Pain Association; Norwegian Chiropractic Associations; Wilhelmsens Research Fund; Norwegian Foundation for Health and Rehabilitation; Norwegian Low Back Pain Association; Oslo University Hospital Ulleval	Norwegian Foundation for Health and Rehabilitation through the Norwegian Low Back Pain Association; Norwegian Chiropractic Associations; Wilhelmsens Research Fund; Norwegian Foundation for Health and Rehabilitation; Norwegian Low Back Pain Association; Oslo University Hospital Ulleval	The study was supported by grants from the EXTRA funds from the Norwegian Foundation for Health and Rehabilitation through the Norwegian Low Back Pain Association, Norwegian Chiropractic Associations Research Fund, and Wilhelmsens Research Fund. The study medications (glucosamine and placebo) were produced by and purchased from Pharma Nord. Pharma Nord was chosen as the study agent supplier after all companies with marketing approvals in Norway were asked if they wanted to contribute with their product to the trial.; The Norwegian Foundation for Health and Rehabilitation, the Norwegian Low Back Pain Association, Norwegian Chiropractic Associations Research Fund, and Wilhelmsens Research Fund had no role in design or conduct of the study, collection or analysis of the data, or preparation of the manuscript. Pharma Nord had no involvement in conducting the study, or publishing results from the study.; We thank the patients who participated in the trial, the support form Oslo University Hospital Ulleval, and the referring health personnel. We would also like to thank Leiv Sandvik, PhD (professor in biostatistics, Oslo University Hospital), for statistical advice, and Irene Syse, BSN (Oslo University Hospital), for data monitoring, for which they received no compensation. Additionally, we would like to thank Lucy Hyatt, PhD, for critically editing the manuscript, for which she received 275 pound.	APRILL C, 1992, BRIT J RADIOL, V65, P361, DOI 10.1259/0007-1285-65-773-361; Assmann SF, 2000, LANCET, V355, P1064, DOI 10.1016/S0140-6736(00)02039-0; Borenstein David, 2004, Curr Pain Headache Rep, V8, P512, DOI 10.1007/s11916-004-0075-z; Clegg DO, 2006, NEW ENGL J MED, V354, P795, DOI 10.1056/NEJMoa052771; DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102; Deyo RA, 2001, NEW ENGL J MED, V344, P363, DOI 10.1056/NEJM200102013440508; DROVANTI A, 1980, CLIN THER, V3, P260; *EUR JOURN CTR, MED LAND; Farrar JT, 2001, PAIN, V94, P149, DOI 10.1016/S0304-3959(01)00349-9; Grotle M, 2003, J REHABIL MED, V35, P241, DOI 10.1080/16501970306094; GRUNDNES O, GLUCOSAMINE STUDY EF; Herrero-Beaumont G, 2007, ARTHRITIS RHEUM-US, V56, P555, DOI 10.1002/art.22371; HERREROBEAUMONT G, 2005, ARTHRITIS RHEUM S, V9, P1203, DOI DOI 10.1016/S1063-4584(05)80353-X; Hopman WM, 2006, OSTEOARTHR CARTILAGE, V14, P1288, DOI 10.1016/j.joca.2006.06.003; Igarashi A, 2007, J ORTHOP SCI, V12, P154, DOI 10.1007/s00776-006-1105-y; Largo R, 2003, OSTEOARTHR CARTILAGE, V11, P290, DOI 10.1016/S1063-4584(03)00028-1; Le Maitre CL, 2007, BIOCHEM SOC T, V35, P652, DOI 10.1042/BST0350652; Lee YH, 2010, RHEUMATOL INT, V30, P357, DOI 10.1007/s00296-009-0969-5; Leffler CT, 1999, MIL MED, V164, P85, DOI 10.1093/milmed/164.2.85; Luoma K, 2000, SPINE, V25, P487, DOI 10.1097/00007632-200002150-00016; McAlindon TE, 2000, JAMA-J AM MED ASSOC, V283, P1469, DOI 10.1001/jama.283.11.1469; Meulenbelt I, 2007, OSTEOARTHR CARTILAGE, V15, P379, DOI 10.1016/j.joca.2006.09.007; MODIC MT, 1988, RADIOLOGY, V166, P193, DOI 10.1148/radiology.166.1.3336678; Ostelo RWJG, 2005, BEST PRACT RES CL RH, V19, P593, DOI 10.1016/j.berh.2005.03.003; PATHRIA M, 1987, RADIOLOGY, V164, P227, DOI 10.1148/radiology.164.1.3588910; Pavelka K, 2002, ARCH INTERN MED, V162, P2113, DOI 10.1001/archinte.162.18.2113; Persiani S, 2005, OSTEOARTHR CARTILAGE, V13, P1041, DOI 10.1016/j.joca.2005.07.009; Richy F, 2003, ARCH INTERN MED, V163, P1514, DOI 10.1001/archinte.163.13.1514; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Rozendaal RM, 2008, ANN INTERN MED, V148, P268, DOI 10.7326/0003-4819-148-4-200802190-00005; Solberg TK, 2005, EUR SPINE J, V14, P1000, DOI 10.1007/s00586-005-0898-2; Stratford PW, 1996, PHYS THER, V76, P359, DOI 10.1093/ptj/76.4.359; Tant L, 2005, CURR THER RES CLIN E, V66, P511, DOI 10.1016/j.curtheres.2005.12.009; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Towheed TE, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002946.pub2; Towheed TE, 2001, COCHRANE DB SYST REV; van Tulder M, 2006, EUR SPINE J, V15, pS169, DOI 10.1007/s00586-006-1071-2; Vlad SC, 2007, ARTHRITIS RHEUM-US, V56, P2267, DOI 10.1002/art.22728; WADDELL G, 1993, PAIN, V52, P157, DOI 10.1016/0304-3959(93)90127-B; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	40	51	55	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					45	52		10.1001/jama.2010.893	http://dx.doi.org/10.1001/jama.2010.893			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606148	Bronze			2022-12-28	WOS:000279519600020
J	Hicks, WM; Kim, M; Haber, JE				Hicks, Wade M.; Kim, Minlee; Haber, James E.			Increased Mutagenesis and Unique Mutation Signature Associated with Mitotic Gene Conversion	SCIENCE			English	Article							STRAND-BREAK-REPAIR; DNA-POLYMERASE-EPSILON; SACCHAROMYCES-CEREVISIAE; HETERODUPLEX DNA; CANCER; RECOMBINATION; DELTA; MODEL; YEAST; REPLICATION	To examine the fidelity of DNA synthesis during double-strand break (DSB) repair in Saccharomyces cerevisiae we studied gene conversion in which both strands of DNA are newly synthesized. The mutation rate increases up to 1400 times over spontaneous events, with a significantly different mutation signature. Especially prominent are microhomology-mediated template switches. Recombination-induced mutations are largely independent of mismatch repair, by DNA polymerases Pol zeta, Pol eta, and Pol32, but result from errors made by Pol delta and Pol epsilon. These observations suggest that increased DSB frequencies in oncogene-activated mammalian cells may also increase the probability of acquiring mutations required for transition to a cancerous state.	[Haber, James E.] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA; Brandeis Univ, Rosenstiel Ctr, Waltham, MA 02454 USA	Brandeis University; Brandeis University	Haber, JE (corresponding author), Brandeis Univ, Dept Biol, Waltham, MA 02454 USA.	haber@brandeis.edu		Haber, James/0000-0002-1878-0610	NIH [GM007122, GM20056]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020056, R37GM020056, T32GM007122] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Kl-URA3 (GenBank: Y00454) was a gift from O. Zill and J. Rine. pol30-K127,164R was a gift from H. Ulrich. NIH Genetics Training Grant GM007122 supported W.M.H. NIH grant GM20056 to J.E.H. supported the research.	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; BUDD ME, 1995, MOL CELL BIOL, V15, P2173; Datta A, 2000, MOL CELL, V6, P593, DOI 10.1016/S1097-2765(00)00058-7; Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003; Greenblatt MS, 1996, CANCER RES, V56, P2130; HABER JE, 1993, P NATL ACAD SCI USA, V90, P3363, DOI 10.1073/pnas.90.8.3363; Haber JE, 1998, ANNU REV GENET, V32, P561, DOI 10.1146/annurev.genet.32.1.561; Halas A, 1999, ACTA BIOCHIM POL, V46, P863; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Holbeck SL, 1997, GENETICS, V147, P1017; Kunkel TA, 2003, DNA REPAIR, V2, P135, DOI 10.1016/S1568-7864(02)00224-0; Lang GI, 2008, GENETICS, V178, P67, DOI 10.1534/genetics.107.071506; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Loeb LA, 2008, CANCER RES, V68, P3551, DOI 10.1158/0008-5472.CAN-07-5835; Lydeard JR, 2007, NATURE, V448, P820, DOI 10.1038/nature06047; Maloisel L, 2008, MOL CELL BIOL, V28, P1373, DOI 10.1128/MCB.01651-07; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Payen C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000175; Rattray AJ, 2002, GENETICS, V162, P1063; RIPLEY LS, 1982, P NATL ACAD SCI-BIOL, V79, P4128, DOI 10.1073/pnas.79.13.4128; Smith CE, 2009, MOL CELL BIOL, V29, P1432, DOI 10.1128/MCB.01469-08; Stith CM, 2008, J BIOL CHEM, V283, P34129, DOI 10.1074/jbc.M806668200; STRATHERN JN, 1995, GENETICS, V140, P965; Wang X, 2004, MOL CELL BIOL, V24, P6891, DOI 10.1128/MCB.24.16.6891-6899.2004; Weinberg RA, 1996, SCI AM, V275, P62, DOI 10.1038/scientificamerican0996-62; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264	29	189	190	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					82	85		10.1126/science.1191125	http://dx.doi.org/10.1126/science.1191125			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595613	Green Accepted			2022-12-28	WOS:000279402700037
J	Steele, A; McCubbin, FM; Fries, M; Glamoclija, M; Kater, L; Nekvasil, H				Steele, A.; McCubbin, F. M.; Fries, M.; Glamoclija, M.; Kater, L.; Nekvasil, H.			Graphite in an Apollo 17 Impact Melt Breccia	SCIENCE			English	Article							LUNAR REGOLITH; WHISKERS		[Steele, A.; McCubbin, F. M.; Glamoclija, M.] Carnegie Inst Washington, Geophys Lab, Washington, DC 20015 USA; [Fries, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Kater, L.] Witec GmbH, D-89081 Ulm, Germany; [Nekvasil, H.] SUNY Stony Brook, Dept Geosci, Stony Brook, NY 11794 USA	Carnegie Institution for Science; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); WITec; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Steele, A (corresponding author), Carnegie Inst Washington, Geophys Lab, 5251 Broad Branch Rd NW, Washington, DC 20015 USA.	asteele@ciw.edu	McCubbin, Francis/D-1698-2009; McCubbin, Francis/AAG-1095-2020; Steele, Andrew/A-3573-2013; Glamoclija, Mihaela/GWQ-3360-2022	Steele, Andrew/0000-0001-9643-2841; Glamoclija, Mihaela/0000-0003-4327-6480	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	NASA Astrobiology Science and Technology; Sample Return Laboratory; Data Analysis; Lunar Advanced Science and Exploration Research; Mars Fundamental Research	We acknowledge support from NASA Astrobiology Science and Technology for Exploring Planets, Sample Return Laboratory Instrument and Data Analysis, Lunar Advanced Science and Exploration Research, and Mars Fundamental Research programs and thank Witec, J. Alton, and G. Lofgren. Dedicated to the memory of Annie Steele.	Dikov YP, 2002, SOLAR SYST RES+, V36, P1, DOI 10.1023/A:1014297009479; Fries M, 2008, SCIENCE, V320, P91, DOI 10.1126/science.1153578; Meyer C., 2009, LUNAR SAMPLE COMPEND; PILLINGER CT, 1977, PHILOS T R SOC A, V285, P369, DOI 10.1098/rsta.1977.0076; RYDER G, 1993, JSC PUBLICATION; Tan PH, 2004, PHILOS T R SOC A, V362, P2289, DOI 10.1098/rsta.2004.1442	6	35	35	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					51	51		10.1126/science.1190541	http://dx.doi.org/10.1126/science.1190541			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595608				2022-12-28	WOS:000279402700027
J	Moran, U; Phillips, R; Milo, R				Moran, Uri; Phillips, Rob; Milo, Ron			SnapShot: Key Numbers in Biology	CELL			English	Editorial Material									[Moran, Uri; Milo, Ron] Weizmann Inst Sci, Rehovot, Israel; [Phillips, Rob] CALTECH, Pasadena, CA USA	Weizmann Institute of Science; California Institute of Technology	Moran, U (corresponding author), Weizmann Inst Sci, Rehovot, Israel.		Milo, Hilla/C-8767-2016	Milo, Ron/0000-0003-1641-2299					0	121	122	2	26	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1262	1262	1262.e1	10.1016/j.cell.2010.06.019	http://dx.doi.org/10.1016/j.cell.2010.06.019			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603006	Bronze			2022-12-28	WOS:000279148100022
J	Maemondo, M; Inoue, A; Kobayashi, K; Sugawara, S; Oizumi, S; Isobe, H; Gemma, A; Harada, M; Yoshizawa, H; Kinoshita, I; Fujita, Y; Okinaga, S; Hirano, H; Yoshimori, K; Harada, T; Ogura, T; Ando, M; Miyazawa, H; Tanaka, T; Saijo, Y; Hagiwara, K; Morita, S; Nukiwa, T				Maemondo, Makoto; Inoue, Akira; Kobayashi, Kunihiko; Sugawara, Shunichi; Oizumi, Satoshi; Isobe, Hiroshi; Gemma, Akihiko; Harada, Masao; Yoshizawa, Hirohisa; Kinoshita, Ichiro; Fujita, Yuka; Okinaga, Shoji; Hirano, Haruto; Yoshimori, Kozo; Harada, Toshiyuki; Ogura, Takashi; Ando, Masahiro; Miyazawa, Hitoshi; Tanaka, Tomoaki; Saijo, Yasuo; Hagiwara, Koichi; Morita, Satoshi; Nukiwa, Toshihiro		NE Japan Study Grp	Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROWTH-FACTOR-RECEPTOR; PREVIOUSLY TREATED PATIENTS; RANDOMIZED PHASE-III; JAPANESE PATIENTS; MUTATIONS; SURVIVAL; PACLITAXEL; DOCETAXEL; DISEASE; TRIAL	Background: Non-small-cell lung cancer with sensitive mutations of the epidermal growth factor receptor (EGFR) is highly responsive to EGFR tyrosine kinase inhibitors such as gefitinib, but little is known about how its efficacy and safety profile compares with that of standard chemotherapy. Methods: We randomly assigned 230 patients with metastatic, non-small-cell lung cancer and EGFR mutations who had not previously received chemotherapy to receive gefitinib or carboplatin-paclitaxel. The primary end point was progression-free survival; secondary end points included overall survival, response rate, and toxic effects. Results: In the planned interim analysis of data for the first 200 patients, progression-free survival was significantly longer in the gefitinib group than in the standard-chemotherapy group (hazard ratio for death or disease progression with gefitinib, 0.36; P<0.001), resulting in early termination of the study. The gefitinib group had a significantly longer median progression-free survival (10.8 months, vs. 5.4 months in the chemotherapy group; hazard ratio, 0.30; 95% confidence interval, 0.22 to 0.41; P<0.001), as well as a higher response rate (73.7% vs. 30.7%, P<0.001). The median overall survival was 30.5 months in the gefitinib group and 23.6 months in the chemotherapy group (P=0.31). The most common adverse events in the gefitinib group were rash (71.1%) and elevated aminotransferase levels (55.3%), and in the chemotherapy group, neutropenia (77.0%), anemia (64.6%), appetite loss (56.6%), and sensory neuropathy (54.9%). One patient receiving gefitinib died from interstitial lung disease. Conclusions: First-line gefitinib for patients with advanced non-small-cell lung cancer who were selected on the basis of EGFR mutations improved progression-free survival, with acceptable toxicity, as compared with standard chemotherapy. (UMIN-CTR number, C000000376.) N Engl J Med 2010;362:2380-8.	[Inoue, Akira] Tohoku Univ Hosp, Dept Resp Med, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Maemondo, Makoto] Miyagi Canc Ctr, Sendai, Miyagi, Japan; [Sugawara, Shunichi] Sendai Kousei Hosp, Sendai, Miyagi, Japan; [Nukiwa, Toshihiro] Tohoku Univ, Grad Sch Med, Sendai, Miyagi 980, Japan; [Kobayashi, Kunihiko] Saitama Med Univ, Int Med Ctr, Saitama, Japan; [Oizumi, Satoshi] Hokkaido Univ, Sch Med, Sapporo, Hokkaido 060, Japan; [Isobe, Hiroshi] Kokka Komuin Kyosai Kumiai Rengokai Sapporo Med C, Sapporo, Hokkaido, Japan; [Harada, Masao] Natl Hosp Org, Hokkaido Canc Ctr, Sapporo, Hokkaido, Japan; [Kinoshita, Ichiro] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan; [Harada, Toshiyuki] Hokkaido Social Insurance Hosp, Sapporo, Hokkaido, Japan; [Gemma, Akihiko] Nippon Med Sch, Tokyo 113, Japan; [Yoshimori, Kozo] Fukujuji Hosp, AntiTB Assoc, Tokyo, Japan; [Yoshizawa, Hirohisa] Niigata Univ, Med & Dent Hosp, Niigata, Japan; [Fujita, Yuka] Dohoku Natl Hosp, Natl Hosp Org, Asahikawa, Hokkaido, Japan; [Hirano, Haruto] Iwate Cent Prefectural Hosp, Morioka, Iwate, Japan; [Ogura, Takashi] Kanagawa Cardiovasc & Resp Ctr, Yokohama, Kanagawa, Japan; [Morita, Satoshi] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa 232, Japan; [Ando, Masahiro] Tsuboi Canc Ctr Hosp, Koriyama, Fukushima, Japan; [Saijo, Yasuo] Hirosaki Univ, Grad Sch Med, Hirosaki, Aomori, Japan	Tohoku University; Miyagi Cancer Center; Sendai Kousei Hospital; Tohoku University; Saitama Medical University; Hokkaido University; Hokkaido University; Nippon Medical School; Fukujuji Hospital; Niigata University; Iwate Prefectural Central Hospital; Kanagawa Cardiovascular & Respiratory Center; Yokohama City University; Hirosaki University	Inoue, A (corresponding author), Tohoku Univ Hosp, Dept Resp Med, Aoba Ku, 1-1 Seiryomachi, Sendai, Miyagi 9808574, Japan.	akinoue@idac.tohoku.ac.jp	Oizumi, Satoshi/G-6717-2012	Usui, Kazuhiro/0000-0002-4492-9327	Japan Society for Promotion of Science; Japanese Foundation for the Multidisciplinary Treatment of Cancer; Tokyo Cooperative Oncology Group; Grants-in-Aid for Scientific Research [21591006] Funding Source: KAKEN	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Foundation for the Multidisciplinary Treatment of Cancer; Tokyo Cooperative Oncology Group; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Supported by grants-in-aid from the Japan Society for Promotion of Science and the Japanese Foundation for the Multidisciplinary Treatment of Cancer and a grant from the Tokyo Cooperative Oncology Group.	Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Asahina H, 2006, BRIT J CANCER, V95, P998, DOI 10.1038/sj.bjc.6603393; Bell DW, 2005, J CLIN ONCOL, V23, P8081, DOI 10.1200/JCO.2005.02.7078; Cohen MH, 2003, ONCOLOGIST, V8, P303, DOI 10.1634/theoncologist.8-4-303; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Inoue, 2009, J CLIN ONCOL, V27, P3071, DOI 10.1200/JCO.2009.23.6935; Inoue A, 2003, LANCET, V361, P137, DOI 10.1016/S0140-6736(03)12190-3; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Isomura M, 2004, J CLIN ONCOL, V22, p200S; Kim ES, 2008, LANCET, V372, P1809, DOI 10.1016/S0140-6736(08)61758-4; KOBAYASHI K, 2009, J CLIN ONCOL S, V27, pS411, DOI DOI 10.1056/NEJMOA0904554; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kudoh S, 2008, AM J RESP CRIT CARE, V177, P1348, DOI 10.1164/rccm.200710-1501OC; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maruyama R, 2008, J CLIN ONCOL, V26, P4244, DOI 10.1200/JCO.2007.15.0185; Mitsudomi T, 2005, J CLIN ONCOL, V23, P2513, DOI 10.1200/JCO.2005.00.992; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Morita S, 2009, CLIN CANCER RES, V15, P4493, DOI 10.1158/1078-0432.CCR-09-0391; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Sutani A, 2006, BRIT J CANCER, V95, P1483, DOI 10.1038/sj.bjc.6603466; Tanaka T, 2010, INT J CANCER, V126, P651, DOI 10.1002/ijc.24746; Thatcher N, 2005, LANCET, V366, P1527, DOI 10.1016/S0140-6736(05)67625-8; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Toyooka S, 2008, CANCER SCI, V99, P303, DOI 10.1111/j.1349-7006.2007.00688.x	32	4162	4403	9	360	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2380	2388		10.1056/NEJMoa0909530	http://dx.doi.org/10.1056/NEJMoa0909530			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573926	Bronze			2022-12-28	WOS:000279043800007
J	McPhee, CK; Logan, MA; Freeman, MR; Baehrecke, EH				McPhee, Christina K.; Logan, Mary A.; Freeman, Marc R.; Baehrecke, Eric H.			Activation of autophagy during cell death requires the engulfment receptor Draper	NATURE			English	Article							STARVATION-INDUCED AUTOPHAGY; DROSOPHILA FAT-BODY; GENE-EXPRESSION; GROWTH ARREST; PHAGOCYTOSIS; DEGRADATION; INDUCTION; OOGENESIS; PATHWAY	Autophagy degrades cytoplasmic components that are required for cell survival in response to starvation(1). Autophagy has also been associated with cell death, but it is unclear how this is distinguished from autophagy during cell survival. Drosophila salivary glands undergo programmed cell death that requires autophagy genes(2), and engulfment of salivary gland cells by phagocytes does not appear to occur(3). Here we show that Draper (Drpr), the Drosophila melanogaster orthologue of the Caenorhabditis elegans engulfment receptor CED-1, is required for autophagy during cell death. Null mutations in, and salivary gland-specific knockdown of, drpr inhibit salivary gland degradation. Knockdown of drpr prevents the induction of autophagy in dying salivary glands, and expression of the Atg1 autophagy regulator in drpr mutants suppresses the failure in degradation of salivary glands. Surprisingly, drpr is required in the same dying salivary gland cells in which it regulates autophagy induction, but drpr knockdown does not prevent starvation-induced autophagy in the fat body, which is associated with survival. In addition, components of the conserved engulfment pathway are required for clearance of dying salivary glands. To our knowledge, this is the first example of an engulfment factor that is required for self-clearance of cells. Further, Drpr is the first factor that distinguishes autophagy that is associated with cell death from autophagy associated with cell survival.	[McPhee, Christina K.; Baehrecke, Eric H.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [McPhee, Christina K.] Univ Maryland, Dept Mol Genet & Cell Biol, College Pk, MD 20742 USA; [Logan, Mary A.; Freeman, Marc R.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA; [Freeman, Marc R.] Univ Massachusetts, Sch Med, Howard Hughes Med Inst, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Maryland; University of Maryland College Park; University of Massachusetts System; University of Massachusetts Worcester; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Baehrecke, EH (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA.	Eric.Baehrecke@umassmed.edu		Kary, Christina/0000-0002-2586-4185; Freeman, Marc/0000-0003-3481-3715	American Cancer Society [PF-07-258-01-CSM]; NIH [NS053538, GM079431]; Merck and Co. Inc.; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053538, R37NS053538] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck and Co. Inc.(Merck & Company); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Bergmann, U. Gaul, H. Kramer, E. Kurant, T. P. Neufeld, T. E. Rusten, H. Stenmark, the Bloomington Stock Center, the VDRC, and the Developmental Studies Hybridoma Bank for flies and antibodies, and R. Simin, T. Fortier and A. Sheehan for technical support. This work was supported by American Cancer Society Postdoctoral Fellowship PF-07-258-01-CSM to MAL, NIH grants NS053538 to M. R. F. and GM079431 to E. H. B., and Merck and Co. Inc. for E. H. B. E. H. B. is a member of the UMass DERC (DK32520).	Berry DL, 2007, CELL, V131, P1137, DOI 10.1016/j.cell.2007.10.048; BRAND AH, 1993, DEVELOPMENT, V118, P401; Denton D, 2009, CURR BIOL, V19, P1741, DOI 10.1016/j.cub.2009.08.042; Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052; Freeman MR, 2003, NEURON, V38, P567, DOI 10.1016/S0896-6273(03)00289-7; HAY BA, 1994, DEVELOPMENT, V120, P2121; Hou YCC, 2008, J CELL BIOL, V182, P1127, DOI 10.1083/jcb.200712091; Jiang CG, 1997, DEVELOPMENT, V124, P4673; Joubert PE, 2009, CELL HOST MICROBE, V6, P354, DOI 10.1016/j.chom.2009.09.006; Kuraishi T, 2009, EMBO J, V28, P3868, DOI 10.1038/emboj.2009.343; Kurant E, 2008, CELL, V133, P498, DOI 10.1016/j.cell.2008.02.052; Lee CY, 2003, CURR BIOL, V13, P350, DOI 10.1016/S0960-9822(03)00085-X; Lee CY, 2001, DEVELOPMENT, V128, P1443; Lee YS, 2003, METHODS, V30, P322, DOI 10.1016/S1046-2023(03)00051-3; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; MacDonald JM, 2006, NEURON, V50, P869, DOI 10.1016/j.neuron.2006.04.028; Martin DN, 2004, DEVELOPMENT, V131, P275, DOI 10.1242/dev.00933; Mohseni N, 2009, AUTOPHAGY, V5, P329, DOI 10.4161/auto.5.3.7444; Muro I, 2006, DEVELOPMENT, V133, P3305, DOI 10.1242/dev.02495; Nezis IP, 2009, AUTOPHAGY, V5, P298, DOI 10.4161/auto.5.3.7454; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; YU L, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09076; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	29	108	109	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1093	U159		10.1038/nature09127	http://dx.doi.org/10.1038/nature09127			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577216	Green Accepted, Green Submitted			2022-12-28	WOS:000279056900056
J	Gerstein, HC				Gerstein, Hertzel C.			More insights on the dysglycaemia-cardiovascular connection	LANCET			English	Editorial Material							RISK; METAANALYSIS; DYSGLYCEMIA; GLUCOSE		[Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; Population Health Research Institute	Gerstein, HC (corresponding author), McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada.	gerstein@mcmaster.ca	Gerstein, Hertzel C/B-1235-2013; Gerstein, Hertzel/ABB-8781-2020	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS62, DOI 10.2337/dc10-s062; Cowie CC, 1995, NIH PUBLICATION, V95-1468, P117; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Gerstein HC, 2007, DIABETES RES CLIN PR, V78, P305, DOI 10.1016/j.diabres.2007.05.004; Gerstein HC, 2009, NAT REV ENDOCRINOL, V5, P270, DOI 10.1038/nrendo.2009.49; Gerstein HC, 2009, CIRCULATION, V119, P773, DOI 10.1161/CIRCULATIONAHA.108.834408; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Sung J, 2009, CIRCULATION, V119, P812, DOI 10.1161/CIRCULATIONAHA.108.776989; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0	12	23	24	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2195	2196		10.1016/S0140-6736(10)60973-7	http://dx.doi.org/10.1016/S0140-6736(10)60973-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609955				2022-12-28	WOS:000279652900004
J	Hanefeld, M; Forst, T				Hanefeld, Markolf; Forst, Thomas			Dapagliflozin, an SGLT2 inhibitor, for diabetes	LANCET			English	Editorial Material							MELLITUS		[Hanefeld, Markolf] Tech Univ Dresden, Ctr Clin Studies, Gesell Wissens & Technol Transfer, D-01307 Dresden, Germany; [Forst, Thomas] Mainz Inst Clin Res & Dev, Mainz, Germany	Technische Universitat Dresden	Hanefeld, M (corresponding author), Tech Univ Dresden, Ctr Clin Studies, Gesell Wissens & Technol Transfer, D-01307 Dresden, Germany.	hanefeld@gwtonline-zks.de						Bailey CJ, 2010, LANCET, V375, P2223, DOI 10.1016/S0140-6736(10)60407-2; Brown JS, 2005, DIABETES CARE, V28, P177, DOI 10.2337/diacare.28.1.177; Del Prato S, 2009, DIABETIC MED, V26, P1185, DOI 10.1111/j.1464-5491.2009.02847.x; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Geerlings SE, 2000, EUR J CLIN INVEST, V30, P995, DOI 10.1046/j.1365-2362.2000.00745.x; Gerich JE, 2010, DIABETIC MED, V27, P136, DOI 10.1111/j.1464-5491.2009.02894.x; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Home PD, 2009, LANCET, V373, P2125, DOI 10.1016/S0140-6736(09)60953-3; Idris I, 2009, DIABETES OBES METAB, V11, P79, DOI 10.1111/j.1463-1326.2008.00982.x; Neumiller JJ, 2010, DRUGS, V70, P377, DOI 10.2165/11318680-000000000-00000; Santer R, 2003, J AM SOC NEPHROL, V14, P2873, DOI 10.1097/01.ASN.0000092790.89332.D2	11	21	23	2	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2196	2198		10.1016/S0140-6736(10)60749-0	http://dx.doi.org/10.1016/S0140-6736(10)60749-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609956				2022-12-28	WOS:000279652900005
J	Rosenstock, J; Lorber, DL; Gnudi, L; Howard, CP; Bilheimer, DW; Chang, PC; Petrucci, RE; Boss, AH; Richardson, PC				Rosenstock, Julio; Lorber, Daniel L.; Gnudi, Luigi; Howard, Campbell P.; Bilheimer, David W.; Chang, P-C; Petrucci, Richard E.; Boss, Anders H.; Richardson, Peter C.			Prandial inhaled insulin plus basal insulin glargine versus twice daily biaspart insulin for type 2 diabetes: a multicentre randomised trial	LANCET			English	Article							TECHNOSPHERE INSULIN; GLYCEMIC CONTROL; GLUCOSE CONTROL; THERAPY; EFFICACY; EXUBERA; SAFETY; STATEMENT; TARGET; LISPRO	Background Insulin therapy is often a delayed strategy in patients with type 2 diabetes mellitus because it is associated with weight gain, hypoglycaemia, and the need for subcutaneous injections. We aimed to assess the efficacy and safety of prandial Technosphere inhaled insulin compared with twice daily biaspart insulin Methods In this randomised, open-label, parallel-group study, adult patients with type 2 diabetes mellitus and poor glycaemic control despite insulin therapy, with or without oral antidiabetes drugs, were enrolled from ten countries between Feb 23,2006, and Aug 8,2007. Patients were randomly allocated in a 1:1 ratio to receive 52 weeks' treatment with: prandial Technosphere inhaled insulin powder plus bedtime insulin glargine; or twice daily premixed biaspart insulin (70% insulin aspart protamine suspension and 30% insulin aspart of rDNA origin). The primary endpoint was a comparison of change in glycosylated haemoglobin (HbA) from baseline to week 52 between treatment groups; the non-inferiority margin was 0.4%. Analysis was by per protocol for non-inferiority testing of the primary endpoint. This study is registered with ClinicalTrials.gov, number NCT00309244. Findings 334 patients were allocated to inhaled insulin plus insulin glargine, and 343 to biaspart insulin; 107 patients on inhaled insulin plus insulin glargine and 85 on biaspart insulin discontinued the trial. 211 patients on inhaled insulin plus insulin glargine and 237 on biaspart insulin were included in per-protocol analyses. Change in HbA,, with inhaled insulin plus insulin glargine (-0-68%, SE 0.077, 95% CI -0.83 to -0.53) was similar and non-inferior to that with biaspart insulin (-0.76%, 0.071, -0.90 to -0.62). The between-group difference was 0.07% (SE 0.102, 95% CI -0.13 to 0.27). Patients had significantly lower weight gain and had fewer mild-to-moderate and severe hypoglycaemic events on inhaled insulin plus insulin glargine than on biaspart insulin. The safety and tolerability profile was similar for both treatments, apart from increased occurrence of cough and change in pulmonary function in the group receiving inhaled insulin plus insulin glargine. Interpretation This study is part of a large clinical development programme addressing the efficacy and tolerability of use of Technosphere inhaled insulin in a wide variety of patients.	[Rosenstock, Julio] Dallas Diabet & Endocrine Ctr Med City, Dallas, TX 75230 USA; [Lorber, Daniel L.] Diabet Control Fdn, Diabet Care & Informat Ctr, Flushing, NY USA; [Gnudi, Luigi] Kings Coll London, Metab Med Unit, Div Cardiovasc, London WC2R 2LS, England; [Howard, Campbell P.; Bilheimer, David W.; Chang, P-C; Petrucci, Richard E.; Boss, Anders H.; Richardson, Peter C.] MannKind Corp, Valencia, CA USA	Diabetes & Endocrine Center; University of London; King's College London	Rosenstock, J (corresponding author), Dallas Diabet & Endocrine Ctr Med City, 7777 Forest Lane C-685, Dallas, TX 75230 USA.	juliorosenstock@dallasdiabetes.com	Boss, Anders H./AAA-5004-2019	gnudi, luigi/0000-0002-6353-630X	MannKind; Pfizer; Roche; Sanofi-Aventis; Novo Nordisk; Eli Lilly; GlaxoSmithKline; Takeda; Daiichi SanIcyo; Forest; Johnson Johnson; Novartis; Boehringer Ingelheim; Amylin; Merck; Bristol-Myers Squibb; AstraZeneca; Daiidii Sankyo; Sirtris; Servier	MannKind; Pfizer(Pfizer); Roche(Roche Holding); Sanofi-Aventis(Sanofi-Aventis); Novo Nordisk(Novo Nordisk); Eli Lilly(Eli Lilly); GlaxoSmithKline(GlaxoSmithKline); Takeda(Takeda Pharmaceutical Company Ltd); Daiichi SanIcyo(Daiichi Sankyo Company Limited); Forest; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Novartis(Novartis); Boehringer Ingelheim(Boehringer Ingelheim); Amylin; Merck(Merck & Company); Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Daiidii Sankyo; Sirtris; Servier(Servier)	Funding MannKind.JR has served on advisory boards and received honoraria or consulting fees from Pfizer, Roche, Sanofi-Aventis, Novo Nordisk, Eli Lilly, MannKind, GlaxoSmithKline, Takeda, Daiichi SanIcyo, Forest, Johnson & Johnson, Novartis, Boehringer Ingelheim, and Amylin; and has received research grants from Merck, Pfizer, Sanofi-Aventis, Novo Nordisk, Roche, Bristol-Myers Squibb, Eli Lilly, Forest, GlaxoSmithKline, Takeda, Novartis, AstraZeneca, Amylin, Johnson & Johnson, Daiidii Sankyo, MannKind, and Boehringer Ingelheim. DLL's institution has received research support and DLL has received travel reimbursement related to this study from MannKind. DLL has received research support and honoraria from Novo Nordisk; has served as a consultant and speaker for Novo Nordisk; has received travel reimbursement from MannKind; and is a board member for and stockholder in Biodel. LG's institution has received research support and LG has received travel reimbursement related to this study from MannKind; and LG has received honoraria from Takeda, Johnson & Johnson, GlaxoSmithKline, Sirtris, and Servier. CPH, DWB, P-CC, REP, AHB, and PCR are employees of and have shares or stocks in MannKind. No author received honoraria related to the development of this report.	BOSS AH, 2009, AM DIAB ASS 65 SCI S; BRAIN J, 2008, AM THOR SOC ANN M TO; Bretzel RG, 2008, LANCET, V371, P1073, DOI 10.1016/S0140-6736(08)60485-7; CASSIDY JP, 2009, AM DIAB ASS 69 SCI S; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Heller SR, 2009, DIABETES CARE, V32, pS357, DOI 10.2337/dc09-S339; Hollander PA, 2010, DIABETES TECHNOL THE, V12, P185, DOI 10.1089/dia.2009.0114; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Holman RR, 2009, NEW ENGL J MED, V361, P1736, DOI 10.1056/NEJMoa0905479; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Khutsoane D, 2008, DIABETES OBES METAB, V10, P212, DOI 10.1111/j.1463-1326.2007.00826.x; Leone-Bay A, 2008, MODIFIED RELEASE DRU, P673; Monnier L, 2009, DIABETES CARE, V32, pS199, DOI 10.2337/dc09-S310; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Petrucci R, 2009, DIABETOLOGIA, V52, pS361; Pfutzner Andreas, 2005, Expert Opin Drug Deliv, V2, P1097, DOI 10.1517/17425247.2.6.1097; Pfutzner Andreas, 2002, Diabetes Technol Ther, V4, P589, DOI 10.1089/152091502320798204; POTOCKA E, 2009, AM DIAB ASS 69 SCI S; Ramlo-Halsted BA, 1999, PRIMARY CARE, V26, P771, DOI 10.1016/S0095-4543(05)70130-5; Raskin P, 2005, DIABETES CARE, V28, P260, DOI 10.2337/diacare.28.2.260; Rave K, 2007, DIABETES CARE, V30, P2307, DOI 10.2337/dc07-0478; Roden M, 2009, NEW ENGL J MED, V361, P1801, DOI 10.1056/NEJMe0908706; Rosenstock J, 2008, DIABETES CARE, V31, P2177, DOI 10.2337/dc08-0315; Rosenstock J, 2008, DIABETES CARE, V31, P1723, DOI 10.2337/dc08-0159; Rosenstock J, 2008, DIABETES CARE, V31, P20, DOI 10.2337/dc07-1122; Rosenstock J, 2009, DIABETES TECHNOL THE, V11, P697, DOI 10.1089/dia.2009.0062; Steiner S, 2002, EXP CLIN ENDOCR DIAB, V110, P17, DOI 10.1055/s-2002-19989; Swinnen SG, 2009, DIABETES CARE, V32, pS253, DOI 10.2337/dc09-S318	30	79	105	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2244	2253		10.1016/S0140-6736(10)60632-0	http://dx.doi.org/10.1016/S0140-6736(10)60632-0			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609970				2022-12-28	WOS:000279652900021
J	Zhou, TQ; Georgiev, I; Wu, XL; Yang, ZY; Dai, KF; Finzi, A; Kwon, YD; Scheid, JF; Shi, W; Xu, L; Yang, YP; Zhu, JA; Nussenzweig, MC; Sodroski, J; Shapiro, L; Nabel, GJ; Mascola, JR; Kwong, PD				Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Finzi, Andres; Kwon, Young Do; Scheid, Johannes F.; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Nussenzweig, Michel C.; Sodroski, Joseph; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.			Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01	SCIENCE			English	Article							GP120 ENVELOPE GLYCOPROTEIN; RECEPTOR; SITE; EPITOPE; SURFACE; INDIVIDUALS; ATTACHMENT; MATURATION; HYPOTHESIS; VACCINES	During HIV-1 infection, antibodies are generated against the region of the viral gp120 envelope glycoprotein that binds CD4, the primary receptor for HIV-1. Among these antibodies, VRC01 achieves broad neutralization of diverse viral strains. We determined the crystal structure of VRC01 in complex with a human immunodeficiency virus HIV-1 gp120 core. VRC01 partially mimics CD4 interaction with gp120. A shift from the CD4-defined orientation, however, focuses VRC01 onto the vulnerable site of initial CD4 attachment, allowing it to overcome the glycan and conformational masking that diminishes the neutralization potency of most CD4-binding-site antibodies. To achieve this recognition, VRC01 contacts gp120 mainly through immunoglobulin V-gene regions substantially altered from their genomic precursors. Partial receptor mimicry and extensive affinity maturation thus facilitate neutralization of HIV-1 by natural human antibodies.	[Zhou, Tongqing; Georgiev, Ivelin; Wu, Xueling; Yang, Zhi-Yong; Dai, Kaifan; Kwon, Young Do; Shi, Wei; Xu, Ling; Yang, Yongping; Zhu, Jiang; Shapiro, Lawrence; Nabel, Gary J.; Mascola, John R.; Kwong, Peter D.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Finzi, Andres; Sodroski, Joseph] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Dept Pathol,Div AIDS, Boston, MA 02115 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA; [Scheid, Johannes F.; Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Sodroski, Joseph] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Shapiro, Lawrence] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; Harvard University; Harvard T.H. Chan School of Public Health; Columbia University	Kwong, PD (corresponding author), NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA.	pdkwong@nih.gov	Nussenzweig, Michel/AAE-7292-2019; Do Kwon, Young/A-6957-2010; Shapiro, Lawrence/AAE-7172-2019; Mascola, John/AAI-7193-2021; Zhou, Tongqing/A-6880-2010	Do Kwon, Young/0000-0002-1188-7458; Zhou, Tongqing/0000-0002-3935-4637; Finzi, Andres/0000-0002-4992-5288	NIH; International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science [W-31-109-Eng-38]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005095, P30AI060354, ZIAAI005022] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International AIDS Vaccine Initiative's Neutralizing Antibody Consortium; U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	T.Z., I.G., Z.Y., J.S., L.S., G.J.N., J.R.M., and P.D.K. designed the research; T.Z., I.G., X.W., Z.Y., K.D.A.F., W.S., L.X., Y.Y., and J.Z. performed the research; X.W., Y.K., J.F.S., M.C.N., and J.R.M. contributed new reagents or reference data; T.Z., I.G., X.W., J.S., L.S., G.J.N., J.R.M., and P.D.K. analyzed the data; and T.Z., I.G., J.S., L.S., G.J.N., J.R.M., and P.D.K. wrote the paper, on which all authors commented. We thank I.A. Wilson and members of the Structural Biology Section and Structural Bioinformatics Core, Vaccine Research Center, for discussions and comments on the manuscript; the staff of sector 22 for assistance with data collection; and J. Stuckey for assistance with figures. Support for this work was provided by the Intramural Research Program of NIH and by grants from NIH and from the International AIDS Vaccine Initiative's Neutralizing Antibody Consortium. Use of sector 22 (Southeast Region Collaborative Access team) at the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract W-31-109-Eng-38. Coordinates and structure factors for the VRC01-gp120 complex have been deposited with the PDB under accession code 3NGB.	Anderson JP, 2000, J VIROL, V74, P10752, DOI 10.1128/JVI.74.22.10752-10765.2000; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891; Calarese DA, 2003, SCIENCE, V300, P2065, DOI 10.1126/science.1083182; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; CONNOLLY ML, 1993, J MOL GRAPH MODEL, V11, P139, DOI 10.1016/0263-7855(93)87010-3; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; Dhillon AK, 2007, J VIROL, V81, P6548, DOI 10.1128/JVI.02749-06; Dimitrov DS, 2010, MABS-AUSTIN, V2, P347, DOI 10.4161/mabs.2.3.11779; Dodson EJ, 1997, METHOD ENZYMOL, V277, P620, DOI 10.1016/S0076-6879(97)77034-4; Finzi A, 2010, MOL CELL, V37, P656, DOI 10.1016/j.molcel.2010.02.012; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; Huang CC, 2004, P NATL ACAD SCI USA, V101, P2706, DOI 10.1073/pnas.0308527100; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; MADDON PJ, 1985, CELL, V42, P93, DOI 10.1016/S0092-8674(85)80105-7; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Myszka DG, 2000, P NATL ACAD SCI USA, V97, P9026, DOI 10.1073/pnas.97.16.9026; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Pancera M, 2010, J VIROL, V84, P8098, DOI 10.1128/JVI.00966-10; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rits-Volloch S, 2006, EMBO J, V25, P5026, DOI 10.1038/sj.emboj.7601358; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; Sanders RW, 2002, J VIROL, V76, P7293, DOI 10.1128/JVI.76.14.7293-7305.2002; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Smith TJ, 1996, NATURE, V383, P350, DOI 10.1038/383350a0; WEISS RA, 1985, NATURE, V316, P69, DOI 10.1038/316069a0; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Xiang SH, 2002, J VIROL, V76, P9888, DOI 10.1128/JVI.76.19.9888-9899.2002; Xiao XD, 2009, VIRUSES-BASEL, V1, P802, DOI 10.3390/v1030802; Xiao XD, 2009, BIOCHEM BIOPH RES CO, V390, P404, DOI 10.1016/j.bbrc.2009.09.029; Zhou TQ, 2007, NATURE, V445, P732, DOI 10.1038/nature05580	38	857	922	0	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	AUG 13	2010	329	5993					811	817		10.1126/science.1192819	http://dx.doi.org/10.1126/science.1192819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20616231	Green Accepted, Green Published			2022-12-28	WOS:000280809900043
J	Kravitz, AV; Freeze, BS; Parker, PRL; Kay, K; Thwin, MT; Deisseroth, K; Kreitzer, AC				Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Deisseroth, Karl; Kreitzer, Anatol C.			Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry	NATURE			English	Article							SUBTHALAMIC NUCLEUS; MOVEMENT-DISORDERS; IN-VIVO; NEURONS; INTERNEURONS; LESIONS; MODELS; MICE	Neural circuits of the basal ganglia are critical for motor planning and action selection(1-3). Two parallel basal ganglia pathways have been described(4), and have been proposed to exert opposing influences on motor function(5-7). According to this classical model, activation of the 'direct' pathway facilitates movement and activation of the 'indirect' pathway inhibits movement. However, more recent anatomical and functional evidence has called into question the validity of this hypothesis(8-10). Because this model has never been empirically tested, the specific function of these circuits in behaving animals remains unknown. Here we report direct activation of basal ganglia circuitry in vivo, using optogenetic control(11-14) of direct-and indirect-pathway medium spiny projection neurons (MSNs), achieved through Cre-dependent viral expression of channelrhodopsin-2 in the striatum of bacterial artificial chromosome transgenic mice expressing Cre recombinase under control of regulatory elements for the dopamine D1 or D2 receptor. Bilateral excitation of indirect-pathway MSNs elicited a parkinsonian state, distinguished by increased freezing, bradykinesia and decreased locomotor initiations. In contrast, activation of direct-pathway MSNs reduced freezing and increased locomotion. In a mouse model of Parkinson's disease, direct-pathway activation completely rescued deficits in freezing, bradykinesia and locomotor initiation. Taken together, our findings establish a critical role for basal ganglia circuitry in the bidirectional regulation of motor behaviour and indicate that modulation of direct-pathway circuitry may represent an effective therapeutic strategy for ameliorating parkinsonian motor deficits.	[Kravitz, Alexxai V.; Freeze, Benjamin S.; Parker, Philip R. L.; Kay, Kenneth; Thwin, Myo T.; Kreitzer, Anatol C.] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Kreitzer, Anatol C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Parker, Philip R. L.; Kreitzer, Anatol C.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Freeze, Benjamin S.; Kreitzer, Anatol C.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA; [Freeze, Benjamin S.; Kay, Kenneth; Kreitzer, Anatol C.] Univ Calif San Francisco, Med Scientist Training Program, San Francisco, CA 94143 USA; [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Deisseroth, Karl] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Stanford University; Stanford University	Kreitzer, AC (corresponding author), Gladstone Inst Neurol Dis, 1650 Owens St, San Francisco, CA 94158 USA.	akreitzer@gladstone.ucsf.edu	Core, Vector/CAF-4832-2022	Kravitz, Alexxai/0000-0001-5983-0218; Parker, Philip R. L./0000-0002-6224-9747	W.M. Keck Foundation; Pew Biomedical Scholars Program; McKnight Foundation; NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064984] Funding Source: NIH RePORTER	W.M. Keck Foundation(W.M. Keck Foundation); Pew Biomedical Scholars Program; McKnight Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank T. Marzullo and NeuroNexus Technologies for their assistance with the custom probe design, the Nikon Imaging Center at UCSF for assistance with image acquisition, R. Javier and A. Gittis for assistance with slice electrophysiology experiments, and L. Shoenfeld for assistance with genotyping and histology. A. C. K and co-workers are funded by the W.M. Keck Foundation, the Pew Biomedical Scholars Program, the McKnight Foundation and the NIH.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; Arenkiel BR, 2007, NEURON, V54, P205, DOI 10.1016/j.neuron.2007.03.005; BERGMAN H, 1994, J NEUROPHYSIOL, V72, P507, DOI 10.1152/jn.1994.72.2.507; BERGMAN H, 1990, SCIENCE, V249, P1436, DOI 10.1126/science.2402638; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Gatev P, 2006, MOVEMENT DISORD, V21, P1566, DOI 10.1002/mds.21033; GERFEN CR, 1990, SCIENCE, V250, P1429, DOI 10.1126/science.2147780; Gong SC, 2007, J NEUROSCI, V27, P9817, DOI 10.1523/JNEUROSCI.2707-07.2007; Gradinaru V, 2007, J NEUROSCI, V27, P14231, DOI 10.1523/JNEUROSCI.3578-07.2007; GRAYBIEL AM, 1994, SCIENCE, V265, P1826, DOI 10.1126/science.8091209; Hikosaka O, 2000, PHYSIOL REV, V80, P953, DOI 10.1152/physrev.2000.80.3.953; Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445; KAWAGUCHI Y, 1990, J NEUROSCI, V10, P3421; Kreitzer AC, 2007, NATURE, V445, P643, DOI 10.1038/nature05506; Kreitzer AC, 2009, ANNU REV NEUROSCI, V32, P127, DOI 10.1146/annurev.neuro.051508.135422; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Schwarting RKW, 1996, PROG NEUROBIOL, V49, P215, DOI 10.1016/S0301-0082(96)00015-9; Smith Y, 1998, NEUROSCIENCE, V86, P353; Sohal VS, 2009, NATURE, V459, P698, DOI 10.1038/nature07991; Surmeier DJ, 2005, CURR OPIN NEUROBIOL, V15, P312, DOI 10.1016/j.conb.2005.05.007; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	27	1157	1201	4	314	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					622	U7		10.1038/nature09159	http://dx.doi.org/10.1038/nature09159			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20613723	Green Accepted, Bronze			2022-12-28	WOS:000280412100053
J	Masuda, S; Awaji, T; Sugiura, N; Matthews, JP; Toyoda, T; Kawai, Y; Doi, T; Kouketsu, S; Igarashi, H; Katsumata, K; Uchida, H; Kawano, T; Fukasawa, M				Masuda, Shuhei; Awaji, Toshiyuki; Sugiura, Nozomi; Matthews, John Philip; Toyoda, Takahiro; Kawai, Yoshimi; Doi, Toshimasa; Kouketsu, Shinya; Igarashi, Hiromichi; Katsumata, Katsuro; Uchida, Hiroshi; Kawano, Takeshi; Fukasawa, Masao			Simulated Rapid Warming of Abyssal North Pacific Waters	SCIENCE			English	Article							SOUTHERN-OCEAN; BOTTOM WATER; CIRCULATION; SENSITIVITY; ADJOINT; ATLANTIC; 1950S; DEEP; SEA	Recent observational surveys have shown significant oceanic bottom-water warming. However, the mechanisms causing such warming remain poorly understood, and their time scales are uncertain. Here, we report computer simulations that reveal a fast teleconnection between changes in the surface air-sea heat flux off the Adelie Coast of Antarctica and the bottom-water warming in the North Pacific. In contrast to conventional estimates of a multicentennial time scale, this link is established over only four decades through the action of internal waves. Changes in the heat content of the deep ocean are thus far more sensitive to the air-sea thermal interchanges than previously considered. Our findings require a reassessment of the role of the Southern Ocean in determining the impact of atmospheric warming on deep oceanic waters.	[Masuda, Shuhei; Toyoda, Takahiro; Kawai, Yoshimi; Doi, Toshimasa; Kouketsu, Shinya; Katsumata, Katsuro; Uchida, Hiroshi; Kawano, Takeshi; Fukasawa, Masao] Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa 2360001, Japan; [Awaji, Toshiyuki; Sugiura, Nozomi; Igarashi, Hiromichi] JAMSTEC, Data Management & Engn Dept, Data Res Ctr Marine Earth Sci, Yokohama, Kanagawa 2360001, Japan; [Awaji, Toshiyuki; Matthews, John Philip] Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan; [Matthews, John Philip] Environm Satellite Applicat, Llys Awel, Menai Bridge LL59 5BW, Gwynedd, Wales	Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Japan Agency for Marine-Earth Science & Technology (JAMSTEC); Kyoto University	Masuda, S (corresponding author), Japan Agcy Marine Earth Sci & Technol JAMSTEC, Res Inst Global Change, Yokohama, Kanagawa 2360001, Japan.	smasuda@jamstec.go.jp	Kawai, Yoshimi/AAK-1539-2020; Katsumata, Katsuro/AAR-5034-2020	Katsumata, Katsuro/0000-0002-4683-7610; Masuda, Shuhei/0000-0001-6157-0101; Sugiura, Nozomi/0000-0001-6634-1340; Kouketsu, Shinya/0000-0002-8217-5888	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Y. Ishikawa and the late I. Kaneko for helpful discussions and Y. Sasaki and Y. Hiyoshi for technical support. This work was supported in part by the Data Integration and Analysis System of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Curran MAJ, 2003, SCIENCE, V302, P1203, DOI 10.1126/science.1087888; Fukasawa M, 2004, NATURE, V427, P825, DOI 10.1038/nature02337; Fukumori I, 2004, J PHYS OCEANOGR, V34, P582, DOI 10.1175/2515.1; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Johnson GC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026769; Kawano T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027933; KAWASE M, 1987, J PHYS OCEANOGR, V17, P2294, DOI 10.1175/1520-0485(1987)017<2294:EODOCD>2.0.CO;2; Kohl A, 2005, J PHYS OCEANOGR, V35, P1455, DOI 10.1175/JPO2767.1; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; MANTYLA AW, 1983, DEEP-SEA RES, V30, P805, DOI 10.1016/0198-0149(83)90002-X; Marotzke J, 1999, J GEOPHYS RES-OCEANS, V104, P29529, DOI 10.1029/1999JC900236; Masuda S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017604; Meredith MP, 2008, J CLIMATE, V21, P3327, DOI 10.1175/2007JCLI2238.1; Moore AM, 2009, J PHYS OCEANOGR, V39, P702, DOI 10.1175/2008JPO3740.1; Nakano H, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001065; Orsi AH, 1999, PROG OCEANOGR, V43, P55, DOI 10.1016/S0079-6611(99)00004-X; Pedlosky J., 1996, OCEAN CIRCULATION TH, DOI [10.1007/978-3-662-03204-6_1, DOI 10.1007/978-3-662-03204-6_1]; SASAKI Y, 1970, MON WEATHER REV, V98, P875, DOI 10.1175/1520-0493(1970)098<0875:SBFINV>2.3.CO;2; SCHMITZ WJ, 1995, REV GEOPHYS, V33, P151, DOI 10.1029/95RG00879; SCHROTER J, 1986, J PHYS OCEANOGR, V16, P1855, DOI 10.1175/1520-0485(1986)016<1855:SONFDO>2.0.CO;2; SUGINOHARA N, 1988, J OCEANOGR SOC JAPAN, V44, P315; van Aken H.M., 2006, OCEANIC THERMOHALINE; Wunsch C., 1996, OCEAN CIRCULATION IN	23	100	107	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 16	2010	329	5989					319	322		10.1126/science.1188703	http://dx.doi.org/10.1126/science.1188703			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576848				2022-12-28	WOS:000279925900040
J	Lawler, MJ; Fujita, K; Lee, J; Schmidt, AR; Kohsaka, Y; Kim, CK; Eisaki, H; Uchida, S; Davis, JC; Sethna, JP; Kim, EA				Lawler, M. J.; Fujita, K.; Lee, Jhinhwan; Schmidt, A. R.; Kohsaka, Y.; Kim, Chung Koo; Eisaki, H.; Uchida, S.; Davis, J. C.; Sethna, J. P.; Kim, Eun-Ah			Intra-unit-cell electronic nematicity of the high-T-c copper-oxide pseudogap states	NATURE			English	Article							FLUCTUATING STRIPES; MAGNETIC ORDER; PHASE; SYMMETRY; INSULATOR; BREAKING	In the high-transition-temperature (high-T-c) superconductors the pseudogap phase becomes predominant when the density of doped holes is reduced(1). Within this phase it has been unclear which electronic symmetries (if any) are broken, what the identity of any associated order parameter might be, and which microscopic electronic degrees of freedom are active. Here we report the determination of a quantitative order parameter representing intra-unit-cell nematicity: the breaking of rotational symmetry by the electronic structure within each CuO2 unit cell. We analyse spectroscopic-imaging scanning tunnelling microscope images of the intra-unit-cell states in underdoped Bi2Sr2CaCu2O8 + delta and, using two independent evaluation techniques, find evidence for electronic nematicity of the states close to the pseudogap energy. Moreover, we demonstrate directly that these phenomena arise from electronic differences at the two oxygen sites within each unit cell. If the characteristics of the pseudogap seen here and by other techniques all have the same microscopic origin, this phase involves weak magnetic states at the O sites that break 90 degrees-rotational symmetry within every CuO2 unit cell.	[Lawler, M. J.; Fujita, K.; Lee, Jhinhwan; Schmidt, A. R.; Kim, Chung Koo; Davis, J. C.; Sethna, J. P.; Kim, Eun-Ah] Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA; [Lawler, M. J.] SUNY Binghamton, Dept Phys Appl Phys & Astron, Binghamton, NY 13902 USA; [Fujita, K.; Lee, Jhinhwan; Schmidt, A. R.; Kim, Chung Koo; Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Fujita, K.; Uchida, S.] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Lee, Jhinhwan] Korea Adv Inst Sci & Technol, Dept Phys, Taejon 305701, South Korea; [Kohsaka, Y.] RIKEN, Magnet Mat Lab, Wako, Saitama 3510198, Japan; [Eisaki, H.] Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland	Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; United States Department of Energy (DOE); Brookhaven National Laboratory; University of Tokyo; Korea Advanced Institute of Science & Technology (KAIST); RIKEN; National Institute of Advanced Industrial Science & Technology (AIST); University of St Andrews	Kim, EA (corresponding author), Cornell Univ, Dept Phys, Atom & Solid State Phys Lab, Ithaca, NY 14853 USA.	eun-ah.kim@cornell.edu	Eisaki, Hiroshi/F-6317-2018; Kim, Eun-Ah/K-6711-2012; Kohsaka, Yuhki/A-4428-2009; Lee, Jhinhwan/I-3727-2012; Lawler, Michael/K-6770-2012; Lee, Jhinhwan/C-2074-2011	Eisaki, Hiroshi/0000-0002-8299-6416; Kim, Eun-Ah/0000-0002-9554-4443; Kohsaka, Yuhki/0000-0002-6459-2661; Lee, Jhinhwan/0000-0001-7159-6305; Lawler, Michael/0000-0002-2319-2274; KIM, CHUNG KOO/0000-0002-2463-197X	NSF [DMR-0520404]; Center for Emergent Superconductivity; Energy Frontier Research Center; US Department of Energy [DE-2009-BNL-PM015]; Ministry of Science and Education (Japan); Japan Society for the Promotion of Science; US Army Research Office; Physics and Astronomy Department at the University of British Columbia, Vancouver, Canada; Division Of Materials Research [1005479] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Center for Emergent Superconductivity; Energy Frontier Research Center; US Department of Energy(United States Department of Energy (DOE)); Ministry of Science and Education (Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); US Army Research Office; Physics and Astronomy Department at the University of British Columbia, Vancouver, Canada; Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We are grateful to P. Abbamonte, D. Bonn, J.C. Campuzano, D.M. Eigler, E. Fradkin, T. Hanaguri, W. Hardy, J. E. Hoffman, S. Kivelson, A.P. Mackenzie, M. Norman, B. Ramshaw, S. Sachdev, G. Sawatzky, H. Takagi, J. Tranquada and J. Zaanen, for discussions and communications. Theoretical studies were supported by NSF DMR-0520404 to the Cornell Center for Materials Research. Experimental studies are supported by the Center for Emergent Superconductivity, an Energy Frontier Research Center, headquartered at Brookhaven National Laboratory and funded by the US Department of Energy, under DE-2009-BNL-PM015, as well as by a Grant-in-Aid for Scientific Research from the Ministry of Science and Education (Japan) and the Global Centers of Excellence Program for Japan Society for the Promotion of Science. A.R.S. acknowledges support from the US Army Research Office. M.J.L., J.C.D. and E.-A.K. thank KITP for its hospitality. J.C.D. acknowledges gratefully the hospitality and support of the Physics and Astronomy Department at the University of British Columbia, Vancouver, Canada.	Alldredge JW, 2008, NAT PHYS, V4, P319, DOI 10.1038/nphys917; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Cvetkovic V, 2008, EPL-EUROPHYS LETT, V81, DOI 10.1209/0295-5075/81/27001; Daou R, 2010, NATURE, V463, P519, DOI 10.1038/nature08716; Del Maestro A, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.024520; FRADKIN E, 2010, ANN REV CONDENS MATT, V1; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Hufner S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/6/062501; Kaminski A, 2002, NATURE, V416, P610, DOI 10.1038/416610a; Kim EA, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.184514; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lee J, 2009, SCIENCE, V325, P1099, DOI 10.1126/science.1176369; Lee WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104438; Li Y, 2008, NATURE, V455, P372, DOI 10.1038/nature07251; Lv WC, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.224506; McElroy K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.197005; Orenstein J, 2000, SCIENCE, V288, P468, DOI 10.1126/science.288.5465.468; Raghu S, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.214402; Robertson JA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134507; Sun K, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.106405; Sun XF, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.107001; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; ZAANEN J, 1985, PHYS REV LETT, V55, P418, DOI 10.1103/PhysRevLett.55.418	30	419	421	3	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					347	351		10.1038/nature09169	http://dx.doi.org/10.1038/nature09169			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631795	Green Submitted			2022-12-28	WOS:000279867100044
J	Macilwain, C				Macilwain, Colin			ERA of austerity	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	1	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					314	314		10.1038/466314a	http://dx.doi.org/10.1038/466314a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625BP	20631775	Bronze			2022-12-28	WOS:000279867100013
J	Maxmen, A				Maxmen, Amy			Fighting the monster	NATURE			English	Editorial Material							TUBERCULOSIS THERAPY; ANTIRETROVIRAL DRUGS											Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Garcia-Vidal C, 2010, NEW ENGL J MED, V362, P2137; Kadhiravan T, 2010, NEW ENGL J MED, V362, P2138; Karim SSA, 2010, NEW ENGL J MED, V362, P697, DOI 10.1056/NEJMoa0905848; Lawn SD, 2010, CURR OPIN HIV AIDS, V5, P18, DOI 10.1097/COH.0b013e328333850f; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Wilson D, 2010, NEW ENGL J MED, V362, P2137, DOI 10.1056/NEJMc1003767	7	3	3	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S18	S19		10.1038/nature09243	http://dx.doi.org/10.1038/nature09243			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631699	Bronze			2022-12-28	WOS:000279867100032
J	Liu, K; Nie, ZH; Zhao, NN; Li, W; Rubinstein, M; Kumacheva, E				Liu, Kun; Nie, Zhihong; Zhao, Nana; Li, Wei; Rubinstein, Michael; Kumacheva, Eugenia			Step-Growth Polymerization of Inorganic Nanoparticles	SCIENCE			English	Article							GOLD NANORODS; NANOCRYSTALS; ORGANIZATION; MECHANISM	Self-organization of nanoparticles is an efficient strategy for producing nanostructures with complex, hierarchical architectures. The past decade has witnessed great progress in nanoparticle self-assembly, yet the quantitative prediction of the architecture of nanoparticle ensembles and of the kinetics of their formation remains a challenge. We report on the marked similarity between the self-assembly of metal nanoparticles and reaction-controlled step-growth polymerization. The nanoparticles act as multifunctional monomer units, which form reversible, noncovalent bonds at specific bond angles and organize themselves into a colloidal polymer. We show that the kinetics and statistics of step-growth polymerization enable a quantitative prediction of the architecture of linear, branched, and cyclic self-assembled nanostructures; their aggregation numbers and size distribution; and the formation of structural isomers.	[Rubinstein, Michael] Univ N Carolina, Dept Chem, Chapel Hill, NC 27599 USA; [Liu, Kun; Nie, Zhihong; Zhao, Nana; Li, Wei; Kumacheva, Eugenia] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Kumacheva, Eugenia] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Kumacheva, Eugenia] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada	University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University of Toronto; University of Toronto	Rubinstein, M (corresponding author), Univ N Carolina, Dept Chem, CB 3290, Chapel Hill, NC 27599 USA.	mr@unc.edu; ekumache@chem.utoronto.ca	Kumacheva, Eugenia/U-7612-2019; Li, Wei/P-3546-2016; Nie, Zhihong/D-7495-2011; Liu, Kun/H-9600-2013	Li, Wei/0000-0002-4738-1475; Nie, Zhihong/0000-0001-9639-905X; Liu, Kun/0000-0003-2940-9814	National Science and Engineering Research Council of Canada; NSF [CHE-0911588, DMR-0907515, CBET-0609087]; NIH [1-R01-HL077546-03A2]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL107168, R01HL077546, P01HL108808] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [0907515] Funding Source: National Science Foundation; Division Of Chemistry [0911588] Funding Source: National Science Foundation	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the National Science and Engineering Research Council of Canada (under Discovery program and Canada Research Chair program) for financial support. M. R. acknowledges financial support from the NSF under grants CHE-0911588, DMR-0907515, and CBET-0609087 and the NIH under grant 1-R01-HL077546-03A2. The authors are grateful to Y. Chen and G. Wu for their contribution in image analysis.	Anker JN, 2008, NAT MATER, V7, P442, DOI 10.1038/nmat2162; Caswell KK, 2003, J AM CHEM SOC, V125, P13914, DOI 10.1021/ja037969i; Colby R.H., 2003, POLYM PHYS; Courty A, 2005, NAT MATER, V4, P395, DOI 10.1038/nmat1366; DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162; Flory PJ., 1953, PRINCIPLES POLYM CHE, V672; Glotzer SC, 2005, CURR OPIN COLLOID IN, V10, P287, DOI 10.1016/j.cocis.2005.09.011; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Hermanson KD, 2001, SCIENCE, V294, P1082, DOI 10.1126/science.1063821; Huynh WU, 2002, SCIENCE, V295, P2425, DOI 10.1126/science.1069156; Kawamura G, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2752026; Kuchanov S, 2004, PROG POLYM SCI, V29, P563, DOI 10.1016/j.progpolymsci.2004.02.001; Leunissen ME, 2009, NAT MATER, V8, P590, DOI [10.1038/nmat2471, 10.1038/NMAT2471]; Maier SA, 2003, NAT MATER, V2, P229, DOI 10.1038/nmat852; Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z; Nie ZH, 2008, J AM CHEM SOC, V130, P3683, DOI 10.1021/ja711150k; Nie ZH, 2007, NAT MATER, V6, P609, DOI 10.1038/nmat1954; Nie ZH, 2010, NAT NANOTECHNOL, V5, P15, DOI [10.1038/NNANO.2009.453, 10.1038/nnano.2009.453]; Nikoobakht B, 2003, CHEM MATER, V15, P1957, DOI 10.1021/cm0207321; Nomura W, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1920419; Odian G., 2004, PRINCIPLES POLYM, V4th; Orendorff CJ, 2006, J PHYS CHEM B, V110, P3990, DOI 10.1021/jp0570972; Ribeiro C, 2006, CHEMPHYSCHEM, V7, P664, DOI 10.1002/cphc.200500508; Rycenga M, 2008, ADV MATER, V20, P2416, DOI 10.1002/adma.200800360; Shanbhag S, 2007, ACS NANO, V1, P126, DOI 10.1021/nn7000905; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; Wang CJ, 2006, NANO LETT, V6, P2549, DOI 10.1021/nl061958g; Xiang YJ, 2008, J PHYS CHEM C, V112, P3203, DOI 10.1021/jp710505t; Yatsui T, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3372639; Zerrouki D, 2008, NATURE, V455, P380, DOI 10.1038/nature07237	30	402	402	14	603	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					197	200		10.1126/science.1189457	http://dx.doi.org/10.1126/science.1189457			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616274	Green Submitted, Green Accepted			2022-12-28	WOS:000279635200043
J	Nasca, TJ; Day, SH; Amis, ES				Nasca, Thomas J.; Day, Susan H.; Amis, E. Stephen, Jr.		ACGME Duty Hour Task Force	The New Recommendations on Duty Hours from the ACGME Task Force	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MEDICAL ERRORS; WORK HOURS; MORTALITY; INTERNS; REFORM; SLEEP		[Amis, E. Stephen, Jr.] ACGME Council, Chicago, IL USA; [Nasca, Thomas J.] Thomas Jefferson Univ, Jefferson Med Coll, Philadelphia, PA 19107 USA; [Day, Susan H.] Calif Pacific Med Ctr, Dept Ophthalmol, San Francisco, CA USA; [Amis, E. Stephen, Jr.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY 10467 USA; [Amis, E. Stephen, Jr.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Nasca, Thomas J.; Day, Susan H.; Amis, E. Stephen, Jr.] ACGME, Duty Hour Task Force, Chicago, IL USA	Jefferson University; California Pacific Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Nasca, TJ (corresponding author), 515 N State St,Suite 2000, Chicago, IL 60654 USA.							*ACCR COUNC GRAD M, ACGME RES FELL SURV; Arora VM, 2008, JAMA-J AM MED ASSOC, V300, P1146, DOI 10.1001/jama.300.10.1146; Friesen LD, 2008, J GEN INTERN MED, V23, P1981, DOI 10.1007/s11606-008-0798-3; Landrigan CP, 2008, PEDIATRICS, V122, P250, DOI 10.1542/peds.2007-2306; Landrigan CP, 2004, NEW ENGL J MED, V351, P1838, DOI 10.1056/NEJMoa041406; M. Institute of, 2003, CROSS QUAL CHASM; MCCOLLOUGH LB, 2006, ADV BIOETH, V10, P17; Nasca TJ, 2010, COMMUNICATION   0504; Philibert I, 2002, JAMA-J AM MED ASSOC, V288, P1112, DOI 10.1001/jama.288.9.1112; Philibert Ingrid, 2009, J Grad Med Educ, V1, P334, DOI 10.4300/JGME-D-09-00076.1; Singh H, 2007, ARCH INTERN MED, V167, P2030, DOI 10.1001/archinte.167.19.2030; Ulmer C, 2009, RESIDENT DUTY HOURS: ENHANCING SLEEP, SUPERVISION, AND SAFETY, P1; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Volpp KG, 2009, J GEN INTERN MED, V24, P1149, DOI 10.1007/s11606-009-1011-z	15	391	395	1	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2								10.1056/NEJMsb1005800	http://dx.doi.org/10.1056/NEJMsb1005800			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621JY	20573917				2022-12-28	WOS:000279574100015
J	Tay, S; Hughey, JJ; Lee, TK; Lipniacki, T; Quake, SR; Covert, MW				Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Lipniacki, Tomasz; Quake, Stephen R.; Covert, Markus W.			Single-cell NF-kappa B dynamics reveal digital activation and analogue information processing	NATURE			English	Article							VARIABILITY; STABILITY; RESPONSES	Cells operate in dynamic environments using extraordinary communication capabilities that emerge from the interactions of genetic circuitry. The mammalian immune response is a striking example of the coordination of different cell types(1). Cell-to-cell communication is primarily mediated by signalling molecules that form spatiotemporal concentration gradients, requiring cells to respond to a wide range of signal intensities(2). Here we use high-throughput microfluidic cell culture(3) and fluorescence microscopy, quantitative gene expression analysis and mathematical modelling to investigate how single mammalian cells respond to different concentrations of the signalling molecule tumour-necrosis factor (TNF)-alpha, and relay information to the gene expression programs by means of the transcription factor nuclear factor (NF)-kappa B. We measured NF-kappa B activity in thousands of live cells under TNF-alpha doses covering four orders of magnitude. We find, in contrast to population-level studies with bulk assays(2), that the activation is heterogeneous and is a digital process at the single-cell level with fewer cells responding at lower doses. Cells also encode a subtle set of analogue parameters to modulate the outcome; these parameters include NF-kappa B peak intensity, response time and number of oscillations. We developed a stochastic mathematical model that reproduces both the digital and analogue dynamics as well as most gene expression profiles at all measured conditions, constituting a broadly applicable model for TNF-alpha-induced NF-kappa B signalling in various types of cells. These results highlight the value of high-throughput quantitative measurements with single-cell resolution in understanding how biological systems operate.	[Tay, Savas; Hughey, Jacob J.; Lee, Timothy K.; Quake, Stephen R.; Covert, Markus W.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Tay, Savas; Quake, Stephen R.] Howard Hughes Med Inst, Stanford, CA 94305 USA; [Lipniacki, Tomasz] Inst Fundamental Technol Res, PL-02106 Warsaw, Poland	Stanford University; Howard Hughes Medical Institute; Polish Academy of Sciences; Institute of Fundamental Technological Research of the Polish Academy of Sciences	Covert, MW (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	tlipnia@ippt.gov.pl; quake@stanford.edu; mcovert@stanford.edu	Lipniacki, Tomasz/AAC-6744-2019	Lipniacki, Tomasz/0000-0002-3488-2561; Hughey, Jacob/0000-0002-1558-6089; Covert, Markus/0000-0002-5993-8912	NIH; NCI [K99CA125994]; Foundation for Polish Science [TEAM 2009-3/6]; NSF/NIH [R01-GM086885]; Stanford Graduate Fellowship; Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE [R00CA125994, K99CA125994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086885] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission); NSF/NIH(National Science Foundation (NSF)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Graduate Fellowship(Stanford University); Stanford Bio-X Graduate Fellowship; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Leyrat and R. Gomez-Sjoberg for development of the automated cell culture system, assistance with the software, and for contributions to experimental design and preliminary data. This research was supported in part by an NIH Director's Pioneer Award (to S.R.Q.), an NCI Pathway to Independence Award (K99CA125994) (to M.W.C.), the Foundation for Polish Science (TEAM 2009-3/6) and NSF/NIH grant no. R01-GM086885 (to T.L.), a Stanford Graduate Fellowship (to T.K.L.), and a Stanford Bio-X Graduate Fellowship (to J.J.H.).	Ashall L, 2009, SCIENCE, V324, P242, DOI 10.1126/science.1164860; Batchelor E, 2009, NAT REV CANCER, V9, P371, DOI 10.1038/nrc2604; Bhat S, 2009, ANAL BIOANAL CHEM, V394, P457, DOI 10.1007/s00216-009-2729-5; CHEN YM, 2004, J PHARMACOL EXP THER, V103; Cheong R, 2006, J BIOL CHEM, V281, P2945, DOI 10.1074/jbc.M510085200; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Covert MW, 2005, SCIENCE, V309, P1854, DOI 10.1126/science.1112304; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Giorgetti L, 2010, MOL CELL, V37, P418, DOI 10.1016/j.molcel.2010.01.016; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hoffmann A, 2006, IMMUNOL REV, V210, P171, DOI 10.1111/j.0105-2896.2006.00375.x; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lee TK, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000599; Lipniacki T, 2004, J THEOR BIOL, V228, P195, DOI 10.1016/j.jtbi.2004.01.001; Lipniacki T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-376; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Snijder B, 2009, NATURE, V461, P520, DOI 10.1038/nature08282; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; St-Pierre F, 2008, P NATL ACAD SCI USA, V105, P20705, DOI 10.1073/pnas.0808831105; Toepke MW, 2006, LAB CHIP, V6, P1484, DOI 10.1039/b612140c; WILSON JW, 1999, APOPTOSIS GENES	28	577	586	5	141	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					267	U149		10.1038/nature09145	http://dx.doi.org/10.1038/nature09145			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20581820	Green Accepted			2022-12-28	WOS:000279580800043
J	Santosham, M; Chandran, A; Fitzwater, S; Fischer-Walker, C; Baqui, AH; Black, R				Santosham, Mathuram; Chandran, Aruna; Fitzwater, Sean; Fischer-Walker, Christa; Baqui, Abdullah H.; Black, Robert			Progress and barriers for the control of diarrhoeal disease	LANCET			English	Review							ZINC SUPPLEMENTATION; ORAL REHYDRATION; MORTALITY; COUNTRIES; CHILDREN	Discovery of intestinal sodium-glucose transport was the basis for development of oral rehydration solution, and was hailed as potentially the most important medical advance of the 20th century. Before widespread use of oral rehydration solution, treatment for diarrhoea was restricted to intravenous fluid replacement, for which patients had to go to a health-care facility to access appropriate equipment. These facilities were usually neither available nor reasonable to use in the resource-poor settings most affected by diarrhoea. Use of oral rehydration solution has stagnated, despite being effective, inexpensive, and widely available. Thus, diarrhoea continues to be a leading cause of child death with consistent mortality rates during the past 5 years. New methods for prevention, management, and treatment of diarrhoea-including an improved oral rehydration formulation, zinc supplementation, and rotavirus vaccines-make now the time to revitalise efforts to reduce diarrhoea mortality worldwide.	[Santosham, Mathuram; Chandran, Aruna; Fitzwater, Sean; Fischer-Walker, Christa; Baqui, Abdullah H.; Black, Robert] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Santosham, M (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, 615 N Wolfe St, Baltimore, MD 21205 USA.	msantosh@jhsph.edu		Black, Robert/0000-0001-9926-7984				[Anonymous], 1978, LANCET, V2, P300; [Anonymous], 2009, Wkly Epidemiol Rec, V84, P220; Awasthi S, 2006, J PEDIATR GASTR NUTR, V42, P300; Baqui AH, 2002, BRIT MED J, V325, P1059, DOI 10.1136/bmj.325.7372.1059; Bhandari N, 2008, PEDIATRICS, V121, pE1279, DOI 10.1542/peds.2007-1939; Bhutta ZA, 1999, J PEDIATR-US, V135, P689, DOI 10.1016/S0022-3476(99)70086-7; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; CLAESON M, 1990, PEDIATR INFECT DIS J, V9, P345, DOI 10.1097/00006454-199005000-00008; ELRAFIE M, 1990, LANCET, V335, P334; Forsberg BC, 2007, B WORLD HEALTH ORGAN, V85, P42, DOI 10.2471/BLT.06.030866; Hahn S., 2002, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002847; Howteerakul N, 2003, SOC SCI MED, V57, P1031, DOI 10.1016/S0277-9536(02)00478-1; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Lazzerini M, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005436.pub2; MILLER P, 1995, SOC SCI MED, V40, pS1, DOI 10.1016/0277-9536(95)00001-N; Podewils Laura Jean, 2004, Semin Pediatr Infect Dis, V15, P155, DOI 10.1053/j.spid.2004.05.008; Ryland S, 1998, DHS COMP STUDIES; Santosham M, 1987, Pediatr Rev, V8, P273, DOI 10.1542/pir.8-9-273; Santosham M, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.5.e10; Taneja D K, 1996, Indian Pediatr, V33, P117; TAYLOR CE, 1989, ANNU REV PUBL HEALTH, V10, P221, DOI 10.1146/annurev.pu.10.050189.001253; *UNICEF OFF STAT M, CHILD MON SIT CHILDR; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Victora CG, 1996, HEALTH POLICY PLANN, V11, P132, DOI 10.1093/heapol/11.2.132; Walker CLF, 2009, B WORLD HEALTH ORGAN, V87, P780, DOI 10.2471/BLT.08.058990; WHO/UNICEF, 2009, DIARRH WHY CHILDR AR; WHO/UNICEF, 2004, CLIN MAN AC DIARRH; World Health Organization, 2003, AN REV INT MAN CHILD; World Health Organization, 2005, TREATM DIARRH MAN PH; 1988, WKLY EPIDEMIOL REC, V63, P49; 2009, ICF MACRO DEMOGRAPHI	31	154	162	0	27	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					63	67		10.1016/S0140-6736(10)60356-X	http://dx.doi.org/10.1016/S0140-6736(10)60356-X			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20609988				2022-12-28	WOS:000279841600025
J	May, RM				May, Robert M.			Tropical Arthropod Species, More or Less?	SCIENCE			English	Editorial Material									Univ Oxford, Dept Zool, Oxford OX1 3PS, England	University of Oxford	May, RM (corresponding author), Univ Oxford, Dept Zool, S Parks Rd, Oxford OX1 3PS, England.	robert.may@zoo.ox.ac.uk						ERWIN T L, 1982, Coleopterists Bulletin, V36, P74; Hamilton AJ, 2010, AM NAT, V176, P90, DOI 10.1086/652998; MAY RM, 1990, PHILOS T R SOC B, V330, P293, DOI 10.1098/rstb.1990.0200; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; *UK HL SCI TECHN S, 2007, 5 UK HOUS LORDS SCI	5	74	80	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					41	42		10.1126/science.1191058	http://dx.doi.org/10.1126/science.1191058			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595603				2022-12-28	WOS:000279402700022
J	Jamerson, KA; Bakris, GL; Weber, MA				Jamerson, Kenneth A.; Bakris, George L.; Weber, Michael A.			24-Hour Ambulatory Blood Pressure in the ACCOMPLISH Trial	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							BENAZEPRIL PLUS AMLODIPINE; HYDROCHLOROTHIAZIDE		[Jamerson, Kenneth A.] Univ Michigan Hlth Syst, Ann Arbor, MI USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Chicago, IL 60637 USA; [Weber, Michael A.] SUNY Downstate Med Coll, Brooklyn, NY USA	University of Michigan System; University of Michigan; University of Chicago; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Jamerson, KA (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI USA.	jamerson@umich.edu						Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Jamerson KA, 2009, NEW ENGL J MED, V360, P1149; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE	3	18	18	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					98	98		10.1056/NEJMc1001410	http://dx.doi.org/10.1056/NEJMc1001410			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592305	Bronze			2022-12-28	WOS:000279343000031
J	Stettenheim, J; Thalakulam, M; Pan, F; Bal, M; Ji, ZQ; Xue, WW; Pfeiffer, L; West, KW; Blencowe, MP; Rimberg, AJ				Stettenheim, Joel; Thalakulam, Madhu; Pan, Feng; Bal, Mustafa; Ji, Zhonqing; Xue, Weiwei; Pfeiffer, Loren; West, K. W.; Blencowe, M. P.; Rimberg, A. J.			A macroscopic mechanical resonator driven by mesoscopic electrical back-action	NATURE			English	Article							QUANTUM POINT-CONTACT; SHOT-NOISE; TRANSISTOR; TRANSPORT; JUNCTION; DETECTOR; MOTION; CAVITY	Systems with coupled mechanical and optical or electrical degrees of freedom(1,2) have fascinating dynamics that, through macroscopic manifestations of quantum behaviour(3), provide new insights into the transition between the classical and quantum worlds. Of particular interest is the back-action of electrons and photons on mechanical oscillators, which can lead to cooling and amplification of mechanical motion(4-6). Furthermore, feedback, which is naturally associated with back-action, has been predicted to have significant consequences for the noise of a detector coupled to a mechanical oscillator(7,8). Recently it has also been demonstrated that such feedback effects lead to strong coupling between single-electron transport and mechanical motion in carbon nanotube nanomechanical resonators(9,10). Here we present noise measurements which show that the mesoscopic back-action of electrons tunnelling through a radio-frequency quantum point contact(11) causes driven vibrations of the host crystal. This effect is a remarkable macroscopic manifestation of microscopic quantum behaviour, where the motion of a mechanical oscillator-the host crystal, which consists of on the order of 10(20) atoms-is determined by statistical fluctuations of tunnelling electrons.	[Stettenheim, Joel; Pan, Feng; Bal, Mustafa; Xue, Weiwei; Blencowe, M. P.; Rimberg, A. J.] Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA; [Thalakulam, Madhu] Rice Univ, Rice Quantum Inst, Houston, TX 77005 USA; [Ji, Zhonqing] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Pfeiffer, Loren; West, K. W.] Alcatel Lucent, Bell Labs, Murray Hill, NJ 07974 USA	Dartmouth College; Rice University; Rice University; Alcatel-Lucent; AT&T	Rimberg, AJ (corresponding author), Dartmouth Coll, Dept Phys & Astron, Hanover, NH 03755 USA.	ajrimberg@dartmouth.edu		Blencowe, Miles/0000-0003-0051-0492; BAL, MUSTAFA/0000-0003-0751-6774	NSF [DMR-0804488, DMR-0804477]; ARO [W911NF-06-1-0312, W911NF-06-1-0361]; NSA, LPS and ARO [W911-NF-08-1-0482]; Division Of Materials Research [0804488] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ARO; NSA, LPS and ARO(National Security Agency); Division Of Materials Research(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank A. D. Armour, A. A. Clerk, J. G. E. Harris and D. A. Rodrigues for discussions. This work was supported by the NSF under grant nos DMR-0804488 and DMR-0804477, by the ARO under agreement nos W911NF-06-1-0312 and W911NF-06-1-0361, and by the NSA, LPS and ARO under agreement no. W911-NF-08-1-0482.	Armour AD, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165315; Aspelmeyer M, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095001; Blanter YM, 2000, PHYS REP, V336, P1, DOI 10.1016/S0370-1573(99)00123-4; Blencowe M, 2004, PHYS REP, V395, P159, DOI 10.1016/j.physrep.2003.12.005; Braginsky V B, 1992, QUANTUM MEASUREMENT, P76; Clerk AA, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.121303; Cronenwett SM, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.226805; DiCarlo L, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.036810; Groblacher S, 2009, NAT PHYS, V5, P485, DOI 10.1038/NPHYS1301; Kippenberg TJ, 2008, SCIENCE, V321, P1172, DOI 10.1126/science.1156032; Kippenberg TJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.033901; Knobel RG, 2003, NATURE, V424, P291, DOI 10.1038/nature01773; Koch J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206804; KOGAN S, 1996, ELECT NOISE FLUCTUAT, P145; Korotkov AN, 1999, APPL PHYS LETT, V74, P4052, DOI 10.1063/1.123258; Lassagne B, 2009, SCIENCE, V325, P1107, DOI 10.1126/science.1174290; LESOVIK GB, 1994, PHYS REV LETT, V72, P538, DOI 10.1103/PhysRevLett.72.538; Meir Y, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.196802; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Ohno I., 1976, Journal of Physics of the Earth, V24, P355, DOI 10.4294/jpe1952.24.355; Poggio M, 2008, NAT PHYS, V4, P635, DOI 10.1038/nphys992; Reilly DJ, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794995; Reydellet LH, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.176803; Rodrigues DA, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.067202; Schoelkopf RJ, 1998, PHYS REV LETT, V80, P2437, DOI 10.1103/PhysRevLett.80.2437; Schoelkopf RJ, 1998, SCIENCE, V280, P1238, DOI 10.1126/science.280.5367.1238; SODERKVIST J, 1992, SENSOR ACTUAT A-PHYS, V32, P567, DOI 10.1016/0924-4247(92)80045-5; Steele GA, 2009, SCIENCE, V325, P1103, DOI 10.1126/science.1176076; Usmani O, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195312; VISSCHER WM, 1991, J ACOUST SOC AM, V90, P2154, DOI 10.1121/1.401643	30	24	24	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					86	U100		10.1038/nature09123	http://dx.doi.org/10.1038/nature09123			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596016				2022-12-28	WOS:000279343800039
J	Annaert, W; De Strooper, B				Annaert, Wim; De Strooper, Bart			Alzheimer's Disease neurons fail the Acid Test	CELL			English	Editorial Material							AUTOPHAGY		[Annaert, Wim; De Strooper, Bart] KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium; [Annaert, Wim; De Strooper, Bart] VIB, Dept Mol & Dev Genet, B-3000 Louvain, Belgium	KU Leuven; Flanders Institute for Biotechnology (VIB)	Annaert, W (corresponding author), KULeuven, Ctr Human Genet, B-3000 Louvain, Belgium.	wim.annaert@cme.vib-kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019; De Strooper, Bart/F-6507-2012	De Strooper, Bart/0000-0001-5455-5819				Esselens C, 2004, J CELL BIOL, V166, P1041, DOI 10.1083/jcb.200406060; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Sannerud R, 2009, SEMIN CELL DEV BIOL, V20, P183, DOI 10.1016/j.semcdb.2008.11.004; Tooze SA, 2008, CURR OPIN NEUROBIOL, V18, P504, DOI 10.1016/j.conb.2008.09.015; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Wilson CA, 2004, J CELL BIOL, V165, P335, DOI 10.1083/jcb.200403061	8	5	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1112	1114		10.1016/j.cell.2010.06.009	http://dx.doi.org/10.1016/j.cell.2010.06.009			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602994	Green Published, Bronze			2022-12-28	WOS:000279148100008
J	Cerutti, A				Cerutti, Andrea			IgA Changes the Rules of Memory	SCIENCE			English	Editorial Material							INTESTINAL BACTERIA; CELL; GUT; GENERATION; RESPONSES		[Cerutti, Andrea] IMIM Hosp del Mar, Catalan Inst Res & Adv Studies, Barcelona 08003, Spain; [Cerutti, Andrea] Mt Sinai Sch Med, Dept Med, Inst Immunol, New York, NY 10029 USA	ICREA; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Hospital del Mar; Icahn School of Medicine at Mount Sinai	Cerutti, A (corresponding author), IMIM Hosp del Mar, Catalan Inst Res & Adv Studies, Barcelona Biomed Res Pk, Barcelona 08003, Spain.	acerutti@imim.es		Cerutti, Andrea/0000-0003-3026-4704	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI061093, R01AI057653] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057653, P01 AI061093] Funding Source: Medline; ICREA Funding Source: Custom	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); ICREA(ICREA)		Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cerutti A, 2008, IMMUNITY, V28, P740, DOI 10.1016/j.immuni.2008.05.001; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; El Shikh MEM, 2009, J IMMUNOL, V182, P3482, DOI 10.4049/jimmunol.0802317; Hapfelmeier S, 2010, SCIENCE, V328, P1705, DOI 10.1126/science.1188454; He B, 2007, IMMUNITY, V26, P812, DOI 10.1016/j.immuni.2007.04.014; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Tokuhara D, 2010, P NATL ACAD SCI USA, V107, P8794, DOI 10.1073/pnas.0914121107; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152	15	18	21	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1646	1647		10.1126/science.1192488	http://dx.doi.org/10.1126/science.1192488			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576880	Green Accepted			2022-12-28	WOS:000279107400030
J	Iskow, RC; McCabe, MT; Mills, RE; Torene, S; Pittard, WS; Neuwald, AF; Van Meir, EG; Vertino, PM; Devine, SE				Iskow, Rebecca C.; McCabe, Michael T.; Mills, Ryan E.; Torene, Spencer; Pittard, W. Stephen; Neuwald, Andrew F.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.			Natural Mutagenesis of Human Genomes by Endogenous Retrotransposons	CELL			English	Article							TRANSPOSABLE ELEMENTS; L1 RETROTRANSPOSITION; STRUCTURAL VARIATION; INSERTION; SEQUENCE; HYPOMETHYLATION; FREQUENCY; TUMORS; GENE	Two abundant classes of mobile elements, namely Alu and L1 elements, continue to generate new retrotransposon insertions in human genomes. Estimates suggest that these elements have generated millions of new germline insertions in individual human genomes worldwide. Unfortunately, current technologies are not capable of detecting most of these young insertions, and the true extent of germline mutagenesis by endogenous human retrotransposons has been difficult to examine. Here, we describe technologies for detecting these young retrotransposon insertions and demonstrate that such insertions indeed are abundant in human populations. We also found that new somatic L1 insertions occur at high frequencies in human lung cancer genomes. Genome-wide analysis suggests that altered DNA methylation may be responsible for the high levels of L1 mobilization observed in these tumors. Our data indicate that transposon-mediated mutagenesis is extensive in human genomes and is likely to have a major impact on human biology and diseases.	[Iskow, Rebecca C.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA; [Iskow, Rebecca C.; Mills, Ryan E.; Torene, Spencer; Devine, Scott E.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [McCabe, Michael T.; Vertino, Paula M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Neurosurg, Atlanta, GA 30322 USA; [Van Meir, Erwin G.] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [McCabe, Michael T.; Van Meir, Erwin G.; Vertino, Paula M.; Devine, Scott E.] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA; [Neuwald, Andrew F.; Devine, Scott E.] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 20201 USA; [Neuwald, Andrew F.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Dept Med, Div Endocrinol Diabet & Nutr, Baltimore, MD 20201 USA; [Devine, Scott E.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 20201 USA	Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Devine, SE (corresponding author), Emory Univ, Genet & Mol Biol Grad Program, Atlanta, GA 30322 USA.	sdevine@som.umaryland.edu	Mills, Ryan/F-4225-2010	Mills, Ryan/0000-0003-3425-6998; Van Meir, Erwin G./0000-0003-2444-7707	American Cancer Society [PF-07-130-01-MGO]; SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH) [R01GM078541]; National Cancer Institute, NIH [R01CA086335, R01CA116804, 1R01CA132065, 5P01CA116676]; National Human Genome Research Institute, NIH [F32HG004207, R01HG002898]; NATIONAL CANCER INSTITUTE [R01CA086335, R01CA132065, P01CA116676, R01CA116804] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002898, F32HG004207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078541, T32GM008490] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); SUN Microsystems; National Institute for General Medical Sciences, National Insitutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kristie Jones and Luke Tallon for help with 454 Titanium sequencing. We also thank Shari Corin, Julienne Mullaney, Michael Zwick, Ichiro Matsumura, and Xiaodong Cheng for helpful advice and Mark Mazaitis for help with artwork. This work was funded by grants from the American Cancer Society (PF-07-130-01-MGO to M. T. M.), SUN Microsystems (to W. S. P. and S. E. D.), the National Institute for General Medical Sciences, National Insitutes of Health (NIH) (R01GM078541 to A.F.N.), the National Cancer Institute, NIH (R01CA086335 and R01CA116804 to E. G. V. M.; 1R01CA132065 and 5P01CA116676 to P. M. V.), and the National Human Genome Research Institute, NIH (F32HG004207 to R. E. M. and R01HG002898 to S. E. D.).	Badge RM, 2003, AM J HUM GENET, V72, P823, DOI 10.1086/373939; BATZER MA, 2002, NAT REV GENET, V35, P501; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Bestor TH, 1998, NOVART FDN SYMP, V214, P228; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2001, MOL BIOL EVOL, V18, P926, DOI 10.1093/oxfordjournals.molbev.a003893; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; Collins FS, 1998, GENOME RES, V8, P1229, DOI 10.1101/gr.8.12.1229; Cordaux R, 2006, GENE, V373, P134, DOI 10.1016/j.gene.2006.01.019; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Daskalos A, 2009, INT J CANCER, V124, P81, DOI 10.1002/ijc.23849; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Howard G, 2008, ONCOGENE, V27, P404, DOI 10.1038/sj.onc.1210631; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; Kazazian HH, 1999, NAT GENET, V22, P130, DOI 10.1038/9638; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; KIMURA M, 1971, NATURE, V229, P467, DOI 10.1038/229467a0; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li XM, 2001, HUM MUTAT, V17, P511, DOI 10.1002/humu.1134; Liu J, 1997, GENE CHROMOSOME CANC, V18, P232, DOI 10.1002/(SICI)1098-2264(199703)18:3<232::AID-GCC10>3.0.CO;2-K; MIKI Y, 1992, CANCER RES, V52, P643; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; MORSE B, 1988, NATURE, V333, P87, DOI 10.1038/333087a0; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Ovchinnikov I, 2001, GENOME RES, V11, P2050, DOI 10.1101/gr.194701; PEARSON M, 1985, ANNU REV MED, V36, P471; Sheen FM, 2000, GENOME RES, V10, P1496, DOI 10.1101/gr.149400; SIEBERT PD, 1995, NUCLEIC ACIDS RES, V23, P1087, DOI 10.1093/nar/23.6.1087; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; TAYLOR J, 2007, CURRENT PROTOCOLS BI; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109	44	399	423	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1253	U268		10.1016/j.cell.2010.05.020	http://dx.doi.org/10.1016/j.cell.2010.05.020			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603005	Green Accepted, Bronze			2022-12-28	WOS:000279148100021
J	Marcheva, B; Ramsey, KM; Buhr, ED; Kobayashi, Y; Su, H; Ko, CH; Ivanova, G; Omura, C; Mo, S; Vitaterna, MH; Lopez, JP; Philipson, LH; Bradfield, CA; Crosby, SD; JeBailey, L; Wang, XZ; Takahashi, JS; Bass, J				Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Su, Hong; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Mo, Shelley; Vitaterna, Martha H.; Lopez, James P.; Philipson, Louis H.; Bradfield, Christopher A.; Crosby, Seth D.; JeBailey, Lellean; Wang, Xiaozhong; Takahashi, Joseph S.; Bass, Joseph			Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes	NATURE			English	Article							CIRCADIAN GENE-EXPRESSION; INSULIN-SECRETION; MOUSE; LIVER; MICE; TRANSCRIPTION; CHOLESTEROL; BIOLOGY	The molecular clock maintains energy constancy by producing circadian oscillations of rate-limiting enzymes involved in tissue metabolism across the day and night(1-3). During periods of feeding, pancreatic islets secrete insulin to maintain glucose homeostasis, and although rhythmic control of insulin release is recognized to be dysregulated in humans with diabetes(4), it is not known how the circadian clock may affect this process. Here we show that pancreatic islets possess self-sustained circadian gene and protein oscillations of the transcription factors CLOCK and BMAL1. The phase of oscillation of islet genes involved in growth, glucose metabolism and insulin signalling is delayed in circadian mutant mice, and both Clock(5,6) and Bmal1(7) (also called Arntl) mutants show impaired glucose tolerance, reduced insulin secretion and defects in size and proliferation of pancreatic islets that worsen with age. Clock disruption leads to transcriptome-wide alterations in the expression of islet genes involved in growth, survival and synaptic vesicle assembly. Notably, conditional ablation of the pancreatic clock causes diabetes mellitus due to defective beta-cell function at the very latest stage of stimulus-secretion coupling. These results demonstrate a role for the beta-cell clock in coordinating insulin secretion with the sleep-wake cycle, and reveal that ablation of the pancreatic clock can trigger the onset of diabetes mellitus.	[Marcheva, Biliana; Ramsey, Kathryn Moynihan; Kobayashi, Yumiko; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Marcheva, Biliana; Ramsey, Kathryn Moynihan; Buhr, Ethan D.; Kobayashi, Yumiko; Ko, Caroline H.; Ivanova, Ganka; Omura, Chiaki; Bass, Joseph] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Su, Hong; Wang, Xiaozhong] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Mo, Shelley] Northwestern Univ, Weinberg Coll Arts & Sci, Evanston, IL 60208 USA; [Vitaterna, Martha H.; Bass, Joseph] Northwestern Univ, Ctr Sleep & Circadian Biol, Evanston, IL 60208 USA; [Lopez, James P.; Philipson, Louis H.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Bradfield, Christopher A.] Univ Wisconsin, Sch Med & Publ Hlth, McArdle Lab Canc Res, Madison, WI 53706 USA; [Crosby, Seth D.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63108 USA; [JeBailey, Lellean] GeneGo Inc, St Joseph, MI 49085 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Takahashi, Joseph S.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; Northwestern University; Northwestern University; University of Chicago; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Bass, J (corresponding author), Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA.	j-bass@northwestern.edu	Takahashi, Joseph S./Y-2781-2019; Takahashi, Joseph S/E-8482-2012	Takahashi, Joseph S./0000-0003-0384-8878; Takahashi, Joseph S/0000-0003-0384-8878; Buhr, Ethan/0000-0002-9250-6644; Marcheva, Biliana/0000-0001-8697-2625	National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health [R37-ES-005703]; Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation; National Institute of Mental Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097817] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES005703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG011412] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chicago Biomedical Consortium; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank F. Turek, R. Allada and G. Bell for discussions and comments on the manuscript. We thank A. Kohsaka, E. Chen, J. Doering and C. Radosevich for their technical support, as well as the Biological Imaging Facility at Northwestern University and the Islet Biology Core of the University of Chicago DRTC. We thank D. Melton for the PdxCre mice. Work was supported by grants from the National Institute of Diabetes and Digestive and Kidney Diseases to K. M. R. and L. H. P.; the National Institutes of Health, Chicago Biomedical Consortium Searle Funds, and Juvenile Diabetes Research Foundation to J. B.; grant R37-ES-005703 from the National Institutes of Health to C. A. B.; and the National Institute of Mental Health to J.S.T.	Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Duez H, 2008, GASTROENTEROLOGY, V135, P689, DOI 10.1053/j.gastro.2008.05.035; Fu LN, 2005, CELL, V122, P803, DOI 10.1016/j.cell.2005.06.028; Gao N, 2007, CELL METAB, V6, P267, DOI 10.1016/j.cmet.2007.08.015; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Gu GQ, 2002, DEVELOPMENT, V129, P2447; King DP, 1997, CELL, V89, P641, DOI 10.1016/S0092-8674(00)80245-7; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Kudo T, 2008, AM J PHYSIOL-ENDOC M, V294, pE120, DOI 10.1152/ajpendo.00061.2007; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; POLONSKY KS, 1988, NEW ENGL J MED, V318, P1231, DOI 10.1056/NEJM198805123181903; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Rulifson IC, 2007, P NATL ACAD SCI USA, V104, P6247, DOI 10.1073/pnas.0701509104; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Stoffers DA, 2000, DIABETES, V49, P741, DOI 10.2337/diabetes.49.5.741; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Westgate EJ, 2008, CIRCULATION, V117, P2087, DOI 10.1161/CIRCULATIONAHA.107.739227; Withers DJ, 1998, NATURE, V391, P900, DOI 10.1038/36116; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	30	976	1029	8	150	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 29	2010	466	7306					627	631		10.1038/nature09253	http://dx.doi.org/10.1038/nature09253			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20562852	Green Accepted			2022-12-28	WOS:000280412100054
J	Padma, TV				Padma, T. V.			Developing solutions	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S16	S17		10.1038/nature09242	http://dx.doi.org/10.1038/nature09242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631698				2022-12-28	WOS:000279867100031
J	Willyard, C				Willyard, Cassandra			Joining forces	NATURE			English	Editorial Material							MICROBICIDES											Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Saxena BB, 2009, AIDS, V23, P917, DOI 10.1097/QAD.0b013e32832af57c; Watts C, 2001, AIDS, V15, pS43, DOI 10.1097/00002030-200102001-00064	3	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S9	S10		10.1038/nature09239	http://dx.doi.org/10.1038/nature09239			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631707	Bronze			2022-12-28	WOS:000279867100028
J	Roehr, B				Roehr, Bob			Drug laws in Latin America	BRITISH MEDICAL JOURNAL			English	Editorial Material												BobRoehr@aol.com							0	0	0	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 13	2010	341								c3752	10.1136/bmj.c3752	http://dx.doi.org/10.1136/bmj.c3752			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627981				2022-12-28	WOS:000280156600019
J	Pieper, AA; Xie, SH; Capota, E; Estill, SJ; Zhong, JN; Long, JM; Becker, GL; Huntington, P; Goldman, SE; Shen, CH; Capota, M; Britt, JK; Kotti, T; Ure, K; Brat, DJ; Williams, NS; MacMillan, KS; Naidoo, J; Melito, L; Hsieh, J; De Brabander, J; Ready, JM; McKnight, SL				Pieper, Andrew A.; Xie, Shanhai; Capota, Emanuela; Estill, Sandi Jo; Zhong, Jeannie; Long, Jeffrey M.; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Shen, Ching-Han; Capota, Maria; Britt, Jeremiah K.; Kotti, Tiina; Ure, Kerstin; Brat, Daniel J.; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; Hsieh, Jenny; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.			Discovery of a Proneurogenic, Neuroprotective Chemical	CELL			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; TRANSCRIPTION FACTOR; DENTATE GYRUS; CYTOCHROME-C; CELL-DEATH; NEURONS; BRAIN; NPAS3; MICE	An in vivo screen was performed in search of chemicals capable of enhancing neuron formation in the hippocampus of adult mice. Eight of 1000 small molecules tested enhanced neuron formation in the subgranular zone of the dentate gyrus. Among these was an aminopropyl carbazole, designated P7C3, endowed with favorable pharmacological properties. In vivo studies gave evidence that P7C3 exerts its proneurogenic activity by protecting newborn neurons from apoptosis. Mice missing the gene encoding neuronal PAS domain protein 3 (NPAS3) are devoid of hippocampal neurogenesis and display malformation and electrophysiological dysfunction of the dentate gyrus. Prolonged administration of P7C3 to npas3(-/-) mice corrected these deficits by normalizing levels of apoptosis of newborn hippocampal neurons. Prolonged administration of P7C3 to aged rats also enhanced neurogenesis in the dentate gyrus, impeded neuron death, and preserved cognitive capacity as a function of terminal aging.	[Pieper, Andrew A.; Xie, Shanhai; Estill, Sandi Jo; Long, Jeffrey M.; Shen, Ching-Han; Kotti, Tiina; Williams, Noelle S.; MacMillan, Karen S.; Naidoo, Jacinth; Melito, Lisa; De Brabander, Jef; Ready, Joseph M.; McKnight, Steven L.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Pieper, Andrew A.; Capota, Emanuela; Zhong, Jeannie; Becker, Ginger L.; Huntington, Paula; Goldman, Shauna E.; Capota, Maria; Britt, Jeremiah K.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ure, Kerstin; Hsieh, Jenny] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Brat, Daniel J.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30332 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Emory University	Pieper, AA (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	andrew.pieper@utsouthwestern.edu; steven.mcknight@utsouthwestern.edu	Britt, Jeremiah/L-9441-2015; Pieper, Andrew A/R-5552-2016	Britt, Jeremiah/0000-0003-4010-662X; Goldman, Shauna/0000-0001-5729-890X; Pieper, Andrew/0000-0001-6299-6577	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression; Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH] [RO1, 1RO1MH087986]; National Institutes of Health (NIH); National Institute of General Medical Sciences [5DP1OD000276]; NIH Method to Extend Research [NIMH RO1MH59388]; National Cancer Institute Program [5PO1CA95471]; Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE [P01CA095471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059388, R01MH087986, R37MH059388] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000276] Funding Source: NIH RePORTER	Hartwell Foundation; Staglin Family fund; University of Texas Southwestern Medical Center High Risk/High Impact research fund; National Alliance for Research on Schizophrenia and Depression(NARSAD); Morton H. Meyerson Family Tzedakah Fund; National Institute of Mental Health [NIMH](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH Method to Extend Research; National Cancer Institute Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simons Foundation Autism Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Wang lab for extensive help in establishing the live-cell imaging assay used to measure mitochondrial membrane permeability; Xiaodong Wang and Sol Snyder for invaluable scientific input; Patrick Harran for helping select the 1000 chemicals chosen for in vivo screening; David Russell and members of the Russell lab for extensive help in electrophysiological recording assays; Christopher Cowan and members of the Cowan laboratory for assistance with primary neuronal cultures; Farah Veerjee, Saira Hussein, Latisha McDaniel, Ruth Starwalt, and Leeju Wu for technical assistance; and Huda Zoghbi, Sol Snyder, Joe Goldstein, Ueli Schibler, Al Gilman, Mike Brown, Richard Axel, and Martin Raff for critical review of the manuscript. We thank Angela Diehl for help with the graphical abstract artwork. This work was supported by grants from The Hartwell Foundation, Staglin Family fund, University of Texas Southwestern Medical Center High Risk/High Impact research fund, National Alliance for Research on Schizophrenia and Depression, and Morton H. Meyerson Family Tzedakah Fund awarded to A.A.P.; a Transformative RO1 grant (National Institute of Mental Health [NIMH] 1RO1MH087986) awarded to A.A.P. and S.L.M.; and a National Institutes of Health (NIH) Pioneer grant (National Institute of General Medical Sciences 5DP1OD000276), an NIH Method to Extend Research in Time grant (NIMH RO1MH59388), a National Cancer Institute Program Project Grant (5PO1CA95471), a Simons Foundation Autism Research Initiative grant from the Simons Foundation, and funds from an anonymous donor provided to S.L.M.	ALTMAN J, 1962, SCIENCE, V135, P1127, DOI 10.1126/science.135.3509.1127; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Bachurin S, 2001, ANN NY ACAD SCI, V939, P425; Bachurin SO, 2003, ANN NY ACAD SCI, V993, P334, DOI 10.1111/j.1749-6632.2003.tb07541.x; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Bombrun A, 2003, J MED CHEM, V46, P4365, DOI 10.1021/jm034107j; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Burns A, 2008, LANCET, V372, P179, DOI 10.1016/S0140-6736(08)61046-6; Distelmaier F, 2008, CYTOM PART A, V73A, P129, DOI 10.1002/cyto.a.20503; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; Driscoll I, 2006, NEUROSCIENCE, V139, P1173, DOI 10.1016/j.neuroscience.2006.01.040; Erbel-Sieler C, 2004, P NATL ACAD SCI USA, V101, P13648, DOI 10.1073/pnas.0405310101; Gross CG, 2000, NAT REV NEUROSCI, V1, P67, DOI 10.1038/35036235; Kamnasaran D, 2003, J MED GENET, V40, P325, DOI 10.1136/jmg.40.5.325; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SE, 2010, EXP GERONTOL, V45, P357, DOI 10.1016/j.exger.2010.02.005; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Macintyre G, 2010, SCHIZOPHR RES, V120, P143, DOI 10.1016/j.schres.2010.04.002; Martin DSD, 2002, J BIOL CHEM, V277, P34239, DOI 10.1074/jbc.M205289200; McKnight SL, 2010, US Patent, Patent No. [2010/020681, 2010020681]; Miller G, 2010, SCIENCE, V327, P1309, DOI 10.1126/science.327.5971.1309; O'Brien JT, 2008, LANCET NEUROL, V7, P768, DOI 10.1016/S1474-4422(08)70177-7; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Pickard BS, 2009, MOL PSYCHIATR, V14, P874, DOI 10.1038/mp.2008.24; Pickard BS, 2006, ANN MED, V38, P439, DOI 10.1080/07853890600946500; Pickard BS, 2005, AM J MED GENET B, V136B, P26, DOI 10.1002/ajmg.b.30204; Pieper AA, 2005, P NATL ACAD SCI USA, V102, P14052, DOI 10.1073/pnas.0506713102; Schmidt HD, 2007, BEHAV PHARMACOL, V18, P391, DOI 10.1097/FBP.0b013e3282ee2aa8; STANFIELD BB, 1988, CEREB CORTEX, V7, P91; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; YANG J, 1997, SCIENCE, V275, P1132	34	266	282	1	30	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					39	51		10.1016/j.cell.2010.06.018	http://dx.doi.org/10.1016/j.cell.2010.06.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603013	Green Accepted, Bronze			2022-12-28	WOS:000279637300011
J	Cooper-DeHoff, RM; Gong, Y; Handberg, EM; Bavry, AA; Denardo, SJ; Bakris, GL; Pepine, CJ				Cooper-DeHoff, Rhonda M.; Gong, Yan; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Bakris, George L.; Pepine, Carl J.			Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							VERAPAMIL SR-TRANDOLAPRIL; METAANALYSIS; ASSOCIATION; MANAGEMENT; MORTALITY; INVEST	Context Hypertension guidelines advocate treating systolic blood pressure (BP) to less than 130 mm Hg for patients with diabetes mellitus; however, data are lacking for the growing population who also have coronary artery disease (CAD). Objective To determine the association of systolic BP control achieved and adverse cardiovascular outcomes in a cohort of patients with diabetes and CAD. Design, Setting, and Patients Observational subgroup analysis of 6400 of the 22 576 participants in the International Verapamil SR-Trandolapril Study (INVEST). For this analysis, participants were at least 50 years old and had diabetes and CAD. Participants were recruited between September 1997 and December 2000 from 862 sites in 14 countries and were followed up through March 2003 with an extended follow-up through August 2008 through the National Death Index for US participants. Intervention Patients received first-line treatment of either a calcium antagonist or beta-blocker followed by angiotensin-converting enzyme inhibitor, a diuretic, or both to achieve systolic BP of less than 130 and diastolic BP of less than 85 mm Hg. Patients were categorized as having tight control if they could maintain their systolic BP at less than 130 mm Hg; usual control if it ranged from 130 mm Hg to less than 140 mm Hg; and uncontrolled if it was 140 mm Hg or higher. Main Outcome Measures Adverse cardiovascular outcomes, including the primary outcomes which was the first occurrence of all-cause death, nonfatal myocardial infarction, or nonfatal stroke. Results During 16 893 patient-years of follow-up, 286 patients (12.7%) who maintained tight control, 249 (12.6%) who had usual control, and 431 (19.8%) who had uncontrolled systolic BP experienced a primary outcome event. Patients in the usual-control group had a cardiovascular event rate of 12.6% vs a 19.8% event rate for those in the uncontrolled group (adjusted hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.25-1.71; P<.001). However, little difference existed between those with usual control and those with tight control. Their respective event rates were 12.6% vs 12.7% (adjusted HR, 1.11; 95% CI, 0.93-1.32; P=.24). The all-cause mortality rate was 11.0% in the tight-control group vs 10.2% in the usual-control group (adjusted HR, 1.20; 95% CI, 0.99-1.45; P=.06); however, when extended follow-up was included, risk of all-cause mortality was 22.8% in the tight control vs 21.8% in the usual control group (adjusted HR, 1.15; 95% CI, 1.01-1.32; P=.04). Conclusion Tight control of systolic BP among patients with diabetes and CAD was not associated with improved cardiovascular outcomes compared with usual control.	[Cooper-DeHoff, Rhonda M.; Gong, Yan] Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, Gainesville, FL 32610 USA; [Cooper-DeHoff, Rhonda M.; Handberg, Eileen M.; Bavry, Anthony A.; Denardo, Scott J.; Pepine, Carl J.] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA; [Bakris, George L.] Univ Chicago, Pritzker Sch Med, Dept Med, Hypertens Dis Unit,Sec Endocrinol Diabet & Metab, Chicago, IL 60637 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Chicago	Cooper-DeHoff, RM (corresponding author), Univ Florida, Dept Pharmacotherapy & Translat Res, Coll Pharm, 1600 SW Archer Rd,POB 100486, Gainesville, FL 32610 USA.	dehoff@cop.ufl.edu		Patt, Mitchell/0000-0001-9696-4477; Handberg, Eileen/0000-0002-7805-9577	Abbott Laboratories; National Heart, Lung, and Blood Institute (NHLBI); Fujisawa; Pfizer; GlaxoSmithKline; Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA); Juvenile Diabetes Research Foundation; Forest Laboratories; CVRx; Merck; Novartis; Boehringer-Ingelheim; Takeda; Walgreens; Bristol Meyer Squibb/Sanofi; Gilead; Forest Labs; Fibrogen; Spherix; Johnson Johnson; Daiichi Sankyo; Bioheart Inc; AstraZeneca; AtCor Medical Inc; Daiichi Sankyo Inc; Eli Lilly; Pfizer Inc; Sanofi-Aventis; Schering-Plough; University of Florida; National Institutes of Health [K23HL086558, UOIGM074492]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL086558] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM074492] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fujisawa; Pfizer(Pfizer); GlaxoSmithKline(GlaxoSmithKline); Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA)(Sanofi-AventisMerck & CompanySchering Plough CorporationAstraZeneca); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Forest Laboratories; CVRx; Merck(Merck & Company); Novartis(Novartis); Boehringer-Ingelheim(Boehringer Ingelheim); Takeda(Takeda Pharmaceutical Company Ltd); Walgreens; Bristol Meyer Squibb/Sanofi; Gilead(Gilead Sciences); Forest Labs; Fibrogen; Spherix; Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Daiichi Sankyo(Daiichi Sankyo Company Limited); Bioheart Inc; AstraZeneca(AstraZeneca); AtCor Medical Inc; Daiichi Sankyo Inc(Daiichi Sankyo Company Limited); Eli Lilly(Eli Lilly); Pfizer Inc(Pfizer); Sanofi-Aventis(Sanofi-Aventis); Schering-Plough(Merck & CompanySchering Plough Corporation); University of Florida(University of Florida); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr Cooper-DeHoff reported receiving research funding from Abbott Laboratories during the conduct of INVEST. Dr Handberg reported receiving grant support from National Heart, Lung, and Blood Institute (NHLBI), Abbott Laboratories, Fujisawa, Pfizer, GlaxoSmithKline, and educational grants from the Vascular Biology Working Group (AstraZeneca, Sanofi Aventis, Schering-Plough, Daiichi Sankyo Lilly, AtCor Medical, XOMA. Dr Bakris reported receiving grant and research support from the Juvenile Diabetes Research Foundation, GlaxoSmithKline, Forest Laboratories, and CVRx; reported also serving as a consultant for GlaxoSmithKline, Merck, Novartis, Boehringer-Ingelheim, Takeda, Abbott Laboratories, Walgreens, Bristol Meyer Squibb/Sanofi, Gilead, Forest Labs and CVRx, Fibrogen, Spherix, Johnson & Johnson, Daiichi Sankyo, and Mitsubishi. Dr Pepine reported receiving research grants from the NHLBI, Abbott Laboratories, Baxter, Pfizer, GlaxoSmithKline, and Bioheart Inc; serving as consultant for Abbott Laboratories, Forest Laboratories, Novartis/Cleveland Clinic, NicOx, Angloblast, Sanofi-Aventis, NHLBI, NIH, Medtelligence, and SLACK Inc; receiving unrestricted educational grants from AstraZeneca, AtCor Medical Inc, Daiichi Sankyo Inc, Eli Lilly, Pfizer Inc, Sanofi-Aventis, and Schering-Plough. Drs Gong, Bavry, and Denardo reported that they have no financial disclosures.; INVEST was funded by a grant from Abbott Laboratories and the University of Florida Opportunity Fund. The present research is supported in part by grants K23HL086558 and UOIGM074492 from the National Institutes of Health (Dr Cooper-DeHoff).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; *AM DIAB ASS, 2002, DIABETES CARE S1, V25, pS85, DOI DOI 10.2337/DIACARE.25.2007.S85; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P213; Amer Diabet Assoc, 2002, DIABETES CARE, V25, P199; Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; [Anonymous], 1984, ARCH INTERN MED, V144, P1045; [Anonymous], 1993, ARCH INTERN MED, V153, P154, DOI DOI 10.1001/archinte.1993.00410020010002; Bakris GL, 2004, HYPERTENSION, V44, P637, DOI 10.1161/01.HYP.0000143851.23721.26; Bavry AA, 2010, HYPERTENSION, V55, P48, DOI 10.1161/HYPERTENSIONAHA.109.142240; Berl T, 2005, J AM SOC NEPHROL, V16, P2170, DOI 10.1681/ASN.2004090763; Boutitie F, 2002, ANN INTERN MED, V136, P438, DOI 10.7326/0003-4819-136-6-200203190-00007; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Denardo SJ, 2009, HYPERTENSION, V53, P624, DOI 10.1161/HYPERTENSIONAHA.108.111542; Estacio RO, 2000, DIABETES CARE, V23, pB54; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Holman RR, 2008, NEW ENGL J MED, V359, P1565, DOI 10.1056/NEJMoa0806359; Kalaitzidis R, 2009, J CLIN HYPERTENS, V11, P345, DOI 10.1111/j.1751-7176.2009.00143.x; Khosla N, 2009, MED CLIN N AM, V93, P697, DOI 10.1016/j.mcna.2009.02.001; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mancia G, 2009, J HYPERTENS, V27, P2121, DOI 10.1097/HJH.0b013e328333146d; Messerli FH, 2006, ANN INTERN MED, V144, P884, DOI 10.7326/0003-4819-144-12-200606200-00005; Pepine CJ, 1998, J AM COLL CARDIOL, V32, P1228, DOI 10.1016/S0735-1097(98)00423-9; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Verdecchia P, 2009, LANCET, V374, P525, DOI 10.1016/S0140-6736(09)61340-4	27	476	504	0	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					61	68		10.1001/jama.2010.884	http://dx.doi.org/10.1001/jama.2010.884			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606150	Bronze, Green Accepted			2022-12-28	WOS:000279519600022
J	Lamont, T; Coates, T; Mathew, D; Scarpello, J; Slater, A				Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John; Slater, Andrew			Safety Alerts Checking for pregnancy before surgery: summary of a safety report from the National Patient Safety Agency	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Coates, Tracy; Mathew, Dinah; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [Slater, Andrew] E Sussex Hosp Trust, Eastbourne BN21 2UD, England		Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						*DEP HLTH, 2004, BEST PRACT GUID DOCT; Kahn RL, 2008, ANESTH ANALG, V106, P1127, DOI 10.1213/ane.0b013e31816788df; National Collaborating Centre for Acute Care, 2003, PREOP TESTS US ROUT; Royal College of Obstetricians and Gynaecologists, 2008, OBT VAL CONS; The National Patient Safety Agency, 2009, WHO SURG SAF CHECKL; Twersky RS, 1996, ANESTH ANALG, V83, P438, DOI 10.1097/00000539-199608000-00059; WALL BF, 2009, 9 RCE HLTH PROT AG; Wilcox AJ, 2001, JAMA-J AM MED ASSOC, V286, P1759, DOI 10.1001/jama.286.14.1759	8	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2010	341								c3402	10.1136/bmj.c3402	http://dx.doi.org/10.1136/bmj.c3402			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DK	20605880				2022-12-28	WOS:000279874200004
J	Cadwell, K; Patel, KK; Maloney, NS; Liu, TC; Ng, ACY; Storer, CE; Head, RD; Xavier, R; Stappenbeck, TS; Virgin, HW				Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Ng, Aylwin C. Y.; Storer, Chad E.; Head, Richard D.; Xavier, Ramnik; Stappenbeck, Thaddeus S.; Virgin, Herbert W.			Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine	CELL			English	Article							GENOME-WIDE ASSOCIATION; INFLAMMATORY-BOWEL-DISEASE; MURINE NOROVIRUS; MURINE-NOROVIRUS-1 INFECTION; MONOCLONAL-ANTIBODIES; INFLUENZA-VIRUS; CELIAC-DISEASE; MOUSE MODEL; IN-VITRO; KEY ROLE	It is unclear why disease occurs in only a small proportion of persons carrying common risk alleles of disease susceptibility genes. Here we demonstrate that an interaction between a specific virus infection and a mutation in the Crohn's disease susceptibility gene Atg16L1 induces intestinal pathologies in mice. This virus-plus-susceptibility gene interaction generated abnormalities in granule packaging and unique patterns of gene expression in Paneth cells. Further, the response to injury induced by the toxic substance dextran sodium sulfate was fundamentally altered to include pathologies resembling aspects of Crohn's disease. These pathologies triggered by virus-plus-susceptibility gene interaction were dependent on TNF alpha and IFN gamma and were prevented by treatment with broad spectrum antibiotics. Thus, we provide a specific example of how a virus-plus-susceptibility gene interaction can, in combination with additional environmental factors and commensal bacteria, determine the phenotype of hosts carrying common risk alleles for inflammatory disease.	[Cadwell, Ken; Patel, Khushbu K.; Maloney, Nicole S.; Liu, Ta-Chiang; Stappenbeck, Thaddeus S.; Virgin, Herbert W.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Ctr Computat & Integrat Biol, Sch Med, Boston, MA 02114 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] MIT, Broad Inst, Program Med & Populat Genet, Cambridge, MA 02142 USA; [Ng, Aylwin C. Y.; Xavier, Ramnik] Harvard Univ, Cambridge, MA 02142 USA; [Storer, Chad E.; Head, Richard D.] Pfizer Global Res & Dev, Inflammat & Immunol Res Unit, St Louis, MO 63017 USA; [Virgin, Herbert W.] Midwest Reg Ctr Excellence Biodefense & Emerging, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Pfizer	Stappenbeck, TS (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	stappenb@wustl.edu; virgin@wustl.edu	Storer, Chad/GZM-2678-2022; Ng, Aylwin/AAQ-6478-2020	Storer, Chad/0000-0002-0139-0819; Cadwell, Ken/0000-0002-5860-0661; Liu, Ta-Chiang/0000-0002-2800-9360; Virgin, Herbert/0000-0001-8580-7628	Project 5 [U54 AI057160]; Broad Foundation [R01 AI084887]; Damon Runyon Cancer Research Foundation [DRG-1972-08]; NIH [T32-AI007172]; Pew Foundation; Washington University Digestive Diseases Research Core Center [DK52574]; Crohn's and Colitis Foundation of America [DK83756, DK086502, DK043351]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007172, R01AI084887, U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, RC1DK086502, R01DK083756, P30DK043351, P30DK052574] Funding Source: NIH RePORTER	Project 5; Broad Foundation; Damon Runyon Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pew Foundation; Washington University Digestive Diseases Research Core Center; Crohn's and Colitis Foundation of America; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by grant U54 AI057160 Project 5 and the Broad Foundation (K. C., N.M., and H. W. V.), R01 AI084887 (T. S. S. and H. W. V.), the Lallage Feazel Wall Fellowship DRG-1972-08 from the Damon Runyon Cancer Research Foundation (K. C.), training grant NIH T32-AI007172 (N.M.), the Pew Foundation (K. K. P. and T. S. S.), Washington University Digestive Diseases Research Core Center DK52574, Pfizer biomedical agreement with Washington University, fellowship award from the Crohn's and Colitis Foundation of America (A.C.Y.N), and grants DK83756, DK086502, and DK043351 (R.J.X.). Washington University holds U. S. patents 7,041,444 B2, 7,264,923, and US 7,455,972 related to growth and detection of MNV. Washington University and H. W. V. receive income based on licenses for MNV technology.	AGUS SG, 1973, ANN INTERN MED, V79, P18, DOI 10.7326/0003-4819-79-1-18; Alberto L, 2006, GASTROENTEROLOGY, V130, P1588, DOI 10.1053/j.gastro.2006.02.004; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Ammann CG, 2009, J VIROL, V83, P13037, DOI 10.1128/JVI.01445-09; Barnes MJ, 2009, IMMUNITY, V31, P401, DOI 10.1016/j.immuni.2009.08.011; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Brem-Exner BG, 2008, J IMMUNOL, V180, P335, DOI 10.4049/jimmunol.180.1.335; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brockman MA, 2009, BLOOD, V114, P346, DOI 10.1182/blood-2008-12-191296; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chand N, 2006, J CLIN GASTROENTEROL, V40, P3, DOI 10.1097/01.mcg.0000190644.01661.2b; Day DW, 2003, MORSON DAWSONS GASTR; DOLIN R, 1975, AM J MED, V59, P761, DOI 10.1016/0002-9343(75)90461-1; Doom CM, 2009, VIROLOGY, V392, P153, DOI 10.1016/j.virol.2009.05.035; DYRBERG T, 1988, J CLIN INVEST, V81, P928, DOI 10.1172/JCI113405; FAIS S, 1991, GUT, V32, P403, DOI 10.1136/gut.32.4.403; Fuss IJ, 1996, J IMMUNOL, V157, P1261; Goto K, 2009, EXP ANIM TOKYO, V58, P135, DOI 10.1538/expanim.58.135; GOVERMAN J, 1993, CELL, V72, P551, DOI 10.1016/0092-8674(93)90074-Z; Gradel KO, 2009, GASTROENTEROLOGY, V137, P495, DOI 10.1053/j.gastro.2009.04.001; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Hensley SE, 2009, J VIROL, V83, P7357, DOI 10.1128/JVI.00623-09; Hsu CC, 2005, CLIN DIAGN LAB IMMUN, V12, P1145, DOI 10.1128/CDLI.12.10.1145-1151.2005; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ju JS, 2009, AUTOPHAGY, V5, P511, DOI 10.4161/auto.5.4.7761; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Karst SM, 2003, SCIENCE, V299, P1575, DOI 10.1126/science.1077905; Lencioni KC, 2008, COMPARATIVE MED, V58, P522; Marsolais D, 2009, P NATL ACAD SCI USA, V106, P1560, DOI 10.1073/pnas.0812689106; Mastroianni JR, 2009, J BIOL CHEM, V284, P27848, DOI 10.1074/jbc.M109.050773; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mumphrey SM, 2007, J VIROL, V81, P3251, DOI 10.1128/JVI.02096-06; Nedjic J, 2008, NATURE, V455, P396, DOI 10.1038/nature07208; OLDSTONE MBA, 1988, SCIENCE, V239, P500, DOI 10.1126/science.3277269; Ouellette AJ, 2006, CURR TOP MICROBIOL, V306, P1; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Piguet PF, 1999, LAB INVEST, V79, P495; Porter CK, 2008, GASTROENTEROLOGY, V135, P781, DOI 10.1053/j.gastro.2008.05.081; Porter EM, 2002, CELL MOL LIFE SCI, V59, P156, DOI 10.1007/s00018-002-8412-z; Pritchett-Corning KR, 2009, LAB ANIM-UK, V43, P165, DOI 10.1258/la.2008.008009; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; ROBERTS ME, 2009, SURG PATHOLOGY GI TR; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Sartor RB, 1997, RES IMMUNOL, V148, P567, DOI 10.1016/S0923-2494(98)80151-X; Scholtens D, 2004, J MULTIVARIATE ANAL, V90, P19, DOI 10.1016/j.jmva.2004.02.004; SCHREIBER RD, 1985, J IMMUNOL, V134, P1609; Shapira SD, 2009, CELL, V139, P1255, DOI 10.1016/j.cell.2009.12.018; SHEEHAN KCF, 1989, J IMMUNOL, V142, P3884; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Stappenbeck TS, 2003, P NATL ACAD SCI USA, V100, P1004, DOI 10.1073/pnas.242735899; Suk K, 2001, J IMMUNOL, V166, P4481, DOI 10.4049/jimmunol.166.7.4481; Tal MC, 2009, P NATL ACAD SCI USA, V106, P2770, DOI 10.1073/pnas.0807694106; Targan SR, 1997, NEW ENGL J MED, V337, P1029, DOI 10.1056/NEJM199710093371502; Thackray LB, 2007, J VIROL, V81, P10460, DOI 10.1128/JVI.00783-07; TONIETTI G, 1970, J EXP MED, V132, P89, DOI 10.1084/jem.132.1.89; Vaishnava S, 2008, P NATL ACAD SCI USA, V105, P20858, DOI 10.1073/pnas.0808723105; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Weersma RK, 2008, AM J GASTROENTEROL, V103, P621, DOI 10.1111/j.1572-0241.2007.01660.x; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15	71	666	674	0	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1135	U64		10.1016/j.cell.2010.05.009	http://dx.doi.org/10.1016/j.cell.2010.05.009			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602997	Green Accepted, Bronze			2022-12-28	WOS:000279148100011
J	Coura, JR; Vinas, PA				Coura, Jose Rodrigues; Vinas, Pedro Albajar			Chagas disease: a new worldwide challenge	NATURE			English	Editorial Material							NONENDEMIC COUNTRIES; EPIDEMIOLOGY		[Coura, Jose Rodrigues] Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil; [Coura, Jose Rodrigues] Fiocruz MS, Minist Hlth, Inst Oswaldo Cruz, Parasit Dis Lab, Rio De Janeiro, Brazil; [Vinas, Pedro Albajar] WHO, NTD, Chagas Dis Programme, New York, NY USA	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; World Health Organization	Coura, JR (corresponding author), Univ Fed Rio de Janeiro, BR-21941 Rio De Janeiro, Brazil.	coura@ioc.fiocruz.br; albajarvinasp@who.int						Araujo A, 2009, MEM I OSWALDO CRUZ, V104, P9, DOI 10.1590/S0074-02762009000900004; Aufderheide AC, 2004, P NATL ACAD SCI USA, V101, P2034, DOI 10.1073/pnas.0307312101; Chagas Carlos, 1909, Memorias do Instituto Oswaldo Cruz, V1; Coura JR, 2007, MEM I OSWALDO CRUZ, V102, P113, DOI 10.1590/S0074-02762007000900018; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; Jackson Y, 2009, Bull Soc Pathol Exot, V102, P326; Schmunis GA, 2007, ISBT SCI SERIES, V2, P6, DOI 10.1111/j.1751-2824.2007.00052.x; Schmunis GA, 2007, MEM I OSWALDO CRUZ, V102, P75, DOI 10.1590/S0074-02762007005000093; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; Schofield CJ, 2009, ENFERM EMERG, V11, P20	10	389	399	0	41	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					S6	S7		10.1038/nature09221	http://dx.doi.org/10.1038/nature09221			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571554				2022-12-28	WOS:000279056900025
J	Arif, S; Cox, P; Afzali, B; Lombardi, G; Lechler, RI; Peakman, M; Mirenda, V				Arif, Sefina; Cox, Patricia; Afzali, Behdad; Lombardi, Giovanna; Lechler, Robert I.; Peakman, Mark; Mirenda, Vincenzo			Anti-TNF alpha therapy-killing two birds with one stone?	LANCET			English	Editorial Material									[Cox, Patricia; Mirenda, Vincenzo] Kings Coll London, Diabet & Endocrine Dept, Div Cardiovasc Med, London SE1 9NH, England; [Arif, Sefina; Peakman, Mark] Kings Coll London, Guys Hosp, Dept Immunobiol, London WC2R 2LS, England; [Afzali, Behdad; Lombardi, Giovanna; Lechler, Robert I.] Kings Coll London, Guys Hosp, MRC, Ctr Transplantat, London WC2R 2LS, England	University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Mirenda, V (corresponding author), Kings Coll London, Diabet & Endocrine Dept, Div Cardiovasc Med, Waterloo Campus, London SE1 9NH, England.	vincenzo.mirenda@kcl.ac.uk	Afzali, Behdad/H-8565-2013	Afzali, Behdad/0000-0003-2968-1156; Peakman, Mark/0000-0003-3328-3513	Medical Research Council [G0500429] Funding Source: Medline; Department of Health Funding Source: Medline; MRC [G0500429] Funding Source: UKRI; Medical Research Council [G0600698B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Liao KP, 2009, ARTHRITIS RHEUM-US, V60, P653, DOI 10.1002/art.24362; Palmer JP, 2005, DIABETES, V54, pS62, DOI 10.2337/diabetes.54.suppl_2.S62; Somers EC, 2006, EPIDEMIOLOGY, V17, P202, DOI 10.1097/01.ede.0000193605.93416.df	4	8	9	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2278	2278		10.1016/S0140-6736(10)60394-7	http://dx.doi.org/10.1016/S0140-6736(10)60394-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609973				2022-12-28	WOS:000279652900024
J	Bai, XY; Kim, J; Yang, ZA; Jurynec, MJ; Akie, TE; Lee, J; LeBlanc, J; Sessa, A; Jiang, H; DiBiase, A; Zhou, Y; Grunwald, DJ; Lin, S; Cantor, AB; Orkin, SH; Zon, LI				Bai, Xiaoying; Kim, Jonghwan; Yang, Zhongan; Jurynec, Michael J.; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; Jiang, Hong; DiBiase, Anthony; Zhou, Yi; Grunwald, David J.; Lin, Shuo; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.			TIF1 gamma Controls Erythroid Cell Fate by Regulating Transcription Elongation	CELL			English	Article							POLYMERASE-II ELONGATION; RNA-POLYMERASE; P-TEFB; PAF1 COMPLEX; GATA-1; GENES; DSIF; IDENTIFICATION; HEMATOPOIESIS; METHYLATION	Recent genome-wide studies have demonstrated that pausing of RNA polymerase II (Pol II) occurred on many vertebrate genes. By genetic studies in the zebrafish tif1 gamma mutant moonshine we found that loss of function of Pol II-associated factors PAF or DSIF rescued erythroid gene transcription in tif1 gamma-deficient animals. Biochemical analysis established physical interactions among TIF1 gamma, the blood-specific SCL transcription complex, and the positive elongation factors p-TEFb and FACT. Chromatin immunoprecipitation assays in human CD34(+) cells supported a TIF1 gamma-dependent recruitment of positive elongation factors to erythroid genes to promote transcription elongation by counteracting Pol II pausing. Our study establishes a mechanism for regulating tissue cell fate and differentiation through transcription elongation.	[Bai, Xiaoying; Kim, Jonghwan; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Orkin, Stuart H.; Zon, Leonard I.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Bai, Xiaoying; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Bai, Xiaoying; Kim, Jonghwan; Akie, Thomas E.; Lee, Joseph; LeBlanc, Jocelyn; Sessa, Anna; DiBiase, Anthony; Zhou, Yi; Cantor, Alan B.; Orkin, Stuart H.; Zon, Leonard I.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Div Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Yang, Zhongan; Jiang, Hong; Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Jurynec, Michael J.; Grunwald, David J.] Univ Utah, Dept Human Genet, Salt Lake City, UT 84112 USA	Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of California System; University of California Los Angeles; Utah System of Higher Education; University of Utah	Zon, LI (corresponding author), Howard Hughes Med Inst, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021; Jurynec, Michael/AAH-8765-2020	Cantor, Alan/0000-0002-5136-028X; Kim, Jonghwan/0000-0002-9919-9843	National Institutes of Health [5PO1HL32262-28, 5R37 DK55381-010]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262, R01HL048801] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK055381, P30DK049216, R01DK053298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. H. Chen, S. Guo, S. Takada, E.H. Bresnick, and S.J. Brandt for providing regents, Y. Huang, A. Chen, and R. Mathieu for technical assistance. We are grateful to Drs. T.V. Bowman, C. Ceol, and R. White for helpful discussion and critical comments. This study was supported by National Institutes of Health grants 5PO1HL32262-28 and 5R37 DK55381-010. X. Bai and J. Kim are Howard Hughes Medical Institute (HHMI) research fellows. L.I. Zon and S.H. Orkin are HHMI investigators. L.I.Z. is a founder and stock holder of Fate, Inc. and a scientific advisor for Stemgent.	Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Choe SE, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r16; Dupont S, 2005, CELL, V121, P87, DOI 10.1016/j.cell.2005.01.033; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Elagib KE, 2008, BLOOD, V112, P4884, DOI 10.1182/blood-2008-03-145722; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Guo S, 2000, NATURE, V408, P366, DOI 10.1038/35042590; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Ivanov D, 2000, MOL CELL BIOL, V20, P2970, DOI 10.1128/MCB.20.9.2970-2983.2000; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Keegan BR, 2002, DEVELOPMENT, V129, P1623; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim JB, 2001, J BIOL CHEM, V276, P12317, DOI 10.1074/jbc.M010908200; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Krishnan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003621; LeDouarin B, 1996, PHILOS T R SOC B, V351, P569, DOI 10.1098/rstb.1996.0056; Lenox LE, 2005, BLOOD, V105, P2741, DOI 10.1182/blood-2004-02-0703; Long QM, 1997, DEVELOPMENT, V124, P4105; Meier N, 2006, DEVELOPMENT, V133, P4913, DOI 10.1242/dev.02656; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; Ransom DG, 1996, DEVELOPMENT, V123, P311; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Saunders A, 2003, SCIENCE, V301, P1094, DOI 10.1126/science.1085712; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schuh AH, 2005, MOL CELL BIOL, V25, P10235, DOI 10.1128/MCB.25.23.10235-10250.2005; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; SOLNICAKREZEL L, 1994, GENETICS, V136, P1401; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Wada T, 2000, MOL CELL, V5, P1067, DOI 10.1016/S1097-2765(00)80272-5; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Weinstein BM, 1996, DEVELOPMENT, V123, P303; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	51	158	164	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 9	2010	142	1					133	143		10.1016/j.cell.2010.05.028	http://dx.doi.org/10.1016/j.cell.2010.05.028			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603019	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000279637300019
J	Dean, SM; McNeill, LC; Henstock, TJ; Bull, JM; Gulick, SPS; Austin, JA; Bangs, NLB; Djajadihardja, YS; Permana, H				Dean, Simon M.; McNeill, Lisa C.; Henstock, Timothy J.; Bull, Jonathan M.; Gulick, Sean P. S.; Austin, James A., Jr.; Bangs, Nathan L. B.; Djajadihardja, Yusuf S.; Permana, Haryadi			Contrasting Decollement and Prism Properties over the Sumatra 2004-2005 Earthquake Rupture Boundary	SCIENCE			English	Article							BARBADOS RIDGE DECOLLEMENT; ANDAMAN EARTHQUAKE; SUBDUCTION ZONE; MEGATHRUST; MORPHOLOGY; MECHANICS; EVOLUTION; TRENCH; SLIP	Styles of subduction zone deformation and earthquake rupture dynamics are strongly linked, jointly influencing hazard potential. Seismic reflection profiles across the trench west of Sumatra, Indonesia, show differences across the boundary between the major 2004 and 2005 plate interface earthquakes, which exhibited contrasting earthquake rupture and tsunami generation. In the southern part of the 2004 rupture, we interpret a negative-polarity sedimentary reflector similar to 500 meters above the subducting oceanic basement as the seaward extension of the plate interface. This predecollement reflector corresponds to unusual prism structure, morphology, and seismogenic behavior that are absent along the 2005 rupture zone. Although margins like the 2004 rupture zone are globally rare, our results suggest that sediment properties influence earthquake rupture, tsunami hazard, and prism development at subducting plate boundaries.	[Dean, Simon M.; McNeill, Lisa C.; Henstock, Timothy J.; Bull, Jonathan M.] Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England; [Gulick, Sean P. S.; Austin, James A., Jr.; Bangs, Nathan L. B.] Univ Texas Austin, Jackson Sch Geosci, Inst Geophys, Austin, TX 78758 USA; [Djajadihardja, Yusuf S.] Agcy Assessment & Applicat Technol BPPT, Jakarta 10340, Indonesia; [Permana, Haryadi] Indonesia Inst Sci, Res Ctr Geotechnol, Bandung 40135, Indonesia	NERC National Oceanography Centre; University of Southampton; University of Texas System; University of Texas Austin; Agency for the Assessment & Application of Technology (BPPT); Indonesian Institute of Sciences	Dean, SM (corresponding author), Univ Southampton, Natl Oceanog Ctr, Southampton SO14 3ZH, Hants, England.	smd9@noc.soton.ac.uk	Gulick, Sean P. S./C-1039-2008; Henstock, Timothy J/C-3583-2014; Gulick, Sean/GNH-2042-2022; Bangs, Nathan/A-1584-2009; Permana, Haryadi/HGB-6201-2022	Gulick, Sean P. S./0000-0003-4740-9068; Henstock, Timothy J/0000-0002-2132-2514; Gulick, Sean/0000-0003-4740-9068; Bangs, Nathan/0000-0002-4377-3463; Bull, Jonathan/0000-0003-3373-5807; McNeill, Lisa/0000-0002-8689-5882	Natural Environment Research Council [NE/D004381/1]; NSF [OCE-0623165]; NERC [NE/I006184/1, NE/D004381/1] Funding Source: UKRI; Natural Environment Research Council [NE/I006184/1] Funding Source: researchfish; Directorate For Geosciences [0623165] Funding Source: National Science Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NSF(National Science Foundation (NSF)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank the master and crew of the F/S Sonne and all those involved in SO198-2 for their assistance, and our partners BPPT, Jakarta, for their logistical assistance. This work was funded by Natural Environment Research Council (NE/D004381/1) and NSF (OCE-0623165).	Ammon CJ, 2005, SCIENCE, V308, P1133, DOI 10.1126/science.1112260; Araki E, 2006, EARTH PLANETS SPACE, V58, P113, DOI 10.1186/BF03353367; Bangs NL, 2004, GEOLOGY, V32, P273, DOI 10.1130/G20211.2; Bangs NLB, 1999, J GEOPHYS RES-SOL EA, V104, P20399, DOI 10.1029/1999JB900133; Briggs RW, 2006, SCIENCE, V311, P1897, DOI 10.1126/science.1122602; BYRNE DE, 1988, TECTONICS, V7, P833, DOI 10.1029/TC007i004p00833; COCHRANE GR, 1994, J GEOPHYS RES-SOL EA, V99, P7033, DOI 10.1029/93JB03206; Curray JR, 2002, MAR PETROL GEOL, V19, P1191, DOI 10.1016/S0264-8172(03)00035-7; DAVIS D, 1983, J GEOPHYS RES, V88, P1153, DOI 10.1029/JB088iB02p01153; Franke D, 2008, EARTH PLANET SC LETT, V269, P118, DOI 10.1016/j.epsl.2008.01.047; Graindorge D, 2008, EARTH PLANET SC LETT, V275, P201, DOI 10.1016/j.epsl.2008.04.053; Henstock TJ, 2006, GEOLOGY, V34, P485, DOI 10.1130/22426.1; International Seismological Centre, 2001, INT SEISM CTR ON LIN; Kopp H, 2008, BASIN RES, V20, P519, DOI 10.1111/j.1365-2117.2008.00381.x; Lin JY, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002454; MIKADA H, 2002, P OCEAN DRILL PROG I, V196; Moore G., 1993, P OCEAN DRILLING PRO, P73; Moore G. F., 2005, P ODP SCI RESULTS, V190, P1, DOI DOI 10.2973/ODP.PROC.SR.190196.190201.192005; Moore JC, 1998, GEOLOGY, V26, P811; MOORE JC, 2000, P OCEAN DRILL PROG A, V171; PLAFKER G, 1972, J GEOPHYS RES, V77, P901, DOI 10.1029/JB077i005p00901; Sandwell DT, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006008; SHIPLEY TH, 1994, GEOLOGY, V22, P411, DOI 10.1130/0091-7613(1994)022<0411:SIDDNB>2.3.CO;2; Tilmann FJ, 2010, GEOPHYS J INT, V181, P1261, DOI 10.1111/j.1365-246X.2010.04597.x; Vigny C, 2005, NATURE, V436, P201, DOI 10.1038/nature03937; Wang KL, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004094; Wells RE, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002072	27	69	69	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					207	210		10.1126/science.1189373	http://dx.doi.org/10.1126/science.1189373			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616276	Green Accepted			2022-12-28	WOS:000279635200046
J	Moiseff, A; Copeland, J				Moiseff, Andrew; Copeland, Jonathan			Firefly Synchrony: A Behavioral Strategy to Minimize Visual Clutter	SCIENCE			English	Article									[Moiseff, Andrew] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Copeland, Jonathan] Georgia So Univ, Dept Biol, Statesboro, GA 30460 USA	University of Connecticut; University System of Georgia; Georgia Southern University	Moiseff, A (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA.	Andrew.Moiseff@UConn.edu			Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Georgia Southern University Department of Biology; University of Connecticut Research Foundation	Support for portions of this study were provided by the Georgia Southern University Department of Biology and the University of Connecticut Research Foundation. We thank L. Faust for assistance in the field, E. Lechowicz for technical support, and W. Chapple for commenting on the manuscript. K. Langdon and the Great Smoky Mountain National Park provided logistical support.	ADAMS G, 1981, FLA ENTOMOL, V64, P66, DOI 10.2307/3494601; BUCK J, 1981, J COMP PHYSIOL, V144, P287, DOI 10.1007/BF00612560; BUCK J, 1988, Q REV BIOL, V63, P265, DOI 10.1086/415929; BUCK J, 1968, SCIENCE, V159, P1319, DOI 10.1126/science.159.3821.1319; Buck JB, 1938, Q REV BIOL, V13, P301, DOI 10.1086/394562; GREENFIELD MD, 1994, ANNU REV ECOL SYST, V25, P97, DOI 10.1146/annurev.es.25.110194.000525; LLOYD JAMES E., 1966, MISC PUBLICATIONS MUS ZOOL UNIV MICH, V130, P1; LLOYD JE, 1989, BIOTROPICA, V21, P373, DOI 10.2307/2388290; Morse E. S., 1916, Science, V43, DOI 10.1126/science.43.1101.169; OTTE D, 1980, AM NAT, V116, P587, DOI 10.1086/283648; Strogatz S.H., 2003, SYNC EMERGING SCI SP	11	55	55	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					181	181		10.1126/science.1190421	http://dx.doi.org/10.1126/science.1190421			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616271				2022-12-28	WOS:000279635200038
J	Young, L; Kanter, EP; Krassig, B; Li, Y; March, AM; Pratt, ST; Santra, R; Southworth, SH; Rohringer, N; DiMauro, LF; Doumy, G; Roedig, CA; Berrah, N; Fang, L; Hoener, M; Bucksbaum, PH; Cryan, JP; Ghimire, S; Glownia, JM; Reis, DA; Bozek, JD; Bostedt, C; Messerschmidt, M				Young, L.; Kanter, E. P.; Kraessig, B.; Li, Y.; March, A. M.; Pratt, S. T.; Santra, R.; Southworth, S. H.; Rohringer, N.; DiMauro, L. F.; Doumy, G.; Roedig, C. A.; Berrah, N.; Fang, L.; Hoener, M.; Bucksbaum, P. H.; Cryan, J. P.; Ghimire, S.; Glownia, J. M.; Reis, D. A.; Bozek, J. D.; Bostedt, C.; Messerschmidt, M.			Femtosecond electronic response of atoms to ultra-intense X-rays	NATURE			English	Article							K-SHELL; FLUORESCENCE YIELDS; CROSS-SECTIONS; LASER; PHOTOIONIZATION; IONIZATION; NEON; LIGHT; SCATTERING; RADIATION	An era of exploring the interactions of high-intensity, hard X-rays with matter has begun with the start-up of a hard-X-ray free-electron laser, the Linac Coherent Light Source (LCLS). Understanding how electrons in matter respond to ultra-intense X-ray radiation is essential for all applications. Here we reveal the nature of the electronic response in a free atom to unprecedented high-intensity, short-wavelength, high-fluence radiation (respectively 10(18) W cm(-2), 1.5-0.6 nm, similar to 10(5) X-ray photons per angstrom(2)). At this fluence, the neon target inevitably changes during the course of a single femtosecond-duration X-ray pulse-by sequentially ejecting electrons-to produce fully-stripped neon through absorption of six photons. Rapid photoejection of inner-shell electrons produces 'hollow' atoms and an intensity-induced X-ray transparency. Such transparency, due to the presence of inner-shell vacancies, can be induced in all atomic, molecular and condensed matter systems at high intensity. Quantitative comparison with theory allows us to extract LCLS fluence and pulse duration. Our successful modelling of X-ray/atom interactions using a straightforward rate equation approach augurs favourably for extension to complex systems.	[Young, L.; Kanter, E. P.; Kraessig, B.; Li, Y.; March, A. M.; Pratt, S. T.; Santra, R.; Southworth, S. H.] Argonne Natl Lab, Argonne, IL 60439 USA; [Santra, R.] Univ Chicago, Chicago, IL 60637 USA; [Rohringer, N.] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [DiMauro, L. F.; Doumy, G.; Roedig, C. A.] Ohio State Univ, Columbus, OH 43210 USA; [Berrah, N.; Fang, L.; Hoener, M.] Western Michigan Univ, Kalamazoo, MI 49008 USA; [Hoener, M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Bucksbaum, P. H.; Cryan, J. P.; Ghimire, S.; Glownia, J. M.; Reis, D. A.] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Bozek, J. D.; Bostedt, C.; Messerschmidt, M.] SLAC Natl Accelerator Lab, Linac Coherent Light Source, Menlo Pk, CA 94025 USA	United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; University System of Ohio; Ohio State University; Western Michigan University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory	Young, L (corresponding author), Argonne Natl Lab, 9700 S Cass Ave, Argonne, IL 60439 USA.	young@anl.gov	Rohringer, Nina/N-3238-2014; Rohringer, Nina/B-8030-2012; Messerschmidt, Marc/Y-8929-2019; Bozek, John D/E-9260-2010; Bozek, John D/E-4689-2010; Rohringer, Nina/AAI-9477-2020; Messerschmidt, Marc/F-3796-2010; Santra, Robin/E-8332-2014	Rohringer, Nina/0000-0001-7905-3567; Messerschmidt, Marc/0000-0002-8641-3302; Bozek, John D/0000-0001-7486-7238; Rohringer, Nina/0000-0001-7905-3567; Messerschmidt, Marc/0000-0002-8641-3302; Santra, Robin/0000-0002-1442-9815; Li, Yuelin/0000-0002-6229-7490; Bucksbaum, Philip/0000-0003-1258-5571	Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy [DE-AC02-06CH11357, DE-FG02-04ER15614, DE-FG02-92ER14299]; US Department of Energy, Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Alexander von Humboldt Foundation; Department of Energy, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division and Division of Materials Science and Engineering; US Department of Energy's Office of Basic Energy Sciences	Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy(United States Department of Energy (DOE)); US Department of Energy, Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Department of Energy, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division and Division of Materials Science and Engineering(United States Department of Energy (DOE)); US Department of Energy's Office of Basic Energy Sciences(United States Department of Energy (DOE))	We thank P. Emma, Z. Huang, R. Iverson, F. J. Decker, J. Frisch, and J. Turner for discussions that allowed us to realize, and subsequently utilize, the flexibility of the LCLS to maximum benefit. We are indebted to the operations staff for the performance of the LCLS in the many modes and energies that we requested throughout the course of this experiment. We thank the software engineers for producing advanced control, data acquisition and analysis capabilities during the experiment. This work was supported by the Chemical Sciences, Geosciences, and Biosciences Division of the Office of Basic Energy Sciences, Office of Science, US Department of Energy (DE-AC02-06CH11357, DE-FG02-04ER15614, DE-FG02-92ER14299). N.R. was supported by the US Department of Energy by Lawrence Livermore National Laboratory (DE-AC52-07NA27344). M. H. thanks the Alexander von Humboldt Foundation for a Feodor Lynen fellowship. P. H. B., J. P. C., S. G., J. M. G. and D. A. R. were supported through the PULSE Institute, which is jointly funded by the Department of Energy, Basic Energy Sciences, Chemical Sciences, Geosciences and Biosciences Division and Division of Materials Science and Engineering. Portions of this research were carried out at the LCLS at the SLAC National Accelerator Laboratory. LCLS is funded by the US Department of Energy's Office of Basic Energy Sciences.	Ackermann W, 2007, NAT PHOTONICS, V1, P336, DOI 10.1038/nphoton.2007.76; ALBIEZ A, 1990, Z PHYS D ATOM MOL CL, V16, P97, DOI 10.1007/BF01679570; AMUSIA MY, 1992, PHYS REV A, V45, P4576, DOI 10.1103/PhysRevA.45.4576; AUGST S, 1989, PHYS REV LETT, V63, P2212, DOI 10.1103/PhysRevLett.63.2212; Ayvazyan V, 2006, EUR PHYS J D, V37, P297, DOI 10.1140/epjd/e2005-00308-1; Bane KLF, 2009, PHYS REV SPEC TOP-AC, V12, DOI 10.1103/PhysRevSTAB.12.030704; Barty A, 2009, OPT EXPRESS, V17, P15508, DOI 10.1364/OE.17.015508; BHALLA CP, 1973, PHYS REV A, V8, P649, DOI 10.1103/PhysRevA.8.649; BONIFACIO R, 1994, PHYS REV LETT, V73, P70, DOI 10.1103/PhysRevLett.73.70; BONIFACIO R, 1984, OPT COMMUN, V50, P373, DOI 10.1016/0030-4018(84)90105-6; Bostedt C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.133401; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Chalupsky J, 2007, OPT EXPRESS, V15, P6036, DOI 10.1364/OE.15.006036; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; CHEN MH, 1991, PHYS REV A, V44, P239, DOI 10.1103/PhysRevA.44.239; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; Eberly J., 1988, LASERS; Emma P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074801; EMMA P, P 2009 PART IN PRESS, P23114; FRISCH J, 2008, P BIW08, P17; Gaffney KJ, 2007, SCIENCE, V316, P1444, DOI 10.1126/science.1135923; Hau-Riege SP, 2008, J APPL PHYS, V103, DOI 10.1063/1.2844478; Hau-Riege SP, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.042511; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; HOENER M, PHYS REV LETT UNPUB, P3114; Kanngiesser B, 2000, PHYS REV A, V62, DOI 10.1103/PhysRevA.62.014702; Kelez N., 2009, P FEL2009, P546; Kondratenko A. M., 1979, Soviet Physics - Doklady, V24, P986; Krainov VP, 2000, J PHYS B-AT MOL OPT, V33, P1585, DOI 10.1088/0953-4075/33/8/309; KRAUSE MO, 1964, PHYS REV A-GEN PHYS, V133, pA385, DOI 10.1103/PhysRev.133.A385; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307, DOI 10.1063/1.555594; Lee RW, 2003, J OPT SOC AM B, V20, P770, DOI 10.1364/JOSAB.20.000770; Makris MG, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.033002; MANSON ST, 1968, PHYS REV, V165, P126, DOI 10.1103/PhysRev.165.126; McNeil B, 2009, NAT PHOTONICS, V3, P375, DOI 10.1038/nphoton.2009.110; Nagler B, 2009, NAT PHYS, V5, P693, DOI 10.1038/NPHYS1341; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Novikov SA, 2000, J PHYS B-AT MOL OPT, V33, P2287, DOI 10.1088/0953-4075/33/12/310; Ostermeier C, 1997, CURR OPIN STRUC BIOL, V7, P697, DOI 10.1016/S0959-440X(97)80080-2; Palaniyappan S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.243003; Paul H, 2003, ATOM DATA NUCL DATA, V85, P377, DOI 10.1016/j.adt.2003.08.003; Reiche S, 2008, NUCL INSTRUM METH A, V593, P45, DOI 10.1016/j.nima.2008.04.061; Richter M, 2009, J PHYS CONF SER, V141, DOI 10.1088/1742-6596/141/1/012014; Richter M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.163002; Rohringer N, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.033416; SAITO N, 1992, PHYS SCRIPTA, V45, P253, DOI 10.1088/0031-8949/45/3/008; Saldin E. L., 2000, PHYS FREE ELECT LASE; Saldin EL, 1998, OPT COMMUN, V148, P383, DOI 10.1016/S0030-4018(97)00670-6; Sorokin AA, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.213002; Sorokin AA, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2397561; Southworth SH, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.062712; Stephenson GB, 2009, NAT MATER, V8, P702, DOI 10.1038/nmat2521; Veigele Wm. J., 1973, Atomic Data, V5, P51, DOI 10.1016/S0092-640X(73)80015-4; Wabnitz H, 2002, NATURE, V420, P482, DOI 10.1038/nature01197; WUILLEUMIER F, 1974, PHYS REV A, V10, P242, DOI 10.1103/PhysRevA.10.242; Ziaja B, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.205002	57	622	631	4	197	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					56	U66		10.1038/nature09177	http://dx.doi.org/10.1038/nature09177			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596013				2022-12-28	WOS:000279343800034
J	Ackerman, JM; Nocera, CC; Bargh, JA				Ackerman, Joshua M.; Nocera, Christopher C.; Bargh, John A.			Incidental Haptic Sensations Influence Social Judgments and Decisions	SCIENCE			English	Article							TOUCH; EMBODIMENT; EMOTION; CHOICE; MIND	Touch is both the first sense to develop and a critical means of information acquisition and environmental manipulation. Physical touch experiences may create an ontological scaffold for the development of intrapersonal and interpersonal conceptual and metaphorical knowledge, as well as a springboard for the application of this knowledge. In six experiments, holding heavy or light clipboards, solving rough or smooth puzzles, and touching hard or soft objects nonconsciously influenced impressions and decisions formed about unrelated people and situations. Among other effects, heavy objects made job candidates appear more important, rough objects made social interactions appear more difficult, and hard objects increased rigidity in negotiations. Basic tactile sensations are thus shown to influence higher social cognitive processing in dimension-specific and metaphor-specific ways.	[Ackerman, Joshua M.] MIT, Alfred P Sloan Sch Management, Cambridge, MA 02142 USA; [Nocera, Christopher C.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Bargh, John A.] Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Massachusetts Institute of Technology (MIT); Harvard University; Yale University	Ackerman, JM (corresponding author), MIT, Alfred P Sloan Sch Management, 77 Massachusetts Ave,E62, Cambridge, MA 02142 USA.		Ackerman, Joshua/A-9315-2013		Sloan School of Management; National Institute of Mental Health [MH60767]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060767] Funding Source: NIH RePORTER	Sloan School of Management; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by the Sloan School of Management and by National Institute of Mental Health grant MH60767 to J.B. We thank L. Williams, E. Morsella, the Yale ACME lab, and many research assistants for their feedback and aid.	Anderson ML, 2007, PHILOS PSYCHOL, V20, P143, DOI 10.1080/09515080701197163; Barsalou LW, 2003, LANG COGNITIVE PROC, V18, P513, DOI 10.1080/01690960344000026; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Clark H.H., 1996, USING LANGUAGE; DeYoung CG, 2002, PERS INDIV DIFFER, V33, P533, DOI 10.1016/S0191-8869(01)00171-4; Gallace A, 2008, CONSCIOUS COGN, V17, P370, DOI 10.1016/j.concog.2007.01.005; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; GIBSON JJ, 1962, PSYCHOL REV, V69, P477, DOI 10.1037/h0046962; Goldinger SD, 2005, PSYCHOL SCI, V16, P525, DOI 10.1111/j.0956-7976.2005.01569.x; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Jostmann NB, 2009, PSYCHOL SCI, V20, P1169, DOI 10.1111/j.1467-9280.2009.02426.x; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Kovecses Zoltan, 2005, METAPHOR CULTURE UNI; Krishna A, 2008, J CONSUM RES, V34, P807, DOI 10.1086/523286; Lakoff G., 1980, METAPHORS WE LIVE; LEDERMAN SJ, 1987, COGNITIVE PSYCHOL, V19, P342, DOI 10.1016/0010-0285(87)90008-9; MANDLER JM, 1992, PSYCHOL REV, V99, P587, DOI 10.1037/0033-295X.99.4.587; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; MESSICK DM, 1968, J EXP SOC PSYCHOL, V4, P1, DOI 10.1016/0022-1031(68)90046-2; Mortensen CR, 2010, PSYCHOL SCI, V21, P440, DOI 10.1177/0956797610361706; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2005, PERS SOC PSYCHOL REV, V9, P184, DOI 10.1207/s15327957pspr0903_1; Peck J, 2003, J CONSUM RES, V30, P430, DOI 10.1086/378619; Schacter DL, 2007, CURR OPIN NEUROBIOL, V17, P171, DOI 10.1016/j.conb.2007.02.001; Van Lange PAM, 1999, J PERS SOC PSYCHOL, V77, P337, DOI 10.1037/0022-3514.77.2.337; Wegner D. M., 1998, HDB SOCIAL PSYCHOL, P446; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Williams LE, 2009, EUR J SOC PSYCHOL, V39, P1257, DOI 10.1002/ejsp.665	28	285	311	4	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1712	1715		10.1126/science.1189993	http://dx.doi.org/10.1126/science.1189993			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576894	Green Accepted			2022-12-28	WOS:000279107400049
J	Huang, CRL; Schneider, AM; Lu, YQ; Niranjan, T; Shen, PL; Robinson, MA; Steranka, JP; Valle, D; Civin, CI; Wang, T; Wheelan, SJ; Ji, HK; Boeke, JD; Burns, KH				Huang, Cheng Ran Lisa; Schneider, Anna M.; Lu, Yunqi; Niranjan, Tejasvi; Shen, Peilin; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Civin, Curt I.; Wang, Tao; Wheelan, Sarah J.; Ji, Hongkai; Boeke, Jef D.; Burns, Kathleen H.			Mobile Interspersed Repeats Are Major Structural Variants in the Human Genome	CELL			English	Article							RETROTRANSPOSON INSERTION; L1 RETROTRANSPOSITION; LINE-1; GENE; SEQUENCE; ELEMENTS; DATABASE; FAMILY; IMPACT	Characterizing structural variants in the human genome is of great importance, but a genome wide analysis to detect interspersed repeats has not been done. Thus, the degree to which mobile DNAs contribute to genetic diversity, heritable disease, and oncogenesis remains speculative. We perform transposon insertion profiling by microarray (TIP-chip) to map human L1(Ta) retrotransposons (LINE-1 s) genome-wide. This identified numerous novel human L1(Ta) insertional polymorphisms with highly variant allelic frequencies. We also explored TIP-chip's usefulness to identify candidate alleles associated with different phenotypes in clinical cohorts. Our data suggest that the occurrence of new insertions is twice as high as previously estimated, and that these repeats are under-recognized as sources of human genomic and phenotypic diversity. We have just begun to probe the universe of human L1(Ta) polymorphisms, and as TIP-chip is applied to other insertions such as Alu SINEs, it will expand the catalog of genomic variants even further.	[Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Steranka, Jared P.; Boeke, Jef D.] Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA; [Huang, Cheng Ran Lisa; Lu, Yunqi; Niranjan, Tejasvi; Robinson, Matoya A.; Steranka, Jared P.; Valle, David; Wang, Tao; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Inst Med Genet, Baltimore, MD 21287 USA; [Schneider, Anna M.; Shen, Peilin; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21287 USA; [Civin, Curt I.; Wheelan, Sarah J.; Boeke, Jef D.; Burns, Kathleen H.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21287 USA; [Wheelan, Sarah J.; Ji, Hongkai] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Boeke, JD (corresponding author), Johns Hopkins Univ, Sch Med, High Throughput Biol Ctr, Baltimore, MD 21287 USA.	jboeke@jhmi.edu	Burns, Kathleen/A-3360-2011; Niranjan, Tejasvi/ABD-2892-2020	Boeke, Jef/0000-0001-5322-4946; Niranjan, Tejasvi/0000-0002-6458-2017; Burns, Kathleen/0000-0003-1620-3761	NIH [P01-CA16319, RC1 HG005359, K08-CA134746]; Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation; NATIONAL CANCER INSTITUTE [K08CA134746, P01CA016519] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC1HG005359] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brain Science Institute at Johns Hopkins University School of Medicine; Goldhirsh Foundation; Burroughs Wellcome Foundation(Burroughs Wellcome Fund); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Supported in part by NIH grant P01-CA16319, RC1 HG005359 and grants from the Brain Science Institute at Johns Hopkins University School of Medicine and the Goldhirsh Foundation (J.D.B.), and NIH grant K08-CA134746 and a Career Award for Medical Scientists from the Burroughs Wellcome Foundation (K. H. B.). We thank Jon Alder, Joe Costello, Lisa Scheifele, Daniel Yuan, Syntyche Walker, Ed Davis, Kate O'Donnell, Lixin Dai, Wengfeng An, and Christina Schrum for helpful discussions and Audrey Hendley, Naera El-Sharkawy, Lisa Scheifele, and Daniel Yuan for technical assistance. We thank Robert B. Weiss and Kevin M. Flanigan for X-linked dilated cardiomyopathy and Becker muscular dystrophy patient samples; Cindy Skinner, Cassandra Obie, and Abby Adamczyk for assistance in providing X-linked intellectual disability genomic DNA samples; and Pei-Lung Chen, Darci Ferrer, Sarah E. Ritter, and Gary Cutting for familial and twin genomic DNA. Finally, we thank Bang Wong at ClearScience and Cheng Lai Victor Huang for assistance with artwork.	Arnold C, 1991, PCR Methods Appl, V1, P39; Bailey JA, 2000, P NATL ACAD SCI USA, V97, P6634, DOI 10.1073/pnas.97.12.6634; Beck CR, 2010, CELL, V141, P1159, DOI 10.1016/j.cell.2010.05.021; Belancio VP, 2008, GENE, V411, P38, DOI 10.1016/j.gene.2007.12.022; Bennettt EA, 2004, GENETICS, V168, P933, DOI 10.1534/genetics.104.031757; Boissinot S, 2000, MOL BIOL EVOL, V17, P915, DOI 10.1093/oxfordjournals.molbev.a026372; Boissinot S, 2004, GENOME RES, V14, P1221, DOI 10.1101/gr.2326704; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; Cooper GM, 2007, NAT GENET, V39, pS22, DOI 10.1038/ng2054; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Credille KM, 2009, BRIT J DERMATOL, V161, P265, DOI 10.1111/j.1365-2133.2009.09161.x; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; Gasior SL, 2007, GENE, V390, P190, DOI 10.1016/j.gene.2006.08.024; Gresham D, 2008, NAT REV GENET, V9, P291, DOI 10.1038/nrg2335; Gu Wenli, 2008, Pathogenetics, V1, P4, DOI 10.1186/1755-8417-1-4; Han JS, 2005, BIOESSAYS, V27, P775, DOI 10.1002/bies.20257; Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756; Iskow RC, 2010, CELL, V141, P1253, DOI 10.1016/j.cell.2010.05.020; Kano H, 2009, GENE DEV, V23, P1303, DOI 10.1101/gad.1803909; KAZAZIAN HH, 1988, NATURE, V332, P164, DOI 10.1038/332164a0; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kolomietz E, 2002, GENE CHROMOSOME CANC, V35, P97, DOI 10.1002/gcc.10111; Konkel MK, 2007, GENE, V390, P28, DOI 10.1016/j.gene.2006.07.040; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Martini SR, 2000, DEVELOPMENT, V127, P2663; MIKI Y, 1992, CANCER RES, V52, P643; Moran JV, 1996, CELL, V87, P917, DOI 10.1016/S0092-8674(00)81998-4; Morisada N, 2010, PEDIATR NEPHROL, V25, P1343, DOI 10.1007/s00467-010-1445-x; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Myers JS, 2002, AM J HUM GENET, V71, P312, DOI 10.1086/341718; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Rozen S, 2000, Methods Mol Biol, V132, P365; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Schwahn U, 1998, NAT GENET, V19, P327, DOI 10.1038/1214; SKOWRONSKI J, 1988, MOL CELL BIOL, V8, P1385, DOI 10.1128/MCB.8.4.1385; Smit A.F.A, 1996, REPEATMASKER OPEN 3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; Van de Water N, 1998, THROMB HAEMOSTASIS, V79, P938; van den Hurk JAJM, 2007, HUM MOL GENET, V16, P1587, DOI 10.1093/hmg/ddm108; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang JX, 2006, HUM MUTAT, V27, P323, DOI 10.1002/humu.20307; Wheelan SJ, 2006, P NATL ACAD SCI USA, V103, P17632, DOI 10.1073/pnas.0605450103; Wheelan SJ, 2005, GENOME RES, V15, P1073, DOI 10.1101/gr.3688905; Witherspoon DJ, 2006, HUM HERED, V62, P30, DOI 10.1159/000095851; Xing JC, 2009, GENOME RES, V19, P1516, DOI 10.1101/gr.091827.109; Yajima I, 1999, HUM MOL GENET, V8, P1431, DOI 10.1093/hmg/8.8.1431	54	190	194	1	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1171	U129		10.1016/j.cell.2010.05.026	http://dx.doi.org/10.1016/j.cell.2010.05.026			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602999	Bronze, Green Accepted			2022-12-28	WOS:000279148100014
J	Petherick, A				Petherick, Anna			Country by country	NATURE			English	Editorial Material							CHAGAS-DISEASE; OUTBREAK; SCHOOL											Ache Alberto, 2001, Revista do Instituto de Medicina Tropical de Sao Paulo, V43, P37, DOI 10.1590/S0036-46652001000100008; Aguilar HM, 2007, MEM I OSWALDO CRUZ, V102, P47, DOI 10.1590/S0074-02762007005000098; de Noya BA, 2010, J INFECT DIS, V201, P1308, DOI 10.1086/651608; Miles MA, 2010, J INFECT DIS, V201, P1282, DOI 10.1086/651609	4	24	24	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S10	S11		10.1038/nature09223	http://dx.doi.org/10.1038/nature09223			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571547	Bronze			2022-12-28	WOS:000279056900027
J	Morris, MC; Tangney, CC				Morris, Martha Clare; Tangney, Christine C.			Diet and Prevention of Alzheimer Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; PATTERNS		[Morris, Martha Clare] Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, Chicago, IL 60612 USA; [Morris, Martha Clare] Rush Univ, Med Ctr, Dept Internal Med, Chicago, IL 60612 USA; [Morris, Martha Clare] Rush Univ, Med Ctr, Dept Prevent Med, Chicago, IL 60612 USA; [Tangney, Christine C.] Rush Univ, Med Ctr, Dept Clin Nutr, Chicago, IL 60612 USA	Rush University; Rush University; Rush University; Rush University	Morris, MC (corresponding author), Rush Univ, Med Ctr, Sect Nutr & Nutr Epidemiol, 1725 W Harrison,Ste 206, Chicago, IL 60612 USA.	Martha_C_Morris@rush.edu						Alzheimer's Association, 2010 ALZH DIS FACTS; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Carmel R, 1997, AM J CLIN NUTR, V66, P750, DOI 10.1093/ajcn/66.4.750; Gu YA, 2010, ARCH NEUROL-CHICAGO, V67, P699, DOI 10.1001/archneurol.2010.84; GUYONNET SG, 2007, J NUTR HEALTH AGING, V11, P132; Hebert LE, 2003, ARCH NEUROL-CHICAGO, V60, P1119, DOI 10.1001/archneur.60.8.1119; Hoffmann K, 2004, AM J EPIDEMIOL, V159, P935, DOI 10.1093/aje/kwh134; *NIH, 2010, STAT OF THE SCI C ST; Scarmeas N, 2006, ANN NEUROL, V59, P912, DOI 10.1002/ana.20854	9	8	8	1	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2519	2520		10.1001/jama.2010.844	http://dx.doi.org/10.1001/jama.2010.844			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20578272				2022-12-28	WOS:000279010900030
J	Hui, E; Bravis, V; Hassanein, M; Hanif, W; Malik, R; Chowdhury, TA; Suliman, M; Devendra, D				Hui, E.; Bravis, V.; Hassanein, M.; Hanif, W.; Malik, R.; Chowdhury, T. A.; Suliman, M.; Devendra, D.			Management of people with diabetes wanting to fast during Ramadan	BMJ-BRITISH MEDICAL JOURNAL			English	Review							INSULIN GLARGINE; TYPE-2; REPAGLINIDE; ACARBOSE; MUSLIMS; SAFETY; LISPRO		[Hui, E.; Bravis, V.; Devendra, D.] Univ London Imperial Coll Sci Technol & Med, Dept Investigat Sci, London, England; [Hanif, W.] Univ Hosp Birmingham, Dept Endocrinol & Diabet, Birmingham, W Midlands, England; [Hassanein, M.] Glan Clwyd Gen Hosp, Dept Diabet, Rhyl, Wales; [Malik, R.] Univ Manchester, Cardiovasc Res Grp, Manchester, Lancs, England; [Chowdhury, T. A.] Barts & London NHS Trust, Dept Diabet, London, England; [Suliman, M.] Royal Preston Hosp, Dept Med, Preston, Lancs, England; [Devendra, D.] NW London NHS Trust & Brent Community Serv, London, England	Imperial College London; University of Birmingham; University of Manchester; Barts Health NHS Trust; Royal Preston Hospital	Devendra, D (corresponding author), Cent Middlesex Hosp, Jeffrey Kelson Diabet Ctr, London NW10 7NS, England.	d.devendra@imperial.ac.uk	Malik, Rayaz/H-9231-2019	Malik, Rayaz/0000-0002-7188-8903	National Institute for Health Research [ACF-2007-21-021] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Al-Arouj M, 2005, DIABETES CARE, V28, P2305, DOI 10.2337/diacare.28.9.2305; [Anonymous], KORAN, V2, P256; Anwar A, 2006, Med J Malaysia, V61, P28; Azar Sami T, 2008, J Med Liban, V56, P46; Bakiner O, 2009, ACTA DIABETOL, V46, P63, DOI 10.1007/s00592-008-0062-7; BELKHADIR J, 1993, BRIT MED J, V307, P292, DOI 10.1136/bmj.307.6899.292; Benaji B, 2006, DIABETES RES CLIN PR, V73, P117, DOI 10.1016/j.diabres.2005.10.028; Beshyah SA, 2009, IBNOSINA J MED BIOME, V1, P58; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Bravis V, 2010, DIABETIC MED, V27, P327, DOI 10.1111/j.1464-5491.2010.02948.x; Cesur M, 2007, DIABETES RES CLIN PR, V75, P141, DOI 10.1016/j.diabres.2006.05.012; Devendra D, 2009, INT J CLIN PRACT, V63, P1446, DOI 10.1111/j.1742-1241.2009.02171.x; HUI E, 2010, INT J CLIN PRAC 0310; Kadiri A, 2001, DIABETES METAB, V27, P482; Mafauzy M, 2002, DIABETES RES CLIN PR, V58, P45, DOI 10.1016/S0168-8227(02)00104-3; Mattoo V, 2003, DIABETES RES CLIN PR, V59, P137, DOI 10.1016/S0168-8227(02)00202-4; Metzger BE, 2008, NEW ENGL J MED, V358, P1991, DOI 10.1056/NEJMoa0707943; Mojaddidi M, 2006, PRESCRIBER, P38; *MUSL SPIR CAR DIV, RAM HLTH FACTSH 2009; National Institute for Health and Clinical Excellence, 2009, TYP 2 DIAB NEW AG PA; Norris SL, 2009, DIABETIC MED, V26, P837, DOI 10.1111/j.1464-5491.2009.02790.x; Pan C, 2008, DIABETIC MED, V25, P435, DOI 10.1111/j.1464-5491.2008.02391.x; RASHED AH, 1992, BRIT MED J, V304, P521, DOI 10.1136/bmj.304.6826.521; Rohban T, 2005, DIABETES CARE, V28, P421; Rosak C, 2009, CURR DIABETES REV, V5, P157, DOI 10.2174/157339909788920910; Salti I, 2004, DIABETES CARE, V27, P2306, DOI 10.2337/diacare.27.10.2306; Sari R, 2004, ENDOCR RES, V30, P169, DOI 10.1081/ERC-200027375; Senthil Vasan, 2006, International Journal of Diabetes in Developing Countries, V26, P70; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Uysal AR, 1998, DIABETES CARE, V21, P2033, DOI 10.2337/diacare.21.11.2033	30	67	68	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3053	10.1136/bmj.c3053	http://dx.doi.org/10.1136/bmj.c3053			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618IO	20570867				2022-12-28	WOS:000279346300003
J	Bento, G; Ogawa, A; Sommer, RJ				Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.			Co-option of the hormone-signalling module dafachronic acid-DAF-12 in nematode evolution	NATURE			English	Article							PHENOTYPIC PLASTICITY; NUCLEAR RECEPTOR; DAUER FORMATION; DAF-12; IDENTIFICATION; ORIGINS	Morphological novelties are lineage-specific traits that serve new functions(1,2). Developmental polyphenisms have been proposed to be facilitators of phenotypic evolution, but little is known about the interplay between the associated genetic and environmental factors(3-11). Here, we study two alternative morphologies in the mouth of the nematode Pristionchus pacificus and the formation of teeth-like structures that are associated with bacteriovorous feeding and predatory behaviour on fungi and other worms(12-16). These teeth-like denticles represent an evolutionary novelty, which is restricted to some members of the nematode family Diplogastridae but is absent from Caenorhabditis elegans and related nematodes(14). We show that the mouth dimorphism is a polyphenism that is controlled by starvation and the co-option of an endocrine switch mechanism. Mutations in the nuclear hormone receptor DAF-12 and application of its ligand, the sterol hormone dafachronic acid, strongly influence this switch mechanism. The dafachronic acid-DAF-12 module has been shown to control the formation of arrested dauer larvae in both C. elegans and P. pacificus, as well as related life-history decisions in distantly related nematodes(17-20). The comparison of dauer formation and mouth morphology switch reveals that different thresholds of dafachronic acid signalling provide specificity. This study shows how hormonal signalling acts by coupling environmental change and genetic regulation and identifies dafachronic acid as a key hormone in nematode evolution.	[Bento, Gilberto; Ogawa, Akira; Sommer, Ralf J.] Max Planck Inst Dev Biol, Dept Evolutionary Biol, D-72076 Tubingen, Germany	Max Planck Society	Sommer, RJ (corresponding author), Max Planck Inst Dev Biol, Dept Evolutionary Biol, Spemannstr 37, D-72076 Tubingen, Germany.	ralf.sommer@tuebingen.mpg.de	Bento, Gilberto/AAY-8654-2020	Bento, Gilberto/0000-0002-8455-6625				Antebi A, 2000, GENE DEV, V14, P1512; Brakefield PM, 1998, AM NAT, V152, P853, DOI 10.1086/286213; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; CASSADA RC, 1975, DEV BIOL, V46, P326, DOI 10.1016/0012-1606(75)90109-8; CREELMAN RA, 1995, P NATL ACAD SCI USA, V92, P4114, DOI 10.1073/pnas.92.10.4114; Dieterich C, 2008, NAT GENET, V40, P1193, DOI 10.1038/ng.227; Fielenbach N, 2008, GENE DEV, V22, P2149, DOI 10.1101/gad.1701508; GOLDEN JW, 1982, SCIENCE, V218, P578, DOI 10.1126/science.6896933; Herrmann M, 2007, ZOOL SCI, V24, P883, DOI 10.2108/zsj.24.883; Hirschmann H., 1951, Zoologische Jahrbuecher (Systematik), V80, P132; Jeong PY, 2005, NATURE, V433, P541, DOI 10.1038/nature03201; Macosko EZ, 2009, NATURE, V458, P1171, DOI 10.1038/nature07886; Mayr E., 1960, EVOLUTION DARWIN; Moczek AP, 2002, EVOL DEV, V4, P252, DOI 10.1046/j.1525-142X.2002.02014.x; Moczek AP, 2008, BIOESSAYS, V30, P432, DOI 10.1002/bies.20754; Motola DL, 2006, CELL, V124, P1209, DOI 10.1016/j.cell.2006.01.037; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; NIJHOUT HF, 1994, INSECT PHEROMONES; Ogawa A, 2009, CURR BIOL, V19, P67, DOI 10.1016/j.cub.2008.11.063; Pigliucci M., 2001, SYN ECO EVO; Pigliucci M, 2006, J EXP BIOL, V209, P2362, DOI 10.1242/jeb.02070; Quinn GP, 2003, EXPT DESIGN DATA ANA; Saenko SV, 2008, PHILOS T R SOC B, V363, P1549, DOI 10.1098/rstb.2007.2245; Schlichting CD, 2003, EVOL DEV, V5, P98, DOI 10.1046/j.1525-142X.2003.03015.x; Sommer RJ, 1996, FUND APPL NEMATOL, V19, P511; Srinivasan J, 2008, NATURE, V454, P1115, DOI 10.1038/nature07168; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; von Lieven AF, 2000, J ZOOL SYST EVOL RES, V38, P37, DOI 10.1046/j.1439-0469.2000.381125.x; WADDINGTON CH, 1953, EVOLUTION, V7, P118, DOI 10.2307/2405747; Wang Z, 2009, P NATL ACAD SCI USA, V106, P9138, DOI 10.1073/pnas.0904064106; West-Eberhard Mary Jane, 2003, pi	31	144	144	1	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					494	U9		10.1038/nature09164	http://dx.doi.org/10.1038/nature09164			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592728				2022-12-28	WOS:000280141200037
J	Iglehart, JK				Iglehart, John K.			The ACA's New Weapons against Health Care Fraud	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Iglehart JK, 2009, HEALTH AFFAIR, V28, pW688, DOI 10.1377/hlthaff.28.4.w688; SEBELIUS K, 2010, COMMUNICATION   0128	2	7	7	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 22	2010	363	4					304	306		10.1056/NEJMp1007088	http://dx.doi.org/10.1056/NEJMp1007088			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	628RU	20592295				2022-12-28	WOS:000280139300002
J	Comita, LS; Muller-Landau, HC; Aguilar, S; Hubbell, SP				Comita, Liza S.; Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.			Asymmetric Density Dependence Shapes Species Abundances in a Tropical Tree Community	SCIENCE			English	Article							LOCAL NEIGHBORHOOD; NEOTROPICAL FOREST; SHADE TOLERANCE; DIVERSITY; SURVIVAL; COEXISTENCE; RECRUITMENT; PATHOGENS; SEEDLINGS; GROWTH	The factors determining species commonness and rarity are poorly understood, particularly in highly diverse communities. Theory predicts that interactions with neighbors of the same (conspecific) and other (heterospecific) species can influence a species' relative abundance, but empirical tests are lacking. By using a hierarchical model of survival for more than 30,000 seedlings of 180 tropical tree species on Barro Colorado Island, Panama, we tested whether species' sensitivity to neighboring individuals relates to their relative abundance in the community. We found wide variation among species in the effect of conspecific, but not heterospecific, neighbors on survival, and we found a significant relationship between the strength of conspecific neighbor effects and species abundance. Specifically, rare species suffered more from the presence of conspecific neighbors than common species did, suggesting that conspecific density dependence shapes species abundances in diverse communities.	[Comita, Liza S.] Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Comita, Liza S.; Muller-Landau, Helene C.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Muller-Landau, Helene C.; Aguilar, Salomon; Hubbell, Stephen P.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Hubbell, Stephen P.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90024 USA	National Center for Ecological Analysis & Synthesis; University of Minnesota System; University of Minnesota Twin Cities; Smithsonian Institution; Smithsonian Tropical Research Institute; University of California System; University of California Los Angeles	Comita, LS (corresponding author), Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	comita@nceas.ucsb.edu		Comita, Liza/0000-0002-9169-1331; Muller-Landau, Helene C./0000-0002-3526-9021	Packard Fellowship for Science and Engineering; NSF [DEB-0075102, 0425651, 0710211, 0823728]; Andrew W. Mellon Foundation; HSBC	Packard Fellowship for Science and Engineering; NSF(National Science Foundation (NSF)); Andrew W. Mellon Foundation; HSBC	We thank the dozens of field assistants who conducted the seedling and tree censuses; R. Perez for assistance with species identifications; S. Lao for help with data management; and S. Banerjee, S. M. Lee, M. Schofield, and A. Gelman for statistical advice. The study was financially supported by a Packard Fellowship for Science and Engineering (to H.C.M.), NSF (grants DEB-0075102, 0425651, 0710211, and 0823728 to S. P. H.), the Andrew W. Mellon Foundation, and the HSBC Climate Partnership, with logistical support from the Center of Tropical Forest Science, Smithsonian Tropical Research Institute, and University of Georgia.	Alonso D, 2008, ECOL LETT, V11, P93, DOI 10.1111/j.1461-0248.2007.01127.x; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; CONNELL J H, 1971, P298; CONNELL JH, 1984, ECOL MONOGR, V54, P141, DOI 10.2307/1942659; Freckleton RP, 2006, P R SOC B, V273, P2909, DOI 10.1098/rspb.2006.3660; Gaston K.J., 1994, RARITY, P1; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harpole WS, 2006, ECOL LETT, V9, P15, DOI 10.1111/j.1461-0248.2005.00836.x; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hubbell SP, 1986, CONSERVATION BIOL SC, P205; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Klironomos JN, 2002, NATURE, V417, P67, DOI 10.1038/417067a; Kunin W.E., 1997, J ANIM ECOL, DOI DOI 10.2307/6011; MANGAN SA, 2010, NATURE; May R, 1999, PHILOS T R SOC B, V354, P1951, DOI 10.1098/rstb.1999.0534; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; McGill BJ, 2006, SCIENCE, V314, P770, DOI 10.1126/science.1134920; Novotny V, 2007, SCIENCE, V315, DOI 10.1126/science.1139702; Paine CET, 2008, BIOTROPICA, V40, P432, DOI 10.1111/j.1744-7429.2007.00390.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; SCHUPP EW, 1992, AM NAT, V140, P526, DOI 10.1086/285426; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Webb CO, 1999, ECOLOGY, V80, P2006, DOI 10.1890/0012-9658(1999)080[2006:SDDPCO]2.0.CO;2; Wills C, 1997, P NATL ACAD SCI USA, V94, P1252, DOI 10.1073/pnas.94.4.1252; Wills C, 2006, SCIENCE, V311, P527, DOI 10.1126/science.1117715	32	468	490	21	343	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 16	2010	329	5989					330	332		10.1126/science.1190772	http://dx.doi.org/10.1126/science.1190772			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625VW	20576853				2022-12-28	WOS:000279925900044
J	Pronovost, PJ				Pronovost, Peter J.			Learning Accountability for Patient Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BLOOD-STREAM INFECTIONS; QUALITY; SAFETY		[Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Dept Hlth Policy & Management, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Pronovost, PJ (corresponding author), Qual & Safety Res Grp, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Berenholtz SM, 2004, CRIT CARE MED, V32, P2014, DOI 10.1097/01.CCM.0000142399.70913.2F; *COMM QUAL HLTH CA, 1999, ERR IS HUM BUID SAF; Edwards JR, 2009, AM J INFECT CONTROL, V37, P783, DOI 10.1016/j.ajic.2009.10.001; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miller MR, 2010, PEDIATRICS, V125, P206, DOI 10.1542/peds.2009-1382; Pronovost PJ, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c309; Pronovost PJ, 2009, JAMA-J AM MED ASSOC, V301, P1273, DOI 10.1001/jama.2009.388; U.S. Department of Health and Human Services Office of the Secretary Office of the Assistant Secretary for Health, HHS ACT PLAN PREV HE; Wachter RM, 2009, NEW ENGL J MED, V361, P1401, DOI 10.1056/NEJMsb0903885	10	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					204	205		10.1001/jama.2010.979	http://dx.doi.org/10.1001/jama.2010.979			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628135				2022-12-28	WOS:000279811000028
J	Baarlink, C; Brandt, D; Grosse, R				Baarlink, Christian; Brandt, Dominique; Grosse, Robert			SnapShot: Formins	CELL			English	Editorial Material							ACTIN; ASSOCIATION; NUCLEATION; MECHANISM; PROFILIN		[Baarlink, Christian; Brandt, Dominique; Grosse, Robert] Univ Marburg, D-35032 Marburg, Germany	Philipps University Marburg	Baarlink, C (corresponding author), Univ Marburg, D-35032 Marburg, Germany.			Grosse, Robert/0000-0002-3380-5273				Brown EJ, 2010, NAT GENET, V42, P72, DOI 10.1038/ng.505; Chesarone MA, 2010, NAT REV MOL CELL BIO, V11, P62, DOI 10.1038/nrm2816; Kitzing TM, 2010, ONCOGENE, V29, P2441, DOI 10.1038/onc.2009.515; Madrid R, 2010, DEV CELL, V18, P814, DOI [10.1016/j.devcel.2010.04.001, 10.1016/j.devce1.2010.04.001]; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Palazzo AF, 2001, NAT CELL BIOL, V3, P723, DOI 10.1038/35087035; Paul AS, 2009, CELL MOTIL CYTOSKEL, V66, P606, DOI 10.1002/cm.20379; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044	10	22	22	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1							172.e1	10.1016/j.cell.2010.06.030	http://dx.doi.org/10.1016/j.cell.2010.06.030			1	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603022	Bronze			2022-12-28	WOS:000279637300023
J	Jewkes, R				Jewkes, Rachel			Gender Inequities Must Be Addressed in HIV Prevention	SCIENCE			English	Editorial Material							INTIMATE-PARTNER VIOLENCE; SEXUALLY-TRANSMITTED INFECTION; RURAL SOUTH-AFRICA; RELATIONSHIP POWER; WOMEN; RISK; ABUSE; HIV/AIDS; TRIAL; MEN		MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa		Jewkes, R (corresponding author), MRC, Gender & Hlth Res Unit, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267				Bennet, 2000, AIDS BEHAV, V4, P261, DOI [https://doi.org/10.1023/A:1009568718804, DOI 10.1023/A:1009568718804, 10.1023/A:1009568718804.]; Campbell JC, 2008, INT J INJ CONTROL SA, V15, P221, DOI 10.1080/17457300802423224; Decker MR, 2009, JAIDS-J ACQ IMM DEF, V51, P593, DOI 10.1097/QAI.0b013e3181a255d6; DUDE AM, 2009, AIDS BEHAV; Dude A, 2007, STUD FAMILY PLANN, V38, P89, DOI 10.1111/j.1728-4465.2007.00120.x; Dunkle KL, 2004, LANCET, V363, P1415, DOI 10.1016/S0140-6736(04)16098-4; El-Bassel N, 2001, J SUBST ABUSE, V13, P29, DOI 10.1016/S0899-3289(01)00068-2; Gielen AC, 2007, TRAUMA VIOLENCE ABUS, V8, P178, DOI 10.1177/1524838007301476; *GLOB COAL WOM AID, VIOL WOM; Greig A, 2008, AIDS, V22, pS35, DOI 10.1097/01.aids.0000327435.28538.18; Jewkes R., 2009, UNDERSTANDING MENS H; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Jewkes R, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a506; JEWKES RK, CHILD ABUSE IN PRESS; JEWKES RK, LANCET; Joint United Nations Programme on HIV/ AIDS (UNAIDS), 2010, AG ACC COUNTR ACT WO; Maman S, 2002, AM J PUBLIC HEALTH, V92, P1331, DOI 10.2105/AJPH.92.8.1331; Martin SL, 1999, JAMA-J AM MED ASSOC, V282, P1967, DOI 10.1001/jama.282.20.1967; Nascimento, 2007, ENGAGING MEN BOYS TR; PETTIFOR AE, 1996, EMERG INFECT DIS, V10, P2004; Pronyk PM, 2006, LANCET, V368, P1973, DOI 10.1016/S0140-6736(06)69744-4; Pulerwitz J, 2000, SEX ROLES, V42, P637, DOI 10.1023/A:1007051506972; Silverman JG, 2007, SEX TRANSM INFECT, V83, P211, DOI 10.1136/sti.2006.023366; VANDERSTRATEN A, 1998, AIDS BEHAV, V2, P61, DOI DOI 10.1023/A:1022311424652; Wang S. K., 2007, RAPE WOMEN COMMUNITY; Wingood GM, 1997, AM J PREV MED, V13, P380, DOI 10.1016/S0749-3797(18)30158-2; World Health Organization Joint United Nations Programme on HIV/AIDS, 2010, ADDR VIOL WOM HIV AI	28	54	55	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					145	147		10.1126/science.1193794	http://dx.doi.org/10.1126/science.1193794			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616253				2022-12-28	WOS:000279635200020
J	Trono, D; Van Lint, C; Rouzioux, C; Verdin, E; Barre-Sinoussi, F; Chun, TW; Chomont, N				Trono, Didier; Van Lint, Carine; Rouzioux, Christine; Verdin, Eric; Barre-Sinoussi, Francoise; Chun, Tae-Wook; Chomont, Nicolas			HIV Persistence and the Prospect of Long-Term Drug-Free Remissions for HIV-Infected Individuals	SCIENCE			English	Review							CD4(+) T-CELLS; ACTIVE ANTIRETROVIRAL THERAPY; RALTEGRAVIR INTENSIFICATION; DISEASE PROGRESSION; CELLULAR RESERVOIRS; ANTIVIRAL THERAPY; EXTENDED PERIODS; LATENT RESERVOIR; VIRUS-INFECTIONS; VALPROIC ACID	HIV infection can persist in spite of efficacious antiretroviral therapies. Although incomplete inhibition of viral replication may contribute to this phenomenon, this is largely due to the early establishment of a stable reservoir of latently infected cells. Thus, life-long antiviral therapy may be needed to control HIV. Such therapy is prone to drug resistance and cumulative side effects and is an unbearable financial burden for regions of the world hit hardest by the epidemic. This review discusses our current understanding of HIV persistence and the limitations of potential approaches to eradicate the virus and accordingly pleads for a joint multidisciplinary effort toward two highly related goals: the development of an HIV prophylactic vaccine and the achievement of long-term drug-free remissions in HIV-infected individuals.	[Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Trono, Didier] Ecole Polytech Fed Lausanne, Frontiers in Genet Program, CH-1015 Lausanne, Switzerland; [Van Lint, Carine] Univ Libre Bruxelles, IBMM, B-6041 Gosselies, Belgium; [Rouzioux, Christine] Univ Paris 05, CHU Necker, F-75743 Paris, France; [Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Barre-Sinoussi, Francoise] Inst Pasteur, Dept Virol, Unit Regulat Retroviral Infect, F-75015 Paris, France; [Chun, Tae-Wook] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Chomont, Nicolas] Vaccine & Gene Therapy Inst Florida, Port St Lucie, FL 34987 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite Libre de Bruxelles; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California San Francisco; The J David Gladstone Institutes; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Vaccine & Gene Therapy Institute of Florida	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	Didier.trono@epfl.ch	Chun, Tae-Wook/W-9187-2019; Chun, Tae-Wook/AAC-3101-2020; Barre-Sinoussi, Françoise/G-8355-2011; Verdin, Eric/AAB-7999-2019; Chomont, Nicolas/ABG-2545-2020	Chun, Tae-Wook/0000-0001-5153-7340; Chomont, Nicolas/0000-0001-9747-5018; Verdin, Eric/0000-0003-3703-3183	Swiss National Science Foundation; National Institutes of Health; Belgian National Fund for Scientific Research; Programme of Excellence "Cibles" of the Walloon Region; Agence Nationale de Recherche sur le Syndrome d'Immuno-Deficience Acquis (SIDA); SIDACTION (Ensemble Contre le SIDA); AMfAR (the Foundation for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000851] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Programme of Excellence "Cibles" of the Walloon Region; Agence Nationale de Recherche sur le Syndrome d'Immuno-Deficience Acquis (SIDA)(French National Research Agency (ANR)); SIDACTION (Ensemble Contre le SIDA); AMfAR (the Foundation for AIDS Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Marie-Capucine Penicaud, from the International AIDS Society, for coordinating the launching of this review, and the Swiss National Science Foundation, the National Institutes of Health, the Belgian National Fund for Scientific Research, the Programme of Excellence "Cibles" of the Walloon Region, the Agence Nationale de Recherche sur le Syndrome d'Immuno-Deficience Acquis (SIDA), SIDACTION (Ensemble Contre le SIDA), AMfAR (the Foundation for AIDS Research), and other agencies and foundations supporting work in our laboratories.	Appay V, 2002, NAT MED, V8, P379, DOI 10.1038/nm0402-379; Archin NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009390; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carter CC, 2010, NAT MED, V16, P446, DOI 10.1038/nm.2109; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Chomont N, 2009, NAT MED, V15, P893, DOI 10.1038/nm.1972; Chun TW, 2008, J INFECT DIS, V197, P714, DOI 10.1086/527324; Chun TW, 2007, J INFECT DIS, V195, P1762, DOI 10.1086/518250; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 2001, P NATL ACAD SCI USA, V98, P253, DOI 10.1073/pnas.98.1.253; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Colin L, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-111; Connick E, 2001, J INFECT DIS, V184, P1465, DOI 10.1086/324488; Contreras X, 2007, PLOS PATHOG, V3, P1459, DOI 10.1371/journal.ppat.0030146; Corbeau P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000162; Dalmasso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003907; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Efstathiou S, 2005, VIRUS RES, V111, P108, DOI 10.1016/j.virusres.2005.04.017; Este JA, 2010, ANTIVIR RES, V85, P25, DOI 10.1016/j.antiviral.2009.10.007; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Geeraert L, 2008, ANNU REV MED, V59, P487, DOI 10.1146/annurev.med.59.062806.123001; Guidotti LG, 2006, ANNU REV PATHOL-MECH, V1, P23, DOI 10.1146/annurev.pathol.1.110304.100230; Gulick RM, 2007, AIDS, V21, P813, DOI 10.1097/QAD.0b013e32805e8753; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hocqueloux L, 2010, AIDS, V24, P1598, DOI 10.1097/QAD.0b013e32833b61ba; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Kalams SA, 1999, J VIROL, V73, P6721, DOI 10.1128/JVI.73.8.6721-6728.1999; Kauder SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000495; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; LACKNER AA, 1965, GASTROENTEROLOGY, V136, P2009; Ladell K, 2008, J IMMUNOL, V180, P7907, DOI 10.4049/jimmunol.180.12.7907; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; Lori F, 2000, SCIENCE, V290, P1591, DOI 10.1126/science.290.5496.1591; Marban C, 2007, EMBO J, V26, P412, DOI 10.1038/sj.emboj.7601516; McMahon D, 2010, CLIN INFECT DIS, V50, P912, DOI 10.1086/650749; McMichael AJ, 2006, ANNU REV IMMUNOL, V24, P227, DOI 10.1146/annurev.immunol.24.021605.090605; Mellors JW, 1996, SCIENCE, V272, P1167, DOI 10.1126/science.272.5265.1167; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; O'Connell KA, 2009, TRENDS PHARMACOL SCI, V30, P631, DOI 10.1016/j.tips.2009.09.005; PAIARDINI M, 2010, 17 C RETR OPP INF SA; PANTALEO G, 1990, P NATL ACAD SCI USA, V87, P4818, DOI 10.1073/pnas.87.12.4818; PANTALEO G, 1990, J IMMUNOL, V144, P1696; Perelson AS, 1997, NATURE, V387, P188, DOI 10.1038/387188a0; Pereyra F, 2008, J INFECT DIS, V197, P563, DOI 10.1086/526786; Pitcher CJ, 1999, NAT MED, V5, P518, DOI 10.1038/8400; Reuse S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006093; Riou C, 2007, J EXP MED, V204, P79, DOI 10.1084/jem.20061681; Rong LB, 2009, J THEOR BIOL, V260, P308, DOI 10.1016/j.jtbi.2009.06.011; Rosenberg ES, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010555; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Siliciano JD, 2007, J INFECT DIS, V195, P833, DOI 10.1086/511823; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; van Grevenynghe J, 2008, NAT MED, V14, P266, DOI 10.1038/nm1728; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VANNOESEL CJM, 1990, J CLIN INVEST, V86, P293, DOI 10.1172/JCI114698; Verhoeven D, 2008, J VIROL, V82, P4016, DOI 10.1128/JVI.02164-07; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wang FX, 2005, J CLIN INVEST, V115, P128, DOI 10.1172/JCI200522574; Younes SA, 2003, J EXP MED, V198, P1909, DOI 10.1084/jem.20031598; Younes SA, 2007, J IMMUNOL, V178, P788, DOI 10.4049/jimmunol.178.2.788; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565; Zhou Y, 2005, J VIROL, V79, P2199, DOI 10.1128/JVI.79.4.2199-2210.2005	74	229	233	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					174	180		10.1126/science.1191047	http://dx.doi.org/10.1126/science.1191047			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616270				2022-12-28	WOS:000279635200037
J	Grashoff, C; Hoffman, BD; Brenner, MD; Zhou, RB; Parsons, M; Yang, MT; McLean, MA; Sligar, SG; Chen, CS; Ha, T; Schwartz, MA				Grashoff, Carsten; Hoffman, Brenton D.; Brenner, Michael D.; Zhou, Ruobo; Parsons, Maddy; Yang, Michael T.; McLean, Mark A.; Sligar, Stephen G.; Chen, Christopher S.; Ha, Taekjip; Schwartz, Martin A.			Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics	NATURE			English	Article							CELL-MATRIX ADHESIONS; FORCE; ACTIN; TALIN; MECHANOSENSORS; COMPLEX; SWITCH	Mechanical forces are central to developmental, physiological and pathological processes(1). However, limited understanding of force transmission within sub-cellular structures is a major obstacle to unravelling molecular mechanisms. Here we describe the development of a calibrated biosensor that measures forces across specific proteins in cells with piconewton (pN) sensitivity, as demonstrated by single molecule fluorescence force spectroscopy(2). The method is applied to vinculin, a protein that connects integrins to actin filaments and whose recruitment to focal adhesions (FAs) is force-dependent(3). We show that tension across vinculin in stable FAs is similar to 2.5 pN and that vinculin recruitment to FAs and force transmission across vinculin are regulated separately. Highest tension across vinculin is associated with adhesion assembly and enlargement. Conversely, vinculin is under low force in disassembling or sliding FAs at the trailing edge of migrating cells. Furthermore, vinculin is required for stabilizing adhesions under force. Together, these data reveal that FA stabilization under force requires both vinculin recruitment and force transmission, and that, surprisingly, these processes can be controlled independently.	[Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Grashoff, Carsten; Hoffman, Brenton D.; Schwartz, Martin A.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Ctr Phys Living Cells, Urbana, IL 61801 USA; [Brenner, Michael D.; Zhou, Ruobo; Ha, Taekjip] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Brenner, Michael D.; Ha, Taekjip] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Yang, Michael T.; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [McLean, Mark A.; Sligar, Stephen G.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA; [Ha, Taekjip] Howard Hughes Med Inst, Urbana, IL 61801 USA; [Schwartz, Martin A.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia; University of Virginia; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of London; King's College London; University of Pennsylvania; University of Illinois System; University of Illinois Urbana-Champaign; Howard Hughes Medical Institute; University of Virginia	Schwartz, MA (corresponding author), Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA 22908 USA.	tjha@illinois.edu; maschwartz@virginia.edu	Parsons, Maddy/B-2203-2013; Chen, Christopher S./ABD-8499-2021; Ha, Taekjip/B-9506-2009	Parsons, Maddy/0000-0002-2021-8379; Chen, Christopher S./0000-0003-2445-8449; Ha, Taekjip/0000-0003-2195-6258; Zhou, Ruobo/0000-0001-8628-0282; schwartz, martin/0000-0002-2071-1243; McLean, Mark/0000-0001-9125-293X	USPHS [U54 GM64346, 5T32-HL007284, R21 RR025341]; Deutsche Forschungsgemeinschaft (DFG) [GR3399/1-1]; AHA; US National Science Foundation Physics Frontier Center [0822613]; Royal Society; National Science Foundation [DGE-0221664]; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR025341] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007284] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346, R01GM033775] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); AHA(American Heart Association); US National Science Foundation Physics Frontier Center; Royal Society(Royal Society of London); National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R. Horwitz, M. Vicente-Manzanares, D. Schafer, L.K. Tamm and K.A. DeMali for reagents and M. Gardel for critical reading of the manuscript. This work was supported by USPHS grant U54 GM64346 to M.A.S., C.G. was supported by a Research Fellowship from the Deutsche Forschungsgemeinschaft (DFG, GR3399/1-1). B.D.H. was supported by USPHS training grant 5T32-HL007284 and an AHA Postdoctoral Fellowship. M.D.B., R.Z. and T.H. were supported by the US National Science Foundation Physics Frontier Center grant 0822613 and by USPHS grant R21 RR025341. T.H. is an investigator with the Howard Hughes Medical Institute. M.P. was supported by a Royal Society University Research Fellowship (UK). M.T.Y. was supported by an IGERT fellowship from the National Science Foundation (DGE-0221664).	Alenghat FJ, 2000, BIOCHEM BIOPH RES CO, V277, P93, DOI 10.1006/bbrc.2000.3636; Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Ballestrem C, 2001, J CELL BIOL, V155, P1319, DOI 10.1083/jcb.200107107; Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen H, 2005, J CELL BIOL, V169, P459, DOI 10.1083/jcb.200410100; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Crocker JC, 2007, METHOD CELL BIOL, V83, P141, DOI 10.1016/S0091-679X(07)83007-X; Day RN, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2939094; Galbraith CG, 2002, J CELL BIOL, V159, P695, DOI 10.1083/jcb.200204153; Hohng S, 2007, SCIENCE, V318, P279, DOI 10.1126/science.1146113; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ji L, 2008, NAT CELL BIOL, V10, P1393, DOI 10.1038/ncb1797; Kolega J, 2003, MOL BIOL CELL, V14, P4745, DOI 10.1091/mbc.E03-04-0205; Meng F, 2008, FEBS J, V275, P3072, DOI 10.1111/j.1742-4658.2008.06461.x; Mierke CT, 2008, BIOPHYS J, V94, P661, DOI 10.1529/biophysj.107.108472; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Parsons M, 2008, J CELL SCI, V121, P265, DOI 10.1242/jcs.018440; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Pertz O, 2006, NATURE, V440, P1069, DOI 10.1038/nature04665; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Shemesh T, 2005, P NATL ACAD SCI USA, V102, P12383, DOI 10.1073/pnas.0500254102; Tan JL, 2003, P NATL ACAD SCI USA, V100, P1484, DOI 10.1073/pnas.0235407100; Xu WM, 1998, DEVELOPMENT, V125, P327; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zamir E, 1999, J CELL SCI, V112, P1655; Ziegler WH, 2008, BIOCHEM SOC T, V36, P235, DOI 10.1042/BST0360235	30	985	1002	10	372	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					263	U143		10.1038/nature09198	http://dx.doi.org/10.1038/nature09198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613844	Green Accepted			2022-12-28	WOS:000279580800042
J	Custers, R; Aarts, H				Custers, Ruud; Aarts, Henk			The Unconscious Will: How the Pursuit of Goals Operates Outside of Conscious Awareness	SCIENCE			English	Review							AUTOMATICITY; ACTIVATION; MECHANISMS; ATTENTION; FRAMEWORK; BEHAVIOR	People often act in order to realize desired outcomes, or goals. Although behavioral science recognizes that people can skillfully pursue goals without consciously attending to their behavior once these goals are set, conscious will is considered to be the starting point of goal pursuit. Indeed, when we decide to work hard on a task, it feels as if that conscious decision is the first and foremost cause of our behavior. That is, we are likely to say, if asked, that the decision to act produced the actions themselves. Recent discoveries, however, challenge this causal status of conscious will. They demonstrate that under some conditions, actions are initiated even though we are unconscious of the goals to be attained or their motivating effect on our behavior. Here we analyze how goal pursuit can possibly operate unconsciously.	[Custers, Ruud; Aarts, Henk] Univ Utrecht, Dept Psychol, NL-3584 CS Utrecht, Netherlands	Utrecht University	Custers, R (corresponding author), Univ Utrecht, Dept Psychol, Heidelberglaan 1, NL-3584 CS Utrecht, Netherlands.	r.custers@uu.nl; h.aarts@uu.nl	Custers, Ruud/G-4851-2013	Custers, Ruud/0000-0002-4431-738X	Netherlands Organization for Scientific Research [451-06-014, 453-06-002]	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO))	We thank M. Brass, D. T. Gilbert, T. M. Kenter, W. Stroebe, K. Van den Bos, the Goallab group (www.goallab.nl), and three anonymous reviewers for comments. This work was financially supported by the Netherlands Organization for Scientific Research (VENI grant 451-06-014 and VICI grant 453-06-002).	Aarts H, 2000, J PERS SOC PSYCHOL, V78, P53, DOI 10.1037/0022-3514.78.1.53; Aarts H, 2005, SOC COGNITION, V23, P465, DOI 10.1521/soco.2005.23.6.465; Aarts H, 2003, J PERS SOC PSYCHOL, V84, P18, DOI 10.1037/0022-3514.84.1.18; Aarts H, 2008, SCIENCE, V319, P1639, DOI 10.1126/science.1150432; Aarts H, 2009, J PERS SOC PSYCHOL, V96, P967, DOI 10.1037/a0015000; Abrams RL, 2000, PSYCHOL SCI, V11, P118, DOI 10.1111/1467-9280.00226; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Austin JT, 1996, PSYCHOL BULL, V120, P338, DOI 10.1037/0033-2909.120.3.338; Bargh JA, 2006, EUR J SOC PSYCHOL, V36, P147, DOI 10.1002/ejsp.336; Bargh JA, 2001, J PERS SOC PSYCHOL, V81, P1014, DOI 10.1037//0022-3514.81.6.1014; Bargh JA, 2000, PSYCHOL BULL, V126, P925, DOI 10.1037//0033-2909.126.6.925; Bijleveld E, 2010, COGNITION, V115, P330, DOI 10.1016/j.cognition.2009.12.012; Bijleveld E, 2009, PSYCHOL SCI, V20, P1313, DOI 10.1111/j.1467-9280.2009.02443.x; Chen M, 1997, J EXP SOC PSYCHOL, V33, P541, DOI 10.1006/jesp.1997.1329; Custers R, 2005, J PERS SOC PSYCHOL, V89, P129, DOI 10.1037/0022-3514.89.2.129; Custers R, 2008, EUR J SOC PSYCHOL, V38, P1013, DOI 10.1002/ejsp.484; Custers R, 2007, PERS SOC PSYCHOL B, V33, P623, DOI 10.1177/0146167206297404; Custers R, 2007, J EXP SOC PSYCHOL, V43, P312, DOI 10.1016/j.jesp.2006.02.005; Deci E. L., 1985, INTRINSIC MOTIVATION; Dijksterhuis A, 2010, ANNU REV PSYCHOL, V61, P467, DOI 10.1146/annurev.psych.093008.100445; Ferguson MJ, 2007, J PERS SOC PSYCHOL, V92, P596, DOI 10.1037/0022-3514.92.4.596; Fitzsimons GM, 2003, J PERS SOC PSYCHOL, V84, P148, DOI 10.1037/0022-3514.84.1.148; Fourneret P, 1998, NEUROPSYCHOLOGIA, V36, P1133, DOI 10.1016/S0028-3932(98)00006-2; Frith CD, 2000, PHILOS T R SOC B, V355, P1771, DOI 10.1098/rstb.2000.0734; Gollwitzer P.M., 1993, EUR REV SOC PSYCHOL, V4, DOI [10.1080/14792779343000059, DOI 10.1080/14792779343000059]; Goodale MA, 2003, PROG BRAIN RES, V144, P131, DOI 10.1016/S0079-6123(03)14400-9; Gray HM, 2007, SCIENCE, V315, P619, DOI 10.1126/science.1134475; Hart W, 2009, J PERS SOC PSYCHOL, V97, P1129, DOI 10.1037/a0017146; Hassin R.R., 2005, NEW UNCONSCIOUS, P196, DOI [10.1093/acprof:oso/9780195307696.003.0009, DOI 10.1093/ACPROF:OSO/9780195307696.003.0009]; Hassin RR, 2009, SOC COGNITION, V27, P20, DOI 10.1521/soco.2009.27.1.20; Holland RW, 2005, PSYCHOL SCI, V16, P689, DOI 10.1111/j.1467-9280.2005.01597.x; Hommel B, 2001, BEHAV BRAIN SCI, V24, P849, DOI 10.1017/S0140525X01000103; James W., 1890, PRINCIPLES PSYCHOL, P449, DOI [https://doi.org/10.1037/11059-009, DOI 10.1037/11059-009]; Jaynes J., 1976, ORIGIN CONSCIOUSNESS; Kay AC, 2004, ORGAN BEHAV HUM DEC, V95, P83, DOI 10.1016/j.obhdp.2004.06.003; Koch C, 2007, TRENDS COGN SCI, V11, P16, DOI 10.1016/j.tics.2006.10.012; Lau HC, 2007, J NEUROSCI, V27, P5805, DOI 10.1523/JNEUROSCI.4335-06.2007; LIBET B, 1983, BRAIN, V106, P623, DOI 10.1093/brain/106.3.623; Miller NE., 1941, SOCIAL LEARNING IMIT; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Monsell S., 2000, CONTROL COGNITIVE PR; Naccache L, 2001, COGNITION, V80, P215, DOI 10.1016/S0010-0277(00)00139-6; Pessiglione M, 2007, SCIENCE, V316, P904, DOI 10.1126/science.1140459; POWERS WT, 1973, SCIENCE, V179, P351, DOI 10.1126/science.179.4071.351; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Schlaghecken F, 2004, PSYCHON B REV, V11, P463, DOI 10.3758/BF03196596; Schultz W, 2006, ANNU REV PSYCHOL, V57, P87, DOI 10.1146/annurev.psych.56.091103.070229; Sheeran P, 2005, BRIT J SOC PSYCHOL, V44, P47, DOI 10.1348/014466604X23446; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Strahan EJ, 2002, J EXP SOC PSYCHOL, V38, P556, DOI 10.1016/S0022-1031(02)00502-4; Veltkamp M, 2009, EUR REV SOC PSYCHOL, V20, P345, DOI 10.1080/10463280903388665; Wegner DM, 2002, BRADFORD BOOKS, P1	52	341	353	2	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					47	50		10.1126/science.1188595	http://dx.doi.org/10.1126/science.1188595			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	619BL	20595607				2022-12-28	WOS:000279402700026
J	Yi, X; Liang, Y; Huerta-Sanchez, E; Jin, X; Cuo, ZXP; Pool, JE; Xu, X; Jiang, H; Vinckenbosch, N; Korneliussen, TS; Zheng, HC; Liu, T; He, WM; Li, K; Luo, RB; Nie, XF; Wu, HL; Zhao, MR; Cao, HZ; Zou, J; Shan, Y; Li, SZ; Yang, Q; Asan; Ni, PX; Tian, G; Xu, JM; Liu, XA; Jiang, T; Wu, RH; Zhou, GY; Tang, MF; Qin, JJ; Wang, T; Feng, SJ; Li, GH; Huasang; Luosang, JB; Wang, W; Chen, F; Wang, YD; Zheng, XG; Li, Z; Bianba, ZM; Yang, G; Wang, XP; Tang, SH; Gao, GY; Chen, Y; Luo, Z; Gusang, L; Cao, Z; Zhang, QH; Ouyang, WH; Ren, XL; Liang, HQ; Zheng, HS; Huang, YB; Li, JX; Bolund, L; Kristiansen, K; Li, YR; Zhang, Y; Zhang, XQ; Li, RQ; Li, SG; Yang, HM; Nielsen, R; Wang, J; Wang, JA				Yi, Xin; Liang, Yu; Huerta-Sanchez, Emilia; Jin, Xin; Cuo, Zha Xi Ping; Pool, John E.; Xu, Xun; Jiang, Hui; Vinckenbosch, Nicolas; Korneliussen, Thorfinn Sand; Zheng, Hancheng; Liu, Tao; He, Weiming; Li, Kui; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Bianba, Zhuoma; Yang, Ge; Wang, Xinping; Tang, Shuhui; Gao, Guoyi; Chen, Yong; Luo, Zhen; Gusang, Lamu; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian			Sequencing of 50 Human Exomes Reveals Adaptation to High Altitude	SCIENCE			English	Article							HEMOGLOBIN LEVELS; POINT MUTATIONS; GENE; TIBETAN; ASSOCIATION; HIF-1-ALPHA; SELECTION; LHASA; LOCI	Residents of the Tibetan Plateau show heritable adaptations to extreme altitude. We sequenced 50 exomes of ethnic Tibetans, encompassing coding sequences of 92% of human genes, with an average coverage of 18x per individual. Genes showing population-specific allele frequency changes, which represent strong candidates for altitude adaptation, were identified. The strongest signal of natural selection came from endothelial Per-Arnt-Sim (PAS) domain protein 1 (EPAS1), a transcription factor involved in response to hypoxia. One single-nucleotide polymorphism (SNP) at EPAS1 shows a 78% frequency difference between Tibetan and Han samples, representing the fastest allele frequency change observed at any human gene to date. This SNP's association with erythrocyte abundance supports the role of EPAS1 in adaptation to hypoxia. Thus, a population genomic survey has revealed a functionally important locus in genetic adaptation to high altitude.	[Yi, Xin; Liang, Yu; Jin, Xin; Xu, Xun; Jiang, Hui; Zheng, Hancheng; Liu, Tao; He, Weiming; Luo, Ruibang; Nie, Xifang; Wu, Honglong; Zhao, Meiru; Cao, Hongzhi; Zou, Jing; Shan, Ying; Li, Shuzheng; Yang, Qi; Asan; Ni, Peixiang; Tian, Geng; Xu, Junming; Liu, Xiao; Jiang, Tao; Wu, Renhua; Zhou, Guangyu; Tang, Meifang; Qin, Junjie; Wang, Tong; Feng, Shuijian; Li, Guohong; Huasang; Luosang, Jiangbai; Wang, Wei; Chen, Fang; Wang, Yading; Zheng, Xiaoguang; Li, Zhuo; Cao, Zheng; Zhang, Qinghui; Ouyang, Weihan; Ren, Xiaoli; Liang, Huiqing; Zheng, Huisong; Huang, Yebo; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Li, Yingrui; Zhang, Yong; Zhang, Xiuqing; Li, Ruiqiang; Li, Songgang; Yang, Huanming; Nielsen, Rasmus; Wang, Jun; Wang, Jian] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Yi, Xin; Liang, Yu; Cuo, Zha Xi Ping; Li, Kui; Tian, Geng; Zheng, Xiaoguang] Chinese Acad Sci, Grad Univ, Beijing 100062, Peoples R China; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94820 USA; [Huerta-Sanchez, Emilia; Pool, John E.; Vinckenbosch, Nicolas; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94820 USA; [Jin, Xin; Zheng, Hancheng; Luo, Ruibang; Shan, Ying] S China Univ Technol, Innovat Program Undergrad Students, Sch Biosci & Biotechnol, Guangzhou 510641, Guangdong, Peoples R China; [Cuo, Zha Xi Ping; Li, Kui; Chen, Yong; Luo, Zhen; Gusang, Lamu] Peoples Hosp Tibet Autonomous Reg, Lhasa 850000, Peoples R China; [Pool, John E.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Korneliussen, Thorfinn Sand; Kristiansen, Karsten; Li, Ruiqiang; Nielsen, Rasmus; Wang, Jun] Univ Copenhagen, Dept Biol, DK-1165 Copenhagen, Denmark; [He, Weiming] S China Univ Technol, Sch Sci, Innovat Program Undergrad Students, Guangzhou 510641, Guangdong, Peoples R China; [Wu, Honglong; Cao, Hongzhi; Jiang, Tao] Shenzhen Univ, Genome Res Inst, Sch Med, Shenzhen 518060, Peoples R China; [Bianba, Zhuoma; Yang, Ge] Peoples Hosp Lhasa, Lhasa 850000, Peoples R China; [Wang, Xinping; Tang, Shuhui] Mil Gen Hosp Tibet, Lhasa 850007, Peoples R China; [Gao, Guoyi] Hosp XiShuangBanNa Dai Nationalities, Autonomous Jinghong 666100, Yunnan, Peoples R China	Beijing Genomics Institute (BGI); Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Berkeley; University of California System; University of California Berkeley; South China University of Technology; University of California System; University of California Davis; University of Copenhagen; South China University of Technology; Shenzhen University	Nielsen, R (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	rasmus_nielsen@berkeley.edu; wangj@genomics.org; wangjian@genomics.org.cn	wang, jian/GVS-0711-2022; Korneliussen, Thorfinn Sand/ABB-7656-2021; Kristiansen, Karsten/J-5148-2014; Liu, Xiao/P-2732-2015; Xu, Xun/AAI-6763-2020; Li, Yingrui/K-1064-2015; Jin, Xin/ABF-1329-2020; Korneliussen, Thorfinn Sand/F-6421-2014; Nielsen, Rasmus/D-4405-2009; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Kristiansen, Karsten/0000-0002-6024-0917; Liu, Xiao/0000-0002-8073-0534; Xu, Xun/0000-0002-5338-5173; Jin, Xin/0000-0001-7554-4975; Korneliussen, Thorfinn Sand/0000-0001-7576-5380; Nielsen, Rasmus/0000-0003-0513-6591; Shan, Ying/0000-0003-3253-3197; Luo, Ruibang/0000-0001-9711-6533; Wang, Jun/0000-0002-8540-8931; Pool, John/0000-0003-2968-9545; Wang, Jun/0000-0002-2113-5874	National Natural Science Foundation of China [30890032, 30725008]; Ministry of Science and Technology of China [2006AA02A302, 2009AA022707, 2006CB504103]; Shenzhen Municipal Government of China [JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, ZYC200903240080A]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; Lundbeck Foundation; Swiss National Science Foundation [PBLAP3-124318]; U.S. NIH [R01MHG084695, R01HG003229]; U.S. NSF [DBI-0906065]; Chinese Academy of Sciences [KSCX2-YW-R-76]; Tibet Autonomous Region [2007-2-18]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084695] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Lundbeck Foundation(Lundbeckfonden); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. NSF(National Science Foundation (NSF)); Chinese Academy of Sciences(Chinese Academy of Sciences); Tibet Autonomous Region; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was funded by the National Natural Science Foundation of China (grants 30890032 and 30725008), the Ministry of Science and Technology of China (863 program, grants 2006AA02A302 and 2009AA022707; 973 program, grant 2006CB504103), the Shenzhen Municipal Government of China (grants JC200903190772A, CXB200903110066A, ZYC200903240077A, ZYC200903240076A, and ZYC200903240080A), the Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), the Danish Strategic Research Council grant (2106-07-0021), the Lundbeck Foundation, the Swiss National Science Foundation (PBLAP3-124318), the U.S. NIH R01MHG084695 and R01HG003229), the U.S. NSF (DBI-0906065), the Chinese Academy of Sciences (KSCX2-YW-R-76), and the Science and Technology Plan of the Tibet Autonomous Region (no. 2007-2-18). We are also indebted to many additional faculty and staff of BGI-Shenzhen who contributed to this teamwork and to X. Wang (South China University of Technology). The data have NCBI Short Read Archive accession no. SRA012603.	Acampora D, 1996, NAT GENET, V14, P218, DOI 10.1038/ng1096-218; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Bigham Abigail W., 2009, Human Genomics, V4, P79; Choudhury K, 2007, AM J HUM GENET, V80, P664, DOI 10.1086/513475; Gaetani M, 2008, BLOOD, V111, P5712, DOI 10.1182/blood-2007-11-122457; Gutenkunst RN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000695; Henderson J, 2005, HUM GENET, V118, P416, DOI 10.1007/s00439-005-0066-0; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Itan Y, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000491; Jain S, 1998, MECH DEVELOP, V73, P117, DOI 10.1016/S0925-4773(98)00038-0; KANNO H, 1992, BLOOD, V79, P1347, DOI 10.1182/blood.V79.5.1347.bloodjournal7951347; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; NIERMEYER S, 1995, NEW ENGL J MED, V333, P1248, DOI 10.1056/NEJM199511093331903; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Rottgardt I, 2010, ANTHROPOL SCI, V118, P41, DOI 10.1537/ase.090402; Shriver Mark D, 2004, Hum Genomics, V1, P274; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; To KKW, 2005, J BIOL CHEM, V280, P38102, DOI 10.1074/jbc.M504342200; Wu TY, 2005, J APPL PHYSIOL, V98, P598, DOI 10.1152/japplphysiol.01034.2002; Zhang XL, 2005, BLOOD, V106, P75, DOI 10.1182/blood-2004-08-3033; Zhuang JG, 1996, RESP PHYSIOL, V103, P75, DOI 10.1016/0034-5687(95)00041-0	25	979	1059	12	506	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 2	2010	329	5987					75	78		10.1126/science.1190371	http://dx.doi.org/10.1126/science.1190371			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595611	Green Accepted			2022-12-28	WOS:000279402700035
J	Smith-Bindman, R				Smith-Bindman, Rebecca			Is Computed Tomography Safe?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Smith-Bindman, Rebecca] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Smith-Bindman, R (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.							Board of Radiation Effects Research Division on Earth and Life Sciences National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Eisenberg RL, 2010, RADIOLOGY, V255, P218, DOI 10.1148/radiol.09091556; Giovagnoni A, 2007, EUR RADIOL, V17, pB18, DOI 10.1007/s10406-007-0209-6; *MED PAYM ADV COMM, 2009, HEALTHC SPEND MED PR; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427	5	220	224	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					1	4		10.1056/NEJMp1002530	http://dx.doi.org/10.1056/NEJMp1002530			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20573919				2022-12-28	WOS:000279343000001
J	Helliwell, PS; Crawshaw, DP; Hensor, EMA; Hay, EM; Aldous, SJ; Conaghan, PG				Helliwell, Philip S.; Crawshaw, Dickon P.; Hensor, Elizabeth M. A.; Hay, Elaine M.; Aldous, Simon J.; Conaghan, Philip G.			Exercise therapy after corticosteroid injection for moderate to severe shoulder pain: large pragmatic randomised trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MANUAL PHYSICAL-THERAPY; DOUBLE-BLIND; SUPERVISED EXERCISES; GENERAL-PRACTICE; ARTHROSCOPIC SURGERY; IMPINGEMENT SYNDROME; PRIMARY-CARE; PHYSIOTHERAPY; DISORDERS; SINGLE	Objective To compare the effectiveness of subacromial corticosteroid injection combined with timely exercise and manual therapy (injection plus exercise) or exercise and manual therapy alone (exercise only) in patients with subacromial impingement syndrome. Design Pragmatic randomised clinical trial. Setting Primary care based musculoskeletal service. Patients Adults aged 40 or over with subacromial impingement syndrome with moderate or severe shoulder pain. Interventions Injection plus exercise or exercise only. Main outcome measures Primary outcome was the difference in improvement in the total shoulder pain and disability index at 12 weeks. Results 232 participants were randomised (115 to injection plus exercise, 117 to exercise only). The mean age was 56 (range 40-78), 127 were women, and all had had a median of 16 weeks of shoulder pain (interquartile range 1228). At week 12 there was no significant difference between the groups in change in total pain and disability index (mean difference between change in groups 3.26 (95% confidence interval -0.81 to 7.34), P=0.116). Improvement was significantly greater in the injection plus exercise group at week 1 (6.56, 4.30 to 8.82) and week 6 (7.37, 4.34 to 10.39) for the total pain and disability index (P<0.001), with no differences at week 24 (-2.26, -6.77 to 2.25, P=0.324). Conclusions In the treatment of patients with subacromial impingement syndrome, injection plus exercise and exercise only are similarly effective at 12 weeks.	[Crawshaw, Dickon P.] Leeds Community Healthcare, Leeds Musculoskelet & Rehab Serv, Leeds LS7 4SA, W Yorkshire, England; [Helliwell, Philip S.; Crawshaw, Dickon P.; Conaghan, Philip G.] Univ Leeds, Leeds Inst Mol Med, Leeds LS7 4SA, W Yorkshire, England; [Hensor, Elizabeth M. A.; Conaghan, Philip G.] Chapel Allerton Hosp, Leeds Musculoskelet & Rehab Serv, NIHR Leeds Musculoskelet Biomed Res Unit, Leeds LS7 4SA, W Yorkshire, England; [Hay, Elaine M.] Keele Univ, Arthrit Res UK Natl Primary Care Res Ctr, Keele ST5 5BG, Staffs, England; [Aldous, Simon J.] Leeds Teaching Hosp NHS Trust, Physiother Dept, Leeds LS9 7TF, W Yorkshire, England	University of Leeds; Chapel Allerton Hospital; Keele University; University of Leeds	Conaghan, PG (corresponding author), Leeds Community Healthcare, Leeds Musculoskelet & Rehab Serv, Leeds LS7 4SA, W Yorkshire, England.	p.conaghan@leeds.ac.uk		Conaghan, Philip/0000-0002-3478-5665; Hensor, Elizabeth/0000-0002-5245-4755	Arthritis Research UK [17236]	Arthritis Research UK(Versus Arthritis)	The study was funded by a project grant 17236 from Arthritis Research UK.	ACPOM, 1999, CLIN GUID US INJ THE; ADEBAJO AO, 1990, J RHEUMATOL, V17, P1207; Arroll B, 2005, BRIT J GEN PRACT, V55, P224; Bamji AN, 2004, ANN RHEUM DIS, V63, P607; Bang MD, 2000, J ORTHOP SPORT PHYS, V30, P126, DOI 10.2519/jospt.2000.30.3.126; Blair B, 1996, J BONE JOINT SURG AM, V78A, P1685, DOI 10.2106/00004623-199611000-00007; Brox JI, 1999, J SHOULDER ELB SURG, V8, P102, DOI 10.1016/S1058-2746(99)90001-0; BROX JI, 1993, BMJ-BRIT MED J, V307, P899, DOI 10.1136/bmj.307.6909.899; Brox JI, 1997, ARCH PHYS MED REHAB, V78, P1260, DOI 10.1016/S0003-9993(97)90341-5; Calis M, 2000, ANN RHEUM DIS, V59, P44, DOI 10.1136/ard.59.1.44; Carette S, 2003, ARTHRITIS RHEUM, V48, P829, DOI 10.1002/art.10954; CHARD MD, 1991, ARTHRITIS RHEUM-US, V34, P766, DOI 10.1002/art.1780340619; Croft P, 1996, BRIT MED J, V313, P601; Ekeberg OM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3112; Engebretsen K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3360; Foster NE, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-3; Green S, 1998, BRIT MED J, V316, P354, DOI 10.1136/bmj.316.7128.354; Green S, 2003, Cochrane Database Syst Rev, pCD004258; Hay EM, 2003, ANN RHEUM DIS, V62, P394, DOI 10.1136/ard.62.5.394; Kuhn JE, 2009, J SHOULDER ELB SURG, V18, P138, DOI 10.1016/j.jse.2008.06.004; Kuijpers T, 2006, PAIN, V120, P276, DOI 10.1016/j.pain.2005.11.004; Linsell L, 2006, RHEUMATOLOGY, V45, P215, DOI 10.1093/rheumatology/kei139; MacDonald PB, 2000, J SHOULDER ELB SURG, V9, P299, DOI 10.1067/mse.2000.106918; McInerney JJ, 2003, EMERG MED J, V20, P218, DOI 10.1136/emj.20.3.218; Morrison DS, 1997, J BONE JOINT SURG AM, V79A, P732, DOI 10.2106/00004623-199705000-00013; Naredo E, RANDOMIZED COMP STUD; NEER CS, 1983, CLIN ORTHOP RELAT R, P70; Ostor AJK, 2005, RHEUMATOLOGY, V44, P800, DOI 10.1093/rheumatology/keh598; PETRI M, 1987, ARTHRITIS RHEUM-US, V30, P1040, DOI 10.1002/art.1780300911; Plafki C, 2000, INT ORTHOP, V24, P40, DOI 10.1007/s002640050010; Roach K E, 1991, Arthritis Care Res, V4, P143, DOI 10.1002/art.1790040403; Roland M, 1998, BRIT MED J, V316, P285, DOI 10.1136/bmj.316.7127.285; Sauers EL, 2005, J ATHL TRAINING, V40, P221; Saunders S, 1997, INJECTION TECHNIQUES; Senbursa G, 2007, KNEE SURG SPORT TR A, V15, P915, DOI 10.1007/s00167-007-0288-x; Tennant A, 2007, ARTHRIT RHEUM-ARTHR, V57, P1358, DOI 10.1002/art.23108; van der Windt DAWM, 1998, BRIT MED J, V317, P1292, DOI 10.1136/bmj.317.7168.1292; vanderWindt DAWM, 1996, BRIT J GEN PRACT, V46, P519; VANDERWINDT DAWM, 1995, ANN RHEUM DIS, V54, P959, DOI 10.1136/ard.54.12.959; VECCHIO PC, 1993, BRIT J RHEUMATOL, V32, P743; Watson J, 2008, RHEUMATOLOGY, V47, P1795, DOI 10.1093/rheumatology/ken360; WILLIAMS JW, 1995, J RHEUMATOL, V22, P727; Winters JC, 1997, BRIT MED J, V314, P1320, DOI 10.1136/bmj.314.7090.1320	43	55	58	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 28	2010	340								c3037	10.1136/bmj.c3037	http://dx.doi.org/10.1136/bmj.c3037			21	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	845JZ	20584793	Green Published, hybrid			2022-12-28	WOS:000296820300001
J	Kwon, OH; Zewail, AH				Kwon, Oh-Hoon; Zewail, Ahmed H.			4D Electron Tomography	SCIENCE			English	Article							CARBON NANOTUBES; YOUNGS MODULUS; MICROSCOPY; 3D; RECONSTRUCTION; IRRADIATION; MICROGRAPHS; SCIENCES; CELLS; BEAM	Electron tomography provides three-dimensional (3D) imaging of noncrystalline and crystalline equilibrium structures, as well as elemental volume composition, of materials and biological specimens, including those of viruses and cells. We report the development of 4D electron tomography by integrating the fourth dimension (time resolution) with the 3D spatial resolution obtained from a complete tilt series of 2D projections of an object. The different time frames of tomograms constitute a movie of the object in motion, thus enabling studies of nonequilibrium structures and transient processes. The method was demonstrated using carbon nanotubes of a bracelet-like ring structure for which 4D tomograms display different modes of motion, such as breathing and wiggling, with resonance frequencies up to 30 megahertz. Applications can now make use of the full space-time range with the nanometer-femtosecond resolution of ultrafast electron tomography.	[Kwon, Oh-Hoon; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Kwon, Oh-Hoon/B-3324-2015	Kwon, Oh-Hoon/0000-0001-7114-8617; gaber, sarah/0000-0002-5995-7291	NSF [DMR-0964886]; Air Force Office of Scientific Research [FA9550-07-1-0484]; Gordon and Betty Moore Foundation at Caltech	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Gordon and Betty Moore Foundation at Caltech(Gordon and Betty Moore Foundation)	Supported by NSF (grant DMR-0964886) and Air Force Office of Scientific Research (grant FA9550-07-1-0484) in the Physical Biology Center for Ultrafast Science and Technology supported by Gordon and Betty Moore Foundation at Caltech. A patent application has been filed by Caltech based on the methodology presented	Banhart F, 2006, J MATER SCI, V41, P4505, DOI 10.1007/s10853-006-0081-0; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Cha JJ, 2007, NANO LETT, V7, P3770, DOI 10.1021/nl072251c; Colliex C, 2009, PHILOS T R SOC A, V367, P3845, DOI 10.1098/rsta.2009.0128; Crespi VH, 1996, PHYS REV B, V54, P5927, DOI 10.1103/PhysRevB.54.5927; CROWTHER RA, 1970, NATURE, V226, P421, DOI 10.1038/226421a0; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; Frank J., 2010, ELECT TOMOGRAPHY MET; Friedrich H, 2009, CHEM REV, V109, P1613, DOI 10.1021/cr800434t; Gass MH, 2006, NANO LETT, V6, P376, DOI [10.1021/nl052120g, 10.1021/nl521020g]; HART RG, 1968, SCIENCE, V159, P1464, DOI 10.1126/science.159.3822.1464; Hartland GV, 2006, ANNU REV PHYS CHEM, V57, P403, DOI 10.1146/annurev.physchem.57.032905.104533; HAWKES PW, 2006, SCI MICROSCOPY, V1; HOPPE W, 1968, NATURWISSENSCHAFTEN, V55, P333, DOI 10.1007/BF00600449; Jonic S, 2009, CURR OPIN PHARMACOL, V9, P636, DOI 10.1016/j.coph.2009.04.006; Kwon OH, 2008, NANO LETT, V8, P3557, DOI 10.1021/nl8029866; Li HY, 2009, SCIENCE, V326, P1244, DOI 10.1126/science.1178583; Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Meirovich L, 1986, ELEMENTS VIBRATION A; Messaoudil C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-288; Midgley PA, 2003, ULTRAMICROSCOPY, V96, P413, DOI 10.1016/S0304-3991(03)00105-0; Midgley PA, 2007, CHEM SOC REV, V36, P1477, DOI 10.1039/b701569k; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Nakamiya T, 2009, THIN SOLID FILMS, V517, P3854, DOI 10.1016/j.tsf.2009.01.097; Ni C, 2009, CARBON, V47, P2898, DOI 10.1016/j.carbon.2009.06.038; Poncharal P, 1999, SCIENCE, V283, P1513, DOI 10.1126/science.283.5407.1513; Sorzano COS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-124; Thomas JM, 2004, ANGEW CHEM INT EDIT, V43, P6745, DOI 10.1002/anie.200461453; Treacy MMJ, 1996, NATURE, V381, P678, DOI 10.1038/381678a0; Wei XL, 2008, ADV FUNCT MATER, V18, P1555, DOI 10.1002/adfm.200701105; Zewail A H, 2009, 4D ELECT MICROSCOPY; Zewail AH, 2010, SCIENCE, V328, P187, DOI 10.1126/science.1166135; Zheng QXS, 2004, J STRUCT BIOL, V147, P91, DOI 10.1016/j.jsb.2004.02.005	34	89	94	7	117	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1668	1673		10.1126/science.1190470	http://dx.doi.org/10.1126/science.1190470			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576886				2022-12-28	WOS:000279107400036
J	Todd, JA				Todd, John A.			D'oh! genes and environment cause crohn's Disease	CELL			English	Editorial Material							AUTOPHAGY; ATG16L1		Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Dept Med Genet,Wellcome Trust Diabet & Inflammat, Cambridge CB2 0XY, England	University of Cambridge	Todd, JA (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Juvenile Diabet Res Fdn, Dept Med Genet,Wellcome Trust Diabet & Inflammat, Cambridge CB2 0XY, England.	john.todd@cimr.cam.ac.uk	Todd, John/A-3542-2010	Todd, John/0000-0003-2740-8148	Wellcome Trust [061858] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Massey DCO, 2008, GUT, V57, P1294, DOI 10.1136/gut.2008.157297; McCartney SA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000108; Patel CJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010746; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Todd JA, 2010, IMMUNITY, V32, P457, DOI 10.1016/j.immuni.2010.04.001; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336	9	12	13	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1114	1116		10.1016/j.cell.2010.06.015	http://dx.doi.org/10.1016/j.cell.2010.06.015			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20602995	hybrid, Green Published			2022-12-28	WOS:000279148100009
J	Palmer, J; Pini, P				Palmer, Joanna; Pini, Pia			The Wakley Prize 2010	LANCET			English	Editorial Material									[Palmer, Joanna; Pini, Pia] The Lancet, London NW1 7BY, England		Palmer, J (corresponding author), The Lancet, London NW1 7BY, England.							Levine JA, 2009, LANCET, V374, P2126, DOI 10.1016/S0140-6736(09)61995-4	1	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2131	2131		10.1016/S0140-6736(10)60969-5	http://dx.doi.org/10.1016/S0140-6736(10)60969-5			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20609939				2022-12-28	WOS:000279255100009
J	Clarke, OB; Caputo, AT; Hill, AP; Vandenberg, JI; Smith, BJ; Gulbis, JM				Clarke, Oliver B.; Caputo, Alessandro T.; Hill, Adam P.; Vandenberg, Jamie I.; Smith, Brian J.; Gulbis, Jacqueline M.			Domain Reorientation and Rotation of an Intracellular Assembly Regulate Conduction in Kir Potassium Channels	CELL			English	Article							RECTIFIER K+ CHANNEL; CRYSTAL-STRUCTURE; MOLECULAR DETERMINANTS; INWARD RECTIFICATION; QUATERNARY AMMONIUM; SELECTIVITY FILTER; ION CONDUCTION; BINDING-SITES; GATING HINGES; C-TERMINUS	Potassium channels embedded in cell membranes employ gates to regulate K+ current. While a specific constriction in the permeation pathway has historically been implicated in gating, recent reports suggest that the signature ion selectivity filter located in the outer membrane leaflet may be equally important. Inwardly rectifying K+ channels also control the directionality of flow, using intracellular polyamines to stem ion efflux by a valve-like action. This study presents crystallographic evidence of interdependent gates in the conduction pathway and reveals the mechanism of polyamine block. Reorientation of the intracellular domains, concomitant with activation, instigates polyamine release from intracellular binding sites to block the permeation pathway. Conformational adjustments of the slide helices, achieved by rotation of the cytoplasmic assembly relative to the pore, are directly correlated to the ion configuration in the selectivity filter. Ion redistribution occurs irrespective of the constriction, suggesting a more expansive role of the selectivity filter in gating than previously appreciated.	[Clarke, Oliver B.; Caputo, Alessandro T.; Smith, Brian J.; Gulbis, Jacqueline M.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia; [Clarke, Oliver B.; Caputo, Alessandro T.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia; [Hill, Adam P.; Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW 2010, Australia	Walter & Eliza Hall Institute; University of Melbourne; Victor Chang Cardiac Research Institute	Gulbis, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic 3052, Australia.	jgulbis@wehi.edu.au	Caputo, Alessandro/AFM-4954-2022; Vandenberg, Jamie I/B-6608-2013; Smith, Brian J/F-8282-2011	Caputo, Alessandro/0000-0001-5007-6896; Vandenberg, Jamie I/0000-0002-3859-3716; Smith, Brian J/0000-0003-0498-1910	Australian National Health and Medical Research Council (NHMRC) [361646]; Victorian State Government; Wellcome Trust; Australian Research Council Centre of Excellence	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian State Government; Wellcome Trust(Wellcome TrustEuropean Commission); Australian Research Council Centre of Excellence(Australian Research Council)	We thank Janet Newman at the Bio21 C3 crystallization facility, Clemens Schulze-Briese, support staff at the Swiss Light Source, support staff at the Australian Synchrotron, Marc Kvansakul and Peter Czabotar for help with data collection, Peter Colman, Pauline Crewther, and James Blake for input on the manuscript, and Declan Doyle for the KirBac3.1 construct. We acknowledge assistance from the Australian Synchrotron Research Program for travel to the Swiss Light Source, the Australian National Health and Medical Research Council (NHMRC) for project funding, NHMRC Independent Research Institutes Infrastructure Support Scheme grant number 361646, and Victorian State Government Operational Infrastructure Support grants. J.M.G. thanks the Wellcome Trust for an International Senior Research Fellowship and the Australian Research Council Centre of Excellence in Coherent X-ray Science for travel assistance. O.B.C. is supported by an Australian Postgraduate Award.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; ARMSTRON.CM, 1969, J GEN PHYSIOL, V54, P553, DOI 10.1085/jgp.54.5.553; ARMSTRONG CM, 1971, J GEN PHYSIOL, V58, P413, DOI 10.1085/jgp.58.4.413; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; ASHCROFT FM, 1988, J PHYSIOL-LONDON, V400, P501, DOI 10.1113/jphysiol.1988.sp017134; Battle AR, 2009, FEBS LETT, V583, P407, DOI 10.1016/j.febslet.2008.12.033; BAUKROWITZ T, 1995, NEURON, V15, P951, DOI 10.1016/0896-6273(95)90185-X; Berneche S, 2001, NATURE, V414, P73, DOI 10.1038/35102067; Blunck R, 2006, J GEN PHYSIOL, V128, P569, DOI 10.1085/jgp.200609638; Cheng WWL, 2009, J GEN PHYSIOL, V133, P295, DOI 10.1085/jgp.200810125; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Decher N, 2007, CARDIOVASC RES, V75, P748, DOI 10.1016/j.cardiores.2007.05.010; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gao LZ, 2005, P NATL ACAD SCI USA, V102, P17630, DOI 10.1073/pnas.0505158102; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Hardman RM, 2007, J BIOL CHEM, V282, P31972, DOI 10.1074/jbc.M705835200; Hille B., 1992, IONIC CHANNELS EXCIT; HOSHI T, 1991, NEURON, V7, P547, DOI 10.1016/0896-6273(91)90367-9; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jones PA, 2001, FEBS LETT, V508, P85, DOI 10.1016/S0014-5793(01)03023-X; Kollewe A, 2009, J GEN PHYSIOL, V134, P53, DOI 10.1085/jgp.200910235; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Logothetis DE, 2007, PFLUG ARCH EUR J PHY, V455, P83, DOI 10.1007/s00424-007-0276-5; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Loussouarn G, 2005, MOL PHARMACOL, V68, P298, DOI 10.1124/mol.105.012377; Lu T, 2001, NAT NEUROSCI, V4, P239, DOI 10.1038/85080; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; MILLER C, 1987, BIOPHYS J, V52, P123, DOI 10.1016/S0006-3495(87)83196-X; Osawa M, 2009, J BIOL CHEM, V284, P26117, DOI 10.1074/jbc.M109.029355; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Shang L, 2008, EUR BIOPHYS J BIOPHY, V37, P165, DOI 10.1007/s00249-007-0206-7; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Sobolevsky AI, 2009, NATURE, V462, P745, DOI 10.1038/nature08624; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Thompson AN, 2009, NAT STRUCT MOL BIOL, V16, P1317, DOI 10.1038/nsmb.1703; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; Wilkens CM, 2006, J GEN PHYSIOL, V128, P347, DOI 10.1085/jgp.200609579; YELLEN G, 1991, SCIENCE, V251, P939, DOI 10.1126/science.2000494; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	119	120	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 11	2010	141	6					1018	1029		10.1016/j.cell.2010.05.003	http://dx.doi.org/10.1016/j.cell.2010.05.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	608XH	20564790	Bronze			2022-12-28	WOS:000278618800016
J	Misra, A; Joshi, S				Misra, Anoop; Joshi, Shashank			Longacting exenatide in diabetes: DURATION-3	LANCET			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; GLYCEMIC CONTROL; TREATED PATIENTS; OPEN-LABEL; TYPE-2; METFORMIN; EXENDIN-4; SULFONYLUREA		[Misra, Anoop] Fortis Hosp, New Delhi 110070, India; [Joshi, Shashank] Lilavati & Bhatia Hosp, Mumbai, Maharashtra, India		Misra, A (corresponding author), Fortis Hosp, New Delhi 110070, India.	anoopmisra@metabolicresearchindia.com						Bergenstal RM, 2008, CIRCULATION, V118, pS1086; Bergenstal RWC, 2009, AM DIAB ASS 2009 SCI; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Buse JB, 2007, CLIN THER, V29, P139, DOI 10.1016/j.clinthera.2007.01.015; Buse JB, 2010, DIABETES CARE, V33, P1255, DOI 10.2337/dc09-1914; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Knudsen LB, 2010, ENDOCRINOLOGY, V151, P1473, DOI 10.1210/en.2009-1272; Matveyenko AV, 2009, DIABETES, V58, P1604, DOI 10.2337/db09-0058; Nikolaidis LA, 2004, CIRCULATION, V109, P962, DOI 10.1161/01.CIR.0000120505.91348.58; Scheen AJ, 2008, LANCET, V372, P1197, DOI 10.1016/S0140-6736(08)61207-6; US Food and Drug Administration, 2009, BYETT EX REN FAIL; 2007, BYETTA EXENATIDE INJ	16	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2198	2199		10.1016/S0140-6736(10)60836-7	http://dx.doi.org/10.1016/S0140-6736(10)60836-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609957				2022-12-28	WOS:000279652900006
J	Gao, J; Wang, WY; Mao, YW; Graff, J; Guan, JS; Pan, L; Mak, G; Kim, D; Su, SC; Tsai, LH				Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei			A novel pathway regulates memory and plasticity via SIRT1 and miR-134	NATURE			English	Article							LONG-TERM-MEMORY; SYNAPTIC PLASTICITY; BDNF TRANSCRIPTION; NEURONAL-ACTIVITY; CIRCADIAN CONTROL; RECOGNITION; HIPPOCAMPUS; EXPRESSION; NEURODEGENERATION; INHIBITION	The NAD-dependent deacetylase Sir2 was initially identified as a mediator of replicative lifespan in budding yeast and was subsequently shown to modulate longevity in worms and flies(1,2). Its mammalian homologue, SIRT1, seems to have evolved complex systemic roles in cardiac function, DNA repair and genomic stability. Recent studies suggest a functional relevance of SIRT1 in normal brain physiology and neurological disorders. However, it is unknown if SIRT1 has a role in higher-order brain functions. We report that SIRT1 modulates synaptic plasticity and memory formation via a microRNA-mediated mechanism. Activation of SIRT1 enhances, whereas its loss-of-function impairs, synaptic plasticity. Surprisingly, these effects were mediated via post-transcriptional regulation of cAMP response binding protein (CREB) expression by a brain-specific microRNA, miR-134. SIRT1 normally functions to limit expression of miR-134 via a repressor complex containing the transcription factor YY1, and unchecked miR-134 expression following SIRT1 deficiency results in the downregulated expression of CREB and brain-derived neurotrophic factor (BDNF), thereby impairing synaptic plasticity. These findings demonstrate a new role for SIRT1 in cognition and a previously unknown microRNA-based mechanism by which SIRT1 regulates these processes. Furthermore, these results describe a separate branch of SIRT1 signalling, in which SIRT1 has a direct role in regulating normal brain function in a manner that is disparate from its cell survival functions, demonstrating its value as a potential therapeutic target for the treatment of central nervous system disorders.	[Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Graeff, Johannes; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Gao, Jun; Wang, Wen-Yuan; Mao, Ying-Wei; Guan, Ji-Song; Pan, Ling; Mak, Gloria; Kim, Dohoon; Su, Susan C.; Tsai, Li-Huei] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA; [Gao, Jun] Nanjing Univ, MOE Key Lab Model Anim Dis Study, Model Anim Res Ctr, Nanjing 210061, Peoples R China; [Graeff, Johannes; Tsai, Li-Huei] Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Nanjing University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Tsai, LH (corresponding author), MIT, Dept Brain & Cognit Sci, Picower Inst Learning & Memory, E25-618, Cambridge, MA 02139 USA.	lhtsai@mit.edu	Pan, Ling/K-9333-2013; wang, wenyuan/F-7218-2011	Pan, Ling/0000-0001-9947-9071; Guan, Ji-Song/0000-0001-5219-0289; Mao, Yingwei/0000-0001-7339-1565; Graff, Johannes/0000-0002-3219-3578; Gao, Jun/0000-0002-5925-537X	NIH [PO1 AG027916]; Simons Foundation; Swiss National Science Foundation; Howard Hughes Medical Institute; NATIONAL INSTITUTE ON AGING [P01AG027916] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank R. Jaenisch and M. Rios for providing BDNF knockout frozen brains, L. Guarente and D. Cohen for providing SIRT1 Delta and SIRT1 knockout mice, Y. Shi for providing the plasmids expressing YY1 and YY1 shRNA, A. Mungenast for manuscript editing, K. Singh and M. Dobbin for critical reading of the manuscript, M. Dobbin for help with Supplementary Fig. 5, X. Ge for help with model illustration, and N. Joseph for help with mouse colony maintenance. This work is partially supported by an NIH grant, PO1 AG027916, to L.-H.T.; W.-Y.W. is supported by a Postdoctoral Fellowship from the Simons Foundation; J.Gr. is supported by a Prospective Researchers Fellowship from the Swiss National Science Foundation; J.Gao is supported by the Howard Hughes Medical Institute. L.-H.T. is an investigator of the Howard Hughes Medical Institute.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Broadbent NJ, 2004, P NATL ACAD SCI USA, V101, P14515, DOI 10.1073/pnas.0406344101; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; Calhoun ME, 1996, J NEUROCYTOL, V25, P821, DOI 10.1007/BF02284844; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chiaruttini C, 2008, MOL CELL NEUROSCI, V37, P11, DOI 10.1016/j.mcn.2007.08.011; Cohen DE, 2009, GENE DEV, V23, P2812, DOI 10.1101/gad.1839209; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Fanselow MS, 2003, ANN NY ACAD SCI, V985, P125; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fiore R, 2008, BBA-GENE REGUL MECH, V1779, P471, DOI 10.1016/j.bbagrm.2007.12.006; Fischer A, 2005, NEURON, V48, P825, DOI 10.1016/j.neuron.2005.10.033; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; FRANK DA, 1994, CELL, V79, P5, DOI 10.1016/0092-8674(94)90394-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; KANG HJ, 1995, SCIENCE, V267, P1658, DOI 10.1126/science.7886457; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; SHI Y, 1997, BIOCHIM BIOPHYS ACTA, V1332, P49; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; TIMMUSK T, 1993, NEURON, V10, P475, DOI 10.1016/0896-6273(93)90335-O; van der Veer E, 2007, J BIOL CHEM, V282, P10841, DOI 10.1074/jbc.C700018200	30	713	754	6	148	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 26	2010	466	7310					1105	U120		10.1038/nature09271	http://dx.doi.org/10.1038/nature09271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	642IK	20622856	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000281203600040
J	Sigmund, K; De Silva, H; Traulsen, A; Hauert, C				Sigmund, Karl; De Silva, Hannelore; Traulsen, Arne; Hauert, Christoph			Social learning promotes institutions for governing the commons	NATURE			English	Article							PUBLIC-GOODS GAMES; ALTRUISTIC PUNISHMENT; COSTLY PUNISHMENT; COOPERATION; EVOLUTION; RECIPROCITY; ADVANTAGE; SOCIETIES; HUMANS	Theoretical and empirical research highlights the role of punishment in promoting collaborative efforts(1-5). However, both the emergence and the stability of costly punishment are problematic issues. It is not clear how punishers can invade a society of defectors by social learning or natural selection, or how second-order free-riders (who contribute to the joint effort but not to the sanctions) can be prevented from drifting into a coercion-based regime and subverting cooperation. Here we compare the prevailing model of peer-punishment(6-8) with pool-punishment, which consists in committing resources, before the collaborative effort, to prepare sanctions against free-riders. Pool-punishment facilitates the sanctioning of second-order free-riders, because these are exposed even if everyone contributes to the common good. In the absence of such second-order punishment, peer-punishers do better than pool-punishers; but with second-order punishment, the situation is reversed. Efficiency is traded for stability. Neither other-regarding tendencies or preferences for reciprocity and equity, nor group selection or prescriptions from higher authorities, are necessary for the emergence and stability of rudimentary forms of sanctioning institutions regulating common pool resources and enforcing collaborative efforts.	[Sigmund, Karl] Univ Vienna, Fac Math, A-1090 Vienna, Austria; [Sigmund, Karl] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [De Silva, Hannelore] WU Vienna Univ Econ & Business, A-1090 Vienna, Austria; [Traulsen, Arne] Max Planck Inst Evolutionary Biol, D-24306 Plon, Germany; [Hauert, Christoph] Univ British Columbia, Dept Math, Vancouver, BC V6T 1Z2, Canada	University of Vienna; International Institute for Applied Systems Analysis (IIASA); Vienna University of Economics & Business; Max Planck Society; University of British Columbia	Sigmund, K (corresponding author), Univ Vienna, Fac Math, Waehringer Guertel 18, A-1090 Vienna, Austria.	karl.sigmund@univie.ac.at	Traulsen, Arne/A-4955-2009; Hauert, Christoph/E-5369-2011	Traulsen, Arne/0000-0002-0669-5267; Hauert, Christoph/0000-0002-1239-281X				Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Ertan A, 2009, EUR ECON REV, V53, P495, DOI 10.1016/j.euroecorev.2008.09.007; Falk A, 2002, DRAMA COMMONS, P157; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2003, NATURE, V422, P137, DOI 10.1038/nature01474; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; FRANK SA, 1995, NATURE, V377, P520, DOI 10.1038/377520a0; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Gardner A, 2004, AM NAT, V164, P753, DOI 10.1086/425623; Gurerk O, 2006, SCIENCE, V312, P108, DOI 10.1126/science.1123633; Hauert C, 2002, SCIENCE, V296, P1129, DOI 10.1126/science.1070582; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kiyonari T, 2004, INT J PSYCHOL, V39, P329; Kosfeld M, 2009, AM ECON REV, V99, P1335, DOI 10.1257/aer.99.4.1335; Lehmann L, 2007, AM NAT, V170, P21, DOI 10.1086/518568; Levin SA, 2009, SPRINGER SER GAME TH, P1, DOI 10.1007/978-3-540-85436-4; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; Nakamaru M, 2006, J THEOR BIOL, V240, P475, DOI 10.1016/j.jtbi.2005.10.011; ORBELL JM, 1993, AM SOCIOL REV, V58, P787, DOI 10.2307/2095951; Ostrom E., 1990, GOVERNING COMMONS EV; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Semmann D, 2003, NATURE, V425, P390, DOI 10.1038/nature01986; Smith J. M., 1997, MAJOR TRANSITIONS EV; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	30	334	340	8	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					861	863		10.1038/nature09203	http://dx.doi.org/10.1038/nature09203			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	636TT	20631710	Green Submitted			2022-12-28	WOS:000280766100035
J	McCance, DR; Holmes, VA; Maresh, MJA; Patterson, CC; Walker, JD; Pearson, DWM; Young, IS				McCance, David R.; Holmes, Valerie A.; Maresh, Michael J. A.; Patterson, Christopher C.; Walker, James D.; Pearson, Donald W. M.; Young, Ian S.		DAPIT Study Grp	Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial	LANCET			English	Article							OXIDATIVE STRESS; PREGNANT-WOMEN; RISK; SUPPLEMENTATION	Background Results of several trials of antioxidant use during pregnancy have not shown a reduction in pre-eclampsia, but the effect in women with diabetes is unknown. We aimed to assess whether supplementation with vitamins C and E reduced incidence of pre-eclampsia in women with type 1 diabetes. Methods We enrolled women from 25 UK antenatal metabolic clinics in a multicentre randomised placebo-controlled trial. Eligibility criteria were type 1 diabetes preceding pregnancy, presentation between 8 weeks' and 22 weeks' gestation, singleton pregnancy, and age 16 years or older. Women were randomly allocated in a 1:1 ratio to receive 1000 mg vitamin C and 400 IU vitamin E (alpha-tocopherol) or matched placebo daily until delivery. The randomisation sequence was stratified by centre with balanced blocks of eight patients. All trial personnel and participants were masked to treatment allocation. The primary endpoint was pre-eclampsia, which we defined as gestational hypertension with proteinuria. Analysis was by modified intention to treat. This study is registered, ISRCTN27214045. Findings Between April, 2003, and June, 2008, 762 women were randomly allocated to treatment groups (379 vitamin supplementation, 383 placebo). The primary endpoint was assessed for 375 women allocated to receive vitamins, and 374 allocated to placebo. Rates of pre-eclampsia did not differ between vitamin (15%, n=57) and placebo (19%, 70) groups (risk ratio 0.81, 95% CI 0.59-1.12). No adverse maternal or neonatal outcomes were reported. Interpretation Supplementation with vitamins C and E did not reduce risk of pre-eclampsia in women with type 1 diabetes. However, the possibility that vitamin supplementation might be beneficial in women with a low antioxidant status at baseline needs further testing.	[McCance, David R.] Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland; [Holmes, Valerie A.] Queens Univ Belfast, Nursing & Midwifery Res Unit, Sch Nursing & Midwifery, Belfast, Antrim, North Ireland; [Patterson, Christopher C.; Young, Ian S.] Queens Univ Belfast, Ctr Publ Hlth, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland; [Maresh, Michael J. A.] St Marys Hosp Women & Children, Dept Obstet & Gynaecol, Manchester, Lancs, England; [Walker, James D.] St Johns Hosp Howden, Dept Diabet, Livingston, Scotland; [Pearson, Donald W. M.] Aberdeen Royal Infirm, Dept Diabet, Aberdeen, Scotland	Queens University Belfast; Queens University Belfast; University of Aberdeen	McCance, DR (corresponding author), Royal Victoria Hosp, Reg Ctr Endocrinol & Diabet, Belfast BT12 6BA, Antrim, North Ireland.	david.mccance@belfasttrust.hscni.net	Holmes, Valerie/F-5815-2011	Halliday, Henry/0000-0001-7978-4992; Holmes, Valerie/0000-0001-6229-5703; Young, Ian/0000-0003-3890-3152	The Wellcome Trust [067028/Z/02/Z, 083145/Z/07/Z]; ESRC [ES/G007438/1] Funding Source: UKRI; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish	The Wellcome Trust(Wellcome Trust); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study is funded by grants 067028/Z/02/Z and 083145/Z/07/Z from The Wellcome Trust (registered charity number 210183). We thank the Clinical Research Support Centre, The Royal Hospitals, Belfast, UK, and the Centre for Public Health, Queen's University Belfast, UK for their assistance with data entry; Victoria Pharmaceuticals, The Royal Hospitals, Belfast, UK for packaging and distribution of trial drugs; LifeScan Inc for the supply of blood-glucose meters to trial participants; and Action on Pre-eclampsia (registered charity number 1013557) for publicity.	Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Cederberg J, 2005, BIRTH DEFECTS RES A, V73, P498, DOI 10.1002/bdra.20144; Chappell LC, 1999, LANCET, V354, P810, DOI 10.1016/S0140-6736(99)80010-5; Cole TJ, 1998, STAT MED, V17, P407, DOI 10.1002/(SICI)1097-0258(19980228)17:4&lt;407::AID-SIM742&gt;3.0.CO;2-L; DEMETS DL, 1994, STAT MED, V13, P1341, DOI 10.1002/sim.4780131308; Dominguez C, 1998, DIABETES CARE, V21, P1736, DOI 10.2337/diacare.21.10.1736; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; GARDOSI J, 1992, LANCET, V339, P283, DOI 10.1016/0140-6736(92)91342-6; GARNER PR, 1990, AM J OBSTET GYNECOL, V163, P505, DOI 10.1016/0002-9378(90)91184-E; Giugliano D, 1996, DIABETES CARE, V19, P257, DOI 10.2337/diacare.19.3.257; Holmes VA, 2005, P NUTR SOC, V64, P491, DOI 10.1079/PNS2005469; Holmes VA, 2004, INT J GYNECOL OBSTET, V87, P66, DOI 10.1016/j.ijgo.2004.06.015; HUBEL CA, 1989, AM J OBSTET GYNECOL, V161, P1025, DOI 10.1016/0002-9378(89)90778-3; Jensen DM, 2004, DIABETES CARE, V27, P2819, DOI 10.2337/diacare.27.12.2819; Martin-Gallan P, 2003, FREE RADICAL BIO MED, V34, P1563, DOI 10.1016/S0891-5849(03)00185-0; Meis PJ, 1998, AM J OBSTET GYNECOL, V178, P562, DOI 10.1016/S0002-9378(98)70439-9; Moher David, 2012, Int J Surg, V10, P28, DOI 10.1016/j.ijsu.2011.10.001; Persson M, 2009, DIABETES CARE, V32, P2005, DOI 10.2337/dc09-0656; Peuchant E, 2004, CLIN BIOCHEM, V37, P293, DOI 10.1016/j.clinbiochem.2003.12.005; Poston L, 2006, LANCET, V367, P1145, DOI 10.1016/S0140-6736(06)68433-X; Roberts J M, 2009, Placenta, V30 Suppl A, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2010, NEW ENGL J MED, V362, P1282, DOI 10.1056/NEJMoa0908056; Roberts JM, 1999, LANCET, V354, P788, DOI 10.1016/S0140-6736(99)80002-6; RUMBOLD A, 2005, COCHRANE DB SYST REV, V2; Rumbold AR, 2006, NEW ENGL J MED, V354, P1796, DOI 10.1056/NEJMoa054186; Spinnato JA, 2007, OBSTET GYNECOL, V110, P1311, DOI 10.1097/01.AOG.0000289576.43441.1f; Toescu V, 2004, CLIN SCI, V106, P93, DOI 10.1042/CS20030175; Villar J, 2009, BJOG-INT J OBSTET GY, V116, P780, DOI 10.1111/j.1471-0528.2009.02158.x; VILLAR J, 2003, PREECLAMPSIA, P57; Xu HR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.050	30	105	109	0	153	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 24	2010	376	9737					259	266		10.1016/S0140-6736(10)60630-7	http://dx.doi.org/10.1016/S0140-6736(10)60630-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	632VM	20580423	Green Published			2022-12-28	WOS:000280457200035
J	Pakull, MW; Soria, R; Motch, C				Pakull, Manfred W.; Soria, Roberto; Motch, Christian			A 300-parsec-long jet-inflated bubble around a powerful microquasar in the galaxy NGC 7793	NATURE			English	Article							X-RAY SOURCES; SUPERNOVA-REMNANTS; RADIO; MODEL	Black-hole accretion states near or above the Eddington luminosity (the point at which radiation force outwards overcomes gravity) are still poorly known because of the rarity of such sources. Ultraluminous X-ray sources 1 are the most luminous class of black hole (L-X approximate to 10(40) erg s(-1)) located outside the nuclei of active galaxies. They are likely to be accreting at super-Eddington rates, if they are powered by black holes with masses less than 100 solar masses. They are often associated with shock-ionized nebulae 2,3, though with no evidence of collimated jets. Microquasars with steady jets are much less luminous. Here we report that the large nebula S26 (ref. 4) in the nearby galaxy NGC 7793 is powered by a black hole with a pair of collimated jets. It is similar to the famous Galactic source SS433 (ref. 5), but twice as large and a few times more powerful. We determine a mechanical power of around a few 10(40) erg s(-1). The jets therefore seem 10(4) times more energetic than the X-ray emission from the core. S26 has the structure of a Fanaroff-Riley type II (FRII-type) active galaxy: X-ray and optical core, X-ray hot spots, radio lobes 6 and an optical and X-ray cocoon. It is a microquasar where most of the jet power is dissipated in thermal particles in the lobes rather than relativistic electrons.	[Pakull, Manfred W.; Motch, Christian] Univ Strasbourg, CNRS, UMR 7550, Astron Observ, F-67000 Strasbourg, France; [Soria, Roberto] Univ Coll London, MSSL, Holmbury RH5 6NT, Surrey, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of London; University College London	Pakull, MW (corresponding author), Univ Strasbourg, CNRS, UMR 7550, Astron Observ, 11 Rue Univ, F-67000 Strasbourg, France.	manfred.pakull@astro.unistra.fr; rsoria@physics.usyd.edu.au	Soria, Roberto/AAU-3154-2020	Soria, Roberto/0000-0002-4622-796X	Early-Career Leverhulme Fellowship	Early-Career Leverhulme Fellowship	This work was based on observations made with ESO telescopes at the Paranal Observatory under program 084.D-0881 (M. W. P.), and made use of the ESO/ST-ECF Science Archive facility, which is a joint collaboration of the ESO and the Space Telescope European Coordinating Facility. Data were obtained from the Chandra Data Archive and software was provided by the Chandra X-ray Center. R. S. acknowledges support from an Early-Career Leverhulme Fellowship and hospitality at the University of Sydney during part of this work.	Allen MG, 2008, ASTROPHYS J SUPPL S, V178, P20, DOI 10.1086/589652; Asvarov AI, 2006, ASTRON ASTROPHYS, V459, P519, DOI 10.1051/0004-6361:20041155; Begelman MC, 2006, MON NOT R ASTRON SOC, V370, P399, DOI 10.1111/j.1365-2966.2006.10469.x; BEGELMAN MC, 1980, ASTROPHYS J, V238, P722, DOI 10.1086/158029; Blair WP, 1997, ASTROPHYS J SUPPL S, V108, P261, DOI 10.1086/312958; Bogovalov SV, 2005, ASTRON REP+, V49, P57, DOI 10.1134/1.1850206; Clark JS, 2004, ASTRON ASTROPHYS, V414, pL45, DOI 10.1051/0004-6361:20031762; Dopita MA, 1996, ASTROPHYS J SUPPL S, V102, P161, DOI 10.1086/192255; DOPITA MA, 2003, ASTR AST LI, P1; Fabrika S., 2004, ASTROPHYS SPACE PHYS, V12, P1; Heinz S, 2002, ASTRON ASTROPHYS, V388, pL40, DOI 10.1051/0004-6361:20020402; Ito H, 2008, ASTROPHYS J, V685, P828, DOI 10.1086/591036; Kaiser CR, 1997, MON NOT R ASTRON SOC, V286, P215, DOI 10.1093/mnras/286.1.215; Karachentsev ID, 2003, ASTRON ASTROPHYS, V404, P93, DOI 10.1051/0004-6361:20030170; Kennedy Charles, 2008, V11, P247; Lozinskaya TA, 2007, MON NOT R ASTRON SOC, V381, pL26, DOI 10.1111/j.1745-3933.2007.00359.x; Pakull M. W., 2002, OPTICAL COUNTERPARTS; Pakull M.W., 2006, IAU S 230 POPULATION, P293; Pakull M. W., 2003, REV MEX ASTRON ASTR, V15, P197; Pakull MW, 2008, AIP CONF PROC, V1010, P303, DOI 10.1063/1.2945062; Pannuti TG, 2002, ASTROPHYS J, V565, P966, DOI 10.1086/337918; RAYMOND JC, 1988, ASTROPHYS J, V324, P869, DOI 10.1086/165945; Read AM, 1999, ASTRON ASTROPHYS, V341, P8; Silverman JM, 2008, ASTROPHYS J LETT, V678, pL17, DOI 10.1086/588096; Ward M, 2002, PHILOS T R SOC A, V360, P1991, DOI 10.1098/rsta.2002.1049; WEAVER R, 1977, ASTROPHYS J, V218, P377, DOI 10.1086/155692; Wilson A. S., 2006, Astrophysical Journal, Letters, V644, pL9, DOI 10.1086/504108	27	100	100	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					209	212		10.1038/nature09168	http://dx.doi.org/10.1038/nature09168			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613836				2022-12-28	WOS:000279580800030
J	Rama, P; Matuska, S; Paganoni, G; Spinelli, A; De Luca, M; Pellegrini, G				Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra; De Luca, Michele; Pellegrini, Graziella			Limbal Stem-Cell Therapy and Long-Term Corneal Regeneration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN OCULAR SURFACE; CULTURED EPITHELIUM; TRANSPLANTATION; FIBRIN; BURNS; P63; KERATINOCYTES; ISOFORMS; CYCLE	BACKGROUND Corneal renewal and repair are mediated by stem cells of the limbus, the narrow zone between the cornea and the bulbar conjunctiva. Ocular burns may destroy the limbus, causing limbal stem-cell deficiency. We investigated the long-term clinical results of cell therapy in patients with burn-related corneal destruction associated with limbal stem-cell deficiency, a highly disabling ocular disease. METHODS We used autologous limbal stem cells cultivated on fibrin to treat 112 patients with corneal damage, most of whom had burn-dependent limbal stem-cell deficiency. Clinical results were assessed by means of Kaplan-Meier, Kruskal-Wallis, and univariate and multivariate logistic-regression analyses. We also assessed the clinical outcome according to the percentage of holoclone-forming stem cells, detected as cells that stain intensely (p63-bright cells) in the cultures. RESULTS Permanent restoration of a transparent, renewing corneal epithelium was attained in 76.6% of eyes. The failures occurred within the first year. Restored eyes remained stable over time, with up to 10 years of follow-up (mean, 2.91 +/- 1.99; median, 1.93). In post hoc analyses, success - that is, the generation of normal epithelium on donor stroma - was associated with the percentage of p63-bright holoclone-forming stem cells in culture. Cultures in which p63-bright cells constituted more than 3% of the total number of clonogenic cells were associated with successful transplantation in 78% of patients. In contrast, cultures in which such cells made up 3% or less of the total number of cells were associated with successful transplantation in only 11% of patients. Graft failure was also associated with the type of initial ocular damage and postoperative complications. CONCLUSIONS Cultures of limbal stem cells represent a source of cells for transplantation in the treatment of destruction of the human cornea due to burns.	[De Luca, Michele; Pellegrini, Graziella] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Modena, Italy; [Rama, Paolo; Matuska, Stanislav; Paganoni, Giorgio; Spinelli, Alessandra] Ist Sci San Raffaele, Ophthalmol Unit, I-20132 Milan, Italy	Universita di Modena e Reggio Emilia; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Pellegrini, G (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, Via Glauco Gottardi 100, Modena, Italy.	graziella.pellegrini@unimore.it	De Luca, Michele/N-5883-2014; Spinelli, Antonello E/K-1256-2018; Pellegrini, Graziella/E-1189-2015; Rama, Paolo/S-5150-2019	De Luca, Michele/0000-0002-0850-8445; Spinelli, Antonello E/0000-0001-5762-3426; Pellegrini, Graziella/0000-0001-9861-0736; Rama, Paolo/0000-0002-2429-159X	Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; European Commission; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem) [HEALTH-F5-2009-223098]; Regione Emilia-Romagna	Italian Ministry for Education, University and Research and Ministry of Health(Ministry of Education, Universities and Research (MIUR)); l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon(Association Francaise contre les Myopathies); European Commission(European CommissionEuropean Commission Joint Research Centre); Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem); Regione Emilia-Romagna(Regione Emilia Romagna)	Supported by grants from the Italian Ministry for Education, University and Research and Ministry of Health; l'Association Francaise contre les Myopathies et les Maladies Neuromusculaires (AFM) Telethon; the European Commission Sixth Framework Program for Research and Technological Development (corneal engineering) and Seventh Framework Program; Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases (OptiStem, HEALTH-F5-2009-223098); Regione Emilia-Romagna (area 1b, medicina rigenerativa); and the Italian Ministry of Health.	Barbaro V, 2007, J CELL BIOL, V177, P1037, DOI 10.1083/jcb.200703003; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Daya SM, 2005, OPHTHALMOLOGY, V112, P470, DOI 10.1016/j.ophtha.2004.09.023; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; DELUCA M, 1989, BURNS, V15, P303, DOI 10.1016/0305-4179(89)90007-7; DELUCA M, 1992, ARCH DERMATOL, V128, P633, DOI 10.1001/archderm.128.5.633; Di Iorio E, 2005, P NATL ACAD SCI USA, V102, P9523, DOI 10.1073/pnas.0503437102; Di Iorio E, 2006, MICROSC RES TECHNIQ, V69, P983, DOI 10.1002/jemt.20375; Dua HS, 2000, SURV OPHTHALMOL, V44, P415, DOI 10.1016/S0039-6257(00)00109-0; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Henderson TRM, 2001, BRIT J OPHTHALMOL, V85, P604, DOI 10.1136/bjo.85.5.604; KENYON KR, 1989, OPHTHALMOLOGY, V96, P709; LINDBERG K, 1993, INVEST OPHTH VIS SCI, V34, P2672; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Pellegrini G, 1997, LANCET, V349, P990, DOI 10.1016/S0140-6736(96)11188-0; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769; Pellegrini G, 1999, TRANSPLANTATION, V68, P868, DOI 10.1097/00007890-199909270-00021; Pellegrini G, 2004, NEW ENGL J MED, V351, P1170, DOI 10.1056/NEJMp048199; Pellegrini G, 2009, J PATHOL, V217, P217, DOI 10.1002/path.2441; Rama P, 2001, TRANSPLANTATION, V72, P1478, DOI 10.1097/00007890-200111150-00002; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; Ronfard V, 2000, TRANSPLANTATION, V70, P1588, DOI 10.1097/00007890-200012150-00009; Schwab IR, 2006, ARCH OPHTHALMOL-CHIC, V124, P1734, DOI 10.1001/archopht.124.12.1734; Shortt AJ, 2007, SURV OPHTHALMOL, V52, P483, DOI 10.1016/j.survophthal.2007.06.013; Wagoner MD, 1997, SURV OPHTHALMOL, V41, P275, DOI 10.1016/S0039-6257(96)00007-0; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0	30	777	814	2	95	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					147	155		10.1056/NEJMoa0905955	http://dx.doi.org/10.1056/NEJMoa0905955			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20573916	Green Published			2022-12-28	WOS:000279574100007
J	Powers, BJ; Trinh, JV; Bosworth, HB				Powers, Benjamin J.; Trinh, Jane V.; Bosworth, Hayden B.			Can This Patient Read and Understand Written Health Information?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NEWEST VITAL SIGN; IDENTIFY PATIENTS; LITERACY SKILLS; SCREENING QUESTIONS; LIKELIHOOD RATIOS; ADULT LITERACY; PRIMARY-CARE; OUTCOMES; EDUCATION; COMMUNICATION	Context Patients with limited literacy are at higher risk for poor health outcomes; however, physicians' perceptions are inaccurate for identifying these patients. Objective To systematically review the accuracy of brief instruments for identifying patients with limited literacy. Data Sources Search of the English-language literature from 1969 through February 2010 using PubMed, Psychinfo, and bibliographies of selected manuscripts for articles on health literacy, numeracy, reading ability, and reading skill. Study Selection Prospective studies including adult patients 18 years or older that evaluated a brief instrument for identifying limited literacy in a health care setting compared with an accepted literacy reference standard. Data Extraction Studies were evaluated independently by 2 reviewers who each abstracted information and assigned an overall quality rating. Disagreements were adjudicated by a third reviewer. Data Synthesis Ten studies using 6 different instruments met inclusion criteria. Among multi-item measures, the Newest Vital Sign (English) performed moderately well for identifying limited literacy based on 3 studies. Among the single-item questions, asking about a patient's use of a surrogate reader, confidence filling out medical forms, and self-rated reading ability performed moderately well in identifying patients with inadequate or marginal literacy. Asking a patient, "How confident are you in filling out medical forms by yourself?" is associated with a summary likelihood ratio (LR) for limited literacy of 5.0 (95% confidence interval [CI], 3.8-6.4) for an answer of "a little confident" or "not at all confident"; a summary LR of 2.2 (95% CI, 1.5-3.3) for "somewhat confident"; and a summary LR of 0.44 (95% CI, 0.24-0.82) for "quite a bit" or "extremely confident." Conclusion Several single-item questions, including use of a surrogate reader and confidence with medical forms, were moderately effective for quickly identifying patients with limited literacy. JAMA. 2010;304(1):76-84 www.jama.com	[Powers, Benjamin J.; Bosworth, Hayden B.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Powers, Benjamin J.; Trinh, Jane V.; Bosworth, Hayden B.] Duke Univ, Dept Med, Div Gen Internal Med, Durham, NC 27706 USA; [Trinh, Jane V.] Duke Univ, Dept Pediat, Durham, NC 27706 USA; [Bosworth, Hayden B.] Duke Univ, Dept Psychiat & Behav Sci, Durham, NC 27706 USA; [Bosworth, Hayden B.] Duke Univ, Ctr Aging & Human Dev, Durham, NC 27706 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University; Duke University; Duke University	Powers, BJ (corresponding author), Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, 508 Fulton St, Durham, NC 27705 USA.	power017@mc.duke.edu			KL2 career development award [RR024127-02]; American Heart Association; Health Services Research and Development, Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024127] Funding Source: NIH RePORTER	KL2 career development award; American Heart Association(American Heart Association); Health Services Research and Development, Veterans Affairs Medical Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Powers is supported by KL2 career development award RR024127-02. Dr Bosworth is supported by an Established Investigator Award from the American Heart Association and a Career Scientist Award from Health Services Research and Development, Veterans Affairs Medical Center.	Arozullah AM, 2007, MED CARE, V45, P1026, DOI 10.1097/MLR.0b013e3180616c1b; Baker DW, 1999, PATIENT EDUC COUNS, V38, P33, DOI 10.1016/S0738-3991(98)00116-5; Baker FM, 1996, PSYCHIATR SERV, V47, P194; Bass PF, 2003, J GEN INTERN MED, V18, P1036, DOI 10.1111/j.1525-1497.2003.10651.x; Bass PF, 2002, ACAD MED, V77, P1039, DOI 10.1097/00001888-200210000-00021; Chew LD, 2004, FAM MED, V36, P588; Chew LD, 2008, J GEN INTERN MED, V23, P561, DOI 10.1007/s11606-008-0520-5; Clement S, 2009, PATIENT EDUC COUNS, V75, P340, DOI 10.1016/j.pec.2009.01.008; Davis T C, 1993, Fam Med, V25, P391; Davis T C, 1991, Fam Med, V23, P433; DAVIS TC, 1990, J FAM PRACTICE, V31, P533; Davis TC, 2006, ANN INTERN MED, V145, P887, DOI 10.7326/0003-4819-145-12-200612190-00144; DeWalt DA, 2004, J GEN INTERN MED, V19, P1228, DOI 10.1111/j.1525-1497.2004.40153.x; Gazmararian JA, 1999, JAMA-J AM MED ASSOC, V281, P545, DOI 10.1001/jama.281.6.545; HASSELBLAD V, 1995, PSYCHOL BULL, V117, P167, DOI 10.1037/0033-2909.117.1.167; *HLTH LIT AM AD, 2006, RES 2003 NAT ASS AD; *I MED, 2004, HLTH LIT PRESCR END; Jeppesen KM, 2009, ANN FAM MED, V7, P24, DOI 10.1370/afm.919; Kelly PA, 2007, PATIENT EDUC COUNS, V66, P119, DOI 10.1016/j.pec.2006.10.007; Mancuso CA, 2006, J GEN INTERN MED, V21, P813, DOI 10.1111/j.1525-1497.2006.00528.x; MEADE CD, 1989, AM J PUBLIC HEALTH, V79, P204, DOI 10.2105/AJPH.79.2.204; Morris Nancy S, 2006, BMC Fam Pract, V7, P21, DOI 10.1186/1471-2296-7-21; Osborn CY, 2007, AM J HEALTH BEHAV, V31, pS36; Paasche-Orlow MK, 2005, J GEN INTERN MED, V20, P175, DOI 10.1111/j.1525-1497.2005.40245.x; Paosche-Orlow MK, 2008, J GEN INTERN MED, V23, P100, DOI 10.1007/s11606-007-0447-2; Parikh NS, 1996, PATIENT EDUC COUNS, V27, P33, DOI 10.1016/0738-3991(95)00787-3; PARKER RM, 1995, J GEN INTERN MED, V10, P537, DOI 10.1007/BF02640361; Pignone M, 2005, J GEN INTERN MED, V20, P185, DOI 10.1111/j.1525-1497.2005.40208.x; Powell CK, 2005, J GEN INTERN MED, V20, P1042, DOI 10.1007/s11606-005-0246-6; Powers BJ, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-219; Rawson KA, 2010, J GEN INTERN MED, V25, P67, DOI 10.1007/s11606-009-1158-7; Rothman RL, 2004, JAMA-J AM MED ASSOC, V292, P1711, DOI 10.1001/jama.292.14.1711; Schillinger D, 2002, JAMA-J AM MED ASSOC, V288, P475, DOI 10.1001/jama.288.4.475; Schillinger D, 2003, ARCH INTERN MED, V163, P83, DOI 10.1001/archinte.163.1.83; Schillinger D, 2006, J HEALTH COMMUN, V11, P651, DOI 10.1080/10810730600934500; Seligman HK, 2005, J GEN INTERN MED, V20, P1001, DOI 10.1111/j.1525-1497.2005.00189.x; SIMEL DL, 1993, J CLIN EPIDEMIOL, V46, P85, DOI 10.1016/0895-4356(93)90012-P; SIMEL DL, 1991, J CLIN EPIDEMIOL, V44, P763, DOI 10.1016/0895-4356(91)90128-V; Simel DL., 2009, RATIONAL CLIN EXAMIN, V2 ed, P9; Sudore RL, 2006, J GEN INTERN MED, V21, P806, DOI 10.1111/j.1525-1497.2006.00539.x; Wallace LS, 2006, J GEN INTERN MED, V21, P874, DOI 10.1111/j.1525-1497.2006.00532.x; Weiss BD, 2005, ANN FAM MED, V3, P514, DOI 10.1370/afm.405; WILLIAMS MV, 1995, JAMA-J AM MED ASSOC, V274, P1677; Wilson JF, 2003, ANN INTERN MED, V139, P875, DOI 10.7326/0003-4819-139-10-200311180-00038; Wolf MS, 2007, J HEALTH COMMUN, V12, P721, DOI 10.1080/10810730701672173; Wolf MS, 2005, ARCH INTERN MED, V165, P1946, DOI 10.1001/archinte.165.17.1946	46	186	187	1	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					76	84		10.1001/jama.2010.896	http://dx.doi.org/10.1001/jama.2010.896			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606152				2022-12-28	WOS:000279519600024
J	Kerr, E; Arulraj, N; Scott, M; McDowall, M; van Dijke, M; Keir, S; Sandercock, P; Dennis, M				Kerr, Enda; Arulraj, Nolan; Scott, Maggie; McDowall, Mike; van Dijke, Margrethe; Keir, Sarah; Sandercock, Peter; Dennis, Martin			Quality Improvement Report A telephone hotline for transient ischaemic attack and stroke: prospective audit of a model to improve rapid access to specialist stroke care	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK	Problem Patients with transient ischaemic attack or stroke benefit from early diagnosis, specialist assessment, and treatment with thrombolysis, and from stroke unit care and secondary prevention. The challenge with such patients is to minimise delays and ensure that treatment is appropriate, and to provide this care with the available resources. Design An ongoing prospective audit of a transient ischaemic attack and stroke clinic (1 January 2005 to 30 September 2009), as part of the Scottish Stroke Care Audit, and a three month targeted audit of immediate telephone access to a specialist stroke consultant (1 February 2009 to 30 April 2009). Setting Stroke and transient ischaemic attack services in Lothian, a region of Scotland with a population of 810 000. Key measures for improvement Delays to assessment at a rapid access transient ischaemic attack and stroke clinic; delays to appropriate treatment. Strategy for change In February 2007 we introduced a 24 hours a day, seven days a week hotline to a consultant, who provided immediate advice on diagnosis, investigation, and emergency treatment for patients with transient ischaemic attack or stroke, and suggested the most appropriate care pathway, which might include an early appointment in a transient ischaemic attack and stroke clinic. Effects of change The introduction of the hotline was associated with an immediate and sustained reduction in delays to assessment (from 13 to three days) and treatment. The proportion of participants taking statins at the time of visiting the clinic increased from 40% before the introduction of the hotline to 60% after the hotline was in place. Also, the hotline contributed to a reduction in the delay from last event to carotid surgery, from 58 days to 21.5 days. A total of 376 calls were received during the three month audit. Of the 273 (88%) referrers who responded to our questionnaire, 257 (94%) were very satisfied with the advice given over the hotline. Lessons learnt Although associated with some disruption to the activities of the consultants, a 24 hours a day, seven days a week telephone hotline to a consultant is a feasible and effective means of reducing delays to specialist assessment and treatment of patients with transient ischaemic attack or stroke.	[Scott, Maggie; Dennis, Martin] Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Edinburgh EH4 2XU, Midlothian, Scotland	University of Edinburgh	Dennis, M (corresponding author), Western Gen Hosp, Dept Clin Neurosci, Transient Ischaem Attack Clin, Crewe Rd, Edinburgh EH4 2XU, Midlothian, Scotland.	martin.dennis@ed.ac.uk		dennis, martin/0000-0003-1148-8972; Sandercock, Peter/0000-0001-8484-0135				Department of Health, 2007, NAT STROK STRAT; Giles MF, 2007, LANCET NEUROL, V6, P1063, DOI 10.1016/S1474-4422(07)70274-0; Henderson GR, 2008, QUAL SAF HEALTH CARE, V17, P301, DOI 10.1136/qshc.2006.020784; Johnston SC, 2006, ANN NEUROL, V60, P301, DOI 10.1002/ana.20942; Kennedy J, 2007, LANCET NEUROL, V6, P961, DOI 10.1016/S1474-4422(07)70250-8; Lavallee PC, 2007, LANCET NEUROL, V6, P953, DOI 10.1016/S1474-4422(07)70248-X; *NAT AUD OFF, 2005, 452 HC NAT AUD OFF; National Institute for Health and Clinical Excellence, 2008, DIAGN IN MAN AC STRO; *NHS QUAL IMPR SCO, 2004, CLIN STAND STROK SER; Rothwell PM, 2007, LANCET, V370, P1432, DOI 10.1016/S0140-6736(07)61448-2; Rothwell PM, 2005, LANCET, V366, P29, DOI 10.1016/S0140-6736(05)66702-5; Royal College of Physicians of England and Wales, 2007, NAT SENT STROK AUD 2; *SCOTT STROK CAR A, 2009, 2009 NAT REP STROK S; *STROK FDN NZ INC, 2008, NZ GUID ASS MAN PAT	14	9	9	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 3	2010	341								c3265	10.1136/bmj.c3265	http://dx.doi.org/10.1136/bmj.c3265			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NY	20601699				2022-12-28	WOS:000279586800001
J	Volberding, PA; Deeks, SG				Volberding, Paul A.; Deeks, Steven G.			Antiretroviral therapy and management of HIV infection	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; T-CELL DEPLETION; TERM-FOLLOW-UP; DRUG-RESISTANCE; IMMUNE ACTIVATION; VIRAL LOAD; INITIAL TREATMENT; 2008 RECOMMENDATIONS; CARDIOVASCULAR RISK; SPARING REGIMENS	Antiretroviral therapy of HIV infection has changed a uniformly fatal into a potentially chronic disease. There are now 17 drugs in common use for HIV treatment. Patients who can access and adhere to combination therapy should be able to achieve durable, potentially lifelong suppression of HIV replication. Despite the unquestioned success of antiretroviral therapy, limitations persist. Treatment success needs strict lifelong drug adherence. Although the widely used drugs are generally well tolerated, most have some short-term toxic effects and all have the potential for both known and unknown long-term toxic effects. Drug and administration costs limit treatment in resource-poor regions, and are a growing concern even in resource rich settings. Finally, complete or near complete control of viral replication does not fully restore health. Long-term treated patients who are on an otherwise effective regimen often show persistent immune dysfunction and have higher than expected risk for various non-AIDS-related complications, including heart, bone, liver, kidney, and neurocognitive diseases.	[Volberding, Paul A.] Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Med, San Francisco, CA 94121 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Volberding, PA (corresponding author), Univ Calif San Francisco, San Francisco Vet Affairs Med Ctr, Dept Med, 4150 Clement St, San Francisco, CA 94121 USA.	paul.volberding@va.gov	Franzeck, Fabian C/B-5055-2011		UCSF-Gladstone Institute of Virology and Immunology Centers for AIDS Research [PO AI027763]; NIH [AI087145, AI069994]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI087145, K24AI069994, P30AI027763] Funding Source: NIH RePORTER	UCSF-Gladstone Institute of Virology and Immunology Centers for AIDS Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported in part by the UCSF-Gladstone Institute of Virology and Immunology Centers for AIDS Research (PO AI027763) (PAV, SGD). Additional support was provided by the NIH (AI087145, AI069994) (SGD). We thank Warner Greene for permission to use figure 1, John C W Carroll for assistance with graphic design, and Pam Derish for copy editing assistance.	Abrams D, 2009, NEW ENGL J MED, V361, P1548, DOI 10.1056/NEJMoa0903175; Ances BM, 2010, J INFECT DIS, V201, P336, DOI 10.1086/649899; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Bedimo RJ, 2009, JAIDS-J ACQ IMM DEF, V52, P203, DOI 10.1097/QAI.0b013e3181b033ab; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Brenner BG, 2007, J INFECT DIS, V195, P951, DOI 10.1086/512088; Brown TT, 2006, AIDS, V20, P2165, DOI 10.1097/QAD.0b013e32801022eb; Buzon MJ, 2010, NAT MED, V16, P460, DOI 10.1038/nm.2111; Carr A, 1998, AIDS, V12, pF51, DOI 10.1097/00002030-199807000-00003; Castagna A, 2006, AIDS, V20, P795, DOI 10.1097/01.aids.0000218542.08845.b2; Centers for Disease Control and Prevention (CDC), 2006, MMWR Morb Mortal Wkly Rep, V55, P592; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Deeks SG, 2005, J INFECT DIS, V192, P1537, DOI 10.1086/496892; Deeks SG, 2004, BLOOD, V104, P942, DOI 10.1182/blood-2003-09-3333; Deeks SG, 2009, CLIN INFECT DIS, V49, P1582, DOI 10.1086/644768; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Dieffenbach CW, 2009, JAMA-J AM MED ASSOC, V301, P2380, DOI 10.1001/jama.2009.828; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; El-Sadr WM, 2006, NEW ENGL J MED, V355, P2283, DOI 10.1056/NEJMoa062360; El-Sadr WM, 2010, NEW ENGL J MED, V362, P967, DOI 10.1056/NEJMp1000069; Elzi L, 2010, ARCH INTERN MED, V170, P57, DOI 10.1001/archinternmed.2009.432; Eshleman SH, 2001, AIDS, V15, P1951, DOI 10.1097/00002030-200110190-00006; European AIDS Clinical Society (EACS), 2009, GUID CLIN MAN TREATM; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; Fauci AS, 2009, HEALTH AFFAIR, V28, P1629, DOI 10.1377/hlthaff.28.6.1629; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Ferry T, 2009, JAIDS-J ACQ IMM DEF, V51, P407, DOI 10.1097/QAI.0b013e3181acb65f; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Friis-Moller N, 2007, NEW ENGL J MED, V356, P1723, DOI 10.1056/NEJMoa062744; Fundaro C, 2002, AIDS, V16, P299, DOI 10.1097/00002030-200201250-00025; GALLO RC, 1984, SCIENCE, V224, P500, DOI 10.1126/science.6200936; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Gazzard BG, 2008, HIV MED, V9, P563, DOI 10.1111/j.1468-1293.2008.00636.x; Gill VS, 2010, CLIN INFECT DIS, V50, P98, DOI 10.1086/648729; Giorgi JV, 1999, J INFECT DIS, V179, P859, DOI 10.1086/314660; Glass WG, 2006, J EXP MED, V203, P35, DOI 10.1084/jem.20051970; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Gras L, 2007, JAIDS-J ACQ IMM DEF, V45, P183, DOI 10.1097/QAI.0b013e31804d685b; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Grund B, 2009, AIDS, V23, P1519, DOI 10.1097/QAD.0b013e32832c1792; Gulick RM, 2008, NEW ENGL J MED, V359, P1429, DOI 10.1056/NEJMoa0803152; Gulick RM, 2006, JAMA-J AM MED ASSOC, V296, P769, DOI 10.1001/jama.296.7.769; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Hare CB, 2008, CLIN INFECT DIS, V47, P421, DOI 10.1086/589867; HATANO H, 2010, J ACQUIR IMMUNE DEFI; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Hawkins CA, 2009, JAIDS-J ACQ IMM DEF, V52, P228, DOI 10.1097/QAI.0b013e3181b06125; Hazenberg MD, 2000, NAT IMMUNOL, V1, P285, DOI 10.1038/79724; Hecht FM, 2010, AIDS, V24, P941, DOI 10.1097/QAD.0b013e328337b12e; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; Hirsch MS, 2008, CLIN INFECT DIS, V47, P266, DOI 10.1086/589297; HO DD, 1995, NEW ENGL J MED, V333, P450, DOI 10.1056/NEJM199508173330710; Hogg R, 2008, LANCET, V372, P293, DOI 10.1016/S0140-6736(08)61113-7; Hogg RS, 2001, JAMA-J AM MED ASSOC, V286, P2568, DOI 10.1001/jama.286.20.2568; Hsue PY, 2009, AIDS, V23, P1059, DOI 10.1097/QAD.0b013e32832b514b; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Hunt PW, 2003, J INFECT DIS, V187, P1534, DOI 10.1086/374786; Jiang W, 2009, J INFECT DIS, V199, P1177, DOI 10.1086/597476; Johnson JA, 2008, PLOS MED, V5, P1112, DOI 10.1371/journal.pmed.0050158; Johnson Victoria A, 2009, Top HIV Med, V17, P138; Joos B, 2008, P NATL ACAD SCI USA, V105, P16725, DOI 10.1073/pnas.0804192105; Jourdain G, 2004, NEW ENGL J MED, V351, P229, DOI 10.1056/NEJMoa041305; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Keele BF, 2006, SCIENCE, V313, P523, DOI 10.1126/science.1126531; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lennox JL, 2009, LANCET, V374, P796, DOI 10.1016/S0140-6736(09)60918-1; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lima V, 2009, JAIDS-J ACQ IMM DEF, V51, P3, DOI 10.1097/QAI.0b013e31819e721b; Little SJ, 2002, NEW ENGL J MED, V347, P385, DOI 10.1056/NEJMoa013552; Lockman S, 2007, NEW ENGL J MED, V356, P135, DOI 10.1056/NEJMoa062876; Lodwick R, 2010, ARCH INTERN MED, V170, P410, DOI 10.1001/archinternmed.2009.472; Lohse N, 2007, ANN INTERN MED, V146, P87, DOI 10.7326/0003-4819-146-2-200701160-00003; Longenecker CT, 2009, AIDS, V23, P1089, DOI 10.1097/QAD.0b013e32832a3f24; Losina E, 2009, CLIN INFECT DIS, V49, P1570, DOI 10.1086/644772; Madruga JV, 2007, LANCET, V370, P49, DOI 10.1016/S0140-6736(07)61049-6; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Mallal S, 2008, NEW ENGL J MED, V358, P568, DOI 10.1056/NEJMoa0706135; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Martin A, 2009, CLIN INFECT DIS, V49, P1591, DOI 10.1086/644769; McCune JM, 2001, NATURE, V410, P974, DOI 10.1038/35073648; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mehandru S, 2006, PLOS MED, V3, P2335, DOI 10.1371/journal.pmed.0030484; Mellors JW, 2007, JAMA-J AM MED ASSOC, V297, P2349, DOI 10.1001/jama.297.21.2349; Mettenleiter T.C., 2009, Revue Scientifique et Technique Office International des Epizooties, V28, P1; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Monforte AD, 2008, AIDS, V22, P2143, DOI 10.1097/QAD.0b013e3283112b77; Montaner JSG, 2006, LANCET, V368, P531, DOI 10.1016/S0140-6736(06)69162-9; Moore JP, 2004, AIDS RES HUM RETROV, V20, P111, DOI 10.1089/088922204322749567; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Murray JS, 1999, AIDS, V13, P797, DOI 10.1097/00002030-199905070-00008; Obel N, 2007, CLIN INFECT DIS, V44, P1625, DOI 10.1086/518285; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Paredes R, 2010, J INFECT DIS, V201, P662, DOI 10.1086/650543; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; Phillips AN, 2007, LANCET, V370, P1923, DOI 10.1016/S0140-6736(07)61815-7; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Reiss P, 2009, CLIN INFECT DIS, V49, P1602, DOI 10.1086/644770; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Robertson KR, 2010, NEUROLOGY, V74, P1260, DOI 10.1212/WNL.0b013e3181d9ed09; Rodriguez B, 2006, JAMA-J AM MED ASSOC, V296, P1498, DOI 10.1001/jama.296.12.1498; Sabin CA, 2008, AIDS, V22, P1463; Sabin CA, 2008, LANCET, V371, P1417, DOI 10.1016/S0140-6736(08)60423-7; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Schacker TW, 2005, AIDS, V19, P2169, DOI 10.1097/01.aids.0000194801.51422.03; Schacker TW, 2002, J CLIN INVEST, V110, P1133, DOI [10.1172/JCI200216413, 10.1172/JCI0216413]; Severe P, 2009, 49 INT C ANT AG CHEM; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Triant VA, 2008, J CLIN ENDOCR METAB, V93, P3499, DOI 10.1210/jc.2008-0828; Triant VA, 2007, J CLIN ENDOCR METAB, V92, P2506, DOI 10.1210/jc.2006-2190; Tural C, 2002, AIDS, V16, P209, DOI 10.1097/00002030-200201250-00010; van Leth F, 2004, LANCET, V363, P1253, DOI 10.1016/S0140-6736(04)15997-7; Vercauteren J, 2009, J INFECT DIS, V200, P1503, DOI 10.1086/644505; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632; Wensing AMJ, 2005, J INFECT DIS, V192, P958, DOI 10.1086/432916; Wheeler WH, 2010, AIDS, V24, P1203, DOI 10.1097/QAD.0b013e3283388742; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Wood E, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1649; Woods SP, 2009, NEUROPSYCHOL REV, V19, P152, DOI 10.1007/s11065-009-9102-5; Yilmaz A, 2008, JAIDS-J ACQ IMM DEF, V47, P168, DOI 10.1097/QAI.0b013e31815ace97; Zolopa AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005575	146	279	288	0	22	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 3	2010	376	9734					49	62		10.1016/S0140-6736(10)60676-9	http://dx.doi.org/10.1016/S0140-6736(10)60676-9			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624SR	20609987				2022-12-28	WOS:000279841600024
J	Storz, JF				Storz, Jay F.			Genes for High Altitudes	SCIENCE			English	Editorial Material							HEMOGLOBIN CONCENTRATION; ADAPTATION; MECHANISM; TIBETAN		Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA	University of Nebraska System; University of Nebraska Lincoln	Storz, JF (corresponding author), Univ Nebraska, Sch Biol Sci, Lincoln, NE 68588 USA.	jstorz2@unl.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087216] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL087216] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Beall CM, 1998, AM J PHYS ANTHROPOL, V106, P385, DOI 10.1002/(SICI)1096-8644(199807)106:3<385::AID-AJPA10>3.3.CO;2-6; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Gonzales GF, 2009, AM J PHYSIOL-REG I, V297, pR1477, DOI 10.1152/ajpregu.00275.2009; JESSEN TH, 1991, P NATL ACAD SCI USA, V88, P6519, DOI 10.1073/pnas.88.15.6519; Moore LG, 2004, PLACENTA, V25, pS60, DOI 10.1016/j.placenta.2004.01.008; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Storz JF, 2009, P NATL ACAD SCI USA, V106, P14450, DOI 10.1073/pnas.0905224106; Villafuerte FC, 2004, J APPL PHYSIOL, V96, P1581, DOI 10.1152/japplphysiol.00328.2003; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zhao M, 2009, P NATL ACAD SCI USA, V106, P21230, DOI 10.1073/pnas.0907844106	12	59	64	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					40	41		10.1126/science.1192481	http://dx.doi.org/10.1126/science.1192481			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595602	Green Accepted			2022-12-28	WOS:000279402700021
J	Henrich, J; Heine, SJ; Norenzayan, A				Henrich, Joseph; Heine, Steven J.; Norenzayan, Ara			Most people are not WEIRD	NATURE			English	Editorial Material									[Henrich, Joseph; Heine, Steven J.; Norenzayan, Ara] Univ British Columbia, Dept Psychol, Vancouver, BC V6T 1Z4, Canada; [Henrich, Joseph] Univ British Columbia, Dept Econ, Vancouver, BC V6T 1Z4, Canada	University of British Columbia; University of British Columbia	Henrich, J (corresponding author), Univ British Columbia, Dept Psychol, 2136 W Mall, Vancouver, BC V6T 1Z4, Canada.	joseph.henrich@gmail.com	Heine, Steven/C-6975-2011					Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; Foote C, 2009, POLICYMAKING INSIGHT; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Ji LJ, 2008, J BEHAV DECIS MAKING, V21, P399, DOI 10.1002/bdm.595	6	1319	1333	5	146	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					29	29		10.1038/466029a	http://dx.doi.org/10.1038/466029a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618HW	20595995	Bronze			2022-12-28	WOS:000279343800019
J	Liu, AY; Lowe, RC; Levy, BD; Katz, JT; Loscalzo, J				Liu, Anne Y.; Lowe, Robert C.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph			A Rash Hypothesis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MAST-CELL DISEASE; SYSTEMIC MASTOCYTOSIS; TRYPTASE LEVELS; PROGNOSIS; MUTATION; CRITERIA; BLOOD; KIT	A 40-year-old woman presented with diarrhea, reporting to her physician that she had been having loose stools for 2 years, with 4 to 5 bowel movements per day, progressing over the previous 6 months to 15 large-volume, watery stools daily, including nocturnal stools. Abdominal cramps preceded these episodes and were partially relieved by bowel movements. Loperamide increased stool bulk but did not alter frequency. She noted no blood or oil in the stool. She had also been vomiting over the previous 2 months, more recently up to four times daily. The frequency of her diarrhea was not affected by food intake, although eating often precipitated vomiting. Despite a weight loss of nearly 7 kg (15 lb) in the previous 6 months, her abdominal girth had increased. She noted occasional palpitations and headaches but no fevers, night sweats, hematemesis, cough, or shortness of breath.	[Liu, Anne Y.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Liu, Anne Y.; Levy, Bruce D.; Katz, Joel T.; Loscalzo, Joseph] Harvard Univ, Sch Med, Boston, MA USA; [Lowe, Robert C.] Boston Med Ctr, Dept Med, Boston, MA USA; [Lowe, Robert C.] Boston Univ, Sch Med, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston Medical Center; Boston University	Katz, JT (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021	Lowe, Robert/0000-0002-6046-913X				Brockow K, 2003, J AM ACAD DERMATOL, V48, P508, DOI 10.1067/mjd.2003.98; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; Hennessy B, 2004, AM J HEMATOL, V77, P209, DOI 10.1002/ajh.20211; KEYZER JJ, 1983, NEW ENGL J MED, V309, P1603, DOI 10.1056/NEJM198312293092603; Klion AD, 2003, BLOOD, V101, P4660, DOI 10.1182/blood-2003-01-0006; Kluin-Nelemans HC, 2003, BLOOD, V102, P4270, DOI 10.1182/blood-2003-05-1699; LAWRENCE JB, 1991, AM J MED, V91, P612, DOI 10.1016/0002-9343(91)90214-I; NAGATA H, 1995, P NATL ACAD SCI USA, V92, P10560, DOI 10.1073/pnas.92.23.10560; Pardanani A, 2004, LEUKEMIA RES, V28, P127, DOI 10.1016/S0145-2126(03)00185-1; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; Schwartz LB, 2003, J IMMUNOL, V170, P5667, DOI 10.4049/jimmunol.170.11.5667; Sperr WR, 2002, LEUKEMIA LYMPHOMA, V43, P1097, DOI 10.1080/10428190290021470; Sperr WR, 2001, BLOOD, V98, P2200, DOI 10.1182/blood.V98.7.2200; Taira M, 2002, J ASTHMA, V39, P315, DOI 10.1081/JAS-120002288; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8	16	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					72	78		10.1056/NEJMcps0708369	http://dx.doi.org/10.1056/NEJMcps0708369			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592300				2022-12-28	WOS:000279343000012
J	Sarewitz, D				Sarewitz, Daniel			Entertaining science	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					27	27		10.1038/466027a	http://dx.doi.org/10.1038/466027a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	618HW	20595990	Bronze			2022-12-28	WOS:000279343800014
J	Glover, JD; Reganold, JP; Bell, LW; Borevitz, J; Brummer, EC; Buckler, ES; Cox, CM; Cox, TS; Crews, TE; Culman, SW; DeHaan, LR; Eriksson, D; Gill, BS; Holland, J; Hu, F; Hulke, BS; Ibrahim, AMH; Jackson, W; Jones, SS; Murray, SC; Paterson, AH; Ploschuk, E; Sacks, EJ; Snapp, S; Tao, D; Van Tassel, DL; Wade, LJ; Wyse, DL; Xu, Y				Glover, J. D.; Reganold, J. P.; Bell, L. W.; Borevitz, J.; Brummer, E. C.; Buckler, E. S.; Cox, C. M.; Cox, T. S.; Crews, T. E.; Culman, S. W.; DeHaan, L. R.; Eriksson, D.; Gill, B. S.; Holland, J.; Hu, F.; Hulke, B. S.; Ibrahim, A. M. H.; Jackson, W.; Jones, S. S.; Murray, S. C.; Paterson, A. H.; Ploschuk, E.; Sacks, E. J.; Snapp, S.; Tao, D.; Van Tassel, D. L.; Wade, L. J.; Wyse, D. L.; Xu, Y.			Increased Food and Ecosystem Security via Perennial Grains	SCIENCE			English	Editorial Material									[Glover, J. D.; Cox, C. M.; Cox, T. S.; DeHaan, L. R.; Jackson, W.; Van Tassel, D. L.] Land Inst, Salina, KS 67401 USA; [Reganold, J. P.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Bell, L. W.] Commonwealth Sci & Ind Res Org Australia, Sustainable Ecosyst Agr Prod Syst Res Unit, Toowoomba, Qld 4350, Australia; [Borevitz, J.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Brummer, E. C.] Univ Georgia, Inst Plant Breeding Genet & Genom, Athens, GA 30602 USA; [Buckler, E. S.] ARS, USDA, Ithaca, NY 14853 USA; [Buckler, E. S.] Cornell Univ, Inst Genom Divers, Ithaca, NY 14853 USA; [Crews, T. E.] Prescott Coll, Prescott, AZ 86301 USA; [Culman, S. W.; Snapp, S.] Michigan State Univ, Kellogg Biol Stn, Hickory Corners, MI 49060 USA; [Eriksson, D.] Swedish Univ Agr Sci, Dept Plant Breeding & Biotechnol, Alnarp, Sweden; [Gill, B. S.] Kansas State Univ, Wheat Genet & Genom Resources Ctr, Manhattan, KS 66506 USA; [Holland, J.] N Carolina State Univ, USDA ARS, Plant Sci Res Unit, Raleigh, NC 27695 USA; [Hu, F.; Tao, D.] Yunnan Acad Agr Sci, Food Crops Res Inst, Kunming 650205, Peoples R China; [Hulke, B. S.] USDA ARS, Sunflower Res Unit, No Crop Sci Lab, Fargo, ND 58105 USA; [Ibrahim, A. M. H.; Murray, S. C.] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA; [Jones, S. S.] Washington State Univ, Dept Crop & Soil Sci, Mt Vernon, WA 98273 USA; [Paterson, A. H.] Univ Georgia, Plant Genome Mapping Lab, Athens, GA 30602 USA; [Ploschuk, E.] Univ Buenos Aires, Fac Agron, Catedra Cultivos Ind, Buenos Aires, DF, Argentina; [Sacks, E. J.] Univ Illinois, Dept Crop Sci, Urbana, IL 61801 USA; [Wade, L. J.] Charles Sturt Univ, EH Graham Ctr Agr Innovat, Wagga Wagga, NSW 2678, Australia; [Wyse, D. L.] Univ Minnesota, Dept Agron & Plant Genet, St Paul, MN 55108 USA; [Xu, Y.] Int Maize & Wheat Improvement Ctr, Global Maize Program, Mexico City, DF, Mexico	Washington State University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Chicago; University System of Georgia; University of Georgia; United States Department of Agriculture (USDA); Cornell University; Michigan State University; Swedish University of Agricultural Sciences; Kansas State University; United States Department of Agriculture (USDA); University of North Carolina; North Carolina State University; Yunnan Academy of Agricultural Sciences; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Washington State University; University System of Georgia; University of Georgia; University of Buenos Aires; University of Illinois System; University of Illinois Urbana-Champaign; Charles Sturt University; University of Minnesota System; University of Minnesota Twin Cities; CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Glover, JD (corresponding author), Land Inst, Salina, KS 67401 USA.	glover@landinstitute.org	Buckler, Edward/GPS-4932-2022; Wade, Len J/A-8872-2008; Tao, Dayun/AAI-8321-2020; Snapp, Sieg/GWQ-5774-2022; Buckler, Edward/L-7651-2019; Eriksson, Dennis/ABF-5510-2020; Bell, Lindsay/B-9769-2008; Ploschuk, Edmundo/AAO-7875-2020; Eriksson, Dennis/J-4592-2012; DeHaan, Lee R./AAF-5048-2019; Borevitz, Justin/B-5423-2012; Hulke, Brent/GZG-4449-2022; Snapp, Sieglinde S/D-5109-2013; Snapp, Sieglinde/AAU-8121-2020	Wade, Len J/0000-0002-1321-4310; Buckler, Edward/0000-0002-3100-371X; Eriksson, Dennis/0000-0002-5205-3396; DeHaan, Lee R./0000-0002-6368-5241; Borevitz, Justin/0000-0001-8408-3699; Snapp, Sieglinde/0000-0002-9738-0649; Bell, Lindsay/0000-0002-5064-2947; Holland, James/0000-0002-4341-9675; Murray, Seth/0000-0002-2960-8226; Culman, Steve/0000-0003-3985-257X; Tao, Dayun/0000-0002-8884-1589				Bell LW, 2008, AGR SYST, V96, P166, DOI 10.1016/j.agsy.2007.07.007; Cox CM, 2005, PLANT DIS, V89, P1235, DOI 10.1094/PD-89-1235; Cox TS, 2006, BIOSCIENCE, V56, P649, DOI 10.1641/0006-3568(2006)56[649:PFDPGC]2.0.CO;2; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Eriksson D., 2009, THESIS SWEDISH U AGR; Eswaran H., 1999, American Journal of Alternative Agriculture, V14, P129, DOI 10.1017/S0889189300008250; Food and Agriculture Organization of the United Nations (FAO), 2009, STAT FOOD INS WORLD; Glover JD, 2007, SCI AM, V297, P82, DOI 10.1038/scientificamerican0807-82; Glover JD, 2010, AGR ECOSYST ENVIRON, V137, P3, DOI 10.1016/j.agee.2009.11.001; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Monfreda C, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002947; Pimm SL, 2001, WORLD ACCORDING PIMM; Ploschuk EL, 2005, ANN BOT-LONDON, V96, P127, DOI 10.1093/aob/mci158; Qi LL, 2007, CHROMOSOME RES, V15, P3, DOI 10.1007/s10577-006-1108-8; Randall GW, 1997, J ENVIRON QUAL, V26, P1240, DOI 10.2134/jeq1997.00472425002600050007x; Sacks EJ, 2003, CROP SCI, V43, P120, DOI 10.2135/cropsci2003.0120; Snapp S, 2003, HORTSCIENCE, V38, P187, DOI 10.21273/HORTSCI.38.2.187; Tilman D, 2009, SCIENCE, V325, P270, DOI 10.1126/science.1177970; Wallace JS, 2000, AGR ECOSYST ENVIRON, V82, P105, DOI 10.1016/S0167-8809(00)00220-6; Xu YB, 2008, CROP SCI, V48, P391, DOI 10.2135/cropsci2007.04.0191	20	282	294	14	221	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1638	1639		10.1126/science.1188761	http://dx.doi.org/10.1126/science.1188761			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576874				2022-12-28	WOS:000279107400024
J	Snellen, IAG; de Kok, RJ; de Mooij, EJW; Albrecht, S				Snellen, Ignas A. G.; de Kok, Remco J.; de Mooij, Ernst J. W.; Albrecht, Simon			The orbital motion, absolute mass and high-altitude winds of exoplanet HD 209458b	NATURE			English	Article							DAYSIDE SPECTRUM; WATER; ATMOSPHERE; METHANE	For extrasolar planets discovered using the radial velocity method 1, the spectral characterization of the host star leads to a mass estimate of the star and subsequently of the orbiting planet. If the orbital velocity of the planet could be determined, the masses of both star and planet could be calculated using Newton's law of gravity, just as in the case of stellar double-line eclipsing binaries. Here we report high-dispersion ground-based spectroscopy of a transit of the extrasolar planet HD 209458b. We see a significant wavelength shift in absorption lines from carbon monoxide in the planet's atmosphere, which we conclude arises from a change in the radial component of the planet's orbital velocity. The masses of the star and planet are 1.00 +/- 0.22M(Sun) and 0.64 +/- 0.09M(Jup) respectively. A blueshift of the carbon monoxide signal of approximately 2 km s(-1) with respect to the systemic velocity of the host star suggests the presence of a strong wind flowing from the irradiated dayside to the non-irradiated nightside of the planet within the 0.01-0.1 mbar atmospheric pressure range probed by these observations. The strength of the carbon monoxide signal suggests a carbon monoxide mixing ratio of (1-3) x 10(-3) in this planet's upper atmosphere.	[Snellen, Ignas A. G.; de Mooij, Ernst J. W.; Albrecht, Simon] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [de Kok, Remco J.] SRON, NL-3584 CA Utrecht, Netherlands; [Albrecht, Simon] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Albrecht, Simon] MIT, Dept Phys, Cambridge, MA 02139 USA	Leiden University; Leiden University - Excl LUMC; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Snellen, IAG (corresponding author), Leiden Univ, Leiden Observ, Postbus 9513, NL-2300 RA Leiden, Netherlands.	snellen@strw.leidenuniv.nl	de Kok, Remco/U-5637-2019	de Kok, Remco/0000-0001-6906-2662; Snellen, Ignas/0000-0003-1624-3667; de Mooij, Ernst/0000-0001-6391-9266	Netherlands Organisation for Scientific Research (NWO)	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank the ESO support staff of the Paranal Observatory for their help during the observations. This work is based on observations collected at the European Southern Observatory (383.C-0045A). S.A. acknowledges support by a Rubicon fellowship from the Netherlands Organisation for Scientific Research (NWO).	Arsenault R, 2003, P SOC PHOTO-OPT INS, V4839, P174, DOI 10.1117/12.458836; Beaulieu JP, 2010, MON NOT R ASTRON SOC, V409, P963, DOI 10.1111/j.1365-2966.2010.16516.x; Burrows A, 2008, ASTROPHYS J, V682, P1277, DOI 10.1086/589824; Butler RP, 2006, ASTROPHYS J, V646, P505, DOI 10.1086/504701; Cody AM, 2002, ASTROPHYS J, V569, P451, DOI 10.1086/339281; Deming D, 2005, NATURE, V434, P740, DOI 10.1038/nature03507; Fischer DA, 2005, ASTROPHYS J, V622, P1102, DOI 10.1086/428383; Goodman J, 2009, ASTROPHYS J, V693, P1645, DOI 10.1088/0004-637X/693/2/1645; Grillmair CJ, 2008, NATURE, V456, P767, DOI 10.1038/nature07574; Kaufl HU, 2004, P SOC PHOTO-OPT INS, V5492, P1218, DOI 10.1117/12.551480; Knutson HA, 2007, ASTROPHYS J, V655, P564, DOI 10.1086/510111; Laughlin G, 2005, ASTROPHYS J, V629, pL121, DOI 10.1086/444558; Madhusudhan N, 2009, ASTROPHYS J, V707, P24, DOI 10.1088/0004-637X/707/1/24; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; SCHNEIDER J, EXTRASOLAR PLANETS E; Showman AP, 2008, ASTROPHYS J, V682, P559, DOI 10.1086/589325; Swain MR, 2009, ASTROPHYS J, V704, P1616, DOI 10.1088/0004-637X/704/2/1616; Swain MR, 2009, ASTROPHYS J LETT, V690, pL114, DOI 10.1088/0004-637X/690/2/L114; Swain MR, 2008, NATURE, V452, P329, DOI 10.1038/nature06823; Tinetti G, 2007, NATURE, V448, P169, DOI 10.1038/nature06002; [No title captured]	21	459	461	1	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1049	1051		10.1038/nature09111	http://dx.doi.org/10.1038/nature09111			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577209	Green Submitted			2022-12-28	WOS:000279056900046
J	Renehan, A; Smith, U; Kirkman, MS				Renehan, Andrew; Smith, Ulf; Kirkman, M. Sue			Linking diabetes and cancer: a consensus on complexity	LANCET			English	Editorial Material							METAANALYSIS; MELLITUS; RISK; MORTALITY		[Kirkman, M. Sue] Amer Diabet Assoc, Alexandria, VA 22311 USA; [Renehan, Andrew] Univ Manchester, Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Sch Canc & Enabling Sci, Manchester, Lancs, England; [Smith, Ulf] Sahlgrens Univ Hosp, Dept Mol & Clin Med, Lundberg Lab Diabet Res, Gothenburg, Sweden	American Diabetes Association; Christie NHS Foundation Trust; University of Manchester; Sahlgrenska University Hospital	Kirkman, MS (corresponding author), Amer Diabet Assoc, Alexandria, VA 22311 USA.	skirkman@diabetes.org	Renehan, Andrew/K-5992-2015	Renehan, Andrew/0000-0003-4309-4396				*AM CANC SOC, 2008, CANC STAT 2008; Barone BB, 2010, DIABETES CARE, V33, P931, DOI 10.2337/dc09-1721; Barone BB, 2008, JAMA-J AM MED ASSOC, V300, P2754, DOI 10.1001/jama.2008.824; *ECCO, 2007, CANC SCAL PROBL; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Giovannucci E, 2010, CA-CANCER J CLIN, V60, P207, DOI 10.3322/caac.20078; Huxley R, 2005, BRIT J CANCER, V92, P2076, DOI 10.1038/sj.bjc.6602619; International Diabetes Federation, 2009, IDF DIAB ATL; Kasper JS, 2006, CANCER EPIDEM BIOMAR, V15, P2056, DOI 10.1158/1055-9965.EPI-06-0410; Larsson SC, 2005, JNCI-J NATL CANCER I, V97, P1679, DOI 10.1093/jnci/dji375; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Larsson SC, 2008, EUR J CANCER, V44, P2655, DOI 10.1016/j.ejca.2008.07.012; Lipscombe LL, 2005, ARCH INTERN MED, V165, P2090, DOI 10.1001/archinte.165.18.2090; Mitri J, 2008, DIABETES CARE, V31, P2391, DOI 10.2337/dc08-1034; Pocock SJ, 2009, LANCET, V374, P511, DOI 10.1016/S0140-6736(09)61307-6; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; World Cancer Research Fund & American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	19	72	76	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2201	2202		10.1016/S0140-6736(10)60706-4	http://dx.doi.org/10.1016/S0140-6736(10)60706-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	622HS	20609959				2022-12-28	WOS:000279652900008
J	Jacob, Y; Stroud, H; LeBlanc, C; Feng, SH; Zhuo, LT; Caro, E; Hassel, C; Gutierrez, C; Michaels, SD; Jacobsen, SE				Jacob, Yannick; Stroud, Hume; LeBlanc, Chantal; Feng, Suhua; Zhuo, Luting; Caro, Elena; Hassel, Christiane; Gutierrez, Crisanto; Michaels, Scott D.; Jacobsen, Steven E.			Regulation of heterochromatic DNA replication by histone H3 lysine 27 methyltransferases	NATURE			English	Article							ARABIDOPSIS-THALIANA; GENE REPRESSION; METHYLATION; SET; PROTEIN; REREPLICATION; MAINTENANCE; GENOME; PCNA; FORK	Multiple pathways prevent DNA replication from occurring more than once per cell cycle(1). These pathways block re-replication by strictly controlling the activity of pre-replication complexes, which assemble at specific sites in the genome called origins. Here we show that mutations in the homologous histone 3 lysine 27 (H3K27) monomethyltransferases, ARABIDOPSIS TRITHORAX-RELATED PROTEIN5 (ATXR5) and ATXR6, lead to re-replication of specific genomic locations. Most of these locations correspond to transposons and other repetitive and silent elements of the Arabidopsis genome. These sites also correspond to high levels of H3K27 monomethylation, and mutation of the catalytic SET domain is sufficient to cause the re-replication defect. Mutation of ATXR5 and ATXR6 also causes upregulation of transposon expression and has pleiotropic effects on plant development. These results uncover a novel pathway that prevents over-replication of heterochromatin in Arabidopsis.	[Jacob, Yannick; LeBlanc, Chantal; Zhuo, Luting; Hassel, Christiane; Michaels, Scott D.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Stroud, Hume; Caro, Elena; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Feng, Suhua; Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Gutierrez, Crisanto] Univ Autonoma Madrid, CSIC, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain	Indiana University System; Indiana University Bloomington; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Michaels, SD (corresponding author), Indiana Univ, Dept Biol, 915 E 3rd St, Bloomington, IN 47405 USA.	michaels@indiana.edu; jacobsen@ucla.edu	Caro, Elena/G-6352-2012; Gutierrez, Crisanto/ABH-8782-2020; Michaels, Scott/D-5458-2009; Caro, Elena/A-8097-2011; Caro, Elena/D-2611-2014	Caro, Elena/0000-0002-1034-1621; Michaels, Scott/0000-0001-5248-3487; Gutierrez, Crisanto/0000-0001-8905-8222	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT); National Institutes of Health [GM075060]; Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation [BFU2009-9783, CSD2007-57B]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075060] Funding Source: NIH RePORTER	Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT)(FQRNT); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Indiana METACyt Initiative of Indiana University; Lilly Endowment, Inc.; Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Lambert and D. Galbraith for assistance with flow cytometry; Y. Bernatavichute for assistance with ChIP experiments; and M. Pellegrini and S. Cokus for advice on data analyses. Y.J. was supported by a fellowship from Le Fonds Quebecois de la Recherche sur la Nature et les Technologies (FQRNT). S. F. is a Howard Hughes Medical Institute Fellow of the Life Science Research Foundation. Research in the Michaels' laboratory was supported by grants from the National Institutes of Health (GM075060), the Indiana METACyt Initiative of Indiana University, and the Lilly Endowment, Inc. C. G. was supported by grants from the Spanish Ministry of Science and Innovation (BFU2009-9783 and CSD2007-57B). S.E.J. is an investigator of the Howard Hughes Medical Institute.	Arias EE, 2007, GENE DEV, V21, P497, DOI 10.1101/gad.1508907; Bernatavichute YV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003156; Caro Elena, 2008, SEB Exp Biol Ser, V59, P167; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Davidson IF, 2006, MOL CELL, V24, P433, DOI 10.1016/j.molcel.2006.09.010; Dillon SC, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-227; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Fransz P, 2006, CHROMOSOME RES, V14, P71, DOI 10.1007/s10577-005-1022-5; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; GALBRAITH DW, 1991, PLANT PHYSIOL, V96, P985, DOI 10.1104/pp.96.3.985; Gomez M, 2008, CELL CYCLE, V7, P1313, DOI 10.4161/cc.7.10.5881; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jeddeloh JA, 1999, NAT GENET, V22, P94, DOI 10.1038/8803; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Joshi P, 2008, J BIOL CHEM, V283, P27757, DOI 10.1074/jbc.M804442200; Lan F, 2007, NATURE, V448, P718, DOI 10.1038/nature06034; Lindroth AM, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600430; Malagnac F, 2002, EMBO J, V21, P6842, DOI 10.1093/emboj/cdf687; Mathieu O, 2005, EMBO J, V24, P2783, DOI 10.1038/sj.emboj.7600743; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Musselman CA, 2009, MOL INTERV, V9, P314, DOI 10.1124/mi.9.6.7; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Soppe WJJ, 2002, EMBO J, V21, P6549, DOI 10.1093/emboj/cdf657; VONGS A, 1993, SCIENCE, V260, P1926, DOI 10.1126/science.8316832; Zhang L, 2009, NEURAL REGEN RES, V4, P10	29	126	132	0	107	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 19	2010	466	7309					987	U117		10.1038/nature09290	http://dx.doi.org/10.1038/nature09290			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	640ED	20631708	Green Accepted			2022-12-28	WOS:000281030300037
J	Yan, JS; Aldrich, RW				Yan, Jiusheng; Aldrich, Richard W.			LRRC26 auxiliary protein allows BK channel activation at resting voltage without calcium	NATURE			English	Article							LEUCINE-RICH REPEAT; POTASSIUM CHANNELS; BETA-SUBUNITS; CLONING; SENSOR; CELLS; EXPRESSION; HKCNMB3; FAMILY; CANCER	Large-conductance, voltage-and calcium-activated potassium (BK, or K(Ca)1.1) channels are ubiquitously expressed in electrically excitable and non-excitable cells(1,2), either as alpha-subunit (BK alpha) tetramers or together with tissue specific auxiliary beta-subunits (beta 1-beta 4)(3-5). Activation of BK channels typically requires coincident membrane depolarization and elevation in free cytosolic Ca2+ concentration ([Ca2+](i))(6,7), which are not physiological conditions for most non-excitable cells. Here we present evidence that in non-excitable LNCaP prostate cancer cells, BK channels can be activated at negative voltages without rises in [Ca2+](i) through their complex with an auxiliary protein, leucine-rich repeat (LRR)-containing protein 26 (LRRC26). LRRC26 modulates the gating of a BK channel by enhancing the allosteric coupling between voltage-sensor activation and the channel's closed-open transition. This finding reveals a novel auxiliary protein of a voltage- gated ion channel that gives an unprecedentedly large negative shift (similar to-140 mV) in voltage dependence and provides a molecular basis for activation of BK channels at physiological voltages and calcium levels in non-excitable cells.	[Yan, Jiusheng; Aldrich, Richard W.] Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Aldrich, RW (corresponding author), Univ Texas Austin, Ctr Learning & Memory, Neurobiol Sect, Austin, TX 78712 USA.	raldrich@mail.utexas.edu			American Heart Association	American Heart Association(American Heart Association)	We are grateful to I. Pastan and X. F. Liu for the generous gift of LRRC26 antibody and plasmids. We thank J. Trimmer for discussion and W. Li, L. Scott, J. Greeson, X. Chen and H. Liu for reading the manuscript. We thank A. Hall, H. Cha and U. Bagaria for research assistance. Mass spectrometry was performed at the UC Davis Proteomics Facility. J. Y. acknowledges postdoctoral fellowship support from the American Heart Association.	Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; BARRETT JN, 1982, J PHYSIOL-LONDON, V331, P211, DOI 10.1113/jphysiol.1982.sp014370; Behrens R, 2000, FEBS LETT, V474, P99, DOI 10.1016/S0014-5793(00)01584-2; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Bloch M, 2007, ONCOGENE, V26, P2525, DOI 10.1038/sj.onc.1210036; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Cambien B, 2008, INT J CANCER, V123, P365, DOI 10.1002/ijc.23511; Egland KA, 2006, P NATL ACAD SCI USA, V103, P5929, DOI 10.1073/pnas.0601296103; Fodor AA, 2009, ANNU REV PHYSIOL, V71, P19, DOI 10.1146/annurev.physiol.010908.163124; Gessner G, 2005, J MEMBRANE BIOL, V208, P229, DOI 10.1007/s00232-005-0830-z; Horrigan FT, 2008, J GEN PHYSIOL, V131, P13, DOI 10.1085/jgp.200709877; Horrigan FT, 2002, J GEN PHYSIOL, V120, P267, DOI 10.1085/jgp.20028605; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; KOLB HA, 1990, REV PHYSIOL BIOCH P, V115, P51; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Salkoff L, 2006, NAT REV NEUROSCI, V7, P921, DOI 10.1038/nrn1992; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Tang XD, 2004, NAT STRUCT MOL BIOL, V11, P171, DOI 10.1038/nsmb725; Thurm H, 2005, J PHYSIOL-LONDON, V569, P137, DOI 10.1113/jphysiol.2005.094680; Uebele VN, 2000, J BIOL CHEM, V275, P23211, DOI 10.1074/jbc.M910187199; Wang B, 2006, J GEN PHYSIOL, V127, P449, DOI 10.1085/jgp.200509436; Weaver AK, 2004, J NEUROSCI RES, V78, P224, DOI 10.1002/jnr.20240; Xia XM, 2002, NATURE, V418, P880, DOI 10.1038/nature00956; Yan JS, 2008, MOL CELL PROTEOMICS, V7, P2188, DOI 10.1074/mcp.M800063-MCP200; Yang HH, 2008, NAT STRUCT MOL BIOL, V15, P1152, DOI 10.1038/nsmb.1507	28	164	168	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					513	U15		10.1038/nature09162	http://dx.doi.org/10.1038/nature09162			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613726				2022-12-28	WOS:000280141200041
J	Mandavilli, A				Mandavilli, Apoorva			HIV/AIDS	NATURE			English	Editorial Material																			0	0	0	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S1	S1		10.1038/466S1a	http://dx.doi.org/10.1038/466S1a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	625BP	20631695	Bronze			2022-12-28	WOS:000279867100022
J	Pallares-Sanmartin, A; Leiro-Fernandez, V; Cebreiro, TL; Botana-Rial, M; Fernandez-Villar, A				Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto			Validity and Reliability of the Schamroth Sign for the Diagnosis of Clubbing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Pallares-Sanmartin, Abel; Leiro-Fernandez, Virginia; Lourido Cebreiro, Tamara; Botana-Rial, Maribel; Fernandez-Villar, Alberto] Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain	Complexo Hospitalario Universitario de Vigo	Pallares-Sanmartin, A (corresponding author), Complexo Hosp Univ Vigo, Pulmonol Serv, Vigo, Spain.	alberto.fernandez.villar@sergas.es	Fernandez, Virginia Leiro/B-9679-2018	Fernandez, Virginia Leiro/0000-0001-9613-430X; Lourido Cebreiro, Tamara/0000-0002-0391-898X; FERNANDEZ-VILLAR, ALBERTO/0000-0001-7407-5249				[Anonymous], 2007, EVIDENCE BASED PHYS; LAMPE RM, 1983, CLIN PEDIATR, V22, P125, DOI 10.1177/000992288302200207; Martinez-Lavin M, 2007, SEMIN ARTHRITIS RHEU, V36, P380, DOI 10.1016/j.semarthrit.2006.11.004; Maslovsky I, 2005, AM J MED, V118, P1350, DOI 10.1016/j.amjmed.2005.09.036; Myers KA, 2001, JAMA-J AM MED ASSOC, V286, P341, DOI 10.1001/jama.286.3.341; SCHAMROTH L, 1976, S AFR MED J, V50, P297	6	9	9	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					159	161		10.1001/jama.2010.935	http://dx.doi.org/10.1001/jama.2010.935			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628128				2022-12-28	WOS:000279811000020
J	Basaria, S; Coviello, AD; Travison, TG; Storer, TW; Farwell, WR; Jette, AM; Eder, R; Tennstedt, S; Ulloor, J; Zhang, AQ; Choong, K; Lakshman, KM; Mazer, NA; Miciek, R; Krasnoff, J; Elmi, A; Knapp, PE; Brooks, B; Appleman, E; Aggarwal, S; Bhasin, G; Hede-Brierley, L; Bhatia, A; Collins, L; LeBrasseur, N; Fiore, LD; Bhasin, S				Basaria, Shehzad; Coviello, Andrea D.; Travison, Thomas G.; Storer, Thomas W.; Farwell, Wildon R.; Jette, Alan M.; Eder, Richard; Tennstedt, Sharon; Ulloor, Jagadish; Zhang, Anqi; Choong, Karen; Lakshman, Kishore M.; Mazer, Norman A.; Miciek, Renee; Krasnoff, Joanne; Elmi, Ayan; Knapp, Philip E.; Brooks, Brad; Appleman, Erica; Aggarwal, Sheetal; Bhasin, Geeta; Hede-Brierley, Leif; Bhatia, Ashmeet; Collins, Lauren; LeBrasseur, Nathan; Fiore, Louis D.; Bhasin, Shalender			Adverse Events Associated with Testosterone Administration	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANABOLIC-ANDROGENIC STEROIDS; OLDER MEN; MUSCLE STRENGTH; CARDIOVASCULAR-DISEASE; PHYSICAL FUNCTION; BODY-COMPOSITION; DOUBLE-BLIND; ENDOGENOUS TESTOSTERONE; FUNCTIONAL LIMITATIONS; SERUM TESTOSTERONE	BACKGROUND Testosterone supplementation has been shown to increase muscle mass and strength in healthy older men. The safety and efficacy of testosterone treatment in older men who have limitations in mobility have not been studied. METHODS Community-dwelling men, 65 years of age or older, with limitations in mobility and a total serum testosterone level of 100 to 350 ng per deciliter (3.5 to 12.1 nmol per liter) or a free serum testosterone level of less than 50 pg per milliliter (173 pmol per liter) were randomly assigned to receive placebo gel or testosterone gel, to be applied daily for 6 months. Adverse events were categorized with the use of the Medical Dictionary for Regulatory Activities classification. The data and safety monitoring board recommended that the trial be discontinued early because there was a significantly higher rate of adverse cardiovascular events in the testosterone group than in the placebo group. RESULTS A total of 209 men (mean age, 74 years) were enrolled at the time the trial was terminated. At baseline, there was a high prevalence of hypertension, diabetes, hyperlipidemia, and obesity among the participants. During the course of the study, the testosterone group had higher rates of cardiac, respiratory, and dermatologic events than did the placebo group. A total of 23 subjects in the testosterone group, as compared with 5 in the placebo group, had cardiovascular-related adverse events. The relative risk of a cardiovascular-related adverse event remained constant throughout the 6-month treatment period. As compared with the placebo group, the testosterone group had significantly greater improvements in leg-press and chest-press strength and in stair climbing while carrying a load. CONCLUSIONS In this population of older men with limitations in mobility and a high prevalence of chronic disease, the application of a testosterone gel was associated with an increased risk of cardiovascular adverse events. The small size of the trial and the unique population prevent broader inferences from being made about the safety of testosterone therapy. (ClinicalTrials.gov number, NCT00240981.)	[Basaria, Shehzad; Coviello, Andrea D.; Travison, Thomas G.; Storer, Thomas W.; Eder, Richard; Ulloor, Jagadish; Zhang, Anqi; Choong, Karen; Lakshman, Kishore M.; Mazer, Norman A.; Miciek, Renee; Krasnoff, Joanne; Elmi, Ayan; Knapp, Philip E.; Brooks, Brad; Appleman, Erica; Aggarwal, Sheetal; Bhasin, Geeta; Hede-Brierley, Leif; Bhatia, Ashmeet; Collins, Lauren; LeBrasseur, Nathan; Bhasin, Shalender] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA; [Basaria, Shehzad; Coviello, Andrea D.; Travison, Thomas G.; Storer, Thomas W.; Eder, Richard; Ulloor, Jagadish; Zhang, Anqi; Choong, Karen; Lakshman, Kishore M.; Mazer, Norman A.; Miciek, Renee; Krasnoff, Joanne; Elmi, Ayan; Knapp, Philip E.; Brooks, Brad; Appleman, Erica; Aggarwal, Sheetal; Bhasin, Geeta; Hede-Brierley, Leif; Bhatia, Ashmeet; Collins, Lauren; LeBrasseur, Nathan; Bhasin, Shalender] Boston Med Ctr, Boston, MA USA; [Travison, Thomas G.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Jette, Alan M.] Boston Univ, Sch Publ Hlth, Hlth & Disabil Res Inst, Boston, MA 02118 USA; [Farwell, Wildon R.] Brigham & Womens Hosp, Dept Med, Div Aging, Boston, MA 02115 USA; [Farwell, Wildon R.] Harvard Univ, Sch Med, Boston, MA USA; [Farwell, Wildon R.; Fiore, Louis D.] VA Boston Healthcare Syst, Jamaica Plain, MA USA; [Tennstedt, Sharon] New England Res Inst, Watertown, MA 02172 USA	Boston University; Boston Medical Center; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; HealthCore, Inc	Bhasin, S (corresponding author), Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, 670 Albany St, Boston, MA 02118 USA.	bhasin@bu.edu	Mazer, Norman A/HGU-8266-2022	Basaria, Shehzad/0000-0002-8533-2383; LeBrasseur, Nathan/0000-0002-2002-0418; Knapp, Philip/0000-0002-5290-6125; Zhang, Anqi/0000-0003-3723-8293; Krasnoff, Joanne B./0000-0002-0285-7521; Jette, Alan/0000-0002-2117-9973; Coviello, Andrea/0000-0003-0244-9787; Basaria, Shehzad/0000-0003-1749-8549	National Institutes on Aging [1UO1AG14369]; Boston Claude D. Pepper Older Americans Independence Center [5P30AG031679]; Boston University Clinical and Translational Science Institute [1UL1RR025771]; Novartis; GlaxoSmithKline; Solvay Pharmaceuticals; Merck; Ligand Pharmaceuticals; Lipocine and Solvay Pharmaceuticals; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG014369, R01AG037193, P30AG031679] Funding Source: NIH RePORTER	National Institutes on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Boston Claude D. Pepper Older Americans Independence Center; Boston University Clinical and Translational Science Institute; Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Solvay Pharmaceuticals(Solvay SA); Merck(Merck & Company); Ligand Pharmaceuticals; Lipocine and Solvay Pharmaceuticals(Solvay SA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Supported primarily by the National Institutes on Aging under a cooperative agreement (1UO1AG14369). Additional support was provided by grants from the Boston Claude D. Pepper Older Americans Independence Center (5P30AG031679) and the Boston University Clinical and Translational Science Institute (1UL1RR025771). A part of the work was supported by the resources and facilities of the Veterans Affairs Boston Healthcare System. Testosterone and placebo gel for the study were provided by Auxilium Pharmaceuticals, Norristown, PA.; Dr. Bhasin reports receiving consulting fees and payments for travel or accommodation expenses from Novartis and GlaxoSmithKline and grant support from Solvay Pharmaceuticals, Merck, and Ligand Pharmaceuticals; Dr. Coviello, receiving compensation from Endo Pharmaceuticals for participation in a 1-day discussion group; Dr. Mazer, receiving consulting fees from Lipocine and Solvay Pharmaceuticals and a fee for expert testimony from Watson Laboratories and being a full-time employee of Hoffmann-La Roche Pharmaceuticals; and Dr. Tennstedt, receiving grant support from Auxilium for data analysis. No other potential conflict of interest relevant to this article was reported.	AJAYI AAL, 1995, CIRCULATION, V91, P2742, DOI 10.1161/01.CIR.91.11.2742; Araujo AB, 2008, J AM GERIATR SOC, V56, P2000, DOI 10.1111/j.1532-5415.2008.01965.x; Baumgartner RN, 1999, MECH AGEING DEV, V107, P123, DOI 10.1016/S0047-6374(98)00130-4; Bhasin S, 2005, J CLIN ENDOCR METAB, V90, P678, DOI 10.1210/jc.2004-1184; Bhasin S, 2000, JAMA-J AM MED ASSOC, V283, P763, DOI 10.1001/jama.283.6.763; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/NEJM199607043350101; Bhasin S, 2010, J CLIN ENDOCR METAB, V95, P2536, DOI 10.1210/jc.2009-2354; Brockenbrough AT, 2006, AM J KIDNEY DIS, V47, P251, DOI 10.1053/j.ajkd.2005.10.022; Calof OM, 2005, J GERONTOL A-BIOL, V60, P1451, DOI 10.1093/gerona/60.11.1451; Caminiti G, 2009, J AM COLL CARDIOL, V54, P919, DOI 10.1016/j.jacc.2009.04.078; D'Andrea A, 2007, BRIT J SPORT MED, V41, P149, DOI 10.1136/bjsm.2006.030171; Emmelot-Vonk MH, 2008, JAMA-J AM MED ASSOC, V299, P39, DOI 10.1001/jama.2007.51; Ferrando AA, 2002, AM J PHYSIOL-ENDOC M, V282, pE601, DOI 10.1152/ajpendo.00362.2001; Fried LP, 1998, JAMA-J AM MED ASSOC, V279, P585, DOI 10.1001/jama.279.8.585; Gardener EA, 2006, J GEN INTERN MED, V21, P1091, DOI 10.1111/j.1525-1497.2006.00564.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haddad RM, 2007, MAYO CLIN PROC, V82, P29; Hennekens CH, 2009, JAMA-J AM MED ASSOC, V302, P2361, DOI 10.1001/jama.2009.1756; Johannsson G, 2005, J CLIN ENDOCR METAB, V90, P3989, DOI 10.1210/jc.2005-0553; Karila TAM, 2003, INT J SPORTS MED, V24, P337; KELLYHAYES M, 1992, AM J PUBLIC HEALTH, V82, P841, DOI 10.2105/AJPH.82.6.841; Kenny AM, 2002, J GERONTOL A-BIOL, V57, pM460, DOI 10.1093/gerona/57.7.M460; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; KRASNOFF JB, 2010, J CLIN ENDOCRIN 0409; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; LeBrasseur NK, 2008, J AM GERIATR SOC, V56, P2118, DOI 10.1111/j.1532-5415.2008.01953.x; LeBrasseur NK, 2009, CONTEMP CLIN TRIALS, V30, P133, DOI 10.1016/j.cct.2008.10.005; LUNDH B, 1971, SCAND J CLIN LAB INV, V28, P71, DOI 10.3109/00365517109090665; Maggio M, 2007, ARCH INTERN MED, V167, P2249, DOI 10.1001/archinte.167.20.2249; Malkin CJ, 2006, EUR HEART J, V27, P57, DOI 10.1093/eurheartj/ehi443; Marks LS, 2006, JAMA-J AM MED ASSOC, V296, P2351, DOI 10.1001/jama.296.19.2351; Mazer NA, 2010, STEROIDS, V75, P517, DOI 10.1016/j.steroids.2010.03.003; Mazer NA, 2009, STEROIDS, V74, P512, DOI 10.1016/j.steroids.2009.01.008; Menke A, 2010, AM J EPIDEMIOL, V171, P583, DOI 10.1093/aje/kwp415; Fernandez-Balsells MM, 2010, J CLIN ENDOCR METAB, V95, P2560, DOI 10.1210/jc.2009-2575; Metter EJ, 2005, J GERONTOL A-BIOL, V60, P840, DOI 10.1093/gerona/60.7.840; Nair KS, 2006, NEW ENGL J MED, V355, P1647, DOI 10.1056/NEJMoa054629; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Newman AB, 2001, J GERONTOL A-BIOL, V56, pM158, DOI 10.1093/gerona/56.3.M158; Orwoll E, 2006, ARCH INTERN MED, V166, P2124, DOI 10.1001/archinte.166.19.2124; Ostchega Y, 2000, J AM GERIATR SOC, V48, P1132, DOI 10.1111/j.1532-5415.2000.tb04791.x; Page ST, 2005, J CLIN ENDOCR METAB, V90, P1502, DOI 10.1210/jc.2004-1933; Quan A, 2004, AM J PHYSIOL-RENAL, V287, pF452, DOI 10.1152/ajprenal.00188.2003; Roy TA, 2002, AM J PHYSIOL-ENDOC M, V283, pE284, DOI 10.1152/ajpendo.00334.2001; Salameh WA, 2010, STEROIDS, V75, P169, DOI 10.1016/j.steroids.2009.11.004; Schaap LA, 2005, CLIN ENDOCRINOL, V63, P152, DOI 10.1111/j.1365-2265.2005.02315.x; Sih R, 1997, J CLIN ENDOCR METAB, V82, P1661, DOI 10.1210/jc.82.6.1661; Snyder PJ, 1999, J CLIN ENDOCR METAB, V84, P2647, DOI 10.1210/jc.84.8.2647; Srinivas-Shankar U, 2010, J CLIN ENDOCR METAB, V95, P639, DOI 10.1210/jc.2009-1251; Steidle C, 2003, J CLIN ENDOCR METAB, V88, P2673, DOI 10.1210/jc.2002-021058; Storer TW, 2003, J CLIN ENDOCR METAB, V88, P1478, DOI 10.1210/jc.2002-021231; Tan R S, 2003, Aging Male, V6, P13, DOI 10.1080/713604736; TENOVER JS, 1992, J CLIN ENDOCR METAB, V75, P1092, DOI 10.1210/jc.75.4.1092; von Bonsdorff M, 2006, GERONTOLOGY, V52, P359, DOI 10.1159/000094985; Wittert GA, 2003, J GERONTOL A-BIOL, V58, P618	55	993	1020	1	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 8	2010	363	2					109	122		10.1056/NEJMoa1000485	http://dx.doi.org/10.1056/NEJMoa1000485			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621JY	20592293	Green Accepted			2022-12-28	WOS:000279574100004
J	Boiko, AD; Razorenova, OV; van de Rijn, M; Swetter, SM; Johnson, DL; Ly, DP; Butler, PD; Yang, GP; Joshua, B; Kaplan, MJ; Longaker, MT; Weissman, IL				Boiko, Alexander D.; Razorenova, Olga V.; van de Rijn, Matt; Swetter, Susan M.; Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Joshua, Benzion; Kaplan, Michael J.; Longaker, Michael T.; Weissman, Irving L.			Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271	NATURE			English	Article							CANCER STEM-CELLS; PROSPECTIVE IDENTIFICATION; PROGENITORS	The question of whether tumorigenic cancer stem cells exist in human melanomas has arisen in the last few years(1). Here we show that in melanomas, tumour stem cells (MTSCs, for melanoma tumour stem cells) can be isolated prospectively as a highly enriched CD271(+) MTSC population using a process that maximizes viable cell transplantation(1,2). The tumours sampled in this study were taken from a broad spectrum of sites and stages. High-viability cells isolated by fluorescence-activated cell sorting and re-suspended in a matrigel vehicle were implanted into T-, B- and natural-killer-deficient Rag2(-/-) gamma c(-/-) mice. The CD271(+) subset of cells was the tumour-initiating population in 90% (nine out of ten) of melanomas tested. Transplantation of isolated CD271(+) melanoma cells into engrafted human skin or bone in Rag2(-/-) gamma c(-/-) mice resulted in melanoma; however, melanoma did not develop after transplantation of isolated CD271(-) cells. We also show that in mice, tumours derived from transplanted human CD271(-) melanoma cells were capable of metastatsis in vivo. CD271(+) melanoma cells lacked expression of TYR, MART1 and MAGE in 86%, 69% and 68% of melanoma patients, respectively, which helps to explain why T-cell therapies directed at these antigens usually result in only temporary tumour shrinkage.	[Boiko, Alexander D.; Longaker, Michael T.; Weissman, Irving L.] Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA; [Razorenova, Olga V.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA; [van de Rijn, Matt; Weissman, Irving L.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Pathol, Stanford, CA 94305 USA; [Swetter, Susan M.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Dermatol,Pigmented Les & Melanoma Program, Stanford, CA 94305 USA; [Swetter, Susan M.; Yang, George P.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA 94304 USA; [Johnson, Denise L.; Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Surg, Stanford, CA 94305 USA; [Ly, Daphne P.; Butler, Paris D.; Yang, George P.; Longaker, Michael T.] Stanford Univ, Sch Med, Dept Surg, Hagey Lab Pediat Regenerat Med,Div Plast & Recons, Stanford, CA 94305 USA; [Joshua, Benzion; Kaplan, Michael J.] Stanford Univ, Med Ctr, Stanford Canc Ctr, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA	Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; Stanford Cancer Institute; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford Cancer Institute; Stanford University; Stanford University; Stanford Cancer Institute; Stanford University	Boiko, AD (corresponding author), Stanford Univ, Sch Med, Stanford Canc Ctr, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94304 USA.	aboiko@stanford.edu; irv@stanford.edu	Ferris, Laura/I-7689-2012; Razorenova, Olga V/A-6400-2014	Rinner, Beate/0000-0002-6340-4905; van de Rijn, Matt/0000-0002-1909-9739; Joshua, Ben-Zion/0000-0002-2010-892X	American Cancer Society; NIH [F32 CA126252, 1RC2 DE02077-01]; Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR [UL1 RR025744]; Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE [F32CA126252] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001085] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025744] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia & D.K. Ludwig Fund for Cancer Research; NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Oak Foundation; Ellenburg Faculty Scholar Endowment; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank J. Bueno and S. Hicks for obtaining patient consent and specimens; K. Montgomery for immunohistochemistry analyses; D. Kim for NSG bone-grafted mice; K. Chan, L. Ailles and C. Park for advice and help in FACS and tumour transplantation assays; L. Cohen for MAGE antibodies; L. Jerabek, T. Storm and A. Mosley for laboratory and mouse management; P. Lovelace for FACS management; A. Olson for help with microscopy; all members of the Weissman Laboratory for experimental suggestions; and M. Clarke and members of his laboratory for critical discussions and reading. This research was initially supported in part by the American Cancer Society fellowship and in part by NIH F32 CA126252 NRSA fellowship to A. D. B.; the Virginia & D.K. Ludwig Fund for Cancer Research to I. L. W.; NIH/NCRR CTSA grant UL1 RR025744 to Stanford Spectrum M.v.d.R.; The Oak Foundation and NIH 1RC2 DE02077-01 to M. T. L.; the Oak Foundation and Ellenburg Faculty Scholar Endowment to G.P.Y.	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Chan KS, 2009, P NATL ACAD SCI USA, V106, P14016, DOI 10.1073/pnas.0906549106; CHESA PG, 1988, J HISTOCHEM CYTOCHEM, V36, P383, DOI 10.1177/36.4.2831267; Cormier JN, 1997, CANCER J, V3, P37; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Eaves CJ, 2008, NATURE, V456, P581, DOI 10.1038/456581a; HERIN M, 1987, INT J CANCER, V39, P390, DOI 10.1002/ijc.2910390320; Iwamoto S, 1996, J AM ACAD DERMATOL, V35, P725, DOI 10.1016/S0190-9622(96)90728-8; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; La Porta C, 2009, STEM CELL REV REP, V5, P61, DOI 10.1007/s12015-008-9048-7; MARCHETTI D, 1993, INT J CANCER, V55, P692, DOI 10.1002/ijc.2910550430; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Passegue E, 2009, NAT MED, V15, P612, DOI [10.1038/nm0109-23, 10.1038/nm0609-612]; Pietra G, 2009, INT IMMUNOL, V21, P793, DOI 10.1093/intimm/dxp047; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rosenberg SA, 1996, J NATL CANCER I, V88, P1635, DOI 10.1093/jnci/88.22.1635; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Scheibenbogen C, 2000, J IMMUNOTHER, V23, P275, DOI 10.1097/00002371-200003000-00012; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2003, CANCER RES, V63, P5821; Truzzi F, 2008, J INVEST DERMATOL, V128, P2031, DOI 10.1038/jid.2008.21; VANDERBRUGGEN P, 1991, SCIENCE, V254, P1643, DOI 10.1126/science.1840703; Weissman I, 2005, JAMA-J AM MED ASSOC, V294, P1359, DOI 10.1001/jama.294.11.1359	30	538	557	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					133	U155		10.1038/nature09161	http://dx.doi.org/10.1038/nature09161			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596026	Green Accepted, Green Submitted			2022-12-28	WOS:000279343800049
J	Llopis, PM; Jackson, AF; Sliusarenko, O; Surovtsev, I; Heinritz, J; Emonet, T; Jacobs-Wagner, C				Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Emonet, Thierry; Jacobs-Wagner, Christine			Spatial organization of the flow of genetic information in bacteria	NATURE			English	Article							CELL-CYCLE PROGRESSION; MESSENGER-RNA DECAY; ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; TRANSCRIPTION; TRANSLATION; EXPRESSION; DNA; VISUALIZATION; LOCALIZATION	Eukaryotic cells spatially organize mRNA processes such as translation and mRNA decay. Much less is clear in bacterial cells where the spatial distribution of mature mRNA remains ambiguous. Using a sensitive method based on quantitative fluorescence in situ hybridization, we show here that in Caulobacter crescentus and Escherichia coli, chromosomally expressed mRNAs largely display limited dispersion from their site of transcription during their lifetime. We estimate apparent diffusion coefficients at least two orders of magnitude lower than expected for freely diffusing mRNA, and provide evidence in C. crescentus that this mRNA localization restricts ribosomal mobility. Furthermore, C. crescentus RNase E appears associated with the DNA independently of its mRNA substrates. Collectively, our findings show that bacteria can spatially organize translation and, potentially, mRNA decay by using the chromosome layout as a template. This chromosome-centric organization has important implications for cellular physiology and for our understanding of gene expression in bacteria.	[Llopis, Paula Montero; Jackson, Audrey F.; Sliusarenko, Oleksii; Emonet, Thierry; Jacobs-Wagner, Christine] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Sliusarenko, Oleksii; Surovtsev, Ivan; Heinritz, Jennifer; Jacobs-Wagner, Christine] Yale Univ, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Emonet, Thierry] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Jacobs-Wagner, Christine] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University; Yale University; Yale University	Jacobs-Wagner, C (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	christine.jacobs-wagner@yale.edu	Emonet, Thierry/AAI-3740-2020; Llopis, Paula Montero/AAG-2853-2019	Jacobs-Wagner, Christine/0000-0003-0980-5334	Howard Hughes Medical Institute; National Institutes of Health [GM065835]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065835] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Angelastro, N. Ausmees, T. Cox, I. Golding, H. Lam, D. S. Peabody, D Leach, D. J. Sherratt and P. Viollier for strains and constructs, M. Cabeen for editorial help, and S. R. Kushner, J. Belasco, K. C. Huang, the Lambda lunch group at NIH, and the Jacobs-Wagner laboratory for valuable discussions. This work was funded in part by a Howard Hughes Medical Institute Predoctoral Fellowship (to A. F. J.), the National Institutes of Health (GM065835 to C.J.-W.) and the Howard Hughes Medical Institute.	Avedissian M, 1996, MOL MICROBIOL, V19, P79, DOI 10.1046/j.1365-2958.1996.347879.x; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Briegel A, 2006, MOL MICROBIOL, V62, P5, DOI 10.1111/j.1365-2958.2006.05355.x; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Deana A, 2005, GENE DEV, V19, P2526, DOI 10.1101/gad.1348805; Derman AI, 2008, MOL MICROBIOL, V67, P935, DOI 10.1111/j.1365-2958.2007.06066.x; Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; ELY B, 1991, METHOD ENZYMOL, V204, P372; Epshtein V, 2003, SCIENCE, V300, P801, DOI 10.1126/science.1083219; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; Fang G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-4; FORCHHAMMER J, 1971, J MOL BIOL, V55, P563, DOI 10.1016/0022-2836(71)90337-8; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Golding I, 2004, P NATL ACAD SCI USA, V101, P11310, DOI 10.1073/pnas.0404443101; Guet CC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn329; Jensen RB, 1999, P NATL ACAD SCI USA, V96, P10661, DOI 10.1073/pnas.96.19.10661; Khemici V, 2008, MOL MICROBIOL, V70, P799, DOI 10.1111/j.1365-2958.2008.06454.x; Lau IF, 2003, MOL MICROBIOL, V49, P731, DOI 10.1046/j.1365-2958.2003.03640.x; Lewis PJ, 2000, EMBO J, V19, P710, DOI 10.1093/emboj/19.4.710; LIM F, 1994, NUCLEIC ACIDS RES, V22, P3748, DOI 10.1093/nar/22.18.3748; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Mangan EK, 1999, J BACTERIOL, V181, P6160, DOI 10.1128/JB.181.19.6160-6170.1999; Mascarenhas J, 2001, EMBO REP, V2, P685, DOI 10.1093/embo-reports/kve160; MILLER OL, 1970, SCIENCE, V169, P392, DOI 10.1126/science.169.3943.392; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Passalacqua KD, 2009, J BACTERIOL, V191, P3203, DOI 10.1128/JB.00122-09; Pilhofer M, 2009, SYST APPL MICROBIOL, V32, P186, DOI 10.1016/j.syapm.2008.12.007; Taghbalout A, 2007, P NATL ACAD SCI USA, V104, P1667, DOI 10.1073/pnas.0610491104; Tamames J, 2001, GENOME BIOL, V2; Valencia-Burton M, 2007, NAT METHODS, V4, P421, DOI 10.1038/NMETH1023; Valencia-Burton M, 2009, P NATL ACAD SCI USA, V106, P16399, DOI 10.1073/pnas.0907495106; Viollier PH, 2004, CURR OPIN MICROBIOL, V7, P572, DOI 10.1016/j.mib.2004.10.005; Viollier PH, 2004, P NATL ACAD SCI USA, V101, P9257, DOI 10.1073/pnas.0402606101; VOGEL U, 1994, J BACTERIOL, V176, P2807, DOI 10.1128/JB.176.10.2807-2813.1994; Ward D, 1997, MOL MICROBIOL, V26, P897, DOI 10.1046/j.1365-2958.1997.6242005.x; Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2; YARCHUK O, 1992, J MOL BIOL, V226, P581, DOI 10.1016/0022-2836(92)90617-S	38	275	279	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					77	U90		10.1038/nature09152	http://dx.doi.org/10.1038/nature09152			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562858	Green Accepted			2022-12-28	WOS:000279343800037
J	Sozzani, R; Cui, H; Moreno-Risueno, MA; Busch, W; Van Norman, JM; Vernoux, T; Brady, SM; Dewitte, W; Murray, JAH; Benfey, PN				Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Dewitte, W.; Murray, J. A. H.; Benfey, P. N.			Spatiotemporal regulation of cell-cycle genes by SHORTROOT links patterning and growth	NATURE			English	Article							ARABIDOPSIS ROOT; EXPRESSION; SCARECROW; PROGRESSION; ENDODERMIS; MECHANISM; MOVEMENT; DIVISION; PATHWAY; SHR	The development of multicellular organisms relies on the coordinated control of cell divisions leading to proper patterning and growth(1-3). The molecular mechanisms underlying pattern formation, particularly the regulation of formative cell divisions, remain poorly understood. In Arabidopsis, formative divisions generating the root ground tissue are controlled by SHORTROOT (SHR) and SCARECROW (SCR)(4-6). Here we show, using cell-type-specific transcriptional effects of SHR and SCR combined with data from chromatin immunoprecipitation-based microarray experiments, that SHR regulates the spatiotemporal activation of specific genes involved in cell division. Coincident with the onset of a specific formative division, SHR and SCR directly activate a D-type cyclin; furthermore, altering the expression of this cyclin resulted in formative division defects. Our results indicate that proper pattern formation is achieved through transcriptional regulation of specific cell-cycle genes in a cell-type-and developmental-stage-specific context. Taken together, we provide evidence for a direct link between developmental regulators, specific components of the cell-cycle machinery and organ patterning.	[Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Sozzani, R.; Cui, H.; Moreno-Risueno, M. A.; Busch, W.; Van Norman, J. M.; Vernoux, T.; Brady, S. M.; Benfey, P. N.] Duke Univ, IGSP Ctr Syst Biol, Durham, NC 27708 USA; [Dewitte, W.; Murray, J. A. H.] Cardiff Sch Biosci, Cardiff CF10 3AX, Wales	Duke University; Duke University; Cardiff University	Benfey, PN (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	philip.benfey@duke.edu	Brady, Siobhan/AAY-1729-2021; Murray, James AH/D-3399-2009; MORENO-RISUENO, MIGUEL ANGEL/J-8832-2016; Cui, Hongchang/ABD-3278-2021; Busch, Wolfgang/B-8593-2008; Dewitte, Walter/B-4560-2011; Vernoux, Teva/J-1695-2019	Murray, James AH/0000-0002-2282-3839; MORENO-RISUENO, MIGUEL ANGEL/0000-0002-9794-1450; Cui, Hongchang/0000-0002-9870-748X; Busch, Wolfgang/0000-0003-2042-7290; Vernoux, Teva/0000-0002-8257-4088; Dewitte, Walter/0000-0002-0606-1686; Brady, Siobhan/0000-0001-9424-8055; Sozzani, Rosangela/0000-0003-3316-2367	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council [BB/E022383]; European Research Area in Plant Genomics network on Plant Stem Cells [BB/E024858]; NIH [RO1-GM043778, P50-GM081883]; NSF [AT2010 0618304]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043778, P50GM081883] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/E022383/1, BB/E024858/1, BB/E022383/2] Funding Source: researchfish; BBSRC [BB/E022383/1, BB/E022383/2, BB/E024858/1] Funding Source: UKRI	Ministerio de Ciencia y Innovacion (Spain); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Research Area in Plant Genomics network on Plant Stem Cells; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank D. Orlando and R. Twigg for generating the list of probes for the ChIP-array; J. Nieuwland, S. Maughan and C. Collins for construction of the CYCD6; 1 reporter line and assistance in isolation of the cycd6; 1 mutant; L. Sanz, F. Patell and S. Scofield for isolation of the cycd2; 1 and cycd5; 1 mutants; J. Dinneny, M. Noor and members of the Benfey laboratory for their comments on the manuscript. Funding to M.A.M.-R. is provided by the Ministerio de Ciencia y Innovacion (Spain). W. D. and J.A.H.M. were funded by a Biotechnology and Biological Sciences Research Council grant (BB/E022383) and the European Research Area in Plant Genomics network on Plant Stem Cells (BB/E024858). This work was funded by grants to P.N.B. from the NIH (RO1-GM043778 and P50-GM081883) and from the NSF (AT2010 0618304).	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; BENFEY PN, 1993, DEVELOPMENT, V119, P57; Benkova E, 2003, CELL, V115, P591, DOI 10.1016/S0092-8674(03)00924-3; Birnbaum K, 2003, SCIENCE, V302, P1956, DOI 10.1126/science.1090022; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Blilou I, 2002, GENE DEV, V16, P2566, DOI 10.1101/gad.237302; Bougourd S, 2000, PLANT J, V24, P543, DOI 10.1046/j.1365-313x.2000.00892.x; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Busch W, 2010, DEV CELL, V18, P849, DOI 10.1016/j.devcel.2010.03.012; Casamitjana-Martinez E, 2003, CURR BIOL, V13, P1435, DOI 10.1016/S0960-9822(03)00533-5; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; De Smet I, 2008, SCIENCE, V322, P594, DOI 10.1126/science.1160158; DiLaurenzio L, 1996, CELL, V86, P423, DOI 10.1016/S0092-8674(00)80115-4; Ebel C, 2004, NATURE, V429, P776, DOI 10.1038/nature02637; FOE VE, 1989, DEVELOPMENT, V107, P1; Fukaki H, 1998, PLANT J, V14, P425, DOI 10.1046/j.1365-313X.1998.00137.x; Gallagher KL, 2009, PLANT J, V57, P785, DOI 10.1111/j.1365-313X.2008.03735.x; Gallagher KL, 2004, CURR BIOL, V14, P1847, DOI 10.1016/j.cub.2004.09.081; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Haseloff J, 1999, METHOD CELL BIOL, V58, P139; Heidstra R, 2004, GENE DEV, V18, P1964, DOI 10.1101/gad.305504; Helariutta Y, 2000, CELL, V101, P555, DOI 10.1016/S0092-8674(00)80865-X; Herranz H, 2008, CELL CYCLE, V7, P3335, DOI 10.4161/cc.7.21.6996; Levesque MP, 2006, PLOS BIOL, V4, P739, DOI 10.1371/journal.pbio.0040143; Lewis J, 2008, SCIENCE, V322, P399, DOI 10.1126/science.1166154; Menges M, 2005, PLANT J, V41, P546, DOI 10.1111/j.1365-313X.2004.02319.x; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Paquette AJ, 2005, PLANT PHYSIOL, V138, P636, DOI 10.1104/pp.104.058362; Pysh LD, 1999, PLANT J, V18, P111, DOI 10.1046/j.1365-313X.1999.00431.x; Sabatini S, 2003, GENE DEV, V17, P354, DOI 10.1101/gad.252503; Schiefelbein J, 2003, CURR OPIN PLANT BIOL, V6, P74, DOI 10.1016/S136952660200002X; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weigmann K, 1997, DEVELOPMENT, V124, P3555; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593	38	281	290	2	75	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					128	U149		10.1038/nature09143	http://dx.doi.org/10.1038/nature09143			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596025	Green Accepted			2022-12-28	WOS:000279343800048
J	Hanotte, O; Dessie, T; Kemp, S				Hanotte, Olivier; Dessie, Tadelle; Kemp, Steve			Time to Tap Africa's Livestock Genomes	SCIENCE			English	Editorial Material							LANDSCAPE GENOMICS; SELECTION		[Hanotte, Olivier] Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England; [Dessie, Tadelle] ILRI, Addis Ababa, Ethiopia; [Kemp, Steve] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Kemp, Steve] ILRI, Nairobi, Kenya	University of Nottingham; CGIAR; International Livestock Research Institute (ILRI); University of Liverpool; CGIAR; International Livestock Research Institute (ILRI)	Hanotte, O (corresponding author), Univ Nottingham, Sch Biol, Nottingham NG7 2RD, England.	olivier.hanotte@nottingham.ac.uk	Hanotte, Olivier/B-4669-2013	Hanotte, Olivier/0000-0002-2877-4767				Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; KEMP S, DAGRIS 2007 DOMESTIC; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Pariset L, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-7	7	36	38	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1640	1641		10.1126/science.1186254	http://dx.doi.org/10.1126/science.1186254			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576875				2022-12-28	WOS:000279107400025
J	Kollman, JM; Polka, JK; Zelter, A; Davis, TN; Agard, DA				Kollman, Justin M.; Polka, Jessica K.; Zelter, Alex; Davis, Trisha N.; Agard, David A.			Microtubule nucleating gamma-TuSC assembles structures with 13-fold microtubule-like symmetry	NATURE			English	Article							TUBULIN RING COMPLEX; ALPHA-BETA-TUBULIN; SPINDLE POLE BODY; ELECTRON-MICROSCOPY; CENTROSOME; TEMPLATE; RECONSTITUTION; LATTICE	Microtubules are nucleated in vivo by gamma-tubulin complexes. The 300-kDa gamma-tubulin small complex (gamma-TuSC), consisting of two molecules of gamma-tubulin and one copy each of the accessory proteins Spc97 and Spc98, is the conserved, essential core of the microtubule nucleating machinery(1,2). In metazoa multiple gamma-TuSCs assemble with other proteins into gamma-tubulin ring complexes (gamma-TuRCs). The structure of gamma-TuRC indicated that it functions as a microtubule template(2-5). Because each gamma-TuSC contains two molecules of gamma-tubulin, it was assumed that the gamma-TuRC-specific proteins are required to organize gamma-TuSCs to match 13-fold microtubule symmetry. Here we show that Saccharomyces cerevisiae gamma-TuSC forms rings even in the absence of other gamma-TuRC components. The yeast adaptor protein Spc110 stabilizes the rings into extended filaments and is required for oligomer formation under physiological buffer conditions. The 8-angstrom cryo-electron microscopic reconstruction of the filament reveals 13 gamma-tubulins per turn, matching microtubule symmetry, with plus ends exposed for interaction with microtubules, implying that one turn of the filament constitutes a microtubule template. The domain structures of Spc97 and Spc98 suggest functions for conserved sequence motifs, with implications for the gamma-TuRC-specific proteins. The gamma-TuSC filaments nucleate microtubules at a low level, and the structure provides a strong hypothesis for how nucleation is regulated, converting this less active form to a potent nucleator.	[Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Kollman, Justin M.; Agard, David A.] Univ Calif San Francisco, Keck Adv Microscopy Ctr, San Francisco, CA 94158 USA; [Zelter, Alex; Davis, Trisha N.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Washington; University of Washington Seattle	Agard, DA (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, Howard Hughes Med Inst, San Francisco, CA 94158 USA.	agard@msg.ucsf.edu	Davis, Trisha/F-8584-2010; Kollman, Justin/F-3012-2012	Davis, Trisha/0000-0003-4797-3152	National Institutes of Health (NIH) through the National Center for Research Resources'; NIH; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078790, R01GM031627, R01GM040506] Funding Source: NIH RePORTER	National Institutes of Health (NIH) through the National Center for Research Resources'(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Braunfeld and A. Avila-Sakar for microscopy assistance; Y. Cheng, E. Muller, M. Moritz and K. Huang for helpful discussions; and B. Carragher, C. Potter and J. Quispe for the use of their electron microscopy facilities and technical assistance with data collection. Some of the work presented here was conducted at the National Resource for Automated Molecular Microscopy, which is supported by the National Institutes of Health (NIH) through the National Center for Research Resources' P41 program. This work was supported by the NIH (D. A. A. and T.N.D.) and the Howard Hughes Medical Institute (D. A. A.). J. M. K. was a NIH Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral fellow.	Aldaz H, 2005, NATURE, V435, P523, DOI 10.1038/nature03586; BYERS B, 1978, J CELL SCI, V30, P331; Choy RM, 2009, J STRUCT BIOL, V168, P571, DOI 10.1016/j.jsb.2009.08.012; CHRETIEN D, 1991, BIOL CELL, V71, P161, DOI 10.1016/0248-4900(91)90062-R; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Erickson HP, 2000, NAT CELL BIOL, V2, pE93, DOI 10.1038/35014084; EVANS L, 1985, J CELL BIOL, V100, P1185, DOI 10.1083/jcb.100.4.1185; Frank J., 1996, 3 DIMENSIONAL ELECT, Ved, ppp 54; Goshima G, 2008, J CELL BIOL, V181, P421, DOI 10.1083/jcb.200711053; Goshima G, 2007, SCIENCE, V316, P417, DOI 10.1126/science.1141314; Gunawardane RN, 2000, J CELL BIOL, V151, P1513, DOI 10.1083/jcb.151.7.1513; Keating TJ, 2000, NAT CELL BIOL, V2, P352, DOI 10.1038/35014045; Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985; Kollman JM, 2008, MOL BIOL CELL, V19, P207, DOI 10.1091/mbc.E07-09-0879; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Moritz M, 2000, NAT CELL BIOL, V2, P365, DOI 10.1038/35014058; MORITZ M, 1995, J CELL BIOL, V130, P1149, DOI 10.1083/jcb.130.5.1149; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Oegema K, 1999, J CELL BIOL, V144, P721, DOI 10.1083/jcb.144.4.721; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quispe J, 2007, MICROSC MICROANAL, V13, P365, DOI 10.1017/S1431927607070791; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Verollet C, 2006, J CELL BIOL, V172, P517, DOI 10.1083/jcb.200511071; Vinh DBN, 2002, MOL BIOL CELL, V13, P1144, DOI 10.1091/mbc.02-01-0607; Wiese C, 2000, NAT CELL BIOL, V2, P358, DOI 10.1038/35014051; ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0	30	174	174	2	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	AUG 12	2010	466	7308					879	U114		10.1038/nature09207	http://dx.doi.org/10.1038/nature09207			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	636TT	20631709	Green Accepted			2022-12-28	WOS:000280766100039
J	Chew, EY; Ambrosius, WT; Davis, MD; Danis, RP; Gangaputra, S; Greven, CM; Hubbard, L; Esser, BA; Lovato, JF; Perdue, LH; Goff, DC; Cushman, WC; Ginsberg, HN; Elam, MB; Genuth, S; Gerstein, HC; Schubart, U; Fine, LJ				Chew, Emily Y.; Ambrosius, Walter T.; Davis, Matthew D.; Danis, Ronald P.; Gangaputra, Sapna; Greven, Craig M.; Hubbard, Larry; Esser, Barbara A.; Lovato, James F.; Perdue, Letitia H.; Goff, David C., Jr.; Cushman, William C.; Ginsberg, Henry N.; Elam, Marshall B.; Genuth, Saul; Gerstein, Hertzel C.; Schubart, Ulrich; Fine, Lawrence J.		ACCORD Study Grp; ACCORD Eye Study Grp	Effects of Medical Therapies on Retinopathy Progression in Type 2 Diabetes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MICROVASCULAR COMPLICATIONS; TRIAL; RISK	Background: We investigated whether intensive glycemic control, combination therapy for dyslipidemia, and intensive blood-pressure control would limit the progression of diabetic retinopathy in persons with type 2 diabetes. Previous data suggest that these systemic factors may be important in the development and progression of diabetic retinopathy. Methods: In a randomized trial, we enrolled 10,251 participants with type 2 diabetes who were at high risk for cardiovascular disease to receive either intensive or standard treatment for glycemia (target glycated hemoglobin level, <6.0% or 7.0 to 7.9%, respectively) and also for dyslipidemia (160 mg daily of fenofibrate plus simvastatin or placebo plus simvastatin) or for systolic blood-pressure control (target, <120 or <140 mm Hg). A subgroup of 2856 participants was evaluated for the effects of these interventions at 4 years on the progression of diabetic retinopathy by 3 or more steps on the Early Treatment Diabetic Retinopathy Study Severity Scale (as assessed from seven-field stereoscopic fundus photographs, with 17 possible steps and a higher number of steps indicating greater severity) or the development of diabetic retinopathy necessitating laser photocoagulation or vitrectomy. Results: At 4 years, the rates of progression of diabetic retinopathy were 7.3% with intensive glycemia treatment, versus 10.4% with standard therapy (adjusted odds ratio, 0.67; 95% confidence interval [CI], 0.51 to 0.87; P=0.003); 6.5% with fenofibrate for intensive dyslipidemia therapy, versus 10.2% with placebo (adjusted odds ratio, 0.60; 95% CI, 0.42 to 0.87; P=0.006); and 10.4% with intensive blood-pressure therapy, versus 8.8% with standard therapy (adjusted odds ratio, 1.23; 95% CI, 0.84 to 1.79; P=0.29). Conclusions: Intensive glycemic control and intensive combination treatment of dyslipidemia, but not intensive blood-pressure control, reduced the rate of progression of diabetic retinopathy. (Funded by the National Heart, Lung, and Blood Institute and others; ClinicalTrials.gov numbers, NCT00000620 for the ACCORD study and NCT00542178 for the ACCORD Eye study.) N Engl J Med 2010;363:233-44.	[Chew, Emily Y.] NEI, NIH, Clin Res Ctr, Bethesda, MD 20892 USA; [Ambrosius, Walter T.; Greven, Craig M.; Lovato, James F.; Perdue, Letitia H.; Goff, David C., Jr.] Wake Forest Univ, Sch Med, Winston Salem, NC 27109 USA; [Davis, Matthew D.; Danis, Ronald P.; Gangaputra, Sapna; Hubbard, Larry; Esser, Barbara A.] Univ Wisconsin, Madison, WI 53706 USA; [Cushman, William C.; Elam, Marshall B.] Vet Affairs Med Ctr, Memphis, TN USA; [Ginsberg, Henry N.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA; [Genuth, Saul] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Gerstein, Hertzel C.] McMaster Univ, Hamilton, ON, Canada; [Schubart, Ulrich] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Fine, Lawrence J.] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Wake Forest University; University of Wisconsin System; University of Wisconsin Madison; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Columbia University; Case Western Reserve University; McMaster University; Yeshiva University; Albert Einstein College of Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Chew, EY (corresponding author), NEI, NIH, Clin Res Ctr, Bldg 10,Rm 3-2531,10 Ctr Dr,Mail Stop Ctr 1204, Bethesda, MD 20892 USA.	echew@nei.nih.gov	Buse, John Bernard/J-9742-2019; Gerstein, Hertzel/ABB-8781-2020; Hramiak, Irene/G-3305-2011; Friedewald, William T/C-8034-2011; Bryan, R. Nick/P-1661-2014; Force, Rex W/K-4094-2012; Gerstein, Hertzel C/B-1235-2013	Buse, John Bernard/0000-0002-9723-3876; Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Yusuf, Salim/0000-0003-4776-5601; Kaiser, Peter/0000-0001-5126-045X; Arrey, Frida/0000-0003-4543-4219; Kiss, Szilard/0000-0003-3433-8432; Bryan, Robert Nick/0000-0002-2327-4579	National Heart, Lung, and Blood Institute [N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, IAA-Y1-HC-1010]; National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases; National Eye Institute; National Institute on Aging; Centers for Disease Control and Prevention; General Clinical Research Centers; Merck and money; Novartis; Takeda; Sanofi-Aventis; Bristol-Myers Squibb; King Pharmaceuticals; Daiichi-Sankyo; Gilead; Theravance; Pharmacopeia; Sciele; GlaxoSmithKline; Merck; Abbott-AstraZeneca; Roche; Isis-Genzyme; Pfizer; Regeneron-Sanofi-Aventis; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095183, N01HC095181, N01HC095184, N01HC095178, N01HC095180, N01HC095182, N01HC095179] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [ZIAEY000410] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073030, R44HL095181, R43HL095181] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); General Clinical Research Centers(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Merck and money; Novartis(Novartis); Takeda(Takeda Pharmaceutical Company Ltd); Sanofi-Aventis(Sanofi-Aventis); Bristol-Myers Squibb(Bristol-Myers Squibb); King Pharmaceuticals; Daiichi-Sankyo(Daiichi Sankyo Company Limited); Gilead(Gilead Sciences); Theravance; Pharmacopeia; Sciele; GlaxoSmithKline(GlaxoSmithKline); Merck(Merck & Company); Abbott-AstraZeneca(Abbott LaboratoriesAstraZeneca); Roche(Roche Holding); Isis-Genzyme(Sanofi-AventisGenzyme Corporation); Pfizer(Pfizer); Regeneron-Sanofi-Aventis(Sanofi-Aventis); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by contracts (N01-HC-95178, N01-HC-95179, N01-HC-95180, N01-HC-95181, N01-HC-95182, N01-HC-95183, N01-HC-95184, IAA-Y1-HC-9035, and IAA-Y1-HC-1010) from the National Heart, Lung, and Blood Institute and the National Institutes of Health, with additional support from the National Institute of Diabetes and Digestive and Kidney Diseases, the National Eye Institute, the National Institute on Aging, and the Centers for Disease Control and Prevention. General Clinical Research Centers provided support at many sites. The following companies donated study medications, equipment, or supplies: Abbott Laboratories, Amylin Pharmaceutical, AstraZeneca Pharmaceuticals, Bayer HealthCare, Closer Healthcare, GlaxoSmithKline Pharmaceuticals, King Pharmaceuticals, Merck, Novartis Pharmaceuticals, Novo Nordisk, Omron Healthcare, SanofiAventis U.S., and Takeda Pharmaceuticals.; Dr. Goff reports receiving grant support or pending grant support from Merck and money for serving as a data and safety monitoring board member for a trial of a diabetes medication from Takeda; Dr. Cushman, consulting fees from Novartis, Takeda, Sanofi-Aventis, Bristol-Myers Squibb, King Pharmaceuticals, Daiichi-Sankyo, Gilead, Theravance, Pharmacopeia, and Sciele and grant support or pending grant support from Novartis, GlaxoSmithKline, and Merck; Dr. Ginsberg, advisory fees from Merck, Merck-Schering Plough, and Bristol-Myers SquibbAstraZeneca; consulting fees from Merck, Abbott-AstraZeneca, Bristol-Myers Squibb, Roche, Isis-Genzyme, GlaxoSmithKline, Novartis, Pfizer, and Regeneron-Sanofi-Aventis; grant support or pending grant support from Merck, Isis-Genzyme, Roche, and AstraZeneca; payment for development of education presentations from Pfizer; and payment for travel and accommodation expenses from all these companies; Dr. Elam, payment for development of education presentations from Pfizer, Abbott Pharmaceuticals, and Merck-Schering Plough; and Dr. Gerstein, consulting fees from Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Novo Nordisk, AstraZeneca, Bristol-Myers Squibb, Roche, Medtronic, Merck, Bayer, Bioavail, and Jansen Ortho; grant support or pending grant support from Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Merck, Pronova, and Roche; honoraria from Sanofi-Aventis, GlaxoSmithKline, Solvay, Boehringer Ingelheim, Servier, Bayer, Eli Lilly, Novo Nordisk, and Takeda; and payment for travel and accommodation expenses from all these companies; Dr. Schubart reports participating in trials sponsored by Sanofi-Aventis, Merck, and Johnson & Johnson. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 1991, Ophthalmology, V98, P823; Beulens JWJ, 2009, DIABETOLOGIA, V52, P2027, DOI 10.1007/s00125-009-1457-x; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Chew EY, 2007, AM J CARDIOL, V99, p103I, DOI 10.1016/j.amjcard.2007.03.028; Chew EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P1079, DOI 10.1001/archopht.1996.01100140281004; Cullen J F, 1964, Trans Ophthalmol Soc U K, V84, P281; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Davis MD, 1998, INVEST OPHTH VIS SCI, V39, P233; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; DUNCAN LJP, 1968, DIABETES, V17, P458, DOI 10.2337/diab.17.7.458; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Ginsberg HN, 2007, AM J CARDIOL, V99, p56I, DOI 10.1016/j.amjcard.2007.03.024; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Gupta A, 2004, AM J OPHTHALMOL, V137, P675, DOI 10.1016/j.ajo.2003.11.017; HARROLD BP, 1969, DIABETES, V18, P285, DOI 10.2337/diab.18.5.285; ISMAILBEIGI F, 2010, LANCET, V375, P26; Keech AC, 2007, LANCET, V370, P1687, DOI 10.1016/S0140-6736(07)61607-9; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; KLEIN BEK, 1991, OPHTHALMOLOGY, V98, P1261; Miljanovic B, 2004, DIABETES, V53, P2883, DOI 10.2337/diabetes.53.11.2883; OHKUBO Y, 1995, DIABETES RES CLIN PR, V28, P103, DOI 10.1016/0168-8227(95)01064-K; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; REICHARD P, 1993, NEW ENGL J MED, V329, P304, DOI 10.1056/NEJM199307293290502; RUBIN DB, 1987, MULTIPLE IMPUTATION, P169; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; 1995, ARCH OPHTHALMOL, V113, P361	27	823	858	3	65	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 15	2010	363	3					233	244		10.1056/NEJMoa1001288	http://dx.doi.org/10.1056/NEJMoa1001288			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625AR	20587587	Green Accepted, Green Submitted			2022-12-28	WOS:000279864200006
J	Karagas, MR; Waterboer, T; Li, ZZ; Nelson, HH; Michael, KM; Bavinck, JNB; Perry, AE; Spencer, SK; Daling, J; Green, AC; Pawlita, M				Karagas, Margaret R.; Waterboer, Tim; Li, Zhongze; Nelson, Heather H.; Michael, Kristina M.; Bavinck, Jan Nico Bouwes; Perry, Ann E.; Spencer, Steven K.; Daling, Janet; Green, Adele C.; Pawlita, Michael		New Hampshire Skin Canc Study Grp	Genus beta human papillomaviruses and incidence of basal cell and squamous cell carcinomas of skin: population based case-control study	BRITISH MEDICAL JOURNAL			English	Article							GLUTATHIONE-S-TRANSFERASE; VIRUS-LIKE PARTICLES; ACTINIC KERATOSES; SUN EXPOSURE; CANCER; RISK; ANTIBODIES; INFECTION; PROTEINS; SEROREACTIVITY	Objective To investigate the association between genus beta human papillomaviruses and the incidence of nonmelanocytic skin cancer in the general population. Design Population based case-control study. Setting New Hampshire, USA. Participants 2366 skin cancer cases and controls from the general population aged 25 to 74 years (663 squamous cell carcinoma, 898 basal cell carcinoma, 805 controls), with plasma samples tested for L1 antibodies to 16 genus beta human papillomaviruses by multiplex serology. Main outcome measures Odds ratios for squamous cell carcinoma and basal cell carcinoma associated with seropositivity to beta human papillomaviruses. Results Squamous cell carcinoma, but not basal cell carcinoma, cases had a higher prevalence of each of the individual beta human papillomaviruses assayed compared with controls. The odds ratios for squamous cell carcinoma increased with the number of beta types positive (odds ratio for one type positive 0.99 (95% confidence interval 0.74 to 1.33); two to three types positive 1.44 (1.03 to 2.01); four to eight types positive 1.51 (1.03 to 2.20); more than eight types positive 1.71 (1.12 to 2.62); P for trend (categorical)<0.001; P for trend (continuous)=0.003). With limited statistical power, the association was stronger among long term users of systemic glucocorticoids (odds ratio 3.21, 1.22 to 8.44) than among non-users (1.23, 0.97 to 1.55). Conclusions These findings support a relation between genus beta human papillomavirus infection and the incidence of squamous cell carcinoma of the skin in the general population, as well as potential enhancement of risk by immunosuppression.	[Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA; [Karagas, Margaret R.; Li, Zhongze; Perry, Ann E.; Spencer, Steven K.] Dartmouth Med Sch, Norris Cotton Canc Ctr, Lebanon, NH 03756 USA; [Waterboer, Tim; Michael, Kristina M.; Pawlita, Michael] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Nelson, Heather H.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Bavinck, Jan Nico Bouwes] Leiden Univ, Med Ctr, NL-2300 RC Leiden, Netherlands; [Daling, Janet] Univ Washington, Seattle, WA 98109 USA; [Green, Adele C.] PO Royal Brisbane Hosp, Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Daling, Janet] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Dartmouth College; Dartmouth College; Norris Cotton Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ); University of Minnesota System; University of Minnesota Twin Cities; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Washington; University of Washington Seattle; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital; Fred Hutchinson Cancer Center	Karagas, MR (corresponding author), Dartmouth Med Sch, Dept Community & Family Med, Epidemiol & Biostat Sect, Lebanon, NH 03756 USA.	margaret.karagas@dartmouth.edu	Waterboer, Tim/G-1252-2010; Green, Adele C/B-5324-2011; Green, Adele C/P-2736-2014; Pawlita, Labor/C-9720-2011	Green, Adele C/0000-0002-2753-4841; Mittleman, Murray/0000-0001-9788-7274; Pawlita, Michael/0000-0002-4720-8306; Nelson, Heather/0000-0003-1901-9513	US National Institutes of Health, National Cancer Institute [CA118443, CA57494]; European Community [QLK2-CT-2002-01179]; NATIONAL CANCER INSTITUTE [P30CA023108, R01CA118443, R01CA057494] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); European Community(European Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The study was funded in part by grants CA118443 and CA57494 of the US National Institutes of Health, National Cancer Institute and grant QLK2-CT-2002-01179 of the European Community. The NCI and the EC were not involved in the design and conduct of the study or the collection, management, analysis, and interpretation of the data. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NCI or the EC.	Andersson K, 2008, CANCER EPIDEM BIOMAR, V17, P189, DOI 10.1158/1055-9965.EPI-07-0405; Bavinck JNB, 1996, TRANSPLANTATION, V61, P715, DOI 10.1097/00007890-199603150-00008; Bavinck JNB, 2000, BRIT J DERMATOL, V142, P103, DOI 10.1046/j.1365-2133.2000.03248.x; BRESLOW NE, 1980, STATISTICAL METHODS, V1, P1; Casabonne D, 2007, INT J CANCER, V121, P1862, DOI 10.1002/ijc.22885; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; Dondog B, 2008, CANCER EPIDEM BIOMAR, V17, P1731, DOI 10.1158/1055-9965.EPI-07-2796; Feltkamp MCW, 2003, CANCER RES, V63, P2695; GREENBERG ER, 1990, NEW ENGL J MED, V323, P789, DOI 10.1056/NEJM199009203231204; *INT AG RES CTR, 2007, IARC MON, V90; Karagas M, 2006, CANC EPIDEMIOLOGY PR; Karagas MR, 2007, AM J EPIDEMIOL, V165, P719, DOI 10.1093/aje/kwk055; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1996, J NATL CANCER I, V88, P1848, DOI 10.1093/jnci/88.24.1848; Karagas MR, 2001, BRIT J CANCER, V85, P683, DOI 10.1054/bjoc.2001.1931; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Karagas MR, 2001, AM J EPIDEMIOL, V153, P559, DOI 10.1093/aje/153.6.559; KRICKER A, 1994, CANCER CAUSE CONTROL, V5, P367, DOI 10.1007/BF01804988; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; Masini C, 2003, ARCH DERMATOL, V139, P890, DOI 10.1001/archderm.139.7.890; Michael KM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000091; MIETTINEN O, 1976, AM J EPIDEMIOL, V103, P226, DOI 10.1093/oxfordjournals.aje.a112220; Nindl I, 2007, DIS MARKERS, V23, P247, DOI 10.1155/2007/942650; Sehr P, 2002, J VIROL METHODS, V106, P61, DOI 10.1016/S0166-0934(02)00134-9; Sehr P, 2001, J IMMUNOL METHODS, V253, P153, DOI 10.1016/S0022-1759(01)00376-3; Sorensen HT, 2004, JNCI-J NATL CANCER I, V96, P709, DOI 10.1093/jnci/djh118; Stark S, 1998, J INVEST DERMATOL, V111, P696, DOI 10.1046/j.1523-1747.1998.00360.x; STEGER G, 1990, J VIROL, V64, P4399, DOI 10.1128/JVI.64.9.4399-4406.1990; Struijk L, 2006, CANCER EPIDEM BIOMAR, V15, P529, DOI 10.1158/1055-9965.EPI-05-0747; Underbrink MP, 2008, J VIROL, V82, P10408, DOI 10.1128/JVI.00902-08; Waterboer T, 2008, BRIT J DERMATOL, V159, P457, DOI 10.1111/j.1365-2133.2008.08621.x; Waterboer T, 2005, CLIN CHEM, V51, P1845, DOI 10.1373/clinchem.2005.052381	32	64	64	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 8	2010	341								c2986	10.1136/bmj.c2986	http://dx.doi.org/10.1136/bmj.c2986			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DM	20616098	Green Published, hybrid			2022-12-28	WOS:000279874400001
J	Zeng, L; Zhang, Q; Li, S; Plotnikov, AN; Walsh, MJ; Zhou, MM				Zeng, Lei; Zhang, Qiang; Li, Side; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming			Mechanism and regulation of acetylated histone binding by the tandem PHD finger of DPF3b	NATURE			English	Article							LYSINE-4 TRIMETHYLATION; AUTOIMMUNE REGULATOR; PLANT HOMEODOMAIN; H3; RECOGNITION; METHYLATION; BROMODOMAIN; NMR; DOMAIN; H3K4ME3	Histone lysine acetylation and methylation have an important role during gene transcription in a chromatin context(1,2). Knowledge concerning the types of protein modules that can interact with acetyl-lysine has so far been limited to bromodomains(1). Recently, a tandem plant homeodomain (PHD) finger(3) (PHD1-PHD2, or PHD12) of human DPF3b, which functions in association with the BAF chromatin remodelling complex to initiate gene transcription during heart and muscle development, was reported to bind histones H3 and H4 in an acetylation-sensitive manner(4), making it the first alternative to bromodomains for acetyl-lysine binding(5). Here we report the structural mechanism of acetylated histone binding by the double PHD fingers of DPF3b. Our three-dimensional solution structures and biochemical analysis of DPF3b highlight the molecular basis of the integrated tandem PHD finger, which acts as one functional unit in the sequence-specific recognition of lysine-14-acetylated histone H3 (H3K14ac). Whereas the interaction with H3 is promoted by acetylation at lysine 14, it is inhibited by methylation at lysine 4, and these opposing influences are important during transcriptional activation of the mouse DPF3b target genes Pitx2 and Jmjd1c. Binding of this tandem protein module to chromatin can thus be regulated by different histone modifications during the initiation of gene transcription.	[Zeng, Lei; Zhang, Qiang; Plotnikov, Alexander N.; Walsh, Martin J.; Zhou, Ming-Ming] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Li, Side; Walsh, Martin J.] Mt Sinai Sch Med, Dept Paediat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Zhou, MM (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, 1425 Madison Ave,Box 1677, New York, NY 10029 USA.	ming-ming.zhou@mssm.edu			National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA087658] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We acknowledge the use of the NMR Facility at the New York Structural Biology Center. We thank S. Hearn of Cold Spring Harbor Laboratory microscopy facility for help with confocal microscopy study, and A. Buku and G. Gerona-Navarro for technical advice on peptide binding analysis. This work was supported by grants from the National Institutes of Health (M.-M.Z.).	Bienz M, 2006, TRENDS BIOCHEM SCI, V31, P35, DOI 10.1016/j.tibs.2005.11.001; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chakravarty S, 2009, STRUCTURE, V17, P670, DOI 10.1016/j.str.2009.02.017; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Dhalluin C, 1999, NATURE, V399, P491, DOI 10.1038/20974; Fischle W, 2005, NATURE, V438, P1116, DOI 10.1038/nature04219; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Furlan-Magaril M, 2009, METHODS MOL BIOL, V543, P253, DOI 10.1007/978-1-60327-015-1_17; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Lange M, 2008, GENE DEV, V22, P2370, DOI 10.1101/gad.471408; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Mujtaba S, 2004, MOL CELL, V13, P251, DOI 10.1016/S1097-2765(03)00528-8; Ooi SKT, 2007, NATURE, V448, P714, DOI 10.1038/nature05987; Org T, 2008, EMBO REP, V9, P370, DOI [10.1038/embor.2008.11, 10.1038/sj.embor.2008.11]; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Phanstiel D, 2008, P NATL ACAD SCI USA, V105, P4093, DOI 10.1073/pnas.0710515105; Portier GL, 1999, IN VITRO CELL DEV-AN, V35, P219, DOI 10.1007/s11626-999-0030-8; Qian CM, 2005, NAT STRUCT MOL BIOL, V12, P1078, DOI 10.1038/nsmb1022; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Rieping W, 2007, BIOINFORMATICS, V23, P381, DOI 10.1093/bioinformatics/btl589; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sanchez R, 2009, CURR OPIN DRUG DISC, V12, P659; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010; Zeng L, 2008, NAT STRUCT MOL BIOL, V15, P626, DOI 10.1038/nsmb.1416	30	211	214	2	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					258	U138		10.1038/nature09139	http://dx.doi.org/10.1038/nature09139			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613843	Green Accepted			2022-12-28	WOS:000279580800041
J	Jacobson, PD; Gostin, LO				Jacobson, Peter D.; Gostin, Lawrence O.			Restoring Health to Health Reform	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PUBLIC-HEALTH; JUSTICE; CARE		[Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC 20001 USA; [Jacobson, Peter D.] Univ Michigan, Sch Publ Hlth, Dept Hlth Management & Policy, Ctr Law Eth & Hlth, Ann Arbor, MI 48109 USA	Georgetown University; University of Michigan System; University of Michigan	Gostin, LO (corresponding author), Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, 600 New Jersey Ave NW, Washington, DC 20001 USA.	gostin@law.georgetown.edu		Gostin, Lawrence/0000-0001-5286-4044				French M., 2009, SHIFTING COURSE OUR; Galarneau CA, 2002, HASTINGS CENT REP, V32, P33, DOI 10.2307/3528711; Gostin LO, 2006, HEALTH AFFAIR, V25, P1053, DOI 10.1377/hlthaff.25.4.1053; Hemenway D, 2010, NEW ENGL J MED, V362, P1657, DOI 10.1056/NEJMp1001784; Institute of Medicine, 2002, FUT PUBL HLTH 21 CEN; Jacobson PD, 2009, HEALTH SERV RES, V44, P1880, DOI 10.1111/j.1475-6773.2009.01013.x; Kindig D, 2003, AM J PUBLIC HEALTH, V93, P380, DOI 10.2105/AJPH.93.3.380; Lurie N, 2002, HEALTH AFFAIR, V21, P28, DOI 10.1377/hlthaff.21.6.28; Murray CJL, 2010, NEW ENGL J MED, V362, P98, DOI 10.1056/NEJMp0910064; Sensenig Arthur L, 2007, J Public Health Manag Pract, V13, P103	10	9	9	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					85	86		10.1001/jama.2010.917	http://dx.doi.org/10.1001/jama.2010.917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606153	Green Published			2022-12-28	WOS:000279519600025
J	Hull, RD; Schellong, SM; Tapson, VF; Monreal, M; Samama, MM; Nicol, P; Vicaut, E; Turpie, AGG; Yusen, RD				Hull, Russell D.; Schellong, Sebastian M.; Tapson, Victor F.; Monreal, Manuel; Samama, Meyer-Michel; Nicol, Philippe; Vicaut, Eric; Turpie, Alexander G. G.; Yusen, Roger D.		EXCLAIM Extended Prophylaxis Venou	Extended-Duration Venous Thromboembolism Prophylaxis in Acutely III Medical Patients With Recently Reduced Mobility	ANNALS OF INTERNAL MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; PLACEBO-CONTROLLED TRIAL; METAANALYSIS; PREVENTION; DALTEPARIN; RISK; THROMBOPROPHYLAXIS; ENOXAPARIN; MORTALITY; EFFICACY	Background: Extended-duration low-molecular-weight heparin has been shown to prevent venous thromboembolism (VTE) in high-risk surgical patients. Objective: To evaluate the efficacy and safety of extended-duration enoxaparin thromboprophylaxis in acutely ill medical patients. Design: Randomized, parallel, placebo-controlled trial. Randomization was computer-generated. Allocation was centralized. Patients, caregivers, and outcome assessors were blinded to group assignment. (ClinicalTrials.gov registration number: NCT00077753) Setting: 370 sites in 20 countries across North and South America, Europe, and Asia. Patients: Acutely ill medical patients 40 years or older with recently reduced mobility (bed rest or sedentary without [ level 1] or with [ level 2] bathroom privileges). Eligibility criteria for patients with level 2 immobility were amended to include only those who had additional VTE risk factors (age >75 years, history of VTE, or active or previous cancer) after interim analyses suggested lower-than-expected VTE rates. Intervention: Enoxaparin, 40 mg/d subcutaneously (2975 patients), or placebo (2988 patients), for 28 +/- 4 days after receiving open-label enoxaparin for an initial 10 +/- 4 days. Measurements: Incidence of VTE up to day 28 and of major bleeding events up to 48 hours after the last study treatment dose. Results: Extended-duration enoxaparin reduced VTE incidence compared with placebo (2.5% vs. 4%; absolute risk difference favoring enoxaparin, -1.53% [95.8% CI, -2.54% to -0.52%]). Enoxaparin increased major bleeding events (0.8% vs. 0.3%; absolute risk difference favoring placebo, 0.51% [95% CI, 0.12% to 0.89%]). The benefits of extended-duration enoxaparin seemed to be restricted to women, patients older than 75 years, and those with level 1 immobility. Limitation: Estimates of efficacy and safety for the overall trial population are difficult to interpret because of the change in eligibility criteria during the trial. Conclusion: Use of extended-duration enoxaparin reduces VTE more than it increases major bleeding events in acutely ill medical patients with level 1 immobility, those older than 75 years, and women.	[Hull, Russell D.] Univ Calgary, Thrombosis Res Unit, Foothills Hosp, Calgary, AB T2N 2T9, Canada; McMaster Univ, Hamilton, ON, Canada; HHSC McMaster Clin, Hamilton, ON, Canada; Hosp Carl Gustav Carus, Dresden, Germany; Duke Univ, Med Ctr, Durham, NC USA; Hosp Badalona Germans Trias & Pujol, Barcelona, Spain; Hotel Dieu & Sanofi Aventis, Serv Hematol Biol, Paris, France; Washington Univ, Sch Med, St Louis, MO USA	University of Calgary; McMaster University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Duke University; Hospital Germans Trias i Pujol; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; Sanofi-Aventis; Sanofi France; Washington University (WUSTL)	Hull, RD (corresponding author), Univ Calgary, Thrombosis Res Unit, Foothills Hosp, Room 601,South Tower,1403 29th St NW, Calgary, AB T2N 2T9, Canada.	rdhull@ucalgary.ca	Deitelzweig, Steven B/H-9395-2012; Ost, David E./AAT-9505-2021; Piradov, Michael A/B-4407-2012; Ruiz-Galiana, Julian/Q-1692-2015; Zanatta, Nilo/P-7137-2017; Quere, Isabelle/AAB-8519-2020; Otero-Candelera, Remedios/G-7312-2016	Ost, David E./0000-0001-6351-5552; Piradov, Michael A/0000-0002-6338-0392; Ruiz-Galiana, Julian/0000-0002-9422-515X; Zanatta, Nilo/0000-0002-0959-9043; Quere, Isabelle/0000-0002-1492-9764; Otero-Candelera, Remedios/0000-0002-2265-1221; Aburto, Myriam/0000-0001-8644-1015; Dennis, Rodolfo J/0000-0003-3215-9721; LE MOIGNE, Emmanuelle/0000-0001-5103-2406; SANCHEZ, Olivier/0000-0003-1633-8391; Dumoulin, Franz Ludwig/0000-0002-1058-7867; Harenberg, Job/0000-0003-4590-4225	Sanofi-aventis	Sanofi-aventis(Sanofi-Aventis)	Primary Funding Source: Sanofi-aventis.	Baglin TP, 1997, J CLIN PATHOL, V50, P609, DOI 10.1136/jcp.50.7.609; Bergqvist D, 2002, NEW ENGL J MED, V346, P975, DOI 10.1056/NEJMoa012385; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; Eikelboom JW, 2001, LANCET, V358, P9, DOI 10.1016/S0140-6736(00)05249-1; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Hirsh J, 2008, CHEST, V133, P1293, DOI 10.1378/chest.08-0782; Hull RD, 2001, ANN INTERN MED, V135, P858, DOI 10.7326/0003-4819-135-10-200111200-00006; Hull RD, 2008, ANN INTERN MED, V149, P137, DOI 10.7326/0003-4819-149-2-200807150-00010; Hull RD, 2006, J THROMB THROMBOLYS, V22, P31, DOI 10.1007/s11239-006-7732-5; Kucher N, 2005, ARCH INTERN MED, V165, P341, DOI 10.1001/archinte.165.3.341; Leizorovicz A, 2004, CIRCULATION, V110, P874, DOI 10.1161/01.CIR.0000138928.83266.24; Lloyd NS, 2008, J THROMB HAEMOST, V6, P405, DOI 10.1111/j.1538-7836.2007.02847.x; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Rasmussen MS, 2006, J THROMB HAEMOST, V4, P2384, DOI 10.1111/j.1538-7836.2006.02153.x; Rodger MA, 2008, CAN MED ASSOC J, V179, P417, DOI 10.1503/cmaj.080493; Samama MM, 1999, NEW ENGL J MED, V341, P793, DOI 10.1056/NEJM199909093411103; Stein PD, 2004, ARCH INTERN MED, V164, P2260, DOI 10.1001/archinte.164.20.2260; Vaitkus PT, 2005, THROMB HAEMOSTASIS, V93, P76, DOI 10.1160/TH04-05-0323; Wille-Jorgensen P, 2005, THROMB HAEMOSTASIS, V93, P236, DOI 10.1160/TH04-09-0570	20	283	292	1	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					8	+		10.7326/0003-4819-153-1-201007060-00004	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00004			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20621900				2022-12-28	WOS:000279487700002
J	Jena, AB; Goldman, DP; Kamdar, A; Lakdawalla, DN; Lu, Y				Jena, Anupam B.; Goldman, Dana P.; Kamdar, Amee; Lakdawalla, Darius N.; Lu, Yang			Sexually Transmitted Diseases Among Users of Erectile Dysfunction Drugs: Analysis of Claims Data	ANNALS OF INTERNAL MEDICINE			English	Article							UNITED-STATES; SILDENAFIL USE; RISK BEHAVIORS; HIV-INFECTION; SAN-FRANCISCO; OLDER-PEOPLE; MEN; ATTITUDES; VIAGRA; ADULTS	Background: Pharmacologic treatments for erectile dysfunction (ED) have gained popularity among middle-aged and older men. Increased sexual activity among those who use these drugs raises concerns about sexually transmitted diseases (STDs). Objective: To examine the rates of STDs in men who use and do not use ED drugs. Design: Retrospective cohort study. Setting: Database of claims from 1997 to 2006 for 1 410 806 men older than age 40 years with private, employer-based insurance from 44 large companies. Patients: 33 968 men with at least 1 filled prescription for an ED drug and 1 376 838 patients with no prescription. Measurements: STD prevalence among users and nonusers of ED drugs. Results: Users of ED drugs had higher rates of STDs than nonusers the year before initiating ED drug therapy (214 vs. 106 annually per 100 000 persons; P = 0.003) and the year after (105 vs. 65; P = 0.004). After adjustment for age and other comorbid conditions, users of ED drugs had an odds ratio (OR) for an STD of 2.80 (95% CI, 2.10 to 3.75) in the year before initiating drug therapy; the OR was 2.65 (CI, 1.84 to 3.81) in the year after. These differences were largely due to infections with HIV. The OR for HIV infection was 3.32 (CI, 2.38 to 4.36) in the year before and 3.19 (CI, 2.11 to 4.83) in the year after an ED drug prescription was filled. Significant changes in STD rates from the year before to the year after the first ED drug prescription was filled were not documented (adjusted OR for STD for users before vs. after the first ED drug prescription was filled, 0.96 [CI, 0.87 to 1.06]). Limitation: Selection bias precludes conclusions about whether use of ED treatments directly leads to increases in STDs. Conclusion: Men who use ED drugs have higher rates of STDs, particularly HIV infection, both in the year before and after use of these drugs. The observed association between ED drug use and STDs may have more to do with the types of patients using ED drugs rather than a direct effect of ED drug availability on STD rates. Counseling about safe sexual practices and screening for STDs should accompany the prescription of ED drugs.	Harvard Univ, Sch Med, Boston, MA USA; Univ So Calif, Los Angeles, CA USA; Univ Chicago, Booth Grad Sch Business, Chicago, IL 60637 USA; RAND Corp, Santa Monica, CA USA	Harvard University; Harvard Medical School; University of Southern California; University of Chicago; RAND Corporation	Jena, AB (corresponding author), Massachusetts Gen Hosp, Dept Med, Wang Ambulatory Care Ctr, 15 Parkman St, Boston, MA 02114 USA.	jena.anupam@mgh.harvard.edu	Goldman, Dana P/E-7667-2013; Lakdawalla, Darius/B-4409-2011	Goldman, Dana P/0000-0001-8498-6396; Lakdawalla, Darius/0000-0001-5934-8042; Lu, Yang/0000-0003-2905-7302	RAND Roybal Center; National Institutes of Health; Agency for Healthcare Research and Quality; Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation [P30AG024968]; National Institutes of Health [5 T32 GM07281]; Agency for Healthcare Research and Quality through a University of California, Los Angeles [T32 HS 000046]; National Institute for Child Health and Human Development [1R01HD054877]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000046, F32HS000046] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD054877] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024968] Funding Source: NIH RePORTER	RAND Roybal Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Bing Center for Health Economics; RAND Roybal Center for Health Policy Simulation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality through a University of California, Los Angeles; National Institute for Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Primary Funding Source: RAND Roybal Center, National Institutes of Health, and Agency for Healthcare Research and Quality.; By the Bing Center for Health Economics and RAND Roybal Center for Health Policy Simulation (grant P30AG024968), a National Institutes of Health Medical Scientist National Research Award (grant 5 T32 GM07281 to Dr. Jena), the Agency for Healthcare Research and Quality through a University of California, Los Angeles/RAND Training Grant (grant T32 HS 000046 to Dr. Jena), and the National Institute for Child Health and Human Development (grant 1R01HD054877 to Dr. Jena).	Araujo AB, 2004, J AM GERIATR SOC, V52, P1502, DOI 10.1111/j.0002-8614.2004.52413.x; Armstrong K, 1999, NEW ENGL J MED, V341, P1389, DOI 10.1056/NEJM199910283411810; BACON CG, 2003, ANN INTERN MED, V50, P139; Bodley-Tickell AT, 2008, SEX TRANSM INFECT, V84, P312, DOI 10.1136/sti.2007.027847; Cachay E, 2004, AIDS PATIENT CARE ST, V18, P349, DOI 10.1089/1087291041444050; Chu PL, 2003, JAIDS-J ACQ IMM DEF, V33, P191, DOI 10.1097/00126334-200306010-00012; Delate T, 2004, INT J IMPOT RES, V16, P313, DOI 10.1038/sj.ijir.3901191; Enzlin P, 2004, INT J IMPOT RES, V16, P512, DOI 10.1038/sj.ijir.3901221; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Joyce GF, 2002, JAMA-J AM MED ASSOC, V288, P1733, DOI 10.1001/jama.288.14.1733; Karlovsky M, 2004, SCAND J UROL NEPHROL, V38, P247, DOI 10.1080/00365590410025488; Kim AA, 2002, AIDS, V16, P1425, DOI 10.1097/00002030-200207050-00017; Kuehn BM, 2008, JAMA-J AM MED ASSOC, V300, P1285, DOI 10.1001/jama.300.11.1285; Laumann EO, 2005, INT J IMPOT RES, V17, P39, DOI 10.1038/sj.ijir.3901250; Laumann EO, 1999, JAMA-J AM MED ASSOC, V281, P537, DOI 10.1001/jama.281.6.537; Lindau ST, 2007, NEW ENGL J MED, V357, P762, DOI 10.1056/NEJMoa067423; Lindau ST, 2006, J WOMENS HEALTH, V15, P747, DOI 10.1089/jwh.2006.15.747; Moreira ED, 2005, INT J CLIN PRACT, V59, P6, DOI 10.1111/j.1742-1241.2005.00382.x; Nicolosi A, 2004, UROLOGY, V64, P991, DOI 10.1016/j.urology.2004.06.055; Ory MG, 1998, RES AGING, V20, P653, DOI 10.1177/0164027598206002; Patel D, 2003, SEX TRANSM DIS, V30, P216, DOI 10.1097/00007435-200303000-00008; Paul JP, 2005, SEX TRANSM DIS, V32, P531, DOI 10.1097/01.olq.0000175294.76494.77; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; SHARPLES T, 2008, TIME            0702; Skiest DJ, 1997, ARCH FAM MED, V6, P289, DOI 10.1001/archfami.6.3.289; Smith KP, 2009, AM J PUBLIC HEALTH, V99, P2055, DOI 10.2105/AJPH.2009.160119; STALL R, 1994, ARCH INTERN MED, V154, P57, DOI 10.1001/archinte.154.1.57; Swearingen SG, 2005, AM J MED, V118, P571, DOI 10.1016/j.amjmed.2005.01.042	30	39	40	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					1	+		10.7326/0003-4819-153-1-201007060-00003	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620GS	20621899				2022-12-28	WOS:000279487700001
J	Lodwick, RK; Sabin, CA; Porter, K; Ledergerber, B; van Sighem, A; Cozzi-Lepri, A; Khaykin, P; Mocroft, A; Jacobson, L; De Wit, S; Obel, N; Castagna, A; Wasmuth, JC; Gill, J; Klein, MB; Gange, S; Riera, M; Mussini, C; Gutierrez, F; Touloumi, G; Carrieri, P; Guest, JL; Brockmeyer, NH; Phillips, AN				Lodwick, Rebecca K.; Sabin, Caroline A.; Porter, Kholoud; Ledergerber, Bruno; van Sighem, Ard; Cozzi-Lepri, Alessandro; Khaykin, Pavel; Mocroft, Amanda; Jacobson, Lisa; De Wit, Stephane; Obel, Niels; Castagna, Antonella; Wasmuth, Jan-Christian; Gill, John; Klein, Manna B.; Gange, Stephen; Riera, Melchor; Mussini, Cristina; Gutierrez, Felix; Touloumi, Giota; Carrieri, Patrizia; Guest, Jodie L.; Brockmeyer, Norbert H.; Phillips, Andrew N.		CD4 Count Antiretroviral Naive	Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per mu L in Europe and North America: a pooled cohort observational study	LANCET			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; GENERAL-POPULATION; INFECTED ADULTS; MORTALITY; THERAPY; AIDS; INDIVIDUALS; RISK; SEROCONVERSION; DISEASES	Background Whether people living with HIV who have not received antiretroviral therapy (ART) and have high CD4 cell counts have higher mortality than the general population is unknown. We aimed to examine this by analysis of pooled data from industrialised countries. Methods We merged data on demographics, CD4 cell counts, viral-load measurements, hepatitis C co-infection status, smoking status, date of death, and whether death was AIDS-related or not from 23 European and North American cohorts. We calculated standardised mortality ratios (SMRs) standardised by age, sex, and year, stratifying by risk group. Data were included for patients aged 20-59 years who had at least one CD4 count greater than 350 cells per mu L while ART naive. All pre-ART CD4 counts greater than 350 cells per mu L from January, 1990, to December, 2004, were included. We investigated mortality for four risk groups men who have sex with men, heterosexual people, injecting drug users, and those at other or unknown risk. The association between CD4 cell count and death rate was investigated by use of Poisson regression methods. Findings Data were analysed for 40 830 patients contributing 80 682 person-years of follow-up. Of 419 deaths, 401 were used in the SMR analysis: 100 men who have sex with men (SMR 1.30 , 95% CI 1.06-1 58); 68 heterosexual people (2.94, 2.28-3.73); 203 injecting drug users (9.37, 8.13-10.75); and 30 in the other or unknown risk category (4.57, 3.09-6.53). Compared with CD4 counts of 350-499 cells per mu L, death rate was lower in patients with counts of 500-699 cells per mu L (adjusted rate ratio 0-77, 95% CI 0.61-0.95) and counts of 700 cells per mu L (0.66, 0.52-0.85). Interpretation In HIV-infected ART-naive patients with high CD4 cell counts, death rates were raised compared with the general population. In men who have sex with men this was modest, suggesting that a substantial proportion of the increased risk in other groups is due to confounding by other factors. Even though the increased risk is small, new studies of potential benefits of ART in this group are merited.	[Lodwick, Rebecca K.] UCL Med Sch, Res Dept Infect & Populat Hlth, HIV Epidemiol & Biostat Grp, London NW3 2PF, England	University of London; University College London	Lodwick, RK (corresponding author), UCL Med Sch, Res Dept Infect & Populat Hlth, HIV Epidemiol & Biostat Grp, Royal Free Campus,Rowland Hill St, London NW3 2PF, England.		perno, carlo federico/O-1544-2016; Riera, Melchor/AEU-0584-2022; Soriano, Vicente/O-5730-2018; Mocroft, Amanda/G-8748-2011; Mussini, Cristina/K-8672-2016; Phillips, Andrew N/B-4427-2008; Spire, Bruno/F-5546-2013; DEL AMO VALERO, JULIA/M-7020-2015; Pantaleo, Giuseppe/K-6163-2016; Pulido, Federico/B-8417-2009; Lodwick, Rebecca/B-7578-2015; Ippolito, Giuseppe/J-7207-2017; VALLET, Yannick/F-9979-2011; Muga, Roberto/AAY-8655-2021; Gange, Stephen/AGY-5004-2022; Dodsley, Maria/G-7083-2016; Antinori, Andrea/K-7125-2016; Vehreschild, Jörg J/G-6764-2013; Sabin, Caroline/C-2464-2008; Sobrino-Vegas, Paz/E-1741-2015; Castagna, Antonella/K-3280-2018; Ledergerber, Bruno/B-5656-2009; Rodero, Félix Gutiérrez/Q-7880-2018; Gill, Michael John/G-7083-2016	Soriano, Vicente/0000-0002-4624-5199; Mocroft, Amanda/0000-0001-8316-1122; Mussini, Cristina/0000-0002-6615-4198; Phillips, Andrew N/0000-0003-2384-4807; Spire, Bruno/0000-0002-3546-8020; DEL AMO VALERO, JULIA/0000-0002-3104-540X; Pulido, Federico/0000-0002-7414-8812; Lodwick, Rebecca/0000-0003-2558-4762; Muga, Roberto/0000-0001-6301-431X; Gange, Stephen/0000-0001-7842-512X; Dodsley, Maria/0000-0001-7587-558X; Antinori, Andrea/0000-0003-2121-4684; Vehreschild, Jörg J/0000-0002-5446-7170; Sabin, Caroline/0000-0001-5173-2760; Sobrino-Vegas, Paz/0000-0002-0775-1558; Castagna, Antonella/0000-0002-8338-9714; Ledergerber, Bruno/0000-0002-6881-4401; Rodero, Félix Gutiérrez/0000-0002-9485-6867; Gill, Michael John/0000-0002-8546-8790; Casabona-Barbara, Jordi/0000-0003-4816-5536; Leen, Clifford/0000-0001-8439-7719; Ippolito, Giuseppe/0000-0002-1076-2979; Carrieri, Patrizia/0000-0002-6794-4837; PERNO, CARLO FEDERICO/0000-0002-0825-5388; CAUDA, Roberto/0000-0002-1498-4229; JARRIN, INMA/0000-0002-7485-2252; Easterbrook, Philippa/0000-0002-2603-5418; delpech, valerie/0000-0002-9952-8109	Dutch Health; Red de Investigacien en SIDA [ISCIII-RETIC-RD06/0006]; European Commission [CT94-1637, CT97-2713, QLK2-2000-00773, LSHP-CT-2006-018632]; Gilead; Pfizer; Merck and Co; Swiss Federal Office for Education and Science; Abbott; Boehringer Ingelheim; Bristol-Myers Squibb; GlaxoSmithKline; Federal Ministry of Education and Research [FK01KI0501]; National Institute of Allergy and Infectious Diseases, National Cancer Institute [UO1-A1-35042, 5-MO1-RR-00052, UO1-AI-35043, UO1-AI-35039, UO1-AI-35040, UO1-AI-35041]; Fonds de recherche en sante du Quebec, Reseau SIDA/maladies infectieuses (FRSQ); Fundacion para la Investigacion y la Prevencion del SIDA en Espaila (FIPSE); Catalan Health Department (Generalitat de Catalunya); Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP); Swiss National Science Foundation UK; Medical Research Council; National Institutes of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000052, UL1RR025005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035042, U01AI035041, U01AI035040, U01AI035039, U01AI035043] Funding Source: NIH RePORTER; Medical Research Council [MC_U122886351, G0900274] Funding Source: researchfish; MRC [G0900274, MC_U122886351] Funding Source: UKRI	Dutch Health; Red de Investigacien en SIDA; European Commission(European CommissionEuropean Commission Joint Research Centre); Gilead(Gilead Sciences); Pfizer(Pfizer); Merck and Co(Merck & Company); Swiss Federal Office for Education and Science; Abbott(Abbott Laboratories); Boehringer Ingelheim(Boehringer Ingelheim); Bristol-Myers Squibb(Bristol-Myers Squibb); GlaxoSmithKline(GlaxoSmithKline); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); National Institute of Allergy and Infectious Diseases, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Allergy & Infectious Diseases (NIAID)); Fonds de recherche en sante du Quebec, Reseau SIDA/maladies infectieuses (FRSQ)(Fonds de la Recherche en Sante du Quebec); Fundacion para la Investigacion y la Prevencion del SIDA en Espaila (FIPSE); Catalan Health Department (Generalitat de Catalunya)(Generalitat de Catalunya); Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP); Swiss National Science Foundation UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	ATHENA The ATHENA database is supported by a grant from the Dutch Health NI mister and was set up and is maintained by the Stichting HIV Monitoring CoRIS and CoRIS-MD Supported by Red de Investigacien en SIDA (ISCIII-RETIC-RD06/0006) EuroSIDA Primary support for EuroSIDA is provided by the European Commission BIOMED 1 (CT94-1637). BIOM ED 2 (CT97-2713), the 5th Framework (QLK2-2000-00773) and the 6th Framework (LSHP-CT-2006-018632) programmes Current support also includes unrestricted grants by Gilead. Pfizer, and Merck and Co The participation of centres from Switzerland was supported by a grant from the Swiss Federal Office for Education and Science ICONA The Icona Foundation Study is supported by unrestricted educational grants from Abbott, Boehringer Ingelheim, Bristol-Myers Squibb, Gilead. GlaxoSmithKline, Pfizer and Janssen-Cilag KOMPNET The German Competence Network for HIV/AIDS is supported by the Federal Ministry of Education and Research (FK01KI0501) and the Ruhr-Unwersitat Bochum MACS Funded by the National Institute of Allergy and Infectious Diseases, with additional supplemental funding from the National Cancer Institute UO1-A1-35042, 5-MO1-RR-00052 (GCRC). UO1-AI-35043. UO1-AI-35039, UO1-AI-35040, UO1-AI-35041 Website located at http//www.statepi.jhsph.edu/macs/macs.html Montreal Chest Immunodeficiency Cohort Founded by Richard Lalonde and has received infrastructure funding from the Fonds de recherche en sante du Quebec, Reseau SIDA/maladies infectieuses (FRSQ) Marina Klein is supported by a Chercheur-Boursier clinicien senior career award from the FRSQ PISCIS Supported by the Fundacion para la Investigacion y la Prevencion del SIDA en Espaila (FIPSE). the Catalan Health Department (Generalitat de Catalunya), and the Centro de Investigacion Biomedica en Red de Epidemiologia y Salud Publica (CIBERESP) Swiss HIV Cohort Study Supported by the Swiss National Science Foundation UK CHIC Funded by the Medical Research Council. UK WIHS Funded by the National Institutes of Health	Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; Bhaskaran K, 2008, JAMA-J AM MED ASSOC, V300, P51, DOI 10.1001/jama.300.1.51; Clumeck N, 2008, HIV MED, V9, P65, DOI 10.1111/j.1468-1293.2007.00533.x; Emery S, 2008, J INFECT DIS, V197, P1133, DOI 10.1086/586713; HAMMER SM, 2008, JAMA-J AM MED ASSOC, V300, pS55; Hansen ABE, 2007, J INFECT DIS, V195, P230, DOI 10.1086/510246; *INSIGHT, STRAT TIM ANT TREATM, P24501; Jaggy C, 2003, LANCET, V362, P877, DOI 10.1016/S0140-6736(03)14307-3; Kitahata MM, 2009, NEW ENGL J MED, V360, P1815, DOI 10.1056/NEJMoa0807252; Kjaer J, 2004, ANTIVIR THER, V9, P631; Lampe FC, 2007, ARCH INTERN MED, V167, P692, DOI 10.1001/archinte.167.7.692; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Lloyd-Smith E, 2006, AIDS, V20, P445, DOI 10.1097/01.aids.0000206508.32030.92; MANN B, 2009, AIDS, V23, P1743; Neaton JD, 2008, CURR OPIN HIV AIDS, V3, P112, DOI 10.1097/COH.0b013e3282f3808b; PHILLIPS AN, 1992, JAMA-J AM MED ASSOC, V268, P2662, DOI 10.1001/jama.268.19.2662; Phillips AN, 2007, AIDS, V21, P1717; Phillips AN, 2008, AIDS, V22, P2409, DOI 10.1097/QAD.0b013e3283174636; Sabin CA, 2010, AIDS, V24, P723, DOI 10.1097/QAD.0b013e328333fa0f; Smit C, 2006, AIDS, V20, P741, DOI 10.1097/01.aids.0000216375.99560.a2; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; van Sighem A, 2005, JAIDS-J ACQ IMM DEF, V40, P212, DOI 10.1097/01.qai.0000165911.97085.d0; Weber R, 2006, ARCH INTERN MED, V166, P1632, DOI 10.1001/archinte.166.15.1632	23	67	70	0	19	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL-AUG	2010	376	9738					340	345		10.1016/S0140-6736(10)60932-4	http://dx.doi.org/10.1016/S0140-6736(10)60932-4			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	636FW	20638118	Green Submitted, Green Accepted			2022-12-28	WOS:000280717900032
J	Ayoya, MA				Ayoya, Mohamed Ag			Personal View G8 leaders must seize their chance to tackle undernutrition	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Unicef Country Off, New Delhi, India		Ayoya, MA (corresponding author), Unicef Country Off, New Delhi, India.	mayoya@unicef.org						Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Unicef, 2009, TRACK PROGR CHILD MA; United Nations, 2008, MILL DEV GOALS REP; Wardlaw T, 2010, LANCET, V375, P870, DOI 10.1016/S0140-6736(09)61798-0; *WHO STAT INF SYST, 2008, DAT AN	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 23	2010	340								c3289	10.1136/bmj.c3289	http://dx.doi.org/10.1136/bmj.c3289			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IP	20573765				2022-12-28	WOS:000279346400007
J	Cosford, PA; Thomas, JM				Cosford, Paul A.; Thomas, Justyn M.			Safer out of hours primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE		[Cosford, Paul A.; Thomas, Justyn M.] NHS E England, Cambridge CB21 5XB, England		Cosford, PA (corresponding author), NHS E England, Cambridge CB21 5XB, England.	paul.cosford@eoe.nhs.uk						[Anonymous], 2010, IMPR OUT HOURS CAR W; *CAR QUAL COMM, 2009, UPD ENQ TAK CAR NOW; Colin-Thome D, 2010, GEN PRACTICE OUT OF; *DEP HLTH, 2009, TRACKL LOC PERF LIST; Department of Health, 2000, ORG MEM; Frankel A, 2007, JT COMM J QUAL PATIE, V33, P549, DOI 10.1016/S1553-7250(07)33059-6; General Medical Council, GOOD MED PRACT DUT D; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; *HC HLTH COMM, 5 HC HLTH COMM; Leape L, 2009, QUAL SAF HEALTH CARE, V18, P424, DOI 10.1136/qshc.2009.036954; Leonard M, 2004, QUAL SAF HEALTH CARE, V13, pI85, DOI 10.1136/qshc.2004.010033; Marshall M, 2009, BRIT J GEN PRACT, V59, P476, DOI 10.3399/bjgp09X453486; *NAT PAT SAF AG, 2006, SAF PRACT NOT ENS SA; *ROYAL COLL GEN PR, OUT HOURS CLIN AUD T; Vincent C, 2003, NEW ENGL J MED, V348, P1051, DOI 10.1056/NEJMhpr020760; Vincent CA, 2004, QUAL SAF HEALTH CARE, V13, P242, DOI 10.1136/qshc.2004.010454	16	8	8	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 22	2010	340								c3194	10.1136/bmj.c3194	http://dx.doi.org/10.1136/bmj.c3194			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IO	20570866				2022-12-28	WOS:000279346300006
J	Kang, S				Kang, Seema			Anecdotes in medicine-15 years of Lancet Case Reports	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Kang, S (corresponding author), The Lancet, London NW1 7BY, England.	seema.kang@lancet.com						BIGNALL J, 1995, LANCET, V346, P1246, DOI 10.1016/S0140-6736(95)91859-0; Coles A, 2003, LANCET, V361, P1230, DOI 10.1016/S0140-6736(03)12946-7; Handel AE, 2009, LANCET, V373, P1763, DOI 10.1016/S0140-6736(09)60982-X; MCBRIDE WG, 1961, LANCET, V2, P1358	4	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT-NOV	2010	376	9751					1448	1449		10.1016/S0140-6736(10)60624-1	http://dx.doi.org/10.1016/S0140-6736(10)60624-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	680QC	20630581				2022-12-28	WOS:000284248500009
J	Steegers, EAP; von Dadelszen, P; Duvekot, JJ; Pijnenborg, R				Steegers, Eric A. P.; von Dadelszen, Peter; Duvekot, Johannes J.; Pijnenborg, Robert			Pre-eclampsia	LANCET			English	Article							PLACENTAL OXIDATIVE STRESS; EARLY-ONSET PREECLAMPSIA; HYPERTENSIVE DISORDERS; BLOOD-PRESSURE; GESTATIONAL HYPERTENSION; PREGNANCY COMPLICATIONS; ANGIOGENIC FACTORS; UNITED-STATES; RISK-FACTORS; URIC-ACID	Pre-eclampsia remains a leading cause of maternal and perinatal mortality and morbidity. It is a pregnancy-specific disease characterised by de-novo development of concurrent hypertension and proteinuria, sometimes progressing into a multiorgan cluster of varying clinical features. Poor early placentation is especially associated with early onset disease. Predisposing cardiovascular or metabolic risks for endothelial dysfunction, as part of an exaggerated systemic inflammatory response, might dominate in the origins of late onset pre-eclampsia. Because the multifactorial pathogenesis of different pre-eclampsia phenotypes has not been fully elucidated, prevention and prediction are still not possible, and symptomatic clinical management should be mainly directed to prevent maternal morbidity (eg, eclampsia) and mortality. Expectant management of women with early onset disease to improve perinatal outcome should not preclude timely delivery the only definitive cure. Pre-eclampsia foretells raised rates of cardiovascular and metabolic disease in later life, which could be reason for subsequent lifestyle education and intervention.	[Steegers, Eric A. P.; Duvekot, Johannes J.] Erasmus MC, Univ Med Ctr Rotterdam, Div Obstet & Prenatal Med, Dept Obstet & Gynaecol, NL-3000 CB Rotterdam, Netherlands; [von Dadelszen, Peter] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC V5Z 1M9, Canada; [Pijnenborg, Robert] Catholic Univ Louvain, Univ Hosp Gasthuisberg, Dept Obstet & Gynaecol, B-3000 Louvain, Belgium	Erasmus University Rotterdam; Erasmus MC; University of British Columbia; KU Leuven; University Hospital Leuven; Universite Catholique Louvain	Steegers, EAP (corresponding author), Erasmus MC, Univ Med Ctr Rotterdam, Div Obstet & Prenatal Med, Dept Obstet & Gynaecol, NL-3000 CB Rotterdam, Netherlands.	e.a.p.steegers@erasmusmc.nl	von Dadelszen, Peter/AAP-7480-2021	von Dadelszen, Peter/0000-0003-4136-3070	WHO; Canadian Institutes of Health Research; Michael Smith Foundation for Health Research; Child and Family Research Institute	WHO(World Health Organization); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Child and Family Research Institute	No funding was used for the preparation or submission of this report. We thank the PhD fellows Durk Berks, Meeke Hoedjes, Nienke Bergen, and Evelyne van Uitert for assisting in the literature search; Jolanda Claessens for her secretarial support; and Frits Wilbrink for his contribution to the graphics of the figure. Peter von Dadelszen receives funding support from WHO, the Canadian Institutes of Health Research, the Michael Smith Foundation for Health Research, and the Child and Family Research Institute.	Abalos E, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002252.pub3; ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Allen Rebecca, 2009, Rev Obstet Gynecol, V2, P159; Arngrimsson R, 2005, NAT GENET, V37, P460, DOI 10.1038/ng0505-460; Askie LM, 2007, LANCET, V369, P1791, DOI 10.1016/S0140-6736(07)60712-0; Bainbridge SA, 2005, MED HYPOTHESES, V64, P17, DOI 10.1016/j.mehy.2004.06.019; Barton JR, 2008, OBSTET GYNECOL, V112, P359, DOI 10.1097/AOG.0b013e3181801d56; Bellamy L, 2007, BMJ-BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.385301.BE; Berends AL, 2008, HYPERTENSION, V51, P1034, DOI 10.1161/HYPERTENSIONAHA.107.101873; Berg CJ, 2009, OBSTET GYNECOL, V113, P1075, DOI 10.1097/AOG.0b013e3181a09fc0; Berks D, 2009, OBSTET GYNECOL, V114, P1307, DOI 10.1097/AOG.0b013e3181c14e3e; Blankley RT, 2009, BJOG-INT J OBSTET GY, V116, P1473, DOI 10.1111/j.1471-0528.2009.02283.x; Brosens I A, 1972, Obstet Gynecol Annu, V1, P177; Brosens JJ, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.11.037; BROWN MA, 1995, AUST NZ J OBSTET GYN, V35, P366, DOI 10.1111/j.1479-828X.1995.tb02143.x; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Brownfoot F. C., 2008, COCHRANE DB SYST REV, V4; Buimer M, 2008, PLACENTA, V29, P444, DOI 10.1016/j.placenta.2008.02.007; Burton GJ, 2009, PLACENTA, V30, pS43, DOI 10.1016/j.placenta.2008.11.003; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Burton GJ, 2004, J SOC GYNECOL INVEST, V11, P342, DOI 10.1016/j.jsgi.2004.03.003; Burton GJ, 2009, J ANAT, V215, P27, DOI 10.1111/j.1469-7580.2008.00978.x; Caughey AB, 2005, OBSTET GYNECOL, V106, P156, DOI 10.1097/01.AOG.0000164478.91731.06; Cavkaytar S, 2007, ACTA OBSTET GYN SCAN, V86, P648, DOI 10.1080/00016340601185384; Chung Y, 2009, HYPERTENS PREGNANCY, V28, P348, DOI 10.1080/10641950802601286; CHURCHILL D, 2002, COCHRANE DB SYST REV, V3; Cnossen JS, 2008, BMJ-BRIT MED J, V336, P1117, DOI 10.1136/bmj.39540.522049.BE; Conde-Agudelo A, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P189, DOI 10.1016/B978-0-12-374213-1.00011-2; Cote AM, 2008, BRIT MED J, V336, P1003, DOI 10.1136/bmj.39532.543947.BE; Cote AM, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2008.06.009; de Groot CJM, 2007, PROTEOM CLIN APPL, V1, P325, DOI 10.1002/prca.200600911; Dizon-Townson D, 2005, OBSTET GYNECOL, V106, P517, DOI 10.1097/01.AOG.0000173986.32528.ca; Duckitt K, 2005, BRIT MED J, V330, P565, DOI 10.1136/bmj.38380.674340.E0; Duley L, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001449.pub2, 10.1002/14651858.CD001449.pub3]; Duley L, 2006, BMJ-BRIT MED J, V332, P463, DOI 10.1136/bmj.332.7539.463; DULEY L, 1995, LANCET, V345, P1455; Duley L, 2002, LANCET, V359, P1877, DOI 10.1016/s0140-6736(02)08778-0; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Facchinetti F, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.032; Freeman RK, 2008, SEMIN PERINATOL, V32, P271, DOI 10.1053/j.semperi.2008.04.009; Ganzevoort W, 2005, BJOG-INT J OBSTET GY, V112, P1358, DOI 10.1111/j.1471-0528.2005.00687.x; Gaugler-Senden IPM, 2006, EUR J OBSTET GYN R B, V128, P216, DOI 10.1016/j.ejogrb.2005.11.011; Getahun D, 2007, OBSTET GYNECOL, V110, P1319, DOI 10.1097/01.AOG.0000292090.40351.30; Goldman-Wohl DS, 2000, MOL HUM REPROD, V6, P88, DOI 10.1093/molehr/6.1.88; Grossman E, 1996, JAMA-J AM MED ASSOC, V276, P1328, DOI 10.1001/jama.276.16.1328; Gruslin A, 2008, J OBSTET GYNAECOL CA, V30, P1000, DOI 10.1016/S1701-2163(16)32993-0; Haig D, 1996, AM J REPROD IMMUNOL, V35, P226; Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452; Haram K, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-8; Hennessy A, 2007, AUST NZ J OBSTET GYN, V47, P279, DOI 10.1111/j.1479-828X.2007.00738.x; Horlocker TT, 2003, REGION ANESTH PAIN M, V28, P172, DOI 10.1053/rapm.2003.50046; Hossain N, 2009, THROMB RES, V124, P653, DOI 10.1016/j.thromres.2009.08.001; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Irani RA, 2008, PLACENTA, V29, P763, DOI 10.1016/j.placenta.2008.06.011; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Jauniaux E, 2006, HUM REPROD UPDATE, V12, P747, DOI 10.1093/humupd/dml016; Jeyabalan A, 2008, AM J HYPERTENS, V21, P943, DOI 10.1038/ajh.2008.219; Kahn SR, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.09.023; Kanter D, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.005; Karumanchi SA, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P87, DOI 10.1016/B978-0-12-374213-1.00006-9; Katz L, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.10.797; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Knight M, 2007, BJOG-INT J OBSTET GY, V114, P1072, DOI 10.1111/j.1471-0528.2007.01423.x; Kocher O, 2007, AM J CLIN PATHOL, V127, P68, DOI 10.1309/JWL27GRGU71VP5QL; Koga K, 2010, FERTIL STERIL, V94, P305, DOI 10.1016/j.fertnstert.2009.02.015; Koopmans CM, 2009, LANCET, V374, P979, DOI 10.1016/S0140-6736(09)60736-4; Krause B, 2009, CURR VASC PHARMACOL, V7, P513, DOI 10.2174/157016109789043883; Kusanovic JP, 2009, J MATERN-FETAL NEO M, V22, P1021, DOI 10.3109/14767050902994754; Lambers MJ, 2009, HUM REPROD, V24, P2447, DOI 10.1093/humrep/dep245; Le Bouteiller P, 2003, J REPROD IMMUNOL, V59, P219, DOI 10.1016/S0165-0378(03)00049-4; Leveno KJ, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P389, DOI 10.1016/B978-0-12-374213-1.00021-5; Levine RJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4336; Lindheimer MD, 2010, OBSTET GYNECOL, V115, P365, DOI 10.1097/AOG.0b013e3181cb9644; Lindheimer MD, 2008, J AM SOC HYPERTENS, V2, P484, DOI 10.1016/j.jash.2008.10.001; Lowe SA, 2009, AUST NZ J OBSTET GYN, V49, P242, DOI 10.1111/j.1479-828X.2009.01003.x; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Magee LA, 2009, HYPERTENS PREGNANCY, V28, P312, DOI 10.1080/10641950802601252; Magee LA, 2005, AM J OBSTET GYNECOL, V193, P153, DOI 10.1016/j.ajog.2004.11.059; Magee LA, 2003, BMJ-BRIT MED J, V327, P955, DOI 10.1136/bmj.327.7421.955; Magee LA, 2009, SEMIN PERINATOL, V33, P138, DOI 10.1053/j.semperi.2009.02.001; Maggard MA, 2008, JAMA-J AM MED ASSOC, V300, P2286, DOI 10.1001/jama.2008.641; Magnussen EB, 2007, BRIT MED J, V335, P978, DOI 10.1136/bmj.39366.416817.BE; Martin JN, 2005, OBSTET GYNECOL, V105, P246, DOI 10.1097/01.AOG.0000151116.84113.56; Matchaba PT, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002076.pub3; Meads CA, 2008, HEALTH TECHNOL ASSES, V12, P1; Menzies J, 2007, OBSTET GYNECOL, V110, P121, DOI 10.1097/01.AOG.0000266977.26311.f0; Milne F, 2005, BRIT MED J, V330, P576, DOI 10.1136/bmj.330.7491.576; MILNE F, 2009, BMJ-BRIT MED J, V339, P626; Moffett A, 2007, PLACENTA, V28, pS51, DOI 10.1016/j.placenta.2006.11.008; Mosca L, 2004, ARTERIOSCL THROM VAS, V24, pE29, DOI 10.1161/01.ATV.0000114834.85476.81; Mostello D, 2008, AM J OBSTET GYNECOL, V199, DOI 10.1016/j.ajog.2007.11.058; Muetze S, 2008, J PERINAT MED, V36, P38, DOI 10.1515/JPM.2008.004; Myers J, 2005, HYPERTENSION, V45, P258, DOI 10.1161/01.HYP.0000153461.58298.a4; Nafee TM, 2008, BJOG-INT J OBSTET GY, V115, P158, DOI 10.1111/j.1471-0528.2007.01528.x; *NAT I CLIN EXC SC, 2007, SAV MOTH LIV 2003 20; Nelson-Piercy C, 2004, THROMBOPROPHYLAXIS P, V37; Newstead J, 2007, Expert Rev Cardiovasc Ther, V5, P283, DOI 10.1586/14779072.5.2.283; Ng EHY, 2006, HUM REPROD, V21, P1612, DOI 10.1093/humrep/dei502; Oglaend B, 2009, J HYPERTENS, V27, P2051, DOI 10.1097/HJH.0b013e328330052a; Oudejans CBM, 2008, PLACENTA, V29, pS78, DOI 10.1016/j.placenta.2007.09.005; Pabinger I, 2009, THROMB RES, V123, pS16, DOI 10.1016/S0049-3848(09)70128-8; Pandian Z, 2001, HUM REPROD, V16, P2593, DOI 10.1093/humrep/16.12.2593; Pijnenborg R, 2006, PLACENTA, V27, P939, DOI 10.1016/j.placenta.2005.12.006; PIJNENBORG R, 2010, PLACENTAL BED DISORD, P97, DOI DOI 10.1016/J.JSGI.2004.03.003; Plasencia W, 2007, ULTRASOUND OBST GYN, V30, P742, DOI 10.1002/uog.5157; Poel YHM, 2009, J PSYCHOSOM OBST GYN, V30, P65, DOI 10.1080/01674820802545990; Poon LCY, 2009, HYPERTENSION, V53, P812, DOI 10.1161/HYPERTENSIONAHA.108.127977; Rao YD, 2006, CHINESE EDUC SOC, V39, P41; Redman CWG, 2009, PLACENTA, V30, pS38, DOI 10.1016/j.placenta.2008.11.021; Redman CWG, 2009, CHESLEY'S HYPERTENSIVE DISORDERS IN PREGNANCY, 3RD EDITION, P129, DOI 10.1016/B978-0-12-374213-1.00008-2; Redman CWG, 1999, AM J OBSTET GYNECOL, V180, P499, DOI 10.1016/S0002-9378(99)70239-5; REDMAN CWG, 1991, PLACENTA, V12, P301, DOI 10.1016/0143-4004(91)90339-H; Rep A, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.045; Roberts JM, 2009, PLACENTA, V30, pS32, DOI 10.1016/j.placenta.2008.11.009; Roberts JM, 2005, HYPERTENSION, V46, P1263, DOI 10.1161/01.HYP.0000188703.27002.14; Robertson L, 2006, BRIT J HAEMATOL, V132, P171, DOI 10.1111/j.1365-2141.2005.05847.x; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Schutte JM, 2008, BJOG-INT J OBSTET GY, V115, P732, DOI 10.1111/j.1471-0528.2008.01702.x; Sep SJS, 2009, REPROD SCI, V16, P80, DOI 10.1177/1933719108324889; Sibai BM, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.048; Sibai BM, 2009, SEMIN PERINATOL, V33, P196, DOI 10.1053/j.semperi.2009.02.004; Sibai BM, 2006, SEMIN PERINATOL, V30, P16, DOI 10.1053/j.semperi.2006.01.008; Sibai BM, 2004, OBSTET GYNECOL, V103, P981, DOI 10.1097/01.AOG.0000126245.35811.2a; Sibai BM, 2003, OBSTET GYNECOL, V102, P181, DOI 10.1016/S0029-7844(03)00475-7; Sikkema JM, 2002, PLACENTA, V23, P337, DOI 10.1053/plac.2001.0785; Silva LM, 2008, J HYPERTENS, V26, P1200, DOI 10.1097/HJH.0b013e3282fcc36e; Silver RM, 2006, CLIN OBSTET GYNECOL, V49, P906, DOI 10.1097/01.grf.0000211959.53498.a4; Steegers-Theunissen RP, 2004, OBSTET GYNECOL, V104, P336, DOI 10.1097/01.AOG.0000129955.47943.2a; Stone CD, 2007, J PERINAT MED, V35, P28, DOI 10.1515/JPM.2007.003; Sunderji S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.07.025; Tenhola S, 2006, PEDIATR RES, V59, P320, DOI 10.1203/01.pdr.0000196734.54473.e3; Thangaratinam S, 2006, BJOG-INT J OBSTET GY, V113, P369, DOI 10.1111/j.1471-0528.2006.00908.x; Toal M, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.897; Trogstad L, 2009, BJOG-INT J OBSTET GY, V116, P108, DOI 10.1111/j.1471-0528.2008.01978.x; Trumbo PR, 2007, NUTR REV, V65, P78, DOI [10.1111/j.1753-4887.2007.tb00284.x, 10.1301/nr.2007.feb.78-87]; Tuffnell DJ, 2005, BJOG-INT J OBSTET GY, V112, P875, DOI 10.1111/j.1471-0528.2005.00565.x; TUFFNELL DJ, 2006, MANAGEMENT SEVERE PR; Turner JA, 2009, AM J THER, V16, P284, DOI 10.1097/MJT.0b013e31816f6fd8; van Rijn BB, 2006, AM J OBSTET GYNECOL, V195, P723, DOI 10.1016/j.ajog.2006.06.044; Verlohren S, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.09.016; WALKER MC, 2003, COCHRANE DB SYST REV, V2; Wallis AB, 2008, AM J HYPERTENS, V21, P521, DOI 10.1038/ajh.2008.20; Wikstrom AK, 2009, REPROD SCI, V16, P995, DOI 10.1177/1933719109339348; WILSON JMG, 1969, PUBLIC HLTH PAPERS, V34; Wu CS, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.060; Zeeman GG, 2009, SEMIN PERINATOL, V33, P166, DOI 10.1053/j.semperi.2009.02.003; Zetterstrom K, 2007, BJOG-INT J OBSTET GY, V114, P319, DOI 10.1111/j.1471-0528.2006.01231.x; Zusterzeel PLM, 2007, GYNECOL OBSTET INVES, V63, P209, DOI 10.1159/000097987	149	2205	2322	8	220	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 21	2010	376	9741					631	644		10.1016/S0140-6736(10)60279-6	http://dx.doi.org/10.1016/S0140-6736(10)60279-6			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643PB	20598363				2022-12-28	WOS:000281309100034
J	Saravanan, P; Davidson, NC; Schmidt, EB; Calder, PC				Saravanan, Palaniappan; Davidson, Neil C.; Schmidt, Erik B.; Calder, Philip C.			Cardiovascular effects of marine omega-3 fatty acids	LANCET			English	Review							POLYUNSATURATED-FATTY-ACIDS; CORONARY-HEART-DISEASE; FISH-OIL SUPPLEMENTATION; ARTERY-BYPASS SURGERY; RAT VENTRICULAR MYOCYTES; ATRIAL-FIBRILLATION; EICOSAPENTAENOIC ACID; MYOCARDIAL-INFARCTION; DOCOSAHEXAENOIC ACID; DIETARY FISH	Much evidence shows that the marine omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid have beneficial effects in various cardiac disorders, and their use is recommended in guidelines for management of patients after myocardial infarction. However, questions have been raised about their usefulness alongside optimum medical therapies with agents proven to reduce risk of cardiac events in high-risk patients. Additionally, there is some evidence for a possible pro-arrhythmic effect in subsets of cardiac patients. Some uncertainly exists about the optimum dose needed to obtain beneficial effects and the relative merit of dietary intake of omega-3 polyunsaturated fatty acids versus supplements. We review evidence for the effects of omega-3 polyunsaturated fatty acids on various cardiac disorders and the risk factors for cardiac disease. We also assess areas of uncertainty needing further research.	[Saravanan, Palaniappan] Univ Manchester, Cardiovasc Res Grp, Core Technol Facil, Manchester Acad Hlth Sci Ctr, Manchester M13 9NT, Lancs, England; [Saravanan, Palaniappan; Davidson, Neil C.] Univ Hosp S Manchester NHS Fdn Trust, Manchester, Lancs, England; [Schmidt, Erik B.] Aarhus Univ Hosp, Aalborg Hosp, Cardiovasc Res Ctr, Dept Cardiol, Aalborg, Denmark; [Calder, Philip C.] Univ Southampton, Sch Med, Inst Human Nutr, Southampton, Hants, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Aalborg University; Aalborg University Hospital; Aarhus University; University of Southampton	Saravanan, P (corresponding author), Univ Manchester, Cardiovasc Res Grp, Core Technol Facil, Manchester Acad Hlth Sci Ctr, 3rd Floor,46 Grafton St, Manchester M13 9NT, Lancs, England.	drplsuk@yahoo.co.uk	Calder, Philip C/E-9739-2013	Calder, Philip C/0000-0002-6038-710X; saravanan, Palaniappan/0000-0002-9687-4145	Omacor; Solvay Healthcare (UK); Solvay Pharmaceuticals (Germany); Pronova Biocare	Omacor; Solvay Healthcare (UK)(Solvay SA); Solvay Pharmaceuticals (Germany); Pronova Biocare	EBS has received research funding from Pronova Biocare-manufacturer of Omacor. PCC has received speaking fees from Solvay Healthcare (UK) and Solvay Pharmaceuticals (Germany), both suppliers of Omacor, and has previously received research funding from Pronova Biocare. As an employee of the University of Southampton, PCC was named as an inventor on patent application 0210212.7 ("Effects of dietary n-3 and n-6 PUFA intake on atheromatous plaque stability") filed in 2002 and licensed to Pronova Biocare in 2003. PS and NCD declare that they have no conflicts of interest.	Abdukeyum GG, 2008, J NUTR, V138, P1902, DOI 10.1093/jn/138.10.1902; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Albert CM, 1998, JAMA-J AM MED ASSOC, V279, P23, DOI 10.1001/jama.279.1.23; Alexander JW, 1998, TRANSPLANTATION, V65, P1304, DOI 10.1097/00007890-199805270-00004; Arnesen H, 2001, LIPIDS, V36, pS103, DOI 10.1007/s11745-001-0690-z; Balk EM, 2006, ATHEROSCLEROSIS, V189, P19, DOI 10.1016/j.atherosclerosis.2006.02.012; Bang HO, 1980, ADV NUTR RES, P1, DOI [DOI 10.1007/978-1-4757-4448-4_1, 10.1007/978-1-4757-4448-4_1]; Berecki G, 2007, HEART RHYTHM, V4, P1452, DOI 10.1016/j.hrthm.2007.07.015; Bierregaard LJ, 2010, EUR HEART J, V31, P29, DOI 10.1093/eurheartj/ehp375; Billman GE, 1999, CIRCULATION, V99, P2452, DOI 10.1161/01.CIR.99.18.2452; Bogdanov KY, 1998, AM J PHYSIOL-HEART C, V274, pH571, DOI 10.1152/ajpheart.1998.274.2.H571; Brouwer IA, 2006, AM HEART J, V151, P857, DOI 10.1016/j.ahj.2005.07.029; Brouwer IA, 2006, JAMA-J AM MED ASSOC, V295, P2613, DOI 10.1001/jama.295.22.2613; Brouwer IA, 2009, EUR HEART J, V30, P820, DOI 10.1093/eurheartj/ehp003; Bucher HC, 2002, AM J MED, V112, P298, DOI 10.1016/S0002-9343(01)01114-7; BURR ML, 1989, LANCET, V2, P757; Burr ML, 2003, EUR J CLIN NUTR, V57, P193, DOI 10.1038/sj.ejcn.1601539; Calder PC, 2009, BIOCHIMIE, V91, P791, DOI 10.1016/j.biochi.2009.01.008; Calo L, 2005, J AM COLL CARDIOL, V45, P1723, DOI 10.1016/j.jacc.2005.02.079; CHRISTENSEN JH, 1996, BMJ-BRIT MED J, V31, P677; *CLIN GOV, 2002, NCT00135226 CLIN GOV; Coronel R, 2007, CARDIOVASC RES, V73, P386, DOI 10.1016/j.cardiores.2006.10.006; De Caterina R, 2007, DIABETES CARE, V30, P1012, DOI 10.2337/dc06-1332; Den Ruijter HM, 2008, CIRCULATION, V117, P536, DOI 10.1161/CIRCULATIONAHA.107.733329; Den Ruijter HM, 2007, CARDIOVASC RES, V73, P316, DOI 10.1016/j.cardiores.2006.06.014; Dhein S, 2005, N-S ARCH PHARMACOL, V371, P202, DOI 10.1007/s00210-005-1024-z; DOLECEK TA, 1991, WORLD REV NUTR DIET, V66, P205; Dujardin KS, 2008, AM J PHYSIOL-HEART C, V295, pH1414, DOI 10.1152/ajpheart.01219.2007; DYERBERG J, 1978, LANCET, V2, P117, DOI 10.1016/s0140-6736(78)91505-2; Eritsland J, 1996, AM J CARDIOL, V77, P31, DOI 10.1016/S0002-9149(97)89130-8; ERITSLAND J, 1995, BLOOD COAGUL FIBRIN, V6, P17, DOI 10.1097/00001721-199502000-00003; Ferrier GR, 2002, CARDIOVASC RES, V54, P601, DOI 10.1016/S0008-6363(02)00275-4; Frost L, 2005, AM J CLIN NUTR, V81, P50; GAPINSKI JP, 1993, ARCH INTERN MED, V153, P1595, DOI 10.1001/archinte.153.13.1595; Geleijnse JM, 2002, J HYPERTENS, V20, P1493, DOI 10.1097/00004872-200208000-00010; Gerstein HC, 2008, AM HEART J, V155, P26, DOI 10.1016/j.ahj.2007.09.009; Guallar E, 1999, ARTERIOSCL THROM VAS, V19, P1111, DOI 10.1161/01.ATV.19.4.1111; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Harris WS, 2004, CLEV CLIN J MED, V71, P208, DOI 10.3949/ccjm.71.3.208; Hartweg J, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003205.pub2; Heidt MC, 2009, THORAC CARDIOV SURG, V57, P276, DOI 10.1055/s-0029-1185301; Iso H, 2006, CIRCULATION, V113, P195, DOI 10.1161/CIRCULATIONAHA.105.581355; KAGAWA Y, 1982, J NUTR SCI VITAMINOL, V28, P441, DOI 10.3177/jnsv.28.441; KNAPP HR, 1986, NEW ENGL J MED, V314, P937, DOI 10.1056/NEJM198604103141501; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Kristensen SD, 2001, LIPIDS, V36, pS79, DOI 10.1007/s11745-001-0671-2; KROMHOUT D, 1995, INT J EPIDEMIOL, V24, P340, DOI 10.1093/ije/24.2.340; KROMHOUT D, 1985, NEW ENGL J MED, V312, P1205, DOI 10.1056/NEJM198505093121901; Kromhout D, 1996, INT J EPIDEMIOL, V25, P753, DOI 10.1093/ije/25.4.753; Leaf A, 2005, CIRCULATION, V112, P2762, DOI 10.1161/CIRCULATIONAHA.105.549527; Leifert WR, 2000, J NUTR BIOCHEM, V11, P38, DOI 10.1016/S0955-2863(99)00069-8; Leifert WR, 1999, J PHYSIOL-LONDON, V520, P671, DOI 10.1111/j.1469-7793.1999.00671.x; Leifert WR, 2000, J NUTR BIOCHEM, V11, P382, DOI 10.1016/S0955-2863(00)00094-2; Lemaitre RN, 2003, AM J CLIN NUTR, V77, P319, DOI 10.1093/ajcn/77.2.319; Leon H., 2008, BMJ-BRIT MED J, V337, P2931; London B, 2007, CIRCULATION, V116, pE320, DOI 10.1161/CIRCULATIONAHA.107.712984; Macchia A, 2005, EUR J HEART FAIL, V7, P904, DOI 10.1016/j.ejheart.2005.04.008; Macleod JC, 1998, EUR J PHARMACOL, V356, P261, DOI 10.1016/S0014-2999(98)00528-7; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; McKenney JM, 2007, PHARMACOTHERAPY, V27, P715, DOI 10.1592/phco.27.5.715; MCLENNAN PL, 1993, AM J CLIN NUTR, V58, P666, DOI 10.1093/ajcn/58.5.666; MCLENNAN PL, 1993, AM J CLIN NUTR, V57, P207, DOI 10.1093/ajcn/57.2.207; MCLENNAN PL, 1988, AM HEART J, V116, P709, DOI 10.1016/0002-8703(88)90328-6; Mori TA, 2006, CURR OPIN CLIN NUTR, V9, P95, DOI 10.1097/01.mco.0000214566.67439.58; MORRIS MC, 1993, CIRCULATION, V88, P523, DOI 10.1161/01.CIR.88.2.523; Mozaffarian D, 2005, J AM COLL CARDIOL, V45, P2015, DOI 10.1016/j.jacc.2005.03.038; Mozaffarian D, 2005, CIRCULATION, V112, P1945, DOI 10.1161/CIRCULATIONAHA.105.556886; Mozaffarian D, 2004, CIRCULATION, V110, P368, DOI 10.1161/01.CIR.0000138154.00779.A5; Mozaffarian D, 2008, CIRCULATION, V117, P1130, DOI 10.1161/CIRCULATIONAHA.107.732826; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; NICE, 2007, NICE CLIN GUID, V48; Nodari S, 2009, CARDIOVASC DRUG THER, V23, P5, DOI 10.1007/s10557-008-6142-7; O'Keefe JH, 2006, AM J CARDIOL, V97, P1127, DOI 10.1016/j.amjcard.2005.11.025; OIKAWA S, 2008, ATHEROSCLEROSIS, V200, P135; Plutzky J, 1999, AM J CARDIOL, V84, p15J; Raitt MH, 2005, JAMA-J AM MED ASSOC, V293, P2884, DOI 10.1001/jama.293.23.2884; Rees D, 2006, AM J CLIN NUTR, V83, P331; Sakabe M, 2007, CIRCULATION, V116, P2101, DOI 10.1161/CIRCULATIONAHA.107.704759; Saravanan P, 2010, CIRC-ARRHYTHMIA ELEC, V3, P46, DOI 10.1161/CIRCEP.109.899633; Sekikawa A, 2008, J AM COLL CARDIOL, V52, P417, DOI 10.1016/j.jacc.2008.03.047; Sekikawa A, 2007, AM J EPIDEMIOL, V165, P617, DOI 10.1093/aje/kwk053; SENGES S, 2009, ANN SCI SESS AM COLL; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2000, J PHYSIOL PHARMACOL, V51, P643; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Streppel MT, 2008, EUR HEART J, V29, P2024, DOI 10.1093/eurheartj/ehn294; Svensson M, 2006, CLIN J AM SOC NEPHRO, V1, P780, DOI 10.2215/CJN.00630206; Swan JS, 2003, CARDIOVASC RES, V60, P337, DOI 10.1016/S0008-6363(03)00545-5; Tavazzi L, 2008, LANCET, V372, P1223, DOI 10.1016/S0140-6736(08)61239-8; Thies F, 2003, LANCET, V361, P477, DOI 10.1016/S0140-6736(03)12468-3; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Verkerk AO, 2006, CARDIOVASC RES, V70, P509, DOI 10.1016/j.cardiores.2006.02.022; Verkerk AO, 2009, HEART RHYTHM, V6, P1485, DOI 10.1016/j.hrthm.2009.07.024; Virtanen JK, 2009, CIRCULATION, V120, P2315, DOI 10.1161/CIRCULATIONAHA.109.852657; Watson PD, 2009, AM J CARDIOL, V104, P1052, DOI 10.1016/j.amjcard.2009.05.055; Wood DA, 2008, LANCET, V371, P1999, DOI 10.1016/S0140-6736(08)60868-5; Xiao YF, 2004, BIOCHEM BIOPH RES CO, V321, P116, DOI 10.1016/j.bbrc.2004.06.114; XIAO YF, 1995, P NATL ACAD SCI USA, V92, P11000, DOI 10.1073/pnas.92.24.11000; Xiao YF, 1998, P NATL ACAD SCI USA, V95, P2680, DOI 10.1073/pnas.95.5.2680; Xiao YF, 2008, AM J PHYSIOL-HEART C, V294, pH2212, DOI 10.1152/ajpheart.91502.2007; Yamagishi K, 2008, AM HEART J, V156, P965, DOI 10.1016/j.ahj.2008.06.017; Yamagishi K, 2008, J AM COLL CARDIOL, V52, P988, DOI 10.1016/j.jacc.2008.06.018; Yin R, 2008, PEDIATR TRANSPLANT, V12, P550, DOI 10.1111/j.1399-3046.2007.00849.x; Yokoyama M, 2007, LANCET, V369, P1090, DOI 10.1016/S0140-6736(07)60527-3; Zhao YT, 2009, J INT MED RES, V37, P1831, DOI 10.1177/147323000903700619	106	384	401	1	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 14	2010	376	9740					540	550		10.1016/S0140-6736(10)60445-X	http://dx.doi.org/10.1016/S0140-6736(10)60445-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	643BE	20638121				2022-12-28	WOS:000281266800033
J	Koole, O; Colebunders, R				Koole, Olivier; Colebunders, Robert			ART in low-resource settings: how to do more with less	LANCET			English	Editorial Material							1ST-LINE ANTIRETROVIRAL THERAPY; COUNTRIES; MORTALITY; FAILURE; AFRICA		[Koole, Olivier; Colebunders, Robert] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Colebunders, Robert] Univ Antwerp, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp	Koole, O (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.			Koole, Olivier/0000-0002-1122-5382				Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; *CAMP ACC ESS MED, 2009, MED SANS FRONT PUN S; *COMM SOC DET HLTH, 2008, CLOS GAP EGN HLTH EQ; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Lawn SD, 2005, AIDS, V19, P2141, DOI 10.1097/01.aids.0000194802.89540.e1; Lynen L, 2009, JAIDS-J ACQ IMM DEF, V52, P40, DOI 10.1097/QAI.0b013e3181af6705; MAY M, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60666-6; Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Renggli V, 2008, LANCET, V372, P341, DOI 10.1016/S0140-6736(08)61119-8; Roehr B, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2284; World Health Organization, 2009, RAP ADV ANT THER HIV; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	14	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 7	2010	376	9739					396	398		10.1016/S0140-6736(10)61020-3	http://dx.doi.org/10.1016/S0140-6736(10)61020-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20638119				2022-12-28	WOS:000281012900007
J	May, M; Boulle, A; Phiri, S; Messou, E; Myer, L; Wood, R; Keiser, O; Sterne, JAC; Dabis, F; Egger, M				May, Margaret; Boulle, Andrew; Phiri, Sam; Messou, Eugene; Myer, Landon; Wood, Robin; Keiser, Olivia; Sterne, Jonathan A. C.; Dabis, Francois; Egger, Matthias		IeDEA So Africa W Africa	Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes	LANCET			English	Article							HIV-1-INFECTED PATIENTS; POSITIVE PATIENTS; SURVIVAL; ANEMIA; MORTALITY; ADULTS; SETTINGS; GENDER; MODEL; ERA	Background Prognostic models have been developed for patients infected with HIV-1 who start combination antiretroviral therapy (ART) in high-income countries, but not for patients in sub-Saharan Africa. We developed two prognostic models to estimate the probability of death in patients starting ART in sub-Saharan Africa. Methods We analysed data for adult patients who started ART in four scale-up programmes in Cote d'Ivoire, South Africa, and Malawi from 2004 to 2007. Patients lost to follow-up in the first year were excluded. We used Weibull survival models to construct two prognostic models: one with CD4 cell count, clinical stage, bodyweight, age, and sex (CD4 count model); and one that replaced CD4 cell count with total lymphocyte count and severity of anaemia (total lymphocyte and haemoglobin model), because CD4 cell count is not routinely measured in many African ART programmes. Death from all causes in the first year of ART was the primary outcome. Findings 912 (8.2%) of 11 153 patients died in the first year of ART. 822 patients were lost to follow-up and not included in the main analysis; 10331 patients were analysed. Mortality was strongly associated with high baseline CD4 cell count (>= 200 cells per mu L vs <25; adjusted hazard ratio 0.21, 95% CI 0.17-0.27), WHO clinical stage (stages III-IV vs I-II; 3.45, 2.43-4.90), bodyweight (60 kg vs <45 kg; 0.23, 0.18-0.30), and anaemia status (none vs severe: 0.27, 0.20-0.36). Other independent risk factors for mortality were low total lymphocyte count, advanced age, and male sex. Probability of death at 1 year ranged from 0.9% (95% CI 0.6-1.4) to 52.5% (43.8-61.7) with the CD4 model, and from 0.9% (0.5-1.4) to 59.6% (48.2-71.4) with the total lymphocyte and haemoglobin model. Both models accurately predict early mortality in patients starting ART in sub-Saharan Africa compared with observed data. Interpretation Prognostic models should be used to counsel patients, plan health services, and predict outcomes for patients with HIV-1 infection in sub-Saharan Africa.	[Keiser, Olivia; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, CH-3012 Bern, Switzerland; [May, Margaret; Sterne, Jonathan A. C.] Univ Bristol, Dept Social Med, Bristol, Avon, England; [Boulle, Andrew; Myer, Landon] Univ Cape Town, Sch Publ Hlth & Family Med, Ctr Infect Dis Epidemiol & Res, ZA-7925 Cape Town, South Africa; [Myer, Landon] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, New York, NY USA; [Myer, Landon] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Phiri, Sam] Lighthouse Trust Kamuzu Cent Hosp, Lilongwe, Malawi; [Messou, Eugene] CEPREF Clin, Abidjan, Cote Ivoire; [Messou, Eugene] Programme PAC CI, Abidjan, Cote Ivoire; [Wood, Robin] Univ Cape Town, Fac Hlth Sci, Inst Infect Dis & Mol Med, Desmond Tutu HIV Ctr, ZA-7925 Cape Town, South Africa; [Dabis, Francois] Univ Victor Segalen, ISPED, INSERM, U897, Bordeaux, France	University of Bern; University of Bristol; University of Cape Town; Columbia University; Columbia University; University of Cape Town; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Egger, M (corresponding author), Univ Bern, Inst Social & Prevent Med, Finkenhubelweg 11, CH-3012 Bern, Switzerland.	egger@ispm.unibe.ch	May, Margaret T/E-8099-2013; Boulle, Andrew/C-1413-2008; DABIS, FRANCOIS/S-9298-2019; Sterne, Jonathan/Z-3106-2019; Wood, Robin/G-8509-2011	May, Margaret T/0000-0002-9733-1003; Boulle, Andrew/0000-0002-7713-8062; DABIS, FRANCOIS/0000-0002-1614-8857; Sterne, Jonathan/0000-0001-8496-6053; Keiser, Olivia/0000-0001-8191-2789; Egger, Matthias/0000-0001-7462-5132	National Institute of Allergy And Infectious Diseases (NIAID) [1U01AI069924, 5U01AI069919]; National Cancer Institute (NCI); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); United Kingdom Medical Research Council [G0700820]; French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales [ANRS 12101, ANRS 12138]; Swiss National Science Foundation [32473B-122116]; Office of AIDS Research of the National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069924, U01AI069919] Funding Source: NIH RePORTER; Medical Research Council [G0700820, G0100221] Funding Source: researchfish; MRC [G0700820, G0100221] Funding Source: UKRI	National Institute of Allergy And Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales(ANRS); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Office of AIDS Research of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all patients, doctors, and study nurses associated with the four cohort studies. The International epidemiologic Databases to Evaluate AIDS (IeDEA) is supported by the National Institute of Allergy And Infectious Diseases (NIAID) (grant 1U01AI069924 to the Southern African Region and 5U01AI069919 to the West African Region), the National Cancer Institute (NCI) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). MM and JACS were supported by the United Kingdom Medical Research Council (grant G0700820), FD was supported by the French Agence Nationale de Recherches sur le SIDA et les Hepatites Virales (grants ANRS 12101 and 12138) and ME was supported by the Swiss National Science Foundation (grant 32473B-122116) and the Office of AIDS Research of the National Institutes of Health.	Beadles WI, 2009, TROP DOCT, V39, P78, DOI 10.1258/td.2008.080213; Boulle A, 2010, AIDS, V24, P563, DOI 10.1097/QAD.0b013e328333bfb7; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Braitstein P, 2008, J WOMENS HEALTH, V17, P47, DOI 10.1089/jwh.2007.0353; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Clark TG, 2003, J CLIN EPIDEMIOL, V56, P28, DOI 10.1016/S0895-4356(02)00539-5; Cornell M, 2009, TROP MED INT HEALTH, V14, P722, DOI 10.1111/j.1365-3156.2009.02290.x; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Harris RJ, 2008, ANTIVIR THER, V13, P959; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Keiser O, 2008, PLOS MED, V5, P1102, DOI 10.1371/journal.pmed.0050148; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lewis DK, 2005, T ROY SOC TROP MED H, V99, P561, DOI 10.1016/j.trstmh.2005.01.002; Lundgren JD, 2002, J INFECT DIS, V185, P178, DOI 10.1086/338267; Madec Y, 2009, AIDS, V23, P853, DOI 10.1097/QAD.0b013e32832913ee; Mangili A, 2006, CLIN INFECT DIS, V42, P836, DOI 10.1086/500398; May M, 2004, STAT MED, V23, P2375, DOI 10.1002/sim.1825; May M, 2007, AIDS, V21, P1185, DOI 10.1097/QAD.0b013e328133f285; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moore RD, 1998, J ACQ IMMUN DEF SYND, V19, P29, DOI 10.1097/00042560-199809010-00004; Moses A, 1998, BLOOD, V91, P1479, DOI 10.1182/blood.V91.5.1479.1479_1479_1495; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Mwamburi DM, 2005, CLIN INFECT DIS, V40, P167, DOI 10.1086/426591; Ojikutu B, 2008, SAMJ S AFR MED J, V98, P204; Royston P, 2004, STAT MED, V23, P907, DOI 10.1002/sim.1691; Royston P, 2004, STAT MED, V23, P723, DOI 10.1002/sim.1621; Royston P, 2002, STAT MED, V21, P2175, DOI 10.1002/sim.1203; Semba RD, 2002, CLIN INFECT DIS, V34, P260, DOI 10.1086/338151; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Toure S, 2008, AIDS, V22, P873, DOI 10.1097/QAD.0b013e3282f768f8; Volberding PA, 2004, CLIN INFECT DIS, V38, P1459, DOI 10.1086/383031; *WHO, UN ACC SCAL PRIOR HI; World Health Organization, 2004, SCAL ANT THER RES LT	34	179	179	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					449	457		10.1016/S0140-6736(10)60666-6	http://dx.doi.org/10.1016/S0140-6736(10)60666-6			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20638120	Green Accepted			2022-12-28	WOS:000281012900030
J	Lai, KJ; Nakamura, M; Kundhikanjana, W; Kawasaki, M; Tokura, Y; Kelly, MA; Shen, ZX				Lai, Keji; Nakamura, Masao; Kundhikanjana, Worasom; Kawasaki, Masashi; Tokura, Yoshinori; Kelly, Michael A.; Shen, Zhi-Xun			Mesoscopic Percolating Resistance Network in a Strained Manganite Thin Film	SCIENCE			English	Article							DOPED MANGANITES; PHASE-SEPARATION; TRANSITION; COEXISTENCE; FIELD	Many unusual behaviors in complex oxides are deeply associated with the spontaneous emergence of microscopic phase separation. Depending on the underlying mechanism, the competing phases can form ordered or random patterns at vastly different length scales. By using a microwave impedance microscope, we observed an orientation-ordered percolating network in strained Nd(1/2)Sr(1/2)MnO(3) thin films with a large period of 100 nanometers. The filamentary metallic domains align preferentially along certain crystal axes of the substrate, suggesting the anisotropic elastic strain as the key interaction in this system. The local impedance maps provide microscopic electrical information of the hysteretic behavior in strained thin film manganites, suggesting close connection between the glassy order and the colossal magnetoresistance effects at low temperatures.	[Lai, Keji; Kundhikanjana, Worasom; Kelly, Michael A.; Shen, Zhi-Xun] Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA; [Lai, Keji; Kundhikanjana, Worasom; Kelly, Michael A.; Shen, Zhi-Xun] Stanford Univ, Dept Appl Phys, Stanford, CA 94305 USA; [Nakamura, Masao; Kawasaki, Masashi; Tokura, Yoshinori] RIKEN, Adv Sci Inst, Cross Correlated Mat Grp CMRG, Wako, Saitama 3510198, Japan; [Nakamura, Masao; Kawasaki, Masashi; Tokura, Yoshinori] RIKEN, Adv Sci Inst, Correlated Electron Res Grp, Wako, Saitama 3510198, Japan; [Kawasaki, Masashi] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Tokura, Yoshinori] Univ Tokyo, Dept Appl Phys, Tokyo 1138586, Japan	Stanford University; Stanford University; RIKEN; RIKEN; Tohoku University; University of Tokyo	Shen, ZX (corresponding author), Stanford Univ, Dept Phys, Geballe Lab Adv Mat, Stanford, CA 94305 USA.	zxshen@stanford.edu	Kawasaki, Masashi/B-5826-2008; Nakamura, Masao/B-2528-2013; Tokura, Yoshinori/C-7352-2009	Nakamura, Masao/0000-0002-6812-6334; Tokura, Yoshinori/0000-0002-2732-4983	NSF [DMR-0906027, PHY-0425897]; Department of Energy [DE-FG03-01ER45929-A001]; Japan Society for the Promotion of Science (JSPS); King Abdullah University of Science and Technology [KUS-F1-033-02]	NSF(National Science Foundation (NSF)); Department of Energy(United States Department of Energy (DOE)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	We thank X.-L. Qi, Y. Chen, J. C. Davis, and S. A. Kivelson for valuable discussions. The work is supported by NSF (grants DMR-0906027 and Center of Probing the Nanoscale PHY-0425897), Department of Energy (DE-FG03-01ER45929-A001), Funding Program for World-Loading Innovative R and D on Science and Technology (FIRST) of Japan Society for the Promotion of Science (JSPS), and King Abdullah University of Science and Technology Fellowship (KUS-F1-033-02). Stanford University has filed a patent application with the U. S. Patent Office on the AFM compatible microwave imaging technique. This technology was modified for low-temperature measurement in this report.	Ahn KH, 2004, NATURE, V428, P401, DOI 10.1038/nature02364; Aliaga H, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.104405; Burgy J, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.097202; Dagotto E, 2005, SCIENCE, V309, P257, DOI 10.1126/science.1107559; Fath M, 1999, SCIENCE, V285, P1540, DOI 10.1126/science.285.5433.1540; Hanaguri T, 2004, NATURE, V430, P1001, DOI 10.1038/nature02861; Higuchi T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3193667; Howald C, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.014533; KIRKPATRICK S, 1973, REV MOD PHYS, V45, P574, DOI 10.1103/RevModPhys.45.574; KUWAHARA H, 1995, SCIENCE, V270, P961, DOI 10.1126/science.270.5238.961; Lai K, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2949109; LAI K, 2008, PHYS LETT, V93; Loudon JC, 2002, NATURE, V420, P797, DOI 10.1038/nature01299; Mathur ND, 2001, SOLID STATE COMMUN, V119, P271, DOI 10.1016/S0038-1098(01)00112-0; Mayr M, 2001, PHYS REV LETT, V86, P135, DOI 10.1103/PhysRevLett.86.135; Moreo A, 2000, PHYS REV LETT, V84, P5568, DOI 10.1103/PhysRevLett.84.5568; Nakamura M, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1923754; Renner C, 2002, NATURE, V416, P518, DOI 10.1038/416518a; Robertson JA, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.134507; Rosner BT, 2002, REV SCI INSTRUM, V73, P2505, DOI 10.1063/1.1482150; Sarma DD, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.097202; Tao J, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.097202; Tokura Y, 2006, REP PROG PHYS, V69, P797, DOI 10.1088/0034-4885/69/3/R06; Uehara M, 1999, NATURE, V399, P560, DOI 10.1038/21142; Vershinin M, 2004, SCIENCE, V303, P1995, DOI 10.1126/science.1093384; Wakabayashi Y, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.017202; Wang ZY, 2002, J APPL PHYS, V92, P808, DOI 10.1063/1.1481199; Wu WD, 2006, NAT MATER, V5, P881, DOI 10.1038/nmat1743; Yunoki S, 1998, PHYS REV LETT, V80, P845, DOI 10.1103/PhysRevLett.80.845; Zhang LW, 2002, SCIENCE, V298, P805, DOI 10.1126/science.1077346	30	169	173	1	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					190	193		10.1126/science.1189925	http://dx.doi.org/10.1126/science.1189925			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616272	Green Submitted			2022-12-28	WOS:000279635200041
J	Perkins, EA; Moran, JA				Perkins, Elizabeth A.; Moran, Julie A.			Aging Adults With Intellectual Disabilities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE ACCESS; DISPARITIES		[Perkins, Elizabeth A.] Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, Tampa, FL 33612 USA; [Moran, Julie A.] Beth Israel Deaconess Med Ctr, Div Gerontol, Boston, MA 02215 USA	State University System of Florida; University of South Florida; Harvard University; Beth Israel Deaconess Medical Center	Perkins, EA (corresponding author), Univ S Florida, Coll Behav & Community Sci, Dept Child & Family Studies, Florida Ctr Inclus Communities UCEDD, 13301 Bruce B Downs Blvd,MHC 2113A, Tampa, FL 33612 USA.	eperkins@mail.usf.edu			PHS HHS [K01-HP00007-01] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bittles AH, 2002, J GERONTOL A-BIOL, V57, pM470, DOI 10.1093/gerona/57.7.M470; Haveman M, 2010, J POLICY PRACT INTEL, V7, P59, DOI 10.1111/j.1741-1130.2010.00248.x; Havercamp SM, 2004, PUBLIC HEALTH REP, V119, P418, DOI 10.1016/j.phr.2004.05.006; Janicki MP, 2008, DISABIL HEALTH J, V1, P116, DOI 10.1016/j.dhjo.2008.02.004; Janicki MP, 1999, DISABIL REHABIL, V21, P284; Krahn GL, 2006, MENT RETARD DEV D R, V12, P70, DOI 10.1002/mrdd.20098; Krahn GL, 2007, MENT RETARD DEV D R, V13, P160, DOI 10.1002/mrdd.20149; U.S Department of Health and Human Services, 2005, SURG GEN CALL ACT IM; *US BUR CENS, TABL 2A PROJ POP US; US Public Health Service, 2002, CLOS GAP NAT BLUEPR	10	64	66	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					91	92		10.1001/jama.2010.906	http://dx.doi.org/10.1001/jama.2010.906			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606156				2022-12-28	WOS:000279519600028
J	Behrends, C; Sowa, ME; Gygi, SP; Harper, JW				Behrends, Christian; Sowa, Mathew E.; Gygi, Steven P.; Harper, J. Wade			Network organization of the human autophagy system	NATURE			English	Article							PROTEIN; UBIQUITIN; ACCUMULATION; COMPLEXES; RUBICON; ATG14L; LC3	Autophagy, the process by which proteins and organelles are sequestered in autophagosomal vesicles and delivered to the lysosome/vacuole for degradation, provides a primary route for turnover of stable and defective cellular proteins. Defects in this system are linked with numerous human diseases. Although conserved protein kinase, lipid kinase and ubiquitin-like protein conjugation subnetworks controlling autophagosome formation and cargo recruitment have been defined, our understanding of the global organization of this system is limited. Here we report a proteomic analysis of the autophagy interaction network in human cells under conditions of ongoing (basal) autophagy, revealing a network of 751 interactions among 409 candidate interacting proteins with extensive connectivity among subnetworks. Many new autophagy interaction network components have roles in vesicle trafficking, protein or lipid phosphorylation and protein ubiquitination, and affect autophagosome number or flux when depleted by RNA interference. The six ATG8 orthologues in humans (MAP1LC3/GABARAP proteins) interact with a cohort of 67 proteins, with extensive binding partner overlap between family members, and frequent involvement of a conserved surface on ATG8 proteins known to interact with LC3-interacting regions in partner proteins. These studies provide a global view of the mammalian autophagy interaction landscape and a resource for mechanistic analysis of this critical protein homeostasis pathway.	[Behrends, Christian; Sowa, Mathew E.; Harper, J. Wade] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Harper, JW (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA.	wade_harper@hms.harvard.edu	Behrends, Christian/AAX-4201-2021	Behrends, Christian/0000-0002-9184-7607; Harper, Jeffrey/0000-0002-6944-7236	Millennium Pharmaceuticals; National Institutes of Health; Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054137, R01GM070565, R01GM095567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011085] Funding Source: NIH RePORTER	Millennium Pharmaceuticals(Takeda Pharmaceutical Company Ltd); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul F. Glenn Foundation on Aging; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank I. Dikic for discussions and for sharing unpublished data, D. Bowman and J. Ringeling for assistance with Acapela software, N. Perrimon, S. Mohr and M. Ocana for access to the Opera microscope, and N. Gray for Torin1. This work was supported by grants to J. W. H. from Millennium Pharmaceuticals, the National Institutes of Health, and the Paul F. Glenn Foundation on Aging. C. B. is a Humboldt Postdoctoral Fellow.	Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Jeffries TR, 2004, MOL BIOL CELL, V15, P2652, DOI 10.1091/mbc.E03-10-0732; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Jung CH, 2009, MOL BIOL CELL, V20, P1992, DOI 10.1091/mbc.E08-12-1249; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; KARNITZ LM, 2007, SCI STKE, pPE22; Kinchen JM, 2010, NATURE, V464, P778, DOI 10.1038/nature08853; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Legakis JE, 2007, AUTOPHAGY, V3, P422, DOI 10.4161/auto.4129; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lippai M, 2008, AUTOPHAGY, V4, P476, DOI 10.4161/auto.5719; Lynch-Day MA, 2010, P NATL ACAD SCI USA, V107, P7811, DOI 10.1073/pnas.1000063107; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CURR OPIN CELL BIOL, V22, P132, DOI 10.1016/j.ceb.2009.12.004; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Noda NN, 2008, GENES CELLS, V13, P1211, DOI 10.1111/j.1365-2443.2008.01238.x; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Sadler KC, 2005, DEVELOPMENT, V132, P3561, DOI 10.1242/dev.01918; Sakata T, 2004, CURR BIOL, V14, P2228, DOI 10.1016/j.cub.2004.12.028; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Shvets E, 2009, METHOD ENZYMOL, V452, P131, DOI 10.1016/S0076-6879(08)03609-4; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Spiess C, 2004, TRENDS CELL BIOL, V14, P598, DOI 10.1016/j.tcb.2004.09.015; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854	38	1120	1171	10	201	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					68	U84		10.1038/nature09204	http://dx.doi.org/10.1038/nature09204			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20562859	Green Accepted			2022-12-28	WOS:000279343800036
J	Loder, E				Loder, Elizabeth			Triptan Therapy in Migraine	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLINICAL-TRIALS; DOUBLE-BLIND; INTERMITTENT PREVENTION; CARDIOVASCULAR-DISEASE; 5-HT1B/1D AGONISTS; RANDOMIZED-TRIAL; COST BURDEN; HEADACHE; TOLERABILITY; SUMATRIPTAN	An otherwise healthy 23-year-old woman presents to her internist with a report of headaches and associated symptoms that occur twice a month. A diagnosis of migraine without aura is made. The patient's headaches last up to a day and cause her to miss work. The headaches have not responded reliably to analgesics or to combinations of analgesics with caffeine. Her internist has previously recommended the combination of aspirin and metoclopramide, which usually diminishes but does not eliminate her headache pain. On one occasion, her headache progressed despite treatment, and the patient went to the emergency department. She received subcutaneous sumatriptan for a presumptive diagnosis of migraine. Her headache and nausea resolved, but she had a sensation of mild chest pressure for about 5 minutes, without associated symptoms. Her internist refers her to a headache specialist with the question of what therapy should be used to treat her headache episodes.	[Loder, Elizabeth] Faulkner Hosp, John R Graham Headache Ctr, Boston, MA 02130 USA; [Loder, Elizabeth] Brigham & Womens Hosp, Div Headache & Pain, Dept Neurol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital	Loder, E (corresponding author), Faulkner Hosp, John R Graham Headache Ctr, Boston, MA 02130 USA.	eloder@partners.org						Adelman JU, 2005, NEUROLOGY, V64, P931, DOI 10.1212/WNL.64.5.931; Adeney KL, 2006, HEADACHE, V46, P794, DOI 10.1111/j.1526-4610.2006.00432.x; Afridi SK, 2005, BRAIN, V128, P932, DOI 10.1093/brain/awh416; *ASTRAZENECA, 2009, INF VERM PRESCR PRES; Aurora SK, 2009, HEADACHE, V49, P1001, DOI 10.1111/j.1526-4610.2009.01429.x; Bartsch T, 2004, ANN NEUROL, V56, P371, DOI 10.1002/ana.20193; BATES D, 1994, NEUROLOGY, V44, P1587, DOI 10.1212/WNL.44.9.1587; Bigal ME, 2008, HEADACHE, V48, P1157, DOI 10.1111/j.1526-4610.2008.01217.x; Brandes JL, 2009, HEADACHE, V49, P1435, DOI 10.1111/j.1526-4610.2009.01530.x; Cady RK, 2009, HEADACHE, V49, P350, DOI 10.1111/j.1526-4610.2009.01340.x; Cunnington M, 2009, HEADACHE, V49, P1414, DOI 10.1111/j.1526-4610.2009.01529.x; Diener HC, 2002, EUR NEUROL, V47, P99, DOI 10.1159/000047960; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; Dodick DW, 2005, HEADACHE, V45, P156, DOI 10.1111/j.1526-4610.2005.05031.x; Evers S, 2009, EUR J NEUROL, V16, P968, DOI 10.1111/j.1468-1331.2009.02748.x; Ferrari MD, 2002, CEPHALALGIA, V22, P633, DOI 10.1046/j.1468-2982.2002.00404.x; *FOOD DRUG ADM, 2006, PUBL HLTH ADV COMB U; Geraud G, 2002, EUR NEUROL, V47, P88, DOI 10.1159/000047959; Goadsby PJ, 2007, CEPHALALGIA, V27, P254, DOI 10.1111/j.1468-2982.2007.01278.x; Goadsby PJ, 2009, BRAIN, V132, P6, DOI 10.1093/brain/awn321; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; Goldstein JN, 2006, CEPHALALGIA, V26, P684, DOI 10.1111/j.1468-2982.2006.01093.x; Hall GC, 2004, NEUROLOGY, V62, P563, DOI 10.1212/01.WNL.0000110312.36809.7F; Hawkins K, 2008, HEADACHE, V48, P553, DOI 10.1111/j.1526-4610.2007.00990.x; Hawkins K, 2007, J OCCUP ENVIRON MED, V49, P368, DOI 10.1097/JOM.0b013e31803b9510; HING E, 2006, 374 NAT CTR HLTH STA; Kallen B, 2001, HEADACHE, V41, P351, DOI 10.1046/j.1526-4610.2001.111006351.x; Levy D, 2004, P NATL ACAD SCI USA, V101, P4274, DOI 10.1073/pnas.0306147101; Linde M, 2004, CEPHALALGIA, V24, P455, DOI 10.1111/j.1468-2982.2004.00703.x; LINET MS, 1989, JAMA-J AM MED ASSOC, V261, P2211, DOI 10.1001/jama.261.15.2211; Lipton RB, 2004, CEPHALALGIA, V24, P321, DOI 10.1111/j.1468-2982.2003.00690.x; McKenzie JA, 2009, HEADACHE, V49, P669, DOI 10.1111/j.1526-4610.2009.01411.x; Nappi G, 2003, DRUG SAFETY, V26, P93, DOI 10.2165/00002018-200326020-00003; Olesen C, 2000, HEADACHE, V40, P20, DOI 10.1046/j.1526-4610.2000.00003.x; Peroutka SJ, 1998, HEADACHE, V38, P18, DOI 10.1046/j.1526-4610.1998.3801018.x; Pitts Stephen R, 2008, Natl Health Stat Report, P1; Schurks M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3914; Shields KG, 2006, NEUROBIOL DIS, V23, P491, DOI 10.1016/j.nbd.2006.04.003; Silberstein, 2001, NEUROLOGY, V56, P142; Silberstein SD, 2000, NEUROLOGY, V55, P754, DOI 10.1212/WNL.55.6.754; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Silberstein SD, 2005, HEADACHE, V45, P1250, DOI 10.1111/j.1526-4610.2005.00250.x; Silberstein SD, 2004, NEUROLOGY, V63, P261, DOI 10.1212/01.WNL.0000134620.30129.D6; Snow V, 2002, ANN INTERN MED, V137, P840, DOI 10.7326/0003-4819-137-10-200211190-00014; Sprenger T, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-71; Stewart WF, 2008, CEPHALALGIA, V28, P1170, DOI 10.1111/j.1468-2982.2008.01666.x; Tfelt-Hansen P, 2000, DRUGS, V60, P1259, DOI 10.2165/00003495-200060060-00003; Tfelt-Hansen PC, 2009, LANCET, V374, P1501, DOI 10.1016/S0140-6736(09)61906-1; van der Heijden AW, 2006, NEUROLOGY, V67, P1128, DOI 10.1212/01.wnl.0000240128.76399.fa; Welch KMA, 2001, CEPHALALGIA, V21, P164; Welch KMA, 2000, CEPHALALGIA, V20, P687, DOI 10.1046/j.1468-2982.2000.00116.x; World Health Organization, 2008, GLOB BURD DIS 2004 U	52	125	129	1	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					63	70		10.1056/NEJMct0910887	http://dx.doi.org/10.1056/NEJMct0910887			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592298				2022-12-28	WOS:000279343000009
J	Dickson, N				Dickson, Niall			Locum Staff Responsibilities of individual doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material									Gen Med Council, London NW1 3JN, England		Dickson, N (corresponding author), Gen Med Council, London NW1 3JN, England.	ndickson@gmc-uk.org							0	1	1	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 29	2010	340								c3385	10.1136/bmj.c3385	http://dx.doi.org/10.1136/bmj.c3385			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NS	20587553				2022-12-28	WOS:000279586200018
J	Chen, M; Galvao, RM; Li, MN; Burger, B; Bugea, J; Bolado, J; Chory, J				Chen, Meng; Galvao, Rafaelo M.; Li, Meina; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne			Arabidopsis HEMERA/pTAC12 Initiates Photomorphogenesis by Phytochromes	CELL			English	Article							BHLH TRANSCRIPTION FACTORS; E3 UBIQUITIN LIGASE; LIGHT CONTROL; INTERACTING FACTORS; BINDING PROTEIN; NUCLEAR-BODIES; DEGRADATION; DNA; PROTEASOME; EXPRESSION	Light plays a profound role in plant development, yet how photoreceptor excitation directs phenotypic plasticity remains elusive. One of the earliest effects of light is the regulated translocation of the red/far-red photoreceptors, phytochromes, from the cytoplasm to subnuclear foci called phytochrome nuclear bodies. The function of these nuclear bodies is unknown. We report the identification of hemera, a seedling lethal mutant of Arabidopsis with altered phytochrome nuclear body patterns. hemera mutants are impaired in all phytochrome responses examined, including proteolysis of phytochrome A and phytochrome-interacting transcription factors. HEMERA was identified previously as pTAC12, a component of a plastid complex associated with transcription. Here, we show that HEMERA has a function in the nucleus, where it acts specifically in phytochrome signaling, is predicted to be structurally similar to the multiubiquitin-binding protein, RAD23, and can partially rescue yeast rad23mutants. Together, these results implicate phytochrome nuclear bodies as sites of proteolysis.	[Chen, Meng; Burger, Brian; Bugea, Jane; Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Bolado, Jack; Chory, Joanne] Salk Inst Biol Studies, Howard Hughes Med Inst, La Jolla, CA 92037 USA; [Chen, Meng; Galvao, Rafaelo M.; Li, Meina] Duke Univ, Dept Biol, Durham, NC 27708 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Duke University	Chen, M (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	chen.meng@duke.edu; chory@salk.edu	Chen, Meng/C-7109-2014	Chen, Meng/0000-0003-0351-5897	National Institutes of Health [R01GM52413]; Duke University [4314268]; National Science Foundation [IOS-0923722]; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052413, R01GM087388] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Duke University; National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Akira Nagatani for providing the PBG line, Clark Lagarias for the PHYBYH line, Peter Quail and Sabine Heinhorst for anti-PHYA and anti-SiR antibodies, Kiran Madura for the yeast rad23 Delta rpn10 Delta double mutant, and Enamul Huq for pif1-2 seeds. Benjamin Cole and Kazumasa Nito made critical comments and suggestions regarding this manuscript. The work was supported by a grant from the National Institutes of Health (R01GM52413) to J.C., the Howard Hughes Medical Institute (J.C.), a startup fund (4314268) to M. C. from Duke University, and a grant from the National Science Foundation to M. C. (IOS-0923722).	Al-Sady B, 2006, MOL CELL, V23, P439, DOI 10.1016/j.molcel.2006.06.011; Al-Sady B, 2008, P NATL ACAD SCI USA, V105, P2232, DOI 10.1073/pnas.0711675105; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; ANG LH, 1994, PLANT CELL, V6, P613, DOI 10.1105/tpc.6.5.613; Bauer D, 2004, PLANT CELL, V16, P1433, DOI 10.1105/tpc.021568; Castillon A, 2007, TRENDS PLANT SCI, V12, P514, DOI 10.1016/j.tplants.2007.10.001; Chen HD, 2006, PLANT CELL, V18, P1991, DOI 10.1105/tpc.106.043224; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; Chen M, 2004, ANNU REV GENET, V38, P87, DOI 10.1146/annurev.genet.38.072902.092259; Chen M, 2005, CURR BIOL, V15, P637, DOI 10.1016/j.cub.2005.02.028; Chen M, 2003, P NATL ACAD SCI USA, V100, P14493, DOI 10.1073/pnas.1935989100; Chen M, 2000, PLANT J, V22, P303, DOI 10.1046/j.1365-313x.2000.00738.x; Chen M, 2008, CURR OPIN PLANT BIOL, V11, P503, DOI 10.1016/j.pbi.2008.06.012; Chi-Ham CL, 2002, PLANT MOL BIOL, V49, P621, DOI 10.1023/A:1015500431421; CHORY J, 1993, TRENDS GENET, V9, P167, DOI 10.1016/0168-9525(93)90163-C; Clough RC, 1997, PLANT CELL ENVIRON, V20, P713, DOI 10.1046/j.1365-3040.1997.d01-107.x; Desveaux D, 2004, DEV CELL, V6, P229, DOI 10.1016/S1534-5807(04)00028-0; Elich TD, 1997, PLANT CELL, V9, P2271, DOI 10.1105/tpc.9.12.2271; Farmer LM, 2010, PLANT CELL, V22, P124, DOI 10.1105/tpc.109.072660; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jeong SY, 2003, NUCLEIC ACIDS RES, V31, P5175, DOI 10.1093/nar/gkg693; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; Khanna R, 2006, PLANT CELL, V18, P2157, DOI 10.1105/tpc.106.042200; Kircher S, 2002, PLANT CELL, V14, P1541, DOI 10.1105/tpc.001156; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lambertson D, 1999, GENETICS, V153, P69; Lee J, 2008, J NEUROSCI RES, V86, P961, DOI 10.1002/jnr.21564; Leivar P, 2008, CURR BIOL, V18, P1815, DOI 10.1016/j.cub.2008.10.058; Leivar P, 2008, PLANT CELL, V20, P337, DOI 10.1105/tpc.107.052142; Leivar P, 2009, PLANT CELL, V21, P3535, DOI 10.1105/tpc.109.070672; Lorrain S, 2008, PLANT J, V53, P312, DOI 10.1111/j.1365-313X.2007.03341.x; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; MACKENZIE JM, 1975, P NATL ACAD SCI USA, V72, P799, DOI 10.1073/pnas.72.3.799; Maloof JN, 2001, NAT GENET, V29, P441, DOI 10.1038/ng777; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Meier I, 1996, PLANT CELL, V8, P2105, DOI 10.1105/tpc.8.11.2105; Moll UM, 2006, ONCOGENE, V25, P4725, DOI 10.1038/sj.onc.1209601; PARKS BM, 1991, PLANT CELL, V3, P1177, DOI 10.1105/tpc.3.11.1177; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; PRATT LH, 1974, BIOCHIM BIOPHYS ACTA, V365, P93, DOI 10.1016/0005-2795(74)90253-0; Prikryl J, 2008, NUCLEIC ACIDS RES, V36, P5152, DOI 10.1093/nar/gkn492; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Reed Jason W., 1994, Seminars in Cell Biology, V5, P327, DOI 10.1006/scel.1994.1039; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Romero-Perez L, 2007, J BIOL CHEM, V282, P35574, DOI 10.1074/jbc.M704857200; Rosler J, 2007, P NATL ACAD SCI USA, V104, P10737, DOI 10.1073/pnas.0703855104; Sauer M, 2006, NAT PROTOC, V1, P98, DOI 10.1038/nprot.2006.15; Schroeder DF, 2002, CURR BIOL, V12, P1462, DOI 10.1016/S0960-9822(02)01106-5; Seo HS, 2004, GENE DEV, V18, P617, DOI 10.1101/gad.1187804; Sessions A, 1999, PLANT J, V20, P259, DOI 10.1046/j.1365-313x.1999.00594.x; Shen H, 2008, PLANT CELL, V20, P1586, DOI 10.1105/tpc.108.060020; Su YS, 2007, PLANT CELL, V19, P2124, DOI 10.1105/tpc.107.051516; Wei N, 1996, PLANT PHYSIOL, V112, P871, DOI 10.1104/pp.112.3.871; Yamaguchi R, 1999, J CELL BIOL, V145, P437, DOI 10.1083/jcb.145.3.437; Yoo HH, 2007, PLANT J, V49, P442, DOI 10.1111/j.1365-313X.2006.02974.x; Yoo SY, 2005, PLANTA, V221, P523, DOI 10.1007/s00425-004-1466-4; Yu XH, 2009, PLANT CELL, V21, P118, DOI 10.1105/tpc.108.061663; Zhang Y, 2008, PLANT CELL, V20, P1437, DOI 10.1105/tpc.108.058891	59	166	176	2	44	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUN 25	2010	141	7					1230	U237		10.1016/j.cell.2010.05.007	http://dx.doi.org/10.1016/j.cell.2010.05.007			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603003	Green Accepted, Bronze			2022-12-28	WOS:000279148100019
J	Clayton, J				Clayton, Julie			The promise of T-cruzi genomics	NATURE			English	Editorial Material																		ELSAYED NM, SCIENCE, V309, P409; ELSAYED NM, SCIENCE, V309, P404	2	6	6	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S16	S17		10.1038/nature09225	http://dx.doi.org/10.1038/nature09225			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571549	Bronze			2022-12-28	WOS:000279056900029
J	Modlin, JF				Modlin, John F.			Focus on Research: The Bumpy Road to Polio Eradication.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VACCINE-DERIVED POLIOVIRUS		Dartmouth Med Sch, Lebanon, NH USA	Dartmouth College	Modlin, JF (corresponding author), Dartmouth Med Sch, Lebanon, NH USA.							Kew OM, 2004, B WORLD HEALTH ORGAN, V82, P16; Kew OM, 1998, J CLIN MICROBIOL, V36, P2893, DOI 10.1128/JCM.36.10.2893-2899.1998; OFOSUAMAAH S, 1984, REV INFECT DIS, V6, pS318; Tebbens RJD, 2006, RISK ANAL, V26, P1471, DOI 10.1111/j.1539-6924.2006.00827.x; 2009, MMWR MORB MORTAL WKL, V58, P1002	5	30	29	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2346	2349		10.1056/NEJMp1005405	http://dx.doi.org/10.1056/NEJMp1005405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20573922	Bronze			2022-12-28	WOS:000279043800003
J	Krieger, GR; Utzinger, J; Winkler, MS; Divall, MJ; Phillips, SD; Balge, MZ; Singer, BH				Krieger, Gary R.; Utzinger, Juerg; Winkler, Mirko S.; Divall, Mark J.; Phillips, Scott D.; Balge, Marci Z.; Singer, Burton H.			Barbarians at the gate: storming the Gothenburg consensus	LANCET			English	Editorial Material							HEALTH IMPACT ASSESSMENT		[Krieger, Gary R.; Phillips, Scott D.; Balge, Marci Z.] NewFields, Denver, CO USA; [Utzinger, Juerg; Winkler, Mirko S.] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland; [Divall, Mark J.] NewFields, Pretoria, South Africa; [Singer, Burton H.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA	University of Basel; Swiss Tropical & Public Health Institute; State University System of Florida; University of Florida	Utzinger, J (corresponding author), NewFields, Denver, CO USA.	juerg.utzinger@unibas.ch		Winkler, Mirko/0000-0001-7387-3863				Bosshard P., 2008, SAIS WORKING PAPERS; Douglas MJ, 2001, J PUBLIC HEALTH MED, V23, P148, DOI 10.1093/pubmed/23.2.148; Erlanger TE, 2008, ENVIRON IMPACT ASSES, V28, P349, DOI 10.1016/j.eiar.2007.07.003; *INT FIN CORP, 2006, PERF STAND INT FIN C; Kemm J., 2004, HLTH IMPACT ASSESSME; Lerer LB, 1999, HEALTH POLICY PLANN, V14, P198, DOI 10.1093/heapol/14.2.198; LISTORTI JA, 2001, ENV HLTH BRIDGING GA; ScottSamuel A, 1996, BRIT MED J, V313, P183, DOI 10.1136/bmj.313.7051.183; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Whitehead M, 1991, GEOL FORENINGAN STOC; WHO Commission on Social Determinants of Health World Health Organization, 2008, CLOS GAP GEN HLTH EQ; *WHO REG OFF EUR E, 1999, HLTH IMP ASS MAIN CO	12	24	24	1	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 19	2010	375	9732					2129	2131		10.1016/S0140-6736(10)60591-0	http://dx.doi.org/10.1016/S0140-6736(10)60591-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	617BF	20609938				2022-12-28	WOS:000279255100008
J	Lim, SS; Dandona, L; Hoisington, JA; James, SL; Hogan, MC; Gakidou, E				Lim, Stephen S.; Dandona, Lalit; Hoisington, Joseph A.; James, Spencer L.; Hogan, Margaret C.; Gakidou, Emmanuela			India's Janani Suraksha Yojana, a conditional cash transfer programme to increase births in health facilities: an impact evaluation	LANCET			English	Article							CHILD HEALTH; MEXICO; INTERVENTIONS; INSURANCE; POOR	Background In 2005, with the goal of reducing the numbers of maternal and neonatal deaths, the Government of India launched Janani Suraksha Yojana (JSY), a conditional cash transfer scheme, to incentivise women to give birth in a health facility We independently assessed the effect of JSY on intervention coverage and health outcomes Methods We used data from the nationwide district-level household surveys done in 2002-04 and 2007-09 to assess receipt of financial assistance from JSY as a function of socioeconomic and demographic characteristics; and used three analytical approaches (matching, with-versus-without comparison, and differences in differences) to assess the effect of JSY on antenatal care, in-facility births, and perinatal, neonatal, and maternal deaths Findings Implementation of JSY in 2007-08 was highly variable by state from less than 5% to 44% of women giving birth receiving cash payments from JSY. The poorest and least educated women did not always have the highest odds of receiving JSY payments. JSY had a significant effect on increasing antenatal care and in-facility births. In the matching analysis, JSY payment was associated with a reduction of 3.7 (95% CI 2.2-5.2) perinatal deaths per 1000 pregnancies and 2.3 (0 9-3.7) neonatal deaths per 1000 livebirths In the with-versus-without comparison, the reductions were 4.1 (2.5-5.7) perinatal deaths per 1000 pregnancies and 2.4 (0 7-4 1) neonatal deaths per 1000 livebirths. Interpretation The findings of this assessment are encouraging, but they also emphasise the need for improved targeting of the poorest women and attention to quality of obstetric care in health facilities. Continued independent monitoring and evaluations are important to measure the effect of JSY as financial and political commitment to the programme intensifies.	[Lim, Stephen S.; Dandona, Lalit; Hoisington, Joseph A.; James, Spencer L.; Hogan, Margaret C.; Gakidou, Emmanuela] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98121 USA; [Dandona, Lalit] Publ Hlth Fdn India, New Delhi, India	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Public Health Foundation of India	Gakidou, E (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA.		Lim, Stephen S/B-4055-2012		Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	Funding Bill & Melinda Gates Foundation.	[Anonymous], DEM SID FIN PIL MAT; ASHENFELTER O, 1985, REV ECON STAT, V67, P648, DOI 10.2307/1924810; Attanasio O., 2005, SHORT TERM IMPACT CO; Barber SL, 2009, HEALTH POLICY PLANN, V24, P18, DOI 10.1093/heapol/czn039; BARBER SL, 2009, EUR J PUBLIC HEALTH, DOI DOI 10.1093/EURPUBICKP184; Bleich SN, 2007, BMJ-BRIT MED J, V335, P875, DOI 10.1136/bmj.39350.617616.BE; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; DEVADASAN N, 2008, REDUCING FINANCIAL B, P257; Ferguson B, 2003, HLTH SYSTEMS PERFORM; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Fernald LCH, 2009, LANCET, V374, P1997, DOI 10.1016/S0140-6736(09)61676-7; Gakidou E, 2007, JAMA-J AM MED ASSOC, V298, P1876, DOI 10.1001/jama.298.16.1876; Gakidou E, 2006, LANCET, V368, P1920, DOI 10.1016/S0140-6736(06)69568-8; *GOV NEP, 2005, OP GUID INC SAF DEL; Government of India  Ministry of Health and Family Welfare Maternal Health Division New Delhi, JAN SUR YOJ FEAT FRE; Ho DE, 2007, POLIT ANAL, V15, P199, DOI 10.1093/pan/mpl013; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; *IIPS, 2010, NAT HLTH FAM SURV 20; King G, 2009, LANCET, V373, P1447, DOI 10.1016/S0140-6736(09)60239-7; Lagarde M, 2007, JAMA-J AM MED ASSOC, V298, P1900, DOI 10.1001/jama.298.16.1900; Lahariya Chandrakant, 2009, Indian J Community Med, V34, P15, DOI 10.4103/0970-0218.45370; Maluccio J., 2005, IMPACT EVALUATION CO; Mavalankar D, 2009, INT J GYNECOL OBSTET, V107, P271, DOI 10.1016/j.ijgo.2009.09.008; Morris SS, 2004, J NUTR, V134, P2336, DOI 10.1093/jn/134.9.2336; Powell-Jackson T, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-97; Raban MZ, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-208; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rawlings LB, 2005, WORLD BANK RES OBSER, V20, P29, DOI 10.1093/wbro/lki001; Sharma M P, 2009, Indian J Public Health, V53, P177; Sosa-Rubi SG, 2009, B WORLD HEALTH ORGAN, V87, P512, DOI 10.2471/BLT.08.053256; Thornton RL, 2008, AM ECON REV, V98, P1829, DOI 10.1257/aer.98.5.1829; United Nations Population Fund India, 2009, CONC ASS JAN SUR YOJ; Vapattanawong P, 2007, LANCET, V369, P850, DOI 10.1016/S0140-6736(07)60413-9; Victora CG, 2000, LANCET, V356, P1093, DOI 10.1016/S0140-6736(00)02741-0; Vora KS, 2009, J HEALTH POPUL NUTR, V27, P184, DOI 10.3329/jhpn.v27i2.3363; World Health Organization (WHO), 2008, PROP BIRTHS ATT SKIL	36	465	469	3	68	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2010	375	9730					2009	2023		10.1016/S0140-6736(10)60744-1	http://dx.doi.org/10.1016/S0140-6736(10)60744-1			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569841				2022-12-28	WOS:000278689600028
J	Victora, CG; Black, RE; Boerma, JT; Bryce, J				Victora, Cesar G.; Black, Robert E.; Boerma, J. Ties; Bryce, Jennifer			Measuring impact in the Millennium Development Goal era and beyond: a new approach to large-scale effectiveness evaluations	LANCET			English	Article							CHILDHOOD ILLNESS STRATEGY; INTEGRATED MANAGEMENT; HEALTH INTERVENTIONS; SURVIVAL; INDICATORS; MORTALITY; PROGRAM; PERU; IMCI	Evaluation of large-scale programmes and initiatives aimed at improvement of health in countries of low and middle income needs a new approach. Traditional designs, which compare areas with and without a given programme, are no longer relevant at a time when many programmes are being scaled up in virtually every district in the world. We propose an evolution in evaluation design, a national platform approach that: uses the district as the unit of design and analysis; is based on continuous monitoring of different levels of indicators; gathers additional data before, during, and after the period to be assessed by multiple methods; uses several analytical techniques to deal with various data gaps and biases; and includes interim and summative evaluation analyses. This new approach will promote country ownership, transparency, and donor coordination while providing a rigorous comparison of the cost-effectiveness of different scale-up approaches.	[Victora, Cesar G.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Victora, Cesar G.; Black, Robert E.; Bryce, Jennifer] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD USA; [Boerma, J. Ties] WHO, CH-1211 Geneva, Switzerland	Universidade Federal de Pelotas; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization	Victora, CG (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	cvictora@terra.com.br	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Black, Robert/0000-0001-9926-7984	Canadian International Development Agency; Bill & Melinda Gates Foundation	Canadian International Development Agency; Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank Hilde De Graeve and Bert Schreuder for allowing reproduction of figure 2; Baltazar Chilundo, Fatima Abacassamo, and Ina Santos for insights into the adaptation of the method to the Mozambique situation; Jennifer Requejo, Kate Gilroy, and David Peters for comments on the text; Agbessi Amouzou and Larry Moulton for inputs on sample size calculations; and Gareth Jones for comments on the plan of statistical analyses. Members of the Catalytic Initiative Evaluation project group at the Institute for International Programs of Johns Hopkins Bloomberg School of Public Health have contributed in important ways to the experience and thinking described in this report. This work was supported by the Canadian International Development Agency and the Bill & Melinda Gates Foundation through subcontracts to the Institute for International Programs at the Johns Hopkins Bloomberg School of Public Health for independent evaluations of the Catalytic Initiative to Save a Million Lives and of the Rapid Scale Up of the Partnership for Maternal, Newborn and Child Health.	Amaral J, 2005, HEALTH POLICY PLANN, V20, pI42, DOI 10.1093/heapol/czi058; [Anonymous], 2010, LANCET, V375, P526, DOI 10.1016/S0140-6736(10)60056-6; [Anonymous], 2008, CATALYTIC INITIATIVE; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Bryce J, 2005, HEALTH POLICY PLANN, V20, pI94, DOI 10.1093/heapol/czi056; Bryce J, 2003, LANCET, V362, P159, DOI 10.1016/S0140-6736(03)13870-6; Bryce J, 2008, LANCET, V371, P1247, DOI 10.1016/S0140-6736(08)60559-0; Bryce J, 2010, LANCET, V375, P572, DOI 10.1016/S0140-6736(09)62060-2; Canadian International Development Agency, 2007, CAT IN SAV MILL LIV; [Department of International Health Johns Hopkins Bloomberg School of Public Health], LIST LIV SAV TOOL EV; Evaluation Gap Working Group, 2006, WILL WE EV LEARN IMP; Grassly NC, 2001, B WORLD HEALTH ORGAN, V79, P1121; Gregson S, 2007, PLOS MED, V4, P545, DOI 10.1371/journal.pmed.0040102; Habicht JP, 1999, INT J EPIDEMIOL, V28, P10, DOI 10.1093/ije/28.1.10; Huicho L, 2005, HEALTH POLICY PLANN, V20, pI32, DOI 10.1093/heapol/czi052; Huicho L, 2005, HEALTH POLICY PLANN, V20, P14, DOI 10.1093/heapol/czi002; IIPS and Macro International, 2007, NATL FAMILY HLTH SUR, V1; McKeown Thomas, 1976, MODERN RISE POPULATI; Measure DHS, 2010, MAL STAND DHS; Measure DHS, DEM HLTH SURV DHS OV; Measure DHS, AIS SURV AIS OV; Measure OHS, MAL IND SURV; ODAmoz, 2008, MOZ DON ATL 2008; OECD, 2005, PAR DECL AID EFF OWN; Oxman AD, 2010, LANCET, V375, P427, DOI 10.1016/S0140-6736(09)61251-4; Peters DH, 2009, DIR DEV, P1, DOI 10.1596/978-0-8213-7888-5; Rao J.N.K., 2003, SMALL AREA ESTIMATIO; Rowe AK, 2009, AM J TROP MED HYG, V80, P971, DOI 10.4269/ajtmh.2009.80.971; Rutstein S., 2006, ONLINE GUIDE DHS STA; Schellenberg JRMA, 2004, LANCET, V364, P1583, DOI 10.1016/S0140-6736(04)17311-X; Victora CG, 2006, B WORLD HEALTH ORGAN, V84, P792, DOI 10.2471/BLT.06.030502; Victora CG, 2009, B WORLD HEALTH ORGAN, V87, P83, DOI 10.2471/BLT.09.062828; West BT, 2008, STATA J, V8, P520, DOI 10.1177/1536867X0800800404; *WHO, 1995, TECHN REP SER WHO, V854; World Bank, 2008, RES BAS FIN RBF; World Bank, 2019, LIV STAND MEAS STUD	38	349	426	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 1	2011	377	9759					85	95		10.1016/S0140-6736(10)60810-0	http://dx.doi.org/10.1016/S0140-6736(10)60810-0			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	709MQ	20619886				2022-12-28	WOS:000286445200034
J	Burls, A				Burls, Amanda			AGREE II-improving the quality of clinical care	LANCET			English	Editorial Material							PRACTICE GUIDELINES; APPRAISAL; NEED		Univ Oxford, Dept Primary Hlth Care, Oxford OX2 7LF, England	University of Oxford	Burls, A (corresponding author), Univ Oxford, Dept Primary Hlth Care, Old Rd Campus, Oxford OX2 7LF, England.	amanda.burls@dphpc.ox.ac.uk	Burls, Amanda J.E./D-7641-2011	Burls, Amanda/0000-0001-9540-622X				*AGREE NEXT STEPS, 2010, AGREE 2 ADV GUID DEV; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Burgers Jako, 2003, Z Arztl Fortbild Qualitatssich, V97, P81; Cluzeau F, 1994, Qual Health Care, V3, P121, DOI 10.1136/qshc.3.3.121; Cluzeau F, 2003, QUAL SAF HEALTH CARE, V12, P18; Dawes M, 2010, FAM PRACT, V27, P1, DOI 10.1093/fampra/cmp106; Foureur M, 2010, BIRTH-ISS PERINAT C, V37, P3, DOI 10.1111/j.1523-536X.2009.00372.x; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; LOHR K, 1992, PROVISIONAL INSTRUME; National Institute for Health and Clinical Excellence, 2009, GUID MAN; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Watine JC, 2008, CLIN BIOCHEM, V41, P459, DOI 10.1016/j.clinbiochem.2007.12.020	12	49	57	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	OCT 2	2010	376	9747					1128	1129		10.1016/S0140-6736(10)61034-3	http://dx.doi.org/10.1016/S0140-6736(10)61034-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	663UN	20599263				2022-12-28	WOS:000282915700010
J	Serra, AL; Poster, D; Kistler, AD; Krauer, F; Raina, S; Young, J; Rentsch, KM; Spanaus, KS; Senn, O; Kristanto, P; Scheffel, H; Weishaupt, D; Wuthrich, RP				Serra, Andreas L.; Poster, Diane; Kistler, Andreas D.; Krauer, Fabienne; Raina, Shagun; Young, James; Rentsch, Katharina M.; Spanaus, Katharina S.; Senn, Oliver; Kristanto, Paulus; Scheffel, Hans; Weishaupt, Dominik; Wuethrich, Rudolf P.			Sirolimus and Kidney Growth in Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYST GROWTH; RAT MODEL; RAPAMYCIN; PROGRESSION; ADPKD; THERAPY; MTOR; INHIBITION; VOLUME; PKD	BACKGROUND In autosomal dominant polycystic kidney disease (ADPKD), aberrant activation of the mammalian target of rapamycin (mTOR) pathway is associated with progressive kidney enlargement. The drug sirolimus suppresses mTOR signaling. METHODS In this 18-month, open-label, randomized, controlled trial, we sought to determine whether sirolimus halts the growth in kidney volume among patients with ADPKD. We randomly assigned 100 patients between the ages of 18 and 40 years to receive either sirolimus (target dose, 2 mg daily) or standard care. All patients had an estimated creatinine clearance of at least 70 ml per minute. Serial magnetic resonance imaging was performed to measure the volume of polycystic kidneys. The primary outcome was total kidney volume at 18 months on blinded assessment. Secondary outcomes were the glomerular filtration rate and urinary albumin excretion rate at 18 months. RESULTS At randomization, the median total kidney volume was 907 cm(3) (interquartile range, 577 to 1330) in the sirolimus group and 1003 cm(3) (interquartile range, 574 to 1422) in the control group. The median increase over the 18-month period was 99 cm(3) (interquartile range, 43 to 173) in the sirolimus group and 97 cm(3) (interquartile range, 37 to 181) in the control group. At 18 months, the median total kidney volume in the sirolimus group was 102% of that in the control group (95% confidence interval, 99 to 105; P = 0.26). The glomerular filtration rate did not differ significantly between the two groups; however, the urinary albumin excretion rate was higher in the sirolimus group. CONCLUSIONS In adults with ADPKD and early chronic kidney disease, 18 months of treatment with sirolimus did not halt polycystic kidney growth. (Funded by Wyeth and others; ClinicalTrials.gov number, NCT00346918.)	[Serra, Andreas L.; Poster, Diane; Kistler, Andreas D.; Krauer, Fabienne; Raina, Shagun; Wuethrich, Rudolf P.] Univ Zurich Hosp, Div Nephrol, CH-8091 Zurich, Switzerland; [Rentsch, Katharina M.; Spanaus, Katharina S.] Univ Zurich Hosp, Inst Clin Chem, CH-8091 Zurich, Switzerland; [Senn, Oliver] Univ Zurich Hosp, Inst Gen Practice & Hlth Serv Res, CH-8091 Zurich, Switzerland; [Scheffel, Hans; Weishaupt, Dominik] Univ Zurich Hosp, Div Diagnost & Intervent Radiol, CH-8091 Zurich, Switzerland; Univ Zurich, Zurich, Switzerland; [Young, James] Biometr Practice BIOP, Basel, Switzerland; [Kristanto, Paulus] Pharm Res Ctr, Vise, Belgium	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich	Wuthrich, RP (corresponding author), Univ Zurich Hosp, Div Nephrol, Ramistr 100, CH-8091 Zurich, Switzerland.	rudolf.wuethrich@usz.ch		Krauer, Fabienne/0000-0001-8341-4011; Kistler, Andreas/0000-0002-4114-9560; Young, Jim/0000-0002-4314-3007; Senn, Oliver/0000-0003-4422-7250	Swiss National Science Foundation [310000-118166]; Polycystic Kidney Foundation; Pfizer; Binelli and Ehrsam Foundation; Pfizer, Switzerland; Hoffmann-La Roche; Nycomed; Genzyme; Amgen; Bayer Schering Pharma; General Electric Healthcare; University Hospital Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Polycystic Kidney Foundation; Pfizer(Pfizer); Binelli and Ehrsam Foundation; Pfizer, Switzerland(Pfizer); Hoffmann-La Roche(Hoffmann-La Roche); Nycomed; Genzyme(Sanofi-AventisGenzyme Corporation); Amgen(Amgen); Bayer Schering Pharma(Bayer AG); General Electric Healthcare(General ElectricGE Healthcare); University Hospital Zurich	Supported by a grant from the Swiss National Science Foundation (310000-118166), by the Polycystic Kidney Foundation, by an unrestricted research grant from Wyeth (now Pfizer), and by the Binelli and Ehrsam Foundation. Wyeth Switzerland (now Pfizer) provided the sirolimus, and GE Healthcare Switzerland provided an Advantage Workstation for volumetric analysis of MRI data.; Dr. Serra reports receiving consulting fees from Hoffmann-La Roche and Nycomed, lecture fees from Genzyme, and travel grants from Wyeth and Amgen; Dr. Poster, travel support from Wyeth; Dr. Kistler, lecture fees from Wyeth; Dr. Young, being an employee of Biometrical Practice BIOP; Dr. Kristanto, being an employee of Aardex; Dr. Weishaupt, receiving lecture fees from Bayer Schering Pharma and consulting fees from General Electric Healthcare and grant support from Bayer Schering paid to his institution, University Hospital Zurich; and Dr. Wuthrich, receiving consulting and lecture fees and travel support from Genzyme, Novartis, and Wyeth. No other potential conflict of interest relevant to this article was reported.	Berthier CC, 2008, NEPHROL DIAL TRANSPL, V23, P880, DOI 10.1093/ndt/gfm697; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Chapman JR, 2010, AM J KIDNEY DIS, V55, P213, DOI 10.1053/j.ajkd.2009.12.003; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; DALGAARD O Z, 1957, Acta Med Scand Suppl, V328, P1; DIGGLE P, 1995, ANAL LONGITUDINAL DA, P41; GOLBAEKDAL K, 1994, TRANSPLANTATION, V58, P1153, DOI 10.1097/00007890-199412150-00002; Grantham JJ, 2010, CLIN J AM SOC NEPHRO, V5, P889, DOI 10.2215/CJN.00550110; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Harris PC, 2009, ANNU REV MED, V60, P321, DOI 10.1146/annurev.med.60.101707.125712; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; KLAHR S, 1995, J AM SOC NEPHROL, V5, P2037; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; RAVINE D, 1994, LANCET, V343, P824, DOI 10.1016/S0140-6736(94)92026-5; Reichardt W, 2009, MAGN RESON MATER PHY, V22, P143, DOI 10.1007/s10334-008-0158-7; Schrier RW, 2006, NEPHROLOGY, V11, P124, DOI 10.1111/j.1440-1797.2006.00535.x; Serra Andreas L, 2007, BMC Nephrol, V8, P13, DOI 10.1186/1471-2369-8-13; Serra AL, 2009, NEPHROL DIAL TRANSPL, V24, P3334, DOI 10.1093/ndt/gfp280; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Shillingford JM, 2010, J AM SOC NEPHROL, V21, P489, DOI 10.1681/ASN.2009040421; Spirli C, 2010, HEPATOLOGY, V51, P1778, DOI 10.1002/hep.23511; Stengel B, 2003, NEPHROL DIAL TRANSPL, V18, P1824, DOI 10.1093/ndt/gfg233; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2006, NAT CLIN PRACT NEPHR, V2, P40, DOI 10.1038/ncpneph0070; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Trotti A, 2003, SEMIN RADIAT ONCOL, V13, P176, DOI 10.1016/S1053-4296(03)00031-6; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; WANG SK, 1987, BIOMETRICS, V43, P193, DOI 10.2307/2531959; Wu M, 2007, KIDNEY BLOOD PRESS R, V30, P253, DOI 10.1159/000104818; Wu M, 2009, AM J PHYSIOL-RENAL, V297, pF1597, DOI 10.1152/ajprenal.00430.2009; Zafar I, 2009, NEPHROL DIAL TRANSPL, V24, P2349, DOI 10.1093/ndt/gfp129	32	404	421	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					820	829		10.1056/NEJMoa0907419	http://dx.doi.org/10.1056/NEJMoa0907419			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20581391	Green Accepted			2022-12-28	WOS:000281196600005
J	Ahn, YY; Bagrow, JP; Lehmann, S				Ahn, Yong-Yeol; Bagrow, James P.; Lehmann, Sune			Link communities reveal multiscale complexity in networks	NATURE			English	Article							HIERARCHICAL ORGANIZATION	Networks have become a key approach to understanding systems of interacting objects, unifying the study of diverse phenomena including biological organisms and human society(1-3). One crucial step when studying the structure and dynamics of networks is to identify communities(4,5): groups of related nodes that correspond to functional subunits such as protein complexes(6,7) or social spheres(8-10). Communities in networks often overlap(9,10) such that nodes simultaneously belong to several groups. Meanwhile, many networks are known to possess hierarchical organization, where communities are recursively grouped into a hierarchical structure(11-13). However, the fact that many real networks have communities with pervasive overlap, where each and every node belongs to more than one group, has the consequence that a global hierarchy of nodes cannot capture the relationships between overlapping groups. Here we reinvent communities as groups of links rather than nodes and show that this unorthodox approach successfully reconciles the antagonistic organizing principles of overlapping communities and hierarchy. In contrast to the existing literature, which has entirely focused on grouping nodes, link communities naturally incorporate overlap while revealing hierarchical organization. We find relevant link communities in many networks, including major biological networks such as protein-protein interaction(6,7,14) and metabolic networks(11,15,16), and show that a large social network(10,17,18) contains hierarchically organized community structures spanning inner-city to regional scales while maintaining pervasive overlap. Our results imply that link communities are fundamental building blocks that reveal overlap and hierarchical organization in networks to be two aspects of the same phenomenon.	[Lehmann, Sune] Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Northeastern Univ, Dept Phys, Ctr Complex Network Res, Boston, MA 02115 USA; [Ahn, Yong-Yeol; Bagrow, James P.] Harvard Univ, Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02215 USA; [Lehmann, Sune] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA	Harvard University; Northeastern University; Harvard University; Dana-Farber Cancer Institute; Northeastern University	Lehmann, S (corresponding author), Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA.	sune.lehmann@gmail.com	Ahn, Yong-Yeol/C-6334-2011; Bagrow, James/E-1701-2016	Ahn, Yong-Yeol/0000-0002-4352-4301; Bagrow, James/0000-0002-4614-0792; Lehmann, Sune/0000-0001-6099-2345	James S. McDonnell Foundation; NSF-DDDAS [CNS-0540348]; NSF-ITR [DMR-0426737]; US ONR [N00014-07-C]; NIH [U01 A1070499-01, 111620-2]; DTRA [BRBAA07-J-2-0035]; US ARL [W911NF-09-2-0053]; NKTH NAP [KCKHA005]; Danish Natural Science Research Council;  [NSF-IIS-0513650]	James S. McDonnell Foundation; NSF-DDDAS(National Science Foundation (NSF)); NSF-ITR(National Science Foundation (NSF)); US ONR(Office of Naval Research); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DTRA(United States Department of DefenseDefense Threat Reduction Agency); US ARL; NKTH NAP; Danish Natural Science Research Council(Danish Natural Science Research Council); 	The authors thank A.-L. Barabasi, S. Ahnert, J. Park, D.-S. Lee, P.-J. Kim, N. Blumm, D. Wang, M. A. Yildirim and H. Yu. The authors acknowledge the Center for Complex Network Research, supported by the James S. McDonnell Foundation 21st Century Initiative in Studying Complex Systems; the NSF-DDDAS (CNS-0540348), NSF-ITR (DMR-0426737) and NSF-IIS-0513650 programmes; US ONR Award N00014-07-C; the NIH (U01 A1070499-01/Sub #:111620-2); the DTRA (BRBAA07-J-2-0035); the NS-CTA sponsored by US ARL (W911NF-09-2-0053); and NKTH NAP (KCKHA005). S. L. acknowledges support from the Danish Natural Science Research Council.	Caldarelli G., 2007, SCALE FREE NETWORKS; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Clauset A, 2008, NATURE, V453, P98, DOI 10.1038/nature06830; Dorogovtsev SN, 2008, REV MOD PHYS, V80, P1275, DOI 10.1103/RevModPhys.80.1275; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; EVANS TS, 2009, EDGE PARTITIONS OVER; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Harris MA, 2008, NUCLEIC ACIDS RES, V36, pD440, DOI 10.1093/nar/gkm883; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LANCICHINETTI A, 2009, PHYS REV E 2, V80, DOI DOI 10.1103/PHYSREVE.80.056117; Lancichinetti A, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033015; Li D, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.168701; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Onnela JP, 2007, P NATL ACAD SCI USA, V104, P7332, DOI 10.1073/pnas.0610245104; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reichardt J, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.218701; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sales-Pardo M, 2007, P NATL ACAD SCI USA, V104, P15224, DOI 10.1073/pnas.0703740104; Wasserman, 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	30	1168	1310	14	304	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	AUG 5	2010	466	7307					761	U11		10.1038/nature09182	http://dx.doi.org/10.1038/nature09182			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	634EN	20562860	Green Submitted			2022-12-28	WOS:000280562500040
J	Pertsinidis, A; Zhang, YX; Chu, S				Pertsinidis, Alexandros; Zhang, Yunxiang; Chu, Steven			Subnanometre single-molecule localization, registration and distance measurements	NATURE			English	Article							HIGH-RESOLUTION COLOCALIZATION; FLUORESCENCE MICROSCOPY; E-CADHERIN; STIMULATED-EMISSION; DIFFRACTION-LIMIT; CALCIUM-BINDING; HOMOASSOCIATION; PRECISION; TRACKING; ADHESION	Remarkable progress in optical microscopy has been made in the measurement of nanometre distances. If diffraction blurs the image of a point object into an Airy disk with a root-mean-squared (r.m.s.) size of s = 0.44 lambda/2NA (similar to 90 nm for light with a wavelength of lambda = 600 nm and an objective lens with a numerical aperture of NA = 1.49), limiting the resolution of the far-field microscope in use to d = 2.4s approximate to 200 nm, additional knowledge about the specimen can be used to great advantage. For example, if the source is known to be two spatially resolved fluorescent molecules, the distance between them is given by the separation of the centres of the two fluorescence images(1). In high-resolution microwave and optical spectroscopy, there are numerous examples where the line centre is determined with a precision of less than 10(-6) of the linewidth. In contrast, in biological applications the brightest single fluorescent emitters can be detected with a signal-to-noise ratio of similar to 100, limiting the centroid localization precision to s(loc) >= 1% (>= 1 nm) of the r.m.s. size, s, of the microscope point spread function (PSF)(2). Moreover, the error in co-localizing two or more single emitters is notably worse, remaining greater than 5-10% (5-10 nm) of the PSF size(3-8). Here we report a distance resolution of s(reg) = 0.50 nm (1 sigma) and an absolute accuracy of s(distance) = 0.77 nm (1 sigma) in a measurement of the separation between differently coloured fluorescent molecules using conventional far-field fluorescence imaging in physiological buffer conditions. The statistical uncertainty in the mean for an ensemble of identical single-molecule samples is limited only by the total number of collected photons, to s(loc) approximate to 0.3 nm, which is similar to 3 x 10(-3) times the size of the optical PSF. Our method may also be used to improve the resolution of many subwavelength, far-field imaging methods such as those based on co-localization of molecules that are stochastically switched on in space(6-8). The improved resolution will allow the structure of large, multisubunit biological complexes in biologically relevant environments to be deciphered at the single-molecule level.	[Pertsinidis, Alexandros; Zhang, Yunxiang; Chu, Steven] Stanford Univ, Dept Phys, Stanford, CA 94305 USA; [Pertsinidis, Alexandros; Zhang, Yunxiang; Chu, Steven] Univ Calif Berkeley, Calif Inst Quantitat Biosci QB3, Berkeley, CA 94720 USA; [Chu, Steven] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Chu, Steven] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA; [Chu, Steven] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	Stanford University; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Pertsinidis, A (corresponding author), Stanford Univ, Dept Phys, Stanford, CA 94305 USA.	pertsin@berkeley.edu; the.secretary@hq.doe.gov		Zhang, Yunxiang/0000-0002-6635-6443	National Institutes of Health; National Science Foundation; National Aeronautics and Space Administration; Defense Advanced Research Projects Agency	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Aeronautics and Space Administration(National Aeronautics & Space Administration (NASA)); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	A.P. wishes to thank S. R. Park for assistance with sample preparation and N. Gemelke, E. Sarajlic and H. Mueller for advice on electronics construction. Y.Z. is grateful to J. Nelson and A. Brunger for generously making laboratory facilities available. We thank A. Brunger for critical reading of the manuscript. This work was supported by the National Institutes of Health, the National Science Foundation, the National Aeronautics and Space Administration and the Defense Advanced Research Projects Agency.	Antelman J, 2009, NANO LETT, V9, P2199, DOI 10.1021/nl901163k; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; BOBROFF N, 1986, REV SCI INSTRUM, V57, P1152, DOI 10.1063/1.1138619; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Bornfleth H, 1998, J MICROSC-OXFORD, V189, P118, DOI 10.1046/j.1365-2818.1998.00276.x; Brau RR, 2006, BIOPHYS J, V91, P1069, DOI 10.1529/biophysj.106.082602; BURNS DH, 1985, APPL OPTICS, V24, P154, DOI 10.1364/AO.24.000154; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Cheezum MK, 2001, BIOPHYS J, V81, P2378, DOI 10.1016/S0006-3495(01)75884-5; Churchman LS, 2005, P NATL ACAD SCI USA, V102, P1419, DOI 10.1073/pnas.0409487102; Gordon MP, 2004, P NATL ACAD SCI USA, V101, P6462, DOI 10.1073/pnas.0401638101; He WZ, 2003, SCIENCE, V302, P109, DOI 10.1126/science.1086957; Heilemann M, 2002, ANAL CHEM, V74, P3511, DOI 10.1021/ac025576g; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Kingshott P, 2002, BIOMATERIALS, V23, P2043, DOI 10.1016/S0142-9612(01)00334-9; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Koyama-Honda I, 2005, BIOPHYS J, V88, P2126, DOI 10.1529/biophysj.104.048967; Lacoste TD, 2000, P NATL ACAD SCI USA, V97, P9461, DOI 10.1073/pnas.170286097; Lang MJ, 2004, NAT METHODS, V1, P133, DOI 10.1038/NMETH714; Lauer TR, 1999, PUBL ASTRON SOC PAC, V111, P1434, DOI 10.1086/316460; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x; Qu XH, 2004, P NATL ACAD SCI USA, V101, P11298, DOI 10.1073/pnas.0402155101; Ram S, 2006, P NATL ACAD SCI USA, V103, P4457, DOI 10.1073/pnas.0508047103; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Rittweger E, 2009, NAT PHOTONICS, V3, P144, DOI 10.1038/NPHOTON.2009.2; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sivasankar S, 2009, STRUCTURE, V17, P1075, DOI 10.1016/j.str.2009.06.012; Speidel M, 2003, OPT LETT, V28, P69, DOI 10.1364/OL.28.000069; van Dijk MA, 2004, J PHYS CHEM B, V108, P6479, DOI 10.1021/jp049805+; van Oijen AM, 1999, J OPT SOC AM A, V16, P909, DOI 10.1364/JOSAA.16.000909; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Zhang YX, 2009, P NATL ACAD SCI USA, V106, P109, DOI 10.1073/pnas.0811350106	39	225	235	8	167	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 29	2010	466	7306					647	U11		10.1038/nature09163	http://dx.doi.org/10.1038/nature09163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	632HA	20613725				2022-12-28	WOS:000280412100058
J	Babour, A; Bicknell, AA; Tourtellotte, J; Niwa, M				Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho			A Surveillance Pathway Monitors the Fitness of the Endoplasmic Reticulum to Control Its Inheritance	CELL			English	Article							CELL-WALL INTEGRITY; CORTICAL ER INHERITANCE; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TRANSMEMBRANE PROTEIN; SEPTIN RING; MAP KINASE; YEAST; STRESS; GENE	The endoplasmic reticulum (ER) plays an essential role in the production of lipids and secretory proteins. Because the ER cannot be generated de novo, it must be faithfully transmitted or divided at each cell division. Little is known of how cells monitor the functionality of the ER during the cell cycle or how this regulates inheritance. We report here that ER stress in S. cerevisiae activates the MAP kinase Slt2 in a new ER stress surveillance (ERSU) pathway, independent of the unfolded protein response. Upon ER stress, ERSU alters the septin complex to delay ER inheritance and cytokinesis. In the absence of Slt2 kinase, the stressed ER is transmitted to the daughter cell, causing the death of both mother and daughter cells. Furthermore, Slt2 is activated via the cell surface receptor Wsc1 by a previously undescribed mechanism. We conclude that the ERSU pathway ensures inheritance of a functional ER.	[Babour, Anna; Bicknell, Alicia A.; Tourtellotte, Joel; Niwa, Maho] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Niwa, M (corresponding author), Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	niwa@ucsd.edu		Babour, Anna/0000-0002-0212-3528	American Cancer Society [RSG-05-01GMC]; CRCC [6-447140-34384]; NIH [RO1GM087415]; Searle [03-G107]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); CRCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Douglass Forbes for critical reading, many insightful suggestions, and support throughout the study. We also thank Lorraine Pillus and Rei Otsuka for their help for generating a strain critical for the experiments and Lorraine Pillus for support throughout the study. We thank Randy Hampton, Jason Brickner, and Jim Umen for their suggestion and careful reading of the manuscript, David E. Levin, for providing the bck1 Delta, mkk1 Delta mkk2 Delta yeast strains, pkc1 Delta yeast strain, and plasmids p2188, p2190, and p2193, and Enrique Herrero for providing the pkc1D strain. We also thank Peter Novick for providing the sec1-1 strain and Yves Barral for providing the cdc12-6 strain and Gregory Payne for wsc1<SUP>AAA</SUP> mutant strain. We thank Randy Hampton, Jodi Nunnari, and Svetlana Dokudovskaya for providing plasmids pRH475 and pRH1827, pVT100-ds-RedT1, and Vph1-mCherry, respectively. A. B. was partially supported by the ARC. This work was supported by the American Cancer Society RSG-05-01GMC), CRCC (6-447140-34384), NIH (RO1GM087415), and Searle 03-G107 to M.N.	Bertin A, 2008, P NATL ACAD SCI USA, V105, P8274, DOI 10.1073/pnas.0803330105; Bicknell A.A., 2009, HDB CELL SIGNALING, P2511; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Bonilla M, 2003, MOL BIOL CELL, V14, P4296, DOI 10.1091/mbc.E03-02-0113; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Carr CM, 1999, J CELL BIOL, V146, P333, DOI 10.1083/jcb.146.2.333; Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247; Chen YJ, 2005, MOL CANCER RES, V3, P669, DOI 10.1158/1541-7786.MCR-05-0181; Cid VJ, 1998, MICROBIOL-SGM, V144, P3463, DOI 10.1099/00221287-144-12-3463; COX JS, 1993, CELL, V73, P1197, DOI 10.1016/0092-8674(93)90648-A; de Martin PE, 2005, BIOCHEM CELL BIOL, V83, P752, DOI 10.1139/O05-159; de Nobel H, 2000, MICROBIOL-SGM, V146, P2121, DOI 10.1099/00221287-146-9-2121; Dobbelaere J, 2003, DEV CELL, V4, P345, DOI 10.1016/S1534-5807(03)00061-3; Du YR, 2001, MOL BIOL CELL, V12, P2614, DOI 10.1091/mbc.12.9.2614; Du YR, 2006, EMBO J, V25, P4413, DOI 10.1038/sj.emboj.7601319; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Essary BD, 2009, J MICROBIOL METH, V78, P208, DOI 10.1016/j.mimet.2009.05.018; Estrada P, 2003, J CELL BIOL, V163, P1255, DOI 10.1083/jcb.200304030; Frand AR, 1998, MOL CELL, V1, P161, DOI 10.1016/S1097-2765(00)80017-9; Gasper R, 2009, NAT REV MOL CELL BIO, V10, P423, DOI 10.1038/nrm2689; Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7; Gray JV, 1997, EMBO J, V16, P4924, DOI 10.1093/emboj/16.16.4924; Hampton RY, 1996, P NATL ACAD SCI USA, V93, P828, DOI 10.1073/pnas.93.2.828; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; HUANG KN, 1995, GENETICS, V141, P1275; HUFFAKER TC, 1988, J CELL BIOL, V106, P1997, DOI 10.1083/jcb.106.6.1997; Iwase M, 2006, MOL BIOL CELL, V17, P1110, DOI 10.1091/mbc.E05-08-0793; JACOBS CW, 1988, J CELL BIOL, V107, P1409, DOI 10.1083/jcb.107.4.1409; Jimenez J, 1998, J CELL BIOL, V143, P1617, DOI 10.1083/jcb.143.6.1617; Jin Y, 2009, MOL BIOL CELL, V20, P1312, DOI 10.1091/mbc.E08-09-0954; Ketela T, 1999, J BACTERIOL, V181, P3330, DOI 10.1128/JB.181.11.3330-3340.1999; KIM HB, 1991, J CELL BIOL, V112, P535, DOI 10.1083/jcb.112.4.535; Kim KY, 2008, MOL CELL BIOL, V28, P2579, DOI 10.1128/MCB.01795-07; Koning AJ, 2002, GENETICS, V160, P1335; Kozubowski L, 2005, MOL BIOL CELL, V16, P3455, DOI 10.1091/mbc.E04-09-0764; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Liu BD, 2010, CELL, V140, P257, DOI 10.1016/j.cell.2009.12.031; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Longtine MS, 1998, J CELL BIOL, V143, P719, DOI 10.1083/jcb.143.3.719; Martin H, 2005, MOL MICROBIOL, V58, P6, DOI 10.1111/j.1365-2958.2005.04822.x; McMaster CR, 2001, BIOCHEM CELL BIOL, V79, P681, DOI 10.1139/bcb-79-6-681; McMurray MA, 2009, CELL CYCLE, V8, P195, DOI 10.4161/cc.8.2.7381; Merksamer PI, 2008, CELL, V135, P933, DOI 10.1016/j.cell.2008.10.011; Millard PJ, 1997, APPL ENVIRON MICROB, V63, P2897, DOI 10.1128/AEM.63.7.2897-2905.1997; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; MORI K, 1993, CELL, V74, P743; MURRAY AW, 1983, CELL, V34, P961, DOI 10.1016/0092-8674(83)90553-6; Nanduri J, 2001, MOL CELL, V8, P281, DOI 10.1016/S1097-2765(01)00312-4; NOVICK P, 1983, J CELL BIOL, V96, P541, DOI 10.1083/jcb.96.2.541; Peng YT, 2008, DEV CELL, V15, P478, DOI 10.1016/j.devcel.2008.07.007; Philip B, 2001, MOL CELL BIOL, V21, P271, DOI 10.1128/MCB.21.1.271-280.2001; Piao HL, 2007, MOL BIOL CELL, V18, P57, DOI 10.1091/mbc.e06-08-0721; Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0; PREUSS D, 1991, YEAST, V7, P891, DOI 10.1002/yea.320070902; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Roeder AD, 1998, MOL BIOL CELL, V9, P917, DOI 10.1091/mbc.9.4.917; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Sagot I, 2002, NAT CELL BIOL, V4, P42, DOI 10.1038/ncb719; Scrimale T, 2009, MOL BIOL CELL, V20, P164, DOI 10.1091/mbc.E08-08-0809; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; SPECTOR I, 1983, SCIENCE, V219, P493, DOI 10.1126/science.6681676; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Verna J, 1997, P NATL ACAD SCI USA, V94, P13804, DOI 10.1073/pnas.94.25.13804; Voeltz GK, 2002, EMBO REP, V3, P944, DOI 10.1093/embo-reports/kvf202; WATANABE M, 1994, J BIOL CHEM, V269, P16829; Wiederkehr A, 2003, MOL BIOL CELL, V14, P4770, DOI 10.1091/mbc.E03-04-0229; Zu T, 2001, MOL GENET GENOMICS, V266, P142, DOI 10.1007/s004380100537	71	75	78	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					256	269		10.1016/j.cell.2010.06.006	http://dx.doi.org/10.1016/j.cell.2010.06.006			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20619447	Green Accepted, Bronze			2022-12-28	WOS:000280204300017
J	Kwon, ES; Narasimhan, D; Yen, K; Tissenbaum, HA				Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.			A new DAF-16 isoform regulates longevity	NATURE			English	Article							C-ELEGANS DAF-16; LIFE-SPAN; CAENORHABDITIS-ELEGANS; STRESS; GENE; INSULIN/IGF-1; RESISTANCE	The insulin/IGF-1 signalling (IIS) pathway has diverse roles from metabolism to longevity(1-5). In Caenorhabditis elegans, the single forkhead box O (FOXO) homologue, DAF-16, functions as the major target of the IIS pathway(2,3,6,7). One of two isoforms(4,5,8), DAF-16a, is known to regulate longevity, stress response and dauer diapause(8-11). However, it remains unclear how DAF-16 achieves its specificity in regulating these various biological processes. Here we identify a new isoform, DAF-16d/f, as an important isoform regulating longevity. We show that DAF-16 isoforms functionally cooperate to modulate IIS-mediated processes through differential tissue enrichment, preferential modulation by upstream kinases, and regulating distinct and overlapping target genes. Promoter-swapping experiments show both the promoter and the coding region of DAF-16 are important for its function. Importantly, in mammals, four FOXO genes have overlapping and different functions(6,12), and in C. elegans, a single FOXO/DAF-16 uses distinct isoforms to fine-tune the IIS-mediated processes in the context of a whole organism.	[Kwon, Eun-Soo; Narasimhan, Devi; Yen, Kelvin; Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA; [Tissenbaum, Heidi A.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Tissenbaum, HA (corresponding author), Univ Massachusetts, Sch Med, Program Gene Funct & Express, Worcester, MA 01605 USA.	heidi.tissenbaum@umassmed.edu	Yen, Kelvin/J-5378-2019	Yen, Kelvin/0000-0003-4595-971X	National Institutes of Health National Center for Research Resources; National Institute of Aging [AG025891, AG031237]; Glenn Foundation for Medical Research; Ellison Medical Foundation; William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING [R01AG025891, R01AG031237] Funding Source: NIH RePORTER	National Institutes of Health National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Glenn Foundation for Medical Research; Ellison Medical Foundation(Lawrence Ellison Foundation); William Randolph Hearst Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We are grateful to A. Mukhopadhyay and S. Padmanabhan for advice, M. Green and M. Walhout for advice and comments on the manuscript and N. Bhabhalia for technical support. We thank M. Grabowski Auclair for generating several strains used in this manuscript and G. Ruvkun and M. Walhout for plasmids and strains. We apologize to all those whose original work was not cited because of space limitations. Some of the strains were provided by T. Stiernagle at the Caenorhabditis Genetics Center, which is funded by the National Institutes of Health National Center for Research Resources. H. A. T. is a William Randolph Hearst Young Investigator. This project was funded in part by grants from the National Institute of Aging AG025891 and AG031237), the Glenn Foundation for Medical Research, the Ellison Medical Foundation and an endowment from the William Randolph Hearst Foundation.	Antebi A, 2007, PLOS GENET, V3, P1565, DOI 10.1371/journal.pgen.0030129; Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Berdichevsky A, 2006, CELL, V125, P1165, DOI 10.1016/j.cell.2006.04.036; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Henderson ST, 2001, CURR BIOL, V11, P1975, DOI 10.1016/S0960-9822(01)00594-2; Herman RK, 1995, METHOD CELL BIOL, V48, P123; Honda Y, 1999, FASEB J, V13, P1385, DOI 10.1096/fasebj.13.11.1385; HOSONO R, 1982, EXP GERONTOL, V17, P163, DOI 10.1016/0531-5565(82)90052-3; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Lee RYN, 2001, CURR BIOL, V11, P1950, DOI 10.1016/S0960-9822(01)00595-4; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Libina N, 2003, CELL, V115, P489, DOI 10.1016/S0092-8674(03)00889-4; Lin K, 2001, NAT GENET, V28, P139, DOI 10.1038/88850; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; McElwee J, 2003, AGING CELL, V2, P111, DOI 10.1046/j.1474-9728.2003.00043.x; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mukhopadhyay A, 2006, EXP GERONTOL, V41, P928, DOI 10.1016/j.exger.2006.05.020; Murakami S, 1996, GENETICS, V143, P1207; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Narasimhan SD, 2009, CURR BIOL, V19, pR657, DOI 10.1016/j.cub.2009.06.013; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Oh SW, 2006, NAT GENET, V38, P251, DOI 10.1038/ng1723; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Riddle DL, 1997, C ELEGANS, P739; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Stiernagle Theresa, 2006, WormBook, P1	30	122	140	1	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					498	502		10.1038/nature09184	http://dx.doi.org/10.1038/nature09184			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20613724	Green Accepted			2022-12-28	WOS:000280141200038
J	Buchanan, TA; Xiang, AH				Buchanan, Thomas A.; Xiang, Anny H.			Preventing type 2 diabetes with low-dose combinations	LANCET			English	Editorial Material							BETA-CELL FUNCTION; RISK		[Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 91011 USA; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 91011 USA; [Buchanan, Thomas A.] Univ So Calif, Keck Sch Med, Dept Physiol & Biophys, Los Angeles, CA 91011 USA; [Xiang, Anny H.] Kaiser Permanente So Calif, Dept Res & Evaluat, Pasadena, CA USA	University of Southern California; University of Southern California; University of Southern California; Kaiser Permanente	Buchanan, TA (corresponding author), Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 91011 USA.	buchanan@usc.edu		Xiang, Anny/0000-0003-2786-1268				Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Buchanan TA, 2007, DIABETES, V56, P1502, DOI 10.2337/db07-0140; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; HAZZARD WR, 1968, DIABETES, V17, P179, DOI 10.2337/diab.17.4.179; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; McMurray JJ, 2010, NEW ENGL J MED, V362, P1477, DOI 10.1056/NEJMoa1001121; Torgerson JS, 2004, DIABETES CARE, V27, P155, DOI 10.2337/diacare.27.1.155; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Xiang AH, 2006, DIABETES, V55, P517, DOI 10.2337/diabetes.55.02.06.db05-1066; ZINMAN B, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60490-4	11	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					72	74		10.1016/S0140-6736(10)60900-2	http://dx.doi.org/10.1016/S0140-6736(10)60900-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20605203				2022-12-28	WOS:000279943200005
J	Kappeler, L; Meaney, MJ				Kappeler, Laurent; Meaney, Michael J.			Enriching Stress Research	CELL			English	Editorial Material							RESISTANCE		[Kappeler, Laurent; Meaney, Michael J.] McGill Univ, Sackler Program Epigenet & Psychobiol, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada	McGill University	Meaney, MJ (corresponding author), McGill Univ, Sackler Program Epigenet & Psychobiol, Douglas Mental Hlth Univ Inst, Verdun, PQ H4H 1R3, Canada.	michael.meaney@mcgill.ca	Kappeler, Laurent/N-6327-2017; Meaney, Michael/N-5931-2019	Kappeler, Laurent/0000-0001-7971-0838; 				Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Antoni MH, 2006, NAT REV CANCER, V6, P240, DOI 10.1038/nrc1820; BERKMAN LF, 1979, AM J EPIDEMIOL, V109, P186, DOI 10.1093/oxfordjournals.aje.a112674; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Hermes GL, 2009, P NATL ACAD SCI USA, V106, P22393, DOI 10.1073/pnas.0910753106; Melamed R, 2005, BRAIN BEHAV IMMUN, V19, P114, DOI 10.1016/j.bbi.2004.07.004; Nithianantharajah J, 2006, NAT REV NEUROSCI, V7, P697, DOI 10.1038/nrn1970; SKLAR LS, 1979, SCIENCE, V205, P513, DOI 10.1126/science.109924	8	4	4	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					15	17		10.1016/j.cell.2010.06.025	http://dx.doi.org/10.1016/j.cell.2010.06.025			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603008	Bronze			2022-12-28	WOS:000279637300006
J	Parfitt, SA; Ashton, NM; Lewis, SG; Abel, RL; Coope, GR; Field, MH; Gale, R; Hoare, PG; Larkin, NR; Lewis, MD; Karloukovski, V; Maher, BA; Peglar, SM; Preece, RC; Whittaker, JE; Stringer, CB				Parfitt, Simon A.; Ashton, Nick M.; Lewis, Simon G.; Abel, Richard L.; Coope, G. Russell; Field, Mike H.; Gale, Rowena; Hoare, Peter G.; Larkin, Nigel R.; Lewis, Mark D.; Karloukovski, Vassil; Maher, Barbara A.; Peglar, Sylvia M.; Preece, Richard C.; Whittaker, John E.; Stringer, Chris B.			Early Pleistocene human occupation at the edge of the boreal zone in northwest Europe	NATURE			English	Article							COLONIZATION; TEMPERATURES; MECHANISMS; DISPERSAL; SEDIMENTS; RECORD	The dispersal of early humans from Africa by 1.75 Myr ago led to a marked expansion of their range, from the island of Flores in the east to the Iberian peninsula in the west(1-5). This range encompassed tropical forest, savannah and Mediterranean habitats, but has hitherto not been demonstrated beyond 45 degrees N. Until recently, early colonization in Europe was thought to be confined to the area south of the Pyrenees and Alps. However, evidence from Pakefield (Suffolk, UK) at similar to 0.7 Myrindicated that humans occupied northern European latitudes when a Mediterranean-type climate prevailed(6). This provided the basis for an 'ebb and flow' model, where human populations were thought to survive in southern refugia during cold stages, only expanding northwards during fully temperate climates(5). Here we present new evidence from Happisburgh (Norfolk, UK) demonstrating that Early Pleistocene hominins were present in northern Europe >0.78 Myr ago when they were able to survive at the southern edge of the boreal zone. This has significant implications for our understanding of early human behaviour, adaptation and survival, as well as the tempo and mode of colonization after their first dispersal out of Africa.	[Ashton, Nick M.] British Museum, Dept Prehistory & Europe, London N1 5QJ, England; [Parfitt, Simon A.] UCL, Inst Archaeol, London WC1H 0PY, England; [Parfitt, Simon A.; Lewis, Mark D.; Peglar, Sylvia M.; Whittaker, John E.; Stringer, Chris B.] Nat Hist Museum, Dept Palaeontol, London SW7 5BD, England; [Lewis, Simon G.] Queen Mary Univ London, Dept Geog, London E1 4NS, England; [Abel, Richard L.] Nat Hist Museum, Dept Mineral, London SW7 5BD, England; [Field, Mike H.] Leiden Univ, Dept Archaeol, NL-2300 RA Leiden, Netherlands; [Coope, G. Russell] Univ Birmingham, Sch Earth Sci, Birmingham B15 2TT, W Midlands, England; [Gale, Rowena] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3AB, Surrey, England; [Hoare, Peter G.] Univ Sydney, Sch Geosci, Sydney, NSW 2006, Australia; [Larkin, Nigel R.] Norfolk Museums & Archaeol Serv, Norwich NR1 3JQ, Norfolk, England; [Karloukovski, Vassil; Maher, Barbara A.] Univ Lancaster, Ctr Environm Magnetism & Palaeomagnetism, Lancaster Environm Ctr, Lancaster LA1 4YQ, England; [Preece, Richard C.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	Natural History Museum London; University of London; University College London; Natural History Museum London; University of London; Queen Mary University London; Natural History Museum London; Leiden University; Leiden University - Excl LUMC; University of Birmingham; Royal Botanic Gardens, Kew; University of Sydney; Lancaster University; University of Cambridge	Ashton, NM (corresponding author), British Museum, Dept Prehistory & Europe, Franks House,38-56 Orsman Rd, London N1 5QJ, England.	nashton@thebritishmuseum.ac.uk	Maher, Barbara A/K-6234-2012; Abel, Richard/C-9913-2011	Maher, Barbara A/0000-0002-8759-8214; Ashton, Nick/0000-0001-9787-3892	British Museum; Ancient Human Occupation of Britain (AHOB); Natural Environment Research Council [ceh010010] Funding Source: researchfish	British Museum; Ancient Human Occupation of Britain (AHOB); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the British Museum for funding the excavations; C. and S. Stockton for practical support; B. Farrow and P. Frew (North Norfolk District Council), E. Couzens, the Lomax family (local landowners) and M. Kerby (North Norfolk Coastal Concern Group) for permission and facilitating excavation; and J. Roylance and M. Appleford for plant hire and machining. We also thank A. Ball, S. Bello, P. Crabb and K. Johnson, C. Williams, A. Brumm, M. Pitts and M. Page for the figures and photographs; R. Herrington, C. Halls and T. Wighton for thin sections and mineral identification; M. Barclay, M. Breda, S. Feist-Burkhardt, J. Chitolie, P. Gibbard, M. Hounslow, A. Lister, T. Meijer, S. Moore-Fay, J. Rose, M. Spencer, H. van Essen and R. West for discussion about the project. We are also grateful to A. Roberts for his comments on the manuscript. Finally, we thank all who participated in the site excavation. This work is part of the Leverhulme-funded Ancient Human Occupation of Britain (AHOB) Project.	ATKINSON TC, 1987, NATURE, V325, P587, DOI 10.1038/325587a0; Azzaroli A., 1996, P45; Bintanja R, 2005, NATURE, V437, P125, DOI 10.1038/nature03975; Brumm A, 2010, NATURE, V464, P748, DOI 10.1038/nature08844; Carbonell E, 2008, J ANTHROPOL RES, V64, P195, DOI 10.3998/jar.0521004.0064.202; Carbonell E, 2008, NATURE, V452, P465, DOI 10.1038/nature06815; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Gamble Clive., 1986, PALAEOLITHIC SETTLEM; Giddings JW, 1997, GEOL MIJNBOUW-N J G, V76, P35, DOI 10.1023/A:1003096005078; HEY RW, 1977, GEOL MAG, V114, P219, DOI 10.1017/S0016756800044800; Lisiecki L.E., 2005, PALEOCEANOGRAPHY, V20, DOI [10.1029/2004PA001071, DOI 10.1029/2004PA001071]; Lister A.M., 1996, P25; MAGRI D, 2009, QUATERNARY INT; Maher BA, 2005, J QUATERNARY SCI, V20, P79, DOI 10.1002/jqs.894; Maher BA, 2005, J QUATERNARY SCI, V20, P67, DOI 10.1002/jqs.890; Maul LC, 2007, QUATERN INT, V160, P81, DOI 10.1016/j.quaint.2006.09.010; Parfitt SA, 2005, NATURE, V438, P1008, DOI 10.1038/nature04227; Preece RC, 2009, J QUATERNARY SCI, V24, P557, DOI 10.1002/jqs.1245; RANOV VA, 1995, CURR ANTHROPOL, V36, P337, DOI 10.1086/204366; Reid C, 1882, GEOLOGY COUNTRY CROM; Roberts AP, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034719; Roberts AP, 2005, EARTH PLANET SC LETT, V231, P263, DOI 10.1016/j.epsl.2004.11.024; Roebroeks W, 2001, J HUM EVOL, V41, P437, DOI 10.1006/jhev.2001.0499; Roebroeks W, 2006, J QUATERNARY SCI, V21, P425, DOI 10.1002/jqs.1044; Rose J, 2001, QUATERN INT, V79, P5, DOI 10.1016/S1040-6182(00)00119-1; Sagnotti L, 1999, EARTH PLANET SC LETT, V165, P67, DOI 10.1016/S0012-821X(98)00248-9; WEST R. G., 1980, PREGLACIAL PLEISTOCE; Zhu RX, 2004, NATURE, V431, P559, DOI 10.1038/nature02829	30	253	260	1	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 8	2010	466	7303					229	233		10.1038/nature09117	http://dx.doi.org/10.1038/nature09117			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613840				2022-12-28	WOS:000279580800035
J	Hajkova, P; Jeffries, SJ; Lee, C; Miller, N; Jackson, SP; Surani, MA				Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Miller, Nigel; Jackson, Stephen P.; Surani, M. Azim			Genome-Wide Reprogramming in the Mouse Germ Line Entails the Base Excision Repair Pathway	SCIENCE			English	Article							DNA METHYLATION; MAMMALIAN-CELLS; PATERNAL GENOME; DEMETHYLATION; CHROMATIN; 5-HYDROXYMETHYLCYTOSINE; POLY(ADP-RIBOSYL)ATION; EMBRYOGENESIS; ARABIDOPSIS; DEMETER	Genome-wide active DNA demethylation in primordial germ cells (PGCs), which reprograms the epigenome for totipotency, is linked to changes in nuclear architecture, loss of histone modifications, and widespread histone replacement. Here, we show that DNA demethylation in the mouse PGCs is mechanistically linked to the appearance of single-stranded DNA (ssDNA) breaks and the activation of the base excision repair (BER) pathway, as is the case in the zygote where the paternal pronucleus undergoes active DNA demethylation shortly after fertilization. Whereas BER might be triggered by deamination of a methylcytosine (5mC), cumulative evidence indicates other mechanisms in germ cells. We demonstrate that DNA repair through BER represents a core component of genome-wide DNA demethylation in vivo and provides a mechanistic link to the extensive chromatin remodeling in developing PGCs.	[Hajkova, Petra; Jeffries, Sean J.; Lee, Caroline; Jackson, Stephen P.; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England; [Miller, Nigel] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England; [Hajkova, Petra] MRC, Ctr Clin Sci, London W12 0NN, England; [Jeffries, Sean J.] Templeman Automat, Somerville, MA 02143 USA; [Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England	University of Cambridge; University of Cambridge; University of Cambridge	Hajkova, P (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Tennis Court Rd, Cambridge CB2 1QN, England.	petra.hajkova@csc.mrc.ac.uk; a.surani@gurdon.cam.ac.uk	Dry, Kate/I-2328-2014; Jackson, Stephen Philip/R-4548-2019	Jackson, Stephen Philip/0000-0001-9317-7937; Surani, Azim/0000-0002-8640-4318; Hajkova, Petra/0000-0003-4145-1468	Wellcome Trust; Cancer Research UK [11224] Funding Source: researchfish; Medical Research Council [G0800784B, MC_U120092689, G0800784] Funding Source: researchfish; MRC [MC_U120092689, G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Y. Galanty, S. Polo, and members of the Surani lab for stimulating discussions. S.J.J. was a NIH-Cambridge Health Science Scholar. This work was funded by grants from the Wellcome Trust to M.A.S.	Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gehring M, 2006, CELL, V124, P495, DOI 10.1016/j.cell.2005.12.034; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; HOWLETT SK, 1986, ROUX ARCH DEV BIOL, V195, P499, DOI 10.1007/BF00375890; HULETSKY A, 1989, J BIOL CHEM, V264, P8878; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kwon K, 2008, IMMUNITY, V28, P751, DOI 10.1016/j.immuni.2008.04.014; LENK R, 1977, CELL, V10, P67, DOI 10.1016/0092-8674(77)90141-6; Madhusudan S, 2005, NUCLEIC ACIDS RES, V33, P4711, DOI 10.1093/nar/gki781; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Nazarkina ZK, 2007, DNA REPAIR, V6, P254, DOI 10.1016/j.dnarep.2006.10.002; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Popp C, 2010, NATURE, V463, P1101, DOI 10.1038/nature08829; PURNELL MR, 1980, BIOCHEM J, V185, P775, DOI 10.1042/bj1850775; Quenet D, 2009, INT J BIOCHEM CELL B, V41, P60, DOI 10.1016/j.biocel.2008.07.023; RODMAN TC, 1981, J CELL BIOL, V90, P351, DOI 10.1083/jcb.90.2.351; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Svetlova M, 1999, FEBS LETT, V463, P49, DOI 10.1016/S0014-5793(99)01592-6; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Tulin A, 2003, SCIENCE, V299, P560, DOI 10.1126/science.1078764; Wong E, 2002, P NATL ACAD SCI USA, V99, P14937, DOI 10.1073/pnas.232579299	29	347	358	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 2	2010	329	5987					78	82		10.1126/science.1187945	http://dx.doi.org/10.1126/science.1187945			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	619BL	20595612	Green Accepted			2022-12-28	WOS:000279402700036
J	Tate, CG				Tate, Christopher G.			Membrane Protein Gymnastics	SCIENCE			English	Editorial Material							EVOLUTION; TOPOLOGY		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Tate, CG (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	cgt@mrc-lmb.cam.ac.uk		Tate, Christopher/0000-0002-2008-9183	Medical Research Council [MC_U105197215] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Becker T, 2009, SCIENCE, V326, P1369, DOI 10.1126/science.1178535; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; GAFVELIN G, 1994, CELL, V77, P401, DOI 10.1016/0092-8674(94)90155-4; Hamman BD, 1997, CELL, V89, P535, DOI 10.1016/S0092-8674(00)80235-4; Korkhov VM, 2009, ACTA CRYSTALLOGR D, V65, P186, DOI 10.1107/S0907444908036640; Rapp M, 2007, SCIENCE, V315, P1282, DOI 10.1126/science.1135406; Schuldiner S, 2009, BBA-PROTEINS PROTEOM, V1794, P748, DOI 10.1016/j.bbapap.2008.12.018; Seppala S, 2010, SCIENCE, V328, P1698, DOI 10.1126/science.1188950; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; Vinothkumar KR, 2010, Q REV BIOPHYS, V43, P65, DOI 10.1017/S0033583510000041; VONHEIJNE G, 1989, NATURE, V341, P456, DOI 10.1038/341456a0; Xie K, 2008, NAT REV MICROBIOL, V6, P234, DOI 10.1038/nrmicro3595	12	4	4	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1644	1645		10.1126/science.1193065	http://dx.doi.org/10.1126/science.1193065			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576878				2022-12-28	WOS:000279107400028
J	Ko, K; Arauzo-Bravo, MJ; Tapia, N; Kim, J; Lin, Q; Bernemann, C; Han, DW; Gentile, L; Reinhardt, P; Greber, B; Schneider, RK; Kliesch, S; Zenke, M; Scholer, HR				Ko, Kinarm; Arauzo-Bravo, Marcos J.; Tapia, Natalia; Kim, Julee; Lin, Qiong; Bernemann, Christof; Han, Dong Wook; Gentile, Luca; Reinhardt, Peter; Greber, Boris; Schneider, Rebekka K.; Kliesch, Sabine; Zenke, Martin; Schoeler, Hans R.			Human adult germline stem cells in question	NATURE			English	Letter							GENERATION		[Ko, Kinarm; Arauzo-Bravo, Marcos J.; Tapia, Natalia; Kim, Julee; Bernemann, Christof; Han, Dong Wook; Gentile, Luca; Reinhardt, Peter; Greber, Boris; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Lin, Qiong; Schneider, Rebekka K.; Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany; [Lin, Qiong; Schneider, Rebekka K.; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany; [Kliesch, Sabine] Univ Munster, Dept Clin Androl, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; University of Munster; University of Munster	Ko, K (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Marcos, Arauzo-Bravo/A-1706-2011; Gentile, Luca/E-4908-2019; Han, Dong Wook/D-6041-2011; , HS/AAB-4434-2019; Lin, Qiong/J-6880-2015; Tapia, Natalia/H-5500-2012	Marcos, Arauzo-Bravo/0000-0002-3264-464X; Gentile, Luca/0000-0002-7393-7502; , HS/0000-0003-2643-5136; Lin, Qiong/0000-0002-7964-6191; Greber, Boris/0000-0002-9404-7293; Tapia, Natalia/0000-0003-0226-1952				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; CHEN ATL, 1975, IN VITRO CELL DEV B, V11, P313; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Conrad S, 2009, NATURE, V460, DOI 10.1038/nature08353; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Nakagawa H, 2004, ONCOGENE, V23, P7366, DOI 10.1038/sj.onc.1208013; Vockerodt M, 2008, J PATHOL, V216, P83, DOI 10.1002/path.2384; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	9	61	64	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					E1	E2		10.1038/nature09089	http://dx.doi.org/10.1038/nature09089			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577160				2022-12-28	WOS:000279056900040
J	Poliseno, L; Salmena, L; Zhang, JW; Carver, B; Haveman, WJ; Pandolfi, PP				Poliseno, Laura; Salmena, Leonardo; Zhang, Jiangwen; Carver, Brett; Haveman, William J.; Pandolfi, Pier Paolo			A coding-independent function of gene and pseudogene mRNAs regulates tumour biology	NATURE			English	Article							HUMAN GENOME; MICRORNAS; EXPRESSION; CANCER; TRANSFORMATION; AUTOIMMUNITY; RECOGNITION; SIGNATURE; REVEALS; TARGETS	The canonical role of messenger RNA (mRNA) is to deliver protein-coding information to sites of protein synthesis. However, given that microRNAs bind to RNAs, we hypothesized that RNAs could possess a regulatory role that relies on their ability to compete for microRNA binding, independently of their protein-coding function. As a model for the protein-coding-independent role of RNAs, we describe the functional relationship between the mRNAs produced by the PTEN tumour suppressor gene and its pseudogene PTENP1 and the critical consequences of this interaction. We find that PTENP1 is biologically active as it can regulate cellular levels of PTEN and exert a growth-suppressive role. We also show that the PTENP1 locus is selectively lost in human cancer. We extended our analysis to other cancer-related genes that possess pseudogenes, such as oncogenic KRAS. We also demonstrate that the transcripts of protein-coding genes such as PTEN are biologically active. These findings attribute a novel biological role to expressed pseudogenes, as they can regulate coding gene expression, and reveal a non-coding function for mRNAs.	[Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Poliseno, Laura; Salmena, Leonardo; Haveman, William J.; Pandolfi, Pier Paolo] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Pathol, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA; [Zhang, Jiangwen] Harvard Univ, FAS Res Comp, Cambridge, MA 02138 USA; [Zhang, Jiangwen] Harvard Univ, FAS Ctr Syst Biol, Cambridge, MA 02138 USA; [Carver, Brett] Mem Sloan Kettering Canc Ctr, Dept Surg, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard University; Memorial Sloan Kettering Cancer Center	Pandolfi, PP (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr,Dept Med, Canc Genet Program,Beth Israel Deaconess Canc Ctr, Boston, MA 02215 USA.	ppandolf@bidmc.harvard.edu	Chan, Edward K. L./B-5671-2009; Califano, Andrea/F-7239-2012; Zhang, Jiangwen/A-7654-2013; Poliseno, Laura/B-5711-2012	Chan, Edward K. L./0000-0003-3938-9503; Zhang, Jiangwen/0000-0002-2911-8446; Salmena, Leonardo/0000-0003-4023-658X; Poliseno, Laura/0000-0001-6557-955X	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program; Canadian Institutes of Health Research; NIH [R01 CA-82328-09]; NATIONAL CANCER INSTITUTE [R01CA082328, R01CA102142] Funding Source: NIH RePORTER	Istituto Toscano Tumori; American Italian Cancer Foundation; Human Frontier Science Program(Human Frontier Science Program); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Pandolfi laboratory members for critical discussions, in particular A. Carracedo for critical input; S. Feng for technical assistance. We thank B. Vogelstein for DICER<SUP>-/-</SUP> cells; T. Yuan for assistance with FACS analysis; A. Tuccoli for assistance with miRNA RT-PCR; I. Osman for support and suggestions. L. P. was supported by fellowships from the Istituto Toscano Tumori and the American Italian Cancer Foundation. L.S. was supported by fellowships from the Human Frontier Science Program and the Canadian Institutes of Health Research. This work was supported by NIH grant R01 CA-82328-09 to P.P.P.	ALIMONTI A, 2010, NATURE GENET; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Balasubramanian S, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r2; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BRISTOW J, 1993, J BIOL CHEM, V268, P12919; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; D'Errico Ilenia, 2004, Briefings in Functional Genomics & Proteomics, V3, P157, DOI 10.1093/bfgp/3.2.157; Di Cristofano A, 1999, SCIENCE, V285, P2122, DOI 10.1126/science.285.5436.2122; Drabkin H, 2002, LEUKEMIA, V16, P186, DOI 10.1038/sj.leu.2402354; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Frith MC, 2006, PLOS GENET, V2, P504, DOI 10.1371/journal.pgen.0020023; Fujii GH, 1999, ONCOGENE, V18, P1765, DOI 10.1038/sj.onc.1202492; Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Harrison PM, 2005, NUCLEIC ACIDS RES, V33, P2374, DOI 10.1093/nar/gki531; Huse JT, 2009, GENE DEV, V23, P1327, DOI 10.1101/gad.1777409; JIANG SL, 1995, J IMMUNOL, V154, P825; Kato M, 2009, NAT CELL BIOL, V11, P881, DOI 10.1038/ncb1897; Kawahara Y, 2007, SCIENCE, V315, P1137, DOI 10.1126/science.1138050; Kim J, 2009, NAT BIOTECHNOL, V27, P472, DOI 10.1038/nbt.1540; Lal A, 2009, MOL CELL, V35, P610, DOI 10.1016/j.molcel.2009.08.020; Lee JJ, 2009, J FORAMIN RES, V39, P4, DOI 10.2113/gsjfr.39.1.4; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lu Z, 2008, ONCOGENE, V27, P4373, DOI 10.1038/onc.2008.72; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Meng FY, 2006, GASTROENTEROLOGY, V130, P2113, DOI 10.1053/j.gastro.2006.02.057; Myers MP, 1997, P NATL ACAD SCI USA, V94, P9052, DOI 10.1073/pnas.94.17.9052; Okamura K, 2008, CELL CYCLE, V7, P2840, DOI 10.4161/cc.7.18.6734; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Plantaz D, 1997, AM J PATHOL, V150, P81; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Seitz H, 2009, CURR BIOL, V19, P870, DOI 10.1016/j.cub.2009.03.059; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Suo GL, 2005, BIOCHEM BIOPH RES CO, V337, P1047, DOI 10.1016/j.bbrc.2005.09.157; Takakura S, 2008, CANCER SCI, V99, P1147, DOI 10.1111/j.1349-7006.2008.00800.x; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; van der Wal JE, 2003, J CLIN PATHOL, V56, P26, DOI 10.1136/jcp.56.1.26; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zimonjic DB, 1999, HEPATOLOGY, V29, P1208, DOI 10.1002/hep.510290410	52	1765	1891	5	186	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1033	U90		10.1038/nature09144	http://dx.doi.org/10.1038/nature09144			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577206	Green Accepted			2022-12-28	WOS:000279056900043
J	Ryan, DP; Engelman, JA; Ferrone, CR; Sahani, DV; Lisovsky, M				Ryan, David P.; Engelman, Jeffrey A.; Ferrone, Cristina R.; Sahani, Dushyant V.; Lisovsky, Mikhail			Case 19-2010: A 35-Year-Old Man with Adenocarcinoma of the Cecum.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							METASTATIC COLORECTAL-CANCER; INITIAL TREATMENT; CHEMOTHERAPY; CETUXIMAB; MANAGEMENT; SURGERY		[Ryan, David P.; Engelman, Jeffrey A.] Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA; [Ferrone, Cristina R.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Sahani, Dushyant V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Lisovsky, Mikhail] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Ryan, David P.; Engelman, Jeffrey A.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Ferrone, Cristina R.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Sahani, Dushyant V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Lisovsky, Mikhail] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Lisovsky, Mikhail] Dartmouth Hitchcock Med Ctr, Dept Pathol, Lebanon, NH 03766 USA; [Lisovsky, Mikhail] Dartmouth Coll, Hitchcock Med Ctr, Dartmouth Med Sch, Hanover, NH 03756 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Dartmouth College; Dartmouth College	Ryan, DP (corresponding author), Massachusetts Gen Hosp, Div Hematol & Oncol, Boston, MA 02114 USA.				NCI NIH HHS [P50 CA127003, P50 CA127003-03, K08 CA120060-04, P50 CA127003-04, K08 CA120060] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K08CA120060, P50CA127003] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Badgwell BD, 2008, ANN ONCOL, V19, P577, DOI 10.1093/annonc/mdm508; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Dy GK, 2009, CLIN COLORECTAL CANC, V8, P88, DOI 10.3816/CCC.2009.n.014; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Esquivel J, 2007, ANN SURG ONCOL, V14, P128, DOI 10.1245/s10434-006-9185-7; GIOVANNUCCI E, 1995, ANN INTERN MED, V122, P327, DOI 10.7326/0003-4819-122-5-199503010-00002; Greene FL, 2002, AJCC CANC STAGING HD; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Khambata-Ford S, 2007, J CLIN ONCOL, V25, P3230, DOI 10.1200/JCO.2006.10.5437; Kohne CH, 2002, ANN ONCOL, V13, P308, DOI 10.1093/annonc/mdf034; Kozloff M, 2009, ONCOLOGIST, V14, P862, DOI 10.1634/theoncologist.2009-0071; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; Ronnett BM, 2001, CANCER, V92, P85, DOI 10.1002/1097-0142(20010701)92:1<85::AID-CNCR1295>3.0.CO;2-R; Sanoff HK, 2008, J CLIN ONCOL, V26, P5721, DOI 10.1200/JCO.2008.17.7147; Scheer MGW, 2008, ANN ONCOL, V19, P1829, DOI 10.1093/annonc/mdn398; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Zbuk K, 2009, SEMIN ONCOL, V36, P439, DOI 10.1053/j.seminoncol.2009.07.008	22	1	1	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2411	2419		10.1056/NEJMcpc1003885	http://dx.doi.org/10.1056/NEJMcpc1003885			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573930	Green Accepted			2022-12-28	WOS:000279043800012
J	McClellan, J; King, MC				McClellan, Jon; King, Mary-Claire			Genomic Analysis of Mental Illness A Changing Landscape	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COMMON VARIANTS; SCHIZOPHRENIA; ASSOCIATION; RISK		[McClellan, Jon] Univ Washington, Dept Psychiat, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	McClellan, J (corresponding author), Univ Washington, Dept Psychiat, Box 356560, Seattle, WA 98195 USA.	drjack@uw.edu		King, Mary-Claire/0000-0001-9426-1743				McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Shi JX, 2009, NATURE, V460, P753, DOI 10.1038/nature08192; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Williams HJ, 2011, MOL PSYCHIATR, V16, P429, DOI 10.1038/mp.2010.36; Xu B, 2008, NAT GENET, V40, P880, DOI 10.1038/ng.162	10	48	49	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2523	2524		10.1001/jama.2010.869	http://dx.doi.org/10.1001/jama.2010.869			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571020				2022-12-28	WOS:000279010900032
J	Walz, G; Budde, K; Mannaa, M; Nurnberger, J; Wanner, C; Sommerer, C; Kunzendorf, U; Banas, B; Horl, WH; Obermuller, N; Arns, W; Pavenstadt, H; Gaedeke, J; Buchert, M; May, C; Gschaidmeier, H; Kramer, S; Eckardt, KU				Walz, Gerd; Budde, Klemens; Mannaa, Marwan; Nuernberger, Jens; Wanner, Christoph; Sommerer, Claudia; Kunzendorf, Ulrich; Banas, Bernhard; Hoerl, Walter H.; Obermueller, Nicholas; Arns, Wolfgang; Pavenstaedt, Hermann; Gaedeke, Jens; Buechert, Martin; May, Christoph; Gschaidmeier, Harald; Kramer, Stefan; Eckardt, Kai-Uwe			Everolimus in Patients with Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PRIMARY CILIUM; ADPKD; PROGRESSION; CYSTOGENESIS; INHIBITION; PATHWAY; VOLUME; MODEL; MTOR	BACKGROUND Autosomal dominant polycystic kidney disease (ADPKD) is a slowly progressive hereditary disorder that usually leads to end-stage renal disease. Although the underlying gene mutations were identified several years ago, efficacious therapy to curtail cyst growth and prevent renal failure is not available. Experimental and observational studies suggest that the mammalian target of rapamycin (mTOR) pathway plays a critical role in cyst growth. METHODS In this 2-year, double-blind trial, we randomly assigned 433 patients with ADPKD to receive either placebo or the mTOR inhibitor everolimus. The primary outcome was the change in total kidney volume, as measured on magnetic resonance imaging, at 12 and 24 months. RESULTS Total kidney volume increased between baseline and 1 year by 102 ml in the everolimus group, versus 157 ml in the placebo group (P = 0.02) and between baseline and 2 years by 230 ml and 301 ml, respectively (P = 0.06). Cyst volume increased by 76 ml in the everolimus group and 98 ml in the placebo group after 1 year (P = 0.27) and by 181 ml and 215 ml, respectively, after 2 years (P = 0.28). Parenchymal volume increased by 26 ml in the everolimus group and 62 ml in the placebo group after 1 year (P = 0.003) and by 56 ml and 93 ml, respectively, after 2 years (P = 0.11). The mean decrement in the estimated glomerular filtration rate after 24 months was 8.9 ml per minute per 1.73 m(2) of body-surface area in the everolimus group versus 7.7 ml per minute in the placebo group (P = 0.15). Drug-specific adverse events were more common in the everolimus group; the rate of infection was similar in the two groups. CONCLUSIONS Within the 2-year study period, as compared with placebo, everolimus slowed the increase in total kidney volume of patients with ADPKD but did not slow the progression of renal impairment. (Funded by Novartis; EudraCT number, 2006001485-16; ClinicalTrials.gov number, NCT00414440.)	[Walz, Gerd] Univ Hosp Freiburg, Div Renal, D-79106 Freiburg, Germany; [Budde, Klemens; Gaedeke, Jens] Charite, D-13353 Berlin, Germany; [Nuernberger, Jens] Univ Hosp Duisburg Essen, Essen, Germany; [Wanner, Christoph] Univ Hosp Wurzburg, Wurzburg, Germany; [Sommerer, Claudia] Univ Hosp, Heidelberg, Germany; [Kunzendorf, Ulrich] Univ Hosp, Kiel, Germany; [Banas, Bernhard] Univ Hosp, Regensburg, Germany; [Obermueller, Nicholas] Univ Hosp, Frankfurt, Germany; [Arns, Wolfgang] Merheim Med Ctr, Cologne, Germany; [Pavenstaedt, Hermann] Univ Hosp, Munster, Germany; [May, Christoph; Gschaidmeier, Harald; Kramer, Stefan] Novartis Germany, Nurnberg, Germany; [Eckardt, Kai-Uwe] Univ Erlangen Nurnberg, Erlangen, Germany; [Eckardt, Kai-Uwe] Community Hosp Nurnberg, Erlangen, Germany; [Hoerl, Walter H.] Med Univ Vienna, Vienna, Austria	University of Freiburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Duisburg Essen; University of Wurzburg; Ruprecht Karls University Heidelberg; University of Kiel; Schleswig Holstein University Hospital; University of Regensburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital; University of Munster; Novartis; University of Erlangen Nuremberg; Medical University of Vienna	Walz, G (corresponding author), Univ Hosp Freiburg, Div Renal, Hugstetter St 55, D-79106 Freiburg, Germany.	gerd.walz@uniklinik-freiburg.de	Buechert, Martin/B-3107-2011; Kunzendorf, Ulrich/A-8257-2010; Budde, Klemens/AAD-2170-2020	Buechert, Martin/0000-0001-5844-8711; Budde, Klemens/0000-0002-7929-5942; Banas, Bernhard/0000-0003-2076-2195	Novartis	Novartis(Novartis)	Supported by Novartis.	Bonnet CS, 2009, HUM MOL GENET, V18, P2166, DOI 10.1093/hmg/ddp149; Chapman AB, 2003, KIDNEY INT, V64, P1035, DOI 10.1046/j.1523-1755.2003.00185.x; Grantham JJ, 2008, NEW ENGL J MED, V359, P1477, DOI 10.1056/NEJMcp0804458; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Hartman TR, 2009, HUM MOL GENET, V18, P151, DOI 10.1093/hmg/ddn325; King BF, 2003, KIDNEY INT, V64, P2214, DOI 10.1046/j.1523-1755.2003.00326.x; Levey AS, 2008, ANN INTERN MED, V149, P519, DOI 10.7326/0003-4819-149-7-200810070-00023; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lieberthal W, 2009, J AM SOC NEPHROL, V20, P2493, DOI 10.1681/ASN.2008111186; Molenberghs G., 2007, MISSING DATA CLIN ST; Perico N, 2010, J AM SOC NEPHROL, V21, P1031, DOI 10.1681/ASN.2009121302; Qian Q, 2008, J AM SOC NEPHROL, V19, P631, DOI 10.1681/ASN.2007050626; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; Tao YX, 2005, J AM SOC NEPHROL, V16, P46, DOI 10.1681/ASN.2004080660; Torres VE, 2007, LANCET, V369, P1287, DOI 10.1016/S0140-6736(07)60601-1; Troendle JF, 2005, STAT MED, V24, P3239, DOI 10.1002/sim.2194; Wahl PR, 2006, NEPHROL DIAL TRANSPL, V21, P598, DOI 10.1093/ndt/gfi181; Wilson PD, 2004, NEW ENGL J MED, V350, P151, DOI 10.1056/NEJMra022161; Wong H, 2004, AM J KIDNEY DIS, V43, P624, DOI 10.1053/j.ajkd.2003.12.026; Wu M, 2007, KIDNEY BLOOD PRESS R, V30, P253, DOI 10.1159/000104818	21	408	426	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	AUG 26	2010	363	9					830	840		10.1056/NEJMoa1003491	http://dx.doi.org/10.1056/NEJMoa1003491			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	642HG	20581392				2022-12-28	WOS:000281196600006
J	Seida, JC; LeBlanc, C; Schouten, JR; Mousavi, SS; Hartling, L; Vandermeer, B; Tjosvold, L; Sheps, DM				Seida, Jennifer C.; LeBlanc, Claire; Schouten, Janine R.; Mousavi, Shima S.; Hartling, Lisa; Vandermeer, Ben; Tjosvold, Lisa; Sheps, David M.			Systematic Review: Nonoperative and Operative Treatments for Rotator Cuff Tears	ANNALS OF INTERNAL MEDICINE			English	Review							SUPRASPINATUS TENDON REPAIR; CONTINUOUS PASSIVE MOTION; ARTHROSCOPIC SINGLE-ROW; MINI-OPEN; SUBACROMIAL DECOMPRESSION; CLINICAL-OUTCOMES; LONG-TERM; QUALITY; SUTURE; PHYSIOTHERAPY	Background: Many approaches exist for managing rotator cuff tears. Purpose: To compare the benefits and harms of nonoperative and operative interventions on clinically important outcomes in adults with rotator cuff tears. Data Sources: 12 electronic databases (1990 to September 2009), gray literature, trial registries, and reference lists were searched. Study Selection: Controlled and uncontrolled studies that assessed nonoperative or operative treatments or postoperative rehabilitation for adults with confirmed rotator cuff tears were included. Operative studies in English-language publications and nonoperative and postoperative rehabilitation studies in English, French, or German were considered. Studies were assessed in duplicate. Data Extraction: 2 reviewers assessed risk for bias by using the Cochrane Risk of Bias tool and the Newcastle-Ottawa Scale. One reviewer rated the evidence by using a modified GRADE (Grading of Recommendations Assessment, Development, and Evaluation) approach. Data were extracted by one reviewer and verified by another. Data Synthesis: 137 studies met eligibility criteria. All trials had high risk for bias. Cohort and uncontrolled studies were of moderate quality. Reported functional outcomes did not differ between open versus mini-open repair, mini-open versus arthroscopic repair, arthroscopic repair with versus without acromioplasty, or single-row versus double-row fixation. Earlier return to work was reported for mini-open repair versus open repair and for continuous passive motion with physical therapy versus physical therapy alone. Open repairs showed greater improvement in function than did arthroscopic debridement. Complication rates were low across all interventions. Limitations: Limited evidence, which was often of low quality, precluded conclusions for most comparisons. Language restrictions may have excluded some relevant studies, and selective outcome reporting may have introduced bias. Conclusion: Evidence on the comparative effectiveness and harms of various operative and nonoperative treatments for rotator cuff tears is limited and inconclusive.	[Seida, Jennifer C.] Univ Alberta, Alberta Res Ctr Hlth Evidence, Edmonton, AB T6G 2J3, Canada	University of Alberta	Seida, JC (corresponding author), Univ Alberta, Alberta Res Ctr Hlth Evidence, 11402 Univ Ave, Edmonton, AB T6G 2J3, Canada.	jennifer.seida@ualberta.ca		Schouten, Janine/0000-0001-7913-7242; Tjosvold, Lisa/0000-0002-5667-6312	Agency for Healthcare Research and Quality; Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services [290-02-0023]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Primary Funding Source: Agency for Healthcare Research and Quality.; Grant Support: By the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services (contract 290-02-0023).	BAKER CL, 1995, AM J SPORT MED, V23, P99, DOI 10.1177/036354659502300117; BARTOLOZZI A, 1994, CLIN ORTHOP RELAT R, P90; Bennett WF, 2003, ARTHROSCOPY, V19, P21, DOI 10.1053/jars.2003.50023; Bigoni M, 2009, J SHOULDER ELB SURG, V18, P178, DOI 10.1016/j.jse.2008.09.002; Bishop J, 2006, J SHOULDER ELB SURG, V15, P290, DOI 10.1016/j.jse.2005.09.017; Boehm TD, 2005, J BONE JOINT SURG BR, V87B, P819, DOI 10.1302/0301-620X.87B6.15638; Boileau P, 2007, J BONE JOINT SURG AM, V89A, P747, DOI 10.2106/JBJS.E.01097; Boissonnault WG, 2007, J ORTHOP SPORT PHYS, V37, P312, DOI 10.2519/jospt.2007.2448; Brady B, 2008, PHYSIOTHER RES INT, V13, P153, DOI 10.1002/pri.403; Buess E, 2005, ARTHROSCOPY, V21, P597, DOI 10.1016/j.arthro.2005.01.002; Burks RT, 2009, AM J SPORT MED, V37, P674, DOI 10.1177/0363546508328115; Charousset C, 2007, AM J SPORT MED, V35, P1247, DOI 10.1177/0363546507301661; Colegate-Stone T, 2009, KNEE SURG SPORT TR A, V17, P691, DOI 10.1007/s00167-008-0661-4; COSTOUROS J, 2006, 20 C EUR SOC SURG SH; Crusher R H, 2000, Accid Emerg Nurs, V8, P129, DOI 10.1054/aaen.2000.0132; Cummins CA, 2003, ARTHROSCOPY, V19, P239, DOI 10.1053/jars.2003.50013; DECARLI A, 2006, J ORTHOP TRAUMATOL, V7, pS51; Deeks J.J., 2001, SYSTEMATIC REV HLTH, P285, DOI DOI 10.1002/9780470693926.CH15; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Delbrouck C., 2003, Annales de Readaptation et de Medecine Physique, V46, P207, DOI 10.1016/S0168-6054(03)00054-0; FAVARD L, 2009, ORTHOP TRAUMATOL S S, V65, P95; Franceschi F, 2008, AM J SPORT MED, V36, P247, DOI 10.1177/0363546507308194; Franceschi F, 2007, AM J SPORT MED, V35, P1254, DOI 10.1177/0363546507302218; Franceschi F, 2007, INT ORTHOP, V31, P537, DOI 10.1007/s00264-006-0206-8; Gartsman GM, 2004, J SHOULDER ELB SURG, V13, P424, DOI 10.1016/j.jse.2004.02.006; Ghodadra NS, 2009, J ORTHOP SPORT PHYS, V39, P81, DOI 10.2519/jospt.2009.2918; Grant Heather J, 2004, J Hand Ther, V17, P274, DOI 10.1197/j.jht.2004.02.013; Grasso A, 2009, ARTHROSCOPY, V25, P4, DOI 10.1016/j.arthro.2008.09.018; Hata Y, 2004, J BONE JOINT SURG AM, V86A, P1414, DOI 10.2106/00004623-200407000-00008; Hayes K, 2004, AUST J PHYSIOTHER, V50, P77, DOI 10.1016/S0004-9514(14)60099-4; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524; Ide J, 2005, ARTHROSCOPY, V21, P1090, DOI 10.1016/j.arthro.2005.05.010; Ito J, 2003, INT ORTHOP, V27, P228, DOI 10.1007/s00264-003-0459-4; Kim SH, 2003, ARTHROSCOPY, V19, P746, DOI 10.1016/S0749-8063(03)00395-5; Klinger HM, 2005, ACTA CHIR BELG, V105, P297, DOI 10.1080/00015458.2005.11679720; Klintberg IH, 2009, CLIN REHABIL, V23, P622, DOI 10.1177/0269215509102952; Ko SH, 2008, ARTHROSCOPY, V24, P1005, DOI 10.1016/j.arthro.2008.04.074; Ko SH, 2009, ARTHROSCOPY, V25, P583, DOI 10.1016/j.arthro.2008.11.001; Kose KC, 2008, ADV THER, V25, P249, DOI 10.1007/s12325-008-0031-0; Lastayo PC, 1998, J BONE JOINT SURG AM, V80A, P1002, DOI 10.2106/00004623-199807000-00009; LEROUX JL, 1993, EUR J PHYS MED REHAB, V3, P242; Liem D, 2007, ARTHROSCOPY, V23, P514, DOI 10.1016/j.arthro.2006.12.028; Lunn JV, 2008, J SHOULDER ELB SURG, V17, P546, DOI 10.1016/j.jse.2007.11.016; MARC T, 2009, KINESITHERAPIE REV, V89, P36; Matis Nicholas, 2006, Oper Orthop Traumatol, V18, P1, DOI 10.1007/s00064-006-1159-1; McIntyre LF, 2006, ARTHROSCOPY, V22, P833, DOI 10.1016/j.arthro.2006.04.097; Michael JWP, 2005, Z ORTHOP GRENZGEB, V143, P438, DOI 10.1055/s-2005-836806; Milano G, 2007, ARTHROSCOPY, V23, P81, DOI 10.1016/j.arthro.2006.10.011; Millar NL, 2009, CLIN ORTHOP RELAT R, V467, P966, DOI 10.1007/s11999-009-0706-0; MILROY DR, 2008, J ORTHOP SPORT PHYS, V38, pA17; Moher D, 2001, BMC Med Res Methodol, V1, P2, DOI 10.1186/1471-2288-1-2; Mohtadi NG, 2008, AM J SPORT MED, V36, P1043, DOI 10.1177/0363546508314409; Montgomery T J, 1994, J Shoulder Elbow Surg, V3, P70, DOI 10.1016/S1058-2746(09)80113-4; Moosmayer S, 2010, J BONE JOINT SURG BR, V92B, P83, DOI 10.1302/0301-620X.92B1.22609; Moser M, 2007, ORTHOPEDICS, V30, P479, DOI 10.3928/01477447-20070601-05; Motycka T, 2004, ARCH ORTHOP TRAUM SU, V124, P654, DOI 10.1007/s00402-004-0737-7; MULLETT H, 2006, 20 C EUR SOC SURG SH; OGILVIEHARRIS DJ, 1993, J BONE JOINT SURG BR, V75, P416, DOI 10.1302/0301-620X.75B3.8496210; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Park JY, 2008, AM J SPORT MED, V36, P1310, DOI 10.1177/0363546508315039; PEARSALL AW, 2007, J ORTHOP SURG RES, V4, P2; Raab M G, 1996, Am J Orthop (Belle Mead NJ), V25, P214; Roddey TS, 2002, J ORTHOP SPORT PHYS, V32, P548, DOI 10.2519/jospt.2002.32.11.548; Sauerbrey AM, 2005, ARTHROSCOPY, V21, P1415, DOI 10.1016/j.arthro.2005.09.008; Severud EL, 2003, ARTHROSCOPY, V19, P234, DOI 10.1053/jars.2003.50036; Shibita Y, 2001, J SHOULDER ELB SURG, V10, P209, DOI 10.1067/mse.2001.113501; Suenaga N, 2000, J SHOULDER ELB SURG, V9, P275, DOI 10.1067/mse.2000.106084; Sugaya H, 2005, ARTHROSCOPY, V21, P1307, DOI 10.1016/j.arthro.2005.08.011; Torrens C, 2003, J SHOULDER ELB SURG, V12, P9, DOI 10.1067/mse.2003.128198; Vad VB, 2002, CLIN J SPORT MED, V12, P151, DOI 10.1097/00042752-200205000-00002; Verma NN, 2006, ARTHROSCOPY, V22, P587, DOI 10.1016/j.arthro.2006.01.019; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Walton JR, 2007, J BONE JOINT SURG AM, V89A, P786, DOI 10.2106/JBJS.F.00315; Warner JJP, 2005, ARTHROSCOPY, V21, P328, DOI 10.1016/j.arthro.2004.11.006; Wells G.A., 2009, NEWCASTLE OTTAWA SCA; Wilson F, 2002, ARTHROSCOPY, V18, P136, DOI 10.1053/jars.2002.30443; Wittenberg RH, 2001, ARCH ORTHOP TRAUM SU, V121, P56, DOI 10.1007/s004020000195; Yamada Nari, 2000, Tokai Journal of Experimental and Clinical Medicine, V25, P151; Youm T, 2005, J SHOULDER ELB SURG, V14, P455, DOI 10.1016/j.jse.2005.02.002	81	81	82	0	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 17	2010	153	4					246	255		10.7326/0003-4819-153-4-201008170-00263	http://dx.doi.org/10.7326/0003-4819-153-4-201008170-00263			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639KF	20621893				2022-12-28	WOS:000280973000005
J	Graham, DJ; Ouellet-Hellstrom, R; MaCurdy, TE; Ali, F; Sholley, C; Worrall, C; Kelman, JA				Graham, David J.; Ouellet-Hellstrom, Rita; MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher; Worrall, Christopher; Kelman, Jeffrey A.			Risk of Acute Myocardial Infarction, Stroke, Heart Failure, and Death in Elderly Medicare Patients Treated With Rosiglitazone or Pioglitazone	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSITIVE PREDICTIVE-VALUE; CARDIOVASCULAR OUTCOMES; ADMINISTRATIVE DATA; CODING ACCURACY; UNITED-STATES; DATABASE; DISEASE; EVENTS; COHORT; THIAZOLIDINEDIONES	Context Studies have suggested that the use of rosiglitazone may be associated with an increased risk of serious cardiovascular events compared with other treatments for type 2 diabetes. Objective To determine if the risk of serious cardiovascular harm is increased by rosiglitazone compared with pioglitazone, the other thiazolidinedione marketed in the United States. Design, Setting, and Patients Nationwide, observational, retrospective, inception cohort of 227 571 Medicare beneficiaries aged 65 years or older (mean age, 74.4 years) who initiated treatment with rosiglitazone or pioglitazone through a Medicare Part D prescription drug plan from July 2006-June 2009 and who underwent follow-up for up to 3 years after thiazolidinedione initiation. Main Outcome Measures Individual end points of acute myocardial infarction (AMI), stroke, heart failure, and all-cause mortality (death), and composite end point of AMI, stroke, heart failure, or death, assessed using incidence rates by thiazolidinedione, attributable risk, number needed to harm, Kaplan-Meier plots of time to event, and Cox proportional hazard ratios for time to event, adjusted for potential confounding factors, with pioglitazone as reference. Results A total of 8667 end points were observed during the study period. The adjusted hazard ratio for rosiglitazone compared with pioglitazone was 1.06 (95% confidence interval [CI], 0.96-1.18) for AMI; 1.27 (95% CI, 1.12-1.45) for stroke; 1.25 (95% CI, 1.16-1.34) for heart failure; 1.14 (95% CI, 1.05-1.24) for death; and 1.18 (95% CI, 1.12-1.23) for the composite of AMI, stroke, heart failure, or death. The attributable risk for this composite end point was 1.68 (95% CI, 1.27-2.08) excess events per 100 person-years of treatment with rosiglitazone compared with pioglitazone. The corresponding number needed to harm was 60 (95% CI, 48-79) treated for 1 year. Conclusion Compared with prescription of pioglitazone, prescription of rosiglitazone was associated with an increased risk of stroke, heart failure, and all-cause mortality and an increased risk of the composite of AMI, stroke, heart failure, or all-cause mortality in patients 65 years or older. JAMA. 2010;304(4):411-418 www.jama.com	[Graham, David J.; Ouellet-Hellstrom, Rita] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA; [MaCurdy, Thomas E.] Stanford Univ, Stanford, CA 94305 USA; [MaCurdy, Thomas E.; Ali, Farzana; Sholley, Christopher] Acumen LLC, Burlingame, CA USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicare Serv, Washington, DC USA; [Worrall, Christopher; Kelman, Jeffrey A.] Ctr Medicaid Serv, Washington, DC USA	US Food & Drug Administration (FDA); Stanford University; Centers for Medicare & Medicaid Services; Centers for Medicare & Medicaid Services	Graham, DJ (corresponding author), US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, 10903 New Hampshire Ave,Bldg 22,Room 4314, Silver Spring, MD 20993 USA.	david.graham1@fda.hhs.gov			Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	Office of the Assistant Secretary for Planning and Evaluation (ASPE); Centers for Medicare & Medicaid Services (CMS); US Food and Drug Administration (FDA); Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services	This study was funded by the Office of the Assistant Secretary for Planning and Evaluation (ASPE), the Centers for Medicare & Medicaid Services (CMS), and the US Food and Drug Administration (FDA).; We thank the Office of the Assistant Secretary for Planning and Evaluation in the Department of Health and Human Services for scientific contributions and financial support of this study and the SafeRx Project. We also extend special thanks to Mark Levenson, PhD, and Stephine Keeton, PhD (both with the FDA Office of Biostatistics), for providing statistical advice and to Pallavi Mukherji, MSc, Richard Domurat, BS, Jonathan Gibbs, BA, and Konrad Turski, MSc ( all with Acumen LLC), for assistance with programming and data analysis. These individuals are salaried employees of their respective organizations and received no additional compensation related to their contributions to this study.	Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Barsheshet A, 2010, EUR J HEART FAIL, V12, P833, DOI 10.1093/eurjhf/hfq079; Birman-Deych E, 2005, MED CARE, V43, P480, DOI 10.1097/01.mlr.0000160417.39497.a9; Brownstein JS, 2010, DIABETES CARE, V33, P526, DOI 10.2337/dc09-1506; Centers for Medicare and Medicaid Services, MED PROGR GEN INF OV; Centers for Medicare & Medicaid Services, PRESCR DRUG COV GEN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Chung CP, 2010, PHARMACOEPIDEM DR S, V19, P563, DOI 10.1002/pds.1888; *CTR DIS CONTR PRE, 2007, NAT DIAB FACT SHEET; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dormandy JA, 2005, LANCET, V366, P1279, DOI 10.1016/S0140-6736(05)67528-9; Dormuth CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006080; Gerrits CM, 2007, PHARMACOEPIDEM DR S, V16, P1065, DOI 10.1002/pds.1470; *GLAXOSMITHKLINE, 2008, AV ROS PROD LAB; Goff DC, 2000, ARCH INTERN MED, V160, P197, DOI 10.1001/archinte.160.2.197; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Habib ZA, 2009, PHARMACOEPIDEM DR S, V18, P437, DOI 10.1002/pds.1722; Hennessy S, 2007, MED CARE, V45, P1216, DOI 10.1097/MLR.0b013e318148435a; Hill ME, 2001, SOC SECUR BULL, V64, P45; Jong P, 2003, CIRCULATION, V108, P184, DOI 10.1161/01.CIR.0000080290.39027.48; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Kiyota Y, 2004, AM HEART J, V148, P99, DOI 10.1016/j.ahj.2004.02.013; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Lago RM, 2007, LANCET, V370, P1129, DOI 10.1016/S0140-6736(07)61514-1; Levy AR, 1999, CAN J CARDIOL, V15, P1277; Lincoff AM, 2007, JAMA-J AM MED ASSOC, V298, P1180, DOI 10.1001/jama.298.10.1180; Mamdani M, 2005, BMJ-BRIT MED J, V330, P960, DOI 10.1136/bmj.330.7497.960; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; *OFF ASS SECR PLAN, OV UN US AN 2005 CUR; Pantalone KM, 2009, ACTA DIABETOL, V46, P145, DOI 10.1007/s00592-008-0090-3; Petersen LA, 1999, J GEN INTERN MED, V14, P555, DOI 10.1046/j.1525-1497.1999.10198.x; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; *TAK PHARM AM INC, 2008, ACT PIOGL HYDR PROD; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Walker AM, 2008, PHARMACOEPIDEM DR S, V17, P760, DOI 10.1002/pds.1598; Winkelmayer WC, 2008, ARCH INTERN MED, V168, P2368, DOI 10.1001/archinte.168.21.2368; Zheng ZJ, 2001, CIRCULATION, V104, P2158, DOI 10.1161/hc4301.098254; Ziyadeh N, 2009, CLIN THER, V31, P2665, DOI 10.1016/j.clinthera.2009.11.003	39	386	405	0	25	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 28	2010	304	4					411	418		10.1001/jama.2010.920	http://dx.doi.org/10.1001/jama.2010.920			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	631MA	20584880	Bronze			2022-12-28	WOS:000280350100024
J	Nelson, HD; Haney, EM; Dana, T; Bougatsos, C; Chou, R				Nelson, Heidi D.; Haney, Elizabeth M.; Dana, Tracy; Bougatsos, Christina; Chou, Roger			Screening for Osteoporosis: An Update for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							BONE-MINERAL DENSITY; ESTROGEN PLUS PROGESTIN; EARLY POSTMENOPAUSAL WOMEN; VERTEBRAL FRACTURE RISK; X-RAY ABSORPTIOMETRY; INITIATIVE RANDOMIZED-TRIAL; CYCLICAL ETIDRONATE THERAPY; PLACEBO-CONTROLLED TRIAL; CONJUGATED EQUINE ESTROGENS; HORMONE REPLACEMENT THERAPY	Background: This review updates evidence since the 2002 U. S. Preventive Services Task Force recommendation on osteoporosis screening. Purpose: To determine the effectiveness and harms of osteoporosis screening in reducing fractures for men and postmenopausal women without known previous fractures; the performance of risk-assessment instruments and bone measurement tests in identifying persons with osteoporosis; optimal screening intervals; and the efficacy and harms of medications to reduce primary fractures. Data Sources: Cochrane Central Register of Controlled Trials and Cochrane Database of Systematic Reviews (through the fourth quarter of 2009), MEDLINE (January 2001 to December 2009), reference lists, and Web of Science. Study Selection: Randomized, controlled trials of screening or medications with fracture outcomes published in English; performance studies of validated risk-assessment instruments; and systematic reviews and population-based studies of bone measurement tests or medication harms. Data Extraction: Data on patient populations, study design, analysis, follow-up, and results were abstracted, and study quality was rated by using established criteria. Data Synthesis: Risk-assessment instruments are modest predictors of low bone density (area under the curve, 0.13 to 0.87; 14 instruments) and fractures (area under the curve, 0.48 to 0.89; 11 instruments); simple and complex instruments perform similarly. Dual-energy x-ray absorptiometry predicts fractures similarly for men and women; calcaneal quantitative ultrasonography also predicts fractures, but correlation with dual-energy x-ray absorptiometry is low. For postmenopausal women, bisphosphonates, parathyroid hormone, raloxifene, and estrogen reduce primary vertebral fractures. Trials are lacking for men. Bisphosphonates are not consistently associated with serious adverse events; raloxifene and estrogen increase thromboembolic events; and estrogen causes additional adverse events. Limitation: Trials of screening with fracture outcomes, screening intervals, and medications to reduce primary fractures, particularly those enrolling men, are lacking. Conclusion: Although methods to identify risk for osteoporotic fractures are available and medications to reduce fractures are effective, no trials directly evaluate screening effectiveness, harms, and intervals.	[Nelson, Heidi D.] Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC, Portland, OR 97239 USA; Childrens Hlth Res Ctr, Portland, OR USA	Oregon Health & Science University	Nelson, HD (corresponding author), Oregon Hlth & Sci Univ, Oregon Evidence Based Practice Ctr, Mailcode BICC, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	nelsonh@ohsu.edu		Chou, Roger/0000-0001-9889-8610	Oregon Evidence-based Practice Center [290-02-0024]; National Institute of Arthritis and Musculoskeletal and Skin Diseases [K23 AR051926]; Agency for Healthcare Research and Quality; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR051926] Funding Source: NIH RePORTER	Oregon Evidence-based Practice Center; National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Grant Support: This manuscript is based on research conducted by the Oregon Evidence-based Practice Center under contract to the AHRQ (contract 290-02-0024). Dr. Haney was supported by a career development award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (K23 AR051926).; Primary Funding Source: Agency for Healthcare Research and Quality.	Adler RA, 2003, MAYO CLIN PROC, V78, P723, DOI 10.4065/78.6.723; Alexandersen P, 2005, OSTEOPOROSIS INT, V16, P1071, DOI 10.1007/s00198-004-1810-3; Anderson GL, 2003, JAMA-J AM MED ASSOC, V290, P1739, DOI 10.1001/jama.290.13.1739; Anderson GL, 2004, JAMA-J AM MED ASSOC, V291, P1701, DOI 10.1001/jama.291.14.1701; Ascott-Evans BH, 2003, ARCH INTERN MED, V163, P789, DOI 10.1001/archinte.163.7.789; Barrett-Connor E, 2006, NEW ENGL J MED, V355, P125, DOI 10.1056/NEJMoa062462; Bauer DC, 2007, OSTEOPOROSIS INT, V18, P771, DOI 10.1007/s00198-006-0317-5; Bauer DC, 1997, ARCH INTERN MED, V157, P629, DOI 10.1001/archinte.157.6.629; Ben Sedrine W, 2001, BONE, V29, P374, DOI 10.1016/S8756-3282(01)00583-X; Berg AO, 2002, ANN INTERN MED, V137, P526, DOI 10.7326/0003-4819-137-6-200209170-00014; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Black DM, 2010, NEW ENGL J MED, V362, P1761, DOI 10.1056/NEJMoa1001086; Black DM, 2001, OSTEOPOROSIS INT, V12, P519, DOI 10.1007/s001980170072; Bliuc D, 2009, JAMA-J AM MED ASSOC, V301, P513, DOI 10.1001/jama.2009.50; Bone HG, 1997, J CLIN ENDOCR METAB, V82, P265, DOI 10.1210/jc.82.1.265; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; Brenneman Susan K, 2003, Dis Manag, V6, P159, DOI 10.1089/109350703322425509; Cadarette SM, 2004, OSTEOPOROSIS INT, V15, P361, DOI 10.1007/s00198-003-1552-7; Cadarette SM, 2001, JAMA-J AM MED ASSOC, V286, P57, DOI 10.1001/jama.286.1.57; Cass AR, 2006, J GEN INTERN MED, V21, P630, DOI 10.1111/j.1525-1497.2006.00459.x; Cauley JA, 2003, JAMA-J AM MED ASSOC, V290, P1729, DOI 10.1001/jama.290.13.1729; Cauley JA, 2000, OSTEOPOROSIS INT, V11, P556, DOI 10.1007/s001980070075; Center JR, 1999, LANCET, V353, P878, DOI 10.1016/S0140-6736(98)09075-8; Chesnut CH, 2004, J BONE MINER RES, V19, P1241, DOI 10.1359/JBMR.040325; CHESTNUT CH, 1995, AM J MED, V99, P144, DOI 10.1016/S0002-9343(99)80134-X; Chlebowski RT, 2004, NEW ENGL J MED, V350, P991, DOI 10.1056/NEJMoa032071; Chlebowski RT, 2003, JAMA-J AM MED ASSOC, V289, P3243, DOI 10.1001/jama.289.24.3243; Colon-Emeric CS, 2002, OSTEOPOROSIS INT, V13, P955, DOI 10.1007/s001980200133; Cook RB, 2005, OSTEOPOROSIS INT, V16, P1565, DOI 10.1007/s00198-005-1864-x; Cummings SR, 1998, JAMA-J AM MED ASSOC, V280, P2077, DOI 10.1001/jama.280.24.2077; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; Cummings SR, 2006, J BONE MINER RES, V21, P1550, DOI 10.1359/JBMR.060708; Curb JD, 2006, ARCH INTERN MED, V166, P772, DOI 10.1001/archinte.166.7.772; Cushman M, 2004, JAMA-J AM MED ASSOC, V292, P1573, DOI 10.1001/jama.292.13.1573; D'Amelio P, 2005, CALCIFIED TISSUE INT, V77, P72, DOI 10.1007/s00223-004-0253-3; deGroen PC, 1996, NEW ENGL J MED, V335, P1016, DOI 10.1056/NEJM199610033351403; Delmas PD, 2002, J CLIN ENDOCR METAB, V87, P3609, DOI 10.1210/jc.87.8.3609; Department of Health and Human Services Public Health Office Food and Drug Administration, 2004, ODS POSTM SAF REV; Donaldson MG, 2009, J BONE MINER RES, V24, P1793, DOI 10.1359/jbmr.090511; Dunfield L, 2007, 94 CAN AG DRUGS TECH; Dursun N, 2001, INT J CLIN PRACT, V55, P505; Ebeling PR, 2008, NEW ENGL J MED, V358, P1474, DOI 10.1056/NEJMcp0707217; Ensrud KE, 2008, J BONE MINER RES, V23, P112, DOI 10.1359/JBMR.070904; Ensrud KE, 2009, ARCH INTERN MED, V169, P2087, DOI 10.1001/archinternmed.2009.404; Ettinger B, 1999, JAMA-J AM MED ASSOC, V282, P637, DOI 10.1001/jama.282.7.637; Fogelman I, 2000, J CLIN ENDOCR METAB, V85, P1895, DOI 10.1210/jc.85.5.1895; Frediani B, 2006, CALCIFIED TISSUE INT, V79, P223, DOI 10.1007/s00223-005-0098-4; George A, 2003, J BONE MINER RES, V18, P2238, DOI 10.1359/jbmr.2003.18.12.2238; Girman CJ, 2002, J AM GERIATR SOC, V50, P1341, DOI 10.1046/j.1532-5415.2002.50354.x; Gluer MG, 2005, J CLIN DENSITOM, V8, P386; Gnudi S, 2005, J CLIN DENSITOM, V8, P199, DOI 10.1385/JCD:8:2:199; Goh SK, 2007, J BONE JOINT SURG BR, V89B, P349, DOI 10.1302/0301-620X.89B3.18146; Gonnelli S, 2005, OSTEOPOROSIS INT, V16, P963, DOI 10.1007/s00198-004-1771-6; Gourlay ML, 2005, OSTEOPOROSIS INT, V16, P921, DOI 10.1007/s00198-004-1775-2; Greenspan SL, 1998, J BONE MINER RES, V13, P1431, DOI 10.1359/jbmr.1998.13.9.1431; Greenspan SL, 2002, ANN INTERN MED, V136, P742, DOI 10.7326/0003-4819-136-10-200205210-00009; Greenspan SL, 2007, ANN INTERN MED, V146, P326, DOI 10.7326/0003-4819-146-5-200703060-00005; Hans D, 1996, LANCET, V348, P511, DOI 10.1016/S0140-6736(95)11456-4; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Harrison EJ, 2006, CALCIFIED TISSUE INT, V79, P199, DOI 10.1007/s00223-005-0302-6; Heaney RP, 1998, ANN INTERN MED, V128, P313, DOI 10.7326/0003-4819-128-4-199802150-00014; Heckbert SR, 2008, ARCH INTERN MED, V168, P826, DOI 10.1001/archinte.168.8.826; Herd RJM, 1997, AM J MED, V103, P92, DOI 10.1016/S0002-9343(97)00019-3; Hillier TA, 2007, ARCH INTERN MED, V167, P155, DOI 10.1001/archinte.167.2.155; Hippisley-Cox J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4229; Hooper MJ, 2005, CLIMACTERIC, V8, P251, DOI 10.1080/13697130500118126; Hosking D, 1998, NEW ENGL J MED, V338, P485, DOI 10.1056/NEJM199802193380801; Hsia J, 2006, AM HEART J, V152, P170, DOI 10.1016/j.ahj.2005.09.005; Ishida Y, 2004, AM J MED, V117, P549, DOI 10.1016/j.amjmed.2004.05.019; Kado DM, 1999, ARCH INTERN MED, V159, P1215, DOI 10.1001/archinte.159.11.1215; Kanis JA, 2007, OSTEOPOROSIS INT, V18, P1033, DOI 10.1007/s00198-007-0343-y; KANIS JA, 1994, OSTEOPOROSIS INT, V4, P368, DOI 10.1007/BF01622200; Kanis JA, 2008, ASSESSMENT OSTEOPORO; Karam R, 2007, NEW ENGL J MED, V357, P712; Kaufman JM, 2005, OSTEOPOROSIS INT, V16, P510, DOI 10.1007/s00198-004-1713-3; Khaw KT, 2004, LANCET, V363, P197, DOI 10.1016/S0140-6736(03)15325-1; Kiebzak GM, 2002, ARCH INTERN MED, V162, P2217, DOI 10.1001/archinte.162.19.2217; Leibson CL, 2002, J AM GERIATR SOC, V50, P1644, DOI 10.1046/j.1532-5415.2002.50455.x; Lenart BA, 2008, NEW ENGL J MED, V358, P1304, DOI 10.1056/NEJMc0707493; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Lynn HS, 2008, OSTEOPOROSIS INT, V19, P1087, DOI 10.1007/s00198-007-0553-3; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Martinez-Aguila D, 2007, J RHEUMATOL, V34, P1307; Martino S, 2005, CURR MED RES OPIN, V21, P1441, DOI 10.1185/030079905X61839; Masoni A, 2005, MATURITAS, V51, P314, DOI 10.1016/j.maturitas.2004.08.015; Mauck KF, 2005, ARCH INTERN MED, V165, P530, DOI 10.1001/archinte.165.5.530; McClung MR, 2001, NEW ENGL J MED, V344, P333, DOI 10.1056/NEJM200102013440503; McClung MR, 2004, J BONE MINER RES, V19, P11, DOI 10.1359/JBMR.0301202; MELTON LJ, 1992, J BONE MINER RES, V7, P1005, DOI 10.1002/jbmr.5650070902; Meunier PJ, 1997, J CLIN ENDOCR METAB, V82, P2784, DOI 10.1210/jc.82.9.2784; Minnock E, 2008, J CLIN DENSITOM, V11, P485, DOI 10.1016/j.jocd.2008.04.002; Montessori MLM, 1997, OSTEOPOROSIS INT, V7, P52, DOI 10.1007/BF01623461; Morris CA, 2004, J GEN INTERN MED, V19, P783, DOI 10.1111/j.1525-1497.2004.30240.x; Mortensen L, 1998, J CLIN ENDOCR METAB, V83, P396, DOI 10.1210/jc.83.2.396; Mulleman D, 2002, OSTEOPOROSIS INT, V13, P388, DOI 10.1007/s001980200044; NELSON DA, 1995, J BONE MINER RES, V10, P782; Nelson HD, 2002, ANN INTERN MED, V137, P529, DOI 10.7326/0003-4819-137-6-200209170-00015; NELSON HD, 2010, SCREENING O IN PRESS; Nelson HD, 2009, ANN INTERN MED, V151, P703, DOI [10.7326/0000605-200911170-00147, 10.7326/0003-4819-151-10-200911170-00147]; Nguyen TV, 2004, OSTEOPOROSIS INT, V15, P49, DOI 10.1007/s00198-003-1511-3; Odvina CV, 2005, J CLIN ENDOCR METAB, V90, P1294, DOI 10.1210/jc.2004-0952; Office of the Surgeon General (US), 2004, BON HLTH OST REP SUR; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Pluijm SMF, 2009, J BONE MINER RES, V24, P768, DOI [10.1359/JBMR.081244, 10.1359/jbmr.081244]; Pols HAP, 1999, OSTEOPOROSIS INT, V9, P461, DOI 10.1007/PL00004171; Pouilles JM, 1997, OSTEOPOROSIS INT, V7, P213, DOI 10.1007/BF01622291; Recker R, 2004, BONE, V34, P890, DOI 10.1016/j.bone.2004.01.008; Reid IR, 2002, NEW ENGL J MED, V346, P653, DOI 10.1056/NEJMoa011807; Richy F, 2004, MAYO CLIN PROC, V79, P1402, DOI 10.4065/79.11.1402; Robbins J, 2007, JAMA-J AM MED ASSOC, V298, P2389, DOI 10.1001/jama.298.20.2389; Rossouw JE, 2007, JAMA-J AM MED ASSOC, V297, P1465, DOI 10.1001/jama.297.13.1465; Rud B, 2005, OSTEOPOROSIS INT, V16, P764, DOI 10.1007/s00198-004-1748-5; Rucker G, 2009, STAT MED, V28, P721, DOI 10.1002/sim.3511; Salaffi F, 2005, CLIN RHEUMATOL, V24, P203, DOI 10.1007/s10067-004-1014-4; Sandhu SK, 2010, OSTEOPOROSIS INT, V21, P863, DOI 10.1007/s00198-009-1026-7; Schuit SCE, 2004, BONE, V34, P195, DOI 10.1016/j.bone.2003.10.001; Sedrine WB, 2002, GYNECOL ENDOCRINOL, V16, P245; Shepherd AJ, 2007, ANN FAM MED, V5, P540, DOI 10.1370/afm.753; Sinnott B, 2006, OSTEOPOROSIS INT, V17, P684, DOI 10.1007/s00198-005-0034-5; Siris ES, 2005, J BONE MINER RES, V20, P1514, DOI 10.1359/JBMR.050509; Sorensen HT, 2008, BMJ-BRIT MED J, V336, P813, DOI 10.1136/bmj.39507.551644.BE; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647; Stewart A, 2006, J BONE MINER RES, V21, P413, DOI 10.1359/JBMR.051205; Sweeting MJ, 2004, STAT MED, V23, P1351, DOI 10.1002/sim.1761; U.S. Preventive Services Task Force, 2002, SCREEN OST POSTM WOM; *US FDA, UPD SAF REV FOLL UP; Valimaki MJ, 2007, CLIN THER, V29, P1937, DOI 10.1016/j.clinthera.2007.09.017; Van Der Klift M, 2002, J BONE MINER RES, V17, P1051, DOI 10.1359/jbmr.2002.17.6.1051; van Staa T, 1997, AM J MED, V103, P462, DOI 10.1016/S0002-9343(97)00242-8; Varenna M, 2005, OSTEOPOROSIS INT, V16, P1749, DOI 10.1007/s00198-005-1914-4; Wassertheil-Smoller S, 2003, JAMA-J AM MED ASSOC, V289, P2673, DOI 10.1001/jama.289.20.2673; Wei GS, 2004, MIL MED, V169, P1000, DOI 10.7205/MILMED.169.12.1000; Wells G, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004523.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003376.pub3; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Wilkins CH, 2004, J NATL MED ASSOC, V96, P461; Wysowski DK, 2009, NEW ENGL J MED, V360, P89, DOI 10.1056/NEJMc0808738	140	126	131	0	16	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 20	2010	153	2					99	W43		10.7326/0003-4819-153-2-201007200-00262	http://dx.doi.org/10.7326/0003-4819-153-2-201007200-00262			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628DU	20621892				2022-12-28	WOS:000280095400005
J	Ide, S				Ide, Satoshi			Striations, duration, migration and tidal response in deep tremor	NATURE			English	Article							SLOW SLIP EVENTS; NON-VOLCANIC TREMOR; SOUTHWEST JAPAN; SUBDUCTION ZONE; EPISODIC TREMOR; EARTHQUAKES	Deep tremor in subduction zones is thought to be caused by small repeating shear slip events on the plate interface with significant slow components(1-4). It occurs at a depth of about 30 kilometres and provides valuable information on deep plate motion and shallow stress accumulation on the fault plane of megathrust earthquakes. Tremor has been suggested to repeat at a regular interval(1,2), migrate at various velocities(4-7) and be modulated by tidal stress(6,8,9). Here I show that some time-invariant interface property controls tremor behaviour, using precise location of tremor sources with event duration in western Shikoku in the Nankai subduction zone, Japan. In areas where tremor duration is short, tremor is more strongly affected by tidal stress and migration is inhibited. Where tremor lasts longer, diffusive migration occurs with a constant diffusivity of 10(4) m(2) s(-1). The control property may be the ratio of brittle to ductile areas, perhaps determined by the influence of mantle wedge serpentinization on the plate interface. The spatial variation of the controlling property seems to be characterized by striations in tremor source distribution, which follows either the current or previous plate subduction directions. This suggests that the striations and corresponding interface properties are formed through the subduction of inhomogeneous structure, such as seamounts, for periods as long as ten million years.	Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Ide, S (corresponding author), Univ Tokyo, Dept Earth & Planetary Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	ide@eps.s.u-tokyo.ac.jp	IDE, SATOSHI/G-4887-2014	IDE, SATOSHI/0000-0003-0063-548X	JSPS [20340115]; MEXT [21107007]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	I thank G. C. Beroza for many useful comments. Comments from K. Wang and discussions with S. Yoshioka, T. Hori, B. Shibazaki, R. Ando and A. Namiki were helpful. This work is supported by JSPS KAKENHI (20340115) and MEXT KAKENHI (21107007). The figures were prepared using the Generic Mapping Tool (P. Wessel and W. H. F. Smith, 1998).	Brown JR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040027; Ghosh A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2009GL042301; Hirose H, 2005, EARTH PLANETS SPACE, V57, P961, DOI 10.1186/BF03351875; Hyndman RD, 2003, EARTH PLANET SC LETT, V212, P417, DOI 10.1016/S0012-821X(03)00263-2; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Ide S, 2007, NATURE, V447, P76, DOI 10.1038/nature05780; Ide S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034821; Ito Y, 2007, SCIENCE, V315, P503, DOI 10.1126/science.1134454; Kato A, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL043723; Katsumata A, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2002GL015981; Kodaira S, 2000, SCIENCE, V289, P104, DOI 10.1126/science.289.5476.104; Maeda T, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006043; Matsubara M, 2009, TECTONOPHYSICS, V472, P6, DOI 10.1016/j.tecto.2008.06.013; Miyazaki S, 2001, J GEOPHYS RES-SOL EA, V106, P4305, DOI 10.1029/2000JB900312; Nakata R, 2008, NAT GEOSCI, V1, P676, DOI 10.1038/ngeo288; Obara K, 2006, TECTONOPHYSICS, V417, P33, DOI 10.1016/j.tecto.2005.04.013; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; OBARA K, 2009, EOS, V90; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubin AM, 1999, NATURE, V400, P635, DOI 10.1038/23196; Rubinstein JL, 2008, SCIENCE, V319, P186, DOI 10.1126/science.1150558; Rubinstein JL, 2010, INT YEAR PLANET EART, P287, DOI 10.1007/978-90-481-2737-5_8; Schwartz SY, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000208; SENO T, 1984, TECTONOPHYSICS, V102, P53, DOI 10.1016/0040-1951(84)90008-8; Shelly DR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001640; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shiomi K, 2006, TECTONOPHYSICS, V420, P205, DOI 10.1016/j.tecto.2006.01.017; Takahashi M., 2006, MOVE, P116, DOI DOI 10.5026/JGE0GRAPHY.115.116; Wada I, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005190	30	131	131	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					356	U105		10.1038/nature09251	http://dx.doi.org/10.1038/nature09251			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631797				2022-12-28	WOS:000279867100046
J	Kher, U				Kher, Unmesh			A call for collaboration	NATURE			English	Editorial Material																			0	3	3	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S21	S22		10.1038/nature09245	http://dx.doi.org/10.1038/nature09245			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631702	Bronze			2022-12-28	WOS:000279867100034
J	Zalmout, IS; Sanders, WJ; MacLatchy, LM; Gunnell, GF; Al-Mufarreh, YA; Ali, MA; Nasser, AAH; Al-Masari, AM; Al-Sobhi, SA; Nadhra, AO; Matari, AH; Wilson, JA; Gingerich, PD				Zalmout, Iyad S.; Sanders, William J.; MacLatchy, Laura M.; Gunnell, Gregg F.; Al-Mufarreh, Yahya A.; Ali, Mohammad A.; Nasser, Abdul-Azziz H.; Al-Masari, Abdu M.; Al-Sobhi, Salih A.; Nadhra, Ayman O.; Matari, Adel H.; Wilson, Jeffrey A.; Gingerich, Philip D.			New Oligocene primate from Saudi Arabia and the divergence of apes and Old World monkeys	NATURE			English	Article							CATARRHINE PRIMATES; EARLY MIOCENE; AEGYPTOPITHECUS; MORPHOLOGY; EVOLUTION	It is widely understood that Hominoidea (apes and humans) and Cercopithecoidea (Old World monkeys) have a common ancestry as Catarrhini deeply rooted in Afro-Arabia(1-4). The oldest stem Catarrhini in the fossil record are Propliopithecoidea, known from the late Eocene to early Oligocene epochs (roughly 35-30 Myr ago) of Egypt, Oman and possibly Angola(5-10). Genome-based estimates for divergence of hominoids and cercopithecoids range into the early Oligocene(11); however, the mid-to-late Oligocene interval from 30 to 23 Myr ago has yielded little fossil evidence documenting the morphology of the last common ancestor of hominoids and cercopithecoids, the timing of their divergence, or the relationship of early stem and crown catarrhines. Here we describe the partial cranium of a new medium-sized (about 15-20 kg) fossil catarrhine, Saadanius hijazensis, dated to 29-28 Myr ago. Comparative anatomy and cladistic analysis shows that Saadanius is an advanced stem catarrhine close to the base of the hominoid-cercopithecoid clade. Saadanius is important for assessing competing hypotheses about the ancestral morphotype for crown catarrhines(1,12-14), early catarrhine phylogeny(12,15) and the age of hominoid-cercopithecoid divergence(11). Saadanius has a tubular ectotympanic but lacks synapomorphies of either group of crown Catarrhini, and we infer that the hominoid-cercopithecoid split happened later, between 29-28 and 24 Myr ago.	[Zalmout, Iyad S.; Sanders, William J.; MacLatchy, Laura M.; Gunnell, Gregg F.; Wilson, Jeffrey A.; Gingerich, Philip D.] Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA; [Zalmout, Iyad S.; Wilson, Jeffrey A.; Gingerich, Philip D.] Univ Michigan, Dept Geol Sci, Ann Arbor, MI 48109 USA; [Sanders, William J.; MacLatchy, Laura M.; Gingerich, Philip D.] Univ Michigan, Dept Anthropol, Ann Arbor, MI 48109 USA; [Al-Mufarreh, Yahya A.; Ali, Mohammad A.; Nasser, Abdul-Azziz H.; Al-Masari, Abdu M.; Al-Sobhi, Salih A.; Nadhra, Ayman O.; Matari, Adel H.] Saudi Geol Survey, Paleontol Unit, Jeddah 21514, Saudi Arabia	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Saudi Geological Survey	Zalmout, IS (corresponding author), Univ Michigan, Museum Paleontol, 1109 Geddes Ave, Ann Arbor, MI 48109 USA.	zalmouti@umich.edu; wsanders@umich.edu; gingeric@umich.edu	Gingerich, Philip D/A-6903-2008; Wilson, Jeffrey/C-2737-2008	Gingerich, Philip D/0000-0002-1550-2674; 	US National Science Foundation [EAR-0517773]; Division Of Earth Sciences [0920972] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank Saudi Geological Survey (Jeddah) officials Z. A. Nawab, A. M. Al Attas and A. F. Al Khattabi for the invitation to undertake fieldwork in western Saudi Arabia; E. Mbua (National Museums of Kenya) for permission to study of catarrhine fossils in her care; A. Walker for access to micro-CT facilities at Pennsylvania State University; T. Ryan for scanning; A. Rountrey, D. Erickson and B. Miljour for assistance with interpretation of micro-CT scans, photography, and figures; T. Harrison for phylogenetic discussion and advice; E. Seiffert for CT images and photographs of propliopithecoid fossils; B. Benefit for information on the ectotympanic of Victoriapithecus; D. T. Rasmussen and M. Gutierrez for information about fossil mammals from Lothidok, Kenya; M. Halawani, A. Memesh, S. Dini, C. Spencer and G. W. Hughes for information about the geology and lithostratigraphy of the research area; and E. Seiffert for improving the manuscript. The research was supported by a US National Science Foundation grant (EAR-0517773) to P.D.G.	ABOUOUF MA, 1998, SEDIMENTATION TECTON, P135; ALSHANTI AMS, 1966, SAUDI ARABIAN DIR GE, V2, P1; Begun DR, 2001, HOM EVOLUT CLIMAT CH, V2, P231; Begun DR, 2002, CAM S BIO EVOL ANTHR, V33, P221; Benefit BR, 2002, CAM S BIO EVOL ANTHR, V33, P241; BENEFIT BR, 1993, AM J PHYS ANTHROPOL, V92, P329, DOI 10.1002/ajpa.1330920307; Delson E., 1975, P405; FERAUD G, 1991, GEOPHYS RES LETT, V18, P195, DOI 10.1029/91GL00207; Goloboff P, 2008, CLADISTICS, V24, P91; HARRISON T, 1987, J HUM EVOL, V16, P41, DOI 10.1016/0047-2484(87)90060-1; Harrison T, 2002, CAM S BIO EVOL ANTHR, V33, P311; HARRISON T, 1988, FOLIA PRIMATOL, V50, P59, DOI 10.1159/000156334; Kelley Jay, 1997, P173; LEAKEY MG, 1995, J HUM EVOL, V28, P519, DOI 10.1006/jhev.1995.1040; LEAKEY MG, 1991, FOLIA PRIMATOL, V56, P65, DOI 10.1159/000156531; LEAKEY RE, 1988, AM J PHYS ANTHROPOL, V76, P289, DOI 10.1002/ajpa.1330760303; Miller ER, 2009, J HUM EVOL, V57, P195, DOI 10.1016/j.jhevol.2009.06.006; MOLTZER JG, 1981, SAUDI ARABIAN DIR GE, V4, P47; PICKFORD M, 1986, CR ACAD SCI II, V302, P1205; Rae TC, 2004, ANN ANAT, V186, P417, DOI 10.1016/S0940-9602(04)80074-8; Rae TC, 1999, FOLIA PRIMATOL, V70, P125, DOI 10.1159/000021685; Rae Todd C., 1997, P59; Rasmussen DT, 2002, CAM S BIO EVOL ANTHR, V33, P203; Seiffert ER, 2007, FOLIA PRIMATOL, V78, P314, DOI 10.1159/000105147; SIMONS EL, 1987, J HUM EVOL, V16, P273, DOI 10.1016/0047-2484(87)90003-0; Simons EL, 2007, P NATL ACAD SCI USA, V104, P8731, DOI 10.1073/pnas.0703129104; Srivastava Satish K., 1991, Palynology, V15, P47; Steiper ME, 2004, P NATL ACAD SCI USA, V101, P17021, DOI 10.1073/pnas.0407270101; TEAFORD MF, 1988, J HUM EVOL, V17, P461, DOI 10.1016/0047-2484(88)90036-X; Thomas H, 1999, FOSSIL VERTEBRATES OF ARABIA, P430	30	63	67	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					360	U111		10.1038/nature09094	http://dx.doi.org/10.1038/nature09094			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631798				2022-12-28	WOS:000279867100047
J	Adrian, RJ				Adrian, Ronald J.			Closing In on Models of Wall Turbulence	SCIENCE			English	Editorial Material									Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA	Arizona State University; Arizona State University-Tempe	Adrian, RJ (corresponding author), Arizona State Univ, Sch Engn Matter Transport & Energy, Tempe, AZ 85287 USA.	rjadrian@asu.edu						Ferrante A, 2004, J FLUID MECH, V503, P345, DOI 10.1017/S0022112004007943; Marusic I, 2003, PHYS FLUIDS, V15, P2461, DOI 10.1063/1.1589014; Marusic I, 2010, SCIENCE, V329, P193, DOI 10.1126/science.1188765; Prandtl L., 1905, VERHANDLUNGEN 3 INTE, P484; Van Dyke M., 1975, PERTURBATION METHODS	5	9	10	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					155	156		10.1126/science.1192013	http://dx.doi.org/10.1126/science.1192013			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616259				2022-12-28	WOS:000279635200026
J	Kimura, H; Takeda, T; Obara, K; Kasahara, K				Kimura, Hisanori; Takeda, Tetsuya; Obara, Kazushige; Kasahara, Keiji			Seismic Evidence for Active Underplating Below the Megathrust Earthquake Zone in Japan	SCIENCE			English	Article							PHILIPPINE SEA PLATE; CRUSTAL STRUCTURE; KANTO DISTRICT; SUBDUCTION; FAULT; DECOLLEMENT; EVOLUTION; PENINSULA; TRANSECT; BENEATH	Determining the structure of subduction zones is important for understanding mechanisms for the generation of interplate phenomena such as megathrust earthquakes. The peeling off of the uppermost part of a subducting slab and accretion to the bottom of an overlying plate (underplating) at deep regions has been inferred from exhumed metamorphic rocks and deep seismic imaging, but direct seismic evidence of this process is lacking. By comparing seismic reflection profiles with microearthquake distributions in central Japan, we show that repeating microearthquakes occur along the bottom interface of the layer peeling off from the subducting Philippine Sea plate. This region coincides with the location of slow-slip events that may serve as signals for monitoring active underplating.	[Kimura, Hisanori; Takeda, Tetsuya; Obara, Kazushige] Natl Res Inst Earth Sci & Disaster Prevent, Tsukuba, Ibaraki 3050006, Japan; [Obara, Kazushige; Kasahara, Keiji] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	National Research Institute for Earth Science & Disaster Resilience; University of Tokyo	Kimura, H (corresponding author), Natl Res Inst Earth Sci & Disaster Prevent, 3-1 Tennodai, Tsukuba, Ibaraki 3050006, Japan.	kimura@bosai.go.jp		Kimura, Hisanori/0000-0002-3769-0530	NIED; Ministry of Education, Culture, Sports, Science, and Technology of Japan	NIED; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank the Japan National Oil Company (JNOC) for providing the industry seismic reflection data. The manuscript benefited from useful comments and discussions by P. Davis and N. Hirata. We also thank the anonymous reviewers for their valuable comments. This work is supported by the project entitled "Research Project for Crustal Activity Based on Seismic Data" at NIED and Special Project for Earthquake Disaster Mitigation in Tokyo Metropolitan Area from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aoya M, 2003, GEOLOGY, V31, P1045, DOI 10.1130/G19927.1; ASANO S, 1985, J PHYS EARTH, V33, P173, DOI 10.4294/jpe1952.33.173; Bangs NL, 2004, GEOLOGY, V32, P273, DOI 10.1130/G20211.2; Calvert AJ, 2004, NATURE, V428, P163, DOI 10.1038/nature02372; Fuis GS, 2008, GEOLOGY, V36, P267, DOI 10.1130/G24257A.1; Hacker B., 1996, SUBDUCTION TOP BOTTO, V96, P337, DOI DOI 10.1029/GM096P0337; HIROSE H, 2008, EOS T AGU, V89; Housen BA, 1996, GEOLOGY, V24, P127, DOI 10.1130/0091-7613(1996)024<0127:SDATDO>2.3.CO;2; ISOZAKI Y, 1990, TECTONOPHYSICS, V181, P179, DOI 10.1016/0040-1951(90)90016-2; Ito T, 2009, TECTONOPHYSICS, V472, P124, DOI 10.1016/j.tecto.2008.05.013; *JNOC, 2000, SHALL OC OFF BOS PEN; KANAMORI H, 1971, B EARTHQ RES I TOKYO, V49, P13; KIMURA G, 1995, GEOLOGY, V23, P217, DOI 10.1130/0091-7613(1995)023<0217:POCISZ>2.3.CO;2; Kimura H, 2006, TECTONOPHYSICS, V417, P101, DOI 10.1016/j.tecto.2005.06.013; Kimura H, 2009, TECTONOPHYSICS, V472, P18, DOI 10.1016/j.tecto.2008.05.012; MOORE JC, 1991, GEOLOGY, V19, P420, DOI 10.1130/0091-7613(1991)019<0420:EDSRTO>2.3.CO;2; MOORE JC, 1988, GEOL SOC AM BULL, V100, P1578, DOI 10.1130/0016-7606(1988)100<1578:TAHOTN>2.3.CO;2; Nadeau RM, 1999, SCIENCE, V285, P718, DOI 10.1126/science.285.5428.718; Ozawa S, 2007, EARTH PLANETS SPACE, V59, P1241, DOI 10.1186/BF03352072; Sato H, 2005, SCIENCE, V309, P462, DOI 10.1126/science.1110489; Seno T, 1996, J GEOPHYS RES-SOL EA, V101, P11305, DOI 10.1029/96JB00532; Suyehiro K, 1996, SCIENCE, V272, P390, DOI 10.1126/science.272.5260.390; Waldhauser F, 2000, B SEISMOL SOC AM, V90, P1353, DOI 10.1785/0120000006; Zelt CA, 1998, J GEOPHYS RES-SOL EA, V103, P7187, DOI 10.1029/97JB03536	24	31	31	1	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					210	212		10.1126/science.1187115	http://dx.doi.org/10.1126/science.1187115			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616277				2022-12-28	WOS:000279635200047
J	Pohl, R; Antognini, A; Nez, F; Amaro, FD; Biraben, F; Cardoso, JMR; Covita, DS; Dax, A; Dhawan, S; Fernandes, LMP; Giesen, A; Graf, T; Hansch, TW; Indelicato, P; Julien, L; Kao, CY; Knowles, P; Le Bigot, EO; Liu, YW; Lopes, JAM; Ludhova, L; Monteiro, CMB; Mulhauser, F; Nebel, T; Rabinowitz, P; dos Santos, JMF; Schaller, LA; Schuhmann, K; Schwob, C; Taqqu, D; Veloso, JFCA; Kottmann, F				Pohl, Randolf; Antognini, Aldo; Nez, Francois; Amaro, Fernando D.; Biraben, Francois; Cardoso, Joao M. R.; Covita, Daniel S.; Dax, Andreas; Dhawan, Satish; Fernandes, Luis M. P.; Giesen, Adolf; Graf, Thomas; Haensch, Theodor W.; Indelicato, Paul; Julien, Lucile; Kao, Cheng-Yang; Knowles, Paul; Le Bigot, Eric-Olivier; Liu, Yi-Wei; Lopes, Jose A. M.; Ludhova, Livia; Monteiro, Cristina M. B.; Mulhauser, Francoise; Nebel, Tobias; Rabinowitz, Paul; dos Santos, Joaquim M. F.; Schaller, Lukas A.; Schuhmann, Karsten; Schwob, Catherine; Taqqu, David; Veloso, Joao F. C. A.; Kottmann, Franz			The size of the proton	NATURE			English	Article							LAMB-SHIFT EXPERIMENT; MUONIC HYDROGEN; RYDBERG CONSTANT; ATOMS; FREQUENCY; DEUTERIUM; RADIUS; LASER; MU	The proton is the primary building block of the visible Universe, but many of its properties-such as its charge radius and its anomalous magneticmoment-are not well understood. The root-meansquare charge radius, r(p), has been determined with an accuracy of 2 per cent (at best) by electron-proton scattering experiments(1,2). The present most accurate value of r(p) (with an uncertainty of 1 per cent) is given by the CODATA compilation of physical constants(3). This value is based mainly on precision spectroscopy of atomic hydrogen(4-7) and calculations of bound-state quantum electrodynamics (QED; refs 8, 9). The accuracy of r(p) as deduced from electron-proton scattering limits the testing of bound-state QED in atomic hydrogen as well as the determination of the Rydberg constant (currently the most accurately measured fundamental physical constant 3). An attractive means to improve the accuracy in the measurement of r(p) is provided by muonic hydrogen (a proton orbited by a negative muon); its much smaller Bohr radius compared to ordinary atomic hydrogen causes enhancement of effects related to the finite size of the proton. In particular, the Lamb shift 10 (the energy difference between the 2S(1/2) and 2P(1/2) states) is affected by as much as 2 per cent. Here we use pulsed laser spectroscopy to measure a muonic Lamb shift of 49,881.88(76) GHz. On the basis of present calculations(11-15) of fine and hyperfine splittings and QED terms, we find r(p) = 0.84184(67) fm, which differs by 5.0 standard deviations from the CODATA value(3) of 0.8768(69) fm. Our result implies that either the Rydberg constant has to be shifted by 2110 kHz/c (4.9 standard deviations), or the calculations of the QED effects in atomic hydrogen or muonic hydrogen atoms are insufficient.	[Pohl, Randolf; Antognini, Aldo; Haensch, Theodor W.; Nebel, Tobias] Max Planck Inst Quantum Opt, D-85748 Garching, Germany; [Nez, Francois; Biraben, Francois; Indelicato, Paul; Julien, Lucile; Le Bigot, Eric-Olivier; Schwob, Catherine] Ecole Normale Super, CNRS, Lab Kastler Brossel, F-75252 Paris 05, France; [Nez, Francois; Biraben, Francois; Indelicato, Paul; Julien, Lucile; Le Bigot, Eric-Olivier; Schwob, Catherine] Univ Paris 06, F-75252 Paris 05, France; [Amaro, Fernando D.; Cardoso, Joao M. R.; Covita, Daniel S.; Fernandes, Luis M. P.; Lopes, Jose A. M.; Monteiro, Cristina M. B.; dos Santos, Joaquim M. F.] Univ Coimbra, Dept Fis, P-3004516 Coimbra, Portugal; [Covita, Daniel S.; Veloso, Joao F. C. A.] Univ Aveiro, Dept Fis, I3N, P-3810193 Aveiro, Portugal; [Dax, Andreas; Dhawan, Satish] Yale Univ, Dept Phys, New Haven, CT 06520 USA; [Giesen, Adolf; Graf, Thomas] Univ Stuttgart, Inst Strahlwerkzeuge, D-70569 Stuttgart, Germany; [Kao, Cheng-Yang; Liu, Yi-Wei] Natl Tsing Hua Univ, Dept Phys, Hsinchu 300, Taiwan; [Indelicato, Paul; Ludhova, Livia; Mulhauser, Francoise; Schaller, Lukas A.] Univ Fribourg, Dept Phys, CH-1700 Fribourg, Switzerland; [Rabinowitz, Paul] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Schuhmann, Karsten] Dausinger & Giesen GmbH, D-70178 Stuttgart, Germany; [Taqqu, David] Paul Scherrer Inst, CH-5232 Villigen, Switzerland; [Kottmann, Franz] ETH, Inst Teilchenphys, CH-8093 Zurich, Switzerland	Max Planck Society; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidade de Coimbra; Universidade de Aveiro; Yale University; University of Stuttgart; National Tsing Hua University; University of Fribourg; Princeton University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; ETH Zurich	Pohl, R (corresponding author), Max Planck Inst Quantum Opt, D-85748 Garching, Germany.	randolf.pohl@mpq.mpg.de	INDELICATO, PAUL/GVT-5812-2022; Biraben, François/AFR-7960-2022; Monteiro, Cristina Maria/R-2097-2017; Fernandes, Luis M P/E-2372-2011; dos Santos, Joaquim M F/B-3058-2015; Monteiro, Cristina Maria Bernardes/ABH-3547-2020; Cardoso, Joao M R/J-4486-2013; Graf, Thomas/F-2963-2012; Indelicato, Paul J/D-7636-2011; Covita, Daniel/J-5627-2013; veloso, joao fca/J-4478-2013; Pohl, Randolf/F-3612-2011; matias-lopes, jose a/H-6074-2012; Amaro, Fernando/M-3250-2013; Ludhova, Livia/AAE-4487-2020; Liu, Yi-wei/C-6825-2013	Monteiro, Cristina Maria/0000-0002-1912-2804; Fernandes, Luis M P/0000-0002-7061-8768; Monteiro, Cristina Maria Bernardes/0000-0002-1912-2804; Cardoso, Joao M R/0000-0002-8832-8208; Graf, Thomas/0000-0002-8466-073X; Indelicato, Paul J/0000-0003-4668-8958; veloso, joao fca/0000-0002-7107-7203; Pohl, Randolf/0000-0001-6435-659X; matias-lopes, jose a/0000-0002-6366-2963; Amaro, Fernando/0000-0001-7315-0550; Ludhova, Livia/0000-0002-3875-0590; Liu, Yi-wei/0000-0002-1090-0665; dos Santos, Joaquim Marques Ferreira/0000-0002-8841-6523; antognini, aldo/0000-0002-1837-0419	Max Planck Society; Max Planck Foundation; Swiss National Science Foundation [200020-100632]; Swiss Academy of Engineering Sciences; BQR de l'UFR de physique fondamentale et appliquee de l'Universite Paris 6; ministere des affaires etrangeres France [07819NH]; Fundacao para a Ciencia e a Tecnologia (Portugal); FEDER [PTDC/FIS/82006/2006, SFRH/BPD/46611/2008]; ExtreMe Matter Institute [HA216/EMMI]	Max Planck Society(Max Planck SocietyFoundation CELLEX); Max Planck Foundation(Foundation CELLEX); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Academy of Engineering Sciences; BQR de l'UFR de physique fondamentale et appliquee de l'Universite Paris 6; ministere des affaires etrangeres France; Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); FEDER(European Commission); ExtreMe Matter Institute	We thank L. Simons and B. Leoni for setting up the cyclotron trap, H. Bruckner, K. Linner, W. Simon, O. Huot and Z. Hochman for technical support, P. Maier-Komor, K. Nacke, M. Horisberger, A. Weber, L. Meier and J. Hehner for thin foils and windows, N. Schlumpf, U. Hartmann and M. Gaspar for electronics, S. Spielmann-Jaeggi and L. Carroll for optical measurements, Ch. Parthey and M. Herrmann for their help, the MEG-collaboration for a share of beam-time, and A. Voss, B. Weichelt and J. Fruechtenicht for the loan of a laser pump diode. We acknowledge the essential contributions of H. Hofer and V. W. Hughes in the initial stages of the experiment. We also thank the PSI accelerator division, the Hallendienst, the workshops at PSI, MPQ and Fribourg, and other support groups for their help. We acknowledge support from the Max Planck Society and the Max Planck Foundation, the Swiss National Science Foundation (project 200020-100632) and the Swiss Academy of Engineering Sciences, the BQR de l'UFR de physique fondamentale et appliquee de l'Universite Paris 6, the program PAI Germaine de Stael no. 07819NH du ministere des affaires etrangeres France, and the Fundacao para a Ciencia e a Tecnologia (Portugal) and FEDER (project PTDC/FIS/82006/2006 and grant SFRH/BPD/46611/2008). P. I. and E.-O.L.B. acknowledge support from the 'ExtreMe Matter Institute, Helmholtz Alliance HA216/EMMI'.	Antognini A, 2005, AIP CONF PROC, V796, P253, DOI 10.1063/1.2130175; Antognini A, 2005, OPT COMMUN, V253, P362, DOI 10.1016/j.optcom.2005.04.079; Antognini A, 2009, IEEE J QUANTUM ELECT, V45, P983, DOI 10.1109/JQE.2009.2014881; Belushkin MA, 2007, PHYS REV C, V75, DOI 10.1103/PhysRevC.75.035202; Blunden PG, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.057601; Borie E, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.032508; de Beauvoir B, 2000, EUR PHYS J D, V12, P61, DOI 10.1007/s100530070043; Eides MI, 2001, PHYS REP, V342, P63, DOI 10.1016/S0370-1573(00)00077-6; Fischer M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.230802; GIESEN A, 1994, APPL PHYS B-LASERS O, V58, P365, DOI 10.1007/BF01081875; Hanneke D, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.120801; Jensen TS, 2002, EUR PHYS J D, V21, P261, DOI 10.1140/epjd/e2002-00207-y; Karshenboim SG, 2005, PHYS REP, V422, P1, DOI 10.1016/j.physrep.2005.08.008; Kilic S, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.042506; LAMB WE, 1947, PHYS REV, V72, P241, DOI 10.1103/PhysRev.72.241; Ludhova L, 2005, NUCL INSTRUM METH A, V540, P169, DOI 10.1016/j.nima.2004.11.017; LUNDEEN SR, 1981, PHYS REV LETT, V46, P232, DOI 10.1103/PhysRevLett.46.232; Martynenko AP, 2008, PHYS ATOM NUCL+, V71, P125, DOI 10.1134/S1063778808010146; Martynenko AP, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.022506; Mohr PJ, 2008, REV MOD PHYS, V80, P633, DOI 10.1103/RevModPhys.80.633; Nebel T, 2007, CAN J PHYS, V85, P469, DOI 10.1139/P07-018; Niering M, 2000, PHYS REV LETT, V84, P5496, DOI 10.1103/PhysRevLett.84.5496; Pachucki K, 1996, PHYS REV A, V53, P2092, DOI 10.1103/PhysRevA.53.2092; Pachucki K, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.113005; Pachucki K, 1999, PHYS REV A, V60, P3593, DOI 10.1103/PhysRevA.60.3593; Pohl R, 2005, CAN J PHYS, V83, P339, DOI 10.1139/P05-016; Pohl R, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.193402; Pohl R, 2009, HYPERFINE INTERACT, V193, P115, DOI 10.1007/s10751-009-0054-1; RABINOWITZ P, 1986, IEEE J QUANTUM ELECT, V22, P797, DOI 10.1109/JQE.1986.1073036; Rothman LS, 2009, J QUANT SPECTROSC RA, V110, P533, DOI 10.1016/j.jqsrt.2009.02.013; Schwob C, 1999, PHYS REV LETT, V82, P4960, DOI 10.1103/PhysRevLett.82.4960; Sick I, 2003, PHYS LETT B, V576, P62, DOI 10.1016/j.physletb.2003.09.092; Toth RA, 1998, J MOL SPECTROSC, V190, P379, DOI 10.1006/jmsp.1998.7611	33	930	939	7	232	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					213	216		10.1038/nature09250	http://dx.doi.org/10.1038/nature09250			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613837				2022-12-28	WOS:000279580800031
J	Sinyor, M; Levitt, AJ				Sinyor, Mark; Levitt, Anthony J.			Effect of a barrier at Bloor Street Viaduct on suicide rates in Toronto: natural experiment	BRITISH MEDICAL JOURNAL			English	Article							GOLDEN GATE BRIDGE; UNITED-KINGDOM; FOLLOW-UP; LEGISLATION; ENGLAND; PREVENTION; WALES	Objective To determine whether rates of suicide changed in Toronto after a barrier was erected at Bloor Street Viaduct, the bridge with the world's second highest annual rate of suicide by jumping after Golden Gate Bridge in San Francisco. Design Natural experiment. Setting City of Toronto and province of Ontario, Canada; records at the chief coroner's office of Ontario 1993-2001 (nine years before the barrier) and July 2003-June 2007 (four years after the barrier). Participants 14 789 people who completed suicide in the city of Toronto and in Ontario. Main outcome measure Changes in yearly rates of suicide by jumping at Bloor Street Viaduct, other bridges, and buildings, and by other means. Results Yearly rates of suicide by jumping in Toronto remained unchanged between the periods before and after the construction of a barrier at Bloor Street Viaduct (56.4 v 56.6, P=0.95). A mean of 9.3 suicides occurred annually at Bloor Street Viaduct before the barrier and none after the barrier (P<0.01). Yearly rates of suicide by jumping from other bridges and buildings were higher in the period after the barrier although only significant for other bridges (other bridges: 8.7 v 14.2, P=0.01; buildings: 38.5 v 42.7, P=0.32). Conclusions Although the barrier prevented suicides at Bloor Street Viaduct, the rate of suicide by jumping in Toronto remained unchanged. This lack of change might have been due to a reciprocal increase in suicides from other bridges and buildings. This finding suggests that Bloor Street Viaduct may not have been a uniquely attractive location for suicide and that barriers on bridges may not alter absolute rates of suicide by jumping when comparable bridges are nearby.	[Sinyor, Mark] Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada; [Sinyor, Mark; Levitt, Anthony J.] Sunnybrook Hlth Sci Ctr, Dept Psychiat, Toronto, ON M4N 3M5, Canada; [Sinyor, Mark; Levitt, Anthony J.] Womens Coll Hosp, Toronto, ON M4N 3M5, Canada	University of Toronto; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Womens College Hospital	Sinyor, M (corresponding author), Univ Toronto, Dept Psychiat, Toronto, ON M5S 1A1, Canada.	mark.sinyor@utoronto.ca	Sinyor, Mark/AAM-5403-2020	Sinyor, Mark/0000-0002-7756-2584				Amos T, 2001, PSYCHOL MED, V31, P935, DOI 10.1017/S0033291701003920; Beautrais AL, 2006, AUST NZ J PSYCHIAT, V40, P253, DOI 10.1111/j.1440-1614.2006.01782.x; Beautrais AL, 2001, AUST NZ J PSYCHIAT, V35, P557, DOI 10.1080/0004867010060501; Beautrais AL, 2009, AUST NZ J PSYCHIAT, V43, P495, DOI 10.1080/00048670902873714; Bennewith O, 2007, BRIT J PSYCHIAT, V190, P266, DOI 10.1192/bjp.bp.106.027136; Blaustein M, 2009, AM J PSYCHIAT, V166, P1111, DOI 10.1176/appi.ajp.2009.09020296; CANTOR CH, 1990, AUST NZ J PSYCHIAT, V24, P377, DOI 10.3109/00048679009077705; Cole-King A, 2010, BRIT J GEN PRACT, V60, P3, DOI 10.3399/bjgp10X482022; Glenn W. M., 2003, MAGNET VEIL, P36; Gunnell D, 2000, SOC PSYCH PSYCH EPID, V35, P437, DOI 10.1007/s001270050261; Gunnell D, 1997, ACTA PSYCHIAT SCAND, V96, P1, DOI 10.1111/j.1600-0447.1997.tb09897.x; HARDING K, 2003, GLOBE MAIL      0906; Hawton K, 2004, BMJ-BRIT MED J, V329, P1076, DOI 10.1136/bmj.38253.572581.7C; Hawton K, 2001, BMJ-BRIT MED J, V322, P1203, DOI 10.1136/bmj.322.7296.1203; KREITMAN N, 1976, BRIT J PREV SOC MED, V30, P86; Leenaars AA, 2003, DEATH STUD, V27, P103, DOI 10.1080/07481180302890; Miller M, 2006, SUICIDE LIFE-THREAT, V36, P1, DOI 10.1521/suli.2006.36.1.1; Ondaatje Michael, 1996, SKIN LION; Pelletier AR, 2007, INJURY PREV, V13, P57, DOI 10.1136/ip.2006.013748; Reisch T, 2005, SUICIDE LIFE-THREAT, V35, P460, DOI 10.1521/suli.2005.35.4.460; RICH CL, 1990, AM J PSYCHIAT, V147, P342; ROSEN DH, 1975, WESTERN J MED, V122, P289; SEIDEN RH, 1978, SUICIDE LIFE-THREAT, V8, P203; SLOAN JH, 1990, NEW ENGL J MED, V322, P369, DOI 10.1056/NEJM199002083220605; Statistics Canada, 2010, POP DWELL COUNTS TOR; *U WAT, 2001, BLOOR STREET VIAD SU; *U WAT, 2005, LUM VEIL PRINC E VIA; Zarkowski P, 2008, AM J PSYCHIAT, V165, P1126, DOI 10.1176/appi.ajp.2008.08050650	28	26	26	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 6	2010	341								c2884	10.1136/bmj.c2884	http://dx.doi.org/10.1136/bmj.c2884			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DK	20605890	Green Published, hybrid			2022-12-28	WOS:000279874200001
J	Yang, ZH; Fujii, Y; Lee, FK; Lam, CH; Tsui, OKC				Yang, Zhaohui; Fujii, Yoshihisa; Lee, Fuk Kay; Lam, Chi-Hang; Tsui, Ophelia K. C.			Glass Transition Dynamics and Surface Layer Mobility in Unentangled Polystyrene Films	SCIENCE			English	Article							POLYMER; TEMPERATURE; RELAXATION; LIQUIDS; BULK	Most polymers solidify into a glassy amorphous state, accompanied by a rapid increase in the viscosity when cooled below the glass transition temperature (T-g). There is an ongoing debate on whether the T-g changes with decreasing polymer film thickness and on the origin of the changes. We measured the viscosity of unentangled, short-chain polystyrene films on silicon at different temperatures and found that the transition temperature for the viscosity decreases with decreasing film thickness, consistent with the changes in the T-g of the films observed before. By applying the hydrodynamic equations to the films, the data can be explained by the presence of a highly mobile surface liquid layer, which follows an Arrhenius dynamic and is able to dominate the flow in the thinnest films studied.	[Yang, Zhaohui; Fujii, Yoshihisa; Lee, Fuk Kay; Tsui, Ophelia K. C.] Boston Univ, Dept Phys, Boston, MA 02215 USA; [Lee, Fuk Kay; Lam, Chi-Hang] Hong Kong Polytech Univ, Dept Appl Phys, Hong Kong, Hong Kong, Peoples R China	Boston University; Hong Kong Polytechnic University	Tsui, OKC (corresponding author), Boston Univ, Dept Phys, 590 Commonwealth Ave, Boston, MA 02215 USA.	okctsui@bu.edu	Yang, Zhaohui/B-9331-2013; Lam, Chi-Hang/A-4626-2009; Fujii, Yoshihisa/F-7799-2019	Lam, Chi-Hang/0000-0002-0476-1857; Fujii, Yoshihisa/0000-0001-9419-8537; Tsui, Ophelia K. C./0000-0001-5987-2733	NSF [DMR-0706096, DMR-0908651]	NSF(National Science Foundation (NSF))	We thank C. A. Angell for useful discussions and G. B. McKenna for critical reading of this paper. Support from NSF (DMR-0706096 and DMR-0908651) is gratefully acknowledged.	Alcoutlabi M, 2005, J PHYS-CONDENS MAT, V17, pR461, DOI 10.1088/0953-8984/17/15/R01; Angell CA, 2000, J APPL PHYS, V88, P3113, DOI 10.1063/1.1286035; Baschnagel J, 2005, J PHYS-CONDENS MAT, V17, pR851, DOI 10.1088/0953-8984/17/32/R02; BOYER RF, 1978, MOL BASIS TRANSITION, P33; CAHN JW, 1965, J CHEM PHYS, V42, P93, DOI 10.1063/1.1695731; DHINOJWALA A, 1994, J CHEM PHYS, V100, P6046, DOI 10.1063/1.467115; Ellison CJ, 2003, NAT MATER, V2, P695, DOI 10.1038/nmat980; Fakhraai Z, 2008, SCIENCE, V319, P600, DOI 10.1126/science.1151205; Forrest JA, 1996, PHYS REV LETT, V77, P2002, DOI 10.1103/PhysRevLett.77.2002; Forrest JA, 2001, ADV COLLOID INTERFAC, V94, P167, DOI 10.1016/S0001-8686(01)00060-4; Herminghaus S, 2001, EUR PHYS J E, V5, P531, DOI 10.1007/s101890170036; Herminghaus S, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.017801; Herminghaus S, 2002, EUR PHYS J E, V8, P237, DOI 10.1140/epje/i2001-10056-0; Kawana S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021501; KEDDIE JL, 1994, EUROPHYS LETT, V27, P59, DOI 10.1209/0295-5075/27/1/011; Long D, 2001, EUR PHYS J E, V4, P371, DOI 10.1007/s101890170120; Majeste JC, 1998, RHEOL ACTA, V37, P486, DOI 10.1007/s003970050135; Peter S, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/20/205119; Roth CB, 2005, J ELECTROANAL CHEM, V584, P13, DOI 10.1016/j.jelechem.2004.03.003; Sharp JS, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031805; Tanaka K, 2000, MACROMOLECULES, V33, P7588, DOI 10.1021/ma000406w; Tsui OKC, 2001, MACROMOLECULES, V34, P9139, DOI 10.1021/ma0102159; TSUI OKC, 2008, SERIES SOFT CONDENSE, P267; Tsui OKC, 2008, MACROMOLECULES, V41, P1465, DOI 10.1021/ma702374g; Varnik F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.021507; VRIJ A, 1968, J AM CHEM SOC, V90, P3074, DOI 10.1021/ja01014a015; Wang YJ, 2006, J NON-CRYST SOLIDS, V352, P4977, DOI 10.1016/j.jnoncrysol.2006.01.152; Yang ZH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3158956	28	393	401	11	299	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1676	1679		10.1126/science.1184394	http://dx.doi.org/10.1126/science.1184394			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576887				2022-12-28	WOS:000279107400038
J	Lee, C				Lee, Ching-Hsing			Radiologic Signs of Pneumoperitoneum.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Chang Gung Mem Hosp, Tao Yuan, Taiwan	Chang Gung Memorial Hospital	Lee, C (corresponding author), Chang Gung Mem Hosp, Tao Yuan, Taiwan.	lancetlee@gmail.com							0	5	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2410	2410		10.1056/NEJMicm0904627	http://dx.doi.org/10.1056/NEJMicm0904627			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	614GO	20573929				2022-12-28	WOS:000279043800010
J	Quere, Y				Quere, Yves			Academies must engage with society	NATURE			English	Editorial Material									Acad Sci Delegat Enseignement & Format, F-75006 Paris, France		Quere, Y (corresponding author), Acad Sci Delegat Enseignement & Format, 23 Quai Conti, F-75006 Paris, France.	yves.quere@academie-sciences.fr							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1009	1009		10.1038/4651009a	http://dx.doi.org/10.1038/4651009a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KI	20577191				2022-12-28	WOS:000279056900019
J	Stuckler, D; Basu, S; McKee, M				Stuckler, David; Basu, Sanjay; McKee, Martin			Budget crises, health, and social welfare programmes	BRITISH MEDICAL JOURNAL			English	Editorial Material							PUBLIC-HEALTH; BARRIERS		[Stuckler, David] Univ Oxford, Dept Sociol, Oxford, England; [Stuckler, David] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Basu, Sanjay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Basu, Sanjay] San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA USA; [McKee, Martin] London Sch Hyg & Trop Med, European Ctr Hlth Soc Transit, London, England	University of Oxford; University of London; London School of Hygiene & Tropical Medicine; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of London; London School of Hygiene & Tropical Medicine	Stuckler, D (corresponding author), Univ Oxford, Dept Sociol, Oxford, England.	David.stuckler@chch.ox.ac.uk	McKee, Marc D/E-2187-2011; Mckee, Martin/E-6673-2018; Stuckler, David/H-2261-2012	McKee, Marc D/0000-0001-8349-965X; Mckee, Martin/0000-0002-0121-9683; Stuckler, David/0000-0002-1288-8401				[Anonymous], 2010, FISC MON; Appleby J, 2009, COLD WILL IT BE PROS; Berkeley D, 2006, SOC SCI MED, V63, P179, DOI 10.1016/j.socscimed.2005.11.057; *DEP HLTH, CHIEF MED OFF PUBL H; EAGLESHAM J, 2010, FINANCIAL TIMES 0218; GILES C, 2010, FINANCIAL TIMES 0103; Jones A, 2000, HDB HLTH EC, P265; Marmot M, 2010, FAIR SOC HLTH LIVES; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Mckee M, 2009, J PUBLIC HEALTH-UK, V31, P462, DOI 10.1093/pubmed/fdp091; *OECD, 2008, ORG EC COOP DEV SOC; PORTER A, 2010, DAILY TELEGRAPH 0401; Pritchett L, 1996, J HUM RESOUR, V31, P841, DOI 10.2307/146149; Sloper P, 2004, CHILD CARE HLTH DEV, V30, P571, DOI 10.1111/j.1365-2214.2004.00468.x; STUCKLER D, J PUB HLTH IN PRESS; Stuckler D, 2010, NATURE, V465, P289, DOI 10.1038/465289a; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; SWIFT R, HLTH EC IN PRESS; *TOT PLAC, 2010, TOT PLAC BETT LESS; WHO (World Health Organization), 2008, WHO EUR HLTH ALL DAT; Wismar M, 2008, TARGETS HLTH USES AB; World Health Organization, 2009, FIN CRIS GLOB HLTH R	22	92	94	0	19	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 24	2010	340								c3311	10.1136/bmj.c3311	http://dx.doi.org/10.1136/bmj.c3311			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IQ	20576709	Green Accepted			2022-12-28	WOS:000279346500005
J	Zhao, Z; Andersen, SU; Ljung, K; Dolezal, K; Miotk, A; Schultheiss, SJ; Lohmann, JU				Zhao, Zhong; Andersen, Stig U.; Ljung, Karin; Dolezal, Karel; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.			Hormonal control of the shoot stem-cell niche	NATURE			English	Article							AUXIN RESPONSE FACTORS; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CYTOKININ; MERISTEM; WUSCHEL; FATE; EMBRYOGENESIS; BIOSYNTHESIS	The classic phytohormones cytokinin and auxin play essential roles in the maintenance of stem-cell systems embedded in shoot and root meristems, and exhibit complex functional interactions(1-4). Here we show that the activity of both hormones directly converges on the promoters of two A-type ARABIDOPSIS RESPONSE REGULATOR (ARR) genes, ARR7 and ARR15, which are negative regulators of cytokinin signalling(5) and have important meristematic functions(3). Whereas ARR7 and ARR15 expression in the shoot apical meristem (SAM) is induced by cytokinin, auxin has a negative effect, which is, at least in part, mediated by the AUXIN RESPONSE FACTOR5/MONOPTEROS (MP) transcription factor(6). Our results provide a mechanistic framework for hormonal control of the apical stem-cell niche and demonstrate how root and shoot stem-cell systems differ in their response to phytohormones.	[Zhao, Zhong; Miotk, Andrej; Lohmann, Jan U.] Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany; [Zhao, Zhong; Andersen, Stig U.; Miotk, Andrej; Schultheiss, Sebastian J.; Lohmann, Jan U.] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany; [Ljung, Karin; Dolezal, Karel] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, S-90183 Umea, Sweden; [Dolezal, Karel] Palacky Univ, Lab Growth Regulators, Olomouc 78371, Czech Republic; [Dolezal, Karel] Acad Sci Czech Republ, Inst Expt Bot, Olomouc 78371, Czech Republic; [Schultheiss, Sebastian J.] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany	Ruprecht Karls University Heidelberg; Max Planck Society; Swedish University of Agricultural Sciences; Umea University; Palacky University Olomouc; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Eberhard Karls University of Tubingen; Max Planck Society	Lohmann, JU (corresponding author), Heidelberg Univ, Dept Stem Cell Biol, D-69120 Heidelberg, Germany.	jlohmann@meristemania.org	Lohmann, Jan/T-3776-2019; Zhao, Zhong/N-1999-2013; Doležal, Karel/H-2436-2014; Ljung, Karin/AAE-8691-2019	Lohmann, Jan/0000-0003-3667-187X; Zhao, Zhong/0000-0001-8044-0409; Doležal, Karel/0000-0003-4938-0350; Ljung, Karin/0000-0003-2901-189X; Andersen, Stig U./0000-0002-1096-1468; Schultheiss, Sebastian J/0000-0001-8488-906X	Human Frontier Science Program; EMBO; Carlsberg Foundation; Czech Ministry of Education [MSM 6198959216]; Max Planck Society;  [SFB446]	Human Frontier Science Program(Human Frontier Science Program); EMBO(European Molecular Biology Organization (EMBO)); Carlsberg Foundation(Carlsberg Foundation); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Max Planck Society(Max Planck Society); 	We thank G. Jurgens, K. Schneitz and D. Weigel for reading the manuscript, and I. Weisswange for imaging. This work was supported by a Human Frontier Science Program Career Development Award, an EMBO Young Investigator Award, the SFB446 (all to J.U.L.), a Carlsberg Foundation fellowship (to S. U. A.), a Czech Ministry of Education grant (MSM 6198959216) (to K. D.) and the Max Planck Society.	Andersen SU, 2008, PLANT CELL, V20, P88, DOI 10.1105/tpc.107.054676; Brand U, 2000, SCIENCE, V289, P617, DOI 10.1126/science.289.5479.617; Cheng YF, 2006, GENE DEV, V20, P1790, DOI 10.1101/gad.1415106; Dello Ioio R, 2008, SCIENCE, V322, P1380, DOI 10.1126/science.1164147; Fletcher LC, 1999, SCIENCE, V283, P1911, DOI 10.1126/science.283.5409.1911; Furutani M, 2004, DEVELOPMENT, V131, P5021, DOI 10.1242/dev.01388; Giulini A, 2004, NATURE, V430, P1031, DOI 10.1038/nature02778; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Guilfoyle TJ, 2007, CURR OPIN PLANT BIOL, V10, P453, DOI 10.1016/j.pbi.2007.08.014; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Heisler MG, 2005, CURR BIOL, V15, P1899, DOI 10.1016/j.cub.2005.09.052; Hwang I, 2001, NATURE, V413, P383, DOI 10.1038/35096500; Jasinski S, 2005, CURR BIOL, V15, P1560, DOI 10.1016/j.cub.2005.07.023; KIEBER JJ, 2002, ARABIDOPSIS BOOK; Kurakawa T, 2007, NATURE, V445, P652, DOI 10.1038/nature05504; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; Muller B, 2008, NATURE, V453, P1094, DOI 10.1038/nature06943; Nordstrom A, 2004, ANAL CHEM, V76, P2869, DOI 10.1021/ac0499017; Ohyama K, 2009, NAT CHEM BIOL, V5, P578, DOI 10.1038/nchembio.182; Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Schlereth A, 2010, NATURE, V464, P913, DOI 10.1038/nature08836; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schoof H, 2000, CELL, V100, P635, DOI 10.1016/S0092-8674(00)80700-X; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; SKOOG F, 1957, Symp Soc Exp Biol, V11, P118; Speed T., 2003, STAT ANAL GENE EXPRE; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; Vidaurre DP, 2007, DEVELOPMENT, V134, P2561, DOI 10.1242/dev.006759; Weigel D., 2002, ARABIDOPSIS LAB MANU; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yanai O, 2005, CURR BIOL, V15, P1566, DOI 10.1016/j.cub.2005.07.060	34	331	355	9	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1089	U154		10.1038/nature09126	http://dx.doi.org/10.1038/nature09126			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577215				2022-12-28	WOS:000279056900055
J	Sokol, DK				Sokol, Daniel K.			Ethics Man How to think like an ethicist	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Beauchamp Tom L., 2019, PRINCIPLES BIOMEDICA, V8th; JONSEN AR, 2006, CLIN ETHICS PRACTICA	2	3	3	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2010	340								c3256	10.1136/bmj.c3256	http://dx.doi.org/10.1136/bmj.c3256			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IP	20573764				2022-12-28	WOS:000279346400006
J	Bailey, CJ; Gross, JL; Pieters, A; Bastien, A; List, JF				Bailey, Clifford J.; Gross, Jorge L.; Pieters, Anne; Bastien, Arnaud; List, James F.			Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							SERUM URIC-ACID; SGLT2 INHIBITOR; METABOLIC SYNDROME; CLINICAL-TRIALS; RISK-FACTORS; MELLITUS; THERAPY; ASSOCIATION; MONOTHERAPY; ADJUSTMENT	Background Correction of hyperglycaemia and prevention of glucotoxicity are important objectives in the management of type 2 diabetes. Dapagliflozin, a selective sodium-glucose cotransporter-2 inhibitor, reduces renal glucose reabsorption in an insulin-independent manner. We assessed the efficacy and safety of dapagliflozin in patients who have inadequate glycaemic control with metformin. Methods In this phase 3, multicentre, double-blind, parallel-group, placebo-controlled trial, 546 adults with type 2 diabetes who were receiving daily metformin (>= 1500 mg per day) and had inadequate glycaemic control were randomly assigned to receive one of three doses of dapagliflozin (2.5 mg, n=137; 5 mg, n=137; or 10 mg, n=135) or placebo (n=137) orally once daily. Randomisation was computer generated and stratified by site, implemented with a central, telephone-based interactive voice response system. Patients continued to receive their pre-study metformin dosing. The primary outcome was change from baseline in haemoglobin A(1c) (HbA(1c)) at 24 weeks. All randomised patients who received at least one dose of double-blind study medication and who had both a baseline and at least one post-baseline measurement (last observation carried forward) were included in the analysis. Data were analysed by use of ANCOVA models. This trial is registered with ClinicalTrials.gov, number NCT00528879. Findings 534 patients were included in analysis of the primary endpoint (dapagliflozin 2.5 mg, n=135; dapagliflozin 5 mg, n=133; dapagliflozin 10 mg, n=132; placebo, n=134). At week 24, mean HbA(1c) had decreased by -0-30% (95% CI -0.44 to -0.16) in the placebo group, compared with -0.67% (-0.81 to -0.53, p=0-0002) in the dapagliflozin 2.5 mg group, -0.70% (-0.85 to -0.56, p<0.0001) in the dapagliflozin 5 mg group, and -0.84% (-0.98 to -0.70, p<0.0001) in the dapagliflozin 10 mg group. Symptoms of hypoglycaemia occurred in similar proportions of patients in the dapagliflozin (2-4%) and placebo groups (3%). Signs, symptoms, and other reports suggestive of genital infections were more frequent in the dapagliflozin groups (2.5 mg, 11 patients [8%]; 5 mg, 18 [13%]; 10 mg, 12 [9%]) than in the placebo group (seven [5%]). 17 patients had serious adverse events (four in each of the dapagliflozin groups and five in the placebo group). Interpretation Addition of dapagliflozin to metformin provides a new therapeutic option for treatment of type 2 diabetes in patients who have inadequate glycaemic control with metformin alone.	[Bailey, Clifford J.] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Gross, Jorge L.] Univ Fed Rio Grande do Sul, Div Endocrine, Porto Alegre, RS, Brazil; [Pieters, Anne] Bristol Myers Squibb Co, Global Biometr Sci, Braine Lalleud, Belgium; [Bastien, Arnaud; List, James F.] Bristol Myers Squibb Co, Global Clin Res, Princeton, NJ USA	Aston University; Universidade Federal do Rio Grande do Sul; Bristol-Myers Squibb; Bristol-Myers Squibb	Bailey, CJ (corresponding author), Aston Univ, Birmingham B4 7ET, W Midlands, England.	c.j.bailey@aston.ac.uk		Bailey, Clifford J/0000-0002-6998-6811	Bristol-Myers Squibb; AstraZeneca; Sanofi-Aventis; GlaxoSmithKline; Merck Serono; Merck Sharp Dohme	Bristol-Myers Squibb(Bristol-Myers Squibb); AstraZeneca(AstraZeneca); Sanofi-Aventis(Sanofi-Aventis); GlaxoSmithKline(GlaxoSmithKline); Merck Serono(Merck & Company); Merck Sharp Dohme(Merck & Company)	Funding Bristol-Myers Squibb and AstraZeneca.; AP, AB, and JFL are employees of Bristol-Myers Squibb and hold stock interests in the company. CJB has attended advisory board meetings of Bristol-Myers Squibb and AstraZeneca; undertaken ad-hoc consultancy for Bristol-Myers Squibb, AstraZeneca, Merck Sharp & Dohme, Novo Nordisk, GlaxoSmithKline, and Takeda; received research grants from AstraZeneca and Sanofi-Aventis; delivered continuing medical educational programmes sponsored by Bristol-Myers Squibb, AstraZeneca, GlaxoSmithKline, Merck Serono, and Merck Sharp & Dohme; and received travel or accommodation reimbursement from GlaxoSmithKline and Bristol-Myers Squibb. JLG, a trialist for this study, has attended advisory board meetings, received research support, and undertaken clinical trials sponsored by Bristol-Myers Squibb.; Dapagliflozin is being developed by an alliance of Bristol-Myers Squibb and AstraZeneca. This study was funded by both companies. We thank Alan G Hernpel, an employee of Bristol-Myers Squibb, for writing and editorial assistance.	Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; BERGER TG, 2009, CURRENT MED DIAGNOSI, P121; Boyko E.J., 1995, DIABETES AM, V2nd, P485; Buse JB, 2005, CLIN THER, V27, P1181, DOI 10.1016/j.clinthera.2005.08.005; de Leon EM, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-1; DeSouza C, 2009, NAT REV DRUG DISCOV, V8, P361, DOI 10.1038/nrd2872; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Dodd AH, 2009, CURR MED RES OPIN, V25, P1605, DOI 10.1185/03007990902973300; DUPONT AG, 1993, CARDIOVASC DRUG THER, V7, P55, DOI 10.1007/BF00877958; Ellsworth BA, 2008, BIOORG MED CHEM LETT, V18, P4770, DOI 10.1016/j.bmcl.2008.07.109; Fukui M, 2008, METABOLISM, V57, P625, DOI 10.1016/j.metabol.2007.12.005; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Harris SB, 2005, DIABETES RES CLIN PR, V70, P90, DOI 10.1016/j.diabres.2005.03.024; *INT DIAB FED, FOR IDF DIAB ATL; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kodama S, 2009, DIABETES CARE, V32, P1737, DOI 10.2337/dc09-0288; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P520, DOI 10.1038/clpt.2008.251; Komoroski B, 2009, CLIN PHARMACOL THER, V85, P513, DOI 10.1038/clpt.2008.250; Krentz AJ, 2008, DRUGS, V68, P2131, DOI 10.2165/00003495-200868150-00005; Liebl A, 2002, DIABETOLOGIA, V45, pS23, DOI 10.1007/s00125-002-0863-0; List JF, 2009, DIABETES CARE, V32, P650, DOI 10.2337/dc08-1863; MACKAY HT, 2009, CURRENT MED DIAGNOSI, P659; Meng W, 2008, J MED CHEM, V51, P1145, DOI 10.1021/jm701272q; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Neter JE, 2003, HYPERTENSION, V42, P878, DOI 10.1161/01.HYP.0000094221.86888.AE; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Sobel JD, 1998, AM J OBSTET GYNECOL, V178, P203, DOI 10.1016/S0002-9378(98)80001-X; Stewart GL, 2007, REV PANAM SALUD PUBL, V22, P12, DOI 10.1590/S1020-49892007000600002; Tsiatis AA, 2008, STAT MED, V27, P4658, DOI 10.1002/sim.3113; Wilding JPH, 2009, DIABETES CARE, V32, P1656, DOI 10.2337/dc09-0517; Zhang M, 2008, BIOMETRICS, V64, P707, DOI 10.1111/j.1541-0420.2007.00976.x	31	613	654	1	120	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2223	2233		10.1016/S0140-6736(10)60407-2	http://dx.doi.org/10.1016/S0140-6736(10)60407-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609968				2022-12-28	WOS:000279652900019
J	Klein, R				Klein, Ronald			Intensive treatment of hyperglycaemia: ACCORD	LANCET			English	Editorial Material							GLUCOSE CONTROL; FOLLOW-UP; COMPLICATIONS		Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA	University of Wisconsin System; University of Wisconsin Madison	Klein, R (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53726 USA.	kleinr@epi.ophth.wisc.edu		Klein, Ronald/0000-0002-4428-6237				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; INGELFINGER FJ, 1977, NEW ENGL J MED, V296, P1228, DOI 10.1056/NEJM197705262962111; ISMAELBEIGI F, 2010, LANCET, DOI DOI 10.1016/50140-6736(10)60576-4; KLEIN R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1217, DOI 10.1001/archopht.1994.01090210105023; Nathan DM, 2009, ARCH INTERN MED, V169, P1307, DOI 10.1001/archinternmed.2009.193; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pogach L, 2010, JAMA-J AM MED ASSOC, V303, P2076, DOI 10.1001/jama.2010.655; Riddle MC, 2010, DIABETES CARE, V33, P983, DOI 10.2337/dc09-1278; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	13	4	4	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					391	392		10.1016/S0140-6736(10)61028-8	http://dx.doi.org/10.1016/S0140-6736(10)61028-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	639YK	20594590				2022-12-28	WOS:000281012900004
J	Hettiaratchy, S; Tai, N; Mahoney, P; Hodgetts, T				Hettiaratchy, Shehan; Tai, Nigel; Mahoney, Peter; Hodgetts, Timothy			UK's NHS trauma systems: lessons from military experience	LANCET			English	Editorial Material									[Tai, Nigel] Royal London Hosp, Barts & London NHS Trust, Trauma Clin Acad Unit, London E1 1BB, England; [Hettiaratchy, Shehan] Charing Cross Hosp, Dept Plast & Reconstruct Surg, Imperial Coll Healthcare NHS Trust, London, England; [Hodgetts, Timothy] Royal Ctr Def Med, Acad Dept Mil Emergency Med, Birmingham, W Midlands, England	Barts Health NHS Trust; Royal London Hospital; Imperial College London; Royal Centre for Defence Medicine	Tai, N (corresponding author), Royal London Hosp, Barts & London NHS Trust, Trauma Clin Acad Unit, London E1 1BB, England.	nigel.tai@bartsandthelondon.nhs.uk						*COMM HEALTHC AUD, 2009, DEF MED SERV REV CLI; DAVIES TJ, 2008, ARMY MED CORPS, V154, P195; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hodgetts T, 2008, JOINT SERVICE PUBLIC, V570; Hodgetts TJ, 2006, EMERG MED J, V23, P745, DOI 10.1136/emj.2006.039610; Intercollegiate Group of Trauma Standards, 2009, REG TRAUM SYST INT G; JANSEN JO, 2009, BMJ-BRIT MED J, V338, P1436, DOI DOI 10.1136/BMJ.B1778; Kelly JF, 2008, J TRAUMA, V64, pS21, DOI 10.1097/TA.0b013e318160b9fb; Martin M, 2009, J TRAUMA, V66, pS51, DOI 10.1097/TA.0b013e31819d86ad; National Audit Office, 2010, NATL AUDIT OFFICE; National Audit Office. Ministry of defence, 2010, TREAT INJ ILLN AR MI; Smith Jason, 2007, J R Army Med Corps, V153, P239; JOINT DOCTRINE PUBLI	13	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					149	151		10.1016/S0140-6736(10)60622-8	http://dx.doi.org/10.1016/S0140-6736(10)60622-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	630YP	20638555				2022-12-28	WOS:000280313100008
J	van Rheenen, PF; Van de Vijver, E; Fidler, V				van Rheenen, Patrick F.; Van de Vijver, Els; Fidler, Vaclav			Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							NEUTROPHIL-DERIVED PROTEINS; INTESTINAL INFLAMMATION; CROHNS-DISEASE; NONINVASIVE MARKERS; ULCERATIVE-COLITIS; SURROGATE MARKERS; COLONOSCOPIC PERFORATIONS; COLORECTAL INFLAMMATION; MUCOSAL INFLAMMATION; BIOLOGICAL MARKER	Objective To evaluate whether including a test for faecal calprotectin, a sensitive marker of intestinal inflammation, in the investigation of suspected inflammatory bowel disease reduces the number of unnecessary endoscopic procedures. Design Meta-analysis of diagnostic accuracy studies. Data sources Studies published in Medline and Embase up to October 2009. Interventions reviewed Measurement of faecal calprotectin level (index test) compared with endoscopy and histopathology of segmental biopsy samples (reference standard). Inclusion criteria Studies that had collected data prospectively in patients with suspected inflammatory bowel disease and allowed for construction of a two by two table. For each study, sensitivity and specificity of faecal calprotectin were analysed as bivariate data to account for a possible negative correlation within studies. Results 13 studies were included: six in adults (n=670), seven in children and teenagers (n=371). Inflammatory bowel disease was confirmed by endoscopy in 32% (n=215) of the adults and 61% (n=226) of the children and teenagers. In the studies of adults, the pooled sensitivity and pooled specificity of calprotectin was 0.93 (95% confidence interval 0.85 to 0.97) and 0.96 (0.79 to 0.99) and in the studies of children and teenagers was 0.92 (0.84 to 0.96) and 0.76 (0.62 to 0.86). The lower specificity in the studies of children and teenagers was significantly different from that in the studies of adults (P=0.048). Screening by measuring faecal calprotectin levels would result in a 67% reduction in the number of adults requiring endoscopy. Three of 33 adults who undergo endoscopy will not have inflammatory bowel disease but may have a different condition for which endoscopy is inevitable. The downside of this screening strategy is delayed diagnosis in 6% of adults because of a false negative test result. In the population of children and teenagers, 65 instead of 100 would undergo endoscopy. Nine of them will not have inflammatory bowel disease, and diagnosis will be delayed in 8% of the affected children. Conclusion Testing for faecal calprotectin is a useful screening tool for identifying patients who are most likely to need endoscopy for suspected inflammatory bowel disease. The discriminative power to safely exclude inflammatory bowel disease was significantly better in studies of adults than in studies of children.	[van Rheenen, Patrick F.; Van de Vijver, Els] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, NL-9700 RB Groningen, Netherlands; [Fidler, Vaclav] Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen	van Rheenen, PF (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, POB 30001, NL-9700 RB Groningen, Netherlands.	p.f.van.rheenen@bkk.umcg.nl	van de vijver, els/ABB-5840-2020	/0000-0003-3867-2665				Aadland E, 2002, EUR J GASTROEN HEPAT, V14, P823, DOI 10.1097/00042737-200208000-00002; Ali Sobia, 2008, Curr Gastroenterol Rep, V10, P576, DOI 10.1007/s11894-008-0105-9; Angriman I, 2007, CLIN CHIM ACTA, V381, P63, DOI 10.1016/j.cca.2007.02.025; Araghizadeh FY, 2001, DIS COLON RECTUM, V44, P713, DOI 10.1007/BF02234572; Arnott IDR, 2002, ALIMENT PHARM THER, V16, P857, DOI 10.1046/j.1365-2036.2002.01242.x; Ashorn S, 2009, INFLAMM BOWEL DIS, V15, P199, DOI 10.1002/ibd.20535; Benchimol EI, 2009, GUT, V58, P1490, DOI 10.1136/gut.2009.188383; Bremner A, 2005, ACTA PAEDIATR, V94, P1855, DOI 10.1080/08035250500254639; Bruzzese E, 2004, ALIMENT PHARM THER, V20, P813, DOI 10.1111/j.1365-2036.2004.02174.x; Bunn SK, 2001, J PEDIATR GASTR NUTR, V33, P14, DOI 10.1097/00005176-200107000-00003; Bunn SK, 2001, J PEDIATR GASTR NUTR, V32, P171, DOI 10.1097/00005176-200102000-00015; Canani RB, 2008, DIGEST LIVER DIS, V40, P547, DOI 10.1016/j.dld.2008.01.017; Canani RB, 2006, J PEDIATR GASTR NUTR, V42, P9, DOI 10.1097/01.mpg.0000187818.76954.9a; Canani RB, 2004, DIGEST LIVER DIS, V36, P467, DOI 10.1016/j.dld.2004.02.009; CANANI RB, 2009, MEDICO BAMBINO, V28, P239; Carroccio A, 2003, CLIN CHEM, V49, P861, DOI 10.1373/49.6.861; Casellas F, 2007, ALIMENT PHARM THER, V25, P1061, DOI 10.1111/j.1365-2036.2007.03288.x; Chappell FM, 2009, STAT MED, V28, P2653, DOI 10.1002/sim.3631; Cobb WS, 2004, AM SURGEON, V70, P750; Costa F, 2005, GUT, V54, P364, DOI 10.1136/gut.2004.043406; Costa F, 2003, DIGEST LIVER DIS, V35, P642, DOI 10.1016/S1590-8658(03)00381-5; D'Inca R, 2008, AM J GASTROENTEROL, V103, P2007, DOI 10.1111/j.1572-0241.2008.01870.x; D'Inca R, 2007, INT J COLORECTAL DIS, V22, P429, DOI 10.1007/s00384-006-0159-9; Damms A, 2008, INT J COLORECTAL DIS, V23, P985, DOI 10.1007/s00384-008-0506-0; Damore LJ, 1996, DIS COLON RECTUM, V39, P1308, DOI 10.1007/BF02055129; Desai D, 2007, ALIMENT PHARM THER, V25, P247, DOI 10.1111/j.1365-2036.2006.03184.x; Diamanti A, 2008, INFLAMM BOWEL DIS, V14, P1229, DOI 10.1002/ibd.20472; Dolwani S, 2004, ALIMENT PHARM THER, V20, P615, DOI 10.1111/j.1365-2036.2004.02128.x; Eder Piotr, 2008, Pol Arch Med Wewn, V118, P622; Escher JC, 2005, J PEDIATR GASTR NUTR, V41, P1; Fagerberg UL, 2005, J PEDIATR GASTR NUTR, V40, P450, DOI 10.1097/01.MPG.0000154657.08994.94; Fagerberg UL, 2007, J PEDIATR GASTR NUTR, V45, P414, DOI 10.1097/MPG.0b013e31810e75a9; Foell D, 2009, GUT, V58, P859, DOI 10.1136/gut.2008.170019; Gaya DR, 2005, QJM-INT J MED, V98, P435, DOI 10.1093/qjmed/hci069; Gearry Richard, 2005, N Z Med J, V118, pU1444; Gisbert JP, 2009, DIGEST LIVER DIS, V41, P56, DOI 10.1016/j.dld.2008.05.008; Gisbert JP, 2009, INFLAMM BOWEL DIS, V15, P1746, DOI 10.1002/ibd.20920; Gisbert JP, 2009, INFLAMM BOWEL DIS, V15, P1190, DOI 10.1002/ibd.20933; Gismera CS, 2008, WORLD J GASTROENTERO, V14, P5491, DOI 10.3748/wjg.14.5491; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; HANAUER SB, 2009, GASTROENTEROL HEPATO, V5, P1; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Ho GT, 2009, AM J GASTROENTEROL, V104, P673, DOI 10.1038/ajg.2008.119; Jeffery J, 2009, INFLAMM BOWEL DIS, V15, P1630, DOI 10.1002/ibd.20946; Joishy M, 2009, J PEDIATR GASTR NUTR, V48, P48, DOI 10.1097/MPG.0b013e31816533d3; Jones J, 2008, CLIN GASTROENTEROL H, V6, P1218, DOI 10.1016/j.cgh.2008.06.010; Kaiser T, 2007, GUT, V56, P1706, DOI 10.1136/gut.2006.113431; Kallel L, 2010, EUR J GASTROEN HEPAT, V22, P340, DOI 10.1097/MEG.0b013e32832bab49; Kapel N, 2005, J PEDIATR GASTR NUTR, V41, P396, DOI 10.1097/01.mpg.0000178437.87546.06; Kerkhoff Claus, 2007, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V6, P246; Knottnerus J., 2009, EVIDENCE BASE CLIN D, V2; Kolho KL, 2006, SCAND J GASTROENTERO, V41, P720, DOI 10.1080/00365520500419623; Konikoff MR, 2006, INFLAMM BOWEL DIS, V12, P524, DOI 10.1097/00054725-200606000-00013; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P1085, DOI 10.1097/01.MIB.0000187980.08686.18; Langhorst J, 2008, AM J GASTROENTEROL, V103, P162, DOI 10.1111/j.1572-0241.2007.01556.x; Lasson A, 2008, SCAND J GASTROENTERO, V43, P356, DOI 10.1080/00365520701679116; Limburg PJ, 2000, AM J GASTROENTEROL, V95, P2831, DOI 10.1016/S0002-9270(00)01987-0; LOFTUS EV, 2007, GASTROENTEROL DIS S2, V7, P8; Lundberg J, 2005, NAT CLIN PRACT GASTR, V2, P96, DOI 10.1038/ncpgasthep0094; Marteau P, 2004, ENDOSCOPY, V36, P130, DOI 10.1055/s-2004-814180; Minderhoud IM, 2007, INFLAMM BOWEL DIS, V13, P1567, DOI 10.1002/ibd.20233; Nissen AC, 2004, J PEDIATR GASTR NUTR, V38, P107, DOI 10.1097/00005176-200401000-00025; Olafsdottir E, 2002, ACTA PAEDIATR, V91, P45, DOI 10.1080/080352502753457932; Otten CMT, 2008, CLIN CHEM LAB MED, V46, P1275, DOI 10.1515/CCLM.2008.246; PALLONE F, 2008, DIG LIVER DIS S, V2, P5; Pardi DS, 2005, GUT, V54, P321, DOI 10.1136/gut.2004.048850; Perminow G, 2009, SCAND J GASTROENTERO, V44, P446, DOI 10.1080/00365520802647434; Poullis A, 2003, EUR J GASTROEN HEPAT, V15, P573, DOI 10.1097/01.meg.0000059108.41030.23; Quail MA, 2009, INFLAMM BOWEL DIS, V15, P756, DOI 10.1002/ibd.20820; Reinders CI, 2007, SCAND J GASTROENTERO, V42, P1151, DOI 10.1080/00365520701320505; Ristvedt SL, 2003, AM J GASTROENTEROL, V98, P578, DOI 10.1016/S0002-9270(02)06024-0; Roseth AG, 1999, SCAND J GASTROENTERO, V34, P50; ROSETH AG, 1992, SCAND J GASTROENTERO, V27, P793, DOI 10.3109/00365529209011186; Rugtveit J, 2002, J PEDIATR GASTR NUTR, V34, P323, DOI 10.1097/00005176-200203000-00022; Scarpa M, 2007, DIS COLON RECTUM, V50, P861, DOI 10.1007/s10350-007-0225-6; Schoepfer AM, 2008, INFLAMM BOWEL DIS, V14, P32, DOI 10.1002/ibd.20275; Schoepfer AM, 2007, DIS COLON RECTUM, V50, P1697, DOI 10.1007/s10350-007-0303-9; Schoepfer AM, 2009, INFLAMM BOWEL DIS, V15, P1851, DOI 10.1002/ibd.20986; Schroder O, 2007, ALIMENT PHARM THER, V26, P1035, DOI 10.1111/j.1365-2036.2007.03457.x; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Shastri Y, 2009, CLIN LAB, V55, P53; Shastri YM, 2008, AM J MED, V121, P1099, DOI 10.1016/j.amjmed.2008.06.034; Shitrit ABG, 2007, DIS COLON RECTUM, V50, P2188, DOI 10.1007/s10350-007-9038-x; Sidler MA, 2008, INFLAMM BOWEL DIS, V14, P359, DOI 10.1002/ibd.20336; Silberer H, 2005, CLIN LAB, V51, P117; Sipponen T, 2008, ALIMENT PHARM THER, V28, P1221, DOI 10.1111/j.1365-2036.2008.03835.x; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P1392, DOI 10.1002/ibd.20490; Sipponen T, 2008, INFLAMM BOWEL DIS, V14, P40, DOI 10.1002/ibd.20312; Sostegni R, 2003, ALIMENT PHARM THER, V17, P11, DOI 10.1046/j.1365-2036.17.s2.17.x; Spiller R, 2007, GUT, V56, P1770, DOI 10.1136/gut.2007.119446; Stange EF, 2006, GUT, V55, DOI 10.1136/gut.2005.081950a; Summerton CB, 2002, EUR J GASTROEN HEPAT, V14, P841, DOI 10.1097/00042737-200208000-00005; Sutherland AD, 2008, DIS COLON RECTUM, V51, P1283, DOI 10.1007/s10350-008-9310-8; Tibbe JA, 2001, WORLD J GASTROENTERO, V7, P460; Tibble J, 2000, GUT, V47, P506, DOI 10.1136/gut.47.4.506; Tibble JA, 2000, GASTROENTEROLOGY, V119, P15, DOI 10.1053/gast.2000.8523; Tibble JA, 1999, GUT, V45, P362, DOI 10.1136/gut.45.3.362; Tibble JA, 2002, GASTROENTEROLOGY, V123, P450, DOI 10.1053/gast.2002.34755; Tibble JA, 2001, DRUG TODAY, V37, P85, DOI 10.1358/dot.2001.37.2.614846; Vermeire S, 2006, GUT, V55, P426, DOI 10.1136/gut.2005.069476; von Roon AC, 2007, AM J GASTROENTEROL, V102, P803, DOI 10.1111/j.1572-0241.2007.01126.x; Wagner M, 2008, WORLD J GASTROENTERO, V14, P5584, DOI 10.3748/wjg.14.5584; Walkiewicz D, 2008, INFLAMM BOWEL DIS, V14, P669, DOI 10.1002/ibd.20376; Wassell J, 2004, ANN CLIN BIOCHEM, V41, P230, DOI 10.1258/000456304323019613; Whiting Penny, 2005, BMC Med Res Methodol, V5, P19, DOI 10.1186/1471-2288-5-19; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Wildt S, 2007, EUR J GASTROEN HEPAT, V19, P567, DOI 10.1097/MEG.0b013e328058ed76; Xiang JY, 2008, WORLD J GASTROENTERO, V14, P53, DOI 10.3748/wjg.14.53; Yagmur E, 2006, DEUT MED WOCHENSCHR, V131, P1930, DOI 10.1055/s-2006-949189	109	447	457	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2010	341								c3369	10.1136/bmj.c3369	http://dx.doi.org/10.1136/bmj.c3369			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XD	20634346	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000280156800003
J	Fouyas, IP; Sandercock, PAG; Statham, PFX; Nikolaidis, I				Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.; Nikolaidis, Ioannis			Uncertainties Page How beneficial is surgery for cervical radiculopathy and myelopathy?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SPONDYLOTIC MYELOPATHY; SURGICAL-TREATMENT; NATURAL-HISTORY; MULTICENTER; DISORDER		[Fouyas, Ioannis P.; Sandercock, Peter A. G.; Statham, Patrick F. X.] Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Nikolaidis, Ioannis] Tzaneio Gen State Hosp, Piraeus, Greece	University of Edinburgh	Fouyas, IP (corresponding author), Univ Edinburgh, Western Gen Hosp, Dept Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland.	ioannisfouyas@nhs.net		Sandercock, Peter/0000-0001-8484-0135	Biomet	Biomet	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) no authors have support from any company for the submitted work; (2) PFXS has received consultancy fees for the development of a cervical disc replacement, and has had travel and accommodation expenses covered by Biomet, which might have an interest in the submitted work in the previous three years; (3) none of the authors' spouses, partners, or children have financial relationships that may be relevant to the submitted work; and (4) no authors have non-financial interests that may be relevant to the submitted work.	BARNES MP, 1984, J NEUROL NEUROSUR PS, V47, P17, DOI 10.1136/jnnp.47.1.17; CAMPBELL AMG, 1960, BRIT MED J, V2, P481, DOI 10.1136/bmj.2.5197.481; Hilibrand AS, 1999, J BONE JOINT SURG AM, V81A, P519, DOI 10.2106/00004623-199904000-00009; IRVINE DH, 1965, LANCET, V1, P1089; Kadanka Z, 2002, SPINE, V27, P2205, DOI 10.1097/00007632-200210150-00003; King JT, 2005, J NEUROSURG-SPINE, V2, P526, DOI 10.3171/spi.2005.2.5.0526; LEES F, 1963, BRIT MED J, P1607, DOI 10.1136/bmj.2.5373.1607; Nikolaidis I, 2010, COCHRANE DB SYST REV, V1; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; Persson LCG, 1997, SPINE, V22, P751, DOI 10.1097/00007632-199704010-00007; RADHAKRISHNAN K, 1994, BRAIN, V117, P325, DOI 10.1093/brain/117.2.325; ROWLAND LP, 1992, NEUROLOGY, V42, P5, DOI 10.1212/WNL.42.1.5; Sampath P, 2000, SPINE, V25, P670, DOI 10.1097/00007632-200003150-00004; Sampath P, 1999, SPINE, V24, P591, DOI 10.1097/00007632-199903150-00021; Singh A, 2001, J NEUROSURG, V94, P189, DOI 10.3171/spi.2001.94.2.0189; TERESI LM, 1987, RADIOLOGY, V164, P83, DOI 10.1148/radiology.164.1.3588931	16	8	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 13	2010	341								c3108	10.1136/bmj.c3108	http://dx.doi.org/10.1136/bmj.c3108			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XB	20627982				2022-12-28	WOS:000280156600002
J	Aaen, AM; Moller, K				Aaen, Anne-Marie; Moller, Kirsten			A Patient's Journey Through and beyond anaesthesia awareness	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Moller, Kirsten] Rigshosp, Dept Intens Care, DK-2100 Copenhagen, Denmark	Rigshospitalet; University of Copenhagen		aaen@webspeed.dk; kirsten.moller@dadlnet.dk	Moller, Kirsten/A-4751-2009	Moller, Kirsten/0000-0003-3058-1072					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 12	2010	341								c3669	10.1136/bmj.c3669	http://dx.doi.org/10.1136/bmj.c3669			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628WY	20624831				2022-12-28	WOS:000280156300001
J	Dousse, A; Suffczynski, J; Beveratos, A; Krebs, O; Lemaitre, A; Sagnes, I; Bloch, J; Voisin, P; Senellart, P				Dousse, Adrien; Suffczynski, Jan; Beveratos, Alexios; Krebs, Olivier; Lemaitre, Aristide; Sagnes, Isabelle; Bloch, Jacqueline; Voisin, Paul; Senellart, Pascale			Ultrabright source of entangled photon pairs	NATURE			English	Article							SINGLE QUANTUM-DOT; 2 QUBITS; STATE; MICROCAVITIES; TELEPORTATION; FIDELITY	A source of triggered entangled photon pairs is a key component in quantum information science(1); it is needed to implement functions such as linear quantum computation(2), entanglement swapping(3) and quantum teleportation(4). Generation of polarization entangled photon pairs can be obtained through parametric conversion in nonlinear optical media(5-7) or by making use of the radiative decay of two electron-hole pairs trapped in a semiconductor quantum dot(8-11). Today, these sources operate at a very low rate, below 0.01 photon pairs per excitation pulse, which strongly limits their applications. For systems based on parametric conversion, this low rate is intrinsically due to the Poissonian statistics of the source(12). Conversely, a quantum dot can emit a single pair of entangled photons with a probability near unity but suffers from a naturally very low extraction efficiency. Here we show that this drawback can be overcome by coupling an optical cavity in the formof a 'photonic molecule'(13) to a single quantum dot. Two coupled identical pillars-the photonic molecule-were etched in a semiconductor planar microcavity, using an optical lithography method(14) that ensures a deterministic coupling to the biexciton and exciton energy states of a pre-selected quantum dot. The Purcell effect ensures that most entangled photon pairs are emitted into two cavity modes, while improving the indistinguishability of the two optical recombination paths(15,16). A polarization entangled photon pair rate of 0.12 per excitation pulse (with a concurrence of 0.34) is collected in the first lens. Our results open the way towards the fabrication of solid state triggered sources of entangled photon pairs, with an overall (creation and collection) efficiency of 80%.	[Dousse, Adrien; Suffczynski, Jan; Beveratos, Alexios; Krebs, Olivier; Lemaitre, Aristide; Sagnes, Isabelle; Bloch, Jacqueline; Voisin, Paul; Senellart, Pascale] CNRS, Lab Photon & Nanostruct, F-91460 Marcoussis, France	Centre National de la Recherche Scientifique (CNRS)	Senellart, P (corresponding author), CNRS, Lab Photon & Nanostruct, Route Nozay, F-91460 Marcoussis, France.	Pascale.Senellart@lpn.cnrs.fr	Krebs, Olivier/C-4190-2019; Lemaitre, Aristide/B-9899-2009; SAGNES, Isabelle/ABF-2706-2020; SENELLART, Pascale/C-1771-2017; Suffczynski, Jan/L-3751-2014; Bloch, Jacqueline/S-2062-2017; SENELLART, Pascale/AAK-4950-2021	Krebs, Olivier/0000-0002-9076-2708; Lemaitre, Aristide/0000-0003-1892-9726; SENELLART, Pascale/0000-0002-8727-1086; Suffczynski, Jan/0000-0003-3737-464X; Bloch, Jacqueline/0000-0001-7823-8420; SENELLART, Pascale/0000-0002-8727-1086; SAGNES, isabelle/0000-0001-8068-6599	European Project NanoEPR; French ANR [P3N]	European Project NanoEPR; French ANR(French National Research Agency (ANR))	This work was partly supported by the European Project NanoEPR and by the French ANR P3N DELIGHT. We acknowledge A. Calvar and M. Larque for help with experiments, N. Dupuis for help with molecule modelling theory and I. Robert-Philip for discussions. A. B. acknowledges discussions with B. Kraus and S. Iblisdir.	Akopian N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.130501; Bayer M, 1998, PHYS REV LETT, V81, P2582, DOI 10.1103/PhysRevLett.81.2582; Bennett CH, 1996, PHYS REV LETT, V76, P722, DOI 10.1103/PhysRevLett.76.722; Bouwmeester D, 1997, NATURE, V390, P575, DOI 10.1038/37539; Bouwmeester D., 2000, PHYS QUANTUM INFORM; de Riedmatten H, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.050302; Dousse A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.267404; Ellis DJP, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430489; Fulconis J, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/8/276; Gerard JM, 1999, J LIGHTWAVE TECHNOL, V17, P2089, DOI 10.1109/50.802999; Hafenbrak R, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/9/315; James DFV, 2001, PHYS REV A, V64, DOI 10.1103/PhysRevA.64.052312; Kowalik K, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2805025; KWIAT PG, 1995, PHYS REV LETT, V75, P4337, DOI 10.1103/PhysRevLett.75.4337; Lanyon BP, 2010, NAT CHEM, V2, P106, DOI [10.1038/NCHEM.483, 10.1038/nchem.483]; Larque M, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.042118; Larque M, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/3/033022; Lee KH, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202193; Moreau E, 2001, APPL PHYS LETT, V79, P2865, DOI 10.1063/1.1415346; Muller A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.217402; OU ZY, 1988, PHYS REV LETT, V61, P50, DOI 10.1103/PhysRevLett.61.50; Peres A, 1996, PHYS REV LETT, V77, P1413, DOI 10.1103/PhysRevLett.77.1413; Scarani V, 2005, EUR PHYS J D, V32, P129, DOI 10.1140/epjd/e2004-00170-7; Stace TM, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.085317; Stevenson RM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.170501; Verstraete F, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.022307; Wootters WK, 1998, PHYS REV LETT, V80, P2245, DOI 10.1103/PhysRevLett.80.2245; Young RJ, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/2/029	30	445	449	6	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					217	220		10.1038/nature09148	http://dx.doi.org/10.1038/nature09148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20613838				2022-12-28	WOS:000279580800032
J	Zhang, J; Wagh, P; Guay, D; Sanchez-Pulido, L; Padhi, BK; Korzh, V; Andrade-Navarro, MA; Akimenko, MA				Zhang, Jing; Wagh, Purva; Guay, Danielle; Sanchez-Pulido, Luis; Padhi, Bhaja K.; Korzh, Vladimir; Andrade-Navarro, Miguel A.; Akimenko, Marie-Andree			Loss of fish actinotrichia proteins and the fin-to-limb transition	NATURE			English	Article							APICAL ECTODERMAL RIDGE; IN-SITU HYBRIDIZATION; GENE-EXPRESSION; SONIC-HEDGEHOG; PECTORAL FIN; CAUDAL FIN; ZEBRAFISH; GLI3; MORPHOGENESIS; REGENERATION	The early development of teleost paired fins is strikingly similar to that of tetrapod limb buds and is controlled by similar mechanisms(1,2). One early morphological divergence between pectoral fins and limbs is in the fate of the apical ectodermal ridge (AER), the distal epidermis that rims the bud. Whereas the AER of tetrapods regresses after specification of the skeletal progenitors(3), the AER of teleost fishes forms a fold that elongates(4,5). Formation of the fin fold is accompanied by the synthesis of two rows of rigid, unmineralized fibrils called actinotrichia, which keep the fold straight(6,7) and guide the migration of mesenchymal cells within the fold(5,8). The actinotrichia are made of elastoidin, the components of which, apart from collagen, are unknown. Here we show that two zebrafish proteins, which we name actinodin 1 and 2 (And1 and And2), are essential structural components of elastoidin. The presence of actinodin sequences in several teleost fishes and in the elephant shark (Callorhinchus milii, which occupies a basal phylogenetic position), but not in tetrapods, suggests that these genes have been lost during tetrapod species evolution. Double gene knockdown of and1 and and2 in zebrafish embryos results in the absence of actinotrichia and impaired fin folds. Gene expression profiles in embryos lacking and1 and and2 function are consistent with pectoral fin truncation and may offer a potential explanation for the polydactyly observed in early tetrapod fossils. We propose that the loss of both actinodins and actinotrichia during evolution may have led to the loss of lepidotrichia and may have contributed to the fin-to-limb transition.	[Zhang, Jing; Wagh, Purva; Guay, Danielle; Akimenko, Marie-Andree] Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada; [Sanchez-Pulido, Luis] Univ Oxford, Funct Genom Unit, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Padhi, Bhaja K.] Hlth Canada, Environm Hlth Sci & Res Bur, Ottawa, ON K1A 0L2, Canada; [Korzh, Vladimir] Inst Mol & Cell Biol, Singapore 138673, Singapore; [Andrade-Navarro, Miguel A.] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	University of Ottawa; University of Oxford; Health Canada; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Helmholtz Association; Max Delbruck Center for Molecular Medicine	Akimenko, MA (corresponding author), Univ Ottawa, Dept Biol, CAREG, Ottawa, ON K1N 6N5, Canada.	makimen@uottawa.ca	Korzh, Vladimir P/H-1596-2011; Andrade, Miguel A/B-6565-2008	Korzh, Vladimir P/0000-0002-6580-7986; Andrade, Miguel A/0000-0001-6650-1711; Padhi, Bhaja Krushna/0000-0002-8705-9173; Sanchez Pulido, Luis/0000-0002-2300-8502	European Modular Biology Organization [ALT 325-2008]; Natural Science Engineering and Research Council of Canada; Canadian Institutes of Health Research; Canada Research Chairs; Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore; Medical Research Council [MC_U137761446] Funding Source: researchfish; MRC [MC_U137761446] Funding Source: UKRI	European Modular Biology Organization; Natural Science Engineering and Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs(Canada Research ChairsCGIAR); Helmholtz Alliance on Systems Biology; Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank I. Duran for technical advice, A. Maurya for assistance in the early stages of this work and M. Ekker, F. Avaron and M. Debiais for discussions and critical reading of the manuscript. L.S.-P. is supported by a European Modular Biology Organization Long-Term Fellowship (ALT 325-2008). This work was supported by grants to M.-A.A. from the Natural Science Engineering and Research Council of Canada and the Canadian Institutes of Health Research. M.A.A.-N. received funding from the Canada Research Chairs programme and from the Helmholtz Alliance on Systems Biology. V.K. received funding from the Agency for Science, Technology and Research of Singapore.	Ahn D, 2008, DEV BIOL, V322, P220, DOI 10.1016/j.ydbio.2008.06.032; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; BOUVET J, 1974, ARCH ANAT MICROSC MO, V63, P79; Buscher D, 1997, MECH DEVELOP, V62, P175, DOI 10.1016/S0925-4773(97)00656-4; Choo BG, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-5; DAMODARAN M, 1956, BIOCHEM J, V62, P621, DOI 10.1042/bj0620621; DANE PJ, 1985, J EMBRYOL EXP MORPH, V87, P145; GARRAULT H, 1936, ARCH ANAT MICROSC, V130, P105; GERAUDIE J, 1977, J MORPHOL, V151, P353, DOI 10.1002/jmor.1051510304; GERAUDIE J, 1985, BIOL INVERTEBRATE LO, V451, P455; Grandel H, 1998, MECH DEVELOP, V79, P99, DOI 10.1016/S0925-4773(98)00176-2; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; KIMURA S, 1966, J BIOCHEM-TOKYO, V60, P615, DOI 10.1093/oxfordjournals.jbchem.a128487; KIMURA S, 1986, COMP BIOCHEM PHYS B, V84, P305, DOI 10.1016/0305-0491(86)90081-7; KRUKENBERG CF, 1885, MITT ZOOL STAT NEAPE, V6, P286; Lang C, 1999, J CELL SCI, V112, P749; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Mao JH, 2009, DEV CELL, V16, P600, DOI 10.1016/j.devcel.2009.02.005; Martin GR, 1998, GENE DEV, V12, P1571, DOI 10.1101/gad.12.11.1571; Mercader N, 2007, DEV GROWTH DIFFER, V49, P421, DOI 10.1111/j.1440-169x.2007.00942.x; Nishidate M, 2007, DEV DYNAM, V236, P2685, DOI 10.1002/dvdy.21274; Padhi BK, 2004, DEV DYNAM, V231, P527, DOI 10.1002/dvdy.20153; Pizette S, 1999, DEVELOPMENT, V126, P883; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Smith A, 2008, DEV DYNAM, V237, P417, DOI 10.1002/dvdy.21417; SORDINO P, 1995, NATURE, V375, P678, DOI 10.1038/375678a0; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Thummel R, 2006, DEV DYNAM, V235, P336, DOI 10.1002/dvdy.20630; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; Venkatesh B, 2007, PLOS BIOL, V5, P932, DOI 10.1371/journal.pbio.0050101; WOOD A, 1984, J CELL SCI, V66, P205; WOOD A, 1982, ANAT REC, V204, P349, DOI 10.1002/ar.1092040408; Zakany J, 2007, DEV BIOL, V306, P883, DOI 10.1016/j.ydbio.2007.03.517; Zhang Z, 2009, DEV CELL, V16, P607, DOI 10.1016/j.devcel.2009.02.008	35	92	95	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					234	U106		10.1038/nature09137	http://dx.doi.org/10.1038/nature09137			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	621LR	20574421				2022-12-28	WOS:000279580800036
J	Baron, RJ				Baron, Richard J.			Meaningful Use of Health Information Technology Is Managing Information	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RECORDS		Greenhouse Internists PC, Philadelphia, PA 19119 USA		Baron, RJ (corresponding author), Greenhouse Internists PC, 345 E Mt Airy Ave, Philadelphia, PA 19119 USA.	rbaron@greenhouseinternists.com	Tao, Youyou/D-2367-2014					Baron RJ, 2007, ANN INTERN MED, V147, P549, DOI 10.7326/0003-4819-147-8-200710160-00007; Baron RJ, 2010, NEW ENGL J MED, V362, P1632, DOI 10.1056/NEJMon0910793; Baron RJ, 2005, ANN INTERN MED, V143, P222, DOI 10.7326/0003-4819-143-3-200508020-00008; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Gans D, 2005, HEALTH AFFAIR, V24, P1323, DOI 10.1377/hlthaff.24.5.1323; HOWELL JD, 1984, B HIST MED, V58, P83; Miller RH, 2005, HEALTH AFFAIR, V24, P1127, DOI 10.1377/hlthaff.24.5.1127; Pear R, 2010, NEW YORK TIMES; 2010, FED REG, V75, P1844	9	15	15	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					89	90		10.1001/jama.2010.910	http://dx.doi.org/10.1001/jama.2010.910			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	620SJ	20606155				2022-12-28	WOS:000279519600027
J	Knight, I; Bird, HA				Knight, Isobel; Bird, H. A.			A Patient's Journey Joint hypermobility syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bird, H. A.] Leeds Teaching Hosp NHS Trust, Leeds Gen Infirm, Leeds LS1 3EX, W Yorkshire, England	Leeds General Infirmary; University of Leeds		IKnight@laban.org; Howard.Bird@leedsth.nhs.uk							0	1	2	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 5	2010	341								c3044	10.1136/bmj.c3044	http://dx.doi.org/10.1136/bmj.c3044			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DJ	20603316				2022-12-28	WOS:000279874000001
J	Stulberg, JJ; Delaney, CP; Neuhauser, DV; Aron, DC; Fu, PF; Koroukian, SM				Stulberg, Jonah J.; Delaney, Conor P.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.			Adherence to Surgical Care Improvement Project Measures and the Association With Postoperative Infections	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PERFORMANCE-MEASURES; COLORECTAL SURGERY; CLINICAL-OUTCOMES; HOSPITAL QUALITY; MORTALITY-RATES; SITE INFECTION; CO-MORBIDITY; COMPLICATIONS; PREVENTION; ICD-9-CM	Context The Surgical Care Improvement Project (SCIP) aims to reduce surgical infectious complication rates through measurement and reporting of 6 infection-prevention process-of-care measures. However, an association between SCIP performance and clinical outcomes has not been demonstrated. Objective To examine the relationship between SCIP infection-prevention process-of-care measures and postoperative infection rates. Design, Setting, Participants A retrospective cohort study, using Premier Inc's Perspective Database for discharges between July 1, 2006 and March 31, 2008, of 405 720 patients (69% white and 11% black; 46% Medicare patients; and 68% elective surgical cases) from 398 hospitals in the United States for whom SCIP performance was recorded and submitted for public report on the Hospital Compare Web site. Three original infection-prevention measures (S-INF-Core) and all 6 infection-prevention measures (S-INF) were aggregated into 2 separate all-or-none composite scores. Hierarchical logistical models were used to assess process-of-care relationships at the patient level while accounting for hospital characteristics. Main Outcome Measure The ability of reported adherence to SCIP infection-prevention process-of-care measures (using the 2 composite scores of S-INF and S-INF-Core) to predict postoperative infections. Results There were 3996 documented postoperative infections. The S-INF composite process-of-care measure predicted a decrease in postoperative infection rates from 14.2 to 6.8 per 1000 discharges (adjusted odds ratio, 0.85; 95% confidence interval, 0.76-0.95). The S-INF-Core composite process-of-care measure predicted a decrease in postoperative infection rates from 11.5 to 5.3 per 1000 discharges (adjusted odds ratio, 0.86; 95% confidence interval, 0.74-1.01), which was not a statistically significantly lower probability of infection. None of the individual SCIP measures were significantly associated with a lower probability of infection. Conclusions Among hospitals in the Premier Inc Perspective Database reporting SCIP performance, adherence measured through a global all-or-none composite infection-prevention score was associated with a lower probability of developing a postoperative infection. However, adherence reported on individual SCIP measures, which is the only form in which performance is publicly reported, was not associated with a significantly lower probability of infection. JAMA. 2010; 303(24): 2479-2485 www.jama.com	[Stulberg, Jonah J.; Neuhauser, Duncan V.; Aron, David C.; Fu, Pingfu; Koroukian, Siran M.] Case Western Reserve Univ, Sch Med, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Stulberg, Jonah J.; Delaney, Conor P.] Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, Cleveland, OH 44106 USA; [Aron, David C.] Vet Affairs Med Ctr, Louis Stokes Cleveland Dept, VA HSR&D Ctr Qual Improvement Res, Cleveland, OH USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Stulberg, JJ (corresponding author), Univ Hosp, Case Med Ctr, Dept Surg, Div Colorectal Surg, 11100 Euclid Ave,LKS 7,MS 5047, Cleveland, OH 44106 USA.	Jonah.Stulberg@case.edu	Stulberg, Jonah/J-8713-2019; Fu, Pingfu/O-5415-2019; Stulberg, Jonah/I-7434-2012; Koroukian, Siran/S-9127-2019	Stulberg, Jonah/0000-0001-9971-8693; Fu, Pingfu/0000-0002-2334-5218; Koroukian, Siran/0000-0002-8106-9581	Agency for Healthcare Research and Quality [T32 HS00059]; National Cancer Institute [K07 CA96705]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000059] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [K07CA096705] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: Dr Stulberg was supported, in part, by grant T32 HS00059 from the Agency for Healthcare Research and Quality. Dr Koroukian was supported by career development award K07 CA96705 from the National Cancer Institute at the time this study was conducted.	Birkmeyer JD, 2004, J AM COLL SURGEONS, V198, P626, DOI 10.1016/j.jamcollsurg.2003.11.017; Birkmeyer JD, 2009, ANNU REV MED, V60, P405, DOI 10.1146/annurev.med.60.062107.101214; Bratzler DW, 2006, AM SURGEON, V72, P1010; Bratzler DW, 2006, CLIN INFECT DIS, V43, P322, DOI 10.1086/505220; Bratzler DW, 2005, AM J SURG, V189, P395, DOI 10.1016/j.amjsurg.2005.01.015; Centers for Medicare & Medicaid Services; Joint Commission, SPEC MAN NAT HOSP IN; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung ES, 2008, AM J MED QUAL, V23, P168, DOI 10.1177/1062860608315337; Clancy Carolyn M, 2008, AORN J, V87, P621, DOI 10.1016/j.aorn.2008.02.007; Delaney CP, 2008, ANN SURG, V247, P819, DOI 10.1097/SLA.0b013e31816d950e; Delaney CP, 2001, BRIT J SURG, V88, P1533, DOI 10.1046/j.0007-1323.2001.01905.x; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Dimick JB, 2003, SURGERY, V134, P534, DOI 10.1016/S0039-6060(03)00273-3; Dimick JB, 2004, JAMA-J AM MED ASSOC, V292, P847, DOI 10.1001/jama.292.7.847; ELBADAWI K, 2009, ANN M AM SOC COL REC; Fonarow Gregg C, 2007, Congest Heart Fail, V13, P342, DOI 10.1111/j.1527-5299.2007.07233.x; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; *JOINT COMM, 2008 CERT QUAL REP U; Lawthers AG, 2000, MED CARE, V38, P785, DOI 10.1097/00005650-200008000-00003; Leibson CL, 2008, MED CARE, V46, P127, DOI 10.1097/MLR.0b013e3181589b92; McCarthy EP, 2000, MED CARE, V38, P868, DOI 10.1097/00005650-200008000-00010; MCGLYNN EA, 2003, MED CARE S, V41, P1; Nguyen N, 2008, AM SURGEON, V74, P1012; Nolan T, 2006, JAMA-J AM MED ASSOC, V295, P1168, DOI 10.1001/jama.295.10.1168; Olsen MA, 2008, J AM COLL SURGEONS, V207, P326, DOI 10.1016/j.jamcollsurg.2008.04.021; PASTOR C, 2009, ANN M AM SOC COL REC; Premier inc, PREM PERSP DAT; *QMIS, QUAL NET; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; STRAUBE B, 2005, HLTH AFF MILLWOOD; *US DEP HHS, HOSP COMP QUAL TOOL; US Department of Health and Human Services, 2003, OCR PRIV BRIEF SUMM; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	35	394	397	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2479	2485		10.1001/jama.2010.841	http://dx.doi.org/10.1001/jama.2010.841			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571014	Bronze			2022-12-28	WOS:000279010900025
J	Rahme, E; Bernatsky, S				Rahme, Elham; Bernatsky, Sasha			NSAIDs and risk of lower gastrointestinal bleeding	LANCET			English	Editorial Material							DOUBLE-BLIND; CELECOXIB; ARTHRITIS; TOXICITY		[Rahme, Elham] McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada; McGill Univ, Ctr Hlth, Div Clin Epidemiol, Res Inst, Montreal, PQ H3A 1A1, Canada	McGill University; McGill University	Rahme, E (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A1, Canada.	elham.rahme@mcgill.ca						ALLISON MC, 1992, NEW ENGL J MED, V327, P749, DOI 10.1056/NEJM199209103271101; *AM COLL RHEUM AD, 2010, ARTHRITIS RHEUM, V15, P1058; Chan FKL, 2004, GASTROENTEROLOGY, V127, P1038, DOI 10.1053/j.gastro.2004.07.010; Chan FKL, 2010, LANCET, V376, P173, DOI 10.1016/S0140-6736(10)60673-3; Chan FKL, 2007, LANCET, V369, P1621, DOI 10.1016/S0140-6736(07)60749-1; *CONS MED QUEB, 2010, ALG UT ANT NONST AIN; Goldstein JL, 2007, CLIN GASTROENTEROL H, V5, P1167, DOI 10.1016/j.cgh.2007.06.009; Laine L, 2003, GASTROENTEROLOGY, V124, P288, DOI 10.1053/gast.2003.50054; Pincus T, 2004, ANN RHEUM DIS, V63, P931, DOI 10.1136/ard.2003.020313; Quigley C, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD004847; Rahme E, 2007, ARTHRIT RHEUM-ARTHR, V57, P748, DOI 10.1002/art.22764; Silverstein FE, 2000, JAMA-J AM MED ASSOC, V284, P1247, DOI 10.1001/jama.284.10.1247; Wolfe MM, 1999, NEW ENGL J MED, V340, P1888, DOI 10.1056/NEJM199906173402407	13	25	26	1	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 17	2010	376	9736					146	148		10.1016/S0140-6736(10)60839-2	http://dx.doi.org/10.1016/S0140-6736(10)60839-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	630YP	20638554				2022-12-28	WOS:000280313100006
J	Trivedi, B				Trivedi, Bijal			Learning from the elite	NATURE			English	Editorial Material																		Kosmrlj A, 2010, NATURE, V465, P350, DOI 10.1038/nature08997; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Okulicz JF, 2009, J INFECT DIS, V200, P1714, DOI 10.1086/646609	3	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S4	S4		10.1038/nature09235	http://dx.doi.org/10.1038/nature09235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631703				2022-12-28	WOS:000279867100024
J	Knai, C; Gilmore, A; Lock, K; McKee, M				Knai, Cecile; Gilmore, Anna; Lock, Karen; McKee, Martin			Public health research funding: independence is important	LANCET			English	Editorial Material									[Knai, Cecile; Gilmore, Anna; Lock, Karen; McKee, Martin] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Gilmore, Anna] Univ Bath, Sch Hlth, Bath, Somerset, England	University of London; London School of Hygiene & Tropical Medicine; University of Bath	Knai, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	cecile.knai@lshtm.ac.uk	gilmore, anna B/I-7130-2012; McKee, Marc D/E-2187-2011; McKee, Martin/E-6673-2018	gilmore, anna B/0000-0003-0281-1248; McKee, Marc D/0000-0001-8349-965X; Knai, Cecile/0000-0001-6663-7379; McKee, Martin/0000-0002-0121-9683				*BIOT BIOL SCI RES, 2009, DIET HLTH RES IND CL; *CANC RES UK, 2009, CANC RES UK COD PRAC; Dowler E, 2008, P NUTR SOC, V67, P289, DOI 10.1017/S0029665108008586; *EUR FOOD SAF AUTH, 2009, EFSA DEL ITS 1 SER O; Gray L, 2009, PUBLIC HEALTH NUTR, V12, P1351, DOI 10.1017/S1368980008004047; Gruning T, 2006, AM J PUBLIC HEALTH, V96, P20, DOI 10.2105/AJPH.2004.061507; Knai C, 2005, EUR J PUBLIC HEALTH, V15, P559, DOI 10.1093/eurpub/cki215; Langley C., 2009, SCI CORPORATE AGENDA; Robertson A., 2007, OBESITY SOCIOECONOMI; Smith K., 2009, 14 WORLD C TOB HLTH; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; World Health Organization, 2008, TOB IND INT TOB CONT; Wrieden WL, 2004, PUBLIC HEALTH NUTR, V7, P835, DOI 10.1079/PHN2004636	13	5	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 10	2010	376	9735					75	77		10.1016/S0140-6736(09)62063-8	http://dx.doi.org/10.1016/S0140-6736(09)62063-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	626CJ	20621222				2022-12-28	WOS:000279943200007
J	Abbott, D; Atere-Roberts, N; Williams, A; Oteng-Ntim, E; Chappell, LC				Abbott, Danielle; Atere-Roberts, Natalie; Williams, Andrew; Oteng-Ntim, Eugene; Chappell, Lucy C.			Obstetric anal sphincter injury	BMJ-BRITISH MEDICAL JOURNAL			English	Review							FECAL INCONTINENCE; PRIMARY REPAIR; VAGINAL DELIVERY; CLINICAL-TRIAL; TRAUMA; DAMAGE; TEAR		[Abbott, Danielle; Williams, Andrew; Oteng-Ntim, Eugene] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England; [Atere-Roberts, Natalie] Oxford Radcliffe Hosp NHS Trust, Oxford OX3 9DU, England; [Chappell, Lucy C.] Kings Coll London, London SE1 7EH, England	Guy's & St Thomas' NHS Foundation Trust; Oxford University Hospitals NHS Foundation Trust; University of Oxford; University of London; King's College London	Chappell, LC (corresponding author), Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk						Adams EJ, 2001, INT UROGYNECOL J, V12, P12; Ahmad M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2964; Andrews V, 2006, BJOG-INT J OBSTET GY, V113, P195, DOI 10.1111/j.1471-0528.2006.00799.x; Andrews V., 2003, REV GYNAECOL P, V3, P188; Andrews V, 2009, INT UROGYNECOL J, V20, P193, DOI 10.1007/s00192-008-0756-y; Carroli G, 2009, COCHRANE DB SYST REV, V01, DOI [10.1002/14651858.CD000081.pub2, DOI 10.1002/14651858.CD000081.PUB2]; COATS PM, 1980, BRIT J OBSTET GYNAEC, V87, P408, DOI 10.1111/j.1471-0528.1980.tb04569.x; Duggal N, 2008, OBSTET GYNECOL, V111, P1268, DOI 10.1097/AOG.0b013e31816de8ad; Eogan M, 2007, BJOG-INT J OBSTET GY, V114, P736, DOI 10.1111/j.1471-0528.2007.01331.x; Fernando R, 2006, COCHRANE DB SYST REV, V3; Fernando RJ, 2007, RCOG GREEN TOP GUIDE; Fynes M, 1999, LANCET, V354, P983, DOI 10.1016/S0140-6736(98)11205-9; Goffeng AR, 1998, ACTA OBSTET GYN SCAN, V77, P439, DOI 10.1034/j.1600-0412.1998.770415.x; Harkin R, 2003, EUR J OBSTET GYN R B, V109, P149, DOI 10.1016/S0301-2115(03)00008-3; Jarrett MED, 2008, DIS COLON RECTUM, V51, P531, DOI 10.1007/s10350-008-9199-2; Johanson JF, 1996, AM J GASTROENTEROL, V91, P33; Lal M, 2003, OBSTET GYNECOL, V101, P305, DOI 10.1016/S0029-7844(02)02716-3; Mahony R, 2004, DIS COLON RECTUM, V47, P12, DOI 10.1007/s10350-003-0009-6; Malouf AJ, 2000, LANCET, V355, P260, DOI 10.1016/S0140-6736(99)05218-6; Nordenstam J, 2009, INT UROGYNECOL J, V20, P1029, DOI 10.1007/s00192-009-0901-2; Norton C, 1999, BRIT J SURG, V86, P1159, DOI 10.1046/j.1365-2168.1999.01215.x; Pinedo G, 1999, BRIT J SURG, V86, P66, DOI 10.1046/j.1365-2168.1999.00997.x; Poen AC, 1998, BRIT J SURG, V85, P1433; Scheer I, 2009, INT UROGYNECOL J, V20, P1095, DOI 10.1007/s00192-009-0908-8; SNOOKS SJ, 1984, LANCET, V2, P546; Sultan A. H., 1995, Journal of Obstetrics and Gynaecology (Abingdon), V15, P19, DOI 10.3109/01443619509007724; SULTAN AH, 1993, INT J GYNECOL OBSTET, V43, P263, DOI 10.1016/0020-7292(93)90514-W; Trudinger A, 2008, OBSTET GYNECOL, V111, P1058, DOI 10.1097/AOG.0b013e31816c4433; Williams A, 2005, BJOG-INT J OBSTET GY, V112, P1066, DOI 10.1111/j.1471-0528.2005.00652.x; Williams AB, 2001, OBSTET GYNECOL, V97, P770, DOI 10.1016/S0029-7844(01)01318-7	30	15	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 9	2010	341								c3414	10.1136/bmj.c3414	http://dx.doi.org/10.1136/bmj.c3414			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	625DN	20621967				2022-12-28	WOS:000279874600001
J	Garcia-Pino, A; Balasubramanian, S; Wyns, L; Gazit, E; De Greve, H; Magnuson, RD; Charlier, D; van Nuland, NAJ; Loris, R				Garcia-Pino, Abel; Balasubramanian, Sreeram; Wyns, Lode; Gazit, Ehud; De Greve, Henri; Magnuson, Roy D.; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy			Allostery and Intrinsic Disorder Mediate Transcription Regulation by Conditional Cooperativity	CELL			English	Article							PLASMID ADDICTION SYSTEM; SCATTERING DATA-ANALYSIS; X-RAY-SCATTERING; STRUCTURAL BASIS; CRYSTAL-STRUCTURE; YEFM ANTITOXIN; TOXIN; PHD; PROTEIN; REPRESSOR	Regulation of the phd/doc toxin-antitoxin operon involves the toxin Doc as co- or derepressor depending on the ratio between Phd and Doc, a phenomenon known as conditional cooperativity. The mechanism underlying this observed behavior is not understood. Here we show that monomeric Doc engages two Phd dimers on two unrelated binding sites. The binding of Doc to the intrinsically disordered C-terminal domain of Phd structures its N-terminal DNA-binding domain, illustrating allosteric coupling between highly disordered and highly unstable domains. This allosteric effect also couples Doc neutralization to the conditional regulation of transcription. In this way, higher levels of Doc tighten repression up to a point where the accumulation of toxin triggers the production of Phd to counteract its action. Our experiments provide the basis for understanding the mechanism of conditional cooperative regulation of transcription typical of toxin-antitoxin modules. This model may be applicable for the regulation of other biological systems.	[Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; Charlier, Daniel; van Nuland, Nico A. J.; Loris, Remy] Vrije Univ Brussel, B-1050 Brussels, Belgium; [Garcia-Pino, Abel; Wyns, Lode; De Greve, Henri; van Nuland, Nico A. J.; Loris, Remy] Free Univ Brussels VIB, Dept Mol & Cellular Interact, B-1050 Brussels, Belgium; [Balasubramanian, Sreeram; Magnuson, Roy D.] Univ Alabama, Dept Biol Sci, Huntsville, AL 35899 USA; [Gazit, Ehud] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Microbiol & Biotechnol, IL-69978 Tel Aviv, Israel	Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Alabama System; University of Alabama Huntsville; Tel Aviv University	Garcia-Pino, A (corresponding author), Vrije Univ Brussel, Pl Laan 2, B-1050 Brussels, Belgium.	agarciap@vub.ac.be; reloris@vub.ac.be	Gazit, Ehud/AHE-9332-2022; Gazit, Ehud/C-3715-2011; Loris, Remy/GPG-0894-2022; Gazit, Ehud/M-8026-2019	Gazit, Ehud/0000-0001-5764-1720; Gazit, Ehud/0000-0001-5764-1720; Charlier, Daniel/0000-0002-6844-376X; Garcia-Pino, Abel/0000-0002-0634-0300; Loris, Remy/0000-0002-8862-3338	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS [2R15GM067668-03, 2R15GM067668-04]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM067668] Funding Source: NIH RePORTER	Vlaams Interuniversitair Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge financial support from the Vlaams Interuniversitair Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), the Onderzoeksraad of the Vrije Universiteit Brussel, and NIH NIGMS grants 2R15GM067668-03 and 2R15GM067668-04. The authors acknowledge the use of beamtime at the EMBL beamlines at the DESY (Hamburg, Germany) synchrotron and at the ESRF (Grenoble, France) and SOLEIL (Gif-sur-Yvette, France) synchrotrons. The authors thank Dr. P. Pernot (ESRF) for assistance with the collection of SAXS data and K. Wahni and S. Haesarts for technical support with protein purification.	Afif H, 2001, MOL MICROBIOL, V41, P73, DOI 10.1046/j.1365-2958.2001.02492.x; Afonine P., 2005, CCP4 NEWSL, V42, P1; Albright RA, 1998, P NATL ACAD SCI USA, V95, P3431, DOI 10.1073/pnas.95.7.3431; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Buts L, 2005, TRENDS BIOCHEM SCI, V30, P672, DOI 10.1016/j.tibs.2005.10.004; Dao-Thi MH, 2002, J BIOL CHEM, V277, P3733, DOI 10.1074/jbc.M105505200; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Jonge N, 2009, MOL CELL, V35, P154, DOI 10.1016/j.molcel.2009.05.025; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Pino A, 2008, J BIOL CHEM, V283, P30821, DOI 10.1074/jbc.M805654200; Gazit E, 1999, J BIOL CHEM, V274, P2652, DOI 10.1074/jbc.274.5.2652; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kumar P, 2008, J MOL BIOL, V383, P482, DOI 10.1016/j.jmb.2008.08.067; Lawrence JG, 2003, ANNU REV MICROBIOL, V57, P419, DOI 10.1146/annurev.micro.57.030502.090816; LEHNHERR H, 1993, J MOL BIOL, V233, P414, DOI 10.1006/jmbi.1993.1521; Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247; Liu JG, 2006, BIOCHEMISTRY-US, V45, P6873, DOI 10.1021/bi0602718; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Magnuson R, 1998, J BACTERIOL, V180, P6342; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKinley JE, 2005, J BACTERIOL, V187, P765, DOI 10.1128/JB.187.2.765-770.2005; Monti MC, 2007, NUCLEIC ACIDS RES, V35, P1737, DOI 10.1093/nar/gkm073; Oberer M, 2007, PROTEIN SCI, V16, P1676, DOI 10.1110/ps.062680707; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pollack L, 1999, P NATL ACAD SCI USA, V96, P10115, DOI 10.1073/pnas.96.18.10115; Porod G., 1982, GEN THEORY SMALL ANG; Smith JA, 2004, J BACTERIOL, V186, P2692, DOI 10.1128/JB.186.9.2692-2698.2004; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Zhao XY, 2005, J BACTERIOL, V187, P1901, DOI 10.1128/JB.187.6.1901-1912.2005	38	187	191	0	35	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					101	111		10.1016/j.cell.2010.05.039	http://dx.doi.org/10.1016/j.cell.2010.05.039			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603017	Bronze			2022-12-28	WOS:000279637300016
J	Girard, F; Ford, N; Montaner, J; Cahn, P; Katabira, E				Girard, Francoise; Ford, Nathan; Montaner, Julio; Cahn, Pedro; Katabira, Elly			Universal Access in the Fight Against HIV/AIDS	SCIENCE			English	Editorial Material							GLOBAL HEALTH INITIATIVES; ANTIRETROVIRAL THERAPY; PROSPECTIVE COHORT; HIV TRANSMISSION; SYSTEMS; CHILDREN; POLICY		[Girard, Francoise] Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA; [Ford, Nathan] Med Sans Frontieres, ZA-2017 Cape Town, South Africa; [Montaner, Julio] Univ British Columbia, Div Aids, Vancouver, BC V6Z 1Y6, Canada; [Cahn, Pedro] Fdn Huesped, Buenos Aires, DF, Argentina; [Katabira, Elly] Makerere Med Sch, Dept Res, Kampala, Uganda	University of British Columbia; Makerere University	Girard, F (corresponding author), Open Soc Inst, Publ Hlth Program, New York, NY 10019 USA.	fgirard@sorosny.org	Montaner, Julio/K-7621-2012		NIDA NIH HHS [DP1 DA026182] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026182] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Attia S, 2009, AIDS, V23, P1397, DOI 10.1097/QAD.0b013e32832b7dca; Bendavid E, 2009, ANN INTERN MED, V150, P688, DOI 10.7326/0003-4819-150-10-200905190-00117; Bender MA, 2010, CLIN INFECT DIS, V50, P416, DOI 10.1086/649884; Biesma RG, 2009, HEALTH POLICY PLANN, V24, P239, DOI 10.1093/heapol/czp025; Braitstein P, 2009, PEDIATR INFECT DIS J, V28, P626, DOI 10.1097/INF.0b013e31819665c5; BUFFERY V, 2010, REUTERS         0217; De Cock KM, 2000, JAMA-J AM MED ASSOC, V283, P1175, DOI 10.1001/jama.283.9.1175; Donnell D, 2010, LANCET, V375, P2092, DOI 10.1016/S0140-6736(10)60705-2; England R, 2007, BRIT MED J, V335, P565, DOI 10.1136/bmj.39335.520463.94; Fang CT, 2004, J INFECT DIS, V190, P879, DOI 10.1086/422601; *GFATM, GFATM REP SPEND 30 I; *GFATM, 2009, SCAL IMP RES REP; *GFATM, 2010, RES SCEN 2011 2013 F; *GFATM, 2010, GLOB FUND 2010 INN I; Goemaere E, 2002, LANCET, V360, P86, DOI 10.1016/S0140-6736(02)09343-1; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P1; Lima VD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010991; Mccoy D, 2010, B WORLD HEALTH ORGAN, V88, P478, DOI 10.2471/BLT.09.074419; MCNEILL DG, 2010, NY TIMES        0510, pA10; Mermin J, 2008, LANCET, V371, P752, DOI 10.1016/S0140-6736(08)60345-1; MIDDELKOOP K, 2009, 5 INT AIDS SOC C HIV; MSF, 2009, PUN SUCC EARL SIGNS; Piot P, 2009, LANCET, V374, P260, DOI 10.1016/S0140-6736(09)60321-4; Samb B, 2009, LANCET, V373, P2137, DOI 10.1016/S0140-6736(09)60919-3; STOCKMAN F, 2010, BOSTON GLOBE    0411, pA1; UNAIDS, 2009, WHAT COUNTR NEED INV; United Nations, 2006, ARES60262 UN; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; *WHO UNAIDS UNICEF, 2009, UN ACC SCAL PRIOR IN, P26; World Bank, 2009, IMPROVING EFFECTIVENESS AND OUTCOMES FOR THE POOR IN HEALTH, NUTRITION, AND POPULATION: AN EVALUATION OF WORLD BANK GROUP SUPPORT SINCE 1997, P1, DOI 10.1596/978-0-8213-7542-6; World Health Organisation (WHO), 2007, TOP 10 CAUS DEATH FA	32	5	6	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					147	149		10.1126/science.1193294	http://dx.doi.org/10.1126/science.1193294			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616254				2022-12-28	WOS:000279635200021
J	Hughson, FM				Hughson, Frederick M.			Copy Coats: COPI Mimics Clathrin and COPII	CELL			English	Editorial Material							VESICLES; COATOMER; SUBUNITS		Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu			NIGMS NIH HHS [R01 GM071574] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071574] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Cheng YF, 2007, J MOL BIOL, V365, P892, DOI 10.1016/j.jmb.2006.10.036; Fotin A, 2004, NATURE, V432, P573, DOI 10.1038/nature03079; HARAKUGE S, 1994, J CELL BIOL, V124, P883, DOI 10.1083/jcb.124.6.883; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0	8	10	10	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					19	21		10.1016/j.cell.2010.06.031	http://dx.doi.org/10.1016/j.cell.2010.06.031			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603010	Bronze			2022-12-28	WOS:000279637300008
J	Ricklefs, RE; Outlaw, DC				Ricklefs, Robert E.; Outlaw, Diana C.			A Molecular Clock for Malaria Parasites	SCIENCE			English	Article							AVIAN MALARIA; CO-SPECIATION; EVOLUTION; PLASMODIUM; PREVALENCE; PHYLOGENY; PATTERNS; ORIGIN; GENERA	The evolutionary origins of new lineages of pathogens are fundamental to understanding emerging diseases. Phylogenetic reconstruction based on DNA sequences has revealed the sister taxa of human pathogens, but the timing of host-switching events, including the human malaria pathogen Plasmodium falciparum, remains controversial. Here, we establish a rate for cytochrome b evolution in avian malaria parasites relative to its rate in birds. We found that the parasite cytochrome b gene evolves about 60% as rapidly as that of host cytochrome b, corresponding to similar to 1.2% sequence divergence per million years. This calibration puts the origin of P. falciparum at 2.5 million years ago (Ma), the initial radiation of mammalian Plasmodium at 12.8 Ma, and the contemporary global diversity of the Haemosporida across terrestrial vertebrates at 16.2 Ma.	[Ricklefs, Robert E.; Outlaw, Diana C.] Univ Missouri, Dept Biol, St Louis, MO 63121 USA	University of Missouri System; University of Missouri Saint Louis	Ricklefs, RE (corresponding author), Univ Missouri, Dept Biol, 1 Univ Blvd, St Louis, MO 63121 USA.	ricklefs@umsl.edu			NSF [DEB 0542390]; University of Missouri; Alexander von Humboldt Foundation	NSF(National Science Foundation (NSF)); University of Missouri; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	We thank S. S. Renner and two anonymous reviewers for constructive comments on the manuscript. The study was supported by NSF DEB 0542390 to R.E.R., who also acknowledges the generous support of the Curators of the University of Missouri and the Alexander von Humboldt Foundation.	Arbogast BS, 2002, ANNU REV ECOL SYST, V33, P707, DOI 10.1146/annurev.ecolsys.33.010802.150500; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Fallon SM, 2005, AM NAT, V165, P466, DOI 10.1086/428430; Fallon SM, 2004, P ROY SOC B-BIOL SCI, V271, P493, DOI 10.1098/rspb.2003.2621; Fallon SM, 2003, EVOLUTION, V57, P606, DOI 10.1111/j.0014-3820.2003.tb01552.x; Haag-Liautard C, 2008, PLOS BIOL, V6, P1706, DOI 10.1371/journal.pbio.0060204; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Latta SC, 2010, J AVIAN BIOL, V41, P25, DOI 10.1111/j.1600-048X.2009.04685.x; Lovette IJ, 2004, AUK, V121, P1, DOI 10.1642/0004-8038(2004)121[0001:MDAMSF]2.0.CO;2; Martin MJ, 2005, P NATL ACAD SCI USA, V102, P12819, DOI 10.1073/pnas.0503819102; Martinsen ES, 2008, MOL PHYLOGENET EVOL, V47, P261, DOI 10.1016/j.ympev.2007.11.012; Nerlich AG, 2008, EMERG INFECT DIS, V14, P1317, DOI 10.3201/eid1408.080235; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Outlaw DC, 2010, MOL BIOL EVOL, V27, P537, DOI 10.1093/molbev/msp283; Page RDM, 2003, TANGLED TREES: PHYLOGENY, COSPECIATION AND COEVOLUTION, P1; Page Roderic D. M., 1996, P255; Pauling L, 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477; Perkins SL, 2002, J PARASITOL, V88, P972, DOI 10.1645/0022-3395(2002)088[0972:AMPOMP]2.0.CO;2; Rambaut A, 2004, NAT REV GENET, V5, P52, DOI 10.1038/nrg1246; Rector A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r57; Rich SM, 2000, P NATL ACAD SCI USA, V97, P6994, DOI 10.1073/pnas.97.13.6994; Rich SM, 2009, P NATL ACAD SCI USA, V106, P14902, DOI 10.1073/pnas.0907740106; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; Sallares R, 2004, MED HIST, V48, P311, DOI 10.1017/S0025727300007651; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110	31	105	105	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					226	229		10.1126/science.1188954	http://dx.doi.org/10.1126/science.1188954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616281				2022-12-28	WOS:000279635200052
J	Bergfjord, C; Karg, S; Rast-Eicher, A; Nosch, ML; Mannering, U; Allaby, RG; Murphy, BM; Holst, B				Bergfjord, C.; Karg, S.; Rast-Eicher, A.; Nosch, M. -L.; Mannering, U.; Allaby, R. G.; Murphy, B. M.; Holst, B.			Comment on "30,000-Year-Old Wild Flax Fibers"	SCIENCE			English	Editorial Material							DNA		[Bergfjord, C.; Holst, B.] Univ Bergen, Dept Phys & Technol, N-5007 Bergen, Norway; [Karg, S.] Natl Museum Denmark, DK-1471 Copenhagen, Denmark; [Rast-Eicher, A.] Archeotex, CH-8755 Ennenda, Switzerland; [Nosch, M. -L.; Mannering, U.] Univ Copenhagen, SAXO Inst, Ctr Text Res, Danish Natl Res Fdn, DK-2300 Copenhagen, Denmark; [Allaby, R. G.] Univ Warwick, Warwick HRI, Warwick CV35 9EF, England; [Murphy, B. M.] Univ Kiel, Inst Expt & Appl Phys, D-24098 Kiel, Germany	University of Bergen; Danmarks Grundforskningsfond; University of Copenhagen; University of Warwick; University of Kiel	Holst, B (corresponding author), Univ Bergen, Dept Phys & Technol, Allegaten 55, N-5007 Bergen, Norway.	bodil@cantab.net	Holst, Bodil/B-7201-2012; Murphy, Bridget Mary M/M-2032-2017	Holst, Bodil/0000-0001-6809-2579; Murphy, Bridget Mary M/0000-0002-1354-2381; Karg, Sabine/0000-0002-1011-4859				Catling D, 2004, IDENTIFICATION VEGET; Cutler DF, 2008, PLANT ANATOMY APPL A; HERZOG A, 1953, MIKROPHOTOGRAPHISCHE; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Khalili S, 2002, J APPL BOT-ANGEW BOT, V76, P133; KORBERGROHNE U, 1998, THESIS STUTTGART; Kvavadze E, 2009, SCIENCE, V325, P1359, DOI 10.1126/science.1175404; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Luniak B., 1953, IDENTIFICATION TEXTI; Muller M, 2007, APPL PHYS A-MATER, V89, P877, DOI 10.1007/s00339-007-4219-y; Petraco N., 2004, COLOR ATLAS MANUAL M; Thygesen LG, 2007, J MATER SCI, V42, P558, DOI 10.1007/s10853-006-1113-5; TOBLER F, 1957, HDB PLANZENANTOMIE, P22; VONHOHNEL F, 1884, JB WISSENSCH BOT, V15, P313	14	36	36	0	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986								10.1126/science.1186345	http://dx.doi.org/10.1126/science.1186345			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576873				2022-12-28	WOS:000279107400020
J	Cahill, JF; McNickle, GG; Haag, JJ; Lamb, EG; Nyanumba, SM; Clair, CCS				Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Lamb, Eric G.; Nyanumba, Samson M.; Clair, Colleen Cassady St.			Plants Integrate Information About Nutrients and Neighbors	SCIENCE			English	Article							ROOT; COMMUNICATION		[Cahill, James F., Jr.; McNickle, Gordon G.; Haag, Joshua J.; Nyanumba, Samson M.; Clair, Colleen Cassady St.] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Lamb, Eric G.] Univ Saskatchewan, Dept Plant Sci, Saskatoon, SK S7N 5A8, Canada	University of Alberta; University of Saskatchewan	Cahill, JF (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada.	jc.cahill@ualberta.ca; joshua.j.haag@gmail.com	McNickle, Gordon G/F-3699-2017; McNickle, Gord/AAB-4871-2019; Lamb, Eric G/D-9319-2011; St. Clair, Colleen Cassady/A-3756-2014; Cahill, James/B-6147-2015	McNickle, Gordon G/0000-0002-7188-7265; McNickle, Gord/0000-0002-7188-7265; Lamb, Eric G/0000-0001-5201-4541; Cahill, James/0000-0002-4110-1516	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank G. Law for assistance with the Biotron plant growth facility, C. Wild for explanations of behavioral theory and trait correlations, and three anonymous reviewers for helpful comments. Supported by a Natural Sciences and Engineering Research Council of Canada Discovery Grant to J.F.C.	Gersani M, 2001, J ECOL, V89, P660, DOI 10.1046/j.0022-0477.2001.00609.x; Hodge A, 2004, NEW PHYTOL, V162, P9, DOI 10.1111/j.1469-8137.2004.01015.x; Holzapfel C, 2003, OECOLOGIA, V134, P72, DOI 10.1007/s00442-002-1062-x; Karban R, 2008, ECOL LETT, V11, P727, DOI 10.1111/j.1461-0248.2008.01183.x; Kembel SW, 2005, AM NAT, V166, P216, DOI 10.1086/431287; MAHALL BE, 1991, P NATL ACAD SCI USA, V88, P874, DOI 10.1073/pnas.88.3.874; Stephens D., 2007, FORAGING BEHAV ECOLO	7	209	235	15	279	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1657	1657		10.1126/science.1189736	http://dx.doi.org/10.1126/science.1189736			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576883				2022-12-28	WOS:000279107400033
J	Cho, EJ; Senecal, TD; Kinzel, T; Zhang, Y; Watson, DA; Buchwald, SL				Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.			The Palladium-Catalyzed Trifluoromethylation of Aryl Chlorides	SCIENCE			English	Article							FORMING REDUCTIVE ELIMINATION; CONVENIENT METHOD; ACTIVE CATALYST; PD; (TRIFLUOROMETHYL)COPPER; REACTIVITY; COMPLEXES; HALIDES	The trifluoromethyl group can dramatically influence the properties of organic molecules, thereby increasing their applicability as pharmaceuticals, agrochemicals, or building blocks for organic materials. Despite the importance of this substituent, no general method exists for its installment onto functionalized aromatic substrates. Current methods either require the use of harsh reaction conditions or suffer from a limited substrate scope. Here we report the palladium-catalyzed trifluoromethylation of aryl chlorides under mild conditions, allowing the transformation of a wide range of substrates, including heterocycles, in excellent yields. The process tolerates functional groups such as esters, amides, ethers, acetals, nitriles, and tertiary amines and, therefore, should be applicable to late-stage modifications of advanced intermediates. We have also prepared all the putative intermediates in the catalytic cycle and demonstrated their viability in the process.	[Cho, Eun Jin; Senecal, Todd D.; Kinzel, Tom; Zhang, Yong; Watson, Donald A.; Buchwald, Stephen L.] MIT, Dept Chem, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Buchwald, SL (corresponding author), MIT, Dept Chem, Cambridge, MA 02139 USA.	sbuchwal@mit.edu	Cho, Eun Jin/F-2406-2013	Senecal, Todd/0000-0002-5673-5538	NIH [GM46059]; Merck; Nippon Chemical; Boehringer Ingelheim; BASF; Alexander von Humboldt Foundation; NSF [CHE 9808061, DBI 9729592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM046059, R01GM046059] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Nippon Chemical; Boehringer Ingelheim(Boehringer Ingelheim); BASF(BASF); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the NIH for financial support of this project (grant GM46059) and Merck, Nippon Chemical, Boehringer Ingelheim, and BASF for gifts of chemicals and additional funds. T. K. thanks the Alexander von Humboldt Foundation for a Feodor Lynen postdoctoral fellowship. The Varian NMR instrument that we used was supported by the NSF (grants CHE 9808061 and DBI 9729592). We also thank P. Muller (MIT Chemistry Department, X-Ray Diffraction Facility) for obtaining the crystal structures of 13a and 13b. Cambridge Crystallographic Data Centre (CCDC) 771779 and 771780 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge from the CCDC via www.ccdc.cam.ac.uk/data_request/cif.	Ball ND, 2010, J AM CHEM SOC, V132, P2878, DOI 10.1021/ja100955x; CARR GE, 1988, PERKIN T 1, P921; Cartwright D., 1994, ORGANOFLUORINE CHEM, P237; Chen Q.-Y., 1989, CHEM COMMUN, P705; CLARK JH, 1988, CHEM COMMUN, P638; Cottet F, 2002, EUR J ORG CHEM, V2002, P327; Culkin DA, 2004, ORGANOMETALLICS, V23, P3398, DOI 10.1021/om049726k; Dubinina GG, 2008, J AM CHEM SOC, V130, P8600, DOI 10.1021/ja802946s; Fors BP, 2008, J AM CHEM SOC, V130, P13552, DOI 10.1021/ja8055358; Frisch M.J., 2016, GAUSSIAN16 REV B01; Grushin VV, 2006, J AM CHEM SOC, V128, P12644, DOI 10.1021/ja064935c; Grushin VV, 2006, J AM CHEM SOC, V128, P4632, DOI 10.1021/ja0602389; Kirsch P., 2013, MODERN FLUOROORGANIC; KOBAYASHI Y, 1969, TETRAHEDRON LETT, P4095; KONDRATENKO NV, 1980, SYNTHESIS-STUTTGART, P932; MATSUI K, 1981, CHEM LETT, P1719, DOI 10.1246/cl.1981.1719; MCLOUGHL.VC, 1969, TETRAHEDRON, V25, P5921, DOI 10.1016/S0040-4020(01)83100-8; Milne JE, 2004, J AM CHEM SOC, V126, P13028, DOI 10.1021/ja0474493; Muller K, 2007, SCIENCE, V317, P1881, DOI 10.1126/science.1131943; Naumann D, 2004, Z ANORG ALLG CHEM, V630, P746, DOI 10.1002/zaac.200400020; Oishi M, 2009, CHEM COMMUN, P1909, DOI 10.1039/b823249k; Swarts F., 1892, B ACAD R BELG, V24, P309; Thayer AM, 2006, CHEM ENG NEWS, V84, P15, DOI 10.1021/cen-v084n033.p015; Tyrra W, 2005, CHEM-EUR J, V11, P6514, DOI 10.1002/chem.200500799; URATA H, 1991, TETRAHEDRON LETT, V32, P91, DOI 10.1016/S0040-4039(00)71226-3; Wang XS, 2010, J AM CHEM SOC, V132, P3648, DOI 10.1021/ja909522s; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; WIEMERS DM, 1986, J AM CHEM SOC, V108, P832, DOI 10.1021/ja00264a043	28	593	603	2	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1679	1681		10.1126/science.1190524	http://dx.doi.org/10.1126/science.1190524			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	615BY	20576888	Green Submitted, Green Accepted			2022-12-28	WOS:000279107400039
J	Silverstein, TD; Johnson, RE; Jain, R; Prakash, L; Prakash, S; Aggarwal, AK				Silverstein, Timothy D.; Johnson, Robert E.; Jain, Rinku; Prakash, Louise; Prakash, Satya; Aggarwal, Aneel K.			Structural basis for the suppression of skin cancers by DNA polymerase eta	NATURE			English	Article							XERODERMA-PIGMENTOSUM-VARIANT; CRYSTAL-STRUCTURE; LESION-BYPASS; NUCLEOTIDE INCORPORATION; MOLECULAR ANALYSIS; YEAST; MECHANISM; REPLICATION; MUTATIONS; TEMPLATE	DNA polymerase eta (Pol eta) is unique among eukaryotic polymerases in its proficient ability for error-free replication through ultraviolet-induced cyclobutane pyrimidine dimers, and inactivation of Pol eta (also known as POLH) in humans causes the variant form of xeroderma pigmentosum (XPV). We present the crystal structures of Saccharomyces cerevisiae Pol eta (also known as RAD30) in ternary complex with a cis-syn thymine-thymine (T-T) dimer and with undamaged DNA. The structures reveal that the ability of Pol eta to replicate efficiently through the ultraviolet-induced lesion derives from a simple and yet elegant mechanism, wherein the two Ts of the T-T dimer are accommodated in an active site cleft that is much more open than in other polymerases. We also show by structural, biochemical and genetic analysis that the two Ts are maintained in a stable configuration in the active site via interactions with Gln 55, Arg 73 and Met 74. Together, these features define the basis for Pol eta's action on ultraviolet-damaged DNA that is crucial in suppressing the mutagenic and carcinogenic consequences of sun exposure, thereby reducing the incidence of skin cancers in humans.	[Silverstein, Timothy D.; Jain, Rinku; Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Johnson, Robert E.; Prakash, Louise; Prakash, Satya] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77755 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Medical Branch Galveston	Aggarwal, AK (corresponding author), Mt Sinai Sch Med, Dept Struct & Chem Biol, Box 1677,1425 Madison Ave, New York, NY 10029 USA.	saprakas@utmb.edu; aneel.aggarwal@mssm.edu	Prakash, Louise/C-7891-2012; Prakash, Satya/C-6420-2013	Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444; Silverstein, Timothy/0000-0003-0931-6274	NIH; NATIONAL CANCER INSTITUTE [R01CA107650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES017767] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank the staff at Brookhaven National Laboratory (beamlines X6A and X29) and the Advanced Photon Source (24ID) for facilitating X-ray data collection. We thank D. T. Nair, S. Lone, R. Vasquez-Del Carpio and M. Swan for discussions. This work was supported by NIH grants to A.K.A., S.P. and L.P.	Alt A, 2007, SCIENCE, V318, P967, DOI 10.1126/science.1148242; Broughton BC, 2002, P NATL ACAD SCI USA, V99, P815, DOI 10.1073/pnas.022473899; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Doublie S, 1998, NATURE, V391, P251, DOI 10.1038/34593; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0; Gratchev A, 2003, EXP DERMATOL, V12, P529, DOI 10.1034/j.1600-0625.2003.00124.x; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Kondratick CM, 2001, MOL CELL BIOL, V21, P2018, DOI 10.1128/MCB.21.6.2018-2025.2001; Li Y, 1998, EMBO J, V17, P7514, DOI 10.1093/emboj/17.24.7514; Ling H, 2001, CELL, V107, P91, DOI 10.1016/S0092-8674(01)00515-3; Lone S, 2007, MOL CELL, V25, P601, DOI 10.1016/j.molcel.2007.01.018; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; Tanioka M, 2007, J INVEST DERMATOL, V127, P1745, DOI 10.1038/sj.jid.5700759; Trincao J, 2001, MOL CELL, V8, P417, DOI 10.1016/S1097-2765(01)00306-9; Vaisman A, 2005, EMBO J, V24, P2957, DOI 10.1038/sj.emboj.7600786; Washington MT, 2001, CELL, V107, P917, DOI 10.1016/S0092-8674(01)00613-4; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; Zhou BL, 2001, MOL CELL, V8, P427, DOI 10.1016/S1097-2765(01)00310-0	31	119	120	0	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1039	U96		10.1038/nature09104	http://dx.doi.org/10.1038/nature09104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577207	Green Accepted			2022-12-28	WOS:000279056900044
J	McCartney, G; Collins, C; Dorling, D				McCartney, Gerry; Collins, Chik; Dorling, Danny			Health Inequalities Would action on health inequalities have saved New Labour?	BRITISH MEDICAL JOURNAL			English	Editorial Material							MORTALITY		[McCartney, Gerry] MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland; [Collins, Chik] Univ W Scotland, Sch Social Sci, Paisley, Renfrew, Scotland	MRC/CSO SOCIAL AND PUBLIC HEALTH SCIENCES UNIT; University of West Scotland	McCartney, G (corresponding author), MRC, Social & Publ Hlth Sci Unit, Glasgow, Lanark, Scotland.	gmccartney@nhs.net	Collins, Chik/AAE-6905-2021	Collins, Chik/0000-0003-3906-0695; McCartney, Gerry/0000-0001-6341-3521	Medical Research Council [MC_U130059812] Funding Source: Medline; Chief Scientist Office [SPHSU1] Funding Source: Medline; MRC [MC_U130059812] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Chief Scientist Office; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Dorling D, 2001, BRIT MED J, V322, P1336, DOI 10.1136/bmj.322.7298.1336; Dorling D, 2010, NEW STATESMAN   0614; Dorling D, 2007, CLOSER EQUALITY ASSE; Foot Paul, 2005, VOTE IT WAS WON IT W; HALL C, 1997, DAILY TELEGRAPH 0520, P9; PINCHERL.G, 1969, BRIT J PREV SOC MED, V23, P72; Shaw M, 2005, BMJ-BRIT MED J, V330, P1016, DOI 10.1136/bmj.330.7498.1016; Smith GD, 1996, BRIT MED J, V313, P1573, DOI 10.1136/bmj.313.7072.1573	8	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 23	2010	340								c3294	10.1136/bmj.c3294	http://dx.doi.org/10.1136/bmj.c3294			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IP	20573766				2022-12-28	WOS:000279346400008
J	Benach, J; Muntaner, C; Chung, H; Solar, O; Santana, V; Friel, S; Houweling, TAJ; Marmot, M				Benach, Joan; Muntaner, Carles; Chung, Haejoo; Solar, Orielle; Santana, Vilma; Friel, Sharon; Houweling, Tanja A. J.; Marmot, Michael			Health inequalities The importance of government policies in reducing employment related health inequalities	BRITISH MEDICAL JOURNAL			English	Editorial Material							WEALTHY COUNTRIES; INFORMAL WORK; UNEMPLOYMENT		[Benach, Joan; Muntaner, Carles; Chung, Haejoo; Solar, Orielle] Univ Pompeu Fabra, Employment Condit Knowledge Network EMCONET, Hlth Inequal Res Grp GREDS, Barcelona, Spain; [Muntaner, Carles; Chung, Haejoo] Univ Toronto, Bloomberg Fac Nursing, Toronto, ON M5S 1A1, Canada; [Muntaner, Carles; Chung, Haejoo] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Chung, Haejoo] Korea Univ, Coll Hlth Sci, Dept Healthcare Management, Seoul, South Korea; [Santana, Vilma] Univ Fed Bahia, Inst Collect Hlth, BR-41170290 Salvador, BA, Brazil; [Friel, Sharon; Houweling, Tanja A. J.; Marmot, Michael] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England	Pompeu Fabra University; University of Toronto; University of Toronto; Korea University; Universidade Federal da Bahia; University of London; University College London	Benach, J (corresponding author), Univ Pompeu Fabra, Employment Condit Knowledge Network EMCONET, Hlth Inequal Res Grp GREDS, Barcelona, Spain.	joan.benach@upf.edu	Benach, Joan/H-2519-2013; Marmot, M G/Y-3920-2019; Houweling, Tanja/GRF-6127-2022	Benach, Joan/0000-0003-2285-742X; Marmot, M G/0000-0002-2431-6419; Chung, Haejoo/0000-0002-2661-4161; Houweling, Tanja AJ/0000-0001-6090-4376; Friel, Sharon/0000-0002-8345-5435; Sousa Santana, Vilma/0000-0003-3399-7612	MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G19/35, G8802774, G0902037, G0100222] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Artazcoz L, 2005, J EPIDEMIOL COMMUN H, V59, P761, DOI 10.1136/jech.2004.028704; Artazcoz L, 2004, AM J PUBLIC HEALTH, V94, P82, DOI 10.2105/AJPH.94.1.82; Bartley M, 2004, J EPIDEMIOL COMMUN H, V58, P501, DOI 10.1136/jech.2003.009878; BENACH J, 2010, EMCONET NET IN PRESS; Benach J, 2010, INT J HEALTH SERV, V40, P315, DOI 10.2190/HS.40.2.k; Bosma H, 1997, BRIT MED J, V314, P558, DOI 10.1136/bmj.314.7080.558; Chung H, 2006, SOC SCI MED, V63, P829, DOI 10.1016/j.socscimed.2006.01.030; Chung H, 2010, INT J HEALTH SERV, V40, P229, DOI 10.2190/HS.40.2.e; Concha-Barrientos M, 2005, AM J IND MED, V48, P470, DOI 10.1002/ajim.20226; DIDERICHSEN F, 1997, ANAL PROPORTION TOTA; Dorling D, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b829; Egan M, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.053231; ESPINGANDERSEN G, 2001, WHY DEREGULATE LABOU; Ferrie JE, 2001, J ROY SOC MED, V94, P71, DOI 10.1177/014107680109400206; Giatti L, 2008, J EPIDEMIOL COMMUN H, V62, P1079, DOI 10.1136/jech.2007.069740; Giatti L, 2008, CAD SAUDE PUBLICA, V24, P2396, DOI 10.1590/S0102-311X2008001000020; Hamalainen P, 2006, SAFETY SCI, V44, P137, DOI 10.1016/j.ssci.2005.08.017; Hamalainen P, 2007, AM J IND MED, V50, P28, DOI 10.1002/ajim.20411; International Labour Office, 2010, GLOB EMPL TRENDS; Marmot M., 2006, SOCIAL DETERMINANTS, P97; Marmot M, 1999, SOCIAL DETERMINANTS, V1999, P105, DOI [10.1093/acprof:oso/9780198565895.001.0001, DOI 10.1093/ACPROF:OSO/9780198565895.001.0001]; Mitchell R., 2000, INEQUALITIES LIFE DE; Muntaner C, 2002, INT J HEALTH SERV, V32, P629; *ORG EC COOP DEV, UN OECD COUNTR APPR; Parent-Thirion A., 2007, 4 EUROPEAN WORKING C; Sekine M, 2009, SOC SCI MED, V69, P1417, DOI 10.1016/j.socscimed.2009.08.022; SHAPIRO C, 1984, AM ECON REV, V74, P433; Silver B., 2003, FORCES LABOR; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Tros F., 2004, EUROPEAN REV LABOUR, V10, P166, DOI DOI 10.1177/102425890401000204; Virtanen M, 2005, INT J EPIDEMIOL, V34, P610, DOI 10.1093/ije/dyi024; VIVES A, 2010, OCC ENV MED IN PRESS; *WHO COMM SOC DET, 2008, COMM SOC DET HLTH FI	33	12	13	3	16	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 21	2010	340								c2154	10.1136/bmj.c2154	http://dx.doi.org/10.1136/bmj.c2154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IN	20566594				2022-12-28	WOS:000279346200001
J	Beer, C; Reichstein, M; Tomelleri, E; Ciais, P; Jung, M; Carvalhais, N; Rodenbeck, C; Arain, MA; Baldocchi, D; Bonan, GB; Bondeau, A; Cescatti, A; Lasslop, G; Lindroth, A; Lomas, M; Luyssaert, S; Margolis, H; Oleson, KW; Roupsard, O; Veenendaal, E; Viovy, N; Williams, C; Woodward, FI; Papale, D				Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Ciais, Philippe; Jung, Martin; Carvalhais, Nuno; Roedenbeck, Christian; Arain, M. Altaf; Baldocchi, Dennis; Bonan, Gordon B.; Bondeau, Alberte; Cescatti, Alessandro; Lasslop, Gitta; Lindroth, Anders; Lomas, Mark; Luyssaert, Sebastiaan; Margolis, Hank; Oleson, Keith W.; Roupsard, Olivier; Veenendaal, Elmar; Viovy, Nicolas; Williams, Christopher; Woodward, F. Ian; Papale, Dario			Terrestrial Gross Carbon Dioxide Uptake: Global Distribution and Covariation with Climate	SCIENCE			English	Article							VEGETATION; BIOSPHERE; CO2; RADIATION; PRODUCTS; FRACTION; SULFIDE; NETWORK; IMPACT; MODEL	Terrestrial gross primary production (GPP) is the largest global CO2 flux driving several ecosystem functions. We provide an observation-based estimate of this flux at 123 +/- 8 petagrams of carbon per year (Pg C year(-1)) using eddy covariance flux data and various diagnostic models. Tropical forests and savannahs account for 60%. GPP over 40% of the vegetated land is associated with precipitation. State-of-the-art process-oriented biosphere models used for climate predictions exhibit a large between-model variation of GPP's latitudinal patterns and show higher spatial correlations between GPP and precipitation, suggesting the existence of missing processes or feedback mechanisms which attenuate the vegetation response to climate. Our estimates of spatially distributed GPP and its covariation with climate can help improve coupled climate-carbon cycle process models.	[Beer, Christian; Reichstein, Markus; Tomelleri, Enrico; Jung, Martin; Carvalhais, Nuno; Lasslop, Gitta] Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany; [Ciais, Philippe; Viovy, Nicolas] CEA CNRS UVSQ, Inst Pierre Simon Laplace, Lab Sci Climat & Environm, Gif Sur Yvette, France; [Carvalhais, Nuno] Univ Nova Lisboa, FCT, Caparica, Portugal; [Arain, M. Altaf] McMaster Univ, McMaster Ctr Climate Change, Hamilton, ON, Canada; [Baldocchi, Dennis] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Baldocchi, Dennis] Univ Calif Berkeley, Berkeley Atmospher Sci Ctr, Berkeley, CA 94720 USA; [Bonan, Gordon B.; Oleson, Keith W.] Natl Ctr Atmospher Res, Boulder, CO 80305 USA; [Bondeau, Alberte] Potsdam Inst Climate Impact Res PIK, D-14473 Potsdam, Germany; [Cescatti, Alessandro] Commiss European Communities, DG Joint Res Ctr, Inst Environm & Sustainabil, Climate Change Unit, Ispra, Italy; [Lindroth, Anders] Lund Univ, Dept Earth & Ecosyst Sci, S-22100 Lund, Sweden; [Lomas, Mark] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England; [Luyssaert, Sebastiaan] Univ Antwerp, Dept Biol, Antwerp, Belgium; [Margolis, Hank] Univ Laval, Ctr Etud Foret, Fac Foresterie Geogr & Geomat, Quebec City, PQ, Canada; [Roupsard, Olivier] Cirad Persyst, UPR80, Fonct & Pilotage Ecosyst Plantat, Montpellier, France; [Roupsard, Olivier] CATIE, Turrialba, Costa Rica; [Veenendaal, Elmar] Wageningen Univ, Nat Conservat & Plant Ecol Grp, Wageningen, Netherlands; [Williams, Christopher] Clark Univ, Grad Sch Geog, Worcester, MA 01610 USA; [Papale, Dario] Univ Tuscia, Dept Forest Enviromm & Resources, Viterbo, Italy	Max Planck Society; UDICE-French Research Universities; Universite Paris Cite; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); Universidade Nova de Lisboa; McMaster University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; National Center Atmospheric Research (NCAR) - USA; Potsdam Institut fur Klimafolgenforschung; European Commission Joint Research Centre; EC JRC ISPRA Site; Lund University; University of Sheffield; University of Antwerp; Laval University; CIRAD; Wageningen University & Research; Clark University; Tuscia University	Beer, C (corresponding author), Max Planck Inst Biogeochem, Biogeochem Model Data Integrat Grp, D-07745 Jena, Germany.	christian.beer@bgc-jena.mpg.de	Roupsard, Olivier/C-1219-2008; Cescatti, Alessandro/ABE-6319-2020; Viovy, Nicolas/S-2631-2018; Oleson, Keith/A-9328-2008; Papale, Dario/W-7302-2019; Reichstein, Markus/A-7494-2011; Beer, Christian/D-2296-2013; Ciais, Philippe/A-6840-2011; Arain, M. Altaf/ABA-9750-2020; Woodward, Ian F/B-7762-2008; Bondeau, Alberte/E-9909-2012; Veenendaal, Elmar M/B-4628-2009; Tomelleri, Enrico/AAJ-3219-2020; Luyssaert, Sebastiaan/F-6684-2011; Lindroth, Anders/N-4697-2014; Baldocchi, Dennis/A-1625-2009; Tomelleri, Enrico/N-6147-2014; Woodward, Frank Ian/P-4530-2019	Roupsard, Olivier/0000-0002-1319-142X; Viovy, Nicolas/0000-0002-9197-6417; Oleson, Keith/0000-0002-0057-9900; Papale, Dario/0000-0001-5170-8648; Reichstein, Markus/0000-0001-5736-1112; Beer, Christian/0000-0002-5377-3344; Ciais, Philippe/0000-0001-8560-4943; Arain, M. Altaf/0000-0002-1433-5173; Bondeau, Alberte/0000-0002-8729-5061; Tomelleri, Enrico/0000-0001-6546-6459; Luyssaert, Sebastiaan/0000-0003-1121-1869; Lindroth, Anders/0000-0002-7669-784X; Baldocchi, Dennis/0000-0003-3496-4919; Tomelleri, Enrico/0000-0001-6546-6459; Carvalhais, Nuno/0000-0003-0465-1436; Williams, Christopher A./0000-0002-5047-0639; Lasslop, Gitta/0000-0001-9939-1459	Department of Energy, Biological and Environmental Research [DE-FG02-04ER63917, DE-FG02-04ER63911]; AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP; CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC; BIOCAP; Environment Canada; NRCan; GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation; University of Tuscia; Universite Laval; Div Atmospheric & Geospace Sciences [0910766] Funding Source: National Science Foundation; Natural Environment Research Council [earth010003] Funding Source: researchfish; NERC [earth010003] Funding Source: UKRI	Department of Energy, Biological and Environmental Research(United States Department of Energy (DOE)); AfriFlux; AsiaFlux; CarboAfrica; CarboEuropeIP(European Commission); CarboItaly; CarboMont; ChinaFlux; Fluxnet-Canada; CFCAS; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); BIOCAP; Environment Canada(CGIAR); NRCan(Natural Resources Canada); GreenGrass; KoFlux; LBA; NECC; OzFlux; TCOS-Siberia; USCCC; FAO-GTOS-TCO; Integrated Land Ecosystem-Atmosphere Processes Study; MaxPlanck Institute for Biogeochemistry; National Science Foundation(National Science Foundation (NSF)); University of Tuscia; Universite Laval; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work used eddy covariance data acquired by the FLUXNET community and in particular by the following networks: AmeriFlux [U.S. Department of Energy, Biological and Environmental Research, Terrestrial Carbon Program (DEFG02-04ER63917 and DE-FG02-04ER63911)], AfriFlux, AsiaFlux, CarboAfrica, CarboEuropeIP, CarboItaly, CarboMont, ChinaFlux, Fluxnet-Canada (supported by CFCAS, NSERC, BIOCAP, Environment Canada, and NRCan), GreenGrass, KoFlux, LBA, NECC, OzFlux, TCOS-Siberia, and USCCC. We acknowledge the support to the eddy covariance data harmonization provided by CarboEuropeIP, FAO-GTOS-TCO, Integrated Land Ecosystem-Atmosphere Processes Study, MaxPlanck Institute for Biogeochemistry, National Science Foundation, University of Tuscia, Universite Laval and Environment Canada and U.S. Department of Energy and the database development and technical support from Berkeley Water Center, Lawrence Berkeley National Laboratory, Microsoft Research eScience, Oak Ridge National Laboratory, University of California-Berkeley, and University of Virginia. Remotely sensed land cover, fAPAR, and LAI were available through the Joint Research Centre of the European Commission, the National Aeronautics and Space Administration, and the projects GLC2000 and CYCLOPES. Climate data came from the European Centre for Medium-Range Weather Forecasts, the Climate Research Unit of the University of East Anglia, and the GEWEX project GPCP. We thank Mahendra K. Karki at GMAO/NASA for extracting the MOD17 required surface meteorological variables from the GMAO reanalysis dataset and Maosheng Zhao at NTSG of University of Montana for calculating the respective daytime VPD. We further acknowledge support by the European Commission FP7 projects COMBINE and CARBO-Extreme and a grant from the Max-Planck Society establishing the MPRG Biogeochemical Model-Data Integration. C.B., D.P., M.R., P.C., D.B., and S.L. conceived the study. C.B., C.R., D.P., E.T., M.J., M.R., and N.C. contributed diagnostic modeling results. C.B., A.B., G.B.B., M.L., F.I.W., and N.V. contributed process model results. C.B., E.T., and M.R. performed the analysis. C.B. and M.R. wrote the manuscript. All other coauthors contributed with data or substantial input to the manuscript.	Baldocchi D, 2008, AUST J BOT, V56, P1, DOI 10.1071/BT07151; Baret F, 2007, REMOTE SENS ENVIRON, V110, P275, DOI 10.1016/j.rse.2007.02.018; Beer C, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL029006; Beer C, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003233; Bondeau A, 2007, GLOBAL CHANGE BIOL, V13, P679, DOI 10.1111/j.1365-2486.2006.01305.x; Campbell JE, 2008, SCIENCE, V322, P1085, DOI 10.1126/science.1164015; Ciais P, 1997, J GEOPHYS RES-ATMOS, V102, P5857, DOI 10.1029/96JD02360; DeLucia EH, 2007, GLOBAL CHANGE BIOL, V13, P1157, DOI 10.1111/j.1365-2486.2007.01365.x; FARQUHAR GD, 1993, NATURE, V363, P439, DOI 10.1038/363439a0; Fekete BM, 2004, J CLIMATE, V17, P294, DOI 10.1175/1520-0442(2004)017<0294:UIPATI>2.0.CO;2; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerten D, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024247; Gobron N, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006511; Jung M, 2009, BIOGEOSCIENCES, V6, P2001, DOI 10.5194/bg-6-2001-2009; Lieth H., 1975, PRIMARY PRODUCTIVITY, V14, P237, DOI [10.1007/978-3-642-80913-2_12, DOI 10.1007/978-3-642-80913-2_12]; Litton CM, 2007, GLOBAL CHANGE BIOL, V13, P2089, DOI 10.1111/j.1365-2486.2007.01420.x; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mercado LM, 2009, NATURE, V458, P1014, DOI 10.1038/nature07949; Mitchell TD, 2005, INT J CLIMATOL, V25, P693, DOI 10.1002/joc.1181; MONTEITH JL, 1972, J APPL ECOL, V9, P747, DOI 10.2307/2401901; Myneni RB, 2002, REMOTE SENS ENVIRON, V83, P214, DOI 10.1016/S0034-4257(02)00074-3; Nemani RR, 2003, SCIENCE, V300, P1560, DOI 10.1126/science.1082750; New M, 2002, CLIMATE RES, V21, P1, DOI 10.3354/cr021001; Papale D, 2003, GLOBAL CHANGE BIOL, V9, P525, DOI 10.1046/j.1365-2486.2003.00609.x; POORTER H, 1990, PLANT PHYSIOL, V94, P621, DOI 10.1104/pp.94.2.621; Prentice IC, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P183; Rodenbeck C, 2003, ATMOS CHEM PHYS, V3, P1919; Running SW, 2000, METHODS IN ECOSYSTEM SCIENCE, P44; Sandoval-Soto L, 2005, BIOGEOSCIENCES, V2, P125, DOI 10.5194/bg-2-125-2005; Saugier B., 2001, TERRESTRIAL GLOBAL P, P401; Schulze E. D., 1970, Flora, Jena, V159, P177; Simmons A, 2007, ECMWF NEWSLETTER; Suntharalingam P, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034332; Whittaker RH, 1975, PRIMARY PRODUCTIVITY, P305, DOI DOI 10.1007/978-3-642-80913-2_15; Wingate L, 2009, P NATL ACAD SCI USA, V106, P22411, DOI 10.1073/pnas.0905210106; Zhao M, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2004JG000004	37	1613	1713	80	1271	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	AUG 13	2010	329	5993					834	838		10.1126/science.1184984	http://dx.doi.org/10.1126/science.1184984			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	637ID	20603496	Green Published			2022-12-28	WOS:000280809900049
J	Bergenstal, RM; Wysham, C; MacConell, L; Malloy, J; Walsh, B; Yan, P; Wilhelm, K; Malone, J; Porter, LE				Bergenstal, Richard M.; Wysham, Carol; MacConell, Leigh; Malloy, Jaret; Walsh, Brandon; Yan, Ping; Wilhelm, Ken; Malone, Jim; Porter, Lisa E.		DURATION-2 Study Grp	Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial	LANCET			English	Article							GLYCEMIC CONTROL; TREATED PATIENTS; EUROPEAN-ASSOCIATION; CONSENSUS STATEMENT; EXENDIN-4; THERAPY; ALGORITHM; WEIGHT; HYPERGLYCEMIA; ADJUSTMENT	Background Most patients with type 2 diabetes begin pharmacotherapy with metformin, but eventually need additional treatment. We assessed the safety and efficacy of once weekly exenatide, a glucagon-like peptide 1 receptor agonist, versus maximum approved doses of the dipeptidyl peptidase-4 inhibitor, sitagliptin, or the thiazolidinedione, pioglitazone, in patients treated with metformin. Methods In this 26-week randomised, double-blind, double-dummy, superiority trial, patients with type 2 diabetes who had been treated with metformin, and at baseline had mean glycosylated haemoglobin (HbA(1c)) of 8.5% (SD 1.1), fasting plasma glucose of 9.1 mmol/L (2.6), and weight of 88.0 kg (20.1), were enrolled and treated at 72 sites in the USA, India, and Mexico. Patients were randomly assigned to receive: 2 mg injected exenatide once weekly plus oral placebo once daily; 100 mg oral sitagliptin once daily plus injected placebo once weekly; or 45 mg oral pioglitazone once daily plus injected placebo once weekly. Primary endpoint was change in HbA(1c) between baseline and week 26. Analysis was by intention to treat, for all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov, number NCT00637273. Findings 170 patients were assigned to receive once weekly exenatide, 172 to receive sitagliptin, and 172 to receive pioglitazone. 491 patients received at least one dose of study drug and were included in the intention-to-treat analysis (160 on exenatide, 166 on sitagliptin, and 165 on pioglitazone). Treatment with exenatide reduced HbA(1c) (least square mean -1.5%, 95% CI -1.7 to -1.4) significantly more than did sitagliptin (-0.9%, -1.1 to -0.7) or pioglitazone (-1.2%, -1.4 to -1.0). Treatment differences were -0.6% (95% CI -0.9 to -0.4, p<0.0001) for exenatide versus sitagliptin, and -0.3% (-0.6 to -0.1, p=0.0165) for exenatide versus pioglitazone. Weight loss with exenatide (-2.3 kg, 95% CI-2.9 to -1.7) was significantly greater than with sitagliptin (difference -1.5 kg, 95% CI -2.4 to -0.7, p=0.0002) or pioglitazone (difference -5.1 kg, -5.9 to -4.3, p<0.0001). No episodes of major hypoglycaemia occurred. The most frequent adverse events with exenatide and sitagliptin were nausea (n=38, 24%, and n=16, 10%, respectively) and diarrhoea (n=29, 18%, and n=16, 10%, respectively); upper-respiratory-tract infection (n=17, 10%) and peripheral oedema (n=13, 8%) were the most frequent events with pioglitazone. Interpretation The goal of many clinicians who manage diabetes is to achieve optimum glucose control alongside weight loss and a minimum number of hypoglycaemic episodes. Addition of exenatide once weekly to metformin achieved this goal more often than did addition of maximum daily doses of either sitagliptin or pioglitazone.	[Bergenstal, Richard M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA; [Wysham, Carol] Rockwood Clin, Spokane, WA USA; [MacConell, Leigh; Malloy, Jaret; Walsh, Brandon; Yan, Ping; Wilhelm, Ken; Porter, Lisa E.] Amylin Pharmaceut, San Diego, CA USA; [Malone, Jim] Eli Lilly & Co, Indianapolis, IN 46285 USA	International Diabetes Center; Bristol-Myers Squibb; Amylin Pharmaceuticals, LLC; Eli Lilly	Bergenstal, RM (corresponding author), Int Diabet Ctr Pk Nicollet, 3800 Pk Nicollet Blvd, Minneapolis, MN 55416 USA.	richard.bergenstal@parknicollet.com	Buse, John Bernard/J-9742-2019	Buse, John Bernard/0000-0002-9723-3876	Amylin Pharmaceuticals; Eli Lilly	Amylin Pharmaceuticals(Bristol-Myers Squibb); Eli Lilly(Eli Lilly)	We thank the DURATION-2 Study Group and their staff for their excellent work in the conduct, reporting, and quality control of the study; the study patients for their participation; Kristin Taylor and Larry Shen (employees of Amylin Pharmaceuticals) for assistance with study design and data interpretation; and Alkermes for the development and manufacture of the longacting release formulation of exenatide. This study was supported by Amylin Pharmaceuticals and Eli Lilly.	Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; Bradley C., 1994, HDB PSYCHOL DIABETES, P111; Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; Cheung BMY, 2009, AM J MED, V122, P443, DOI 10.1016/j.amjmed.2008.09.047; Clarke P, 2002, MED DECIS MAKING, V22, P340, DOI 10.1177/027298902400448902; Conway PH, 2009, NEW ENGL J MED, V361, P328, DOI 10.1056/NEJMp0905631; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Dupuy H.J., 1984, ASSESSMENT QUALITY L, P170; Fineman MS, 2003, DIABETES CARE, V26, P2370, DOI 10.2337/diacare.26.8.2370; Goldberg RB, 2005, DIABETES CARE, V28, P1547, DOI 10.2337/diacare.28.7.1547; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Kim S, 2009, CURR MICROBIOL, V58, P159, DOI 10.1007/s00284-008-9294-6; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Kolotkin RL, 2003, DIABETES RES CLIN PR, V61, P125, DOI 10.1016/S0168-8227(03)00113-X; *MERCK, 2009, JAN SIT TABL PRESCR; Nathan DM, 2006, DIABETES CARE, V29, P1963, DOI 10.2337/dc06-9912; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pradhan AD, 2009, JAMA-J AM MED ASSOC, V302, P1186, DOI 10.1001/jama.2009.1347; Ratner RE, 2006, DIABETES OBES METAB, V8, P419, DOI 10.1111/j.1463-1326.2006.00589.x; Rodbard HW, 2009, ENDOCR PRACT, V15, P540, DOI 10.4158/EP.15.6.540; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; *TAK PHARM AM, 2009, ACT PIOGL HYDR TABL; Tan MH, 2005, DIABETES CARE, V28, P544, DOI 10.2337/diacare.28.3.544; Williams-Herman DE, 2009, DIABETES, V58, pA144; *WORLD MED ASS DEC, 1997, JAMA-J AM MED ASSOC, V277, P925, DOI DOI 10.1001/JAMA.1997.03540350075038; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003	30	478	504	1	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 7	2010	376	9739					431	439		10.1016/S0140-6736(10)60590-9	http://dx.doi.org/10.1016/S0140-6736(10)60590-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20580422				2022-12-28	WOS:000281012900028
J	Luzzatto, L				Luzzatto, Lucio			The rise and fall of the antimalarial Lapdap: a lesson in pharmacogenetics	LANCET			English	Editorial Material							UNCOMPLICATED FALCIPARUM-MALARIA; CHLORPROGUANIL-DAPSONE; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; SULFADOXINE-PYRIMETHAMINE; ARTEMETHER-LUMEFANTRINE; RANDOMIZED-TRIAL; AFRICAN CHILDREN; PLUS ARTESUNATE; DEHYDROGENASE; LEPROSY		Ist Toscano Tumori, I-50139 Florence, Italy	ISPRO Istituto per lo studio, la prevenzione e la rete oncologica	Luzzatto, L (corresponding author), Ist Toscano Tumori, Via Taddeo Alderotti 26N, I-50139 Florence, Italy.							Alloueche A, 2004, LANCET, V363, P1843, DOI 10.1016/S0140-6736(04)16350-2; [Anonymous], 1967, World Health Organ Tech Rep Ser, V366, P1; BIENZLE U, 1972, LANCET, V1, P107; BRUCECHWATT LJ, 1982, BRIT MED J, V284, P767, DOI 10.1136/bmj.284.6318.767; Bukirwa H, 2004, COCHRANE DB SYST REV, V4; BYRD SR, 1991, LEPROSY REV, V62, P171; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; *DAC LAPD, UPD GSKS MAL TREATM; DEGOWIN RL, 1966, B WORLD HEALTH ORGAN, V35, P165; Fanello CI, 2008, T ROY SOC TROP MED H, V102, P412, DOI 10.1016/j.trstmh.2008.01.013; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Jalloh A, 2004, TROP MED INT HEALTH, V9, P615, DOI 10.1111/j.1365-3156.2004.01237.x; Krattiger A., 2007, EXECUTIVE GUIDE INTE, P11; Kremsner PG, 2004, LANCET, V364, P285, DOI 10.1016/S0140-6736(04)16680-4; Owusu-Agyei S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002530; PONNAMPALAM JT, 1981, TROP GEOGR MED, V33, P401; Premji Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006682; PUAVILAI S, 1984, J MED ASSOC THAILAND, V67, P404; Sulo J, 2002, LANCET, V360, P1136, DOI 10.1016/S0140-6736(02)11198-6; Winstanley P, 2001, TROP MED INT HEALTH, V6, P952, DOI 10.1046/j.1365-3156.2001.00751.x; WOODRUFF AW, 1981, BMJ-BRIT MED J, V282, P988; [No title captured]; 2004, REV SAFETY CHLORPROG	24	44	44	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG-SEP	2010	376	9742					739	741		10.1016/S0140-6736(10)60396-0	http://dx.doi.org/10.1016/S0140-6736(10)60396-0			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	646YW	20599264				2022-12-28	WOS:000281582900033
J	Lassance, JM; Groot, AT; Lienard, MA; Antony, B; Borgwardt, C; Andersson, F; Hedenstrom, E; Heckel, DG; Lofstedt, C				Lassance, Jean-Marc; Groot, Astrid T.; Lienard, Marjorie A.; Antony, Binu; Borgwardt, Christin; Andersson, Fredrik; Hedenstrom, Erik; Heckel, David G.; Lofstedt, Christer			Allelic variation in a fatty-acyl reductase gene causes divergence in moth sex pheromones	NATURE			English	Article							EUROPEAN CORN-BORER; DESATURASE GENE; LEPIDOPTERA; POLYMORPHISM; EVOLUTION; SPECIFICITY; SPECIATION; SOFTWARE; LINKAGE; SYSTEM	Pheromone-based behaviours are crucial in animals from insects to mammals(1,2), and reproductive isolation is often based on pheromone differences(1-4). However, the genetic mechanisms by which pheromone signals change during the evolution of new species are largely unknown(4). In the sexual communication system of moths (Insecta: Lepidoptera), females emit a species-specific pheromone blend that attracts males over long distances(1,2,4). The European corn borer, Ostrinia nubilalis, consists of two sex pheromone races, Z and E, that use different ratios of the cis and trans isomers of acetate pheromone components(5). This subtle difference leads to strong reproductive isolation in the field between the two races(6,7), which could represent a first step in speciation. Female sex pheromone production and male behavioural response are under the control of different major genes(8,9), but the identity of these genes is unknown. Here we show that allelic variation in a fatty-acyl reductase gene essential for pheromone biosynthesis accounts for the phenotypic variation in female pheromone production, leading to race-specific signals. Both the cis and trans isomers of the pheromone precursors are produced by both races, but the precursors are differentially reduced to yield opposite ratios in the final pheromone blend as a result of the substrate specificity of the enzymes encoded by the Z and E alleles. This is the first functional characterization of a gene contributing to intraspecific behavioural reproductive isolation in moths, highlighting the importance of evolutionary diversification in a lepidopteran-specific family of reductases. Accumulation of substitutions in the coding region of a single biosynthetic enzyme can produce pheromone differences resulting in reproductive isolation, with speciation as a potential end result.	[Lassance, Jean-Marc; Lienard, Marjorie A.; Antony, Binu; Lofstedt, Christer] Lund Univ, Dept Biol, S-22362 Lund, Sweden; [Groot, Astrid T.; Borgwardt, Christin; Heckel, David G.] Max Planck Inst Chem Ecol, Dept Entomol, D-07745 Jena, Germany; [Andersson, Fredrik; Hedenstrom, Erik] Mid Sweden Univ, Dept Nat Sci Engn & Math, S-85170 Sundsvall, Sweden	Lund University; Max Planck Society; Mid-Sweden University	Lassance, JM (corresponding author), Lund Univ, Dept Biol, S-22362 Lund, Sweden.	jean-marc.lassance@ekol.lu.se; christer.lofstedt@ekol.lu.se	Groot, Astrid/A-8954-2013; Lassance, Jean-Marc/AAF-3933-2020; Löfstedt, Christer/G-2016-2014; Heckel, David G/K-2138-2013; Antony, Binu/M-8562-2015	Groot, Astrid/0000-0001-9595-0161; Lassance, Jean-Marc/0000-0002-3675-6956; Löfstedt, Christer/0000-0002-3116-6922; Heckel, David G/0000-0001-8991-2150; Antony, Binu/0000-0002-6292-620X; Lienard, Marjorie/0000-0003-3193-3666	Swedish Research Council (VR); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS); Max-Planck-Gesellschaft	Swedish Research Council (VR)(Swedish Research Council); Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS)(Swedish Research Council Formas); Max-Planck-Gesellschaft(Max Planck Society)	We thank R.G. Harrison for his comments and advice. This research was funded by the Swedish Research Council (VR), the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (FORMAS) and the Max-Planck-Gesellschaft.	Antony B, 2009, INSECT BIOCHEM MOLEC, V39, P90, DOI 10.1016/j.ibmb.2008.10.008; CARDE RT, 1978, SCIENCE, V199, P555, DOI 10.1126/science.199.4328.555; COYNE J.A., 2004, SPECIATION; COYNE JA, 1994, SCIENCE, V265, P1461, DOI 10.1126/science.8073292; Dallerac R, 2000, P NATL ACAD SCI USA, V97, P9449, DOI 10.1073/pnas.150243997; Dopman EB, 2005, P NATL ACAD SCI USA, V102, P14706, DOI 10.1073/pnas.0502054102; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Greenberg AJ, 2003, SCIENCE, V302, P1754, DOI 10.1126/science.1090432; GUTHRIE W. D., 1965, ANN ENTOMOL SOC AMER, V58, P100, DOI 10.1093/aesa/58.1.100; HANSSON BS, 1987, NATURWISSENSCHAFTEN, V74, P497, DOI 10.1007/BF00447935; HECKEL DG, 1993, ANNU REV ENTOMOL, V38, P381, DOI 10.1146/annurev.en.38.010193.002121; Ishikawa Y, 1999, ENTOMOL EXP APPL, V91, P237, DOI 10.1023/A:1003601407578; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; KLUN JA, 1973, SCIENCE, V181, P661, DOI 10.1126/science.181.4100.661; KLUN JA, 1979, ENVIRON ENTOMOL, V8, P423, DOI 10.1093/ee/8.3.423; Knipple DC, 2002, GENETICS, V162, P1737; Kochansky J, 1975, J CHEM ECOL, V1, P225, DOI 10.1007/BF00987871; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lassance JM, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-10; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lienard MA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-270; LOFSTEDT C, 1989, GENETICS, V123, P553; Malausa T, 2005, SCIENCE, V308, P258, DOI 10.1126/science.1107577; Moto K, 2003, P NATL ACAD SCI USA, V100, P9156, DOI 10.1073/pnas.1531993100; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; ROELOFS W, 1987, P NATL ACAD SCI USA, V84, P7585, DOI 10.1073/pnas.84.21.7585; Roelofs WL, 2002, P NATL ACAD SCI USA, V99, P13621, DOI 10.1073/pnas.152445399; Shirangi TR, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000168; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang J, 2005, NUCLEIC ACIDS RES, V33, pD399, DOI 10.1093/nar/gki116; WOLF WA, 1987, J CHEM ECOL, V13, P1019, DOI 10.1007/BF01020535; Wyatt T. D., 2003, PHEROMONES ANIMAL BE, DOI 10.1017/CBO9780511615061; Wyatt TD, 2009, NATURE, V457, P262, DOI 10.1038/457262a; Xue BY, 2007, P NATL ACAD SCI USA, V104, P4467, DOI 10.1073/pnas.0700422104; Zhu JW, 1996, INSECT BIOCHEM MOLEC, V26, P171, DOI 10.1016/0965-1748(95)00079-8	37	151	160	0	80	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					486	U7		10.1038/nature09058	http://dx.doi.org/10.1038/nature09058			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20592730				2022-12-28	WOS:000280141200035
J	Basu, P				Basu, Paroma			Forgotten lessons	NATURE			English	Editorial Material																			0	2	2	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 15	2010	466	7304					S14	S15		10.1038/nature09241	http://dx.doi.org/10.1038/nature09241			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631697	Bronze			2022-12-28	WOS:000279867100030
J	Sastre, EA				Sastre, Elizabeth Ann			The Hike	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												elizabeth.a.sastre@vanderbilt.edu							0	0	0	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					134	135		10.1001/jama.2010.882	http://dx.doi.org/10.1001/jama.2010.882			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628118				2022-12-28	WOS:000279811000001
J	Berger, SL				Berger, Shelley L.			Keeping p53 in Check: A High-Stakes Balancing Act	CELL			English	Editorial Material									[Berger, Shelley L.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Berger, Shelley L.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Berger, SL (corresponding author), Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	bergers@upenn.edu		Berger, Shelley/0000-0001-5398-4400	NATIONAL CANCER INSTITUTE [R01CA078831] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA078831] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Huang J, 2008, CURR OPIN GENET DEV, V18, P152, DOI 10.1016/j.gde.2008.01.012; Huang J, 2007, NATURE, V449, P105, DOI 10.1038/nature06092; Huang J, 2010, J BIOL CHEM, V285, P9636, DOI 10.1074/jbc.M109.062588; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037	7	19	21	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					17	19		10.1016/j.cell.2010.06.026	http://dx.doi.org/10.1016/j.cell.2010.06.026			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603009	Green Accepted, Bronze			2022-12-28	WOS:000279637300007
J	Houtkooper, RH; Williams, RW; Auwerx, J				Houtkooper, Riekelt H.; Williams, Robert W.; Auwerx, Johan			Metabolic Networks of Longevity	CELL			English	Article							EXTENDS LIFE-SPAN; MITOCHONDRIAL-FUNCTION; INSULIN SENSITIVITY; ENERGY-EXPENDITURE; C-ELEGANS; RESVERATROL; SIRT1; MICE; RESTRICTION; DIET		[Houtkooper, Riekelt H.; Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland; [Williams, Robert W.] Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA; [Williams, Robert W.] Ctr Integrat & Translat Genom, Memphis, TN 38163 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Tennessee System; University of Tennessee Health Science Center	Auwerx, J (corresponding author), Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, CH-1015 Lausanne, Switzerland.	johan.auwerx@epfl.ch	Auwerx, Johan/ABE-9307-2021; Houtkooper, Riekelt H/E-1602-2011; Houtkooper, Riekelt/P-5001-2019; Williams, Robert W./H-8789-2016	Houtkooper, Riekelt H/0000-0001-9961-0842; Williams, Robert W./0000-0001-8924-4447; Auwerx, Johan/0000-0002-5065-5393	Netherlands Organization for Scientific Research; NIAAA; NIDA; NIMH; Ecole Polytechnique Federale de Lausanne; NIH [DK59820]; EU [ERC-2008-AdG-23118]; Swiss National Science Foundation (SNF) [31003A-124713]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK059820] Funding Source: NIH RePORTER	Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); NIAAA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Ecole Polytechnique Federale de Lausanne; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); Swiss National Science Foundation (SNF)(Swiss National Science Foundation (SNSF)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Ed Baetge, Ann Kato, Carles Canto, Penelope Andreux, and Evan G. Williams for helpful suggestions. R.H.H. is supported by a Rubicon fellowship of the Netherlands Organization for Scientific Research. GeneNetwork is supported by grants from the NIAAA, NIDA, and NIMH. The authors are supported by the Ecole Polytechnique Federale de Lausanne, NIH (DK59820), the EU Ideas program (Sirtuins; ERC-2008-AdG-23118), and the Swiss National Science Foundation (SNF 31003A-124713).	Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Argmann C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000752; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bellizzi D, 2005, GENOMICS, V85, P258, DOI 10.1016/j.ygeno.2004.11.003; Bjedov I, 2010, CELL METAB, V11, P35, DOI 10.1016/j.cmet.2009.11.010; CANTO C, 2010, J CELL METAB, V11, P213; Canto C, 2009, TRENDS ENDOCRIN MET, V20, P325, DOI 10.1016/j.tem.2009.03.008; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Curtsinger JW, 2002, MECH AGEING DEV, V123, P81, DOI 10.1016/S0047-6374(01)00345-1; De Haan G, 1999, FASEB J, V13, P707, DOI 10.1096/fasebj.13.6.707; de Magalhaes JP, 2009, AGING CELL, V8, P65, DOI 10.1111/j.1474-9726.2008.00442.x; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; GELMAN R, 1988, GENETICS, V118, P693; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Heikkinen S, 2009, CELL METAB, V9, P88, DOI 10.1016/j.cmet.2008.11.007; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Libert S, 2007, CELL, V131, P1231, DOI 10.1016/j.cell.2007.12.002; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Miller RA, 2005, AGING CELL, V4, P119, DOI 10.1111/j.1474-9726.2005.00152.x; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837; Russell SJ, 2007, NAT REV MOL CELL BIO, V8, P681, DOI 10.1038/nrm2234; Rutanen J, 2010, DIABETES, V59, P829, DOI 10.2337/db09-1191; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Stanfel MN, 2009, BBA-GEN SUBJECTS, V1790, P1067, DOI 10.1016/j.bbagen.2009.06.007; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Xue HL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100189; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	39	146	153	0	37	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JUL 9	2010	142	1					9	14		10.1016/j.cell.2010.06.029	http://dx.doi.org/10.1016/j.cell.2010.06.029			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	622CU	20603007	Bronze, Green Accepted			2022-12-28	WOS:000279637300005
J	Jasny, B; Mueller, K; Roberts, L				Jasny, Barbara; Mueller, Kristen; Roberts, Leslie			HIV/AIDS: Eastern Europe INTRODUCTION	SCIENCE			English	Editorial Material																			0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					159	159		10.1126/science.329.5988.159	http://dx.doi.org/10.1126/science.329.5988.159			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	622CB	20616261				2022-12-28	WOS:000279635200028
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Listen up: deafness and personal audio players	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUL 7	2010	341								c3539	10.1136/bmj.c3539	http://dx.doi.org/10.1136/bmj.c3539			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	625DL	20610496				2022-12-28	WOS:000279874300011
J	Willeit, P; Willeit, J; Mayr, A; Weger, S; Oberhollenzer, F; Brandstatter, A; Kronenberg, F; Kiechl, S				Willeit, Peter; Willeit, Johann; Mayr, Agnes; Weger, Siegfried; Oberhollenzer, Friedrich; Brandstaetter, Anita; Kronenberg, Florian; Kiechl, Stefan			Telomere Length and Risk of Incident Cancer and Cancer Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN FIBROBLASTS; DYSFUNCTION; INSTABILITY; EXPRESSION; CARCINOMA; DISEASE; MEN	Context Telomeres are essential to preserve the integrity of the genome. Critically short telomeres lead to replicative cell senescence and chromosomal instability and may thereby increase cancer risk. Objective To determine the association between baseline telomere length and incident cancer and cancer mortality. Design, Setting, and Participants Leukocyte telomere length was measured by quantitative polymerase chain reaction in 787 participants free of cancer at baseline in 1995 from the prospective, population-based Bruneck Study in Italy. Main Outcome Measures Incident cancer and cancer mortality over a follow-up period of 10 years (1995-2005 with a follow-up rate of 100%). Results A total of 92 of 787 participants (11.7%) developed cancer (incidence rate, 13.3 per 1000 person-years). Short telomere length at baseline was associated with incident cancer independently of standard cancer risk factors (multivariable hazard ratio [HR] per 1-SD decrease in loge-transformed telomere length, 1.60; 95% confidence interval [CI], 1.30-1.98; P<.001). Compared with participants in the longest telomere length group, the multivariable HR for incident cancer was 2.15 (95% CI, 1.12-4.14) in the middle length group and 3.11 (95% CI, 1.65-5.84) in the shortest length group (P<.001). Incidence rates were 5.1 (95% CI, 2.9-8.7) per 1000 person-years in the longest telomere length group, 14.2 (95% CI, 10.0-20.1) per 1000 person-years in the middle length group, and 22.5 (95% CI, 16.9-29.9) per 1000 person-years in the shortest length group. The association equally applied to men and women and emerged as robust under a variety of circumstances. Furthermore, short telomere length was associated with cancer mortality (multivariable HR per 1-SD decrease in loge-transformed telomere length, 2.13; 95% CI, 1.58-2.86; P<.001) and individual cancer subtypes with a high fatality rate. Conclusion In this study population, there was a statistically significant inverse relationship between telomere length and both cancer incidence and mortality. JAMA. 2010;304(1):69-75 www.jama.com	[Willeit, Peter; Willeit, Johann; Kiechl, Stefan] Innsbruck Med Univ, Dept Neurol, A-6020 Innsbruck, Austria; [Brandstaetter, Anita; Kronenberg, Florian] Innsbruck Med Univ, Div Genet Epidemiol, Dept Human Genet Mol & Clin Pharmacol, A-6020 Innsbruck, Austria; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England; [Mayr, Agnes] Bruneck Hosp, Dept Lab Med, Brunico, Italy; [Weger, Siegfried; Oberhollenzer, Friedrich] Bruneck Hosp, Dept Internal Med, Brunico, Italy	Medical University of Innsbruck; Medical University of Innsbruck; University of Cambridge	Kiechl, S (corresponding author), Innsbruck Med Univ, Dept Neurol, Anichstr 35, A-6020 Innsbruck, Austria.	stefan.kiechl@i-med.ac.at	Kronenberg, Florian/B-1736-2008; Willeit, Peter/HCI-7091-2022	Kronenberg, Florian/0000-0003-2229-1120; Willeit, Peter/0000-0002-1866-7159; , Agnes Mayr/0000-0001-9363-873X; Kloss-Brandstatter, Anita/0000-0002-0873-6704	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr Johannes and Hertha Tuba Foundation; Competence Centers for Excellent Technologies Center; ONCOTYROL; Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University; Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck; Assessorat fuer Gesundheit, Province of Bolzano, Italy	Dr P. Willeit was supported by a scholarship from the Dr Johannes and Hertha Tuba Foundation. Dr Kronenberg was supported by a grant from the Competence Centers for Excellent Technologies Center, ONCOTYROL, and the Integriertes Forschungs- und Therapiezentrum of Innsbruck Medical University. The study was supported by the Pustertaler Verein zur Pravention von Herz-und Hirngefaesserkrankungen, Gesundheitsbezirk Bruneck, and the Assessorat fuer Gesundheit, Province of Bolzano, Italy.	Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Broberg K, 2005, CARCINOGENESIS, V26, P1263, DOI 10.1093/carcin/bgi063; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chin K, 2004, NAT GENET, V36, P984, DOI 10.1038/ng1409; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; DAVIDSON HR, 1988, J MED GENET, V25, P843, DOI 10.1136/jmg.25.12.843; De Vivo I, 2009, CANCER EPIDEM BIOMAR, V18, P1152, DOI 10.1158/1055-9965.EPI-08-0998; Hashimoto Y, 2008, J GASTROINTEST SURG, V12, P17, DOI 10.1007/s11605-007-0383-9; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Kiechl S, 2002, NEW ENGL J MED, V347, P185, DOI 10.1056/NEJMoa012673; Kiechl S, 2007, CIRCULATION, V116, P385, DOI 10.1161/CIRCULATIONAHA.106.686774; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Lan Q, 2009, CLIN CANCER RES, V15, P7429, DOI 10.1158/1078-0432.CCR-09-0845; Lee IM, 2010, CLIN CHEM LAB MED, V48, P259, DOI 10.1515/CCLM.2010.049; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Mukhopadhyay D, 2004, SEMIN CANCER BIOL, V14, P123, DOI 10.1016/j.semcancer.2003.09.019; Plentz RR, 2004, HEPATOLOGY, V40, P80, DOI 10.1002/hep.20271; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Rudolph KL, 2001, NAT GENET, V28, P155, DOI 10.1038/88871; Shao L, 2007, J UROLOGY, V178, P1492, DOI 10.1016/j.juro.2007.05.112; Shen J, 2009, INT J CANCER, V124, P1637, DOI 10.1002/ijc.24105; Svenson U, 2008, CANCER RES, V68, P3618, DOI 10.1158/0008-5472.CAN-07-6497; Weng NP, 1997, IMMUNOL REV, V160, P43, DOI 10.1111/j.1600-065X.1997.tb01026.x; Wenning GK, 2005, LANCET NEUROL, V4, P815, DOI 10.1016/S1474-4422(05)70226-X; Wood C, 2005, CELL RES, V15, P947, DOI 10.1038/sj.cr.7290372; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; XU QB, 1993, LANCET, V341, P255, DOI 10.1016/0140-6736(93)92613-X; Zee RYL, 2009, CANCER EPIDEM BIOMAR, V18, P2280, DOI 10.1158/1055-9965.EPI-09-0360	34	358	375	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 7	2010	304	1					69	75		10.1001/jama.2010.897	http://dx.doi.org/10.1001/jama.2010.897			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620SJ	20606151	Bronze			2022-12-28	WOS:000279519600023
J	El Albani, A; Bengtson, S; Canfield, DE; Bekker, A; Macchiarelli, R; Mazurier, A; Hammarlund, EU; Boulvais, P; Dupuy, JJ; Fontaine, C; Fursich, FT; Gauthier-Lafaye, F; Janvier, P; Javaux, E; Ossa, FO; Pierson-Wickmann, AC; Riboulleau, A; Sardini, P; Vachard, D; Whitehouse, M; Meunier, A				El Albani, Abderrazak; Bengtson, Stefan; Canfield, Donald E.; Bekker, Andrey; Macchiarelli, Roberto; Mazurier, Arnaud; Hammarlund, Emma U.; Boulvais, Philippe; Dupuy, Jean-Jacques; Fontaine, Claude; Fuersich, Franz T.; Gauthier-Lafaye, Francois; Janvier, Philippe; Javaux, Emmanuelle; Ossa, Frantz Ossa; Pierson-Wickmann, Anne-Catherine; Riboulleau, Armelle; Sardini, Paul; Vachard, Daniel; Whitehouse, Martin; Meunier, Alain			Large colonial organisms with coordinated growth in oxygenated environments 2.1 Gyr ago	NATURE			English	Article							NUCLEAR-FISSION REACTORS; GABON; DEPOSITS; URANIUM; EUKARYOTES; FOSSILS; CARBON; OKLO	The evidence for macroscopic life during the Palaeoproterozoic era (2.5-1.6 Gyr ago) is controversial(1-5). Except for the nearly 2-Gyr-old coil-shaped fossil Grypania spiralis(6,7), which may have been eukaryotic, evidence for morphological and taxonomic bio-diversification of macroorganisms only occurs towards the beginning of the Mesoproterozoic era (1.6-1.0 Gyr)(8). Here we report the discovery of centimetre-sized structures from the 2.1-Gyr-old black shales of the Palaeoproterozoic Francevillian B Formation in Gabon, which we interpret as highly organized and spatially discrete populations of colonial organisms. The structures are up to 12 cm in size and have characteristic shapes, with a simple but distinct ground pattern of flexible sheets and, usually, a permeating radial fabric. Geochemical analyses suggest that the sediments were deposited under an oxygenated water column. Carbon and sulphur isotopic data indicate that the structures were distinct biogenic objects, fossilized by pyritization early in the formation of the rock. The growth patterns deduced from the fossil morphologies suggest that the organisms showed cell-to-cell signalling and coordinated responses, as is commonly associated with multicellular organization(9). The Gabon fossils, occurring after the 2.45-2.32-Gyr increase in atmospheric oxygen concentration(10), may be seen as ancient representatives of multicellular life, which expanded so rapidly 1.5 Gyr later, in the Cambrian explosion.	[El Albani, Abderrazak; Fontaine, Claude; Ossa, Frantz Ossa; Sardini, Paul; Meunier, Alain] Univ Poitiers, CNRS, UMR INSU 6269, Lab HYDRASA, F-86022 Poitiers, France; [Bengtson, Stefan; Hammarlund, Emma U.] Swedish Museum Nat Hist, Dept Palaeozool, SE-10405 Stockholm, Sweden; [Canfield, Donald E.; Hammarlund, Emma U.] Nord Ctr Earth Evolut, DK-5230 Odense M, Denmark; [Bekker, Andrey] Univ Manitoba, Dept Geol Sci, Winnipeg, MB R3T 2N2, Canada; [Macchiarelli, Roberto] Univ Poitiers, Dept Geosci, Ctr Microtomog, F-86022 Poitiers, France; [Macchiarelli, Roberto] Museum Natl Hist Nat, CNRS, UMR 7194, Dept Prehist, F-75005 Paris, France; [Mazurier, Arnaud] CRI Biopole, Soc Etud Rech Mat, F-86000 Poitiers, France; [Hammarlund, Emma U.] Stockholm Univ, Dept Geol Sci, S-10691 Stockholm, Sweden; [Boulvais, Philippe; Pierson-Wickmann, Anne-Catherine] Univ Rennes, UMR 6118, Dept Geosci, F-35042 Rennes, France; [Dupuy, Jean-Jacques] Bur Rech Geol & Minieres, F-45060 Orleans, France; [Fuersich, Franz T.] Univ Erlangen Nurnberg, GeoZentrum Nordbayern, Fachgrp Palaoumwelt, D-91054 Erlangen, Germany; [Gauthier-Lafaye, Francois] CNRS, UMR 7517, Lab Hydrol & Geochim Strasbourg, F-67084 Strasbourg, France; [Janvier, Philippe] Museum Natl Hist Nat, CNRS, UMR 7207, Dept Hist Terre, F-75005 Paris, France; [Javaux, Emmanuelle] Univ Liege, Dept Geol, Unite Rech Paleobot Paleopalynol Micropaleontol, B-4000 Sart Tilman Par Liege, Belgium; [Riboulleau, Armelle; Vachard, Daniel] Univ Lille 1, CNRS, FRE 3298, Lab Geosyst, F-59655 Villeneuve Dascq, France; [Whitehouse, Martin] Swedish Museum Nat Hist, Lab Isotope Geol, SE-10405 Stockholm, Sweden	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Swedish Museum of Natural History; University of Manitoba; Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); Universite de Poitiers; Stockholm University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite de Rennes; Bureau de Recherches Geologiques et Minieres (BRGM); University of Erlangen Nuremberg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Liege; Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille; Swedish Museum of Natural History	El Albani, A (corresponding author), Univ Poitiers, CNRS, UMR INSU 6269, Lab HYDRASA, F-86022 Poitiers, France.	abder.albani@univ-poitiers.fr	Arnaud, Mazurier/Q-3199-2017; Canfield, Don/C-1735-2012; Arnaud, Mazurier/R-4577-2019; Whitehouse, Martin J/E-1425-2013; Pierson-Wickmann, Anne-Catherine/J-3383-2012; Frantz, Stefan/G-1723-2012	Arnaud, Mazurier/0000-0003-1894-0554; Canfield, Don/0000-0001-7602-8366; Arnaud, Mazurier/0000-0003-1894-0554; Whitehouse, Martin J/0000-0003-2227-577X; Pierson-Wickmann, Anne-Catherine/0000-0002-7715-3772; Hammarlund, Emma/0000-0001-7625-4793; Bekker, Andrey/0000-0002-1154-0585; Bengtson, Stefan/0000-0003-0206-5791; Riboulleau, Armelle/0000-0002-2717-8330; Ossa Ossa, Frantz/0000-0003-1875-8082	French Embassy at Libreville; French Ministry for Foreign Affairs; Knut and Alice Wallenberg Foundation; French CNRS-INSU; Bureau de Recherches Geologiques et Minieres (BRGM); Danish National Research Foundation; Swedish Research Council	French Embassy at Libreville; French Ministry for Foreign Affairs; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); French CNRS-INSU(Centre National de la Recherche Scientifique (CNRS)); Bureau de Recherches Geologiques et Minieres (BRGM); Danish National Research Foundation(Danmarks Grundforskningsfond); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank the Ministry of Mines, Oil, Energy and Hydraulic Resources and the General Direction of Mines and Geology of Gabon for collaboration and assistance, and the French Embassy at Libreville and the French Ministry for Foreign Affairs for support. We thank F. Mayaga-Mikolo, D. Beaufort, B. Cost, D. Thieblemont, F. Pambo and H. Sigmund for discussions. For assistance in Gabon and France, we acknowledge S. Accolas, T. Bonifait, B. Braconnier, N. Dauger, F. Duru, D. Fabry, F. Haessler, M. Jouve, G. Letort, D. Paquet, J.-C. Parneix, D. Proust, M. Stampanoni and X. Valentin. We also acknowledge the Institut Francais du Petrole, the Swiss Light Source (TOMCAT beamline) at the Paul Scherrer Institute, and the Centre de Microtomographie at the University of Poitiers (CdMT). Nordsim is operated under an agreement of the Joint Committee of the Nordic Research Councils for Natural Sciences (NOS-N), with further funding from the Knut and Alice Wallenberg Foundation; this is Nordsim contribution 256. Research was supported by the French CNRS-INSU, the Bureau de Recherches Geologiques et Minieres (BRGM), the Danish National Research Foundation and the Swedish Research Council.	Allwood AC, 2006, NATURE, V441, P714, DOI 10.1038/nature04764; Bekker A, 2008, EARTH PLANET SC LETT, V271, P278, DOI 10.1016/j.epsl.2008.04.021; Bekker A, 2004, NATURE, V427, P117, DOI 10.1038/nature02260; Ben-Jacob E, 2003, PHILOS T R SOC A, V361, P1283, DOI 10.1098/rsta.2003.1199; Bengtson S, 2007, PALEOBIOLOGY, V33, P351, DOI 10.1666/04040.1; Bengtson S, 2009, P NATL ACAD SCI USA, V106, P7729, DOI 10.1073/pnas.0812460106; Bonner JT., 2000, 1 SIGNALS EVOLUTION; Bose P. K., 2007, ATLAS MICROBIAL MAT, P117; BROS R, 1992, EARTH PLANET SC LETT, V113, P207, DOI 10.1016/0012-821X(92)90220-P; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; CORTIAL F, 1990, ORG GEOCHEM, V15, P73, DOI 10.1016/0146-6380(90)90185-3; Dutkiewicz A, 2007, CHEM GEOL, V244, P130, DOI 10.1016/j.chemgeo.2007.06.010; Farrell UC, 2009, GEOLOGY, V37, P907, DOI 10.1130/G30177A.1; Frei R, 2009, NATURE, V461, P250, DOI 10.1038/nature08266; Gancarz A. J., 1978, Natural Fission Reactors, P513; Gauthier-Lafaye F, 2003, PRECAMBRIAN RES, V120, P81, DOI 10.1016/S0301-9268(02)00163-8; GAUTHIERLAFAYE F, 1989, ECON GEOL, V84, P2267, DOI 10.2113/gsecongeo.84.8.2267; Grazhdankin D, 2007, LETHAIA, V40, P201, DOI 10.1111/j.1502-3931.2007.00025.x; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; HAN TM, 1992, SCIENCE, V257, P232, DOI 10.1126/science.1631544; HOORI K, 2005, 15 ANN GOLDSCHM C, P23114; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Lamb DM, 2007, PRECAMBRIAN RES, V154, P236, DOI 10.1016/j.precamres.2006.12.012; Mossman DJ, 2001, PRECAMBRIAN RES, V106, P135, DOI 10.1016/S0301-9268(00)00129-7; Rasmussen B, 2008, NATURE, V455, P1101, DOI 10.1038/nature07381; Schneider DA, 2002, CAN J EARTH SCI, V39, P999, DOI 10.1139/E02-016; Seilacher A, 1998, SCIENCE, V282, P80, DOI 10.1126/science.282.5386.80; Seilacher A, 2005, PALAEOGEOGR PALAEOCL, V227, P323, DOI 10.1016/j.palaeo.2005.06.003; Shapiro JA, 1997, BACTERIA MULTICELLUL; Wacey D., 2009, EARLY LIFE EARTH PRA	30	142	143	7	127	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 1	2010	466	7302					100	104		10.1038/nature09166	http://dx.doi.org/10.1038/nature09166			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596019				2022-12-28	WOS:000279343800042
J	Hang, CT; Yang, J; Han, P; Cheng, HL; Shang, C; Ashley, E; Zhou, B; Chang, CP				Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Zhou, Bin; Chang, Ching-Pin			Chromatin regulation by Brg1 underlies heart muscle development and disease	NATURE			English	Article							MYOSIN HEAVY-CHAIN; GENE-EXPRESSION; DILATED CARDIOMYOPATHY; ISOFORM EXPRESSION; CARDIAC GROWTH; POLY(ADP-RIBOSE); HYPERTROPHY; INHIBITION; VENTRICLE	Cardiac hypertrophy and failure are characterized by transcriptional reprogramming of gene expression. Adult cardiomyocytes in mice primarily express alpha-myosin heavy chain (alpha-MHC, also known as Myh6), whereas embryonic cardiomyocytes express beta-MHC (also known as Myh7). Cardiac stress triggers adult hearts to undergo hypertrophy and a shift from alpha-MHC to fetal beta-MHC expression. Here we show that Brg1, a chromatin-remodelling protein, has a critical role in regulating cardiac growth, differentiation and gene expression. In embryos, Brg1 promotes myocyte proliferation by maintaining Bmp10 and suppressing p57(kip2) expression. It preserves fetal cardiac differentiation by interacting with histone deacetylase (HDAC) and poly (ADP ribose) polymerase (PARP) to repress alpha-MHC and activate beta-MHC. In adults, Brg1 (also known as Smarca4) is turned off in cardiomyocytes. It is reactivated by cardiac stresses and forms a complex with its embryonic partners, HDAC and PARP, to induce a pathological alpha-MHC to beta-MHC shift. Preventing Brg1 re-expression decreases hypertrophy and reverses this MHC switch. BRG1 is activated in certain patients with hypertrophic cardiomyopathy, its level correlating with disease severity and MHC changes. Our studies show that Brg1 maintains cardiomyocytes in an embryonic state, and demonstrate an epigenetic mechanism by which three classes of chromatin-modifying factors-Brg1, HDAC and PARP-cooperate to control developmental and pathological gene expression.	[Hang, Calvin T.; Yang, Jin; Han, Pei; Cheng, Hsiu-Ling; Shang, Ching; Ashley, Euan; Chang, Ching-Pin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Mol Genet, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Pediat, Bronx, NY 10461 USA; [Zhou, Bin] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA	Stanford University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Chang, CP (corresponding author), Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	chingpin@stanford.edu	Yang, Jin/C-5468-2013; Pei, Han/E-8237-2012		NIH; American Heart Association (AHA); Children's Heart Foundation; March of Dimes Foundation; Office of the University of California; California Institute of Regenerative Medicine; Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085345] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); Children's Heart Foundation; March of Dimes Foundation(March of Dimes); Office of the University of California; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Kaiser Foundation; Baxter Foundation; Oak Foundation; Stanford Cardiovascular Institute; Kirschstein-NRSA Postdoctoral Fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank B. Black for providing Mef2c-cre mice; G. R. Crabtree, D. Bernstein, M. Rabinovitch, R. Robbins, V. Christoffels, W. Shou, J. Wysocka and K. Zhao for materials and discussions; B. Wu, A. Sun, J. Lehrer-Graiwer, W. Li, C. Y. Lin and C. J. Lin for technical assistance; M. Zhao, M. Zeini and K. Stankunas for technical advice to H.-L. C., P. H. and C. T. H. C.-P. C. was supported by funds from the NIH, American Heart Association (AHA), Children's Heart Foundation, March of Dimes Foundation, Office of the University of California, California Institute of Regenerative Medicine, Kaiser Foundation, Baxter Foundation, Oak Foundation, Stanford Cardiovascular Institute and W. Younger. C. T. H. was supported by predoctoral training fellowships from the NIH and AHA; H.-L. C. by a visiting scholar fellowship; C. S. by Kirschstein-NRSA Postdoctoral Fellowship; B.Z. by NIH and AHA grants.	Abraham WT, 2002, MOL MED, V8, P750, DOI 10.1007/BF03402039; Antos CL, 2003, J BIOL CHEM, V278, P28930, DOI 10.1074/jbc.M303113200; Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Bartha E, 2009, CARDIOVASC RES, V83, P501, DOI 10.1093/cvr/cvp144; Blaxall BC, 2003, J AM COLL CARDIOL, V41, P1096, DOI 10.1016/S0735-1097(03)00043-3; Boucher P, 2003, SCIENCE, V300, P329, DOI 10.1126/science.1082095; Braunwald E., 1997, HEART DIS TXB CARDIO, V5th; Bultman S, 2000, MOL CELL, V6, P1287, DOI 10.1016/S1097-2765(00)00127-1; Chang CP, 2003, GENESIS, V36, P7, DOI 10.1002/gene.10186; Chang CP, 2004, CELL, V118, P649, DOI 10.1016/j.cell.2004.08.010; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Herron TJ, 2002, CIRC RES, V90, P1150, DOI 10.1161/01.RES.0000022879.57270.11; Ho L, 2010, NATURE, V463, P474, DOI 10.1038/nature08911; James J, 2005, CIRCULATION, V111, P2339, DOI 10.1161/01.CIR.0000164233.09448.B1; Kee HJ, 2006, CIRCULATION, V113, P51, DOI 10.1161/CIRCULATIONAHA.105.559724; Kinugawa K, 2001, CIRC RES, V89, P591, DOI 10.1161/hh1901.096706; Kong YL, 2006, CIRCULATION, V113, P2579, DOI 10.1161/CIRCULATIONAHA.106.625467; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Liu R, 2001, CELL, V106, P309, DOI 10.1016/S0092-8674(01)00446-9; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Lowes BD, 1997, J CLIN INVEST, V100, P2315, DOI 10.1172/JCI119770; McKinsey TA, 2005, J CLIN INVEST, V115, P538, DOI 10.1172/JCI200524144; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; MORROW AG, 1961, ANN SURG, V154, P181, DOI 10.1097/00000658-196108000-00003; MUCHARDT C, 1993, EMBO J, V12, P4279, DOI 10.1002/j.1460-2075.1993.tb06112.x; Pandya K, 2008, P NATL ACAD SCI USA, V105, P13063, DOI 10.1073/pnas.0805120105; Pillai JB, 2006, AM J PHYSIOL-HEART C, V291, pH1545, DOI 10.1152/ajpheart.01124.2005; Schmitt JP, 2006, P NATL ACAD SCI USA, V103, P14525, DOI 10.1073/pnas.0606383103; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Stankunas K, 2008, DEV CELL, V14, P298, DOI 10.1016/j.devcel.2007.11.018; SumiIchinose C, 1997, MOL CELL BIOL, V17, P5976, DOI 10.1128/MCB.17.10.5976; Szabo G, 2002, CIRC RES, V90, P100, DOI 10.1161/hh0102.102657; Trivedi CM, 2007, NAT MED, V13, P324, DOI 10.1038/nm1552; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Verzi MP, 2005, DEV BIOL, V287, P134, DOI 10.1016/j.ydbio.2005.08.041; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu BR, 2010, GENESIS, V48, P63, DOI 10.1002/dvg.20573	39	329	347	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					62	U74		10.1038/nature09130	http://dx.doi.org/10.1038/nature09130			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596014	Green Accepted			2022-12-28	WOS:000279343800035
J	Petukhova, L; Duvic, M; Hordinsky, M; Norris, D; Price, V; Shimomura, Y; Kim, H; Singh, P; Lee, A; Chen, WV; Meyer, KC; Paus, R; Jahoda, CAB; Amos, CI; Gregersen, PK; Christiano, AM				Petukhova, Lynn; Duvic, Madeleine; Hordinsky, Maria; Norris, David; Price, Vera; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Lee, Annette; Chen, Wei V.; Meyer, Katja C.; Paus, Ralf; Jahoda, Colin A. B.; Amos, Christopher I.; Gregersen, Peter K.; Christiano, Angela M.			Genome-wide association study in alopecia areata implicates both innate and adaptive immunity	NATURE			English	Article							AUTOIMMUNE-DISEASE; HAIR FOLLICLE; NKG2D LIGAND; RISK LOCUS; EXPRESSION; CANCER; GENES; CELLS; PEROXIREDOXIN-5; SUSCEPTIBILITY	Alopecia areata (AA) is among the most highly prevalent human autoimmune diseases, leading to disfiguring hair loss due to the collapse of immune privilege of the hair follicle and subsequent autoimmune attack(1,2). The genetic basis of AA is largely unknown. We undertook a genome-wide association study (GWAS) in a sample of 1,054 cases and 3,278 controls and identified 139 single nucleotide polymorphisms that are significantly associated with AA (P <= 5 x 10(-7)). Here we show an association with genomic regions containing several genes controlling the activation and proliferation of regulatory T cells (T-reg cells), cytotoxic T lymphocyte-associated antigen 4 (CTLA4), interleukin (IL)-2/IL-21, IL-2 receptor A (IL-2RA; CD25) and Eos (also known as Ikaros family zinc finger 4; IKZF4), as well as the human leukocyte antigen (HLA) region. We also find association evidence for regions containing genes expressed in the hair follicle itself (PRDX5 and STX17). A region of strong association resides within the ULBP (cytomegalovirus UL16-binding protein) gene cluster on chromosome 6q25.1, encoding activating ligands of the natural killer cell receptor NKG2D that have not previously been implicated in an autoimmune disease. By probing the role of ULBP3 in disease pathogenesis, we also show that its expression in lesional scalp from patients with AA is markedly upregulated in the hair follicle dermal sheath during active disease. This study provides evidence for the involvement of both innate and acquired immunity in the pathogenesis of AA. We have defined the genetic underpinnings of AA, placing it within the context of shared pathways among autoimmune diseases, and implicating a novel disease mechanism, the upregulation of ULBP ligands, in triggering autoimmunity.	[Petukhova, Lynn; Shimomura, Yutaka; Kim, Hyunmi; Singh, Pallavi; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Duvic, Madeleine] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Hordinsky, Maria] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA; [Norris, David] Univ Colorado, Dept Dermatol, Denver, CO 80010 USA; [Price, Vera] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94115 USA; [Lee, Annette; Gregersen, Peter K.] N Shore LIJHS, Feinstein Inst Med Res, Manhasset, NY 11030 USA; [Chen, Wei V.; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Epidemiol, Houston, TX 77030 USA; [Meyer, Katja C.; Paus, Ralf] Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Paus, Ralf] Univ Manchester, Sch Translat Med, Manchester M13 9PT, Lancs, England; [Jahoda, Colin A. B.] Univ Durham, Dept Biol Sci, Durham DH1 3LE, England; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Denver; University of California System; University of California San Francisco; Northwell Health; University of Texas System; UTMD Anderson Cancer Center; University of Lubeck; University of Manchester; Durham University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu	; Paus, Ralf/B-5279-2015	Jahoda, Colin/0000-0002-1762-1220; Paus, Ralf/0000-0002-3492-9358	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces; National Institutes of Health [R01AR44422, R01CA133996, P30CA016772, R01AR52579, R01AR56016]; NATIONAL CANCER INSTITUTE [R01CA133996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044422, R01AR056016, R01AR052579] Funding Source: NIH RePORTER	National Alopecia Areata Foundation (NAAF); DFG Cluster of Excellence, Inflammation at Interfaces(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank the many patients and their family members who participated in the National Alopecia Areata Registry from which the patient cohort was derived; S. Schwartz, D. A. Greenberg, S. E. Hodge, R. Ottman, K. Kiryluk, J. Lee, J. D. Terwilliger and R. Plenge for discussions about statistical methodology; A. Bowcock, M. Girardi, R. Clark, J. Trowsdale, R. Clynes, S. Ghosh and R. Bernstein for critical insights and perspectives on genetics, hair and immunobiology; C. Higgins, M. Kurban, M. Kiuru, H. Lam and M. Zhang for expert assistance in the laboratory; A. Martinez-Mir, M. Peacocke, A. Zlotogorski, M. Grossman, P. Schneiderman, D. Gordon and J. Ott for their critical input in the early phases of this study. We are grateful to the National Alopecia Areata Foundation (NAAF) for support of funding the initial studies, and to V. Kalabokes and her staff at NAAF for their efforts on our behalf. The patient cohort was collected and maintained by the National Alopecia Areata Registry (N01AR62279) (to M. D.). This work was supported in part by the DFG Cluster of Excellence, Inflammation at Interfaces (to R. P.) and by the National Institutes of Health grants R01AR44422 (to C. I. A. and P. K. G.), R01CA133996 and P30CA016772 (to C. I. A.) and R01AR52579 and R01AR56016 (to A. M. C.).	Akar A, 2002, J DERMATOL SCI, V29, P85, DOI 10.1016/S0923-1811(02)00015-4; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bazzi H, 2006, DIFFERENTIATION, V74, P129, DOI 10.1111/j.1432-0436.2006.00061.x; Borchers MT, 2009, J CLIN INVEST, V119, P636, DOI 10.1172/JCI34462; Caillat-Zucman S, 2006, HUM IMMUNOL, V67, P204, DOI 10.1016/j.humimm.2006.02.013; Cooper GS, 2009, J AUTOIMMUN, V33, P197, DOI 10.1016/j.jaut.2009.09.008; Duvic M, 2003, J INVEST DERM SYMP P, V8, P219, DOI 10.1046/j.1087-0024.2003.00814.x; Eagle RA, 2007, NAT REV IMMUNOL, V7, P737, DOI 10.1038/nri2144; Eagle RA, 2009, EUR J IMMUNOL, V39, P3207, DOI 10.1002/eji.200939502; Gerard AC, 2005, THYROID, V15, P205, DOI 10.1089/thy.2005.15.205; Gilhar A, 1999, J INVEST DERM SYMP P, V4, P207, DOI 10.1038/sj.jidsp.5640212; Gilhar A, 2003, CLIN IMMUNOL, V106, P181, DOI 10.1016/S1521-6616(02)00042-6; Gilhar A, 2007, J CLIN INVEST, V117, P2019, DOI 10.1172/JCI31942; Gregersen PK, 2009, ANNU REV IMMUNOL, V27, P363, DOI 10.1146/annurev.immunol.021908.132653; Holley JE, 2007, MULT SCLER, V13, P955, DOI 10.1177/1352458507078064; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Ito T, 2008, J INVEST DERMATOL, V128, P1196, DOI 10.1038/sj.jid.5701183; Ito Taisuke, 2008, V10, P27, DOI 10.1159/000131412; Jackow C, 1998, J AM ACAD DERMATOL, V38, P418, DOI 10.1016/S0190-9622(98)70499-2; JELINEK JE, 1972, B NEW YORK ACAD MED, V48, P1003; Karasawa R, 2005, MICROBIOL IMMUNOL, V49, P57, DOI 10.1111/j.1348-0421.2005.tb03640.x; Martinez-Mir A, 2007, AM J HUM GENET, V80, P316, DOI 10.1086/511442; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; McDonagh AJG, 2002, CLIN EXP DERMATOL, V27, P409, DOI 10.1046/j.1365-2230.2002.01077.x; Mitchell MK, 2004, J URBAN HEALTH, V81, P301, DOI 10.1093/jurban/jth116; Monteleone G, 2009, TRENDS PHARMACOL SCI, V30, P441, DOI 10.1016/j.tips.2009.05.006; Pan F, 2009, SCIENCE, V325, P1142, DOI 10.1126/science.1176077; Pielberg GR, 2008, NAT GENET, V40, P1004, DOI 10.1038/ng.185; Plenge RM, 2007, NEW ENGL J MED, V357, P1199, DOI 10.1056/NEJMoa073491; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Radosavljevic M, 2002, GENOMICS, V79, P114, DOI 10.1006/geno.2001.6673; SAFAVI KH, 1995, MAYO CLIN PROC, V70, P628, DOI 10.4065/70.7.628; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Tian C, 2009, MOL MED, V15, P371, DOI 10.2119/molmed.2009.00094; VANDERSTEEN P, 1992, ACTA DERM-VENEREOL, V72, P373; Wang MX, 2002, FEBS LETT, V531, P359, DOI 10.1016/S0014-5793(02)03511-1; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005	39	472	491	4	79	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 1	2010	466	7302					113	U129		10.1038/nature09114	http://dx.doi.org/10.1038/nature09114			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	618HW	20596022	Green Accepted			2022-12-28	WOS:000279343800045
J	Overpeck, J; Udall, B				Overpeck, Jonathan; Udall, Bradley			Dry Times Ahead	SCIENCE			English	Editorial Material							VARIABILITY; MORTALITY; INCREASE; DROUGHT		[Overpeck, Jonathan] Univ Arizona, Tucson, AZ 85721 USA; [Udall, Bradley] Univ Colorado, Boulder, CO 80305 USA	University of Arizona; University of Colorado System; University of Colorado Boulder	Overpeck, J (corresponding author), Univ Arizona, 845 N Pk Ave,Suite 532, Tucson, AZ 85721 USA.	jto@email.arizona.edu; bradley.udall@colorado.edu						[Anonymous], 2009, CLIMATE CHANGE IMPAC, DOI DOI 10.1111/j.1365-2664.2010.01827.x; Barnett TP, 2008, SCIENCE, V319, P1080, DOI 10.1126/science.1152538; Breshears DD, 2005, P NATL ACAD SCI USA, V102, P15144, DOI 10.1073/pnas.0505734102; Conroy JL, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039558; Cook ER, 2010, J QUATERNARY SCI, V25, P48, DOI 10.1002/jqs.1303; Graham NE, 2007, CLIMATIC CHANGE, V83, P241, DOI [10.1007/s10584-007-9239-2, 10.1007/s 10584-007-9239-2]; McAfee SA, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034828; McAuliffe JR, 2010, J ARID ENVIRON, V74, P885, DOI 10.1016/j.jaridenv.2010.01.001; Rajagopalan B, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007652; Seager R, 2007, SCIENCE, V316, P1181, DOI 10.1126/science.1139601; Seager R, 2009, J CLIMATE, V22, P5021, DOI 10.1175/2009JCLI2683.1; Solomon S., 2007, PHYS SCI BASIS WORKI; van Mantgem PJ, 2009, SCIENCE, V323, P521, DOI 10.1126/science.1165000; Westerling AL, 2006, SCIENCE, V313, P940, DOI 10.1126/science.1128834; Woodhouse CA, 1998, B AM METEOROL SOC, V79, P2693, DOI 10.1175/1520-0477(1998)079<2693:YODVIT>2.0.CO;2	15	146	148	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1642	1643		10.1126/science.1186591	http://dx.doi.org/10.1126/science.1186591			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	615BY	20576877				2022-12-28	WOS:000279107400027
J	Garcia-Pagan, JC; Caca, K; Bureau, C; Laleman, W; Appenrodt, B; Luca, A; Abraldes, JG; Nevens, F; Vinel, JP; Mossner, J; Bosch, J				Carlos Garcia-Pagan, Juan; Caca, Karel; Bureau, Christophe; Laleman, Wim; Appenrodt, Beate; Luca, Angelo; Abraldes, Juan G.; Nevens, Frederik; Vinel, Jean Pierre; Moessner, Joachim; Bosch, Jaime		Early TIPS Cooperative Study Grp	Early Use of TIPS in Patients with Cirrhosis and Variceal Bleeding.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRAHEPATIC PORTOSYSTEMIC SHUNT; PORTAL-HYPERTENSION; BACTERIAL-INFECTION; CONSENSUS WORKSHOP; PREVENTION; POLYTETRAFLUOROETHYLENE; METHODOLOGY; THERAPY; FAILURE; STENTS	Background: Patients with cirrhosis in Child-Pugh class C or those in class B who have persistent bleeding at endoscopy are at high risk for treatment failure and a poor prognosis, even if they have undergone rescue treatment with a transjugular intrahepatic portosystemic shunt (TIPS). This study evaluated the earlier use of TIPS in such patients. Methods: We randomly assigned, within 24 hours after admission, a total of 63 patients with cirrhosis and acute variceal bleeding who had been treated with vasoactive drugs plus endoscopic therapy to treatment with a polytetrafluoroethylene-covered stent within 72 hours after randomization (early-TIPS group, 32 patients) or continuation of vasoactive-drug therapy, followed after 3 to 5 days by treatment with propranolol or nadolol and long-term endoscopic band ligation (EBL), with insertion of a TIPS if needed as rescue therapy (pharmacotherapy-EBL group, 31 patients). Results: During a median follow-up of 16 months, rebleeding or failure to control bleeding occurred in 14 patients in the pharmacotherapy-EBL group as compared with 1 patient in the early-TIPS group (P=0.001). The 1-year actuarial probability of remaining free of this composite end point was 50% in the pharmacotherapy-EBL group versus 97% in the early-TIPS group (P<0.001). Sixteen patients died (12 in the pharmacotherapy-EBL group and 4 in the early-TIPS group, P=0.01). The 1-year actuarial survival was 61% in the pharmacotherapy-EBL group versus 86% in the early-TIPS group (P<0.001). Seven patients in the pharmacotherapy-EBL group received TIPS as rescue therapy, but four died. The number of days in the intensive care unit and the percentage of time in the hospital during follow-up were significantly higher in the pharmacotherapy-EBL group than in the early-TIPS group. No significant differences were observed between the two treatment groups with respect to serious adverse events. Conclusions: In these patients with cirrhosis who were hospitalized for acute variceal bleeding and at high risk for treatment failure, the early use of TIPS was associated with significant reductions in treatment failure and in mortality. (Current Controlled Trials number, ISRCTN58150114.) N Engl J Med 2010;362:2370-9.	[Carlos Garcia-Pagan, Juan] Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, Inst Invest Biomed August Pi i Sunyer, E-08036 Barcelona, Spain; [Carlos Garcia-Pagan, Juan; Abraldes, Juan G.; Bosch, Jaime] Univ Barcelona, Liver Unit, Hepat Hemodynam Lab, Inst Malalties Digest & Metab, Barcelona, Spain; [Carlos Garcia-Pagan, Juan; Abraldes, Juan G.; Bosch, Jaime] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Caca, Karel] Klinikum Ludwigsburg, Med Klin 1, Ludwigsburg, Germany; [Appenrodt, Beate] Univ Bonn, Dept Med 1, D-5300 Bonn, Germany; [Moessner, Joachim] Univ Klinikum Leipzig, Med Klin & Poliklin 1, Leipzig, Germany; [Bureau, Christophe; Vinel, Jean Pierre] CHU Purpan, Serv Hepatogastroenterol, Toulouse, France; [Laleman, Wim; Nevens, Frederik] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Hepatol, Louvain, Belgium; [Luca, Angelo] Ist Mediterraneo Trapianti & Terapie Alta Special, Palermo, Italy	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Bonn; Leipzig University; CHU de Toulouse; KU Leuven; University Hospital Leuven; IRCCS Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (ISMETT)	Garcia-Pagan, JC (corresponding author), Hosp Clin Barcelona, Liver Unit, Hepat Hemodynam Lab, Inst Invest Biomed August Pi i Sunyer, Villarroel 170, E-08036 Barcelona, Spain.	jcgarcia@clinic.ub.es; jbosch@clinic.ub.es	Selves, Janick/M-7719-2014; Bosch, Jaime/AFF-8344-2022; Bosch, Jaime/AAF-1006-2022; Laleman, Wim/H-7272-2019; Garcia-Pagan, Juan-Carlos/P-6291-2015	Laleman, Wim/0000-0002-0842-7813; Garcia-Pagan, Juan-Carlos/0000-0001-9032-4954; Gonzalez-Abraldes, Juan/0000-0003-3421-937X	Instituto de Salud Carlos III (Spain) [FIS 06/0623, 04/1031, 08/0504]; Ministerio de Educacion y Ciencia (Spain) [SAF-07/61298]; University Hospital Center of Toulouse [04 036 03]; Fund for Scientific Research - Flanders (Fundamenteel Klinisch Mandaat - FWO Vlaanderen); Gore; Astellas; Actelion; Axcan; NicOx; Chiasma; Dominion Pharmakine	Instituto de Salud Carlos III (Spain)(Instituto de Salud Carlos III); Ministerio de Educacion y Ciencia (Spain)(Spanish Government); University Hospital Center of Toulouse; Fund for Scientific Research - Flanders (Fundamenteel Klinisch Mandaat - FWO Vlaanderen)(FWO); Gore; Astellas(Astellas Pharmaceuticals); Actelion; Axcan; NicOx; Chiasma; Dominion Pharmakine	Supported in part by grants (FIS 06/0623, 04/1031, and 08/0504) from Instituto de Salud Carlos III (Spain), a grant (SAF-07/61298) from Ministerio de Educacion y Ciencia (Spain), a grant (04 036 03) from the University Hospital Center of Toulouse, a grant from the Fund for Scientific Research - Flanders (Fundamenteel Klinisch Mandaat - FWO Vlaanderen, to Dr. Laleman), and an educational grant from Gore. Centro de Investigacion Biomedica en Red de Enfermedades Hepaticas y Digestivas is funded by Instituto de Salud Carlos III.; Dr. Garcia-Pagan reports receiving grant support from Gore and reimbursement for travel expenses from Gore, Cook Medical, and Ferring; Dr. Bosch, receiving grant support and reimbursement for travel expenses from Gore and consulting fees from Astellas, Actelion, Axcan, NicOx, Chiasma, and Dominion Pharmakine; Dr. Caca, receiving lecture fees and reimbursement for travel expenses from Gore; and Dr. Appenrodt, receiving reimbursement for travel expenses from Gore. No other potential conflict of interest relevant to this article was reported.	Abraldes JG, 2005, AM J GASTROENTEROL, V100, P2696, DOI 10.1111/j.1572-0241.2005.00290.x; Azoulay D, 2001, J HEPATOL, V35, P590, DOI 10.1016/S0168-8278(01)00185-4; Banares R, 1998, AM J GASTROENTEROL, V93, P75, DOI 10.1111/j.1572-0241.1998.075_c.x; Ben-Ari Z, 1999, J HEPATOL, V31, P443, DOI 10.1016/S0168-8278(99)80035-X; Ben-Ari Z, 2001, J HEPATOL, V34, P39; BERNARD B, 1995, GASTROENTEROLOGY, V108, P1828, DOI 10.1016/0016-5085(95)90146-9; Bosch J, 2004, GASTROENTEROLOGY, V127, P1123, DOI 10.1053/j.gastro.2004.07.015; Bosch J, 2008, SEMIN LIVER DIS, V28, P3, DOI 10.1055/s-2008-1040318; Bureau C, 2004, GASTROENTEROLOGY, V126, P469, DOI 10.1053/j.gastro.2003.11.016; Bureau C, 2007, LIVER INT, V27, P742, DOI 10.1111/j.1478-3231.2007.01522.x; D'Amico G, 2003, HEPATOLOGY, V38, P599, DOI 10.1053/jhep.2003.50385; de Franchis R, 2000, J HEPATOL, V33, P846; de Franchis R, 2005, J HEPATOL, V43, P167, DOI 10.1016/j.jhep.2005.05.009; Dunnett CW, 1996, STAT MED, V15, P1729; Escorsell A, 2002, HEPATOLOGY, V35, P385, DOI 10.1053/jhep.2002.30418; Garcia-Pagan JC, 2009, GUT, V58, P1144, DOI 10.1136/gut.2008.171207; Garcia-Pagan JC, 2004, RECENT ADV PATHOPHYS, P287; Garcia-Tsao G, 2007, AM J GASTROENTEROL, V102, P2086, DOI 10.1111/j.1572-0241.2007.01481.x; Goulis J, 1998, HEPATOLOGY, V27, P1207, DOI 10.1002/hep.510270504; Luca A, 1999, RADIOLOGY, V212, P411, DOI 10.1148/radiology.212.2.r99au46411; Malinchoc M, 2000, HEPATOLOGY, V31, P864, DOI 10.1053/he.2000.5852; Moitinho E, 1999, GASTROENTEROLOGY, V117, P626, DOI 10.1016/S0016-5085(99)70455-5; Monescillo A, 2004, HEPATOLOGY, V40, P793, DOI 10.1002/hep.20386; Papatheodoridis GV, 1999, HEPATOLOGY, V30, P612, DOI 10.1002/hep.510300316; Sackett DL., 2006, CLIN EPIDEMIOLOGY DO; SPINA GP, 1990, SURG GYNECOL OBSTET, V171, P456; Villanueva C, 1999, HEPATOLOGY, V30, P384, DOI 10.1002/hep.510300222	27	693	765	2	49	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 24	2010	362	25					2370	2379		10.1056/NEJMoa0910102	http://dx.doi.org/10.1056/NEJMoa0910102			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	614GO	20573925	Green Submitted, Green Published			2022-12-28	WOS:000279043800006
J	Grayson, M				Grayson, Michelle			CHAGAS DISEASE	NATURE			English	Editorial Material																			0	14	14	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S3	S3		10.1038/465S3a	http://dx.doi.org/10.1038/465S3a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	614KI	20571552	Bronze			2022-12-28	WOS:000279056900023
J	Iannacone, M; Moseman, EA; Tonti, E; Bosurgi, L; Junt, T; Henrickson, SE; Whelan, SP; Guidotti, LG; von Andrian, UH				Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Junt, Tobias; Henrickson, Sarah E.; Whelan, Sean P.; Guidotti, Luca G.; von Andrian, Ulrich H.			Subcapsular sinus macrophages prevent CNS invasion on peripheral infection with a neurotropic virus	NATURE			English	Article							LIPOSOME-MEDIATED DEPLETION; VESICULAR STOMATITIS-VIRUS; IN-VIVO DEPLETION; CD8(+) T-CELLS; LYMPH-NODES; B-CELLS; DENDRITIC CELLS; MICE; ACTIVATION; ANTIGEN	Lymph nodes (LNs) capture microorganisms that breach the body's external barriers and enter draining lymphatics, limiting the systemic spread of pathogens(1). Recent work has shown that CD11b(+)CD169(+) macrophages, which populate the subcapsular sinus (SCS) of LNs, are critical for the clearance of viruses from the lymph and for initiating antiviral humoral immune responses(2-4). Here we show, using vesicular stomatitis virus (VSV), a relative of rabies virus transmitted by insect bites, that SCS macrophages perform a third vital function: they prevent lymph-borne neurotropic viruses from infecting the central nervous system (CNS). On local depletion of LN macrophages, about 60% of mice developed ascending paralysis and died 7-10 days after subcutaneous infection with a small dose of VSV, whereas macrophage-sufficient animals remained asymptomatic and cleared the virus. VSV gained access to the nervous system through peripheral nerves in macrophage-depleted LNs. In contrast, within macrophage-sufficient LNs VSV replicated preferentially in SCS macrophages but not in adjacent nerves. Removal of SCS macrophages did not compromise adaptive immune responses against VSV, but decreased type I interferon (IFN-I) production within infected LNs. VSV-infected macrophages recruited IFN-I-producing plasmacytoid dendritic cells to the SCS and in addition were a major source of IFN-I themselves. Experiments in bone marrow chimaeric mice revealed that IFN-I must act on both haematopoietic and stromal compartments, including the intranodal nerves, to prevent lethal infection with VSV. These results identify SCS macrophages as crucial gatekeepers to the CNS that prevent fatal viral invasion of the nervous system on peripheral infection.	[Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Iannacone, Matteo; Moseman, E. Ashley; Tonti, Elena; Bosurgi, Lidia; Henrickson, Sarah E.; von Andrian, Ulrich H.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Iannacone, Matteo; Guidotti, Luca G.] Ist Sci San Raffaele, Dept Immunol Infect Dis & Transplantat, I-20132 Milan, Italy; [Junt, Tobias] Novartis Inst BioMed Res, CH-4002 Basel, Switzerland; [Whelan, Sean P.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Novartis; Harvard University; Harvard Medical School	von Andrian, UH (corresponding author), Harvard Univ, Sch Med, Immune Dis Inst, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	Matteo_Iannacone@hms.harvard.edu; uva@hms.harvard.edu	Junt, Tobias/AAE-4389-2021; von Andrian, Ulrich H/A-5775-2008; Iannacone, Matteo/I-8507-2018; Guidotti, Luca G. G/I-8542-2018	Iannacone, Matteo/0000-0002-9370-2671; Guidotti, Luca G. G/0000-0002-0205-2678; Henrickson, Sarah/0000-0001-5569-4132; Bosurgi, Lidia/0000-0002-8775-4950; Tonti, Elena/0000-0001-5002-7613; Whelan, Sean/0000-0003-1564-8590	National Institutes of Health (NIH) [AI069259, AI072252, AI078897, AR42689]; Giovanni Armenise-Harvard Foundation; NIH; NATIONAL CANCER INSTITUTE [P01CA071932] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069259, P01AI078897, R01AI072252] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR042689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Giovanni Armenise-Harvard Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank G. Cheng and M. Flynn for technical support; J. Alton for secretarial assistance; D. Cureton for help and advice with VSV preparations; H. Leung for help with image quantification; R. M. Zinkernagel and H. Hengartner for providing tg7 mice; R. Bronson for help with reading neuropathology; S. Cohen for advice on nerve staining; N. van Rooijen for clodronate liposomes; and the members of the von Andrian laboratory for discussion. This work was supported by National Institutes of Health (NIH) grants AI069259, AI072252, AI078897 and AR42689 (to U.H.v.A.), the Giovanni Armenise-Harvard Foundation (to M.I.) and a NIH T32 Training Grant in Hematology (to E.A.M.).	Asselin-Paturel C, 2001, NAT IMMUNOL, V2, P1144, DOI 10.1038/ni736; Brundler MA, 1996, EUR J IMMUNOL, V26, P2257, DOI 10.1002/eji.1830260943; Carrasco YR, 2007, IMMUNITY, V27, P160, DOI 10.1016/j.immuni.2007.06.007; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; DELEMARRE FGA, 1990, J LEUKOCYTE BIOL, V47, P251, DOI 10.1002/jlb.47.3.251; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Hangartner L, 2006, NAT REV IMMUNOL, V6, P231, DOI 10.1038/nri1783; Hickman HD, 2008, NAT IMMUNOL, V9, P155, DOI 10.1038/ni1557; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Iannacone M, 2008, P NATL ACAD SCI USA, V105, P629, DOI 10.1073/pnas.0711200105; Iparraguirre A, 2008, J LEUKOCYTE BIOL, V83, P610, DOI 10.1189/jlb.0807511; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Junt T, 2007, NATURE, V450, P110, DOI 10.1038/nature06287; Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1363; Maloy KJ, 1999, J IMMUNOL, V162, P2867; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Phan TG, 2007, NAT IMMUNOL, V8, P992, DOI 10.1038/ni1494; Probst HC, 2005, CLIN EXP IMMUNOL, V141, P398, DOI 10.1111/j.1365-2249.2005.02868.x; Purtha WE, 2008, J VIROL, V82, P10964, DOI 10.1128/JVI.01646-08; Shao CX, 2007, MICROSURG, V27, P487, DOI 10.1002/micr.20392; Thomsen AR, 1997, INT IMMUNOL, V9, P1757, DOI 10.1093/intimm/9.11.1757; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; WHELAN SPJ, 1995, P NATL ACAD SCI USA, V92, P8388, DOI 10.1073/pnas.92.18.8388	26	236	237	2	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					1079	U143		10.1038/nature09118	http://dx.doi.org/10.1038/nature09118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577213	Green Accepted			2022-12-28	WOS:000279056900053
J	[Anonymous]				[Anonymous]			Who, how, what and where?	NATURE			English	Editorial Material																			0	5	5	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 24	2010	465	7301					S8	S9		10.1038/nature09222	http://dx.doi.org/10.1038/nature09222			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571555	Bronze			2022-12-28	WOS:000279056900026
J	Nauck, MA; Meier, JJ				Nauck, Michael A.; Meier, Juris J.			Individualised incretin-based treatment for type 2 diabetes	LANCET			English	Editorial Material							GLUCAGON-LIKE PEPTIDE-1; OPEN-LABEL; GLYCEMIC CONTROL; INHIBITORS; EXENATIDE; METFORMIN; TRIAL		[Nauck, Michael A.] Diabet Zentrum Bad Lauterberg, D-37431 Bad Lauterberg Im Harz, Germany; [Meier, Juris J.] Klinikum Ruhr Univ Bochum, St Josef Hosp, Dept Med 1, Bochum, Germany	Ruhr University Bochum	Nauck, MA (corresponding author), Diabet Zentrum Bad Lauterberg, D-37431 Bad Lauterberg Im Harz, Germany.	nauck@diabeteszentrum.de	Nauck, Michael Albrecht/ABA-9752-2021	Nauck, Michael Albrecht/0000-0002-5749-6954				Bergenstal RM, 2010, LANCET, V376, P431, DOI 10.1016/S0140-6736(10)60590-9; Diamant M, 2010, LANCET, V375, P2234, DOI 10.1016/S0140-6736(10)60406-0; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Drucker DJ, 2006, LANCET, V368, P1696, DOI 10.1016/S0140-6736(06)69705-5; Elbrond B, 2002, DIABETES CARE, V25, P1398, DOI 10.2337/diacare.25.8.1398; Nauck M, 2009, BEST PRACT RES CL EN, V23, P513, DOI 10.1016/j.beem.2009.03.002; Nauck MA, 2005, REGUL PEPTIDES, V128, P135, DOI 10.1016/j.regpep.2004.07.014; Nauck MA, 2009, DIABETES CARE, V32, P1237, DOI 10.2337/dc08-1961; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Rachman J, 1996, DIABETES, V45, P1524, DOI 10.2337/diabetes.45.11.1524; Rosenstock J, 2009, DIABETES CARE, V32, P1880, DOI 10.2337/dc09-0366; Toft-Nielsen MB, 2001, J CLIN ENDOCR METAB, V86, P3853, DOI 10.1210/jc.86.8.3853	12	9	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 7	2010	376	9739					393	394		10.1016/S0140-6736(10)60998-1	http://dx.doi.org/10.1016/S0140-6736(10)60998-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	639YK	20580425				2022-12-28	WOS:000281012900005
J	Liu, W; Tanasa, B; Tyurina, OV; Zhou, TY; Gassmann, R; Liu, WT; Ohgi, KA; Benner, C; Garcia-Bassets, I; Aggarwal, AK; Desai, A; Dorrestein, PC; Glass, CK; Rosenfeld, MG				Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Gassmann, Reto; Liu, Wei Ting; Ohgi, Kenneth A.; Benner, Chris; Garcia-Bassets, Ivan; Aggarwal, Aneel K.; Desai, Arshad; Dorrestein, Pieter C.; Glass, Christopher K.; Rosenfeld, Michael G.			PHF8 mediates histone H4 lysine 20 demethylation events involved in cell cycle progression	NATURE			English	Article							S-PHASE; CHROMOSOME STRUCTURE; MENTAL-RETARDATION; HEAT REPEATS; METHYLATION; IDENTIFICATION; STABILITY; BINDING; PROTEIN; GENOME	While reversible histone modifications are linked to an ever-expanding range of biological functions(1-5), the demethylases for histone H4 lysine 20 and their potential regulatory roles remain unknown. Here we report that the PHD and Jumonji C (JmjC) domain-containing protein, PHF8, while using multiple substrates, including H3K9me1/2 and H3K27me2, also functions as an H4K20me1 demethylase. PHF8 is recruited to promoters by its PHD domain based on interaction with H3K4me2/3 and controls G1-S transition in conjunction with E2F1, HCF-1 (also known as HCFC1) and SET1A (also known as SETD1A), at least in part, by removing the repressive H4K20me1 mark from a subset of E2F1-regulated gene promoters. Phosphorylation-dependent PHF8 dismissal from chromatin in prophase is apparently required for the accumulation of H4K20me1 during early mitosis, which might represent a component of the condensin II loading process. Accordingly, the HEAT repeat clusters in two non-structuralmaintenance of chromosomes (SMC) condensin II subunits, N-CAPD3 and N-CAPG2 (also known as NCAPD3 and NCAPG2, respectively), are capable of recognizing H4K20me1, and ChIP-Seq analysis demonstrates a significant overlap of condensin II and H4K20me1 sites in mitotic HeLa cells. Thus, the identification and characterization of an H4K20me1 demethylase, PHF8, has revealed an intimate link between this enzyme and two distinct events in cell cycle progression.	[Liu, Wen; Tanasa, Bogdan; Tyurina, Oksana V.; Zhou, Tian Yuan; Ohgi, Kenneth A.; Garcia-Bassets, Ivan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Liu, Wen] Univ Calif San Diego, Grad Program Biol, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Gassmann, Reto; Desai, Arshad] Univ Calif San Diego, Dept Cellular & Mol Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Liu, Wei Ting; Dorrestein, Pieter C.] Univ Calif San Diego, Dept Chem & Biochem, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Aggarwal, Aneel K.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Icahn School of Medicine at Mount Sinai	Rosenfeld, MG (corresponding author), Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mrosenfeld@ucsd.edu	Dorrestein, Pieter/ABF-2930-2020; Glass, Christopher/AAI-3933-2021; Dorrestein, Pieter/D-5012-2012; Garcia-Bassets, Ivan/F-5075-2010; Gassmann, Reto/M-6488-2013	Glass, Christopher/0000-0003-4344-3592; Gassmann, Reto/0000-0002-0360-2977; Garcia-Bassets, Ivan/0000-0002-6941-9585; Benner, Christopher/0000-0002-4618-0719; Liu, Wen/0000-0003-3434-4162	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA097134-09, R01 CA097134] Funding Source: Medline; NHLBI NIH HHS [R01 HL065445] Funding Source: Medline; NIDDK NIH HHS [R01 DK018477-35, R01 DK039949, R01 DK039949-18, R37 DK039949, R01 DK018477] Funding Source: Medline; NINDS NIH HHS [R01 NS034934-21, R01 NS034934] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA097134] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039949, R01DK018477, R37DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115; Belmont AS, 2006, CURR OPIN CELL BIOL, V18, P632, DOI 10.1016/j.ceb.2006.09.007; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Feng WJ, 2010, NAT STRUCT MOL BIOL, V17, P445, DOI 10.1038/nsmb.1778; Fortschegger K, 2010, MOL CELL BIOL, V30, P3286, DOI 10.1128/MCB.01520-09; Garcia-Bassets I, 2007, CELL, V128, P505, DOI 10.1016/j.cell.2006.12.038; Haering CH, 2009, CHROMOSOME RES, V17, P127, DOI 10.1007/s10577-008-9008-8; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Horton JR, 2010, NAT STRUCT MOL BIOL, V17, P38, DOI 10.1038/nsmb.1753; Houston SI, 2008, J BIOL CHEM, V283, P19478, DOI 10.1074/jbc.M710579200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Kleine-Kohlbrecher D, 2010, MOL CELL, V38, P165, DOI 10.1016/j.molcel.2010.03.002; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kouzarides T, 2002, CURR OPIN GENET DEV, V12, P198, DOI 10.1016/S0959-437X(02)00287-3; Lachner M, 2003, J CELL SCI, V116, P2117, DOI 10.1242/jcs.00493; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Loenarz C, 2010, HUM MOL GENET, V19, P217, DOI 10.1093/hmg/ddp480; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Neuwald AF, 2000, GENOME RES, V10, P1445, DOI 10.1101/gr.147400; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sasik R, 2004, J MOL ENDOCRINOL, V33, P1, DOI 10.1677/jme.0.0330001; Schwender H, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-144; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tanner S, 2005, ANAL CHEM, V77, P4626, DOI 10.1021/ac050102d; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Wolf F, 2007, CELL CYCLE, V6, P1408; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yeong FM, 2003, CURR BIOL, V13, P2058, DOI 10.1016/j.cub.2003.10.032; Yin Y, 2008, CELL CYCLE, V7, P1423, DOI 10.4161/cc.7.10.5867; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	42	289	300	0	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 22	2010	466	7305					508	U14		10.1038/nature09272	http://dx.doi.org/10.1038/nature09272			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	628SJ	20622854	Green Accepted, Green Published			2022-12-28	WOS:000280141200040
J	Davidoff, F				Davidoff, Frank			Checklists and Guidelines Imaging Techniques for Visualizing What to Do	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Davidoff, Frank] Inst Healthcare Improvement, Cambridge, MA USA	Institute for Healthcare Improvement	Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; DAVIDOFF F, 1987, TXB GEN MED PRIMARY, P27; DAVIDOFF F, 1996, WHO HAS SEEN BLOOD S, P24; Equator Network, ENH QUAL TRANSP HLTH; Gawande A., 2009, CHECKLIST MANIFESTO; Grimshaw J, 2006, J GEN INTERN MED, V21, pS14, DOI 10.1111/j.1525-1497.2006.00357.x; Haynes AB, 2009, NEW ENGL J MED, V360, P491, DOI 10.1056/NEJMsa0810119; HURST JW, 1971, ARCH INTERN MED, V128, P818, DOI 10.1001/archinte.128.5.818; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; RENNIE D, 1995, JAMA-J AM MED ASSOC, V273, P1054, DOI 10.1001/jama.273.13.1054	10	16	16	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUL 14	2010	304	2					206	207		10.1001/jama.2010.972	http://dx.doi.org/10.1001/jama.2010.972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624IN	20628136				2022-12-28	WOS:000279811000029
J	ten Hacken, NHT; van der Molen, T				ten Hacken, Nick H. T.; van der Molen, Thys			Easily Missed? Bronchiectasis	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[ten Hacken, Nick H. T.; van der Molen, Thys] Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands	University of Groningen	ten Hacken, NHT (corresponding author), Univ Groningen, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands.	n.h.t.ten.hacken@long.umcg.nl						BARKER AF, 2008, CLIN MANIFESTATIONS; Chang AB, 2002, MED J AUSTRALIA, V177, P200, DOI 10.5694/j.1326-5377.2002.tb04733.x; Evans DJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001392.pub2; GUDBJERG CE, 1955, ACTA RADIOL, V43, P209, DOI 10.3109/00016925509172763; JONES AP, 2000, COCHRANE DB SYST REV; Keistinen T, 1997, EUR RESPIR J, V10, P2784, DOI 10.1183/09031936.97.10122784; King PT, 2009, COPD, V6, P130, DOI 10.1080/15412550902766934; Li AM, 2005, EUR RESPIR J, V26, P8, DOI 10.1183/09031936.05.00127704; NICOTRA MB, 1995, CHEST, V108, P955, DOI 10.1378/chest.108.4.955; Parr DG, 2007, AM J RESP CRIT CARE, V176, P1215, DOI 10.1164/rccm.200703-489OC; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Onen ZP, 2007, RESP MED, V101, P1390, DOI 10.1016/j.rmed.2007.02.002; Rosen MJ, 2006, CHEST, V129, p122S, DOI 10.1378/chest.129.1_suppl.122S; Smith IE, 1996, BRIT J RADIOL, V69, P589, DOI 10.1259/0007-1285-69-823-589; TENHACKEN N, 2008, CLIN EVID; vanderBruggenBogaarts BAHA, 1996, CHEST, V109, P608, DOI 10.1378/chest.109.3.608; Weycker D., 2005, Clinical Pulmonary Medicine, V12, P205, DOI 10.1097/01.cpm.0000171422.98696.ed	17	3	3	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 14	2010	341								c2766	10.1136/bmj.c2766	http://dx.doi.org/10.1136/bmj.c2766			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XC	20630967				2022-12-28	WOS:000280156700002
J	Zinman, B; Harris, SB; Neuman, J; Gerstein, HC; Retnakaran, RR; Raboud, J; Qi, Y; Hanley, AJG				Zinman, Bernard; Harris, Stewart B.; Neuman, Jan; Gerstein, Hertzel C.; Retnakaran, Ravi R.; Raboud, Janet; Qi, Ying; Hanley, Anthony J. G.			Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study	LANCET			English	Article							IMPAIRED GLUCOSE-TOLERANCE; BETA-CELL FUNCTION; INSULIN-RESISTANCE; LIFE-STYLE; ASSOCIATION; SENSITIVITY; PEOPLE	Background The evolving epidemic of type 2 diabetes has challenged health-care providers to assess the safety and efficacy of various diabetes prevention strategies. The CANOE (CAnadian Normoglycemia Outcomes Evaluation) trial investigated whether low-dose combination therapy would affect development of type 2 diabetes. Methods In this double-blind, randomised controlled trial undertaken in clinics in Canadian centres, 207 patients with impaired glucose tolerance were randomly assigned to receive combination rosiglitazone (2 mg) and metformin (500 mg) twice daily or matching placebo for a median of 3.9 years (IQR 3.0-4.6). Randomisation was computer-generated in blocks of four, with both participants and investigators masked to treatment allocation. The primary outcome was time to development of diabetes, measured by an oral glucose tolerance test or two fasting plasma glucose values of 7.0 mmol/L or greater. Analysis was by intention to treat. This study is registered with ClinicalTrials.gov, number NCT00116932. Findings 103 participants were assigned to rosiglitazone and metformin, and 104 to placebo; all were analysed. Vital status was obtained in 198 (96%) participants, and medication compliance (taking at least 80% of assigned medication) was 78% (n=77) in the metformin and rosiglitazone group and 81% (n=80) in the placebo group. Incident diabetes occurred in significantly fewer individuals in the active treatment group (n=14 [14%]) than in the placebo group (n=41 [39%]; p<0.0001). The relative risk reduction was 66% (95% CI 41-80) and the absolute risk reduction was 26% (14-37), yielding a number needed to treat of 4 (2.70-7.14). 70 (80%) patients in the treatment group regressed to normal glucose tolerance compared with 52 (53%) in the placebo group (p=0.0002). Insulin sensitivity decreased by study end in the placebo group (median -1.24, IQR -2.38 to -0.08) and remained unchanged with rosiglitazone and metformin treatment (-0.39, -1.30 to 0.84; p=0.0006 between groups). The change in beta-cell function, as measured by the insulin secretion-sensitivity index-2, did not differ between groups (placebo -252.3, -382.2 to -58.0 vs rosiglitazone and metformin -221.8, -330.4 to -87.8; p=0.28). We recorded an increase in diarrhoea in participants in the active treatment group compared with the placebo group (16 [16%] vs 6 [6%]; p=0.0253). Interpretation Low-dose combination therapy with rosiglitazone and metformin was highly effective in prevention of type 2 diabetes in patients with impaired glucose tolerance, with little effect on the clinically relevant adverse events of these two drugs.	[Zinman, Bernard; Neuman, Jan; Retnakaran, Ravi R.; Qi, Ying; Hanley, Anthony J. G.] Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Dept Med, Toronto, ON M5T 3L9, Canada; [Raboud, Janet] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Zinman, Bernard] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5T 3L9, Canada; [Harris, Stewart B.] Univ Western Ontario, Ctr Studies Family Med, London, ON, Canada; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Div Endocrinol & Metab, Hamilton, ON, Canada; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Dept Med, Populat Hlth Res Inst, Hamilton, ON, Canada; [Raboud, Janet] Univ Hlth Network, Div Infect Dis, Toronto, ON, Canada; [Hanley, Anthony J. G.] Univ Toronto, Dept Nutr & Publ Hlth Sci, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Western University (University of Western Ontario); McMaster University; McMaster University; Population Health Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto	Zinman, B (corresponding author), Mt Sinai Hosp, Leadership Sinai Ctr Diabet, Dept Med, 60 Murray St,Mail Box 17, Toronto, ON M5T 3L9, Canada.	zinman@lunenfeld.ca	Gerstein, Hertzel/ABB-8781-2020; Zinman, Bernard/E-7266-2013; Gerstein, Hertzel C/B-1235-2013; Retnakaran, Ravi/P-2002-2015	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836; Retnakaran, Ravi/0000-0003-1989-027X	GlaxoSmithKline; Sanofi-Aventis; Eli Lilly; Novo Nordisk; AstraZeneca; BMS; Roche; Medtronic; Merck; Bayer; Biovail; Jansen Ortho; Canadian Institutes of Health Research; Canadian Diabetes Association; University of Toronto Banting and Best Diabetes Centre	GlaxoSmithKline(GlaxoSmithKline); Sanofi-Aventis(Sanofi-Aventis); Eli Lilly(Eli Lilly); Novo Nordisk(Novo Nordisk); AstraZeneca(AstraZeneca); BMS(Bristol-Myers Squibb); Roche(Roche Holding); Medtronic(Medtronic); Merck(Merck & Company); Bayer(Bayer AG); Biovail; Jansen Ortho; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association; University of Toronto Banting and Best Diabetes Centre	Funding GlaxoSmithKline.; BZ reports having received consulting fees, honoraria, and grant support from GlaxoSmithKline. SBH reports advisory board membership and having received consulting fees, travel and lecture fees, and grant support from GlaxoSmithKline. HCG reports having received consulting fees from Sanofi-Aventis, GlaxoSmithKline, Eli Lilly, Novo Nordisk, AstraZeneca, BMS, Roche, Medtronic, Merck, Bayer, Biovail, and Jansen Ortho; honoraria from Sanofi-Aventis, GlaxoSmithKline, Servier, Bayer, Eli Lilly, and Novo Nordisk; and grant support from Sanofi-Aventis, GlaxoSmithKline, Novo Nordisk, Merck, and Roche. JN, RRR, JR, YQ, and AjGH declare that they have no conflicts of interest.; We thank the research staff at the study sites in Toronto (Jan Neuman, Stella Kink, and Annette Bamie) and London (Sheila Porter, Mauricio Mann, and Susan Webster-Bogart), whose dedication and hard work were essential to the successful implementation of the CANOE study; and the Data Safety and Monitoring Board members (jean Louis Chiaison [chair], Jean Francois Yale, and Andrew Willan) for their contribution to the study. RRR is supported by a Canadian Institutes of Health Research New Investigator Award, Canadian Diabetes Association Clinician-Scientist funding, and the University of Toronto Banting and Best Diabetes Centre. AJGH holds a tier two Canada Research Chair in Diabetes and Epidemiology and is supported by a scholarship from the Canadian Diabetes Association. BZ holds the Sam and Judy Pencer Family Chair in Diabetes Research at Mount Sinai Hospital and University of Toronto. SBH holds a Canadian Diabetes Association Chair in Diabetes Management and an Ian McWhinney Family Medicine Chair at the University of Western Ontario.	Bosch J, 2006, NEW ENGL J MED, V355, P1551; Buchanan TA, 2002, DIABETES, V51, P2796, DOI 10.2337/diabetes.51.9.2796; Chiasson JL, 2002, LANCET, V359, P2072, DOI 10.1016/S0140-6736(02)08905-5; Colhoun HM, 2004, LANCET, V364, P685, DOI 10.1016/S0140-6736(04)16895-5; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Diabetes Prevention Progam, 2005, DIABETES, V54, P1150; Gerstein HC, 2006, LANCET, V368, P1096, DOI 10.1016/S0140-6736(06)69420-8; Hanley AJ, 2010, DIABETES CARE, V33, P608, DOI 10.2337/dc09-1579; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Holman RR, 2010, NEW ENGL J MED, V362, P1463, DOI 10.1056/NEJMoa1001122; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kahn SE, 2008, DIABETES CARE, V31, P845, DOI 10.2337/dc07-2270; Kaul S, 2010, CIRCULATION, V121, P1868, DOI 10.1161/CIR.0b013e3181d34114; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Nathan D, 2009, DIABETOLOGIA, V52, P17, DOI 10.1007/s00125-008-1157-y; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; RIDDLE M, 2000, AM J MED S6A, V108, P155; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Scheen AJ, 2007, DIABETES METAB, V33, P3, DOI 10.1016/j.diabet.2006.11.005; Stearne MR, 1998, BMJ-BRIT MED J, V317, P703; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zinman B, 2006, DIABETES OBES METAB, V8, P531, DOI 10.1111/j.1463-1326.2005.00540.x	28	160	163	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 10	2010	376	9735					103	111		10.1016/S0140-6736(10)60746-5	http://dx.doi.org/10.1016/S0140-6736(10)60746-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	626CJ	20605202				2022-12-28	WOS:000279943200026
J	Bayon, R; Jenkins, M				Bayon, Ricardo; Jenkins, Michael			The business of biodiversity	NATURE			English	Editorial Material									[Bayon, Ricardo] EKO Asset Management Partners, New York, NY 10019 USA; [Jenkins, Michael] Forest Trends, Washington, DC 20007 USA		Bayon, R (corresponding author), EKO Asset Management Partners, 1350 Ave Amer,29th Floor, New York, NY 10019 USA.	rbayon@ekoamp.com; mjenkins@Forest-trends.org						BAYON R, 2008, WORLD 2008 INNOVATIO, P123; *BUS BIOD OFFS PRO, 2009, BBOP PIL PROJ CAS ST; Hamilton K., 2010, BUILDING BRIDGES STA; Madsen B., 2010, STATE BIODIVERSITY M; PERROTMAITRE D, 2010, MOUNTAIN FORUM B; Stanton T, 2010, STATE WATERSHED PAYM	6	44	45	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUL 8	2010	466	7303					184	185		10.1038/466184a	http://dx.doi.org/10.1038/466184a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	621LR	20613823				2022-12-28	WOS:000279580800018
J	Al Barqouni, LN; Skaik, SI; Abu Shaban, NR; Barqouni, N				Al Barqouni, Loai Nabil; Skaik, Sobhi I.; Abu Shaban, Nafiz R.; Barqouni, Nabil			White phosphorus burn	LANCET			English	Editorial Material							MANAGEMENT		[Al Barqouni, Loai Nabil] Al Quds Univ, Fac Med, IL-00970 Jerusalem, Israel; [Skaik, Sobhi I.] Shifa Med Ctr, Dept Surg, Gaza, Israel; [Abu Shaban, Nafiz R.] Shifa Med Ctr, Dept Plast Surg & Burns, Gaza, Israel; [Barqouni, Nabil] Al Nasser Pediat Hosp, Gaza, Israel		Al Barqouni, LN (corresponding author), Al Quds Univ, Fac Med, IL-00970 Jerusalem, Israel.	lnb6des@hotmail.com	Albarqouni, Loai/I-1295-2019; Albarqouni, Loai/M-7773-2014	Albarqouni, Loai/0000-0002-4114-9106; 				Chou TD, 2001, BURNS, V27, P492, DOI 10.1016/S0305-4179(01)00003-1; Davis KG, 2002, MIL MED, V167, P83, DOI 10.1093/milmed/167.1.83; ELDAD A, 1991, BURNS, V17, P198, DOI 10.1016/0305-4179(91)90103-N; LISANDRO I, 2007, CBRNE INCENDIARY AGE	4	16	16	2	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 3	2010	376	9734					68	68		10.1016/S0140-6736(10)60812-4	http://dx.doi.org/10.1016/S0140-6736(10)60812-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	624SR	20609989				2022-12-28	WOS:000279841600026
J	Horton, R				Horton, Richard			The Lancet-Palestinian Health Alliance in 2010	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.							2009, LANCET          0304	1	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUL 3	2010	376	9734					7	8		10.1016/S0140-6736(10)61035-5	http://dx.doi.org/10.1016/S0140-6736(10)61035-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	624SR	20609977				2022-12-28	WOS:000279841600007
J	Ekser, B; Rigotti, P				Ekser, Burcin; Rigotti, Paolo			Autosomal Dominant Polycystic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ekser, Burcin; Rigotti, Paolo] Univ Padua, Padua, Italy	University of Padua	Ekser, B (corresponding author), Univ Padua, Padua, Italy.	paolo.rigotti@unipd.it	Ekser, Burcin/I-3288-2019	Ekser, Burcin/0000-0003-0741-8007; RIGOTTI, PAOLO/0000-0002-8895-935X					0	6	7	1	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JUL 1	2010	363	1					71	71		10.1056/NEJMicm0905399	http://dx.doi.org/10.1056/NEJMicm0905399			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	618HR	20592299				2022-12-28	WOS:000279343000010
J	Delamothe, T				Delamothe, Tony			On the Contrary Patient choice minus the ulterior motive	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London, England			tdelamothe@bmj.com							0	0	0	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 30	2010	340								c3457	10.1136/bmj.c3457	http://dx.doi.org/10.1136/bmj.c3457			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	621NT	20591967				2022-12-28	WOS:000279586300019
J	Denton, GH; Anderson, RF; Toggweiler, JR; Edwards, RL; Schaefer, JM; Putnam, AE				Denton, G. H.; Anderson, R. F.; Toggweiler, J. R.; Edwards, R. L.; Schaefer, J. M.; Putnam, A. E.			The Last Glacial Termination	SCIENCE			English	Review							MILLENNIAL-SCALE CHANGES; ABRUPT CLIMATE-CHANGE; ANTARCTIC ICE-SHEET; ATMOSPHERIC CO2; SOUTHERN-OCEAN; YOUNGER DRYAS; NORTHEASTERN BRAZIL; BIPOLAR SEESAW; ATLANTIC-OCEAN; NORTH-ATLANTIC	A major puzzle of paleoclimatology is why, after a long interval of cooling climate, each late Quaternary ice age ended with a relatively short warming leg called a termination. We here offer a comprehensive hypothesis of how Earth emerged from the last global ice age. A prerequisite was the growth of very large Northern Hemisphere ice sheets, whose subsequent collapse created stadial conditions that disrupted global patterns of ocean and atmospheric circulation. The Southern Hemisphere westerlies shifted poleward during each northern stadial, producing pulses of ocean upwelling and warming that together accounted for much of the termination in the Southern Ocean and Antarctica. Rising atmospheric CO2 during southern upwelling pulses augmented warming during the last termination in both polar hemispheres.	[Anderson, R. F.; Schaefer, J. M.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Denton, G. H.; Putnam, A. E.] Univ Maine, Dept Earth Sci, Orono, ME 04469 USA; [Denton, G. H.; Putnam, A. E.] Univ Maine, Climate Change Inst, Bryand Global Sci Ctr, Orono, ME 04469 USA; [Anderson, R. F.; Schaefer, J. M.] Columbia Univ, Dept Earth & Environm Sci, New York, NY 10025 USA; [Toggweiler, J. R.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Edwards, R. L.] Univ Minnesota, Dept Geol & Geophys, Minneapolis, MN 55455 USA	Columbia University; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Columbia University; National Oceanic Atmospheric Admin (NOAA) - USA; University of Minnesota System; University of Minnesota Twin Cities	Anderson, RF (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, POB 1000, Palisades, NY 10964 USA.	boba@ldeo.columbia.edu	Toggweiler, J. R./O-5883-2019; Edwards, R. Lawrence/I-3124-2014	Toggweiler, J. R./0000-0001-6345-5756; Edwards, R. Lawrence/0000-0002-7027-5881; Putnam, Aaron/0000-0002-5358-1473; Anderson, Robert/0000-0002-8472-2494	National Oceanic and Atmospheric Administration; Gary C. Comer Science and Education Foundation	National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Gary C. Comer Science and Education Foundation	Comments from W. S. Broecker and three anonymous reviewers improved this manuscript. S. Birkel assisted in drafting the figures. Work described in this paper was funded by a grants/cooperative agreement from the National Oceanic and Atmospheric Administration and by the Gary C. Comer Science and Education Foundation. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its subagencies. This is Lamont-Doherty Earth Observatory contribution number 7368.	Ahn J, 2008, SCIENCE, V322, P83, DOI 10.1126/science.1160832; Altabet MA, 2002, NATURE, V415, P159, DOI 10.1038/415159a; Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; Arz HW, 1998, QUATERNARY RES, V50, P157, DOI 10.1006/qres.1998.1992; Asmerom Y, 2010, NAT GEOSCI, V3, P114, DOI 10.1038/NGEO754; Bard E, 2000, SCIENCE, V289, P1321, DOI 10.1126/science.289.5483.1321; Bard E, 2009, NATURE, V460, P380, DOI 10.1038/nature08189; Barker S, 2009, NATURE, V457, P1097, DOI 10.1038/nature07770; BARNETT TP, 1988, SCIENCE, V239, P504, DOI 10.1126/science.239.4839.504; Barrows TT, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001328; BENSON L, 1995, PALAEOGEOGR PALAEOCL, V117, P1, DOI 10.1016/0031-0182(94)00103-F; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BOND GC, 1995, SCIENCE, V267, P1005, DOI 10.1126/science.267.5200.1005; Broecker WS, 1998, PALEOCEANOGRAPHY, V13, P119, DOI 10.1029/97PA03707; BROECKER WS, 1982, PROG OCEANOGR, V11, P151, DOI 10.1016/0079-6611(82)90007-6; BROECKER WS, 1970, REV GEOPHYS SPACE GE, V8, P169, DOI 10.1029/RG008i001p00169; BROECKER WS, 1990, SCI AM, V262, P48, DOI 10.1038/scientificamerican0190-48; Calvo E, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029937; Cheng H, 2009, SCIENCE, V326, P248, DOI 10.1126/science.1177840; Chiang JCH, 2005, CLIM DYNAM, V25, P477, DOI 10.1007/s00382-005-0040-5; Chiang JCH, 2009, ANNU REV EARTH PL SC, V37, P263, DOI 10.1146/annurev.earth.031208.100217; Conway H, 1999, SCIENCE, V286, P280, DOI 10.1126/science.286.5438.280; Crowley TJ, 1992, PALEOCEANOGRAPHY, V7, P489, DOI 10.1029/92PA01058; Denton G. H., 1981, LAST GREAT ICE SHEET; Denton G.H., 2006, PAGES NEWS, V14, P14, DOI DOI 10.22498/PAGES.14.2.14; Denton GH, 2005, QUATERNARY SCI REV, V24, P1159, DOI 10.1016/j.quascirev.2004.12.002; Denton GH, 1999, GEOGR ANN A, V81A, P107, DOI 10.1111/j.0435-3676.1999.00055.x; Denton GH, 2002, QUATERNARY SCI REV, V21, P193, DOI 10.1016/S0277-3791(01)00090-7; Dyke A.S., 1987, GEOGR PHYS QUATERNAI, V2, P237, DOI [10.7202/032681ar, DOI 10.7202/032681AR]; Gasse F, 2008, QUATERNARY SCI REV, V27, P2316, DOI 10.1016/j.quascirev.2008.08.027; Gersonde R, 2005, QUATERNARY SCI REV, V24, P869, DOI 10.1016/j.quascirev.2004.07.015; Griffiths ML, 2009, NAT GEOSCI, V2, P636, DOI 10.1038/NGEO605; HEINRICH H, 1988, QUATERNARY RES, V29, P142, DOI 10.1016/0033-5894(88)90057-9; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Isarin RFB, 1998, J QUATERNARY SCI, V13, P447, DOI 10.1002/(SICI)1099-1417(1998090)13:5<447::AID-JQS402>3.3.CO;2-2; Isarin RFB, 1999, EARTH-SCI REV, V48, P1, DOI 10.1016/S0012-8252(99)00047-1; Kaiser J, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001146; Kawamura K, 2007, NATURE, V448, P912, DOI 10.1038/nature06015; Knutti R, 2004, NATURE, V430, P851, DOI 10.1038/nature02786; Lamy F, 2007, EARTH PLANET SC LETT, V259, P400, DOI 10.1016/j.epsl.2007.04.040; Leduc G, 2009, QUATERNARY RES, V72, P123, DOI 10.1016/j.yqres.2009.03.006; Lee S, 2003, J ATMOS SCI, V60, P1490, DOI 10.1175/1520-0469(2003)060<1490:TDRBSA>2.0.CO;2; Levermann A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030255; LINDZEN RS, 1988, J ATMOS SCI, V45, P2416, DOI 10.1175/1520-0469(1988)045<2416:HCFZAH>2.0.CO;2; Lisiecki LE, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2005PA001164; Liu Z, 2009, SCIENCE, V325, P310, DOI 10.1126/science.1171041; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; MERCER JH, 1984, CLIMATE PROCESSES CL, P307; Milankovitch M., 1941, ROYAL SERBIAN ACAD S, V132; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Moreno PI, 1999, GEOGR ANN A, V81A, P285, DOI 10.1111/1468-0459.00059; Muller J, 2008, QUATERNARY SCI REV, V27, P468, DOI 10.1016/j.quascirev.2007.11.006; Naughton F, 2009, EARTH PLANET SC LETT, V284, P329, DOI 10.1016/j.epsl.2009.05.001; Ortiz JD, 2004, GEOLOGY, V32, P521, DOI 10.1130/G20234.1; Peeters FJC, 2004, NATURE, V430, P661, DOI 10.1038/nature02785; Peterson LC, 2000, SCIENCE, V290, P1947, DOI 10.1126/science.290.5498.1947; Raymo ME, 1997, PALEOCEANOGRAPHY, V12, P577, DOI 10.1029/97PA01169; Renssen H, 2001, GLOBAL PLANET CHANGE, V30, P117, DOI 10.1016/S0921-8181(01)00082-0; Roe G, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027817; Saikku R, 2009, QUATERNARY SCI REV, V28, P2374, DOI 10.1016/j.quascirev.2009.05.007; Screen JA, 2009, J CLIMATE, V22, P806, DOI 10.1175/2008JCLI2416.1; Severinghaus JP, 1998, NATURE, V391, P141, DOI 10.1038/34346; Sikes EL, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001659; STRELIN J, 2005, P 16 C GEOL ARG CD R; Stuiver M, 2000, QUATERNARY RES, V53, P277, DOI 10.1006/qres.2000.2127; Svendsen JI, 2004, QUATERNARY SCI REV, V23, P1229, DOI 10.1016/j.quascirev.2003.12.008; Thompson WG, 2006, QUATERNARY SCI REV, V25, P3207, DOI 10.1016/j.quascirev.2006.02.007; Toucanne S, 2009, QUATERNARY SCI REV, V28, P1238, DOI 10.1016/j.quascirev.2009.01.006; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wang YJ, 2001, SCIENCE, V294, P2345, DOI 10.1126/science.1064618; Wolff EW, 2009, NAT GEOSCI, V2, P206, DOI 10.1038/NGEO442; Yuan DX, 2004, SCIENCE, V304, P575, DOI 10.1126/science.1091220	73	548	569	13	307	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 25	2010	328	5986					1652	1656		10.1126/science.1184119	http://dx.doi.org/10.1126/science.1184119			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576882				2022-12-28	WOS:000279107400032
J	Hapfelmeier, S; Lawson, MAE; Slack, E; Kirundi, JK; Stoel, M; Heikenwalder, M; Cahenzli, J; Velykoredko, Y; Balmer, ML; Endt, K; Geuking, MB; Curtiss, R; McCoy, KD; Macpherson, AJ				Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Heikenwalder, Mathias; Cahenzli, Julia; Velykoredko, Yuliya; Balmer, Maria L.; Endt, Kathrin; Geuking, Markus B.; Curtiss, Roy, III; McCoy, Kathy D.; Macpherson, Andrew J.			Reversible Microbial Colonization of Germ-Free Mice Reveals the Dynamics of IgA Immune Responses	SCIENCE			English	Article							PLASMA-CELLS; COMMENSAL BACTERIA; T-CELLS; MEMORY; MAINTENANCE; GUT	The lower intestine of adult mammals is densely colonized with nonpathogenic (commensal) microbes. Gut bacteria induce protective immune responses, which ensure host-microbial mutualism. The continuous presence of commensal intestinal bacteria has made it difficult to study mucosal immune dynamics. Here, we report a reversible germ-free colonization system in mice that is independent of diet or antibiotic manipulation. A slow (more than 14 days) onset of a long-lived (half-life over 16 weeks), highly specific anticommensal immunoglobulin A (IgA) response in germ-free mice was observed. Ongoing commensal exposure in colonized mice rapidly abrogated this response. Sequential doses lacked a classical prime-boost effect seen in systemic vaccination, but specific IgA induction occurred as a stepwise response to current bacterial exposure, such that the antibody repertoire matched the existing commensal content.	[Hapfelmeier, Siegfried; Slack, Emma; Kirundi, Jorum K.; Balmer, Maria L.; Macpherson, Andrew J.] Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland; [Hapfelmeier, Siegfried; Lawson, Melissa A. E.; Slack, Emma; Kirundi, Jorum K.; Stoel, Maaike; Cahenzli, Julia; Velykoredko, Yuliya; Geuking, Markus B.; McCoy, Kathy D.; Macpherson, Andrew J.] McMaster Univ, Farncombe Family Digest Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada; [Heikenwalder, Mathias] Univ Zurich Hosp, Dept Pathol, CH-8091 Zurich, Switzerland; [Endt, Kathrin] Fed Inst Technol, Inst Microbiol, CH-8093 Zurich, Switzerland; [Curtiss, Roy, III] Arizona State Univ, Biodesign Inst, Ctr Infect Dis & Vaccinol, Tempe, AZ 85287 USA	University of Bern; University Hospital of Bern; McMaster University; University of Zurich; University Zurich Hospital; Arizona State University; Arizona State University-Tempe	Hapfelmeier, S (corresponding author), Univ Bern, Univ Klin Viszerale Chirurg & Med UVCM, DKF Maurice Muller Labs, MEM, CH-3013 Bern, Switzerland.	hapfelmeier@gmail.com; andrew.macpherson@insel.ch	Hapfelmeier, Siegfried/B-6005-2011; Slack, Emma/B-1612-2016; McCoy, Kathy/ABD-5814-2021; Balmer, Maria L/A-8546-2013; Balmer, Maria Luisa/AAB-8993-2021; Slack, Emma/AAD-5837-2019; Lawson, Melissa/K-5848-2014; Heikenwalder, Mathias/AAA-2269-2020	Hapfelmeier, Siegfried/0000-0002-6913-7932; Slack, Emma/0000-0002-2473-1145; Balmer, Maria Luisa/0000-0003-0356-6352; Slack, Emma/0000-0002-2473-1145; Lawson, Melissa/0000-0001-9882-8663; Kirundi, Jorum/0000-0001-9617-0634	Swiss National Science Foundation [310030_124732]; Canadian Institutes of Health Research; Crohn's and Colitis Foundation of Canada; Genome Canada; Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program; Oncosuisse Foundation [OCS 02113-08-2007]; German Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060557] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Crohn's and Colitis Foundation of Canada; Genome Canada(Genome Canada); Farncombe Foundation; Canadian Association of Gastroenterology; Canada Research Chairs program(Canada Research Chairs); Oncosuisse Foundation; German Science Foundation(German Research Foundation (DFG)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Zhang, H. Roberts, J. Notarangelo, S. Armstrong, S. Competente, M. Provenza, J. Bodewes, and R. McArthur for their technical support and B. Stecher, W.-D. Hardt, A. J. Muller, N. A. Bos, C. Mueller, R. M. Zinkernagel, A. G. Rolink, A. Lanzavecchia, and C. Reis e Sousa for their helpful comments and editing the manuscript. Grant support: Swiss National Science Foundation (310030_124732), Canadian Institutes of Health Research, Crohn's and Colitis Foundation of Canada, Genome Canada, Farncombe Foundation, Canadian Association of Gastroenterology. This research was also supported with funding from the Canada Research Chairs program to K. D. M. and A. J. M. M. H. is a fellow of the Prof. Dr. Max Cloetta foundation and was supported by grants of the Oncosuisse Foundation (OCS 02113-08-2007). S. H. was supported in part by a German Science Foundation fellowship, and the clean mouse facility Bern was supported by the Genaxen Foundation. The authors have no conflicts of interests to declare.	BENTLEY AT, 1988, J BACTERIOL, V170, P1063, DOI 10.1128/jb.170.3.1063-1068.1988; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; FECSIK AI, 1964, J EXP MED, V120, P1041, DOI 10.1084/jem.120.6.1041; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Manz RA, 1997, NATURE, V388, P133, DOI 10.1038/40540; MATTIOLI CA, 1973, J EXP MED, V138, P452, DOI 10.1084/jem.138.2.452; NAKAYAMA K, 1988, BIO-TECHNOL, V6, P693, DOI 10.1038/nbt0688-693; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Stecher B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000711; Tough DF, 2003, TRENDS IMMUNOL, V24, P404, DOI 10.1016/S1471-4906(03)00169-8; Zinkernagel RM, 2006, IMMUNOL REV, V211, P310, DOI 10.1111/j.0105-2896.2006.00402.x	16	486	527	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUN 25	2010	328	5986					1705	1709		10.1126/science.1188454	http://dx.doi.org/10.1126/science.1188454			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	615BY	20576892	Green Accepted			2022-12-28	WOS:000279107400047
J	Martello, G; Rosato, A; Ferrari, F; Manfrin, A; Cordenonsi, M; Dupont, S; Enzo, E; Guzzardo, V; Rondina, M; Spruce, T; Parenti, AR; Daidone, MG; Bicciato, S; Piccolo, S				Martello, Graziano; Rosato, Antonio; Ferrari, Francesco; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Guzzardo, Vincenza; Rondina, Maria; Spruce, Thomas; Parenti, Anna R.; Daidone, Maria Grazia; Bicciato, Silvio; Piccolo, Stefano			A MicroRNA Targeting Dicer for Metastasis Control	CELL			English	Article							EXPRESSION; DEFINITION; SIGNATURE; INVASION; SUBTYPES; GENES; FILES; ZEB1; RNAS	Although specific microRNAs (miRNAs) can be upregulated in cancer, global miRNA downregulation is a common trait of human malignancies. The mechanisms of this phenomenon and the advantages it affords remain poorly understood. Here we identify a microRNA family, miR-103/107, that attenuates miRNA biosynthesis by targeting Dicer, a key component of the miRNA processing machinery. In human breast cancer, high levels of miR-103/107 are associated with metastasis and poor outcome. Functionally, miR-103/107 confer migratory capacities in vitro and empower metastatic dissemination of otherwise nonaggressive cells in vivo. Inhibition of miR-103/107 opposes migration and metastasis of malignant cells. At the cellular level, a key event fostered by miR-103/107 is induction of epithelial-to-mesenchymal transition (EMT), attained by downregulating miR-200 levels. These findings suggest a new pathway by which Dicer inhibition drifts epithelial cancer toward a less-differentiated, mesenchymal fate to foster metastasis.	[Martello, Graziano; Manfrin, Andrea; Cordenonsi, Michelangelo; Dupont, Sirio; Enzo, Elena; Piccolo, Stefano] Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, I-35126 Padua, Italy; [Rosato, Antonio; Rondina, Maria] Univ Padua, Dept Oncol & Surg Sci, I-35126 Padua, Italy; [Rosato, Antonio] Ist Oncol Veneto, I-35126 Padua, Italy; [Ferrari, Francesco; Bicciato, Silvio] Univ Modena & Reggio Emilia, Dept Biomed Sci, Ctr Genome Res, I-41100 Modena, Italy; [Guzzardo, Vincenza; Parenti, Anna R.] Univ Padua, Sect Pathol, Dept Med Diagnost Sci & Special Therapies, I-35126 Padua, Italy; [Spruce, Thomas] Univ London Imperial Coll Sci Technol & Med, MRC, Mol Embryol Grp, Ctr Clin Sci, London W12 0NN, England; [Daidone, Maria Grazia] Natl Canc Inst, Dept Expt Oncol, I-20133 Milan, Italy	University of Padua; IRCCS Istituto Oncologico Veneto (IOV); University of Padua; IRCCS Istituto Oncologico Veneto (IOV); Universita di Modena e Reggio Emilia; University of Padua; Imperial College London; Fondazione IRCCS Istituto Nazionale Tumori Milan	Piccolo, S (corresponding author), Univ Padua, Sch Med, Dept Histol Microbiol & Med Biotechnol, Viale Colombo 3, I-35126 Padua, Italy.	piccolo@bio.unipd.it	Manfrin, Andrea/AAC-1066-2020; Rosato, Antonio/E-8626-2010; Spruce, Thomas/K-7520-2017; Cordenonsi, Michelangelo/K-7692-2016; Daidone, Maria Grazia/E-9232-2017; BICCIATO, Silvio/J-4466-2019; Ferrari, Francesco/H-5007-2012; Dupont, Sirio/AAP-8133-2021; Bicciato, Silvio/C-9825-2009; Martello, Graziano/AAM-3325-2021	Manfrin, Andrea/0000-0002-1519-6582; Rosato, Antonio/0000-0002-5263-8386; Spruce, Thomas/0000-0001-7389-9254; Cordenonsi, Michelangelo/0000-0002-8253-5724; Daidone, Maria Grazia/0000-0002-4786-1321; BICCIATO, Silvio/0000-0002-1944-7078; Ferrari, Francesco/0000-0002-9811-3753; Bicciato, Silvio/0000-0002-1944-7078; Dupont, Sirio/0000-0002-6869-1966; Enzo, Elena/0000-0001-9768-6368; PICCOLO, STEFANO/0000-0002-2037-0004; Martello, Graziano/0000-0001-5520-085X	Cariparo Foundation; Carimodena Foundation; AIRC; University of Padua; IIT (Italian Institute of Technology); Telethon; ISSN "Giovani Ricercatori"	Cariparo Foundation(Fondazione Cariparo); Carimodena Foundation; AIRC(Fondazione AIRC per la ricerca sul cancro); University of Padua; IIT (Italian Institute of Technology)(Istituto Italiano di Tecnologia - IIT); Telethon(Fondazione Telethon); ISSN "Giovani Ricercatori"	This work is supported by Cariparo Foundation Excellence-grant and Carimodena Foundation international grants to S. B., and AIRC, University of Padua Strategic-grant, Cariparo Foundation Excellence-grant, IIT (Italian Institute of Technology), and Telethon grants to S. P., and ISSN "Giovani Ricercatori" to G. M. We thank T. Rodriguez, O. Wessely, and D. Volpin for comments on the manuscript; the anonymous reviewers for thoughtful directions; and S. Bobisse and R. Venerando for help with cytofluorimeter. We are grateful to colleagues for gifts of reagents: L. Naldini (lentiviral vectors), T. Jacks (mouse shDicer plasmid), P. Provost (Dicer cDNA), W. Filipowicz (Dicer antibody), R. Agami (miR-Vec), F. Miller (4T1 cells), G. Hannon (Dicer null cells), and R. Weinberg (SUM149 cells).	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bicciato S, 2009, NUCLEIC ACIDS RES, V37, P5057, DOI 10.1093/nar/gkp520; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Charafe-Jauffret E, 2009, CANCER RES, V69, P1302, DOI 10.1158/0008-5472.CAN-08-2741; Desmedt C, 2007, CLIN CANCER RES, V13, P3207, DOI 10.1158/1078-0432.CCR-06-2765; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Ferrari F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-446; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fukagawa T, 2004, NAT CELL BIOL, V6, P784, DOI 10.1038/ncb1155; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; Lee KH, 2009, PANCREATOLOGY, V9, P293, DOI 10.1159/000186051; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Loi S, 2007, CRIT REV ONCOL HEMAT, V61, P187, DOI 10.1016/j.critrevonc.2006.09.005; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Martello G, 2007, NATURE, V449, P183, DOI 10.1038/nature06100; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Schmittgen TD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh040; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Ventura A, 2009, CELL, V136, P586, DOI 10.1016/j.cell.2009.02.005; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Zhang Y, 2009, CANCER RES, V69, P3795, DOI 10.1158/0008-5472.CAN-08-4596	46	528	556	1	63	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1195	U176		10.1016/j.cell.2010.05.017	http://dx.doi.org/10.1016/j.cell.2010.05.017			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603000	Bronze			2022-12-28	WOS:000279148100016
J	Alvarez, SE; Harikumar, KB; Hait, NC; Allegood, J; Strub, GM; Kim, EY; Maceyka, M; Jiang, HL; Luo, C; Kordula, T; Milstien, S; Spiegel, S				Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Jiang, Hualiang; Luo, Cheng; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah			Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2	NATURE			English	Article							SPHINGOSINE 1-PHOSPHATE; TNF-ALPHA; ACTIVATION; KINASE; RIP1; IKK; UBIQUITYLATION; BINDING; CELLS; P38	Tumour-necrosis factor (TNF) receptor-associated factor 2 (TRAF2) is a key component in NF-kappa B signalling triggered by TNF-alpha(1,2). Genetic evidence indicates that TRAF2 is necessary for the polyubiquitination of receptor interacting protein 1 (RIP1)(3) that then serves as a platform for recruitment and stimulation of I kappa B kinase, leading to activation of the transcription factor NF-kappa B. Although TRAF2 is a RING domain ubiquitin ligase, direct evidence that TRAF2 catalyses the ubiquitination of RIP1 is lacking. TRAF2 binds to sphingosine kinase 1 (SphK1)(4), one of the isoenzymes that generates the pro-survival lipid mediator sphingosine-1-phosphate (S1P) inside cells. Here we show that SphK1 and the production of S1P is necessary for lysine-63-linked polyubiquitination of RIP1, phosphorylation of I kappa B kinase and I kappa B alpha, and I kappa B alpha degradation, leading to NF-kappa B activation. These responses were mediated by intracellular S1P independently of its cell surface G-protein-coupled receptors. S1P specifically binds to TRAF2 at the amino-terminal RING domain and stimulates its E3 ligase activity. S1P, but not dihydro-S1P, markedly increased recombinant TRAF2-catalysed lysine-63-linked, but not lysine-48-linked, polyubiquitination of RIP1 in vitro in the presence of the ubiquitin conjugating enzymes (E2) UbcH13 or UbcH5a. Our data show that TRAF2 is a novel intracellular target of S1P, and that S1P is the missing cofactor for TRAF2 E3 ubiquitin ligase activity, indicating a new paradigm for the regulation of lysine-63-linked polyubiquitination. These results also highlight the key role of SphK1 and its product S1P in TNF-alpha signalling and the canonical NF-kappa B activation pathway important in inflammatory, antiapoptotic and immune processes.	[Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, Richmond, VA 23298 USA; [Alvarez, Sergio E.; Harikumar, Kuzhuvelil B.; Hait, Nitai C.; Allegood, Jeremy; Strub, Graham M.; Kim, Eugene Y.; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Massey Canc Ctr, Sch Med, Richmond, VA 23298 USA; [Jiang, Hualiang; Luo, Cheng] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China	Virginia Commonwealth University; Virginia Commonwealth University; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biophys, Sch Med, 1101 E Marshall St, Richmond, VA 23298 USA.	sspiegel@vcu.edu	Harikumar, Kuzhuvelil/AAC-2407-2020; Maceyka, Michael/B-9277-2008	Harikumar, Kuzhuvelil/0000-0002-1763-4179; 	National Institute of Health [R37GM043880, R01CA61774, R01AI50094, U19AI077435]; Ministry of Scientific and Technology of China [2009CB918502]; NATIONAL CANCER INSTITUTE [R01CA061774] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050094, U19AI077435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043880] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Scientific and Technology of China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Z. J. Chen, B. Darnay and M. Karin for HA-ubiquitin and TRAF constructs, and R. Proia for the Sphk1<SUP>-/-</SUP> mice. This work was supported by grants from the National Institute of Health (R37GM043880, R01CA61774, R01AI50094, U19AI077435 to S.S.) and in part by the Ministry of Scientific and Technology of China (2009CB918502 to C.L.).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Ea CK, 2006, MOL CELL, V22, P245, DOI 10.1016/j.molcel.2006.03.026; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Ki SH, 2007, J BIOL CHEM, V282, P1938, DOI 10.1074/jbc.M606080200; Kimura T, 2006, J BIOL CHEM, V281, P37457, DOI 10.1074/jbc.M605823200; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li S, 2009, MOL CELL, V33, P30, DOI 10.1016/j.molcel.2008.11.023; Maceyka M, 2008, MOL CELL BIOL, V28, P5687, DOI 10.1128/MCB.00465-08; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Paugh SW, 2008, BLOOD, V112, P1382, DOI 10.1182/blood-2008-02-138958; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Theiss AL, 2009, MOL BIOL CELL, V20, P4412, DOI 10.1091/mbc.E09-05-0361; VAN BJ, 1998, J CELL BIOL, V142, P229; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Wang HP, 2008, P NATL ACAD SCI USA, V105, P20197, DOI 10.1073/pnas.0810461105; Wu CJ, 2006, NAT CELL BIOL, V8, P398, DOI 10.1038/ncb1384; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Xu M, 2009, MOL CELL, V36, P302, DOI 10.1016/j.molcel.2009.10.002; Yin Q, 2009, BIOCHEMISTRY-US, V48, P10558, DOI 10.1021/bi901462e; Zhao YT, 2007, J BIOL CHEM, V282, P14165, DOI 10.1074/jbc.M701279200	30	548	583	8	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1084	U149		10.1038/nature09128	http://dx.doi.org/10.1038/nature09128			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20577214	Green Accepted			2022-12-28	WOS:000279056900054
J	Petherick, A				Petherick, Anna			Chagas disease in the Chaco	NATURE			English	Editorial Material							TRIATOMA-INFESTANS											Ceballos LA, 2009, J MED ENTOMOL, V46, P1195, DOI 10.1603/033.046.0530; Cecere MC, 2006, EMERG INFECT DIS, V12, P1096; Cohen JE, 2001, SCIENCE, V293, P694, DOI 10.1126/science.1060638; Gurtler RE, 2007, P NATL ACAD SCI USA, V104, P16194, DOI 10.1073/pnas.0700863104; Vazquez-Prokopec GM, 2006, MED VET ENTOMOL, V20, P273, DOI 10.1111/j.1365-2915.2006.00637.x	5	4	4	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					S18	S20		10.1038/nature09226	http://dx.doi.org/10.1038/nature09226			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	614KI	20571550	Bronze			2022-12-28	WOS:000279056900030
J	Shen, B; Makley, DM; Johnston, JN				Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.			Umpolung reactivity in amide and peptide synthesis	NATURE			English	Article							NITROALDOL HENRY REACTION; CHIRAL PROTON CATALYSIS; STAUDINGER LIGATION; ENANTIOSELECTIVE SYNTHESIS; OXIDATIVE AMIDATION; ACID-DERIVATIVES; BOND FORMATION; BRONSTED ACID; CATHEPSIN-K; ALDEHYDES	The amide bond is one of nature's most common functional and structural elements, as the backbones of all natural peptides and proteins are composed of amide bonds. Amides are also present in many therapeutic small molecules. The construction of amide bonds using available methods relies principally on dehydrative approaches, although oxidative and radical-based methods are representative alternatives. In nearly every example, carbon and nitrogen bear electrophilic and nucleophilic character, respectively, during the carbon-nitrogen bond-forming step. Here we show that activation of amines and nitroalkanes with an electrophilic iodine source can lead directly to amide products. Preliminary observations support a mechanism in which the polarities of the two reactants are reversed (German, umpolung) during carbon-nitrogen bond formation relative to traditional approaches. The use of nitroalkanes as acyl anion equivalents provides a conceptually innovative approach to amide and peptide synthesis, and one that might ultimately provide for efficient peptide synthesis that is fully reliant on enantioselective methods.	[Shen, Bo; Makley, Dawn M.; Johnston, Jeffrey N.] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA	Vanderbilt University	Johnston, JN (corresponding author), Vanderbilt Univ, Vanderbilt Inst Chem Biol, Dept Chem, Nashville, TN 37235 USA.	jeffrey.n.johnston@vanderbilt.edu	Johnston, Jeff/AAW-1271-2021; Shen, Bo/D-6294-2011	Johnston, Jeff/0000-0002-0885-636X; 	Vanderbilt Institute of Chemical Biology; NIH [GM084333, T32 GM065086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063557, T32GM065086, R56GM063557, R01GM084333] Funding Source: NIH RePORTER	Vanderbilt Institute of Chemical Biology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Vanderbilt Institute of Chemical Biology, and in part (catalyst preparation and development) by the NIH (GM084333 and Chemistry-Biology Interface training grant T32 GM065086 in support of D.M.M.).	Ballini R, 2004, TETRAHEDRON, V60, P1017, DOI 10.1016/j.tet.2003.11.016; Bode JW, 2006, CURR OPIN DRUG DISC, V9, P765; Bode JW, 2006, ANGEW CHEM INT EDIT, V45, P1248, DOI 10.1002/anie.200503991; Cassidy MP, 2006, ANGEW CHEM INT EDIT, V45, P3154, DOI 10.1002/anie.200503805; Chan WK, 2006, J AM CHEM SOC, V128, P14796, DOI 10.1021/ja064479s; Cho SH, 2005, J AM CHEM SOC, V127, P16046, DOI 10.1021/ja056399e; Davis TA, 2010, J AM CHEM SOC, V132, P2880, DOI 10.1021/ja908814h; DAWSON PE, 1994, SCIENCE, V266, P776, DOI 10.1126/science.7973629; ERDIK E, 1989, CHEM REV, V89, P1947, DOI 10.1021/cr00098a014; Gao J, 2008, J ORG CHEM, V73, P2955, DOI 10.1021/jo800075t; Gauthier JY, 2008, BIOORG MED CHEM LETT, V18, P923, DOI 10.1016/j.bmcl.2007.12.047; Grayson EJ, 2005, ORG LETT, V7, P2361, DOI 10.1021/ol050624f; GROBEL BT, 1977, SYNTHESIS-STUTTGART, P357; Gunanathan C, 2007, SCIENCE, V317, P790, DOI 10.1126/science.1145295; Katoh T, 2008, TETRAHEDRON LETT, V49, P598, DOI 10.1016/j.tetlet.2007.11.162; Kohn M, 2004, ANGEW CHEM INT EDIT, V43, P3106, DOI 10.1002/anie.200401744; KOVACIC P, 1970, CHEM REV, V70, P639, DOI 10.1021/cr60268a002; Li XC, 2008, J AM CHEM SOC, V130, P5446, DOI 10.1021/ja800612r; Marques-Lopez E, 2009, EUR J ORG CHEM, V2009, P2401, DOI 10.1002/ejoc.200801097; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; MERRIFIELD RB, 1964, J AM CHEM SOC, V86, P304, DOI 10.1021/ja01056a056; Nilsson BL, 2000, ORG LETT, V2, P1939, DOI 10.1021/ol0060174; Nordstrom LU, 2008, J AM CHEM SOC, V130, P17672, DOI 10.1021/ja808129p; Nugent BM, 2004, J AM CHEM SOC, V126, P3418, DOI 10.1021/ja031906i; Ono N., 2001, NITRO GROUP ORGANIC; Palmer JT, 2005, J MED CHEM, V48, P7520, DOI 10.1021/jm058198r; Palomo C, 2004, ANGEW CHEM INT EDIT, V43, P5442, DOI 10.1002/anie.200460506; Palomo C, 2007, EUR J ORG CHEM, V2007, P2561, DOI 10.1002/ejoc.200700021; Pinnick H. W., 1990, ORG REACT, V38, P655, DOI [10.1002/0471264180.or038.03, DOI 10.1002/0471264180.0R038.03]; Saxon E, 2002, J AM CHEM SOC, V124, P14893, DOI 10.1021/ja027748x; Saxon E, 2000, SCIENCE, V287, P2007, DOI 10.1126/science.287.5460.2007; Saxon E, 2000, ORG LETT, V2, P2141, DOI 10.1021/ol006054v; SEEBACH D, 1975, J ORG CHEM, V40, P231, DOI 10.1021/jo00890a018; SEEBACH D, 1979, ANGEW CHEM INT EDIT, V18, P239, DOI 10.1002/anie.197902393; Shen B, 2008, ORG LETT, V10, P4397, DOI 10.1021/ol801797h; Singh A, 2008, J AM CHEM SOC, V130, P5866, DOI 10.1021/ja8011808; Singh A, 2007, J AM CHEM SOC, V129, P3466, DOI 10.1021/ja068073r; Stenmark HG, 2000, J ORG CHEM, V65, P3875, DOI 10.1021/jo000055j; Valeur E, 2009, CHEM SOC REV, V38, P606, DOI 10.1039/b701677h; Westermann B, 2003, ANGEW CHEM INT EDIT, V42, P151, DOI 10.1002/anie.200390071; WILLIAMS RM, 1992, CHEM REV, V92, P889, DOI 10.1021/cr00013a007; Wilt JC, 2008, CHEM COMMUN, P4177, DOI 10.1039/b808393b; Wong FT, 2008, ORG LETT, V10, P2333, DOI 10.1021/ol8004276; Yoo WJ, 2006, J AM CHEM SOC, V128, P13064, DOI 10.1021/ja064315b; Zhong YL, 2005, TETRAHEDRON LETT, V46, P1099, DOI 10.1016/j.tetlet.2004.12.088	45	238	239	6	116	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 24	2010	465	7301					1027	U82		10.1038/nature09125	http://dx.doi.org/10.1038/nature09125			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	614KI	20577205	Green Accepted			2022-12-28	WOS:000279056900042
J	Bailey, CJ; Barnett, AH				Bailey, Clifford J.; Barnett, Anthony H.			Inhaled insulin: new formulation, new trial	LANCET			English	Editorial Material							TO-TARGET TRIAL; BASAL INSULIN; ORAL-THERAPY; NPH INSULIN; TYPE-2; GLARGINE		[Bailey, Clifford J.] Aston Univ, Birmingham B4 7ET, W Midlands, England; [Bailey, Clifford J.] Birmingham Childrens Hosp, Birmingham, W Midlands, England; [Barnett, Anthony H.] Birmingham Heartlands Hosp, Heart England NHS Fdn Trust, Birmingham B9 5ST, W Midlands, England; [Barnett, Anthony H.] Univ Birmingham, Sch Med, Birmingham, W Midlands, England	Aston University; University of Birmingham; Heart of England NHS Foundation Trust; University of Birmingham; University of Birmingham	Bailey, CJ (corresponding author), Aston Univ, Birmingham B4 7ET, W Midlands, England.	c.j.bailey@aston.ac.uk		Bailey, Clifford J/0000-0002-6998-6811				Amer Diabet Assoc, 2010, DIABETES CARE, V33, pS11, DOI 10.2337/dc10-S011; BAILEY CJ, 2007, BR J DIABETES VASC D, V7, P255; BAILEY CJ, 2007, BRIT MED J, V35, P1156; BELLARY S, 2006, BR J DIABETES VASC D, V6, P103; CHAIKEN RL, 2008, PFIZER          0409; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Hermansen K, 2006, DIABETES CARE, V29, P1269, DOI 10.2337/dc05-1365; Holman RR, 2007, NEW ENGL J MED, V357, P1716, DOI 10.1056/NEJMoa075392; Nathan DM, 2006, DIABETOLOGIA, V49, P1711, DOI 10.1007/s00125-006-0316-2; Neumiller JJ, 2010, BIODRUGS, V24, P165, DOI 10.2165/11536700-000000000-00000; Riddle MC, 2003, DIABETES CARE, V26, P3080, DOI 10.2337/diacare.26.11.3080; Rosenstock J, 2005, ANN INTERN MED, V143, P549, DOI 10.7326/0003-4819-143-8-200510180-00005; Rosenstock J, 2010, LANCET, V375, P2244, DOI 10.1016/S0140-6736(10)60632-0; Skyler JS, 2007, DIABETES CARE, V30, P579, DOI 10.2337/dc06-1863	14	6	6	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUN-JUL	2010	375	9733					2199	2201		10.1016/S0140-6736(10)60885-9	http://dx.doi.org/10.1016/S0140-6736(10)60885-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20609958				2022-12-28	WOS:000279652900007
J	Cheng, MH				Cheng, Margaret Harris			Asia-Pacific faces diabetes challenge	LANCET			English	News Item																		2010, N ENGL J MED, V362, P1090	1	33	35	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN-JUL	2010	375	9733					2207	2210		10.1016/S0140-6736(10)61014-8	http://dx.doi.org/10.1016/S0140-6736(10)61014-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	622HS	20626091				2022-12-28	WOS:000279652900012
J	Cantagrel, V; Lefeber, DJ; Ng, BG; Guan, ZQ; Silhavy, JL; Bielas, SL; Lehle, L; Hombauer, H; Adamowicz, M; Swiezewska, E; De Brouwer, AP; Blumel, P; Sykut-Cegielska, J; Houliston, S; Swistun, D; Ali, BR; Dobyns, WB; Babovic-Vuksanovic, D; van Bokhoven, H; Wevers, RA; Raetz, CRH; Freeze, HH; Morava, E; Al-Gazali, L; Gleeson, JG				Cantagrel, Vincent; Lefeber, Dirk J.; Ng, Bobby G.; Guan, Ziqiang; Silhavy, Jennifer L.; Bielas, Stephanie L.; Lehle, Ludwig; Hombauer, Hans; Adamowicz, Maciej; Swiezewska, Ewa; De Brouwer, Arjan P.; Bluemel, Peter; Sykut-Cegielska, Jolanta; Houliston, Scott; Swistun, Dominika; Ali, Bassam R.; Dobyns, William B.; Babovic-Vuksanovic, Dusica; van Bokhoven, Hans; Wevers, Ron A.; Raetz, Christian R. H.; Freeze, Hudson H.; Morava, Eva; Al-Gazali, Lihadh; Gleeson, Joseph G.			SRD5A3 Is Required for Converting Polyprenol to Dolichol and Is Mutated in a Congenital Glycosylation Disorder	CELL			English	Article							IONIZATION-MASS-SPECTROMETRY; AUTOSOMAL RECESSIVE SYNDROME; RATE-LIMITING STEP; STEROID 5-ALPHA-REDUCTASE; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; RAT-LIVER; BIOSYNTHESIS; PHOSPHATE; CDG	N-linked glycosylation is the most frequent modification of secreted and membrane-bound proteins in eukaryotic cells, disruption of which is the basis of the congenital disorders of glycosylation (CDGs). We describe a new type of CDG caused by mutations in the steroid 5 alpha-reductase type 3 (SRD5A3) gene. Patients have mental retardation and ophthalmologic and cerebellar defects. We found that SRD5A3 is necessary for the reduction of the alpha-isoprene unit of polyprenols to form dolichols, required for synthesis of dolichol-linked monosaccharides, and the oligosaccharide precursor used for N-glycosylation. The presence of residual dolichol in cells depleted for this enzyme suggests the existence of an unexpected alternative pathway for dolichol de novo biosynthesis. Our results thus suggest that SRD5A3 is likely to be the long-sought polyprenol reductase and reveal the genetic basis of one of the earliest steps in protein N-linked glycosylation.	[Ali, Bassam R.; Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pediat, Al Ain 17666, U Arab Emirates; [Cantagrel, Vincent; Silhavy, Jennifer L.; Bielas, Stephanie L.; Swistun, Dominika; Gleeson, Joseph G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Neurosci & Pediat, Inst Genom Med,Neurogenet Lab, La Jolla, CA 92093 USA; [Lefeber, Dirk J.; Wevers, Ron A.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Lab Med, NL-6500 HB Nijmegen, Netherlands; [Lefeber, Dirk J.] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6500 HB Nijmegen, Netherlands; [De Brouwer, Arjan P.; van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [van Bokhoven, Hans] Radboud Univ Nijmegen, Med Ctr, Donders Inst Brain Cognit & Behav, Dept Cognit Neurosci, NL-6500 HB Nijmegen, Netherlands; [Morava, Eva] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Dept Paediat, NL-6500 HB Nijmegen, Netherlands; [Ng, Bobby G.; Houliston, Scott; Freeze, Hudson H.] Sanford Burnham Med Res Inst, Sanford Childrens Hlth Res Ctr, Genet Dis Program, La Jolla, CA 92037 USA; [Guan, Ziqiang; Raetz, Christian R. H.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA; [Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenbiochem, D-93053 Regensburg, Germany; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, Ludwig Inst Canc Res,Dept Med, La Jolla, CA 92093 USA; [Hombauer, Hans] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Adamowicz, Maciej] Childrens Mem Hlth Inst, Dept Biochem & Expt Med, PL-04730 Warsaw, Poland; [Sykut-Cegielska, Jolanta] Childrens Mem Hlth Inst, Dept Metab Dis Endocrinol & Diabetol, PL-04730 Warsaw, Poland; [Swiezewska, Ewa] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland; [Bluemel, Peter] Preyersches Kinderspital, A-1100 Vienna, Austria; [Dobyns, William B.] Univ Chicago, Dept Human Genet Neurol & Pediat, Chicago, IL 60637 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Med Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Neurol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Lab Genet, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Pediat Endocrinol, Rochester, MN 55905 USA; [Babovic-Vuksanovic, Dusica] Mayo Clin, Dept Dermatol, Rochester, MN 55905 USA	United Arab Emirates University; United Arab Emirates University; Howard Hughes Medical Institute; University of California System; University of California San Diego; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Sanford Burnham Prebys Medical Discovery Institute; Duke University; University of Regensburg; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; Children's Memorial Health Institute; Children's Memorial Health Institute; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Chicago; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Al-Gazali, L (corresponding author), United Arab Emirates Univ, Sch Med & Hlth Sci, Dept Pathol, Al Ain 17666, U Arab Emirates.	algazali@hotmail.com; jogleeson@ucsd.edu	lefeber, dirk/G-5063-2012; Wevers, Ron A./H-8116-2014; Dobyns, William/AAI-2768-2020; van Bokhoven, Hans/D-8764-2012; de Brouwer, Arjan PM/P-5949-2015; Sykut-Cegielska, Jolanta/V-4253-2019; Dobyns, William Brian/ABC-6525-2021; Guan, Ziqiang/AAE-5110-2019; Lefeber, Dirk DJ/A-2146-2014; Vincent, Cantagrel/H-8698-2017; Bokhoven, J.H.L.M. van van/H-8015-2014; Morava, E./L-4529-2015; Ali, Bassam/J-7014-2012; Hombauer, Hans/B-9712-2019	Wevers, Ron A./0000-0003-2278-9746; Dobyns, William/0000-0002-7681-2844; Sykut-Cegielska, Jolanta/0000-0003-0762-3721; Vincent, Cantagrel/0000-0002-5180-4848; Bokhoven, J.H.L.M. van van/0000-0002-2153-9254; Bielas, Stephanie/0000-0003-0567-5632; Hombauer, Hans/0000-0002-2100-564X; Ali, Bassam R/0000-0003-1306-6618; Freeze, Hudson/0000-0001-6316-0501; Swiezewska, Ewa/0000-0002-3439-8948	Rocket Fund [R01 DK55615]; Sanford Children's Health Research Center; Euroglycanet [LSHM-CT2005-512131]; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft; Korber-Stiftung; National Institutes of Health [GM-069338]; Fondation pour la Recherche Medicale; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055615, R24DK080506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052455, P30NS047101, R01NS048453] Funding Source: NIH RePORTER	Rocket Fund; Sanford Children's Health Research Center; Euroglycanet; Metakids and the Netherlands Brain Foundation; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korber-Stiftung; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank G. R. Fink, A. Jansen, F. Karst, K. Gable, T. M. Dunn, and R. Kolodner for providing yeast strains and helpful advice. We are grateful to J.H. Lin for valuable discussion. We thank D. Matern and the Mayo Clinic for providing complete results of patients' transferrin analysis and also C. Sault for additional clinical results from family CVH-385. We thank the University of California, San Francisco, microscopy core (P30 NS047101 and DK80506) and the Biomedical Genomics Core for help in imaging and microarray data analysis. A. de Rooij and K. Huyben are gratefully acknowledged for technical assistance. H. H. F. is a Sanford Research Professor. He and B.N. are supported by the Rocket Fund, R01 DK55615, and the Sanford Children's Health Research Center. Financial support from Euroglycanet (LSHM-CT2005-512131) to R. W. and Metakids and the Netherlands Brain Foundation to D. L. are kindly acknowledged. L. L. was supported by grants from the Deutsche Forschungsgemeinschaft and the Korber-Stiftung. The mass-spectrometry facility in the Department of Biochemistry of the Duke University Medical Center and Z.G. are supported by the LIPID MAPS Large Scale Collaborative Grant GM-069338 from the National Institutes of Health. V. C. is supported by a fellowship from Fondation pour la Recherche Medicale, and J.G.G. is an Investigator of the Howard Hughes Medical Institute. L.A.-G. ascertained and phenotyped family CVH-385 and MR3 and proposed the collaboration to identify the defective gene. W. B. D. reviewed brain imaging and suggested CDG defects, and H. F. suggested SRD5A3 as the polyprenol reductase. D. S., A. P. D. B., and H. v. B. coordinated homozygosity mapping. J.L.S. identified the SRD5A3 mutation, and S. L. B. performed linkage analysis and initiated generation of the gene trap mouse line. E. M. performed CDG Ix phenotype assessment on the remaining patients. D.J.L. performed biochemical diagnosis, functional studies, and dolichol analysis. R. A. W. coordinated biochemical analysis and homozygosity mapping. L. L. suggested a defect in dolichol biosynthesis and performed dolichol rescue experiments. E. S. helped with dolichol standards. D. B.-V., M. A., P. B., and J.S.C. contributed patients. Mass-spectrometry analysis was performed by Z.G. under the guidance of C.R.H.R. B.G.N. performed lipid extraction and patient LLO analysis. S. H. and B. R. A. provided technical assistance, discussions, and control samples. H. H. provided assistance with standard yeast techniques. V. C. performed all other experiments. J.G.G. directed the project. V. C. and J.G.G. wrote the manuscript, with help from the other authors.	Acosta-Serrano A, 2004, EUKARYOT CELL, V3, P255, DOI 10.1128/EC.3.2.255-263.2004; Aebi M, 2001, TRENDS CELL BIOL, V11, P136, DOI 10.1016/S0962-8924(01)01925-0; Aggarwal S, 2010, STEROIDS, V75, P109, DOI 10.1016/j.steroids.2009.10.005; Al-Gazali L, 2008, AM J MED GENET A, V146A, P813, DOI 10.1002/ajmg.a.32114; ALBER T, 1982, Journal of Molecular and Applied Genetics, V1, P419; ALLEN CM, 1978, BIOCHEMISTRY-US, V17, P5020, DOI 10.1021/bi00616a025; ANDERSSON S, 1991, NATURE, V354, P159, DOI 10.1038/354159a0; BEHRENS NH, 1970, P NATL ACAD SCI USA, V66, P153, DOI 10.1073/pnas.66.1.153; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chavan M, 2006, TRENDS BIOCHEM SCI, V31, P17, DOI 10.1016/j.tibs.2005.11.010; CHOJNACKI T, 1988, BIOCHEM J, V251, P1; D'Alexandri FL, 2006, ANAL BIOCHEM, V355, P189, DOI 10.1016/j.ab.2006.06.014; DEJONG G, 1994, ADV EXP MED BIOL, V356, P51; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Eklund Erik A, 2006, NeuroRx, V3, P254; EKSTROM TJ, 1987, J BIOL CHEM, V262, P4090; EKSTROM TJ, 1984, J BIOL CHEM, V259, P460; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Garrett TA, 2007, METHOD ENZYMOL, V432, P117, DOI 10.1016/S0076-6879(07)32005-3; Grunewald S, 2000, NEUROPEDIATRICS, V31, P57, DOI 10.1055/s-2000-7487; Haeuptle MA, 2009, HUM MUTAT, V30, P1628, DOI 10.1002/humu.21126; HASILIK A, 1978, EUR J BIOCHEM, V91, P567, DOI 10.1111/j.1432-1033.1978.tb12710.x; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HELLER L, 1992, P NATL ACAD SCI USA, V89, P7013, DOI 10.1073/pnas.89.15.7013; Hoffmann K, 2005, BIOINFORMATICS, V21, P3565, DOI 10.1093/bioinformatics/bti571; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jaeken J, 2009, BBA-MOL BASIS DIS, V1792, P825, DOI 10.1016/j.bbadis.2009.08.005; Jones MB, 2009, BBA-GEN SUBJECTS, V1790, P485, DOI 10.1016/j.bbagen.2009.03.030; Kahrizi K, 2009, EUR J HUM GENET, V17, P125, DOI 10.1038/ejhg.2008.159; KATO S, 1980, BIOCHEM BIOPH RES CO, V95, P770, DOI 10.1016/0006-291X(80)90853-0; KELLER RK, 1982, J BIOL CHEM, V257, P8985; Kohlwein SD, 2001, MOL CELL BIOL, V21, P109, DOI 10.1128/MCB.21.1.109-125.2001; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Mahendroo MS, 1999, REV REPROD, V4, P179, DOI 10.1530/ror.0.0040179; Marek KW, 1999, GLYCOBIOLOGY, V9, P1263; Morava E, 2008, J INHERIT METAB DIS, V31, P450, DOI 10.1007/s10545-008-0822-0; Morava E, 2009, BRIT J OPHTHALMOL, V93, P350, DOI 10.1136/bjo.2008.145359; Mosch HU, 1997, GENETICS, V145, P671; Murray SS, 2004, NAT METHODS, V1, P113, DOI 10.1038/NMETH712; Nishikawa A, 2001, BIOCHEM J, V355, P245, DOI 10.1042/0264-6021:3550245; O'Brien JF, 2007, CURR PROTOC HUM GENE; RENARD JP, 1984, J EXP ZOOL, V230, P443, DOI 10.1002/jez.1402300313; RIP JW, 1985, PROG LIPID RES, V24, P269, DOI 10.1016/0163-7827(85)90008-6; ROSENWALD AG, 1993, GLYCOBIOLOGY, V3, P481, DOI 10.1093/glycob/3.5.481; ROSSIGNOL DP, 1983, J BIOL CHEM, V258, P9122; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; RUSSELL DW, 1994, ANNU REV BIOCHEM, V63, P25, DOI 10.1146/annurev.bi.63.070194.000325; SAGAMI H, 1993, J BIOL CHEM, V268, P10109; Sagami H, 1996, J BIOL CHEM, V271, P9560, DOI 10.1074/jbc.271.16.9560; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Sidbury R, 2001, PEDIATR DERMATOL, V18, P252, DOI 10.1046/j.1525-1470.2001.018003252.x; Swiezewska E, 2005, PROG LIPID RES, V44, P235, DOI 10.1016/j.plipres.2005.05.002; Thiel C, 2002, BIOCHEM J, V367, P195, DOI 10.1042/BJ20020794; Uemura M, 2008, CANCER SCI, V99, P81, DOI 10.1111/j.1349-7006.2007.00656.x; Vermeer S, 2007, J NEUROL, V254, P1356, DOI 10.1007/s00415-007-0546-3; Vleugels W, 2009, HUM MUTAT, V30, P1428, DOI 10.1002/humu.21085; WIGLEY WC, 1994, BIOCHEMISTRY-US, V33, P1265, DOI 10.1021/bi00171a029; WOLF M J, 1991, Glycobiology, V1, P405, DOI 10.1093/glycob/1.4.405; YASUGI E, 1994, BBA-LIPID LIPID MET, V1211, P107, DOI 10.1016/0005-2760(94)90144-9	60	200	213	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUL 23	2010	142	2					203	217		10.1016/j.cell.2010.06.001	http://dx.doi.org/10.1016/j.cell.2010.06.001			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	629MT	20637498	Green Accepted, Bronze			2022-12-28	WOS:000280204300013
J	Hunte, C; Zickermann, V; Brandt, U				Hunte, Carola; Zickermann, Volker; Brandt, Ulrich			Functional Modules and Structural Basis of Conformational Coupling in Mitochondrial Complex I	SCIENCE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; YARROWIA-LIPOLYTICA; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; QUINONE OXIDOREDUCTASE; ELECTRON-TRANSFER; OXIDATIVE STRESS; 49-KDA SUBUNIT; BINDING; SYSTEM	Proton-pumping respiratory complex I is one of the largest and most complicated membrane protein complexes. Its function is critical for efficient energy supply in aerobic cells, and malfunctions are implicated in many neurodegenerative disorders. Here, we report an x-ray crystallographic analysis of mitochondrial complex I. The positions of all iron-sulfur clusters relative to the membrane arm were determined in the complete enzyme complex. The ubiquinone reduction site resides close to 30 angstroms above the membrane domain. The arrangement of functional modules suggests conformational coupling of redox chemistry with proton pumping and essentially excludes direct mechanisms. We suggest that a similar to 60-angstrom-long helical transmission element is critical for transducing conformational energy to proton-pumping elements in the distal module of the membrane arm.	[Zickermann, Volker; Brandt, Ulrich] Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany; [Hunte, Carola] Univ Freiburg, Ctr Biol Signalling Studies BIOSS, Inst Biochem & Mol Biol, D-79104 Freiburg, Germany; [Hunte, Carola] Univ Leeds, Inst Membrane & Syst Biol, Leeds LS2 9JT, W Yorkshire, England; [Hunte, Carola] Max Planck Inst Biophys, Dept Mol Membrane Biol, D-60438 Frankfurt, Germany	Goethe University Frankfurt; University of Freiburg; University of Leeds; Max Planck Society	Brandt, U (corresponding author), Goethe Univ Frankfurt, Ctr Membrane Prote, Sch Med, Mol Bioenerget Grp, D-60596 Frankfurt, Germany.	brandt@zbc.kgu.de	Brandt, Ulrich/GLV-1242-2022; Hunte, Carola/E-4071-2015; Brandt, Ulrich/C-4406-2008	Brandt, Ulrich/0000-0003-1869-6811; Hunte, Carola/0000-0002-0826-3986; Brandt, Ulrich/0000-0003-1869-6811	Deutsche Forschungsgemeinschaft [P2, P17]; Excellence Initiative of the German Federal and State Governments [EXC 115, EXC 294]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Excellence Initiative of the German Federal and State Governments	Excellent technical assistance by K. Siegmund and technical support by A. Duchene, F. Streb, and B. Wenzel are gratefully acknowledged. We thank S. Kerscher for his essential contributions regarding all aspects of Y. lipolytica genetics and B. Wrzesniewska for testing the impact of antibody fragments to improve crystallization. We are indebted to H. Michel for valuable advice during the initial stages of the project and for his continuous support. We thank the European Synchrotron Radiation Facility and the Swiss Light Source (SLS) for granting beam time, many scientists especially at SLS beamlines X06SA and X10SA for constantly supporting our work, and the staff of the Helmholtz Zentrum fur Infektionsforschung (HZI)/Gesellschaft fur Biotechnologische Forschung, Braunschweig for large-scale fermentation of Y. lipolytica. Funding by the Deutsche Forschungsgemeinschaft (SFB 472 Projects P2 and P17) is gratefully acknowledged. This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 115 and EXC 294). Electron density maps are available on request.	Abdrakhmanova A, 2004, BBA-BIOENERGETICS, V1658, P148, DOI 10.1016/j.bbabio.2004.04.019; Baranova EA, 2007, J STRUCT BIOL, V159, P238, DOI 10.1016/j.jsb.2007.01.009; Belevich G, 2007, BIOCHEMISTRY-US, V46, P526, DOI 10.1021/bi062062t; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Clason T, 2010, J STRUCT BIOL, V169, P81, DOI 10.1016/j.jsb.2009.08.017; Clason T, 2007, J STRUCT BIOL, V159, P433, DOI 10.1016/j.jsb.2007.05.002; Esterhazy D, 2008, BIOCHEMISTRY-US, V47, P3964, DOI 10.1021/bi702243b; Fendel U, 2008, BBA-BIOENERGETICS, V1777, P660, DOI 10.1016/j.bbabio.2008.04.033; Friedrich T, 2001, J BIOENERG BIOMEMBR, V33, P169, DOI 10.1023/A:1010722717257; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Kerscher S, 2002, BBA-BIOENERGETICS, V1555, P83, DOI 10.1016/S0005-2728(02)00259-1; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Mathiesen C, 2002, BBA-BIOENERGETICS, V1556, P121, DOI 10.1016/S0005-2728(02)00343-2; Morgan DJ, 2008, BBA-BIOENERGETICS, V1777, P711, DOI 10.1016/j.bbabio.2008.03.023; Morgner N, 2008, BBA-BIOENERGETICS, V1777, P1384, DOI 10.1016/j.bbabio.2008.08.001; Radermacher M, 2006, J STRUCT BIOL, V154, P269, DOI 10.1016/j.jsb.2006.02.011; Rhein V, 2009, P NATL ACAD SCI USA, V106, P20057, DOI 10.1073/pnas.0905529106; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Tocilescu MA, 2007, J BIOL CHEM, V282, P29514, DOI 10.1074/jbc.M704519200; Tocilescu MA, 2010, BBA-BIOENERGETICS, V1797, P625, DOI 10.1016/j.bbabio.2010.01.029; Verkhovskaya ML, 2008, P NATL ACAD SCI USA, V105, P3763, DOI 10.1073/pnas.0711249105; WIKSTROM M, 1984, FEBS LETT, V169, P300, DOI 10.1016/0014-5793(84)80338-5; Zickermann V, 2003, J BIOL CHEM, V278, P29072, DOI 10.1074/jbc.M302713200; Zickermann V, 2009, BBA-BIOENERGETICS, V1787, P574, DOI 10.1016/j.bbabio.2009.01.012; Zwicker K, 2006, J BIOL CHEM, V281, P23013, DOI 10.1074/jbc.M603442200	31	294	300	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 23	2010	329	5990					448	451		10.1126/science.1191046	http://dx.doi.org/10.1126/science.1191046			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	629KJ	20595580				2022-12-28	WOS:000280196500039
J	Marris, E				Marris, Emma			On high alert	NATURE			English	Editorial Material							T-CELL DEPLETION; IMMUNE ACTIVATION; INFECTION											Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; GIORGI JV, 1993, J ACQ IMMUN DEF SYND, V6, P904; Guadalupe M, 2003, J VIROL, V77, P11708, DOI 10.1128/JVI.77.21.11708-11717.2003; Hunt PW, 2008, J INFECT DIS, V197, P126, DOI 10.1086/524143; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Sodora DL, 2008, AIDS, V22, P439, DOI 10.1097/QAD.0b013e3282f2dbe7	8	1	1	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUL 15	2010	466	7304					S2	S3		10.1038/nature09234	http://dx.doi.org/10.1038/nature09234			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	625BP	20631700				2022-12-28	WOS:000279867100023
J	Pasupathy, D; Wood, AM; Pell, JP; Fleming, M; Smith, GCS				Pasupathy, Dharmintra; Wood, Angela M.; Pell, Jill P.; Fleming, Michael; Smith, Gordon C. S.			Time of birth and risk of neonatal death at term: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PERINATAL DEATH; CESAREAN DELIVERY; UNITED-STATES; MORTALITY; STILLBIRTH; INTRAPARTUM; ASPHYXIA; SCOTLAND; INFANTS; WALES	Objective To determine the effect of time and day of birth on the risk of neonatal death at term. Design Population based retrospective cohort study. Setting Data from the linked Scottish morbidity records, Stillbirth and Infant Death Survey, and birth certificate database of live births in Scotland, 1985-2004. Subjects Liveborn term singletons with cephalic presentation. Perinatal deaths from congenital anomalies excluded. Final sample comprised 1 039 560 live births. Main outcome measure All neonatal deaths (in the first four weeks of life) unrelated to congenital abnormality, plus a subgroup of deaths ascribed to intrapartum anoxia. Results The risk of neonatal death was 4.2 per 10 000 during the normal working week (Monday to Friday, 09001700) and 5.6 per 10 000 at all other times (out of hours) (unadjusted odds ratio 1.3, 95% confidence interval 1.1 to 1.6). Adjustment for maternal characteristics had no material effect. The higher rate of death out of hours was because of an increased risk of death ascribed to intrapartum anoxia (adjusted odds ratio 1.7, 1.2 to 2.3). Though exclusion of elective caesarean deliveries attenuated the association between death ascribed to anoxia and delivery out of hours, a significant association persisted (adjusted odds ratio 1.5, 1.1 to 2.0). The attributable fraction of neonatal deaths ascribed to intrapartum anoxia associated with delivery out of hours was 26% (95% confidence interval 5% to 42%). Conclusions Delivering an infant outside the normal working week was associated with an increased risk of neonatal death at term ascribed to intrapartum anoxia.	[Pasupathy, Dharmintra; Smith, Gordon C. S.] Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England; [Pasupathy, Dharmintra; Smith, Gordon C. S.] NIHR Cambridge Comprehens Biomed Res Ctr, Cambridge CB2 2SW, England; [Wood, Angela M.] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge CB1 8RN, England; [Pell, Jill P.] Univ Glasgow, Publ Hlth Sect, Glasgow G12 8TA, Lanark, Scotland; [Fleming, Michael] NHS Natl Serv Scotland, Informat Serv Div, Paisley PA3 2SJ, Renfrew, Scotland	University of Cambridge; University of Cambridge; University of Glasgow; NHS National Services Scotland	Smith, GCS (corresponding author), Univ Cambridge, Dept Obstet & Gynaecol, Cambridge CB2 2SW, England.	gcss2@cam.ac.uk	Pasupathy, Dharmintra/N-9586-2019; Smith, Gordon/A-8070-2008; Wood, Angela/GZA-5762-2022	Pasupathy, Dharmintra/0000-0002-6722-1006; Smith, Gordon/0000-0003-2124-0997; Wood, Angela/0000-0002-7937-304X; Pell, Jill/0000-0002-8898-7035; fleming, michael/0000-0002-2185-4502	Medical Research Council; Royal College of Obstetricians and Gynaecologists; MRC [G0600469] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [G0600469] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal College of Obstetricians and Gynaecologists; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	DP was supported by the Medical Research Council and the Royal College of Obstetricians and Gynaecologists (Florence and William-Blair Bell Memorial Fellowship Fund) clinical research fellowship. His current affiliation is clinical lecturer in Maternal and Fetal Medicine in the Academic Department of Women's Health, King's College London. The funding source had no involvement in the design of the study and collection, analysis, and interpretation of the data.	COLE SK, 1980, PERINATAL AUDIT SURV, P39; Cutler DM, 2006, NEW ENGL J MED, V355, P920, DOI 10.1056/NEJMsa054744; Gould JB, 2005, OBSTET GYNECOL, V106, P352, DOI 10.1097/01.AOG.0000168627.33566.3c; Gould JB, 2003, JAMA-J AM MED ASSOC, V289, P2958, DOI 10.1001/jama.289.22.2958; Heller G, 2000, BRIT MED J, V321, P274, DOI 10.1136/bmj.321.7256.274; HEY EN, 1986, BRIT J OBSTET GYNAEC, V93, P1213, DOI 10.1111/j.1471-0528.1986.tb07854.x; *INF STAT DIV NAT, 2000, SCOTT PER INF MORT M; Landon MB, 2004, NEW ENGL J MED, V351, P2581, DOI 10.1056/NEJMoa040405; Little R, 2008, STAT ANAL MISSING DA; Luo ZC, 2004, CAN MED ASSOC J, V170, P337; Luo ZC, 2001, BRIT MED J, V323, P1327, DOI 10.1136/bmj.323.7325.1327; MACFARLANE A, 1978, BRIT MED J, V2, P1670, DOI 10.1136/bmj.2.6153.1670; MANGOLD WD, 1981, AM J PUBLIC HEALTH, V71, P601, DOI 10.2105/AJPH.71.6.601; MATHERS CD, 1983, J EPIDEMIOL COMMUN H, V37, P57, DOI 10.1136/jech.37.1.57; MCILWAINE GM, 1985, BRIT J OBSTET GYNAEC, V92, P9, DOI 10.1111/j.1471-0528.1985.tb01041.x; PACCAUD F, 1988, LANCET, V1, P340, DOI 10.1016/S0140-6736(88)91130-0; Pasupathy D, 2009, JAMA-J AM MED ASSOC, V302, P660, DOI 10.1001/jama.2009.1111; Pasupathy D, 2009, INT J EPIDEMIOL, V38, P490, DOI 10.1093/ije/dyn225; RUFFIEUX C, 1992, AM J EPIDEMIOL, V135, P936, DOI 10.1093/oxfordjournals.aje.a116389; Slickers JE, 2008, AM J EPIDEMIOL, V168, P1259, DOI 10.1093/aje/kwn248; Smith GCS, 2003, LANCET, V362, P1779, DOI 10.1016/S0140-6736(03)14896-9; Smith GCS, 2002, JAMA-J AM MED ASSOC, V287, P2684, DOI 10.1001/jama.287.20.2684; Smith GCS, 2007, LANCET, V370, P1715, DOI 10.1016/S0140-6736(07)61723-1; Stephansson O, 2003, EPIDEMIOLOGY, V14, P218, DOI 10.1097/00001648-200303000-00017; Stewart JH, 1998, BRIT MED J, V316, P657, DOI 10.1136/bmj.316.7132.657; Tomashek KM, 2007, J PEDIATR-US, V151, P450, DOI 10.1016/j.jpeds.2007.05.002	26	66	69	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUL 15	2010	341								c3498	10.1136/bmj.c3498	http://dx.doi.org/10.1136/bmj.c3498			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	628XD	20634347	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000280156800004
J	Gahlay, G; Gauthier, L; Baibakov, B; Epifano, O; Dean, J				Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien			Gamete Recognition in Mice Depends on the Cleavage Status of an Egg's Zona Pellucida Protein	SCIENCE			English	Article							SPERM RECEPTOR ACTIVITY; MOUSE SPERM; FERTILIZATION; ZP3; BINDING; INACTIVATION; FERTILITY; GLYCANS; GENE	At fertilization, mouse sperm bind to the zona pellucida (which consists of glycoproteins ZP1, ZP2, and ZP3) that surrounds eggs. A ZP2 cleavage model of gamete recognition requires intact ZP2, and a glycan release model postulates that zona glycans are ligands for sperm. These two models were tested by replacing endogenous protein with ZP2 that cannot be cleaved (Zp2(Mut)) or with ZP3 lacking implicated O glycans (Zp3(Mut)). Sperm bound to two-cell Zp2(Mut) embryos despite fertilization and cortical granule exocytosis. Contrary to prediction, sperm fertilized Zp3(Mut) eggs. Sperm at the surface of the zona pellucida remained acrosome-intact for more than 2 hours and were displaced by additional sperm. These data indicate that sperm-egg recognition depends on the cleavage status of ZP2 and that binding at the surface of the zona is not sufficient to induce sperm acrosome exocytosis.	[Gahlay, Gagandeep; Gauthier, Lyn; Baibakov, Boris; Epifano, Olga; Dean, Jurrien] NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Dean, J (corresponding author), NIDDKD, Cellular & Dev Biol Lab, NIH, Bethesda, MD 20892 USA.	jurrien@helix.nih.gov	Gahlay, Gagandeep/F-3975-2010; Gahlay, Gagandeep/AAO-7928-2020	Gahlay, Gagandeep/0000-0002-0058-2827; 	NIH, National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK015603] Funding Source: NIH RePORTER	NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by the Intramural Research Program of NIH, National Institute of Diabetes and Digestive and Kidney Diseases.	Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Boja ES, 2003, J BIOL CHEM, V278, P34189, DOI 10.1074/jbc.M304026200; Chen J, 1998, P NATL ACAD SCI USA, V95, P6193, DOI 10.1073/pnas.95.11.6193; EAST IJ, 1985, DEV BIOL, V109, P268, DOI 10.1016/0012-1606(85)90454-3; FLORMAN HM, 1985, CELL, V41, P313, DOI 10.1016/0092-8674(85)90084-4; Jungnickel MK, 2003, CELL, V114, P401, DOI 10.1016/S0092-8674(03)00648-2; LEYTON L, 1989, J CELL BIOL, V108, P2163, DOI 10.1083/jcb.108.6.2163; LOPEZ LC, 1985, J CELL BIOL, V101, P1501, DOI 10.1083/jcb.101.4.1501; Lowe JB, 2003, ANNU REV BIOCHEM, V72, P643, DOI 10.1146/annurev.biochem.72.121801.161809; Rankin T, 1996, DEVELOPMENT, V122, P2903; Rankin T, 1999, DEVELOPMENT, V126, P3847; Rankin TL, 2003, DEV CELL, V5, P33, DOI 10.1016/S1534-5807(03)00195-3; Rankin TL, 1998, DEVELOPMENT, V125, P2415; Shi SL, 2004, MOL CELL BIOL, V24, P9920, DOI 10.1128/MCB.24.22.9920-9929.2004; THALL AD, 1995, J BIOL CHEM, V270, P21437, DOI 10.1074/jbc.270.37.21437; Tulsiani DRP, 1997, BIOL REPROD, V57, P487, DOI 10.1095/biolreprod57.3.487; Williams SA, 2007, J CELL SCI, V120, P1341, DOI 10.1242/jcs.004291	18	123	131	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JUL 9	2010	329	5988					216	219		10.1126/science.1188178	http://dx.doi.org/10.1126/science.1188178			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616279	Green Accepted			2022-12-28	WOS:000279635200049
J	Okazaki, Y; Timmermann, A; Menviel, L; Harada, N; Abe-Ouchi, A; Chikamoto, MO; Mouchet, A; Asahi, H				Okazaki, Y.; Timmermann, A.; Menviel, L.; Harada, N.; Abe-Ouchi, A.; Chikamoto, M. O.; Mouchet, A.; Asahi, H.			Deepwater Formation in the North Pacific During the Last Glacial Termination	SCIENCE			English	Article							INTERMEDIATE WATER; BERING-SEA; AMS C-14; CIRCULATION; ATLANTIC; RECORD; OCEAN; PRODUCTIVITY; DEGLACIATION; HYDROGRAPHY	Between similar to 17,500 and 15,000 years ago, the Atlantic meridional overturning circulation weakened substantially in response to meltwater discharges from disintegrating Northern Hemispheric glacial ice sheets. The global effects of this reorganization of poleward heat flow in the North Atlantic extended to Antarctica and the North Pacific. Here we present evidence from North Pacific paleo surface proxy data, a compilation of marine radiocarbon age ventilation records, and global climate model simulations to suggest that during the early stages of the Last Glacial Termination, deep water extending to a depth of similar to 2500 to 3000 meters was formed in the North Pacific. A switch of deepwater formation between the North Atlantic and the North Pacific played a key role in regulating poleward oceanic heat transport during the Last Glacial Termination.	[Timmermann, A.; Menviel, L.] Univ Hawaii, Sch Ocean & Earth Sci & Technol, Int Pacific Res Ctr, Honolulu, HI 96822 USA; [Okazaki, Y.; Harada, N.; Abe-Ouchi, A.; Chikamoto, M. O.] Japan Agcy Marine Earth Sci & Technol, Yokosuka, Kanagawa 2370061, Japan; [Abe-Ouchi, A.; Asahi, H.] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778568, Japan; [Mouchet, A.] Univ Liege, Lab Phys Atmospher & Planetaire, B-4000 Liege, Belgium	University of Hawaii System; Japan Agency for Marine-Earth Science & Technology (JAMSTEC); University of Tokyo; University of Liege	Timmermann, A (corresponding author), Univ Hawaii, Sch Ocean & Earth Sci & Technol, Int Pacific Res Ctr, 2525 Correa Rd, Honolulu, HI 96822 USA.	axel@hawaii.edu	Menviel, Laurie/O-7833-2019; Mouchet, Anne/K-1911-2014; Timmermann, Axel/F-4977-2011; Timmermann, Axel/Y-2799-2019; Menviel, Laurie/D-6902-2013; Abe-Ouchi, Ayako/M-6359-2013	Mouchet, Anne/0000-0002-8846-3063; Timmermann, Axel/0000-0003-0657-2969; Timmermann, Axel/0000-0003-0657-2969; Menviel, Laurie/0000-0002-5068-1591; Abe-Ouchi, Ayako/0000-0003-1745-5952; Okazaki, Yusuke/0000-0002-2406-3466	NSF [ATM-0712690]; Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NASA [NNX07AG53G]; National Oceanic and Atmospheric Administration [NA09OAR4320075]; Belgian Federal Science Policy [SD/CS/01]	NSF(National Science Foundation (NSF)); Japan Agency for Marine-Earth Science and Technology (JAMSTEC); NASA(National Aeronautics & Space Administration (NASA)); National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA); Belgian Federal Science Policy(Belgian Federal Science Policy Office)	This research was supported by NSF grant number ATM-0712690. Additional support was provided by the Japan Agency for Marine-Earth Science and Technology (JAMSTEC), by NASA through grant number NNX07AG53G, and by the National Oceanic and Atmospheric Administration through grant number NA09OAR4320075, all of which sponsor research at the International Pacific Research Center. A. M. acknowledges funding from the Belgian Federal Science Policy (contract SD/CS/01).	Adkins JF, 1997, PALEOCEANOGRAPHY, V12, P337, DOI 10.1029/97PA00379; Ahagon N, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018287; BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; Broecker W, 2008, EARTH PLANET SC LETT, V274, P322, DOI 10.1016/j.epsl.2008.07.035; Crusius J, 2004, GEOLOGY, V32, P633, DOI 10.1130/G20508.1; de Vernal A, 1997, PALEOCEANOGRAPHY, V12, P821, DOI 10.1029/97PA02167; DUPLESSY JC, 1989, RADIOCARBON, V31, P493; Galbraith ED, 2007, NATURE, V449, P890, DOI 10.1038/nature06227; Horikawa K, 2010, GEOLOGY, V38, P435, DOI 10.1130/G30225.1; Hoshiba M, 2006, MAR MICROPALEONTOL, V61, P196, DOI 10.1016/j.marmicro.2006.07.001; Hu AX, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028906; Keigwin LD, 1998, PALEOCEANOGRAPHY, V13, P323, DOI 10.1029/98PA00874; KENNETT JP, 1995, NATURE, V377, P510, DOI 10.1038/377510a0; Kiefer T, 2005, QUATERNARY SCI REV, V24, P1063, DOI 10.1016/j.quascirev.2004.02.021; Krebs U, 2007, J CLIMATE, V20, P4940, DOI 10.1175/JCLI4296.1; Marchitto TM, 2007, SCIENCE, V316, P1456, DOI 10.1126/science.1138679; Matsumoto K, 2002, QUATERNARY SCI REV, V21, P1693, DOI 10.1016/S0277-3791(01)00142-1; McCreary JP, 2001, J PHYS OCEANOGR, V31, P932, DOI 10.1175/1520-0485(2001)031<0932:IOTITO>2.0.CO;2; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; Menviel L, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001445; Mikolajewicz U, 1997, NATURE, V387, P384, DOI 10.1038/387384a0; Minoshima K, 2007, NUCL INSTRUM METH B, V259, P448, DOI 10.1016/j.nimb.2007.01.225; Mix AC, 1999, GEOPH MONOG SERIES, V112, P127; MURAYAMA M, 1992, SUMMARIES RES USING, V3, P114; Okazaki Y, 2005, DEEP-SEA RES PT II, V52, P2150, DOI 10.1016/j.dsr2.2005.07.003; Okumura YM, 2009, J CLIMATE, V22, P1424, DOI 10.1175/2008JCLI2511.1; Reimer PJ, 2009, RADIOCARBON, V51, P1111, DOI 10.1017/S0033822200034202; Saenko OA, 2004, J CLIMATE, V17, P2033, DOI 10.1175/1520-0442(2004)017<2033:TAS>2.0.CO;2; Sagawa T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035133; Sarnthein M., 2007, OCEAN CIRCULATION ME, P175, DOI [10.1029/173gm13, DOI 10.1029/173GM13]; Shibahara A, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2005PA001234; STOMMEL H, 1961, TELLUS, V13, P224, DOI 10.1111/j.2153-3490.1961.tb00079.x; Stott L, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001690; TALLEY LD, 1993, J PHYS OCEANOGR, V23, P517, DOI 10.1175/1520-0485(1993)023<0517:DAFONP>2.0.CO;2	34	195	201	2	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUL 9	2010	329	5988					200	204		10.1126/science.1190612	http://dx.doi.org/10.1126/science.1190612			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	622CB	20616275				2022-12-28	WOS:000279635200044
J	Saitz, R				Saitz, Richard			Candidate Performance Measures for Screening for, Assessing, and Treating Unhealthy Substance Use in Hospitals: Advocacy or Evidence-Based Practice?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BRIEF INTERVENTIONS; CONTROLLED-TRIAL; TRAUMA CENTER; ALCOHOL-USE; CARE; DRINKING; INJURY; RISK	The Joint Commission recently proposed candidate performance measures addressing unhealthy substance use in hospitalized patients. The proposed measures of screening and brief intervention (SBI) assume that interventions that work in one setting (primary care outpatient practice) would work in another (hospital); treatment would have the same benefits for persons identified by screening as for those with symptoms who seek help; treatments that work for persons less severely affected by substance use would also work for those with more severe illness; and an approach that works for nondependent, unhealthy alcohol use would work for drug use. However, these assumptions extrapolate evidence of the effectiveness of SBI for primary care outpatients with nondependent, unhealthy alcohol use to the inpatient setting, persons with dependence, and other substances. Although quality of care for unhealthy substance use in all medical settings needs to improve, the evidence base for SBI in the hospital is too limited for the implementation of performance measures assessing this care.	[Saitz, Richard] Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, Boston, MA 02118 USA; [Saitz, Richard] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA	Boston Medical Center; Boston University; Boston University	Saitz, R (corresponding author), Boston Univ, Gen Internal Med Sect, Clin Addict Res & Educ Unit, Boston Med Ctr,Sch Med, 801 Massachusetts Ave,2nd Floor, Boston, MA 02118 USA.	rsaitz@bu.edu		/0000-0002-2535-1427				*AM COLL SURG COMM, 2006, FAQ RES OPT CAR INJ; [Anonymous], National Drug Control Strategy 2016; Bernstein J, 2005, DRUG ALCOHOL DEPEN, V77, P49, DOI 10.1016/j.drugalcdep.2004.07.006; Center for Medicare & Medicaid Services, PHYS QUAL REP IN; De Micheli Denise, 2004, Rev. Assoc. Med. Bras., V50, P305, DOI 10.1590/S0104-42302004000300040; ELVY GA, 1988, BRIT J ADDICT, V83, P83; Gentilello LM, 1999, ANN SURG, V230, P473, DOI 10.1097/00000658-199910000-00003; *JOINT COMM, CAND MEAS PROF ASS T; *JOINT COMM, ATTR COR PERF MEAS A; Madras BK, 2009, DRUG ALCOHOL DEPEN, V99, P280, DOI 10.1016/j.drugalcdep.2008.08.003; McQueen J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005191.pub2; Saitz R, 2007, ANN INTERN MED, V146, P167, DOI 10.7326/0003-4819-146-3-200702060-00005; Schermer CR, 2006, J TRAUMA, V60, P29, DOI 10.1097/01.ta.0000199420.12322.5d; SMITH PC, 2010, ARCH INTERN IN PRESS; Soderstrom CA, 2007, J TRAUMA, V62, P1102, DOI 10.1097/TA.0b013e31804bdb26; Sommers MS, 2006, J TRAUMA, V61, P523, DOI 10.1097/01.ta.0000221756.67126.91; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Zatzick D, 2004, ARCH GEN PSYCHIAT, V61, P498, DOI 10.1001/archpsyc.61.5.498	18	31	31	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUL 6	2010	153	1					40	43		10.7326/0003-4819-153-1-201007060-00008	http://dx.doi.org/10.7326/0003-4819-153-1-201007060-00008			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	620GS	20621901				2022-12-28	WOS:000279487700006
J	Dyer, C; Tuffs, A				Dyer, Clare; Tuffs, Annette			Cross border regulation of doctors	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dyer, Clare] BMJ, London, England										0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	JUN 30	2010	340								c3502	10.1136/bmj.c3502	http://dx.doi.org/10.1136/bmj.c3502			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591949				2022-12-28	WOS:000279586300008
J	Spence, D				Spence, Des			From the Frontline Medicalisation of ageing: plastic people	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JUN 30	2010	340								c3494	10.1136/bmj.c3494	http://dx.doi.org/10.1136/bmj.c3494			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	621NT	20591946				2022-12-28	WOS:000279586300016
J	Jin, H; White, SR; Shida, T; Schulz, S; Aguiar, M; Gygi, SP; Bazan, JF; Nachury, MV				Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Schulz, Stefan; Aguiar, Mike; Gygi, Steven P.; Bazan, J. Fernando; Nachury, Maxence V.			The Conserved Bardet-Biedl Syndrome Proteins Assemble a Coat that Traffics Membrane Proteins to Cilia	CELL			English	Article							COMPLEX; IDENTIFICATION; MUTATIONS; DEFECTS; BBSOME; CARGO; LOCALIZATION; TRANSPORT; VESICLES; INPP5E	The BBSome is a complex of Bardet-Biedl Syndrome (BBS) proteins that shares common structural elements with COPI, COPII, and clathrin coats. Here, we show that the BBSome constitutes a coat complex that sorts membrane proteins to primary cilia. The BBSome is the major effector of the Arf-like GTPase Arl6/BBS3, and the BBSome and GTP-bound Arl6 colocalize at ciliary punctae in an interdependent manner. Strikingly, Arl6(GTP)-mediated recruitment of the BBSome to synthetic liposomes produces distinct patches of polymerized coat apposed onto the lipid bilayer. Finally, the ciliary targeting signal of somatostatin receptor 3 needs to be directly recognized by the BBSome in order to mediate targeting of membrane proteins to cilia. Thus, we propose that trafficking of BBSome cargoes to cilia entails the coupling of BBSome coat polymerization to the recognition of sorting signals by the BBSome.	[Jin, Hua; White, Susan Roehl; Shida, Toshinobu; Nachury, Maxence V.] Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Schulz, Stefan] Univ Jena, Inst Pharmacol & Toxicol, D-07743 Jena, Germany; [Aguiar, Mike; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Bazan, J. Fernando] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA	Stanford University; Friedrich Schiller University of Jena; Harvard University; Harvard Medical School; Roche Holding; Genentech	Nachury, MV (corresponding author), Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA.	nachury@stanford.edu	Nachury, Maxence/H-3695-2019; Bazan, J. Fernando/B-4562-2010; Nachury, Maxence/A-8759-2008; Schulz, Stefan/A-6928-2017	Nachury, Maxence/0000-0003-4918-1562; Nachury, Maxence/0000-0003-4918-1562; Schulz, Stefan/0000-0002-5997-8885; Aguiar, Mike/0000-0001-8175-010X	American Heart Association [AHA-0930365N]; March of Dimes [5-FY09-112]; National Institutes of Health/National Institute of General Medical Sciences [R01GM089933]; Sloan Research Fellowship [BR-5014]; Klingenstein Fellowship; NIH/NIGMS [F32GM089218]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM089218, R01GM089933] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); March of Dimes(March of Dimes); National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Sloan Research Fellowship(Alfred P. Sloan Foundation); Klingenstein Fellowship(Klingenstein Philanthropies); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Suzanne Pfeffer and Scott Seeley for comments on the manuscript; Randy Schekman, Sean Studer, Susan Hamamoto, Ken Matsuoka and Chris Fromme for advice on liposome preparation and processing for EM; John Perrino and Jon Mulholland for assistance with EM; members of Dick Tsien's laboratory for help with hippocampal neuron culture; Brian Kobilka and Juan Jose Fung for help with liposome preparation; Val Sheffield for the BBS1 antibody; Melanie Tallent for the SSTR3 knockout; Joachim Seemann for the CD8 alpha cDNA; and Applied Precision for OMX imaging. This work was supported in part by grants to M.V.N. from the American Heart Association (AHA-0930365N), the March of Dimes (5-FY09-112), National Institutes of Health/National Institute of General Medical Sciences (R01GM089933), a Sloan Research Fellowship (BR-5014) and a Klingenstein Fellowship and by an NIH/NIGMS fellowship to S.R.W (F32GM089218). J.F.B. is an employee of Genentech, Inc.	Berbari NF, 2008, MOL BIOL CELL, V19, P1540, DOI 10.1091/mbc.E07-09-0942; Berbari NF, 2008, P NATL ACAD SCI USA, V105, P4242, DOI 10.1073/pnas.0711027105; Bielas SL, 2009, NAT GENET, V41, P1032, DOI 10.1038/ng.423; Blacque OE, 2004, GENE DEV, V18, P1630, DOI 10.1101/gad.1194004; Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6; Chaudhuri I, 2008, PROTEINS, V71, P795, DOI 10.1002/prot.21764; Chiang AP, 2004, AM J HUM GENET, V75, P475, DOI 10.1086/423903; Christoforidis S, 2000, METHODS, V20, P403, DOI 10.1006/meth.2000.0953; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Einstein EB, 2010, J NEUROSCI, V30, P4306, DOI 10.1523/JNEUROSCI.5295-09.2010; Fan YL, 2004, NAT GENET, V36, P989, DOI 10.1038/ng1414; Fliegauf M, 2007, NAT REV MOL CELL BIO, V8, P880, DOI 10.1038/nrm2278; Follit JA, 2010, J CELL BIOL, V188, P21, DOI 10.1083/jcb.200910096; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Jacoby M, 2009, NAT GENET, V41, P1027, DOI 10.1038/ng.427; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Kim JC, 2004, NAT GENET, V36, P462, DOI 10.1038/ng1352; Koenig JH, 1996, J CELL BIOL, V135, P797, DOI 10.1083/jcb.135.3.797; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lechtreck KF, 2009, J CELL BIOL, V187, P1117, DOI 10.1083/jcb.200909183; Loktev AV, 2008, DEV CELL, V15, P854, DOI 10.1016/j.devcel.2008.11.001; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; MALGAROLI A, 1992, NATURE, V357, P134, DOI 10.1038/357134a0; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Milenkovic L, 2009, J CELL BIOL, V187, P365, DOI 10.1083/jcb.200907126; Moritz OL, 2001, MOL BIOL CELL, V12, P2341, DOI 10.1091/mbc.12.8.2341; Mykytyn K, 2004, P NATL ACAD SCI USA, V101, P8664, DOI 10.1073/pnas.0402354101; Mykytyn K, 2002, NAT GENET, V31, P435, DOI 10.1038/ng935; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; Nachury MV, 2010, ANNU REV CELL DEV BI, V26, P59, DOI 10.1146/annurev.cellbio.042308.113337; Nishimura DY, 2004, P NATL ACAD SCI USA, V101, P16588, DOI 10.1073/pnas.0405496101; Ou GS, 2005, NATURE, V436, P583, DOI 10.1038/nature03818; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Saffarian S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000191; Santagata S, 2001, SCIENCE, V292, P2041, DOI 10.1126/science.1061233; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Seo S, 2010, P NATL ACAD SCI USA, V107, P1488, DOI 10.1073/pnas.0910268107; Seo SJ, 2009, HUM MOL GENET, V18, P1323, DOI 10.1093/hmg/ddp031; Shimoni Y, 2002, METHOD ENZYMOL, V351, P258; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199; Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010; Tam BM, 2000, J CELL BIOL, V151, P1369, DOI 10.1083/jcb.151.7.1369; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	52	406	414	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 25	2010	141	7					1208	U198		10.1016/j.cell.2010.05.015	http://dx.doi.org/10.1016/j.cell.2010.05.015			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	615PV	20603001	Bronze, Green Accepted			2022-12-28	WOS:000279148100017
J	McPherson, K				McPherson, Klim			Screening for breast cancer-balancing the debate	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED-TRIAL; OVERDIAGNOSIS; WOMEN				McPherson, K (corresponding author), Univ Oxford, Oxford OX1 2JD, England.	klim.mcpherson@obs-gyn.ox.ac.uk						Banks E, 2001, J MED SCREEN, V8, P29, DOI 10.1136/jms.8.1.29; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; *CANC RES UK, BREAST CANC FACTS; Duffy SW, 2010, J MED SCREEN, V17, P25, DOI 10.1258/jms.2009.009094; *EL RESP, 2009, ANN INT MED; Flanders J, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b958; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Gotzsche PC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b86; Jorgensen KJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2587; Jorgensen KJ, 2010, BMJ; Kamerow D, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5175; Miller AB, 2000, JNCI-J NATL CANCER I, V92, P1490, DOI 10.1093/jnci/92.18.1490; Moser K, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b2025; Moss S, 2005, BREAST CANCER RES, V7, P230, DOI 10.1186/bcr1314; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Olsen O, 2001, LANCET, V358, P1340, DOI 10.1016/S0140-6736(01)06449-2; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Thompson A, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1983; Welch HG, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b1425; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	20	36	37	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JUN 24	2010	340								c3106	10.1136/bmj.c3106	http://dx.doi.org/10.1136/bmj.c3106			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	618IQ	20576707				2022-12-28	WOS:000279346500001
J	Burns, R				Burns, Robert			Rubbing Against the Late Day	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												geriatricsmemphis@yahoo.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2449	2450		10.1001/jama.2010.802	http://dx.doi.org/10.1001/jama.2010.802			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571001				2022-12-28	WOS:000279010900001
J	Stein, BL; Moliterno, AR				Stein, Brady L.; Moliterno, Alison R.			Primary Myelofibrosis and the Myeloproliferative Neoplasms The Role of Individual Variation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							INTERNATIONAL WORKING GROUP; ESSENTIAL THROMBOCYTHEMIA MYELOFIBROSIS; AGNOGENIC MYELOID METAPLASIA; STEM-CELL TRANSPLANTATION; TYROSINE KINASE JAK2; BONE-MARROW FIBROSIS; POLYCYTHEMIA-VERA; IDIOPATHIC MYELOFIBROSIS; ACTIVATING MUTATION; SCORING SYSTEM	The classic myeloproliferative neoplasms-essential thrombocytosis, polycythemia vera, and primary myelofibrosis-are acquired, clonal hematopoietic stem cell disorders characterized by an overproduction of mature blood cells, bone marrow hypercellularity, extramedullary hematopoiesis, a tendency for thrombosis, and, rarely, leukemic transformation. Despite being classified as neoplastic diseases, the myeloproliferative neoplasms are often characterized by longevity, with survival measured in decades, even in the absence of treatment. Primary myelofibrosis is the rarest of the myeloproliferative neoplasms, is the most obscure with regard to its pathophysiology, and carries the least favorable although highly variable natural history. The identification of molecular lesions specific to the myeloproliferative neoplasms, in particular JAK2 V617F, has broadened understanding of the common features within these disorders and has advanced diagnostic, prognostic, and therapeutic tools. This article highlights the challenges inherent in the management of primary myelofibrosis and presents an opportunity to address the basis of individual variation within a rare and complex disorder. JAMA. 2010; 303(24): 2513-2518	[Stein, Brady L.; Moliterno, Alison R.] Johns Hopkins Univ, Sch Med, Div Hematol, Baltimore, MD 21205 USA	Johns Hopkins University	Moliterno, AR (corresponding author), Johns Hopkins Univ, Sch Med, Div Hematol, Ross Res Bldg 1025,720 Rutland Ave, Baltimore, MD 21205 USA.	amoliter@jhmi.edu			National Institutes of Health [RO1HL082995, K12HL087169-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL087169, R01HL082995] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grants RO1HL082995 and K12HL087169-03.	Barbui T, 2010, BLOOD, V115, P778, DOI 10.1182/blood-2009-08-238956; Barosi G, 2008, LEUKEMIA, V22, P437, DOI 10.1038/sj.leu.2404914; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Campbell PJ, 2006, NEW ENGL J MED, V355, P2452, DOI 10.1056/NEJMra063728; Cervantes F, 2006, LEUKEMIA, V20, P55, DOI 10.1038/sj.leu.2404048; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Chagraoui H, 2002, BLOOD, V100, P3495, DOI 10.1182/blood-2002-04-1133; DAMESHEK W, 1951, BLOOD, V6, P372, DOI 10.1182/blood.V6.4.372.372; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Dupriez B, 1996, BLOOD, V88, P1013; Guglielmelli P, 2009, BLOOD, V114, P1477, DOI 10.1182/blood-2009-04-216044; Hoffman R, 2009, HEMATOLOGY BASIC PRI; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Jones AV, 2009, NAT GENET, V41, P446, DOI 10.1038/ng.334; Kilpivaara O, 2009, NAT GENET, V41, P455, DOI 10.1038/ng.342; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kroger N, 2007, EXP HEMATOL, V35, P1719, DOI 10.1016/j.exphem.2007.08.022; Kuter DJ, 2007, BRIT J HAEMATOL, V139, P351, DOI 10.1111/j.1365-2141.2007.06807.x; Kutlar A, 2007, HEMOGLOBIN, V31, P209, DOI 10.1080/03630260701290233; Lambert JR, 2009, BLOOD, V114, P3018, DOI 10.1182/blood-2009-03-209916; Lambert JR, 2009, BRIT J HAEMATOL, V145, P128, DOI 10.1111/j.1365-2141.2009.07597.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lussana F, 2009, THROMB RES, V124, pE19, DOI [10.1016/j.thromres.2009.02.004, 10.1016/j.thromres.2009.06.031]; Macdonald D, 2007, PATHOBIOLOGY, V74, P81, DOI 10.1159/000101707; Mesa RA, 1999, AM J HEMATOL, V61, P10, DOI 10.1002/(SICI)1096-8652(199905)61:1<10::AID-AJH3>3.3.CO;2-9; Mesa RA, 2007, LEUKEMIA RES, V31, P737, DOI 10.1016/j.leukres.2006.12.002; Mesa RA, 2009, LEUKEMIA RES, V33, P1199, DOI 10.1016/j.leukres.2009.01.035; Mesa RA, 2009, BLOOD, V113, P5394, DOI 10.1182/blood-2009-02-195974; Moliterno AR, 2008, EXP HEMATOL, V36, P1480, DOI 10.1016/j.exphem.2008.05.006; Moliterno AR, 2006, BLOOD, V108, P3913, DOI 10.1182/blood-2006-03-008805; Olcaydu D, 2009, NAT GENET, V41, P450, DOI 10.1038/ng.341; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Rollison DE, 2008, BLOOD, V112, P45, DOI 10.1182/blood-2008-01-134858; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Stein BL, 2010, HAEMATOL-HEMATOL J, V95, P1090, DOI 10.3324/haematol.2009.014407; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; Thiele J, 2005, HISTOL HISTOPATHOL, V20, P879, DOI 10.14670/HH-20.879; Tiedt R, 2008, BLOOD, V111, P3931, DOI 10.1182/blood-2007-08-107748; Vaidya R, 2009, MAYO CLIN PROC, V84, P1114, DOI 10.4065/mcp.2009.0543; Vannucchi AM, 2008, LEUKEMIA, V22, pCP5, DOI 10.1038/leu.2008.113; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verstovsek S, 2009, THERAPEUTIC POTENTIA; WINTROBE MM, 1981, WINTROBES CLIN HEMAT	43	12	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JUN 23	2010	303	24					2513	2518		10.1001/jama.2010.853	http://dx.doi.org/10.1001/jama.2010.853			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	613VM	20571018				2022-12-28	WOS:000279010900029
J	Du, SD; Mao, YL; Sang, XT; Lu, X; Yang, ZY; Zhong, SX; Huang, JF				Du, Shunda; Mao, Yilei; Sang, Xinting; Lu, Xin; Yang, Zhiying; Zhong, Shouxian; Huang, Jiefu			Bleeding ectopics	LANCET			English	Editorial Material									[Du, Shunda; Mao, Yilei; Sang, Xinting; Lu, Xin; Yang, Zhiying; Zhong, Shouxian; Huang, Jiefu] Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Liver Surg, Beijing 100730, Peoples R China; [Du, Shunda; Mao, Yilei; Sang, Xinting; Lu, Xin; Yang, Zhiying; Zhong, Shouxian; Huang, Jiefu] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Mao, YL (corresponding author), Beijing Union Med Coll Hosp, Chinese Acad Med Sci, Dept Liver Surg, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China.	pumchliver@hotmail.com			CMB [06-837]	CMB	A CMB grant (06-837) was used to help support writing the report.	Harry Rachael, 2002, Curr Opin Crit Care, V8, P164, DOI 10.1097/00075198-200204000-00013; KINKHABWALA M, 1977, AM J ROENTGENOL, V129, P514, DOI 10.2214/ajr.129.3.514; Norton ID, 1998, HEPATOLOGY, V28, P1154, DOI 10.1002/hep.510280434	3	1	1	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 19	2010	375	9732					2192	2192		10.1016/S0140-6736(10)60633-2	http://dx.doi.org/10.1016/S0140-6736(10)60633-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	617BF	20609951				2022-12-28	WOS:000279255100030
J	Erne, BV; Exner, C; Frauenfelder, T; Schmid, S; Weder, W				Erne, Barbara V.; Exner, Carolin; Frauenfelder, Thomas; Schmid, Simone; Weder, Walter			A curious case of convulsion	LANCET			English	Editorial Material							MANAGEMENT; ABSCESSES		[Erne, Barbara V.; Weder, Walter] Univ Zurich Hosp, Div Thorac Surg, CH-8091 Zurich, Switzerland; [Exner, Carolin] Univ Zurich Hosp, Dept Internal Med Med Oncol, CH-8091 Zurich, Switzerland; [Frauenfelder, Thomas] Univ Zurich Hosp, Dept Med Radiol, Inst Diagnost Radiol, CH-8091 Zurich, Switzerland; [Schmid, Simone] Univ Zurich Hosp, Dept Pathol, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Erne, BV (corresponding author), Univ Zurich Hosp, Div Thorac Surg, Raemistr 100, CH-8091 Zurich, Switzerland.		Frauenfelder, Thomas/O-1734-2016	Frauenfelder, Thomas/0000-0002-3295-6619; Erne, Barbara/0000-0001-7669-8896				Belko J, 2002, PEDIATR INFECT DIS J, V21, P715, DOI 10.1097/00006454-200208000-00002; Kowlessar PI, 2006, J INFECTION, V52, P443, DOI 10.1016/j.jinf.2005.08.028; Moorthy RK, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/6/E3; Tran MP, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-154; WONG CA, 1995, THORAX, V50, P1093, DOI 10.1136/thx.50.10.1093	5	4	4	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JUN 5	2010	375	9730					2050	2050		10.1016/S0140-6736(10)60592-2	http://dx.doi.org/10.1016/S0140-6736(10)60592-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	609WT	20569845				2022-12-28	WOS:000278689600032
J	Shiffman, J				Shiffman, Jeremy			Issue attention in global health: the case of newborn survival	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; 4-MILLION NEONATAL DEATHS; SERVICE-DELIVERY; MORTALITY; INTERVENTIONS; INDIA; CARE; MANAGEMENT; OUTCOMES; DONE		American Univ, Sch Publ Affairs, Washington, DC 20016 USA	American University	Shiffman, J (corresponding author), American Univ, Sch Publ Affairs, 4400 Massachusetts Ave NW, Washington, DC 20016 USA.			Shiffman, Jeremy/0000-0002-1693-4671				Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; BANG AT, 1990, LANCET, V336, P201, DOI 10.1016/0140-6736(90)91733-Q; Baqui AH, 2008, LANCET, V371, P1936, DOI 10.1016/S0140-6736(08)60835-1; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; *BILL M GAT FDN, GRANT SEARCH; *CHILD HLTH RES PR, 1999, RED PER NEON MORT; DADHICH J, 2004, STATE INDIAS NEWBORN; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Haws RA, 2007, HEALTH POLICY PLANN, V22, P193, DOI 10.1093/heapol/czm009; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; *INT HLTH PARTN, CONS MAT NEWB CHILD; Keck ME., 2014, ACTIVISTS BORDERS AD; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Kingdon JohnW., 2003, AGENDAS ALTERNATIVES; Kumar V, 2008, LANCET, V372, P1151, DOI 10.1016/S0140-6736(08)61483-X; Lawn JE, 2006, LANCET, V367, P1541, DOI 10.1016/S0140-6736(06)68587-5; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Lawn JE, 2006, INT J EPIDEMIOL, V35, P706, DOI 10.1093/ije/dyl043; Lawn JE, 2009, INT J GYNECOL OBSTET, V107, pS5, DOI 10.1016/j.ijgo.2009.07.016; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; *PARTN MAT NEWB CH, WHO WE AR; *SAV CHILDR, 2001, STAT WORLDS NEWB REP; Shiffman J, 2007, LANCET, V370, P1370, DOI 10.1016/S0140-6736(07)61579-7; Sines BE., 2006, MATERNAL NEWBORN CHI; STONE DA, 1989, POLIT SCI QUART, V104, P281, DOI 10.2307/2151585; UNICEF W. H. O, 2006, PNEUM FORG KILL CHIL; United Nations Children's Fund (UNICEF), 2014, STATE WORLDS CHILDRE; World Health Organization, 2006, NEON PER MORT COUNTR; World Health Organization, 2005, WORLD HLTH REP 2005; World Health Organization (WHO), 2007, NEON PER MORT COUNTR; Yin R. K., 1994, CASE STUDY RES DESIG	32	106	108	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 5	2010	375	9730					2045	2049		10.1016/S0140-6736(10)60710-6	http://dx.doi.org/10.1016/S0140-6736(10)60710-6			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	609WT	20569844				2022-12-28	WOS:000278689600031
J	Schlessinger, J				Schlessinger, J			Cell signaling by receptor tyrosine kinases	CELL			English	Review							EPIDERMAL GROWTH-FACTOR; PLECKSTRIN HOMOLOGY DOMAIN; HIGH-AFFINITY BINDING; SRC FAMILY KINASES; PROTEIN-KINASE; CRYSTAL-STRUCTURE; INOSITOL PHOSPHATES; INSULIN-RECEPTOR; PHOSPHORYLATION; ACTIVATION		NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA; NYU Med Ctr, Skirball Inst, New York, NY 10016 USA	New York University; New York University	Schlessinger, J (corresponding author), NYU Med Ctr, Dept Pharmacol, 550 1st Ave, New York, NY 10016 USA.	schlej01@popmail.med.nyu.edu		Lemmon, Mark/0000-0002-3379-5319	NCI NIH HHS [R01 CA125432-05, R01-CA096768, R01 CA096768-05, R01-CA079992, R01 CA125432, R01 CA096768, R01-CA125432, R01 CA079992-13, R01 CA079992] Funding Source: Medline; NIAMS NIH HHS [P50 AR054086, R01 AR051448, R01 AR051448-05, R01-AR051886, R01 AR051886-05, R01 AR051886, R01-AR051448, P50 AR054086-040003, P50-AR054086] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Anderson KE, 1998, CURR BIOL, V8, P684, DOI 10.1016/S0960-9822(98)70274-X; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bolland S, 1998, IMMUNITY, V8, P509, DOI 10.1016/S1074-7613(00)80555-5; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Carpenter G, 1999, J CELL BIOL, V146, P697, DOI 10.1083/jcb.146.4.697; CARR A, 1994, REV MED VIROL, V4, P5, DOI 10.1002/rmv.1980040104; Casci T, 1999, CANCER METAST REV, V18, P181, DOI 10.1023/A:1006313122373; COCHET C, 1984, J BIOL CHEM, V259, P2553; Czech MP, 2000, CELL, V100, P603, DOI 10.1016/S0092-8674(00)80696-0; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; DAVIS RJ, 1985, P NATL ACAD SCI USA, V82, P1974, DOI 10.1073/pnas.82.7.1974; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Caestecker MP, 1998, GENE DEV, V12, P1587, DOI 10.1101/gad.12.11.1587; Edidin M, 1997, CURR OPIN STRUC BIOL, V7, P528, DOI 10.1016/S0959-440X(97)80117-0; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Falasca M, 1998, EMBO J, V17, P414, DOI 10.1093/emboj/17.2.414; Fambrough D, 1999, CELL, V97, P727, DOI 10.1016/S0092-8674(00)80785-0; Ferguson KM, 2000, EMBO J, V19, P4632, DOI 10.1093/emboj/19.17.4632; FERGUSON KM, 1995, CELL, V83, P1037, DOI 10.1016/0092-8674(95)90219-8; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Fruman DA, 1999, CELL, V97, P817, DOI 10.1016/S0092-8674(00)80792-8; Gamett DC, 1997, J BIOL CHEM, V272, P12052, DOI 10.1074/jbc.272.18.12052; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gomperts SN, 1996, CELL, V84, P659, DOI 10.1016/S0092-8674(00)81043-0; Hackel PO, 1999, CURR OPIN CELL BIOL, V11, P184, DOI 10.1016/S0955-0674(99)80024-6; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; HONEGGER AM, 1990, MOL CELL BIOL, V10, P4035, DOI 10.1128/MCB.10.8.4035; Huang GC, 1998, BIOCHEM J, V331, P113, DOI 10.1042/bj3310113; Hubbard SR, 1997, EMBO J, V16, P5572, DOI 10.1093/emboj/16.18.5572; HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0; Hubbard SR, 1998, J BIOL CHEM, V273, P11987, DOI 10.1074/jbc.273.20.11987; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; HUNTER T, 1980, P NATL ACAD SCI-BIOL, V77, P1311, DOI 10.1073/pnas.77.3.1311; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; JAYE M, 1992, BIOCHIM BIOPHYS ACTA, V1135, P185, DOI 10.1016/0167-4889(92)90136-Y; Jiang GQ, 1999, CURR BIOL, V9, pR568, DOI 10.1016/S0960-9822(99)80357-1; Jin MH, 2000, MOL CELL BIOL, V20, P2098, DOI 10.1128/MCB.20.6.2098-2107.2000; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jordan JD, 2000, CELL, V103, P193, DOI 10.1016/S0092-8674(00)00112-4; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; KARIN M, 1995, CURR BIOL, V5, P747, DOI 10.1016/S0960-9822(95)00151-5; KIM HK, 1991, CELL, V65, P435, DOI 10.1016/0092-8674(91)90461-7; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kossiakoff AA, 1999, ADV PROTEIN CHEM, V52, P67; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Kretzschmar M, 1997, NATURE, V389, P618, DOI 10.1038/39348; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Lee SR, 1998, J BIOL CHEM, V273, P15366, DOI 10.1074/jbc.273.25.15366; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; LEMMON MA, 1995, P NATL ACAD SCI USA, V92, P10472, DOI 10.1073/pnas.92.23.10472; Lemmon MA, 2000, BIOCHEM J, V350, P1, DOI 10.1042/0264-6021:3500001; LEMMON MA, 1994, TRENDS BIOCHEM SCI, V19, P459, DOI 10.1016/0968-0004(94)90130-9; Lemmon MA, 1996, CELL, V85, P621, DOI 10.1016/S0092-8674(00)81022-3; Levchenko A, 2000, P NATL ACAD SCI USA, V97, P5818, DOI 10.1073/pnas.97.11.5818; Luttrell LM, 1999, CURR OPIN CELL BIOL, V11, P177, DOI 10.1016/S0955-0674(99)80023-4; Madhani HD, 1998, TRENDS GENET, V14, P151, DOI 10.1016/S0168-9525(98)01425-5; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; Margolis B, 1999, TRENDS ENDOCRIN MET, V10, P262, DOI 10.1016/S1043-2760(99)00168-X; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; MASKI MD, 1998, FRONT BIOSCI, V3, pD781; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Mohammadi M, 1996, CELL, V86, P577, DOI 10.1016/S0092-8674(00)80131-2; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PAWSON T, 1993, CURR BIOL, V3, P434, DOI 10.1016/0960-9822(93)90350-W; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Plotnikov AN, 2000, CELL, V101, P413, DOI 10.1016/S0092-8674(00)80851-X; QIAN XL, 1994, P NATL ACAD SCI USA, V91, P1500, DOI 10.1073/pnas.91.4.1500; Rameh LE, 1999, J BIOL CHEM, V274, P8347, DOI 10.1074/jbc.274.13.8347; Rodrigues GA, 2000, MOL CELL BIOL, V20, P1448, DOI 10.1128/MCB.20.4.1448-1459.2000; Sahni M, 1999, GENE DEV, V13, P1361, DOI 10.1101/gad.13.11.1361; SCHLESSINGER J, 1988, TRENDS BIOCHEM SCI, V13, P443, DOI 10.1016/0968-0004(88)90219-8; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLESSINGER J, 1994, CURR OPIN GENET DEV, V4, P25, DOI 10.1016/0959-437X(94)90087-6; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; Sun X, 1999, GENE DEV, V13, P1834, DOI 10.1101/gad.13.14.1834; SUN XJ, 1993, MOL CELL BIOL, V13, P7418, DOI 10.1128/MCB.13.12.7418; Teruel MN, 2000, CELL, V103, P181, DOI 10.1016/S0092-8674(00)00109-4; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Tzahar E, 1997, EMBO J, V16, P4938, DOI 10.1093/emboj/16.16.4938; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; VANOBBERGHEN E, 1994, DIABETOLOGIA, V37, pS125, DOI 10.1007/BF00400836; WADA T, 1990, CELL, V61, P1339, DOI 10.1016/0092-8674(90)90697-D; WANG F, 1995, J BIOL CHEM, V270, P10231, DOI 10.1074/jbc.270.17.10231; WASKIEWICZ AJ, 1995, CURR OPIN CELL BIOL, V7, P798, DOI 10.1016/0955-0674(95)80063-8; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0; Zhang ZJ, 1998, RNA, V4, P394; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	108	3805	4013	16	427	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	OCT 13	2000	103	2					211	225		10.1016/S0092-8674(00)00114-8	http://dx.doi.org/10.1016/S0092-8674(00)00114-8			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	363YB	20602996	Bronze			2022-12-28	WOS:000089864300006
